PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lawson, TG; Gronros, DL; Evans, PE; Bastien, MC; Michalewich, KM; Clark, JK; Edmonds, JH; Graber, KH; Werner, JA; Lurvey, BA; Cate, JM				Lawson, TG; Gronros, DL; Evans, PE; Bastien, MC; Michalewich, KM; Clark, JK; Edmonds, JH; Graber, KH; Werner, JA; Lurvey, BA; Cate, JM			Identification and characterization of a protein destruction signal in the encephalomyocarditis virus 3C protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END RULE PATHWAY; HEPATITIS-A VIRUS; UBIQUITIN-CONJUGATING ENZYME; MEDIATED PROTEOLYTIC SYSTEM; AMINO-ACID-SEQUENCES; SACCHAROMYCES-CEREVISIAE; RECOGNITION COMPONENT; NUCLEOTIDE-SEQUENCE; CYCLIN DEGRADATION; RNA-POLYMERASE	The amino acid sequence LLVRGRTLW, which is probably located in a strand-turn-strand structure, has been identified as a protein destruction signal in the rapidly degraded encephalomyocarditis virus 3C protease. Mutations within this sequence reduced the susceptibility of the 3C protease toward ubiquitination and degradation in rabbit reticulocyte lysate. This signal is transferable, since poliovirus 3C protease, which is a poor ubiquitin-mediated proteolytic system substrate, was found to be ubiquitinated and degraded when the signal sequence was either generated at an internal location in the protein or fused to the N terminus. An evaluation of the behavior of 3C protease proteins containing mutations in the signal region indicates that considerable variability in the primary structure is tolerated, although the conservation of certain features appears to be required for signal function. Two E3 ubiquitin-protein ligases that recognize the encephalomyocarditis virus 3C protease as a substrate were also partially purified. One of these was identified as the previously described E3 alpha, and this was shown to require the destruction signal sequence to catalyze efficiently the ubiquitination of the 3C protease. The other is a UbcB-dependent E3 that appears to recognize a different, unidentified feature of the 3C protease.	Bates Coll, Dept Chem, Lewiston, ME 04240 USA		Lawson, TG (corresponding author), Bates Coll, Dept Chem, Lewiston, ME 04240 USA.							ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Funabiki H, 1997, EMBO J, V16, P5977, DOI 10.1093/emboj/16.19.5977; GAUSSMULLER V, 1991, VIROLOGY, V182, P861, DOI 10.1016/0042-6822(91)90630-T; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Gladding RL, 1997, BIOCHEM BIOPH RES CO, V238, P119, DOI 10.1006/bbrc.1997.7251; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; HATEBORER G, 1996, GENE DEV, V10, P2969; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; HERSHKO A, 1986, J BIOL CHEM, V261, P1992; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; KAPLON T, 1995, J BIOL CHEM, V270, P20742, DOI 10.1074/jbc.270.35.20742; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Klotzbucher A, 1996, EMBO J, V15, P3053, DOI 10.1002/j.1460-2075.1996.tb00668.x; KORNITZER D, 1994, EMBO J, V13, P6021, DOI 10.1002/j.1460-2075.1994.tb06948.x; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; KRAUSSLICH HG, 1988, BIOCHIMIE, V70, P119, DOI 10.1016/0300-9084(88)90166-6; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; LAWSON TG, 1994, J BIOL CHEM, V269, P28429; LAWSON TG, 1989, J VIROL, V63, P5013, DOI 10.1128/JVI.63.12.5013-5022.1989; MADURA K, 1994, SCIENCE, V265, P1454, DOI 10.1126/science.8073290; MATTHEWS DA, 1994, CELL, V77, P761, DOI 10.1016/0092-8674(94)90059-0; MAYER AN, 1989, BIOCHEMISTRY-US, V28, P166, DOI 10.1021/bi00427a024; Mosimann SC, 1997, J MOL BIOL, V273, P1032, DOI 10.1006/jmbi.1997.1306; Nielsen KH, 1997, MOL CELL BIOL, V17, P7132, DOI 10.1128/MCB.17.12.7132; NISHIZAWA M, 1993, EMBO J, V12, P4021, DOI 10.1002/j.1460-2075.1993.tb06080.x; OBERST MD, 1993, VIROLOGY, V193, P28, DOI 10.1006/viro.1993.1100; PALMENBERG AC, 1990, ANNU REV MICROBIOL, V44, P603, DOI 10.1146/annurev.mi.44.100190.003131; PALMENBERG AC, 1984, NUCLEIC ACIDS RES, V12, P2969, DOI 10.1093/nar/12.6.2969; PAUL AV, 1987, VIRUS RES, V8, P153, DOI 10.1016/0168-1702(87)90026-8; RACANIELLO VR, 1981, P NATL ACAD SCI-BIOL, V78, P4887, DOI 10.1073/pnas.78.8.4887; REISS Y, 1989, J BIOL CHEM, V264, P10378; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Roth AF, 1998, J CELL BIOL, V142, P949, DOI 10.1083/jcb.142.4.949; Ryan MD, 1997, J GEN VIROL, V78, P699, DOI 10.1099/0022-1317-78-4-699; SADIS S, 1995, MOL CELL BIOL, V15, P4086; SALAMA SR, 1994, MOL CELL BIOL, V14, P7953, DOI 10.1128/MCB.14.12.7953; Schauber C, 1998, GENES CELLS, V3, P307, DOI 10.1046/j.1365-2443.1998.00192.x; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Scheffner M., 1998, UBIQUITIN BIOL CELL, P65; Schwarz SE, 1998, J BIOL CHEM, V273, P12148, DOI 10.1074/jbc.273.20.12148; SOKOLIK CW, 1991, J BIOL CHEM, V266, P9100; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; TESER M, 1994, VIROLOGY, V198, P524; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; TSURUMI C, 1995, MOL CELL BIOL, V15, P5682; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; YAGLOM J, 1995, MOL CELL BIOL, V15, P731; YPMAWONG MF, 1987, J VIROL, V61, P3181, DOI 10.1128/JVI.61.10.3181-3189.1987	61	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9871	9880		10.1074/jbc.274.14.9871	http://dx.doi.org/10.1074/jbc.274.14.9871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092683	hybrid			2022-12-27	WOS:000079451800098
J	Forgac, M				Forgac, M			Structure and properties of the vacuolar (H+)-ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							VESICLE PROTON PUMP; SITE-DIRECTED MUTAGENESIS; YEAST V-ATPASE; H+-ATPASE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; TRANSLOCATING ATPASE; MUTATIONAL ANALYSIS; NEUROSPORA-CRASSA; PLASMA-MEMBRANE		Tufts Univ, Sch Med, Dept Cellular & Mol Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Cellular & Mol Physiol, 136 Harrison Ave, Boston, MA 02111 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 34478, R01 GM034478] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ADACHI I, 1990, J BIOL CHEM, V265, P967; ANRAKU Y, 1992, J BIOENERG BIOMEMBR, V24, P395, DOI 10.1007/BF00762532; ARAI H, 1988, J BIOL CHEM, V263, P8796; Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065; BIRKENHAGER R, 1995, EUR J BIOCHEM, V230, P58, DOI 10.1111/j.1432-1033.1995.tb20534.x; Boekema EJ, 1997, P NATL ACAD SCI USA, V94, P14291, DOI 10.1073/pnas.94.26.14291; BOWMAN EJ, 1995, BBA-BIOMEMBRANES, V1237, P95, DOI 10.1016/0005-2736(95)00108-F; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BOWMAN J, 1996, MYCOTA, V3, P57; CAIN BD, 1988, J BIOL CHEM, V263, P6606; CHATTERJEE D, 1992, P NATL ACAD SCI USA, V89, P6257, DOI 10.1073/pnas.89.14.6257; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Crider BP, 1997, J BIOL CHEM, V272, P10721; Cross RL, 1996, J BIOENERG BIOMEMBR, V28, P403, DOI 10.1007/BF02113981; CROSS RL, 1990, FEBS LETT, V259, P227, DOI 10.1016/0014-5793(90)80014-A; DSCHIDA WJ, 1992, J BIOL CHEM, V267, P18783; DSCHIDA WJA, 1995, J BIOL CHEM, V270, P1557, DOI 10.1074/jbc.270.4.1557; FENG Y, 1992, J BIOL CHEM, V267, P5817; FENG Y, 1992, J BIOL CHEM, V267, P19769; FENG Y, 1994, J BIOL CHEM, V269, P13224; Fillingame RH, 1997, J EXP BIOL, V200, P217; Forgac M, 1999, J BIOL CHEM, V274, P1301, DOI 10.1074/jbc.274.3.1301; Forgac M, 1998, FEBS LETT, V440, P258, DOI 10.1016/S0014-5793(98)01425-2; GLUCK SL, 1992, J BIOENERG BIOMEMBR, V24, P351, DOI 10.1007/BF00762528; GOLDSTEIN DJ, 1991, NATURE, V352, P347, DOI 10.1038/352347a0; GOTTLIEB RA, 1995, P NATL ACAD SCI USA, V92, P5965, DOI 10.1073/pnas.92.13.5965; Graham LA, 1998, J CELL BIOL, V142, P39, DOI 10.1083/jcb.142.1.39; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; HO MN, 1993, J BIOL CHEM, V268, P18286; HOLZENBURG A, 1993, EUR J BIOCHEM, V213, P21, DOI 10.1111/j.1432-1033.1993.tb17730.x; Junge W, 1996, BER BUNSEN PHYS CHEM, V100, P2014, DOI 10.1002/bbpc.19961001215; KANE PM, 1995, J BIOL CHEM, V270, P17025; KANE PM, 1992, J BIOL CHEM, V267, P447; KLIONSKY DJ, 1992, J BIOL CHEM, V267, P3416; Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; Liu Q, 1996, J BIOL CHEM, V271, P2018, DOI 10.1074/jbc.271.4.2018; Liu Q, 1997, J BIOL CHEM, V272, P11750, DOI 10.1074/jbc.272.18.11750; MacLeod KJ, 1998, J BIOL CHEM, V273, P150, DOI 10.1074/jbc.273.1.150; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; MORIYAMA Y, 1992, J EXP BIOL, V172, P171; Muller ML, 1997, J BIOL CHEM, V272, P12762, DOI 10.1074/jbc.272.19.12762; NELSON H, 1995, P NATL ACAD SCI USA, V92, P497, DOI 10.1073/pnas.92.2.497; NELSON N, 1992, J BIOENERG BIOMEMBR, V24, P407, DOI 10.1007/BF00762533; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ogilvie I, 1997, J BIOL CHEM, V272, P16652, DOI 10.1074/jbc.272.26.16652; Oluwatosin YE, 1997, J BIOL CHEM, V272, P28149, DOI 10.1074/jbc.272.44.28149; PERIN MS, 1991, J BIOL CHEM, V266, P3877; PUOPOLO K, 1992, J BIOL CHEM, V267, P5171; Sahagian G. Gary, 1994, P275; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; SWALLOW CJ, 1993, J CELL PHYSIOL, V157, P453, DOI 10.1002/jcp.1041570304; Tomashek JJ, 1997, J BIOL CHEM, V272, P26787, DOI 10.1074/jbc.272.42.26787; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Vasilyeva E, 1996, J BIOL CHEM, V271, P12775, DOI 10.1074/jbc.271.22.12775; VIK SB, 1994, J BIOL CHEM, V269, P30364; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803; WIECZOREK H, 1991, J BIOL CHEM, V266, P15340; Wilkens S, 1998, NATURE, V393, P29, DOI 10.1038/29908; ZHANG JM, 1995, J BIOL CHEM, V270, P15494, DOI 10.1074/jbc.270.26.15494; ZHANG JM, 1994, J BIOL CHEM, V269, P23518	67	248	259	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					12951	12954		10.1074/jbc.274.19.12951	http://dx.doi.org/10.1074/jbc.274.19.12951			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224039	hybrid			2022-12-27	WOS:000080200400001
J	Cooke, DW; Lane, MD				Cooke, DW; Lane, MD			The transcription factor nuclear factor I mediates repression of the GLUT4 promoter by insulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; GLUCOSE-TRANSPORTER GLUT4; TRANSGENIC MICE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; EUKARYOTIC TRANSCRIPTION; PROTEIN PROMOTER; BINDING PROTEIN; ADIPOSE-TISSUE; EXPRESSION; GENE	Insulin represses GLUT4 expression in 3T3-L1 adipocytes through an insulin response element located at bases -706 to -676 in the 5'-flanking sequence. Nuclear proteins related to the nuclear factor I (NF1) family of transcription factors bind to this insulin response element. Mutations that disrupt binding of NF1 proteins to the insulin response element impair the insulin response in reporter gene assays. Insulin treatment of 3T3-L1 adipocytes induces a rapid change in the level of phosphorylation of NF1 proteins, providing a potential mechanism for insulin's ability to regulate gene expression through NF1. Another as yet unidentified protein, not related to NF1, also binds to the GLUT4 insulin response element and is able to mediate partial repression of the GLUT4 promoter in reporter gene assays.	Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University	Cooke, DW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, 600 N Wolfe St, Baltimore, MD 21287 USA.				NIDDK NIH HHS [DK14575, DK02223] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K11DK002223, R01DK014575] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BODEN G, 1996, DIABETES, V46, P3; Candeliere GA, 1996, MOL CELL BIOL, V16, P584; CARDINAUX JR, 1994, J BIOL CHEM, V269, P32947; CHAN CP, 1988, P NATL ACAD SCI USA, V85, P6257, DOI 10.1073/pnas.85.17.6257; CHEN BW, 1994, BIOTECHNIQUES, V17, P657; Cooke DW, 1998, J BIOL CHEM, V273, P6210, DOI 10.1074/jbc.273.11.6210; Darne CH, 1997, MOL CELL ENDOCRINOL, V132, P13, DOI 10.1016/S0303-7207(97)00116-0; DEEMS RO, 1994, DIABETOLOGIA, V37, P1097, DOI 10.1007/s001250050222; FLORESRIVEROS JR, 1993, P NATL ACAD SCI USA, V90, P512, DOI 10.1073/pnas.90.2.512; Fukuda H, 1997, FEBS LETT, V406, P243, DOI 10.1016/S0014-5793(97)00219-6; GIBBS EM, 1995, J CLIN INVEST, V95, P1512, DOI 10.1172/JCI117823; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAVES RA, 1991, GENE DEV, V5, P428, DOI 10.1101/gad.5.3.428; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; IKEMOTO S, 1995, P NATL ACAD SCI USA, V92, P3096, DOI 10.1073/pnas.92.8.3096; INOUE T, 1990, J BIOL CHEM, V265, P19065; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; JACOB KK, 1995, J BIOL CHEM, V270, P27773, DOI 10.1074/jbc.270.46.27773; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KAHN BB, 1992, J CLIN INVEST, V89, P1367, DOI 10.1172/JCI115724; Kahn BB, 1996, DIABETES, V45, P1644, DOI 10.2337/diabetes.45.11.1644; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; KRUSE U, 1994, FEBS LETT, V348, P46, DOI 10.1016/0014-5793(94)00585-0; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; LIU ML, 1993, P NATL ACAD SCI USA, V90, P11346, DOI 10.1073/pnas.90.23.11346; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; OBRIEN RM, 1994, J BIOL CHEM, V269, P30419; OBRIEN RM, 1995, MOL CELL BIOL, V15, P1747; Ouyang LH, 1996, J BIOL CHEM, V271, P10425, DOI 10.1074/jbc.271.18.10425; Roder K, 1997, J BIOL CHEM, V272, P21616, DOI 10.1074/jbc.272.34.21616; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; SRINIVASAN M, 1994, J BIOL CHEM, V269, P16662; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; STEPHENS JM, 1995, ENDOCR REV, V16, P529, DOI 10.1210/er.16.4.529; Streicher R, 1996, J BIOL CHEM, V271, P7128, DOI 10.1074/jbc.271.12.7128; WANG D, 1995, J BIOL CHEM, V270, P28716, DOI 10.1074/jbc.270.48.28716; Wang D, 1997, J BIOL CHEM, V272, P26367, DOI 10.1074/jbc.272.42.26367; YANG BS, 1993, MOL CELL BIOL, V13, P3093, DOI 10.1128/MCB.13.5.3093	40	61	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12917	12924		10.1074/jbc.274.18.12917	http://dx.doi.org/10.1074/jbc.274.18.12917			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212282	hybrid			2022-12-27	WOS:000080056800102
J	Dupuy, F; Petit, JM; Mollicone, R; Oriol, R; Julien, R; Maftah, A				Dupuy, F; Petit, JM; Mollicone, R; Oriol, R; Julien, R; Maftah, A			A single amino acid in the hypervariable stem domain of vertebrate alpha 1,3/1,4-fucosyltransferases determines the type 1 type 2 transfer - Characterization of acceptor substrate specificity of the Lewis enzyme by site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA(1,3)FUCOSYLTRANSFERASE GENE; FUCOSYL-TRANSFERASE; MOLECULAR-CLONING; HUMAN ALPHA-1,3/4-FUCOSYL-TRANSFERASES; ALPHA(1,3)-FUCOSYL-TRANSFERASE GENE; HUMAN ALPHA-1,3-FUCOSYL-TRANSFERASE-V; HELICOBACTER-PYLORI; SEQUENCE ALIGNMENT; EXPRESSION CLONING; SELECTIN LIGANDS	Alignment of 15 vertebrate alpha 1,3-fucosyltransferases revealed one arginine conserved in all the enzymes employing exclusively type 2 acceptor substrates. At the equivalent position, a tryptophan was found in FUT3-encoded Lewis alpha 1,3/1,4-fucosyltransferase (Fuc-TIII) and FUT5-encoded alpha 1,3/1,4-fucosyltransferase, the only fucosyltransferases that can also transfer fucose in alpha 1,4-linkage, The single amino acid substitution Trp(111) --> Arg in Fuc-TIII was sufficient to change the specificity of fucose transfer from H-type 1 to H-type 2 accepters. The additional mutation of Asp(112) --> Glu increased the type 2 activity of the double mutant Fuc-TIII enzyme, but the single substitution of the acidic residue Asp(112) in Fuc-TIII by Glu decreased the activity of the enzyme and did not interfere with H-type 1/H-type 2 specificity. In contrast, substitution of Arg(115) in bovine futb-encoded alpha 1,3-fucosyltransferase (Fuc-Tb) by Trp generated a protein unable to transfer fucose either on H-type 1 or H-type 2 accepters. However, the double mutation Arg(115) --> TrP/Glu(116) --> Asp of Fuc-Tb slightly increased H-type 1 activity. The acidic residue adjacent to the candidate amino acid Trp/Arg seems to modulate the relative type 1/type 2 acceptor specificity, and its presence is necessary for enzyme activity since its substitution by the corresponding amide inactivated both Fuc-TIII and Fuc-Tb enzymes.	Univ Limoges, Fac Sci, Inst Biotechnol, F-87060 Limoges, France; Univ Paris 11, INSERM U504, F-94807 Villejuif, France	Universite de Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Maftah, A (corresponding author), Univ Limoges, Fac Sci, Inst Biotechnol, 123 Ave Albert Thomas, F-87060 Limoges, France.	maftah@unilim.fr						BERG EL, 1992, BIOCHEM BIOPH RES CO, V184, P1048, DOI 10.1016/0006-291X(92)90697-J; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breton C, 1996, GLYCOBIOLOGY, V6, pR7; Breton C, 1998, GLYCOBIOLOGY, V8, P87, DOI 10.1093/glycob/8.1.87; Britten CJ, 1997, BBA-GEN SUBJECTS, V1334, P57, DOI 10.1016/S0304-4165(96)00076-1; CANDELIER JJ, 1993, LAB INVEST, V69, P449; CHANDRASEKARAN EV, 1995, BIOCHEMISTRY-US, V34, P4748, DOI 10.1021/bi00014a032; Costache M, 1997, J BIOL CHEM, V272, P29721, DOI 10.1074/jbc.272.47.29721; DeBose-Boyd RA, 1998, GLYCOBIOLOGY, V8, P905, DOI 10.1093/glycob/8.9.905; DEVRIES T, 1995, J BIOL CHEM, V270, P8712, DOI 10.1074/jbc.270.15.8712; DeVries T, 1997, GLYCOBIOLOGY, V7, P921, DOI 10.1093/glycob/7.7.921; Du M, 1996, CARBOHYD RES, V286, P87, DOI 10.1016/0008-6215(96)00047-X; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; GALLETPF, 1998, GLYCOBIOLOGY, V8, P919; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Ge ZM, 1997, J BIOL CHEM, V272, P21357, DOI 10.1074/jbc.272.34.21357; GERSTEN KM, 1995, J BIOL CHEM, V270, P25047, DOI 10.1074/jbc.270.42.25047; GOELZ SE, 1990, CELL, V63, P1349, DOI 10.1016/0092-8674(90)90430-M; Hakomori S, 1997, CHEM BIOL, V4, P97, DOI 10.1016/S1074-5521(97)90253-2; HENDRICKSON TL, 1995, BIOCHEMISTRY-US, V34, P9444, DOI 10.1021/bi00029a020; HINDSGAUL O, 1991, J BIOL CHEM, V266, P17858; Kudo T, 1998, J BIOL CHEM, V273, P26729, DOI 10.1074/jbc.273.41.26729; KUKOWSKALATALLO JF, 1990, GENE DEV, V4, P1288, DOI 10.1101/gad.4.8.1288; Lee KP, 1996, J BIOL CHEM, V271, P32960, DOI 10.1074/jbc.271.51.32960; LEGAULT DJ, 1995, J BIOL CHEM, V270, P20987, DOI 10.1074/jbc.270.36.20987; LOWE JB, 1990, CELL, V63, P475, DOI 10.1016/0092-8674(90)90444-J; Martin SL, 1997, J BIOL CHEM, V272, P21349, DOI 10.1074/jbc.272.34.21349; MOLLICONE R, 1994, J BIOL CHEM, V269, P20987; Murray BW, 1997, BIOCHEMISTRY-US, V36, P823, DOI 10.1021/bi962284z; Murray BW, 1996, BIOCHEMISTRY-US, V35, P11183, DOI 10.1021/bi961065a; Nguyen AT, 1998, J BIOL CHEM, V273, P25244, DOI 10.1074/jbc.273.39.25244; Oriol R, 1999, GLYCOBIOLOGY, V9, P323, DOI 10.1093/glycob/9.4.323; Oriol R., 1995, BLOOD CEL B, P37; Oulmouden A, 1997, J BIOL CHEM, V272, P8764, DOI 10.1074/jbc.272.13.8764; SajdelSulkowska EM, 1997, GLYCOCONJUGATE J, V14, P249, DOI 10.1023/A:1018550023637; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAKI K, 1994, J BIOL CHEM, V269, P14730; Sherwood AL, 1998, J BIOL CHEM, V273, P25256, DOI 10.1074/jbc.273.39.25256; Smith PL, 1996, J BIOL CHEM, V271, P8250, DOI 10.1074/jbc.271.14.8250; Smith SL, 1997, BIOCHEM SOC T, V25, pS630, DOI 10.1042/bst025s630; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vo L, 1998, J BIOL CHEM, V273, P25250, DOI 10.1074/jbc.273.39.25250; WESTON BW, 1992, J BIOL CHEM, V267, P4152; WESTON BW, 1992, J BIOL CHEM, V267, P24575; Xu XH, 1996, J BIOL CHEM, V271, P8818, DOI 10.1074/jbc.271.15.8818	45	64	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12257	12262		10.1074/jbc.274.18.12257	http://dx.doi.org/10.1074/jbc.274.18.12257			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212193	hybrid			2022-12-27	WOS:000080056800013
J	Pfennig, F; Schauwecker, F; Keller, U				Pfennig, F; Schauwecker, F; Keller, U			Molecular characterization of the genes of actinomycin synthetase I and of a 4-methyl-3-hydroxyanthranilic acid carrier protein involved in the assembly of the acylpeptide chain of actinomycin in Streptomyces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; YERSINIA-PESTIS; BIOSYNTHESIS; EXPRESSION; ENTEROBACTIN; PURIFICATION; CLONING; ENZYME; CHRYSOMALLUS	Actinomycin synthetase I (ACMS I) activates 4-methyl-3-hydroxyanthranilic acid, the precursor of the chromophoric moiety of the actinomycin, as adenylate, The gene acmA of ACMS I was identified upstream of the genes acmB and acmC encoding the two peptide synthetases ACMS II and ACMS III, respectively, which assemble the pentapeptide lactone rings of the antibiotic. Sequence analysis and expression of acmA in Streptomyces lividans as enzymatically active hexa-His-fusion confirmed the acmA gene product to be ACMS I. An open reading frame of 234 base pairs (acmD), which encodes a 78-amino acid protein with similarity to various acyl carrier proteins, is located downstream of acmA. The acmD gene was expressed in Escherichia coli as hexa-His-fusion protein (Acm acyl carrier protein (AcmACP)), ACMS I in the presence of ATP acylated the purified AcmACP with radioactive p-toluic acid, used as substrate in place of 4-MHA Only 10% of the AcmACP from E. coli was acylated, suggesting insufficient modification with 4'-phosphopantetheine cofactor. Incubation of this AcmACP with a holo-ACP synthase and coenzyme A quantitatively established the hole-form of AcmACP. Enzyme assays in the presence of ACMS II showed that toluyl-AcmACP directly acylated the thioester-bound threonine on ACMS II. Thus, AcmACP is a 4-MHA carrier protein in the peptide chain initiation of actinomycin synthesis.	Tech Univ Berlin, Max Volmer Inst Biophys Chem & Biochem, Fachgebiet Biochem & Mol Biol, D-10587 Berlin, Germany	Technical University of Berlin	Keller, U (corresponding author), Tech Univ Berlin, Max Volmer Inst Biophys Chem & Biochem, Fachgebiet Biochem & Mol Biol, Franklinstr 29, D-10587 Berlin, Germany.							August PR, 1998, CHEM BIOL, V5, P69, DOI 10.1016/S1074-5521(98)90141-7; Bearden SW, 1997, INFECT IMMUN, V65, P1659, DOI 10.1128/IAI.65.5.1659-1668.1997; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Debabov DV, 1996, J BACTERIOL, V178, P3869, DOI 10.1128/jb.178.13.3869-3876.1996; deCrecyLagard V, 1997, J BACTERIOL, V179, P705, DOI 10.1128/jb.179.3.705-713.1997; FREI E, 1974, CANCER CHEMOTH REP 1, V58, P49; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P2648, DOI 10.1021/bi9726584; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P11637, DOI 10.1021/bi9812571; GUILVOUT I, 1995, J BACTERIOL, V177, P1780, DOI 10.1128/jb.177.7.1780-1787.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HEATON MP, 1994, J BACTERIOL, V176, P681, DOI 10.1128/jb.176.3.681-690.1994; Hopwood D.A., 1985, GENETIC MANIPULATION; JONES GH, 1997, BIOTECHNOLOGY ANTIBI, P187; KATZ E, 1962, J BIOL CHEM, V237, P882; KATZ E, 1983, J GEN MICROBIOL, V129, P2703; Katz E., 1967, ANTIBIOTICS, V2, P276; KELLER U, 1987, J BIOL CHEM, V262, P5852; KELLER U, 1984, BIOCHEMISTRY-US, V23, P1479, DOI 10.1021/bi00302a022; KELLER U, 1984, J BIOL CHEM, V259, P8226; KELLER U, 1992, J BIOL CHEM, V267, P11745; KELLER U, 1995, PETPIDOLACTONES, P71; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LI Y, 1990, GENE, V91, P9, DOI 10.1016/0378-1119(90)90156-L; LOYOZA E, 1988, EUR J BIOCHEM, V176, P661; MARAHIEL MA, 1992, FEBS LETT, V307, P40, DOI 10.1016/0014-5793(92)80898-Q; Meienhofer J, 1973, Adv Appl Microbiol, V16, P203, DOI 10.1016/S0065-2164(08)70028-5; Motamedi H, 1998, EUR J BIOCHEM, V256, P528, DOI 10.1046/j.1432-1327.1998.2560528.x; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RUSNAK F, 1991, BIOCHEMISTRY-US, V30, P2916, DOI 10.1021/bi00225a027; RUSNAK F, 1989, BIOCHEMISTRY-US, V28, P6827, DOI 10.1021/bi00443a008; RUSNAK F, 1990, BIOCHEMISTRY-US, V29, P1425, DOI 10.1021/bi00458a013; Sambrook J., 2002, MOL CLONING LAB MANU; Schauwecker F, 1998, J BACTERIOL, V180, P2468, DOI 10.1128/JB.180.9.2468-2474.1998; STAAB JF, 1989, FEMS MICROBIOL LETT, V59, P15; Staunton J, 1997, CHEM REV, V97, P2611, DOI 10.1021/cr9600316; STINDL A, 1994, BIOCHEMISTRY-US, V33, P9358, DOI 10.1021/bi00197a041; STINDL A, 1993, J BIOL CHEM, V268, P10612; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	41	32	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12508	12516		10.1074/jbc.274.18.12508	http://dx.doi.org/10.1074/jbc.274.18.12508			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212227	hybrid			2022-12-27	WOS:000080056800047
J	Togawa, A; Morinaga, N; Ogasawara, M; Moss, J; Vaughan, M				Togawa, A; Morinaga, N; Ogasawara, M; Moss, J; Vaughan, M			Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST GOLGI-APPARATUS; CHOLERA-TOXIN; HOMOLOGY DOMAINS; PHOSPHOLIPASE-D; SEC7 DOMAIN; ARF; CYTOHESIN-1; PLECKSTRIN; EXPRESSION; TRANSPORT	Activation of ADP-ribosylation factors (ARFs), similar to 20-kDa guanine nucleotide-binding proteins that play an important role in intracellular vesicular trafficking, depends on guanine nucleotide-exchange proteins (GEPs), which accelerate replacement of bound GDP with GTP. Two major families of ARF GEPs are known: similar to 200-kDa molecules that are inhibited by brefeldin A (BFA), a fungal metabolite that blocks protein secretion and causes apparent disintegration of Golgis structure, and similar to 50-kDa GEPs that are insensitive to BFA. We describe here two human brain cDNAs that encode BFA-inhibited GEPs. One is a similar to 209-kDa protein 99.5% identical in deduced amino acid sequence (1,849 residues) to a BFA-inhibited ARF GEP (p200) from bovine brain. The other smaller protein, which is similar to 74% identical (1,785 amino acids), represents a previously unknown gene. We propose that the former, p200, be named BIG1 for (brefeldin A-inhibited GEP1) and the second, which encodes a similar to 202-kDa protein, BIG2. A protein containing sequences found in BIG2 had been purified earlier from bovine brain. Human tissues contained a 7.5-kilobase BIG1 mRNA and a 9.4-kilobase BIG2 transcript. The BIG1 and BIG2 genes were localized, respectively, to chromosomes 8 and 20, BIG2, synthesized as a His, fusion protein in Sf9 cells, accelerated guanosine 5'-3-O-(thio)triphosphate binding by recombinant ARF1, ARF5, and ARF6, It activated native ARF (mixture of ARF1 and ARF3) more effectively than it did any of the nonmyristoylated recombinant ARFs, BIG2 activity was inhibited by BFA in a concentration-dependent manner but not by B17, a structural analog without effects on Golgi function. Although several clones for similar to 50-kDa BFA-insensitive ARF GEPs are known, these new clones for the similar to 200-kDa BIG1 and BIG2 should facilitate characterization of this rather different family of proteins as well as the elucidation of mechanisms of regulation of BFA-sensitive ARF function in Golgi transport.	NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Togawa, A (corresponding author), NHLBI, Pulm Crit Care Med Branch, NIH, Rm 5N-307,Bldg 10,10 Ctr Dr,MSC 1434, Bethesda, MD 20892 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000627, Z01HL000656, Z01HL000627, Z01HL000638] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACHSTETTER T, 1988, J BIOL CHEM, V263, P11711; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Franco M, 1998, P NATL ACAD SCI USA, V95, P9926, DOI 10.1073/pnas.95.17.9926; FRANZUSOFF A, 1989, EMBO J, V8, P2695, DOI 10.1002/j.1460-2075.1989.tb08410.x; Godi A, 1998, P NATL ACAD SCI USA, V95, P8607, DOI 10.1073/pnas.95.15.8607; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Hemmings BA, 1997, SCIENCE, V275, P1899, DOI 10.1126/science.275.5308.1899; KAHN RA, 1984, J BIOL CHEM, V259, P6228; Klarlund JK, 1998, J BIOL CHEM, V273, P1859, DOI 10.1074/jbc.273.4.1859; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LIU L, 1992, BIOCHIM BIOPHYS ACTA, V1132, P75, DOI 10.1016/0167-4781(92)90055-5; Meacci E, 1997, P NATL ACAD SCI USA, V94, P1745, DOI 10.1073/pnas.94.5.1745; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Morinaga N, 1997, P NATL ACAD SCI USA, V94, P12926, DOI 10.1073/pnas.94.24.12926; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; MOSS J, 1995, J BIOL CHEM, V270, P12327, DOI 10.1074/jbc.270.21.12327; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Pacheco-Rodriguez G, 1998, J BIOL CHEM, V273, P26543, DOI 10.1074/jbc.273.41.26543; Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Sata M, 1998, P NATL ACAD SCI USA, V95, P4204, DOI 10.1073/pnas.95.8.4204; Telemenakis I, 1997, EUR J CELL BIOL, V74, P143; TSUCHIYA M, 1991, J BIOL CHEM, V266, P2772; WELSH CF, 1994, MOL CELL BIOCHEM, V138, P157, DOI 10.1007/BF00928458	28	118	123	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12308	12315		10.1074/jbc.274.18.12308	http://dx.doi.org/10.1074/jbc.274.18.12308			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212200	hybrid			2022-12-27	WOS:000080056800020
J	Imanaka, T; Aihara, K; Takano, T; Yamashita, A; Sato, R; Suzuki, Y; Yokota, S; Osumi, T				Imanaka, T; Aihara, K; Takano, T; Yamashita, A; Sato, R; Suzuki, Y; Yokota, S; Osumi, T			Characterization of the 70-kDa peroxisomal membrane protein, an ATP binding cassette transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; CLOFIBRATE-TREATED RATS; FATTY-ACID OXIDATION; SACCHAROMYCES-CEREVISIAE; ABC-TRANSPORTER; BETA-OXIDATION; 3-KETOACYL-COA THIOLASE; ZELLWEGER-SYNDROME; LIVER PEROXISOMES; SIGNAL PEPTIDE	The 70-kDa peroxisomal membrane protein (PMP70) is one of the major components of rat liver peroxisomal membranes and belongs to a superfamily of proteins known as ATP binding cassette transporters. PMP70 is markedly induced by administration of hypolipidemic agents in parallel with peroxisome proliferation and induction of peroxisomal fatty acid beta-oxidation enzymes, To characterize the role of PMP70 in biogenesis and function of peroxisomes, we transfected the cDNA of rat PMP70 into Chinese hamster ovary cells and established cell lines stably expressing PMP70. The content of PMP70 in the transfectants increased about 5-fold when compared with the control cells. A subcellular fractionation study showed that overexpressed PMP70 was enriched in peroxisomes, This peroxisomal localization was confirmed by immunofluorescence and immunoelectron microscopy. The number of immune-gold particles corresponding to PMP70 on peroxisomes increased markedly in the transfectants, but the size and the number of peroxisomes were essentially the same in both the transfectants and the control cells. beta-Oxidation of palmitic acid increased about 2-3-fold in the transfectants, whereas the oxidation of lignoceric acid decreased about 30-40%. When intact peroxisomes prepared from both the cell lines were incubated with palmitoyl-CoA, oxidation was stimulated with ATP, but the degree of the stimulation was higher in the transfectants than in the control cells. Furthermore, we established three Chinese hamster ovary cell lines stably expressing mutant PMP70. In these cells, beta-oxidation of palmitic acid decreased markedly, These results suggest that PMP70 is involved in metabolic transport of long chain acyl-CoA across peroxisomal membranes and that increase of PMP70 is not associated with proliferation of peroxisomes.	Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Dept Biol Chem, Toyama 9300194, Japan; Teikyo Univ, Fac Pharmaceut Sci, Dept Microbiol & Mol Pathol, Kanagawa 1990145, Japan; Teikyo Univ, Fac Pharmaceut Sci, Dept Hyg Chem & Nutr, Kanagawa 1990145, Japan; Osaka Univ, Grad Sch Pharmaceut Sci, Biochem & Mol Biol Lab, Osaka 5650871, Japan; Gifu Univ, Sch Med, Dept Pediat, Gifu 5008076, Japan; Yamanashi Med Univ, Biol Lab, Yamanashi 4903898, Japan; Himeji Inst Technol, Dept Life Sci, Kamigori, Hyogo 6781297, Japan	University of Toyama; Teikyo University; Teikyo University; Osaka University; Gifu University; University of Yamanashi; University of Hyogo	Imanaka, T (corresponding author), Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Dept Biol Chem, 2630 Sugitani, Toyama 9300194, Japan.	imanaka@ms.toyama-mpu.ac.jp		Yamashita, Atsushi/0000-0002-2544-2134; Imanaka, Tsuneo/0000-0003-4677-1356				Aubourg P, 1996, ANN NY ACAD SCI, V804, P461, DOI 10.1111/j.1749-6632.1996.tb18637.x; BOSSIER P, 1994, YEAST, V10, P681, DOI 10.1002/yea.320100512; DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323; DICZFALUSY U, 1990, J LIPID RES, V31, P307; DRAYE JP, 1988, EUR J BIOCHEM, V178, P183, DOI 10.1111/j.1432-1033.1988.tb14442.x; FARRANTS AKO, 1989, BIOCHIM BIOPHYS ACTA, V1002, P198, DOI 10.1016/0005-2760(89)90287-7; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; HARTL FU, 1987, ARCH BIOCHEM BIOPHYS, V255, P109, DOI 10.1016/0003-9861(87)90300-6; HASHIMOTO T, 1986, J BIOCHEM-TOKYO, V100, P301, DOI 10.1093/oxfordjournals.jbchem.a121716; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V237, P152, DOI 10.1006/bbrc.1997.7102; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V239, P261, DOI 10.1006/bbrc.1997.7391; Imanaka T, 1996, J BIOL CHEM, V271, P3706; IMANAKA T, 1991, BIOCHIM BIOPHYS ACTA, V1062, P264, DOI 10.1016/0005-2736(91)90401-S; JEDLITSCHKY G, 1991, J BIOL CHEM, V266, P24763; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; KAMIJO K, 1992, BIOCHIM BIOPHYS ACTA, V1129, P323, DOI 10.1016/0167-4781(92)90510-7; Kawabe Y, 1998, CELL STRUCT FUNCT, V23, P187, DOI 10.1247/csf.23.187; KERPPOLA RE, 1992, J BIOL CHEM, V267, P2329; KOSTER W, 1992, MOL GEN GENET, V232, P399; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; MANNAERTS GP, 1979, J BIOL CHEM, V254, P4585; MANNAERTS GP, 1982, BIOCHEM J, V204, P17, DOI 10.1042/bj2040017; Moser HW, 1995, METABOLIC MOL BASES, V7h, P2325; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; OMOTE H, 1992, J BIOL CHEM, V267, P20571; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; PAHAN K, 1995, J LIPID RES, V36, P986; Paton BC, 1997, AM J HUM GENET, V60, P1535; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Shan N, 1996, J BIOL CHEM, V271, P8725, DOI 10.1074/jbc.271.15.8725; Shani N, 1997, HUM MOL GENET, V6, P1925, DOI 10.1093/hmg/6.11.1925; SHANI N, 1995, P NATL ACAD SCI USA, V92, P6012, DOI 10.1073/pnas.92.13.6012; SMALL GM, 1988, ANAL BIOCHEM, V169, P405, DOI 10.1016/0003-2697(88)90304-1; SUZUKI Y, 1991, BIOCHEM PHARMACOL, V41, P453, DOI 10.1016/0006-2952(91)90544-F; Swartzman EE, 1996, J CELL BIOL, V132, P549, DOI 10.1083/jcb.132.4.549; THOMAS J, 1980, BIOCHEM J, V190, P485, DOI 10.1042/bj1900485; TSUKAMOTO T, 1994, J BIOL CHEM, V269, P6001; TURNBULL DM, 1984, BIOCHEM PHARMACOL, V33, P475, DOI 10.1016/0006-2952(84)90243-0; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; VANVELDHOVEN PP, 1987, J BIOL CHEM, V262, P4310; Verhoeven NM, 1997, J LIPID RES, V38, P2062; Verleur N, 1997, EUR J BIOCHEM, V249, P657, DOI 10.1111/j.1432-1033.1997.00657.x; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WOLVETANG EJ, 1990, BIOCHEM BIOPH RES CO, V170, P1135, DOI 10.1016/0006-291X(90)90511-K; YOKOTA S, 1982, ANN NY ACAD SCI, V386, P491, DOI 10.1111/j.1749-6632.1982.tb21460.x	50	76	76	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11968	11976		10.1074/jbc.274.17.11968	http://dx.doi.org/10.1074/jbc.274.17.11968			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207018	hybrid			2022-12-27	WOS:000079834800074
J	Kim, SY; Hwang, KY; Kim, SH; Sung, HC; Han, YS; Cho, YJ				Kim, SY; Hwang, KY; Kim, SH; Sung, HC; Han, YS; Cho, YJ			Structural basis for cold adaptation - Sequence, biochemical properties, and crystal structure of malate dehydrogenase from a psychrophile Aquaspirillium arcticum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE CITRATE SYNTHASE; ESCHERICHIA-COLI; LACTATE-DEHYDROGENASE; ANTARCTIC BACTERIUM; RESOLUTION; ENZYMES; THERMOSTABILITY; PURIFICATION; EXPRESSION; STABILITY	Aquaspillium arcticum is a psychrophilic bacterium that was isolated from arctic sediment and grows optimally at 4 degrees C, We have cloned, purified, and characterized malate dehydrogenase from A. arcticum (Aa MDH). We also have determined the crystal structures of apo-Aa MDH, Aa MDH.NADH binary complex, and Aa MDH.NAD.oxaloacetate ternary complex at 1.9-, 2.1-, and 2.5-Angstrom resolutions, respectively. The Aa MDH sequence is most closely related to the sequence of a thermophilic MDH from Thermus flavus (Tf MDH), showing 61% sequence identity and over 90% sequence similarity. Stability studies show that Aa MDH has a half-life of 10 min at 55 degrees C, whereas Tf MDH is fully active at 90 degrees C for 1 h. Aa MDH shows 2-3-fold higher catalytic efficiency compared with a mesophilic or a thermophilic MDH at the temperature range 4-10 degrees C. Structural comparison of Aa MDH and Tf MDH suggests that the increased relative flexibility of active site residues, favorable surface charge distribution for substrate and cofactor, and the reduced intersubunit ion pair interactions may be the major factors for the efficient catalytic activity of Aa MDH at low temperatures.	Korea Inst Sci & Technol, Struct Biol Ctr, Seoul 130650, South Korea; Korea Univ, Dept Biotechnol, Seoul, South Korea; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	Korea Institute of Science & Technology (KIST); Korea University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cho, YJ (corresponding author), Korea Inst Sci & Technol, Struct Biol Ctr, POB 131, Seoul 130650, South Korea.							ABADZAPATERO C, 1987, J MOL BIOL, V198, P445, DOI 10.1016/0022-2836(87)90293-2; BIRKTOFT JJ, 1989, BIOCHEMISTRY-US, V28, P6065, DOI 10.1021/bi00440a051; Bonisch H, 1996, ARCH BIOCHEM BIOPHYS, V333, P75, DOI 10.1006/abbi.1996.0366; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Danson MJ, 1997, COMP BIOCHEM PHYS A, V117, P307, DOI 10.1016/S0300-9629(96)00268-X; DAVAIL S, 1994, J BIOL CHEM, V269, P17448; DUNN CR, 1991, PHILOS T ROY SOC B, V332, P177, DOI 10.1098/rstb.1991.0047; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Feller G, 1997, CELL MOL LIFE SCI, V53, P830, DOI 10.1007/s000180050103; FELLER G, 1994, EUR J BIOCHEM, V222, P441, DOI 10.1111/j.1432-1033.1994.tb18883.x; Feller G, 1996, FEMS MICROBIOL REV, V18, P189, DOI 10.1016/0168-6445(96)00011-3; Frolow F, 1996, NAT STRUCT BIOL, V3, P452, DOI 10.1038/nsb0596-452; Gerike U, 1997, EUR J BIOCHEM, V248, P49, DOI 10.1111/j.1432-1033.1997.00049.x; GLEASON WB, 1994, BIOCHEMISTRY-US, V33, P2078, DOI 10.1021/bi00174a014; Goldman A, 1995, STRUCTURE, V3, P1277, DOI 10.1016/S0969-2126(01)00263-5; GOWARD CR, 1994, PROTEIN SCI, V3, P1883, DOI 10.1002/pro.5560031027; HALL MD, 1993, J MOL BIOL, V232, P213, DOI 10.1006/jmbi.1993.1377; HALL MD, 1992, J MOL BIOL, V226, P867, DOI 10.1016/0022-2836(92)90637-Y; HERBERT RA, 1992, TRENDS BIOTECHNOL, V10, P395, DOI 10.1016/0167-7799(92)90282-Z; JORDAN DC, 1979, CAN J MICROBIOL, V25, P947, DOI 10.1139/m79-144; KELLY CA, 1993, BIOCHEMISTRY-US, V32, P3913, DOI 10.1021/bi00066a010; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KORNDORFER I, 1995, J MOL BIOL, V246, P511, DOI 10.1006/jmbi.1994.0103; LETHERBARROW RJ, 1987, ENZFITTER NONLINEAR; Lim JH, 1997, J MOL BIOL, V270, P259, DOI 10.1006/jmbi.1997.1105; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Russell RJM, 1998, STRUCTURE, V6, P351, DOI 10.1016/S0969-2126(98)00037-9; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; SILVERSTEIN E, 1969, BIOCHEMISTRY-US, V8, P2543, DOI 10.1021/bi00834a042; Tsigos I, 1998, EUR J BIOCHEM, V254, P356, DOI 10.1046/j.1432-1327.1998.2540356.x; Xu D, 1997, J MOL BIOL, V265, P68, DOI 10.1006/jmbi.1996.0712; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9	33	136	146	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11761	11767		10.1074/jbc.274.17.11761	http://dx.doi.org/10.1074/jbc.274.17.11761			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206992	hybrid			2022-12-27	WOS:000079834800048
J	Okajima, T; Fukumoto, S; Miyazaki, H; Ishida, H; Kiso, M; Furukawa, K; Urano, T; Furukawa, K				Okajima, T; Fukumoto, S; Miyazaki, H; Ishida, H; Kiso, M; Furukawa, K; Urano, T; Furukawa, K			Molecular cloning of a novel alpha 2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA(1,3)FUCOSYLTRANSFERASE GENE; EXPRESSION CLONING; GAL-BETA-1,3GALNAC ALPHA-2,3-SIALYLTRANSFERASE; LEWIS-X; GAL-BETA-1,3(4)GLCNAC ALPHA-2,3-SIALYLTRANSFERASE; GALNAC ALPHA-2,6-SIALYLTRANSFERASE; SUBSTRATE SPECIFICITIES; MONOCLONAL-ANTIBODY; MASS-SPECTROMETRY; HUMAN CDNA	A novel member of the human CMP-NeuAc:beta-galacto side alpha 2,3-sialyltransferase (ST) subfamily, designated ST3Gal VI, was identified based on BLAST analysis of expressed sequence tags, and a cDNA clone was isolated from a human melanoma line library. The sequence of ST3Gal VI encoded a type II membrane protein with 2 amino acids of cytoplasmic domain, 32 amino acids of transmembrane region, and a large catalytic domain with 297 amino acids; and showed homology to previously cloned ST3Gal III, ST3Gal IV, and ST3Gal V at 34, 38, and 33%, respectively. Extracts from L cells transfected with ST3Gal VI cDNA in a expression vector and a fusion protein with protein A showed an enzyme activity of alpha 2,3-sialyltransferase toward Gal beta 1,4GlcNAc structure on glycoproteins and glycolipids, In contrast to ST3Gal III and ST3Gal IV, this enzyme exhibited restricted substrate specificity, i.e. it utilized Gal beta 1,4GlcNAc on glycoproteins, and neolactotetraosylceramide and neolactohexaosylceramide, but not lactotetraosylceramide, lactosylceramide, or asialo-GM1. Consequently, these data indicated that this enzyme is involved in the synthesis of sialyl-paragloboside, a precursor of sialyl-Lewis X determinant.	Nagoya Univ, Sch Med, Dept Biochem, Nagoya, Aichi 4660065, Japan; Nagasaki Univ, Sch Dent, Dept Pediat Dent, Nagasaki 8528501, Japan; Gifu Univ, Fac Agr, Dept Appl Bioorgan Chem, Gifu 5011193, Japan	Nagoya University; Nagasaki University; Gifu University	Furukawa, K (corresponding author), Nagoya Univ, Sch Med, Dept Biochem 2, Showa Ku, 65 Tsurumai, Nagoya, Aichi 466, Japan.	koichi@med.nagoya-u.ac.jp	Okajima, Tetsuya/I-7332-2014	Okajima, Tetsuya/0000-0002-3677-648X; Fukumoto, Satoshi/0000-0002-5046-6891; Urano, Takeshi/0000-0003-3383-3554				DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; Datta AK, 1998, J BIOL CHEM, V273, P9608, DOI 10.1074/jbc.273.16.9608; FURUKAWA K, 1988, J BIOL CHEM, V263, P14939; GILLESPIE W, 1992, J BIOL CHEM, V267, P21004; GOELZ SE, 1990, CELL, V63, P1349, DOI 10.1016/0092-8674(90)90430-M; GRUNDMANN U, 1990, NUCLEIC ACIDS RES, V18, P667, DOI 10.1093/nar/18.3.667; HAKOMORI S, 1991, CURR OPIN IMMUNOL, V3, P646, DOI 10.1016/0952-7915(91)90091-E; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; HARAGUCHI M, 1994, P NATL ACAD SCI USA, V91, P10455, DOI 10.1073/pnas.91.22.10455; HIRABAYASHI Y, 1985, J BIOL CHEM, V260, P3328; Ishii A, 1998, J BIOL CHEM, V273, P31652, DOI 10.1074/jbc.273.48.31652; IUPAC-IUB Commission on Biochemical Nomenclature, 1977, LIPIDS, V12, P455; KAWASHIMA H, 1993, J BIOL CHEM, V268, P27118; Kim YJ, 1996, BIOCHEM BIOPH RES CO, V228, P324, DOI 10.1006/bbrc.1996.1660; KITAGAWA H, 1994, J BIOL CHEM, V269, P1394; KITAGAWA H, 1993, BIOCHEM BIOPH RES CO, V194, P375, DOI 10.1006/bbrc.1993.1830; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kono M, 1997, GLYCOBIOLOGY, V7, P469, DOI 10.1093/glycob/7.4.469; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KUKOWSKALATALLO JF, 1990, GENE DEV, V4, P1288, DOI 10.1101/gad.4.8.1288; Kurosawa N, 1996, J BIOL CHEM, V271, P15109, DOI 10.1074/jbc.271.25.15109; KUROSAWA N, 1994, J BIOL CHEM, V269, P1402; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE YC, 1994, J BIOL CHEM, V269, P10028; MCEVER RP, 1994, CURR OPIN IMMUNOL, V6, P75, DOI 10.1016/0952-7915(94)90037-X; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; Miyamoto D, 1995, BIOCHEM BIOPH RES CO, V217, P852, DOI 10.1006/bbrc.1995.2850; Miyazaki H, 1997, J BIOL CHEM, V272, P24794, DOI 10.1074/jbc.272.40.24794; NAGATA Y, 1992, J BIOL CHEM, V267, P12082; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; NARA K, 1994, P NATL ACAD SCI USA, V91, P7952, DOI 10.1073/pnas.91.17.7952; NARIMATSU H, 1986, P NATL ACAD SCI USA, V83, P4720, DOI 10.1073/pnas.83.13.4720; PAULSON JC, 1989, TRENDS BIOCHEM SCI, V14, P272, DOI 10.1016/0968-0004(89)90062-5; SASAKI K, 1993, J BIOL CHEM, V268, P22782; SASAKI K, 1994, J BIOL CHEM, V269, P14730; SASAKI S, 1994, EXP NEPHROL, V2, P269; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; Schwientek T, 1998, J BIOL CHEM, V273, P29331, DOI 10.1074/jbc.273.45.29331; Sjoberg ER, 1996, J BIOL CHEM, V271, P7450, DOI 10.1074/jbc.271.13.7450; SPIRO RG, 1974, J BIOL CHEM, V249, P5704; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STAMENKOVIC I, 1990, J EXP MED, V172, P641, DOI 10.1084/jem.172.2.641; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; TAKI T, 1994, ANAL BIOCHEM, V221, P312, DOI 10.1006/abio.1994.1418; TAKI T, 1988, LIPIDS, V23, P192, DOI 10.1007/BF02535457; THAMPOE IJ, 1989, CANCER RES, V49, P6258; Tsuji S, 1996, GLYCOBIOLOGY, V6, pR5; TSUJI T, 1986, CARBOHYD RES, V151, P391, DOI 10.1016/S0008-6215(00)90358-6; VALKI A, 1994, P NATL ACAD SCI USA, V91, P7390; VARKI A, 1992, Current Opinion in Cell Biology, V4, P257, DOI 10.1016/0955-0674(92)90041-A; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13835; WEN DX, 1992, J BIOL CHEM, V267, P21011; WESTON BW, 1992, J BIOL CHEM, V267, P4152; WESTON BW, 1992, J BIOL CHEM, V267, P24575; YAMASHIRO S, 1995, J BIOL CHEM, V270, P6149, DOI 10.1074/jbc.270.11.6149	55	130	140	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11479	11486		10.1074/jbc.274.17.11479	http://dx.doi.org/10.1074/jbc.274.17.11479			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206952	hybrid			2022-12-27	WOS:000079834800008
J	Suzuki, Y; Itakura, M; Kashiwagi, M; Nakamura, N; Matsuki, T; Sakuta, H; Naito, N; Takano, K; Fujita, T; Hirose, S				Suzuki, Y; Itakura, M; Kashiwagi, M; Nakamura, N; Matsuki, T; Sakuta, H; Naito, N; Takano, K; Fujita, T; Hirose, S			Identification by differential display of a hypertonicity-inducible inward rectifier potassium channel highly expressed in chloride cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING K+ CHANNELS; ARBITRARILY PRIMED PCR; CLONING; REGION; RNA; EPITHELIUM; BRAIN; FISH	By using differential mRNA display to monitor the molecular alterations associated with adaptation of euryhaline eels to different salinities, we identified a cDNA fragment strongly induced in seawater eel gills. Cloning of a full-length cDNA and its expression in COS-7 cells indicated that the clone codes for an inward rectifier Rt channel (eKir) of 372 amino acid residues, which has two transmembrane segments and a typical pore-forming region (H5), Only low sequence similarities are present, except the H5 region, compared with other members of the inward rectifier K+ channel family (Kir), Consistent with this divergence in the amino acid sequence, a phylogenetic analysis indicated early divergence and independent evolution of eRir from other members; it is only distantly related to the Kir5.0 subfamily members. RNase protection analysis showed that eKir is highly expressed in the seawater eel gill, kidney, and posterior intestine but very weakly in freshwater eels. Immunohistochemistry of gill sections revealed dense localization of eKir in the chloride cells. Immunoelectron microscopy indicated that eKir is mainly present in the microtubular system in the chloride cell. This location and its salt-inducible nature suggest that the eKir channel cloned here is a novel member of the Kir5.0 subfamily in the Kir family and is implicated in osmoregulation.	Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Showa Univ, Coll Med Sci, Midori Ku, Yokohama, Kanagawa 2268555, Japan; Univ Tokyo, Sch Med, Dept Internal Med 4, Tokyo 1120015, Japan	Tokyo Institute of Technology; Showa University; University of Tokyo	Hirose, S (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.		Nakamura, Nobuhiro/C-4265-2015	Nakamura, Nobuhiro/0000-0002-0249-2665; SUZUKI, YOSHIRO/0000-0003-0010-1867; Matsuki, Taizo/0000-0002-0591-4261				BOND CT, 1994, RECEPTOR CHANNEL, V2, P183; BURRY RW, 1992, J HISTOCHEM CYTOCHEM, V40, P1849, DOI 10.1177/40.12.1453003; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; EVANS DH, 1990, ANNU REV PHYSIOL, V52, P43; Goksoyr A, 1995, Arch Toxicol Suppl, V17, P80; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; INAGAKI N, 1995, J BIOL CHEM, V270, P5691, DOI 10.1074/jbc.270.11.5691; KATAFUCHI T, 1994, EUR J BIOCHEM, V222, P835, DOI 10.1111/j.1432-1033.1994.tb18930.x; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Kubo Y, 1996, J BIOL CHEM, V271, P15729, DOI 10.1074/jbc.271.26.15729; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Loretz C.A., 1995, CELLULAR MOL APPROAC, P25, DOI [10.1016/s1546-5098(08)60241-1, DOI 10.1016/S1546-5098(08)60241-1]; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MCCLELLAND M, 1995, TRENDS GENET, V11, P242, DOI 10.1016/S0168-9525(00)89058-7; MCGLADE J, 1993, EMBO J, V12, P3073, DOI 10.1002/j.1460-2075.1993.tb05976.x; MIZOGUCHI A, 1994, BIOCHEM BIOPH RES CO, V202, P1235, DOI 10.1006/bbrc.1994.2063; NAVARATNAM DS, 1995, J BIOL CHEM, V270, P19238, DOI 10.1074/jbc.270.33.19238; Pessia M, 1996, EMBO J, V15, P2980, DOI 10.1002/j.1460-2075.1996.tb00661.x; PISAM M, 1987, AM J ANAT, V179, P40, DOI 10.1002/aja.1001790106; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; SCHWALBE RA, 1995, J BIOL CHEM, V270, P15336, DOI 10.1074/jbc.270.25.15336; SHIRAI N, 1972, Journal of the Faculty of Science University of Tokyo Section IV Zoology, V12, P385; TAKUMI T, 1995, J BIOL CHEM, V270, P16339, DOI 10.1074/jbc.270.27.16339; WELSH J, 1992, NUCLEIC ACIDS RES, V20, P4965, DOI 10.1093/nar/20.19.4965; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	31	52	57	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11376	11382		10.1074/jbc.274.16.11376	http://dx.doi.org/10.1074/jbc.274.16.11376			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196230	hybrid			2022-12-27	WOS:000079751900098
J	Chen, J; Zou, AR; Splawski, I; Keating, MT; Sanguinetti, MC				Chen, J; Zou, AR; Splawski, I; Keating, MT; Sanguinetti, MC			Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INWARD RECTIFIER; CARDIAC-ARRHYTHMIA; PORE REGION; VOLTAGE-DEPENDENCE; MISSENSE MUTATION; XENOPUS OOCYTES; K+ CHANNELS; INACTIVATION; RECTIFICATION; SPECIFICITY	Mutations in the human ether-a-go-go-related gene (HERG) cause long QT syndrome, an inherited disorder of cardiac repolarization that predisposes affected individuals to life-threatening arrhythmias, HERG encodes the cardiac rapid delayed rectifier potassium channel that mediates repolarization of ventricular action potentials. In this study, we used the oocyte expression system and voltage clamp techniques to determine the functional consequences of eight long QT syndrome-associated mutations located in the amino-terminal region of HERG (F29L, N33T, G53R, R56Q, C66G, H70R, A78P, and L86R), Mutant subunits formed functional channels with altered gating properties when expressed alone in oocytes, Deactivation was accelerated by all mutations. Some mutants shifted the voltage dependence of channel availability to more positive potentials. Voltage ramps indicated that fast deactivation of mutant channels would reduce outward current during the repolarization phase of the cardiac action potential and cause prolongation of the corrected QT interval, QT(c), The amino-terminal region of HERG was recently crystallized and shown to possess a Per-Amt-Sim (PAS) domain. The location of these mutations suggests they may disrupt the PAS domain and interfere with its interaction with the S4-S5 linker of the HERG channel.	Univ Utah, Eccles Inst Human Genet, Dept Med, Div Cardiol, Salt Lake City, UT 84112 USA; Univ Utah, Eccles Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Genet, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Sanguinetti, MC (corresponding author), Univ Utah, Eccles Inst Human Genet, Dept Med, Div Cardiol, 15 N 2030 East,Rm 4220, Salt Lake City, UT 84112 USA.	mike.sanguinetti@hci.utah.edu	Sanguinetti, Michael/AAN-2615-2020		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL052338, R01HL055236] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL55236, HL52338] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akimoto K, 1998, HUM MUTAT, pS184; Benson DW, 1996, CIRCULATION, V93, P1791, DOI 10.1161/01.CIR.93.10.1791; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Dausse E, 1996, J MOL CELL CARDIOL, V28, P1609, DOI 10.1006/jmcc.1996.0151; Dunlap JC, 1998, CURR OPIN GENET DEV, V8, P400, DOI 10.1016/S0959-437X(98)80109-3; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; LeesMiller JP, 1997, CIRC RES, V81, P719; Li XD, 1997, J BIOL CHEM, V272, P705, DOI 10.1074/jbc.272.2.705; London B, 1997, CIRC RES, V81, P870; Nakajima T, 1998, CIRC RES, V83, P415, DOI 10.1161/01.RES.83.4.415; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Pongratz I, 1998, MOL CELL BIOL, V18, P4079, DOI 10.1128/MCB.18.7.4079; Roden DM, 1996, CIRCULATION, V94, P1996, DOI 10.1161/01.CIR.94.8.1996; Rowlands JC, 1997, CRIT REV TOXICOL, V27, P109, DOI 10.3109/10408449709021615; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Satler CA, 1996, AM J MED GENET, V65, P27, DOI 10.1002/(SICI)1096-8628(19961002)65:1<27::AID-AJMG4>3.3.CO;2-J; Satler CA, 1998, HUM GENET, V102, P265, DOI 10.1007/s004390050690; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; SchulzeBahr E, 1995, NEW ENGL J MED, V333, P1783; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Splawski I, 1998, GENOMICS, V51, P86, DOI 10.1006/geno.1998.5361; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; Tanaka T, 1997, CIRCULATION, V95, P565, DOI 10.1161/01.CIR.95.3.565; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang SM, 1997, FEBS LETT, V417, P43, DOI 10.1016/S0014-5793(97)01245-3; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061; Zou AR, 1998, J PHYSIOL-LONDON, V509, P129, DOI 10.1111/j.1469-7793.1998.129bo.x	38	184	189	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10113	10118		10.1074/jbc.274.15.10113	http://dx.doi.org/10.1074/jbc.274.15.10113			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187793	hybrid			2022-12-27	WOS:000079663500032
J	Li, WM; Nagineni, CN; Ge, H; Efiok, B; Chepelinsky, AB; Egwuagu, CE				Li, WM; Nagineni, CN; Ge, H; Efiok, B; Chepelinsky, AB; Egwuagu, CE			Interferon consensus sequence-binding protein is constitutively expressed and differentially regulated in the ocular lens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR FAMILY; TRANSCRIPTION FACTORS; GAMMA-INTERFERON; ALPHA-CRYSTALLIN; GENE-EXPRESSION; TRANSGENIC MICE; HISTONE GENE; ICSBP GENE; IFN; RESPONSES	Interferon signaling is mediated by STATs and interferon regulatory factor (IRF) families of transcription factors. Ten distinct IRFs have been described and most are expressed in a variety of cells except for interferon consensus sequence-binding protein (ICSBP) and lymphoid-specific IRF/Pip that are thought to be exclusively expressed in lymphoid cells. We show here for the first time that ICSBP is constitutively and inducibly expressed in the mouse lens, In contrast to lymphoid cells with exclusive expression of ICSBP in the nucleus, ICSBP is present in both the cytoplasm and nucleus of the lens cell. However, ICSBP in the nucleus is of lower apparent molecular weight. We further show that the ICSBP promoter is constitutively bound by lens nuclear factors and that its activation requires binding of additional factors including STAT1. Furthermore, transcriptional activation of ICSBP gene by interferon gamma is accompanied by selective nuclear localization of ICSBP in proliferating epithelial cells but not in the nuclei of nondividing cells in the lens fiber compartment. Constitutive and inducible expression of ICSBP in the ocular lens and differential regulation of its subcellular localization in the developing lens suggest that ICSBP may have nonimmunity related functions and that the commonly held view that it is lymphoid-specific be modified.	NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA; NEI, Mol & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; NHLBI, Lab Mol Hematol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Egwuagu, CE (corresponding author), NEI, Immunol Lab, NIH, Bldg 10,10-10N116,10 Ctr Dr,1858, Bethesda, MD 20892 USA.				NATIONAL EYE INSTITUTE [Z01EY000253, Z01EY000315, ZIAEY000315] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Dosch E, 1998, GENE, V210, P265, DOI 10.1016/S0378-1119(98)00063-8; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; EGWUAGU CE, 1994, DEV BIOL, V166, P557, DOI 10.1006/dbio.1994.1337; EGWUAGU CE, 1994, INVEST OPHTH VIS SCI, V35, P332; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; GAO CY, 1995, DEV BIOL, V169, P185, DOI 10.1006/dbio.1995.1136; Gao CY, 1997, DEV GENET, V20, P267; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; JUNWIRTH C, 1995, P NATL ACAD SCI USA, V92, P3105; KANNO Y, 1993, MOL CELL BIOL, V13, P3951, DOI 10.1128/MCB.13.7.3951; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Moore DD, 1995, GLOB MOB SURV; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Nelson N, 1996, J IMMUNOL, V156, P3711; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; POLITIS AD, 1994, J IMMUNOL, V152, P2270; SABATH DE, 1990, GENE, V91, P185, DOI 10.1016/0378-1119(90)90087-8; SAUNDERS NA, 1994, J BIOL CHEM, V269, P2016; SAX CM, 1995, EXP EYE RES, V61, P125, DOI 10.1016/S0014-4835(95)80066-2; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHARF R, 1995, J BIOL CHEM, V270, P13063, DOI 10.1074/jbc.270.22.13063; Sharf R, 1997, J BIOL CHEM, V272, P9785; Taniguchi T, 1997, J CELL PHYSIOL, V173, P128, DOI 10.1002/(SICI)1097-4652(199711)173:2<128::AID-JCP8>3.0.CO;2-P; TANIGUCHI T, 1995, J CANCER RES CLIN, V121, P516, DOI 10.1007/BF01197763; VALENTE G, 1992, EUR J IMMUNOL, V22, P2403, DOI 10.1002/eji.1830220933; VAUGHAN PS, 1995, NATURE, V377, P362, DOI 10.1038/377362a0; Vaughan PS, 1997, J MOL MED-JMM, V75, P348, DOI 10.1007/s001090050120; YAMADA T, 1990, CURR EYE RES, V9, P31, DOI 10.3109/02713689009000052; Yamagata T, 1996, MOL CELL BIOL, V16, P1283	36	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9686	9691		10.1074/jbc.274.14.9686	http://dx.doi.org/10.1074/jbc.274.14.9686			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092656	hybrid			2022-12-27	WOS:000079451800075
J	Harvey, KF; Dinudom, A; Komwatana, P; Jolliffe, CN; Day, ML; Parasivam, G; Cook, DI; Kumar, S				Harvey, KF; Dinudom, A; Komwatana, P; Jolliffe, CN; Day, ML; Parasivam, G; Cook, DI; Kumar, S			All three WW domains of murine Nedd4 are involved in the regulation of epithelial sodium channels by intracellular Na+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OOCYTE EXPRESSION SYSTEM; LIDDLES-SYNDROME; CYTOSOLIC NA+; BETA-SUBUNIT; MISSENSE MUTATION; SALIVARY DUCTS; G-PROTEIN; PY MOTIF; HYPERTENSION; IDENTIFICATION	The amiloride-sensitive epithelial sodium channel (ENaC) plays a critical role in fluid and electrolyte homeostasis and consists of alpha, beta, and gamma subunits. The carboxyl terminus of each ENaC subunit contains a PPxY motif which is necessary for interaction with the WW domains of the ubiquitin-protein ligase, Nedd4, Disruption of this interaction, as in Liddle's syndrome where mutations delete or alter the PY motif of either the beta or gamma subunits, results in increased ENac activity. We have recently shown using the whole-cell patch clamp technique that Nedd4 mediates the ubiquitin dependent down-regulation of Na+ channel activity in response to increased intracellular Na+. In this paper, we demonstrate that WW domains 2 and 3 bind alpha-, beta-, and gamma-ENaC with varying degrees of affinity, whereas WW domain 1 does not bind to any of the subunits. We further show using whole-cell patch clamp techniques that Nedd4-mediated down-regulation of ENaC in mouse mandibular duct cells involves binding of the WW domains of Nedd4 to three distinct sites. We propose that Nedd4-mediated down-regulation of Na+ channels involves the binding of WW domains 2 and 3 to the Na+ channel and of WW domain 1 to an unknown associated protein.	Inst Med & Vet Sci, Hanson Ctr Canc Res, Adelaide, SA 5000, Australia; Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia	Institute Medical & Veterinary Science Australia; University of Sydney	Kumar, S (corresponding author), Inst Med & Vet Sci, Hanson Ctr Canc Res, POB 14,Rundle Mall,Frome Rd, Adelaide, SA 5000, Australia.		Harvey, Kieran/AAD-5268-2022; Kumar, Sharad/AAX-7787-2020	Kumar, Sharad/0000-0001-7126-9814; Harvey, Kieran/0000-0001-7845-369X; Day, Margot/0000-0002-8689-7458				Awayda MS, 1997, AM J PHYSIOL-CELL PH, V273, pC1889; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Chan DC, 1996, EMBO J, V15, P1045, DOI 10.1002/j.1460-2075.1996.tb00442.x; DINUDOM A, 1995, J PHYSIOL-LONDON, V487, P549, DOI 10.1113/jphysiol.1995.sp020899; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Farman N, 1997, AM J PHYSIOL-CELL PH, V272, pC131, DOI 10.1152/ajpcell.1997.272.1.C131; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gavva NR, 1997, J BIOL CHEM, V272, P24105, DOI 10.1074/jbc.272.39.24105; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Hatakeyama S, 1997, J BIOL CHEM, V272, P15085, DOI 10.1074/jbc.272.24.15085; Jeunemaitre X, 1997, J HYPERTENS, V15, P1091, DOI 10.1097/00004872-199715100-00007; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Komwatana P, 1998, J MEMBRANE BIOL, V162, P225, DOI 10.1007/s002329900360; Komwatana P, 1996, P NATL ACAD SCI USA, V93, P8107, DOI 10.1073/pnas.93.15.8107; Kosari F, 1998, J BIOL CHEM, V273, P13469, DOI 10.1074/jbc.273.22.13469; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; Matsushita K, 1996, AM J PHYSIOL-LUNG C, V271, pL332, DOI 10.1152/ajplung.1996.271.2.L332; PLANT P, 1997, J BIOL CHEM, V472, P32329; PORONNIK P, 1995, PFLUG ARCH EUR J PHY, V429, P852, DOI 10.1007/BF00374810; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 1997, AM J PHYSIOL-CELL PH, V272, pC1871, DOI 10.1152/ajpcell.1997.272.6.C1871; Tamura H, 1996, J CLIN INVEST, V97, P1780, DOI 10.1172/JCI118606; XU X, 1995, J BIOL CHEM, V270, P19606, DOI 10.1074/jbc.270.33.19606	38	107	109	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12525	12530		10.1074/jbc.274.18.12525	http://dx.doi.org/10.1074/jbc.274.18.12525			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212229	hybrid			2022-12-27	WOS:000080056800049
J	Hernando, Y; Carter, AT; Parr, A; Hove-Jensen, B; Schweizer, M				Hernando, Y; Carter, AT; Parr, A; Hove-Jensen, B; Schweizer, M			Genetic analysis and enzyme activity suggest the existence of more than one minimal functional unit capable of synthesizing phosphoribosyl pyrophosphate in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHETASE-ASSOCIATED PROTEIN; COMPLETE CDNA SEQUENCE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; RAT-LIVER; CATALYTIC SUBUNITS; MOLECULAR-CLONING; PURIFIED ENZYME; PRS; NUCLEOTIDE	The PRS gene family in Saccharomyces cerevisiae consists of five genes each capable of encoding a 5-phosphoribosyl-1(alpha)-pyrophosphate synthetase polypeptide, To gain insight into the functional organization of this gene family we have constructed a collection of strains containing all possible combinations of disruptions in the five PRS genes. Phenotypically these deletant strains can be classified into three groups: (i) a lethal phenotype that corresponds to strains containing a double disruption in PRS2 and PRS4 in combination with a disruption in either PRS1 or PRS3; simultaneous deletion of PRS1 and PRS5 or PRS3 and PRS5 are also lethal combinations; (ii) a second phenotype that is encountered in strains containing disruptions in PRS and PRS3 together or in combination with any of the other PRS genes manifests itself as a reduction in growth rate, enzyme activity, and nucleotide content; (iii) a third phenotype that corresponds to strains that, although affected in their phosphoribosyl pyrophosphate-synthesizing ability, are unimpaired for growth and have nucleotide profiles virtually the same as the mild type. Deletions of PRS2, PRS4, and PRS5 or combinations thereof cause this phenotype, These results suggest that the polypeptides encoded by the members of the PRS gene family may be organized into two functional entities, Evidence that these polypeptides interact with each other in vivo was obtained using the yeast two-hybrid system. Specifically PRS1 and PRS3 polypeptides interact strongly with each other, and there are significant interactions between the PRS5 polypeptide and either the PRS2 or PRS4 polypeptides. These data suggest that yeast phosphoribosyl pyrophosphate synthetase exists in vivo as multimeric complex(es).	Inst Food Res, Dept Genet & Microbiol, Norwich NR4 7UA, Norfolk, England; Univ Copenhagen, Inst Mol Biol, Ctr Enzyme Res, DK-1307 Copenhagen K, Denmark	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Copenhagen	Schweizer, M (corresponding author), Inst Food Res, Dept Genet & Microbiol, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	Michael.Schweizer@bbsrc.ac.uk	Hernando, Yolanda/D-2520-2014	Hernando, Yolanda/0000-0001-7378-9434				Bentsen AK, 1996, PROTEINS, V24, P238, DOI 10.1002/(SICI)1097-0134(199602)24:2<238::AID-PROT10>3.0.CO;2-O; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; BOWER SG, 1988, J BACTERIOL, V170, P3243, DOI 10.1128/jb.170.7.3243-3248.1988; BOWER SG, 1989, J BIOL CHEM, V264, P10287; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARTER AT, 1994, YEAST, V10, P1031, DOI 10.1002/yea.320100805; Carter AT, 1997, MOL GEN GENET, V254, P148, DOI 10.1007/s004380050402; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; FEILOTTER HE, 1994, NUCLEIC ACIDS RES, V22, P1502, DOI 10.1093/nar/22.8.1502; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gallois R, 1997, PLANT PHYSIOL, V115, P847, DOI 10.1104/pp.115.2.847; Gietz R.D., 1994, MOL GENETICS YEAST P, P121; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HENDRICKSON N, 1993, MOL BIOCHEM PARASIT, V59, P15, DOI 10.1016/0166-6851(93)90003-G; Hernando Y, 1998, J BACTERIOL, V180, P6404; Horton P., 1996, P INT SYST MOL BIOL, V4, P109; HOVEJENSEN B, 1986, J BIOL CHEM, V261, P6765; HOVEJENSEN B, 1988, J BACTERIOL, V170, P1148, DOI 10.1128/jb.170.3.1148-1152.1988; HOVEJENSEN B, 1992, J BACTERIOL, V174, P6852, DOI 10.1128/JB.174.21.6852-6856.1992; IIZASA T, 1989, FEBS LETT, V244, P47, DOI 10.1016/0014-5793(89)81159-7; ISHIJIMA S, 1989, NUCLEIC ACIDS RES, V17, P8860, DOI 10.1093/nar/17.21.8860; ISHIJIMA S, 1989, NUCLEIC ACIDS RES, V17, P8859, DOI 10.1093/nar/17.21.8859; Ishizuka T, 1996, BBA-GENE STRUCT EXPR, V1306, P27, DOI 10.1016/0167-4781(96)00030-9; JARORI GK, 1995, EUR J BIOCHEM, V230, P517; JOHNSON DR, 1994, J CELL BIOL, V127, P751, DOI 10.1083/jcb.127.3.751; Kaiser C., 1994, METHODS YEAST GENETI, P209; Katashima R, 1998, BBA-GENE STRUCT EXPR, V1396, P245, DOI 10.1016/S0167-4781(97)00217-0; KHORANA HG, 1958, J BIOL CHEM, V230, P941; KITA K, 1994, J BIOL CHEM, V269, P8334; KITA K, 1989, J BIOCHEM, V105, P736, DOI 10.1093/oxfordjournals.jbchem.a122737; KNOLL LJ, 1995, J BIOL CHEM, V270, P20090, DOI 10.1074/jbc.270.34.20090; Krath BN, 1999, PLANT PHYSIOL, V119, P497, DOI 10.1104/pp.119.2.497; NAGAYA M, 1993, BIOSCI BIOTECH BIOCH, V57, P1958, DOI 10.1271/bbb.57.1958; NILSSON D, 1989, MOL GEN GENET, V218, P565, DOI 10.1007/BF00332425; OCHI K, 1987, J GEN MICROBIOL, V133, P2787; ROESSLER BJ, 1990, NUCLEIC ACIDS RES, V18, P193, DOI 10.1093/nar/18.1.193; Sambrook J., 2002, MOL CLONING LAB MANU; Scherman MS, 1996, J BIOL CHEM, V271, P29652, DOI 10.1074/jbc.271.47.29652; SHIMADA H, 1990, J BIOL CHEM, V265, P3956; SIKORSKI RS, 1989, GENETICS, V122, P19; Sonoda T, 1997, BBA-GENE STRUCT EXPR, V1350, P6, DOI 10.1016/S0167-4781(96)00190-X; Sonoda T, 1997, J BIOCHEM-TOKYO, V122, P635; STRAUCH E, 1991, MOL MICROBIOL, V5, P289, DOI 10.1111/j.1365-2958.1991.tb02109.x; SWITZER RL, 1969, J BIOL CHEM, V244, P2854; TAIRA M, 1990, J BIOL CHEM, V265, P16491; TAIRA M, 1987, J BIOL CHEM, V262, P14867; TAKEDA M, 1995, J BIOCHEM, V118, P607, DOI 10.1093/oxfordjournals.jbchem.a124953; TATIBANA M, 1995, ADV ENZYME REGUL, V35, P229, DOI 10.1016/0065-2571(94)00017-W; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310	54	24	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12480	12487		10.1074/jbc.274.18.12480	http://dx.doi.org/10.1074/jbc.274.18.12480			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212224	hybrid			2022-12-27	WOS:000080056800044
J	Puglielli, L; Mandon, EC; Hirschberg, CB				Puglielli, L; Mandon, EC; Hirschberg, CB			Identification, purification, and characterization of the rat liver Golgi membrane ATP transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; HEPARAN-SULFATE; NUCLEOTIDE SULFATE; MAMMARY-GLAND; APPARATUS; PROTEIN; PHOSPHORYLATION; PROTEOLIPOSOMES; RECONSTITUTION; TRANSLOCATION	Phosphorylation of secretory and integral membrane proteins and of proteoglycans also occurs in the lumen of the Golgi apparatus, ATP, the phosphate donor in these reactions, must first cross the Golgi membrane before it can serve as substrate. The existence of a specific ATP transporter in the Golgi membrane has been previously demonstrated in vitro using intact Golgi membrane vesicles from rat liver and mammary gland. We have now identified and purified the rat liver Golgi membrane ATP transporter. The transporter was purified to apparent homogeneity by a combination of conventional ion exchange, dye color, and affinity chromatography, An similar to 70,000-fold purification (2% yield) was achieved starting from crude rat liver Golgi membranes. A protein with an apparent molecular mass of 60 kDa was identified as the putative transporter by a combination of column chromatography, photoaffinity labeling with an analog of ATP, and native functional size determination on a glycerol gradient, The purified transporter appears to exist as a homodimer within the Golgi membrane, and when reconstituted into phosphatidylcholine liposomes, was active in ATP but not nucleotide sugar or adenosine 3'-phosphate 8'-phosphosulfate transport. The transport activity was saturable with an apparent K-m very similar to that of intact Golgi vesicles.	Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol W200, Boston, MA 02118 USA; Univ Massachusetts, Med Ctr, Dept Biochem & Mol Biol, Worcester, MA 01655 USA	Boston University; University of Massachusetts System; University of Massachusetts Worcester	Hirschberg, CB (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol W200, 715 Albany St, Boston, MA 02118 USA.			Hirschberg, Carlos/0000-0003-2299-7721	NIGMS NIH HHS [GM34396] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeijon C, 1997, TRENDS BIOCHEM SCI, V22, P203, DOI 10.1016/S0968-0004(97)01053-0; BINGHAM EW, 1974, J BIOL CHEM, V249, P3647; BRANDAN E, 1988, J BIOL CHEM, V263, P2417; CAPASSO JM, 1989, J BIOL CHEM, V264, P5233; CAREY DJ, 1981, J BIOL CHEM, V256, P989; CLAIRMONT CA, 1992, J BIOL CHEM, V267, P3983; FRANSSON LA, 1985, J BIOL CHEM, V260, P4722; GLOSSL J, 1986, J BIOL CHEM, V261, P1920; GUILLEN E, 1995, BIOCHEMISTRY-US, V34, P5472, DOI 10.1021/bi00016a018; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; HORWICH AL, 1995, CURR BIOL, V5, P455, DOI 10.1016/S0960-9822(95)00089-3; KLINGENBERG M, 1985, ENZYMES BIOL MEMBR, V4, P511; LEELAVATHI DE, 1970, BIOCHIM BIOPHYS ACTA, V211, P124, DOI 10.1016/0005-2736(70)90087-8; MANDON E, 1994, J BIOL CHEM, V269, P11729; MANDON EC, 1994, P NATL ACAD SCI USA, V91, P10707, DOI 10.1073/pnas.91.22.10707; MILLA ME, 1989, P NATL ACAD SCI USA, V86, P1786, DOI 10.1073/pnas.86.6.1786; MILLA ME, 1992, J BIOL CHEM, V267, P103; OEGEMA TR, 1984, J BIOL CHEM, V259, P1720; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P833; Puglielli L, 1999, J BIOL CHEM, V274, P4474, DOI 10.1074/jbc.274.7.4474; QUEMENEUR E, 1994, J BIOL CHEM, V269, P5485; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; WANG SY, 1982, J BIOL CHEM, V257, P3837; WICKNER WT, 1994, SCIENCE, V266, P1197, DOI 10.1126/science.7973701	24	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12665	12669		10.1074/jbc.274.18.12665	http://dx.doi.org/10.1074/jbc.274.18.12665			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212247	hybrid			2022-12-27	WOS:000080056800067
J	Shimizu, N; Itoh, R; Hirono, Y; Otera, H; Ghaedi, K; Tateishi, K; Tamura, S; Okumoto, K; Harano, T; Mukai, S; Fujiki, Y				Shimizu, N; Itoh, R; Hirono, Y; Otera, H; Ghaedi, K; Tateishi, K; Tamura, S; Okumoto, K; Harano, T; Mukai, S; Fujiki, Y			The peroxin Pex14p - cDNA cloning by functional complementation on a Chinese hamster ovary cell mutant, characterization, and functional analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; RAT-LIVER PEROXISOMES; HUMAN PTS1 RECEPTOR; ASSEMBLY FACTOR-II; ACYL-COA OXIDASE; 3-KETOACYL-COA THIOLASE; BIOGENESIS DISORDERS; ZELLWEGER-SYNDROME; MEMBRANE-PROTEIN; TARGETING SIGNAL	Rat cDNA encoding a 376-amino acid peroxin was isolated by functional complementation of a peroxisome-deficient Chinese hamster ovary cell mutant, ZP110, of complementation group 14 (CG14), The primary sequence showed 28 and 24% amino acid identity with the yeast Pex14p from Hansenula polymorpha and Saccharomyces cerevisiae, respectively; therefore, we termed this cDNA rat PEX14 (RnPEX14). Human and Chinese hamster Pex14p showed 96 and 94% identity to rat Pex14p, except that both Pex14p comprised 377 amino acids. Pex14p was characterized as an integral membrane protein of peroxisomes, exposing its N- and C-terminal parts to the cytosol. Pex14p interacts with both Pex5p and Pex7p, the receptors for peroxisome targeting signal type 1 (PTS1) and PTS2, respectively, together with the receptors' cargoes, PTS1 and PTS2 proteins. Mutation in PEX14 from ZP161, the same CG as ZP110, was determined by reverse transcription-PCR as follows. A 133-base pair deletion at nucleotide residues 37-169 in one allele created a termination codon at 40-42; in addition to this mutation, 103 base pairs were deleted at positions 385-487, resulting in the second termination immediately downstream the second deletion site in the other allele. Neither of these two mutant forms of Pex14p restored peroxisome biogenesis in ZP110 and ZP161, thereby demonstrating PEX14 to be responsible for peroxisome deficiency in CG14.	Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan; Japan Sci & Technol Corp, CREST, Tokyo 1700013, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Fujiki, Y (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.		Ghaedi, Kamran/X-9824-2018	Ghaedi, Kamran/0000-0002-9790-5644				Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; BODIER C, 1981, J BIOL CHEM, V256, P1604; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brocard C, 1997, EMBO J, V16, P5491, DOI 10.1093/emboj/16.18.5491; Chang CC, 1997, NAT GENET, V15, P385, DOI 10.1038/ng0497-385; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FUJIKI Y, 1984, P NATL ACAD SCI-BIOL, V81, P7127, DOI 10.1073/pnas.81.22.7127; Fujiki Y, 1997, BBA-MOL BASIS DIS, V1361, P235, DOI 10.1016/S0925-4439(97)00051-3; FUJIKI Y, 1982, J CELL BIOL, V93, P103, DOI 10.1083/jcb.93.1.103; Fukuda S, 1996, AM J HUM GENET, V59, P1210; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; HESS R, 1965, NATURE, V208, P856, DOI 10.1038/208856a0; HIJIKATA M, 1987, J BIOL CHEM, V262, P8151; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Kinoshita N, 1998, J BIOL CHEM, V273, P24122, DOI 10.1074/jbc.273.37.24122; Komori M, 1997, EMBO J, V16, P44, DOI 10.1093/emboj/16.1.44; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; MIURA S, 1994, J BIOCHEM-TOKYO, V115, P1064, DOI 10.1093/oxfordjournals.jbchem.a124458; MIURA S, 1992, J BIOL CHEM, V267, P14405; MIYAZAWA S, 1989, MOL CELL BIOL, V9, P83, DOI 10.1128/MCB.9.1.83; MIYAZAWA S, 1987, J BIOL CHEM, V262, P8131; MORAND OH, 1990, BIOCHIM BIOPHYS ACTA, V1034, P132, DOI 10.1016/0304-4165(90)90066-6; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Okumoto K, 1997, EXP CELL RES, V233, P11, DOI 10.1006/excr.1997.3552; Okumoto K, 1997, NAT GENET, V17, P265, DOI 10.1038/ng1197-265; Okumoto K, 1998, HUM MOL GENET, V7, P1399, DOI 10.1093/hmg/7.9.1399; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Portsteffen H, 1997, NAT GENET, V17, P449, DOI 10.1038/ng1297-449; POULOS A, 1995, J PEDIATR-US, V127, P596, DOI 10.1016/S0022-3476(95)70121-4; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; RACHUBINSKI RA, 1984, J CELL BIOL, V99, P2241, DOI 10.1083/jcb.99.6.2241; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; SHIMOZAWA N, 1992, J CLIN INVEST, V90, P1864, DOI 10.1172/JCI116063; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Tamura S, 1998, P NATL ACAD SCI USA, V95, P4350, DOI 10.1073/pnas.95.8.4350; Tateishi K, 1997, EUR J CELL BIOL, V73, P352; TSUKAMOTO T, 1994, J BIOL CHEM, V269, P6001; Tsukamoto T, 1997, BIOCHEM BIOPH RES CO, V230, P402, DOI 10.1006/bbrc.1996.5971; TSUKAMOTO T, 1994, MOL CELL BIOL, V14, P5458, DOI 10.1128/MCB.14.8.5458; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; TSUKAMOTO T, 1995, NAT GENET, V11, P395, DOI 10.1038/ng1295-395; TSUKAMOTO T, 1991, NATURE, V350, P77, DOI 10.1038/350077a0; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Warren DS, 1998, AM J HUM GENET, V63, P347, DOI 10.1086/301963; WENDLAND M, 1993, J CLIN INVEST, V92, P2462, DOI 10.1172/JCI116854; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x; ZOELLER RA, 1989, J BIOL CHEM, V264, P21872; ZOELLER RA, 1988, J BIOL CHEM, V263, P11590	58	135	141	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12593	12604		10.1074/jbc.274.18.12593	http://dx.doi.org/10.1074/jbc.274.18.12593			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212238	hybrid			2022-12-27	WOS:000080056800058
J	Menon, S; Ragsdale, SW				Menon, S; Ragsdale, SW			The role of an iron-sulfur cluster in an enzymatic methylation reaction - Methylation of CO dehydrogenase/acetyl-CoA synthase by the methylated corrinoid iron-sulfur protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COENZYME-A; CARBON-MONOXIDE DEHYDROGENASE; COMPLETE GENOME SEQUENCE; CLOSTRIDIUM-THERMOACETICUM; METHIONINE SYNTHASE; REDUCTIVE ACTIVATION; MECHANISM; NICKEL; METHYLTETRAHYDROFOLATE; METHYLCOBALAMIN	This paper focuses on how a methyl group is transferred from a methyl-cobalt(III) species on one protein (the corrinoid iron-sulfur protein (CFeSP)) to a nickel iron-sulfur cluster on another protein (carbon monoxide dehydrogenase/acetyl-CoA synthase). This is an essential step in the Wood-Ljungdahl pathway of anaerobic CO and CO2 fixation. The results described here strongly indicate that transfer of methyl group to carbon monoxide dehydrogenase/acetyl-CoA synthase occurs by an S(N)2 pathway. They also provide convincing evidence that oxidative inactivation of Co(I) competes with methylation. Under the conditions of our anaerobic assay, Co(I) escapes from the catalytic cycle one in every 100 turnover cycles. Reductive activation of the CFeSP is required to regenerate Co(I) and recruit the protein back into the catalytic cycle. Our results strongly indicate that the [4Fe-4S] cluster of the CFeSP is required for reductive activation. They support the hypothesis that the [4Fe-4S] cluster of the CFeSP does not participate directly in the methyl transfer step but provides a conduit for electron flow from physiological reductants to the cobalt center.	Univ Nebraska, Beadle Ctr, Dept Biochem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Ragsdale, SW (corresponding author), Univ Nebraska, Beadle Ctr, Dept Biochem, Lincoln, NE 68588 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039451, R29GM039451, R37GM039451] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-39451] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABBANAT DR, 1991, P NATL ACAD SCI USA, V88, P3272, DOI 10.1073/pnas.88.8.3272; BANERJEE RV, 1990, BIOCHEMISTRY-US, V29, P11101, DOI 10.1021/bi00502a013; BANERJEE RV, 1990, BIOCHEMISTRY-US, V29, P1129, DOI 10.1021/bi00457a005; Barondeau DP, 1997, J AM CHEM SOC, V119, P3959, DOI 10.1021/ja963597k; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; DIEKERT G, 1994, ANTON LEEUW INT J G, V66, P209, DOI 10.1007/BF00871640; Dixon MM, 1996, STRUCTURE, V4, P1263, DOI 10.1016/S0969-2126(96)00135-9; DRAKE HL, 1981, J BIOL CHEM, V256, P1137; ELLIOTT JI, 1982, J BACTERIOL, V151, P328, DOI 10.1128/JB.151.1.328-333.1982; ELLIOTT JI, 1978, ARCH BIOCHEM BIOPHYS, V190, P351, DOI 10.1016/0003-9861(78)90285-0; GORST CM, 1991, J BIOL CHEM, V266, P20687; GRAHAME DA, 1995, BIOCHEMISTRY-US, V34, P4617, DOI 10.1021/bi00014a015; Gulati S, 1996, HUM MOL GENET, V5, P1859, DOI 10.1093/hmg/5.12.1859; HARDER SR, 1989, BIOCHEMISTRY-US, V28, P9080, DOI 10.1021/bi00449a019; Jarrett JT, 1996, BIOCHEMISTRY-US, V35, P2464, DOI 10.1021/bi952389m; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; KUMAR M, 1995, SCIENCE, V270, P628, DOI 10.1126/science.270.5236.628; LEBERTZ H, 1987, J AM CHEM SOC, V109, P3173, DOI 10.1021/ja00244a066; LINDAHL PA, 1990, J BIOL CHEM, V265, P3873; LU WP, 1991, J BIOL CHEM, V266, P3554; LU WP, 1990, J BIOL CHEM, V265, P3124; MARTIN BD, 1990, J AM CHEM SOC, V112, P2419, DOI 10.1021/ja00162a053; MATTHEWS R G, 1990, Biofactors, V2, P147; Menon S, 1998, BIOCHEMISTRY-US, V37, P5689, DOI 10.1021/bi9727996; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; RAGSDALE SW, 1987, J BIOL CHEM, V262, P14289; Ragsdale SW, 1996, J BIOL INORG CHEM, V1, P489, DOI 10.1007/s007750050082; Ragsdale SW, 1996, MICROBIAL GROWTH ON C(1) COMPOUNDS, P191; Ragsdale SW, 1998, CURR OPIN CHEM BIOL, V2, P208, DOI 10.1016/S1367-5931(98)80062-8; Ragsdale SW, 1996, CHEM REV, V96, P2515, DOI 10.1021/cr950058+; RAGSDALE SW, 1983, J BIOL CHEM, V258, P2364; RAGSDALE SW, 1994, ACETOGENESIS, P88; RAGSDALE SW, 1998, VITAMIN B12 B12 PROT, P167; RAGSDALE SW, 1997, BIOFACTORS, V9, P1; RAM MS, 1995, J AM CHEM SOC, V117, P2365, DOI 10.1021/ja00113a032; Ram MS, 1997, J AM CHEM SOC, V119, P1648, DOI 10.1021/ja963061z; ROBERTS JR, 1992, J BACTERIOL, V174, P4667, DOI 10.1128/JB.174.14.4667-4676.1992; Seravalli J, 1997, BIOCHEMISTRY-US, V36, P11241, DOI 10.1021/bi970590m; SHIN W, 1992, BIOCHEMISTRY-US, V31, P6003, DOI 10.1021/bi00141a007; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; ZHAO SY, 1995, BIOCHEMISTRY-US, V34, P15075, DOI 10.1021/bi00046a013; Zhao SY, 1996, BIOCHEMISTRY-US, V35, P2476, DOI 10.1021/bi952310d; ZIMMERLE CT, 1989, BIOCHEM J, V258, P381, DOI 10.1042/bj2580381	44	50	52	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11513	11518		10.1074/jbc.274.17.11513	http://dx.doi.org/10.1074/jbc.274.17.11513			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206956	hybrid			2022-12-27	WOS:000079834800012
J	Rajotte, D; Ruoslahti, E				Rajotte, D; Ruoslahti, E			Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; DEHYDROPEPTIDASE-I; FILAMENTOUS PHAGE; RAT BREAST; ADHESION; LIBRARIES; METASTASIS; INTEGRINS; CELLS; RGD	In vivo phage display is a powerful method to study organ- and tissue-specific vascular addresses. Using this approach, peptides capable of tissue-specific homing can be identified by performing a selection for that trait in vivo. We recently showed that the CGFECVRQCPERC (termed GFE-1) peptide can selectively bind to mouse lung vasculature after an intravenous injection, Our aim in the present study was to identify the receptor for this lung-homing peptide. By using affinity chromatography, we isolated a 55-kDa lung cell-surface protein that selectively binds to the GFE-1 peptide. Protein sequencing established the identity of the receptor as membrane dipeptidase (MDP), a cell-surface zinc metalloprotease involved in the metabolism of glutathione, leukotriene D-4, and certain beta-lactam antibiotics. Phage particles displaying the GFE-1 peptide selectively bind to COS-1 cells transfected with the murine MDP cDNA. Moreover, the synthetic GFE-1 peptide could inhibit MDP activity. By establishing MDP as the receptor for the GFE-1 peptide, our results suggest potential applications for both MDP and the GFE-1 peptide in delivery of compounds to the lungs. This work also demonstrates that cell-surface proteases can be involved in tissue-specific homing.	Burnham Inst, Ctr Canc Res, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute	Ruoslahti, E (corresponding author), Burnham Inst, Ctr Canc Res, 10901 N Torrey Pines Rd, La Jolla, CA 92093 USA.				NCI NIH HHS [CA 78804, CA 30199, CA 74238] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA030199, R01CA078804, R01CA074238] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; AUERBACH R, 1987, CANCER RES, V47, P1492; Burritt JB, 1996, ANAL BIOCHEM, V238, P1, DOI 10.1006/abio.1996.0241; Cheng HC, 1998, J BIOL CHEM, V273, P24207, DOI 10.1074/jbc.273.37.24207; DelaFuente EK, 1997, AM J PHYSIOL-LUNG C, V272, pL461, DOI 10.1152/ajplung.1997.272.3.L461; Elble RC, 1997, J BIOL CHEM, V272, P27853, DOI 10.1074/jbc.272.44.27853; GARDNER DJ, 1995, LAB ANIM SCI, V45, P199; Habib GM, 1996, J BIOL CHEM, V271, P16273, DOI 10.1074/jbc.271.27.16273; Habib GM, 1998, P NATL ACAD SCI USA, V95, P4859, DOI 10.1073/pnas.95.9.4859; HEYWOOD SP, 1995, ANAL BIOCHEM, V226, P10, DOI 10.1006/abio.1995.1184; HIROTA T, 1986, EUR J BIOCHEM, V160, P521, DOI 10.1111/j.1432-1033.1986.tb10070.x; Hooper NM, 1997, BIOCHEM J, V324, P151, DOI 10.1042/bj3240151; INAMURA T, 1994, PROSTAG LEUKOTR ESS, V50, P85, DOI 10.1016/0952-3278(94)90152-X; JOHNSON RC, 1991, CANCER RES, V51, P394; JOHNSON RC, 1993, J CELL BIOL, V121, P1423, DOI 10.1083/jcb.121.6.1423; Keynan S, 1997, BIOCHEM J, V326, P47, DOI 10.1042/bj3260047; Keynan S, 1996, BIOCHEMISTRY-US, V35, P12511, DOI 10.1021/bi961193z; Keynan S, 1996, ZINC METALLOPROTEASE, P285; KOIVUNEN E, 1994, METHOD ENZYMOL, V245, P346; KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265; PASQUALINI R, 1995, J CELL BIOL, V130, P1189, DOI 10.1083/jcb.130.5.1189; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; PASQUALINI R, 1999, IN PRESS PHAGE DISPL; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; PYTELA R, 1987, METHOD ENZYMOL, V144, P475; Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Salmi M, 1997, ADV IMMUNOL, V64, P139, DOI 10.1016/S0065-2776(08)60889-5; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; Yamaya M, 1998, RESP PHYSIOL, V111, P101, DOI 10.1016/S0034-5687(97)00099-6	31	139	179	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11593	11598		10.1074/jbc.274.17.11593	http://dx.doi.org/10.1074/jbc.274.17.11593			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206967	hybrid			2022-12-27	WOS:000079834800023
J	Swantek, JL; Christerson, L; Cobb, MH				Swantek, JL; Christerson, L; Cobb, MH			Lipopolysaccharide-induced tumor necrosis factor-alpha promoter activity is inhibitor of nuclear factor-kappa B kinase-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC PHOSPHORYLATION; PRIMARY MACROPHAGES; FACTOR BIOSYNTHESIS; GENE-REGULATION; HUMAN MONOCYTES; ACTIVATION; CACHECTIN; ENDOTOXIN; COMPLEX; PATHWAY	The adverse effects of lipopolysaccharide (LPS) are primarily mediated by tumor necrosis factor-alpha (TNF-alpha). TNF-alpha production by LPS-stimulated macrophages is regulated both transcriptionally and post-transcriptionally. Transcriptional regulation of the TNF-alpha gene is dependent on nuclear factor-kappa B (NF-kappa B), We examined the signaling pathways involved in the regulation of NF-kappa B that lead to TNF-alpha promoter activity. We determined a role for one or both of the recently identified inhibitor of NF-kappa B kinases, I kappa B kinase-1 and I kappa B kinase-2, in LPS induction of an NF-kappa B reporter and of TNF-alpha promoter activity. I kappa B kinase activation is one of the earliest signaling events known to be induced by LPS. Furthermore, our results suggest roles for the I kappa B kinases NF-kappa B-inducing kinase and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase I in the regulation of I kappa B kinase-2, as well as in LPS-induced TNF-alpha transcription.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	mcobb@mednet.swmed.edu		Cobb, Melanie/0000-0003-0833-5473	NIDDK NIH HHS [DK34128] Funding Source: Medline; NIGMS NIH HHS [GM18550-01, GM53032] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034128, R01DK034128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM018550] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEUTLER B, 1985, J EXP MED, V161, P984, DOI 10.1084/jem.161.5.984; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; BEUTLER B, 1986, SCIENCE, V232, P977, DOI 10.1126/science.3754653; BEUTLER B, 1992, TUMOR NECROSIS FACTO, P561; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DROUET C, 1991, J IMMUNOL, V147, P1694; GEPPERT TD, 1994, MOL MED, V1, P93; GOLDFELD AE, 1991, J EXP MED, V174, P73, DOI 10.1084/jem.174.1.73; GOLDFELD AE, 1990, P NATL ACAD SCI USA, V87, P9769, DOI 10.1073/pnas.87.24.9769; Han J, 1990, Eur Cytokine Netw, V1, P71; HAN J, 1991, J IMMUNOL, V146, P1843; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; HAN J, 1990, J EXP MED, V172, P391, DOI 10.1084/jem.172.1.391; Hirano M, 1996, J BIOL CHEM, V271, P13234, DOI 10.1074/jbc.271.22.13234; Ishizuka T, 1997, P NATL ACAD SCI USA, V94, P6358, DOI 10.1073/pnas.94.12.6358; KRUYS V, 1989, SCIENCE, V245, P852, DOI 10.1126/science.2672333; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; LEITMAN DC, 1991, J BIOL CHEM, V266, P9343; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MORRISON DC, 1979, ADV IMMUNOL, V294, P293; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xu SC, 1996, P NATL ACAD SCI USA, V93, P5291, DOI 10.1073/pnas.93.11.5291; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; ZIEGLERHEITBROCK HWL, 1993, J IMMUNOL, V151, P6986	41	56	56	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11667	11671		10.1074/jbc.274.17.11667	http://dx.doi.org/10.1074/jbc.274.17.11667			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206979	hybrid			2022-12-27	WOS:000079834800035
J	Bonini, MG; Radi, R; Ferrer-Sueta, G; Ferreira, AMD; Augusto, O				Bonini, MG; Radi, R; Ferrer-Sueta, G; Ferreira, AMD; Augusto, O			Direct EPR detection of the carbonate radical anion produced from peroxynitrite and carbon dioxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; FLASH-PHOTOLYSIS; AQUEOUS-SOLUTION; SUPEROXIDE; DECOMPOSITION; OXIDATIONS; RESONANCE; CHEMISTRY; TYROSINE; KINETICS	The biological effects of peroxynitrite have been recently considered to be largely dependent on its reaction with carbon dioxide, which is present in high concentrations in intra- and extracellular compartments, Peroxynitrite anion (ONOO-) reacts rapidly with carbon dioxide, forming an adduct, nitrosoperoxocarboxylate (ONOOCO2-), whose decomposition has been proposed to produce reactive intermediates such as the carbonate radical (CO3radical anion). Here, by the use of rapid mixing continuous flow electron paramagnetic resonance (EPR), we directly detected the carbonate radical in flow mixtures of peroxynitrite with bicarbonate-carbon dioxide over the pH range of 6-9. The radical was unambiguously identified by its EPR parameters (g = 2.0113; line width = 5.5 G) and by experiments with bicarbonate labeled with C-13. In this case, the singlet EPR signal obtained with C-12 bicarbonate splits into the expected doublet because of C-13 (a(C-13)= 11.7 G). The singlet spectrum of the unlabeled radical was invariant between pH 6 and 9, confirming that in this pH range the detected radical is the carbonate radical anion (CO3radical anion). Importantly, in addition to contributing to the understanding of nitrosoperoxocarboxylate decomposition pathways, this is the first report unambiguously demonstrating the formation of the carbonate radical anion at physiological pHs by direct EPR spectroscopy.	Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05599970 Sao Paulo, Brazil; Univ Sao Paulo, Inst Quim, Dept Quim, BR-05599970 Sao Paulo, Brazil; Univ Republ, Fac Ciencias, Unidad Asociada Enzimol, Montevideo 11800, Uruguay; Univ Republ, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Augusto, O (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Caixa Postal 26077, BR-05599970 Sao Paulo, Brazil.		Ferrer-Sueta, Gerardo/C-3316-2011; Da Costa Ferreira, Ana Maria/C-2244-2012; Augusto, Ohara/D-3839-2012	Ferrer-Sueta, Gerardo/0000-0002-8663-8480; Da Costa Ferreira, Ana Maria/0000-0001-9898-1692; Augusto, Ohara/0000-0002-7220-4286				[Anonymous], [No title captured]; Augusto O, 1996, BRAZ J MED BIOL RES, V29, P853; AUGUSTO O, 1994, ARCH BIOCHEM BIOPHYS, V310, P118, DOI 10.1006/abbi.1994.1147; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445; BEHAR D, 1972, J PHYS CHEM-US, V76, P1710, DOI 10.1021/j100656a007; Bisby RH, 1998, J CHEM SOC FARADAY T, V94, P2069, DOI 10.1039/a801239c; BUETTNER GR, 1990, METHOD ENZYMOL, V186, P127; CHANTRY GW, 1962, MOL PHYS, V5, P589, DOI 10.1080/00268976200100671; CHEN S, 1973, J PHYS CHEM-US, V77, P1111, DOI 10.1021/j100628a006; Dean J.A., 1979, LANGES HDB CHEM, Vtwelth, P5; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; ERIKSEN TE, 1985, RADIAT PHYS CHEM, V26, P197, DOI 10.1016/0146-5724(85)90185-2; Gatti RM, 1998, ARCH BIOCHEM BIOPHYS, V349, P36, DOI 10.1006/abbi.1997.0451; Goldstein S, 1998, J AM CHEM SOC, V120, P3458, DOI 10.1021/ja9733043; GOMES LF, 1996, THESIS U SAO PAULO; HISATSUN.IC, 1970, J PHYS CHEM-US, V74, P3225, DOI 10.1021/j100711a013; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017; LEVINSKY NG, 1994, HARRISONS PRINCIPLES, P253; LILIE J, 1978, RADIAT PHYS CHEM, V11, P225, DOI 10.1016/0146-5724(78)90101-2; LYMAR SV, 1995, J AM CHEM SOC, V117, P8867, DOI 10.1021/ja00139a027; Lymar SV, 1996, CHEM RES TOXICOL, V9, P845, DOI 10.1021/tx960046z; Lymar SV, 1996, BIOCHEMISTRY-US, V35, P7855, DOI 10.1021/bi960331h; Lymar SV, 1998, INORG CHEM, V37, P294, DOI 10.1021/ic970946i; MEHLHORN RJ, 1972, MEMBRANE MOL BIOL, P192; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Merenyi G, 1997, CHEM RES TOXICOL, V10, P1216, DOI 10.1021/tx970101j; Merenyi G, 1998, CHEM RES TOXICOL, V11, P712, DOI 10.1021/tx980043h; MICHELSON AM, 1983, BIOCHIMIE, V65, P95, DOI 10.1016/S0300-9084(83)80179-5; PRYOR WA, 1988, FREE RADICAL BIO MED, V4, P219, DOI 10.1016/0891-5849(88)90043-3; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; RADI R, 1993, BIOCHEM J, V290, P51, DOI 10.1042/bj2900051; Richeson CE, 1998, J AM CHEM SOC, V120, P7211, DOI 10.1021/ja980871x; Saha A, 1998, FREE RADICAL BIO MED, V24, P653, DOI 10.1016/S0891-5849(97)00365-1; Squadrito GL, 1998, FREE RADICAL BIO MED, V25, P392, DOI 10.1016/S0891-5849(98)00095-1; SYMONS M, 1987, CHEM BIOCH ASPECTS E, P16; TREININ A, 1970, J AM CHEM SOC, V92, P5821, DOI 10.1021/ja00723a001; Uppu RM, 1996, ARCH BIOCHEM BIOPHYS, V327, P335, DOI 10.1006/abbi.1996.0131; Wertz J.E., 1972, ELECTRON SPIN RESON, P450; WOLCOTT RG, 1994, J BIOL CHEM, V269, P9721	43	269	276	3	74	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10802	10806		10.1074/jbc.274.16.10802	http://dx.doi.org/10.1074/jbc.274.16.10802			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196155	hybrid			2022-12-27	WOS:000079751900023
J	Palmer, HJ; Tuzon, CT; Paulson, KE				Palmer, HJ; Tuzon, CT; Paulson, KE			Age-dependent decline in mitogenic stimulation of hepatocytes - Reduced association between Shc and the epidermal growth factor receptor is coupled to decreased activation of Raf and extracellular signal-regulated kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; AUTOPHOSPHORYLATION SITES; DIFFERENTIAL ACTIVATION; PHOSPHOTYROSINE-BINDING; TRANSDUCTION PATHWAY; INTACT-CELLS; IN-VIVO; T-CELLS; DOMAIN	The proliferative potential of the liver has been well documented to decline with age. However, the molecular mechanism of this phenomenon is not well understood. Cellular proliferation is the result of growth factor-receptor binding and activation of cellular signaling pathways to regulate specific gene transcription. To determine the mechanism of the age-related difference in proliferation, we evaluated extracellular signal-regulated kinase-mitogen-activated protein kinase activation and events upstream in the signaling pathway in epidermal growth factor (EGF)-stimulated hepatocytes isolated from young and old rats. We confirm the age-associated decrease in extracellular signal-regulated kinase-mitogen-activated protein kinase activation in response to EGF that has been previously reported. We also find that the activity of the upstream kinase, Raf kinase, is decreased in hepatocytes from old compared with young rats, An early age-related difference in the EGF-stimulated pathway is shown to be the decreased ability of the adapter protein, Shc, to associate with the EGF receptor through the Shc phosphotyrosine binding domain. To address the mechanism of decreased Shc/ EGF receptor interaction, we examined the phosphorylation of the EGF receptor at tyrosine 1173, a site recognized by the Shc phosphotyrosine binding domain, Tyrosine 1173 of the EGF receptor is underphosphorylated in the hepatocytes from old animals compared with young in a Western blot analysis using a phosphospecific antibody that recognizes phosphotyrosine 1173 of the EGF receptor. These data suggest that a molecular mechanism underlying the age-associated decrease in hepatocyte proliferation involves an age-dependent regulation of site-specific tyrosine residue phosphorylation on the EGF receptor.	Tufts Univ, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts University; United States Department of Agriculture (USDA); Tufts University	Paulson, KE (corresponding author), Tufts Univ, USDA, Human Nutr Res Ctr Aging, 711 Washington St, Boston, MA 02111 USA.	kpaulson@hnrc.tufts.edu	Tuzon, Creighton/K-3398-2019	Tuzon, Creighton/0000-0001-9706-610X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928, R01DK050442] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK34928, R01 DK50442] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALVAREZ CV, 1995, J BIOL CHEM, V270, P16271, DOI 10.1074/jbc.270.27.16271; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; BATZER AG, 1995, MOL CELL BIOL, V15, P4403; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; BEYER HS, 1991, J LAB CLIN MED, V117, P101; BRONDELLO JM, 1995, ONCOGENE, V10, P1895; BUCHER NLR, 1964, CANCER RES, V24, P509; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Gallo R, 1997, ONCOGENE, V15, P1929, DOI 10.1038/sj.onc.1201344; Garcia GG, 1997, CELL IMMUNOL, V175, P51, DOI 10.1006/cimm.1996.1040; GHOSH J, 1995, MECH AGEING DEV, V80, P171, DOI 10.1016/0047-6374(94)01568-7; GOTOH N, 1994, P NATL ACAD SCI USA, V91, P167, DOI 10.1073/pnas.91.1.167; Gotoh N, 1997, MOL CELL BIOL, V17, P1824, DOI 10.1128/MCB.17.4.1824; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Huang GC, 1998, BIOCHEM J, V331, P113, DOI 10.1042/bj3310113; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; ISHIGAMI A, 1993, BIOCHEM BIOPH RES CO, V196, P181, DOI 10.1006/bbrc.1993.2232; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; Kim HH, 1998, BIOCHEM J, V334, P189, DOI 10.1042/bj3340189; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; LI NX, 1994, ONCOGENE, V9, P3457; Lim YP, 1997, J BIOL CHEM, V272, P29892, DOI 10.1074/jbc.272.47.29892; Liu YS, 1996, J BIOL CHEM, V271, P3604; Liu YS, 1996, FREE RADICAL BIO MED, V21, P771, DOI 10.1016/0891-5849(96)00176-1; Logan SK, 1997, MOL CELL BIOL, V17, P5784, DOI 10.1128/MCB.17.10.5784; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; OKABAYASHI Y, 1994, J BIOL CHEM, V269, P18674; Pahlavani MA, 1998, CELL IMMUNOL, V185, P39, DOI 10.1006/cimm.1998.1274; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; RANA B, 1994, MOL CELL BIOL, V14, P5858, DOI 10.1128/MCB.14.9.5858; REENSTRA WR, 1993, EXP CELL RES, V209, P118, DOI 10.1006/excr.1993.1291; Reenstra WR, 1996, EXP CELL RES, V227, P252, DOI 10.1006/excr.1996.0274; Ricketts WA, 1996, J BIOL CHEM, V271, P26165, DOI 10.1074/jbc.271.42.26165; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Sakaguchi K, 1998, MOL ENDOCRINOL, V12, P536, DOI 10.1210/me.12.4.536; SALCINI AE, 1994, ONCOGENE, V9, P2827; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shapiro PS, 1998, J BIOL CHEM, V273, P1788, DOI 10.1074/jbc.273.3.1788; Shi ZQ, 1998, J BIOL CHEM, V273, P4904, DOI 10.1074/jbc.273.9.4904; SOLER C, 1994, ONCOGENE, V9, P2207; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Tridandapani S, 1997, J IMMUNOL, V158, P1125; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; XIAO S, 1994, J BIOL CHEM, V269, P21244; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	57	44	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11424	11430		10.1074/jbc.274.16.11424	http://dx.doi.org/10.1074/jbc.274.16.11424			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196236	hybrid			2022-12-27	WOS:000079751900104
J	Stoss, O; Schwaiger, FW; Cooper, TA; Stamm, S				Stoss, O; Schwaiger, FW; Cooper, TA; Stamm, S			Alternative splicing determines the intracellular localization of the novel nuclear protein Nop30 and its interaction with the splicing factor SRp30c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; C-TERMINAL DOMAIN; MESSENGER-RNA; FIBRILLAR CENTERS; SERINE-RICH; SR PROTEINS; IN-VIVO; EXPRESSION; GENE; TRANSCRIPTION	We report on the molecular cloning of a novel human cDNA by its interaction with the splicing factor SRp30c in a yeast two-hybrid screen. This cDNA is predominantly expressed in muscle and encodes a protein that is present in the nucleoplasm and concentrated in nucleoli. It was therefore termed Nop30 (nucleolar protein of 30 kDa). We have also identified a related cDNA with a different carboxyl terminus. Sequencing of the NOP gene demonstrated that both cDNAs are generated by alternative 5' splice site usage from a single gene that consists of four exons, spans at least 1800 nucleotides, and is located on chromosome 16q21-q23. The alternative 5' splice site usage introduces a frameshift creating two different carboxyl termini. The carboxyl terminus of Nop30 is rich in serines and arginines and has been found to target the protein into the nucleus, whereas its isoform is characterized by proline/glutamic acid dipeptides in its carboxyl terminus and is predominantly found in the cytosol. Interaction studies in yeast, in vitro protein interaction assays, and co-immunoprecipitations demonstrated that Nop30 multimerizes and binds to the RS domain of SRp30c but not to other splicing factors tested. Overexpression of Nop30 changes alternative exon usage in preprotachykinin and SRp20 reporter genes, suggesting that Nop30 influences alternative splice site selection in vivo.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	Max Planck Society; Baylor College of Medicine; Baylor College of Medicine	Stamm, S (corresponding author), Max Planck Inst Neurobiol, Am Klopferspitz 18A, D-82152 Martinsried, Germany.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045565, R29HL045565] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45565] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beil B, 1997, DNA CELL BIOL, V16, P679, DOI 10.1089/dna.1997.16.679; BINGHAM PM, 1988, TRENDS GENET, V4, P134, DOI 10.1016/0168-9525(88)90136-9; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; BORGESE N, 1993, FEBS LETT, V325, P70, DOI 10.1016/0014-5793(93)81416-W; Bourquin JP, 1997, NUCLEIC ACIDS RES, V25, P2055, DOI 10.1093/nar/25.11.2055; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOU TB, 1987, EMBO J, V6, P4095, DOI 10.1002/j.1460-2075.1987.tb02755.x; Corden JL, 1997, TRENDS BIOCHEM SCI, V22, P413, DOI 10.1016/S0968-0004(97)01125-0; delaLuna S, 1996, J CELL SCI, V109, P2443; DERENZINI M, 1993, J HISTOCHEM CYTOCHEM, V41, P829, DOI 10.1177/41.6.8315275; Du KY, 1997, MOL CELL BIOL, V17, P4096, DOI 10.1128/MCB.17.7.4096; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FU XD, 1995, RNA, V1, P663; GE H, 1991, CELL, V66, P373, DOI 10.1016/0092-8674(91)90626-A; Geertman R, 1996, BBA-GENE STRUCT EXPR, V1306, P147, DOI 10.1016/0167-4781(96)00036-X; Genetic Computer Group, 1994, PROGR MAN WISC PACK; GRUMONT RJ, 1994, P NATL ACAD SCI USA, V91, P4367, DOI 10.1073/pnas.91.10.4367; Hanamura A, 1998, RNA, V4, P430; HANAUER A, 1983, NUCLEIC ACIDS RES, V11, P3503, DOI 10.1093/nar/11.11.3503; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; IWATA H, 1995, UROL RES, V23, P27, DOI 10.1007/BF00298847; JORDAN EG, 1981, J CELL SCI, V52, P373; Jumaa H, 1997, EMBO J, V16, P5077, DOI 10.1093/emboj/16.16.5077; Korb J, 1996, ACTA VIROL, V40, P81; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; KUO HC, 1991, SCIENCE, V251, P1045, DOI 10.1126/science.1825520; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; MATTOX W, 1991, GENE DEV, V5, P786, DOI 10.1101/gad.5.5.786; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; MCKEOWN M, 1992, ANNU REV CELL BIOL, V8, P133, DOI 10.1146/annurev.cb.08.110192.001025; MCLAUGHLIN S, 1993, J BIOL CHEM, V268, P6839; MCLONE DG, 1975, AM J ANAT, V142, P273, DOI 10.1002/aja.1001420302; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; MIKHAYLOVA VT, 1994, EXP CELL RES, V212, P10, DOI 10.1006/excr.1994.1112; Monaghan KG, 1997, AM J MED GENET, V73, P180, DOI 10.1002/(SICI)1096-8628(1997)73:2<180::AID-AJMG13>3.0.CO;2-Q; Nayler O, 1998, NUCLEIC ACIDS RES, V26, P3542, DOI 10.1093/nar/26.15.3542; Nayler O, 1997, BIOCHEM J, V326, P693, DOI 10.1042/bj3260693; OCHS R, 1983, EXP CELL RES, V146, P139, DOI 10.1016/0014-4827(83)90332-4; OCHS RL, 1989, EXP CELL RES, V184, P552, DOI 10.1016/0014-4827(89)90354-6; Ochs RL, 1996, MOL BIOL CELL, V7, P1015, DOI 10.1091/mbc.7.7.1015; PARI G, 1991, MOL CELL BIOL, V11, P4796, DOI 10.1128/MCB.11.9.4796; PFEFFER U, 1995, CANCER RES, V55, P2158; Sambrook J., 2002, MOL CLONING LAB MANU; Sarkissian M, 1996, J BIOL CHEM, V271, P31106, DOI 10.1074/jbc.271.49.31106; SCHMAUSS C, 1989, NUCLEIC ACIDS RES, V17, P1733, DOI 10.1093/nar/17.4.1733; SCHMITT AB, 1999, IN PRESS J NEUROBIOL; Schul W, 1998, J CELL BIOCHEM, V70, P159, DOI 10.1002/(SICI)1097-4644(19980801)70:2<159::AID-JCB2>3.0.CO;2-N; SHAW PJ, 1995, EMBO J, V14, P2896, DOI 10.1002/j.1460-2075.1995.tb07289.x; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Snow BE, 1997, GENOMICS, V43, P165, DOI 10.1006/geno.1997.4794; SOMMERVILLE J, 1986, TRENDS BIOCHEM SCI, V11, P438, DOI 10.1016/0968-0004(86)90242-2; STAMM S, 1994, NUCLEIC ACIDS RES, V22, P1515, DOI 10.1093/nar/22.9.1515; Steinmetz EJ, 1997, CELL, V89, P491, DOI 10.1016/S0092-8674(00)80230-5; SUN Q, 1993, GENE DEV, V7, P3519; Vilardell J, 1997, MOL CELL BIOL, V17, P1959, DOI 10.1128/MCB.17.4.1959; Vissers CJ, 1996, ACTA HISTOCHEM, V98, P113, DOI 10.1016/S0065-1281(96)80028-6; WANG J, 1995, RNA, V1, P335; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0	63	33	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10951	10962		10.1074/jbc.274.16.10951	http://dx.doi.org/10.1074/jbc.274.16.10951			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196175	hybrid			2022-12-27	WOS:000079751900043
J	Zhang, J; Barak, LS; Anborgh, PH; Laporte, SA; Caron, MG; Ferguson, SSG				Zhang, J; Barak, LS; Anborgh, PH; Laporte, SA; Caron, MG; Ferguson, SSG			Cellular trafficking of G protein-coupled receptor/beta-arrestin endocytic complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; BETA-ARRESTIN; INTERNALIZATION SIGNAL; PLASMA-MEMBRANE; DESENSITIZATION; SEQUESTRATION; RESENSITIZATION; PHOSPHORYLATION; KINASE; DEPHOSPHORYLATION	beta-Arrestins are multifunctional proteins identified on the basis of their ability to bind and uncouple G protein-coupled receptors (GPCR) from heterotrimeric G proteins, In addition, beta-arrestins play a central role in mediating GPCR endocytosis, a key regulatory step in receptor resensitization. In this study, we visualize the intracellular trafficking of beta-arrestin2 in response to activation of several distinct GPCRs including the beta(2)-adrenergic receptor (beta(2)AR), angiotensin II type 1A receptor (AT(1A)R), dopamine D1A receptor (D1AR), endothelin type A receptor (ETAR), and neurotensin receptor (NTR). Our results reveal that in response to beta(2)AR activation, beta-arrestin2 translocation to the plasma membrane shares the same pharmacological profile as described for receptor activation and sequestration, consistent with a role for beta-arrestin as the agonist-driven switch initiating receptor endocytosis. Whereas redistributed beta-arrestins are confined to the periphery of cells and do not traffic along with activated beta(2)AR, D1AR, and ETAR in endocytic vesicles, activation of AT(1A)R and NTR triggers a clear time-dependent redistribution of beta-arrestins to intracellular vesicular compartments where they colocalize with internalized receptors. Activation of a chimeric AT(1A)R with the beta(2)AR carboxyl-terminal tail results in a beta-arrestin membrane localization pattern similar to that observed in response to beta(2)AR activation. In contrast, the corresponding chimeric beta(2)AR with the AT(1A)R carboxyl-terminal tail gains the ability to translocate beta-arrestin to intracellular vesicles. These results demonstrate that the cellular trafficking of beta-arrestin proteins is differentially regulated by the activation of distinct GPCRs. Furthermore, they suggest that the carboxyl-tail of the receptors might be involved in determining the stability of receptor/beta-arrestin complexes and cellular distribution of beta-arrestins.	Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Med, Durham, NC 27710 USA; Univ Western Ontario, Dept Physiol, John P Robarts Res Inst, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Pharmacol & Toxicol, John P Robarts Res Inst, London, ON N6A 5K8, Canada	Duke University; Duke University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Caron, MG (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3287, Durham, NC 27710 USA.		Laporte, Stephane/ABC-4228-2021; Laporte, Stephane A/F-3282-2012	Laporte, Stephane/0000-0002-0633-543X; 	NINDS NIH HHS [NS 19576] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Bohm SK, 1997, BIOCHEM J, V322, P1; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; CHANG MP, 1993, EMBO J, V12, P2169, DOI 10.1002/j.1460-2075.1993.tb05865.x; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; EBERLE W, 1991, CELL, V67, P1203, DOI 10.1016/0092-8674(91)90296-B; FERGUSON S, 1996, J PHYSIOL PHARMACOL, V74, P1095; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Jockers R, 1996, J BIOL CHEM, V271, P9355, DOI 10.1074/jbc.271.16.9355; Krueger KM, 1997, J BIOL CHEM, V272, P5; KRUPNICK JG, 1994, J BIOL CHEM, V269, P3226; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lazari RDM, 1998, J BIOL CHEM, V273, P18316, DOI 10.1074/jbc.273.29.18316; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; McConalogue K, 1998, MOL BIOL CELL, V9, P2305, DOI 10.1091/mbc.9.8.2305; Nakamura K, 1998, J BIOL CHEM, V273, P24346, DOI 10.1074/jbc.273.38.24346; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; PALCZEWSKI K, 1989, J BIOL CHEM, V264, P15770; PIPPIG S, 1993, J BIOL CHEM, V268, P3201; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; ROTH NS, 1991, P NATL ACAD SCI USA, V88, P6201, DOI 10.1073/pnas.88.14.6201; Schlador ML, 1997, J BIOL CHEM, V272, P18882, DOI 10.1074/jbc.272.30.18882; SIBLEY DR, 1986, P NATL ACAD SCI USA, V83, P9408, DOI 10.1073/pnas.83.24.9408; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; VONZASTROW M, 1994, J BIOL CHEM, V269, P18448; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; YU SS, 1993, J BIOL CHEM, V268, P337; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; Zhang J, 1997, RECEPTOR CHANNEL, V5, P193; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	40	185	191	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10999	11006		10.1074/jbc.274.16.10999	http://dx.doi.org/10.1074/jbc.274.16.10999			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196181	hybrid			2022-12-27	WOS:000079751900049
J	Adduci, AJ; Schlegel, R				Adduci, AJ; Schlegel, R			The transmembrane domain of the E5 oncoprotein contains functionally discrete helical faces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PAPILLOMAVIRUS-E5 TRANSFORMING PROTEIN; VACUOLAR H+-ATPASE; BOVINE PAPILLOMAVIRUS; MEMBRANE-PROTEIN; KIN RECOGNITION; ALPHA-HELICES; GOLGI ENZYMES; AMINO-ACIDS; ION-CHANNEL	The E5 protein of bovine papillomavirus is a 44-amino acid, Golgi-resident, type II transmembrane protein that efficiently transforms immortalized mouse fibroblasts. The transmembrane (TM) domain of E5 is not only critical for biological activity, it also regulates interactions with cellular targets including the platelet derived growth factor receptor (PDGF-R) and the 16-kDa subunit of the vacuolar proton ATPase (V-ATPase), In order to define the specific TM amino acids essential for E5 biological and biochemical activity, we performed scanning alanine mutagenesis on 25 of the 30 potential TRI residues and genetically mapped discrete Lu-helical domains which separately regulated the ability of E5 to bind PDGF-R, activate PDGF-R, and to form oligomers. Alanine substitutions at positions 17, 21, and 24 (which lie on the same helical face) greatly inhibited E5 association with the PDGF-R, suggesting that this region comprises the receptor binding site. PDGF-R activation also mapped to a specific but broader domain in E5; mutant proteins with alanines on one helical face (positions 8, 9, 11, 16, 19, 22, and 23) continued to induce PDGF-R tyrosine phosphorylation, whereas mutant proteins with alanines on the opposite helical face (positions 7, 10, 13, 17, 18, 21, 24, and 25) did not, indicating that the latter helical face was critical for mediating receptor transphosphorylation. Interestingly, these "activation-defective" mutants segregated into two classes: 1) those that were unable to form dimers but that could still form higher order oligomers and transform cells, and 2) those that were defective for PDGF-R binding and were transformation-incompetent. These findings suggest that the ability of E5 to dimerize and to bind PDGF-R is important for receptor activation, However, since several transformation-competent E5 mutants were defective for binding and/or activating PDGF-R, it is apparent that E5 must have additional activities to mediate cell transformation. Finally, alanine substitutions also defined two separate helical faces critical for E5/E5 interactions (homodimer formation). Thus, our data identify distinct E5 helical faces that regulate homologous and heterologous intramembrane interactions and define two new classes of biologically active TM mutants.	Georgetown Univ, Sch Med, Dept Pathol, Washington, DC 20007 USA	Georgetown University	Schlegel, R (corresponding author), Georgetown Univ, Sch Med, Dept Pathol, 3900 Reservoir Rd NW, Washington, DC 20007 USA.	schleger@medlib.georgetown.edu			NCI NIH HHS [R01 CA-53371] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA053371] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDRESSON T, 1995, J BIOL CHEM, V270, P6830, DOI 10.1074/jbc.270.12.6830; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; BURKHARDT A, 1987, EMBO J, V6, P2381, DOI 10.1002/j.1460-2075.1987.tb02515.x; BURKHARDT A, 1989, VIROLOGY, V170, P334, DOI 10.1016/0042-6822(89)90391-7; COHEN BD, 1993, MOL CELL BIOL, V13, P6462, DOI 10.1128/MCB.13.10.6462; COHEN BD, 1993, J VIROL, V67, P5303, DOI 10.1128/JVI.67.9.5303-5311.1993; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; GOLDSTEIN DJ, 1990, EMBO J, V9, P137, DOI 10.1002/j.1460-2075.1990.tb08089.x; GOLDSTEIN DJ, 1992, J VIROL, V66, P405, DOI 10.1128/JVI.66.1.405-413.1992; GOLDSTEIN DJ, 1992, EMBO J, V11, P4851, DOI 10.1002/j.1460-2075.1992.tb05591.x; GOLDSTEIN DJ, 1991, NATURE, V352, P347, DOI 10.1038/352347a0; GOLDSTEIN DJ, 1994, J VIROL, V68, P4432, DOI 10.1128/JVI.68.7.4432-4441.1994; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; HORWITZ BH, 1988, MOL CELL BIOL, V8, P4071, DOI 10.1128/MCB.8.10.4071; KULKE R, 1992, J VIROL, V66, P505, DOI 10.1128/JVI.66.1.505-511.1992; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; LIM PS, 1990, J INFECT DIS, V162, P1263, DOI 10.1093/infdis/162.6.1263; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; MARTIN P, 1989, CELL, V59, P21, DOI 10.1016/0092-8674(89)90866-0; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; NILSON LA, 1993, MOL CELL BIOL, V13, P4137, DOI 10.1128/MCB.13.7.4137; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; PETTI L, 1991, EMBO J, V10, P845, DOI 10.1002/j.1460-2075.1991.tb08017.x; PETTI L, 1994, J VIROL, V68, P3582, DOI 10.1128/JVI.68.6.3582-3592.1994; PETTI L, 1992, P NATL ACAD SCI USA, V89, P6736, DOI 10.1073/pnas.89.15.6736; Petti LM, 1997, J VIROL, V71, P7318, DOI 10.1128/JVI.71.10.7318-7327.1997; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; SCHLEGEL R, 1986, SCIENCE, V233, P464, DOI 10.1126/science.3014660; SCHLEGEL R, 1987, CANCER CELL, V5, P87; SPARKOWSKI J, 1995, EMBO J, V14, P3055, DOI 10.1002/j.1460-2075.1995.tb07308.x; Sparkowski J, 1996, J VIROL, V70, P2420, DOI 10.1128/JVI.70.4.2420-2430.1996; SPARKOWSKI J, 1994, J VIROL, V68, P6120, DOI 10.1128/JVI.68.9.6120-6123.1994; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; TOSTESON MT, 1994, J MEMBRANE BIOL, V142, P117	41	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10249	10258		10.1074/jbc.274.15.10249	http://dx.doi.org/10.1074/jbc.274.15.10249			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187811	hybrid			2022-12-27	WOS:000079663500050
J	Delphin, C; Ronjat, M; Deloulme, JC; Garin, G; Debussche, L; Higashimoto, Y; Sakaguchi, K; Baudier, J				Delphin, C; Ronjat, M; Deloulme, JC; Garin, G; Debussche, L; Higashimoto, Y; Sakaguchi, K; Baudier, J			Calcium-dependent interaction of S100B with the C-terminal domain of the tumor suppressor p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; WILD-TYPE P53; DNA-BINDING; S-100 PROTEINS; IMMUNOHISTOCHEMICAL LOCALIZATION; OLIGOMERIZATION DOMAIN; CA2+-DEPENDENT MANNER; TRANSCRIPTION FACTORS; IONS BINDING; CELL-CYCLE	Irt vitro, the S100B protein interacts with baculovirus recombinant p53 protein and protects p53 from thermal denaturation, This effect is isoform-specific and is not observed with S100A1, S100A6, or calmodulin, Using truncated p53 proteins in the N-terminal (p53(1-320)) and C-terminal (p53(73-393)) domains, we localized the S100B-binding region to the C-terminal region of p53, We have confirmed a calcium-dependent interaction of the S100B with a synthetic peptide corresponding to the C-terminal region of p53 (residues 319-393 in human p53) using plasmon resonance experiments on a BIAcore system. In the presence of calcium, the equilibrium affinity of the S100B for the C-terminal region of p53 immobilized on the sensor chip was 24 +/- 10 nM. To narrow down the region within p53 involved in S100B binding, two synthetic peptides, O1(357-381) (residues 357-381 in mouse p53) and YF-O2(320-346) (residues 320-346 in mouse p53), covering the C-terminal region of p53 were compared for their interaction with purified S100B, Only YF-O2 peptide interacts with S100B with high affinity. The YF-O2 motif is a critical determinant for the thermostability of p53 and also corresponds to a domain responsible for cytoplasmic sequestration of p53, Our results may explain the rescue of nuclear wild type p53 activities by S100B in fibroblast cell lines expressing the temperature-sensitive p53val135 mutant at the nonpermissive temperature.	CEA Grenoble, INSERM, U244,DBMS,BRCE, Ctr Etud Nucl Grenoble, F-38054 Grenoble 9, France; Ctr Etud Nucl Grenoble, Lab Chim Prot, F-38054 Grenoble, France; Ctr Etud Nucl Grenoble, Lab Canaux Ion & Signalizat, F-38054 Grenoble, France; Rhone Poulenc Rorer SA, Ctr Rech Vitry Alfortville, Inst Biotechnol, F-94403 Vitry Sur Seine, France; NIH, Cell Biol Lab, Bethesda, MD 20892 USA	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; CEA; Sanofi-Aventis; Sanofi France; National Institutes of Health (NIH) - USA	Baudier, J (corresponding author), CEA Grenoble, INSERM, U244,DBMS,BRCE, Ctr Etud Nucl Grenoble, 17 Rue Martyrs, F-38054 Grenoble 9, France.	jbaudier@cea.fr	Baudier, Jacques/O-2183-2016; jacques, baudier/T-3300-2019; Deloulme, Jean Christophe/P-6858-2017; Christian, Delphin/P-9284-2017	Deloulme, Jean Christophe/0000-0002-2234-5865; Christian, Delphin/0000-0003-3240-8695; jacques, baudier/0000-0001-8427-4444; Ronjat, Michel/0000-0002-9728-6425; Higashimoto, Yuichiro/0000-0003-1382-8598				BAUDIER J, 1986, J BIOL CHEM, V261, P8204; BAUDIER J, 1982, FEBS LETT, V147, P165, DOI 10.1016/0014-5793(82)81033-8; BAUDIER J, 1986, J BIOL CHEM, V261, P8192; BAUDIER J, 1995, BIOCHEMISTRY-US, V34, P7834, DOI 10.1021/bi00024a007; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; BIANCHI R, 1993, J BIOL CHEM, V268, P12669; CLORE GM, 1994, SCIENCE, V265, P386, DOI 10.1126/science.8023159; Delphin C, 1997, EUR J BIOCHEM, V245, P684, DOI 10.1111/j.1432-1033.1997.t01-1-00684.x; DELPHIN C, 1994, EUR J BIOCHEM, V223, P683, DOI 10.1111/j.1432-1033.1994.tb19041.x; Drohat AC, 1997, PROTEIN SCI, V6, P1577, DOI 10.1002/pro.5560060721; FAN K, 1982, BRAIN RES, V237, P498, DOI 10.1016/0006-8993(82)90462-0; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Hansen S, 1996, J BIOL CHEM, V271, P3917; Hansen S, 1996, J BIOL CHEM, V271, P30922, DOI 10.1074/jbc.271.48.30922; Hermann S, 1998, CELL CALCIUM, V23, P135, DOI 10.1016/S0143-4160(98)90112-9; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; IVANENKOV VV, 1995, J BIOL CHEM, V270, P14651, DOI 10.1074/jbc.270.24.14651; JOHNSON CR, 1995, BIOCHEMISTRY-US, V34, P5309, DOI 10.1021/bi00016a002; Kilby PM, 1996, STRUCTURE, V4, P1041, DOI 10.1016/S0969-2126(96)00111-6; Kinzler KW, 1996, NATURE, V379, P19, DOI 10.1038/379019a0; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Liang SH, 1998, J BIOL CHEM, V273, P19817, DOI 10.1074/jbc.273.31.19817; MARKS A, 1990, EXP CELL RES, V187, P59, DOI 10.1016/0014-4827(90)90116-R; Mateu MG, 1998, EMBO J, V17, P2748, DOI 10.1093/emboj/17.10.2748; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Millward TA, 1998, EMBO J, V17, P5913, DOI 10.1093/emboj/17.20.5913; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; MILNER J, 1995, TRENDS BIOCHEM SCI, V20, P49, DOI 10.1016/S0968-0004(00)88954-9; NAKAJIMA T, 1982, AM J SURG PATHOL, V6, P715, DOI 10.1097/00000478-198212000-00003; Onions J, 1997, J BIOL CHEM, V272, P23930, DOI 10.1074/jbc.272.38.23930; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; Sabapathy K, 1997, EMBO J, V16, P6217, DOI 10.1093/emboj/16.20.6217; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; SAKAMOTO H, 1994, P NATL ACAD SCI USA, V91, P8974, DOI 10.1073/pnas.91.19.8974; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Scotto C, 1998, MOL CELL BIOL, V18, P4272, DOI 10.1128/MCB.18.7.4272; SHAULIAN E, 1995, ONCOGENE, V10, P671; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; SHAULSKY G, 1990, MOL CELL BIOL, V10, P6565, DOI 10.1128/MCB.10.12.6565; Smith SP, 1998, STRUCTURE, V6, P211, DOI 10.1016/S0969-2126(98)00022-7; STURZBECHER HW, 1992, ONCOGENE, V7, P1513; TAKAHASHI K, 1984, AM J PATHOL, V116, P497; Tsoporis JN, 1997, J BIOL CHEM, V272, P31915, DOI 10.1074/jbc.272.50.31915; VANDROMME M, 1995, P NATL ACAD SCI USA, V92, P4646, DOI 10.1073/pnas.92.10.4646; VANELDIK LJ, 1986, J HISTOCHEM CYTOCHEM, V34, P977, DOI 10.1177/34.8.3734419; Wilder PT, 1998, PROTEIN SCI, V7, P794, DOI 10.1002/pro.5560070330; YAHANDA AM, 1995, MOL CELL BIOL, V15, P4249	47	62	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10539	10544		10.1074/jbc.274.15.10539	http://dx.doi.org/10.1074/jbc.274.15.10539			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187847	hybrid			2022-12-27	WOS:000079663500086
J	Nakashima, S; Wang, SL; Hisamoto, N; Sakai, H; Andoh, M; Matsumoto, K; Nozawa, Y				Nakashima, S; Wang, SL; Hisamoto, N; Sakai, H; Andoh, M; Matsumoto, K; Nozawa, Y			Molecular cloning and expression of a stress-responsive mitogen-activated protein kinase-related kinase from Tetrahymena cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; POLYMERASE CHAIN-REACTION; MAP-KINASE; MAMMALIAN-CELLS; DIFFERENTIAL DISPLAY; ARABIDOPSIS-THALIANA; MESSENGER-RNA; SAP KINASES; YEAST; GENE	To identify genes responsive to cold stress, we employed the differential display mRNA analysis technique to isolate a novel gene from Tetrahymena thermophila which encodes a protein kinase of 430 amino acids, A homolog of this kinase with 90% amino acid sequence identity was also found in T, pyriformis. Both kinases contain 11 subdomains typical of protein kinases, Sequence analysis revealed that the predicted amino acid sequences resemble those of mitogen-activated protein kinase (MAPK), especially p38 and stress-activated protein kinase which are known to be involved in various stress responses. However, it should be noted that the tyrosine residue in the normally conserved MAPK phosphorylation site (Thr-X-Tyr) is replaced by histidine (Thr(226)-Gly-His(228)) in this MAPK-related kinase (MRK). The recombinant MRK expressed in Escherichia coli phosphorylated myelin basic protein (MBP) and became autophosphorylated, However, the mutated recombinant protein in which Thr(226) was replaced by Ala lost the ability to phosphorylate MBP, suggesting that Thr(226) residue is essential for kinase activity. The MRK mRNA transcript in T, thermophila increased markedly upon temperature downshift from 35 to 15 degrees C (0.8 degrees C/min), Interestingly, osmotic shock either by sorbitol (100-200 mM) or NaCl (25-100 mM) also induced mRNA expression of the MRK in T, pyriformis. In addition, the activity of the kinase as determined by an immune complex kinase assay using MBP as a substrate was also induced by osmotic stress. This is the first demonstration of a MAPK-related kinase in the unicellular eukaryotic protozoan Tetrahymena that is induced by physical stresses such as cold temperature and osmolarity, The present results suggest that this MRK may function in the stress-signaling pathway in Tetrahymena cells.	Gifu Univ, Sch Med, Dept Biochem, Gifu 5008705, Japan; Gifu Univ, Sch Med, Dept Neurosurg, Gifu 5008705, Japan; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Gifu University; Gifu University; Nagoya University	Nakashima, S (corresponding author), Gifu Univ, Sch Med, Dept Biochem, Tsukasamachi 40, Gifu 5008705, Japan.	bio@cc.gifu-u.ac.jp						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; CUPPLES CG, 1986, P NATL ACAD SCI USA, V83, P5160, DOI 10.1073/pnas.83.14.5160; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Doerig CM, 1996, GENE, V177, P1, DOI 10.1016/0378-1119(96)00281-8; EDAMATSU M, 1991, BIOCHEM BIOPH RES CO, V175, P543, DOI 10.1016/0006-291X(91)91599-8; Elliott A., 1973, BIOL TETRAHYMENA; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; GALL JG, 1974, P NATL ACAD SCI USA, V71, P3078, DOI 10.1073/pnas.71.8.3078; GASKINS C, 1994, MOL CELL BIOL, V14, P6996, DOI 10.1128/MCB.14.10.6996; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; GOTOH Y, 1991, EMBO J, V10, P2661, DOI 10.1002/j.1460-2075.1991.tb07809.x; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; HILL D. L., 1972, BIOCH PHYSL TETRAHYM; HOROWITZ S, 1985, P NATL ACAD SCI USA, V82, P2452, DOI 10.1073/pnas.82.8.2452; ITO T, 1994, FEBS LETT, V351, P231, DOI 10.1016/0014-5793(94)00867-1; ITO W, 1991, GENE, V102, P67, DOI 10.1016/0378-1119(91)90539-N; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; MATSUDA S, 1995, J BIOL CHEM, V270, P12781, DOI 10.1074/jbc.270.21.12781; Mertens S, 1996, FEBS LETT, V383, P273, DOI 10.1016/0014-5793(96)00255-4; MIZOGUCHI T, 1993, FEBS LETT, V336, P440, DOI 10.1016/0014-5793(93)80852-L; Mizoguchi T, 1997, TRENDS BIOTECHNOL, V15, P15, DOI 10.1016/S0167-7799(96)10074-3; Mizoguchi T, 1996, P NATL ACAD SCI USA, V93, P765, DOI 10.1073/pnas.93.2.765; Nakashima S, 1996, BIOCHEM J, V317, P29, DOI 10.1042/bj3170029; NINOMIYATSUJI J, 1991, P NATL ACAD SCI USA, V88, P9006, DOI 10.1073/pnas.88.20.9006; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; NOZAWA Y, 1988, PHYSL REGULATION MEM, P239; NOZAWA Y, 1979, BIOCH PHYSL PROTOZOA, V2, P275; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Rose MD., 1990, METHODS YEAST GENETI; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; SWANSON RV, 1994, TRENDS BIOCHEM SCI, V19, P485, DOI 10.1016/0968-0004(94)90135-X; TAKEMASA T, 1990, J BIOL CHEM, V265, P2514; Thompson G.A. Jr, 1984, Biomembranes, V12, P397; UMEKI S, 1982, BIOCHEM INT, V4, P101; UMEKI S, 1993, ADV CELL MOL BIOL M, V2, P447; WELSH J, 1992, NUCLEIC ACIDS RES, V20, P4965, DOI 10.1093/nar/20.19.4965; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; WILSON C, 1993, PLANT MOL BIOL, V23, P543, DOI 10.1007/BF00019302; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289	56	25	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					9976	9983		10.1074/jbc.274.15.9976	http://dx.doi.org/10.1074/jbc.274.15.9976			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187773	hybrid			2022-12-27	WOS:000079663500012
J	Pilcher, BK; Dumin, J; Schwartz, MJ; Mast, BA; Schultz, GS; Parks, WC; Welgus, HG				Pilcher, BK; Dumin, J; Schwartz, MJ; Mast, BA; Schultz, GS; Parks, WC; Welgus, HG			Keratinocyte collagenase-1 expression requires an epidermal growth factor receptor autocrine mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTITIAL COLLAGENASE; FACTOR-ALPHA; GENE-EXPRESSION; TYROSINE KINASE; 92-KDA GELATINASE; TISSUE INHIBITOR; MICE LACKING; EGF RECEPTOR; HUMAN-SKIN; ACTIVATION	In response to cutaneous injury, expression of collagenase-1 is induced in keratinocytes via alpha(2)beta(1) contact with native type I collagen, and enzyme activity is essential for cell migration over this substratum. However, the cellular mechanism(s) mediating integrin signaling remain poorly understood. We demonstrate here that treatment of keratinocytes cultured on type I collagen with epidermal growth factor receptor (EGFR) blocking antibodies or a specific receptor antagonist inhibited cell migration across type I collagen and the matrix-directed stimulation of collagenase-1 production. Additionally, stimulation of collagenase-1 expression by hepatocyte growth factor, transforming growth factor-beta 1, and interferon-gamma was blocked by EGFR inhibitors, suggesting a required EGFR autocrine signaling step for enzyme expression. Collagenase-1 mRNA was not detectable in keratinocytes isolated immediately from normal skin, but increased progressively following 2 h of contact with collagen, In contrast, EGFR mRNA was expressed at high steady-state levels in keratinocytes isolated immediately from intact skin but was absent following 2 h cell contact with collagen, suggesting down-regulation following receptor activation. Indeed, tyrosine phosphorylation of the EGFR was evident as early as 10 min following cell contact with collagen, Treatment of keratinocytes cultured on collagen with EGFR antagonist or heparin-binding (HB)-EGF neutralizing antibodies dramatically inhibited the sustained expression (6-24 h) of collagenase-1 mRNA, whereas initial induction by collagen alone (2 h) was unaffected. Finally, expression of collagenase-1 in ex vivo wounded skin and re-epithelialization of partial thickness porcine burn wounds was blocked following treatment with EGFR inhibitors. These results demonstrate that keratinocyte contact with type I collagen is sufficient to induce collagenase-1 expression, whereas sustained enzyme production requires autocrine EGFR activation by HB-EGF as an obligatory intermediate step, thereby maintaining collagenase-l-dependent migration during the re-epithelialization of epidermal wounds.	Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Univ Florida, Hlth Sci Ctr, Dept Obstet & Gynecol, Gainesville, FL 32610 USA; Univ Florida, Hlth Sci Ctr, Dept Surg, Gainesville, FL 32610 USA	Washington University (WUSTL); Washington University (WUSTL); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Pilcher, BK (corresponding author), Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO 63110 USA.	bpilcher@im.wustl.edu	Parks, William C./AAH-6786-2021		PHS HHS [K-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BROWN G, 1987, NEW ENGL J MED, V321, P76; BROWN GL, 1986, J EXP MED, V163, P1319; Cha D, 1996, J INVEST DERMATOL, V106, P590, DOI 10.1111/1523-1747.ep12345083; CHEN JD, 1993, EXP CELL RES, V209, P216, DOI 10.1006/excr.1993.1304; CHEN YQ, 1992, J INVEST DERMATOL, V98, P615; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOPER TW, 1982, COLLAGEN REL RES, V3, P205; CYBULSKY AV, 1994, J CLIN INVEST, V94, P68, DOI 10.1172/JCI117350; Doyle GAR, 1997, J BIOL CHEM, V272, P11840, DOI 10.1074/jbc.272.18.11840; Dunsmore SE, 1996, J BIOL CHEM, V271, P24576, DOI 10.1074/jbc.271.40.24576; FEN Z, 1993, BIOCHEMISTRY-US, V32, P7932, DOI 10.1021/bi00082a014; FINI ME, 1994, J BIOL CHEM, V269, P11291; Forsyth IA, 1997, MOL CELL ENDOCRINOL, V126, P41, DOI 10.1016/S0303-7207(96)03967-6; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; GULLICK WJ, 1985, PROC R SOC SER B-BIO, V226, P127, DOI 10.1098/rspb.1985.0087; HASHIMOTO K, 1994, J BIOL CHEM, V269, P20060; IMAI T, 1995, BIOL REPROD, V52, P928, DOI 10.1095/biolreprod52.4.928; INOUE M, 1995, J INVEST DERMATOL, V104, P479, DOI 10.1111/1523-1747.ep12605917; JIANG CK, 1993, P NATL ACAD SCI USA, V90, P6786, DOI 10.1073/pnas.90.14.6786; JU WD, 1993, J INVEST DERMATOL, V100, P628; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; LARJAVA H, 1993, J CLIN INVEST, V92, P1425, DOI 10.1172/JCI116719; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; McCawley LJ, 1997, ENDOCRINOLOGY, V138, P121, DOI 10.1210/en.138.1.121; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Mignatti P., 1996, MOL CELLULAR BIOL WO, P427; Nanney LB, 1996, MOL CELLULAR BIOL WO, P171; PALADINI R, 1995, J CELL BIOL, V132, P381; PARKS WC, 1998, MATRIX METALLOPROTEI; PENTLAND AP, 1986, J CLIN INVEST, V77, P246, DOI 10.1172/JCI112283; Pilcher BK, 1997, J BIOL CHEM, V272, P18147, DOI 10.1074/jbc.272.29.18147; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; PROSSER IW, 1989, AM J PATHOL, V135, P1073; SAARIALHOKERE UK, 1993, J BIOL CHEM, V268, P17354; SAARIALHOKERE UK, 1993, J CLIN INVEST, V92, P2858, DOI 10.1172/JCI116906; SAARIALHOKERE UK, 1995, J INVEST DERMATOL, V104, P982, DOI 10.1111/1523-1747.ep12606231; SAARIALHOKERE UK, 1992, J CLIN INVEST, V90, P1952, DOI 10.1172/JCI116073; SAARIALHOKERE UK, 1993, J INVEST DERMATOL, V100, P335, DOI 10.1111/1523-1747.ep12470032; SCHULTZ GS, 1987, SCIENCE, V235, P350, DOI 10.1126/science.3492044; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Stoll S, 1997, J CLIN INVEST, V100, P1271, DOI 10.1172/JCI119641; Stoll SW, 1998, ONCOGENE, V16, P1493, DOI 10.1038/sj.onc.1201657; STOSCHECK CM, 1992, J INVEST DERMATOL, V99, P645, DOI 10.1111/1523-1747.ep12668143; STRICKLIN GP, 1994, J INVEST DERMATOL, V103, P488, DOI 10.1111/1523-1747.ep12395601; STRICKLIN GP, 1978, BIOCHEMISTRY-US, V17, P2331, DOI 10.1021/bi00605a012; SUDBECK BD, 1994, J BIOL CHEM, V269, P30022; Sudbeck BD, 1997, J BIOL CHEM, V272, P22103, DOI 10.1074/jbc.272.35.22103; SWEE MH, 1995, J BIOL CHEM, V270, P14899, DOI 10.1074/jbc.270.25.14899; THEADGILL DW, 1995, SCIENCE, V269, P230; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; WELGUS HG, 1985, J CLIN INVEST, V76, P219, DOI 10.1172/JCI111949; WESTMAYS JA, 1995, P NATL ACAD SCI USA, V92, P6768, DOI 10.1073/pnas.92.15.6768; WOODLEY DT, 1986, J INVEST DERMATOL, V86, P418, DOI 10.1111/1523-1747.ep12285689	54	45	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10372	10381		10.1074/jbc.274.15.10372	http://dx.doi.org/10.1074/jbc.274.15.10372			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187826	hybrid			2022-12-27	WOS:000079663500065
J	Papi, A; Johnston, SL				Papi, A; Johnston, SL			Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappa B-mediated transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELL LINE; COMMON COLD VIRUS; ASTHMATIC SUBJECTS; ALLERGIC SUBJECTS; OLD CHILDREN; IN-VIVO; EXACERBATIONS; INFLAMMATION; STIMULATION; INDUCTION	Virus infections, the majority of which are rhinovirus infections, are the major cause of asthma exacerbations. Treatment is unsatisfactory, and the pathogenesis unclear. Lower airway lymphocyte and eosinophil recruitment and activation are strongly implicated, but the mechanisms regulating these processes are unknown. Intercellular adhesion molecule-1 (ICAM-1) has a central role in inflammatory cell recruitment to the airways in asthma and is the cellular receptor for 90% of rhinoviruses. We hypothesized that rhinovirus infection of lower airway epithelium might induce ICARI-1 expression, promoting both inflammatory cell infiltration and rhinovirus infection. We therefore investigated the effect of rhinovirus infection on respiratory epithelial cell ICAM-1 expression and regulation to identify new targets for treatment of virus-induced asthma exacerbations. We observed that rhinovirus infection of primary bronchial epithelial cells and the A549 respiratory epithelial cell line increased ICAM-1 cell surface expression over 12- and 3-fold, respectively. We then investigated the mechanisms of this induction in A549 cells and observed rhinovirus-induction of ICAM-1 promoter activity and ICAM-1 mRNA transcription. Rhinovirus induction of ICAM-1 promoter activity was critically dependent upon up-regulation of NP-kappa B proteins binding to the -187/-178 NF-kappa B binding site on the ICAM-1 promoter. The principal components of the rhinovirus-induced binding proteins were NF-kappa B p65 homo- or heterodimers. These studies identify ICAM-1 and NF-kappa B as new targets for the development of therapeutic interventions for virus-induced asthma exacerbations.	Univ Southampton, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England	University of Southampton	Johnston, SL (corresponding author), Univ Southampton, Southampton Gen Hosp, Tramona Rd, Southampton SO16 6YD, Hants, England.	slj1@soton.ac.il	Johnston, Sebastian Lennox/I-2423-2012; Papi, alberto/AAC-1888-2019	Johnston, Sebastian Lennox/0000-0003-3009-9200; PAPI, ALBERTO/0000-0002-6924-4500				BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; BENTLEY AM, 1993, J ALLERGY CLIN IMMUN, V92, P857, DOI 10.1016/0091-6749(93)90064-M; Broide DH, 1998, AM J RESP CELL MOL, V18, P218, DOI 10.1165/ajrcmb.18.2.2829; CALHOUN WJ, 1994, J CLIN INVEST, V94, P2200, DOI 10.1172/JCI117581; CHEUNG D, 1995, AM J RESP CRIT CARE, V152, P1490, DOI 10.1164/ajrccm.152.5.7582282; Chin JE, 1998, AM J RESP CELL MOL, V18, P158, DOI 10.1165/ajrcmb.18.2.2565m; CIPRANDI G, 1994, AM J RESP CRIT CARE, V150, P1653, DOI 10.1164/ajrccm.150.6.7524984; CIPRANDI G, 1993, J ALLERGY CLIN IMMUN, V91, P783, DOI 10.1016/0091-6749(93)90198-O; DAMLE NK, 1992, J IMMUNOL, V148, P1985; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doull IJM, 1997, BMJ-BRIT MED J, V315, P858, DOI 10.1136/bmj.315.7112.858; Dumitrascu D., 1997, Journal of Allergy and Clinical Immunology, V99, pS403; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; FRAENKEL DJ, 1995, AM J RESP CRIT CARE, V151, P879; GELEZIUNAS R, 1994, FASEB J, V8, P593, DOI 10.1096/fasebj.8.9.8005387; Gern JE, 1997, AM J RESP CRIT CARE, V155, P1159, DOI 10.1164/ajrccm.155.3.9117003; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Grunberg K, 1997, AM J RESP CRIT CARE, V156, P609; HALPERIN SA, 1985, AM REV RESPIR DIS, V132, P976; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; Johnston SL, 1998, J IMMUNOL, V160, P6172; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Johnston SL, 1995, DIAGNOSTIC PROCEDURE, P553; Kaur B, 1998, BRIT MED J, V316, P118; KEDINGER C, 1970, BIOCHEM BIOPH RES CO, V38, P165, DOI 10.1016/0006-291X(70)91099-5; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; LEMANSKE RF, 1989, J CLIN INVEST, V83, P1, DOI 10.1172/JCI113843; Maniatis T., 1989, MOL CLONING LAB MANU; MANOLITSAS ND, 1994, EUR RESPIR J, V7, P1438; Mastronarde JG, 1996, J INFECT DIS, V174, P262, DOI 10.1093/infdis/174.2.262; MULLER S, 1995, J INVEST DERMATOL, V104, P970, DOI 10.1111/1523-1747.ep12606225; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Sanders SP, 1998, J VIROL, V72, P934, DOI 10.1128/JVI.72.2.934-942.1998; SCHNEIDERSCHAULIES J, 1995, P NATL ACAD SCI USA, V92, P3943, DOI 10.1073/pnas.92.9.3943; SEMNANI RT, 1994, J EXP MED, V180, P2125, DOI 10.1084/jem.180.6.2125; SHARON RF, 1998, AM J RESP CRIT CARE, V157, P22; SUBAUSTE MC, 1995, J CLIN INVEST, V96, P549, DOI 10.1172/JCI118067; Terajima M, 1997, AM J PHYSIOL-LUNG C, V273, pL749, DOI 10.1152/ajplung.1997.273.4.L749; UNCAPHER CR, 1991, VIROLOGY, V180, P814, DOI 10.1016/0042-6822(91)90098-V; VAN SG, 1990, J IMMUNOL, V144, P4579; VANDESTOLPE A, 1994, J BIOL CHEM, V269, P6185; VANSEVENTER GA, 1991, J EXP MED, V174, P901, DOI 10.1084/jem.174.4.901; VIGNOLA AM, 1993, AM REV RESPIR DIS, V148, P689, DOI 10.1164/ajrccm/148.3.689; WEGNER CD, 1990, SCIENCE, V247, P456, DOI 10.1126/science.1967851; WILSON NM, 1990, ARCH DIS CHILD, V65, P407, DOI 10.1136/adc.65.4.407; WITEK TJ, 1995, J ALLERGY CLIN IMMUN, V95, P258; Zhu Z, 1996, J CLIN INVEST, V97, P421, DOI 10.1172/JCI118431	50	265	274	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9707	9720		10.1074/jbc.274.14.9707	http://dx.doi.org/10.1074/jbc.274.14.9707			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092659	hybrid			2022-12-27	WOS:000079451800078
J	Bendetowicz, AV; Wise, RJ; Gilbert, GE				Bendetowicz, AV; Wise, RJ; Gilbert, GE			Collagen-bound von Willebrand factor has reduced affinity for factor VIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR VWF CDNA; VONWILLEBRAND-FACTOR; BINDING-SITE; HETEROLOGOUS CELLS; FACTOR ASSOCIATION; PLATELET-ADHESION; ENDOTHELIAL-CELLS; LIGHT-CHAIN; PROTEIN; MULTIMERS	von Willebrand factor (vWf) is a multimeric adhesive glycoprotein that serves as a carrier for factor VIII in plasma. Although each vWf subunit displays a high affinity binding site for factor VIII in vitro, in plasma, only 2% of the vWf sites for factor VIII are occupied. We investigated whether interaction of plasma proteins with vWf or adhesion of vWf to collagen may alter the affinity or availability of factor VIII-binding sites on vWf, When vWf was immobilized on agarose-linked monoclonal antibody, factor VIII bound to vWf with high affinity, and neither the affinity nor binding site availability was influenced by the presence of 50% plasma. Therefore, plasma proteins do not alter the affinity or availability of factor Vm-binding sites. In contrast, when vWf was immobilized on agarose-linked collagen, its affinity for factor VIII was reduced 4-fold, with K-D increasing from 0.9 to 3.8 nM, However, one factor VIII-binding site remained available on each vWf subunit. A comparable reduction in affinity for factor VIII was observed when vWf was a constituent of the subendothelial cell matrix and when it was bound to purified type VI collagen. In parallel with the decreased affinity for factor VIII, collagen-bound vWf displayed a 6-fold lower affinity for monoclonal antibody W5-6A, with an epitope composed of residues 78-96 within the factor VIII-binding motif of vWf, We conclude that collagen induces a conformational change within the factor VIII-binding motif of vWf that lowers the affinity for factor VIII.	Brockton W Roxbury Vet Affairs Med Ctr, Dept Med, W Roxbury, MA 02132 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Gilbert, GE (corresponding author), Brockton W Roxbury Vet Affairs Med Ctr, Dept Med, 1400 VFW Pkwy, W Roxbury, MA 02132 USA.	ggilbert@massmed.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL042443] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL42443] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAHOU WF, 1989, J CLIN INVEST, V84, P56, DOI 10.1172/JCI114169; BARUCH D, 1991, BLOOD, V77, P519; Bendetowicz AV, 1998, BLOOD, V92, P529, DOI 10.1182/blood.V92.2.529.414k31_529_538; BONTHRON DT, 1986, NATURE, V324, P270, DOI 10.1038/324270a0; CHOW TW, 1992, BLOOD, V80, P113; CRUZ MA, 1993, J BIOL CHEM, V268, P21238; CRUZ MA, 1995, J BIOL CHEM, V270, P10822, DOI 10.1074/jbc.270.18.10822; DUFFY EJ, 1992, J BIOL CHEM, V267, P17006; FAY PJ, 1991, J BIOL CHEM, V266, P2172; FOSTER PA, 1987, J BIOL CHEM, V262, P8443; GILBERT GE, 1992, J BIOL CHEM, V267, P15861; GILBERT GE, 1991, J BIOL CHEM, V266, P17261; GOTO S, 1995, J BIOL CHEM, V270, P23352, DOI 10.1074/jbc.270.40.23352; HITRAYA EG, 1995, LAB INVEST, V73, P393; HOUDIJK WPM, 1985, J CLIN INVEST, V75, P531, DOI 10.1172/JCI111729; HOYER LW, 1980, BLOOD, V55, P1056; LAJMANOVICH A, 1981, BIOCHIM BIOPHYS ACTA, V678, P132, DOI 10.1016/0304-4165(81)90056-8; LEYTE A, 1989, BIOCHEM J, V257, P679, DOI 10.1042/bj2570679; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; LOLLAR P, 1987, J BIOL CHEM, V262, P17572; LOSCALZO J, 1986, J CLIN INVEST, V78, P1112, DOI 10.1172/JCI112668; MANN KG, 1990, BLOOD, V76, P1; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; MAZURIER C, 1992, THROMB HAEMOSTASIS, V67, P391; NESHEIM M, 1991, J BIOL CHEM, V266, P17815; NESHEIM ME, 1988, J BIOL CHEM, V263, P16467; NISHINO M, 1989, BLOOD, V74, P1591; Rand JH, 1997, THROMB HAEMOSTASIS, V78, P445; RUGGERI ZM, 1981, BLOOD, V57, P1140; SADLER JE, 1985, P NATL ACAD SCI USA, V82, P6394, DOI 10.1073/pnas.82.19.6394; SADLER JE, 1991, J BIOL CHEM, V266, P22777; Saenko EL, 1997, J BIOL CHEM, V272, P18007, DOI 10.1074/jbc.272.29.18007; SAKARIASSEN KS, 1979, NATURE, V279, P636, DOI 10.1038/279636a0; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; VERWEIJ CL, 1986, EMBO J, V5, P1839, DOI 10.1002/j.1460-2075.1986.tb04435.x; VERWEIJ CL, 1987, EMBO J, V6, P2885, DOI 10.1002/j.1460-2075.1987.tb02591.x; VLOT AJ, 1995, BLOOD, V85, P3150, DOI 10.1182/blood.V85.11.3150.bloodjournal85113150; Vlot AJ, 1996, BLOOD, V87, P1809; WAGNER DD, 1984, J CELL BIOL, V99, P2123, DOI 10.1083/jcb.99.6.2123; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; WISE RJ, 1991, J BIOL CHEM, V266, P21948; WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9; ZUCKER MB, 1983, THROMB HAEMOSTASIS, V49, P37	43	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12300	12307		10.1074/jbc.274.18.12300	http://dx.doi.org/10.1074/jbc.274.18.12300			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212199	hybrid			2022-12-27	WOS:000080056800019
J	Ni, L; Heard, TS; Weiner, H				Ni, L; Heard, TS; Weiner, H			In vivo mitochondrial import - A comparison of leader sequence charge and structural relationships with the in vitro model resulting in evidence for co-translational import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F1-ATPASE BETA-SUBUNIT; MICROSOMAL ALDEHYDE DEHYDROGENASE; GREEN FLUORESCENT PROTEIN; YEAST MITOCHONDRIA; ORNITHINE TRANSCARBAMYLASE; ASPARTATE-AMINOTRANSFERASE; PHOSPHOLIPID-BILAYERS; PROCESSING PEPTIDASE; SYNTHESIZED PROTEINS; NEUROSPORA-CRASSA	The positive charges and structural properties of the mitochondrial leader sequence of aldehyde dehydrogenase have been extensively studied in vitro, The results of these studies showed that increasing the helicity of this leader would compensate for reduced import from positive charge substitutions of arginine with glutamine or the insertion of negative charged residues made in the native leader. In this in vivo study, utilizing the green fluorescent protein (GFP) as a passenger protein, import results showed the opposite effect with respect to helicity, but the results from mutations made within the native leader sequence were consistent between the in vitro and in vivo experiments. Leader mutations that reduced the efficiency of import resulted in a cytosolic accumulation of a truncated GFP chimera that was fluorescent but devoid of a mitochondrial leader. The native leader efficiently imported before GFP could achieve a stable, import-incompetent structure, suggesting that import was coupled with translation. As a test for a co-translational mechanism, a chimera of GFP that contained the native leader of aldehyde dehydrogenase attached at the N terminus and a C-terminal endoplasmic reticulum targeting signal attached to the C terminus of GFP was constructed. This chimera was localized exclusively to mitochondria, The import result with the dual signal chimera provides support for a co-translational mitochondrial import pathway.	Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Weiner, H (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.	weiner@biochem.purdue.edu			NIAAA NIH HHS [AA10795] Funding Source: Medline; NIGMS NIH HHS [GM53269] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010795] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ADES IZ, 1980, J BIOL CHEM, V255, P9925; ADES IZ, 1980, J BIOL CHEM, V255, P9918; ARRETZ M, 1994, J BIOL CHEM, V269, P4959; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BEDWELL DM, 1989, MOL CELL BIOL, V9, P1014, DOI 10.1128/MCB.9.3.1014; BEDWELL DM, 1987, MOL CELL BIOL, V7, P4038, DOI 10.1128/MCB.7.11.4038; BRUCH MD, 1992, BIOCHIM BIOPHYS ACTA, V1159, P81, DOI 10.1016/0167-4838(92)90078-R; CHEN WJ, 1987, J BIOL CHEM, V262, P15598; Chupin V, 1996, BIOCHEMISTRY-US, V35, P3141, DOI 10.1021/bi952482a; CLARK BJ, 1991, J BIOL CHEM, V266, P5898; Crowley KS, 1998, J BIOL CHEM, V273, P17278, DOI 10.1074/jbc.273.27.17278; FUJIKI M, 1991, J BIOL CHEM, V266, P6841; FUJIKI M, 1993, J BIOL CHEM, V268, P1914; GASSER SM, 1982, J BIOL CHEM, V257, P3034; HALLERMAYER G, 1977, EUR J BIOCHEM, V81, P523, DOI 10.1111/j.1432-1033.1977.tb11978.x; Hammen PK, 1996, J BIOL CHEM, V271, P21041, DOI 10.1074/jbc.271.35.21041; Hammen PK, 1996, BIOCHEMISTRY-US, V35, P3772, DOI 10.1021/bi951848g; Heard TS, 1998, J BIOL CHEM, V273, P29389, DOI 10.1074/jbc.273.45.29389; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HORWICH AL, 1986, CELL, V44, P451, DOI 10.1016/0092-8674(86)90466-6; HORWICH AL, 1987, J CELL BIOL, V105, P669, DOI 10.1083/jcb.105.2.669; HORWICH AL, 1985, P NATL ACAD SCI USA, V82, P4930, DOI 10.1073/pnas.82.15.4930; JARVIS JA, 1995, J BIOL CHEM, V270, P1323, DOI 10.1074/jbc.270.3.1323; JOHNSON MK, 1960, BIOCHEM J, V77, P610, DOI 10.1042/bj0770610; KARSLAKE C, 1990, BIOCHEMISTRY-US, V29, P9872, DOI 10.1021/bi00494a017; KELLEMS RE, 1974, J BIOL CHEM, V249, P3297; KELLEMS RE, 1975, J CELL BIOL, V65, P1, DOI 10.1083/jcb.65.1.1; KELLEMS RE, 1974, J BIOL CHEM, V249, P3304; King T.E., 1967, METHODS ENZYMOL, P216, DOI DOI 10.1016/0076-6879(67)10043-8; Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886; LAIN B, 1994, J BIOL CHEM, V269, P15588; Lithgow T, 1997, TRENDS BIOCHEM SCI, V22, P110, DOI 10.1016/S0968-0004(97)01007-4; MACCECCHINI ML, 1979, P NATL ACAD SCI USA, V76, P343, DOI 10.1073/pnas.76.1.343; Makino Y, 1997, J BIOL CHEM, V272, P12468, DOI 10.1074/jbc.272.19.12468; MASAKI R, 1994, J CELL BIOL, V126, P1407, DOI 10.1083/jcb.126.6.1407; Masters B, 1967, METHOD ENZYMOL, V10, P565; MATSUURA S, 1978, J CELL BIOL, V78, P503, DOI 10.1083/jcb.78.2.503; MIYAUCHI K, 1991, J BIOL CHEM, V266, P19536; MORITA T, 1982, EUR J BIOCHEM, V122, P501; MOYACAMARENA SY, 1995, PROTOPLASMA, V188, P151, DOI 10.1007/BF01280366; RAYMOND Y, 1979, J BIOL CHEM, V254, P9335; REID GA, 1982, J BIOL CHEM, V257, P3056; REID GA, 1982, J BIOL CHEM, V257, P3062; ROISE D, 1992, P NATL ACAD SCI USA, V89, P608, DOI 10.1073/pnas.89.2.608; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; Segade F, 1996, J BIOL CHEM, V271, P12343, DOI 10.1074/jbc.271.21.12343; Sjoling S, 1996, EUR J BIOCHEM, V242, P114, DOI 10.1111/j.1432-1033.1996.0114r.x; SKERJANC IS, 1988, J BIOL CHEM, V263, P17233; SONDEREGGER P, 1982, J BIOL CHEM, V257, P3339; TERADA K, 1995, MOL CELL BIOL, V15, P3708; THORNTON K, 1993, J BIOL CHEM, V268, P19906; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WANG Y, 1994, BIOCHEMISTRY-US, V33, P12860, DOI 10.1021/bi00209a018; WANG Y, 1993, J BIOL CHEM, V268, P4759; WIENHUES U, 1991, J CELL BIOL, V115, P1601, DOI 10.1083/jcb.115.6.1601; Yano M, 1997, J BIOL CHEM, V272, P8459, DOI 10.1074/jbc.272.13.8459; YASUKOCHI Y, 1976, J BIOL CHEM, V251, P5337; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; ZIMMERMANN R, 1980, EUR J BIOCHEM, V109, P217, DOI 10.1111/j.1432-1033.1980.tb04787.x	61	57	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12685	12691		10.1074/jbc.274.18.12685	http://dx.doi.org/10.1074/jbc.274.18.12685			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212250	hybrid			2022-12-27	WOS:000080056800070
J	Boisfer, E; Lambert, G; Atger, V; Tran, NQ; Pastier, D; Benetollo, C; Trottier, JF; Beaucamps, I; Antonucci, M; Laplaud, M; Griglio, S; Chambaz, J; Kalopissis, AD				Boisfer, E; Lambert, G; Atger, V; Tran, NQ; Pastier, D; Benetollo, C; Trottier, JF; Beaucamps, I; Antonucci, M; Laplaud, M; Griglio, S; Chambaz, J; Kalopissis, AD			Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; HEPATIC LIPASE; TANGIER DISEASE; KNOCKOUT MICE; PLASMA; ATHEROSCLEROSIS; TRIGLYCERIDE; CHOLESTEROL; PARTICLES; HYPERCHOLESTEROLEMIA	Two lines of transgenic mice, hAIItg-delta and hAIItg-lambda, expressing human apolipoprotein (apo)A-II at 2 and 4 times the normal concentration, respectively, displayed on standard chow postprandial chylomicronemia, large quantities of very low density lipoprotein (VLDL) and low density lipoprotein (LDL) but greatly reduced high density lipoprotein (HDL), Hypertriglyceridemia may result from increased VLDL production, decreased VLDL catabolism, or both. Post-Triton VLDL production was comparable in transgenic and control mice. Postheparin lipoprotein lipase (LPL) and hepatic lipase activities decreased at most by 30% in transgenic mice, whereas adipose tissue and muscle LPL activities were unaffected, indicating normal LPL synthesis. However, VLDL-triglyceride hydrolysis by exogenous LPL was considerably slower in transgenic compared with control mice, with the apparent V-max of the reaction decreasing proportionately to human apoA-II expression. Human apoA-II was present in appreciable amounts in the VLDL of transgenic mice, which also carried apoC-II. The addition of purified apoA-II in postheparin plasma from control mice induced a dose-dependent decrease in LPL and hepatic lipase activities. In conclusion, overexpression of human apoA-II in transgenic mice induced the proatherogenic lipoprotein profile of low plasma HDL and postprandial hypertriglyceridemia because of decreased VLDL catabolism by LPL.	Inst Biomed Cordeliers, INSERM, U505, F-75006 Paris, France; Hop Broussais, Biochim Lab, F-75014 Paris, France; Hop La Pitie Salpetriere, INSERM, U321, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Kalopissis, AD (corresponding author), Inst Biomed Cordeliers, INSERM, U505, 15 Rue Ecole Med, F-75006 Paris, France.			Lambert, Gilles/0000-0001-5632-0685				AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Alaupovic P, 1997, ARTERIOSCL THROM VAS, V17, P715, DOI 10.1161/01.ATV.17.4.715; ALAUPOVIC P, 1991, J LIPID RES, V32, P9; Banka CL, 1996, CURR OPIN LIPIDOL, V7, P139, DOI 10.1097/00041433-199606000-00005; BEKAERT ED, 1993, J LIPID RES, V34, P111; Benlian P, 1996, NEW ENGL J MED, V335, P848, DOI 10.1056/NEJM199609193351203; BRASSEUR R, 1992, PROTEINS, V13, P246, DOI 10.1002/prot.340130307; Castellani LW, 1997, J CLIN INVEST, V100, P464, DOI 10.1172/JCI119554; Ebara T, 1997, J CLIN INVEST, V99, P2672, DOI 10.1172/JCI119456; Escola-Gil JC, 1998, J LIPID RES, V39, P457; FIELDING CJ, 1995, J LIPID RES, V36, P211; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRANCONE OL, 1989, BIOCHIM BIOPHYS ACTA, V1002, P28, DOI 10.1016/0005-2760(89)90060-X; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; HOMANICS GE, 1995, J BIOL CHEM, V270, P2974, DOI 10.1074/jbc.270.7.2974; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; KALOPISSIS AD, 1982, BIOCHIM BIOPHYS ACTA, V711, P33, DOI 10.1016/0005-2760(82)90006-6; Koren E, 1996, ATHEROSCLEROSIS, V122, P105, DOI 10.1016/0021-9150(95)05791-9; KUBO M, 1982, J BIOCHEM, V92, P865, DOI 10.1093/oxfordjournals.jbchem.a134000; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGOCKI PA, 1980, J BIOL CHEM, V255, P3701; LOPEZ J, 1994, BIOCHEMISTRY-US, V33, P4056, DOI 10.1021/bi00179a034; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MarzalCasacuberta A, 1996, J BIOL CHEM, V271, P6720, DOI 10.1074/jbc.271.12.6720; Mowri HO, 1996, ARTERIOSCL THROM VAS, V16, P755, DOI 10.1161/01.ATV.16.6.755; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; NILSSONEHLE P, 1977, ARTERY, V3, P194; OTWAY S, 1967, J PHYSIOL-LONDON, V190, P321, DOI 10.1113/jphysiol.1967.sp008211; PETERSON J, 1986, BIOCHIM BIOPHYS ACTA, V878, P65, DOI 10.1016/0005-2760(86)90344-9; Plump AS, 1997, J LIPID RES, V38, P1033; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rader DJ, 1996, CURR OPIN LIPIDOL, V7, P117, DOI 10.1097/00041433-199606000-00002; SCHMITZ G, 1983, J LIPID RES, V24, P1021; Schultz Joshua R., 1994, Current Opinion in Lipidology, V5, P126, DOI 10.1097/00041433-199404000-00009; SCHULTZ JR, 1993, NATURE, V365, P762, DOI 10.1038/365762a0; SCHULTZ JR, 1992, J BIOL CHEM, V267, P21630; SHACHTER NS, 1994, J CLIN INVEST, V93, P1683, DOI 10.1172/JCI117151; Shachter NS, 1996, J CLIN INVEST, V98, P846, DOI 10.1172/JCI118857; SHINOMIYA M, 1982, BIOCHIM BIOPHYS ACTA, V713, P292; TALL AR, 1978, NEW ENGL J MED, V299, P1232, DOI 10.1056/NEJM197811302992207; THUREN T, 1991, J BIOL CHEM, V266, P4853; Vega GL, 1996, CURR OPIN LIPIDOL, V7, P209, DOI 10.1097/00041433-199608000-00007; WANG CS, 1987, BIOCHIM BIOPHYS ACTA, V920, P9, DOI 10.1016/0005-2760(87)90305-5; WANG CS, 1992, BIOCHIM BIOPHYS ACTA, V1123, P1, DOI 10.1016/0005-2760(92)90165-R; WARDEN CH, 1993, SCIENCE, V261, P469, DOI 10.1126/science.8332912; Weng W, 1996, P NATL ACAD SCI USA, V93, P14788, DOI 10.1073/pnas.93.25.14788; WILLIAMSON R, 1992, P NATL ACAD SCI USA, V89, P7134, DOI 10.1073/pnas.89.15.7134; WU AL, 1981, J BIOL CHEM, V256, P3615; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; ZHONG SB, 1994, J CLIN INVEST, V94, P2457, DOI 10.1172/JCI117614	50	83	84	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11564	11572		10.1074/jbc.274.17.11564	http://dx.doi.org/10.1074/jbc.274.17.11564			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206963	hybrid			2022-12-27	WOS:000079834800019
J	Chan, PP; Lin, M; Faruqi, AF; Powell, J; Seidman, MM; Glazer, PM				Chan, PP; Lin, M; Faruqi, AF; Powell, J; Seidman, MM; Glazer, PM			Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-HELICAL DNA; HOMOLOGOUS RECOMBINATION; PSORALEN PHOTOADDUCTS; GENOMIC DNA; MUTAGENESIS; CLEAVAGE; REPAIR; SITE; EXPRESSION; NUCLEASE	Tripler-forming oligonucleotides (TFOs) can bind to polypurine/polypyrimidine regions in DNA in a sequence-specific manner and provoke DNA repair. We have coupled a TFO to a short donor fragment of DNA that shares homology to a selected gene as a strategy to mediate gene targeting and correction. In this bifunctional oligonucleotide, the TFO domain is designed to bind the target gene and stimulate repair and recombination, with the donor domain positioned for recombination and information transfer. A series of these tethered donor-TFO (TD-TFO) molecules with donor domains of 40-44 nucleotides and TFO domains in both the purine and pyrimidine tripler motifs were tested for their ability to mediate either gene correction or mutation of a supF reporter gene contained in a SV40 shuttle vector in mammalian cells. In vitro binding assays revealed that the attachment of the donor domain via a flexible linker did not significantly alter the binding affinity of the TFO domain for the polypurine site in the supF target DNA, with equilibrium dissociation constants in the 10(-8) M range. Experiments in which the target vector and the linked TD-TFOs were pre-incubated in vitro and co-transfected into cells led to conversion frequencies approaching 1%, 4-fold greater than with the two domains unlinked, When cells that had been previously transfected with the SV40 vector were electroporated with the TD-TFOs, frequencies of base pair-specific gene correction were seen in the range of 0.04%, up to 50-fold over background and at least 3-fold over either domain alone or in unlinked combinations. Sequence conversion by the TD-TFOs was achieved using either single- or double-stranded donor domains and either tripler motif, Substitution of either domain in the TD-TFO with control sequences yielded reagents with diminished activity, as did mixtures of unlinked TFO and donor DNA segments, The boost in activity provided by the attached TFO domain was reduced in cells deficient in the nucleotide excision repair factor XPA but was restored in a subclone of these cells expressing XPA cDNA, suggesting a role for nucleotide excision repair in the pathway of triple helix-stimulated gene conversion. The ability to correct or mutate a specific target site in mammalian cells using the TD-TFO strategy may provide a useful tool for research and possibly for therapeutic applications.	Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; NIA, NIH, Baltimore, MD 21224 USA	Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Glazer, PM (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, POB 206040, New Haven, CT 06520 USA.		Glazer, Peter/S-7651-2019	Glazer, Peter/0000-0003-4525-5560	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205, R01GM054731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000738] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM07205, GM54731] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Belousov ES, 1997, NUCLEIC ACIDS RES, V25, P3440, DOI 10.1093/nar/25.17.3440; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHENG AJ, 1994, NUCLEIC ACIDS RES, V22, P4742, DOI 10.1093/nar/22.22.4742; ColeStrauss A, 1996, SCIENCE, V273, P1386, DOI 10.1126/science.273.5280.1386; Faruqi AF, 1996, MOL CELL BIOL, V16, P6820; FOLGER KR, 1982, MOL CELL BIOL, V2, P1372, DOI 10.1128/MCB.2.11.1372; Gunther EJ, 1996, PHOTOCHEM PHOTOBIOL, V63, P207, DOI 10.1111/j.1751-1097.1996.tb03015.x; HAVRE PA, 1993, P NATL ACAD SCI USA, V90, P7879, DOI 10.1073/pnas.90.16.7879; HAVRE PA, 1993, J VIROL, V67, P7324, DOI 10.1128/JVI.67.12.7324-7331.1993; Kunzelmann K, 1996, GENE THER, V3, P859; LANDGRAF R, 1994, BIOCHEMISTRY-US, V33, P10607, DOI 10.1021/bi00201a006; LEVY DD, 1995, CARCINOGENESIS, V16, P1557, DOI 10.1093/carcin/16.7.1557; Majumdar A, 1998, NAT GENET, V20, P212, DOI 10.1038/2530; MOSER HE, 1987, SCIENCE, V238, P645, DOI 10.1126/science.3118463; PEI DH, 1990, P NATL ACAD SCI USA, V87, P9858, DOI 10.1073/pnas.87.24.9858; POVSIC TJ, 1990, J AM CHEM SOC, V112, P9428, DOI 10.1021/ja00181a075; REEVES R, 1985, NUCLEIC ACIDS RES, V13, P3599, DOI 10.1093/nar/13.10.3599; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; RUBNITZ J, 1984, MOL CELL BIOL, V4, P2253, DOI 10.1128/MCB.4.11.2253; SEDIVY JM, 1992, GENE TARGETING; SEGAL DJ, 1995, P NATL ACAD SCI USA, V92, P806, DOI 10.1073/pnas.92.3.806; STROBEL SA, 1988, J AM CHEM SOC, V110, P7927, DOI 10.1021/ja00231a082; TAKASUGI M, 1991, P NATL ACAD SCI USA, V88, P5602, DOI 10.1073/pnas.88.13.5602; WANG G, 1995, J BIOL CHEM, V270, P22595, DOI 10.1074/jbc.270.38.22595; WANG G, 1995, MOL CELL BIOL, V15, P1759; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; WANG YY, 1988, MOL CELL BIOL, V8, P196, DOI 10.1128/MCB.8.1.196	27	105	117	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11541	11548		10.1074/jbc.274.17.11541	http://dx.doi.org/10.1074/jbc.274.17.11541			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206960	hybrid			2022-12-27	WOS:000079834800016
J	Muller, HM; Dimopoulos, G; Blass, C; Kafatos, FC				Muller, HM; Dimopoulos, G; Blass, C; Kafatos, FC			A hemocyte-like cell line established from the malaria vector Anopheles gambiae expresses six prophenoloxidase genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-PHENOL-OXIDASE; MOLECULAR-CLONING; MELANOTIC ENCAPSULATION; ARMIGERES SUBALBATUS; IMMUNE-RESPONSE; MANDUCA-SEXTA; HOST-DEFENSE; BOMBYX-MORI; MOSQUITO; CDNA	Cell lines from the malaria vector Anopheles gambiae have been established as a tool for the study of the mosquito innate immune system in vitro. Here, we describe the first continuous insect cell line that produces prophenoloxidase (PPO), This cell line (4a-3B) expresses constitutively six PPO genes, three of which are novel (PPO4, PPO5, and PPO6), The PPO genes show distinct temporal expression profiles in the intact mosquito, spanning stages from the embryo to the adult in an overlapping manner. Transient induction of larva-specific PPO genes in blood-fed adult females suggests that the developmental hormone 20-hydroxyecdysone may be involved in PPO gene regulation. Indeed, exposure of 4a-3B cells to 20-hydroxyecdysone in culture results in induction of those PPO genes that are mainly expressed in early developmental stages, and repression of PPO5, which is preferentially expressed at the adult stage. The cell line shows bacteria-induced immune transcripts that encode defensin and Gram-negative bacteria-binding protein, but no induction of PPO transcripts. This cell line most likely derives from a hemocyte lineage, and represents an appropriate in vitro model for the study of the humoral and cellular immune defenses of A. gambiae.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Muller, HM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.			Muller, Hans-Michael/0000-0002-2384-7285; Dimopoulos, George/0000-0001-6755-8111				Ashida M., 1990, P239; ASHIDA M, 1995, P NATL ACAD SCI USA, V92, P10698, DOI 10.1073/pnas.92.23.10698; ASHIDA M, 1988, TISSUE CELL, V20, P599, DOI 10.1016/0040-8166(88)90061-4; ASHIDA M, 1981, INSECT BIOCHEM, V11, P57, DOI 10.1016/0020-1790(81)90041-X; Ashida Masaaki, 1998, P135; ASPAN A, 1995, P NATL ACAD SCI USA, V92, P939, DOI 10.1073/pnas.92.4.939; Barillas-Mury C., 1996, EMBO Journal, V15, P4961; Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; BREY PT, 1991, ANAL BIOCHEM, V194, P359, DOI 10.1016/0003-2697(91)90241-K; BREY PT, 1995, EXP PARASITOL, V80, P654, DOI 10.1006/expr.1995.1081; Cho WL, 1998, INSECT MOL BIOL, V7, P31, DOI 10.1046/j.1365-2583.1998.71049.x; Clements AN., 1992, BIOL MOSQUITOES DEV; COLLINS FH, 1994, SCIENCE, V264, P1874, DOI 10.1126/science.8009215; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; COLUZZI M, 1992, PARASITOL TODAY, V8, P113, DOI 10.1016/0169-4758(92)90277-9; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; DRIF L, 1983, DEV COMP IMMUNOL, V7, P687, DOI 10.1016/0145-305X(83)90094-0; Foley D.A., 1978, Comparative Pathobiology, V4, P113; FUJIMOTO K, 1995, P NATL ACAD SCI USA, V92, P7769, DOI 10.1073/pnas.92.17.7769; GAYKEMA WPJ, 1984, NATURE, V309, P23, DOI 10.1038/309023a0; HALL M, 1995, P NATL ACAD SCI USA, V92, P7764, DOI 10.1073/pnas.92.17.7764; HARA T, 1993, COMP BIOCHEM PHYS B, V106, P287, DOI 10.1016/0305-0491(93)90302-L; HERNANDEZ VP, 1994, AM J TROP MED HYG, V50, P440, DOI 10.4269/ajtmh.1994.50.440; HIRUMA K, 1988, DEV BIOL, V130, P87, DOI 10.1016/0012-1606(88)90416-2; Hoffmann JA, 1997, TRENDS CELL BIOL, V7, P309, DOI 10.1016/S0962-8924(97)01087-8; Jiang HB, 1997, INSECT BIOCHEM MOLEC, V27, P693, DOI 10.1016/S0965-1748(97)00045-3; Jiang HB, 1997, INSECT BIOCHEM MOLEC, V27, P835, DOI 10.1016/S0965-1748(97)00066-0; KAAYA GP, 1982, J MORPHOL, V173, P351, DOI 10.1002/jmor.1051730310; KAWABATA T, 1995, P NATL ACAD SCI USA, V92, P7774, DOI 10.1073/pnas.92.17.7774; Komano H., 1988, P75; Kumar V., 1994, Insect Molecular Biology, V3, P41, DOI 10.1111/j.1365-2583.1994.tb00149.x; Lee SY, 1998, EUR J BIOCHEM, V254, P50, DOI 10.1046/j.1432-1327.1998.2540050.x; Lee WJ, 1998, INSECT MOL BIOL, V7, P41, DOI 10.1046/j.1365-2583.1998.71047.x; LI JY, 1992, DEV COMP IMMUNOL, V16, P41, DOI 10.1016/0145-305X(92)90050-M; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; Muller HM, 1995, EXP PARASITOL, V81, P371, DOI 10.1006/expr.1995.1128; NAPPI AJ, 1993, INSECT IMMUNITY, P131; Park DS, 1997, INSECT BIOCHEM MOLEC, V27, P983, DOI 10.1016/S0965-1748(97)00081-7; PASKEWITZ SM, 1989, J PARASITOL, V75, P594, DOI 10.2307/3282911; Perbal B., 1988, PRACTICAL GUIDE MOL; Pudney M., 1979, TCA (TISSUE CULTURE ASSOCIATION) MANUAL, V5, P997, DOI 10.1007/BF00919719; RICH V, 1995, PHYS WORLD, V8, P14; Richman AM, 1997, EMBO J, V16, P6114, DOI 10.1093/emboj/16.20.6114; Richman AM, 1996, INSECT MOL BIOL, V5, P203, DOI 10.1111/j.1365-2583.1996.tb00055.x; RIZKI TM, 1957, J MORPHOL, V100, P437; SALAZAR CE, 1993, NUCLEIC ACIDS RES, V21, P4147, DOI 10.1093/nar/21.17.4147; SAMAKOVLIS C, 1992, BIOCHEM BIOPH RES CO, V188, P1169, DOI 10.1016/0006-291X(92)91354-S; Sidjanski S, 1997, J PARASITOL, V83, P686, DOI 10.2307/3284247; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; STUBER D, 1990, IMMUNOLOGICAL METHOD, V4, P121; Vernick Kenneth D., 1998, P261; ZHAO XL, 1995, DEV COMP IMMUNOL, V19, P205, DOI 10.1016/0145-305X(95)00005-E; Zheng LB, 1997, ARCH INSECT BIOCHEM, V34, P1, DOI 10.1002/(SICI)1520-6327(1997)34:1<1::AID-ARCH1>3.3.CO;2-R	55	223	246	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11727	11735		10.1074/jbc.274.17.11727	http://dx.doi.org/10.1074/jbc.274.17.11727			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206988	hybrid			2022-12-27	WOS:000079834800044
J	Wang, G; Yang, XM; Zhang, Y; Wang, QM; Chen, HP; Wei, HD; Xing, GC; Hu, ZY; Zhang, CG; Fang, DC; Wu, CT; He, FC				Wang, G; Yang, XM; Zhang, Y; Wang, QM; Chen, HP; Wei, HD; Xing, GC; Hu, ZY; Zhang, CG; Fang, DC; Wu, CT; He, FC			Identification and characterization of receptor for mammalian hepatopoietin that is homologous to yeast ERV1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGENERATIVE STIMULATOR SUBSTANCE; FETAL LIVER-CELLS; GROWTH-FACTOR; RAT-LIVER; PRIMARY CULTURES; HUMAN AUGMENTOR; DNA-SYNTHESIS; HEPATOCYTES; EXPRESSION; CLONING	Hepatopoietin (HPO) is a novel polypeptide mitogen specific for hepatocytes and hepatoma cell lines, which is derived from liver and supports its regeneration. To determine whether HPO acts via a receptor-based signal transduction, recombinant human hepatopoietin was labeled by iodination and used to characterize its binding activity by specific displacement test and Scatchard analysis in primarily cultured rat hepatocytes and human hepatoma Hep-G2 cells. The binding was saturable and specific because it was replaceable by HPO but not by epidermal growth factor, transforming growth factor-alpha, or insulin. Scatchard analysis indicated the presence of a single class of high affinity receptor with dissociation constant (K-d) of 2 and 0.7 pM, and a receptor density of about 10,000 sites/cell and 55,000 sites/cell in the rat hepatocytes and human hepatoma cells, respectively. The K-d values were consistent with the half-maximum dose of HPO activity. Affinity cross-linking of the receptor with I-125-HPO revealed a polypeptide of molecular mass approximately 90 kDa by SDS-polyacrylamide gel electrophoresis. Thus, the molecular mass of the HPO receptor was calculated to be about 75 kDa. These data demonstrated the existence of an HPO receptor in hepatocytes and hepatoma cells, which may account for biological effect.	Chinese Natl Human Genome Ctr, Beijing Inst Radiat Med, Beijing 100850, Peoples R China; Third Mil Med Coll, SW Hosp, Chongqing 400042, Peoples R China	Academy of Military Medical Sciences - China; Army Medical University	He, FC (corresponding author), Chinese Natl Human Genome Ctr, Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China.		Zhang, Chenggang/B-1480-2009	Zhang, Chenggang/0000-0002-4521-3304; Wang, Ge/0000-0003-0571-5745				Adachi H, 1997, J BIOL CHEM, V272, P31217, DOI 10.1074/jbc.272.50.31217; BAGLIONI C, 1985, J BIOL CHEM, V260, P3395; FREYCHET P, 1972, J BIOL CHEM, V247, P3953; HABIBULLAH CM, 1994, TRANSPLANTATION, V58, P951, DOI 10.1097/00007890-199410270-00016; HAGIYA M, 1994, P NATL ACAD SCI USA, V91, P8142, DOI 10.1073/pnas.91.17.8142; He FC, 1997, CHINESE SCI BULL, V42, P1505; HE FC, 1992, HEPATOLOGY, V17, P225; HIGUCHI O, 1991, BIOCHEM BIOPH RES CO, V176, P599, DOI 10.1016/S0006-291X(05)80226-8; LABRECQUE DR, 1991, DIGEST DIS SCI, V36, P669, DOI 10.1007/BF01297036; LABRECQUE DR, 1975, J PHYSIOL-LONDON, V248, P273, DOI 10.1113/jphysiol.1975.sp010973; LISOWSKY T, 1995, GENOMICS, V29, P690, DOI 10.1006/geno.1995.9950; MORLEY CGD, 1972, ANAL BIOCHEM, V45, P298, DOI 10.1016/0003-2697(72)90030-9; MOSHAGE H, 1992, J HEPATOL, V15, P404, DOI 10.1016/0168-8278(92)90078-4; NEUFELD G, 1985, J BIOL CHEM, V260, P3860; PILCH PF, 1979, J BIOL CHEM, V254, P3375; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; TOMITA Y, 1981, EXP CELL RES, V135, P363, DOI 10.1016/0014-4827(81)90172-5; TU Q, 1991, J PATHOPHYSIOL, V7, P537; TU Q, 1990, CHIN J APPL PHYSL, V6, P199; TU Q, 1990, J CELL BIOCHEM, V14, P140; WU CT, 1987, THYMUS, V10, P109; XIE L, 1996, CHIN J APPL PHYSL, V12, P324; Yang XM, 1997, ACTA BIOCH BIOPH SIN, V29, P414; Yang XM, 1998, CHINESE SCI BULL, V43, P1026; Yang XM, 1997, SCI CHINA SER C, V40, P642, DOI 10.1007/BF02882695; YAO ZQ, 1990, HEPATOLOGY, V12, P1144; ZARNEGAR R, 1989, BIOCHEM BIOPH RES CO, V163, P1370, DOI 10.1016/0006-291X(89)91130-3; ZARNEGAR R, 1990, BIOCHEM BIOPH RES CO, V173, P1179, DOI 10.1016/S0006-291X(05)80910-6	28	60	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11469	11472		10.1074/jbc.274.17.11469	http://dx.doi.org/10.1074/jbc.274.17.11469			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206950	hybrid			2022-12-27	WOS:000079834800006
J	Choundhury, GG; Kim, YS; Simon, M; Wozney, J; Harris, S; Ghosh-Choundhury, N; Abboud, HE				Choundhury, GG; Kim, YS; Simon, M; Wozney, J; Harris, S; Ghosh-Choundhury, N; Abboud, HE			Bone morphogenetic protein 2 inhibits platelet-derived growth factor-induced c-fos gene transcription and DNA synthesis in mesangial cells - Involvement of mitogen-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASES; FAMILY MEDIATOR SMAD1; TGF-BETA; SIGNALING PATHWAYS; EYE DEVELOPMENT; MAP KINASE; BMP; DIFFERENTIATION; KIDNEY; NUCLEUS	Bone morphogenetic proteins (BMPs) play an important role in nephrogenesis. The biologic effect and mechanism of action of these proteins in the adult kidney has not yet been studied. We investigated the effect of BMP2, a member of these growth and differentiation factors, on mitogenic signal transduction pathways induced by platelet-derived growth factor (PDGF) in glomerular mesangial cells. PDGF is a growth and survival factor for these cells in vitro and in vivo. Incubation of mesangial cells with increasing concentrations of BMP2 inhibited PDGF-induced DNA synthesis in a dose-dependent manner with maximum inhibition at 250 ng/ml. Immune complex tyrosine kinase assay of PDGF receptor beta immunoprecipitates from lysates of mesangial cells treated with PDGF showed no inhibitory effect of BMP2 on PDGF receptor tyrosine phosphorylation, This indicates that the inhibition of DNA synthesis is likely due to postreceptor events. However, BMP2 significantly inhibited PDGF-stimulated mitogen-activated protein kinase (MAPK) activity that phosphorylates the Elk-1 transcription factor, a component of the ternary complex factor. Using a fusion protein-based reporter assay, we also show that BMP2 blocks PDGF-induced Elk-1-mediated transcription. Furthermore, we demonstrate that BMP2 inhibits PDGF-induced transcription of c-fos gene, a natural target of Elk-1 that normally forms a ternary complex that activates the serum response element of the c-fos gene. These data provide the first evidence that in mesangial cells, BMP2 signaling cross-talks with MAPK-based transcriptional events to inhibit PDGF-induced DNA synthesis. One target for this inhibition is the early response gene c-fos.	Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78284 USA; Audie L Murphy Mem Vet Adm Med Ctr, San Antonio, TX 78284 USA; Inst Genet, Cambridge, MA 01810 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Choundhury, GG (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78284 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190, R01DK043988, R29DK050190] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR44728] Funding Source: Medline; NIDDK NIH HHS [DK 50190, DK43988] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abboud Hanna E., 1995, P573; ABBOUD HE, 1995, ANNU REV PHYSIOL, V57, P297; BERNIER SM, 1992, J CELL PHYSIOL, V152, P317, DOI 10.1002/jcp.1041520213; Border WA, 1997, KIDNEY INT, V51, P1388, DOI 10.1038/ki.1997.190; BRUIJN JA, 1994, J LAB CLIN MED, V123, P34; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; CHOUDHURY GG, 1991, J BIOL CHEM, V266, P8068; CHOUDHURY GG, 1994, KIDNEY INT, V46, P37, DOI 10.1038/ki.1994.242; CHOUDHURY GG, 1993, AM J PHYSIOL, V265, pF634, DOI 10.1152/ajprenal.1993.265.5.F634; Choudhury GG, 1997, AM J PHYSIOL-RENAL, V273, pF931, DOI 10.1152/ajprenal.1997.273.6.F931; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; GLASS WF, 1991, AM J PHYSIOL, V261, pF336, DOI 10.1152/ajprenal.1991.261.2.F336; GRANDALIANO G, 1994, AM J PHYSIOL-RENAL, V267, pF528, DOI 10.1152/ajprenal.1994.267.4.F528; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hsuan J J, 1989, Prog Growth Factor Res, V1, P23, DOI 10.1016/0955-2235(89)90039-2; Ide H, 1997, CANCER RES, V57, P5022; IWASAKI S, 1995, J BIOL CHEM, V270, P5476, DOI 10.1074/jbc.270.10.5476; JAFFER F, 1989, AM J PATHOL, V135, P261; JOHANSEN FE, 1995, BBA-REV CANCER, V1242, P1, DOI 10.1016/0304-419X(94)00014-S; JOHNSON RJ, 1993, J LAB CLIN MED, V121, P190; KAZLAUSKAS A, 1994, CURR OPIN GENET DEV, V4, P5, DOI 10.1016/0959-437X(94)90085-X; KNAUSS TC, 1990, J BIOL CHEM, V265, P14457; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; MACKAY NG, 1992, ABSTR KIDN INT, V41, P703; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MARGOLIS B, 1994, J AM SOC NEPHROL, V5, P1288; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; MCKAY K, 1989, J CLIN INVEST, V83, P1160; Nakaoka T, 1997, J CLIN INVEST, V100, P2824, DOI 10.1172/JCI119830; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Niehrs C, 1996, NATURE, V381, P561, DOI 10.1038/381561a0; NISWANDER L, 1993, NATURE, V361, P68, DOI 10.1038/361068a0; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; REDDI AH, 1994, CURR OPIN GENET DEV, V4, P737, DOI 10.1016/0959-437X(94)90141-O; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Treisman R, 1990, Semin Cancer Biol, V1, P47; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Vukicevic S, 1996, P NATL ACAD SCI USA, V93, P9021, DOI 10.1073/pnas.93.17.9021; WHITE MF, 1994, J BIOL CHEM, V269, P1; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212	52	54	56	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10897	10902						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196167				2022-12-27	WOS:000079751900035
J	Fan, LZ; Wiederkehr, MR; Collazo, R; Wang, HM; Crowder, LA; Moe, OW				Fan, LZ; Wiederkehr, MR; Collazo, R; Wang, HM; Crowder, LA; Moe, OW			Dual mechanisms of regulation of Na/H exchanger NHE-3 by parathyroid hormone in rat kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL BRUSH-BORDER; NA+-H+ EXCHANGER; DEPENDENT PROTEIN-KINASE; CAMP-MEDIATED INHIBITION; ACID-BASE HOMEOSTASIS; METABOLIC-ACIDOSIS; PROXIMAL TUBULES; BICARBONATE ABSORPTION; CALCIUM-TRANSPORT; ANGIOTENSIN-II	Parathyroid hormone (PTH) is a potent inhibitor of mammalian renal proximal tubule sodium absorption via suppression of the apical membrane Na/H exchanger (NHE-3). We examined the mechanisms by which PTH inhibits NHE-3 activity by giving an acute intravenous PTD bolus to parathyroidectomized rats. Parathyroidectomy per se increased apical membrane NHE-3 activity and antigen. Acute infusion of PTH caused a time-dependent decrease in NHE-3 activity as early as 30 min. Decrease in NHE-3 activity at 30 and 60 min was accompanied by increased NHE-3 phosphorylation. In contrast to the rapid changes in NHE-3 activity and phosphorylation, decrease in apical membrane NHE-3 antigen was not detectable until 4-12 h after the PTH bolus, The decrease in apical membrane NHE-3 occurred in the absence of changes in total renal cortical NHE-3 antigen. Pretreatment of the animals with the microtubule-disrupting agent colchicine blocked the PTH-induced decrease in apical NHE-3 antigen. We propose that PTH acutely cause a decrease in NHE-3 intrinsic transport activity possibly via a phosphorylation-dependent mechanism followed by a decrease in apical membrane NHE-3 antigen via changes in protein trafficking.	Dept Vet Affairs Med Ctr, Med Serv, Dallas, TX 75225 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75225 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Moe, OW (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.				NIDDK NIH HHS [T32 DK07257-17, DK48482] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK048482, T32DK007257, R01DK048482] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGUS ZS, 1973, AM J PHYSIOL, V224, P1143, DOI 10.1152/ajplegacy.1973.224.5.1143; AMEMIYA M, 1995, KIDNEY INT, V48, P1206, DOI 10.1038/ki.1995.404; AMEMIYA M, 1995, AM J PHYSIOL-CELL PH, V269, pC126, DOI 10.1152/ajpcell.1995.269.1.C126; Azarani A, 1996, J BIOL CHEM, V271, P14931, DOI 10.1074/jbc.271.25.14931; AZARANI A, 1995, J BIOL CHEM, V270, P20004, DOI 10.1074/jbc.270.34.20004; BANK N, 1976, J CLIN INVEST, V58, P336, DOI 10.1172/JCI108477; BIEMESDERFER D, 1993, AM J PHYSIOL, V265, pF736, DOI 10.1152/ajprenal.1993.265.5.F736; Biemesderfer D, 1997, AM J PHYSIOL-RENAL, V273, pF289, DOI 10.1152/ajprenal.1997.273.2.F289; BIEMESDERFER D, 1997, J AM SOC NEPHROL, V8, P3; CHABARDES D, 1975, PFLUG ARCH EUR J PHY, V354, P229, DOI 10.1007/BF00584646; COHN DE, 1983, AM J PHYSIOL, V245, pF217, DOI 10.1152/ajprenal.1983.245.2.F217; COLLAZO R, 1998, J AM SOC NEPHROL, V9, P4; Friedman PA, 1998, ANNU REV PHYSIOL, V60, P179, DOI 10.1146/annurev.physiol.60.1.179; GESEK FA, 1990, AM J PHYSIOL, V258, pF514, DOI 10.1152/ajprenal.1990.258.3.F514; HELMLEKOLB C, 1990, PFLUG ARCH EUR J PHY, V416, P615, DOI 10.1007/BF00370605; HELMLEKOLB C, 1990, PFLUG ARCH EUR J PHY, V415, P461, DOI 10.1007/BF00373624; HENSLEY CB, 1989, AM J PHYSIOL, V257, pC637, DOI 10.1152/ajpcell.1989.257.4.C637; HOLTROP ME, 1979, CALCIFIED TISSUE INT, V27, P129, DOI 10.1007/BF02441175; HULTER H, 1985, AM J PHYSIOL, V248, pF739, DOI 10.1152/ajprenal.1985.248.6.F739; HULTER HN, 1983, AM J PHYSIOL, V245, pF450, DOI 10.1152/ajprenal.1983.245.4.F450; HULTER HN, 1985, KIDNEY INT, V28, P187, DOI 10.1038/ki.1985.139; IINO Y, 1979, AM J PHYSIOL, V236, pF387, DOI 10.1152/ajprenal.1979.236.4.F387; JADHAV AL, 1992, CLIN EXP HYPERTENS A, V14, P653, DOI 10.3109/10641969209036213; JOU YS, 1993, MOL CARCINOGEN, V8, P234, DOI 10.1002/mc.2940080406; KAHN AM, 1985, AM J PHYSIOL, V248, pF212, DOI 10.1152/ajprenal.1985.248.2.F212; KAWASHIMA H, 1982, MINER ELECTROLYTE ME, V9, P227; KEMPSON SA, 1995, AM J PHYSIOL-RENAL, V268, pF784, DOI 10.1152/ajprenal.1995.268.4.F784; Keusch I, 1998, KIDNEY INT, V54, P1224, DOI 10.1046/j.1523-1755.1998.00115.x; Kurashima K, 1997, J BIOL CHEM, V272, P28672, DOI 10.1074/jbc.272.45.28672; KUROKAWA K, 1992, KIDNEY PHYSL PATHOPH; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; LIU FY, 1989, J CLIN INVEST, V84, P83, DOI 10.1172/JCI114174; MARONE CC, 1983, J LAB CLIN MED, V101, P264; MCKINNEY TD, 1980, AM J PHYSIOL, V239, pF127, DOI 10.1152/ajprenal.1980.239.2.F127; MCKINNEY TD, 1980, AM J PHYSIOL, V238, pF166, DOI 10.1152/ajprenal.1980.238.3.F166; MILLER RT, 1987, J BIOL CHEM, V262, P9115; MOE OW, 1995, J CLIN INVEST, V96, P2187, DOI 10.1172/JCI118273; MORAN A, 1988, BIOCHIM BIOPHYS ACTA, V969, P48, DOI 10.1016/0167-4889(88)90087-0; MORI Y, 1992, PHARMACOL TOXICOL, V70, P201, DOI 10.1111/j.1600-0773.1992.tb00457.x; PASTORIZAMUNOZ E, 1992, J CLIN INVEST, V89, P1485, DOI 10.1172/JCI115739; PENG Y, 1998, J AM SOC NEPHROL, V9, P10; POLLOCK AS, 1986, AM J PHYSIOL, V250, pF217, DOI 10.1152/ajprenal.1986.250.2.F217; PREISIG PA, 1987, J CLIN INVEST, V80, P970, DOI 10.1172/JCI113190; PUSCHETT JB, 1976, KIDNEY INT, V9, P501, DOI 10.1038/ki.1976.64; RESHKIN SJ, 1991, J MEMBRANE BIOL, V124, P227, DOI 10.1007/BF01994356; SASAKI S, 1991, AM J PHYSIOL, V260, pF833, DOI 10.1152/ajprenal.1991.260.6.F833; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; SHEIKHHAMAD D, 1993, AM J PHYSIOL, V264, pF737, DOI 10.1152/ajprenal.1993.264.4.F737; SOLEIMANI M, 1992, J CLIN INVEST, V90, P211, DOI 10.1172/JCI115838; SUKI WN, 1979, AM J PHYSIOL, V237, pF1, DOI 10.1152/ajprenal.1979.237.1.F1; SUTTON RAL, 1979, KIDNEY INT, V15, P520, DOI 10.1038/ki.1979.67; WEINMAN EJ, 1987, AM J PHYSIOL, V252, pF19, DOI 10.1152/ajprenal.1987.252.1.F19; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; WEINMAN EJ, 1989, J MEMBRANE BIOL, V109, P233, DOI 10.1007/BF01870280; WEINMAN EJ, 1988, J MEMBRANE BIOL, V101, P11, DOI 10.1007/BF01872815; Wu MS, 1996, J BIOL CHEM, V271, P32749, DOI 10.1074/jbc.271.51.32749; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zhang YB, 1996, AM J PHYSIOL-RENAL, V270, pF1004, DOI 10.1152/ajprenal.1996.270.6.F1004; Zhao H, 1999, J BIOL CHEM, V274, P3978, DOI 10.1074/jbc.274.7.3978	61	60	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11289	11295		10.1074/jbc.274.16.11289	http://dx.doi.org/10.1074/jbc.274.16.11289			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196218	hybrid			2022-12-27	WOS:000079751900086
J	Aparicio, JF; Colina, AJ; Ceballos, E; Martin, JF				Aparicio, JF; Colina, AJ; Ceballos, E; Martin, JF			The biosynthetic gene cluster for the 26-membered ring polyene macrolide pimaricin - A New polyketide synthase organization encoded by two subclusters separated by functionalization genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROPOLYSPORA-ERYTHRAEA; MULTIFUNCTIONAL ENZYME; ACID SYNTHASE; ACTIVE-SITE; SEQUENCE; CLONING; SPECIFICITY; RAPAMYCIN; DOMAINS; MOTIFS	The biosynthetic gene cluster for the 26-membered ring of the polyene macrolide pimaricin extends for about 110 kilobase pairs of contiguous DNA in the genome of Streptomyces natalensis, Two sets of polyketide synthase (PKS) genes are separated by a group of small polyketide-functionalizing genes. Two of the polyketide synthase genes, pimS0 and pimS1, have been fully sequenced and disrupted proving the involvement of each of these genes in pimaricin biosynthesis, The pimS0 gene encodes a relatively small acetate-activating PKS (similar to 193 kDa) that appears to work as a loading protein which "presents" the starter unit to the second PKS subunit. The pimS1 gene encodes a giant multienzyme (similar to 710 kDa) harboring 15 activities responsible for the first four cycles of chain elongation in pimaricin biosynthesis, resulting in formation of the polyene chromophore.	Inst Biotechnol, Leon 24006, Spain		Martin, JF (corresponding author), Inst Biotechnol, Sci Pk Leon,Avda Real N1, Leon 24006, Spain.	degjmm@unileon.es	Aparicio, Jesús F./K-8686-2014	Aparicio, Jesús F./0000-0003-4242-4701				ALBERTINI AM, 1995, MICROBIOL-SGM, V141, P299, DOI 10.1099/13500872-141-2-299; Aparicio JF, 1996, GENE, V169, P9, DOI 10.1016/0378-1119(95)00800-4; APARICIO JF, 1994, J BIOL CHEM, V269, P8524; BEVITT DJ, 1992, EUR J BIOCHEM, V204, P39, DOI 10.1111/j.1432-1033.1992.tb16603.x; BOLARD J, 1986, BIOCHIM BIOPHYS ACTA, V719, P11; Brown DW, 1996, P NATL ACAD SCI USA, V93, P14873, DOI 10.1073/pnas.93.25.14873; CHATER KF, 1981, GENE, V14, P183, DOI 10.1016/0378-1119(81)90114-1; CORTES J, 1990, NATURE, V348, P176, DOI 10.1038/348176a0; CRIADO LM, 1993, GENE, V126, P135, DOI 10.1016/0378-1119(93)90602-Y; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DONADIO S, 1992, GENE, V111, P51, DOI 10.1016/0378-1119(92)90602-L; DONADIO S, 1991, SCIENCE, V252, P675, DOI 10.1126/science.2024119; Gil J.A., 1997, BIOTECHNOLOGY ANTIBI, V2nd ed., P551; Hanahan D, 1985, DNA CLONING PRACTICA; HAYDOCK SF, 1995, FEBS LETT, V374, P246, DOI 10.1016/0014-5793(95)01119-Y; Hopwood D.A., 1985, GENETIC MANIPULATION; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; KATZ L, 1993, ANNU REV MICROBIOL, V47, P875, DOI 10.1146/annurev.mi.47.100193.004303; LESKIW BK, 1991, P NATL ACAD SCI USA, V88, P2461, DOI 10.1073/pnas.88.6.2461; MACNEIL DJ, 1992, GENE, V115, P119, DOI 10.1016/0378-1119(92)90549-5; MANWARING DG, 1969, J ANTIBIOT, V22, P545, DOI 10.7164/antibiotics.22.545; MARSDEN AFA, 1994, SCIENCE, V263, P378, DOI 10.1126/science.8278811; MARTIN JF, 1977, ANNU REV MICROBIOL, V31, P12; MARTIN JF, 1975, BIOCHEM BIOPH RES CO, V71, P1103; MEURER G, 1995, J BACTERIOL, V177, P477, DOI 10.1128/jb.177.2.477-481.1995; OHagan D., 1991, POLYKETIDE METABOLIT; OMURA S, 1984, MACROLIDE ANTIBIOTIC, P351; RODICIO MR, 1985, GENE, V34, P283, DOI 10.1016/0378-1119(85)90137-4; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUPP T, 1995, J BACTERIOL, V177, P3673, DOI 10.1128/jb.177.13.3673-3679.1995; SCHWECKE T, 1995, P NATL ACAD SCI USA, V92, P7839, DOI 10.1073/pnas.92.17.7839; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; Staunton J, 1996, NAT STRUCT BIOL, V3, P188, DOI 10.1038/nsb0296-188; STAUNTON J, 1991, ANGEW CHEM INT EDIT, V30, P1302, DOI 10.1002/anie.199113021; SWAN DG, 1994, MOL GEN GENET, V242, P358, DOI 10.1007/BF00280426; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001	37	97	114	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10133	10139		10.1074/jbc.274.15.10133	http://dx.doi.org/10.1074/jbc.274.15.10133			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187796	hybrid			2022-12-27	WOS:000079663500035
J	Chuang, JL; Wynn, RM; Song, JL; Chuang, DT				Chuang, JL; Wynn, RM; Song, JL; Chuang, DT			GroEL/GroES-dependent reconstitution of alpha(2)beta(2), tetramers of human mitochondrial branched chain alpha-ketoacid decarboxylase - Obligatory interaction of chaperonins with an alpha beta dimeric intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID DEHYDROGENASE COMPLEX; SYRUP-URINE-DISEASE; DODECAMERIC GLUTAMINE-SYNTHETASE; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; PYRUVATE-DEHYDROGENASE; QUATERNARY STRUCTURE; CRYSTAL-STRUCTURE; REACTION CYCLE; IN-VITRO	The decarboxylase component (E1) of the human mitochondrial branched chain alpha-ketoacid dehydrogenase multienzyme complex (similar to 4-5 x 10(3) kDa) is a thiamine pyrophosphate-dependent enzyme, comprising two 45.5-kDa alpha subunits and two 37.8-kDa beta subunits, In the present study, His(6)-tagged E1 alpha(2)beta(2) tetramers (171 kDa) denatured in 8 M urea were competently reconstituted in vitro at 23 degrees C with an absolute requirement for chaperonins GroEL/GroES and Mg-ATP, Unexpectedly, the kinetics for the recovery of El activity was very slow with a rate constant of 290 M-1 s(-1). Renaturation of El with a similarly slow kinetics was also achieved using individual GroEL-alpha and GroEL-beta complexes as combined substrates, However, the beta subunit was markedly more prone to misfolding than the alpha in the absence of GroEL. The alpha subunit was released as soluble monomers from the GroEL-alpha complex alone in the presence of GroES and Mg-ATP, In contrast, the beta subunit discharged from the GroEL-beta complex readily rebound to GroEL when the alpha subunit was absent. Analysis of the assembly state showed that the His(6)-alpha and beta subunits released from corresponding GroEL-polypeptide complexes assembled into a highly structured but inactive 85.5-kDa alpha beta dimeric intermediate, which subsequently dimerized to produce the active alpha(2)beta(2) tetrameter, The purified alpha beta dimer isolated from Escherichia coli lysates was capable of binding to GroEL to produce a stable GroEL-alpha beta ternary complex. Incubation of this novel ternary complex with GroES and Mg-ATP resulted in recovery of E1 activity, which also followed slow kinetics with a rate constant of 138 M-1 s(-1). Dimers were regenerated from the GroEL-alpha beta complex, but they needed to interact with GroEL/GroES again, thereby perpetuating the cycle until the conversion from dimers to tetramers was complete. Our study describes an obligatory role of chaperonins in priming the dimeric intermediate for subsequent tetrameric assembly, which is a slow step in the reconstitution of E1 alpha(2)beta(2) tetramers.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Chuang, DT (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	chuang01@utsw.swmed.edu		Wynn, Richard/0000-0002-1879-2136	NIDDK NIH HHS [DK-26758] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026758] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; CHUANG DT, 1988, METHOD ENZYMOL, V166, P146; CHUANG DT, 1995, METABOLIC MOL BASES, P1239; CHUANG JL, 1995, J CLIN INVEST, V95, P954, DOI 10.1172/JCI117804; Clark AC, 1996, BIOCHEMISTRY-US, V35, P5893, DOI 10.1021/bi953051v; DAVIE JR, 1992, J BIOL CHEM, V267, P16601; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; Fedorov AN, 1997, J MOL BIOL, V268, P712, DOI 10.1006/jmbi.1997.1007; FISHER CR, 1991, J CLIN INVEST, V88, P1034, DOI 10.1172/JCI115363; FISHER MT, 1993, J BIOL CHEM, V268, P13777; FISHER MT, 1992, BIOCHEMISTRY-US, V31, P3955, DOI 10.1021/bi00131a010; FLYNN GC, 1993, P NATL ACAD SCI USA, V90, P10826, DOI 10.1073/pnas.90.22.10826; Glerum DM, 1997, J BIOL CHEM, V272, P19088, DOI 10.1074/jbc.272.30.19088; GLERUM DM, 1995, J BIOL CHEM, V270, P15585, DOI 10.1074/jbc.270.26.15585; GLICK BS, 1995, CELL, V80, P11, DOI 10.1016/0092-8674(95)90444-1; GUZMANVERDUZCO LM, 1987, J BACTERIOL, V169, P5201, DOI 10.1128/jb.169.11.5201-5208.1987; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hawes JW, 1995, J BIOL CHEM, V270, P31071, DOI 10.1074/jbc.270.52.31071; HU CWC, 1983, J BIOL CHEM, V258, P2315; Huang YS, 1999, J BIOL CHEM, V274, P10405, DOI 10.1074/jbc.274.15.10405; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; KIM S, 1994, TRENDS BIOCHEM SCI, V19, P543, DOI 10.1016/0968-0004(94)90058-2; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LESSARD IAD, 1994, J BIOL CHEM, V269, P10378; LILIE H, 1995, P NATL ACAD SCI USA, V92, P8100, DOI 10.1073/pnas.92.18.8100; LILIE H, 1995, J MOL BIOL, V248, P190, DOI 10.1006/jmbi.1995.0211; Llorca O, 1997, FEBS LETT, V405, P195, DOI 10.1016/S0014-5793(97)00186-5; Mande SC, 1996, SCIENCE, V271, P1655; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MENDOZA JA, 1991, J BIOL CHEM, V266, P13587; MENDOZA JA, 1994, J BIOL CHEM, V269, P2447; RANSON NA, 1995, J MOL BIOL, V250, P581, DOI 10.1006/jmbi.1995.0399; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; Sambrook J., 1989, MOL CLONING LABORATO, V3, pA3; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; UNGERMANN C, 1994, SCIENCE, V266, P1250, DOI 10.1126/science.7973708; VIITANEN PV, 1992, J BIOL CHEM, V267, P695; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; WYNN RM, 1992, J BIOL CHEM, V267, P1881; WYNN RM, 1992, J BIOL CHEM, V267, P12400; Wynn RM, 1998, J BIOL CHEM, V273, P13110, DOI 10.1074/jbc.273.21.13110; WYNN RM, 1994, BIOCHEMISTRY-US, V33, P8962, DOI 10.1021/bi00196a014; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; ZHENG XX, 1993, J BIOL CHEM, V268, P7489	52	27	27	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10395	10404		10.1074/jbc.274.15.10395	http://dx.doi.org/10.1074/jbc.274.15.10395			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187829	hybrid			2022-12-27	WOS:000079663500068
J	Hiki, K; D'Andrea, RJ; Furze, J; Crawford, J; Woollatt, E; Sutherland, GR; Vadas, MA; Gamble, JR				Hiki, K; D'Andrea, RJ; Furze, J; Crawford, J; Woollatt, E; Sutherland, GR; Vadas, MA; Gamble, JR			Cloning, characterization, and chromosomal location of a novel human K+-Cl- cotransporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; POTASSIUM CHANNEL GENE; CHLORIDE COTRANSPORTER; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; EPILEPSY; FAMILY; TRANSPORT; MUTATION; RAT	Differential display polymerase chain reaction has been used to isolate genes regulated in vascular endothelial cells by the angiogenic factor vascular endothelial cell growth factor (VEGF). Analysis of one of the bands consistently up-regulated by VEGF led us to the identification of a cDNA from a human umbilical vein endothelial cell library that is 77% identical to the human K+-Cl- cotransporter1 (KCC1), We have referred to the predicted protein as K+-Cl- cotransporter 3 (KCC3), Hydrophobicity analysis of the KCC3 amino acid sequence showed an almost identical pattern to KCC1, suggesting 12 membrane-spanning segments, a large extracellular loop with potential N-glycosylation sites, and cytoplasmic N- and C-terminal regions, The KCC3 mRNA was highly expressed in brain, heart, skeletal muscle, and kidney, showing a distinct pattern and size from KCC1 and KCC2. The KCC3 mRNA level in endothelial cells increased on treatment with VEGF and decreased with the proinflammatory cytokine tumor necrosis factor alpha, whereas KCC1 mRNA levels remained unchanged. Stable overexpression of KCC3 cDNA in HEK293 cells produced a glycoprotein of approximately 150 kDa, which was reduced to 120 kDa by glycosidase digestion. An increased initial uptake rate of Rb-86 was seen in clones with high KCC3 expression, which was dependent on extracellular Cl- but not Na+ and was inhibitable by the loop diuretic agent furosemide, The KCC3 genomic localization was shown to be 15q13 by fluorescence in situ hybridization, Radiation hybrid analysis placed KCC3 within an area associated with juvenile myoclonic epilepsy. These results suggest KCC3 is a new member of the KCC family that is under distinct regulation from KCC1.	Inst Med & Vet Sci, Hanson Ctr Canc Res, Dept Human Immunol, Adelaide, SA 5000, Australia; Univ Adelaide, Adelaide, SA 5000, Australia; Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Ctr Med Genet, N Adelaide, SA 5006, Australia	Institute Medical & Veterinary Science Australia; University of Adelaide	Gamble, JR (corresponding author), Inst Med & Vet Sci, Hanson Ctr Canc Res, Dept Human Immunol, Frome Rd, Adelaide, SA 5000, Australia.		Sutherland, Grant Robert/D-2606-2012; Crawford, Joanna/F-9135-2013; Vadas, Mathew/R-1378-2019	Crawford, Joanna/0000-0003-0786-6889; Gamble, Jennifer/0000-0002-0179-9964				Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; CALLEN DF, 1990, ANN GENET-PARIS, V33, P219; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; ELSLIE FV, 1997, HUM MOL GENET, V6, P1329; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Gibson JS, 1998, J PHYSIOL-LONDON, V511, P225, DOI 10.1111/j.1469-7793.1998.225bi.x; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; HAAS M, 1994, AM J PHYSIOL, V267, P869; Harling H, 1997, EMBO J, V16, P5855, DOI 10.1093/emboj/16.19.5855; Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050; KRAMHOFT B, 1986, AM J PHYSIOL, V251, pC369, DOI 10.1152/ajpcell.1986.251.3.C369; Krarup T, 1998, AM J PHYSIOL-CELL PH, V275, pC239, DOI 10.1152/ajpcell.1998.275.1.C239; LAUF PK, 1983, AM J PHYSIOL, V245, pC445, DOI 10.1152/ajpcell.1983.245.5.C445; LAUF PK, 1992, AM J PHYSIOL, V263, pC917, DOI 10.1152/ajpcell.1992.263.5.C917; Matthews JB, 1998, J CLIN INVEST, V101, P2072, DOI 10.1172/JCI1042; MATTHEWS JB, 1992, J CLIN INVEST, V90, P1608, DOI 10.1172/JCI116030; Moore-Hoon ML, 1998, BIOCHEM BIOPH RES CO, V244, P15, DOI 10.1006/bbrc.1998.8206; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Steinlein OK, 1998, CLIN GENET, V54, P169; TOMIYAMA S, 1987, MANUAL MONOCLONAL AN, P178; Topper JN, 1997, J CLIN INVEST, V99, P2941, DOI 10.1172/JCI119489; WALL RT, 1978, J CELL PHYSIOL, V96, P203, DOI 10.1002/jcp.1040960209; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201; ZADEOPPEN AMM, 1990, J MEMBRANE BIOL, V118, P143, DOI 10.1007/BF01868471	32	147	152	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10661	10667		10.1074/jbc.274.15.10661	http://dx.doi.org/10.1074/jbc.274.15.10661			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187864	hybrid			2022-12-27	WOS:000079663500103
J	Ng, PWP; Porter, AG; Janicke, RU				Ng, PWP; Porter, AG; Janicke, RU			Molecular cloning and characterization of two novel pro-apoptotic isoforms of caspase-10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; ETOPOSIDE-INDUCED APOPTOSIS; DOMAIN-CONTAINING PROTEIN; DEATH GENE CED-3; CELL-DEATH; FAS; PROTEASES; ACTIVATION; HOMOLOG; SPECIFICITIES	Caspase-10/a (Mch4) and caspase-10/b (FLICE2) are related death effector domain-containing cysteine aspartases presumed to be at or near the apex of apoptotic signaling pathways. We report the cloning and characterization of two novel proteins that are splice isoforms of the caspase-10 family. Caspase-10/c is a truncated protein that is essentially a prodomain-only form of the caspase that lacks proteolytic activity in vitro but efficiently induces the formation of perinuclear filamentous structures and cell death in vivo, Caspase-10/c mRNA is specifically up-regulated upon TNF stimulation, suggesting a potential role of this isoform in amplifying the apoptotic response to extracellular stimuli such as cytokines, Caspase-10/d is a hybrid of the known caspases Mch4 and FLICE2, as it is identical to FLICE2 except for the small (p12) catalytic subunit, which is identical to Mch4, Caspase-10/d is proteolytically active in vitro and also induces cell death in vivo, although it is less active than Mch4. The mRNAs for all known isoforms of caspase-10 are abundantly expressed in fetal lung, kidney, and skeletal muscle but are very poorly expressed or absent in these tissues in the adult, implying a possible role for the caspase-10 family in fetal development.	Natl Univ Singapore, Inst Mol & Cell Biol, TNF & Cell Death Grp, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Porter, AG (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, TNF & Cell Death Grp, 30 Med Dr, Singapore 117609, Singapore.							Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Droin N, 1998, ONCOGENE, V16, P2885, DOI 10.1038/sj.onc.1201821; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; Han DKM, 1997, P NATL ACAD SCI USA, V94, P11333, DOI 10.1073/pnas.94.21.11333; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Hu SM, 1998, J BIOL CHEM, V273, P29648, DOI 10.1074/jbc.273.45.29648; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Jiang ZH, 1998, P NATL ACAD SCI USA, V95, P9155, DOI 10.1073/pnas.95.16.9155; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Martins LM, 1997, J BIOL CHEM, V272, P7421, DOI 10.1074/jbc.272.11.7421; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Orth K, 1996, J BIOL CHEM, V271, P20977, DOI 10.1074/jbc.271.35.20977; Ossina NK, 1997, J BIOL CHEM, V272, P16351, DOI 10.1074/jbc.272.26.16351; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; Takahashi A, 1997, ONCOGENE, V14, P2741, DOI 10.1038/sj.onc.1201131; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Tamura T, 1996, BIOCHEM BIOPH RES CO, V229, P21, DOI 10.1006/bbrc.1996.1752; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Wyllie A H, 1980, Int Rev Cytol, V68, P251; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9	37	75	78	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10301	10308		10.1074/jbc.274.15.10301	http://dx.doi.org/10.1074/jbc.274.15.10301			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187817	hybrid			2022-12-27	WOS:000079663500056
J	Shi, L; Carmichael, WW; Kennelly, PJ				Shi, L; Carmichael, WW; Kennelly, PJ			Cyanobacterial PPP family protein phosphatases possess multifunctional capabilities and are resistant to microcystin-LR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE THREONINE PHOSPHATASES; ESCHERICHIA-COLI; SERINE/THREONINE PHOSPHATASE; CATALYTIC SUBUNIT; DIADENOSINE TETRAPHOSPHATASE; HISTIDINE PHOSPHATASES; BACTERIOPHAGE-LAMBDA; SEQUENCE-ANALYSIS; EXPRESSION; SPECIFICITY	The structural gene for a putative PPP family protein-serine/threonine phosphatase from the microcystin-producing cyanobacterium Microcystis aeruginosa PCC 7820, pp1-cyano1, was cloned. The sequence of the predicted gene product, PP1-cyano1, was 98% identical to that of the predicted product of an open reading frame, pp1-cyano2 from a cyanobacterium that does not produce microcystins, M. aeruginosa UTEX 2063, By contrast, PP1-cyano1 displayed less than 20% identity with other PPP family protein phosphatases from eukaryotic, archaeal, or other bacterial organisms. PP1-cyano1 and PP1-cyano2 were expressed in Escherichia coli and purified to homogeneity. Both enzymes exhibited divalent metal dependent phosphohydrolase activity in vitro toward phosphoserine- and phosphotyrosine-containing proteins and 3-phosphohistidine- and phospholysine-containing amino acid homopolymers, This multifunctional potential also was apparent in samples of PP1-cyano1 and PP1-cyano2 isolated from M. aeruginosa, Catalytic activity was insensitive to okadaic acid or the cyanobacterially produced cyclic heptapeptide, microcystin-LR, both potent inhibitors of mammalian PP1 and PP2A. PP1-cyano1 and PP1-cyano2 displayed diadenosine tetraphosphatase activity in vitro. Diadenosine tetraphosphatases share conserved sequence features with PPP family protein phosphatases. The diadenosine tetraphosphatase activity of PP1-cyano1 and PP1-cyano2 confirms that these enzymes share a common catalytic mechanism.	Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA	Virginia Polytechnic Institute & State University; University System of Ohio; Wright State University Dayton	Kennelly, PJ (corresponding author), Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA.	pjkennel@vt.edu			NIGMS NIH HHS [R01 GM55067] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055067] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALESSI DR, 1993, EUR J BIOCHEM, V213, P1055, DOI 10.1111/j.1432-1033.1993.tb17853.x; AZAKAMI H, 1992, J BACTERIOL, V174, P2344, DOI 10.1128/JB.174.7.2344-2351.1992; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; BARIK S, 1993, P NATL ACAD SCI USA, V90, P10633, DOI 10.1073/pnas.90.22.10633; BARTON GJ, 1994, EUR J BIOCHEM, V220, P225, DOI 10.1111/j.1432-1033.1994.tb18618.x; BERNDT N, 1987, FEBS LETT, V223, P340, DOI 10.1016/0014-5793(87)80316-2; BLANCHINROLAND S, 1986, MOL GEN GENET, V205, P515, DOI 10.1007/BF00338091; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURRIDGE K, 1995, ANAL BIOCHEM, V232, P56, DOI 10.1006/abio.1995.9961; Carmichael WW, 1997, ADV BOT RES, V27, P211; CHEN MX, 1994, EMBO J, V13, P4278, DOI 10.1002/j.1460-2075.1994.tb06748.x; CHEN MX, 1993, EUR J BIOCHEM, V218, P689, DOI 10.1111/j.1432-1033.1993.tb18423.x; COHEN P, 1991, METHOD ENZYMOL, V201, P389; COHEN PTW, 1988, GENE, V69, P131, DOI 10.1016/0378-1119(88)90385-X; COHEN PTW, 1989, BIOCHEM J, V260, P931, DOI 10.1042/bj2600931; Cozzone AJ, 1998, BIOCHIMIE, V80, P43, DOI 10.1016/S0300-9084(98)80055-2; DEMOTT WR, 1991, LIMNOL OCEANOGR, V36, P1346, DOI 10.4319/lo.1991.36.7.1346; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Howell LD, 1996, BIOCHEMISTRY-US, V35, P7566, DOI 10.1021/bi9600409; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; Jochimsen EM, 1998, NEW ENGL J MED, V338, P873, DOI 10.1056/NEJM199803263381304; Jung K, 1997, J BIOL CHEM, V272, P10847; Kennelly PJ, 1996, J BACTERIOL, V178, P4759, DOI 10.1128/jb.178.16.4759-4764.1996; KENNELLY PJ, 1993, J BIOL CHEM, V268, P6505; KIM YH, 1993, J BIOL CHEM, V268, P18513; KOONIN EV, 1994, PROTEIN SCI, V3, P356; KOONIN EV, 1993, MOL MICROBIOL, V8, P785, DOI 10.1111/j.1365-2958.1993.tb01622.x; KROLL DJ, 1993, DNA CELL BIOL, V12, P441, DOI 10.1089/dna.1993.12.441; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LENG J, 1995, J BACTERIOL, V177, P6510, DOI 10.1128/jb.177.22.6510-6517.1995; LOHSE DL, 1995, STRUCTURE, V3, P987, DOI 10.1016/S0969-2126(01)00234-9; MACKINTOSH C, 1994, TRENDS BIOCHEM SCI, V19, P444, DOI 10.1016/0968-0004(94)90127-9; MacKintosh C, 1996, FEBS LETT, V397, P235, DOI 10.1016/S0014-5793(96)01175-1; Mai B, 1998, J BACTERIOL, V180, P4030, DOI 10.1128/JB.180.16.4030-4035.1998; MANGOLD HK, 1969, THIN LAYER CHROMATOG, P785; McEvoy MM, 1997, CURR OPIN STRUC BIOL, V7, P793, DOI 10.1016/S0959-440X(97)80148-0; MERTZ LM, 1994, FOCUS, V16, P45; Missiakas D, 1997, EMBO J, V16, P1670, DOI 10.1093/emboj/16.7.1670; OHKURA H, 1989, CELL, V57, P997, DOI 10.1016/0092-8674(89)90338-3; OLSEN GJ, 1993, FASEB J, V7, P113, DOI 10.1096/fasebj.7.1.8422957; OXENRIDER KA, 1993, FEBS LETT, V331, P291, DOI 10.1016/0014-5793(93)80355-X; Perego M, 1997, P NATL ACAD SCI USA, V94, P8612, DOI 10.1073/pnas.94.16.8612; PLATEAU P, 1985, BIOCHEMISTRY-US, V24, P914, DOI 10.1021/bi00325a016; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SHI L, 1995, ARCH MICROBIOL, V163, P7, DOI 10.1007/BF00262197; Shi L, 1997, ARCH MICROBIOL, V168, P528, DOI 10.1007/s002030050531; Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1016/S0168-6445(98)00015-1; SILVA OBD, 1987, FEBS LETT, V221, P415, DOI 10.1016/0014-5793(87)80966-3; Solow B, 1997, J BACTERIOL, V179, P5072, DOI 10.1128/jb.179.16.5072-5075.1997; WONG C, 1993, BIOCHEM J, V296, P293, DOI 10.1042/bj2960293; Zhang CC, 1998, J BACTERIOL, V180, P2616, DOI 10.1128/JB.180.10.2616-2622.1998; ZHANG ZJ, 1994, J BIOL CHEM, V269, P16997; ZHANG ZJ, 1992, J BIOL CHEM, V267, P1484; ZHANG ZJ, 1993, ARCH BIOCHEM BIOPHYS, V303, P402, DOI 10.1006/abbi.1993.1301; ZHOU GC, 1994, J BIOL CHEM, V269, P28084	58	46	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10039	10046		10.1074/jbc.274.15.10039	http://dx.doi.org/10.1074/jbc.274.15.10039			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187782	hybrid			2022-12-27	WOS:000079663500021
J	Takeda, Y; Tashima, M; Takahashi, A; Uchiyama, T; Okazaki, T				Takeda, Y; Tashima, M; Takahashi, A; Uchiyama, T; Okazaki, T			Ceramide generation in nitric oxide-induced apoptosis - Activation of magnesium-dependent neutral sphingomyelinase via caspase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAS-INDUCED APOPTOSIS; LEUKEMIA HL-60 CELLS; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; ACID SPHINGOMYELINASE; PHORBOL ESTER; DEATH; DIFFERENTIATION; MACROPHAGES; REQUIREMENT	Sodium nitroprusside (SNP), a NO donor, has been recognized as an inducer of apoptosis in various cell. lines. Here, we demonstrated the intracellular formation of ceramide, a lipid signal mediator, in SNP-induced apoptosis in human leukemia HL-60 cells and investigated the mechanisms of ceramide generation. The levels of intracellular ceramide increased to, at most, 160% of the control level in a time- and dose-dependent manner when the cells were treated with 1 mM SNP, SNP also decreased the sphingomyelin level to similar to 70% of the control level and increased magnesium-dependent neutral sphingomyelinase (N-SMase) activity to 160% of the control activity 2 h after treatment. Neither acid SMase nor magnesium-independent N-SMase was affected by SNP, Caspases are thought to be key enzymes in apoptotic cell death. Acetyl-Asp-Glu-Val-Asp-aldehyde, a synthetic tetrapeptide inhibitor of caspases, inhibited magnesium-dependent N-SMase, ceramide generation, and apoptosis, Moreover, recombinant purified caspase-3 increased magnesium-dependent N-SMase in a cell-free system. These results suggest that the findings that SNP increased ceramide generation and magnesium-dependent N-SMase activity via caspase-3 are interesting to future study to determine the relation between caspases and sphingolipid metabolites in NO-mediated signaling.	Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Sakyo Ku, Kyoto 6068397, Japan	Kyoto University	Okazaki, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Sakyo Ku, 54 Shogoin Kawaharamachi, Kyoto 6068397, Japan.	toshiroo@kuhp.kyoto-u.ac.jp						ADAMS LB, 1990, J IMMUNOL, V144, P2725; ALBINA JE, 1993, J IMMUNOL, V150, P5080; ANKARCRONA M, 1994, EXP CELL RES, V213, P172, DOI 10.1006/excr.1994.1187; ASAHI M, 1995, J BIOL CHEM, V270, P21035, DOI 10.1074/jbc.270.36.21035; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Brockhaus F, 1998, EXP CELL RES, V238, P33, DOI 10.1006/excr.1997.3778; Chang Y, 1995, P NATL ACAD SCI USA, V92, P12275, DOI 10.1073/pnas.92.26.12275; Dbaibo GS, 1997, J EXP MED, V185, P481, DOI 10.1084/jem.185.3.481; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Dobashi K, 1997, J NEUROCHEM, V68, P1896; DUHE RJ, 1994, J BIOL CHEM, V269, P7290; FEHSEL K, 1995, J IMMUNOL, V155, P2858; Genestier L, 1998, J BIOL CHEM, V273, P5060, DOI 10.1074/jbc.273.9.5060; GOPALAKRISHNA R, 1993, J BIOL CHEM, V268, P27180; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HAWKINS DJ, 1988, BIOCHIM BIOPHYS ACTA, V969, P289, DOI 10.1016/0167-4889(88)90064-X; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Jun CD, 1997, CELL IMMUNOL, V176, P41, DOI 10.1006/cimm.1996.1064; KNOWLES RG, 1992, TRENDS BIOCHEM SCI, V17, P399, DOI 10.1016/0968-0004(92)90008-W; Kuo ML, 1996, BIOCHEM BIOPH RES CO, V219, P502, DOI 10.1006/bbrc.1996.0263; KWON G, 1996, BIOCHIM BIOPHYS ACTA, V1210, P308; LIN KT, 1995, J BIOL CHEM, V270, P16487, DOI 10.1074/jbc.270.28.16487; Liu B, 1998, J BIOL CHEM, V273, P34472, DOI 10.1074/jbc.273.51.34472; LIU J, 1994, J BIOL CHEM, V269, P3047; Loweth AC, 1997, FEBS LETT, V400, P285, DOI 10.1016/S0014-5793(96)01392-0; LOZANO J, 1994, J BIOL CHEM, V269, P19200; Mannick JB, 1997, J BIOL CHEM, V272, P24125, DOI 10.1074/jbc.272.39.24125; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; MESSMER UK, 1995, MOL PHARMACOL, V47, P757; Messmer UK, 1996, BIOCHEM J, V319, P299, DOI 10.1042/bj3190299; Mizushima N, 1996, FEBS LETT, V395, P267, DOI 10.1016/0014-5793(96)01050-2; NGUYEN T, 1992, P NATL ACAD SCI USA, V89, P3030, DOI 10.1073/pnas.89.7.3030; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nishio E, 1996, BIOCHEM BIOPH RES CO, V221, P163, DOI 10.1006/bbrc.1996.0563; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OKAZAKI T, 1990, J BIOL CHEM, V265, P15823; Pahan K, 1998, J BIOL CHEM, V273, P2591, DOI 10.1074/jbc.273.5.2591; Pronk GJ, 1996, SCIENCE, V271, P808, DOI 10.1126/science.271.5250.808; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; SARIH M, 1993, BIOCHEM BIOPH RES CO, V191, P503, DOI 10.1006/bbrc.1993.1246; SAWAI H, 1995, J BIOL CHEM, V270, P27326, DOI 10.1074/jbc.270.45.27326; Sawai H, 1997, J BIOL CHEM, V272, P2452; SCHMIDT HHHW, 1993, BIOCHIM BIOPHYS ACTA, V1178, P153, DOI 10.1016/0167-4889(93)90006-B; Schwandner R, 1998, J BIOL CHEM, V273, P5916, DOI 10.1074/jbc.273.10.5916; Smyth MJ, 1996, BIOCHEM J, V316, P25, DOI 10.1042/bj3160025; STADLER J, 1991, ARCH SURG-CHICAGO, V126, P186; STRUM JC, 1994, J BIOL CHEM, V269, P15493; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Takahashi A, 1997, ONCOGENE, V14, P2741, DOI 10.1038/sj.onc.1201131; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wang SB, 1997, J BIOL CHEM, V272, P5959, DOI 10.1074/jbc.272.9.5959; WOLFF RA, 1994, J BIOL CHEM, V269, P19605; YONEDA T, 1994, JPN J MED TECH, V43, P1045	54	111	115	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10654	10660		10.1074/jbc.274.15.10654	http://dx.doi.org/10.1074/jbc.274.15.10654			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187863	hybrid			2022-12-27	WOS:000079663500102
J	Meakin, SO; MacDonald, JIS; Gryz, EA; Kubu, CJ; Verdi, JM				Meakin, SO; MacDonald, JIS; Gryz, EA; Kubu, CJ; Verdi, JM			The signaling adapter FRS-2 competes with Shc for binding to the nerve growth factor receptor TrkA - A model for discriminating proliferation and differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-DEPENDENT INTERACTION; AFFINITY NEUROTROPHIN RECEPTOR; PC12 CELL-DIFFERENTIATION; NEURONAL DIFFERENTIATION; TYROSINE PHOSPHATASE; INSULIN-RECEPTOR; INTRACELLULAR DOMAIN; KINASE ACTIVATION; NPEY MOTIF; PROTEIN	We have isolated a human cDNA for the signaling adapter molecule FRS-2/suc1-associated neurotrophic factor target and shown that it is tyrosine-phosphorylated in response to nerve growth factor (NGF) stimulation. Importantly, we demonstrate that the phosphotyrosine binding domain of FRS-2 directly binds the Trk receptors at the same phosphotyrosine residue that binds the signaling adapter Shc, suggesting a model in which competitive binding between FRS-2 and Shc regulates differentiation versus proliferation. Consistent with this model, FRS-S binds Grb-2, Crk, the SH2 domain containing tyrosine phosphatase SH-PTP-S, the cyclin-dependent kinase substrate p13(suc1), and the Src homology 3 (SH3) domain of Src, providing a functional link between TrkA, cell cycle, and multiple NGF signaling effectors. Importantly, overexpression of FRS-2 in cells expressing an NGF nonresponsive TrkA receptor mutant reconstitutes the ability of NGF to stop cell cycle progression and to stimulate neuronal differentiation.	John P Robarts Res Inst, Neurodegenerat Res Grp, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; Univ Western Ontario, Grad Program Neurosci, London, ON N6A 5C1, Canada; Univ Western Ontario, Dept Physiol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Meakin, SO (corresponding author), John P Robarts Res Inst, Neurodegenerat Res Grp, 100 Perth Dr, London, ON N6A 5K8, Canada.	smeakin@rri.on.ca	Meakin, Susan/K-8823-2013	Meakin, Susan/0000-0003-2469-6615				ALEMA S, 1985, NATURE, V316, P557, DOI 10.1038/316557a0; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; COLLAZO D, 1992, NEURON, V9, P643, DOI 10.1016/0896-6273(92)90028-C; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CRAPARO A, 1995, J BIOL CHEM, V270, P15639, DOI 10.1074/jbc.270.26.15639; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Frade JM, 1996, NATURE, V383, P166; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Glass David J., 1993, Trends in Cell Biology, V3, P262, DOI 10.1016/0962-8924(93)90054-5; Goldsmith BA, 1997, J NEUROCHEM, V69, P1014; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; He WM, 1996, J BIOL CHEM, V271, P11641, DOI 10.1074/jbc.271.20.11641; James P, 1996, GENETICS, V144, P1425; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; MacDonald JIS, 1996, MOL CELL NEUROSCI, V7, P371, DOI 10.1006/mcne.1996.0027; MacPhee IJ, 1997, J BIOL CHEM, V272, P23547, DOI 10.1074/jbc.272.38.23547; Majdan M, 1997, J NEUROSCI, V17, P6988; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Meakin SO, 1997, J NEUROCHEM, V69, P954; Meakin SO, 1998, J NEUROCHEM, V71, P1875; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; NISHIMURA R, 1993, MOL CELL BIOL, V13, P6889, DOI 10.1128/MCB.13.11.6889; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; ONEILL TJ, 1994, MOL CELL BIOL, V14, P6433, DOI 10.1128/MCB.14.10.6433; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PENG X, 1995, NEURON, V15, P395, DOI 10.1016/0896-6273(95)90043-8; RABIN SJ, 1993, MOL CELL BIOL, V13, P2203, DOI 10.1128/MCB.13.4.2203; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; SIEBERBLUM M, 1991, NEURON, V6, P949, DOI 10.1016/0896-6273(91)90235-R; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; TANAKA S, 1993, MOL CELL BIOL, V13, P4409, DOI 10.1128/MCB.13.7.4409; Verdi JM, 1996, NEURON, V16, P515, DOI 10.1016/S0896-6273(00)80071-9; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Wright JH, 1997, MOL BIOL CELL, V8, P1575, DOI 10.1091/mbc.8.8.1575; Xu H, 1998, J BIOL CHEM, V273, P17987, DOI 10.1074/jbc.273.29.17987; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	53	187	195	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9861	9870		10.1074/jbc.274.14.9861	http://dx.doi.org/10.1074/jbc.274.14.9861			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092678	hybrid			2022-12-27	WOS:000079451800097
J	Narhi, L; Wood, SJ; Steavenson, S; Jiang, YJ; Wu, GM; Anafi, D; Kaufman, SA; Martin, F; Sitney, K; Denis, P; Louis, JC; Wypych, J; Biere, AL; Citron, M				Narhi, L; Wood, SJ; Steavenson, S; Jiang, YJ; Wu, GM; Anafi, D; Kaufman, SA; Martin, F; Sitney, K; Denis, P; Louis, JC; Wypych, J; Biere, AL; Citron, M			Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; LEWY BODIES; DEMENTIA; PROTEIN	Parkinson's disease (PD) is a neurodegenerative disorder that is pathologically characterized by the presence of intracytoplasmic Lewy bodies, the major component of which are filaments consisting of alpha-synuclein. Two recently identified point mutations in alpha-synuclein are the only known genetic causes of PD, but their pathogenic mechanism is not understood. Here we show that both wild type and mutant alpha-synuclein form insoluble fibrillar aggregates with antiparallel beta-sheet structure upon incubation at physiological temperature in vitro. Importantly, aggregate formation is accelerated by both PD-linked mutations. Under the experimental conditions, the lag time for the formation of precipitable aggregates is about 280 h for the wild type protein, 180 h for the A30P mutant, and only 100 h for the A53T mutant protein. These data suggest that the formation of alpha-synuclein aggregates could be a critical step in PD pathogenesis, which is accelerated by the PD-linked mutations.	Amgen Inc, Thousand Oaks, CA 91320 USA	Amgen	Citron, M (corresponding author), Amgen Inc, 1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	mcitron@amgen.com						Baba M, 1998, AM J PATHOL, V152, P879; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; DONG A, 1992, BIOCHEMISTRY-US, V31, P9364, DOI 10.1021/bi00154a006; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lewy F.H., 2017, HDB NEUROLOGIE, V3, P920; POLLANEN MS, 1993, J NEUROPATH EXP NEUR, V52, P183, DOI 10.1097/00005072-199305000-00001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takeda A, 1998, AM J PATHOL, V152, P367; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n	16	610	631	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9843	9846		10.1074/jbc.274.14.9843	http://dx.doi.org/10.1074/jbc.274.14.9843			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092675	hybrid			2022-12-27	WOS:000079451800094
J	Saitoh, O; Kubo, Y; Odagiri, M; Ichikawa, M; Yamagata, K; Sekine, T				Saitoh, O; Kubo, Y; Odagiri, M; Ichikawa, M; Yamagata, K; Sekine, T			RGS7 and RGS8 differentially accelerate G protein-mediated modulation of K+ currents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; MUSCARINIC POTASSIUM CHANNEL; GTPASE-ACTIVATING PROTEINS; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; ALPHA-SUBUNITS; AXIS FORMATION; RAT-BRAIN; EXPRESSION; FAMILY	The recently discovered family of RGS (regulators of G protein signaling) proteins acts as GTPase activating proteins which bind to alpha subunits of heterotrimeric G; proteins. We previously showed that a brain-specific RGS, RGS8 speeds up the activation and deactivation kinetics of the G protein-coupled inward rectifier K+ channel (GIRK) upon receptor stimulation (Saitoh, O., Kubo, Y., Miyatani, Y., Asano, T., and Nakata, H. (1997) Nature 390, 525-529). Here we report the isolation of a full-length rat cDNA of another brain-specific RGS, RGS7. In situ hybridization study revealed that RGS7 mRNA is predominantly expressed in Golgi cells within granule cell layer of cerebellar cortex. We observed that RGS7 recombinant protein binds preferentially to G alpha(o), G alpha(i3), and G alpha(z). When co-expressed with GIRK1/2 in Xenopus oocytes, RGS7 and RGS8 differentially accelerate G protein-mediated modulation of GIRK. RGS7 clearly accelerated activation of GIRK current similarly with RGS8 but the acceleration effect of deactivation was significantly weaker than that of RGS8. These acceleration properties of RGS proteins may play important roles in the rapid regulation of neuronal excitability and the cellular responses to short-lived stimulations.	Tokyo Metropolitan Inst Neurosci, Dept Mol & Cellular Neurobiol, Fuchu, Tokyo 1838526, Japan; Tokyo Metropolitan Inst Neurosci, Dept Neurophysiol, Fuchu, Tokyo 1838526, Japan; Tokyo Metropolitan Inst Neurosci, Dept Anat & Embryol, Fuchu, Tokyo 1838526, Japan; Tokyo Metropolitan Inst Neurosci, Dept Mol Neurobiol, Fuchu, Tokyo 1838526, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Saitoh, O (corresponding author), Tokyo Metropolitan Inst Neurosci, Dept Mol & Cellular Neurobiol, 2-6 Musashidai, Fuchu, Tokyo 1838526, Japan.			Kubo, Yoshihiro/0000-0001-6707-0837				Abe M, 1996, EXP CELL RES, V229, P48, DOI 10.1006/excr.1996.0342; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; Chen CH, 1997, J BIOL CHEM, V272, P8679, DOI 10.1074/jbc.272.13.8679; Chen CK, 1996, P NATL ACAD SCI USA, V93, P12885, DOI 10.1073/pnas.93.23.12885; Chuang HH, 1998, P NATL ACAD SCI USA, V95, P11727, DOI 10.1073/pnas.95.20.11727; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; FAUBOBERT E, 1997, P NATL ACAD SCI USA, V94, P2945; Gold SJ, 1997, J NEUROSCI, V17, P8024; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Karschin C, 1996, J NEUROSCI, V16, P3559; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Koelle MR, 1997, CURR OPIN CELL BIOL, V9, P143, DOI 10.1016/S0955-0674(97)80055-5; Kubo Y, 1996, J BIOL CHEM, V271, P15729, DOI 10.1074/jbc.271.26.15729; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Saitoh O, 1997, NATURE, V390, P525, DOI 10.1038/37385; Shuey DJ, 1998, J NEUROCHEM, V70, P1964; Velimirovic BM, 1996, FEBS LETT, V379, P31, DOI 10.1016/0014-5793(95)01465-9; VRIES LD, 1995, P NATL ACAD SCI USA, V92, P11916; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867, DOI 10.1128/MCB.18.5.2867; Yan YB, 1997, J BIOL CHEM, V272, P11924, DOI 10.1074/jbc.272.18.11924; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	36	73	78	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9899	9904		10.1074/jbc.274.14.9899	http://dx.doi.org/10.1074/jbc.274.14.9899			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092682	hybrid			2022-12-27	WOS:000079451800101
J	Reiske, HR; Kao, SC; Cary, LA; Guan, JL; Lai, JF; Chen, HC				Reiske, HR; Kao, SC; Cary, LA; Guan, JL; Lai, JF; Chen, HC			Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; GROWTH-FACTOR; SIGNAL-TRANSDUCTION; PHOSPHOINOSITIDE 3-KINASE; EXTRACELLULAR-MATRIX; V-SRC; PHOSPHORYLATION; BINDING; ASSOCIATION; P130(CAS)	We have previously shown that overexpression of focal adhesion kinase (FAK) in Chinese hamster ovary (CHO) cells promoted their migration on fibronectin, This effect was dependent on the phosphorylation of FAK at Tyr-397, This residue was known to serve as a binding site for both Src and phosphatidylinositol 3-kinase (PI3K), implying that either one or both are required for FAR to promote cell migration. In this study, we have examined the role of PI3K in FAR-promoted cell migration. We have demonstrated that the PI3K inhibitors, wortmannin and LY294002, were able to inhibit FAR-promoted migration in a dose-dependent manner. Furthermore, a FAK mutant capable of binding Src but not PI3K was generated by a substitution of Asp residue 395 with Ala. When overexpressed in CHO cells, this differential binding mutant failed to promote cell migration although its association with Src was retained. Together, these results strongly suggest that PI3K binding is required for FAK to promote cell migration and that the binding of Src and p130(Cas) to FAK may not be sufficient for this event.	Natl Chung Hsing Univ, Inst Biochem, Taichung 402, Taiwan; Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; Natl Chung Hsing Univ, Dept Zool, Taichung 402, Taiwan	National Chung Hsing University; Cornell University; National Chung Hsing University	Chen, HC (corresponding author), Natl Chung Hsing Univ, Inst Biochem, Taichung 402, Taiwan.							BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; Cary LA, 1996, J CELL SCI, V109, P1787; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Chen HC, 1998, J BIOL CHEM, V273, P25777, DOI 10.1074/jbc.273.40.25777; CHEN HC, 1994, J BIOL CHEM, V269, P31229; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; Guan JL, 1996, INT REV CYTOL, V168, P81, DOI 10.1016/S0074-7696(08)60883-9; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Khwaja A, 1998, J BIOL CHEM, V273, P18793, DOI 10.1074/jbc.273.30.18793; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; MATSUMOTO K, 1994, J BIOL CHEM, V269, P31807; Nakamura I, 1998, J BIOL CHEM, V273, P11144, DOI 10.1074/jbc.273.18.11144; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; SONGYANG Z, 1995, J BIOL CHEM, V270, P14863, DOI 10.1074/jbc.270.25.14863; VOURI K, 1996, MOL CELL BIOL, V16, P2606; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P	38	225	234	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12361	12366		10.1074/jbc.274.18.12361	http://dx.doi.org/10.1074/jbc.274.18.12361			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212207	hybrid			2022-12-27	WOS:000080056800027
J	Zhang, YG; Dickman, MB; Jones, C				Zhang, YG; Dickman, MB; Jones, C			The mycotoxin fumonisin B-1 transcriptionally activates the p21 promoter through a cis-acting element containing two Sp1 binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; RNA-POLYMERASE-II; CELL-CYCLE; PROTEIN-KINASE; SP1-MEDIATED TRANSCRIPTION; P21(WAF1/CIP1) EXPRESSION; SPHINGOLIPID BIOSYNTHESIS; INHIBITOR P21(WAF1/CIP1); FUSARIUM-MONILIFORME; GROWTH	Fumonisin B-1 (FB1) is a food-borne mycotoxin produced by Fusarium moniliforme, Structurally FB1 resembles sphingoid bases, and ingestion of FB1 causes several animal diseases. FB1 will cause hepatic carcinoma in rats and is implicated as a cofactor in esophageal or hepatic carcinoma. Previous studies concluded that FB1 repressed cyclin-dependent kinase 2 (CDK2) activity but induced CDK inhibitors p21(Wafl/Cip1), P27(Kip1), and p57(Kip2) in monkey kidney cells (CV-1). In contrast, CV-1 cells transformed by simian virus 40 are resistant to the antiproliferative or apoptotic effects of FB1. Consequently, FB1 treatment of CV-1 cells leads to cell cycle arrest and apoptosis, In this study, we demonstrate that FB1 transcriptionally activates the p21 promoter. Functional analysis of the p21 promoter by reporter gene assays mapped the FB1-responsive region to -124 to -47. DNase I footprinting analysis revealed two protected motifs that span the FB1-responsive region, -124 to -101 (footprint II) and -89 to -67 (footprint III). Further studies demonstrated that DNA sequences from -124 to -101 were sufficient for FB1 stimulation. DNA sequences from -124 to -101 contain two Sp1 binding sites, and gel shift assays provided evidence that nuclear factors specifically bind to this region. Disruption of the two Sp1 binding sites abrogated the binding of nuclear proteins and prevented activation by FB1. Taken together, these results suggest that Sp1 or Sp1-related proteins mediate FB1-induced activation of the p21 promoter.	Univ Nebraska, Ctr Biotechnol, Dept Vet & Biomed Sci, Lincoln, NE 68503 USA; Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68503 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Jones, C (corresponding author), Univ Nebraska, Ctr Biotechnol, Dept Vet & Biomed Sci, Lincoln, NE 68503 USA.	cj@unlinfo.unl.edu						Appella E, 1998, J PROTEIN CHEM, V17, P527; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CHEN LI, 1994, MOL CELL BIOL, V14, P4380, DOI 10.1128/MCB.14.7.4380; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; CHU FS, 1994, APPL ENVIRON MICROB, V60, P847, DOI 10.1128/AEM.60.3.847-852.1994; Ciacci-Zanella JR, 1998, FOOD CHEM TOXICOL, V36, P791, DOI 10.1016/S0278-6915(98)00034-9; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOMBRINKKURTZMAN MA, 1994, J AOAC INT, V77, P512; DOYLE K, 1996, SOURCE DISCOVERY PRO, P241; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Esposito F, 1997, EUR J BIOCHEM, V245, P730, DOI 10.1111/j.1432-1033.1997.00730.x; GELDERBLOM WCA, 1988, APPL ENVIRON MICROB, V54, P1806, DOI 10.1128/AEM.54.7.1806-1811.1988; GELDERBLOM WCA, 1991, CARCINOGENESIS, V12, P1247, DOI 10.1093/carcin/12.7.1247; GELDERBLOM WCA, 1992, CARCINOGENESIS, V13, P433, DOI 10.1093/carcin/13.3.433; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; Gumprecht Laura A., 1995, Natural Toxins, V3, P395, DOI 10.1002/nt.2620030512; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HARPER JW, 1993, CELL, V75, P805; Harrison L R, 1990, J Vet Diagn Invest, V2, P217; HUANG CX, 1995, CANCER RES, V55, P1655; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; Ji CH, 1997, J BIOL CHEM, V272, P21260, DOI 10.1074/jbc.272.34.21260; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; KELLERMAN TS, 1990, ONDERSTEPOORT J VET, V57, P269; KIM SJ, 1992, MOL CELL BIOL, V12, P2455, DOI 10.1128/MCB.12.6.2455; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; LAGRENADE CEF, 1990, BIODET RES, V3, P189; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Liu M, 1996, J BIOL CHEM, V271, P31723, DOI 10.1074/jbc.271.49.31723; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Marasas W. F. O., 1982, CANCER ESOPHAGUS, V1, P29; Maxam A M, 1980, Methods Enzymol, V65, P499; MERRILL AH, 1993, ADV LIPID RES, V26, P215; Merrill AH, 1996, TRENDS CELL BIOL, V6, P218, DOI 10.1016/0962-8924(96)10021-0; MICHIELI P, 1994, CANCER RES, V54, P3391; MIROCHA CJ, 1992, MYCOPATHOLOGIA, V117, P47, DOI 10.1007/BF00497278; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; PETER M, 1994, CELL, V79, P181, DOI 10.1016/0092-8674(94)90186-4; Prowse DM, 1997, J BIOL CHEM, V272, P1308, DOI 10.1074/jbc.272.2.1308; QURESHI MA, 1992, POULTRY SCI, V71, P104, DOI 10.3382/ps.0710104; RILEY RT, 1994, J NUTR, V124, P594, DOI 10.1093/jn/124.4.594; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Sharma RP, 1997, J COMP PATHOL, V117, P371, DOI 10.1016/S0021-9975(97)80084-9; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; SHIER WT, 1991, MYCOPATHOLOGIA, V116, P97, DOI 10.1007/BF00436371; Shin EK, 1996, J BIOL CHEM, V271, P12261, DOI 10.1074/jbc.271.21.12261; Siavoshian S, 1997, BIOCHEM BIOPH RES CO, V232, P169, DOI 10.1006/bbrc.1997.6255; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; THIEL PG, 1992, MYCOPATHOLOGIA, V117, P3, DOI 10.1007/BF00497272; Tolleson WH, 1996, ADV EXP MED BIOL, V392, P237; Voss Kenneth A., 1993, Natural Toxins, V1, P222, DOI 10.1002/nt.2620010404; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WANG E, 1991, J BIOL CHEM, V266, P14486; Wang H, 1996, P NATL ACAD SCI USA, V93, P3461, DOI 10.1073/pnas.93.8.3461; Wattenberg EV, 1996, BIOCHEM BIOPH RES CO, V227, P622, DOI 10.1006/bbrc.1996.1555; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	67	18	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12367	12371		10.1074/jbc.274.18.12367	http://dx.doi.org/10.1074/jbc.274.18.12367			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212208	hybrid			2022-12-27	WOS:000080056800028
J	Keene, RG; Luse, DS				Keene, RG; Luse, DS			Initially transcribed sequences strongly affect the extent of abortive initiation by RNA polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR LATE PROMOTER; ESCHERICHIA-COLI; TERNARY COMPLEX; CALF THYMUS; DNA HYBRID; IN-VITRO; ELONGATION; ATP; REQUIREMENT; INVITRO	We investigated transcript initiation and early elongation by RNA polymerase II using templates mismatched between -9 and +3 (bubble templates). Highly purified RNA polymerase II alone was able to initiate transcription specifically on these templates in the presence of dinucleotide primers. The length distribution of abortively initiated RNAs was similar for purified RNA polymerase II on bubble templates and polymerase II on double-stranded templates in HeLa nuclear extracts. Increasing the U content in the initial portion of the transcript caused similar increases in abortive initiation for transcription of bubble templates by pure polymerase and double-stranded templates in extracts. Thus, the level of abortive initiation by RNA polymerase II is at least partly determined by interactions of the polymerase with the transcript and/or the template, independent of the general transcription factors. Substitution of 5-bromo-UTP for UTP reduced abortive initiation on bubble templates, consistent with the idea that transcription complex stability during early elongation depends on the strength of the initial RNA-DNA hybrid. Interestingly, transcription of bubble templates in HeLa extracts gave very high levels of abortive initiation, suggesting that inability to reanneal the initially melted template segment inhibits transcript elongation in the presence of the initiation factors.	Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Biol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Luse, DS (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Biol, 9500 Euclid Ave,NC20, Cleveland, OH 44195 USA.	lused@cesmtp.ccf.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029487] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM29487] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Biswas TK, 1997, ARCH BIOCHEM BIOPHYS, V340, P250, DOI 10.1006/abbi.1997.9917; BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; CARPOUSIS AJ, 1985, J MOL BIOL, V183, P165, DOI 10.1016/0022-2836(85)90210-4; COWIE A, 1982, J MOL BIOL, V159, P225, DOI 10.1016/0022-2836(82)90494-6; DAUBE SS, 1994, P NATL ACAD SCI USA, V91, P9539, DOI 10.1073/pnas.91.20.9539; DEDRICK RL, 1985, BIOCHEMISTRY-US, V24, P2245, DOI 10.1021/bi00330a019; Dvir A, 1996, J BIOL CHEM, V271, P23352, DOI 10.1074/jbc.271.38.23352; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; ELLINGER T, 1994, J MOL BIOL, V239, P455, DOI 10.1006/jmbi.1994.1388; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; HODO HG, 1977, BIOCHEMISTRY-US, V16, P2334, DOI 10.1021/bi00630a005; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; HOLSTEGE FCP, 1995, EMBO J, V14, P810, DOI 10.1002/j.1460-2075.1995.tb07059.x; HSU LM, 1995, P NATL ACAD SCI USA, V92, P11588, DOI 10.1073/pnas.92.25.11588; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; JACOB GA, 1994, J BIOL CHEM, V269, P3655; JACOB GA, 1991, J BIOL CHEM, V266, P22537; JOHNSON TL, 1994, CELL, V77, P217, DOI 10.1016/0092-8674(94)90314-X; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Kumar KP, 1998, P NATL ACAD SCI USA, V95, P9767, DOI 10.1073/pnas.95.17.9767; Landick R, 1997, CELL, V88, P741, DOI 10.1016/S0092-8674(00)81919-4; LUSE DS, 1987, J BIOL CHEM, V262, P14990; LUSE DS, 1987, J BIOL CHEM, V262, P289; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; Nudler E, 1998, SCIENCE, V281, P424, DOI 10.1126/science.281.5375.424; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PAN GH, 1994, J BIOL CHEM, V269, P30101; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; REINBERG D, 1987, J BIOL CHEM, V262, P3310; RICE GA, 1991, P NATL ACAD SCI USA, V88, P4245, DOI 10.1073/pnas.88.10.4245; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; SLUDER AE, 1988, J BIOL CHEM, V263, P9917; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X; TANTIN D, 1994, J BIOL CHEM, V269, P17397; THOMPSON NE, 1990, J BIOL CHEM, V265, P7069; TIMMERS HTM, 1994, EMBO J, V13, P391, DOI 10.1002/j.1460-2075.1994.tb06273.x; VONHIPPEL PH, 1984, ANNU REV BIOCHEM, V53, P389, DOI 10.1146/annurev.bi.53.070184.002133	45	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11526	11534		10.1074/jbc.274.17.11526	http://dx.doi.org/10.1074/jbc.274.17.11526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206958	hybrid			2022-12-27	WOS:000079834800014
J	Kohzuma, T; Inoue, T; Yoshizaki, F; Sasakawa, Y; Onodera, K; Nagatomo, S; Kitagawa, T; Uzawa, S; Isobe, Y; Sugimura, Y; Gotowda, M; Kai, Y				Kohzuma, T; Inoue, T; Yoshizaki, F; Sasakawa, Y; Onodera, K; Nagatomo, S; Kitagawa, T; Uzawa, S; Isobe, Y; Sugimura, Y; Gotowda, M; Kai, Y			The structure and unusual pH dependence of plastocyanin from the fern Dryopteris crassirhizoma - The protonation of an active site histidine is hindered by pi-pi interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER REACTION; RESOLUTION SOLUTION STRUCTURE; RESONANCE RAMAN-SPECTRA; AROMATIC RING STACKING; BLUE COPPER PROTEINS; GREEN-ALGA; CRYSTAL-STRUCTURE; CYTOCHROME-F; POPLAR PLASTOCYANIN; NEGATIVE CHARGE	Spectroscopic properties, amino acid sequence, electron transfer kinetics, and crystal structures of the oxidized (at 1.7 Angstrom resolution) and reduced form (at 1.8 Angstrom resolution) of a novel. plastocyanin from the fern Dryopteris crassirhizoma are presented. Kinetic studies show that the reduced form of Dryopteris plastocyanin remains redox-active at low pH, under conditions where the oxidation of the reduced form of other plastocyanins is inhibited by the protonation of a solvent-exposed active site residue, His(87) (equivalent to His(90) in Dryopteris plastocyanin), The x-ray crystal structure analysis of Dryopteris plastocyanin reveals pi-pi stacking between Phe(12) and His(90), suggesting that the active site is uniquely protected against inactivation. Like higher plant plastocyanins, Dryopteris plastocyanin has an acidic patch, but this patch is located closer to the solvent-exposed active site His residue, and the total number of acidic residues is smaller, In the reactions of Dryopteris plastocyanin with inorganic redox reagents, the acidic patch (the "remote" site) and the hydrophobic patch surrounding His(90) (the "adjacent" site) are equally efficient for electron transfer. These results indicate the significance of the lack of protonation at the active site of Dryopteris plastocyanin, the equivalence of the two electron transfer sites in this protein, and a possibility of obtaining a novel insight into the photosynthetic electron transfer system of the first vascular plant fern, including its molecular evolutionary aspects, This is the first report on the characterization of plastocyanin and the first three-dimensional protein structure from fern plant.	Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan; Osaka Univ, Grad Sch Engn, Osaka 5650871, Japan; Toho Univ, Fac Sci, Chiba 2748510, Japan; Inst Mol Sci, Aichi 4448585, Japan	Ibaraki University; Osaka University; Toho University	Kohzuma, T (corresponding author), Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan.	kohzuma@biomol.sci.ibaraki.ac.jp	Kohzuma, Takamitsu/U-2966-2019					Badsberg U, 1996, BIOCHEMISTRY-US, V35, P7021, DOI 10.1021/bi960621y; BAGBY S, 1994, BIOCHEMISTRY-US, V33, P6611, DOI 10.1021/bi00187a031; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P31, DOI 10.1093/nar/25.1.31; BLAIR DF, 1985, J AM CHEM SOC, V107, P5755, DOI 10.1021/ja00306a025; Boulter D., 1977, INT REV BIOCH PLANT, V13, P1; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CHRISTENSEN HEM, 1990, INORG CHEM, V29, P2808, DOI 10.1021/ic00340a019; COLLYER CA, 1990, J MOL BIOL, V211, P617, DOI 10.1016/0022-2836(90)90269-R; COLMAN PM, 1978, NATURE, V272, P319, DOI 10.1038/272319a0; Crnogorac MM, 1996, BIOCHEMISTRY-US, V35, P16465, DOI 10.1021/bi961914u; DAVE BC, 1993, J AM CHEM SOC, V115, P12175, DOI 10.1021/ja00078a070; Dong SL, 1998, J AM CHEM SOC, V120, P10434, DOI 10.1021/ja974377p; GROSS EL, 1991, BIOCHIM BIOPHYS ACTA, V1056, P166, DOI 10.1016/S0005-2728(05)80283-X; GUCKERT JA, 1995, J AM CHEM SOC, V117, P2817, DOI 10.1021/ja00115a016; GUSS JM, 1983, J MOL BIOL, V169, P521; GUSS JM, 1992, ACTA CRYSTALLOGR B, V48, P790, DOI 10.1107/S0108768192004270; GUSS JM, 1986, J MOL BIOL, V192, P361, DOI 10.1016/0022-2836(86)90371-2; HE S, 1991, EMBO J, V10, P4011, DOI 10.1002/j.1460-2075.1991.tb04976.x; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KATOH S, 1961, NATURE, V189, P665, DOI 10.1038/189665a0; KOHZUMA T, 1995, J BIOL CHEM, V270, P25733, DOI 10.1074/jbc.270.43.25733; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LARRSON S, 1995, J PHYS CHEM-US, V99, P4860; LOWERY MD, 1993, J AM CHEM SOC, V115, P3012, DOI 10.1021/ja00060a074; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MERCHANT S, 1997, METAL IONS GENE REGU, P450; MOORE JM, 1991, J MOL BIOL, V221, P533, DOI 10.1016/0022-2836(91)80071-2; MOORE JM, 1988, SCIENCE, V240, P314, DOI 10.1126/science.3353725; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Pierloot K, 1997, J AM CHEM SOC, V119, P218, DOI 10.1021/ja962381f; QIN L, 1993, BIOCHEMISTRY-US, V32, P6073, DOI 10.1021/bi00074a019; QIN L, 1992, BIOCHEMISTRY-US, V31, P5145, DOI 10.1021/bi00137a008; QIU D, 1995, J AM CHEM SOC, V117, P6443, DOI 10.1021/ja00129a005; REDINBO MR, 1993, BIOCHEMISTRY-US, V32, P10560, DOI 10.1021/bi00091a005; SAKABE N, 1991, NUCL INSTRUM METH A, V303, P448, DOI 10.1016/0168-9002(91)90282-U; Sasakawa Y, 1998, INORG CHIM ACTA, V283, P184, DOI 10.1016/S0020-1693(98)00228-X; Sigfridsson K, 1996, BIOCHEMISTRY-US, V35, P1249, DOI 10.1021/bi9520141; SOLOMON EI, 1992, CHEM REV, V92, P521, DOI 10.1021/cr00012a003; Sugimori T, 1997, INORG CHEM, V36, P576, DOI 10.1021/ic9608556; Sykes A. G., 1990, STRUCT BOND, V75, P175; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ubbink M, 1998, STRUCTURE, V6, P323, DOI 10.1016/S0969-2126(98)00035-5; Ullmann GM, 1997, J AM CHEM SOC, V119, P42, DOI 10.1021/ja962237u; ULLMANN GM, 1995, J AM CHEM SOC, V117, P4766, DOI 10.1021/ja00122a005; VANPOUDEROYEN G, 1994, EUR J BIOCHEM, V222, P583; YAMAUCHI O, 1989, INORG CHEM, V28, P4066, DOI 10.1021/ic00321a006; YOSHIZAKI F, 1989, J BIOCHEM-TOKYO, V106, P282, DOI 10.1093/oxfordjournals.jbchem.a122845	47	72	75	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11817	11823		10.1074/jbc.274.17.11817	http://dx.doi.org/10.1074/jbc.274.17.11817			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206999	hybrid			2022-12-27	WOS:000079834800055
J	Schuenemann, D; Amin, P; Hartmann, E; Hoffman, NE				Schuenemann, D; Amin, P; Hartmann, E; Hoffman, NE			Chloroplast SecY is complexed to SecE and involved in the translocation of the 33-kDa but not the 23-kDa subunit of the oxygen-evolving complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; THYLAKOID PRECURSOR PROTEIN; ESCHERICHIA-COLI; MEMBRANE INSERTION; ARABIDOPSIS-THALIANA; TARGETING PATHWAYS; NUCLEAR MUTATIONS; PEA-CHLOROPLASTS; EXPORT PATHWAY; TRANSPORT	SecY is a component of the protein-conducting channel for protein transport across the cytoplasmic membrane of prokaryotes. It is intimately associated with a second integral membrane protein, SecE, and together with SecA forms the minimal core of the preprotein translocase. A chloroplast homologue of SecY (cpSecY has previously been identified and determined to be localized to the thylakoid membrane. In the present work, we demonstrate that a SecE homologue is localized to the thylakoid membrane, where it forms a complex with cpSecY, Digitonin solubilization of thylakoid membranes releases the SecY/E complex in a 180-kDa form, indicating that other components are present and/or the complex is a higher order oligomer of the cpSecY/E dimer, To test whether cpSecY forms the protein-conducting channel of the thylakoid membrane, translocation assays were conducted with the SecA-dependent substrate OE33 and the SecA-independent substrate OE23, in the presence and absence of antibodies raised against cpSecY. The antibodies inhibited translocation of OE33 but not OE23, indicating that cpSecY comprises the protein-conducting channel used in the SecA-dependent pathway, whereas a distinct protein conducting channel is used to translocate OE23.	Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; Zentrum Biochem & Mol Zellbiol, D-37073 Gottingen, Germany	Carnegie Institution for Science	Hoffman, NE (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 260 Panama St, Stanford, CA 94305 USA.	hoffman@andrew2.stanford.edu	Hartmann, Enno/C-5687-2013	Schuenemann, Danja/0000-0001-8894-7685; Hoffman, Neil/0000-0002-4057-555X				ADAM Z, 1993, PLANT PHYSIOL, V102, P35, DOI 10.1104/pp.102.1.35; AKIMARU J, 1991, P NATL ACAD SCI USA, V88, P6545, DOI 10.1073/pnas.88.15.6545; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; BEVAN M, 1998, NATURE, V391, P485; Brink S, 1997, EUR J BIOCHEM, V245, P340, DOI 10.1111/j.1432-1033.1997.00340.x; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; CLINE K, 1992, J BIOL CHEM, V267, P2688; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; CLINE K, 1986, J BIOL CHEM, V261, P4804; Cline K, 1996, ANNU REV CELL DEV BI, V12, P1, DOI 10.1146/annurev.cellbio.12.1.1; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; EMANUELSSON O, 1999, IN PRESS PROTEIN SCI; FRANKLIN AE, 1993, J BIOL CHEM, V268, P22175; FULSON DR, 1988, PLANT PHYSIOL, V88, P1146, DOI 10.1104/pp.88.4.1146; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; HARLOW E, 1988, ANTIBODIES LAB MANUA, P522; HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0; HENRY R, 1994, J BIOL CHEM, V269, P10189; Henry R, 1997, J CELL BIOL, V136, P823, DOI 10.1083/jcb.136.4.823; Hirose T, 1996, EMBO J, V15, P1687, DOI 10.1002/j.1460-2075.1996.tb00514.x; HOFFMAN NE, 1994, PLANT PHYSIOL, V105, P295, DOI 10.1104/pp.105.1.295; HULFORD A, 1994, J BIOL CHEM, V269, P3251; ITO K, 1990, J BIOENERG BIOMEMBR, V22, P353, DOI 10.1007/BF00763172; JAGENDORF AT, 1990, PLANT SCI, V71, P137, DOI 10.1016/0168-9452(90)90001-5; Jenkins BD, 1997, PLANT CELL, V9, P283, DOI 10.1105/tpc.9.3.283; Kim SJ, 1998, FEBS LETT, V424, P105, DOI 10.1016/S0014-5793(98)00148-3; KLEIN RR, 1988, J CELL BIOL, V106, P289, DOI 10.1083/jcb.106.2.289; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; LAIDLER V, 1995, J BIOL CHEM, V270, P17664, DOI 10.1074/jbc.270.30.17664; LI XX, 1995, P NATL ACAD SCI USA, V92, P3789, DOI 10.1073/pnas.92.9.3789; MICHL D, 1994, EMBO J, V13, P1310, DOI 10.1002/j.1460-2075.1994.tb06383.x; MOULD RM, 1991, J BIOL CHEM, V266, P12189; Mould RM, 1997, PLANT J, V11, P1051, DOI 10.1046/j.1365-313X.1997.11051051.x; MURPHY CK, 1994, P NATL ACAD SCI USA, V91, P2557, DOI 10.1073/pnas.91.7.2557; NAKAI M, 1994, J BIOL CHEM, V269, P31338; Nilsson R, 1999, EMBO J, V18, P733, DOI 10.1093/emboj/18.3.733; PERRY SE, 1991, METHOD CELL BIOL, V34, P327; Pilgrim ML, 1998, PLANT J, V13, P177, DOI 10.1046/j.1365-313X.1998.00021.x; Pohlschroder M, 1996, J BIOL CHEM, V271, P19908, DOI 10.1074/jbc.271.33.19908; Price A, 1996, J BIOL CHEM, V271, P31580, DOI 10.1074/jbc.271.49.31580; Robinson C, 1997, TRENDS PLANT SCI, V2, P431, DOI 10.1016/S1360-1385(97)90027-3; ROBINSON C, 1994, EMBO J, V13, P279, DOI 10.1002/j.1460-2075.1994.tb06260.x; Robinson D, 1996, PLANT J, V10, P149, DOI 10.1046/j.1365-313X.1996.10010149.x; Roy LM, 1998, J CELL BIOL, V141, P385, DOI 10.1083/jcb.141.2.385; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; SCHATZ PJ, 1991, EMBO J, V10, P1749, DOI 10.1002/j.1460-2075.1991.tb07699.x; SCHATZ PJ, 1990, ANNU REV GENET, V24, P215, DOI 10.1146/annurev.ge.24.120190.001243; SCHATZ PJ, 1989, GENE DEV, V3, P1035, DOI 10.1101/gad.3.7.1035; Schnell DJ, 1998, ANNU REV PLANT PHYS, V49, P97, DOI 10.1146/annurev.arplant.49.1.97; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; Voelker R, 1997, GENETICS, V145, P467; Voelker R, 1995, MOL GEN GENET, V249, P507, DOI 10.1007/BF00290576; VOELKER R, 1995, EMBO J, V14, P3905, DOI 10.1002/j.1460-2075.1995.tb00062.x; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 1998, FEBS LETT, V431, P339, DOI 10.1016/S0014-5793(98)00790-X; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P101, DOI 10.1146/annurev.bi.60.070191.000533; Wu GJ, 1997, PLANT CELL PHYSIOL, V38, P243, DOI 10.1093/oxfordjournals.pcp.a029159; YUAN JG, 1994, SCIENCE, V266, P796, DOI 10.1126/science.7973633	66	74	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12177	12182		10.1074/jbc.274.17.12177	http://dx.doi.org/10.1074/jbc.274.17.12177			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207046	hybrid			2022-12-27	WOS:000079834800102
J	Im, H; Seo, EJ; Yu, MH				Im, H; Seo, EJ; Yu, MH			Metastability in the inhibitory mechanism of human alpha(1)-antitrypsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; HUMAN ALPHA-1-PROTEINASE INHIBITOR; SERPIN CONFORMATIONAL CHANGE; SERINE-PROTEASE INHIBITOR; INFLUENZA HEMAGGLUTININ; CRYSTAL-STRUCTURE; ENVELOPE GLYCOPROTEIN; HYDROPHOBIC CORE; REACTIVE LOOP; HINGE REGION	Metastability of the native form of proteins has been recognized as a mechanism of biological regulation. The energy-loaded structure of the fusion protein of influenza virus and the strained native structure of serpins (serine protease inhibitors) are typical examples. To understand the structural basis and functional role of the native metastability of inhibitory serpins, we characterized stabilizing mutations of alpha(1)-antitrypsin in a region presumably involved in complex formation with a target protease, We found various unfavorable interactions such as overpacking of side chains, polar-nonpolar interactions, and cavities as the structural basis of the native metastability, For several stabilizing mutations, there was a concomitant decrease in the inhibitory activity. Remarkably, some substitutions at Lys-335 increased the stability over 6 kcal mol(-1) with simultaneous loss of activity over 30% toward porcine pancreatic elastase, Considering the location and energetic cost of Lys-335, we propose that this lysine plays a pivotal role in conformational switch during complex formation. Our current results are quite contradictory to those of previously reported hydrophobic core mutations, which increased the stability up to 9 kcal mol(-1) without any significant loss of activity. It appears that the local strain of inhibitory serpins is critical for the inhibitory activity.	Korea Res Inst Biosci & Biotechnol, Natl Creat Res Initiat Ctr, Taejon 305600, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Yu, MH (corresponding author), Korea Res Inst Biosci & Biotechnol, Natl Creat Res Initiat Ctr, POB 115, Taejon 305600, South Korea.							ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; AERTGEERTS K, 1995, NAT STRUCT BIOL, V2, P891, DOI 10.1038/nsb1095-891; BAUMANN U, 1991, J MOL BIOL, V218, P595, DOI 10.1016/0022-2836(91)90704-A; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P11521, DOI 10.1021/bi00113a006; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Elliott PR, 1996, NAT STRUCT BIOL, V3, P676, DOI 10.1038/nsb0896-676; Elliott PR, 1998, J MOL BIOL, V275, P419, DOI 10.1006/jmbi.1997.1458; Engh RA, 1995, TRENDS BIOTECHNOL, V13, P503, DOI 10.1016/S0167-7799(00)89013-7; Gils A, 1996, BIOCHEMISTRY-US, V35, P7474, DOI 10.1021/bi960079d; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Hillier BJ, 1998, FOLD DES, V3, P87, DOI 10.1016/S1359-0278(98)00014-5; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Huntington JA, 1997, BIOCHEMISTRY-US, V36, P5432, DOI 10.1021/bi9702142; Kocher JP, 1996, STRUCTURE, V4, P1517, DOI 10.1016/S0969-2126(96)00157-8; KWON KS, 1994, J BIOL CHEM, V269, P9627; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lawrence DA, 1997, NAT STRUCT BIOL, V4, P339, DOI 10.1038/nsb0597-339; Lee KN, 1998, J BIOL CHEM, V273, P2509, DOI 10.1074/jbc.273.5.2509; Lee KN, 1996, NAT STRUCT BIOL, V3, P497, DOI 10.1038/nsb0696-497; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Lukacs CM, 1996, NAT STRUCT BIOL, V3, P888, DOI 10.1038/nsb1096-888; LUMB KJ, 1995, BIOCHEMISTRY-US, V34, P8642, DOI 10.1021/bi00027a013; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; MARSHALL CJ, 1993, PHILOS T ROY SOC B, V342, P101, DOI 10.1098/rstb.1993.0141; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; Ryu SE, 1996, STRUCTURE, V4, P1181, DOI 10.1016/S0969-2126(96)00126-8; SCHREIBER C, 1994, STRUCTURE, V2, P945, DOI 10.1016/S0969-2126(94)00096-4; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Stratikos E, 1997, P NATL ACAD SCI USA, V94, P453, DOI 10.1073/pnas.94.2.453; TRAVIS J, 1981, METHOD ENZYMOL, V80, P754; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; WEI AZ, 1994, NAT STRUCT BIOL, V1, P251, DOI 10.1038/nsb0494-251; WEIS WI, 1990, J MOL BIOL, V212, P737, DOI 10.1016/0022-2836(90)90234-D; Wilczynska M, 1997, NAT STRUCT BIOL, V4, P354, DOI 10.1038/nsb0597-354; WRIGHT HT, 1995, PROTEINS, V22, P210, DOI 10.1002/prot.340220303	45	64	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11072	11077		10.1074/jbc.274.16.11072	http://dx.doi.org/10.1074/jbc.274.16.11072			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196190	hybrid			2022-12-27	WOS:000079751900058
J	Muller, ML; Jensen, M; Taiz, L				Muller, ML; Jensen, M; Taiz, L			The vacuolar H+-ATPase of lemon fruits is regulated by variable H+/ATP coupling and slip	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L STORAGE TISSUE; BETA-VULGARIS; PROTON SLIP; ENERGY TRANSDUCTION; TONOPLAST VESICLES; GAMMA-SUBUNIT; SYNTHASE; MECHANISM; PH; INHIBITION	Lemon fruit tonoplasts, unlike those of seedling epicotyls, contain nitrate-insensitive H+-ATPase activity (Muller, M. L,, Irkens-Kiesecker, U,, Rubinstein, B., and Taiz, L. (1996) J, Biol. Chem. 271, 1916-1924). However, the degree of nitrate-insensitivity fluctuates during the course of the year with a seasonal frequency. Nitrate uncouples H+ pumping from ATP hydrolysis both in epicotyls and in nitrate-sensitive fruit V-ATPases. Neither bafilomycin nor oxidation cause uncoupling. The initial rate H+/ATP coupling ratios of epicotyl and the nitrate-sensitive fruit proton pumping activities are the same. However, the H+/ATP coupling ratio of the nitrate-insensitive fruit H+ pumping activity is lower than that of nitrate-sensitive and epicotyl V-ATPases, Several properties of the nitrate-insensitive H+-ATPase of the fruit indicate that it is a modified V-ATPase rather than a P-ATPase: 1) insensitivity to low concentrations of vanadate; 2) it is initially strongly uncoupled by nitrate, but regains coupling as catalysis proceeds; 3) both the nitrate-sensitive and nitrate-insensitive fruit H+-pumps have identical K-m values for MgATP, and show similar pH-dependent slip and proton leakage rates. We conclude that the ability of the juice sac V-ATPase to build up steep pH gradients involves three factors: variable coupling, i.e. the ability to regain coupling under conditions that initially induce uncoupling; a low pH dependent slip rate; the low proton permeability of the membrane.	Univ Calif Santa Cruz, Dept Biol, Sinsheimer Labs, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Taiz, L (corresponding author), Univ Calif Santa Cruz, Dept Biol, Sinsheimer Labs, Santa Cruz, CA 95064 USA.							BENNETT AB, 1984, PLANT PHYSIOL, V74, P545, DOI 10.1104/pp.74.3.545; BOWMAN J, 1996, MYCOTA, V3, P57; BRISKIN DP, 1991, PLANT PHYSIOL, V95, P242, DOI 10.1104/pp.95.1.242; DAVIES JM, 1994, P NATL ACAD SCI USA, V91, P8547, DOI 10.1073/pnas.91.18.8547; DSCHIDA WJA, 1995, J BIOL CHEM, V270, P1557, DOI 10.1074/jbc.270.4.1557; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; Evron Y, 1997, PLANT PHYSIOL, V115, P1549, DOI 10.1104/pp.115.4.1549; EVRON Y, 1990, BIOCHIM BIOPHYS ACTA, V1019, P115, DOI 10.1016/0005-2728(90)90131-M; FENG Y, 1992, J BIOL CHEM, V267, P19769; FENG Y, 1994, J BIOL CHEM, V269, P13224; Finbow ME, 1997, BIOCHEM J, V324, P697, DOI 10.1042/bj3240697; GROTH G, 1993, BIOCHEMISTRY-US, V32, P8103, DOI 10.1021/bi00083a008; GUERN J, 1989, PLANT PHYSIOL, V89, P27, DOI 10.1104/pp.89.1.27; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; KANE PM, 1989, J BIOL CHEM, V264, P19236; KANE PM, 1995, J BIOL CHEM, V270, P17025; KIBAK H, 1993, J BIOL CHEM, V268, P23325; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mattsson JP, 1996, BBA-BIOMEMBRANES, V1280, P98, DOI 10.1016/0005-2736(95)00285-5; Merzendorfer H, 1997, J EXP BIOL, V200, P225; MORIYAMA Y, 1988, ION PUMPS STRUCTURE, P387; Muller ML, 1997, J BIOL CHEM, V272, P12762, DOI 10.1074/jbc.272.19.12762; Muller ML, 1996, J BIOL CHEM, V271, P1916; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; OSTER G, 1999, IN PRESS ENCY MOL BI; PALMGREN MG, 1990, PLANT PHYSIOL, V94, P882, DOI 10.1104/pp.94.3.882; POPE AJ, 1988, PLANT PHYSIOL, V86, P1315, DOI 10.1104/pp.86.4.1315; POPOV N, 1975, ACTA BIOL MED GER, V34, P1441; RAUTIALA TJ, 1993, BIOCHEM BIOPH RES CO, V194, P50, DOI 10.1006/bbrc.1993.1783; REA PA, 1987, PHYSIOL PLANTARUM, V71, P131, DOI 10.1111/j.1399-3054.1987.tb04630.x; REA PA, 1987, BIOCHIM BIOPHYS ACTA, V904, P1, DOI 10.1016/0005-2736(87)90080-0; SCHMIDT AL, 1993, ARCH BIOCHEM BIOPHYS, V301, P165, DOI 10.1006/abbi.1993.1129; Taiz Lincoln, 1996, P291; TU SI, 1987, ARCH BIOCHEM BIOPHYS, V256, P625, DOI 10.1016/0003-9861(87)90620-5; XIE XS, 1993, J BIOL CHEM, V268, P25063; Yasuda R, 1997, J BIOENERG BIOMEMBR, V29, P207, DOI 10.1023/A:1022449708449; ZHANG JM, 1994, J BIOL CHEM, V269, P23518; ZHANG K, 1992, J BIOL CHEM, V267, P14539	38	37	38	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10706	10716		10.1074/jbc.274.16.10706	http://dx.doi.org/10.1074/jbc.274.16.10706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196141	hybrid			2022-12-27	WOS:000079751900009
J	Camarero, S; Sarkar, S; Ruiz-Duenas, FJ; Martinez, MJ; Martinez, AT				Camarero, S; Sarkar, S; Ruiz-Duenas, FJ; Martinez, MJ; Martinez, AT			Description of a versatile peroxidase involved in the natural degradation of lignin that has both manganese peroxidase and lignin peroxidase substrate interaction sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASIDIOMYCETE PHANEROCHAETE-CHRYSOSPORIUM; PLEUROTUS-ERYNGII; WHEAT-STRAW; HORSERADISH-PEROXIDASE; ANGSTROM RESOLUTION; BJERKANDERA-ADUSTA; CRYSTAL-STRUCTURE; BINDING-SITE; OXIDATIVE-DEGRADATION; CATALYTIC PROPERTIES	Two major peroxidases are secreted by the fungus Pleurotus eryngii in lignocellulose cultures. One is similar to Phanerochaete chrysosporium manganese-dependent peroxidase, The second protein (PS1), although catalyzing the oxidation of Mn2+ to Mn3+ by H2O2, differs from the above enzymes by its manganese-independent activity enabling it to oxidize substituted phenols and synthetic dyes, as well as the lignin peroxidase (LiP) substrate veratryl alcohol. This is by a mechanism similar to that reported for LiP, as evidenced by p-dimethoxybenzene oxidation yielding benzoquinone. The apparent kinetic constants showed high activity on Mn2+, but methoxyhydroquinone was the natural substrate with the highest enzyme affinity (this and other phenolic substrates are not efficiently oxidized by the P, chrysosporium peroxidases). A three-dimensional model was built using crystal models from four fungal peroxidase as templates. The model suggests high structural affinity of this versatile peroxidase with LiP but shows a putative Mn2+ binding site near the internal heme propionate, involving G1u(36), Glu(40), and Asp(181). A specific substrate interaction site for Mn2+ is supported by kinetic data showing noncompetitive inhibition with other peroxidase substrates, Moreover, residues reported as involved in LiP interaction with veratryl alcohol and other aromatic substrates are present in peroxidase PS1 such as His(82) at the heme-channel opening, which is remarkably similar to that of P, chrysosporium LiP, and Trp(170) at the protein surface, These residues could be involved in two different hypothetical long range electron transfer pathways from substrate (His(82)-Ala(83)-Asn(84)-His(47)-heme and Trp(170)-Leu(171)-heme) similar to those postulated for LiP.	CSIC, Ctr Invest Biol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Martinez, AT (corresponding author), CSIC, Ctr Invest Biol, Velazquez 144, E-28006 Madrid, Spain.	cibm149@fresno.csic.es	Ruiz-Dueñas, Francisco J/L-9837-2015; Camarero, Susana/K-3172-2014; Martínez, Angel T/G-7284-2017; Martinez, Maria Jesus/F-9147-2015	Ruiz-Dueñas, Francisco J/0000-0002-9837-5665; Camarero, Susana/0000-0002-2812-895X; Martínez, Angel T/0000-0002-1584-2863; Martinez, Maria Jesus/0000-0003-2166-1097				ASADA Y, 1995, BBA-PROTEIN STRUCT M, V1251, P205, DOI 10.1016/0167-4838(95)00102-Z; Banci L, 1997, J BIOTECHNOL, V53, P253, DOI 10.1016/S0168-1656(97)01677-5; BAO WL, 1994, FEBS LETT, V354, P297, DOI 10.1016/0014-5793(94)01146-X; Blodig W, 1998, BIOCHEMISTRY-US, V37, P8832, DOI 10.1021/bi9727186; Camarero S, 1996, APPL ENVIRON MICROB, V62, P1070, DOI 10.1128/AEM.62.3.1070-1072.1996; Camarero S, 1998, J PULP PAP SCI, V24, P197; Caramelo L, 1999, APPL ENVIRON MICROB, V65, P916; DATTA A, 1991, APPL ENVIRON MICROB, V57, P1453, DOI 10.1128/AEM.57.5.1453-1460.1991; Doyle WA, 1998, BIOCHEMISTRY-US, V37, P15097, DOI 10.1021/bi981633h; Eriksson K.-E., 1990, MICROBIAL ENZYMATIC; FAISON BD, 1983, APPL ENVIRON MICROB, V46, P1140, DOI 10.1128/AEM.46.5.1140-1145.1983; FARRELL RL, 1989, ENZYME MICROB TECH, V11, P322, DOI 10.1016/0141-0229(89)90014-8; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; GLENN JK, 1986, ARCH BIOCHEM BIOPHYS, V251, P688, DOI 10.1016/0003-9861(86)90378-4; GLENN JK, 1983, BIOCHEM BIOPH RES CO, V114, P1077, DOI 10.1016/0006-291X(83)90672-1; GLUMOFF T, 1990, EUR J BIOCHEM, V187, P515, DOI 10.1111/j.1432-1033.1990.tb15333.x; GOLD MH, 1993, MICROBIOL REV, V57, P605, DOI 10.1128/MMBR.57.3.605-622.1993; Guillen F, 1997, ARCH BIOCHEM BIOPHYS, V339, P190, DOI 10.1006/abbi.1996.9834; HARVEY PJ, 1990, J BIOTECHNOL, V13, P169, DOI 10.1016/0168-1656(90)90102-H; HATAKKA A, 1994, FEMS MICROBIOL REV, V13, P125, DOI 10.1016/0168-6445(94)90076-0; Heinfling A, 1998, FEMS MICROBIOL LETT, V165, P43, DOI 10.1016/S0378-1097(98)00255-9; Heinfling A, 1998, FEBS LETT, V428, P141, DOI 10.1016/S0014-5793(98)00512-2; Heinfling A, 1998, APPL ENVIRON MICROB, V64, P2788; Higuchi T., 1997, BIOCH MOL BIOL WOOD, P1, DOI [10.1007/978-3-642-60469-0_1, DOI 10.1007/978-3-642-60469-0_1, 10.1007/978-3-642-60469-0]; JOHNSON F, 1994, PROTEINS, V20, P312, DOI 10.1002/prot.340200404; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KERSTEN PJ, 1990, BIOCHEM J, V268, P475, DOI 10.1042/bj2680475; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Kishi K, 1996, BIOCHEMISTRY-US, V35, P8986, DOI 10.1021/bi960679c; KUNISHIMA N, 1994, J MOL BIOL, V235, P331, DOI 10.1016/S0022-2836(05)80037-3; KUWAHARA M, 1984, FEBS LETT, V169, P247, DOI 10.1016/0014-5793(84)80327-0; Lobos S, 1998, GENE, V206, P185, DOI 10.1016/S0378-1119(97)00583-0; MARTINEZ AT, 1994, FEMS MICROBIOL REV, V13, P265, DOI 10.1016/0168-6445(94)90084-1; MARTINEZ AT, 1997, 16 C SOC ESP MICR UL, P89; Martinez MJ, 1996, EUR J BIOCHEM, V237, P424, DOI 10.1111/j.1432-1033.1996.0424k.x; Martinez-Inigo MJ, 1997, HOLZFORSCHUNG, V51, P543, DOI 10.1515/hfsg.1997.51.6.543; Mester T, 1998, J BIOL CHEM, V273, P15412, DOI 10.1074/jbc.273.25.15412; Munoz C, 1997, APPL ENVIRON MICROB, V63, P2166; Palmieri G, 1998, 7TH INTERNATIONAL CONFERENCE ON BIOTECHNOLOGY IN THE PULP AND PAPER INDUSTRY, VOL B, pB253; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; PETERSEN JFW, 1994, FEBS LETT, V339, P291, DOI 10.1016/0014-5793(94)80433-8; PIONTEK K, 1993, FEBS LETT, V315, P119, DOI 10.1016/0014-5793(93)81146-Q; POULOS TL, 1993, J BIOL CHEM, V268, P4429; Ruiz-Duenas FJ, 1999, MOL MICROBIOL, V31, P223, DOI 10.1046/j.1365-2958.1999.01164.x; Sarkar S, 1997, BBA-PROTEIN STRUCT M, V1339, P23, DOI 10.1016/S0167-4838(96)00201-4; Schoemaker H E, 1994, Bioorg Med Chem, V2, P509, DOI 10.1016/0968-0896(94)80021-9; SCHOEMAKER HE, 1994, FEMS MICROBIOL REV, V13, P321, DOI 10.1111/j.1574-6976.1994.tb00052.x; Shimada M., 1991, WOOD CELLULOSIC CHEM, P557; STEINLIN H, 1979, HOLS ALS ROHSTOFF WE, P14; Sundaramoorthy M, 1997, J BIOL CHEM, V272, P17574, DOI 10.1074/jbc.272.28.17574; SUNDERAMOORTHY M, 1984, J BIOL CHEM, V269, P32769; *TAPPI, 1993, TEST METH 1992 1993; TIEN M, 1983, SCIENCE, V221, P661, DOI 10.1126/science.221.4611.661; VARES T, 1995, APPL ENVIRON MICROB, V61, P3515, DOI 10.1128/AEM.61.10.3515-3520.1995; VEITCH NC, 1995, EUR J BIOCHEM, V233, P650, DOI 10.1111/j.1432-1033.1995.650_2.x	55	271	288	2	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10324	10330		10.1074/jbc.274.15.10324	http://dx.doi.org/10.1074/jbc.274.15.10324			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187820	Green Published, hybrid			2022-12-27	WOS:000079663500059
J	Dombrowski, S; Hoffmann, M; Guha, C; Binder, S				Dombrowski, S; Hoffmann, M; Guha, C; Binder, S			Continuous primary sequence requirements in the 18-nucleotide promoter of dicot plant mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION INITIATION SITES; RNA-POLYMERASES; GENE-EXPRESSION; MESSENGER-RNA; IN-VITRO; IDENTIFICATION; ARABIDOPSIS; DNA; PEA; PLASTIDS	The nucleotide requirements of mitochondrial promoters of dicot plants were studied in detail in a pea in vitro transcription system. Deletions in the 5' regions of three different transcription initiation sites from pea, soybean, and Oenothera identified a crucial AT-rich sequence element (AT-Box) comprising nucleotide positions -14 to -9 relative to the first transcribed nucleotide. Transversion of the AT-Box sequence to complementary nucleotide identities results in an almost complete loss of promoter activity, suggesting that primary structure rather than a simple accumulation of adenines and thymidines in this region is essential for promoter activity. This promoter segment thus appears to be involved in sequence specific binding of a respective protein factor(s) rather than merely loosening and melting the DNA helix during or for an initiation event. Manipulation of nucleotide identities in the 3' portion of the pea atp9 promoter and the respective S'-flanking region revealed that essential sequences extend to positions +3/+4 beyond this transcription start site. Efficient transcription initiation at an 18-base pair promoter sequence ranging from nucleotide positions -14 to +4 integrated into different sequence contexts shows this element to be sufficient for autonomous promoter function independent of surrounding sequences.	Univ Ulm, Allgemeine Bot, D-89069 Ulm, Germany	Ulm University	Binder, S (corresponding author), Univ Ulm, Allgemeine Bot, Albert-Einstein-Allee 11, D-89069 Ulm, Germany.	stefan.binder@biologie.uni-ulm.de						ANTOSHECHKIN I, 1995, MOL CELL BIOL, V15, P7032; BINDER S, 1993, J BIOL CHEM, V268, P7849; Binder S, 1996, PLANT MOL BIOL, V32, P303, DOI 10.1007/BF00039387; BINDER S, 1993, NUCLEIC ACIDS RES, V21, P5012, DOI 10.1093/nar/21.22.5012; BINDER S, 1995, J BIOL CHEM, V270, P22182, DOI 10.1074/jbc.270.38.22182; BROWN GG, 1991, MOL GEN GENET, V228, P345, DOI 10.1007/BF00260626; Caoile AGFS, 1997, NUCLEIC ACIDS RES, V25, P4055, DOI 10.1093/nar/25.20.4055; COVELLO PS, 1991, CURR GENET, V20, P245, DOI 10.1007/BF00326239; Dombrowski S, 1998, PLANT MITOCHONDRIA: FROM GENE TO FUNCTION, P165; Giese A, 1996, MOL GEN GENET, V252, P429, DOI 10.1007/BF02173008; GRAY MW, 1989, TRENDS GENET, V5, P294, DOI 10.1016/0168-9525(89)90111-X; Hajdukiewicz PTJ, 1997, EMBO J, V16, P4041, DOI 10.1093/emboj/16.13.4041; Hatzack F, 1998, PLANT PHYSIOL, V116, P519, DOI 10.1104/pp.116.2.519; Hedtke B, 1997, SCIENCE, V277, P809, DOI 10.1126/science.277.5327.809; Hubschmann T, 1998, PLANT MOL BIOL, V36, P493, DOI 10.1023/A:1005924502336; Kapoor S, 1997, PLANT J, V11, P327, DOI 10.1046/j.1365-313X.1997.11020327.x; Larsson NG, 1996, NAT GENET, V13, P296, DOI 10.1038/ng0796-296; Maliga P, 1998, TRENDS PLANT SCI, V3, P4, DOI 10.1016/S1360-1385(97)87981-2; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; MULLIGAN RM, 1991, MOL CELL BIOL, V11, P533, DOI 10.1128/MCB.11.1.533; NAKAZONO M, 1995, PLANT SCI, V105, P227, DOI 10.1016/0168-9452(94)04046-X; RAPP WD, 1993, MOL CELL BIOL, V13, P7232, DOI 10.1128/MCB.13.12.7232; RAPP WD, 1992, EMBO J, V11, P1065, DOI 10.1002/j.1460-2075.1992.tb05145.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SHADEL GS, 1993, J BIOL CHEM, V268, P16083; Sugita M, 1996, PLANT MOL BIOL, V32, P315, DOI 10.1007/BF00039388; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; TRACY RL, 1995, CURR GENET, V28, P205, DOI 10.1007/BF00309779; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Weihe A, 1997, NUCLEIC ACIDS RES, V25, P2319, DOI 10.1093/nar/25.12.2319; Yan B, 1997, CURR GENET, V32, P287, DOI 10.1007/s002940050279	31	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10094	10099		10.1074/jbc.274.15.10094	http://dx.doi.org/10.1074/jbc.274.15.10094			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187790	hybrid			2022-12-27	WOS:000079663500029
J	Haskell, CA; Cleary, MD; Charo, IF				Haskell, CA; Cleary, MD; Charo, IF			Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction - Rapid flow arrest of CX(3)CR1-expressing cells is independent of G-protein activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTORS; DIRECTED MIGRATION; CHEMOTAXIS; CX(3)CR1; LINE; INTERNALIZATION; LYMPHOCYTES; MICROGLIA; ROLES; BRAIN	Fractalkine is a novel multidomain protein expressed on the surface of activated endothelial cells. Cells expressing the chemokine receptor CX(3)CR1 adhere to fractalkine with high affinity, but it is not known if adherence requires G-protein activation and signal transduction. To investigate the cell adhesion properties of fractalkine, we created mutated forms of CX(3)CR1 that have little or no ability to transduce intracellular signals. Cells expressing signaling-incompetent forms of CX(3)CR1 bound rapidly and with high affinity to immobilized fractalkine in both static and flow assays. Video microscopy revealed that CX(3)CR1-expressing cells bound more rapidly to fractalkine than to VCAM-1 (60 versus 190 ms). Unlike VCAM-1, fractalkine did not mediate cell rolling, and after capture on fractalkine, cells did not dislodge. Finally, soluble fractalkine induced intracellular calcium fluxes and chemotaxis, but it did not activate integrins. Taken together these data provide strong evidence that CX(3)CR1, a seven-transmembrane domain receptor, mediates robust cell adhesion to fractalkine in the absence of G-protein activation and suggest a novel role for this receptor as an adhesion molecule.	Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Charo, IF (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, POB 419100, San Francisco, CA 94141 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052773] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL52773] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arai H, 1997, J BIOL CHEM, V272, P25037, DOI 10.1074/jbc.272.40.25037; Arai H, 1997, P NATL ACAD SCI USA, V94, P14495, DOI 10.1073/pnas.94.26.14495; Arai H, 1996, J BIOL CHEM, V271, P21814, DOI 10.1074/jbc.271.36.21814; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Campbell JJ, 1996, J CELL BIOL, V134, P255, DOI 10.1083/jcb.134.1.255; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; DIXON RAF, 1988, COLD SPRING HARB SYM, V53, P487, DOI 10.1101/SQB.1988.053.01.056; Farzan M, 1997, J BIOL CHEM, V272, P6854, DOI 10.1074/jbc.272.11.6854; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Franci C, 1996, J IMMUNOL, V157, P5606; FRASER CM, 1989, MOL PHARMACOL, V36, P840; Gosling J, 1997, P NATL ACAD SCI USA, V94, P5061, DOI 10.1073/pnas.94.10.5061; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; ISHII K, 1993, J BIOL CHEM, V268, P9780; Kuang YN, 1996, J BIOL CHEM, V271, P3975; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Pachynski RK, 1998, J IMMUNOL, V161, P952; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; RAPORT CJ, 1995, GENE, V163, P295, DOI 10.1016/0378-1119(95)00336-5; RETH MG, 1985, NATURE, V317, P353, DOI 10.1038/317353a0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; YEDNOCK TA, 1995, J BIOL CHEM, V270, P28740, DOI 10.1074/jbc.270.48.28740	25	186	198	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10053	10058		10.1074/jbc.274.15.10053	http://dx.doi.org/10.1074/jbc.274.15.10053			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187784	hybrid			2022-12-27	WOS:000079663500023
J	Meng, Q; Malinovskii, V; Huang, W; Hu, YJ; Chung, L; Nagase, H; Bode, W; Maskos, K; Brew, K				Meng, Q; Malinovskii, V; Huang, W; Hu, YJ; Chung, L; Nagase, H; Bode, W; Maskos, K; Brew, K			Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1 ' residue of substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-TISSUE INHIBITOR; GROWTH-PROMOTING ACTIVITY; AMINO-TERMINAL DOMAIN; PROGELATINASE-A; BINDING; FAMILY; STROMELYSIN-1; RECEPTOR; CLONING; REGION	The unregulated activities of matrix metalloproteinases (MMPs) are implicated in disease processes including arthritis and tumor cell invasion and metastasis, NMP activities are controlled by four homologous endogenous protein inhibitors, tissue inhibitors of metalloproteinases (TIMPs), yet different TIMPs show little specificity for individual MMPs. The large interaction interface in the TIMP-1.MMP-3 complex includes a contiguous region of TIMP-1 around the disulfide bond between Cys(1) and Cys(70) that inserts into the active site of MMP-3. The effects of fifteen different substitutions for threonine 2 of this region reveal that this residue makes a large contribution to the stability of complexes with MMPs and has a dominant influence on the specificity for different MMPs. The size, charge, and hydrophobicity of residue 2 are key factors in the specificity of TIMP. Threonine 2 of TIMP-1 interacts with the S1' specificity pocket of MMP-3, which is a key to substrate specificity, but the structural requirements in TIMP-1 residue 2 for MMP binding differ greatly from those for the corresponding residue of a peptide substrate. These results demonstrate that TIMP variants with substitutions for Thr(2) represent suitable starting points for generating more targeted TIMPs for investigation and for intervention in MMP-related diseases.	Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA; Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA; Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany	University of Miami; University of Kansas; University of Kansas Medical Center; Max Planck Society	Brew, K (corresponding author), Univ Miami, Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.		Brew, Keith/A-6746-2009; Brew, Keith/W-1643-2019; Malinovskii, Vladimir A./AAF-9048-2019	Brew, Keith/0000-0003-1306-1032; Malinovskii, Vladimir A./0000-0001-6261-0398	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR40994] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AnandApte B, 1997, INVEST OPHTH VIS SCI, V38, P817; Bigg HF, 1997, J BIOL CHEM, V272, P15496, DOI 10.1074/jbc.272.24.15496; BOONE TC, 1990, P NATL ACAD SCI USA, V87, P2800, DOI 10.1073/pnas.87.7.2800; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Greene J, 1996, J BIOL CHEM, V271, P30375, DOI 10.1074/jbc.271.48.30375; HAYAKAWA T, 1994, J CELL SCI, V107, P2373; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; MURPHY G, 1995, METHOD ENZYMOL, V248, P496; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; Nagase H, 1997, BIOCHEM J, V325, P163, DOI 10.1042/bj3250163; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R; Nagase H, 1996, ZINC METALLOPROTEASE, P153; OSHEA M, 1992, BIOCHEMISTRY-US, V31, P10146, DOI 10.1021/bi00157a002; PAVLOFF N, 1992, J BIOL CHEM, V267, P17321; ROSEMAN MA, 1988, J MOL BIOL, V200, P513, DOI 10.1016/0022-2836(88)90540-2; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SILBIGER SM, 1994, GENE, V141, P293, DOI 10.1016/0378-1119(94)90588-6; STAMS T, 1994, NAT STRUCT BIOL, V1, P119, DOI 10.1038/nsb0294-119; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; WILLIAMSON RA, 1994, BIOCHEMISTRY-US, V33, P11745, DOI 10.1021/bi00205a010; WILLIAMSON RA, 1990, BIOCHEM J, V268, P267, DOI 10.1042/bj2680267; WOESSNER JF, 1994, ANN NY ACAD SCI, V732, P11	36	69	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10184	10189		10.1074/jbc.274.15.10184	http://dx.doi.org/10.1074/jbc.274.15.10184			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187802	hybrid			2022-12-27	WOS:000079663500041
J	Okamoto, PM; Tripet, B; Litowski, J; Hodges, RS; Vallee, RB				Okamoto, PM; Tripet, B; Litowski, J; Hodges, RS; Vallee, RB			Multiple distinct coiled-coils are involved in dynamin self-assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CONFORMATIONAL CHANGE; PLECKSTRIN HOMOLOGY DOMAINS; GTPASE ACTIVITY; MECHANOCHEMICAL ENZYME; ACIDIC PHOSPHOLIPIDS; MAMMALIAN-CELLS; BINDING-SITE; SH3 DOMAINS; PROTEIN; ENDOCYTOSIS	Dynamin, a 100-kDa GTPase, has been implicated to be involved in synaptic vesicle recycling, receptor-mediated endocytosis, and other membrane sorting processes. Dynamin self-assembles into helical collars around the necks of coated pits and other membrane invaginations and mediates membrane scission. In vitro, dynamin has been reported to exist as dimers, tetramers, ring-shaped oligomers, and helical polymers. In this study we sought to define self-assembly regions in dynamin, Deletion of two closely spaced sequences near the dynamin-1 C terminus abolished self-association as assayed by co-immunoprecipitation and the yeast interaction trap, and reduced the sedimentation coefficient from 7.5 to 4.5 S, Circular dichroism spectroscopy and equilibrium ultracentrifugation of synthetic peptides revealed coiled-coil formation within the C-terminal assembly domain and at a third, centrally located site. Two of the peptides formed tetramers, supporting a role for each in the monomer-tetramer transition and providing novel insight into the organization of the tetramer, Partial deletions of the C-terminal assembly domain reversed the dominant inhibition of endocytosis by dynamin-1 GTPase mutants. Self association was also observed between different dynamin isoforms, Taken altogether, our results reveal two distinct coiled-coil-containing assembly domains that can recognize other dynamin isoforms and mediate endocytic inhibition. In addition, our data strongly suggests a parallel model for dynamin subunit self-association.	Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Univ Alberta, MRC, Grp Prot Struct & Funct, Edmonton, AB T6G 2H7, Canada	University of Massachusetts System; University of Massachusetts Worcester; University of Alberta; University of Alberta	Vallee, RB (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026701] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM26701] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSUBEL FM, 1994, CURRENT PROTOCOLS MO, V2; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; GANS PJ, 1991, BIOPOLYMERS, V31, P1605, DOI 10.1002/bip.360311315; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HERSKOVITS JS, 1993, P NATL ACAD SCI USA, V90, P11468, DOI 10.1073/pnas.90.24.11468; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Liu JP, 1996, J NEUROCHEM, V66, P2074; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MELEN K, 1992, J BIOL CHEM, V267, P25898; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; NAKAYAMA M, 1993, J BIOL CHEM, V268, P15033; OBAR RA, 1990, NATURE, V347, P256, DOI 10.1038/347256a0; Okamoto PM, 1997, J BIOL CHEM, V272, P11629; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SEREDA TJ, 1993, J CHROMATOGR, V646, P17, DOI 10.1016/S0021-9673(99)87003-4; SHPETNER HS, 1992, NATURE, V355, P733, DOI 10.1038/355733a0; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Shpetner HS, 1996, J BIOL CHEM, V271, P13, DOI 10.1074/jbc.271.1.13; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; Tripet B, 1997, J BIOL CHEM, V272, P8946; TUMA PL, 1993, J BIOL CHEM, V268, P17240; TUMA PL, 1995, J BIOL CHEM, V270, P26707, DOI 10.1074/jbc.270.44.26707; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; WARNOCK DE, 1995, EMBO J, V14, P1322, DOI 10.1002/j.1460-2075.1995.tb07118.x; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002	43	68	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10277	10286		10.1074/jbc.274.15.10277	http://dx.doi.org/10.1074/jbc.274.15.10277			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187814	hybrid			2022-12-27	WOS:000079663500053
J	Pingoud, V; Thole, H; Christ, F; Grindl, W; Wende, W; Pingoud, A				Pingoud, V; Thole, H; Christ, F; Grindl, W; Wende, W; Pingoud, A			Photocross-linking of the homing endonuclease PI-SceI to its recognition sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC ENDONUCLEASE; DNA-BINDING SITES; CROSS-LINKING; I-CREI; CONFORMATIONAL-CHANGES; ESCHERICHIA-COLI; SUBSTITUTED RNA; PROTEIN; CLEAVAGE; SUBSTRATE	PI-SceI is an intein-encoded protein that belongs to the LAGLIDADG family of homing endonucleases, According to the crystal structure and mutational studies, this endonuclease consists of two domains, one responsible for protein splicing, the other for DNA cleavage, and both presumably for DNA binding, To define the DNA binding site of PI-SceI, photocross-linking was used to identify amino acid residues in contact with DNA, Sixty-three double-stranded oligodeoxynucleotides comprising the minimal recognition sequence and containing single 5-iodopyrimidine substitutions in almost all positions of the recognition sequence were synthesized and irradiated in the presence of PI-SceI with a helium/cadmium laser (325 nm), The best cross-linking yield (approximately 30%) was obtained with an oligodeoxynucleotide with a B-iododeoxyuridine at position +9 in the bottom strand, The subsequent analysis showed that cross-linking had occurred with amino acid His-333, 6 amino acids after the second LAGLIDADG motif, With the H333A variant of PI-SceI or in the presence of excess unmodified oligodeoxynucleotide, no cross-linking was observed, indicating the specificity of the crosslinking reaction. Chemical modification of His residues in PI-SceI by diethylpyrocarbonate leads to a substantial reduction in the binding and cleavage activity of PI-SceI, This inactivation can be suppressed by substrate binding. This result further supports the finding that at least one His residue is in close contact to the DNA, Based on these and published results, conclusions are drawn regarding the DNA binding site of PI-SceI.	Univ Giessen, Inst Biochem, Fachbereich Biol, D-35392 Giessen, Germany; Hannover Med Sch, Zentrum Kinderheilkunde, D-30623 Hannover, Germany	Justus Liebig University Giessen; Hannover Medical School	Pingoud, V (corresponding author), Univ Giessen, Inst Biochem, Fachbereich Biol, FB 15,Heinrich-Buff-Ring 58, D-35392 Giessen, Germany.	vera.pingoud@chemie.bio.uni-giessen.de	Wende, Wolfgang/F-6127-2014; Christ, Frauke/H-7513-2018	Christ, Frauke/0000-0001-9580-3874; Wende, Wolfgang/0000-0001-6577-9535				Aagaard C, 1997, NUCLEIC ACIDS RES, V25, P1523, DOI 10.1093/nar/25.8.1523; Argast GM, 1998, J MOL BIOL, V280, P345, DOI 10.1006/jmbi.1998.1886; Belfort M, 1995, J BIOL CHEM, V270, P30237, DOI 10.1074/jbc.270.51.30237; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; BLATTER EE, 1992, NATURE, V359, P650, DOI 10.1038/359650a0; Curcio MJ, 1996, CELL, V84, P9, DOI 10.1016/S0092-8674(00)80987-3; Dalgaard JZ, 1997, NUCLEIC ACIDS RES, V25, P4626, DOI 10.1093/nar/25.22.4626; Derbyshire V, 1997, J MOL BIOL, V265, P494, DOI 10.1006/jmbi.1996.0754; Duan XQ, 1997, CELL, V89, P555, DOI 10.1016/S0092-8674(00)80237-8; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; Gimble FS, 1996, J MOL BIOL, V263, P163, DOI 10.1006/jmbi.1996.0567; GIMBLE FS, 1995, J BIOL CHEM, V270, P5849, DOI 10.1074/jbc.270.11.5849; GIMBLE FS, 1993, J BIOL CHEM, V268, P21844; Grindl W, 1998, NUCLEIC ACIDS RES, V26, P1857, DOI 10.1093/nar/26.8.1857; He ZN, 1998, J BIOL CHEM, V273, P4607, DOI 10.1074/jbc.273.8.4607; Heath PJ, 1997, NAT STRUCT BIOL, V4, P468, DOI 10.1038/nsb0697-468; HENKE RM, 1995, EMBO J, V14, P5094, DOI 10.1002/j.1460-2075.1995.tb00191.x; HODGES RA, 1992, NUCLEIC ACIDS RES, V20, P6153, DOI 10.1093/nar/20.23.6153; ITO W, 1991, GENE, V102, P67, DOI 10.1016/0378-1119(91)90539-N; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Jin YJ, 1997, J BIOL CHEM, V272, P7352, DOI 10.1074/jbc.272.11.7352; LAMBOWITZ AM, 1993, ANNU REV BIOCHEM, V62, P587, DOI 10.1146/annurev.bi.62.070193.003103; Loizos N, 1996, J MOL BIOL, V255, P412, DOI 10.1006/jmbi.1996.0034; LYKKEANDERSEN J, 1994, NUCLEIC ACIDS RES, V22, P4583, DOI 10.1093/nar/22.22.4583; LykkeAndersen J, 1996, NUCLEIC ACIDS RES, V24, P3982, DOI 10.1093/nar/24.20.3982; LykkeAndersen J, 1997, EMBO J, V16, P3272, DOI 10.1093/emboj/16.11.3272; Malkov VA, 1997, J BIOL CHEM, V272, P23811, DOI 10.1074/jbc.272.38.23811; Meisenheimer KM, 1996, NUCLEIC ACIDS RES, V24, P981, DOI 10.1093/nar/24.5.981; MUELLER JE, 1995, EMBO J, V14, P5724, DOI 10.1002/j.1460-2075.1995.tb00259.x; Mueller JE, 1996, GENE DEV, V10, P2158, DOI 10.1101/gad.10.17.2158; Norris CL, 1996, J AM CHEM SOC, V118, P5796, DOI 10.1021/ja9607852; PERRIN A, 1993, EMBO J, V12, P2939, DOI 10.1002/j.1460-2075.1993.tb05956.x; Pingoud V, 1998, BIOCHEMISTRY-US, V37, P8233, DOI 10.1021/bi980013d; Seligman LM, 1997, GENETICS, V147, P1653; STUMP WT, 1995, RNA, V1, P55; THOLE HH, 1995, EUR J BIOCHEM, V231, P510, DOI 10.1111/j.1432-1033.1995.tb20726.x; Turmel M, 1997, NUCLEIC ACIDS RES, V25, P2610, DOI 10.1093/nar/25.13.2610; Wang Y, 1996, BIOCHEMISTRY-US, V35, P3563, DOI 10.1021/bi952438v; Wende W, 1996, NUCLEIC ACIDS RES, V24, P4123, DOI 10.1093/nar/24.21.4123; WILLIS MC, 1993, SCIENCE, V262, P1255, DOI 10.1126/science.7694369; Wong DL, 1998, NUCLEIC ACIDS RES, V26, P645, DOI 10.1093/nar/26.2.645	41	24	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10235	10243		10.1074/jbc.274.15.10235	http://dx.doi.org/10.1074/jbc.274.15.10235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187809	hybrid			2022-12-27	WOS:000079663500048
J	Van Patten, SM; Hanson, E; Bernasconi, R; Zhang, K; Manavalan, P; Cole, ES; McPherson, JM; Edmunds, T				Van Patten, SM; Hanson, E; Bernasconi, R; Zhang, K; Manavalan, P; Cole, ES; McPherson, JM; Edmunds, T			Oxidation of methionine residues in antithrombin - Effects on biological activity and heparin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-2-ANTIPLASMIN; EMPHYSEMA; ALPHA-1-ANTITRYPSIN; INACTIVATION; INHIBITOR; AFFINITY; ASN-135	Commercially available human plasma-derived preparations of the serine protease inhibitor antithrombin (AT) were shown to contain low levels of oxidation, and we sought to determine whether oxidation might be a means of regulating the protein's inhibitory activity. A recombinant form of AT, with similarly low levels of oxidation as purified, was treated with hydrogen peroxide in order to study the effect of oxidation, specifically methionine oxidation, on the biochemical properties of this protein. AT contains two adjacent methionine residues near the reactive site loop cleaved by thrombin (Met(314) and Met(315)) and two exposed methionines that border on the heparin binding region of AT (Met(17) and Met(20)), In forced oxidations with hydrogen peroxide, the methionines at 314 and 315 were found to be the most susceptible to oxidation, but their oxidation did not affect either thrombin-inhibitory activity or heparin binding, Methionines at positions 17 and 20 were significantly oxidized only at higher concentrations of peroxide, at which point heparin affinity was decreased. However at saturating heparin concentrations, activity was only marginally decreased for these highly oxidized samples of AT. Structural studies indicate that highly oxidized AT is less able to undergo the complete conformational change induced by heparin, most probably due to oxidation of Met(17), Since this does not occur in less oxidized, and presumably more physiologically relevant, forms of AT such as those found in plasma preparations, oxidation does not appear to be a means of controlling AT activity.	Genzyme Corp, Struct Prot Chem Grp, Framingham, MA 01701 USA	Sanofi-Aventis; Genzyme Corporation	Van Patten, SM (corresponding author), Genzyme Corp, Struct Prot Chem Grp, 1Mt Rd, Framingham, MA 01701 USA.							BRENNAN SO, 1987, FEBS LETT, V219, P431, DOI 10.1016/0014-5793(87)80266-1; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; Edmunds T, 1998, BLOOD, V91, P4561, DOI 10.1182/blood.V91.12.4561; FAN BQ, 1993, J BIOL CHEM, V268, P17588; GADEK JE, 1981, J CLIN INVEST, V68, P889, DOI 10.1172/JCI110344; GETTINS PGW, 1996, SERPINS STRUCTURES F; GROSS E, 1968, ANN NY ACAD SCI, V151, P556, DOI 10.1111/j.1749-6632.1968.tb11915.x; JANOFF A, 1983, AM REV RESPIR DIS, V127, pS31; JOHNSON D, 1979, J BIOL CHEM, V254, P4022; JOPPICHKUHN R, 1982, ANAL BIOCHEM, V119, P73, DOI 10.1016/0003-2697(82)90666-2; Keck RG, 1996, ANAL BIOCHEM, V236, P56, DOI 10.1006/abio.1996.0131; Meagher JL, 1998, J BIOL CHEM, V273, P23283, DOI 10.1074/jbc.273.36.23283; OGUSHI F, 1991, J CLIN INVEST, V87, P1060, DOI 10.1172/JCI115066; OLSON ST, 1981, J BIOL CHEM, V256, P1065; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Perlmutter DH, 1996, ANN MED, V28, P385, DOI 10.3109/07853899608999097; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; SHIEH BH, 1987, J BIOL CHEM, V262, P6055; STIEF TW, 1988, THROMB RES, V49, P581, DOI 10.1016/0049-3848(88)90255-1; SWAIM MW, 1988, J LEUKOCYTE BIOL, V43, P365, DOI 10.1002/jlb.43.4.365; TEH LC, 1987, J BIOL CHEM, V262, P6472; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; VANBOECKEL CAA, 1994, NAT STRUCT BIOL, V1, P423, DOI 10.1038/nsb0794-423; VOGT W, 1992, IMMUNOBIOLOGY, V184, P384, DOI 10.1016/S0171-2985(11)80595-4; WEINER H, 1966, J BIOL CHEM, V241, P2687	25	41	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10268	10276		10.1074/jbc.274.15.10268	http://dx.doi.org/10.1074/jbc.274.15.10268			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187813	hybrid			2022-12-27	WOS:000079663500052
J	Wang, Q; Hasan, G; Pikielny, CW				Wang, Q; Hasan, G; Pikielny, CW			Preferential expression of biotransformation enzymes in the olfactory organs of Drosophila melanogaster, the antennae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-GLUCURONOSYLTRANSFERASE ISOZYMES; ANTHERAEA-POLYPHEMUS; SIGNAL SEQUENCES; ODORANT-BINDING; DRUG-METABOLISM; RAT-LIVER; GENE; PROTEIN; SYSTEM; TRANSFERASE	Biotransformation enzymes have been found in the olfactory epithelium of vertebrates, We now show that in Drosophila melanogaster, a UDP-glycosyltransferase (UGT), as well as a short chain dehydrogenase/reductase and a cytochrome P450 are expressed specifically or preferentially in the olfactory organs, the antennae. The evolutionarily conserved expression of biotransformation enzymes in olfactory organs suggests that they play an important role in olfaction, In addition, we describe five Drosophila UGTs belonging to two families. All five UGTs contain a putative transmembrane domain at their C terminus as is the case for vertebrate UGTs where it is required for enzymatic activity, The primary sequence of the C terminus, including part of the transmembrane domain, differs between the two families but is highly conserved not only within each Drosophila family, but also between the members of one of the Drosophila families and vertebrate UGTs, The partial overlap of the conserved primary sequence with the transmembrane domain suggests that this part of the protein is involved in specific interactions occurring at the membrane surface. The presence of different C termini in the two Drosophila families suggests that they interact with different targets, one of which is conserved between Drosophila and vertebrates.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; Natl Ctr Biol Sci, TIFR Ctr, Bangalore 560012, Karnataka, India	Rutgers State University New Brunswick; Rutgers State University Medical Center; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Pikielny, CW (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Lane, Piscataway, NJ 08854 USA.		Hasan, Gaiti/I-5851-2015; Hasan, Gaiti/P-4107-2019	Hasan, Gaiti/0000-0001-7194-383X; Hasan, Gaiti/0000-0001-7194-383X				AHMAD SA, 1992, ARCH INSECT BIOCHEM, V21, P207, DOI 10.1002/arch.940210305; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAKER TC, 1988, J EXP BIOL, V137, P29; BENARIE N, 1993, BIOCHEM J, V292, P379, DOI 10.1042/bj2920379; Bossuyt X, 1997, BIOCHEM J, V323, P645, DOI 10.1042/bj3230645; BRIERLEY CH, 1993, BIOESSAYS, V15, P749, DOI 10.1002/bies.950151108; COHEN MB, 1994, GENE, V146, P267, DOI 10.1016/0378-1119(94)90304-2; Cols N, 1997, FEBS LETT, V413, P191, DOI 10.1016/S0014-5793(97)00894-6; DEAR TN, 1991, BIOCHEMISTRY-US, V30, P10376, DOI 10.1021/bi00107a003; DUTTON DJ, 1962, COMP BIOCH PHYSL, V7, P39; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; GUENGERICH FP, 1993, AM SCI, V81, P440; HekmatScafe DS, 1997, J NEUROSCI, V17, P1616; Hovemann BT, 1997, GENE, V189, P213, DOI 10.1016/S0378-1119(96)00851-7; Hu ZH, 1997, VIRUS RES, V47, P91, DOI 10.1016/S0168-1702(96)01406-2; Ikushiro S, 1997, BIOCHEMISTRY-US, V36, P7154, DOI 10.1021/bi9702344; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; LAZARD D, 1990, BIOCHEMISTRY-US, V29, P7433, DOI 10.1021/bi00484a012; LAZARD D, 1991, NATURE, V349, P790, DOI 10.1038/349790a0; LEE BU, 1995, GENE DEV, V9, P2964, DOI 10.1101/gad.9.23.2964; MACKENZIE PI, 1986, J BIOL CHEM, V261, P6119; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; Maser E, 1997, EUR J BIOCHEM, V249, P365, DOI 10.1111/j.1432-1033.1997.00365.x; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Meech R, 1996, DNA CELL BIOL, V15, P489, DOI 10.1089/dna.1996.15.489; Meech R, 1997, J BIOL CHEM, V272, P26913, DOI 10.1074/jbc.272.43.26913; Meyer UA, 1996, J PHARMACOKINET BIOP, V24, P449, DOI 10.1007/BF02353473; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Nebert DW, 1996, DNA CELL BIOL, V15, P273, DOI 10.1089/dna.1996.15.273; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; Oliver D., 1970, DROS INFORM SERV, V45, P58; OREILLY DR, 1989, SCIENCE, V245, P1110, DOI 10.1126/science.2505387; Owens IS, 1996, J PHARMACOKINET BIOP, V24, P491, DOI 10.1007/BF02353476; PIKIELNY CW, 1994, NEURON, V12, P39; Rausell C, 1997, ARCH INSECT BIOCHEM, V34, P347, DOI 10.1002/(SICI)1520-6327(1997)34:3<347::AID-ARCH8>3.0.CO;2-R; RYBCZYNSKI R, 1990, J BIOL CHEM, V265, P19712; Shen HX, 1997, ONCOL RES, V9, P295; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; TEPHLY TR, 1990, TRENDS PHARMACOL SCI, V11, P276, DOI 10.1016/0165-6147(90)90008-V; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; VONHEIJNE G, 1982, J MOL BIOL, V159, P537, DOI 10.1016/0022-2836(82)90300-X	42	97	106	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10309	10315		10.1074/jbc.274.15.10309	http://dx.doi.org/10.1074/jbc.274.15.10309			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187818	hybrid			2022-12-27	WOS:000079663500057
J	Budd, DC; Rae, A; Tobin, AB				Budd, DC; Rae, A; Tobin, AB			Activation of the mitogen-activated protein kinase pathway by a G(q/11)-coupled muscarinic receptor is independent of receptor internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; CHOLINERGIC RECEPTORS; MEDIATED ENDOCYTOSIS; TYROSINE KINASE; BETA-ARRESTINS; GROWTH-FACTOR; PHOSPHORYLATION; DESENSITIZATION; STIMULATION	A number of recent studies have demonstrated an essential role for receptor endocytosis in the activation of the mitogen-activated protein (MAP) kinases, Erk-1 and Erk-2 (extracellular activated protein kinases 1 and 2), by growth factor receptors and the G-protein coupled beta(2)-adrenergic receptor, Because ligand-mediated receptor endocytosis and activation of the MAP kinase pathway are common phenomena among G-protein coupled receptors, it has been suggested that the essential role of endocytosis in MAP kinase activation identified for the beta(2)-adrenergic receptor may be universal for all G-protein coupled receptors (Daaka,Y,, Luttrell, L, M,, Ahn, S,, Della Rocca, G, J., Ferguson, S, S, G,, Caron, M. G,, and Lefkowitz, R, J, (1998) J, Biol, Chem, 273, 685-688), We tested this hypothesis using the G(q/11)-coupled m3-muscarinic receptor expressed in Chinese hamster ovary cells and an m3-muscarinic receptor mutant that does not undergo endocytosis. We demonstrate that inhibition of endocytosis by concanavalin A and cytochalasin D does not affect the ability of the wild type m3-muscarinic receptor to activate Erk-1/2, Furthermore, the mutant m3-muscarinic receptor that is unable to undergo endocytosis, activates the MAP kinase pathway in an identical manner to the wild type receptor. We conclude that receptor endocytosis is not universally essential for MAP kinase activation by G-protein coupled receptors, We discuss the possibility that the differential roles played by endocytosis in MAP kinase activation between various receptor subtypes may be linked to the mechanism of upstream activation of Raf-1.	Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Tobin, AB (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, POB 138,Med Sci Bldg,Univ Rd, Leicester LE1 9HN, Leics, England.	TBA@le.ac.uk						CHALLISS RAJ, 1988, BIOCHEM BIOPH RES CO, V157, P684, DOI 10.1016/S0006-291X(88)80304-8; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Lee KB, 1998, J BIOL CHEM, V273, P12967, DOI 10.1074/jbc.273.21.12967; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MALARKEY K, 1995, BIOCHEM J, V309, P361, DOI 10.1042/bj3090361; MORO O, 1993, J BIOL CHEM, V268, P6862; OFFERMANNS S, 1993, BIOCHEM J, V294, P545, DOI 10.1042/bj2940545; Tobin AB, 1997, J BIOL CHEM, V272, P20844, DOI 10.1074/jbc.272.33.20844; TOBIN AB, 1993, J BIOL CHEM, V268, P9817; Tolbert LM, 1996, J BIOL CHEM, V271, P17335, DOI 10.1074/jbc.271.29.17335; vanBiesen T, 1996, J BIOL CHEM, V271, P1266, DOI 10.1074/jbc.271.3.1266; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Vogler O, 1998, J BIOL CHEM, V273, P12155, DOI 10.1074/jbc.273.20.12155; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	25	68	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12355	12360		10.1074/jbc.274.18.12355	http://dx.doi.org/10.1074/jbc.274.18.12355			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212206	hybrid			2022-12-27	WOS:000080056800026
J	Hogue, DL; Kerby, L; Ling, V				Hogue, DL; Kerby, L; Ling, V			A mammalian lysosomal membrane protein confers multidrug resistance upon expression in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-CASSETTE TRANSPORTER; P-GLYCOPROTEIN; FUNCTIONAL EXPRESSION; ACID TRANSPORTERS; PLASMA-MEMBRANE; DRUG-RESISTANCE; YEAST; CELLS; CHOLESTEROL; STEROIDS	Mouse transporter protein (MTP) is a highly conserved polytopic membrane protein present in mammalian lysosomes and endosomes. The role of MTP in regulating the in vivo subcellular distribution of numerous structurally distinct small molecules has been examined in this study by its expression in a drug-sensitive strain of the yeast Saccharomyces cerevisiae. Surprisingly, the expression of MTP in membranes of an intracellular compartment resulted in a cellular resistance or hypersensitivity to a range of drugs that included nucleoside and nucleobase analogs, antibiotics, anthracyclines, ionophores, and steroid hormones. The intracellular bioavailability of steroid hormones was altered by MTP, as determined using an in vivo glucocorticoid receptor-driven reporter assay in yeast, suggesting that the MTP-regulated drug sensitivity arose due to a change in the subcellular compartmentalization of steroid hormones and other drugs. MTP-regulated drug sensitivity in yeast was blocked to varying degrees by compounds that inhibit lysosomal function, interfere with intracellular cholesterol transport, or modulate the multidrug resistance phenotype of mammalian cells. These results indicate that MTP is involved in the subcellular compartmentalization of diverse hydrophobic small molecules and contributes to the inherent drug sensitivity or resistance of the mammalian cell.	British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency	Hogue, DL (corresponding author), British Columbia Canc Res Ctr, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.							AIKAWA K, 1994, BBA-LIPID LIPID MET, V1213, P127; BECHHANSEN NT, 1976, J CELL PHYSIOL, V88, P23, DOI 10.1002/jcp.1040880104; BECK WT, 1991, MOL CLIN ADV ANTICAN, P151; BERINSONE P, 1998, ANN NY ACAD SCI, V842, P91; BREUNINGER LM, 1995, CANCER RES, V55, P5342; BUTLER JD, 1992, J BIOL CHEM, V267, P23797; Cabrita M. A., 1996, Molecular Biology of the Cell, V7, p135A; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; DECOTTIGNIES A, 1995, J BIOL CHEM, V270, P18150, DOI 10.1074/jbc.270.30.18150; Egner R, 1998, MOL BIOL CELL, V9, P523, DOI 10.1091/mbc.9.2.523; FINBOW ME, 1995, BIOESSAYS, V17, P247, DOI 10.1002/bies.950170311; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Germann UA, 1996, EUR J CANCER, V32A, P927, DOI 10.1016/0959-8049(96)00057-3; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Gualix J, 1996, J BIOL CHEM, V271, P1957, DOI 10.1074/jbc.271.4.1957; Halliwell WH, 1997, TOXICOL PATHOL, V25, P53, DOI 10.1177/019262339702500111; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Hogue DL, 1996, J BIOL CHEM, V271, P9801, DOI 10.1074/jbc.271.16.9801; Huang PB, 1996, BBA-BIOMEMBRANES, V1281, P80, DOI 10.1016/0005-2736(96)00032-6; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; Hurwitz SJ, 1997, BLOOD, V89, P3745, DOI 10.1182/blood.V89.10.3745.3745_3745_3754; Ishizaki J, 1996, PHARMACEUT RES, V13, P902, DOI 10.1023/A:1016061330387; Kaiser C., 1994, METHODS YEAST GENETI; Kavallaris M, 1997, ANTI-CANCER DRUG, V8, P17, DOI 10.1097/00001813-199701000-00002; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; KRALLI A, 1995, P NATL ACAD SCI USA, V92, P4701, DOI 10.1073/pnas.92.10.4701; Lange Y, 1998, J BIOL CHEM, V273, P18915, DOI 10.1074/jbc.273.30.18915; LEFSTIN JA, 1995, GENE DEV, V8, P2842; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; LIPMAN BJ, 1990, J BIOL CHEM, V265, P2142; Lloyd J B, 1996, Subcell Biochem, V27, P361; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; LUEBE RE, 1987, EMBO J, V6, P3261; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Mahe Y, 1996, J BIOL CHEM, V271, P25167, DOI 10.1074/jbc.271.41.25167; Malandro MS, 1996, ANNU REV BIOCHEM, V65, P305; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; MAZZONE T, 1995, J LIPID RES, V36, P544; Moriyama Y, 1996, J EXP BIOL, V199, P1447; MOSELEY RH, 1995, AM J PHYSIOL-GASTR L, V268, pG480, DOI 10.1152/ajpgi.1995.268.3.G480; Ohkuma S, 1997, CELL STRUCT FUNCT, V22, P253, DOI 10.1247/csf.22.253; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; PICARD D, 1990, GENE, V86, P257, DOI 10.1016/0378-1119(90)90287-2; PISONI RL, 1991, BIOCHIM BIOPHYS ACTA, V1071, P351, DOI 10.1016/0304-4157(91)90002-E; PRITCHARD JB, 1994, AM J PHYSIOL, V266, pF966, DOI 10.1152/ajprenal.1994.266.6.F966; Pritchard JB, 1996, CELL PHYSIOL BIOCHEM, V6, P50, DOI 10.1159/000154794; RANGANATHAN S, 1984, BIOCHEM PHARMACOL, V33, P2377, DOI 10.1016/0006-2952(84)90709-3; Reid RJD, 1997, J BIOL CHEM, V272, P12091, DOI 10.1074/jbc.272.18.12091; REUTZ S, 1994, CELL, V77, P1071; ROOBOL C, 1984, BRIT J CANCER, V49, P739, DOI 10.1038/bjc.1984.116; SantoniRugiu E, 1997, CARCINOGENESIS, V18, P2255, DOI 10.1093/carcin/18.11.2255; SCHULDINER S, 1994, J NEUROCHEM, V62, P2067; SEKLER I, 1995, J BIOL CHEM, V270, P21028, DOI 10.1074/jbc.270.36.21028; SERVOS J, 1993, MOL GEN GENET, V236, P214, DOI 10.1007/BF00277115; Shapiro AB, 1998, INT J CANCER, V76, P857, DOI 10.1002/(SICI)1097-0215(19980610)76:6<857::AID-IJC15>3.0.CO;2-#; SHIRAISHI N, 1986, CANCER LETT, V30, P251, DOI 10.1016/0304-3835(86)90049-2; Stenius K, 1995, J CELL BIOL, V131, P1801, DOI 10.1083/jcb.131.6.1801; Sun-Wada GH, 1998, J BIOCHEM, V123, P912; TAYLOR V, 1995, J BIOL CHEM, V270, P28824, DOI 10.1074/jbc.270.48.28824; Thorens B, 1996, AM J PHYSIOL-GASTR L, V270, pG541, DOI 10.1152/ajpgi.1996.270.4.G541; VANDYKE RW, 1992, J PHARMACOL EXP THER, V261, P1; Verovski VN, 1996, BRIT J CANCER, V73, P596, DOI 10.1038/bjc.1996.103; VIDA TA, 1993, J CELL BIOL, V121, P1245, DOI 10.1083/jcb.121.6.1245; vonDippe P, 1996, J BIOL CHEM, V271, P18176, DOI 10.1074/jbc.271.30.18176; WOHLHEUTER RM, 1980, INT REV CYTOL, V64, P174	67	39	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12877	12882		10.1074/jbc.274.18.12877	http://dx.doi.org/10.1074/jbc.274.18.12877			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212276	hybrid			2022-12-27	WOS:000080056800096
J	Mason, DA; Moore, JD; Green, SA; Liggett, SB				Mason, DA; Moore, JD; Green, SA; Liggett, SB			A gain-of-function polymorphism in a G-protein coupling domain of the human beta(1)-adrenergic receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA(2)-ADRENERGIC RECEPTOR; HUMAN BETA-2-ADRENERGIC RECEPTOR; BETA-ADRENERGIC-RECEPTOR; CONGESTIVE-HEART-FAILURE; TERNARY COMPLEX MODEL; BINDING; LOCALIZATION; MUTAGENESIS; MUTATION; LIGAND	The beta(1)-adrenergic receptor (beta(1)AR) is a key cell surface signaling protein expressed in the heart and other organs that mediates the actions of catecholamines of the sympathetic nervous system. A polymorphism in the intracellular cytoplasmic tail near the seventh transmembrane-spanning segment of the human beta(1)AR has been identified in a cohort of normal individuals. At amino acid position 389, Gly or Arg can be found (allele frequencies 0.26 and 0.74, respectively), the former previously considered as the human wild-type beta(1)AR. Using site-directed mutagenesis to mimic the two variants, CHW-1102 cells were permanently transfected to express the Gly-389 and Arg-389 receptors, In functional studies with matched expression, the Arg-389 receptors had slightly higher basal levels of adenylyl cyclase activities (10.7 +/- 1.2 versus 6.1 +/- 0.4 pmol/min/mg), However, maximal isoproterenol-stimulated levels were markedly higher for the Arg-389 as compared to the Gly-389 receptor (63.3 +/- 6.1 versus 20.9 +/- 2.0 pmol/min/mg), Agonist-promoted [S-35]guanosine 5'-O-(thiotriphosphate) binding was also increased with the Arg-389 receptor consistent with enhanced coupling to G(s) and increased adenylyl cyclase activation. In agonist competition studies carried out in the absence of guanosine 5'-(beta,gamma-imido)triphosphate, high affinity binding could not be resolved with the Gly-389 receptor, whereas Arg-389 displayed an accumulation of the agonist high affinity receptor complex (R-H = 26%). Taken together, these data indicate that this polymorphic variation of the human beta(1)AR results in alterations of receptor-G(s) interaction with functional signal transduction consequences, consistent with its localization in a putative G-protein binding domain. The genetic variation of beta(1)AR at this locus may be the basis of interindividual differences in pathophysiologic characteristics or in the response to therapeutic beta AR agonists and antagonists in cardiovascular and other diseases.	Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Pharmacol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Liggett, SB (corresponding author), Univ Cincinnati, Coll Med, Dept Med, 231 Bethesda Ave, Cincinnati, OH 45267 USA.		liggett, stephen b/E-7453-2012	Liggett, Stephen B./0000-0002-0128-3669	NHLBI NIH HHS [HL41496, HL52318] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL052318, P01HL041496] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Befort K, 1996, NEUROCHEM RES, V21, P1301, DOI 10.1007/BF02532371; BRISTOW MR, 1989, MOL PHARMACOL, V35, P295; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; COSTA T, 1992, MOL PHARMACOL, V41, P549; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Eason MG, 1996, J BIOL CHEM, V271, P12826, DOI 10.1074/jbc.271.22.12826; Flier J, 1996, NEW ENGL J MED, V334, P580, DOI 10.1056/NEJM199602293340907; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; FRIELLE T, 1988, P NATL ACAD SCI USA, V85, P9494, DOI 10.1073/pnas.85.24.9494; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; GREEN SA, 1993, J BIOL CHEM, V268, P23116; GREEN SA, 1994, J BIOL CHEM, V269, P26215; GREEN SA, 1992, MOL PHARMACOL, V41, P889; GREEN SA, 1995, AM J RESP CELL MOL, V13, P25, DOI 10.1165/ajrcmb.13.1.7598936; Green SA, 1996, J BIOL CHEM, V271, P24029, DOI 10.1074/jbc.271.39.24029; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; JONES AS, 1963, NATURE, V199, P280, DOI 10.1038/199280b0; KANNEL WB, 1991, AM HEART J, V121, P951, DOI 10.1016/0002-8703(91)90225-7; KRELL MJ, 1986, AM HEART J, V112, P787, DOI 10.1016/0002-8703(86)90475-8; LIGGETT SB, 1989, AM J PHYSIOL, V256, pE600, DOI 10.1152/ajpendo.1989.256.5.E600; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; Rousseau G, 1996, MOL PHARMACOL, V49, P752; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; van Campen LCMC, 1998, J CARDIOVASC PHARM, V32, pS31, DOI 10.1097/00005344-199806321-00006; YATANI A, 1989, SCIENCE, V245, P71, DOI 10.1126/science.2544999	29	485	524	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12670	12674		10.1074/jbc.274.18.12670	http://dx.doi.org/10.1074/jbc.274.18.12670			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212248	hybrid			2022-12-27	WOS:000080056800068
J	Therien, AG; Karlish, SJD; Blostein, R				Therien, AG; Karlish, SJD; Blostein, R			Expression and functional role of the gamma subunit of the Na,K-ATPase in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL ACTIVITY; XENOPUS OOCYTES; SODIUM-PUMP; PURIFICATION; POLYPEPTIDE; MECHANISMS; ACTIVATION; COMPONENT; KINETICS; OUABAIN	The functional role of the gamma subunit of the Na,K-ATPase was studied using rat gamma cDNA-transfected HEK-293 cells and an antiserum (gamma C33) specific for gamma, Although the sequence for gamma was verified and shown to be larger (7237 Da) than first reported, it still comprises a single initiator methionine despite the expression of a gamma C33-reactive doublet on immunoblots. Kinetic analysis of the enzyme of transfected compared with control cells and of gamma C33-treated kidney pumps shows that gamma regulates the apparent affinity for ATP, Thus, gamma-transfected cells have a decreased K-ATP' as shown in measurements of (i) K-ATP' of Na,K-ATPase activity and (ii) K+ inhibition of Na-ATPase at 1 mu M ATP, Consistent with the behavior of gamma-transfected cells, gamma C33 pretreatment increases K-ATP' of the kidney enzyme and K+ inhibition (1 mu M ATP) of both kidney and gamma-transfected cells. These results are consistent with previous findings that an antiserum raised against the pig gamma subunit stabilizes the E-2(K) form of the enzyme (Therien, A. G., Goldshleger, R,, Karlish, S, J., and Blostein, R, (1997) J, Biol, Chem, 272, 32628-32634), Overall, our data demonstrate that gamma is a tissue (kidney)-specific regulator of the Na,K-ATPase that can increase the apparent affinity of the enzyme for ATP in a manner that is reversible by anti-gamma antiserum.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; Weizmann Inst Sci, Dept Biochem, IL-76100 Rehovot, Israel	McGill University; Weizmann Institute of Science	Blostein, R (corresponding author), Montreal Gen Hosp, 1650 Cedar Ave,Rm L11-132, Montreal, PQ H3G 1A4, Canada.		Therien, Alex/AAS-8437-2021					ATTALI B, 1995, P NATL ACAD SCI USA, V92, P6092, DOI 10.1073/pnas.92.13.6092; Beguin P, 1997, EMBO J, V16, P4250, DOI 10.1093/emboj/16.14.4250; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; BREZIS M, 1993, ANNU REV MED, V44, P27, DOI 10.1146/annurev.me.44.020193.000331; CHOW DC, 1995, J EXP BIOL, V198, P1; COLLINS JH, 1982, BIOCHIM BIOPHYS ACTA, V686, P7, DOI 10.1016/0005-2736(82)90145-6; Daly SE, 1996, J BIOL CHEM, V271, P23683, DOI 10.1074/jbc.271.39.23683; EISNER DA, 1981, J PHYSIOL-LONDON, V319, P403, DOI 10.1113/jphysiol.1981.sp013917; FORBUSH B, 1978, BIOCHEMISTRY-US, V17, P3667, DOI 10.1021/bi00610a037; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; HARDWICKE PMD, 1981, BIOCHEM BIOPH RES CO, V102, P250, DOI 10.1016/0006-291X(81)91514-X; JONES H, 1997, J CELL BIOL, V139, P1545; Kim JW, 1997, BBA-GENE STRUCT EXPR, V1350, P133, DOI 10.1016/S0167-4781(96)00219-9; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; MERCER RW, 1993, J CELL BIOL, V121, P579, DOI 10.1083/jcb.121.3.579; Minor NT, 1998, P NATL ACAD SCI USA, V95, P6521, DOI 10.1073/pnas.95.11.6521; MOORMAN JR, 1995, NATURE, V377, P737, DOI 10.1038/377737a0; MORRISON BW, 1995, J BIOL CHEM, V270, P2176, DOI 10.1074/jbc.270.5.2176; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; POST RL, 1972, J BIOL CHEM, V247, P6530; SCHEINERBOBIS G, 1994, BBA-BIOMEMBRANES, V1193, P226, DOI 10.1016/0005-2736(94)90157-0; Therien AG, 1996, J BIOL CHEM, V271, P7104, DOI 10.1074/jbc.271.12.7104; Therien AG, 1997, J BIOL CHEM, V272, P32628, DOI 10.1074/jbc.272.51.32628	24	120	124	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12252	12256		10.1074/jbc.274.18.12252	http://dx.doi.org/10.1074/jbc.274.18.12252			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212192	hybrid			2022-12-27	WOS:000080056800012
J	Jian, XY; Sainz, E; Clark, WA; Jensen, RT; Battey, JF; Northup, JK				Jian, XY; Sainz, E; Clark, WA; Jensen, RT; Battey, JF; Northup, JK			The bombesin receptor subtypes have distinct G protein specificities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C ISOZYMES; NEUROMEDIN-B RECEPTOR; HUMAN ORPHAN RECEPTOR; BETA-GAMMA-SUBUNITS; PEPTIDE RECEPTOR; ALPHA-SUBUNITS; HIGH-AFFINITY; GUANINE-NUCLEOTIDES; SF9 CELLS; KINASE-C	We used an in situ reconstitution assay to examine the receptor coupling to purified G protein alpha subunits by the bombesin receptor family, including gastrin-releasing peptide receptor (GRP-R), neuromedin B receptor (NMB-R), and bombesin receptor subtype 3 (BRS-3), Cells expressing GRP-R or NMB-R catalyzed the activation of squid retinal G alpha(q) and mouse G alpha(q) but not bovine retinal G alpha(t) or bovine brain G alpha(i/o). The GRP-R- and NMB-R-catalyzed activations of Ga, Were dependent upon and enhanced by different py dimers in the same rank order as follows: bovine brain beta gamma > beta(1)gamma(2) >> beta(1)gamma(1). Despite these qualitative similarities, GRP-R and NMB-R had distinct kinetic properties in receptor-G protein coupling. GRP-R had higher affinities for bovine brain beta gamma, beta(1)gamma(1), and beta(1)gamma(2) and squid retinal G alpha(q). In addition, GRP-R showed higher catalytic activity on squid G alpha(q). Like GRP-R and NMB-R, BRS-3 did not catalyze GTP gamma S binding to G alpha(i/o) or G alpha. However, BRS-3 showed little, if any, coupling with squid G alpha(q) but clearly activated mouse G alpha(q). GRP-R and NMB-R catalyzed GTP gamma S binding to squid and mouse G alpha(q), with GRP-R activating squid G alpha(q) more effectively, and NMB-R also showed slight preference for squid G alpha(q). These studies reveal that the structurally similar bombesin receptor subtypes, in particular BRS-3, possess distinct coupling preferences among members of the G alpha(q) family.	Natl Inst Deafness & Other Commun Disorders, Lab Cellular Biol, Rockville, MD 20850 USA; Natl Inst Deafness & Other Commun Disorders, Mol Biol Lab, Rockville, MD 20850 USA; NIDDKD, Digest Dis Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Northup, JK (corresponding author), Natl Inst Deafness & Other Commun Disorders, Lab Cellular Biol, 5 Res Ct, Rockville, MD 20850 USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000047, ZIADC000047] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Akeson M, 1997, J BIOL CHEM, V272, P17405, DOI 10.1074/jbc.272.28.17405; ASANO T, 1993, J BIOL CHEM, V268, P20512; BENYA RV, 1994, MOL PHARMACOL, V46, P495; BENYA RV, 1995, MOL PHARMACOL, V47, P10; BROWN KD, 1984, BIOCHEM BIOPH RES CO, V123, P377, DOI 10.1016/0006-291X(84)90424-8; FATHI Z, 1993, J BIOL CHEM, V268, P5979; FAWZI AB, 1990, BIOCHEMISTRY-US, V29, P3804, DOI 10.1021/bi00467a030; FAWZI AB, 1991, J BIOL CHEM, V266, P12194; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; Hartman JL, 1996, J BIOL CHEM, V271, P22591, DOI 10.1074/jbc.271.37.22591; Hellmich MR, 1997, P NATL ACAD SCI USA, V94, P751, DOI 10.1073/pnas.94.2.751; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; KOZASA T, 1993, P NATL ACAD SCI USA, V90, P9176, DOI 10.1073/pnas.90.19.9176; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; KROOG GS, 1995, MED RES REV, V15, P389, DOI 10.1002/med.2610150502; KROOG GS, 1995, J BIOL CHEM, V270, P8217, DOI 10.1074/jbc.270.14.8217; KUSUI T, 1995, BIOCHEMISTRY-US, V34, P8061, DOI 10.1021/bi00025a012; LEBACQVERHEYDEN AM, 1990, HDB EXPT PHARM, V95, P71; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; MANTEY S, 1993, MOL PHARMACOL, V43, P762; Mantey SA, 1997, J BIOL CHEM, V272, P26062, DOI 10.1074/jbc.272.41.26062; PARK DG, 1993, J BIOL CHEM, V268, P4573; Ryan RR, 1998, J BIOL CHEM, V273, P13613, DOI 10.1074/jbc.273.22.13613; RYBA NJ, 1993, BIOCHEM J, V292, P333, DOI 10.1042/bj2920333; Sainz E, 1998, J BIOL CHEM, V273, P15927, DOI 10.1074/jbc.273.26.15927; SHAPIRA H, 1994, FEBS LETT, V348, P89, DOI 10.1016/0014-5793(94)00570-2; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; TAMIR H, 1991, BIOCHEMISTRY-US, V30, P3929, DOI 10.1021/bi00230a018; WILDMAN DE, 1993, P NATL ACAD SCI USA, V90, P794, DOI 10.1073/pnas.90.3.794; WILKIE TM, 1991, P NATL ACAD SCI USA, V88, P10049, DOI 10.1073/pnas.88.22.10049	37	57	58	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11573	11581		10.1074/jbc.274.17.11573	http://dx.doi.org/10.1074/jbc.274.17.11573			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206964	hybrid			2022-12-27	WOS:000079834800020
J	Li, JG; Luo, LY; Krupnick, JG; Benovic, JL; Liu-Chen, LY				Li, JG; Luo, LY; Krupnick, JG; Benovic, JL; Liu-Chen, LY			U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism - kappa receptor internalization is not required for mitogen-activated protein kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; COATED VESICLE FORMATION; 3RD CYTOPLASMIC LOOP; HAMSTER OVARY CELLS; BETA(2)-ADRENERGIC RECEPTOR; DOWN-REGULATION; COUPLED RECEPTORS; OPIATE-RECEPTOR; MEDIATED ENDOCYTOSIS; THREONINE RESIDUES	Agonist-promoted internalization of some G protein coupled receptors has been shown to mediate receptor desensitization, resensitization, and down-regulation. In this study, we investigated whether opioids induced internalization of the human and rat kappa opioid receptors stably expressed in Chinese hamster ovary cells, the potential mechanisms involved in this process and its possible rob in activation of mitogen-activated protein (MAP) kinase, Exposure of the human kappa receptor to the agonists U50,488H, U69,593, ethylketocyclazocine, or tifluadom, but not etorphine, promoted receptor internalization. However, none of these agonists induced significant internalization of the rat kappa opioid receptor. U50,488H-induced human kappa receptor internalization was time- and concentration-dependent, with 30-40% of the receptors internalized following a 30-min exposure to 1 mu M U50,488H. Agonist removal resulted in the receptors gradually returning to the cell surface over a 60-min period, The antagonist naloxone blocked U50,488H-induced internalization without affecting internalization itself, while pretreatment with pertussis toxin had no effect on U50,488H-induced internalization. In contrast, incubation with sucrose (0.4-0.8 M) significantly reduced U50,488H-indueed internalization of the kappa receptor. While co-expression of the wild type GRK2, beta-arrestin, or dynamin I had no effect on kappa receptor internalization, co-expression of the dominant negative mutants GRK2-K220R, p-arrestin (319-418), or dynamin I-K44A significantly inhibited receptor internalization. Whether receptor internalization is critical for MAP kinase activation was next investigated. Co-expression of dominant negative mutants of beta-arrestin or dynamin I, which greatly reduced U50,488H-induced internalization, did not affect MAP kinase activation by the agonist, In addition, etorphine, which did not promote human kappa receptor internalization, was able to fully activate MAP kinase. Moreover, U50,488H or etorphine stimulation of the rat kappa receptor, which did not undergo internalization, also effectively activated MAP kinase, Thus, U50,488H-induced internalization of the human kappa opioid receptor in Chinese hamster ovary cells occurs via a GRK-, beta-arrestin-, and dynamin I-dependent process that likely involves clathrin-coated pits. In addition, internalization of the kappa receptor is not required for activation of MAP kinase.	Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University	Liu-Chen, LY (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, 3420 N Broad St, Philadelphia, PA 19140 USA.	liuche@astro.temple.edu			NIDA NIH HHS [DA11263, DA06650, DA04745] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006650, R01DA011263, R29DA004745, R01DA004745] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adler MW, 1993, HDB EXPT PHARM, P205; Appleyard SM, 1997, J NEUROCHEM, V69, P2405; ARDEN JR, 1995, J NEUROCHEM, V65, P1636; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; BARAK LS, 1994, J BIOL CHEM, V269, P2790; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BHARGAVA HN, 1989, J PHARMACOL EXP THER, V251, P21; Bot G, 1997, MOL PHARMACOL, V52, P272, DOI 10.1124/mol.52.2.272; Capeyrou R, 1997, FEBS LETT, V415, P200, DOI 10.1016/S0014-5793(97)01124-1; Chakrabarti S, 1997, MOL PHARMACOL, V52, P105, DOI 10.1124/mol.52.1.105; CHILDERS SR, 1991, LIFE SCI, V48, P1991, DOI 10.1016/0024-3205(91)90154-4; Chu P, 1997, J BIOL CHEM, V272, P27124, DOI 10.1074/jbc.272.43.27124; Cvejic S, 1996, J BIOL CHEM, V271, P4073; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DYKSTRA LA, 1987, J PHARMACOL EXP THER, V242, P413; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fukuda K, 1996, J NEUROCHEM, V67, P1309; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; JOSEPH DB, 1995, J PHARMACOL EXP THER, V272, P970; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; KNAPP RJ, 1995, FASEB J, V9, P516, DOI 10.1096/fasebj.9.7.7737460; KONG GH, 1994, J BIOL CHEM, V269, P13084; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; LAMEH J, 1992, J BIOL CHEM, V267, P13406; LI SX, 1993, BIOCHEM J, V295, P629, DOI 10.1042/bj2950629; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; MORRIS BJ, 1989, NEUROSCIENCE, V29, P433, DOI 10.1016/0306-4522(89)90070-5; Murray SR, 1998, J BIOL CHEM, V273, P24987, DOI 10.1074/jbc.273.39.24987; PALSRYLAARSDAM R, 1995, J BIOL CHEM, V270, P29004, DOI 10.1074/jbc.270.48.29004; PASTERNAK GW, 1988, OPIATE RECEPTORS; PFEIFFER A, 1986, SCIENCE, V233, P774, DOI 10.1126/science.3016896; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; ROETTGER BF, 1995, J CELL BIOL, V128, P1029, DOI 10.1083/jcb.128.6.1029; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Segredo V, 1997, J NEUROCHEM, V68, P2395; SterneMarr R, 1995, VITAM HORM, V51, P193, DOI 10.1016/S0083-6729(08)61039-0; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; TAUB DD, 1991, P NATL ACAD SCI USA, V88, P360, DOI 10.1073/pnas.88.2.360; TOLL L, 1992, J PHARMACOL EXP THER, V260, P9; Trapaidze N, 1996, J BIOL CHEM, V271, P29279, DOI 10.1074/jbc.271.46.29279; TSUGA H, 1994, J BIOL CHEM, V269, P32522; UHL GR, 1994, TRENDS NEUROSCI, V17, P89, DOI 10.1016/0166-2236(94)90110-4; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; VONVOIGTLANDER PF, 1983, J PHARMACOL EXP THER, V224, P7; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; VONZASTROW M, 1993, MOL PHARMACOL, V44, P166; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; YANG J, 1995, MOL PHARMACOL, V48, P477; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302; Zhu JM, 1998, J PHARMACOL EXP THER, V285, P28; Zhu JM, 1997, J PHARMACOL EXP THER, V282, P676; ZHU JM, 1995, LIFE SCI, V56, pPL201, DOI 10.1016/0024-3205(94)00507-O	64	134	135	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12087	12094		10.1074/jbc.274.17.12087	http://dx.doi.org/10.1074/jbc.274.17.12087			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207034	hybrid			2022-12-27	WOS:000079834800090
J	Schmitt, S; Glebe, D; Alving, K; Tolle, TK; Linder, M; Geyer, H; Linder, D; Peter-Katalinic, J; Gerlich, WH; Geyer, R				Schmitt, S; Glebe, D; Alving, K; Tolle, TK; Linder, M; Geyer, H; Linder, D; Peter-Katalinic, J; Gerlich, WH; Geyer, R			Analysis of the pre-S2 N- and O-linked glycans of the M surface protein from human hepatitis B virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDIVIDUAL GLYCOSYLATION SITES; MURINE LEUKEMIA-VIRUS; S-GENE-PRODUCTS; ENVELOPE PROTEIN; MASS-SPECTROMETRY; IMMUNE-RESPONSE; ANTIGEN; OLIGOSACCHARIDES; VACCINE; CELL	The surface antigen of hepatitis B virus comprises a nested set of small (S), middle (M), and large (L) proteins, all of which are partially glycosylated in their S domains. The pre-S2 domain, present only in M and L proteins, is further N-glycosylated at Asn-4 exclusively in the M protein. Since the pre-S2 N-glycan appears to play a crucial role in the secretion of viral particles, the M protein may be considered as a potential target for antiviral therapy. For characterization of the pre-S2 glycosylation, pre-SE (glyco)peptides were released from native, patient-derived hepatitis B virus subviral particles by tryptic digestion, separated from remaining particles, purified by reversed-phase high performance liquid chromatography, and identified by amino acid and N-terminal sequence analysis as well as matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Pre-S2 N-glycans were characterized by anion exchange chromatography, methylation analysis, and on target sequential exoglycosidase digestions in combination with MALDI-TOF-MS, demonstrating the presence of partially sialylated diantennary complex-type oligosaccharides. In addition, the pre-Sa domain of M protein, but not that of L protein, was found to be partially O-glycosylated by a Gal(beta 1-3)Gal-NAc alpha-, Neu5Ac(alpha 2-3)Gal(beta 1-3)GalNAc alpha-, or GalNAc alpha-residue. The respective O-glycosylation site was assigned to Thr-37 by digestion with carboxypeptidases in combination with MALDI-TOF-MS and by quadrupole time-of-flight electrospray mass spectrometry, Analytical data further revealed that about 90% of M protein is N-terminally acetylated.	Univ Giessen, Inst Biochem, D-35392 Giessen, Germany; Univ Giessen, Inst Med Virol, D-35392 Giessen, Germany; Univ Munster, Inst Med Phys & Biophys, D-48149 Munster, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Munster	Geyer, R (corresponding author), Univ Giessen, Inst Biochem, Friedrichstr 24, D-35392 Giessen, Germany.	Rudolf.Geyer@biochemie.med.uni-giessen.de						ALVING K, 1999, IN PRESS J MASS SPEC; BICHKO V, 1985, FEBS LETT, V185, P208, DOI 10.1016/0014-5793(85)80771-7; BLOCK TM, 1994, P NATL ACAD SCI USA, V91, P2235, DOI 10.1073/pnas.91.6.2235; Block TM, 1998, NAT MED, V4, P610, DOI 10.1038/nm0598-610; Bonetto V, 1997, J PROTEIN CHEM, V16, P371, DOI 10.1023/A:1026328520307; BRUSS V, 1994, EMBO J, V13, P2273, DOI 10.1002/j.1460-2075.1994.tb06509.x; BRUSS V, 1991, P NATL ACAD SCI USA, V88, P1059, DOI 10.1073/pnas.88.3.1059; Carman WF, 1997, J VIRAL HEPATITIS, V4, P11, DOI 10.1111/j.1365-2893.1997.tb00155.x; EMINI EA, 1989, J MED VIROL, V28, P7, DOI 10.1002/jmv.1890280103; Gerlich W, 1975, Dev Biol Stand, V30, P78; Geyer H, 1999, ANAL CHEM, V71, P476, DOI 10.1021/ac980712w; GEYER H, 1992, GLYCOBIOLOGY, V2, P299, DOI 10.1093/glycob/2.4.299; GEYER R, 1982, ANAL BIOCHEM, V121, P263, DOI 10.1016/0003-2697(82)90478-X; GEYER R, 1994, METHOD ENZYMOL, V230, P86; GEYER R, 1990, EUR J BIOCHEM, V187, P95, DOI 10.1111/j.1432-1033.1990.tb15281.x; GILLECECASTRO BL, 1987, ARCH BIOCHEM BIOPHYS, V256, P194, DOI 10.1016/0003-9861(87)90437-1; GRGACIC EVL, 1994, J VIROL, V68, P7344, DOI 10.1128/JVI.68.11.7344-7350.1994; GRUBER C, 1985, J GEN VIROL, V66, P417, DOI 10.1099/0022-1317-66-3-417; HANAOKA K, 1986, J BIOCHEM-TOKYO, V99, P1273, DOI 10.1093/oxfordjournals.jbchem.a135591; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Heermann KH, 1999, J CLIN MICROBIOL, V37, P68, DOI 10.1128/JCM.37.1.68-73.1999; HEERMANN KH, 1984, J VIROL, V52, P396, DOI 10.1128/JVI.52.2.396-402.1984; Heermann KH, 1991, MOL BIOL HEPATITIS B, P109; Hildt E, 1996, HEPATOLOGY, V24, P502, DOI 10.1002/hep.510240306; HOLLINGER FB, 1995, FIELDS VIROLOGY, P2739; ITOH Y, 1986, P NATL ACAD SCI USA, V83, P9174, DOI 10.1073/pnas.83.23.9174; JUNGERS P, 1994, J INFECT DIS, V169, P399, DOI 10.1093/infdis/169.2.399; KANN M, 1998, TOPLEY WILSONS MICRO, P745; Lanford RE, 1998, P NATL ACAD SCI USA, V95, P5757, DOI 10.1073/pnas.95.10.5757; LerouxRoels G, 1997, VACCINE, V15, P1732, DOI 10.1016/S0264-410X(97)00118-7; LU XY, 1995, VIROLOGY, V213, P660, DOI 10.1006/viro.1995.0038; Mehta A, 1998, FEBS LETT, V430, P17, DOI 10.1016/S0014-5793(98)00525-0; Mehta A, 1997, P NATL ACAD SCI USA, V94, P1822, DOI 10.1073/pnas.94.5.1822; MILICH DR, 1990, J IMMUNOL, V144, P3535; MILICH DR, 1986, J IMMUNOL, V137, P2703; Moskovitz J, 1999, METHOD ENZYMOL, V300, P239; NAUMANN H, 1993, J GEN VIROL, V74, P1627, DOI 10.1099/0022-1317-74-8-1627; NEURATH AR, 1986, CELL, V46, P429, DOI 10.1016/0092-8674(86)90663-X; NIEMANN H, 1984, EMBO J, V3, P665, DOI 10.1002/j.1460-2075.1984.tb01864.x; Papac DI, 1996, ANAL CHEM, V68, P3215, DOI 10.1021/ac960324z; PAZPARENTE J, 1985, CARBOHYD RES, V141, P41; PERSING DH, 1987, J VIROL, V61, P1672, DOI 10.1128/JVI.61.5.1672-1677.1987; PFEIFFER G, 1993, GLYCOCONJUGATE J, V10, P240, DOI 10.1007/BF00702206; PFEIFFER G, 1990, BIOMED CHROMATOGR, V4, P193, DOI 10.1002/bmc.1130040505; POL S, 1994, LANCET, V344, P342, DOI 10.1016/S0140-6736(94)91384-6; PONTISSO P, 1989, VIROLOGY, V173, P522, DOI 10.1016/0042-6822(89)90564-3; POULTER L, 1990, METHOD ENZYMOL, V193, P661, DOI 10.1016/0076-6879(90)93444-P; Pride MW, 1998, VACCINE, V16, P543, DOI 10.1016/S0264-410X(97)00242-9; Rothmann K, 1998, J VIROL, V72, P10138, DOI 10.1128/JVI.72.12.10138-10147.1998; Rutgers T, 1988, VIRAL HEPATITIS LIVE, P304; SCHLUTER M, 1985, CARBOHYD RES, V138, P305, DOI 10.1016/0008-6215(85)85113-2; SERAFINICESSI F, 1988, J GEN VIROL, V69, P869, DOI 10.1099/0022-1317-69-4-869; SHEU SY, 1994, J GEN VIROL, V75, P3031, DOI 10.1099/0022-1317-75-11-3031; SHIRAKI K, 1992, J GEN VIROL, V73, P1401, DOI 10.1099/0022-1317-73-6-1401; SHOUVAL D, 1994, VACCINE, V12, P1453, DOI 10.1016/0264-410X(94)90155-4; STIBBE W, 1983, DEV BIOL STAND, V54, P33; STIBBE W, 1983, J VIROL, V46, P626, DOI 10.1128/JVI.46.2.626-628.1983; Thomas HC, 1996, LANCET, V348, P1417, DOI 10.1016/S0140-6736(96)05409-8; Tolle TK, 1998, J VIROL, V72, P9978, DOI 10.1128/JVI.72.12.9978-9985.1998; Werr M, 1998, J VIROL, V72, P778, DOI 10.1128/JVI.72.1.778-782.1998; Zuckerman JN, 1997, BRIT MED J, V314, P329, DOI 10.1136/bmj.314.7077.329	61	62	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11945	11957		10.1074/jbc.274.17.11945	http://dx.doi.org/10.1074/jbc.274.17.11945			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207016	hybrid			2022-12-27	WOS:000079834800072
J	Soeder, KJ; Snedden, SK; Cao, WH; Della Rocca, GJ; Daniel, KW; Luttrell, LM; Collins, S				Soeder, KJ; Snedden, SK; Cao, WH; Della Rocca, GJ; Daniel, KW; Luttrell, LM; Collins, S			The beta(3)-adrenergic receptor activates mitogen-activated protein kinase in adipocytes through a G(i)-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATYPICAL BETA-ADRENOCEPTORS; ADENYLATE-CYCLASE ACTIVITY; A1 ADENOSINE RECEPTORS; COUPLED RECEPTORS; BETA-3-ADRENERGIC RECEPTOR; CYCLIC-AMP; ALPHA-SUBUNITS; UNCOUPLING PROTEIN; BROWN ADIPOCYTES; AZIDOANILIDO-GTP	Promiscuous coupling between G protein-coupled receptors and multiple species of heterotrimeric G; proteins provides a potential mechanism for expanding the diversity of G protein-coupled receptor signaling. We have examined the mechanism and functional consequences of dual G(s)/G(i) protein coupling of the beta(3)-adrenergic receptor (beta(3)AR) in 3T3-F442A adipocytes. The beta(3)AR selective agonist disodium (R,R)-5-[2[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL316,243) stimulated a dose-dependent increase in cAMP production in adipocyte plasma membrane preparations, and pretreatment of cells with pertussis toxin resulted in a further a-fold increase in cAMP production by CL316,243, CL316,243 (5 mu M) stimulated the incorporation of 8-azido-[P-32]GTP into G alpha(s) (1.57 +/- 0.12; n = 3) and G alpha(i) (1.68 +/- 0.13; n = 4) in adipocyte plasma membranes, directly demonstrating that beta(3)AR stimulation results in G(i)-GTP exchange. The beta(3)AR-stimulated increase in 8-azido-[P-32]GTP labeling of G alpha(i) was equivalent to that obtained with the A(1)-adenosine receptor agonist N-6-cyclopentyladenosine (1.56 +/- 0.07; n = 4), whereas inclusion of unlabeled GTP (100 mu M) eliminated all binding. Stimulation of the beta(3)AR in 3T3-F442A adipocytes led to a 2-3-fold activation of mitogen-activated protein (MAP) kinase, as measured by extracellular signal-regulated kinase-1 and -2 (ERK1/2) phosphorylation. Pretreatment of cells with pertussis toxin (PTX) eliminated MAP kinase activation by beta(3)AR, demonstrating that this response required receptor coupling to Gi, Expression of the human beta(3)AR in HEK-293 cells reconstituted the PTX-sensitive stimulation of MAP kinase, demonstrating that this phenomenon is not exclusive to adipocytes or to the rodent beta(3)AR, ERK1/2 activation by the beta(3)AR was insensitive to the cAMP-dependent protein kinase inhibitor H-89 but was abolished by genistein and AG1478. These data indicate that constitutive beta(3)AR coupling to G(i) proteins serves both to restrain G(s)-mediated activation of adenylyl cyclase and to initiate additional signal transduction pathways, including the ERK1/2 MAP kinase cascade.	Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Collins, S (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, POB 3557, Durham, NC 27710 USA.	colli008@mc.duke.edu	Della Rocca, Gregory/AAM-5281-2021	Luttrell, Louis/0000-0003-2805-6949	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046793, R56DK053092, R01DK053092, K08DK002352] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46793, DK53092, DK02352] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARCH JRS, 1984, NATURE, V309, P163, DOI 10.1038/309163a0; BEGINHEICK N, 1987, MOL CELL ENDOCRINOL, V53, P1, DOI 10.1016/0303-7207(87)90185-7; BEGINHEICK N, 1995, J CELL BIOCHEM, V58, P464, DOI 10.1002/jcb.240580409; BEGINHEICK N, 1985, J BIOL CHEM, V260, P6187; BEGINHEICK N, 1990, BIOCHEM J, V268, P83, DOI 10.1042/bj2680083; BLOOM JD, 1992, J MED CHEM, V35, P3081, DOI 10.1021/jm00094a025; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAMPIGNY O, 1991, P NATL ACAD SCI USA, V88, P10774, DOI 10.1073/pnas.88.23.10774; CHANG KJ, 1988, P NATL ACAD SCI USA, V85, P4929, DOI 10.1073/pnas.85.13.4929; CHAUDHRY A, 1994, CELL SIGNAL, V6, P457, DOI 10.1016/0898-6568(94)90093-0; CLARK RB, 1986, ADV CYCLIC NUCL PROT, V20, P151; COLLINS S, 1994, MOL ENDOCRINOL, V8, P518, DOI 10.1210/me.8.4.518; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; COOPER DMF, 1979, J BIOL CHEM, V254, P8927; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; DJIAN P, 1985, J CELL PHYSIOL, V124, P554, DOI 10.1002/jcp.1041240327; FIELDS TA, 1994, BIOCHEMISTRY-US, V33, P6877, DOI 10.1021/bi00188a017; GETTYS TW, 1991, J BIOL CHEM, V266, P15949; GETTYS TW, 1994, BIOCHEMISTRY-US, V33, P4283, DOI 10.1021/bi00180a024; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; Herrlich A, 1996, J BIOL CHEM, V271, P16764, DOI 10.1074/jbc.271.28.16764; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; HINSCH KD, 1988, FEBS LETT, V238, P191, DOI 10.1016/0014-5793(88)80254-0; HOLLENGA C, 1991, EUR J PHARMACOL, V200, P325, DOI 10.1016/0014-2999(91)90590-M; HOLLENGA C, 1991, BRIT J PHARMACOL, V102, P577, DOI 10.1111/j.1476-5381.1991.tb12215.x; JOCKERS R, 1994, J BIOL CHEM, V269, P32077; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARGIS EE, 1994, DRUG DEVELOP RES, V32, P69, DOI 10.1002/ddr.430320203; LARROUY D, 1991, EUR J PHARM-MOLEC PH, V206, P139, DOI 10.1016/0922-4106(91)90022-A; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LIGGETT SB, 1993, P NATL ACAD SCI USA, V90, P3665, DOI 10.1073/pnas.90.8.3665; Manara L, 1996, BRIT J PHARMACOL, V117, P435, DOI 10.1111/j.1476-5381.1996.tb15209.x; MUNSHI R, 1991, J BIOL CHEM, V266, P22285; MURAYAMA T, 1983, J BIOL CHEM, V258, P3319; NAHMIAS C, 1991, EMBO J, V10, P3721, DOI 10.1002/j.1460-2075.1991.tb04940.x; NANTEL F, 1993, MOL PHARMACOL, V43, P548; OFFERMANNS S, 1991, METHOD ENZYMOL, V195, P286; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; PFEUFFER T, 1977, J BIOL CHEM, V252, P7224; PITTMAN RN, 1983, MOL PHARMACOL, V24, P398; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; RAVID K, 1988, BIOCHEM J, V249, P377, DOI 10.1042/bj2490377; RODBELL M, 1964, J BIOL CHEM, V239, P375; ROHLFS EM, 1995, J BIOL CHEM, V270, P10723, DOI 10.1074/jbc.270.18.10723; ROUOT B, 1989, BIOCHEM J, V260, P307, DOI 10.1042/bj2600307; Sasaki N, 1998, J VET MED SCI, V60, P465, DOI 10.1292/jvms.60.465; SCHAFER R, 1988, BIOCHEM BIOPH RES CO, V155, P1051, DOI 10.1016/S0006-291X(88)80603-X; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; VANBIESEN T, 1995, NATURE, V376, P781, DOI 10.1038/376781a0; VANNUCCI SJ, 1989, AM J PHYSIOL, V257, pE871, DOI 10.1152/ajpendo.1989.257.6.E871; Wan Y, 1998, J BIOL CHEM, V273, P14533, DOI 10.1074/jbc.273.23.14533; WANGE RL, 1991, J BIOL CHEM, V266, P11409; YOSHIDA T, 1994, LIFE SCI, V54, P491, DOI 10.1016/0024-3205(94)00408-0	58	161	168	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12017	12022		10.1074/jbc.274.17.12017	http://dx.doi.org/10.1074/jbc.274.17.12017			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207024	hybrid			2022-12-27	WOS:000079834800080
J	Basu, SS; White, KA; Que, NLS; Raetz, CRH				Basu, SS; White, KA; Que, NLS; Raetz, CRH			A deacylase in Rhizobium leguminosarum membranes that cleaves the 3-O-linked beta-hydroxymyristoyl moiety of lipid A precursors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE ENDOTOXIN; ESCHERICHIA-COLI; 3-DEOXY-D-MANNO-OCTULOSONIC ACID; LIPOPOLYSACCHARIDE BIOSYNTHESIS; STRUCTURAL CHARACTERIZATION; SIGNAL-TRANSDUCTION; DEFICIENT MUTANT; A BIOSYNTHESIS; HOST-DEFENSE; GENE	Lipid A from the nitrogen-fixing bacterium Rhizobium leguminosarum displays many structural differences compared with lipid A of Escherichia coli, R, Leguminosarum lipid A lacks the usual 1- and 4'-phosphate groups but is derivatized with a galacturonic acid substituent at position 4', R, leguminosarum lipid A often contains an aminogluconic acid moiety in place of the proximal glucosamine l-phosphate unit. Striking differences also exist in the secondary acyl chains attached to E, coli versus R, leguminosarum lipid A, specifically the presence of 27-hydroxyoctacosanoate and the absence of laurate and myristate in R. leguminosarum, Recently, we have found that lipid A isolated by pH 4.5 hydrolysis of R, leguminosaram cells is more heterogeneous than previously reported (Que, N, L, S,, Basu, S, S., White, K, A., and Raetz, C. R. H. (1998) FASEB J. 12, A1284 (abstr.)), Lipid A species lacking the 3-O-linked beta-hydroxymyristoyl residue on the proximal unit contribute to this heterogeneity. We now describe a membrane-bound deacylase from R, leguminosarum that removes a single ester-linked beta-hydroxymyristoyl moiety from some lipid A precursors, including lipid X, lipid IVA, and (3-deoxy-D-manno-octulosonic acid)(2)-lipid IVA. The enzyme does not cleave E. coli lipid A or lipid A precursors containing an acyloxyacyl moiety on the distal glucosamine unit. The enzyme is not present in extracts of E, coli or Rhizobium meliloti, but it is readily demonstrable in membranes of Pseudomonas aeruginosa, which also contains a significant proportion of 3-O-deacylated lipid A species. Optimal reaction rates are seen between pH 5.5 and 6.5. The enzyme requires a nonionic detergent and divalent metal ions for activity. It cleaves the monosaccharide lipid X at about 5% the rate of lipid IVA and (3-deoxy-D-manno-octulosonic acid)(2)-lipid IVA. H-1 MMR spectroscopy of the deacylase reaction product, generated with lipid IVA as the substrate, confirms unequivocally that the enzyme cleaves only the ester-linked beta-hydroxymyristoyl residue at the 3-position of the glucosamine disaccharide.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Raetz, CRH (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	raetz@biochem.duke.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051796, R37GM051796] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-51796, R01 GM051796, R37 GM051796, R01 GM051796-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; BHAT UR, 1991, J BACTERIOL, V173, P2155, DOI 10.1128/JB.173.7.2155-2159.1991; BHAT UR, 1994, J BIOL CHEM, V269, P14402; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boman HG, 1998, SCAND J IMMUNOL, V48, P15; Brozek KA, 1996, J BIOL CHEM, V271, P32112, DOI 10.1074/jbc.271.50.32119; Brozek KA, 1996, J BIOL CHEM, V271, P32126, DOI 10.1074/jbc.271.50.32119; BROZEK KA, 1989, J BIOL CHEM, V264, P6956; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; CAVA JR, 1989, J BACTERIOL, V171, P8, DOI 10.1128/jb.171.1.8-15.1989; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; DROZANSKI W, 1986, EUR J BIOCHEM, V155, P433, DOI 10.1111/j.1432-1033.1986.tb09509.x; Forsberg LS, 1998, J BIOL CHEM, V273, P2747, DOI 10.1074/jbc.273.5.2747; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; Garrett TA, 1998, J BIOL CHEM, V273, P12457, DOI 10.1074/jbc.273.20.12457; HAGEN FS, 1991, BIOCHEMISTRY-US, V30, P8415, DOI 10.1021/bi00098a020; HAMPTON RY, 1988, J BIOL CHEM, V263, P14802; Kadrmas JL, 1998, J BIOL CHEM, V273, P26432, DOI 10.1074/jbc.273.41.26432; Kadrmas JL, 1996, J BIOL CHEM, V271, P32119, DOI 10.1074/jbc.271.50.32112; KARIBIAN D, 1991, INT J MASS SPECTROM, V111, P273, DOI 10.1016/0168-1176(91)85060-Y; KARUNARATNE DN, 1992, ARCH BIOCHEM BIOPHYS, V299, P368, DOI 10.1016/0003-9861(92)90289-9; KULSHIN VA, 1991, EUR J BIOCHEM, V198, P697, DOI 10.1111/j.1432-1033.1991.tb16069.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEVIN J, 1993, BACTERIAL ENDOTOXIN; LIN S, 1998, FASEB J, V12; LONG SR, 1993, CELL, V73, P921, DOI 10.1016/0092-8674(93)90271-Q; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; MORRISON DC, 1992, BACTERIAL ENDOTOXIC, V1; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; PRICE NPJ, 1995, P NATL ACAD SCI USA, V92, P7352, DOI 10.1073/pnas.92.16.7352; PRICE NPJ, 1994, J BACTERIOL, V176, P4646, DOI 10.1128/JB.176.15.4646-4655.1994; Que NLS, 1998, FASEB J, V12, pA1284; RADIKA K, 1988, J BIOL CHEM, V263, P14859; Raetz C. R. H., 1996, ESCHERICHIA COLI SAL, V1, P1035; RAETZ CRH, 1993, J BACTERIOL, V175, P5745, DOI 10.1128/JB.175.18.5745-5753.1993; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; RAY BL, 1984, J BIOL CHEM, V259, P4852; RAY BL, 1987, J BIOL CHEM, V262, P1122; REEVES PR, 1994, BACTERIAL CELL WALL, V27, P281; REYNOLDS LJ, 1991, METHOD ENZYMOL, V197, P3; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; ROSNER MR, 1979, J BIOL CHEM, V254, P5926; RUSSA R, 1985, ARCH MICROBIOL, V141, P284, DOI 10.1007/BF00428838; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STRAIN SM, 1985, J BIOL CHEM, V260, P6089; TAKAYAMA K, 1983, J BIOL CHEM, V258, P7379; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; VERRET CR, 1982, J BIOL CHEM, V257, P222; VERRET CR, 1982, J BIOL CHEM, V257, P228; Whitehead LF, 1997, PHYSIOL PLANTARUM, V100, P30, DOI 10.1034/j.1399-3054.1997.1000103.x; Zarrouk H, 1997, J BACTERIOL, V179, P3756, DOI 10.1128/jb.179.11.3756-3760.1997	56	45	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11150	11158		10.1074/jbc.274.16.11150	http://dx.doi.org/10.1074/jbc.274.16.11150			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196200	hybrid, Green Accepted			2022-12-27	WOS:000079751900068
J	Naver, H; Haldrup, A; Scheller, HV				Naver, H; Haldrup, A; Scheller, HV			Cosuppression of photosystem I subunit PSI-H in Arabidopsis thaliana - Efficient electron transfer and stability of photosystem I is dependent upon the PSI-H subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS-REINHARDTII; SYNECHOCOCCUS-SP; F-B; CORE; FERREDOXIN; COMPLEXES; PROTEIN; IDENTIFICATION; RECONSTITUTION; PLASTOCYANIN	PSI-H is an intrinsic membrane protein of 10 kDa that is a subunit of photosystem I (PSI). PSI-II is one of the three PSI subunits found only in eukaryotes. The function of PSI-H was characterized in Arabidopsis plants transformed with a psaH cDNA in sense orientation. Cosuppressed plants containing less than 3% PSI-H are smaller than wild type when grown on sterile media but are similar to wild type under optimal conditions. PSI complexes lacking PSI-H contain 50% PSI-L, whereas other PSI subunits accumulate in wild type amounts. PSI devoid of PSI-H has only 61% NADP(+) photoreduction activity compared with wild type and is highly unstable in the presence of urea as determined from flash-induced absorbance changes at 834 nm. Our data show that PSI-H is required for stable accumulation of PSI and efficient electron transfer in the complex. The plants lacking PSI-H compensate for the less efficient PSI with a 15% increase in the P700/chlorophyll ratio, and this compensation is sufficient to prevent overreduction of the plastoquinone pool as evidenced by normal photochemical quenching of fluorescence. Nonphotochemical quenching is approximately 60% of the wild type value, suggesting that the proton gradient across the thylakoid membrane is decreased in the absence of PSI-H.	Royal Vet & Agr Univ, Dept Plant Biol, Plant Biochem Lab, DK-1871 Frederiksberg C, Denmark	University of Copenhagen	Scheller, HV (corresponding author), Royal Vet & Agr Univ, Dept Plant Biol, Plant Biochem Lab, 40 Thorvaldsensvej, DK-1871 Frederiksberg C, Denmark.	scheller@biobase.dk	Scheller, Henrik V/A-8106-2008; Scheller, Henrik/AAH-4770-2020	Scheller, Henrik V/0000-0002-6702-3560; Scheller, Henrik/0000-0002-6702-3560; Haldrup, Anna/0000-0002-2348-7072; Naver, Helle/0000-0002-7364-3862				ANDERSEN B, 1992, PHYSIOL PLANTARUM, V84, P154, DOI 10.1111/j.1399-3054.1992.tb08778.x; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Brettel K, 1997, BBA-BIOENERGETICS, V1318, P322, DOI 10.1016/S0005-2728(96)00112-0; CHITNIS VP, 1993, FEBS LETT, V336, P330, DOI 10.1016/0014-5793(93)80831-E; Diaz-Quintana A, 1998, BIOCHEMISTRY-US, V37, P3429, DOI 10.1021/bi972469l; FARAH J, 1995, EMBO J, V14, P4976, DOI 10.1002/j.1460-2075.1995.tb00180.x; FLACHMANN R, 1995, PLANT CELL, V7, P149, DOI 10.1105/tpc.7.2.149; GOLBECK JH, 1988, FEBS LETT, V228, P268, DOI 10.1016/0014-5793(88)80013-9; GOLBECK JH, 1991, CURR TOP BIOENERG, V16, P83; HALDRUP A, 1999, IN PRESS PLANT J, V17; Hippler M, 1997, BIOCHEMISTRY-US, V36, P6343, DOI 10.1021/bi970082c; HOJ PB, 1987, J BIOL CHEM, V262, P12676; Jansson S, 1996, PLANT PHYSIOL, V112, P409, DOI 10.1104/pp.112.1.409; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kjaer B, 1996, PHOTOSYNTH RES, V47, P33, DOI 10.1007/BF00017751; LI N, 1991, BIOCHEMISTRY-US, V30, P7863, DOI 10.1021/bi00245a028; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; LUNEBERG J, 1994, FEBS LETT, V338, P197, DOI 10.1016/0014-5793(94)80364-1; Naver H, 1996, J BIOL CHEM, V271, P8996, DOI 10.1074/jbc.271.15.8996; Naver H, 1998, J BIOL CHEM, V273, P18778, DOI 10.1074/jbc.273.30.18778; Naver H, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P631; NAVER H, 1995, PHYSIOL PLANTARUM, V95, P19, DOI 10.1111/j.1399-3054.1995.tb00802.x; Scheller HV, 1997, PHYSIOL PLANTARUM, V100, P842, DOI 10.1034/j.1399-3054.1997.1000410.x; SCHELLER HV, 1990, PHYSIOL PLANTARUM, V78, P484, DOI 10.1034/j.1399-3054.1990.780326.x; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Schubert WD, 1997, J MOL BIOL, V272, P741, DOI 10.1006/jmbi.1997.1269; SETIF PQY, 1995, BIOCHEMISTRY-US, V34, P9059, DOI 10.1021/bi00028a015; Tjus SE, 1998, PLANT PHYSIOL, V116, P755, DOI 10.1104/pp.116.2.755; ZAMBRYSKI P, 1983, EMBO J, V2, P2143, DOI 10.1002/j.1460-2075.1983.tb01715.x; Zhang H, 1997, PLANT PHYSIOL, V115, P1525, DOI 10.1104/pp.115.4.1525	31	42	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10784	10789		10.1074/jbc.274.16.10784	http://dx.doi.org/10.1074/jbc.274.16.10784			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196152	hybrid			2022-12-27	WOS:000079751900020
J	Fayadat, L; Niccoli-Sire, P; Lanet, J; Franc, JL				Fayadat, L; Niccoli-Sire, P; Lanet, J; Franc, JL			Role of heme in intracellular trafficking of thyroperoxidase and involvement of H2O2 generated at the apical surface of thyroid cells in autocatalytic covalent heme binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-METABOLISM; PEROXIDASE; MYELOPEROXIDASE; LACTOPEROXIDASE; PURIFICATION; RECEPTOR; ENZYMES; PATHWAY; FAMILY	Thyroperoxidase (TPO) is a glycosylated hemoprotein that plays a key role in thyroid hormone synthesis, We previously showed that in CHO cells expressing human TPO (hTPO) only 2% of synthesized hTPO reaches the cell surface. Herein, we investigated the role of heme moiety insertion in the exit of hTPO from the endoplasmic reticulum, Peroxidase activity at the cell surface and cell surface expression of hTPO were decreased by similar to 30 and similar to 80%, respectively, with succinyl acetone, an inhibitor of heme biosynthesis, and were increased by 20% with holotransferrin and aminolevulinic acid, precursors of heme biosynthesis, Results were similar with holotransferrin plus aminolevulinic acid or hemin, but hemin increased cell surface activity more efficiently (+120%) relative to the control, It had been suggested (DePillis, G,, Ozaki, S,, Kuo, J, M,, Maltby, D, A., and Ortiz de Montellano, P, R, (1997) J, Biol, Chem, 272, 8857-8960) that covalent attachment of heme to mammalian peroxidases could be an H2O2-dependent autocatalytic processing. In our study, heme associated intracellularly with hTPO, and we hypothesized that there was insufficient exposure to H2O2 in Chinese hamster ovary cells before hTPO reached the cell surface. After a 10-min incubation, 10 mu M H2O2 led to a 65% increase in cell surface activity. In contrast, in thyroid cells, H2O2 was synthesized at the apical cell surface and allowed covalent attachment of heme, Two-day incubation of primocultures of thyroid cells with catalase led to a 30% decrease in TPO activity at the cell surface. In conclusion, we provide compelling evidence for an essential role of 1) heme incorporation in the intracellular trafficking of hTPO and of 2) H2O2 generated at the apical pole of thyroid cells in the autocatalytic covalent heme binding to the TPO molecule.	Univ Mediterranee, Fac Med, INSERM, U38, F-13385 Marseille 5, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Franc, JL (corresponding author), Univ Mediterranee, Fac Med, INSERM, U38, 27 Bd J Moulin, F-13385 Marseille 5, France.		Franc, Jean-Louis/C-8861-2009	Franc, Jean-Louis/0000-0002-2900-5468				Andersson LA, 1996, J BIOL CHEM, V271, P3406, DOI 10.1074/jbc.271.7.3406; ARNLJOTS K, 1987, J BIOL CHEM, V262, P10430; BANGA JP, 1990, FEBS LETT, V266, P133, DOI 10.1016/0014-5793(90)81524-R; CALS MM, 1991, EUR J BIOCHEM, V198, P733, DOI 10.1111/j.1432-1033.1991.tb16073.x; CHAMBARD M, 1983, J CELL BIOL, V96, P1172, DOI 10.1083/jcb.96.4.1172; DePillis GD, 1997, J BIOL CHEM, V272, P8857; Fan JL, 1996, J AUTOIMMUN, V9, P529, DOI 10.1006/jaut.1996.0071; Fayadat L, 1998, ENDOCRINOLOGY, V139, P4277, DOI 10.1210/en.139.10.4277; FENNA R, 1995, ARCH BIOCHEM BIOPHYS, V316, P653, DOI 10.1006/abbi.1995.1086; Gorin Y, 1996, EUR J BIOCHEM, V240, P807, DOI 10.1111/j.1432-1033.1996.0807h.x; Guo J, 1998, ENDOCRINOLOGY, V139, P999, DOI 10.1210/en.139.3.999; Halliwell B., 1991, FREE RADICAL BIO MED, P86; HOSSAYA T, 1967, J BIOL CHEM, V242, P2828; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; KIMURA S, 1988, PROTEINS, V3, P113, DOI 10.1002/prot.340030206; Kooter IM, 1997, J AM CHEM SOC, V119, P11542, DOI 10.1021/ja9725460; KRINSKY MM, 1971, J BIOL CHEM, V246, P4755; Kuras R, 1997, J BIOL CHEM, V272, P32427, DOI 10.1074/jbc.272.51.32427; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; NAUSEEF WM, 1992, BLOOD, V80, P2622; NEARY JT, 1984, METHOD ENZYMOL, V107, P445; NUNEZ J, 1982, VITAM HORM, V39, P175, DOI 10.1016/S0083-6729(08)61137-1; OHTAKI S, 1985, J BIOL CHEM, V260, P441; Ponka P, 1997, BLOOD, V89, P1; RAWITCH AB, 1979, ARCH BIOCHEM BIOPHYS, V194, P244, DOI 10.1016/0003-9861(79)90615-5; Richardson DR, 1996, BLOOD, V87, P3477, DOI 10.1182/blood.V87.8.3477.bloodjournal8783477; SASSA S, 1976, J EXP MED, V143, P305, DOI 10.1084/jem.143.2.305; Taurog A, 1998, THYROID, V8, P185, DOI 10.1089/thy.1998.8.185; TAUROG A, 1991, THYROID, P51; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288	30	73	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10533	10538		10.1074/jbc.274.15.10533	http://dx.doi.org/10.1074/jbc.274.15.10533			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187846	hybrid			2022-12-27	WOS:000079663500085
J	Hanisch, FG; Muller, S; Hassan, H; Clausen, H; Zachara, N; Gooley, AA; Paulsen, H; Alving, K; Peter-Katalinic, J				Hanisch, FG; Muller, S; Hassan, H; Clausen, H; Zachara, N; Gooley, AA; Paulsen, H; Alving, K; Peter-Katalinic, J			Dynamic epigenetic regulation of initial O-glycosylation by UDP-N-acetylgalactosamine : peptide N-acetylgalactosaminyltransferases - Site-specific glycosylation of MUC1 repeat peptide influences the substrate qualities at adjacent or distant Ser/Thr positions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-D-GALACTOSAMINE; TANDEM REPEAT; SUBMAXILLARY-GLAND; IN-VIVO; LINKED GLYCOSYLATION; GALNAC-TRANSFERASES; LOCALIZATION; SEQUENCES; GLYCOPEPTIDES; CLONING	In search of possible epigenetic regulatory mechanisms ruling the initiation of O-glycosylation by polypeptide:N-acetylgalactosaminyltransferases, we studied the influences of mono- and disaccharide substituents of glycopeptide substrates on the site-specific in vitro addition of N-acetylgalactosamine (GalNAc) residues by recombinant GalNAc-Ts (rGalNAc-T1, -T2, and -T3), The substrates were 20-mers (HGV20) or 21-mers (AHG21) of the MUC1 tandem repeat peptide carrying GalNAc alpha or Gal beta 1-3GalNAc alpha at different positions. The enzymatic products were analyzed by MALDI mass spectrometry and Edman degradation for the number and sites of incorporated GalNAc. Disaccharide placed on the first position of the diad Ser-16-Thr-17 prevents glycosylation of the second, whereas disaccharide on the second position of Ser-16-Thr-17 and Thr-5-Ser-6 does not prevent GalNAc addition to the first. Multiple disaccharide substituents suppress any further glycosylation at the remaining sites. Glycosylation of Ser-16 is negatively affected by glycosylation at position -6 (Thr-10) or -10 (Ser-6) and is inhibited by disaccharide at position -11 (Thr-5), suggesting the occurrence of glycosylation-induced effects on distant acceptor sites. Kinetic studies revealed the accelerated addition of GalNAc to Ser-16 adjacent Do GalNAc-substituted Thr-17, demonstrating positive regulatory effects induced by glycosylation on the monosaccharide level. These antagonistic effects of mono- and disaccharides could underlie a postulated regulatory mechanism.	Univ Cologne, Inst Biochem, D-50931 Cologne, Germany; Univ Copenhagen, Sch Dent, Dept Oral Diagnost, DK-2200 Copenhagen, Denmark; Macquarie Univ, Macquarie Ctr Analyt Biotechnol, Sydney, NSW 2109, Australia; Univ Hamburg, Inst Organ Chem, D-20146 Hamburg, Germany; Univ Munster, Inst Med Phys & Biophys, D-48149 Munster, Germany	University of Cologne; University of Copenhagen; Macquarie University; University of Hamburg; University of Munster	Hanisch, FG (corresponding author), Univ Cologne, Inst Biochem, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	franz.hanisch@uni-koeln.de	clausen, henrik/AAD-8016-2021					Antonyraj KJ, 1998, ARCH BIOCHEM BIOPHYS, V356, P197, DOI 10.1006/abbi.1998.0779; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Brockhausen I, 1996, GLYCOCONJUGATE J, V13, P849, DOI 10.1007/BF00702349; BUTENHOF KJ, 1993, BIOCHEMISTRY-US, V32, P2650, DOI 10.1021/bi00061a025; ECKHARDT AE, 1987, J BIOL CHEM, V262, P11339; FONTENOT JD, 1993, CANCER RES, V53, P5386; Gerken TA, 1998, J BIOL CHEM, V273, P26580, DOI 10.1074/jbc.273.41.26580; Goletz S, 1997, GLYCOBIOLOGY, V7, P881, DOI 10.1093/glycob/7.7.881; GOOLEY AA, 1994, GLYCOBIOLOGY, V4, P413, DOI 10.1093/glycob/4.4.413; HANSEN JE, 1995, BIOCHEM J, V308, P801, DOI 10.1042/bj3080801; Karsten U, 1998, CANCER RES, V58, P2541; Kirnarsky L, 1998, BIOCHEMISTRY-US, V37, P12811, DOI 10.1021/bi981034a; Mathieux N, 1997, J CHEM SOC PERK T 1, P2359, DOI 10.1039/a701742a; MIMURA Y, 1992, INT J BIOL MACROMOL, V14, P242, DOI 10.1016/S0141-8130(05)80036-4; Muller S, 1997, J BIOL CHEM, V272, P24780, DOI 10.1074/jbc.272.40.24780; Nehrke K, 1996, J BIOL CHEM, V271, P7061, DOI 10.1074/jbc.271.12.7061; NISHIMORI I, 1994, J BIOL CHEM, V269, P16123; OCONNELL B, 1991, BIOCHEM BIOPH RES CO, V180, P1024, DOI 10.1016/S0006-291X(05)81168-4; ROTH J, 1994, P NATL ACAD SCI USA, V91, P8935, DOI 10.1073/pnas.91.19.8935; Rottger S, 1998, J CELL SCI, V111, P45; SORENSEN T, 1995, J BIOL CHEM, V270, P24166, DOI 10.1074/jbc.270.41.24166; STADIE TRE, 1995, EUR J BIOCHEM, V229, P140, DOI 10.1111/j.1432-1033.1995.tb20448.x; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; WANG Y, 1993, J BIOL CHEM, V268, P22979; WANG YC, 1992, J BIOL CHEM, V267, P2728; WILSON IBH, 1991, BIOCHEM J, V275, P529, DOI 10.1042/bj2750529; ZACHARA NE, 1998, IN PRESS MUCIN METHO	28	67	69	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					9946	9954		10.1074/jbc.274.15.9946	http://dx.doi.org/10.1074/jbc.274.15.9946			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187769	hybrid			2022-12-27	WOS:000079663500008
J	Schutze, S; Machleidt, T; Adam, D; Schwandner, R; Wiegmann, K; Kruse, ML; Heinrich, M; Wickel, M; Kronke, M				Schutze, S; Machleidt, T; Adam, D; Schwandner, R; Wiegmann, K; Kruse, ML; Heinrich, M; Wickel, M; Kronke, M			Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; INDUCED CELL-DEATH; MEDIATED ENDOCYTOSIS; TNF-RECEPTOR; HUMAN-NEUTROPHILS; GROWTH-FACTOR; NEUTRAL SPHINGOMYELINASE; ACID SPHINGOMYELINASE; PHOSPHOLIPASE-C	The 55-kDa receptor for tumor necrosis factor (TR55) triggers multiple signaling cascades initiated by adapter proteins like TRADD and FAN. By use of the primary amine monodansylcadaverine (MDC), we addressed the functional role of tumor necrosis factor (TNF) receptor internalization for intracellular signal distribution, We show that MDC does not prevent the interaction of the p55 TNF receptor (TR55) with FAN and TRADD, Furthermore, the activation of plasmamembrane-associated neutral sphingomyelinase activation as well as the stimulation of proline-directed protein kinases were not affected in MDC-treated cells. In contrast, activation of signaling enzymes that are linked to the "death domain" of TR55, like acid sphingomyelinase and c-Jun-N-terminal protein kinase as well as TNF signaling of apoptosis in U937 and L929 cells, are blocked in the presence of MDC. The results of our study suggest a role of TR55 internalization for the activation of select TR55 death domain signaling pathways including those leading to apoptosis.	Univ Kiel, Inst Immunol, D-24105 Kiel, Germany; Univ Kiel, Dept Med 1, D-24105 Kiel, Germany	University of Kiel; University of Kiel	Schutze, S (corresponding author), Univ Kiel, Inst Immunol, D-24105 Kiel, Germany.	schuetze@immunologie.uni-kiel.de	Adam, Dieter/E-9763-2010; Schütze, Stefan/C-8596-2011	Adam, Dieter/0000-0002-5668-5032; 				Adam D, 1998, BIOCHEM J, V333, P343, DOI 10.1042/bj3330343; Adam D, 1996, J BIOL CHEM, V271, P14617, DOI 10.1074/jbc.271.24.14617; AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93; ANDRIEU N, 1995, J BIOL CHEM, V270, P24518, DOI 10.1074/jbc.270.41.24518; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEUTLER B, 1986, NATURE, V320, P584, DOI 10.1038/320584a0; BEYAERT R, 1994, FEBS LETT, V340, P9, DOI 10.1016/0014-5793(94)80163-0; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BOUCHER LM, 1995, J EXP MED, V181, P2059, DOI 10.1084/jem.181.6.2059; BRADLEY JR, 1993, J IMMUNOL, V150, P5544; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; Darnay BG, 1997, J LEUKOCYTE BIOL, V61, P559, DOI 10.1002/jlb.61.5.559; DAVIES PJA, 1980, NATURE, V283, P162, DOI 10.1038/283162a0; FIERS W, 1991, FEBS LETT, V285, P199, DOI 10.1016/0014-5793(91)80803-B; FOLK JE, 1973, ADV ENZYMOL RAMB, V38, P109; GEHR G, 1992, J IMMUNOL, V149, P911; GOEDDEL DV, 1986, COLD SPRING HARB SYM, V51, P597, DOI 10.1101/SQB.1986.051.01.072; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; GRELL M, 1994, J IMMUNOL, V153, P1963; HAIGLER HT, 1980, J BIOL CHEM, V255, P1239; HELLER RA, 1994, J CELL BIOL, V126, P5, DOI 10.1083/jcb.126.1.5; HIGUCHI M, 1994, J IMMUNOL, V152, P3550; Hofmeister R, 1997, J BIOL CHEM, V272, P27730, DOI 10.1074/jbc.272.44.27730; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; JOSEPH CK, 1993, J BIOL CHEM, V268, P20002; KULL FC, 1981, CANCER RES, V41, P4885; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Lazdins JK, 1997, J EXP MED, V185, P81, DOI 10.1084/jem.185.1.81; LIU J, 1994, J BIOL CHEM, V269, P3047; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; MARSH M, 1980, J MOL BIOL, V142, P439, DOI 10.1016/0022-2836(80)90281-8; MAXFIELD FR, 1979, NATURE, V277, P661, DOI 10.1038/277661a0; MCGAHON AJ, 1995, METHOD CELL BIOL, V46, P153; MOSSELMANS R, 1988, J IMMUNOL, V141, P3096; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Pastorino JG, 1996, J BIOL CHEM, V271, P29792, DOI 10.1074/jbc.271.47.29792; PEAVY DE, 1984, ENDOCRINOLOGY, V114, P753, DOI 10.1210/endo-114-3-753; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; PORTEU F, 1994, J BIOL CHEM, V269, P2834; RAINES MA, 1993, J BIOL CHEM, V268, P14572; Ray E, 1996, FEBS LETT, V378, P235, DOI 10.1016/0014-5793(95)01462-4; Ray E, 1997, CYTOKINE, V9, P587, DOI 10.1006/cyto.1997.0206; RESINK TJ, 1990, MOL PHARMACOL, V38, P244; RIKIHISA Y, 1994, INFECT IMMUN, V62, P5126, DOI 10.1128/IAI.62.11.5126-5132.1994; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; SAMANTA AK, 1990, J BIOL CHEM, V265, P183; SCHLEGEL R, 1982, P NATL ACAD SCI-BIOL, V79, P2291, DOI 10.1073/pnas.79.7.2291; SCHULZEOSTHOFF K, 1993, EMBO J, V12, P3095, DOI 10.1002/j.1460-2075.1993.tb05978.x; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SCHUTZE S, 1990, J IMMUNOL, V144, P2604; SCHUTZE S, 1991, J EXP MED, V174, P975, DOI 10.1084/jem.174.5.975; SCHUTZE S, 1995, CYTOKINES PRACTICAL, P93; Schwandner R, 1998, J BIOL CHEM, V273, P5916, DOI 10.1074/jbc.273.10.5916; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; TARTAGLIA LA, 1993, CELL, V73, P213, DOI 10.1016/0092-8674(93)90222-C; TARTAGLIA LA, 1993, J IMMUNOL, V151, P4637; VIETOR I, 1993, J BIOL CHEM, V268, P18994; WATANABE N, 1988, J BIOL CHEM, V263, P10262; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; WIEGMANN K, 1992, J BIOL CHEM, V267, P17997; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	66	178	179	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10203	10212		10.1074/jbc.274.15.10203	http://dx.doi.org/10.1074/jbc.274.15.10203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187805	hybrid			2022-12-27	WOS:000079663500044
J	Vassiliev, IR; Yu, JP; Jung, YS; Schulz, R; Ganago, AO; McIntosh, L; Golbeck, JH				Vassiliev, IR; Yu, JP; Jung, YS; Schulz, R; Ganago, AO; McIntosh, L; Golbeck, JH			The cysteine-proximal aspartates in the F-X-binding niche of photosystem I - Effect of alanine and lysine replacements on photoautotrophic growth, electron transfer rates, single-turnover flash efficiency, and EPR spectral properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; IRON-SULFUR CENTERS; CHLAMYDOMONAS-REINHARDTII; 4FE-4S CLUSTERS; ACCEPTOR A(1); PSAC SUBUNIT; FERREDOXIN; CORE; SPECTROSCOPY; CHLOROPLASTS	The F-X electron acceptor in Photosystem I (PS I) is a highly electronegative (E-m = -705 mV) interpolypeptide [4Fe-4S] cluster ligated by cysteines 556 and 565 on PsaB and cysteines 574 and 583 on PsaA in Synechocystis sp, PCC 6803. An aspartic acid is adjacent to each of these cysteines on PsaB and adjacent to the proline-proximal cysteine on PsaA We investigated the effect of D566(saB) and D557(PsaB) on electron transfer through F-X by changing each aspartate to the neutral alanine or to the positively charged lysine either singly (D566A(PsaB), D557A(Psab), D566K(PsaB), and D557K(PsaB)) or in pairs (D557A(PsaB)/D566A(PsaB) and D557K(PsaB)/D566A(PsaB)). All mutants except for D557K(PsaB)/D566A(PsaB) grew photoautotrophically, but the growth of D557K(PsaB) and D557A(PsaB)/D566A(PsaB) was impaired under low light. The doubling time was increased, and the chlorophyll content per cell was lower in D557K(PsaB) and D557A(PsaB)/D566A(PsaB) relative to the wild type and the other mutants. Nevertheless, the rates of NADP(+) photoreduction in PS I complexes from all mutants were no less than 75% of that of the wild type. The kinetics of back-reaction of the electron accepters on a single-turnover flash showed efficient electron transfer to the terminal accepters F-A and F-B in PS I complexes from all mutants. The EPR spectrum of F-X was identical to that in the wild type in all but the single and double D566A(PsaB) mutants, where the high-field resonance was shifted downfield. We conclude that the impaired growth of some of the mutants is related to a reduced accumulation of PS I rather than to photosynthetic efficiency. The chemical nature and the charge of the amino acids adjacent to the cysteine ligands on PsaB do not appear to be significant factors in the efficiency of electron transfer through F-X.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Nebraska System; University of Nebraska Lincoln; Michigan State University	Golbeck, JH (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	jhg5@psu.edu		Yu, Jianping/0000-0003-0466-3197				ANDERSON SL, 1991, J BACTERIOL, V173, P2761, DOI 10.1128/JB.173.9.2761-2767.1991; Berg J.M., 1982, IRON SULFUR PROTEINS, P1; Brettel K, 1995, PHOTOSYNTH RES, V45, P183, DOI 10.1007/BF00015559; CHAMOROVSKY SK, 1982, PHOTOBIOCH PHOTOBIOP, V4, P195; Diaz-Quintana A, 1998, BIOCHEMISTRY-US, V37, P3429, DOI 10.1021/bi972469l; EVANS MCW, 1976, BIOCHEM J, V158, P71, DOI 10.1042/bj1580071; FontecillaCamps JC, 1996, J BIOL INORG CHEM, V1, P91, DOI 10.1007/s007750050027; Golbeck J. H., 1995, CRC HDB ORGANIC PHOT, P1407; GOLBECK JH, 1986, BIOCHIM BIOPHYS ACTA, V849, P16, DOI 10.1016/0005-2728(86)90091-5; GOLBECK JH, 1991, CURR TOP BIOENERG, V16, P83; Hallahan BJ, 1995, PHOTOSYNTH RES, V46, P257, DOI 10.1007/BF00020438; HOJ PB, 1986, J BIOL CHEM, V261, P14292; Jung YS, 1995, PHOTOSYNTH RES, V46, P249, DOI 10.1007/BF00020437; Lojero CG, 1996, PHOTOSYNTH RES, V47, P293, DOI 10.1007/BF02184290; MATHIS P, 1981, ISRAEL J CHEM, V21, P316; Moulis JM, 1996, J BIOL INORG CHEM, V1, P2, DOI 10.1007/s007750050017; Muhlenhoff U, 1996, EMBO J, V15, P488, DOI 10.1002/j.1460-2075.1996.tb00381.x; NITSCHKE W, 1993, BIOCHEMISTRY-US, V32, P8871, DOI 10.1021/bi00085a019; RODDAY SM, 1993, PHOTOSYNTH RES, V36, P1, DOI 10.1007/BF00018069; RODDAY SM, 1995, BIOCHEMISTRY-US, V34, P6328, DOI 10.1021/bi00019a010; Schubert WD, 1997, J MOL BIOL, V272, P741, DOI 10.1006/jmbi.1997.1269; SCHULZ R, 1995, PHOTOSYNTHESIS LIGHT, V2, P119; SMART LB, 1993, P NATL ACAD SCI USA, V90, P1132, DOI 10.1073/pnas.90.3.1132; VANDEREST A, 1994, BIOCHEMISTRY-US, V33, P11789, DOI 10.1021/bi00205a015; Vassiliev IR, 1998, BIOPHYS J, V74, P2029, DOI 10.1016/S0006-3495(98)77909-3; Vassiliev IR, 1997, BIOPHYS J, V72, P301, DOI 10.1016/S0006-3495(97)78669-7; VASSILIEV IR, 1995, BIOPHYS J, V69, P1544, DOI 10.1016/S0006-3495(95)80026-3; VASSILIEV IR, 1995, PHOTOSYNTHESIS LIGHT, V2, P131; WARREN PV, 1993, BIOCHEMISTRY-US, V32, P4411, DOI 10.1021/bi00067a034; WEBBER AN, 1993, J BIOL CHEM, V268, P12990; Yu JP, 1997, J BIOL CHEM, V272, P8032, DOI 10.1074/jbc.272.12.8032; YU JP, 1995, PLANT MOL BIOL, V29, P331, DOI 10.1007/BF00043656	32	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					9993	10001		10.1074/jbc.274.15.9993	http://dx.doi.org/10.1074/jbc.274.15.9993			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187775	hybrid			2022-12-27	WOS:000079663500014
J	Garvish, JF; Lloyd, RS				Garvish, JF; Lloyd, RS			The catalytic mechanism of a pyrimidine dimer-specific glycosylase (pdg) abasic lyase, chlorella virus-pdg	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T4 ENDONUCLEASE-V; FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE; EXCISION-REPAIR ENZYME; BETA-ELIMINATION; AMINO-TERMINUS; FPG PROTEIN; CIS-SYN; SITE; BACTERIOPHAGE-T4; INTERMEDIATE	The repair of UV light-induced cyclobutane pyrimidine dimers can proceed via the base excision repair pathway, in which the initial step is catalyzed by DNA glycosylase/abasic (AP) lyases, The prototypical enzyme studied for this pathway is endonuclease V from the bacteriophage T4 (T4 bacteriophage pyrimidine dimer glycosylase (T4-pdg)), The first homologue for T4-pdg has been found in a strain of Chlorella virus (strain Paramecium bursaria Chlorella virus-1), which contains a gene that predicts an amino acid sequence homology of 41% with T4-pdg. Because both the structure and critical catalytic residues are known for T4-pdg, homology modeling of the Chlorella virus pyrimidine dimer glycosylase (cv-pdg) predicted that a conserved glutamic acid residue (Glu-23) would be important for catalysis at pyrimidine dimers and abasic sites. Site-directed mutations were constructed at Glu-23 to assess the necessity of a negatively charged residue at that position (Gln-23) and the importance of the length of the negatively charged side chain (Asp-23). E23Q lost glycosylase activity completely but retained low levels of AP lyase activity. In contrast, E23D retained near wild type glycosylase and AP lyase activities on cis-syn dimers but completely lost its activity on the trans-syn II dimer, which is very efficiently cleaved by the wild type cv-pdg. As has been shown for other glyscosylases, the wild type cv-pdg catalyzes the cleavage at dimers or AP sites via formation of an imino intermediate, as evidenced by the ability of the enzyme to be covalently trapped on substrate DNA when the reactions are carried out in the presence of a strong reducing agent; in contrast, E23D was very poorly trapped on cis-syn dimers but was readily trapped on DNA containing AP sites. It is proposed that Glu-23 protonates the sugar ring, so that the imino intermediate can be formed.	Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Lloyd, RS (corresponding author), Univ Texas, Med Branch, Sealy Ctr Mol Sci, 301 Univ Blvd, Galveston, TX 77555 USA.	rslloyd@utmb.edu		Lloyd, R. Stephen/0000-0001-7273-372X	NIEHS NIH HHS [ES04091, ES06676] Funding Source: Medline; PHS HHS [T327254] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004091, P30ES006676] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BAILLY V, 1989, BIOCHEM J, V259, P751, DOI 10.1042/bj2590751; Bogenhagen DF, 1998, J BIOL CHEM, V273, P7888, DOI 10.1074/jbc.273.14.7888; CASTAING B, 1992, NUCLEIC ACIDS RES, V20, P389, DOI 10.1093/nar/20.3.389; DODSON ML, 1993, BIOCHEMISTRY-US, V32, P8284, DOI 10.1021/bi00083a032; DODSON ML, 1994, J BIOL CHEM, V269, P32709; DOI T, 1992, P NATL ACAD SCI USA, V89, P9420, DOI 10.1073/pnas.89.20.9420; DOWD DR, 1989, BIOCHEMISTRY-US, V28, P8699, DOI 10.1021/bi00448a005; DOWD DR, 1990, J BIOL CHEM, V265, P3424; DOWD DR, 1989, J MOL BIOL, V208, P701, DOI 10.1016/0022-2836(89)90160-5; Furuta M, 1997, APPL ENVIRON MICROB, V63, P1551, DOI 10.1128/AEM.63.4.1551-1556.1997; HORI N, 1992, NUCLEIC ACIDS RES, V20, P4761, DOI 10.1093/nar/20.18.4761; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Jiang DY, 1997, J BIOL CHEM, V272, P32230, DOI 10.1074/jbc.272.51.32230; KIM J, 1988, NUCLEIC ACIDS RES, V16, P1135, DOI 10.1093/nar/16.3.1135; Lloyd RS, 1999, PROG NUCLEIC ACID RE, V62, P155; Lloyd RS, 1998, MUTAT RES-DNA REPAIR, V408, P159, DOI 10.1016/S0921-8777(98)00032-9; MANAHARAN M, 1988, J AM CHEM SOC, V110, P2690; MANUEL RC, 1995, J BIOL CHEM, V270, P2652, DOI 10.1074/jbc.270.6.2652; Manuel RC, 1997, BIOCHEMISTRY-US, V36, P11140, DOI 10.1021/bi9709708; McCullough AK, 1998, J BIOL CHEM, V273, P13136, DOI 10.1074/jbc.273.21.13136; McCullough AK, 1997, J BIOL CHEM, V272, P27210, DOI 10.1074/jbc.272.43.27210; McCullough AK, 1996, J BIOL CHEM, V271, P32147, DOI 10.1074/jbc.271.50.32147; MORIKAWA K, 1992, SCIENCE, V256, P523, DOI 10.1126/science.1575827; MORIKAWA K, 1995, J MOL BIOL, V249, P360, DOI 10.1006/jmbi.1995.0302; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Scharer OD, 1997, CURR OPIN CHEM BIOL, V1, P526, DOI 10.1016/S1367-5931(97)80048-8; SCHROCK RD, 1991, J BIOL CHEM, V266, P17631; SMITH CA, 1993, J BIOL CHEM, V268, P11143; TCHOU J, 1995, J BIOL CHEM, V270, P11671, DOI 10.1074/jbc.270.19.11671; WANG SY, 1976, PHOTOCHEM PHOTOBIOL, V1, P169; Zharkov DO, 1998, BIOCHEMISTRY-US, V37, P12384, DOI 10.1021/bi981066y; Zharkov DO, 1997, J BIOL CHEM, V272, P5335, DOI 10.1074/jbc.272.8.5335	32	19	20	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9786	9794		10.1074/jbc.274.14.9786	http://dx.doi.org/10.1074/jbc.274.14.9786			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092668	hybrid			2022-12-27	WOS:000079451800087
J	Hayashi, H; De Bellis, L; Ciurli, A; Kondo, M; Hayashi, M; Nishimura, R				Hayashi, H; De Bellis, L; Ciurli, A; Kondo, M; Hayashi, M; Nishimura, R			A novel acyl-CoA oxidase that can oxidize short-chain acyl-CoA in plant peroxisomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-OXIDATION ENZYMES; FATTY-ACID DEGRADATION; PUMPKIN COTYLEDONS; PURIFICATION; EXPRESSION; DEHYDROGENASE; PROTEIN; IDENTIFICATION; MITOCHONDRIAL; BIOSYNTHESIS	Short-chain acyl-CoA oxidases are beta-oxidation enzymes that are active on short-chain acyl-CoAs and that appear to be present in higher plant peroxisomes and absent in mammalian peroxisomes. Therefore, plant peroxisomes are capable of performing complete beta-oxidation of acyl-CoA chains, whereas mammalian peroxisomes can perform beta-oxidation of only those acyl-CoA chains that are larger than octanoyl-CoA (C-8), In this report, we have shown that a novel acyl-CoA oxidase can oxidize short-chain acyl-CoA in plant peroxisomes. A peroxisomal short-chain acyl-CoA oxidase from Arabidopsis was purified following the expression of the Arabidopsis cDNA in a baculovirus expression system, The purified enzyme was active on butyryl-CoA (C-4), hexanoyl-CoA (C-6), and octanoyl-CoA (C-8), Cell fractionation and immunocytochemical analysis revealed that the short-chain acyl-CoA oxidase is localized in peroxisomes, The expression pattern of the short-chain acyl-CoA oxidase was similar to that of peroxisomal 3-ketoacyl-CoA thiolase, a marker enzyme of fatty acid beta-oxidation, during post-germinative growth. Although the molecular structure and amino acid sequence of the enzyme are similar to those of mammalian mitochondrial acyl-CoA dehydrogenase, the purified enzyme has no activity as acyl-CoA dehydrogenase, These results indicate that the short-chain acyl-CoA oxidases function in fatty acid beta-oxidation in plant peroxisomes, and that by the cooperative action of long- and short-chain acyl-CoA oxidases, plant peroxisomes are capable of performing the complete beta-oxidation of acyl-CoA,	Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Dept Mol Biomech, Okazaki, Aichi 4448585, Japan; Dipartimento Biol Piante Agr, I-56124 Pisa, Italy	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Nishimura, R (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan.	mikosome@nibb.ac.jp	De Bellis, Luigi/I-2950-2019	De Bellis, Luigi/0000-0002-6047-3526; Nishimura, Mikio/0000-0001-7960-9721				Aebi H., 1974, METHODS ENZYMATIC AN, Vsecond, P673, DOI [DOI 10.1016/B978-0-12-091302-2.50032-3, 10.1016/B978-0-12-091302-2.50032-3]; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; Battaile KP, 1996, BIOCHEMISTRY-US, V35, P15356, DOI 10.1021/bi961113r; BEEVERS H, 1979, ANNU REV PLANT PHYS, V30, P159, DOI 10.1146/annurev.pp.30.060179.001111; BEEVERS H, 1982, ANN NY ACAD SCI, V386, P243, DOI 10.1111/j.1749-6632.1982.tb21420.x; BROSS P, 1990, J BIOL CHEM, V265, P7116; Do YY, 1997, ARCH BIOCHEM BIOPHYS, V344, P295, DOI 10.1006/abbi.1997.0212; DOMMES V, 1976, ANAL BIOCHEM, V71, P571, DOI 10.1016/S0003-2697(76)80026-7; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; Eccleston VS, 1998, PLANT CELL, V10, P613, DOI 10.1105/tpc.10.4.613; FURUTA S, 1981, J BIOCHEM, V90, P1739, DOI 10.1093/oxfordjournals.jbchem.a133651; GERBLING H, 1987, PLANTA, V171, P386, DOI 10.1007/BF00398684; GERHARDT B, 1987, METHOD ENZYMOL, V148, P516; GERHARDT B, 1983, PLANTA, V159, P238, DOI 10.1007/BF00397531; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; Hashimoto T, 1996, ANN NY ACAD SCI, V804, P86, DOI 10.1111/j.1749-6632.1996.tb18610.x; Hayashi H, 1998, J BIOL CHEM, V273, P8301, DOI 10.1074/jbc.273.14.8301; Hayashi M, 1998, PLANT CELL, V10, P183, DOI 10.1105/tpc.10.2.183; Hodges T K, 1974, Methods Enzymol, V32, P392; Hooks MA, 1996, BIOCHEM J, V320, P607, DOI 10.1042/bj3200607; Hoppe A, 1997, PLANTA, V202, P227, DOI 10.1007/s004250050123; HUANG AHC, 1983, JPLANT PEROXISOME; Kato A, 1996, PLANT MOL BIOL, V31, P843, DOI 10.1007/BF00019471; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; KINDL H, 1993, BIOCHIMIE, V75, P225, DOI 10.1016/0300-9084(93)90080-C; Kleiter AE, 1998, PLANTA, V206, P125, DOI 10.1007/s004250050382; LAZAROW PB, 1978, J BIOL CHEM, V253, P1522; LUCKOW VA, 1988, VIROLOGY, V167, P56, DOI 10.1016/0042-6822(88)90054-2; MAESHIMA M, 1988, PLANT CELL PHYSIOL, V29, P381; MASTERSON C, 1990, PLANTA, V182, P129, DOI 10.1007/BF00239994; MIERNYK JA, 1991, PLANT PHYSIOL, V95, P564, DOI 10.1104/pp.95.2.564; NISHIMURA M, 1993, PROTOPLASMA, V175, P131, DOI 10.1007/BF01385011; PREISIGMULLER R, 1994, J BIOL CHEM, V269, P20475; PREISIGMULLER R, 1993, PLANT MOL BIOL, V22, P59, DOI 10.1007/BF00038995; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Srivastava DK, 1998, BIOCHEMISTRY-US, V37, P8446, DOI 10.1021/bi980380p; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V8, P4321; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wasternack C, 1997, TRENDS PLANT SCI, V2, P302, DOI 10.1016/S1360-1385(97)89952-9; WOOD C, 1986, PLANTA, V167, P54, DOI 10.1007/BF00446368; YAMAGUCHI J, 1984, PLANT PHYSIOL, V74, P261, DOI 10.1104/pp.74.2.261	41	100	108	1	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12715	12721		10.1074/jbc.274.18.12715	http://dx.doi.org/10.1074/jbc.274.18.12715			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212254	hybrid			2022-12-27	WOS:000080056800074
J	Huang, LQ; Wong, TYW; Lin, RCC; Furthmayr, H				Huang, LQ; Wong, TYW; Lin, RCC; Furthmayr, H			Replacement of threonine 558, a critical site of phosphorylation of moesin in vivo, with aspartate activates F-actin binding of moesin - Regulation by conformational change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EZRIN/RADIXIN/MOESIN ERM PROTEINS; MEMBRANE-CYTOSKELETAL LINKER; TYROSINE KINASE SUBSTRATE; MICROVILLAR CORE PROTEIN; CELL-CELL CONTACTS; TERMINAL DOMAIN; HUMAN-PLATELETS; APICAL MICROVILLI; EPITHELIAL-CELLS; T-LYMPHOCYTES	Point and deletion mutants of moesin were examined for F-actin binding by blot overlay and co-sedimentation, and for intra- and intermolecular interactions with N- and C-terminal domains with yeast two-hybrid and in vitro binding assays, Wild-type moesin molecules interact poorly with F-actin and each other, and bind neither C- nor N-terminal fragments. Interaction with F-actin is strongly enhanced by replacement of Thr(558) With aspartate (T558D), by deletion of 11 N-terminal residues (DelN11), by deletion of the entire N-terminal membrane-binding domain of both wild type and T558D mutant molecules, and by exposure to phosphatidylinositol 4,5-diphosphate, Activation of F-actin binding is accompanied by changes in inter- and intramolecular domain interactions. The T558D mutation renders moesin capable of binding wild type but not mutated (T558D) C-terminal or wild type N-terminal fragments. The interaction between the latter two is prevented. DelN11 truncation enables binding of wild type N and C domain fragments. These changes suggest that the T558D mutation, mimicking phosphorylation of Thr(558), promotes F-actin binding by disruption of interdomain interactions between N and C domains and exposure of the high affinity F-actin binding site in the C-terminal domain. Oscillation between activated and resting state could thus provide the structural basis for transient interactions between moesin and the actin cytoskeleton in protruding and retracting microextensions.	Stanford Univ, Sch Med, Dept Pathol, Mol Mech Dis Lab, Stanford, CA 94305 USA	Stanford University	Furthmayr, H (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Mol Mech Dis Lab, Stanford, CA 94305 USA.	hfurthmayr@pathology.stanford.edu	Furthmayr, Heinz -/A-6295-2010					ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; AMIEVA MR, 1994, EXP CELL RES, V210, P140, DOI 10.1006/excr.1994.1021; AMIEVA MR, 1995, EXP CELL RES, V219, P180, DOI 10.1006/excr.1995.1218; Amieva MR, 1999, J CELL SCI, V112, P111; BERRYMAN M, 1995, J CELL BIOL, V131, P1231, DOI 10.1083/jcb.131.5.1231; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; CASELLA JF, 1994, J BIOL CHEM, V269, P6992; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; FAZIOLI F, 1993, ONCOGENE, V8, P1335; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; FUNAYAMA N, 1991, J CELL BIOL, V115, P1039, DOI 10.1083/jcb.115.4.1039; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; GOULD KL, 1986, J CELL BIOL, V102, P660, DOI 10.1083/jcb.102.2.660; GOULD KL, 1989, EMBO J, V8, P4133, DOI 10.1002/j.1460-2075.1989.tb08598.x; HANZEL D, 1991, EMBO J, V10, P2363, DOI 10.1002/j.1460-2075.1991.tb07775.x; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Huang LQ, 1998, BIOCHEM BIOPH RES CO, V248, P548, DOI 10.1006/bbrc.1998.9009; HUG C, 1992, J CELL BIOL, V116, P923, DOI 10.1083/jcb.116.4.923; Jockusch BM, 1996, TRENDS CELL BIOL, V6, P311, DOI 10.1016/0962-8924(96)10022-2; KRIEG J, 1992, J BIOL CHEM, V267, P19258; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; LANKES WT, 1993, BIOCHIM BIOPHYS ACTA, V1216, P479, DOI 10.1016/0167-4781(93)90018-9; MACAULEY A, 1989, MOL CELL BIOL, V9, P2648, DOI 10.1128/MCB.9.6.2648; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; MAGENDANTZ M, 1995, J BIOL CHEM, V270, P25324, DOI 10.1074/jbc.270.43.25324; MARTIN M, 1995, J CELL BIOL, V128, P1081, DOI 10.1083/jcb.128.6.1081; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Nakamura F, 1996, BIOCHEM BIOPH RES CO, V226, P650, DOI 10.1006/bbrc.1996.1410; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; Pearson M, 1998, MOL BIOL CELL, V9, p265A; PESTONJAMASP K, 1995, MOL BIOL CELL, V6, P247, DOI 10.1091/mbc.6.3.247; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roy C, 1997, J BIOL CHEM, V272, P20088, DOI 10.1074/jbc.272.32.20088; SATO N, 1992, J CELL SCI, V103, P131; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Shaw RJ, 1998, MOL BIOL CELL, V9, P403, DOI 10.1091/mbc.9.2.403; TAKEUCHI K, 1994, J CELL BIOL, V125, P1371, DOI 10.1083/jcb.125.6.1371; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; URUSHIDANI T, 1989, AM J PHYSIOL, V256, pG1070, DOI 10.1152/ajpgi.1989.256.6.G1070; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; WILSON DB, 1985, J BIOL CHEM, V260, P1046; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	59	66	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12803	12810		10.1074/jbc.274.18.12803	http://dx.doi.org/10.1074/jbc.274.18.12803			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212266	hybrid			2022-12-27	WOS:000080056800086
J	Mechanic, LE; Hall, MC; Matson, SW				Mechanic, LE; Hall, MC; Matson, SW			Escherichia coli DNA helicase II is active as a monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; SIMPLEX VIRUS TYPE-1; UVRD GENE-PRODUCT; ORIGIN-BINDING PROTEIN; REP HELICASE; CONFORMATIONAL-CHANGES; OLIGOMERIC STRUCTURE; INDUCED DIMERIZATION; CRYSTAL-STRUCTURE; MISMATCH REPAIR	Helicases are thought to function as oligomers (generally dimers or hexamers), Here me demonstrate that although Escherichia coli DNA helicase II (UvrD) is capable of dimerization as evidenced by a positive interaction in the yeast two-hybrid system, gel filtration chromatography, and equilibrium sedimentation ultracentrifugation (K-d = 3.4 mu M), the protein is active in vivo and in vitro as a monomer, A mutant lacking the C-terminal 40 amino acids (UvrD Delta 40C) failed to dimerize and yet was as active as the wild-type protein in ATP hydrolysis and helicase assays. In addition, the uvrD Delta 40C allele fully complemented the loss of helicase II in both methyl-directed mismatch repair and excision repair of pyrimidine dimers, Biochemical inhibition experiments using wild-type UvrD and inactive UvrD point mutants provided further evidence for a functional monomer. This investigation provides the first direct demonstration of an active monomeric helicase, and a model for DNA unwinding by a monomer is presented.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Prot Engn & Mol Genet Training Program, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Mechanic, LE (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.		Hall, Mark C./D-1698-2011	Hall, Mark/0000-0001-6429-2506	NIGMS NIH HHS [GM 33476] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033476] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABDELMONEM M, 1976, EUR J BIOCHEM, V65, P441, DOI 10.1111/j.1432-1033.1976.tb10359.x; ABDELMONEM M, 1976, EUR J BIOCHEM, V65, P431, DOI 10.1111/j.1432-1033.1976.tb10358.x; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; BLOOMFIELD V, 1967, BIOPOLYMERS, V5, P149, DOI 10.1002/bip.1967.360050203; BROSH RM, 1995, J BACTERIOL, V177, P5612, DOI 10.1128/jb.177.19.5612-5621.1995; Brosh RM, 1996, J BIOL CHEM, V271, P25360, DOI 10.1074/jbc.271.41.25360; Brosh RM, 1997, J BIOL CHEM, V272, P572; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; Cantor C. R, 1980, BIOPHYSICAL CHEM 2, P591; CARON PR, 1985, P NATL ACAD SCI USA, V82, P4925, DOI 10.1073/pnas.82.15.4925; CHAO KL, 1991, J MOL BIOL, V221, P1165, DOI 10.1016/0022-2836(91)80119-F; CHAO KL, 1990, J BIOL CHEM, V265, P1067; Cole JL, 1996, BIOCHEMISTRY-US, V35, P15601, DOI 10.1021/bi961719f; DONG F, 1995, J BIOL CHEM, V270, P7462, DOI 10.1074/jbc.270.13.7462; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; FEINSTEIN SI, 1986, GENETICS, V113, P13; FIERER DS, 1995, J BIOL CHEM, V270, P7330, DOI 10.1074/jbc.270.13.7330; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; GEORGE JW, 1994, J MOL BIOL, V235, P424, DOI 10.1006/jmbi.1994.1003; Hall MC, 1998, EMBO J, V17, P1535, DOI 10.1093/emboj/17.5.1535; Hall MC, 1997, J BIOL CHEM, V272, P18614, DOI 10.1074/jbc.272.30.18614; Hall MC, 1998, J MOL BIOL, V277, P257, DOI 10.1006/jmbi.1997.1614; HILL TL, 1981, P NATL ACAD SCI-BIOL, V78, P4796, DOI 10.1073/pnas.78.8.4796; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; HUSAIN I, 1985, P NATL ACAD SCI USA, V82, P6774, DOI 10.1073/pnas.82.20.6774; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KIRKWOOD JG, 1954, J POLYM SCI, V12, P1, DOI 10.1002/pol.1954.120120102; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; KUMURA K, 1984, J BIOL CHEM, V259, P1560; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Laue TM, 1995, METHOD ENZYMOL, V259, P427; LECHNER RL, 1983, J BIOL CHEM, V258, P1185; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Makhov AM, 1996, J MOL BIOL, V258, P789, DOI 10.1006/jmbi.1996.0287; Malik AK, 1996, J VIROL, V70, P7859, DOI 10.1128/JVI.70.11.7859-7866.1996; MASTRANGELO IA, 1989, NATURE, V338, P658, DOI 10.1038/338658a0; MATSON SW, 1991, PROG NUCLEIC ACID RE, V40, P289; MATSON SW, 1987, J BIOL CHEM, V262, P2066; MATSON SW, 1986, J BIOL CHEM, V261, P169; MATSON SW, 1983, J BIOL CHEM, V258, P4009; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; MENDONCA VM, 1993, J BACTERIOL, V175, P4641, DOI 10.1128/JB.175.15.4641-4651.1993; MOREL P, 1993, NUCLEIC ACIDS RES, V21, P3205, DOI 10.1093/nar/21.14.3205; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; PATEL SS, 1993, J BIOL CHEM, V268, P10668; PATEL SS, 1994, BIOCHEMISTRY-US, V33, P7857, DOI 10.1021/bi00191a013; Phillips RJ, 1997, MOL GEN GENET, V254, P319, DOI 10.1007/PL00008605; Philo JS, 1997, BIOPHYS J, V72, P435, DOI 10.1016/S0006-3495(97)78684-3; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; REHAKRANTZ LJ, 1978, J BIOL CHEM, V253, P4043; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; RUNYON GT, 1990, P NATL ACAD SCI USA, V87, P6383, DOI 10.1073/pnas.87.16.6383; Stafford WF, 1994, MODERN ANAL ULTRACEN, P119; STASIAK A, 1994, P NATL ACAD SCI USA, V91, P7618, DOI 10.1073/pnas.91.16.7618; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; VANHOLDE KE, 1975, PROTEINS, P226; WASHBURN BK, 1993, J BACTERIOL, V175, P341, DOI 10.1128/JB.175.2.341-350.1993; WESSEL R, 1990, EUR J BIOCHEM, V192, P695, DOI 10.1111/j.1432-1033.1990.tb19278.x; WONG I, 1992, J BIOL CHEM, V267, P7596; WONG I, 1992, SCIENCE, V256, P350, DOI 10.1126/science.256.5055.350; Wong I, 1997, BIOCHEMISTRY-US, V36, P3115, DOI 10.1021/bi9621977; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; YARRANTON GT, 1979, P NATL ACAD SCI USA, V76, P1658, DOI 10.1073/pnas.76.4.1658; [No title captured]	68	83	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12488	12498		10.1074/jbc.274.18.12488	http://dx.doi.org/10.1074/jbc.274.18.12488			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212225	Green Published, hybrid			2022-12-27	WOS:000080056800045
J	Nelson, D; Potempa, J; Kordula, T; Travis, J				Nelson, D; Potempa, J; Kordula, T; Travis, J			Purification and characterization of a novel cysteine proteinase (periodontain) from Porphyromonas gingivalis - Evidence for a role in the inactivation of human alpha(1)-proteinase inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV-LIKE ACTIVITIES; CREVICULAR FLUID; BACTEROIDES-GINGIVALIS; PATHOGENIC MECHANISM; PROTEOLYTIC-ENZYMES; DISEASE; ELASTASE; GENE; ALPHA(1)-ANTITRYPSIN; DEGRADATION	Periodontal disease is characterized by inflammation of the periodontium manifested by recruitment of neutrophils, which can degranulate, releasing powerful proteinases responsible for destruction of connective tissues, and eventual loss of tooth attachment. Although the presence of host proteinase inhibitors (serpins) should minimize tissue damage by endogenous proteinases, this is not seen clinically, and it has been speculated that proteolytic inactivation of serpins may contribute to progression of the disease. A major pathogen associated with periodontal disease is the Gram-negative anaerobe Porphyromonas gingivalis, and in this report, we describe a novel proteinase that has been isolated from culture supernatants of this organism that is capable of inactivating the human serpin, alpha(1)-proteinase inhibitor, the primary endogenous regulator of human neutrophil elastase, This new enzyme, referred to as periodontain, belongs to the cysteine proteinase family based on inhibition studies and exists as a 75-kDa heterodimer, Furthermore, periodontain shares significant homology to streptopain, a proteinase from Streptococcus pyogenes, and prtT, a putative proteinase from P, gingivalis. Clearly, the presence of this enzyme, which rapidly inactivates alpha(1)-proteinase inhibitor, could result in elevated levels of human neutrophil elastase clinically detected in periodontal disease and should be considered as a potential virulence factor for P, gingivalis.	Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; Jagiellonian Univ, Dept Microbiol & Immunol, PL-31120 Krakow, Poland; Jagiellonian Univ, Dept Anim Biochem, PL-31120 Krakow, Poland	University System of Georgia; University of Georgia; Jagiellonian University; Jagiellonian University	Travis, J (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Life Sci Bldg, Athens, GA 30602 USA.		Nelson, Daniel C./I-2198-2012	Nelson, Daniel C./0000-0003-3248-4831	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE09761] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banbula A, 1999, J BIOL CHEM, V274, P9246, DOI 10.1074/jbc.274.14.9246; BARRETT AJ, 1998, HDB PROTEOLYTIC ENZY, P657; CARLSSON J, 1984, INFECT IMMUN, V43, P644, DOI 10.1128/IAI.43.2.644-648.1984; CHEN ZX, 1992, J BIOL CHEM, V267, P18896; COX SW, 1992, J CLIN PERIODONTOL, V19, P333, DOI 10.1111/j.1600-051X.1992.tb00655.x; COX SW, 1989, J PERIODONTAL RES, V24, P353, DOI 10.1111/j.1600-0765.1989.tb00882.x; CUTLER CW, 1993, J IMMUNOL, V151, P7016; DARANY DG, 1992, J PERIODONTOL, V63, P743, DOI 10.1902/jop.1992.63.9.743; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; Dashper SG, 1998, J DENT RES, V77, P1133; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Elliott PR, 1998, J MOL BIOL, V275, P419, DOI 10.1006/jmbi.1997.1458; Fokkema SJ, 1998, J CLIN PERIODONTOL, V25, P617, DOI 10.1111/j.1600-051X.1998.tb02497.x; Genco CA, 1998, INFECT IMMUN, V66, P4108; Grenier D, 1996, MICROBIOL-UK, V142, P955, DOI 10.1099/00221287-142-4-955; HUYNH C, 1992, J CLIN PERIODONTOL, V19, P187, DOI 10.1111/j.1600-051X.1992.tb00637.x; IMAMURA T, 1995, INFECT IMMUN, V63, P1999, DOI 10.1128/IAI.63.5.1999-2003.1995; Jagels MA, 1996, INFECT IMMUN, V64, P1984, DOI 10.1128/IAI.64.6.1984-1991.1996; KADOWAKI T, 1994, J BIOL CHEM, V269, P21371; Karunakaran T, 1997, J BACTERIOL, V179, P1898, DOI 10.1128/jb.179.6.1898-1908.1997; Kiyama M, 1998, BBA-GENE STRUCT EXPR, V1396, P39, DOI 10.1016/S0167-4781(97)00225-X; Kuramitsu HK, 1998, ORAL MICROBIOL IMMUN, V13, P263, DOI 10.1111/j.1399-302X.1998.tb00706.x; MADDEN TE, 1995, INFECT IMMUN, V63, P238, DOI 10.1128/IAI.63.1.238-247.1995; Madianos PN, 1997, INFECT IMMUN, V65, P3983, DOI 10.1128/IAI.65.10.3983-3990.1997; MAST AE, 1991, J BIOL CHEM, V266, P15810; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Mikolajczyk-Pawlinska J, 1998, FEBS LETT, V440, P282, DOI 10.1016/S0014-5793(98)01461-6; MIYASAKI KT, 1991, J PERIODONTOL, V62, P761, DOI 10.1902/jop.1991.62.12.761; MOORE WEC, 1982, INFECT IMMUN, V38, P1137, DOI 10.1128/IAI.38.3.1137-1148.1982; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619, DOI 10.1074/jbc.270.40.23619; Nelson D, 1998, ANAL BIOCHEM, V260, P230, DOI 10.1006/abio.1998.2708; OTOGOTO JI, 1993, INFECT IMMUN, V61, P117, DOI 10.1128/IAI.61.1.117-123.1993; PIKE R, 1994, J BIOL CHEM, V269, P406; Potempa J, 1998, J BIOL CHEM, V273, P21648, DOI 10.1074/jbc.273.34.21648; Potempa J, 1996, ACTA BIOCHIM POL, V43, P455; Potempa Jan, 1995, Perspectives in Drug Discovery and Design, V2, P445, DOI 10.1007/BF02172037; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHENKEIN HA, 1995, J IMMUNOL, V154, P5331; SLOTS J, 1986, J CLIN PERIODONTOL, V13, P570, DOI 10.1111/j.1600-051X.1986.tb00849.x; Smalley JW, 1998, BIOCHEM J, V331, P681, DOI 10.1042/bj3310681; SMITH QT, 1994, ARCH ORAL BIOL, V39, P301, DOI 10.1016/0003-9969(94)90121-X; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Sugita N, 1998, INFLAMMATION, V22, P253, DOI 10.1023/A:1022344031223; Travis J, 1997, J PERIODONTAL RES, V32, P120, DOI 10.1111/j.1600-0765.1997.tb01392.x; TRAVIS J, 1994, AM J RESP CRIT CARE, V150, pS143, DOI 10.1164/ajrccm/150.6_Pt_2.S143; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Uitto VJ, 1996, J CLIN PERIODONTOL, V23, P30, DOI 10.1111/j.1600-051X.1996.tb00501.x; WHITE D, 1981, J PERIODONTAL RES, V16, P259, DOI 10.1111/j.1600-0765.1981.tb00974.x; WINGROVE JA, 1992, J BIOL CHEM, V267, P18902	50	54	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12245	12251		10.1074/jbc.274.18.12245	http://dx.doi.org/10.1074/jbc.274.18.12245			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212191	hybrid			2022-12-27	WOS:000080056800011
J	Sibinga, NES; Wang, H; Perrella, MA; Endege, WO; Patterson, C; Yoshizumi, M; Haber, E; Lee, ME				Sibinga, NES; Wang, H; Perrella, MA; Endege, WO; Patterson, C; Yoshizumi, M; Haber, E; Lee, ME			Interferon-gamma-mediated inhibition of cyclin A gene transcription is independent of individual cis-acting elements in the cyclin A promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; SENSITIVE HEMATOPOIETIC-CELLS; DEPENDENT KINASE INHIBITOR; MAMMARY EPITHELIAL-CELLS; BARE LYMPHOCYTE SYNDROME; ALPHA-INTERFERON; GROWTH ARREST; TRANSFORMING GROWTH-FACTOR-BETA-1; RETINOBLASTOMA PROTEIN; DOWN-REGULATION	Interferons (IFNs) affect cellular functions by altering gene expression. The eukaryotic cell cycle is governed in part by the periodic transcription of cyclin genes, whose protein products associate with and positively regulate the cyclin-dependent kinases. To understand better the growth inhibitory effect of IFN-gamma on vascular smooth muscle cells (VSMCs), we compared the expression and activity of G(1) and S phase cyclins in control and IFN-gamma treated VSMCs, IFN-gamma treatment did not inhibit the G(1) cyclins but did decrease cyclin A protein, mRNA, and associated kinase activity by 85, 90, and 90%, respectively. Nuclear run-on and mRNA stability determinations indicated that this decrease was the result of transcriptional inhibition. To investigate the molecular basis of this inhibition, we examined protein-DNA interactions involving the cyclin A promoter, Electromobility shift assays showed little change with IFN-gamma treatment in the binding of nuclear proteins to isolated ATF, NF-Y, and CDE elements. In vivo genomic footprinting indicated that IFN-gamma treatment changed the occupancy of chromosomal NF-Y and CDE sites slightly and did not affect occupancy of the ATF site. In a previous study of transforming growth factor-beta 1-mediated inhibition of the cyclin A promoter, we mapped the inhibitory effect to the ATF site; in the present study of IFN-gamma treatment, functional analysis by transient transfection showed that inhibition of the cyclin A promoter persisted despite mutation of the ATF, NF-Y, or CDE elements. We hypothesize that IFN-gamma inhibits cyclin A transcription by modifying co-activators or general transcription factors within the complex that drives transcription of the cyclin A gene.	Harvard Univ, Sch Publ Hlth, Cardiovasc Biol Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Sibinga, NES (corresponding author), Harvard Univ, Sch Publ Hlth, Cardiovasc Biol Lab, 677 Huntington Ave, Boston, MA 02115 USA.		Sibinga, Nicholas/GOJ-8544-2022	Sibinga, Nicholas/0000-0003-4838-910X	NHLBI NIH HHS [HL03194, HL03274] Funding Source: Medline; NIGMS NIH HHS [GM53249] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053249] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BALKWILL FR, 1984, EXP CELL RES, V155, P190, DOI 10.1016/0014-4827(84)90780-8; BARLAT I, 1995, ONCOGENE, V11, P1309; BENNETT MR, 1994, BIOCHEM J, V302, P701, DOI 10.1042/bj3020701; BENNETT MR, 1994, CIRC RES, V74, P525, DOI 10.1161/01.RES.74.3.525; BURKE LC, 1992, ONCOGENE, V7, P783; BYBEE A, 1992, BIOCHIM BIOPHYS ACTA, V1137, P73, DOI 10.1016/0167-4889(92)90102-H; Cao Y, 1998, J BIOL CHEM, V273, P4012, DOI 10.1074/jbc.273.7.4012; Cassatella MA, 1996, IMMUNOL LETT, V49, P79, DOI 10.1016/0165-2478(95)02484-0; CHAN YL, 1983, NUCLEIC ACIDS RES, V11, P7819, DOI 10.1093/nar/11.22.7819; CHAN YL, 1984, J BIOL CHEM, V259, P224; CHIN KC, 1994, IMMUNITY, V1, P687, DOI 10.1016/1074-7613(94)90039-6; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; CHOUBEY D, 1995, J BIOL CHEM, V270, P6134, DOI 10.1074/jbc.270.11.6134; COCKS BG, 1992, J BIOL CHEM, V267, P12307; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dickensheets HL, 1997, J IMMUNOL, V159, P6226; FRIEDMAN RL, 1985, NATURE, V314, P637, DOI 10.1038/314637a0; GENG YJ, 1992, J CLIN INVEST, V89, P1322, DOI 10.1172/JCI115718; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Goodrich JA, 1996, CELL, V84, P825, DOI 10.1016/S0092-8674(00)81061-2; GUNTHER S, 1982, J CELL BIOL, V92, P289, DOI 10.1083/jcb.92.2.289; HANSSON GK, 1991, CIRCULATION, V84, P1266, DOI 10.1161/01.CIR.84.3.1266; HANSSON GK, 1988, CIRC RES, V63, P712, DOI 10.1161/01.RES.63.4.712; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; Harper JW, 1997, CANCER SURV, V29, P91; Harvat BL, 1996, CELL GROWTH DIFFER, V7, P289; Harvat BL, 1997, ONCOGENE, V14, P2111, DOI 10.1038/sj.onc.1201055; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; HERRERA RE, 1989, NATURE, V340, P68, DOI 10.1038/340068a0; Horton MR, 1998, J IMMUNOL, V160, P3023; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Huet X, 1996, MOL CELL BIOL, V16, P3789; HUPPI K, 1994, ONCOGENE, V9, P3017; KARA CJ, 1991, SCIENCE, V252, P709, DOI 10.1126/science.1902592; KNAPEK DF, 1995, CANCER RES, V55, P1607; Kramer A, 1996, J BIOL CHEM, V271, P6579; LEE ME, 1990, J BIOL CHEM, V265, P10446; Li XX, 1996, J BIOL CHEM, V271, P5790, DOI 10.1074/jbc.271.10.5790; MELAMED D, 1993, MOL CELL BIOL, V13, P5255, DOI 10.1128/MCB.13.9.5255; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Patterson C, 1997, J BIOL CHEM, V272, P8410, DOI 10.1074/jbc.272.13.8410; PERRELLA MA, 1994, J BIOL CHEM, V269, P14595; Perrella MA, 1996, J BIOL CHEM, V271, P13776, DOI 10.1074/jbc.271.23.13776; PFEIFER GP, 1991, GENE DEV, V5, P1102, DOI 10.1101/gad.5.6.1102; PINES J, 1994, SEMIN CANCER BIOL, V5, P305; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Polentarutti N, 1998, EUR J IMMUNOL, V28, P496, DOI 10.1002/(SICI)1521-4141(199802)28:02<496::AID-IMMU496>3.0.CO;2-V; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; RESNITZKY D, 1992, P NATL ACAD SCI USA, V89, P402, DOI 10.1073/pnas.89.1.402; SEN GC, 1997, TRANSCRIPTIONAL REGU, P1; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SILVERMAN RH, 1994, J INTERFERON RES, V14, P101, DOI 10.1089/jir.1994.14.101; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; TAMAI K, 1995, J BIOL CHEM, V270, P392, DOI 10.1074/jbc.270.1.392; Tiefenbrun N, 1996, MOL CELL BIOL, V16, P3934; Tsai JC, 1996, J CLIN INVEST, V97, P146, DOI 10.1172/JCI118383; Vadiveloo PK, 1996, ONCOGENE, V13, P599; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Walker SS, 1997, CELL, V90, P607, DOI 10.1016/S0092-8674(00)80522-X; WANG EH, 1994, SCIENCE, V263, P811, DOI 10.1126/science.8303298; WARNER SJC, 1989, J CLIN INVEST, V83, P1174, DOI 10.1172/JCI113998; WATANABE Y, 1978, J GEN VIROL, V41, P411, DOI 10.1099/0022-1317-41-2-411; Yoshizumi M, 1997, J BIOL CHEM, V272, P22259, DOI 10.1074/jbc.272.35.22259; YOSHIZUMI M, 1995, MOL CELL BIOL, V15, P3266; YOSHIZUMI M, 1995, J CLIN INVEST, V95, P2275, DOI 10.1172/JCI117918; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; ZHOU H, 1995, IMMUNITY, V2, P545, DOI 10.1016/1074-7613(95)90034-9; ZWICKER J, 1995, NUCLEIC ACIDS RES, V23, P3822, DOI 10.1093/nar/23.19.3822; ZWICKER J, 1995, EMBO J, V14, P4514, DOI 10.1002/j.1460-2075.1995.tb00130.x	77	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12139	12146		10.1074/jbc.274.17.12139	http://dx.doi.org/10.1074/jbc.274.17.12139			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207041	hybrid			2022-12-27	WOS:000079834800097
J	Basu, SS; York, JD; Raetz, CRH				Basu, SS; York, JD; Raetz, CRH			A phosphotransferase that generates phosphatidylinositol 4-phosphate (PtdIns-4-P) from phosphatidylinositol and lipid A in Rhizobium leguminosarum - A membrane-bound enzyme linking lipid A and PtdIns-4-P biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; ESCHERICHIA-COLI; 3-DEOXY-D-MANNO-OCTULOSONIC ACID; PERIBACTEROID MEMBRANE; SALMONELLA-TYPHIMURIUM; LIPOPOLYSACCHARIDE BIOSYNTHESIS; SIGNAL-TRANSDUCTION; A BIOSYNTHESIS; PURIFICATION; ENDOTOXIN	Membranes of Rhizobium leguminosarum contain a 3-deoxy-D-manno-octulosonic acid (Kdo)-activated lipid A 4'-phosphatase required for generating the unusual phosphate-deficient lipid A found in this organism. The enzyme has been solubilized with Triton X-100 and purified 80-fold. As shown by co-purification and thermal inactivation studies, the 4'-phosphatase catalyzes not only the hydrolysis of (Kdo)(2)-[4'-P-32]lipid IVA but also the transfer the 4'-phosphate of Kdo(2)-[4'-P-32]lipid IVA to the inositol headgroup of phosphatidylinositol (PtdIns) to generate PtdIns-4-P. Like the 4'-phosphatase, the phosphotransferase activity is not present in Escherichia coli, Rhizobium meliloti, or the nodulation-defective mutant 24AR of R. leguminosarum. The specific activity for the phosphotransferase reaction is about 2 times higher than that of the 4'-phosphatase, The phosphotransferase assay conditions are similar to those used for PtdIns kinases, except that ATP and Mg2+ are omitted. The apparent K-m for PtdIns is similar to 500 mu M versus 20-100 mu M for most PtdIns kinases, but the phosphotransferase specific activity in crude cell extracts is higher than that of most PtdIns kinases, The phosphotransferase is absolutely specific for the 4-position of PtdIns and is highly selective for PtdIns as the acceptor. The 4'-phosphatase/phosphotransferase can be eluted from heparin- or Cibacron blue-agarose with PtdIns. A phosphoenzyme intermediate may account for the dual function of this enzyme, since a single P-32-labeled protein species (M-r similar to 68,000) can be trapped and visualized by SDS gel electrophoresis of enzyme preparations incubated with Kdo(2)-[4'-P-32]lipid IVA. Although PtdIns is not detected in cultures ofR, leguminosarum/etli (CE3), PtdIns may be synthesized during nodulation or supplied by plant membranes, given that soybean PtdIns is an excellent phosphate acceptor. A bacterial enzyme for generating PtdIns-4-P and a direct link between lipid A and PtdIns-4-P biosynthesis have not been reported previously.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University; Duke University	Raetz, CRH (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	raetz@biochem.duke.edu			NHLBI NIH HHS [HL-55672] Funding Source: Medline; NIGMS NIH HHS [R37 GM051796, GM-51796, R01 GM051796-01A1, R01 GM051796] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051796, R37GM051796] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAL AK, 1980, CAN J MICROBIOL, V26, P1096, DOI 10.1139/m80-182; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; BHAT UR, 1991, J BACTERIOL, V173, P2155, DOI 10.1128/JB.173.7.2155-2159.1991; BHAT UR, 1994, J BIOL CHEM, V269, P14402; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADLEY DJ, 1986, J CELL SCI, V85, P47; Brewin N. J., 1995, Nitrogen fixation: fundamentals and applications. Proceedings of the 10th International Congress on Nitrogen Fixation, St. Petersburg, Russia, May 28-June 3, 1995., P455; Brozek KA, 1996, J BIOL CHEM, V271, P32112, DOI 10.1074/jbc.271.50.32119; Brozek KA, 1996, J BIOL CHEM, V271, P32126, DOI 10.1074/jbc.271.50.32119; BROZEK KA, 1989, J BIOL CHEM, V264, P6956; BROZEK KA, 1990, J BIOL CHEM, V265, P15410; Carlson R. W., 1992, Plant biotechnology and development., P33; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; DEMAAGD RA, 1989, J BACTERIOL, V171, P1143, DOI 10.1128/jb.171.2.1143-1150.1989; DROBAK BK, 1992, BIOCHEM J, V288, P697, DOI 10.1042/bj2880697; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; FLANAGAN CA, 1992, J BIOL CHEM, V267, P24117; Forsberg LS, 1998, J BIOL CHEM, V273, P2747, DOI 10.1074/jbc.273.5.2747; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; GERSON T, 1975, APPL MICROBIOL, V30, P193, DOI 10.1128/AEM.30.2.193-198.1975; GOLDMAN RC, 1985, J BACTERIOL, V163, P256, DOI 10.1128/JB.163.1.256-261.1985; HONG ZG, 1994, P NATL ACAD SCI USA, V91, P9617, DOI 10.1073/pnas.91.20.9617; HULTQUIST DE, 1966, BIOCHEMISTRY-US, V5, P322, DOI 10.1021/bi00865a041; JENKINS GH, 1991, BIOCHIM BIOPHYS ACTA, V1080, P11, DOI 10.1016/0167-4838(91)90105-9; JONES NC, 1977, J BIOL CHEM, V252, P7405; JONES NC, 1977, J BIOL CHEM, V252, P7398; Kadrmas JL, 1998, J BIOL CHEM, V273, P26432, DOI 10.1074/jbc.273.41.26432; Kadrmas JL, 1996, J BIOL CHEM, V271, P32119, DOI 10.1074/jbc.271.50.32112; KANNENBERG EL, 1992, MOL MICROBIOL, V6, P2477, DOI 10.1111/j.1365-2958.1992.tb01424.x; KANNENBERG EL, 1994, J BACTERIOL, V176, P2021, DOI 10.1128/jb.176.7.2021-2032.1994; Kannenberg Elmar L., 1994, Trends in Microbiology, V2, P277, DOI 10.1016/0966-842X(94)90004-3; Kearns MA, 1998, EMBO J, V17, P4004, DOI 10.1093/emboj/17.14.4004; LARSON TJ, 1976, BIOCHEMISTRY-US, V15, P5212, DOI 10.1021/bi00669a003; LIN S, 1998, FASEB J, V12; LISCOVITCH M, 1995, CELL, V81, P659, DOI 10.1016/0092-8674(95)90525-1; MILLER JH, 1972, EXP MOL GENETICS; Nikaido H., 1996, ESCHERICHIA COLI SAL, P29; NOEL KD, 1986, J BACTERIOL, V168, P1392, DOI 10.1128/jb.168.3.1392-1401.1986; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; ORGAMBIDE GG, 1993, LIPIDS, V28, P975, DOI 10.1007/BF02537117; PEROTTO S, 1994, MOL PLANT MICROBE IN, V7, P99, DOI 10.1094/MPMI-7-0099; PEROTTO S, 1995, MOL PLANT MICROBE IN, V8, P560, DOI 10.1094/MPMI-8-0560; PIKE LJ, 1992, ENDOCR REV, V13, P692, DOI 10.1210/er.13.4.692; PORTER FD, 1988, J BIOL CHEM, V263, P8989; PRICE NPJ, 1995, P NATL ACAD SCI USA, V92, P7352, DOI 10.1073/pnas.92.16.7352; PRICE NPJ, 1994, J BACTERIOL, V176, P4646, DOI 10.1128/JB.176.15.4646-4655.1994; PRIEFER UB, 1989, J BACTERIOL, V171, P6161, DOI 10.1128/jb.171.11.6161-6168.1989; Que NLS, 1998, FASEB J, V12, pA1284; RADIKA K, 1988, J BIOL CHEM, V263, P14859; RAETZ CRH, 1993, J BACTERIOL, V175, P5745, DOI 10.1128/JB.175.18.5745-5753.1993; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; RAETZ CRH, 1996, ESCHERICHIA COLI SAL, P1035; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; ROANTREE RJ, 1967, ANNU REV MICROBIOL, V21, P443, DOI 10.1146/annurev.mi.21.100167.002303; RUSSA R, 1985, ARCH MICROBIOL, V141, P284, DOI 10.1007/BF00428838; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; SINDHU SS, 1990, J BACTERIOL, V172, P1804, DOI 10.1128/jb.172.4.1804-1813.1990; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stolz LE, 1998, J BIOL CHEM, V273, P11852, DOI 10.1074/jbc.273.19.11852; Stukey J, 1997, PROTEIN SCI, V6, P469; Tang Y, 1998, APPL ENVIRON MICROB, V64, P1963; TAO H, 1992, J BACTERIOL, V174, P2222, DOI 10.1128/JB.174.7.2222-2229.1992; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; VAARA M, 1993, ANTIMICROB AGENTS CH, V37, P2255, DOI 10.1128/AAC.37.11.2255; White KA, 1997, J BIOL CHEM, V272, P16555, DOI 10.1074/jbc.272.26.16555; Whitehead LF, 1997, PHYSIOL PLANTARUM, V100, P30, DOI 10.1034/j.1399-3054.1997.1000103.x; Wyckoff TJO, 1998, TRENDS MICROBIOL, V6, P154, DOI 10.1016/S0966-842X(98)01230-X; XIA WM, 1995, J BACTERIOL, V177, P2926, DOI 10.1128/jb.177.10.2926-2928.1995; Zhang XL, 1998, SEMIN CELL DEV BIOL, V9, P153, DOI 10.1006/scdb.1997.0220	71	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11139	11149		10.1074/jbc.274.16.11139	http://dx.doi.org/10.1074/jbc.274.16.11139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196199	hybrid, Green Accepted			2022-12-27	WOS:000079751900067
J	Carpentier, M; Allain, F; Haendler, B; Denys, A; Mariller, C; Benaissa, M; Spik, G				Carpentier, M; Allain, F; Haendler, B; Denys, A; Mariller, C; Benaissa, M; Spik, G			Two distinct regions of cyclophilin B are involved in the recognition of a functional receptor and of glycosaminoglycans on T lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL-PROLYL ISOMERASE; CIS-TRANS ISOMERASE; CYCLOSPORINE-A; BINDING-SITES; HUMAN BLOOD; CRYSTAL-STRUCTURE; CELL-ADHESION; IV COLLAGEN; PROTEIN; SEQUENCE	Cyclophilin B is a cyclosporin A-binding protein exhibiting peptidyl-prolyl cis/trans isomerase activity. We have previously shown that it interacts with two types of binding sites on T lymphocytes. The type I sites correspond to specific functional receptors and the type II sites to sulfated glycosaminoglycans. The interactions of cyclophilin B with type I and type II sites are reduced in the presence of cyclosporin A and of a synthetic peptide mimicking the N-terminal part of cyclophilin B, respectively, suggesting that the protein possesses two distinct binding regions. In this study, we intended to characterize the areas of cyclophilin B involved in the interactions with binding sites present on Jurkat cells. The use of cyclophilin B mutants modified in the N-terminal region demonstrated that the (3)Lys-Lys-Lys(5) and (14)Tyr-Phe-Asp(16) clusters are probably solely required for the interactions with the type II sites. We further engineered mutants of the conserved central core of cyclophilin B, which bears the catalytic and the cyclosporin A binding sites as an approach to localize the binding regions for the type I sites. The enzymatic activity of cyclophilin B was dramatically reduced after substitution of the Arg(62) and Phe(67) residues, whereas the cyclosporin A binding activity was destroyed by mutation of the Trp(128) residue and strongly decreased after modification of the Phe(67) residue. Only the substitution of the Trp(128) residue reduced the binding of the resulting cyclophilin B mutant to type I binding sites. The catalytic site of cyclophilin B therefore did not seem to be essential for cellular binding and the cyclosporin A binding site appeared to be partially involved in the binding to type I sites.	Univ Sci & Tech Lille Flandres Artois, Chim Biol Lab, CNRS, UMR 111, F-59655 Villeneuve Dascq, France; Schering AG, Res Labs, D-13342 Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Schering AG	Spik, G (corresponding author), Univ Sci & Tech Lille Flandres Artois, Chim Biol Lab, CNRS, UMR 111, F-59655 Villeneuve Dascq, France.			Allain, Fabrice/0000-0002-4484-6302				ALLAIN F, 1995, J IMMUNOL METHODS, V178, P113, DOI 10.1016/0022-1759(94)00249-V; Allain F, 1996, BIOCHEM J, V317, P565, DOI 10.1042/bj3170565; ALLAIN F, 1994, J BIOL CHEM, V269, P16537; ARBER S, 1992, J CELL BIOL, V116, P113, DOI 10.1083/jcb.116.1.113; BERGSMA DJ, 1991, J BIOL CHEM, V266, P23204; Denys A, 1997, IMMUNOLOGY, V91, P609, DOI 10.1046/j.1365-2567.1997.00296.x; Denys A, 1998, TRANSPLANTATION, V65, P1076, DOI 10.1097/00007890-199804270-00012; Denys A, 1998, BIOCHEM J, V336, P689, DOI 10.1042/bj3360689; Endrich MM, 1998, EUR J BIOCHEM, V252, P441, DOI 10.1046/j.1432-1327.1998.2520441.x; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; FRIEDMAN J, 1993, P NATL ACAD SCI USA, V90, P6815, DOI 10.1073/pnas.90.14.6815; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; GALAT A, 1993, EUR J BIOCHEM, V216, P689, DOI 10.1111/j.1432-1033.1993.tb18189.x; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GILAT D, 1994, J IMMUNOL, V153, P4899; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; HARDING MW, 1986, J BIOL CHEM, V261, P8547; KE HM, 1991, P NATL ACAD SCI USA, V88, P9483, DOI 10.1073/pnas.88.21.9483; KE HM, 1993, P NATL ACAD SCI USA, V90, P11850, DOI 10.1073/pnas.90.24.11850; KIEFFER LJ, 1992, J BIOL CHEM, V267, P5503; KOLIAKOS GG, 1989, J BIOL CHEM, V264, P2313; LIU J, 1990, P NATL ACAD SCI USA, V87, P2304, DOI 10.1073/pnas.87.6.2304; Mariller C, 1996, BIOCHEM J, V317, P571, DOI 10.1042/bj3170571; Mariller C, 1996, BBA-PROTEIN STRUCT M, V1293, P31, DOI 10.1016/0167-4838(95)00230-8; MIKOL V, 1994, P NATL ACAD SCI USA, V91, P5183, DOI 10.1073/pnas.91.11.5183; MITCHELL WM, 1968, J BIOL CHEM, V243, P4683; PRICE ER, 1994, P NATL ACAD SCI USA, V91, P3931, DOI 10.1073/pnas.91.9.3931; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; RAHMAN M, 1994, J MOL GRAPHICS, V12, P212, DOI 10.1016/0263-7855(94)80090-1; ROT A, 1993, EUR J IMMUNOL, V23, P303, DOI 10.1002/eji.1830230150; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; SCHNEIDER H, 1994, BIOCHEMISTRY-US, V33, P8218, DOI 10.1021/bi00193a007; Sherry B, 1998, P NATL ACAD SCI USA, V95, P1758, DOI 10.1073/pnas.95.4.1758; SPIK G, 1991, J BIOL CHEM, V266, P10735; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; TANAKA Y, 1993, IMMUNOL TODAY, V14, P111, DOI 10.1016/0167-5699(93)90209-4; Tegeder I, 1997, J CLIN IMMUNOL, V17, P380, DOI 10.1023/A:1027364207544; WILKE MS, 1990, J INVEST DERMATOL, V95, P264, DOI 10.1111/1523-1747.ep12484883; XU Q, 1992, J BIOL CHEM, V267, P11968; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	45	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10990	10998		10.1074/jbc.274.16.10990	http://dx.doi.org/10.1074/jbc.274.16.10990			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196180	hybrid			2022-12-27	WOS:000079751900048
J	Heath, RJ; Rubin, JR; Holland, DR; Zhang, EL; Snow, ME; Rock, CO				Heath, RJ; Rubin, JR; Holland, DR; Zhang, EL; Snow, ME; Rock, CO			Mechanism of triclosan inhibition of bacterial fatty acid synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; ESCHERICHIA-COLI; REDUCTASE FABI; MYCOBACTERIUM-TUBERCULOSIS; SALMONELLA-TYPHIMURIUM; BIOSYNTHESIS; TARGET; GENE; NADH; ENVM	Triclosan is a broad-spectrum antibacterial agent that inhibits bacterial fatty acid synthesis at the enoyl-acyl carrier protein reductase (FabI) step. Resistance to triclosan in Escherichia coli is acquired through a missense mutation in the fabI gene that leads to the expression of FabI[G93V], The specific activity and substrate affinities of FabI[G93V] are similar to FabI. Two different binding assays establish that triclosan dramatically increases the affinity of FabI for NAD(+). In contrast, triclosan does not increase the binding of NAD(+) to FabI[G93V]. The x-ray crystal structure of the FabI-NAD(+)-triclosan complex confirms that hydrogen bonds and hydrophobic interactions between triclosan and both the protein and the NAD(+) cofactor contribute to the formation of a stable ternary complex, with the drug binding at the enoyl substrate site. These data show that the formation of a noncovalent "bi-substrate" complex accounts for the effectiveness of triclosan as a FabI inhibitor and illustrates that mutations in the FabI active site that interfere with the formation of a stable FabI-NAD(+)-triclosan ternary complex acquire resistance to the drug.	St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; Parke Davis Pharmaceut Res, Dept Biomol Struct & Drug Design, Ann Arbor, MI 48105 USA; Univ Tennessee, Dept Biochem, Memphis, TN 38163 USA	St Jude Children's Research Hospital; Pfizer; University of Tennessee System; University of Tennessee Health Science Center	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, 332 N Lauderdale St, Memphis, TN 38105 USA.		ID, IMCACAT/D-5867-2014	Heath, Richard/0000-0002-1795-1254	NCI NIH HHS [CA 21765] Funding Source: Medline; NIGMS NIH HHS [GM 34496] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034496, R01GM034496] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldock C, 1996, SCIENCE, V274, P2107, DOI 10.1126/science.274.5295.2107; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; BARTZOKAS CA, 1984, NEW ENGL J MED, V311, P1422, DOI 10.1056/NEJM198411293112207; Bergler H, 1996, EUR J BIOCHEM, V242, P689, DOI 10.1111/j.1432-1033.1996.0689r.x; BERGLER H, 1992, J GEN MICROBIOL, V138, P2093, DOI 10.1099/00221287-138-10-2093; BERGLER H, 1994, J BIOL CHEM, V269, P5493; Bhargava HN, 1996, AM J INFECT CONTROL, V24, P209, DOI 10.1016/S0196-6553(96)90017-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cronan JE, 1996, ESCHERICHIA COLI SAL, V1, P612; EGAN AF, 1973, GENET RES, V21, P3603; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Heath RJ, 1996, J BIOL CHEM, V271, P10996, DOI 10.1074/jbc.271.18.10996; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316; JACKOWSKI S, 1991, EMERGING TARGETS ANT, P151; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; REGOS J, 1979, DERMATOLOGICA, V158, P72, DOI 10.1159/000250746; REGOS J, 1974, ZBL BAKT-INT J MED M, V226, P390; Rock C. O., 1996, NEW COMPREHENSIVE BI, V31, P35; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; TURNOWSKY F, 1989, J BACTERIOL, V171, P6555, DOI 10.1128/jb.171.12.6555-6565.1989; VISCHER WA, 1974, ZBL BAKT-INT J MED M, V226, P376; WEBSTER J, 1992, J HOSP INFECT, V21, P137, DOI 10.1016/0195-6701(92)90033-I; WEEKS G, 1968, J BIOL CHEM, V243, P1180; Zhang Y, 1998, J BACTERIOL, V180, P3295, DOI 10.1128/JB.180.13.3295-3303.1998	27	392	409	7	121	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11110	11114		10.1074/jbc.274.16.11110	http://dx.doi.org/10.1074/jbc.274.16.11110			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196195	hybrid			2022-12-27	WOS:000079751900063
J	Koizumi, J; Okamoto, Y; Onogi, H; Mayeda, A; Krainer, AR; Hagiwara, M				Koizumi, J; Okamoto, Y; Onogi, H; Mayeda, A; Krainer, AR; Hagiwara, M			The subcellular localization of SF2/ASF is regulated by direct interaction with SR protein kinases (SRPKs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICE-SITE SELECTION; ALTERNATIVE 5'; SERINE-RICH; CELL-CYCLE; RNA; PHOSPHORYLATION; DOMAINS; PURIFICATION; FACTOR-SF2; INVITRO	Serine/arginine-rich (SR) proteins play an important role in constitutive and alternative pre-mRNA splicing. The C-terminal arginine serine domain of these proteins, such as SF2/ASF, mediates protein-protein interactions and is phosphorylated in vivo. Using glutathione S-transferase (GST)-SF2/ASF-affinity chromatography, the SF2/ASF kinase activity was co-purified from HeLa cells with a 95-kDa protein, which was recognized by an anti SR protein kinase (SRPK) 1 monoclonal antibody. Recombinant SRPK1 and SRPK2 bound to and phosphorylated GST-SF2/ASF in vitro. Phosphopeptide mapping showed that identical sites were phosphorylated in the pull-down kinase reaction with HeLa extracts and by recombinant SRPKs, Epitope-tagged SF2/ASF transiently expressed in COS7 cells co-immunoprecipitated with SRPKs, Deletion analysis mapped the phosphorylation sites to a region containing an (Arg-Ser)(8) repeat beginning at residue 204, and far-Western analysis showed that the region is required for binding of SRPKs to SF2/ASF, Further binding studies showed that SRPKs bound unphosphorylated SF2/ASF but did not bind phosphorylated SF2/ASF, Expression of an SRPK2 kinase-inactive mutant caused accumulation of SF2/ASF in the cytoplasm. These results suggest that the formation of complexes between SF2/ASF and SRPKs, which is influenced by the phosphorylation state of SF2/ASF, may have regulatory roles in the assembly and localization of this splicing factor.	Tokyo Med & Dent Univ, Med Res Inst, Dept Funct Genom, Bunkyo Ku, Tokyo 113, Japan; Nagoya Univ, Sch Med, Dept Surg, Showa Ku, Nagoya, Aichi 466, Japan; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Tokyo Medical & Dental University (TMDU); Nagoya University; Cold Spring Harbor Laboratory	Hagiwara, M (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Funct Genom, Bunkyo Ku, 1-5-45 Yushima, Tokyo 113, Japan.		Mayeda, Akila/ABC-1134-2020	Mayeda, Akila/0000-0002-9562-550X; Krainer, Adrian/0000-0001-9024-9501	NCI NIH HHS [CA13106] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; CACERESJF, 1998, GENES DEV, V12, P55; Cao WH, 1997, RNA, V3, P1456; CARDINALI B, 1994, FEBS LETT, V352, P276, DOI 10.1016/0014-5793(94)00973-2; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; FU XD, 1992, P NATL ACAD SCI USA, V89, P11224, DOI 10.1073/pnas.89.23.11224; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Kuroyanagi N, 1998, BIOCHEM BIOPH RES CO, V242, P357, DOI 10.1006/bbrc.1997.7913; MERMOUD JE, 1994, EMBO J, V13, P5679, DOI 10.1002/j.1460-2075.1994.tb06906.x; Misteli T, 1997, TRENDS CELL BIOL, V7, P135, DOI 10.1016/S0962-8924(96)20043-1; Nikolakaki E, 1997, J BIOL CHEM, V272, P6208, DOI 10.1074/jbc.272.10.6208; Okamoto Y, 1998, BIOCHEM BIOPH RES CO, V249, P872, DOI 10.1006/bbrc.1998.9247; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; TAKEUCHI M, 1993, MOL BIOL CELL, V4, P247, DOI 10.1091/mbc.4.3.247; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Will CL, 1997, CURR OPIN CELL BIOL, V9, P320, DOI 10.1016/S0955-0674(97)80003-8; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; WOPPMANN A, 1993, NUCLEIC ACIDS RES, V21, P2815, DOI 10.1093/nar/21.12.2815; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	32	108	108	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11125	11131		10.1074/jbc.274.16.11125	http://dx.doi.org/10.1074/jbc.274.16.11125			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196197	hybrid			2022-12-27	WOS:000079751900065
J	Masuda, S; Yoshida, M; Nagashima, KVP; Shimada, K; Matsuura, K				Masuda, S; Yoshida, M; Nagashima, KVP; Shimada, K; Matsuura, K			A new cytochrome subunit bound to the photosynthetic reaction center in the purple bacterium, Rhodovulum sulfidophilum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSULATUS-PUF OPERON; LIGHT-HARVESTING PROTEINS; MESSENGER-RNA STABILITY; AMINO-ACID SEQUENCE; RHODOPSEUDOMONAS-VIRIDIS; RHODOBACTER-CAPSULATUS; RUBRIVIVAX-GELATINOSUS; ELECTRON-TRANSFER; B870 ANTENNA; GENES	The nucleotide sequence of the puf operon, which contains the genes encoding the B870 light-harvesting protein and the reaction center complex of the purple photosynthetic bacterium, Rhodovulum sulfidophilum, was determined. The operon, which consisted of six genes, pufQ, pufB, pufA, pufL, pufM, and pufC, is a new variety in photosynthetic bacteria in the sense that pufQ and pufC coexist. The amino acid sequence of the cytochrome subunit of the reaction center deduced from the pufC sequence revealed that this cytochrome contains only three possible heme binding motifs; the heme-1-binding motif of the corresponding tetraheme cytochrome subunits was not present. This is the first exception of the '"tetraheme" cytochrome family in purple bacteria and green filamentous bacteria. The pufC sequence also revealed that the sixth axial ligands to heme-1 and heme-2 irons were not present in the cytochrome either. This cytochrome was actually detected in membrane preparation as a 43-kDa protein and shown to associate functionally with the photosynthetic reaction center as the immediate electron donor to the photo-oxidized special pair of bacteriochlorophyll, This new cytochrome should be useful for studies on the role of each heme in the cytochrome subunit of the bacterial reaction center and the evolution of proteins in photosynthetic electron transfer systems.	Tokyo Metropolitan Univ, Dept Biol, Tokyo 1920397, Japan	Tokyo Metropolitan University	Masuda, S (corresponding author), Tokyo Metropolitan Univ, Dept Biol, Tokyo 1920397, Japan.		Masuda, Shinji/A-2703-2014; Nagashima, Kenji V. P./M-2208-2017	Masuda, Shinji/0000-0002-5349-4927; Nagashima, Kenji V. P./0000-0002-4526-6625				ALEGRIA G, 1991, BIOCHIM BIOPHYS ACTA, V1057, P239, DOI 10.1016/S0005-2728(05)80107-0; BAUER CE, 1988, J BIOL CHEM, V263, P4820; BAUER CE, 1988, P NATL ACAD SCI USA, V85, P7074, DOI 10.1073/pnas.85.19.7074; BAUER CE, 1995, ANOXYGENIC PHOTOSYNT, P1221; Cogdell R. J., 1995, ANOXYGENIC PHOTOSYNT, P315; DAVIS J, 1988, J BACTERIOL, V170, P320, DOI 10.1128/jb.170.1.320-329.1988; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DRACHEVA S, 1991, BIOCHEMISTRY-US, V30, P11451, DOI 10.1021/bi00112a012; DRACHEVA SM, 1988, EUR J BIOCHEM, V171, P253, DOI 10.1111/j.1432-1033.1988.tb13784.x; Dutton P.L, 1978, PHOTOSYNTHETIC BACTE, P525; GONG L, 1994, J BACTERIOL, V173, P2946; Heck C, 1996, MOL MICROBIOL, V20, P1165, DOI 10.1111/j.1365-2958.1996.tb02637.x; HIRAISHI A, 1994, INT J SYST BACTERIOL, V44, P15, DOI 10.1099/00207713-44-1-15; KLUG G, 1987, EMBO J, V6, P3515, DOI 10.1002/j.1460-2075.1987.tb02677.x; KNAFF DB, 1991, BIOCHEMISTRY-US, V30, P1303, DOI 10.1021/bi00219a021; Kortluke C, 1997, J BACTERIOL, V179, P5247, DOI 10.1128/jb.179.17.5247-5258.1997; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIEBETANZ R, 1991, MOL MICROBIOL, V5, P1459, DOI 10.1111/j.1365-2958.1991.tb00792.x; LILBURN TG, 1992, BIOCHIM BIOPHYS ACTA, V1100, P160; Maniatis T., 1989, MOL CLONING LAB MANU; MASUDA S, 1998, P 11 INT C PHOT; MATSUURA K, 1988, FEBS LETT, V237, P21, DOI 10.1016/0014-5793(88)80163-7; MATSUURA K, 1994, J PLANT RES, V107, P191, DOI 10.1007/BF02346017; Matsuura K., 1990, CURRENT RES PHOTOSYN, V1, P193; MICHEL H, 1986, EMBO J, V5, P1149, DOI 10.1002/j.1460-2075.1986.tb04340.x; Nagashima KVP, 1997, J MOL EVOL, V45, P131, DOI 10.1007/PL00006212; Nagashima KVP, 1996, FEBS LETT, V385, P209, DOI 10.1016/0014-5793(96)00382-1; NAGASHIMA KVP, 1994, J BIOL CHEM, V269, P2477; Nagashima KVP, 1996, PHOTOSYNTH RES, V50, P61, DOI 10.1007/BF00018221; Nagashima KVP, 1997, PLANT CELL PHYSIOL, V38, P1249, DOI 10.1093/oxfordjournals.pcp.a029112; Nagashima KVP, 1998, PHOTOSYNTH RES, V55, P349, DOI 10.1023/A:1005912810674; Nitschke W., 1995, ANOXYGENIC PHOTOSYNT, P775; Osyczka A, 1998, BIOCHEMISTRY-US, V37, P11732, DOI 10.1021/bi980910h; SHIOI Y, 1986, PLANT CELL PHYSIOL, V27, P567; TAYLOR DP, 1983, J BACTERIOL, V154, P580, DOI 10.1128/JB.154.2.580-590.1983; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; VERMEGLIO A, 1989, FEBS LETT, V243, P259, DOI 10.1016/0014-5793(89)80140-1; WEYER KA, 1987, EMBO J, V6, P2197, DOI 10.1002/j.1460-2075.1987.tb02490.x; WIESSNER C, 1990, J BACTERIOL, V172, P2877, DOI 10.1128/jb.172.6.2877-2887.1990; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; YOUVAN DC, 1984, CELL, V37, P949, DOI 10.1016/0092-8674(84)90429-X; ZHU YS, 1986, J BIOL CHEM, V261, P366	42	36	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10795	10801		10.1074/jbc.274.16.10795	http://dx.doi.org/10.1074/jbc.274.16.10795			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196154	hybrid			2022-12-27	WOS:000079751900022
J	Sargent, TG; DuBois, CC; Buller, AM; Lloyd, JA				Sargent, TG; DuBois, CC; Buller, AM; Lloyd, JA			The roles of 5 '-HS2, 5 '-HS3, and the gamma-globin TATA, CACCC, and stage selector elements in suppression of beta-globin expression in early development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; DOMINANT CONTROL REGION; TRANSCRIPTION FACTOR NF-E2; HIGH-LEVEL EXPRESSION; KRUPPEL-LIKE FACTOR; TRANSGENIC MICE; CHROMATIN STRUCTURE; REGULATED TRANSCRIPTION; HYPERSENSITIVE SITE-2; GENE-TRANSCRIPTION	The roles of HS2 and HS3 from the human beta-globin locus control region and of the TATA, CACCC, and stage selector elements of the gamma-globin promoter, in competitive inhibition of beta-globin gene expression in early development, were tested using stable transfections of HEL and K562 cells. Cells with an HS3 gamma beta construct demonstrate that HS3 exhibits enhancing activity, but compared with HS2, this site participates less consistently in the inhibition of embryonic/fetal beta-globin expression. In cells with HS3HS2 gamma beta constructs, the two HS sites act in concert to more effectively enhance gamma-globin gene expression and to drive stage-specific expression of the gamma- and beta-globin genes. A gamma-globin gene with a -161 promoter can competitively inhibit beta-globin gene expression. HS3HS2 gamma beta constructs were used to determine the effects of gamma-globin promoter mutations within this region on competition. The CACCC and TATA elements, but not the stage selector element, inhibit inappropriate embryonic/fetal stage expression of the beta-globin gene. The mutation in the gamma-globin TATA element results in the use of two major alternative transcription start sites, The data suggest that proteins binding to the gamma-globin CACCC and TATA elements interact with those binding to HS2 and/or HS3 to preclude beta-globin transcription in early development.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Human Genet, Richmond, VA 23298 USA	Virginia Commonwealth University	Lloyd, JA (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Human Genet, POB 980033, Richmond, VA 23298 USA.				NHLBI NIH HHS [R01 HL060080] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060080] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON KP, 1993, MOL BIOL CELL, V4, P1077, DOI 10.1091/mbc.4.10.1077; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; ANTONIOU M, 1995, NUCLEIC ACIDS RES, V23, P3473, DOI 10.1093/nar/23.17.3473; ANTONIOU M, 1990, GENE DEV, V4, P1007, DOI 10.1101/gad.4.6.1007; BEHRINGER RR, 1990, GENE DEV, V4, P380, DOI 10.1101/gad.4.3.380; BRESNICK EH, 1993, J BIOL CHEM, V268, P18824; Bresnick EH, 1997, P NATL ACAD SCI USA, V94, P4566, DOI 10.1073/pnas.94.9.4566; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P1006, DOI 10.1093/nar/22.6.1006; COLLIS P, 1990, EMBO J, V9, P233, DOI 10.1002/j.1460-2075.1990.tb08100.x; DONZE D, 1995, J BIOL CHEM, V270, P1955, DOI 10.1074/jbc.270.4.1955; ELLIS J, 1993, EMBO J, V12, P127, DOI 10.1002/j.1460-2075.1993.tb05638.x; Elnitski L, 1997, J BIOL CHEM, V272, P369; ENGEL JD, 1993, TRENDS GENET, V9, P304, DOI 10.1016/0168-9525(93)90248-G; ENVER T, 1989, P NATL ACAD SCI USA, V86, P7033, DOI 10.1073/pnas.86.18.7033; Epner E, 1998, MOL CELL, V2, P447, DOI 10.1016/S1097-2765(00)80144-6; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; FONG TC, 1992, GENE DEV, V6, P521, DOI 10.1101/gad.6.4.521; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; Gallagher PG, 1999, J BIOL CHEM, V274, P6062, DOI 10.1074/jbc.274.10.6062; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; Hardison R, 1997, GENE, V205, P73, DOI 10.1016/S0378-1119(97)00474-5; Hug BA, 1996, MOL CELL BIOL, V16, P2906; Jackson JD, 1996, J BIOL CHEM, V271, P11871, DOI 10.1074/jbc.271.20.11871; JANE SM, 1995, EMBO J, V14, P97, DOI 10.1002/j.1460-2075.1995.tb06979.x; JANE SM, 1992, EMBO J, V11, P2961, DOI 10.1002/j.1460-2075.1992.tb05366.x; Lam LT, 1998, J BIOL CHEM, V273, P24223, DOI 10.1074/jbc.273.37.24223; Lam LT, 1996, J BIOL CHEM, V271, P32421, DOI 10.1074/jbc.271.50.32421; Ley TJ, 1998, ANN NY ACAD SCI, V850, P45, DOI 10.1111/j.1749-6632.1998.tb10461.x; LLOYD JA, 1992, MOL CELL BIOL, V12, P1561, DOI 10.1128/MCB.12.4.1561; MARTIN DI, 1996, CURR OPIN GENE DEV, V4, P488; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; MICHELSON AM, 1983, J BIOL CHEM, V258, P5245; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; MORLEY BJ, 1992, MOL CELL BIOL, V12, P2057, DOI 10.1128/MCB.12.5.2057; Navas PA, 1998, MOL CELL BIOL, V18, P4188, DOI 10.1128/MCB.18.7.4188; NEY PA, 1990, GENE DEV, V4, P993, DOI 10.1101/gad.4.6.993; Perkins AC, 1996, P NATL ACAD SCI USA, V93, P12267, DOI 10.1073/pnas.93.22.12267; Peterson KR, 1996, P NATL ACAD SCI USA, V93, P6605, DOI 10.1073/pnas.93.13.6605; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Ronchi A, 1996, EMBO J, V15, P143, DOI 10.1002/j.1460-2075.1996.tb00342.x; Sabatino DE, 1998, MOL CELL BIOL, V18, P6634, DOI 10.1128/MCB.18.11.6634; Sargent TG, 1999, DNA CELL BIOL, V18, P293, DOI 10.1089/104454999315358; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; TOWNES TM, 1990, TRENDS GENET, V6, P219, DOI 10.1016/0168-9525(90)90182-6; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; TUAN DYH, 1989, P NATL ACAD SCI USA, V86, P2554, DOI 10.1073/pnas.86.8.2554; WAGNER MJ, 1981, P NATL ACAD SCI-BIOL, V78, P1441, DOI 10.1073/pnas.78.3.1441; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; WHITELAW E, 1990, MOL CELL BIOL, V10, P6596, DOI 10.1128/MCB.10.12.6596; Wijgerde M, 1996, GENE DEV, V10, P2894, DOI 10.1101/gad.10.22.2894; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855	58	11	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11229	11236		10.1074/jbc.274.16.11229	http://dx.doi.org/10.1074/jbc.274.16.11229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196210	hybrid			2022-12-27	WOS:000079751900078
J	Takai, D; Isobe, K; Hayashi, JI				Takai, D; Isobe, K; Hayashi, JI			Transcomplementation between different types of respiration-deficient mitochondria with different pathogenic mutant mitochondrial DNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGENERATIVE DISEASES; HUMAN BRAIN; MUTATION; CELLS; RECOMBINATION; DELETIONS	Two cell lines were used for determination of whether interaction occurred between different types of respiration-deficient mitochondria, One was a respiration-deficient rho(-) cell line having mutant mitochondrial DNA (mtDNA) with a 5,196-base pair deletion including five tRNA genes (tRNA(Gly,) (Arg,) (Ser(AGY),) (Leu(CUN),) (His)), Delta mtDNA(5196), causing Kearns-Sayre syndrome. The other was a respiration-deficient syn(-) cell line having mutant mtDNA with an A to G substitution at 4,269 in the tRNA(Ile) gene, mtDNA4269, causing fatal cardiomyopathy, The occurrence of mitochondrial interaction was examined by determining whether cybrids constructed by fusion of enucleated rho(-) Cells with syn(-) cells became respiration competent by exchanging their tRNAs. No cybrids were isolated in selection medium, where only respiration-competent cells could survive, suggesting that no interaction occurred, or that it occurred so slowly that sufficient recovery of mitochondrial respiratory function was not attained by the time of selection. The latter possibility was confirmed by the observations that heteroplasmic cybrids with both mutant mtDNA4269 and Delta mtDNA(5196) isolated without selection showed restored mitochondrial respiration activity. This demonstration of transcomplementation between different respiration-deficient mitochondria will help in understanding the relationship between somatic mutant mtDNAs and the roles of such mutations in aging processes.	Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 305, Japan	University of Tsukuba; University of Tsukuba	Hayashi, JI (corresponding author), Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan.	jih45@sakura.cc.tsukuba.ac.jp						BELLIARD G, 1979, NATURE, V281, P401, DOI 10.1038/281401a0; CLAYTON D, 1984, ANNU REV BIOCHEM, V53, P537; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; DUJON B, 1974, GENETICS, V78, P415; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HAYASHI JI, 1994, J BIOL CHEM, V269, P19060; HAYASHI JI, 1985, EXP CELL RES, V160, P387, DOI 10.1016/0014-4827(85)90185-5; HAYASHI JI, 1994, J CELL BIOL, V125, P43, DOI 10.1083/jcb.125.1.43; Ito S, 1999, P NATL ACAD SCI USA, V96, P2099, DOI 10.1073/pnas.96.5.2099; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; MIYABAYASHI S, 1984, BRAIN DEV-JPN, V6, P362, DOI 10.1016/S0387-7604(84)80112-6; MONNAT RJ, 1986, GENE, V43, P205, DOI 10.1016/0378-1119(86)90208-8; OLIVER NA, 1982, MOL CELL BIOL, V2, P30, DOI 10.1128/MCB.2.1.30; SHAY JW, 1987, MUTAT RES, V186, P149, DOI 10.1016/0165-1110(87)90028-5; Shitara H, 1998, GENETICS, V148, P851; SOONG NW, 1992, NAT GENET, V2, P318; Takai D, 1997, J BIOL CHEM, V272, P6028, DOI 10.1074/jbc.272.9.6028; TANIIKE M, 1992, BIOCHEM BIOPH RES CO, V186, P47, DOI 10.1016/S0006-291X(05)80773-9; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699	22	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11199	11202		10.1074/jbc.274.16.11199	http://dx.doi.org/10.1074/jbc.274.16.11199			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196206	hybrid			2022-12-27	WOS:000079751900074
J	Zhang, HF; Yu, JH; Chen, SH; Morgan, BP; Abagyan, R; Tomlinson, S				Zhang, HF; Yu, JH; Chen, SH; Morgan, BP; Abagyan, R; Tomlinson, S			Identification of the individual residues that determine human CD59 species selective activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT REGULATORY PROTEIN; MOLECULAR-CLONING; C9; C5B-9; SITE; C8; XENOTRANSPLANTATION; INHIBITION; ALGORITHM; PEPTIDES	Formation of the cytolytic membrane attack complex of complement on host cells is inhibited by the membrane-bound glycoprotein, CD59, The inhibitory activity of CD59 is species restricted, and human CD59 is not effective against rat complement. Previous functional analysis of chimeric human/rat CD59 proteins indicated that the residues responsible for the species selective function of human CD59 map to a region contained between positions 40 and 66 in the primary structure. By comparative analysis of rat and human CD59 models and by mutational analysis of candidate residues, we now identify the individual residues within the 40-66 region that confer species selective function on human CD59, All nonconserved residues within the 40-66 sequence were substituted from human to rat residues in a series of chimeric human/rat CD59 mutant proteins. Functional analysis revealed that the individual human to rat residue substitutions F47A, T51L, R55E, and R65Q each produced a mutant human CD59 protein with enhanced rat complement inhibitory activity with the single F47A substitution having the most significant effect. Interestingly, the side chains of the residues at positions 47, 51, and 55 are all located on the short single helix (residues 47-55) of CD59 and form an exposed continuous strip parallel to the helix axis. A single human CD59 mutant protein containing rat residue substitutions at all three helix residues produced a protein with species selective activity comparable to that of rat CD59, We further found that synthetic peptides spanning the human CD59 helix sequence were able to inhibit the binding of human CD59 to human C8, but had little effect on the binding of rat CD59 to rat C8.	NYU, Med Ctr, Dept Pathol, New York, NY 10016 USA; Skirball Inst, Dept Biochem, New York, NY 10016 USA; Univ Wales Coll Med, Dept Biochem Med, Cardiff C4F 4XN, S Glam, Wales	New York University; Cardiff University	Tomlinson, S (corresponding author), NYU, Med Ctr, Dept Pathol, MSB 126,550 1st Ave, New York, NY 10016 USA.	tomlis01@popmail.med.nyu.edu		Morgan, Paul/0000-0003-4075-7676	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI034451, R01AI034451] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 34451] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Bodian DL, 1997, J EXP MED, V185, P507, DOI 10.1084/jem.185.3.507; Byrne G, 1997, TRANSPLANTATION, V63, P149, DOI 10.1097/00007890-199701150-00027; CARDOZO T, 1995, PROTEINS, V23, P403, DOI 10.1002/prot.340230314; DIAZ R, 1988, J BIOL CHEM, V263, P6093; FLETCHER CM, 1994, STRUCTURE, V2, P185, DOI 10.1016/S0969-2126(00)00020-4; Harlow E., 1988, ANTIBODIES LAB MANUA; Hinchliffe SJ, 1998, J IMMUNOL, V160, P3924; JONES J, 1990, COMPLEMENT INFLAMMAT, V7, P42, DOI 10.1159/000463125; KIEFFER B, 1994, BIOCHEMISTRY-US, V33, P4471, DOI 10.1021/bi00181a006; Lehto T, 1997, IMMUNOLOGY, V90, P121, DOI 10.1046/j.1365-2567.1997.00120.x; Maher SE, 1998, TRANSPLANTATION, V66, P1094, DOI 10.1097/00007890-199810270-00021; MCCURRY KR, 1995, NAT MED, V1, P423, DOI 10.1038/nm0595-423; MERI S, 1990, IMMUNOLOGY, V71, P1; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; NINOMIYA H, 1992, J BIOL CHEM, V267, P13675; Petranka J, 1996, BLOOD CELL MOL DIS, V22, P281, DOI 10.1006/bcmd.1996.0111; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; ROLLINS SA, 1991, J IMMUNOL, V146, P2345; RUSHMERE NK, 1994, BIOCHEM J, V304, P595, DOI 10.1042/bj3040595; RYAN US, 1995, NAT MED, V1, P967, DOI 10.1038/nm0995-967; Squinto SP, 1996, CURR OPIN BIOTECH, V7, P641, DOI 10.1016/S0958-1669(96)80076-0; TOMLINSON S, 1994, J IMMUNOL, V152, P1927; Totrov M, 1996, J STRUCT BIOL, V116, P138, DOI 10.1006/jsbi.1996.0022; Yu J, 1999, CLIN EXP IMMUNOL, V115, P13; Yu JH, 1997, BIOCHEMISTRY-US, V36, P9423, DOI 10.1021/bi970832i; Yu JH, 1997, J EXP MED, V185, P745, DOI 10.1084/jem.185.4.745; Zhao XJ, 1998, J BIOL CHEM, V273, P10665, DOI 10.1074/jbc.273.17.10665	29	20	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10969	10974		10.1074/jbc.274.16.10969	http://dx.doi.org/10.1074/jbc.274.16.10969			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196177	hybrid			2022-12-27	WOS:000079751900045
J	Humbert-Lan, G; Pieler, T				Humbert-Lan, G; Pieler, T			Regulation of DNA binding activity and nuclear transport of B-Myb in Xenopus oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; C-MYB; GENE-PRODUCT; FUNCTIONAL DOMAINS; S-PHASE; A-MYB; EXPRESSION; ACTIVATION; TRANSCRIPTION; PROTEINS	DNA binding activity and nuclear transport of B-Myb in Xenopus oocytes are negatively regulated. Two distinct sequence elements in the C-terminal portion of the protein are responsible for these different inhibitory activities. A C-terminal Xenopus B-Myb protein fragment inhibits the DNA binding activity of the N-terminal repeats in trans, indicating that intramolecular folding may result in masking of the DNA binding function. Xenopus B-Myb contains two separate nuclear localization signals (NLSs), which, in Xenopus oocytes, function only outside the context of the full-length protein. Fusion of an additional NLS to the full-length protein overcomes the inhibition of nuclear import, suggesting that masking of the NLS function rather than cytoplasmic anchoring is responsible for the negative regulation of Xenopus B-Myb nuclear transfer. During Xenopus embryogenesis, when inhibition of nuclear import is relieved, Xenopus B-myb is preferentially expressed in the developing nervous system and neural crest cells. Within the developing neural tube, Xenopus B-myb gene transcription occurs preferentially in proliferating, non-differentiated cells.	Univ Gottingen, Inst Biochem & Mol Zellbiol, D-37073 Gottingen, Germany	University of Gottingen	Pieler, T (corresponding author), Univ Gottingen, Inst Biochem & Mol Zellbiol, Humboldtallee 23, D-37073 Gottingen, Germany.	tpieler@gwdg.de						ARSURA M, 1994, BLOOD, V83, P1778, DOI 10.1182/blood.V83.7.1778.bloodjournal8371778; BOUWMEESTER T, 1994, ONCOGENE, V9, P1029; BOUWMEESTER T, 1992, MECH DEVELOP, V37, P57, DOI 10.1016/0925-4773(92)90015-C; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; DUBENDORFF JW, 1992, GENE DEV, V6, P2524, DOI 10.1101/gad.6.12b.2524; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; FAVIER D, 1994, ONCOGENE, V9, P305; GOLAY J, 1991, BLOOD, V77, P149; GONDA TJ, 1985, EMBO J, V4, P2003, DOI 10.1002/j.1460-2075.1985.tb03884.x; Gurdon J.B., 1977, Methods Cell Biol, V16, P125; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; KALKBRENNER F, 1990, ONCOGENE, V5, P6657; Kamano H, 1997, ONCOGENE, V14, P1223, DOI 10.1038/sj.onc.1200945; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KIROV N, 1994, MOL CELL BIOL, V14, P713, DOI 10.1128/MCB.14.1.713; KLEMPNAUER KH, 1987, EMBO J, V6, P2719, DOI 10.1002/j.1460-2075.1987.tb02565.x; LAM EWF, 1995, GENE, V160, P277, DOI 10.1016/0378-1119(95)00184-8; LAM EWF, 1992, ONCOGENE, V7, P1885; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; Lane S, 1997, ONCOGENE, V14, P2445, DOI 10.1038/sj.onc.1201086; Latham KE, 1996, ONCOGENE, V13, P1161; Li HS, 1997, DEVELOPMENT, V124, P603; Lipsick JS, 1996, ONCOGENE, V13, P223; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; MIZUGUCHI G, 1990, J BIOL CHEM, V265, P9280; NAKAGOSHI H, 1993, J BIOL CHEM, V268, P14161; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; RASCHELLA G, 1995, J BIOL CHEM, V270, P8540, DOI 10.1074/jbc.270.15.8540; Robinson C, 1996, ONCOGENE, V12, P1855; Rudt F, 1996, EMBO J, V15, P1383, DOI 10.1002/j.1460-2075.1996.tb00480.x; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; Sala A, 1996, J BIOL CHEM, V271, P9363, DOI 10.1074/jbc.271.16.9363; Sala A, 1997, P NATL ACAD SCI USA, V94, P532, DOI 10.1073/pnas.94.2.532; Sambrook J., 2002, MOL CLONING LAB MANU; Sitzmann J, 1996, ONCOGENE, V12, P1889; TAKEMOTO Y, 1994, FEBS LETT, V350, P55, DOI 10.1016/0014-5793(94)00733-0; TASHIRO S, 1995, ONCOGENE, V10, P1699; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; Ziebold U, 1997, CURR BIOL, V7, P253, DOI 10.1016/S0960-9822(06)00121-7	41	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10293	10300		10.1074/jbc.274.15.10293	http://dx.doi.org/10.1074/jbc.274.15.10293			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187816	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000079663500055
J	Cheng, GM; Hagen, TP; Dawson, ML; Barnes, KV; Menick, DR				Cheng, GM; Hagen, TP; Dawson, ML; Barnes, KV; Menick, DR			The role of GATA, CArG, E-box, and a novel element in the regulation of cardiac expression of the Na+-Ca2+ exchanger gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN GENE; SODIUM-CALCIUM EXCHANGER; SERUM RESPONSE FACTOR; MUSCLE-SPECIFIC EXPRESSION; ALPHA-ACTIN PROMOTER; DEPENDENT REGULATION; PRESSURE-OVERLOAD; TINMAN HOMOLOG; CELLS; IDENTIFICATION	The cardiac Na+-Ca2+ exchanger (NCX1) is the principal Ca2+ efflux mechanism in cardiocytes, The exchanger is up-regulated in both cardiac hypertrophy and failure. In this report, we identify the cis-acting elements that control cardiac expression and ar-adrenergic up-regulation of the exchanger gene. Deletion analysis revealed that a minimal cardiac promoter fragment from -184 to +172 is sufficient for cardiac expression and alpha-adrenergic stimulation. Mutational analysis revealed that both the CArG element at -80 and the GATA element at -50 were required for cardiac expression. Gel mobility shift assay supershift analysis demonstrated that the serum response factor binds to the CArGr element and GATA-4 binds to the GATA element. Point mutations in the -172 E-box demonstrated that it was required for alpha-adrenergic induction. In addition, deletion analysis revealed one or more enhancer elements in the first intron (+103 to +134) that are essential for phenylephrine up-regulation but bear no homology to any known transcription element. Therefore, this work demonstrates that SRF and GATA-4 are critical for NCX1 expression in neonatal cardiomyocytes and that the -172 E-box in addition to a novel enhancer element(s) are required for phenylephrine up-regulation of NCX1 and may mediate its hypertrophic up-regulation.	Med Univ S Carolina, Div Cardiol, Dept Med, Charleston, SC 29425 USA; Med Univ S Carolina, Gazes Cardiac Res Inst, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Menick, DR (corresponding author), Med Univ S Carolina, Div Cardiol, Dept Med, 171 Ashley Ave, Charleston, SC 29425 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048788] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL48788] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMACHER SL, 1993, MOL CELL BIOL, V13, P2753, DOI 10.1128/MCB.13.5.2753; Barnes KV, 1997, J BIOL CHEM, V272, P11510, DOI 10.1074/jbc.272.17.11550; CATALA F, 1995, MOL CELL BIOL, V15, P4585; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Cheng GM, 1998, CIRCULATION, V98, P609; CONDRESCU M, 1995, J BIOL CHEM, V270, P9137, DOI 10.1074/jbc.270.16.9137; FOSTER KA, 1990, AM J PHYSIOL, V259, pH432, DOI 10.1152/ajpheart.1990.259.2.H432; FRENCH BA, 1991, MOL CELL BIOL, V11, P2439, DOI 10.1128/MCB.11.5.2439; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; GRUENEBERG DA, 1995, MOL CELL BIOL, V15, P3318; Hasegawa K, 1997, CIRCULATION, V96, P3943; Herzig TC, 1997, P NATL ACAD SCI USA, V94, P7543, DOI 10.1073/pnas.94.14.7543; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1990, NATURE, V344, P242, DOI 10.1038/344242a0; IP HS, 1994, MOL CELL BIOL, V14, P7517, DOI 10.1128/MCB.14.11.7517; Iwamoto T, 1996, J BIOL CHEM, V271, P13609, DOI 10.1074/jbc.271.23.13609; KENT RL, 1993, AM J PHYSIOL, V265, pH1024, DOI 10.1152/ajpheart.1993.265.3.H1024; KIMURA J, 1986, NATURE, V319, P596, DOI 10.1038/319596a0; KNOWLTON KU, 1991, J BIOL CHEM, V266, P7759; KOFUJI P, 1993, AM J PHYSIOL, V265, pF598, DOI 10.1152/ajprenal.1993.265.4.F598; Kraev A, 1996, GENOMICS, V37, P105, DOI 10.1006/geno.1996.0526; KURABAYASHI M, 1990, J BIOL CHEM, V265, P19271; LEE SL, 1994, J BIOL CHEM, V269, P14849; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; LI ZP, 1991, J BIOL CHEM, V266, P1014; Mably JD, 1996, CIRC RES, V79, P4, DOI 10.1161/01.RES.79.1.4; MABLY JD, 1993, J BIOL CHEM, V268, P476; McGrew MJ, 1996, MOL CELL BIOL, V16, P4524; Menick DR, 1996, ANN NY ACAD SCI, V779, P489, DOI 10.1111/j.1749-6632.1996.tb44823.x; MIWA T, 1987, MOL CELL BIOL, V7, P2803, DOI 10.1128/MCB.7.8.2803; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; MOLKENTIN JD, 1993, J BIOL CHEM, V268, P2602; MUSCAT GE, 1988, MOL CELL BIOL, V8, P4120, DOI 10.1128/MCB.8.10.4120; NAVANKASATTUSAS S, 1994, MOL CELL BIOL, V14, P7331, DOI 10.1128/MCB.14.11.7331; Nicholas SB, 1998, AM J PHYSIOL-HEART C, V274, pH217, DOI 10.1152/ajpheart.1998.274.1.H217; Ojamaa K, 1995, J BIOL CHEM, V270, P31276, DOI 10.1074/jbc.270.52.31276; PAPADOPOULOS N, 1993, MOL CELL BIOL, V13, P6907, DOI 10.1128/MCB.13.11.6907; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; RINDT H, 1993, J BIOL CHEM, V268, P5332; ROY RJ, 1991, BIOTECHNIQUES, V11, P770; SARTORELLI V, 1990, GENE DEV, V4, P1811, DOI 10.1101/gad.4.10.1811; Scheller T, 1998, J BIOL CHEM, V273, P7643, DOI 10.1074/jbc.273.13.7643; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; STUDER R, 1994, CIRC RES, V75, P443, DOI 10.1161/01.RES.75.3.443	46	69	72	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12819	12826		10.1074/jbc.274.18.12819	http://dx.doi.org/10.1074/jbc.274.18.12819			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212268	hybrid			2022-12-27	WOS:000080056800088
J	Schwartz, MP; Huang, SH; Matouschek, A				Schwartz, MP; Huang, SH; Matouschek, A			The structure of precursor proteins during import into mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-AMYLOLIQUEFACIENS BARNASE; SODIUM DODECYL-SULFATE; INTERMEMBRANE SPACE; YEAST MITOCHONDRIA; OUTER-MEMBRANE; MOLTEN-GLOBULE; CYTOCHROME-B2; TRANSLOCATION; RIBONUCLEASE; STABILITY	Precursor proteins must be at least partially unfolded during import into mitochondria, but their actual conformation during translocation is not known. Are proteins fully unfolded and threaded through the import machinery amino acid by amino acid, or do they retain some partial structure? The folding pathway of most proteins in vitro contains a partially folded intermediate known as the molten globule state, and it has been suggested that proteins are in the molten globule state during translocation across membranes. Here we show that precursors are normally fully unfolded during import into mitochondria, However, precursors containing residual structure can be imported, if less efficiently,	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Matouschek, A (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	matouschek@nwu.edu	Matouschek, Andreas/L-9379-2013	Matouschek, Andreas/0000-0001-6016-2341				ARRETZ M, 1994, J BIOL CHEM, V269, P4959; BEASLEY EM, 1993, EMBO J, V12, P2303, DOI 10.1002/j.1460-2075.1993.tb05884.x; CLARKE J, 1995, J MOL BIOL, V253, P493, DOI 10.1006/jmbi.1995.0568; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; DAUM G, 1982, J BIOL CHEM, V257, P3028; EILERS M, 1988, EMBO J, V7, P1139, DOI 10.1002/j.1460-2075.1988.tb02923.x; EISENBERG M, 1979, BIOCHEMISTRY-US, V18, P5213, DOI 10.1021/bi00590a028; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; GLICK BS, 1991, METHOD CELL BIOL, V34, P389; HARTLEY RW, 1989, TRENDS BIOCHEM SCI, V14, P450, DOI 10.1016/0968-0004(89)90104-7; HARTLEY RW, 1975, BIOCHEMISTRY-US, V14, P2367, DOI 10.1021/bi00682a015; HASE T, 1984, EMBO J, V3, P3157, DOI 10.1002/j.1460-2075.1984.tb02274.x; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; MAUGUEN Y, 1982, NATURE, V297, P162, DOI 10.1038/297162a0; MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MOSSAKOWSKA DE, 1989, BIOCHEMISTRY-US, V28, P3843, DOI 10.1021/bi00435a033; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; TARASSOV I, 1995, J MOL BIOL, V245, P315, DOI 10.1006/jmbi.1994.0026; Tzagoloff A, 1982, MITOCHONDRIA; Van Der Goot Francoise G., 1992, Trends in Cell Biology, V2, P343; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; VESTWEBER D, 1988, J CELL BIOL, V107, P2045, DOI 10.1083/jcb.107.6.2045; VESTWEBER D, 1988, J CELL BIOL, V107, P2037, DOI 10.1083/jcb.107.6.2037; VESTWEBER D, 1989, NATURE, V338, P170, DOI 10.1038/338170a0; ZHANG XJ, 1995, J APPL CRYSTALLOGR, V28, P624, DOI 10.1107/S0021889895001063	30	46	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12759	12764		10.1074/jbc.274.18.12759	http://dx.doi.org/10.1074/jbc.274.18.12759			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212260	hybrid			2022-12-27	WOS:000080056800080
J	Kurz, LL; Klink, H; Jakob, I; Kuchenbecker, M; Benz, S; Lehmann-Horn, F; Rudel, R				Kurz, LL; Klink, H; Jakob, I; Kuchenbecker, M; Benz, S; Lehmann-Horn, F; Rudel, R			Identification of three cysteines as targets for the Zn2+ blockade of the human skeletal muscle chloride channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENCE; MYOTONIA; STOICHIOMETRY; MUTATIONS; MUTANT; CIC-1; CLC-1; RAT	Currents through the human skeletal muscle chloride channel hClC-1 can be blocked by external application of 1 mM. Zn2+ or the histidine-reactive compound diethyl pyrocarbonate (DEPC), The current block by Zn2+ strongly depends on the external pH (pK(a) near 6.9), whereas the block by DEPC is rather independent of the pH in the range of 5.5 to 8.5. To identify the target sites of these reagents, we constructed a total of twelve cysteine- and/or histidine-replacement mutants, transfected tsA201 cells with them, and investigated the resulting whole-cell chloride currents. The majority of the mutants exhibited a similar sensitivity toward Zn2+ or DEPC as wild type (WT) channels. Block by I mM Zn2+ was nearly absent only with the mutant C546A, Four mutants (C242A, C254A, H180A, and H451A) were slightly less sensitive to Zn2+ than WT. Tests with double, triple, and quadruple mutants yielded that, in addition to C546, C242 and C254 are also most likely participating in Zn2+-binding.	Univ Ulm, Dept Gen Physiol, D-89069 Ulm, Germany; Univ Ulm, Dept Appl Physiol, D-89069 Ulm, Germany	Ulm University; Ulm University	Kurz, LL (corresponding author), Univ Ulm, Dept Gen Physiol, D-89069 Ulm, Germany.							Fahlke C, 1997, P NATL ACAD SCI USA, V94, P2729, DOI 10.1073/pnas.94.6.2729; Fahlke C, 1997, J GEN PHYSIOL, V109, P93, DOI 10.1085/jgp.109.1.93; Fahlke C, 1996, BIOPHYS J, V71, P695, DOI 10.1016/S0006-3495(96)79269-X; FAHLKE C, 1995, NEURON, V15, P463, DOI 10.1016/0896-6273(95)90050-0; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Fahlke C, 1998, NATURE, V394, P687, DOI 10.1038/29319; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Jentsch TJ, 1997, BIOESSAYS, V19, P117, DOI 10.1002/bies.950190206; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; Kurz LL, 1997, PFLUG ARCH EUR J PHY, V433, P357; LehmannHorn F, 1996, REV PHYSIOL BIOCH P, V128, P195; Ludewig U, 1997, J PHYSIOL-LONDON, V498, P691, DOI 10.1113/jphysiol.1997.sp021893; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; MIDDLETON RE, 1994, BIOCHEMISTRY-US, V33, P13189, DOI 10.1021/bi00249a005; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; Miles E W, 1977, Methods Enzymol, V47, P431; Pusch M, 1995, NEURON, V15, P1455, DOI 10.1016/0896-6273(95)90023-3; Rychkov GY, 1996, J PHYSIOL-LONDON, V497, P423, DOI 10.1113/jphysiol.1996.sp021778; Rychkov GY, 1997, J PHYSIOL-LONDON, V501, P355, DOI 10.1111/j.1469-7793.1997.355bn.x; SchmidtRose T, 1997, P NATL ACAD SCI USA, V94, P7633, DOI 10.1073/pnas.94.14.7633; TAINER JA, 1991, CURR OPIN BIOTECH, V2, P582, DOI 10.1016/0958-1669(91)90084-I; Wagner S, 1998, MUSCLE NERVE, V21, P1122, DOI 10.1002/(SICI)1097-4598(199809)21:9<1122::AID-MUS2>3.0.CO;2-9; Wollnik B, 1997, HUM MOL GENET, V6, P805, DOI 10.1093/hmg/6.5.805; Wooltorton JRA, 1997, J PHYSIOL-LONDON, V505, P633, DOI 10.1111/j.1469-7793.1997.633ba.x	26	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11687	11692		10.1074/jbc.274.17.11687	http://dx.doi.org/10.1074/jbc.274.17.11687			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206982	hybrid			2022-12-27	WOS:000079834800038
J	Shimoyama, Y; Takeda, H; Yoshihara, S; Kitajima, M; Hirohashi, S				Shimoyama, Y; Takeda, H; Yoshihara, S; Kitajima, M; Hirohashi, S			Biochemical characterization and functional analysis of two type II classic cadherins, cadherin-6 and -14, and comparison with E-cadherin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULES; ALPHA-CATENIN; N-CADHERIN; R-CADHERIN; EXPRESSION; CLONING; IDENTIFICATION; SPECIFICITY; UVOMORULIN; SEQUENCE	Classic cadherins can be grouped based on their deduced primary structures. Among them the type I cadherins have been well characterized; however, little is known about non-type I cadherins, In this study we characterized two human type II cadherins, cadherin-6 and cadherin-14, using a cDNA transfection system. They were each detected as two bands electrophoretically, were expressed on the external cell surface at cell-cell contact sites, and were associated with catenins. Direct sequencing of the N-terminal amino acids showed that the two bands of cadherin-14 corresponded to precursor and mature forms, whereas the two bands of cadherin-6 both had the N-terminal sequence of the mature form. Unlike type I cadherins, both cadherin-6 and -14 were not protected from trypsin degradation by Ca2+. We evaluated their adhesive functions by a long term cell aggregation method. The results suggest that both cadherin-g and -14 have cell-cell binding strengths virtually equivalent to that of E-cadherin and that their binding specificities are distinct from that of E-cadherin. Cadherin-6 and -14 interacted with each other in an incomplete manner. They have a QAI tripeptide in the first extracellular subdomain instead of the HAV motif that is characteristic of type I cadherins and is intimately involved in the adhesive function. The QAI tripeptide, however, appeared not to be involved in the adhesive functions of cadherin-6 and 14.	Natl Okura Hosp, Dept Surg, Setagaya Ku, Tokyo 1578535, Japan; Natl Okura Hosp, Dept Clin Res, Setagaya Ku, Tokyo 1578535, Japan; Japan Sci & Technol Corp, Tsukuba Res Consortium, Exploratory Res Adv Technol, Hirohashi Cell Configurat Project, Tsukuba, Ibaraki 3002635, Japan; Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 1608582, Japan; Natl Canc Ctr, Res Inst, Div Pathol, Chuo Ku, Tokyo 1040045, Japan	Japan Science & Technology Agency (JST); Keio University; National Cancer Center - Japan	Shimoyama, Y (corresponding author), Natl Okura Hosp, Dept Surg, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.							Akimoto S, 1998, JPN J CANCER RES, V89, P829, DOI 10.1111/j.1349-7006.1998.tb00636.x; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; BUSSEMAKERS MJG, 1993, MOL BIOL REP, V17, P123, DOI 10.1007/BF00996219; CUNNINGHAM BA, 1984, P NATL ACAD SCI-BIOL, V81, P5787, DOI 10.1073/pnas.81.18.5787; DOHERTY P, 1991, NEURON, V6, P247, DOI 10.1016/0896-6273(91)90360-C; FRIEDLANDER DR, 1989, P NATL ACAD SCI USA, V86, P7043, DOI 10.1073/pnas.86.18.7043; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; INUZUKA H, 1991, NEURON, V7, P69, DOI 10.1016/0896-6273(91)90075-B; KATOH K, 1987, CELL STRUCT FUNCT, V12, P575, DOI 10.1247/csf.12.575; MATSUNAMI H, 1993, J CELL SCI, V106, P401; MURPHYERDOSH C, 1995, J CELL BIOL, V129, P1379, DOI 10.1083/jcb.129.5.1379; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; OKAZAKI M, 1994, J BIOL CHEM, V269, P12092; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; PEYRIERAS N, 1983, P NATL ACAD SCI-BIOL, V80, P6274, DOI 10.1073/pnas.80.20.6274; REID RA, 1990, NUCLEIC ACIDS RES, V18, P5896, DOI 10.1093/nar/18.19.5896; Shibata T, 1997, J BIOL CHEM, V272, P5236, DOI 10.1074/jbc.272.8.5236; SHIMOYAMA Y, 1989, J CELL BIOL, V109, P1787, DOI 10.1083/jcb.109.4.1787; Shimoyama Y, 1998, J BIOL CHEM, V273, P10011, DOI 10.1074/jbc.273.16.10011; SHIMOYAMA Y, 1995, CANCER RES, V55, P2206; SHIMOYAMA Y, 1992, CANCER RES, V52, P5770; SHIRAYOSHI Y, 1986, CELL STRUCT FUNCT, V11, P245, DOI 10.1247/csf.11.245; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; SUZUKI S, 1991, CELL REGUL, V2, P261, DOI 10.1091/mbc.2.4.261; Suzuki ST, 1996, J CELL BIOCHEM, V61, P531, DOI 10.1002/(SICI)1097-4644(19960616)61:4<531::AID-JCB6>3.0.CO;2-P; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; TANIHARA H, 1994, CELL ADHES COMMUN, V2, P15, DOI 10.3109/15419069409014199; TANIHARA H, 1994, J CELL SCI, V107, P1697	38	30	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11987	11994		10.1074/jbc.274.17.11987	http://dx.doi.org/10.1074/jbc.274.17.11987			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207020	hybrid			2022-12-27	WOS:000079834800076
J	Ho, CL; Noji, M; Saito, K				Ho, CL; Noji, M; Saito, K			Plastidic pathway of serine biosynthesis - Molecular cloning and expression of 3-phosphoserine phosphatase from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE DECARBOXYLASE COMPLEX; PHOSPHOSERINE AMINOTRANSFERASE; SEQUENCE; GENES; INHIBITION	In plants, Ser is biosynthesized by two different pathways: a photorespiratory pathway via Gly and a plastidic pathway via the phosphorylated metabolites from 5-phosphoglycerate. In contrast to the better characterization of the photorespiratory pathway at a molecular level, the molecular regulation and significance of the plastidic pathway are not yet well. understood. An Arabidopsis thaliana cDNA encoding 3-phosphoserine phosphatase, the enzyme that is responsible for the conversion of 3-phosphoserine to Ser in the final step of the plastidic pathway of Ser biosynthesis, was cloned by functional complementation of an Escherichia coli serB(-) mutant. The 1.1-kilobase pair full-length cDNA, encoding 295 amino acids in its open reading frame, contains a putative organelle targeting presequence. Chloroplastic targeting has been demonstrated by particle gun bombardment using an N-terminal 60-amino acid green fluorescence protein fusion protein. Southern hybridization suggested the existence of a single-copy gene that mapped to chromosome 1. 3-Phosphoserine phosphatase enzyme activity was detected in vitro in the overexpressed protein in E. coli. Northern analysis revealed preferential gene expression in leaf and root tissues of light-grown plants with an similar to 1.5-fold abundance in the root compared with the leaf tissues. This indicates the possible role of the plastidic pathway in supplying Ser to non-photosynthetic tissues, in contrast to the function of the photorespiratory pathway in photosynthetic tissues. This work completes the molecular cloning and characterization of the three genes involved in the plastidic pathway of Ser biosynthesis in higher plants.	Chiba Univ, Fac Pharmaceut Sci, Res Ctr Med Resources, Lab Mol Biol & Biotechnol,Inage Ku, Chiba 2638522, Japan	Chiba University	Saito, K (corresponding author), Chiba Univ, Fac Pharmaceut Sci, Res Ctr Med Resources, Lab Mol Biol & Biotechnol,Inage Ku, Yayoi Cho 1-33, Chiba 2638522, Japan.		Saito, Kazuki/D-2670-2009	Saito, Kazuki/0000-0001-6310-5342				BRYAN JK, 1988, BIOCH PLANTS COMPREH, V16, P175; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Collet JF, 1997, FEBS LETT, V408, P281, DOI 10.1016/S0014-5793(97)00438-9; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; FELL DA, 1988, BIOCHEM J, V256, P97, DOI 10.1042/bj2560097; FELSENSTEIN J, 1995, PHYLIP 3 57C; Fiske CH, 1925, J BIOL CHEM, V66, P375; GREENLER JM, 1990, PLANT PHYSIOL, V94, P1484, DOI 10.1104/pp.94.3.1484; Ho CL, 1999, J BIOL CHEM, V274, P397, DOI 10.1074/jbc.274.1.397; Ho CL, 1998, PLANT J, V16, P443, DOI 10.1046/j.1365-313x.1998.00313.x; ICHIHARA A, 1957, J BIOL CHEM, V224, P331; KEYS AJ, 1980, BIOCH PLANTS, V5, P359; KREBBERS E, 1988, PLANT MOL BIOL, V11, P745, DOI 10.1007/BF00019515; LARSSON C, 1979, PHYSIOL PLANTARUM, V45, P7, DOI 10.1111/j.1399-3054.1979.tb01654.x; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; PIZER LI, 1964, J BIOL CHEM, V239, P4219; REYNOLDS PH, 1986, PLANT  PHYSL, V81, P283; Saito K, 1997, PLANT MOL BIOL, V33, P359, DOI 10.1023/A:1005730725764; Sambrook J., 2002, MOL CLONING LAB MANU; SERVAITES JC, 1977, PLANT PHYSIOL, V60, P461, DOI 10.1104/pp.60.4.461; SNELL K, 1986, TRENDS BIOCHEM SCI, V11, P241, DOI 10.1016/0968-0004(86)90184-2; SRINIVASAN R, 1995, PLANT PHYSIOL, V109, P161, DOI 10.1104/pp.109.1.161; STOLZ M, 1994, Z NATURFORSCH C, V49, P63; TAKAIWA F, 1985, PLANT MOL BIOL, V4, P355, DOI 10.1007/BF02418257; TOLBERT NE, 1980, BIOCH PLANTS, V2, P488; TURNER SR, 1993, MOL GEN GENET, V236, P402, DOI 10.1007/BF00277140; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; WALKER JL, 1986, ARCH BIOCHEM BIOPHYS, V248, P626, DOI 10.1016/0003-9861(86)90517-5	31	42	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11007	11012		10.1074/jbc.274.16.11007	http://dx.doi.org/10.1074/jbc.274.16.11007			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196182	hybrid			2022-12-27	WOS:000079751900050
J	Chen, JH; Turner, PC; Rees, HH				Chen, JH; Turner, PC; Rees, HH			Molecular cloning and characterization of hemolymph 3-dehydroecdysone 3 beta-reductase from the cotton leafworm, Spodoptera littoralis - A new member of the third superfamily of oxidoreductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ECDYSTEROID BIOSYNTHESIS; ALCOHOL-DEHYDROGENASE; PROTHORACIC GLANDS; MANDUCA-SEXTA; BOMBYX-MORI; PROTEINS; PURIFICATION; EXPRESSION; SEQUENCE; ENZYME	The primary product of the prothoracic glands of last instar larvae of Spodoptera littoralis is 3-dehydroecdysone (3DE). After secretion, 3DE is reduced to ecdysone by 3DE 3 beta-reductase in the hemolymph, We have previously purified and characterized 3DE 3 beta-reductase from the hemolymph of S, littoralis, In this study, cDNA clones encoding the enzyme were obtained by reverse transcription-polymerase chain reaction, employing primers based on the amino acid sequences, in conjunction with 5'- and 3'-rapid amplification of cDNA ends. Multiple polyadenylation signals and AT-rich elements were found in the 3'-untranslated region, suggesting that this region may have a role in regulation of expression of the gene. Conceptual translation and amino acid sequence analysis suggest that 3DE 3 beta-reductase from S, littoralis is a new member of the third superfamily of oxidoreductases, Northern analysis shows that 3DE 3 beta-reductase mRNA transcripts are widely distributed, but are differentially expressed, in some tissues. The developmental profile of the mRNA revealed that the gene encoding 3DE 3 beta-reductase is only transcribed in the second half of the last larval instar and that this fluctuation in expression accounts for the change in the enzyme activity during the instar, Southern analysis indicates that the 3DE 3 beta-reductase is encoded by a single gene, which probably contains at least one intron.	Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	University of Liverpool	Rees, HH (corresponding author), Univ Liverpool, Sch Biol Sci, Life Sci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.							ARONSON BD, 1989, J BIOL CHEM, V264, P5226; BLAIS C, 1991, CR ACAD SCI III-VIE, V313, P359; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; BRUCE NC, 1994, BIOCHEM J, V299, P805, DOI 10.1042/bj2990805; Chen JH, 1996, EUR J BIOCHEM, V242, P394, DOI 10.1111/j.1432-1033.1996.0394r.x; CHEN JH, 1994, BIOCHEM J, V299, P711, DOI 10.1042/bj2990711; EKLUND H, 1985, BIOCHEMISTRY-US, V24, P8005, DOI 10.1021/bi00348a025; EKLUND H, 1989, BIOCHEM SOC T, V17, P293, DOI 10.1042/bst0170293; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; GASSMANN M, 1990, FASEB J, V4, P2528, DOI 10.1096/fasebj.4.8.1970792; GELMAN DB, 1991, ARCH INSECT BIOCHEM, V17, P93, DOI 10.1002/arch.940170204; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; HORJALES E, 1985, J BIOL CHEM, V260, P5445; JEFFERY J, 1988, ADV ENZYMOL RAMB, V61, P47; JORNVALL H, 1981, P NATL ACAD SCI-BIOL, V78, P4226, DOI 10.1073/pnas.78.7.4226; Kiriishi S, 1990, EXPERIENTIA, V46, P57; KOIVUSALO M, 1989, FEBS LETT, V257, P105, DOI 10.1016/0014-5793(89)81797-1; Koolman J, 1989, ECDYSONE; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafont R., 1984, P196; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MOUNIER N, 1991, INSECT BIOCHEM, V21, P523, DOI 10.1016/0020-1790(91)90106-O; Nomura Y, 1996, INSECT BIOCHEM MOLEC, V26, P249, DOI 10.1016/0965-1748(95)00083-6; NUNNARI J, 1992, Current Opinion in Cell Biology, V4, P573, DOI 10.1016/0955-0674(92)90074-M; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; REES HH, 1995, EUR J ENTOMOL, V92, P9; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; SAKURAI S, 1989, ARCH INSECT BIOCHEM, V10, P179, DOI 10.1002/arch.940100303; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wahle E, 1996, TRENDS BIOCHEM SCI, V21, P247, DOI 10.1016/S0968-0004(96)10030-X; WANG XP, 1995, INSECT BIOCHEM MOLEC, V25, P1001, DOI 10.1016/0965-1748(95)00033-R; WARREN JT, 1988, P NATL ACAD SCI USA, V85, P958, DOI 10.1073/pnas.85.3.958; Watson R.D., 1989, P188	33	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10551	10556		10.1074/jbc.274.15.10551	http://dx.doi.org/10.1074/jbc.274.15.10551			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187849	hybrid			2022-12-27	WOS:000079663500088
J	Muller, T; Choidas, A; Reichmann, E; Ullrich, A				Muller, T; Choidas, A; Reichmann, E; Ullrich, A			Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; GLYCOGEN-SYNTHASE KINASE-3; TRANSCRIPTION FACTOR LEF-1; TUMOR-SUPPRESSOR PROTEIN; E-CADHERIN; CARCINOMA-CELLS; ALPHA-CATENIN; FUNCTIONAL INTERACTION; SIGNALING PATHWAY; COMPLEX-FORMATION	Cell migration requires precise control, which is altered or lost when tumor cells become invasive and metastatic, Although the integrity of cell-cell contacts, such as adherens junctions, is essential for the maintenance of functional epithelia, they need to be rapidly disassembled during migration. The transmembrane cell adhesion protein E-cadherin and the cytoplasmic catenins are molecular elements of these structures. Here we demonstrate that epithelial cell migration is accompanied by tyrosine phosphorylation of beta-catenin and an increase of its free cytoplasmic pool. We show further that the protein-tyrosine phosphatase LAR (leukocyte common antigen related) colocalizes with the cadherin-catenin complex in epithelial cells and associates with beta-catenin and plakoglobin, Interestingly, ectopic expression of protein-tyrosine phosphatase (PTP) LAR inhibits epithelial cell migration by preventing phosphorylation and the increase in the free pool of beta-catenin; moreover, it inhibits tumor formation in nude mice. These data support a function for PTP LAR in the regulation of epithelial cell-cell contacts at adherens junctions as well as in the control of beta-catenin signaling functions. Thus PTP-LAR appears to play an important role in the maintenance of epithelial integrity, and a loss of its regulatory function may contribute to malignant progression and metastasis.	Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany; Swiss Inst Expt Canc Res, ISREC, CH-1066 Epalinges, Switzerland	Max Planck Society; Swiss Institute Experimental Cancer Research	Muller, T (corresponding author), ARIAD Pharmaceut Inc, 26 Landsdowne St, Cambridge, MA 02139 USA.	Thomas.Mueller@ariad.com						Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; BECKER KF, 1994, CANCER RES, V54, P3845; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; BIRCHMEIER W, 1995, CIBA F SYMP, V189, P124; BOYER B, 1992, EXP CELL RES, V201, P347, DOI 10.1016/0014-4827(92)90283-E; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; BUCKLEY A, 1985, P NATL ACAD SCI USA, V82, P7340, DOI 10.1073/pnas.82.21.7340; Bullions Linda C., 1998, Current Opinion in Oncology, V10, P81, DOI 10.1097/00001622-199801000-00013; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cheng J, 1997, J BIOL CHEM, V272, P7264, DOI 10.1074/jbc.272.11.7264; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; ELDARFINKELMAN H, 1995, J BIOL CHEM, V270, P987, DOI 10.1074/jbc.270.3.987; Fuchs M, 1996, J BIOL CHEM, V271, P16712, DOI 10.1074/jbc.271.28.16712; Fujii K, 1996, EXP CELL RES, V223, P50, DOI 10.1006/excr.1996.0057; GEBBINK MFBG, 1995, J CELL BIOL, V131, P251, DOI 10.1083/jcb.131.1.251; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; HAMAGUCHI M, 1993, EMBO J, V12, P307, DOI 10.1002/j.1460-2075.1993.tb05658.x; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Huber O, 1996, CURR OPIN CELL BIOL, V8, P685, DOI 10.1016/S0955-0674(96)80110-4; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; LONGO FM, 1993, J BIOL CHEM, V268, P26503; MANSBRIDGE JN, 1992, J CELL PHYSIOL, V151, P433, DOI 10.1002/jcp.1041510302; MANSKE M, 1994, INT REV CYTOL, V155, P49, DOI 10.1016/S0074-7696(08)62096-3; Marrs JA, 1996, INT REV CYTOL, V165, P159, DOI 10.1016/S0074-7696(08)62222-6; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 1997, TRENDS GENET, V13, P256, DOI 10.1016/S0168-9525(97)01196-7; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; OCHIAI A, 1994, BIOCHEM BIOPH RES CO, V205, P73, DOI 10.1006/bbrc.1994.2631; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; RODIER JM, 1995, J CELL BIOL, V131, P761, DOI 10.1083/jcb.131.3.761; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; SHIBAMOTO S, 1994, CELL ADHES COMMUN, V1, P295, DOI 10.3109/15419069409097261; SHIBATA T, 1994, BIOCHEM BIOPH RES CO, V203, P519, DOI 10.1006/bbrc.1994.2213; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOMMERS CL, 1994, CANCER RES, V54, P3544; STREULI M, 1992, EMBO J, V11, P897, DOI 10.1002/j.1460-2075.1992.tb05128.x; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; TCHAO R, 1982, CELL MOTILITY, V4, P333; THIERY JP, 1985, ANNU REV CELL BIOL, V1, P91, DOI 10.1146/annurev.cellbio.1.1.91; TOYOSHIMA K, 1971, JNCI-J NATL CANCER I, V47, P979; TUCKER GC, 1990, CANCER RES, V50, P129; VALLES AM, 1990, P NATL ACAD SCI USA, V87, P1124, DOI 10.1073/pnas.87.3.1124; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; VOLBERG T, 1992, EMBO J, V11, P1733, DOI 10.1002/j.1460-2075.1992.tb05225.x; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Weng LP, 1998, CURR BIOL, V8, P247, DOI 10.1016/S0960-9822(98)70106-X; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; ZHOU P, 1995, GENE DEV, V9, P570	78	267	275	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10173	10183		10.1074/jbc.274.15.10173	http://dx.doi.org/10.1074/jbc.274.15.10173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187801	hybrid			2022-12-27	WOS:000079663500040
J	Ruban, AV; Lee, PJ; Wentworth, M; Young, AJ; Horton, P				Ruban, AV; Lee, PJ; Wentworth, M; Young, AJ; Horton, P			Determination of the stoichiometry and strength of binding of xanthophylls to the photosystem II light harvesting complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPHYLL FLUORESCENCE; HIGHER-PLANTS; GREEN PLANTS; IN-VITRO; PHOTOSYNTHETIC MEMBRANES; CYCLE; PROTEINS; ENERGY; ZEAXANTHIN; PHOTOPROTECTION	Xanthophylls have a crucial role in the structure and function of the light harvesting complexes of photosystem II (LHCII) in plants. The binding of xanthophylls to LHCII has been investigated, particularly with respect to the xanthophyll cycle carotenoids violaxanthin and zeaxanthin, It was found that most of the violaxanthin pool was loosely bound to the major complex and could be removed by mild detergent treatment. Gentle solubilization of photosystem II particles and thylakoids allowed the isolation of complexes, including a newly described oligomeric preparation, enriched in trimers, that retained all of the in vivo violaxanthin pool, It was estimated that each LHCII monomer can bind at least one violaxanthin, The extent to which different pigments can be removed from LHCII indicated that the relative strength of binding was chlorophyll b > neoxanthin > chlorophyll a > lutein > zeaxanthin > violaxanthin. The xanthophyll binding sites are of two types: internal sites binding lutein and peripheral sites binding neoxanthin and violaxanthin, In CP29, a minor LHCII, both a lutein site and the neoxanthin site can be occupied by violaxanthin. Upon activation of the violaxanthin de-epoxidase, the highest de-epoxidation state was found for the main LHCII component and the lowest for CP29, suggesting that only violaxanthin loosely bound to LHCII is available for de-epoxidation.	Univ Sheffield, Dept Mol Biol & Biotechnol, Robert Hill Inst, Sheffield S10 2TN, S Yorkshire, England; Liverpool John Moores Univ, Sch Biol & Earth Sci, Liverpool L3 3AF, Merseyside, England	University of Sheffield; Liverpool John Moores University	Horton, P (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Robert Hill Inst, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	p.horton@sheffield.ac.uk	Horton, Peter/A-3958-2012	Horton, Peter/0000-0002-6095-1460; Young, Andrew/0000-0001-6251-0944				ALFONSO M, 1994, BIOCHEMISTRY-US, V33, P10494, DOI 10.1021/bi00200a034; BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; Boekema EJ, 1998, FEBS LETT, V424, P95, DOI 10.1016/S0014-5793(98)00147-1; Bugos RC, 1998, J BIOL CHEM, V273, P15321, DOI 10.1074/jbc.273.25.15321; CAMERATA KV, 1992, PHOTOSYNTH RES, V33, P235; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DIANESE P, 1991, J BIOL CHEM, V266, P8136; Eskling M, 1997, PHYSIOL PLANTARUM, V100, P806, DOI 10.1034/j.1399-3054.1997.1000407.x; Farber A, 1997, PLANT PHYSIOL, V115, P1609, DOI 10.1104/pp.115.4.1609; FRANK HA, 1994, PHOTOSYNTH RES, V41, P389, DOI 10.1007/BF02183041; Gilmore AM, 1997, PHYSIOL PLANTARUM, V99, P197, DOI 10.1034/j.1399-3054.1997.990127.x; Hankamer B, 1997, ANNU REV PLANT PHYS, V48, P641, DOI 10.1146/annurev.arplant.48.1.641; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Hurry V, 1997, PLANT PHYSIOL, V113, P639, DOI 10.1104/pp.113.2.639; JOHNSON GN, 1993, PLANT CELL ENVIRON, V16, P681, DOI 10.1111/j.1365-3040.1993.tb00486.x; KUHLBRANDT W, 1994, NATURE, V367, P130; LEE AL, 1995, PLANT PHYSIOL, V85, P495; OWENS TG, 1992, RES PHOTOSYNTHESIS, V4, P179; Pagano A, 1998, J BIOL CHEM, V273, P17154, DOI 10.1074/jbc.273.27.17154; PETER GF, 1991, J BIOL CHEM, V266, P16745; PFUNDEL E, 1994, PHOTOSYNTH RES, V42, P89, DOI 10.1007/BF02187121; PHILLIP D, 1995, PHOTOSYNTH RES, V43, P273, DOI 10.1007/BF00029940; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Pogson B, 1996, PLANT CELL, V8, P1627, DOI 10.1105/tpc.8.9.1627; Ros F, 1998, EUR J BIOCHEM, V253, P653, DOI 10.1046/j.1432-1327.1998.2530653.x; Ruban AV, 1998, PHOTOCHEM PHOTOBIOL, V68, P829, DOI 10.1562/0031-8655(1998)068<0829:ESELDN>2.3.CO;2; Ruban AV, 1998, BIOCHEMISTRY-US, V37, P11586, DOI 10.1021/bi9809369; RUBAN AV, 1995, PHOTOCHEM PHOTOBIOL, V61, P216, DOI 10.1111/j.1751-1097.1995.tb03964.x; RUBAN AV, 1994, PLANT PHYSIOL, V104, P227, DOI 10.1104/pp.104.1.227; Ruban AV, 1996, BIOCHEMISTRY-US, V35, P674, DOI 10.1021/bi9524878; RUBAN AV, 1994, BBA-BIOENERGETICS, V1186, P123, DOI 10.1016/0005-2728(94)90143-0; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; Ruban AV, 1997, BIOCHEMISTRY-US, V36, P7855, DOI 10.1021/bi9630725; Sandona D, 1998, BBA-BIOENERGETICS, V1365, P207, DOI 10.1016/S0005-2728(98)00068-1; THAYER SS, 1990, PHOTOSYNTH RES, V23, P331, DOI 10.1007/BF00034864; YAMAMOTO HY, 1962, ARCH BIOCHEM BIOPHYS, V97, P168, DOI 10.1016/0003-9861(62)90060-7; YAMAMOTO HY, 1996, OXYGENIC PHOTOSYNTHE, P539, DOI DOI 10.1007/0-306-48127-8_30	37	227	234	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10458	10465		10.1074/jbc.274.15.10458	http://dx.doi.org/10.1074/jbc.274.15.10458			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187836	hybrid			2022-12-27	WOS:000079663500075
J	Slack, A; Cervoni, N; Pinard, M; Szyf, M				Slack, A; Cervoni, N; Pinard, M; Szyf, M			DNA methyltransferase is a downstream effector of cellular transformation triggered by simian virus 40 large T antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CPG ISLAND; EMBRYO FIBROBLASTS; SIGNALING PATHWAY; GENE-EXPRESSION; CYTOSINE-DNA; METHYLATION; TARGET; (CYTOSINE-5)-METHYLTRANSFERASE; TUMORIGENESIS; ANTISENSE	This paper tests the hypothesis that DNA methyltransferase plays a causal role in cellular transformation induced by SV40 T antigen. We show that T antigen expression results in elevation of DNA methyltransferase (MeTase) mRNA, DNA MeTase protein levels, and global genomic DNA methylation. A T antigen mutant that has lost the ability to bind pRb does not induce DNA MeTase. This up-regulation of DNA MeTase by T antigen occurs mainly at the posttranscriptional level by altering mRNA stability. Inhibition of DNA MeTase by antisense oligonucleotide inhibitors results in inhibition of induction of cellular transformation by T antigen as determined by a transient transfection and soft agar assay. These results suggest that elevation of DNA MeTase is an essential component of the oncogenic program induced by T antigen.	McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	McGill University	Szyf, M (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.							AARONSON SA, 1968, VIROLOGY, V36, P254, DOI 10.1016/0042-6822(68)90142-6; ADAMS RLP, 1979, BIOCHIM BIOPHYS ACTA, V561, P345, DOI 10.1016/0005-2787(79)90143-6; ALMAZAN G, 1992, BRAIN RES, V579, P234, DOI 10.1016/0006-8993(92)90056-F; Belinsky SA, 1996, P NATL ACAD SCI USA, V93, P4045, DOI 10.1073/pnas.93.9.4045; BRINSTER RL, 1984, CELL, V37, P367, DOI 10.1016/0092-8674(84)90367-2; CHRISTMAN JK, 1993, CARCINOGENESIS, V14, P551, DOI 10.1093/carcin/14.4.551; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; JONES PA, 1990, P NATL ACAD SCI USA, V87, P6117, DOI 10.1073/pnas.87.16.6117; KAUTIAINEN TL, 1986, J BIOL CHEM, V261, P1594; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10366, DOI 10.1073/pnas.93.19.10366; LEVINE AJ, 1977, VIROLOGY, V77, P419; MACLEOD AR, 1995, J BIOL CHEM, V270, P11327, DOI 10.1074/jbc.270.19.11327; MACLEOD AR, 1995, J BIOL CHEM, V270, P8037, DOI 10.1074/jbc.270.14.8037; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; NELKIN BD, 1991, BLOOD, V77, P2431; Ramchandani S, 1997, P NATL ACAD SCI USA, V94, P684, DOI 10.1073/pnas.94.2.684; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; ROULEAU J, 1995, J BIOL CHEM, V270, P1595, DOI 10.1074/jbc.270.4.1595; ROULEAU J, 1992, J BIOL CHEM, V267, P7368; ROY N, 1992, NUCLEIC ACIDS RES, V20, P5753, DOI 10.1093/nar/20.21.5753; SAKAMOTO K, 1993, ONCOGENE, V8, P1887; SZYF M, 1991, J BIOL CHEM, V266, P10027; Szyf M, 1996, PHARMACOL THERAPEUT, V70, P1, DOI 10.1016/0163-7258(96)00002-2; SZYF M, 1994, TRENDS PHARMACOL SCI, V7, P238; TEVETHIA MJ, 1984, VIROLOGY, V137, P414, DOI 10.1016/0042-6822(84)90234-4; Vertino PM, 1996, MOL CELL BIOL, V16, P4555, DOI 10.1128/mcb.16.8.4555; WU JJ, 1993, P NATL ACAD SCI USA, V90, P8891, DOI 10.1073/pnas.90.19.8891; Yoder JA, 1996, J BIOL CHEM, V271, P31092, DOI 10.1074/jbc.271.49.31092	34	79	82	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10105	10112		10.1074/jbc.274.15.10105	http://dx.doi.org/10.1074/jbc.274.15.10105			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187792	hybrid			2022-12-27	WOS:000079663500031
J	He, C; Zhang, HL; Mirshahi, T; Logothetis, DE				He, C; Zhang, HL; Mirshahi, T; Logothetis, DE			Identification of a potassium channel site that interacts with G protein beta gamma subunits to mediate agonist-induced signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING K+-CHANNEL; GTP-BINDING PROTEINS; INWARD RECTIFIER; I-KACH; FUNCTIONAL EXPRESSION; ACTIVATION; CLONING; OOCYTES; CELLS; GIRK1	Activation of heterotrimeric GTP-binding (G) proteins by their coupled receptors, causes dissociation of the G protein alpha and beta gamma subunits, G(beta gamma) Subunits interact directly with G protein-gated inwardly rectifying K+ (GIRK) channels to stimulate their activity. In addition, free G(beta gamma) subunits, resulting from agonist-independent dissociation of G protein subunits, can account for a major component of the basal channel activity. Using a series of chimeric constructs between GIRK4 and a G(beta gamma)-insensitive K+ channel, IRK1, we have identified a critical site of interaction of GIRK with G(beta gamma). Mutation of Leu(339) to Glu within this site impaired agonist-induced sensitivity and decreased binding to G(beta gamma), without removing the G(beta gamma) contribution to basal currents. Mutation of the corresponding residue in GIRK1 (Leu(333)) resulted in a similar phenotype, Both the GIRK1 and GIRK4 subunits contributed equally to the agonist-induced sensitivity of the heteromultimeric channel. Thus, we have identified a channel site that interacts specifically with G(beta gamma) subunits released through receptor stimulation.	CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Logothetis, DE (corresponding author), CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, Box 1218,1 Gustave L Levy Pl, New York, NY 10029 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054185] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54185, HL07824] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chan KW, 1996, J GEN PHYSIOL, V107, P381, DOI 10.1085/jgp.107.3.381; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; Cohen NA, 1996, J BIOL CHEM, V271, P32301, DOI 10.1074/jbc.271.50.32301; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Inanobe A, 1995, BIOCHEM BIOPH RES CO, V217, P1238, DOI 10.1006/bbrc.1995.2901; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Krapivinsky G, 1998, J BIOL CHEM, V273, P16946, DOI 10.1074/jbc.273.27.16946; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; Kubo Y, 1996, BIOCHEM BIOPH RES CO, V227, P240, DOI 10.1006/bbrc.1996.1496; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; SUI JI, 1999, IN PRESS ADV 2 MESSE; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; TRAUTWEIN W, 1958, PFLUG ARCH GES PHYS, V266, P324, DOI 10.1007/BF00416781; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Yan K, 1996, J BIOL CHEM, V271, P17597, DOI 10.1074/jbc.271.30.17597	32	99	103	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12517	12524		10.1074/jbc.274.18.12517	http://dx.doi.org/10.1074/jbc.274.18.12517			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212228	hybrid			2022-12-27	WOS:000080056800048
J	Kitchens, ME; Forsthoefel, AM; Rafique, Z; Spencer, HT; Berger, FG				Kitchens, ME; Forsthoefel, AM; Rafique, Z; Spencer, HT; Berger, FG			Ligand-mediated induction of thymidylate synthase occurs by enzyme stabilization - Implications for autoregulation of translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CELLS; BINDING; MECHANISM; ACID; 5-FLUOROURACIL; IDENTIFICATION; RESIDUE-33; SYNTHETASE; CANCER	Thymidylate synthase (TS) is indispensable in the de novo synthesis of dTMP. As such, it has been an important target at which anti-neoplastic drugs are directed. The fluoropyrimidines B-fluorouracil and 5-fluoro-2'-deoxyuridine are cytotoxic as a consequence of inhibition of TS by the metabolite 5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP), This inhibition occurs through formation of a stable ternary complex among the enzyme, the nucleotide analog, and the co-substrate N-5,N-10-methylenetetrahydrofolate. Numerous studies have shown that cellular concentrations of TS undergo about a 2-4-fold induction following treatment with TS inhibitors. An extensive body of in vitro studies has led to the proposal that this induction occurs because of relief of the translational repression brought on by the binding of TS to its own mRNA. In the current study, we have tested several predictions of this autoregulatory translation model. In contrast to expectations, we find that fluoropyrimidines do not cause a change in the extent of ribosome binding to TS mRNA. Furthermore, mutations within the mRNA that abolish its ability to bind TS have no effect on the induction. Finally, enzyme turnover measurements show that the induction is associated with an increase in the stability of the TS polypeptide, Our results, in total, indicate that enzyme stabilization, rather than translational derepression, is the primary mechanism of TS induction by fluoropyrimidines and call into question the general applicability of the autoregulatory translation model.	Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; S Carolina Canc Ctr, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Kitchens, ME (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.							Ardalan B, 1980, Adv Pharmacol Chemother, V17, P289, DOI 10.1016/S1054-3589(08)60013-7; BARBOUR KW, 1992, MOL PHARMACOL, V42, P242; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Chu E, 1996, BIOESSAYS, V18, P191, DOI 10.1002/bies.950180306; CHU E, 1993, P NATL ACAD SCI USA, V90, P517, DOI 10.1073/pnas.90.2.517; CHU E, 1993, MOL PHARMACOL, V43, P527; CHU E, 1991, P NATL ACAD SCI USA, V88, P8977, DOI 10.1073/pnas.88.20.8977; CISNEROS RJ, 1990, ANAL BIOCHEM, V186, P202, DOI 10.1016/0003-2697(90)90067-J; HEIDELBERGER C, 1983, ADV ENZYMOL RAMB, V54, P57; JOHANNES G, 1992, J BIOL CHEM, V267, P10108; KEYOMARSI K, 1988, J BIOL CHEM, V263, P14402; KEYOMARSI K, 1993, J BIOL CHEM, V268, P15142; MOHSEN AWA, 1995, BIOCHEMISTRY-US, V34, P1669; NUSSBAUM RL, 1985, AM J HUM GENET, V37, P1192; PALACIOS R, 1972, J BIOL CHEM, V247, P2316; Reilly RT, 1997, ARCH BIOCHEM BIOPHYS, V342, P338, DOI 10.1006/abbi.1997.0116; SONENBERG N, 1988, PROG NUCLEIC ACID RE, V35, P173, DOI 10.1016/S0079-6603(08)60614-5; SPEARS CP, 1982, CANCER RES, V42, P450; SWAIN SM, 1989, J CLIN ONCOL, V7, P890, DOI 10.1200/JCO.1989.7.7.890; Takemura Y, 1997, ANTI-CANCER DRUG, V8, P3, DOI 10.1097/00001813-199701000-00001; Touroutoglou N, 1996, CLIN CANCER RES, V2, P227; WASHTIEN WL, 1984, MOL PHARMACOL, V25, P171	22	67	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12544	12547		10.1074/jbc.274.18.12544	http://dx.doi.org/10.1074/jbc.274.18.12544			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212232	hybrid			2022-12-27	WOS:000080056800052
J	Lu, WQ; Luo, YD; Kan, MK; McKeehan, WL				Lu, WQ; Luo, YD; Kan, MK; McKeehan, WL			Fibroblast growth factor-10 - A second candidate stromal to epithelial cell andromedin in prostate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR; MESSENGER-RNA; FACTOR FAMILY; HEPARAN-SULFATE; EXPRESSION; RAT; SPECIFICITY; BINDING; ACTIVATION; PROTEIN	Fibroblast growth factor (FGF)-10, a homologue of FGF-7, is expressed significantly in normal rat prostate tissue, well differentiated rat prostate tumors with an epithelial and stromal compartment and only in derived prostate stromal cells in culture. Similar to FGF-7, recombinant rat FGF-10 was a specific mitogen for prostate epithelial cells. In contrast to FGF-7 which is widely expressed among stromal cells in tissues, the expression of FGF-10 correlated with the presence of stromal cells of muscle origin. Radioreceptor binding assays and covalent cross-linking analysis revealed that FGF-10 binds with an affinity equal to FGF-7 to resident epithelial cell receptor, FGFR2IIIb, but unlike FGF-7 also binds the IIIb splice variant of FGFR1. Analysis of mRNA expression by RNase protection revealed that, similar to FGF-7, the expression of FGF-10 was responsive to androgen in stromal cells from normal prostate and nonmalignant differentiated tumors. Although FGF-10 cDNA exhibits a signal sequence for secretion, cultured stromal cells exhibit strictly a cell-associated FGF-10 antigen that correlates with an alternately translated intracellular isoform, FGF-10 requires 1.4 times higher NaCl for elution from immobilized heparin than does FGF-7 and binds to four times the number of sites on the pericellular matrix of epithelial cells. The results show that prostate stromal cell-derived FGF-10, like FGF-7, exhibits the properties of an andromedin which may indirectly mediate control of epithelial cell growth and function by androgen, Although FGF-10 and FGF-7 bind and activate the same resident epithelial cell receptor (FGFR2IIIb), differences in cell type of origin, compartmentation by alternate translation, the affinity for FGFR1IIIb, and access to FGFR by differential interaction with pericellular matrix heparan sulfate suggest they may play both independent and compensatory roles in prostate homeostasis.	Texas A&M Univ, Inst Biosci & Technol, Ctr Canc Biol & Nutr, Hlth Sci Ctr, Houston, TX 77080 USA; Texas A&M Univ, Dept Biochem & Biophys, Houston, TX 77080 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System	McKeehan, WL (corresponding author), Texas A&M Univ, Inst Biosci & Technol, Ctr Canc Biol & Nutr, Hlth Sci Ctr, 2121 W Holcombe Blvd, Houston, TX 77080 USA.	wmckeeha@ibt.tamu.edu			NCI NIH HHS [CA59971] Funding Source: Medline; NIDDK NIH HHS [DK40739, DK35310] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA059971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035310, R01DK040739] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antoine M, 1997, J BIOL CHEM, V272, P29475, DOI 10.1074/jbc.272.47.29475; Beer HD, 1997, ONCOGENE, V15, P2211, DOI 10.1038/sj.onc.1201383; Feng SJ, 1997, CANCER RES, V57, P5369; FUKABORI Y, 1994, IN VITRO CELL DEV-AN, V30A, P745; Gerdes MJ, 1996, ENDOCRINOLOGY, V137, P864, DOI 10.1210/en.137.3.864; Hattori Y, 1997, MOL BRAIN RES, V47, P139, DOI 10.1016/S0169-328X(97)00044-2; Igarashi M, 1998, J BIOL CHEM, V273, P13230, DOI 10.1074/jbc.273.21.13230; ISAACS JT, 1987, CURRENT CONCEPTS APP, P573; Jang JH, 1997, IN VITRO CELL DEV-AN, V33, P819; KAN M, 1991, METHOD ENZYMOL, V198, P158; Kan M, 1996, J BIOL CHEM, V271, P26143, DOI 10.1074/jbc.271.42.26143; KAN M, 1992, IN VITRO CELL DEV-AN, V28A, P515; KAN M, 1999, IN PRESS J BIOL CHEM; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Luo YD, 1998, BIOCHEMISTRY-US, V37, P16506, DOI 10.1021/bi9816599; MANSSON PE, 1989, CANCER RES, V49, P2485; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; REICHSLOTKY R, 1994, J BIOL CHEM, V269, P32279; RUBIN JS, 1995, CELL BIOL INT, V19, P399, DOI 10.1006/cbir.1995.1085; WANG F, 1995, J BIOL CHEM, V270, P10222, DOI 10.1074/jbc.270.17.10222; XU JM, 1992, J BIOL CHEM, V267, P17792; Yamasaki M, 1996, J BIOL CHEM, V271, P15918, DOI 10.1074/jbc.271.27.15918; YAN GC, 1993, MOL CELL BIOL, V13, P4513, DOI 10.1128/MCB.13.8.4513; YAN GC, 1992, MOL ENDOCRINOL, V6, P2123, DOI 10.1210/me.6.12.2123	27	154	159	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12827	12834		10.1074/jbc.274.18.12827	http://dx.doi.org/10.1074/jbc.274.18.12827			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212269	hybrid			2022-12-27	WOS:000080056800089
J	Maechler, P; Kennedy, ED; Sebo, E; Valeva, A; Pozzan, T; Wollheim, CB				Maechler, P; Kennedy, ED; Sebo, E; Valeva, A; Pozzan, T; Wollheim, CB			Secretagogues modulate the calcium concentration in the endoplasmic reticulum of insulin-secreting cells - Studies in aequorin-expressing intact and permeabilized INS-1 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; INDUCED CA2+ RELEASE; HELA-CELLS; IN-SITU; INOSITOL 1,4,5-TRISPHOSPHATE; SARCOPLASMIC-RETICULUM; FLUORESCENT INDICATORS; CYTOPLASMIC CA2+; INTERNAL STORE; CYTOSOLIC CA2+	The precise regulation of the Ca2+ concentration in the endoplasmic reticulum ([Ca2+](er)) is important for protein processing and signal transduction, In the pancreatic beta-cell, dysregulation of [Ca2+](er) may cause impaired insulin secretion. The Ca2+-sensitive photoprotein aequorin mutated to lower its Ca2+ affinity was stably expressed in the endoplasmic reticulum (ER) of rat insulinoma INS-1 cells. The steady state [Ca2+](er) was 267 +/- 9 mu M. Both the Ca2+-ATPase inhibitor cyclopiazonic acid and 4-chloro-m-cresol, an activator of ryanodine receptors, caused an almost complete emptying of ER Ca2+. The inositol 1,4,5-trisphosphate generating agonists, carbachol, and ATP, reduced [Ca2+](er) by 20-25%, Insulin secretagogues that raise cytosolic [Ca2+] by membrane depolarization increased [Ca2+](er) in the potency order K+ much greater than glucose > leucine, paralleling their actions in the cytosolic compartment, Glucose, which augmented [Ca2+](er) by about 25%, potentiated the Ca2+-mobilizing effect of carbachol, explaining the corresponding observation in cytosolic [Ca2+]. The filling of ER Ca2+ by glucose is not directly mediated by ATP production as shown by the continuous monitoring of cytosolic ATP in luciferase expressing cells. Both glucose and K+ increase [Ca2+](er), but only the former generated whereas the latter consumed ATP, Nonetheless, drastic lowering of cellular ATP with a mitochondrial uncoupler resulted in a marked decrease in [Ca2+](er), emphasizing the requirement for mitochondrially derived ATP above a critical threshold concentration. Using alpha-toxin permeabilized cells in the presence of ATP, glucose 6-phosphate did not change [Ca2+](er), invalidating the hypothesis that glucose acts through this metabolite. Therefore, insulin secretagogues that primarily stimulate Ca2+ influx, elevate [Ca2+](er) to ensure beta-cell homeostasis.	Univ Geneva, Med Ctr, Dept Internal Med, Div Clin Biochem & Expt Diabetol, CH-1211 Geneva 4, Switzerland; Johannes Gutenberg Univ Mainz, Hochhaus, Inst Med Microbiol, D-55101 Mainz, Germany; Univ Padua, Natl Ctr Biomembranes, Dept Biomed Sci, I-35121 Padua, Italy	University of Geneva; Johannes Gutenberg University of Mainz; University of Padua	Wollheim, CB (corresponding author), Univ Geneva, Med Ctr, Dept Internal Med, Div Clin Biochem & Expt Diabetol, CH-1211 Geneva 4, Switzerland.	claes.wollheim@medecine.unige.ch		Maechler, Pierre/0000-0002-2005-1433				ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Barrero MJ, 1997, J BIOL CHEM, V272, P27694, DOI 10.1074/jbc.272.44.27694; BASTIANUTTO C, 1995, J CELL BIOL, V130, P847, DOI 10.1083/jcb.130.4.847; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Button D, 1996, MOL BIOL CELL, V7, P419, DOI 10.1091/mbc.7.3.419; Chen W, 1996, J BIOL CHEM, V271, P7398, DOI 10.1074/jbc.271.13.7398; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Detimary P, 1998, BIOCHEM J, V333, P269, DOI 10.1042/bj3330269; GLENNON MC, 1992, J BIOL CHEM, V267, P25568; Guest PC, 1997, BIOCHEM J, V323, P445, DOI 10.1042/bj3230445; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; GYLFE E, 1991, PFLUG ARCH EUR J PHY, V419, P639, DOI 10.1007/BF00370308; GYLFE E, 1988, J BIOL CHEM, V263, P13750; Hajnoczky G, 1997, EMBO J, V16, P3533, DOI 10.1093/emboj/16.12.3533; HAMAKAWA N, 1995, CELL CALCIUM, V17, P21, DOI 10.1016/0143-4160(95)90099-3; HELLMAN B, 1986, BIOCHEM INT, V13, P383; Hofer AM, 1996, CELL CALCIUM, V20, P235, DOI 10.1016/S0143-4160(96)90029-9; HOFER AM, 1995, FASEB J, V9, P788, DOI 10.1096/fasebj.9.9.7601343; HOFER AM, 1993, P NATL ACAD SCI USA, V90, P2598, DOI 10.1073/pnas.90.7.2598; HOKIN LE, 1985, ANNU REV BIOCHEM, V54, P205, DOI 10.1146/annurev.biochem.54.1.205; Islam MS, 1998, P NATL ACAD SCI USA, V95, P6145, DOI 10.1073/pnas.95.11.6145; KENDALL JM, 1992, BIOCHEM BIOPH RES CO, V189, P1008, DOI 10.1016/0006-291X(92)92304-G; Kendall JM, 1996, BIOCHEM J, V318, P383, DOI 10.1042/bj3180383; KENDALL JM, 1994, ANAL BIOCHEM, V221, P173, DOI 10.1006/abio.1994.1394; KENDALL JM, 1992, BIOCHEM BIOPH RES CO, V187, P1091, DOI 10.1016/0006-291X(92)91309-E; Kennedy ED, 1996, J CLIN INVEST, V98, P2524, DOI 10.1172/JCI119071; Kennedy ED, 1998, DIABETES METAB, V24, P15; Landolfi B, 1998, J CELL BIOL, V142, P1235, DOI 10.1083/jcb.142.5.1235; Li GD, 1996, CELL CALCIUM, V19, P535, DOI 10.1016/S0143-4160(96)90063-9; LI GD, 1991, J BIOL CHEM, V266, P3449; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Maechler P, 1997, EMBO J, V16, P3833, DOI 10.1093/emboj/16.13.3833; Maechler P, 1998, FEBS LETT, V422, P328, DOI 10.1016/S0014-5793(97)01618-9; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Miura Y, 1997, J PHYSIOL-LONDON, V503, P387, DOI 10.1111/j.1469-7793.1997.387bh.x; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mogami H, 1998, EMBO J, V17, P435, DOI 10.1093/emboj/17.2.435; Montero M, 1997, FASEB J, V11, P881, DOI 10.1096/fasebj.11.11.9285486; Montero M, 1997, J CELL BIOL, V139, P601, DOI 10.1083/jcb.139.3.601; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; ROE MW, 1994, J BIOL CHEM, V269, P18279; RUTTER GA, 1994, CELL CALCIUM, V16, P71, DOI 10.1016/0143-4160(94)90002-7; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Shimomura O, 1997, BIOCHEM J, V326, P297, DOI 10.1042/bj3260297; Tengholm A, 1998, DIABETES, V47, P1224, DOI 10.2337/diabetes.47.8.1224; THELER JM, 1992, J BIOL CHEM, V267, P18110; TSE FW, 1994, P NATL ACAD SCI USA, V85, P1091; Varadi A, 1996, BIOCHEM J, V319, P521, DOI 10.1042/bj3190521; Wang HY, 1998, EMBO J, V17, P6701, DOI 10.1093/emboj/17.22.6701; WILLMOTT NJ, 1995, FEBS LETT, V371, P99, DOI 10.1016/0014-5793(95)00848-4; WOLF BA, 1988, AM J PHYSIOL, V254, pE121, DOI 10.1152/ajpendo.1988.254.2.E121; WOLF BA, 1986, J BIOL CHEM, V261, P6284; WOLLHEIM CB, 1986, J BIOL CHEM, V261, P8314; WOLLHEIM CB, 1996, DIABETES REV, V4, P276; Zucchi R, 1997, PHARMACOL REV, V49, P1	59	54	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12583	12592		10.1074/jbc.274.18.12583	http://dx.doi.org/10.1074/jbc.274.18.12583			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212237	hybrid			2022-12-27	WOS:000080056800057
J	Malhotra, R; Brosius, FC				Malhotra, R; Brosius, FC			Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYOCARDIAL-INFARCTION; PROGRAMMED CELL-DEATH; CYTOCHROME-C; CASPASE INHIBITOR; POTENTIAL ROLE; HEART-FAILURE; ELEGANS CED-4; BCL-2; MITOCHONDRIA; EXPRESSION	Myocardial ischemia/reperfusion is well recognized as a major cause of apoptotic or necrotic cell death. Neonatal rat cardiac myocytes are intrinsically resistant to hypoxia-induced apoptosis, suggesting a protective role of energy-generating substrates. In the present report, a model of sustained hypoxia of primary cultures of Percoll-enriched neonatal rat cardiac myocytes was used to study specifically the modulatory role of extracellular glucose and other intermediary substrates of energy metabolism (pyruvate, lactate, propionate) as well as glycolytic inhibitors (a-deoxyglucose and iodoacetate) on the induction and maintenance of apoptosis. In the absence of glucose and other substrates, hypoxia (5% CO2 and 95% N-2) caused apoptosis in 14% of cardiac myocytes at 3 h and in 22% of cells at 6-8 h of hypoxia, as revealed by sarcolemmal membrane blebbing, nuclear fragmentation, and chromatin condensation (Hoechst staining), terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining, and DNA laddering, This was accompanied by translocation of cytochrome c from the mitochondria to the cytosol and cleavage of the death substrate poly(ADP-ribose) polymerase, Cleavage of poly(ADP-ribose) polymerase and DNA laddering were prevented by preincubation with the caspase inhibitors benzyloxycarbonyl-val-Ala-Asp-fluoromethyl ketone (zVAD-fmk) and benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethyl ketone (zDEVD-fmk), indicating activation of caspases in the apoptotic process. The caspase inhibitor zDEVD-fmk also partially inhibited cytochrome c translocation. The presence of as little as 1 mM glucose, but not pyruvate, lactate, or propionate, before hypoxia prevented apoptosis, Inhibiting glycolysis by 2-deoxyglucose or iodoacetate, in the presence of glucose, reversed the protective effect of glucose. This study demonstrates that glycolysis of extracellular glucose, and not other metabolic pathways, protects cardiac myocytes from hypoxic injury and subsequent apoptosis.	Univ Michigan, Med Ctr, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; Vet Affairs Med Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Brosius, FC (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Div Nephrol, 1560 MSRB 2, Ann Arbor, MI 48109 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060156] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL060156] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Anversa P, 1998, CIRC RES, V82, P1231, DOI 10.1161/01.RES.82.11.1231; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BEKHEIT S, 1993, J AM COLL CARDIOL, V22, P1214, DOI 10.1016/0735-1097(93)90440-C; Bialik S, 1997, J CLIN INVEST, V100, P1363, DOI 10.1172/JCI119656; Boise LH, 1997, P NATL ACAD SCI USA, V94, P3759, DOI 10.1073/pnas.94.8.3759; Bossenmeyer C, 1998, BRAIN RES, V787, P107, DOI 10.1016/S0006-8993(97)01527-8; Brosius FC, 1997, J MOL CELL CARDIOL, V29, P1675; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; CHENG W, 1995, J CLIN INVEST, V96, P2247, DOI 10.1172/JCI118280; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Chihab R, 1998, J NEUROCHEM, V71, P1177; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573; Chinnaiyan AM, 1997, SCIENCE, V275, P1122, DOI 10.1126/science.275.5303.1122; COTMAN CW, 1995, MOL NEUROBIOL, V10, P19, DOI 10.1007/BF02740836; Doenst T, 1998, CIRCULATION, V97, P2454, DOI 10.1161/01.CIR.97.24.2454; EBERLI FR, 1991, CIRC RES, V68, P466, DOI 10.1161/01.RES.68.2.466; Fliss H, 1996, CIRC RES, V79, P949, DOI 10.1161/01.RES.79.5.949; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Haunstetter A, 1998, CIRC RES, V82, P1111, DOI 10.1161/01.RES.82.11.1111; HEINEMAN FW, 1992, HEART CARDIOVASCULAR, P1641; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; ITOH G, 1995, AM J PATHOL, V146, P1325; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jacobson MD, 1996, J CELL BIOL, V133, P1041, DOI 10.1083/jcb.133.5.1041; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kajstura J, 1996, LAB INVEST, V74, P86; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; Krown KA, 1996, J CLIN INVEST, V98, P2854, DOI 10.1172/JCI119114; Leri A, 1998, J CLIN INVEST, V101, P1326, DOI 10.1172/JCI316; Li ZH, 1997, AM J PHYSIOL-HEART C, V272, pH2313, DOI 10.1152/ajpheart.1997.272.5.H2313; Long XL, 1997, J CLIN INVEST, V99, P2635, DOI 10.1172/JCI119452; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; OWEN P, 1990, CIRC RES, V66, P344, DOI 10.1161/01.RES.66.2.344; Roperch JP, 1998, NAT MED, V4, P835, DOI 10.1038/nm0798-835; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Saraste A, 1997, CIRCULATION, V95, P320; Seshagiri S, 1997, CURR BIOL, V7, P455, DOI 10.1016/S0960-9822(06)00216-8; Sharov VG, 1996, AM J PATHOL, V148, P141; Sheng ZL, 1996, DEVELOPMENT, V122, P419; Sheng ZL, 1997, J BIOL CHEM, V272, P5783, DOI 10.1074/jbc.272.9.5783; Spector MS, 1997, NATURE, V385, P653, DOI 10.1038/385653a0; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; SUN DQ, 1994, CIRCULATION, V89, P793, DOI 10.1161/01.CIR.89.2.793; TAHILIANI AG, 1992, HEART CARDIOVASCULAR, P1599; TANAKA M, 1994, CIRC RES, V75, P426, DOI 10.1161/01.RES.75.3.426; TEIGER E, 1996, J CLIN INVEST, V96, P2247; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; WHEELER TJ, 1994, BBA-BIOMEMBRANES, V1196, P191, DOI 10.1016/0005-2736(94)00211-8; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yaoita H, 1998, CIRCULATION, V97, P276, DOI 10.1161/01.CIR.97.3.276; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; Yoshimura S, 1998, J BIOL CHEM, V273, P6921, DOI 10.1074/jbc.273.12.6921; Yue TL, 1998, CIRC RES, V82, P166; Yue TL, 1998, J MOL CELL CARDIOL, V30, P495, DOI 10.1006/jmcc.1997.0614; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	63	183	196	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12567	12575		10.1074/jbc.274.18.12567	http://dx.doi.org/10.1074/jbc.274.18.12567			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212235	hybrid			2022-12-27	WOS:000080056800055
J	Ogawa, H; Takusagawa, F; Wakaki, K; Kishi, H; Eskandarian, MR; Kobayashi, M; Date, T; Huh, NH; Pitot, HC				Ogawa, H; Takusagawa, F; Wakaki, K; Kishi, H; Eskandarian, MR; Kobayashi, M; Date, T; Huh, NH; Pitot, HC			Rat liver serine dehydratase - Bacterial expression and two folding domains as revealed by limited proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC THREONINE DEAMINASE; GLYCINE N-METHYLTRANSFERASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; ASPARTIC-ACID; MESSENGER-RNA; ACTIVE-SITE; ENZYMES; PROTEIN	A pCW vector harboring rat liver serine dehydratase cDNA was expressed in Escherichia coli, The expressed level was about 5-fold higher in E. coli BL21 than in JM109 cell extract; the former lacked two kinds of proteases. Immunoblot analysis revealed the occurrence of a derivative other than serine dehydratase in the JM109 cell extract. The recombinant enzyme was purified to homogeneity. Staphylococcus aureus V8 protease and trypsin cleaved the enzyme at Glu-206 and Lys-220, respectively, with a concomitant loss of enzyme activity. Spectrophotometrically, the nicked enzyme showed a similar to 50% reduced capacity for binding of the coenzyme pyridoxal phosphate and no spectral change of circular dichroism in the region at 300-480 nm, whereas circular dichroism spectra of both enzymes in the far-UV region were similar, suggesting that proteolysis impairs the coenzyme binding without an accompanying gross change of the secondary structure. Whereas the nicked enzyme behaved like the intact enzyme on Sephadex G-75 column chromatography, it was dissociated into two fragments on the column containing 6 M urea. Upon the removal of urea, both fragments spontaneously refolded. These results suggest that serine dehydratase consists of two folding domains connected by a region that is very susceptible to proteases.	Toyama Med & Pharmaceut Univ, Fac Med, Dept Biochem, Toyama 9300194, Japan; Toyama Med & Pharmaceut Univ, Fac Med, Dept Pathol, Toyama 9300194, Japan; Toyama Med & Pharmaceut Univ, Fac Med, Dept Immunol, Toyama 9300194, Japan; Toyama Med & Pharmaceut Univ, Fac Med, Dept Internal Med, Toyama 9300194, Japan; Univ Kansas, Dept Biochem, Lawrence, KS 66045 USA; Kanazawa Med Univ, Dept Biochem, Uchinada, Ishikawa 9200293, Japan; Univ Wisconsin, Sch Med, Mcardle Lab Canc Res, Madison, WI 53706 USA	University of Toyama; University of Toyama; University of Toyama; University of Toyama; University of Kansas; Kanazawa Medical University; University of Wisconsin System; University of Wisconsin Madison	Ogawa, H (corresponding author), Toyama Med & Pharmaceut Univ, Fac Med, Dept Biochem, Toyama 9300194, Japan.	hogawa@ms.toyama-mpu.ac.jp	HUH, Nam-ho/B-1613-2011					ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; ANTSON AA, 1993, BIOCHEMISTRY-US, V32, P4195, DOI 10.1021/bi00067a006; ARME SA, 1986, BIOCHEMISTRY-US, V25, P3118; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; BORISOV VV, 1980, NATURE, V284, P189, DOI 10.1038/284189a0; BORNAES C, 1992, GENETICS, V131, P531; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN YH, 1971, BIOCHEM BIOPH RES CO, V44, P1285, DOI 10.1016/S0006-291X(71)80225-5; Clausen T, 1996, J MOL BIOL, V262, P202, DOI 10.1006/jmbi.1996.0508; DATTA P, 1987, P NATL ACAD SCI USA, V84, P393, DOI 10.1073/pnas.84.2.393; Dunlop DS, 1997, BIOCHEM BIOPH RES CO, V235, P26, DOI 10.1006/bbrc.1997.6724; DUPOURQUE D, 1966, J BIOL CHEM, V241, P1233; EISENSTEIN E, 1995, BIOCHEMISTRY-US, V34, P9403, DOI 10.1021/bi00029a016; Fu ZJ, 1996, BIOCHEMISTRY-US, V35, P11985, DOI 10.1021/bi961068n; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; GOMI T, 1989, J BIOL CHEM, V264, P16138; GRABOWSKI R, 1993, TRENDS BIOCHEM SCI, V18, P297, DOI 10.1016/0968-0004(93)90040-T; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; Harlow E., 1988, ANTIBODIES LAB MANUA; Hennig M, 1997, P NATL ACAD SCI USA, V94, P4866, DOI 10.1073/pnas.94.10.4866; HYDE CC, 1988, J BIOL CHEM, V263, P17857; INOUE H, 1971, J BIOL CHEM, V246, P2626; Isupov MN, 1998, J MOL BIOL, V276, P603, DOI 10.1006/jmbi.1997.1561; JOHN RA, 1995, BBA-PROTEIN STRUCT M, V1248, P81, DOI 10.1016/0167-4838(95)00025-P; LABOW R, 1966, J BIOL CHEM, V241, P1239; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEONCINI R, 1990, J BIOCHEM BIOPH METH, V20, P97, DOI 10.1016/0165-022X(90)90068-N; LEONCINI R, 1990, ITAL J BIOCHEM, V39, P228; Maniatis T., 1982, MOL CLONING; MARCEAU M, 1988, J BIOL CHEM, V263, P16934; MARCEAU M, 1988, J BIOL CHEM, V263, P16926; NAKAGAWA H, 1967, BIOCHEM BIOPH RES CO, V28, P359, DOI 10.1016/0006-291X(67)90318-X; NAKAGAWA H, 1969, J BIOCHEM-TOKYO, V66, P669; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; OBMOLOVA G, 1990, J MOL BIOL, V214, P641, DOI 10.1016/0022-2836(90)90282-Q; OGAWA H, 1990, J BIOL CHEM, V265, P14407; OGAWA H, 1988, P NATL ACAD SCI USA, V85, P5809, DOI 10.1073/pnas.85.16.5809; OGAWA H, 1989, J BIOL CHEM, V264, P15818; Ogawa H, 1997, BIOCHEM J, V327, P407, DOI 10.1042/bj3270407; OGAWA H, 1989, BIOCHIM BIOPHYS ACTA, V996, P139, DOI 10.1016/0167-4838(89)90106-4; PHILLIPS TA, 1984, J BACTERIOL, V159, P283, DOI 10.1128/JB.159.1.283-287.1984; SAMACH A, 1991, P NATL ACAD SCI USA, V88, P2678, DOI 10.1073/pnas.88.7.2678; SCHULLER DJ, 1995, NAT STRUCT BIOL, V2, P69, DOI 10.1038/nsb0195-69; SIMON D, 1973, BIOCHIM BIOPHYS ACTA, V321, P361, DOI 10.1016/0005-2744(73)90091-0; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; TONEY MD, 1993, SCIENCE, V261, P756, DOI 10.1126/science.8342040; TONG H, 1993, PROTEIN EXPRES PURIF, V4, P438, DOI 10.1006/prep.1993.1058; Wetlaufer D B, 1981, Adv Protein Chem, V34, P61, DOI 10.1016/S0065-3233(08)60518-5	48	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12855	12860		10.1074/jbc.274.18.12855	http://dx.doi.org/10.1074/jbc.274.18.12855			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212273	hybrid			2022-12-27	WOS:000080056800093
J	Rovere, C; Luis, J; Lissitzky, JC; Basak, A; Marvaldi, J; Chretien, M; Seidah, NG				Rovere, C; Luis, J; Lissitzky, JC; Basak, A; Marvaldi, J; Chretien, M; Seidah, NG			The RGD motif and the C-terminal segment of proprotein convertase 1 are critical for its cellular trafficking but not for its intracellular binding to integrin alpha(5)beta(1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROHORMONE CONVERTASES; CHROMOSOMAL LOCALIZATION; SECRETORY PATHWAY; FURIN; CELLS; PROTEINS; PC1; BIOSYNTHESIS; CLEAVAGE; IDENTIFICATION	Cellular trafficking of subtilisin/kexin-like precursor convertases (PCs) may be regulated by a number of motifs, some of which are present within the P-domain and in the C-terminal sequence. Six of the seven known PCs contain a conserved RGD sequence within the P domain. In order to investigate the functional importance of this motif, we generated mutants of PC1 that contain a Myc tag epitope inserted between the prosegment and the catalytic subunit. Cellular expression of vaccinia virus recombinants revealed that this tag did not seem to influence the autocatalytic conversion of proPC1 into PC1 or its bioactivity, The two PC1 variants produced possess either the wild type RGD sequence or its RGE mutant. Stable transfectants of these variants in AtT20 cells revealed that similar to the wild type enzyme, PC1-RGD-Myc is sorted to secretory granules. In contrast, PC1-RGE-Mye exits the cell via the constitutive secretory pathway. In vitro, a 14-mer peptide spanning the RGD sequence of PC1, but not its RGE mutant, binds to cell surface vitronectin-binding integrins of Chinese hamster ovary cells. However, within the endoplasmic reticulum and in an RGD-independent fashion, integrin alpha(5)beta(1), associates primarily with the zymogens proPC1, proPC1-Delta C (missing the C-terminal 137 residues), as well as proPC(2). Thus, the observed discrimination between the secretion routes of PC1-RGD and PC1-RGE does not implicate integrins such as alpha(5)beta(1).	Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; Univ Montreal, Clin Res Inst Montreal, Lab Mol Neuroendocrinol, Montreal, PQ H2W 1R7, Canada; Univ Montreal, Clin Res Inst Montreal, Prot Engn Network Ctr Excellence, Montreal, PQ H2W 1R7, Canada; CNRS, Biochim Cellulaire Lab, Unite Propre Rech Enseignement Super Associee 603, Fac Pharm, F-13385 Marseille 05, France; Hop St Marguerite, INSERM, U387, F-13009 Marseille 29, France	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Seidah, NG (corresponding author), Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@irem.qc.ca	LUIS, José/M-3071-2013; Seidah, Nabil/I-3596-2013; Rovere-Jovene, Carole/O-4557-2016	Seidah, Nabil/0000-0001-6503-9342; Rovere-Jovene, Carole/0000-0001-9400-7972; CHRETIEN, Michel/0000-0002-8588-4460				BAUER JS, 1992, J CELL BIOL, V116, P477, DOI 10.1083/jcb.116.2.477; Bauerfeind R, 1993, CURR OPIN CELL BIOL, V5, P628, DOI 10.1016/0955-0674(93)90132-A; BENJANNET S, 1995, FEBS LETT, V362, P151, DOI 10.1016/0014-5793(95)00228-2; Benjannet S, 1997, J BIOL CHEM, V272, P26210, DOI 10.1074/jbc.272.42.26210; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BENJANNET S, 1988, ENDOCRINOLOGY, V123, P874, DOI 10.1210/endo-123-2-874; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Creemers JWM, 1996, J BIOL CHEM, V271, P25284, DOI 10.1074/jbc.271.41.25284; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; DeBie I, 1996, J CELL BIOL, V135, P1261, DOI 10.1083/jcb.135.5.1261; GLUSCHANKOF P, 1994, EMBO J, V13, P2280, DOI 10.1002/j.1460-2075.1994.tb06510.x; GOODMAN LJ, 1994, BIOCHEM BIOPH RES CO, V201, P795, DOI 10.1006/bbrc.1994.1771; HATSUZAWA K, 1992, J BIOCHEM-TOKYO, V111, P296, DOI 10.1093/oxfordjournals.jbchem.a123753; HEALY JM, 1995, BIOCHEMISTRY-US, V34, P3948, DOI 10.1021/bi00012a012; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Jannatipour M, 1998, BIOCHEMISTRY-US, V37, P17253, DOI 10.1021/bi981785c; Jutras I, 1997, J BIOL CHEM, V272, P15184, DOI 10.1074/jbc.272.24.15184; KULIAWAT R, 1994, J CELL BIOL, V126, P77, DOI 10.1083/jcb.126.1.77; Lehmann M, 1996, BIOCHEM J, V317, P803, DOI 10.1042/bj3170803; Lipkind GM, 1998, P NATL ACAD SCI USA, V95, P7310, DOI 10.1073/pnas.95.13.7310; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Lusson J, 1997, BIOCHEM J, V326, P737, DOI 10.1042/bj3260737; Matter ML, 1998, J CELL BIOL, V141, P1019, DOI 10.1083/jcb.141.4.1019; MILGRAM SL, 1994, J CELL SCI, V107, P737; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Munzer JS, 1997, J BIOL CHEM, V272, P19672, DOI 10.1074/jbc.272.32.19672; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 1998, ANN NY ACAD SCI, V839, P9, DOI 10.1111/j.1749-6632.1998.tb10727.x; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; SEIDAH NG, 1998, MOL B INT U, V2, P49; Steiner DF, 1996, DIABETES METAB, V22, P94; Taylor NA, 1997, BIOCHEM J, V321, P367, DOI 10.1042/bj3210367; VINDROLA O, 1992, MOL ENDOCRINOL, V6, P1088, DOI 10.1210/me.6.7.1088; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; Zhong M, 1996, FEBS LETT, V396, P31, DOI 10.1016/0014-5793(96)01059-9; Zhou A, 1998, J BIOL CHEM, V273, P11107, DOI 10.1074/jbc.273.18.11107; ZHOU A, 1995, J BIOL CHEM, V270, P21509, DOI 10.1074/jbc.270.37.21509; ZHOU Y, 1995, J BIOL CHEM, V270, P24702, DOI 10.1074/jbc.270.42.24702	44	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12461	12467		10.1074/jbc.274.18.12461	http://dx.doi.org/10.1074/jbc.274.18.12461			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212221	hybrid			2022-12-27	WOS:000080056800041
J	Tjernberg, LO; Callaway, DJE; Tjernberg, A; Hahne, S; Lilliehook, C; Terenius, L; Thyberg, J; Nordstedt, C				Tjernberg, LO; Callaway, DJE; Tjernberg, A; Hahne, S; Lilliehook, C; Terenius, L; Thyberg, J; Nordstedt, C			A molecular model of Alzheimer amyloid beta-peptide fibril formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN INTERACTIONS; IN-VITRO; SECONDARY STRUCTURE; PROTEIN; DISEASE; AGGREGATION; AMYLOIDOGENICITY; NEUROTOXICITY; FRAGMENTS	Polymerization of the amyloid beta (A beta) peptide into protease-resistant fibrils is a significant step in the pathogenesis of Alzheimer's disease. It has not been possible to obtain detailed structural information about this process with conventional techniques because the peptide has limited solubility and does not form crystals. In this work, we present experimental results leading to a molecular level model for fibril formation. Systematically selected A beta-fragments containing the A beta(16-20) sequence, previously shown essential for A beta-A beta binding, were incubated in a physiological buffer. Electron microscopy revealed that the shortest fibril-forming sequence was A beta(14-23). Substitutions in this decapeptide impaired fibril formation and deletion of the decapeptide from A beta(1-42) inhibited fibril formation completely. All studied peptides that formed fibrils also formed stable dimers and/or tetramers, Molecular modeling of A beta(14-23) oligomers in an antiparallel beta-sheet conformation displayed favorable hydrophobic interactions stabilized by salt bridges between all charged residues. We propose that this decapeptide sequence forms the core of A beta-fibrils, with the hydrophobic C terminus folding over this core. The identification of this fundamental sequence and the implied molecular model could facilitate the design of potential inhibitors of amyloidogenesis.	Karolinska Hosp, Dept Clin Neurosci, Sect Drug Dependence Res, Lab Biochem & Mol Pharmacol, S-17176 Stockholm, Sweden; Picower Inst Med Res, Manhasset, NY 11030 USA; Pharmacia & Upjohn Inc, Dept Struct Chem, Mass Spectrometr Sect, S-11287 Stockholm, Sweden; Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Northwell Health; Pfizer; Pharmacia Corporation; Karolinska Institutet	Tjernberg, LO (corresponding author), Karolinska Hosp, Dept Clin Neurosci, Sect Drug Dependence Res, Lab Biochem & Mol Pharmacol, CMM L8-01, S-17176 Stockholm, Sweden.	Lars.Tjernberg@cmm.ki.se						CAMILLERI P, 1994, FEBS LETT, V341, P256, DOI 10.1016/0014-5793(94)80467-2; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CLEMENTS A, 1993, NEUROSCI LETT, V161, P17, DOI 10.1016/0304-3940(93)90129-9; FRASER PE, 1991, J NEUROSCI RES, V28, P474, DOI 10.1002/jnr.490280404; FRASER PE, 1991, BIOPHYS J, V60, P1190, DOI 10.1016/S0006-3495(91)82154-3; GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037; Ghanta J, 1996, J BIOL CHEM, V271, P29525, DOI 10.1074/jbc.271.47.29525; HALVERSON K, 1990, BIOCHEMISTRY-US, V29, P2639, DOI 10.1021/bi00463a003; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; Hughes SR, 1996, P NATL ACAD SCI USA, V93, P2065, DOI 10.1073/pnas.93.5.2065; Inouye H, 1996, CIBA F SYMP, V199, P22; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; LANSBURY PT, 1995, NAT STRUCT BIOL, V2, P990, DOI 10.1038/nsb1195-990; LEE JP, 1995, BIOCHEMISTRY-US, V34, P5191, DOI 10.1021/bi00015a033; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Lundberg KM, 1997, CHEM BIOL, V4, P345, DOI 10.1016/S1074-5521(97)90125-3; MAURY CPJ, 1994, LAB INVEST, V70, P558; Naiki H, 1996, LAB INVEST, V74, P374; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; SIMMONS LK, 1994, MOL PHARMACOL, V45, P373; SMITH CK, 1995, SCIENCE, V270, P980, DOI 10.1126/science.270.5238.980; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1997, J BIOL CHEM, V272, P12601, DOI 10.1074/jbc.272.19.12601; TOMIYAMA T, 1994, BIOCHEM BIOPH RES CO, V204, P76, DOI 10.1006/bbrc.1994.2428; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003; WOUTERS MA, 1995, PROTEINS, V22, P119, DOI 10.1002/prot.340220205; ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508	35	325	348	0	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12619	12625		10.1074/jbc.274.18.12619	http://dx.doi.org/10.1074/jbc.274.18.12619			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212241	hybrid			2022-12-27	WOS:000080056800061
J	Walker, D; Bichet, D; Geib, S; Mori, E; Cornet, V; Snutch, TP; Mori, Y; De Waard, M				Walker, D; Bichet, D; Geib, S; Mori, E; Cornet, V; Snutch, TP; Mori, Y; De Waard, M			A new beta subtype-specific interaction in alpha(1A) subunit controls P/Q-type Ca2+ channel activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE CALCIUM-CHANNEL; FUNCTIONAL EXPRESSION; SKELETAL-MUSCLE; AMINO-TERMINUS; RAT-BRAIN; IDENTIFICATION; HETEROGENEITY; CLONING; BINDING; DOMAIN	The cytoplasmic beta subunit of voltage-dependent calcium channels modulates channel properties in a subtype-specific manner and is important in channel targeting. A high affinity interaction site between the alpha(1) interaction domain (AID) in the I-II cytoplasmic loop of alpha(1) and the beta interaction domain (BID) of the beta subunit is highly conserved among subunit subtypes. We describe a new subtype-specific interaction (Ss1) between the amino-terminal cytoplasmic domain of alpha(1A) (BI-2) and the carboxyl terminus of beta(4). Like the interaction identified previously (21) between the carboxyl termini of alpha(1A) and beta(4) (Ss2), the affinity of this interaction is lower than AID-BID, suggesting that these are secondary interactions. Ss1 and Ss2 involve overlapping sites on beta(4) and are competitive, but neither inhibits the interaction with AID. The interaction with the amino terminus of alpha(1) is isoform-dependent, suggesting a role in the specificity of alpha(1)-beta pairing. Coexpression of beta(4) in Xenopus oocytes produces a reduced hyperpolarizing shift in the I-V curve of the (alpha(1A) channel compared with beta(3) (not exhibiting this interaction). Replacing the amino terminus of alpha(1A) with that of alpha(1c) abolishes this difference. Our data contribute to our understanding of the molecular organization of calcium channels, providing a functional basis for variation in subunit composition of native P/Q-type channels.	INSERM, U464, Inst Federatif Jean Roche, Fac Med Nord, F-13916 Marseille 20, France; Natl Inst Physiol Sci, Dept Informat Physiol, Okazaki, Aichi 444, Japan; Univ British Columbia, Biotechnol Lab, Dept Zool, Vancouver, BC V6T 1Z3, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University of British Columbia	De Waard, M (corresponding author), INSERM, U464, Inst Federatif Jean Roche, Fac Med Nord, Bd Pierre Dramard, F-13916 Marseille 20, France.		De Waard, Michel/G-7406-2014; Snutch, Terrance P/L-3464-2019	De Waard, Michel/0000-0002-2782-9615; Snutch, Terrance P/0000-0001-5182-1296; Walker, Denise/0000-0003-1534-1679; Bichet, Delphine/0000-0002-9601-089X				BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DEWAARD M, 1995, J PHYSIOL-LONDON, V485, P619, DOI 10.1113/jphysiol.1995.sp020757; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; FLOCKERZI V, 1986, NATURE, V323, P66, DOI 10.1038/323066a0; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Liu HY, 1996, J BIOL CHEM, V271, P13804, DOI 10.1074/jbc.271.23.13804; Ludwig A, 1997, J NEUROSCI, V17, P1339; MCENERY MW, 1998, SOC NEUR ABSTR, V24, P81; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Page KM, 1998, J NEUROSCI, V18, P4815; PEREZREYES E, 1990, J BIOL CHEM, V265, P20430; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANAKA O, 1995, MOL BRAIN RES, V30, P1, DOI 10.1016/0169-328X(94)00265-G; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; Wei X, 1996, RECEPTOR CHANNEL, V4, P205; WEI XY, 1994, J BIOL CHEM, V269, P1635; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754; WITCHER DR, 1995, J BIOL CHEM, V270, P18088, DOI 10.1074/jbc.270.30.18088; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0	39	74	76	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12383	12390		10.1074/jbc.274.18.12383	http://dx.doi.org/10.1074/jbc.274.18.12383			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212211	Green Published, hybrid			2022-12-27	WOS:000080056800031
J	Gingras, R; Richard, C; El-Alfy, M; Morales, CR; Potier, M; Pshezhetsky, AV				Gingras, R; Richard, C; El-Alfy, M; Morales, CR; Potier, M; Pshezhetsky, AV			Purification, cDNA cloning, and expression of a new human blood plasma glutamate carboxypeptidase homologous to N-acetyl-aspartyl-alpha-glutamate carboxypeptidase/prostate-specific membrane antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AEROMONAS-PROTEOLYTICA AMINOPEPTIDASE; LYSOSOMAL PROTECTIVE PROTEIN; LINKED ACIDIC DIPEPTIDASE; CATHEPSIN-A; BETA-GALACTOSIDASE; CRYSTAL-STRUCTURE; CLEAVAGE SITES; RAT; ACETYLASPARTYLGLUTAMATE; PEPTIDASE	We describe the identification, cDNA cloning, and biochemical characterization of a new human blood plasma glutamate carboxypeptidase (PGCP), PGCP was co-purified from human placenta with lysosomal carboxypeptidase, cathepsin A, lysosomal endopeptidase, cathepsin D, and a gamma-interferon-inducible protein, IP-30, using an affinity chromatography on a Phe-Leu-agarose column. A PC:CP cDNA was obtained as an expressed sequence tag clone and completed at 5'-end by rapid amplification of cDNA ends polymerase chain reaction. The cDNA contained a 1623-base pair open reading frame predicting a 541-amino acid protein, with five putative Asn glycosylation sites and a al-residue signal peptide. PGCP showed significant amino acid sequence homology to several cocatalytic metallopeptidases including a glutamate carboxypeptidase II also known as N-acetyl-aspartyl-alpha-glutamate carboxypeptidase or as prostate-specific membrane antigen and expressed glutamate carboxypeptidase activity. Expression of the PGCP cDNA in COS-l cells, followed by Western blotting and metabolic labeling showed that PGCP is synthesized as a 62-kDa precursor, which is processed to a 56-kDa mature form containing two Asn-linked oligosaccharide chains. The mature form of PGCP was secreted into the culture medium, which is consistent with its intracellular localization in secretion granules. In humans, PGCP is found principally in blood plasma, suggesting a potential role in the metabolism of secreted peptides.	Univ Montreal, Hop St Justine, Dept Pediat, Serv Genet Med, Montreal, PQ H3T 1C5, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	Universite de Montreal; McGill University	Pshezhetsky, AV (corresponding author), Univ Montreal, Hop St Justine, Dept Pediat, Serv Genet Med, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	alex@jusine.umontreal.ca	Morales, Carlos R./H-1055-2011	A, Pshezhetsky/0000-0002-6612-1062				Ardaillou R, 1997, CURR OPIN NEPHROL HY, V6, P28, DOI 10.1097/00041552-199701000-00006; Ashmarin IP, 1997, NEUROSCI RES COMMUN, V21, P153; BARRETT AJ, 1970, BIOCHEM J, V117, P601, DOI 10.1042/bj1170601; Beinfeld MC, 1997, LIFE SCI, V61, P2359, DOI 10.1016/S0024-3205(97)00644-9; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; BLAKELY RD, 1988, INT REV NEUROBIOL, V30, P39; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bzdega T, 1997, J NEUROCHEM, V69, P2270; Carter RE, 1996, P NATL ACAD SCI USA, V93, P749, DOI 10.1073/pnas.93.2.749; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Chevrier B, 1996, EUR J BIOCHEM, V237, P393, DOI 10.1111/j.1432-1033.1996.0393k.x; COSTA E, 1987, FASEB J, V1, P16, DOI 10.1096/fasebj.1.1.3111927; DAZZO A, 1982, P NATL ACAD SCI-BIOL, V79, P4535, DOI 10.1073/pnas.79.15.4535; Elsliger MA, 1996, BIOCHEMISTRY-US, V35, P14899, DOI 10.1021/bi952833l; Greenblatt HM, 1997, J MOL BIOL, V265, P620, DOI 10.1006/jmbi.1996.0729; HANNA WL, 1994, J IMMUNOL, V153, P4663; HERMO L, 1991, BIOL REPROD, V44, P1113, DOI 10.1095/biolreprod44.6.1113; Heston WDW, 1997, UROLOGY, V49, P104, DOI 10.1016/S0090-4295(97)00177-5; HOOGEVEEN AT, 1983, J BIOL CHEM, V258, P2143; HOOK VYH, 1988, CELL MOL NEUROBIOL, V8, P49, DOI 10.1007/BF00712911; ITOH K, 1995, J BIOL CHEM, V270, P515, DOI 10.1074/jbc.270.2.515; JACKMAN HL, 1992, J BIOL CHEM, V267, P2872; JACKMAN HL, 1990, J BIOL CHEM, V265, P11265; KAWAMURA Y, 1976, J BIOCH, V81, P435; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUSTER AD, 1988, J BIOL CHEM, V263, P12036; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; Maniatis T., 1982, MOL CLONING; MATSUDA K, 1976, J BIOCHEM, V80, P659, DOI 10.1093/oxfordjournals.jbchem.a131325; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Passani LA, 1997, MOL CHEM NEUROPATHOL, V31, P97, DOI 10.1007/BF02815236; PINTO T, 1996, CLIN CANCER RES, P1445; Pshezhetsky AV, 1996, J BIOL CHEM, V271, P28359, DOI 10.1074/jbc.271.45.28359; PSHEZHETSKY AV, 1994, ARCH BIOCHEM BIOPHYS, V313, P64, DOI 10.1006/abbi.1994.1359; PSHEZHETSKY AV, 1995, ANAL BIOCHEM, V230, P303, DOI 10.1006/abio.1995.1478; Rawlings ND, 1997, BBA-PROTEIN STRUCT M, V1339, P247, DOI 10.1016/S0167-4838(97)00008-3; ROBINSON MB, 1987, J BIOL CHEM, V262, P14498; ROME LH, 1979, CELL, V17, P143, DOI 10.1016/0092-8674(79)90302-7; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Shneider BL, 1997, J BIOL CHEM, V272, P31006, DOI 10.1074/jbc.272.49.31006; Skidgel RA, 1998, IMMUNOL REV, V161, P129, DOI 10.1111/j.1600-065X.1998.tb01577.x; SKIDGEL RA, 1992, J CARDIOVASC PHARM, V20, pS4, DOI 10.1097/00005344-199200209-00003; STAUCHSLUSHER B, 1990, J BIOL CHEM, V265, P21297; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	44	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11742	11750		10.1074/jbc.274.17.11742	http://dx.doi.org/10.1074/jbc.274.17.11742			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206990	hybrid			2022-12-27	WOS:000079834800046
J	Han, SK; Kim, KP; Koduri, R; Bittova, L; Munoz, NM; Leff, AR; Wilton, DC; Gelb, MH; Cho, WH				Han, SK; Kim, KP; Koduri, R; Bittova, L; Munoz, NM; Leff, AR; Wilton, DC; Gelb, MH; Cho, WH			Roles of Trp(31) in high membrane binding and proinflammatory activity of human group V phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERIZED MIXED LIPOSOMES; SITE-DIRECTED MUTAGENESIS; INTERFACIAL CATALYSIS; ARACHIDONIC-ACID; CELL-MEMBRANES; COMPETITIVE INHIBITORS; IIA; EXPRESSION; RELEASE; SPECIFICITY	Group V phospholipase A(2) is a recently discovered secretory phospholipase A(2) (PLA(2)) that has been shown to be involved in eicosanoid formation in inflammatory cells, such as macrophages and mast cells. We have demonstrated that human group V PLA(2) (hsPL(2)-V) can bind phosphatidylcholine (PC) membranes and hydrolyze PC substrates much more efficiently than human group IIa PLA(2), which makes it better suited for acting on the outer plasma membrane (Han, S.-K., Yoon, E. T., and Cho, W. (1998) Biochem, J. 331, 353-357). In this study, we demonstrate that exogenous hsPLA(2)-V has much greater activity than does group IIa PLA(2) to release fatty acids from various mammalian cells and to elicit leukotriene B-4 formation from human neutrophils, To understand the molecular basis of these activities, we mutated two surface tryptophans of hsPLA(2)-V to alanine (W31A and W79A) and measured the effects of these mutations on the kinetic activity toward various substrates, on the binding affinity for vesicles and phospholipid-coated beads, on the penetration into phospholipid monolayers, and on the activity to release fatty acids and elicit eicosanoid formation from various mammalian cells. These studies show that the relatively high ability of hsPLA(2)-V to induce cellular eicosanoid formation derives from its high affinity for PC membranes and that Trp(31) on its putative interfacial binding surface plays an important role in its binding to PC vesicles and to the outer plasma membrane.	Univ Illinois, Dept Chem MC111, Chicago, IL 60607 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Chicago, Dept Med, Chicago, IL 60307 USA; Univ Southampton, Dept Biochem, Southampton SO9 3TU, Hants, England	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago; University of Southampton	Cho, WH (corresponding author), Univ Illinois, Dept Chem MC111, 845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu	Bittova, Lenka/K-4375-2015	Bittova, Lenka/0000-0002-3556-5234; gelb, michael/0000-0001-7000-5219; Kim, Kwang Pyo/0000-0003-0095-3787	NHLBI NIH HHS [HL46368, HL36235] Funding Source: Medline; NIGMS NIH HHS [GM52598] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036235, R37HL036235, R01HL046368, R23HL036235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052598] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker SF, 1998, BIOCHEMISTRY-US, V37, P13203, DOI 10.1021/bi981223t; Balboa MA, 1996, J BIOL CHEM, V271, P32381, DOI 10.1074/jbc.271.50.32381; Balsinde J, 1998, P NATL ACAD SCI USA, V95, P7951, DOI 10.1073/pnas.95.14.7951; BARTOLI F, 1994, J BIOL CHEM, V269, P15625; BAYBURT T, 1993, BIOCHEMISTRY-US, V32, P573, DOI 10.1021/bi00053a024; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; CHEN J, 1994, J BIOL CHEM, V269, P2365; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; DECHATELET LR, 1982, INFECT IMMUN, V35, P206, DOI 10.1128/IAI.35.1.206-212.1982; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Ghomashchi F, 1998, BIOCHEMISTRY-US, V37, P6697, DOI 10.1021/bi972525i; Han SK, 1998, BIOCHEM J, V331, P353, DOI 10.1042/bj3310353; Han SK, 1997, J BIOL CHEM, V272, P3573, DOI 10.1074/jbc.272.26.16152; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; JAIN MK, 1991, METHOD ENZYMOL, V197, P112; Kates M., 1986, TECHNIQUES LIPIDOLOG, P114; Kim Y, 1997, ANAL BIOCHEM, V250, P109, DOI 10.1006/abio.1997.2200; Koduri RS, 1998, J BIOL CHEM, V273, P32142, DOI 10.1074/jbc.273.48.32142; Krischer SM, 1998, BIOCHEMISTRY-US, V37, P12884, DOI 10.1021/bi980696x; Lee BI, 1996, BIOCHEMISTRY-US, V35, P4231, DOI 10.1021/bi9524777; Lichtenbergova L, 1998, BIOCHEMISTRY-US, V37, P14128, DOI 10.1021/bi980888s; LIU XH, 1995, BIOCHEMISTRY-US, V34, P7322, DOI 10.1021/bi00022a005; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; MURAKAMI M, 1993, J BIOL CHEM, V268, P839; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Othman R, 1996, BBA-LIPID LIPID MET, V1303, P92, DOI 10.1016/0005-2760(96)00083-5; Reddy ST, 1997, J BIOL CHEM, V272, P13591, DOI 10.1074/jbc.272.21.13591; ROGERS J, 1992, BIOCHEMISTRY-US, V31, P6056, DOI 10.1021/bi00141a014; SCOTT DL, 1994, ADV PROTEIN CHEM, V45, P53; SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070; SHEN Z, 1994, BIOCHEMISTRY-US, V33, P11598, DOI 10.1021/bi00204a022; Snitko Y, 1997, BIOCHEM J, V321, P737, DOI 10.1042/bj3210737; Snitko Y, 1997, BIOCHEMISTRY-US, V36, P14325, DOI 10.1021/bi971200z; THANNHAUSER TW, 1984, ANAL BIOCHEM, V138, P181, DOI 10.1016/0003-2697(84)90786-3; Tischfield JA, 1997, J BIOL CHEM, V272, P17247, DOI 10.1074/jbc.272.28.17247; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; WERY JP, 1991, NATURE, V352, P79, DOI 10.1038/352079a0; WU SK, 1994, ANAL BIOCHEM, V221, P152, DOI 10.1006/abio.1994.1391; WU SK, 1993, BIOCHEMISTRY-US, V32, P13902, DOI 10.1021/bi00213a020; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; YUAN W, 1990, BIOCHEMISTRY-US, V29, P6082, DOI 10.1021/bi00477a028	43	163	163	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11881	11888		10.1074/jbc.274.17.11881	http://dx.doi.org/10.1074/jbc.274.17.11881			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207008	hybrid			2022-12-27	WOS:000079834800064
J	Kallen, KJ; Grotzinger, J; Lelievre, E; Vollmer, P; Aasland, D; Renne, C; Mullberg, J; zum Buschenfelde, KHM; Gascan, H; Rose-John, S				Kallen, KJ; Grotzinger, J; Lelievre, E; Vollmer, P; Aasland, D; Renne, C; Mullberg, J; zum Buschenfelde, KHM; Gascan, H; Rose-John, S			Receptor recognition sites of cytokines are organized as exchangeable modules - Transfer of the leukemia inhibitory factor receptor-binding site from ciliary neurotrophic factor to interleukin-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ONCOSTATIN-M; HEXAMERIC COMPLEX; CNTF RECEPTOR; IN-VITRO; GP130; FAMILY; ANTAGONIST; CELLS; IDENTIFICATION	Interleukin-6 (IL-6) and ciliary neurotrophic factor (CNTF) are "4-helical bundle" cytokines of the IL-6 type family of neuropoietic and hematopoietic cytokines, IL-6 signals by induction of a gp130 homodimer (eg. IL-6), whereas CNTF and leukemia inhibitory factor (LIF) signal via a heterodimer of gp130 and LIF receptor (LIFR). Despite binding to the same receptor component (gp130) and a similar protein structure, IL-6 and CNTF share only 6% sequence identity. Using molecular modeling we defined a putative LIFR binding epitope on CNTF that consists of three distinct regions (C-terminal A-helix/N-terminal AB loop, BC loop, C-terminal CD-loop/N-terminal D-helix), A corresponding gp130-binding site on IL-6 was exchanged with this epitope, The resulting IL-6/CNTF chimera lost the capacity to signal via gp130 on cells without LIFR, but acquired the ability to signal via the gp130/LIFR heterodimer and STATE on responsive cells. Besides identifying a specific LIFR binding epitope on CNTF, our results suggest that receptor recognition sites of cytokines are organized as modules that are exchangeable even between cytokines with limited sequence homology.	Johannes Gutenberg Univ Mainz, Abt Pathophysiol, Med Klin 1, D-55101 Mainz, Germany; Rhein Westfal TH Aachen Klinikum, Inst Biochem, D-52057 Aachen, Germany; CHU Angers, INSERM, F-49033 Angers, France	Johannes Gutenberg University of Mainz; RWTH Aachen University; RWTH Aachen University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Rose-John, S (corresponding author), Johannes Gutenberg Univ Mainz, Abt Pathophysiol, Med Klin 1, Obere Zahlbacher Str 63, D-55101 Mainz, Germany.	rosejohn@mail.uni-mainz.de	Rose-John, Stefan/A-7998-2010; Lelievre, Eric/M-2878-2015	Rose-John, Stefan/0000-0002-7519-3279; lelievre, eric/0000-0002-4132-4023				ALI SA, 1995, BIOTECHNIQUES, V18, P746; Anderson KD, 1996, P NATL ACAD SCI USA, V93, P7346, DOI 10.1073/pnas.93.14.7346; BAUMANN H, 1993, J BIOL CHEM, V268, P8414; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; Chevalier S, 1996, J BIOL CHEM, V271, P14764, DOI 10.1074/jbc.271.25.14764; Ciapponi L, 1995, J BIOL CHEM, V270, P31249, DOI 10.1074/jbc.270.52.31249; CLATTERBUCK RE, 1993, P NATL ACAD SCI USA, V90, P2222, DOI 10.1073/pnas.90.6.2222; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DESERIO A, 1995, J MOL BIOL, V254, P795, DOI 10.1006/jmbi.1995.0655; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DiMarco A, 1996, P NATL ACAD SCI USA, V93, P9247, DOI 10.1073/pnas.93.17.9247; EHLERS M, 1994, J IMMUNOL, V153, P1744; EHLERS M, 1995, J BIOL CHEM, V270, P8158, DOI 10.1074/jbc.270.14.8158; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Fourcin M, 1996, J BIOL CHEM, V271, P11756, DOI 10.1074/jbc.271.20.11756; Funakoshi H, 1998, P NATL ACAD SCI USA, V95, P5269, DOI 10.1073/pnas.95.9.5269; GEARING DP, 1994, P NATL ACAD SCI USA, V91, P1119, DOI 10.1073/pnas.91.3.1119; Grotzinger J, 1997, PROTEINS, V27, P96; HELGREN ME, 1994, CELL, V76, P493, DOI 10.1016/0092-8674(94)90113-9; Hudson KR, 1996, J BIOL CHEM, V271, P11971, DOI 10.1074/jbc.271.20.11971; IBANEZ CF, 1993, EMBO J, V12, P2281, DOI 10.1002/j.1460-2075.1993.tb05882.x; Kallen K J, 1997, Expert Opin Investig Drugs, V6, P237, DOI 10.1517/13543784.6.3.237; Koshimizu U, 1996, DEVELOPMENT, V122, P1235; KRUTTGEN A, 1995, BIOCHEM J, V309, P215; KRUTTGEN A, 1990, FEBS LETT, V262, P323, DOI 10.1016/0014-5793(90)80219-9; LAYTON MJ, 1994, J BIOL CHEM, V269, P29891; LEEBEEK FWG, 1992, J BIOL CHEM, V267, P14832; MCDONALD NQ, 1995, EMBO J, V14, P2689, DOI 10.1002/j.1460-2075.1995.tb07269.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oppmann B, 1996, J IMMUNOL METHODS, V195, P153, DOI 10.1016/0022-1759(96)00110-X; OWCZAREK CM, 1993, EMBO J, V12, P3487, DOI 10.1002/j.1460-2075.1993.tb06023.x; PANAYOTATOS N, 1995, J BIOL CHEM, V270, P14007, DOI 10.1074/jbc.270.23.14007; PAONESSA G, 1995, EMBO J, V14, P1942, DOI 10.1002/j.1460-2075.1995.tb07186.x; Renne C, 1998, J BIOL CHEM, V273, P27213, DOI 10.1074/jbc.273.42.27213; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; Robledo O, 1997, J BIOL CHEM, V272, P4855, DOI 10.1074/jbc.272.8.4855; SAGGIO I, 1995, EMBO J, V14, P3045, DOI 10.1002/j.1460-2075.1995.tb07307.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAVINO R, 1994, EMBO J, V13, P5863, DOI 10.1002/j.1460-2075.1994.tb06931.x; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; Sendtner M, 1996, CURR BIOL, V6, P686, DOI 10.1016/S0960-9822(09)00450-3; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Toniatti C, 1996, EMBO J, V15, P2726, DOI 10.1002/j.1460-2075.1996.tb00633.x; VANDAM M, 1993, J BIOL CHEM, V268, P15285; Vernallis AB, 1997, J BIOL CHEM, V272, P26947, DOI 10.1074/jbc.272.43.26947; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WARD LD, 1994, J BIOL CHEM, V269, P23286; Xu GY, 1997, J MOL BIOL, V268, P468, DOI 10.1006/jmbi.1997.0933; Zhang JG, 1997, BIOCHEM J, V325, P693, DOI 10.1042/bj3250693; ZURAWSKI SM, 1993, EMBO J, V12, P5113, DOI 10.1002/j.1460-2075.1993.tb06206.x	55	85	94	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11859	11867		10.1074/jbc.274.17.11859	http://dx.doi.org/10.1074/jbc.274.17.11859			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207005	hybrid			2022-12-27	WOS:000079834800061
J	Sipma, H; De Smet, P; Sienaert, I; Vanlingen, S; Missiaen, L; Parys, JB; De Smedt, H				Sipma, H; De Smet, P; Sienaert, I; Vanlingen, S; Missiaen, L; Parys, JB; De Smedt, H			Modulation of inositol 1,4,5-trisphosphate binding to the recombinant ligand-binding site of the type-1 inositol 1,4,5-trisphosphate receptor by Ca2+ and calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE S-TRANSFERASES; BASOPHILIC LEUKEMIA-CELLS; SMOOTH-MUSCLE CELLS; TRISPHOSPHATE RECEPTORS; CA2+-INDEPENDENT INHIBITION; CALCIUM RELEASE; CYTOSOLIC CA2+; PH; 1,4,5-TRIPHOSPHATE; MOBILIZATION	A recombinant protein (Lbs-1) containing the N-terminal 581 amino acids of the mouse type 1 inositol 1,4,5-trisphosphate receptor (IP3R-1), including the complete IP3-binding site, was expressed in the soluble fraction of E, coli, The characteristics of IP3 binding to this protein were similar as observed previously for the intact IP3R-1, Ca2+ dose-dependently inhibited IP3 binding to Lbs-1 with an IC50 of about 200 nM. This effect represented a decrease in the affinity of Lbs-1 for IP3, because the K-d increased from 115 +/- 15 nM in the absence to 196 +/- 18 nM in the presence of 5 mu M Ca2+, The maximal effect of Ca2+ on Lbs-1 (5 mu M Ca2+, 42.0 +/- 6.4% inhibition) was similar to the maximal inhibition observed for microsomes of insect Sf9 cells expressing full-length IP3R-1 (33.8 +/- 10.2%), Conceivably, the two contiguous Ca2+-binding sites (residues 304-450 of mouse IP3R-1) previously found by us (Sienaert, I., Missiaen, L., De Smedt, H, Parys, J.B., Sipma, H,, and Casteels, R, (1997) J, Biol Chem. 272, 25899-25906) mediate the effect of Ca2+ on IP3 binding to IP3R-1, Calmodulin also dose-dependently inhibited IP3 binding to Lbs-1 with an IC50 of about 3 mu M Maximal inhibition (10 mu M calmodulin, 43.1 +/- 5.9%) was similar as observed for Sf9-IP3R-1 microsomes (35.8 +/- 8.7%). Inhibition by calmodulin occurred independently of Ca2+ and was additive to the inhibitory effect of 5 mu M Ca2+ (together 74.5 +/- 5.1%). These results suggest that the N-terminal Ligand-binding region of IP3R-1 contains a calmodulin-binding domain that binds calmodulin independently of Ca2+ and that mediates the inhibition of IP3 binding to IP3R-1.	Katholieke Univ Leuven, Fysiol Lab, B-3000 Louvain, Belgium	KU Leuven	De Smedt, H (corresponding author), Katholieke Univ Leuven, Fysiol Lab, Campus Gasthuisberg O-N,Herestr 49, B-3000 Louvain, Belgium.	Humbert.DeSmedt@med.kuleuven.ac.be		Parys, Jan/0000-0002-3591-4967				AWASTHI YC, 1994, INT J BIOCHEM, V26, P295, DOI 10.1016/0020-711X(94)90050-7; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Cardy TJA, 1997, BIOCHEM J, V328, P785, DOI 10.1042/bj3280785; Cardy TJA, 1998, BIOCHEM J, V334, P447, DOI 10.1042/bj3340447; COMBETTES L, 1994, J BIOL CHEM, V269, P17561; DANOFF SK, 1988, BIOCHEM J, V254, P701, DOI 10.1042/bj2540701; DESMEDT H, 1994, J BIOL CHEM, V269, P21691; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GUILLEMETTE G, 1988, MOL ENDOCRINOL, V2, P1249, DOI 10.1210/mend-2-12-1249; HIROTA J, 1995, FEBS LETT, V368, P248, DOI 10.1016/0014-5793(95)00659-W; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; Joseph SK, 1997, J BIOL CHEM, V272, P1579, DOI 10.1074/jbc.272.3.1579; Joseph SK, 1996, CELL SIGNAL, V8, P1, DOI 10.1016/0898-6568(95)02012-8; JOSEPH SK, 1989, BIOCHEM J, V258, P261, DOI 10.1042/bj2580261; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIYAWAKI A, 1991, P NATL ACAD SCI USA, V88, P4911, DOI 10.1073/pnas.88.11.4911; NEWTON CL, 1994, J BIOL CHEM, V269, P28613; PARYS JB, 1992, J BIOL CHEM, V267, P18776; PARYS JB, 1995, CELL CALCIUM, V17, P239, DOI 10.1016/0143-4160(95)90070-5; Patel S, 1997, P NATL ACAD SCI USA, V94, P11627, DOI 10.1073/pnas.94.21.11627; Picard L, 1998, CELL CALCIUM, V23, P339, DOI 10.1016/S0143-4160(98)90029-X; RICHARDSON A, 1993, J BIOL CHEM, V268, P11528; Sienaert I, 1998, PFLUG ARCH EUR J PHY, V436, P40, DOI 10.1007/s004240050602; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; SINGH SV, 1987, BIOCHEM J, V246, P179, DOI 10.1042/bj2460179; Sipma H, 1998, CELL CALCIUM, V23, P11, DOI 10.1016/S0143-4160(98)90070-7; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; TAKAHASHI M, 1994, J BIOL CHEM, V269, P369; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; VANDELDEN C, 1993, J BIOL CHEM, V268, P12443; Vanlingen S, 1997, CELL CALCIUM, V22, P475, DOI 10.1016/S0143-4160(97)90075-0; WORLEY PF, 1987, J BIOL CHEM, V262, P12132; YAMADA M, 1995, BIOCHEM J, V308, P83, DOI 10.1042/bj3080083; Yoneshima H, 1997, BIOCHEM J, V322, P591, DOI 10.1042/bj3220591; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277	36	59	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12157	12162		10.1074/jbc.274.17.12157	http://dx.doi.org/10.1074/jbc.274.17.12157			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207043	hybrid			2022-12-27	WOS:000079834800099
J	Ackermann, EJ; Taylor, JK; Narayana, R; Bennett, CF				Ackermann, EJ; Taylor, JK; Narayana, R; Bennett, CF			The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; ALPHA-INDUCED APOPTOSIS; TNF-INDUCED APOPTOSIS; INDUCED CELL-DEATH; CYTOCHROME-C; GENE-EXPRESSION; INHIBITION; MITOCHONDRIA; PROTEASES	In this study, we utilized potent antisense oligonucleotides to examine the role of two Bcl-2 family members found in human umbilical vein endothelial cells (HUVEC). The first, A1, is thought to be a TNF-alpha-inducible cytoprotective gene, and the second, Bcl-XL, is constitutively expressed. Inhibition of the constitutive levels of Bcl-XL caused 10-25% of the cell population to undergo apoptosis and increased the susceptibility of cells to treatment with low concentrations of staurosporin or ceramide. The caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp(OMe)CH, prevented DNA fragmentation and Delta Ym loss caused by Bcl-XL inhibition or Bcl-XL inhibition combined with staurosporin. However, disruption of Delta Ym caused by Bcl-XL inhibition combined with ceramide treatment was not inhibited by benzyloxycarbonyl-Val-Ala-Asp(OMe)-CH2, although DNA fragmentation was completely prevented. Taken together, these results demonstrate a direct protective role for Bcl-XL under normal resting conditions and under low level apoptotic challenges to HUVEC. Furthermore, Bcl-XL protects cells from caspase-dependent and -independent mechanisms of Delta Ym disruption. In contrast to Bcl-XL, Al inhibition did not show a marked effect on the susceptibility of HUVEC to undergo apoptosis in response to TNF-alpha, ceramide, or staurosporin. These results demonstrate that although Al may be a cytoprotective gene induced by TNF-alpha, it is not primarily responsible for HUVEC resistance to this cytokine.	ISIS Pharmaceut, Dept Mol Pharmacol, Carlsbad, CA 92008 USA	Isis Pharmaceuticals Inc	Ackermann, EJ (corresponding author), ISIS Pharmaceut, Dept Mol Pharmacol, 2280 Faraday Ave, Carlsbad, CA 92008 USA.							Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bach FH, 1997, IMMUNOL TODAY, V18, P483, DOI 10.1016/S0167-5699(97)01129-8; Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; BEDNARCZUK TA, 1991, BIOTECHNIQUES, V10, P478; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BENNETT CF, 1992, MOL PHARMACOL, V41, P1023; BENNETT CF, 1994, J IMMUNOL, V152, P3530; Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; CHIANG MY, 1991, J BIOL CHEM, V266, P18162; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; DEMARIA R, 1997, SCIENCE, V277, P1625; DICKINSON JL, 1995, J BIOL CHEM, V270, P27894, DOI 10.1074/jbc.270.46.27894; Hirsch T, 1997, ONCOGENE, V15, P1573, DOI 10.1038/sj.onc.1201324; Jiang YL, 1998, BIOCHEM BIOPH RES CO, V245, P691, DOI 10.1006/bbrc.1998.8390; Karsan A, 1996, J BIOL CHEM, V271, P27201, DOI 10.1074/jbc.271.44.27201; Karsan A, 1996, BLOOD, V87, P3089, DOI 10.1182/blood.V87.8.3089.bloodjournal8783089; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; LESNIK EA, 1993, BIOCHEMISTRY-US, V32, P7832, DOI 10.1021/bi00081a031; Macho A, 1996, CYTOMETRY, V25, P333, DOI 10.1002/(SICI)1097-0320(19961201)25:4<333::AID-CYTO4>3.0.CO;2-E; Marzo I, 1998, FEBS LETT, V427, P198, DOI 10.1016/S0014-5793(98)00424-4; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; MONIA BP, 1993, J BIOL CHEM, V268, P14514; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X; Shimizu S, 1996, ONCOGENE, V13, P21; Slowik MR, 1997, LAB INVEST, V77, P257; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wiesner DA, 1997, J BIOL CHEM, V272, P9868; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zamzami N, 1998, ONCOGENE, V16, P2265, DOI 10.1038/sj.onc.1201989	40	94	102	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11245	11252		10.1074/jbc.274.16.11245	http://dx.doi.org/10.1074/jbc.274.16.11245			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196212	hybrid			2022-12-27	WOS:000079751900080
J	Doering, T; Holleran, WM; Potratz, A; Vielhaber, G; Elias, PM; Suzuki, K; Sandhoff, K				Doering, T; Holleran, WM; Potratz, A; Vielhaber, G; Elias, PM; Suzuki, K; Sandhoff, K			Sphingolipid activator proteins are required for epidermal permeability barrier formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN STRATUM-CORNEUM; GAUCHER-DISEASE; LYSOSOMAL DEGRADATION; ENZYMATIC-HYDROLYSIS; BETA-GLUCOSIDASE; SAPOSIN-C; DEFICIENCY; GLUCOCEREBROSIDASE; CERAMIDES; PATIENT	The epidermal permeability barrier is maintained by extracellular lipid membranes within the interstices of the stratum corneum, Ceramides, the major components of these multilayered membranes, derive in large part from hydrolysis of glucosylceramides mediated by stratum corneum beta-glucocerebrosidase (beta-GlcCerase), Prosaposin (pSAP) is a large precursor protein that is proteolytically cleaved to form four distinct sphingolipid activator proteins, which stimulate enzymatic hydrolysis of sphingolipids, including glucosylceramide, Recently, pSAP has been eliminated in a mouse model using targeted deletion and homologous recombination. In addition to the extracutaneous findings noted previously, our present data indicate that pSAP deficiency in the epidermis has significant consequences including: 1) an accumulation of epidermal glucosylceramides together with below normal levels of ceramides; 2) alterations in lipids that are bound by ester linkages to proteins of the cornified cell envelope; 3) a thickened stratum lucidum with evidence of scaling; and 4) a striking abnormality in lamellar membrane maturation within the interstices of the stratum corneum. Together, these results demonstrate that the production of pSAP, and presumably mature sphingolipid activator protein generation, is required for normal epidermal barrier formation and function. Moreover, detection of significant amounts of covalently bound omega-OH-GlcCer in pSAP-deficient epidermis suggests that deglucosylation to omega-OH-Cer is not a requisite step prior to covalent attachment of lipid to cornified envelope proteins.	Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; Vet Affairs Med Ctr, Dermatol Serv, San Francisco, CA 94121 USA; Vet Affairs Med Ctr, Res Unit 190, San Francisco, CA 94121 USA; Univ Calif San Francisco, Sch Med, Dept Dermatol, San Francisco, CA 94121 USA; Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27599 USA	University of Bonn; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sandhoff, K (corresponding author), Univ Bonn, Kekule Inst Organ Chem & Biochem, Gerhard-Domagh-Str 1, D-53121 Bonn, Germany.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR019098, P01AR039448] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR39448, AR19098] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BERENT SL, 1981, BIOCHIM BIOPHYS ACTA, V664, P572, DOI 10.1016/0005-2760(81)90134-X; BRADOVA V, 1993, HUM GENET, V92, P143, DOI 10.1007/BF00219682; Chang-Yi Cui, 1997, Journal of Investigative Dermatology, V109, P319, DOI 10.1111/1523-1747.ep12335839; DOWNING DT, 1992, J LIPID RES, V33, P301; ELIAS PM, 1991, ADV LIPID RES, V33, P301; FISCHER G, 1978, BIOCHIM BIOPHYS ACTA, V528, P69, DOI 10.1016/0005-2760(78)90053-X; FU Q, 1994, J MOL NEUROSCI, V5, P59, DOI 10.1007/BF02736694; Fujita N, 1996, HUM MOL GENET, V5, P711, DOI 10.1093/hmg/5.6.711; GRAY GM, 1975, J LIPID RES, V16, P441; HARZER K, 1989, EUR J PEDIATR, V149, P31, DOI 10.1007/BF02024331; HO MW, 1975, FEBS LETT, V53, P243, DOI 10.1016/0014-5793(75)80029-9; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; HOLLERAN WM, 1993, J CLIN INVEST, V91, P1656, DOI 10.1172/JCI116374; HOLLERAN WM, 1990, J LIPID RES, V31, P1655; HOLLERAN WM, 1994, J CLIN INVEST, V93, P1756, DOI 10.1172/JCI117160; HOU SYE, 1991, J INVEST DERMATOL, V96, P215, DOI 10.1111/1523-1747.ep12461361; KLEIN A, 1994, BIOCHEM BIOPH RES CO, V200, P1440, DOI 10.1006/bbrc.1994.1612; Liu YJ, 1998, P NATL ACAD SCI USA, V95, P2503, DOI 10.1073/pnas.95.5.2503; MADISON KC, 1990, J INVEST DERMATOL, V95, P657, DOI 10.1111/1523-1747.ep12514333; Marekov LN, 1998, J BIOL CHEM, V273, P17763, DOI 10.1074/jbc.273.28.17763; MOTTA S, 1993, BIOCHIM BIOPHYS ACTA, V1182, P147, DOI 10.1016/0925-4439(93)90135-N; Oya Y, 1998, ACTA NEUROPATHOL, V96, P29, DOI 10.1007/s004010050857; POULOS A, 1984, BIOCHIM BIOPHYS ACTA, V793, P141, DOI 10.1016/0005-2760(84)90315-1; RAFI MA, 1993, SOMAT CELL MOLEC GEN, V19, P1, DOI 10.1007/BF01233949; ROBSON KJ, 1994, J LIPID RES, V35, P2060; SANDHOFF K, 1995, METABOLIC MOL BASES, P2427; SCHNABEL D, 1991, FEBS LETT, V284, P57, DOI 10.1016/0014-5793(91)80760-Z; Sidransky E, 1996, PEDIATR RES, V39, P134, DOI 10.1203/00006450-199601000-00020; SUZUKI K, 1995, ESSAYS BIOCHEM, V29, P25; TAYAMA M, 1993, BIOCHEM J, V290, P401, DOI 10.1042/bj2900401; Vaccaro AM, 1997, J BIOL CHEM, V272, P16862, DOI 10.1074/jbc.272.27.16862; WEILER S, 1995, PROTEIN SCI, V4, P756; WERTZ PW, 1983, J LIPID RES, V24, P753; WERTZ PW, 1985, J INVEST DERMATOL, V84, P410, DOI 10.1111/1523-1747.ep12265510; WERTZ PW, 1989, J INVEST DERMATOL, V92, P109, DOI 10.1111/1523-1747.ep13071317; WERTZ PW, 1987, BIOCHIM BIOPHYS ACTA, V917, P108, DOI 10.1016/0005-2760(87)90290-6; WERTZ PW, 1983, J LIPID RES, V24, P759; Wilkening G, 1998, J BIOL CHEM, V273, P30271, DOI 10.1074/jbc.273.46.30271	38	109	110	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11038	11045		10.1074/jbc.274.16.11038	http://dx.doi.org/10.1074/jbc.274.16.11038			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196186	Green Published, hybrid			2022-12-27	WOS:000079751900054
J	Sugimoto, Y; Sanuki, S; Ohsako, S; Higashimoto, Y; Kondo, M; Kurawaki, J; Ibrahim, HR; Aoki, T; Kusakabe, T; Koga, K				Sugimoto, Y; Sanuki, S; Ohsako, S; Higashimoto, Y; Kondo, M; Kurawaki, J; Ibrahim, HR; Aoki, T; Kusakabe, T; Koga, K			Ovalbumin in developing chicken eggs migrates from egg white to embryonic organs while changing its conformation and thermal stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINASE-INHIBITOR; TRYPSIN-INHIBITOR; YOLK; SEQUENCES; HEN	Ovalbumin was detected in developing chicken eggs. The large majority of these ovalbumin molecules was found to be in a heat-stable form reminiscent of S-ovalbumin, About 83 and 90% of the ovalbumin population was in a heat-stable form in day 14 or stage 40 amniotic fluid and day 18 or stage 44 egg yolk, respectively, whereas ovalbumin in newly deposited eggs was in the heat-unstable, native form. Purified preparations of stable ovalbumin from egg white and amniotic fluid showed a les's ordered configuration than native ovalbumin, as analyzed by circular dichroism and differential scanning calorimetry. In addition, mass spectrometric analysis exhibited distinct size microheterogeneity between the stable and native forms of ovalbumin, Immunohisotochemical study revealed that ovalbumin was present in the central nervous system and other embryonic organs. These results indicated that egg white ovalbumin migrates into the developing embryo while changing its higher order structure.	Kagoshima Univ, Fac Agr, Dept Biochem Sci & Technol, Kagoshima 8900065, Japan; Natl Inst Environm Studies, Tsukuba, Ibaraki 3050053, Japan; Saga Univ, Fac Sci & Engn, Dept Chem, Saga 8408502, Japan; Kagoshima Univ, Fac Sci, Dept Chem, Kagoshima 8900065, Japan; Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Sericulture, Higashi Ku, Fukuoka 8128581, Japan	Kagoshima University; National Institute for Environmental Studies - Japan; Saga University; Kagoshima University; Kyushu University	Sugimoto, Y (corresponding author), Kagoshima Univ, Fac Agr, Dept Biochem Sci & Technol, 1-21-24 Korimoto, Kagoshima 8900065, Japan.		Ibrahim, Hisham/AAB-3945-2021	Ibrahim, Hisham/0000-0002-7809-900X; Higashimoto, Yuichiro/0000-0003-1382-8598				BAINTNER K, 1974, DEV BIOL, V36, P272, DOI 10.1016/0012-1606(74)90050-5; BURLEY RW, 1989, AVIAN EGG CHEM BIOL, P129; CLARKE EP, 1992, BIOCHIM BIOPHYS ACTA, V1129, P246, DOI 10.1016/0167-4781(92)90498-O; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DIERICH A, 1987, EMBO J, V6, P2305, DOI 10.1002/j.1460-2075.1987.tb02505.x; EGELANDSDAL B, 1980, J FOOD SCI, V45, P570, DOI 10.1111/j.1365-2621.1980.tb04103.x; GANNON F, 1979, NATURE, V278, P428, DOI 10.1038/278428a0; GETTINS P, 1993, BIOESSAYS, V15, P461, DOI 10.1002/bies.950150705; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HASSEL J, 1971, DEV BIOL, V26, P3880; HUNTINGTON JA, 1995, PROTEIN SCI, V4, P613; KAWASAKI ES, 1988, P NATL ACAD SCI USA, V85, P5698, DOI 10.1073/pnas.85.15.5698; Koketsu M., 1997, HEN EGGS THEIR BASIC, P99; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marshall ME, 1951, J BIOL CHEM, V185, P155; MCINDOE WM, 1960, J EMBRYOL EXP MORPH, V8, P47; Mellet P, 1996, J BIOL CHEM, V271, P30311, DOI 10.1074/jbc.271.48.30311; Nguyen L. T. H., 1984, CSIRO Food Research Quarterly, V44, P44; NISBET AD, 1981, EUR J BIOCHEM, V115, P335, DOI 10.1111/j.1432-1033.1981.tb05243.x; OSUGA DT, 1977, FOOD PROTEINS, P209; OUCHTERLONY O, 1949, ACTA PATHOL MIC SC, V26, P507; ROMANOFF AL, 1960, AVIAN EMVRYO STRUCTU, P209; SAITO Z, 1966, CAN J BIOCHEM CELL B, V44, P293, DOI 10.1139/o66-035; Sambrook J., 2002, MOL CLONING LAB MANU; SMITH MB, 1964, AUST J BIOL SCI, V17, P261, DOI 10.1071/BI9640261; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; SUGIMOTO Y, 1989, BIOCHIM BIOPHYS ACTA, V992, P400, DOI 10.1016/0304-4165(89)90104-9; SUGIMOTO Y, 1984, BIOCHIM BIOPHYS ACTA, V788, P117, DOI 10.1016/0167-4838(84)90303-0; Sugimoto Y, 1996, BBA-PROTEIN STRUCT M, V1295, P96; Tatsumi E, 1997, J BIOCHEM, V122, P300; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	32	77	78	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11030	11037		10.1074/jbc.274.16.11030	http://dx.doi.org/10.1074/jbc.274.16.11030			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196185	hybrid			2022-12-27	WOS:000079751900053
J	Han, GM; Hampson, DR				Han, GM; Hampson, DR			Ligand binding to the amino-terminal domain of the mGluR4 subtype of metabotropic glutamate receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY SPLICED FORMS; EXTRACELLULAR DOMAIN; AGONIST SELECTIVITY; HIGH-AFFINITY; LOCALIZATION; EXPRESSION; RAT; CHORIOGONADOTROPIN; HIPPOCAMPUS; MODULATION	The metabotropic glutamate receptor (mGluR) 4 subtype of metabotropic glutamate receptor is a presynaptic receptor that modulates neurotransmitter release. We have characterized the properties of a truncated, epitope-tagged construct containing part of the extracellular amino-terminal domain of mGluR4, The truncated receptor was secreted into the cell culture medium of transfected human embryonic kidney cells. The oligomeric structure of the soluble truncated receptor was assessed by gel electrophoresis. In the presence of high concentrations of a reducing agent, the truncated receptor migrated as a monomer; at lower concentrations of the reducing agent, only higher molecular weight oligomers were observed. Competition binding experiments using the radiolabeled agonist [H-3]L-2-amino-4-phosphonobutyric acid revealed that the rank order of potency of metabotropic ligands at the truncated receptor was similar to that of the full-length membrane-bound receptor. However, the truncated receptor displayed higher affinities for agonists and lower affinities for antagonists compared with the full-length receptor. Deglycosylation produced a shift in the relative molecular weight of the soluble protein from M-r = 71,000 to M-r = 63,000; deglycosylation had no effect on the binding of [H-3]L-2-amino-4-phosphonobutyric acid, indicating that the asparagine-linked carbohydrates are not necessary for agonist binding. These results demonstrate that although the primary determinants of ligand binding to mGluR4 are contained within the first 548 amino acids of the receptor, additional amino acids located downstream of this region may influence the affinity of ligands for the binding site.	Univ Toronto, Fac Pharm, Toronto, ON M5S 252, Canada; Univ Toronto, Dept Pharmacol, Toronto, ON M5S 252, Canada	University of Toronto; University of Toronto	Hampson, DR (corresponding author), Univ Toronto, Fac Pharm, 19 Russell St, Toronto, ON M5S 2S2, Canada.							Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bradley SR, 1996, J NEUROSCI, V16, P2044; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Eriksen L, 1995, BRIT J PHARMACOL, V116, P3279, DOI 10.1111/j.1476-5381.1995.tb15136.x; Everts I, 1997, MOL PHARMACOL, V52, P861, DOI 10.1124/mol.52.5.861; FLOR PJ, 1995, NEUROPHARMACOLOGY, V34, P149, DOI 10.1016/0028-3908(94)00149-M; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; HAMPSON DR, 1994, NEUROSCIENCE, V60, P325, DOI 10.1016/0306-4522(94)90246-1; Hudtloff C, 1998, BRIT J PHARMACOL, V124, P971, DOI 10.1038/sj.bjp.0701910; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; Pekhletski R, 1996, J NEUROSCI, V16, P6364; PERTERSON GL, 1984, P NATL ACAD SCI USA, V81, P4993; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; PICKERING DS, 1993, J NEUROCHEM, V61, P85, DOI 10.1111/j.1471-4159.1993.tb03540.x; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Ryu KS, 1998, J BIOL CHEM, V273, P6285, DOI 10.1074/jbc.273.11.6285; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; TAKAHASHI K, 1993, J BIOL CHEM, V268, P19341; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; Thomsen C, 1999, J NEUROCHEM, V72, P835, DOI 10.1046/j.1471-4159.1999.0720835.x; Thomsen C, 1997, NEUROPHARMACOLOGY, V36, P21, DOI 10.1016/S0028-3908(96)00153-0; Tones MA, 1995, NEUROREPORT, V7, P117, DOI 10.1097/00001756-199512290-00028; WREGGETT KA, 1995, J BIOL CHEM, V270, P22488, DOI 10.1074/jbc.270.38.22488; XIE YB, 1990, J BIOL CHEM, V265, P21411	28	70	82	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10008	10013		10.1074/jbc.274.15.10008	http://dx.doi.org/10.1074/jbc.274.15.10008			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187777	hybrid			2022-12-27	WOS:000079663500016
J	Koseki, T; Inohara, N; Chen, S; Carrio, R; Merino, J; Hottiger, MO; Nabel, GJ; Nunez, G				Koseki, T; Inohara, N; Chen, S; Carrio, R; Merino, J; Hottiger, MO; Nabel, GJ; Nunez, G			CIPER, a novel NF kappa B-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; SIGNALING COMPLEX; APOPTOSIS; TNF; KINASE; FAMILY; INTERACTS; ADAPTER; IL-1; SEQUENCE	We have identified and characterized CIPER, a novel protein containing a caspase recruitment domain (CARD) in its N terminus and a C-terminal region rich in serine and threonine residues. The CARD of CIPER showed striking similarity to E10, a product of the equine herpesvirus-a. CIPER formed homodimers via its CARD and interacted with viral E10 but not with several apoptosis regulators containing CARDs including ARC, RAIDD, RICK, caspase-2, caspase-9, or Apaf-1. Expression of CIPER induced NF-kappa B activation, which was inhibited by dominant-negative NIK and a nonphosphorylable I kappa B-alpha mutant but not by dominant-negative RIP. Mutational analysis revealed that the N-terminal region of CIPER containing the CARD was sufficient and necessary for NF-kappa B-inducing activity. Point mutations in highly conserved residues in the CARD of CIPER disrupted the ability of CIPER to activate NF-kappa B and to form homodimers, indicating that the CARD is essential for NF-kappa B activation and dimerization. We propose that CIPER acts in a NIK-dependent pathway of NF-kappa B activation.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Cantabria, Dept Mol Biol, Unidad Inmunol, Santander 39011, Spain	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universidad de Cantabria	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.		Hottiger, Michael O./J-7747-2013; Nuñez, Gabriel/A-7160-2014	Hottiger, Michael O./0000-0002-7323-2270; Carrio, Roberto/0000-0001-5527-8403	NATIONAL CANCER INSTITUTE [R01CA064556, K04CA064421] Funding Source: NIH RePORTER; NCI NIH HHS [CA-64556, CA-64421] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; HSU M, 1996, IMMUNITY, V4, P387; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; INNIS MA, 1990, PCR PROTOCOLS GUIDE, P177; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; Inohara N, 1998, J BIOL CHEM, V273, P8705, DOI 10.1074/jbc.273.15.8705; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; ITOH N, 1993, J BIOL CHEM, V268, P10932; LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Shaham S, 1996, GENE DEV, V10, P578, DOI 10.1101/gad.10.5.578; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; TELFORD EAR, 1995, J MOL BIOL, V249, P520, DOI 10.1006/jmbi.1995.0314; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Ware Carl F., 1998, P549; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Yang XL, 1998, SCIENCE, V281, P1355, DOI 10.1126/science.281.5381.1355; ZANDI E, 1997, CELL, V91, P245	38	132	141	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					9955	9961		10.1074/jbc.274.15.9955	http://dx.doi.org/10.1074/jbc.274.15.9955			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187770	hybrid			2022-12-27	WOS:000079663500009
J	Matsushita, M; Nairn, AC				Matsushita, M; Nairn, AC			Inhibition of the Ca2+/calmodulin-dependent protein kinase I cascade by cAMP-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY INTERACTION; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; INTRASTERIC REGULATION; BRAIN CALMODULIN; CDNA CLONING; RAT-BRAIN; PHOSPHORYLATION; ACTIVATION	Several recent studies have shown that Ca2+/calmodulin-dependent protein kinase I (CaMKI) is phosphorylated and activated by a protein kinase (CaMKK) that is itself subject to regulation by Ca2+/calmodulin. In the present study, we demonstrate that this enzyme cascade is regulated by cAMP-mediated activation of cAMP-dependent protein kinase (PKA), In vitro, CaMKK is phosphorylated by PKA and this is associated with inhibition of enzyme activity. The major site of phosphorylation is threonine 108, although additional sites are phosphorylated with lower efficiency. In vitro, CaMKK is also phosphorylated by CaMKI at the same sites as PKA, suggesting that this regulatory phosphorylation might play a role as a negative-feedback mechanism, In intact PC12 cells, activation of PKA with forskolin resulted in a rapid inhibition of both CaMKK and CaMKI activity. In hippocampal slices CaMKK was phosphorylated under basal conditions, and activation of PKA led to an increase in phosphorylation. Two-dimensional phosphopeptide mapping indicated that activation of PKA led to increased phosphorylation of multiple sites including threonine 108. These results indicate that in vitro and in intact cells the CaMKK/CaMKI cascade is subject to inhibition by PKA-mediated phosphorylation of CaMKK. The phosphorylation and inhibition of CaMKK by PKA is likely to be involved in modulating the balance between cAMP- and Ca2+-dependent signal transduction pathways.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Rockefeller University	Nairn, AC (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10021 USA.	nairn@rockvax.rockefeller.edu		Nairn, Angus/0000-0002-7075-0195				Aletta JM, 1996, J BIOL CHEM, V271, P20930, DOI 10.1074/jbc.271.34.20930; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Bardwell L, 1996, MOL CELL BIOL, V16, P3637; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Brunet A, 1996, SCIENCE, V272, P1652, DOI 10.1126/science.272.5268.1652; BURNS F, 1996, INTRACELLULAR SIGNAL, P29; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Chin D, 1997, J BIOL CHEM, V272, P31235, DOI 10.1074/jbc.272.50.31235; Clancy CE, 1997, J BIOL CHEM, V272, P11812, DOI 10.1074/jbc.272.18.11812; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Cote GP, 1997, J BIOL CHEM, V272, P6846, DOI 10.1074/jbc.272.11.6846; CRUZALEGUI FH, 1993, J BIOL CHEM, V268, P26171; CRUZALEGUI FH, 1992, P NATL ACAD SCI USA, V89, P12127, DOI 10.1073/pnas.89.24.12127; DEREMER MF, 1992, J BIOL CHEM, V267, P13466; Edelman AM, 1996, J BIOL CHEM, V271, P10806, DOI 10.1074/jbc.271.18.10806; ENSLEN H, 1995, BIOCHEM BIOPH RES CO, V207, P1038, DOI 10.1006/bbrc.1995.1289; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; ERREDE B, 1993, NATURE, V362, P261, DOI 10.1038/362261a0; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; GRAND RJA, 1979, BIOCHEM J, V177, P521, DOI 10.1042/bj1770521; Greengard P, 1998, BRAIN RES REV, V26, P274, DOI 10.1016/S0165-0173(97)00057-X; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; Herberg FW, 1997, PROTEIN SCI, V6, P569; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; KEMP BE, 1991, BIOCHIM BIOPHYS ACTA, V1094, P67, DOI 10.1016/0167-4889(91)90027-U; KEMP BE, 1990, PEPTIDES PROTEIN PHO; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; LEE JC, 1995, BIOCHEM BIOPH RES CO, V210, P631, DOI 10.1006/bbrc.1995.1705; LEE JC, 1994, P NATL ACAD SCI USA, V91, P6413, DOI 10.1073/pnas.91.14.6413; Mahalingam M, 1996, MOL CELL BIOL, V16, P405; Matsushita M, 1998, J BIOL CHEM, V273, P21473, DOI 10.1074/jbc.273.34.21473; MITSUI K, 1993, J BIOL CHEM, V268, P13422; MOCHIZUKI H, 1993, BIOCHEM BIOPH RES CO, V197, P1595, DOI 10.1006/bbrc.1993.2661; NAIRN AC, 1987, J BIOL CHEM, V262, P7273; NAIRN AC, 1994, SEMIN CANCER BIOL, V5, P407; NAIRN AC, 1996, TRANSLATIONAL CONTRO, P295; OKUNO S, 1993, J BIOCHEM-TOKYO, V114, P167, DOI 10.1093/oxfordjournals.jbchem.a124149; OKUNO S, 1995, J BIOCHEM-TOKYO, V117, P686, DOI 10.1093/oxfordjournals.jbchem.a124764; PICCIOTTO MR, 1995, SYNAPSE, V20, P75, DOI 10.1002/syn.890200111; PICCIOTTO MR, 1993, J BIOL CHEM, V268, P26512; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; PICCIOTTO MR, 1996, INTRACELLULAR SIGNAL, P251; Pickett-Gies CA., 1986, ENZYMES, V17, P395; Redpath NT, 1996, J BIOL CHEM, V271, P17547, DOI 10.1074/jbc.271.29.17547; REDPATH NT, 1993, BIOCHEM J, V293, P31, DOI 10.1042/bj2930031; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Soderling TR, 1996, BBA-PROTEIN STRUCT M, V1297, P131, DOI 10.1016/S0167-4838(96)00105-7; SUGITA R, 1994, BIOCHEM BIOPH RES CO, V203, P694, DOI 10.1006/bbrc.1994.2238; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; Tokumitsu H, 1997, BIOCHEMISTRY-US, V36, P12823, DOI 10.1021/bi971348i; TOKUMITSU H, 1994, J BIOL CHEM, V269, P28640; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4360; Watanabe S, 1996, J BIOL CHEM, V271, P6903, DOI 10.1074/jbc.271.12.6903; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; YOKOKURA H, 1995, J BIOL CHEM, V270, P23851, DOI 10.1074/jbc.270.40.23851; Yokokura H, 1997, BBA-PROTEIN STRUCT M, V1338, P8, DOI 10.1016/S0167-4838(97)00004-6; ZHOU ZQ, 1993, MOL CELL BIOL, V13, P2069, DOI 10.1128/MCB.13.4.2069	68	63	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10086	10093		10.1074/jbc.274.15.10086	http://dx.doi.org/10.1074/jbc.274.15.10086			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187789	hybrid			2022-12-27	WOS:000079663500028
J	Zou, YZ; Komuro, I; Yamazaki, T; Kudoh, S; Uozumi, H; Kadowaki, T; Yazaki, Y				Zou, YZ; Komuro, I; Yamazaki, T; Kudoh, S; Uozumi, H; Kadowaki, T; Yazaki, Y			Both G(s) and G(i) proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; INDUCED CARDIAC-HYPERTROPHY; BETA-ADRENERGIC-RECEPTOR; ACTIVATES MAP KINASE; TYROSINE KINASE; PERTUSSIS-TOXIN; GROWTH-FACTOR; SRC FAMILY; CYCLIC-AMP; DEPENDENT ACTIVATION	Activation of beta-adrenoreceptors induces cardiomyocyte hypertrophy. In the present study, we examined isoproterenol-evoked intracellular signal transduction pathways leading to activation of extracellular signal-regulated kinases (ERKs) and cardiomyocyte hypertrophy. Inhibitors for cAMP and protein kinase A (PKA) abolished isoproterenol-evoked ERK activation, suggesting that G(s) protein is involved in the activation. Inhibition of G(i) protein by pertussis toxin, however, also suppressed isoproterenol-induced ERK activation. Overexpression of the G(beta gamma) subunit binding domain of the beta-adrenoreceptor kinase 1 and of COOH-terminal Src kinase, which inhibit functions of G(beta gamma) and the Src family tyrosine kinases, respectively, also inhibited isoproterenol-induced ERR activation. Overexpression of dominant-negative mutants of Ras and Raf-1 kinase and of the beta-adrenoreceptor mutant that lacks phosphorylation sites by PICA abolished isoproterenol-stimulated ERK activation. The isoproterenol-induced increase in protein synthesis was also suppressed by inhibitors for PRA, G(i), tyrosine kinases, or Ras. These results suggest that isoproterenol induces ERR activation and cardiomyocyte hypertrophy through two different G proteins, G(s) and G(i). cAMP-dependent PKA activation through G(s), may phosphorylate the beta-adrenoreceptor, leading to coupling of the receptor from G(s) to G(i). Activation of G(i) activates ERKs through G(beta gamma), Src family tyrosine kinases, Ras, and Raf-1 kinase.	Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Hlth Serv Ctr, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Komuro, I (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.							ABRAMSON SN, 1988, BIOCHEM PHARMACOL, V37, P4289, DOI 10.1016/0006-2952(88)90609-0; Bogoyevitch MA, 1996, BIOCHEM J, V314, P115, DOI 10.1042/bj3140115; BRAND T, 1993, J MOL CELL CARDIOL, V25, P1325, DOI 10.1006/jmcc.1993.1145; BURGERING BMT, 1993, EMBO J, V12, P4211, DOI 10.1002/j.1460-2075.1993.tb06105.x; CHEN YH, 1994, J BIOL CHEM, V269, P27372; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; CRESPO P, 1995, J BIOL CHEM, V270, P25259, DOI 10.1074/jbc.270.42.25259; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; ECKEL J, 1985, AM J PHYSIOL, V249, pH212, DOI 10.1152/ajpheart.1985.249.2.H212; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; FAURE M, 1995, MOL BIOL CELL, V6, P1025, DOI 10.1091/mbc.6.8.1025; FAURE M, 1994, J BIOL CHEM, V269, P7851; FRODIN M, 1994, J BIOL CHEM, V269, P6207; GILLESPIEBROWN J, 1995, J BIOL CHEM, V270, P28092; GRAHAM RM, 1990, CLEV CLIN J MED, V57, P481; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; HATA A, 1994, MOL CELL BIOL, V14, P7306, DOI 10.1128/MCB.14.11.7306; HAUSDORFF WP, 1989, CELL SIGNAL, V1, P377, DOI 10.1016/0898-6568(89)90056-9; HEIDEMANN SR, 1985, J CELL BIOL, V100, P916, DOI 10.1083/jcb.100.3.916; HORDIJIK PL, 1994, J BIOL CHEM, V269, P35334; INGLESE J, 1994, P NATL ACAD SCI USA, V91, P3637, DOI 10.1073/pnas.91.9.3637; Jones LG, 1996, LIFE SCI, V58, P617, DOI 10.1016/0024-3205(95)02323-2; KARLINER JS, 1990, EXPERIENTIA, V46, P81, DOI 10.1007/BF01955423; KENT RL, 1989, CIRC RES, V64, P74, DOI 10.1161/01.RES.64.1.74; KINUGAWA KI, 1995, CARDIOVASC RES, V30, P419, DOI 10.1016/S0008-6363(95)00063-1; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LAKS MM, 1973, CHEST, V64, P75, DOI 10.1378/chest.64.1.75; LETTERIO JJ, 1986, SCIENCE, V234, P1117, DOI 10.1126/science.3465038; LONNQVIST F, 1989, BIOCHEM BIOPH RES CO, V161, P654, DOI 10.1016/0006-291X(89)92649-1; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MCDERMOTT PJ, 1989, CIRC RES, V64, P542, DOI 10.1161/01.RES.64.3.542; MCKEE EE, 1978, J BIOL CHEM, V253, P1030; MILANO CA, 1994, P NATL ACAD SCI USA, V91, P10109, DOI 10.1073/pnas.91.21.10109; MORGAN HE, 1991, CIRCULATION, V83, P13, DOI 10.1161/01.CIR.83.1.13; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; OKADA M, 1991, J BIOL CHEM, V266, P24249; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Sadoshima J, 1996, EMBO J, V15, P775, DOI 10.1002/j.1460-2075.1996.tb00413.x; SATOH T, 1992, J BIOL CHEM, V267, P24149; SCHORB W, 1994, J BIOL CHEM, V269, P19626; Sexl V, 1997, J BIOL CHEM, V272, P5792, DOI 10.1074/jbc.272.9.5792; SIMPSON P, 1983, J CLIN INVEST, V72, P732, DOI 10.1172/JCI111023; SIRI FM, 1988, AM J PHYSIOL, V255, pH452, DOI 10.1152/ajpheart.1988.255.3.H452; SLOTKIN TA, 1995, TOXICOL APPL PHARM, V133, P188, DOI 10.1006/taap.1995.1141; STRULOVICI B, 1984, SCIENCE, V225, P837, DOI 10.1126/science.6089331; TERZIC A, 1993, PHARMACOL REV, V45, P147; THORBURN A, 1994, BIOCHEM BIOPH RES CO, V205, P1417, DOI 10.1006/bbrc.1994.2823; VAN BT, 1995, NATURE, V376, P781; VAN CE, 1989, CELL, V59, P45; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wan Y, 1998, J BIOL CHEM, V273, P14533, DOI 10.1074/jbc.273.23.14533; WIESNER RJ, 1991, AM J PHYSIOL, V260, pL179, DOI 10.1152/ajplung.1991.260.4.L179; XIAO RP, 1995, MOL PHARMACOL, V47, P322; Yamazaki T, 1997, CIRCULATION, V95, P1260; YAO H, 1995, J BIOL CHEM, V270, P20748, DOI 10.1074/jbc.270.35.20748; ZIERHUT W, 1989, CIRC RES, V65, P1417, DOI 10.1161/01.RES.65.5.1417; Zou YZ, 1996, J BIOL CHEM, V271, P33592, DOI 10.1074/jbc.271.52.33592; Zou YZ, 1998, CIRC RES, V82, P337, DOI 10.1161/01.RES.82.3.337	63	131	138	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9760	9770		10.1074/jbc.274.14.9760	http://dx.doi.org/10.1074/jbc.274.14.9760			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092665	hybrid			2022-12-27	WOS:000079451800084
J	Zhou, XJ; Liao, J; Hu, LR; Feng, L; Omary, MB				Zhou, XJ; Liao, J; Hu, LR; Feng, L; Omary, MB			Characterization of the major physiologic phosphorylation site of human keratin 19 and its role in filament organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; DEPENDENT PROTEIN-KINASE; INTERMEDIATE FILAMENTS; CULTURED-CELLS; OKADAIC ACID; IN-VITRO; EXPRESSION; CYTOKERATIN; DISEASE; MOUSE	Keratin polypeptide 19 (K19) is a type I intermediate filament protein that is expressed in stratified and simple-type epithelia, Little is known regarding K19 regulation or function, and the only other type I keratin that has been studied in terms of regulation is keratin 18 (K18), We characterized K19 phosphorylation as a handle to study its function. In vivo, serine is the major phosphorylated residue, and phosphopeptide mapping of (PO4)-P-32-labeled K19 generates one major phosphopeptide. Edman degradation suggested that the radiolabeled phosphopeptide represents K19 Ser-10 and/or Ser-35 phosphorylation, Mutation of Ser-10 or Ser-35 followed by transfection confirmed that Ser-35 is the major K19 phosphorylation site. Transfection of Ser-35 --> Ala K19 showed a filament assembly defect as compared with normal or with Ser-10 --> Ala K19, Comparison of K18 and K19 phosphorylation features in interphase cells showed that both are phosphorylated primarily at a single site, preferentially in the soluble versus the insoluble keratin fractions. K19 has higher basal phosphorylation, whereas K18 phosphorylation is far more sensitive to phosphatase type I and IIA inhibition. Our results demonstrate that Ser-35 is the major K19 interphase phosphorylation site and that it plays a role in keratin filament assembly. K19 and K18 phosphorylations share some features but also have distinct properties that suggest different regulation of type I keratins within the same cells.	Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94303 USA; Stanford Univ, Ctr Digest Dis, Palo Alto, CA 94304 USA; CLONTECH Labs, Palo Alto, CA 94303 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Omary, MB (corresponding author), Palo Alto Vet Affairs Med Ctr, 154J,3801 Miranda Ave, Palo Alto, CA 94304 USA.			Omary, Bishr/0000-0002-8624-2347	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007056, P30DK038707, R01DK047918] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47918, DK38707, DK07056] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BADER BL, 1986, EMBO J, V5, P1865, DOI 10.1002/j.1460-2075.1986.tb04438.x; BADER BL, 1988, EUR J CELL BIOL, V47, P300; BERSHADSKY AD, 1988, CYTOSKELETON, P1; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BOTTGER V, 1995, EUR J BIOCHEM, V231, P475, DOI 10.1111/j.1432-1033.1995.tb20721.x; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CHOU CF, 1993, J BIOL CHEM, V268, P4465; ECKERT RL, 1988, P NATL ACAD SCI USA, V85, P1114, DOI 10.1073/pnas.85.4.1114; ERIKSSON J E, 1992, Current Opinion in Cell Biology, V4, P99, DOI 10.1016/0955-0674(92)90065-K; Fradette J, 1998, J BIOL CHEM, V273, P35176, DOI 10.1074/jbc.273.52.35176; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; GILMARTIN ME, 1980, J INVEST DERMATOL, V75, P211, DOI 10.1111/1523-1747.ep12522887; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; Inagaki M, 1996, BIOESSAYS, V18, P481, DOI 10.1002/bies.950180610; KASAHARA K, 1993, J BIOL CHEM, V268, P23531; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Ku NO, 1996, CANCER METAST REV, V15, P429, DOI 10.1007/BF00054011; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Ku NO, 1997, J BIOL CHEM, V272, P7556, DOI 10.1074/jbc.272.11.7556; KU NO, 1995, J CELL BIOL, V131, P1303, DOI 10.1083/jcb.131.5.1303; KU NO, 1994, J CELL BIOL, V127, P161, DOI 10.1083/jcb.127.1.161; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMB NJC, 1989, J CELL BIOL, V108, P2409, DOI 10.1083/jcb.108.6.2409; LEUBE RE, 1986, DIFFERENTIATION, V33, P69, DOI 10.1111/j.1432-0436.1986.tb00412.x; Liao J, 1996, ELECTROPHORESIS, V17, P1671, DOI 10.1002/elps.1150171104; Liao J, 1996, J CELL BIOL, V133, P345, DOI 10.1083/jcb.133.2.345; LIAO J, 1995, J CELL BIOL, V131, P1291, DOI 10.1083/jcb.131.5.1291; LOWTHERT LA, 1995, BIOCHEM BIOPH RES CO, V206, P370, DOI 10.1006/bbrc.1995.1051; LUSSIER M, 1989, GENE, V85, P435, DOI 10.1016/0378-1119(89)90437-X; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; Michel M, 1996, J CELL SCI, V109, P1017; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MOLL R, 1990, J CELL BIOL, V111, P567, DOI 10.1083/jcb.111.2.567; NARISAWA Y, 1994, J INVEST DERMATOL, V103, P191, DOI 10.1111/1523-1747.ep12392730; Omary M B, 1998, Subcell Biochem, V31, P105; Omary MB, 1997, HEPATOLOGY, V25, P1043, DOI 10.1002/hep.510250537; OSHIMA RG, 1982, J BIOL CHEM, V257, P3414; OSHIMA RG, 1986, DIFFERENTIATION, V33, P61, DOI 10.1111/j.1432-0436.1986.tb00411.x; STASIAK PC, 1987, NUCLEIC ACIDS RES, V15, P10058, DOI 10.1093/nar/15.23.10058; STASIAK PC, 1989, J INVEST DERMATOL, V92, P707, DOI 10.1111/1523-1747.ep12721500; STEINERT PM, 1982, BIOCHEMISTRY-US, V21, P177, DOI 10.1021/bi00530a030; STEINERT PM, 1988, J BIOL CHEM, V263, P13333; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; STEINERT PM, 1993, TRENDS GENET, V9, P280, DOI 10.1016/0168-9525(93)90014-9; YANO T, 1991, EUR J BIOCHEM, V197, P281, DOI 10.1111/j.1432-1033.1991.tb15909.x	46	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12861	12866		10.1074/jbc.274.18.12861	http://dx.doi.org/10.1074/jbc.274.18.12861			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212274	hybrid			2022-12-27	WOS:000080056800094
J	Graether, SP; DeLuca, CI; Baardsnes, J; Hill, GA; Davies, PL; Jia, ZC				Graether, SP; DeLuca, CI; Baardsnes, J; Hill, GA; Davies, PL; Jia, ZC			Quantitative and qualitative analysis of type III antifreeze protein structure and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ICE; BINDING; IDENTIFICATION; SURFACE	Some cold water marine fishes avoid cellular damage because of freezing by expressing antifreeze proteins (AFPs) that bind to ice and inhibit its growth; one such protein is the globular type III AFP from eel pout. Despite several studies, the mechanism of ice binding remains unclear because of the difficulty in modeling the AFP-ice interaction. To further explore the mechanism, we have determined the x-ray crystallographic structure of 10 type III AFP mutants and combined that information with 7 previously determined structures to mainly analyze specific AFP-ice interactions such as hydrogen bonds. Quantitative assessment of binding was performed using a neural network with properties of the structure as input and predicted antifreeze activity as output. Using the cross-validation method, a correlation coefficient of 0.60 was obtained between measured and predicted activity, indicating successful learning and good predictive power. A large loss in the predictive power of the neural network occurred after properties related to the hydrophobic surface were left out, suggesting that van der Waal's interactions make a significant contribution to ice binding. By combining the analysis of the neural network with antifreeze activity and x-ray crystallographic structures of the mutants, we extend the existing ice-binding model to a two step process: 1) probing of the surface for the correct ice-binding plane by hydrogen-bonding side chains and 2) attractive van der Waal's interactions between the other residues of the ice-binding surface and the ice, which increases the strength of the protein-ice interaction.	Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Jia, ZC (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.		Graether, Steffen P./AFU-0892-2022; Graether, Steffen P./AAR-8849-2021	Graether, Steffen P./0000-0002-2356-3936; Graether, Steffen P./0000-0002-2356-3936				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1992, XPLOR MANUAL VERSION; CHAO H, 1993, PROTEIN SCI, V2, P1411, DOI 10.1002/pro.5560020906; CHAO H, 1994, PROTEIN SCI, V3, P1760, DOI 10.1002/pro.5560031016; Chao HM, 1997, BIOCHEMISTRY-US, V36, P14652, DOI 10.1021/bi970817d; Davies PL, 1997, CURR OPIN STRUC BIOL, V7, P828, DOI 10.1016/S0959-440X(97)80154-6; DeLuca CI, 1998, J MOL BIOL, V275, P515, DOI 10.1006/jmbi.1997.1482; Haymet ADJ, 1998, FEBS LETT, V430, P301, DOI 10.1016/S0014-5793(98)00652-8; HINTZE J, 1998, NCSS STAT PACKAGE; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Hotelling H, 1933, J EDUC PSYCHOL, V24, P498, DOI 10.1037/h0070888; Jia ZC, 1996, NATURE, V384, P285, DOI 10.1038/384285a0; JIA ZC, 1995, PROTEIN SCI, V4, P1236, DOI 10.1002/pro.5560040621; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Muller B., 1995, NEURAL NETWORKS INTR; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRESNELL SR, 1993, ANNU REV BIOPH BIOM, V22, P283, DOI 10.1146/annurev.bb.22.060193.001435; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; SOENNICHSEN FD, 1996, STRUCTURE LOND, V4, P1325, DOI 10.1016/S0969-2126(96)00140-2; WISHART DS, 1994, VADAR COMPREHENSIVE; Yang DSC, 1998, BIOPHYS J, V74, P2142, DOI 10.1016/S0006-3495(98)77923-8; Ye QL, 1998, ACTA CRYSTALLOGR D, V54, P700, DOI 10.1107/S0907444997020040; ZELL A, 1991, INFORMATIK FACHBERIC, V285, P254	26	64	70	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11842	11847		10.1074/jbc.274.17.11842	http://dx.doi.org/10.1074/jbc.274.17.11842			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207002	hybrid			2022-12-27	WOS:000079834800058
J	Hashida-Okumura, A; Okumura, N; Iwamatsu, A; Buijs, RM; Romijn, HJ; Nagai, K				Hashida-Okumura, A; Okumura, N; Iwamatsu, A; Buijs, RM; Romijn, HJ; Nagai, K			Interaction of neuronal nitric-oxide synthase with alpha 1-syntrophin in rat brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; NERVOUS-SYSTEM; DYSTROPHIN; LOCALIZATION; SYNTROPHIN; PROTEIN; COLOCALIZATION; RELEASE	Neuronal nitric-oxide synthase (nNOS) has a PSD-95/ Dlg/ZO-1 (PDZ) domain that can interact with multiple proteins. nNOS has been known to interact with PSD-95 and a related protein, PSD-93, in brain and with alpha 1-syntrophin in skeletal muscle in mammals. In this study, we have purified an nNOS-interacting protein from bovine brain using an affinity column made of Sepharose conjugated with glutathione S-transferase-rat nNOS fusion protein and identified it as alpha 1-syntrophin by microsequencing. Immunostaining of primary cultures of rat embryonic brain neuronal cells with antibodies against these proteins showed that nNOS and alpha 1-syntrophin were colocalized in neuronal cell bodies and neurites. Immunohistochemical analysis indicated that the nNOS- and alpha 1-syntrophin-like immunoreactive substances were highly expressed in the rat hypothalamic suprachiasmatic nucleus (SCN) and paraventricular nucleus. In the SCN, nNOS- and alpha 1-syntrophin-like immunoreactive substances were colocalized in the same neurons as detected by confocal microscopy. These results indicate that nNOS in brain interacts with alpha 1-syntrophin in specific neurons of the SCN and paraventricular nucleus and that this interaction might play a physiological role in functions of these neurons.	Osaka Univ, Inst Prot Res, Div Prot Metab, Osaka 5650871, Japan; Kirin Brewery Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Kanagawa 2360004, Japan; Netherlands Inst Res, NL-1105 AZ Amsterdam Zuidoost, Netherlands	Osaka University; Kirin Brewery Company Limited	Hashida-Okumura, A (corresponding author), Osaka Univ, Inst Prot Res, Div Prot Metab, 3-2 Yamada Oka, Osaka 5650871, Japan.		Buijs, Rudolf/AAD-5707-2020					ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; AHN AH, 1995, J CELL BIOL, V128, P363, DOI 10.1083/jcb.128.3.363; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Gorecki DC, 1997, EUR J NEUROSCI, V9, P965, DOI 10.1111/j.1460-9568.1997.tb01447.x; HECKER M, 1994, J NEUROCHEM, V62, P1524; Iwamatsu A, 1996, J BIOCHEM-TOKYO, V120, P29; KALSBEEK A, 1992, BRAIN RES, V580, P62, DOI 10.1016/0006-8993(92)90927-2; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; LIDOV HGW, 1990, NATURE, V348, P725, DOI 10.1038/348725a0; MASUTANI H, 1994, BIOL RHYTHM RES, V25, P433, DOI 10.1080/09291019409360313; MATSUMINE A, 1996, SCIENCE, V272, P974; Nagai K, 1996, PROG BRAIN RES, V111, P253, DOI 10.1016/S0079-6123(08)60413-6; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; REUSS S, 1995, BRAIN RES, V695, P257, DOI 10.1016/0006-8993(95)00829-F; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; SCHMIDT HHHW, 1992, J HISTOCHEM CYTOCHEM, V40, P1439, DOI 10.1177/40.10.1382087; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Zhang K, 1997, AM J PHYSIOL-REG I, V273, pR864, DOI 10.1152/ajpregu.1997.273.3.R864	25	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11736	11741		10.1074/jbc.274.17.11736	http://dx.doi.org/10.1074/jbc.274.17.11736			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206989	hybrid			2022-12-27	WOS:000079834800045
J	Hoth, S; Hedrich, R				Hoth, S; Hedrich, R			Distinct molecular bases for pH sensitivity of the guard cell K+ channels KST1 and KAT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING POTASSIUM CHANNEL; INWARD RECTIFIER; ELECTROSTATIC INTERACTIONS; FUNCTIONAL EXPRESSION; IDENTIFICATION; SELECTIVITY; ACTIVATION; MUTATIONS; SUBUNITS; CURRENTS	Acid-induced potassium uptake through Kt channels is a prerequisite for stomatal opening. Our previous studies identified a pore histidine as a major component of the acid activation mechanism of the potato guard cell K+ channel KST1 (1), Although this histidine is highly conserved among all plant K+ uptake channels cloned so far, the pH-dependent gating of the Arabidopsis thaliana guard cell K+ channel KAT1 was not affected by mutations of this histidine, In both channels, KST1 and KAT1, aspartate mutants in the K+ channel consensus sequence GYGD adjacent to the histidine (KST1-D269N and KAT1-D265N) were inhibited by a rise in the extracellular proton concentration. pH changes affected the half-maximal activation voltage Vim of the KST1 mutant, whereas in the mutant channel KAT1-D265N an acid-induced decrease in the maximum conductance g(max) indicated the presence of a proton block. In contrast to the wild type KST1, the S4-mutant chan nel KST1-R181Q exhibited an activation upon alcalization of the extracellular solution. From our electrophysiological studies on channel mutants with respect to the pore histidine as well as the aspartate, we conclude that the common proton-supported shift in the voltage dependence of KST1 and KAT1 is based on distinct molecular elements.	Julius von Sachs Inst Biowissensch, Lehrstuhl Bot 1, D-97082 Wurzburg, Germany	University of Wurzburg	Hedrich, R (corresponding author), Julius von Sachs Inst Biowissensch, Lehrstuhl Bot 1, Julius von Sachs Pl 2, D-97082 Wurzburg, Germany.		Hoth, Stefan/E-8024-2017; Hedrich, Rainer/G-8771-2011	Hedrich, Rainer/0000-0003-3224-1362				ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; Becker D, 1996, P NATL ACAD SCI USA, V93, P8123, DOI 10.1073/pnas.93.15.8123; BLATT MR, 1992, J GEN PHYSIOL, V99, P615, DOI 10.1085/jgp.99.4.615; Bruggemann L, 1999, PLANTA, V207, P370, DOI 10.1007/s004250050494; COULTER KL, 1995, NEURON, V15, P1157, DOI 10.1016/0896-6273(95)90103-5; Dietrich P, 1998, PLANTA, V205, P277, DOI 10.1007/s004250050322; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dreyer I, 1997, BIOPHYS J, V72, P2143, DOI 10.1016/S0006-3495(97)78857-X; Durell SR, 1996, NEUROPHARMACOLOGY, V35, P761, DOI 10.1016/0028-3908(96)00097-4; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; HEDRICH R, 1995, EUR BIOPHYS J, V66, P1061; Hoth S, 1997, P NATL ACAD SCI USA, V94, P4806, DOI 10.1073/pnas.94.9.4806; Hoth S, 1997, J EXP BOT, V48, P415, DOI 10.1093/jxb/48.Special_Issue.415; Ichida AM, 1996, J MEMBRANE BIOL, V151, P53, DOI 10.1007/s002329900057; Ilan N, 1996, J MEMBRANE BIOL, V154, P169, DOI 10.1007/s002329900142; Ketchum KA, 1996, FEBS LETT, V378, P19, DOI 10.1016/0014-5793(95)01417-9; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Marten I, 1998, BIOPHYS J, V74, P2953, DOI 10.1016/S0006-3495(98)78002-6; MULLERROBER B, 1995, EMBO J, V14, P2409, DOI 10.1002/j.1460-2075.1995.tb07238.x; Nakamura RL, 1997, J BIOL CHEM, V272, P1011, DOI 10.1074/jbc.272.2.1011; NAKAMURA RL, 1995, PLANT PHYSIOL, V109, P371, DOI 10.1104/pp.109.2.371; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; Sabirov RZ, 1997, PFLUG ARCH EUR J PHY, V433, P428, DOI 10.1007/s004240050296; SENTENAC H, 1992, SCIENCE, V256, P663, DOI 10.1126/science.1585180; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; UOZUMI N, 1995, J BIOL CHEM, V270, P24276, DOI 10.1074/jbc.270.41.24276; Uozumi N, 1998, P NATL ACAD SCI USA, V95, P9773, DOI 10.1073/pnas.95.17.9773; VERY AA, 1995, PLANT J, V7, P321, DOI 10.1046/j.1365-313X.1995.7020321.x; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253; Zimmermann S, 1998, PLANT PHYSIOL, V116, P879, DOI 10.1104/pp.116.3.879	35	51	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11599	11603		10.1074/jbc.274.17.11599	http://dx.doi.org/10.1074/jbc.274.17.11599			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206968	hybrid			2022-12-27	WOS:000079834800024
J	Nakamura, T; Kambayashi, J; Okuma, M; Tandon, NN				Nakamura, T; Kambayashi, J; Okuma, M; Tandon, NN			Activation of the GP IIb-IIIa complex induced by platelet adhesion to collagen is mediated by both alpha(2)beta(1) integrin and GP VI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-INDEPENDENT ADHESION; MEMBRANE GLYCOPROTEIN-VI; VON-WILLEBRAND-FACTOR; TYROSINE PHOSPHORYLATION; PHOSPHOLIPASE C-GAMMA-2; QUATERNARY STRUCTURE; INDUCED AGGREGATION; FLOW CONDITIONS; I COLLAGEN; C-SRC	alpha(2)beta(1) integrin, CD36, and GP VI have all been implicated in platelet-collagen adhesive interactions. We have investigated the role of these glycoproteins on activation of the GP IIb-IIIa complex induced by platelet adhesion to type I fibrillar and monomeric collagen under static conditions. In the presence of Mg2+, platelet adhesion to fibrillar collagen induced activation of the GP IIb-IIIa complex and complete spreading. Anti-alpha(2)beta(1) integrin and anti-GP VI antibodies inhibited the activation of the GP IIb-IIIa complex by about 40 and 50%, respectively, at 60 min although minimal inhibitory effects on adhesion were seen. Platelet spreading was markedly reduced by anti-alpha(2)beta(1) integrin antibody. The combination of anti-alpha(2)beta(1) integrin with anti-GP VI anti body completely inhibited both platelet adhesion and activation of the GP IIb-IIIa complex. Anti-CD36 antibody had no significant effects on platelet adhesion, spreading, and the activation of the GP IIb-IIIa complex at 60 min. Aspirin and the thromboxane A(2) receptor antagonist SQ29548 inhibited activation of the GP IIb-IIIa complex about 30% but had minimal inhibitory effect on adhesion. In the absence of Mg2+, there was significant activation of the GP IIb-IIIa complex brat minimal spreading was observed. Anti-GP VI antibody completely inhibited adhesion whereas no effect was observed with anti-alpha(2)beta(1) integrin antibody. Anti-CD36 antibody partially inhibited both adhesion and the activation of the GP IIb-IIIa complex. Platelet adhesion to monomeric collagen, which requires Mg2+ and is exclusively mediated by alpha(2)beta(1) integrin, resulted in partial activation of the GPIIb-IIIa complex and spreading. No significant effects were observed by anti-CD36 and anti-GP VI antibodies. These results suggest that both alpha(2)beta(1) integrin and GP VI are involved in inside-out signaling leading to activation of the GP IIb-IIIa complex after platelet adhesion to collagen and generation of thromboxane A(2) may further enhance expression of activated GP IIb-IIIa complexes.	Otsuka Amer Pharmaceut Inc, Maryland Res Labs, Rockville, MD 20850 USA; Takashima Gen Hosp, Shiga 5201121, Japan		Tandon, NN (corresponding author), Otsuka Amer Pharmaceut Inc, Maryland Res Labs, 9900 Med Ctr Dr, Rockville, MD 20850 USA.	narendrt@mrl.oapi.com						ARAI M, 1995, BRIT J HAEMATOL, V89, P124, DOI 10.1111/j.1365-2141.1995.tb08900.x; Asazuma N, 1996, THROMB HAEMOSTASIS, V75, P648; Barnes M J, 1998, Curr Opin Hematol, V5, P314, DOI 10.1097/00062752-199809000-00002; BAUMGARTNER HR, 1977, THROMB HAEMOSTASIS, V37, P1; BEER JH, 1993, BLOOD, V82, P820; BLAKE RA, 1994, FEBS LETT, V353, P212, DOI 10.1016/0014-5793(94)01037-4; BRASS LF, 1974, J CLIN INVEST, V54, P1480, DOI 10.1172/JCI107896; Chiang TM, 1997, J CLIN INVEST, V100, P514, DOI 10.1172/JCI119560; COLLER BS, 1989, BLOOD, V74, P182; COLLER BS, 1993, J CLIN INVEST, V92, P2796, DOI 10.1172/JCI116899; DECKMYN H, 1990, THROMB HAEMOSTASIS, V64, P74; DIAZRICART M, 1993, BLOOD, V82, P491; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; HANDA M, 1995, THROMB HAEMOSTASIS, V73, P521; HAWIGER J, 1987, ANN NY ACAD SCI, V509, P131, DOI 10.1111/j.1749-6632.1987.tb30990.x; Ichinohe T, 1997, J BIOL CHEM, V272, P63; ICHINOHE T, 1995, J BIOL CHEM, V270, P28029; JAFFE R, 1974, J CLIN INVEST, V53, P875, DOI 10.1172/JCI107628; JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035; Keely PJ, 1996, J BIOL CHEM, V271, P26668, DOI 10.1074/jbc.271.43.26668; Kehrel B, 1998, BLOOD, V91, P491; KEHREL B, 1993, BLOOD, V82, P3364; KEHREL B, 1988, BLOOD, V71, P1074; KROLL MH, 1989, BLOOD, V74, P1181; MCKEOWN L, 1994, BLOOD, V83, P2866, DOI 10.1182/blood.V83.10.2866.2866; Moroi M, 1997, THROMB HAEMOSTASIS, V78, P439; Moroi M, 1996, BLOOD, V88, P2081, DOI 10.1182/blood.V88.6.2081.bloodjournal8862081; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; MORTON LF, 1989, BIOCHEM J, V258, P157, DOI 10.1042/bj2580157; MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337; MUGGLI R, 1973, Thrombosis Research, V3, P715, DOI 10.1016/0049-3848(73)90018-2; Nakamura T, 1998, J BIOL CHEM, V273, P4338, DOI 10.1074/jbc.273.8.4338; NIEUWENHUIS HK, 1985, NATURE, V318, P470, DOI 10.1038/318470a0; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; POOLE AW, 1995, BRIT J PHARMACOL, V115, P101, DOI 10.1111/j.1476-5381.1995.tb16326.x; RAO GHR, 1994, J BIOL CHEM, V269, P13899; RYO R, 1992, AM J HEMATOL, V39, P25, DOI 10.1002/ajh.2830390107; SANTORO SA, 1991, CELL REGUL, V2, P905, DOI 10.1091/mbc.2.11.905; SANTORO SA, 1986, CELL, V46, P913, DOI 10.1016/0092-8674(86)90073-5; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Sixma JJ, 1997, THROMB HAEMOSTASIS, V78, P434; SUGIYAMA T, 1987, BLOOD, V69, P1712; TANDON NN, 1989, J BIOL CHEM, V264, P7576; VANWILLIGEN G, 1992, BLOOD, V79, P82, DOI 10.1182/blood.V79.1.82.bloodjournal79182; Verkleij MW, 1998, BLOOD, V91, P3808; YAMAMOTO N, 1990, THROMB HAEMOSTASIS, V63, P97; YAMAMOTO N, 1992, BRIT J HAEMATOL, V81, P86, DOI 10.1111/j.1365-2141.1992.tb08177.x; YANAGA F, 1995, BIOCHEM J, V311, P471, DOI 10.1042/bj3110471; ZIJENAH LS, 1990, BIOCHEM J, V268, P481, DOI 10.1042/bj2680481	50	69	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11897	11903		10.1074/jbc.274.17.11897	http://dx.doi.org/10.1074/jbc.274.17.11897			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207010	hybrid			2022-12-27	WOS:000079834800066
J	Ochiai, M; Ashida, M				Ochiai, M; Ashida, M			A pattern recognition protein for peptidoglycan - Cloning the cDNA and the gene of the silkworm, Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE-BINDING-PROTEIN; NF-KAPPA-B; MOLECULAR-CLONING; BACTERIAL PEPTIDOGLYCAN; HUMORAL LECTIN; HEMOLYMPH; PURIFICATION; CD14; ACTIVATION; DROSOPHILA	Peptidoglycan recognition protein (PGRP) specifically binds to peptidoglycan and is considered to be one of the pattern recognition proteins in the innate immunity of insect. The PGRP is an essential component for peptidoglycan to trigger the prophenoloxidase cascade that is now recognized to be an important insect defense mechanism, We cloned cDNA encoding PGRP from the silkworm fat body cDNA library. Northern blot analysis showed that the PGRP gene is constitutively expressed in the fat body, epithelial cell, and hemocytes of naive silkworms. Furthermore, a bacterial challenge intensified the gene expression, with the maximal period being from 6 to 36 h after infection. The upstream sequence of the cloned PGRP gene was shown to contain putative cis-regulatory elements similar to the NF-kappa B-like element, interferon-response half-element, and GATA motif element, which have been found in the promoters of the acute phase protein genes of mammals and insects. A homology search revealed that the homologs of silkworm PGRP are present in mice, nematodes, and bacteriophages, This suggests that the recognition of peptidoglycan as foreign is effected in both vertebrates and invertebrates by PGRP homologs with an evolutionally common origin.	Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan	Hokkaido University	Ochiai, M (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan.	ochiai@orange.lowtem.hokudai.ac.jp	Ochiai, Masanori/A-4372-2012	Ochiai, Masanori/0000-0002-0022-347X				AMANAI K, 1990, COMP BIOCHEM PHYS B, V97, P471, DOI 10.1016/0305-0491(90)90146-K; Ashida M., 1997, MOL MECH IMMUNE RESP, P135; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; CHENG XD, 1994, P NATL ACAD SCI USA, V91, P4034, DOI 10.1073/pnas.91.9.4034; Dziarski R, 1998, J BIOL CHEM, V273, P8680, DOI 10.1074/jbc.273.15.8680; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; ENGSTROM Y, 1997, MOL MECH IMMUNE RESP, P211; GEGNER JA, 1995, J BIOL CHEM, V270, P5320, DOI 10.1074/jbc.270.10.5320; Gupta D, 1996, J BIOL CHEM, V271, P23310, DOI 10.1074/jbc.271.38.23310; HULTMARK D, 1994, NATURE, V367, P116, DOI 10.1038/367116a0; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; JOMORI T, 1991, J BIOL CHEM, V266, P13318; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; KAPPLER C, 1993, EMBO J, V12, P1561, DOI 10.1002/j.1460-2075.1993.tb05800.x; KATO Y, 1993, INSECT BIOCHEM MOLEC, V23, P285, DOI 10.1016/0965-1748(93)90009-H; Kiselev SL, 1998, J BIOL CHEM, V273, P18633, DOI 10.1074/jbc.273.29.18633; Koizumi N, 1997, EUR J BIOCHEM, V248, P217, DOI 10.1111/j.1432-1033.1997.t01-1-00217.x; KOMANO H, 1985, DEV COMP IMMUNOL, V9, P31, DOI 10.1016/0145-305X(85)90057-6; KOTANI E, 1995, BBA-GENE STRUCT EXPR, V1260, P245, DOI 10.1016/0167-4781(94)00202-E; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Muta T., 1996, Progress in Molecular and Subcellular Biology, V15, P154; OCHIAI M, 1988, J BIOL CHEM, V263, P12056; PENDLAND JC, 1986, DEV COMP IMMUNOL, V10, P477, DOI 10.1016/0145-305X(86)90169-2; SCHMIDT O, 1993, DEV COMP IMMUNOL, V17, P195, DOI 10.1016/0145-305X(93)90038-R; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; SODERHALL K, 1988, INSECT BIOCHEM, V18, P323, DOI 10.1016/0020-1790(88)90045-5; SUN SC, 1990, SCIENCE, V250, P1729, DOI 10.1126/science.2270488; VIRIYAKOSOL S, 1995, J BIOL CHEM, V270, P361, DOI 10.1074/jbc.270.1.361; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; YOSHIDA H, 1986, INSECT BIOCHEM, V16, P539, DOI 10.1016/0020-1790(86)90031-4; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854	34	151	163	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11854	11858		10.1074/jbc.274.17.11854	http://dx.doi.org/10.1074/jbc.274.17.11854			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207004	hybrid			2022-12-27	WOS:000079834800060
J	Sun, YB; Sun, Y; Wenger, L; Rutter, JL; Brinckerhoff, CE; Cheung, HS				Sun, YB; Sun, Y; Wenger, L; Rutter, JL; Brinckerhoff, CE; Cheung, HS			p53 down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; TUMOR-SUPPRESSOR GENE; RHEUMATOID-ARTHRITIS SYNOVIUM; CELL-CYCLE CONTROL; TRANSCRIPTIONAL ACTIVATION; RESPONSE ELEMENT; GROWTH-FACTOR; DNA-BINDING; PROMOTER; REPRESSION	Recent studies show that the p53 tumor suppressor protein is overexpressed in rheumatoid arthritis (RA) synovium and that somatic mutations previously identified in human tumors are present in RA synovium (Firestein, G. S., Echeverri, F., Yeo, M., Zvaifler, N. J., and Green, D. R. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 10895-10900; Firestein, G. S., Nguyen, K., Aupperle, K. R, Yeo, M., Boyle, D. L., and Zvaifler, N. J. (1996) Am. J. Pathol. 149, 2143-2151; Reme, T., Travaglio, A., Gueydon, E., Adla, L, Jorgensen, C., and Sany, J. (1998) Clin. Exp. Immunol. 111, 353-3581). We hypothesize that the abnormality of p53 seen in RA synovium may contribute to joint degeneration through the regulation of human matrix metalloproteinase-1 (hMMP-1, collagenase-1) gene expression. Transcription assays were performed with luciferase reporters driven by the promoter of the hMMP-1 gene or by a minimal promoter containing tandem repeats of the consensus binding sequence for activator protein-1, cotransfected with p53-expressing plasmids, The results revealed that (i) wild-type (wt) p53 down-regulated the promoter activity of hMMP-1 in a dose-dependent fashion; (ii) four of six p53 mutants (commonly found in human cancers) lost this repression activity; and (iii) this p53 repression activity was mediated at least in part by the activator protein-1 sites found in the hMMP-1 promoter. These findings were further confirmed by Northern analysis. The down-regulation of hMMP-1 gene expression by endogenous wt-p53 was shown by treatment of U2-OS cells, a wt-p53-containing osteogenic sarcoma line, and Saos-2 cells, a p53-negative osteogenic sarcoma line, with etoposide, a potent inducer of p53 expression. p53, activated by etoposide, appears to block hMMP-1 promoter activity induced by etoposide in U2-OS cells. In summary, we have shown for the first time that the hMMP-1 gene is a p53 target gene, subject to p53 repression. Because MMP-1 is principally responsible for the irreversible destruction of collagen in articular tissue in RA, abnormality of p53 may contribute to joint degeneration through the regulation of MMP-1 expression.	Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Miami, FL 33101 USA; Univ Miami, Sch Med, Dept Med, Miami, FL 33101 USA; Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Dept Mol Biol, Ann Arbor, MI 48105 USA; Dartmouth Coll, Sch Med, Dept Pharmacol Toxicol, Hanover, NH 03755 USA; Dartmouth Coll, Sch Med, Dept Med, Hanover, NH 03755 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Miami; Pfizer; Dartmouth College; Dartmouth College	Cheung, HS (corresponding author), Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Rm NHCU 207G,1201 NW 16th St, Miami, FL 33125 USA.			Rutter, Joni/0000-0002-6502-2361	NIAMS NIH HHS [AR26599, AR38421, AR08662-33] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR026599, R01AR026599, R37AR008662, R01AR008662, R01AR038421] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AGOFF SN, 1993, SCIENCE, V259, P84, DOI 10.1126/science.8418500; Aho S, 1997, EUR J BIOCHEM, V247, P503, DOI 10.1111/j.1432-1033.1997.00503.x; AREND WP, 1993, TXB RHEUMATOLOGY, P227; AUBLE DT, 1991, BIOCHEMISTRY-US, V30, P4629, DOI 10.1021/bi00232a039; Aupperle KR, 1998, AM J PATHOL, V152, P1091; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Borden P, 1997, CRIT REV EUKAR GENE, V7, P159, DOI 10.1615/CritRevEukarGeneExpr.v7.i1-2.90; BORELLINI F, 1993, J BIOL CHEM, V268, P7923; BRINCKERHOFF C E, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P145; Caron De Fromentel Claude, 1992, Genes Chromosomes and Cancer, V4, P1; Cheung, 1980, J TISS CULT METHODS, V6, P39, DOI 10.1007/BF01665905; Crawford HC, 1996, ENZYME PROTEIN, V49, P20, DOI 10.1159/000468614; Desdouets C, 1996, FEBS LETT, V385, P34, DOI 10.1016/0014-5793(96)00330-4; DONEHOWER LA, 1993, BIOCHIM BIOPHYS ACTA, V1155, P181, DOI 10.1016/0304-419X(93)90004-V; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Firestein GS, 1996, AM J PATHOL, V149, P2143; Firestein GS, 1997, P NATL ACAD SCI USA, V94, P10895, DOI 10.1073/pnas.94.20.10895; Garcia-Bermejo L, 1998, J CELL SCI, V111, P637; GUTMAN A, 1990, EMBO J, V9, P2241, DOI 10.1002/j.1460-2075.1990.tb07394.x; HARRIS DE, 1993, TXB RHEUMATOLOGY, P833; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1995, CANCER METAST REV, V14, P3, DOI 10.1007/BF00690207; KLEY N, 1992, NUCLEIC ACIDS RES, V20, P4083, DOI 10.1093/nar/20.15.4083; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Lindy O, 1997, ARTHRITIS RHEUM-US, V40, P1391, DOI 10.1002/art.1780400806; LIU X, 1993, MOL CELL BIOL, V13, P3291, DOI 10.1128/MCB.13.6.3291; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; MacDougall JR, 1995, CANCER METAST REV, V14, P351, DOI 10.1007/BF00690603; Maiyar AC, 1997, MOL ENDOCRINOL, V11, P312, DOI 10.1210/me.11.3.312; MARTELPELLETIER J, 1994, LAB INVEST, V70, P807; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MAUVIEL A, 1993, J CELL BIOCHEM, V53, P288, DOI 10.1002/jcb.240530404; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, CANCER RES, V54, P3131; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; Pendas AM, 1997, GENOMICS, V40, P222, DOI 10.1006/geno.1996.4554; Reme T, 1998, CLIN EXP IMMUNOL, V111, P353; RUTTER JL, 1997, J CELL BIOCHEM, V66, P1; SANTHANAM U, 1991, P NATL ACAD SCI USA, V88, P7605, DOI 10.1073/pnas.88.17.7605; SETO E, 1992, P NATL ACAD SCI USA, V89, P12028, DOI 10.1073/pnas.89.24.12028; SHIIO Y, 1992, P NATL ACAD SCI USA, V89, P5206, DOI 10.1073/pnas.89.12.5206; Steller MA, 1996, CANCER RES, V56, P5087; SUBLER MA, 1992, J VIROL, V66, P4754; Sudbeck BD, 1997, J BIOL CHEM, V272, P22103, DOI 10.1074/jbc.272.35.22103; SUN Y, 1993, FASEB J, V7, P944, DOI 10.1096/fasebj.7.10.8344492; Vincenti MP, 1996, CRIT REV EUKAR GENE, V6, P391, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.40; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; Wernicke D, 1996, J RHEUMATOL, V23, P590; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7	54	114	123	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11535	11540		10.1074/jbc.274.17.11535	http://dx.doi.org/10.1074/jbc.274.17.11535			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206959	hybrid			2022-12-27	WOS:000079834800015
J	Bahassi, EM; O'Dea, MH; Allali, N; Messens, J; Gellert, M; Couturier, M				Bahassi, EM; O'Dea, MH; Allali, N; Messens, J; Gellert, M; Couturier, M			Interactions of CcdB with DNA gyrase - Inactivation of GyrA, poisoning of the gyrase-DNA complex, and the antidote action of CcdA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI DNA; SEX FACTOR-F; BREAKAGE-REUNION DOMAIN; LETD CCDB; KILLER PROTEIN; PLASMID PROTEINS; SUBUNIT-A; CLEAVAGE; TRANSCRIPTION; REPLICATION	The F plasmid-carried bacterial toxin, the CcdB protein, is known to act on DNA gyrase in two different ways. CcdB poisons the gyrase-DNA complex, blocking the passage of polymerases and leading to double-strand breakage of the DNA. Alternatively, in cells that overexpress CcdB, the A subunit of DNA gyrase (GyrA) has been found as an inactive complex with CcdB, We have reconstituted the inactive GyrA-CcdB complex by denaturation and renaturation of the purified GyrA dimer in the presence of CcdB, This inactivating interaction involves the N-terminal domain of GyrA, because similar inactive complexes were formed by denaturing and renaturing N-terminal fragments of the GyrA protein in the presence of CcdB, Single amino acid mutations, both in GyrA and in CcdB, that prevent CcdB-induced DNA cleavage also prevent formation of the inactive complexes, indicating that some essential interaction sites of GyrA and of CcdB are common to both the poisoning and the inactivation processes. Whereas the lethal effect of CcdB is most probably due to poisoning of the gyrase-DNA complex, the inactivation pathway may prevent cell death through formation of a toxin antitoxin-like complex between CcdB and newly translated GyrA subunits, Both poisoning and inactivation can be prevented and reversed in the presence of the F plasmid-encoded antidote, the CcdA protein. The products of treating the inactive GyrA-CcdB complex with CcdA are free GyrA and a CcdB-CcdA complex of approximately 44 kDa, which may correspond to a (CcdB),(CcdA), heterotetramer.	NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Free Univ Brussels, Dept Biol Mol, Lab Genet Procaryotes, B-1640 Rhode St Genese, Belgium; Free Univ Brussels VIB, B-1640 Rhode St Genese, Belgium	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Gellert, M (corresponding author), NIDDK, Mol Biol Lab, NIH, Bldg 5,Rm 241,5 Ctr Dr, Bethesda, MD 20892 USA.		Messens, Joris/AAH-3008-2020	Messens, Joris/0000-0002-2128-8264				BAHASSI EM, 1995, MOL MICROBIOL, V15, P1031, DOI 10.1111/j.1365-2958.1995.tb02278.x; BAILONE A, 1985, P NATL ACAD SCI USA, V82, P5973, DOI 10.1073/pnas.82.17.5973; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BERNARD P, 1993, J MOL BIOL, V234, P534, DOI 10.1006/jmbi.1993.1609; BERNARD P, 1991, MOL GEN GENET, V226, P297, DOI 10.1007/BF00273616; BEX F, 1983, EMBO J, V2, P1853, DOI 10.1002/j.1460-2075.1983.tb01671.x; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Chen CR, 1996, J MOL BIOL, V258, P627, DOI 10.1006/jmbi.1996.0274; CLERGET M, 1991, NEW BIOL, V3, P780; Critchlow SE, 1997, J MOL BIOL, V273, P826, DOI 10.1006/jmbi.1997.1357; DRLICA K, 1978, J MOL BIOL, V120, P145, DOI 10.1016/0022-2836(78)90061-X; Drlica K, 1994, Adv Pharmacol, V29A, P263; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; GELLERT M, 1981, ANNU REV BIOCHEM, V50, P879, DOI 10.1146/annurev.bi.50.070181.004311; HALLETT P, 1990, GENE, V93, P139, DOI 10.1016/0378-1119(90)90148-K; HANE MW, 1969, J BACTERIOL, V99, P238, DOI 10.1128/JB.99.1.238-241.1969; Hiasa H, 1996, J BIOL CHEM, V271, P26424, DOI 10.1074/jbc.271.42.26424; HOROWITZ DS, 1987, J BIOL CHEM, V262, P5339; HOWARD MT, 1994, P NATL ACAD SCI USA, V91, P12031, DOI 10.1073/pnas.91.25.12031; Kampranis SC, 1996, P NATL ACAD SCI USA, V93, P14416, DOI 10.1073/pnas.93.25.14416; Kaneko T, 1996, MOL GEN GENET, V250, P593; KAROUI H, 1983, EMBO J, V2, P1863, DOI 10.1002/j.1460-2075.1983.tb01672.x; KREUZER KN, 1979, J BACTERIOL, V140, P424, DOI 10.1128/JB.140.2.424-435.1979; Maki S, 1996, J MOL BIOL, V256, P473, DOI 10.1006/jmbi.1996.0102; MAKI S, 1992, J BIOL CHEM, V267, P12244; MAXWELL A, 1992, J ANTIMICROB CHEMOTH, V30, P409, DOI 10.1093/jac/30.4.409; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; MAXWELL A, 1993, MOL MICROBIOL, V9, P681, DOI 10.1111/j.1365-2958.1993.tb01728.x; MENZEL R, 1983, CELL, V34, P105, DOI 10.1016/0092-8674(83)90140-X; Menzel R, 1994, Adv Pharmacol, V29A, P39; MIKI T, 1992, J MOL BIOL, V225, P39, DOI 10.1016/0022-2836(92)91024-J; MIKI T, 1984, J MOL BIOL, V174, P605, DOI 10.1016/0022-2836(84)90086-X; MIZUUCHI K, 1984, J BIOL CHEM, V259, P9199; Murayama N, 1996, J MOL BIOL, V256, P483, DOI 10.1006/jmbi.1996.0103; PATO ML, 1990, P NATL ACAD SCI USA, V87, P8716, DOI 10.1073/pnas.87.22.8716; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; REECE RJ, 1991, J BIOL CHEM, V266, P3540; SALMON MA, 1994, MOL GEN GENET, V244, P530, DOI 10.1007/BF00583904; Scheirer KE, 1997, J BIOL CHEM, V272, P27202, DOI 10.1074/jbc.272.43.27202; STEYAERT J, 1993, J MOL BIOL, V231, P513, DOI 10.1006/jmbi.1993.1301; TAM JE, 1989, MOL GEN GENET, V219, P26, DOI 10.1007/BF00261153; TRAVERS AA, 1982, HEAT SHOCK BACTERIA, P127; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; VIZAN JL, 1991, EMBO J, V10, P467, DOI 10.1002/j.1460-2075.1991.tb07969.x; Wigley D.B., 1995, NUCL ACIDS MOL BIOL, P165; WILLMOTT CJR, 1994, J MOL BIOL, V242, P351, DOI 10.1006/jmbi.1994.1586; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	49	80	83	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10936	10944		10.1074/jbc.274.16.10936	http://dx.doi.org/10.1074/jbc.274.16.10936			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196173	hybrid			2022-12-27	WOS:000079751900041
J	Chang, TM; Chang, CH; Wagner, DR; Chey, WY				Chang, TM; Chang, CH; Wagner, DR; Chey, WY			Porcine pancreatic phospholipase A(2) stimulates secretin release from secretin-producing cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FEEDBACK-REGULATION; BINDING-SITE; CHOLECYSTOKININ; EXPRESSION; PEPTIDE; JUICE; PURIFICATION; MECHANISM; RECEPTOR; RATS	We have isolated, from canine pancreatic juice, two 14-kDa proteins with secretin-releasing activity that had N-terminal sequence homology with canine pancreatic phospholipase A(2) (PLA(2)). In this study we have obtained evidence that secretin-releasing activity is an intrinsic property of pancreatic PLA(2). Porcine pancreatic PLA(2) from Sigma or Boehringer Mannheim was fractionated into several peaks by reverse phase high performance liquid chromatography, They were tested for stimulation of secretin release from murine neuroendocrine intestinal tumor cell line STC-1 and secretin cells enriched mucosal cell preparations isolated from rat upper small intestine. Each enzyme preparation was found to contain several components of secretin-releasing activity, Each bioactive fraction was purified to homogeneity by rechromatography and then subjected to mass spectral analysis and assays of PLA(2) and secretin-releasing activities. It was found that the fraction with highest enzymatic activity also had the highest secretin-releasing activity and the same M-r as porcine pancreatic PLA(2). Moreover, it also had the same N-terminal amino acid sequence (up to 30 residues determined) as that of porcine pancreatic PLA(2), suggesting that it was identical to the enzyme. Purified porcine pancreatic PLA(2) also stimulated secretin release concentration-dependently from both STC-1 cells and a mucosal cell preparation enriched in secretin-containing endocrine cells isolated from rat duodenum. Abolishment of the enzymatic activity by pretreatment with bromophenacyl bromide did not affect its secretin-releasing activity. The stimulatory effect of purified pancreatic PLA(2) on secretin secretion from STC-1 cells was inhibited by an L-type Ca2+ channel blocker, by down-regulation of protein kinase C or by pretreatment of the cell with pertussis toxin, It is concluded that porcine pancreatic PLA(2) possesses an intrinsic secretin-releasing activity that was independent of its enzymatic activity. This action is pertussis toxin-sensitive and is in part dependent on Ca2+ influx through the L-type channel and activation of protein kinase C.	Univ Rochester, Sch Med & Dent, Konar Ctr Digest & Liver Dis, Dept Med, Rochester, NY 14642 USA	University of Rochester	Chang, TM (corresponding author), Univ Rochester, Med Ctr, Konar Ctr Digest & Liver Dis, POB 646,601 Elmwood Ave, Rochester, NY 14642 USA.				NIDDK NIH HHS [DDK25962] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025962] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Balsinde J, 1997, J BIOL CHEM, V272, P16069, DOI 10.1074/jbc.272.26.16069; Chang CH, 1996, AM J PHYSIOL-GASTR L, V271, pG516, DOI 10.1152/ajpgi.1996.271.3.G516; CHANG CH, 1994, BBA-MOL CELL RES, V1221, P339, DOI 10.1016/0167-4889(94)90259-3; CHANG CH, 1998, AM J PHYSIOL, V275, pG190; CHANG TM, 1980, DIGEST DIS SCI, V25, P529, DOI 10.1007/BF01315215; CHANG TM, 1996, REGUL PEP, V64, P22; DEGEUS P, 1987, NUCLEIC ACIDS RES, V15, P3743, DOI 10.1093/nar/15.9.3743; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; HANADA K, 1995, FEBS LETT, V373, P85, DOI 10.1016/0014-5793(95)01005-Y; Herzig KH, 1996, P NATL ACAD SCI USA, V93, P7927, DOI 10.1073/pnas.93.15.7927; ISHIZAKI J, 1993, FEBS LETT, V324, P349, DOI 10.1016/0014-5793(93)80149-O; ISHIZAKI J, 1994, J BIOL CHEM, V269, P5897; IWAI K, 1987, J BIOL CHEM, V262, P8956; KANEMASA T, 1992, FEBS LETT, V303, P217, DOI 10.1016/0014-5793(92)80523-J; KISHINO J, 1994, J BIOL CHEM, V269, P5092; KISHINO J, 1992, BIOCHEM BIOPH RES CO, V186, P1025, DOI 10.1016/0006-291X(92)90849-G; LAMBEAU G, 1995, J BIOL CHEM, V270, P5534, DOI 10.1074/jbc.270.10.5534; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; LI P, 1990, J CLIN INVEST, V86, P1474, DOI 10.1172/JCI114864; LI P, 1994, DIGEST DIS SCI, V39, P1806; LI P, 1998, PANCREAS, V17, P445; LU L, 1989, AM J PHYSIOL, V256, pG430, DOI 10.1152/ajpgi.1989.256.2.G430; MATSUDA Y, 1987, RES COMMUN CHEM PATH, V58, P281; MIYASAKA K, 1989, AM J PHYSIOL, V257, pG175, DOI 10.1152/ajpgi.1989.257.2.G175; MURAKAMI M, 1994, ANN NY ACAD SCI, V744, P84, DOI 10.1111/j.1749-6632.1994.tb52726.x; NOMURA K, 1994, ENDOCRINOLOGY, V135, P603, DOI 10.1210/en.135.2.603; REYNOLDS LJ, 1994, ANAL BIOCHEM, V217, P25, DOI 10.1006/abio.1994.1079; RINDI G, 1990, AM J PATHOL, V136, P1349; SAKATA T, 1989, BIOCHIM BIOPHYS ACTA, V1007, P124, DOI 10.1016/0167-4781(89)90141-3; SCOTT DL, 1994, ADV PROTEIN CHEM, V45, P53; SHIRATORI K, 1986, GASTROENTEROLOGY, V91, P1171, DOI 10.1016/S0016-5085(86)80013-0; Song Y, 1997, GASTROENTEROLOGY, V112, pA483; Soubeyrand S, 1997, J BIOL CHEM, V272, P222, DOI 10.1074/jbc.272.1.222; Spannagel AW, 1996, P NATL ACAD SCI USA, V93, P4415, DOI 10.1073/pnas.93.9.4415; SUN G, 1989, GASTROENTEROLOGY, V96, P1173, DOI 10.1016/0016-5085(89)91638-7; TOHKIN M, 1993, J BIOL CHEM, V268, P2865	36	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10758	10764		10.1074/jbc.274.16.10758	http://dx.doi.org/10.1074/jbc.274.16.10758			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196148	hybrid			2022-12-27	WOS:000079751900016
J	Olshevskaya, EV; Boikov, S; Ermilov, A; Krylov, D; Hurley, JB; Dizhoor, AM				Olshevskaya, EV; Boikov, S; Ermilov, A; Krylov, D; Hurley, JB; Dizhoor, AM			Mapping functional domains of the guanylate cyclase regulator protein, GCAP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT CONE DYSTROPHY; ACTIVATING PROTEIN; CALCIUM-BINDING; PHOTORECEPTOR; EXPRESSION; CLONING; MUTANT; RECOVERIN; VISION; RETGC	Guanylate cyclase regulator protein (GCAP)-2 is a Ca2+-binding protein that regulates photoreceptor outer segment membrane guanylate cyclase (RetGC) in a Ca2+-sensitive manner. GCAP-2 activates RetGC at free Ca2+ concentrations below 100 nM, characteristic of light-adapted photoreceptors, and inhibits RetGC when free Ca2+ concentrations are above the 500 nM level, characteristic of dark-adapted photoreceptors. We have mapped functional domains in GCAP-2 by using deletion mutants and chimeric proteins in which parts of GCAP-2 were substituted with corresponding fragments of other closely related recoverin-like proteins that do not regulate RetGC, We find that in addition to the EF-hand Ca2+-binding centers there are three regions that contain GCAP-2-specific sequences essential for regulation of RetGC. 1) The region between Phe(78) and Asp(113) determines whether GCAP-2 activates outer segment RetGC in low or high Ca2+ concentrations. Substitution of this domain with the corresponding region from neurocalcin causes a paradoxical behavior of the chimeric proteins, They activate RetGC only at high and not at low Ca2+ concentrations, 2) The amino acid sequence of GCAP-2 between Lys(29) and Phe(48) that includes the EF-hand-related motif EF-1 is essential both for activation of RetGC at low Ca2+ and inhibition at high Ca2+ concentrations. Most of the remaining N-terminal region can be substituted with recoverin or neurocalcin sequences without loss of GCAP-2 function. 3) Region Val(171)-Asn(189), adjacent to the C-terminal EF-4 contributes to activation of RetGC, but it is not essential for the ability of Ca2+-loaded GCAP-2 to inhibit RetGC, Other regions of the molecule can be substituted with the corresponding fragments from neurocalcin or recoverin, or even partially deleted without preventing GCAP-2 from regulating RetGC, Substitution of these three domains in GCAP-2 with corresponding neurocalcin sequences also affects activation of individual recombinant RetGC-1 and RetGC-2 expressed in HEK293 cells.	Wayne State Univ, Sch Med, Dept Ophthalmol, Kresge Eye Inst, Detroit, MI 48201 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, HHMI, Seattle, WA 98195 USA	Wayne State University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Dizhoor, AM (corresponding author), Wayne State Univ, Sch Med, Dept Ophthalmol, Kresge Eye Inst, 4717 St Antoine, Detroit, MI 48201 USA.	adizhoor@med.wayne.edu		Dizhoor, Alexander/0000-0001-6770-9186	NATIONAL EYE INSTITUTE [R01EY011522] Funding Source: NIH RePORTER; NEI NIH HHS [EY06641, EY11522] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; Celio MR, 1996, GUIDEBOOK CALCIUM BI; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1992, J BIOL CHEM, V267, P16033; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; GARBERS DL, 1994, J BIOL CHEM, V269, P30741; GORACZNIAK RM, 1994, BIOCHEM J, V302, P455, DOI 10.1042/bj3020455; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; GORCZYCA WA, 1994, BIOCHEMISTRY-US, V36, P11995; Horton MR, 1991, DIRECTED MUTAGENESIS, P217; Howes K, 1998, INVEST OPHTH VIS SCI, V39, P867; Kachi S, 1999, EXP EYE RES, V68, P465, DOI 10.1006/exer.1998.0629; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOCH KW, 1991, J BIOL CHEM, V266, P8634; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; Krishnan A, 1998, MOL CELL BIOCHEM, V178, P251, DOI 10.1023/A:1006860018300; Krylov DM, 1999, J BIOL CHEM, V274, P10833, DOI 10.1074/jbc.274.16.10833; LADANT D, 1995, J BIOL CHEM, V270, P3179; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; OttoBruc A, 1997, BIOCHEMISTRY-US, V36, P4295, DOI 10.1021/bi963000d; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Pugh EN, 1997, BIOSCIENCE REP, V17, P429; RAY S, 1992, P NATL ACAD SCI USA, V89, P5705, DOI 10.1073/pnas.89.13.5705; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; Sampath AP, 1998, J GEN PHYSIOL, V111, P53, DOI 10.1085/jgp.111.1.53; SITARAMAYYA A, 1995, MOL CELL BIOCHEM, V148, P139, DOI 10.1007/BF00928151; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Surguchov A, 1997, GENOMICS, V39, P312, DOI 10.1006/geno.1996.4513; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602	36	45	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10823	10832		10.1074/jbc.274.16.10823	http://dx.doi.org/10.1074/jbc.274.16.10823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196158	hybrid			2022-12-27	WOS:000079751900026
J	Syed, V; Gomez, E; Hecht, NB				Syed, V; Gomez, E; Hecht, NB			mRNAs encoding a von Ebner's-like protein and the Huntington disease protein are induced in rat male germ cells by Sertoli cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERRIN MESSENGER-RNA; RETINOL-BINDING-PROTEIN; GENE-EXPRESSION; APOLIPOPROTEIN-D; GLAND PROTEIN; SULFATED GLYCOPROTEIN-1; SEMINIFEROUS EPITHELIUM; WIDESPREAD EXPRESSION; PARACRINE REGULATION; SPERMATOGENIC CELLS	The success of spermatogenesis is dependent upon closely coordinated interactions between Sertoli cells and germ cells. To identify specific molecules that mediate interactions between somatic cells and germ cells in the rat testis, Sertoli cell-germ cell co-cultures and mRNA differential display were used. Two cDNAs, clone 1 (660 nucleotides) and clone 2 (390 nucleotides) were up-regulated when Sertoli cells were co-cultured with pachytene spermatocytes or round spermatids, Northern blot analyses confirmed the differential display expression patterns. Sequence analyses indicated that clone 1 was similar to a von Ebner's gland protein (87% at the nucleotide level and 80% at the amino acid level) and clone 2 was identical to a region of the Huntington disease protein. The von Ebner's-like protein mRNA was induced after 4 h of co-culture, while the Huntington disease protein required 18 h of co-culture for expression. The von Ebner's-like protein was induced in germ cells by a secreted Sertoli cell factor(s) smaller than 10 kDa that is sensitive to freezing and thawing or boiling, The Huntington disease protein was induced in germ cells by a Sertoli cell secreted factor(s) larger than 10 kDa which survives freezing and thawing, but is inactivated by boiling.	Univ Penn, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA; Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Hecht, NB (corresponding author), Univ Penn, Ctr Res Reprod & Womens Hlth, 415 Curie Blvd,752B CRB 6142, Philadelphia, PA 19104 USA.				NICHD NIH HHS [T32HD07305, HD-11878] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD011878, T32HD007305] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALCIVAR AA, 1989, DEV BIOL, V135, P263, DOI 10.1016/0012-1606(89)90178-4; Avallet O, 1997, BIOCHEM BIOPH RES CO, V238, P905, DOI 10.1006/bbrc.1997.7275; AYERLELIEVRE C, 1988, P NATL ACAD SCI USA, V85, P2628, DOI 10.1073/pnas.85.8.2628; BARDIN CW, 1988, PHYSL REPRODUCTION, V1, P933; BOYLES JK, 1990, J LIPID RES, V31, P2243; Braghiroli L, 1998, BIOL REPROD, V59, P111, DOI 10.1095/biolreprod59.1.111; CHENG CY, 1989, J BIOL CHEM, V264, P21386; Chung SSW, 1998, ENDOCRINOLOGY, V139, P1853, DOI 10.1210/en.139.4.1853; COLLARD MW, 1988, BIOCHEMISTRY-US, V27, P4557, DOI 10.1021/bi00412a050; DRAYNA DT, 1987, DNA-J MOLEC CELL BIO, V6, P199, DOI 10.1089/dna.1987.6.199; Eddy EM, 1998, SEMIN CELL DEV BIOL, V9, P451, DOI 10.1006/scdb.1998.0201; Eddy EM, 1998, CURR TOP DEV BIOL, V37, P141; Flower DR, 1996, BIOCHEM J, V318, P1; FRIEDEN E, 1976, ADV ENZYMOL RAMB, V44, P187; FUJISAWA M, 1992, MOL CELL ENDOCRINOL, V84, P79, DOI 10.1016/0303-7207(92)90074-G; GALDIERI M, 1983, EXP CELL RES, V145, P191, DOI 10.1016/S0014-4827(83)80020-2; GALDIERI M, 1984, J ANDROL, V5, P409; GILMONT RR, 1990, BIOL REPROD, V43, P139, DOI 10.1095/biolreprod43.1.139; GODOVAC-ZIMMERMANN J, 1988, TRENDS BIOCHEM SCI, V13, P64, DOI 10.1016/0968-0004(88)90031-X; GRISMA J, 1998, J BIOL CHEM, V273, P21040; GRISMA J, 1997, J BIOL CHEM, V272, P6499; GRISWOLF MD, 1995, BIOL REPROD, V25, P211; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HALL K, 1986, INSULIN LIKE GROWTH, P611; Hoeben E, 1996, MOL CELL ENDOCRINOL, V118, P37, DOI 10.1016/0303-7207(96)03764-1; HOFFMAN A, 1996, DEV DYNAM, V27, P332; Holzfeind P, 1996, FEBS LETT, V395, P95, DOI 10.1016/0014-5793(96)01008-3; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; HUGGENVIK J, 1981, J REPROD FERTIL, V61, P403, DOI 10.1530/jrf.0.0610403; HUGGENVIK JI, 1987, ENDOCRINOLOGY, V120, P332, DOI 10.1210/endo-120-1-332; IRELAND ME, 1987, ENDOCRINOLOGY, V120, P1317, DOI 10.1210/endo-120-4-1317; JEGOU B, 1993, ENDOCRINOLOGY, V132, P2557, DOI 10.1210/en.132.6.2557; JEGOU B, 1993, INT REV CYTOL, V147, P25, DOI 10.1016/S0074-7696(08)60766-4; JEGOU B, 1984, INT J ANDROL, V7, P244, DOI 10.1111/j.1365-2605.1984.tb00781.x; JOU YS, 1995, HUM MOL GENET, V4, P465, DOI 10.1093/hmg/4.3.465; LANDEGENT JE, 1986, HUM GENET, V73, P354, DOI 10.1007/BF00279100; Lee JW, 1997, ENDOCRINOLOGY, V138, P2081, DOI 10.1210/en.138.5.2081; LEMAGUERESSE B, 1988, J ENDOCRINOL, V118, pR13, DOI 10.1677/joe.0.118R013; LEMAGUERESSE B, 1988, MOL CELL ENDOCRINOL, V58, P65; LEMAGUERESSEBATTISTONI B, 1994, ENDOCRINOLOGY, V135, P2404, DOI 10.1210/en.135.6.2404; LI LY, 1989, BIOL REPROD, V40, P317, DOI 10.1095/biolreprod40.2.317; LIN BY, 1993, HUM MOL GENET, V2, P1541, DOI 10.1093/hmg/2.10.1541; MAGUIRE SM, 1993, MOL CELL ENDOCRINOL, V94, P79, DOI 10.1016/0303-7207(93)90054-N; Maguire SM, 1997, J MOL ENDOCRINOL, V19, P67, DOI 10.1677/jme.0.0190067; MARESCHAL JC, 1980, FEBS LETT, V110, P268, DOI 10.1016/0014-5793(80)80089-5; Monsees TK, 1997, ADV EXP MED BIOL, V424, P111; MORALES CR, 1989, MOL ENDOCRINOL, V3, P725, DOI 10.1210/mend-3-4-725; MORRIS ID, 1987, INT J ANDROL, V10, P691, DOI 10.1111/j.1365-2605.1987.tb00371.x; OBryan MK, 1997, J ANDROL, V18, P637; OLSON L, 1987, CELL TISSUE RES, V248, P275; ONODA M, 1993, BIOCHEM BIOPH RES CO, V197, P688, DOI 10.1006/bbrc.1993.2534; ONODA M, 1991, IN VITRO CELL DEV B, V27, P215; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; PERSICHETTI F, 1995, MOL MED, V1, P374, DOI 10.1007/BF03401575; PERSSON H, 1990, SCIENCE, V247, P704, DOI 10.1126/science.2154035; PINEAU C, 1989, ENDOCRINOLOGY, V124, P2720, DOI 10.1210/endo-124-6-2720; PINEAU C, 1990, MOL CELL ENDOCRINOL, V72, P13, DOI 10.1016/0303-7207(90)90235-Z; PINONLATAILLADE G, 1988, MOL CELL ENDOCRINOL, V58, P51, DOI 10.1016/0303-7207(88)90053-6; PORTER SB, 1985, J ANDROL, V6, P197; PROVOST PR, 1990, J LIPID RES, V31, P2057; REDL B, 1992, J BIOL CHEM, V267, P20282; RITZEN EM, 1983, J STEROID BIOCHEM, V19, P499, DOI 10.1016/0022-4731(83)90209-1; RIVAROLA MA, 1986, INT J ANDROL, V9, P424, DOI 10.1111/j.1365-2605.1986.tb00905.x; RIVAROLA MA, 1985, ENDOCRINOLOGY, V117, P1796, DOI 10.1210/endo-117-5-1796; SANG QX, 1990, BIOL REPROD, V43, P946, DOI 10.1095/biolreprod43.6.946; Schlatt S, 1997, EUR J ENDOCRINOL, V137, P107, DOI 10.1530/eje.0.1370107; SCHMALE H, 1990, NATURE, V343, P366, DOI 10.1038/343366a0; SCHMITT I, 1995, HUM MOL GENET, V4, P1173, DOI 10.1093/hmg/4.7.1173; SCHTEINGART HF, 1989, MOL CELL ENDOCRINOL, V67, P73, DOI 10.1016/0303-7207(89)90232-3; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; SKINNER MK, 1989, ENDOCRINOLOGY, V124, P845, DOI 10.1210/endo-124-2-845; SKINNER MK, 1989, MOL ENDOCRINOL, V3, P625, DOI 10.1210/mend-3-4-625; SKINNER MK, 1991, ENDOCR REV, V12, P45, DOI 10.1210/edrv-12-1-45; SMITH EP, 1987, ENDOCRINOLOGY, V120, P186, DOI 10.1210/endo-120-1-186; STALLARD BJ, 1990, MOL ENDOCRINOL, V4, P393, DOI 10.1210/mend-4-3-393; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; Syed V, 1997, J ANDROL, V18, P264; Syed V, 1998, ENDOCRINOLOGY, V139, P3503, DOI 10.1210/en.139.8.3503; SYED V, 1997, MOL REPROD DEV, V47, P1; SYLVESTER SR, 1984, BIOL REPROD, V31, P1087, DOI 10.1095/biolreprod31.5.1087; TINDALL DJ, 1985, INT REV CYTOL, V94, P127, DOI 10.1016/S0074-7696(08)60395-2; Tokugawa Y, 1998, BIOL REPROD, V58, P600, DOI 10.1095/biolreprod58.2.600; TRES LL, 1986, EXP CELL RES, V162, P33, DOI 10.1016/0014-4827(86)90424-6; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; VANDERDONK JA, 1986, EXP CELL RES, V164, P191, DOI 10.1016/0014-4827(86)90466-0; VANDERHAEGHEN P, 1993, J CELL BIOL, V123, P1441, DOI 10.1083/jcb.123.6.1441; vantHof W, 1997, J BIOL CHEM, V272, P1837; WALENSKY LD, 1995, MOL MED, V1, P130, DOI 10.1007/BF03401561; Walensky LD, 1998, J BIOL CHEM, V273, P9378, DOI 10.1074/jbc.273.16.9378; WRIGHT WW, 1995, DEV GENET, V16, P104, DOI 10.1002/dvg.1020160203; ZHU LJ, 1994, J ANDROL, V15, P575	91	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10737	10742		10.1074/jbc.274.16.10737	http://dx.doi.org/10.1074/jbc.274.16.10737			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196145	hybrid			2022-12-27	WOS:000079751900013
J	Edelstein, C; Shapiro, SD; Klezovitch, O; Scanu, AM				Edelstein, C; Shapiro, SD; Klezovitch, O; Scanu, AM			Macrophage metalloelastase, MMP-12, cleaves human apolipoprotein(a) in the linker region between Kringles IV-4 and IV-5 - Potential relevance to lipoprotein(a) biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATHEROSCLEROTIC PLAQUES; MATRIX METALLOPROTEINASES; INCREASED EXPRESSION; FRAGMENTS; ELASTASE; PROTEIN; LESIONS; ENZYME; URINE; LOCALIZATION	In this study we found that macrophage metalloelastase, MMP-12 cleaves, in vitro, apolipoprotein(a) (apo(a)) in the Asn(3518)-Val(3519) bond located in the linker region between kringles IV-4 and IV-5, a bond immediately upstream of the Ile(3520)-Leu(3521) bond, shown previously to be the site of action by neutrophil elastase (NE), We have also shown that human apo(a) injected into the tail vein of control mice undergoes degradation as reflected by the appearance of immunoreactive fragments in the plasma and in the urine of these animals. To define whether either or both of these enzymes may be responsible for the in vivo apo(a) cleavage, we injected intravenously MMP-12(-/-), NE-/- mice and litter mates, all of the same strain, with either lipoprotein(a) (Lp(a)), full-length free apo(a), or its N-terminal fragment, F1, obtained by the in vitro cleavage of apo(a) by NE. In the plasma of Lp(a)/apo(a)-injected mice, F1 was detected in control and NE-/- mice but was virtually absent in the MMP-12(-/-) mice. Moreover, fragments of the F1 type were present in the urine of the animals except for the MMP-12(-/-) mice. These fragments were significantly smaller in size than those observed in the plasma. All of the animals injected with F1 exhibited small sized fragments in their urine. These observations provide evidence that, in the mouse strain used, MMP-12 plays an important role in the generation of F1 from injected human Lp(a)/apo(a) and that this fragment undergoes further cleavage during renal transit via a mechanism that is neither NE- nor MMP-12-dependent. Thus, factors influencing the expression of MMP-12 may have a modulating action on the biology of Lp(a).	Univ Chicago, Dept Med MC5041, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Washington Univ, Dept Med, St Louis, MO 63110 USA	University of Chicago; University of Chicago; Washington University (WUSTL)	Edelstein, C (corresponding author), Univ Chicago, Dept Med MC5041, 5841 S Maryland Ave, Chicago, IL 60637 USA.	celina@medicine.bsd.uchicago.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594, P01HL018577] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-29594, HL-18577] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Argraves KM, 1997, J CLIN INVEST, V100, P2170, DOI 10.1172/JCI119753; Banda MJ, 1981, BIOCHEM J, V193, P569; Chandler S, 1996, BIOCHEM BIOPH RES CO, V228, P421, DOI 10.1006/bbrc.1996.1677; Edelstein C, 1996, J LIPID RES, V37, P1786; Edelstein C, 1995, BIOCHEMISTRY-US, V34, P16483, DOI 10.1021/bi00050a032; Edelstein C, 1997, J BIOL CHEM, V272, P11079; FLESS GM, 1989, J LIPID RES, V30, P651; FLESS GM, 1994, BIOCHEMISTRY-US, V33, P13492, DOI 10.1021/bi00249a038; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; GALIS ZS, 1995, P NATL ACAD SCI USA, V92, P402, DOI 10.1073/pnas.92.2.402; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; HENNEY AM, 1991, P NATL ACAD SCI USA, V88, P8154, DOI 10.1073/pnas.88.18.8154; Klezovitch O, 1998, J BIOL CHEM, V273, P23856, DOI 10.1074/jbc.273.37.23856; LACKNER C, 1991, J CLIN INVEST, V87, P2153, DOI 10.1172/JCI115248; Lelongt B, 1997, J CELL BIOL, V136, P1363, DOI 10.1083/jcb.136.6.1363; Li ZH, 1996, AM J PATHOL, V148, P121; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Mooser V, 1996, J CLIN INVEST, V98, P2414, DOI 10.1172/JCI119055; Mooser V, 1996, J CLIN INVEST, V97, P858, DOI 10.1172/JCI118487; Nikkari ST, 1996, AM J PATHOL, V149, P1427; OIDA K, 1992, CLIN CHEM, V38, P2244; Piedagnel R, 1999, J BIOL CHEM, V274, P1614, DOI 10.1074/jbc.274.3.1614; Scanu AM, 1997, J LIPID RES, V38, P2193; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; SHAH PK, 1995, CIRCULATION, V92, P1565; SHAPIRO SD, 1992, J BIOL CHEM, V267, P4664; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Shipley JM, 1996, P NATL ACAD SCI USA, V93, P3942, DOI 10.1073/pnas.93.9.3942; THOMPSON RW, 1995, J CLIN INVEST, V93, P9748	29	21	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10019	10023		10.1074/jbc.274.15.10019	http://dx.doi.org/10.1074/jbc.274.15.10019			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187779	hybrid			2022-12-27	WOS:000079663500018
J	Lotti, LV; Mottola, G; Torrisi, MR; Bonatti, S				Lotti, LV; Mottola, G; Torrisi, MR; Bonatti, S			A different intracellular distribution of a single reporter protein is determined at steady state by KKXX or KDEL retrieval signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CD8 GLYCOPROTEIN; LUMINAL ER PROTEINS; ENDOPLASMIC-RETICULUM; INTERMEDIATE COMPARTMENT; GOLGI-COMPLEX; CIS-GOLGI; TRANSMEMBRANE PROTEINS; DISULFIDE-ISOMERASE; TRANSPORT VESICLES; MEMBRANE-PROTEINS	To establish the specific contribution to protein topology of KKXX and KDEL retrieval motifs, we have determined by immunogold electron microscopy and cell fractionation the intracellular distribution at steady state of the transmembrane and anchorless versions of human CD8 protein, tagged with KKXX (CD8-E19) and KDEL (CD8-K), respectively, and stably expressed in epithelial rat cells (Martire, G,, Mottola, G., Pascale, M. C., Malagolini, N., Turrini, I., Serafini-Cessi, F,, Jackson, M, R., and Bonatti, S, (1996) J. Biol. Chem. 271, 3541-3547). The CD8-E19 protein is represented by a single form, initially O-glycosylated: only about half of it is located in the endoplasmic reticulum, whereas more than 30% of the total is present in the intermediate compartment and cis-Golgi complex. In the latter compartments, CD8-E19 colocalizes with beta-coat protein (COP) (COPI component) and shows the higher density of labeling. Conversely, about 90% of the total CD8-KDEL protein is localized in clusters on the endoplasmic reticulum, where significant co-localization with Sec-23p (COPII component) is observed, and unglycosylated and initially O-glycosylated forms apparently constitute a single pool. Altogether, these results suggest that KKXX and KDEL retrieval motifs have different topological effects on theirs own at steady state: the first results in a specific enrichment in the intermediate compartment and cis-Golgi complex, and the latter dictates residency in the endoplasmic reticulum.	Ist Nazl Ric Canc, Sez Biotechnol, I-00161 Rome, Italy; Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, I-00161 Rome, Italy; Ist Dermatol S Maria & S Gallicano, I-00100 Rome, Italy; Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy	University of Genoa; IRCCS AOU San Martino IST; Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); University of Naples Federico II	Bonatti, S (corresponding author), Ist Nazl Ric Canc, Sez Biotechnol, Viale Regina Elena 324, I-00161 Rome, Italy.	bonatti@unina.it	Mottola, Giovanna/Y-7540-2019	Mottola, Giovanna/0000-0002-7541-0472				ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BONATTI S, 1989, J BIOL CHEM, V264, P12590; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; GRIFFITHS G, 1994, J CELL BIOL, V127, P1557, DOI 10.1083/jcb.127.6.1557; ITIN C, 1995, J CELL BIOL, V131, P57, DOI 10.1083/jcb.131.1.57; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Lahtinen U, 1996, J BIOL CHEM, V271, P4031; LEHAY DJ, 1992, CELL, V68, P1145; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; LITTMAN DR, 1985, CELL, V40, P237, DOI 10.1016/0092-8674(85)90138-2; Lotti LV, 1996, EXP CELL RES, V227, P323, DOI 10.1006/excr.1996.0281; LOTTI LV, 1992, J CELL BIOL, V118, P43, DOI 10.1083/jcb.118.1.43; Martire G, 1996, J BIOL CHEM, V271, P3541; MAZZARELLA RA, 1990, J BIOL CHEM, V265, P1094; MIGLIACCIO G, 1989, EXP CELL RES, V185, P203, DOI 10.1016/0014-4827(89)90049-9; MIZUNO M, 1993, P NATL ACAD SCI USA, V90, P5732, DOI 10.1073/pnas.90.12.5732; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; OPRINS A, 1993, J CELL BIOL, V121, P49, DOI 10.1083/jcb.121.1.49; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; PASCALE MC, 1992, J BIOL CHEM, V267, P9940; PASCALE MC, 1992, J BIOL CHEM, V267, P25196; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119; ROTH J, 1994, P NATL ACAD SCI USA, V91, P8935, DOI 10.1073/pnas.91.19.8935; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Rottger S, 1998, J CELL SCI, V111, P45; SARASTE J, 1987, J CELL BIOL, V105, P2021, DOI 10.1083/jcb.105.5.2021; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; SCECKMAN R, 1996, SCIENCE, V271, P1526; SCHRODER S, 1995, J CELL BIOL, V131, P895, DOI 10.1083/jcb.131.4.895; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; SERAFINICESSI F, 1995, ADV EXP MED BIOL, V376, P135; SINGH I, 1990, EMBO J, V9, P631, DOI 10.1002/j.1460-2075.1990.tb08155.x; SLOT JW, 1981, J CELL BIOL, V90, P533, DOI 10.1083/jcb.90.2.533; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011; SWEET DJ, 1992, EMBO J, V11, P423, DOI 10.1002/j.1460-2075.1992.tb05071.x; TAKEMOTO H, 1992, ARCH BIOCHEM BIOPHYS, V296, P129, DOI 10.1016/0003-9861(92)90554-A; TANG BL, 1994, EUR J CELL BIOL, V65, P298; TATU U, 1997, J CELL BIOL, V136, P556; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; VERDE C, 1995, EUR J CELL BIOL, V67, P267; WILSON DW, 1993, J BIOL CHEM, V268, P7465	53	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10413	10420		10.1074/jbc.274.15.10413	http://dx.doi.org/10.1074/jbc.274.15.10413			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187831	hybrid			2022-12-27	WOS:000079663500070
J	Lu, YM; Brush, J; Stewart, TA				Lu, YM; Brush, J; Stewart, TA			NSP1 defines a novel family of adaptor proteins linking integrin and tyrosine kinase receptors to the c-Jun N-terminal kinase stress-activated protein kinase signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; MEDIATED CELL-ADHESION; GROWTH-FACTOR; TRANSCRIPTIONAL ACTIVITY; NH2-TERMINAL KINASE; SUBSTRATE P130(CAS); V-SRC; PHOSPHORYLATION; CRK; CASCADE	As part of a program to further understand the mechanism by which extracellular signals are coordinated and cell-specific outcomes are generated, we have cloned a novel class of related adaptor molecules (NSP1, NSP2, and NSP3) and have characterized in more detail one of the members, NSP1, NSP1 has an She-related SH2 domain and a putative proline/serine-rich SH3 interaction domain. Treatment of cells with epidermal growth factor or insulin leads to NSP1 phosphorylation and increased association with a hypophosphorylated adaptor protein, p130(Cas). In contrast, cell contact with fibronectin results in Cas phosphorylation and a transient dissociation of NSP1 from p130(Cas). Increased expression of NSP1 in 293 cells induces activation of JNK1, but not of ERK2, Consistent with this observation, NSP1 increases the activity of an AP-1-containing promoter. Thus, we have described a novel family of adaptor proteins, one of which may be involved in the process by which receptor tyrosine kinase and integrin receptors control the c-Jun N-terminal kinase/stress-activated protein kinase pathway.	Genentech Inc, Dept Endocrine Res, S San Francisco, CA 94080 USA	Roche Holding; Genentech	Stewart, TA (corresponding author), Genentech Inc, Dept Endocrine Res, M-S 37,1 DNA Way, S San Francisco, CA 94080 USA.							Antonyak MA, 1998, J BIOL CHEM, V273, P2817, DOI 10.1074/jbc.273.5.2817; Astier A, 1997, J BIOL CHEM, V272, P19719, DOI 10.1074/jbc.272.32.19719; Auer KL, 1998, MOL BIOL CELL, V9, P561, DOI 10.1091/mbc.9.3.561; Bost F, 1997, J BIOL CHEM, V272, P33422, DOI 10.1074/jbc.272.52.33422; Casamassima A, 1997, J BIOL CHEM, V272, P9363; Clarke N, 1998, MOL CELL BIOL, V18, P1065, DOI 10.1128/MCB.18.2.1065; Collins LR, 1996, J BIOL CHEM, V271, P17349, DOI 10.1074/jbc.271.29.17349; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; GARDNER AM, 1993, J BIOL CHEM, V268, P17896; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Hamasaki K, 1996, BIOCHEM BIOPH RES CO, V222, P338, DOI 10.1006/bbrc.1996.0745; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Leventhal PS, 1997, J BIOL CHEM, V272, P5214, DOI 10.1074/jbc.272.8.5214; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; LIU F, 1995, P NATL ACAD SCI USA, V92, P10287, DOI 10.1073/pnas.92.22.10287; Liu F, 1996, J BIOL CHEM, V271, P31290, DOI 10.1074/jbc.271.49.31290; Logan SK, 1997, MOL CELL BIOL, V17, P5784, DOI 10.1128/MCB.17.10.5784; MACDONALD SG, 1993, MOL CELL BIOL, V13, P6615, DOI 10.1128/MCB.13.11.6615; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Manie SN, 1997, J BIOL CHEM, V272, P15636, DOI 10.1074/jbc.272.25.15636; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Mo YY, 1996, CANCER RES, V56, P2633; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884, DOI 10.1128/MCB.17.7.3884; Nakamura T, 1996, ONCOGENE, V13, P1111; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398; Ojaniemi M, 1997, J BIOL CHEM, V272, P25993, DOI 10.1074/jbc.272.41.25993; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Sun XJ, 1997, MOL ENDOCRINOL, V11, P251, DOI 10.1210/me.11.2.251; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; van Agthoven T, 1998, EMBO J, V17, P2799, DOI 10.1093/emboj/17.10.2799; Vuori K, 1996, MOL CELL BIOL, V16, P2606; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; YAN MH, 1994, NATURE, V372, P798; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004	48	52	59	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10047	10052		10.1074/jbc.274.15.10047	http://dx.doi.org/10.1074/jbc.274.15.10047			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187783	hybrid			2022-12-27	WOS:000079663500022
J	Yan, MH; Lee, J; Schilbach, S; Goddard, A; Dixit, V				Yan, MH; Lee, J; Schilbach, S; Goddard, A; Dixit, V			mE10, a novel caspase recruitment domain-containing proapoptotic molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE; CELL-DEATH; OLIGOMERIZATION; MUTAGENESIS; APOPTOSIS; CARD	Apoptotic signaling is mediated by homophilic interactions between conserved domains present in components of the death pathway. The death domain, death effector domain, and caspase recruitment domain (CARD) are examples of such interaction motifs, We have identified a novel mammalian CARD-containing adaptor molecule termed mE10 (mammalian E10), The N-terminal CARD of mE10 exhibits significant homology (47% identity and 64% similarity) to the CARD of a gene from Equine Herpesvirus type 2, The C-terminal region is unique. Overexpression of mE10 in MCF-7 human breast carcinoma cells induces apoptosis, Mutational analysis indicates that CARD-mediated mE10 oligomerization is essential for killing activity. The C terminus of mE10 bound to the zymogen form of caspase-9 and promoted its processing to the active dimeric species. Taken together, these data suggest a model where autoproteolytic activation of pro-caspase-9 is mediated by mE10-induced oligomerization.	Genentech Inc, Dept Mol Oncol, S San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, S San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Dixit, V (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, S San Francisco, CA 94080 USA.							Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HENGARTNER MO, 1994, CURR OPIN GENET DEV, V4, P581, DOI 10.1016/0959-437X(94)90076-F; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; MENGARTNER M, 1998, SCIENCE, V281, P1298; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; TELFORD EAR, 1995, J MOL BIOL, V249, P520, DOI 10.1006/jmbi.1995.0314; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Yang XL, 1998, SCIENCE, V281, P1355, DOI 10.1126/science.281.5381.1355	16	103	118	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10287	10292		10.1074/jbc.274.15.10287	http://dx.doi.org/10.1074/jbc.274.15.10287			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187815	hybrid			2022-12-27	WOS:000079663500054
J	Zhang, AM; Potvin, B; Zaiman, A; Chen, W; Kumar, R; Phillips, L; Stanley, P				Zhang, AM; Potvin, B; Zaiman, A; Chen, W; Kumar, R; Phillips, L; Stanley, P			The gain-of-function Chinese hamster ovary mutant LEC11B expresses one of two Chinese hamster FUT6 genes due to the loss of a negative regulatory factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUCOSYL-TRANSFERASE GENES; HUMAN ALPHA(1,3)FUCOSYLTRANSFERASE GENE; MOUSE MAMMARY-GLAND; GDP-FUCOSE; CHO CELLS; ALPHA(1,3)-FUCOSYL-TRANSFERASE GENE; P-SELECTIN; LEUKOCYTE TRAFFICKING; ACCEPTOR SPECIFICITY; HORMONAL-REGULATION	The LEC11 Chinese hamster ovary (CHO) gain-of-function mutant expresses an alpha(1,3)fucosyltransferase (alpha(1,3)Fuc-T) activity that generates the Le(X), sialyl-Le(X), and VIM-2 glycan determinants and has been extensively used for studies of E-selectin ligand specificity, In order to identify regulatory mechanisms that control alpha(1,3)Fuc-T expression in mammals, mechanisms of FUT gene expression were investigated in LEC11 cells and two new, independent mutants, LEC11A and LEC11B. Northern and ribonuclease protection analyses, using probes that span the coding region of a cloned CHO FUT gene, detected transcripts in each LEC11 mutant but not in CHO cells or other gain-of-function CHO mutants that express a different alpha(1,3)Fuc-T activity. Coding region sequence analysis and alpha(1,3)Fuc-T acceptor specificity comparisons with recombinant human Fuc-TV and Fuc0TVI showed that the cloned FUT gene is orthologous to the human FUT6 gene. Southern analyses identified two closely related FUT6 genes in the Chinese hamster, whose evolutionary relationships are discussed. The blots showed that rearrangements had occurred in LEC11A and LEC11 genomic DNA, consistent with a cis mechanism of FUT6 gene activation in these mutants. By contrast, somatic cell hybrid analyses revealed that LEC11B cells express FUT6 gene transcripts due to the loss of a trans-acting, negative regulatory factor. Sequencing of reverse transcriptase-polymerase chain reaction products identified unique 5'- and 3'-untranslated region sequences in FUT6 gene transcripts from each LEC11 mutant. Northern and Southern analyses with gene-specific probes showed that LEC11A cells express only the cgFUT6A gene (where cg is Cricetulus griseus), whereas LEC11 and LEC11B cells express only the cgFUT6 gene. In LEC11A x LEC11B hybrid cells, the cgFUT6A gene was predominantly expressed, as predicted if a trans-acting negative regulatory factor functions to suppress cgFUT6B gene expression in CHO cells. This factor is predicted to be a cell type-specific regulator of FUT6 gene expression in mammals.	Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Cytel Corp, San Diego, CA 92121 USA	Yeshiva University; Albert Einstein College of Medicine	Stanley, P (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	stanley@aecom.yu.edu		Stanley, Pamela/0000-0001-5704-3747	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM T32 07288] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTON GJ, 1993, COMPUT APPL BIOSCI, V9, P729; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BrinkmanVanderLinden ECM, 1996, J BIOL CHEM, V271, P14492, DOI 10.1074/jbc.271.24.14492; CAMERON HS, 1995, J BIOL CHEM, V270, P20112, DOI 10.1074/jbc.270.34.20112; CAMPBELL C, 1983, CELL, V35, P303, DOI 10.1016/0092-8674(83)90233-7; CAMPBELL C, 1984, J BIOL CHEM, V259, P1208; CHANEY WG, 1986, SOMAT CELL MOLEC GEN, V12, P237, DOI 10.1007/BF01570782; Costache M, 1997, J BIOL CHEM, V272, P29721, DOI 10.1074/jbc.272.47.29721; Costache M, 1997, TRANSFUS CLIN BIOL, V4, P367, DOI 10.1016/S1246-7820(97)80042-0; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; DEVRIES T, 1995, J BIOL CHEM, V270, P8712, DOI 10.1074/jbc.270.15.8712; DeVries T, 1997, GLYCOBIOLOGY, V7, P921, DOI 10.1093/glycob/7.7.921; DOBRINA A, 1989, IMMUNOLOGY, V67, P502; FARRELL SA, 1977, SOMAT CELL GENET, V3, P539, DOI 10.1007/BF01539124; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; Fitch W.M., 1970, EVOL BIOL, V4, P67; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; HARDUINLEPERS A, 1993, J BIOL CHEM, V268, P14348; HOLMES EH, 1995, J BIOL CHEM, V270, P8145, DOI 10.1074/jbc.270.14.8145; HOWARD DR, 1987, J BIOL CHEM, V262, P16830; Kannagi R, 1997, GLYCOCONJUGATE J, V14, P577, DOI 10.1023/A:1018532409041; Kim YJ, 1998, P NATL ACAD SCI USA, V95, P9325, DOI 10.1073/pnas.95.16.9325; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Kudo T, 1998, J BIOL CHEM, V273, P26729, DOI 10.1074/jbc.273.41.26729; KUKOWSKALATALLO JF, 1990, GENE DEV, V4, P1288, DOI 10.1101/gad.4.8.1288; KUMAR R, 1991, J BIOL CHEM, V266, P21777; KUMAR R, 1990, P NATL ACAD SCI USA, V87, P9948, DOI 10.1073/pnas.87.24.9948; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LARSEN GR, 1992, J BIOL CHEM, V267, P11104; LEGAULT DJ, 1995, J BIOL CHEM, V270, P20987, DOI 10.1074/jbc.270.36.20987; Lowe JB, 1997, KIDNEY INT, V51, P1418, DOI 10.1038/ki.1997.194; Ma J, 1996, J BIOL CHEM, V271, P11197, DOI 10.1074/jbc.271.19.11197; Ma J, 1997, INDIAN J BIOCHEM BIO, V34, P110; MACHER B A, 1991, Glycobiology, V1, P577, DOI 10.1093/glycob/1.6.577; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Mas E, 1998, GLYCOBIOLOGY, V8, P605, DOI 10.1093/glycob/8.6.605; MCCURLEY RS, 1995, GENOMICS, V26, P142, DOI 10.1016/0888-7543(95)80094-3; Miller M J, 1994, J Comput Biol, V1, P257, DOI 10.1089/cmb.1994.1.257; MOLLICONE R, 1994, J BIOL CHEM, V269, P12662; NISHIHARA S, 1993, BIOCHEM BIOPH RES CO, V190, P42, DOI 10.1006/bbrc.1993.1008; Oulmouden A, 1997, J BIOL CHEM, V272, P8764, DOI 10.1074/jbc.272.13.8764; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; POTVIN B, 1991, CELL REGUL, V2, P989, DOI 10.1091/mbc.2.12.989; POTVIN B, 1990, J BIOL CHEM, V265, P1615; Raju TS, 1998, J BIOL CHEM, V273, P14090, DOI 10.1074/jbc.273.23.14090; REGUIGNE I, 1994, CYTOGENET CELL GENET, V66, P104, DOI 10.1159/000133677; ReguigneArnould I, 1996, CR ACAD SCI III-VIE, V319, P783; RUDNICKI MA, 1988, MOL CELL BIOL, V8, P406, DOI 10.1128/MCB.8.1.406; SALLUSTIO S, 1989, SOMAT CELL MOLEC GEN, V15, P387, DOI 10.1007/BF01534890; STANLEY P, 1975, SOMAT CELL GENET, V1, P3, DOI 10.1007/BF01538729; Stanley P, 1996, GLYCOBIOLOGY, V6, P695, DOI 10.1093/glycob/6.7.695; STANLEY P, 1983, SOMAT CELL GENET, V9, P593, DOI 10.1007/BF01574260; STANLEY P, 1983, METHOD ENZYMOL, V96, P157; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WESTON BW, 1992, J BIOL CHEM, V267, P4152; WESTON BW, 1992, J BIOL CHEM, V267, P24575; Zollner O, 1996, J BIOL CHEM, V271, P33002, DOI 10.1074/jbc.271.51.33002	58	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10439	10450		10.1074/jbc.274.15.10439	http://dx.doi.org/10.1074/jbc.274.15.10439			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187834	hybrid			2022-12-27	WOS:000079663500073
J	Chao, TH; Ember, JA; Ember, JA; Wang, MY; Bayon, Y; Hugli, TE; Ye, RD				Chao, TH; Ember, JA; Ember, JA; Wang, MY; Bayon, Y; Hugli, TE; Ye, RD			Role of the second extracellular loop of human C3a receptor in agonist binding and receptor function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN C5A RECEPTOR; PROTEIN-COUPLED RECEPTORS; HUMAN MAST-CELLS; ANAPHYLATOXIN RECEPTOR; MOLECULAR-CLONING; EXPRESSION CLONING; ACTIVATION; ANTIBODIES; ANALOGS; SITE	The C3a anaphylatoxin receptor (C3aR) is a G protein-coupled receptor with an unusually large second extracellular loop (e2 loop, similar to 172 amino acids). To determine the function of this unique structure, chimeric and deletion mutants were prepared and analyzed in transfected RBL-2H3 cells. Whereas replacement of the C3aR N-terminal segment with that from the human C5a receptor had minimal effect on C3a binding, substitution of the e2 loop with a smaller e2 loop from the C5a receptor (C5aR) abolished binding of I-125-C3a and C3a-stimulated calcium mobilization. However, as much as 65% of the e2 loop sequence (amino acids 198-308) may be removed without affecting C3a binding or calcium responses. The e2 loop sequences adjacent to the transmembrane domains contain multiple aspartate residues and are found to play an important role in C3a binding based on deletion mutagenesis. Replacement of five aspartate residues in the e2 loop with lysyl residues significantly compromised both the binding and functional capabilities of the C3a receptor mediated by intact C3a or by two C3a analog peptides. These data suggest a two-site C3a-C3aR interaction model similar to that established for C5a/C5aR. The anionic residues near the N and C termini of the C3aR e2 loop constitute a non-effector secondary interaction site with cationic residues in the C-terminal helical region of C3a, whereas the C3a C-terminal sequence LGLAR engages the primary effector site in C3aR.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Ye, RD (corresponding author), Univ Illinois, Dept Pharmacol MC868, 835 S Wolcott Ave, Chicago, IL 60612 USA.		Ye, Richard/O-5223-2016; Ye, Richard/ABF-2413-2020; BAyón, Yolanda/L-7635-2014	Ye, Richard/0000-0002-2164-5620; Ye, Richard/0000-0002-2164-5620; BAyón, Yolanda/0000-0003-3089-5485	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI040176, R01AI033503, R01AI041670, R56AI033503, R01AI040176] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40176, AI33503, AI41670] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ames RS, 1996, J BIOL CHEM, V271, P20231, DOI 10.1074/jbc.271.34.20231; Ames RS, 1996, FEBS LETT, V395, P157, DOI 10.1016/0014-5793(96)01018-6; BOULAY F, 1991, BIOCHEMISTRY-US, V30, P2993, DOI 10.1021/bi00226a002; CHENOWETH DE, 1980, MOL IMMUNOL, V17, P151, DOI 10.1016/0161-5890(80)90067-X; CHENOWETH DE, 1979, BIOCHEM BIOPH RES CO, V68, P227; COCHRANE CG, 1968, J EXP MED, V127, P368; Crass T, 1996, EUR J IMMUNOL, V26, P1944, DOI 10.1002/eji.1830260840; DAFFERN PJ, 1995, J EXP MED, V181, P2119, DOI 10.1084/jem.181.6.2119; DEMARTINO JA, 1995, J BIOL CHEM, V270, P15966, DOI 10.1074/jbc.270.27.15966; DEMARTINO JA, 1994, J BIOL CHEM, V269, P14446; EMBER JA, 1991, BIOCHEMISTRY-US, V30, P3603, DOI 10.1021/bi00229a003; Ember JA, 1997, IMMUNOPHARMACOLOGY, V38, P3, DOI 10.1016/S0162-3109(97)00088-X; EMBER JA, 1998, HUMAN COMPLEMENT SYS, P241; Fischer WH, 1997, J IMMUNOL, V159, P4279; FUHLBRIGGE RC, 1988, P NATL ACAD SCI USA, V85, P5649, DOI 10.1073/pnas.85.15.5649; Fukuoka Y, 1998, J IMMUNOL, V161, P2977; Fukuoka Y, 1998, BIOCHEM BIOPH RES CO, V242, P663, DOI 10.1006/bbrc.1997.8034; GERARD C, 1992, J IMMUNOL, V149, P2600; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; GOLDSTEIN IM, 1988, INFLAMMATION BASIC P, P55; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hartmann K, 1997, BLOOD, V89, P2863, DOI 10.1182/blood.V89.8.2863; Hawlisch H, 1998, J IMMUNOL, V160, P2947; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hsu MH, 1997, IMMUNOGENETICS, V47, P64, DOI 10.1007/s002510050327; HUGLI TE, 1981, MOL CELL BIOCHEM, V41, P59; HUGLI TE, 1989, CURR TOP MICROBIOL I, V153, P181; MERY L, 1993, EUR J HAEMATOL, V51, P282; MONK PN, 1995, J BIOL CHEM, V270, P16625, DOI 10.1074/jbc.270.28.16625; MORGAN EL, 1993, J IMMUNOL, V151, P377; Nilsson G, 1996, J IMMUNOL, V157, P1693; OPPERMANN M, 1993, J IMMUNOL, V151, P3785; PERRET JJ, 1992, BIOCHEM J, V288, P911, DOI 10.1042/bj2880911; Phang T, 1998, J BIOL CHEM, V273, P13841, DOI 10.1074/jbc.273.22.13841; Roglic A, 1996, BBA-GENE STRUCT EXPR, V1305, P39, DOI 10.1016/0167-4781(95)00209-X; Samson M, 1997, J BIOL CHEM, V272, P24934, DOI 10.1074/jbc.272.40.24934; SICILIANO SJ, 1990, J BIOL CHEM, V265, P19568; SICILIANO SJ, 1994, P NATL ACAD SCI USA, V91, P1214, DOI 10.1073/pnas.91.4.1214; Tornetta MA, 1997, J IMMUNOL, V158, P5277	40	44	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9721	9728		10.1074/jbc.274.14.9721	http://dx.doi.org/10.1074/jbc.274.14.9721			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092660	hybrid, Green Published			2022-12-27	WOS:000079451800079
J	Eickelberg, O; Pansky, A; Mussmann, R; Bihl, M; Tamm, M; Hildebrand, P; Perruchoud, AP; Roth, M				Eickelberg, O; Pansky, A; Mussmann, R; Bihl, M; Tamm, M; Hildebrand, P; Perruchoud, AP; Roth, M			Transforming growth factor-beta 1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; ALPHA-2(I) COLLAGEN; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; INDUCED PROLIFERATION; PULMONARY FIBROSIS; AP-1 COMPLEX; BINDING-SITE; RECEPTOR; PROMOTER	Transforming growth factor (TGF)-beta 1 induces extracellular matrix deposition and proliferation of mesenchymal cells. We recently reported that interleukin (IL)-6 is an essential mediator of growth factor-induced proliferation of lung fibroblasts. Here, we demonstrate by reverse transcriptase polymerase chain reaction and enzyme-linked immunoassay that TGF-beta 1 is a potent inducer of IL-6 mRNA and protein in primary human lung fibroblasts, Transient transfections of fibroblasts with a luciferase reporter gene construct containing nucleotides -651 to +1 of the human IL-6 promoter revealed that TGF-beta 1 also potently activated IL-6 promoter activity. Progressive 5'-deletions and site-directed mutagenesis of the parental construct located the TGF-pl-responsive cis-regulatory element to a known activating protein-1 (AP-1) sequence (nucleotides -284 to -276). Gel shift analyses revealed that AP-1 DNA binding activity in nuclear extracts was increased 30 min after stimulation with TGF-beta 1. In contrast, neither CCAAT enhancer-binding protein-beta, NF-kappa B, nor Spl were activated by TGF-beta 1, Supershift analyses demonstrated that the AP-1 complex induced by TGF-beta 1 was composed of Jun isoforms and absent of Fos isoforms, Moreover, this complex was found to be a JunD homodimer, Our data thus demonstrate that TGF-beta 1 is a potent inducer of IL-6 in primary human lung fibroblasts, The TGF-beta 1-activated JunD homodimer may be essential for a majority of the biological effects induced by TGF-beta 1 in this cell type, such as proliferation and extracellular matrix synthesis.	Univ Basel Hosp, Dept Res & Internal Med, CH-4031 Basel, Switzerland; Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands	University of Basel; Netherlands Cancer Institute	Eickelberg, O (corresponding author), Yale Univ, Sch Med, Dept Pathol, 310 Cedar St,LB 08, New Haven, CT 06520 USA.	oliver.eickelberg@yale.edu	Eickelberg, Oliver/A-5461-2013; Roth, Michael/H-8657-2019	Eickelberg, Oliver/0000-0001-7170-0360; Roth, Michael/0000-0002-8139-2821				AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; Alevizopoulos A, 1995, GENE DEV, V9, P3051, DOI 10.1101/gad.9.24.3051; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4; Attisano L, 1998, CURR OPIN CELL BIOL, V10, P188, DOI 10.1016/S0955-0674(98)80141-5; Banerjee C, 1996, ENDOCRINOLOGY, V137, P1991, DOI 10.1210/en.137.5.1991; Bihl M, 1998, AM J RESP CELL MOL, V19, P606, DOI 10.1165/ajrcmb.19.4.3247; CENTRELLA M, 1994, ENDOCR REV, V15, P27, DOI 10.1210/er.15.1.27; Chen Y, 1996, J BIOL CHEM, V271, P31602, DOI 10.1074/jbc.271.49.31602; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; Coker RK, 1998, EUR RESPIR J, V11, P1218, DOI 10.1183/09031936.98.11061218; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; GAULDIE J, 1993, THORAX, V48, P931, DOI 10.1136/thx.48.9.931; Greenwel P, 1997, J BIOL CHEM, V272, P19738, DOI 10.1074/jbc.272.32.19738; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; HSU JC, 1993, CANCER RES, V53, P3789; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Jin G, 1997, J BIOL CHEM, V272, P26620, DOI 10.1074/jbc.272.42.26620; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KEETON MR, 1991, J BIOL CHEM, V266, P23048; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Li JM, 1998, NUCLEIC ACIDS RES, V26, P2449, DOI 10.1093/nar/26.10.2449; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Mauviel A, 1996, J BIOL CHEM, V271, P10917, DOI 10.1074/jbc.271.18.10917; Mazzarelli P, 1998, J NEUROIMMUNOL, V87, P185, DOI 10.1016/S0165-5728(98)00110-6; Moses HL, 1996, CURR OPIN GENET DEV, V6, P581, DOI 10.1016/S0959-437X(96)80087-6; OSAWA H, 1995, NEPHROL DIAL TRANSPL, V10, P1592; ROBERTS AB, 1991, CIBA F SYMP, V157, P7; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; Roth M, 1996, J EXP MED, V184, P191, DOI 10.1084/jem.184.1.191; ROTH M, 1995, P NATL ACAD SCI USA, V92, P1312, DOI 10.1073/pnas.92.5.1312; St-Arnaud Rene, 1998, Frontiers in Bioscience, V3, pD838; Tang WL, 1998, J BIOL CHEM, V273, P5506, DOI 10.1074/jbc.273.10.5506; Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769; Wrana JL, 1998, MINER ELECTROL METAB, V24, P120, DOI 10.1159/000057359; YAMASHITA I, 1994, BLOOD, V84, P1573; YAN SF, 1995, J BIOL CHEM, V270, P11463, DOI 10.1074/jbc.270.19.11463; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Zhao Y, 1996, J BIOL CHEM, V271, P2369, DOI 10.1074/jbc.271.5.2369	46	155	158	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12933	12938		10.1074/jbc.274.18.12933	http://dx.doi.org/10.1074/jbc.274.18.12933			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212284	hybrid			2022-12-27	WOS:000080056800104
J	Majcherczyk, PA; Langen, H; Heumann, D; Fountoulakis, M; Glauser, MP; Moreillon, P				Majcherczyk, PA; Langen, H; Heumann, D; Fountoulakis, M; Glauser, MP; Moreillon, P			Digestion of Streptococcus pneumoniae cell walls with its major peptidoglycan hydrolase releases branched stem peptides carrying proinflammatory activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; HUMAN-MONOCYTES; TEICHOIC-ACID; BACTERIAL PEPTIDOGLYCAN; FACTOR-ALPHA; LIPOPOLYSACCHARIDE LPS; PNEUMOCOCCAL AUTOLYSIN; BINDING-PROTEIN; CROSS-LINKING; ORGAN FAILURE	The peptidoglycan of Gram-positive bacteria is known to trigger cytokine release from peripheral blood mononuclear cells (PBMCs), However, it requires 100-1000 times more Gram-positive peptidoglycan than Gramnegative Lipopolysaccharide to release the same amounts of cytokines from target cells. Thus, either peptidoglycan is poorly active or only part of it is required for PBMC activation. To test this hypothesis, purified Streptococcus pneumoniae walls were digested with their major autolysin N-acetylmuramoyl-L-alanine amidase, and/or muramidase, Solubilized walls were separated by reverse phase high pressure chromatography, Individual fractions were tested for their PBMC-stimulating activity, and their composition was determined, Soluble components had a M-r between 600 and 1500, These primarily comprised stem peptides cross-linked to various extents. Simple stem peptides (M-r <750) were 10-fold less active than undigested peptidoglycan. In contrast, tripeptides (M-r >1000) were greater than or equal to 100-fold more potent than the native material. One dipeptide (inactive) and two tripeptides (active) were confirmed by post-source decay analysis. Complex branched peptides represented less than or equal to 2% of the total material, but their activity (w/w) was almost equal to that of LPS, This is the first observation suggesting that peptidoglycan stem peptides carry high tumor necrosis factor-stimulating activity. These types of structures are conserved among Gram-positive bacteria and will provide new material to help elucidate the mechanism of peptidoglycan-induced inflammation.	F Hoffmann La Roche & Co Ltd, Pharmaceut Res Gene Technol, CH-4070 Basel, Switzerland; CHU Vaudois, Div Infect Dis, Dept Internal Med, CH-1011 Lausanne, Switzerland	Roche Holding; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Moreillon, P (corresponding author), CHU Vaudois, Div Infect Dis, Dept Internal Med, CH-1011 Lausanne, Switzerland.				NCI NIH HHS [CA44013] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA044013] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; AWADA A, 1992, CLIN INFECT DIS, V15, P33, DOI 10.1093/clinids/15.1.33; BAUMGARTNER JD, 1990, J EXP MED, V171, P889, DOI 10.1084/jem.171.3.889; BERRY AM, 1989, INFECT IMMUN, V57, P2324, DOI 10.1128/IAI.57.8.2324-2330.1989; BONE RC, 1993, J CRIT CARE, V8, P51, DOI 10.1016/0883-9441(93)90033-H; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; CRASS BA, 1986, J INFECT DIS, V153, P918, DOI 10.1093/infdis/153.5.918; DESCH CE, 1989, LYMPHOKINE RES, V8, P141; DOKTER WHA, 1994, J BIOL CHEM, V269, P4201; DZIARSKI R, 1991, J BIOL CHEM, V266, P4713; Dziarski R, 1998, J BIOL CHEM, V273, P8680, DOI 10.1074/jbc.273.15.8680; ELLOUZ F, 1974, BIOCHEM BIOPH RES CO, V59, P1317, DOI 10.1016/0006-291X(74)90458-6; FISCHER H, 1985, J BACTERIOL, V163, P46, DOI 10.1128/JB.163.1.46-54.1985; Fountoulakis M, 1997, ELECTROPHORESIS, V18, P2968, DOI 10.1002/elps.1150181539; FOX A, 1982, INFECT IMMUN, V35, P1003, DOI 10.1128/IAI.35.3.1003-1010.1982; GARCIA E, 1985, MOL GEN GENET, V201, P225, DOI 10.1007/BF00425663; GARCIA JL, 1988, FEMS MICROBIOL LETT, V52, P133; GARCIA P, 1989, BIOCHEM BIOPH RES CO, V158, P251, DOI 10.1016/S0006-291X(89)80205-0; GARCIABUSTOS J, 1989, J BACTERIOL, V171, P114, DOI 10.1128/jb.171.1.114-119.1989; GARCIABUSTOS JF, 1988, J BACTERIOL, V170, P2143, DOI 10.1128/jb.170.5.2143-2147.1988; GARCIABUSTOS JF, 1987, J BIOL CHEM, V262, P15400; GARCIABUSTOS JF, 1987, J BACTERIOL, V169, P447, DOI 10.1128/jb.169.2.447-453.1987; GLAUSER MP, 1994, CLIN INFECT DIS   S2, V18, P205; Gupta D, 1996, J BIOL CHEM, V271, P23310, DOI 10.1074/jbc.271.38.23310; HEUMANN D, 1994, INFECT IMMUN, V62, P2715, DOI 10.1128/IAI.62.7.2715-2721.1994; HOLTJE JV, 1976, J BIOL CHEM, V251, P4199; Kengatharan KM, 1998, J EXP MED, V188, P305, DOI 10.1084/jem.188.2.305; MATTSSON E, 1993, FEMS IMMUNOL MED MIC, V7, P281, DOI 10.1016/0928-8244(93)90023-W; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; MOSSER JL, 1970, J BIOL CHEM, V245, P287; NATANSON C, 1986, J CLIN INVEST, V78, P259, DOI 10.1172/JCI112559; PARSONNET J, 1989, REV INFECT DIS S1, V11, P263; RIESENFELDORN I, 1989, INFECT IMMUN, V57, P1890, DOI 10.1128/IAI.57.7.1890-1893.1989; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; SEVERIN A, 1995, FEMS MICROBIOL LETT, V130, P31; Sparwasser T, 1997, NATURE, V386, P336, DOI 10.1038/386336a0; Stevens DL, 1996, J INFECT DIS, V173, P619, DOI 10.1093/infdis/173.3.619; TIMMERMAN CP, 1993, INFECT IMMUN, V61, P4167, DOI 10.1128/IAI.61.10.4167-4172.1993; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; TUOMANEN E, 1985, J INFECT DIS, V151, P859, DOI 10.1093/infdis/151.5.859; VAUDAUX P, 1992, J INFECT DIS, V166, P58, DOI 10.1093/infdis/166.1.58; WEIDEMANN B, 1994, INFECT IMMUN, V62, P4709, DOI 10.1128/IAI.62.11.4709-4715.1994; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	45	58	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12537	12543		10.1074/jbc.274.18.12537	http://dx.doi.org/10.1074/jbc.274.18.12537			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212231	hybrid			2022-12-27	WOS:000080056800051
J	Urano, T; Yashiroda, H; Muraoka, M; Tanaka, K; Hosoi, T; Inoue, S; Ouchi, Y; Tanaka, K; Toyoshima, H				Urano, T; Yashiroda, H; Muraoka, M; Tanaka, K; Hosoi, T; Inoue, S; Ouchi, Y; Tanaka, K; Toyoshima, H			p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; CELL-CYCLE ARREST; CDK INHIBITOR; FACTOR-BETA; DIFFERENTIATION; EXPRESSION; P27; PHENOTYPE; P27(KIP1); BONE	Cyclin-dependent kinase inhibitory proteins are negative regulators of the cell cycle. Although all the cyclin-dependent kinase inhibitory proteins may be involved in cell cycle control during a differentiation process, only p57(Kip2) is shown to be essential for embryonic development. However, the role of p57 in the control of the cell cycle is poorly understood. Using osteoblasts derived from the calvaria of rat fetus, we show that p57 is accumulated in cells starved by low serum. Cyclin-dependent kinase 2 activity was suppressed in these cells with a significant amount bound to p57, Treatment of the cells with transforming growth factor beta 1 dramatically reduced the amount of p57, resulting in an activation of cyclin-dependent kinase 2 activity and the stimulation of cell proliferation. The decrease in p57 was inhibited by treating the cells with proteasome inhibitors, Z-Leu-Leu-Leu-aldehyde or lactacystin, but not with Z-Leu-Leu-aldehyde, which is an inhibitor of calpain, indicating that p57 is degraded through the proteasome pathway. p57 was also shown to be ubiquitinated in vitro, Because transforming growth factor beta 1 not only stimulates the growth but also inhibits the differentiation of the cells in this system, our results may suggest a possible involvement of p57 in the control of osteoblastic cell proliferation and differentiation.	Metropolitan Inst Mes Sci, Dept Tumor Biochem, Bunkyo Ku, Tokyo 1138613, Japan; Metropolitan Inst Mes Sci, Dept Chemotherapy & CREST, Japan Sci & Technol Corp, Bunkyo Ku, Tokyo 1138613, Japan; Univ Tokyo, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan	Japan Science & Technology Agency (JST); University of Tokyo	Toyoshima, H (corresponding author), Metropolitan Inst Mes Sci, Dept Tumor Biochem, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.		Urano, Tomohiko/AFS-9574-2022; Yashiroda, Hideki/Y-7641-2019					BREEN EC, 1994, J CELL PHYSIOL, V160, P323, DOI 10.1002/jcp.1041600214; CENTRELLA M, 1987, J BIOL CHEM, V262, P2869; CHAN FKM, 1995, MOL CELL BIOL, V15, P2682; CHENU C, 1988, P NATL ACAD SCI USA, V85, P5683, DOI 10.1073/pnas.85.15.5683; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elledge SJ, 1998, BBA-REV CANCER, V1377, pM61, DOI 10.1016/S0304-419X(98)00005-5; Ezhevsky SA, 1996, MOL BIOL CELL, V7, P553, DOI 10.1091/mbc.7.4.553; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HARPER JW, 1993, CELL, V75, P805; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; KRANENBURG O, 1995, J CELL BIOL, V131, P227, DOI 10.1083/jcb.131.1.227; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; NODA M, 1987, J CELL PHYSIOL, V133, P426, DOI 10.1002/jcp.1041330303; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; POON RYC, 1995, MOL BIOL CELL, V6, P1197, DOI 10.1091/mbc.6.9.1197; ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	41	74	78	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12197	12200		10.1074/jbc.274.18.12197	http://dx.doi.org/10.1074/jbc.274.18.12197			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212182	hybrid			2022-12-27	WOS:000080056800002
J	Xu, F; Palmer, AE; Yaver, DS; Berka, RM; Gambetta, GA; Brown, SH; Solomon, EI				Xu, F; Palmer, AE; Yaver, DS; Berka, RM; Gambetta, GA; Brown, SH; Solomon, EI			Targeted mutations in a Trametes villosa laccase - Axial perturbations of the T1 copper	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGAL LACCASES; ASCORBATE OXIDASE; CRYSTAL-STRUCTURE; REDOX POTENTIALS; ACTIVE-SITE; PROTEINS; AZURIN; CERULOPLASMIN; RESOLUTION; INHIBITION	Trametes villosa laccase was mutated on a tetrapeptide segment near the type 1 site. The mutations F463M and F463L were at the position corresponding to the type 1 copper axial methionine (M517) ligand in Zucchini ascorbate oxidase, The mutations E460S and A461E were near the T1 copper site. The mutated Trametes laccases were expressed in an Aspergillus oryzae host and characterized. The E460S mutation failed to produce a transformant with meaningful expression. The F463L and A461E mutations did not significantly alter the molecular and enzymological properties of the laccase, In contrast, the F463M mutation resulted in a type 1 copper site with an EPR signal intermediate between that of the wild type laccase and plastocyanin, an altered UV-visible spectrum, and a decreased redox potential (by 0.1 V). In oxidizing phenolic substrate, the mutation led to a more basic optimal pH as well as an increase in h(cat) and K-m. These effects are attributed to a significant perturbation of the T1 copper center caused by the coordination of the axial methionine (M463) ligand.	Novo Nordisk Biotech, Davis, CA 95616 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Novo Nordisk; Stanford University	Xu, F (corresponding author), Novo Nordisk Biotech, 1445 Drew Ave, Davis, CA 95616 USA.	fengxu@nnbt.com; fb.eis@forsythe.stanford.edu		Yaver, Debbie/0000-0003-4150-6756; Solomon, Edward/0000-0003-0291-3199; Gambetta, Gregory/0000-0002-8838-5050	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031450, R01DK031450] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 31450] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADELMAN JP, 1983, DNA-J MOLEC CELL BIO, V2, P183, DOI 10.1089/dna.1983.2.183; COLE JL, 1990, J AM CHEM SOC, V112, P2243, DOI 10.1021/ja00162a025; Ducros V, 1998, NAT STRUCT BIOL, V5, P310, DOI 10.1038/nsb0498-310; Eggert C, 1998, APPL ENVIRON MICROB, V64, P1766; Gray H. B., 1983, COMMENTS INORG CHEM, V2, P203; GUCKERT JA, 1995, J AM CHEM SOC, V117, P2817, DOI 10.1021/ja00115a016; KARLSSON BG, 1989, FEBS LETT, V253, P99, DOI 10.1016/0014-5793(89)80938-X; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MAYER AM, 1987, PHYTOCHEMISTRY, V26, P11; MESSERSCHMIDT A, 1990, EUR J BIOCHEM, V187, P341, DOI 10.1111/j.1432-1033.1990.tb15311.x; MESSERSCHMIDT A, 1992, J MOL BIOL, V224, P179, DOI 10.1016/0022-2836(92)90583-6; Messerschmidt A., 1997, MULTICOPPER OXIDASES; NAKAMURA T, 1958, BIOCHIM BIOPHYS ACTA, V30, P44, DOI 10.1016/0006-3002(58)90239-7; PASCHER T, 1993, EUR J BIOCHEM, V212, P289, DOI 10.1111/j.1432-1033.1993.tb17661.x; ROMERO A, 1993, J MOL BIOL, V229, P1007, DOI 10.1006/jmbi.1993.1101; SOLOMON EI, 1997, MULTICOPPER OXIDASES, P103; SPIRASOLOMON DJ, 1986, J AM CHEM SOC, V108, P5318, DOI 10.1021/ja00277a043; Stephens PJ, 1996, CHEM REV, V96, P2491, DOI 10.1021/cr950045w; SYKES AG, 1991, ADV INORG CHEM, V36, P377, DOI 10.1016/S0898-8838(08)60044-6; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WERST MM, 1991, J AM CHEM SOC, V113, P1533, DOI 10.1021/ja00005a011; Xu F, 1996, BIOCHEMISTRY-US, V35, P7608, DOI 10.1021/bi952971a; Xu F, 1997, J BIOL CHEM, V272, P924, DOI 10.1074/jbc.272.2.924; Xu F, 1996, BBA-PROTEIN STRUCT M, V1292, P303, DOI 10.1016/0167-4838(95)00210-3; Xu F, 1998, BIOCHEM J, V334, P63, DOI 10.1042/bj3340063; Yaver DS, 1996, APPL ENVIRON MICROB, V62, P834, DOI 10.1128/AEM.62.3.834-841.1996; Zaitseva I, 1996, J BIOL INORG CHEM, V1, P15, DOI 10.1007/s007750050018	27	154	162	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12372	12375		10.1074/jbc.274.18.12372	http://dx.doi.org/10.1074/jbc.274.18.12372			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212209	hybrid			2022-12-27	WOS:000080056800029
J	Zimmermann, N; Conkright, JJ; Rothenberg, ME				Zimmermann, N; Conkright, JJ; Rothenberg, ME			CC chemokine receptor-3 undergoes prolonged ligand-induced internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUINEA-PIG MODEL; EOTAXIN RECEPTOR; CHEMOATTRACTANT RECEPTORS; EOSINOPHIL RECRUITMENT; CHEMOTACTIC CYTOKINES; ALLERGIC INFLAMMATION; HIV-1 CORECEPTOR; IN-VIVO; EXPRESSION; PROTEIN	CC chemokine receptor-3 (CCR-3) is a major receptor involved in regulating eosinophil trafficking; therefore, elucidation of ligand-induced CCR-3 events has important implications in understanding the biological and pathological properties of eosinophils. Previous studies have demonstrated that unique receptor events occur in different cell types supporting investigation of CCR-3-mediated events in eosinophilic cells. We now report biochemical characterization of CCR-3 internalization following exposure of eosinophils to CCR-3 ligands, Treatment of freshly isolated human eosinophils with CCR-3 ligands resulted in marked and differential internalization of CCR-3 in a dose-dependent manner. Exposure to 100 ng/ml eotaxin reduced surface expression to 43, 43, and 76% at 15 min, 1 h, and 3 h, respectively. RANTES (reduced on activation T cell expressed and secreted) treatment induced more significant and prolonged internalization of CCR-3 than eotaxin; following 100 ng/ml of RANTES, 29, 24, and 47% of the receptor was expressed at 15 min, 3 h, and 18 h, respectively. Confocal microscopy demonstrated that receptor modulation involved receptor internalization by an endocytic pathway shared with the transferrin receptor. Receptor internalization was accompanied by partial degradation of CCR-3, and reexpression of CCR-3 was dependent in part upon de novo protein synthesis. Internalization was not blocked by pretreatment of eosinophils with pertussis toxin. Furthermore, staurosporine did not inhibit internalization although it blocked phorbol la-myristate 13-acetate-induced CCR-3 down-modulation. These results demonstrate that CCR-3 ligands induce differential receptor internalization that is not dependent upon G(i)-protein coupling, calcium transients, or protein kinase C.	Childrens Hosp, Med Ctr, Dept Pediat, Div Pulm Med Allergy & Clin Immunol, Cincinnati, OH 45229 USA; Childrens Hosp, Med Ctr, Dept Pediat, Div Pulm Biol & Neonatol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Rothenberg, ME (corresponding author), Childrens Hosp, Med Ctr, Dept Pediat, Div Pulm Med Allergy & Clin Immunol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	rothm@chmcc.org						Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Bates P, 1996, CELL, V86, P1, DOI 10.1016/S0092-8674(00)80070-7; Bohm SK, 1997, BIOCHEM J, V322, P1; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; CHUNTHARAPAI A, 1995, J IMMUNOL, V155, P2587; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; COMBADIERE C, 1995, J BIOL CHEM, V270, P16491, DOI 10.1074/jbc.270.28.16491; Daugherty BL, 1996, J EXP MED, V183, P2349, DOI 10.1084/jem.183.5.2349; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; ESKELINEN S, 1991, EUR J CELL BIOL, V56, P210; Forster R, 1998, J IMMUNOL, V160, P1522; Franci C, 1996, J IMMUNOL, V157, P5606; GERARD C, 1994, CURR OPIN IMMUNOL, V6, P140, DOI 10.1016/0952-7915(94)90045-0; GLEICH GJ, 1986, ADV IMMUNOL, V39, P177; Gonzalo JA, 1996, J CLIN INVEST, V98, P2332, DOI 10.1172/JCI119045; HANSEL TT, 1991, J IMMUNOL METHODS, V145, P105, DOI 10.1016/0022-1759(91)90315-7; Humbles AA, 1997, J EXP MED, V186, P601, DOI 10.1084/jem.186.4.601; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; Lamkhioued B, 1997, J IMMUNOL, V159, P4593; LANDAU NR, 1992, J VIROL, V66, P5110, DOI 10.1128/JVI.66.8.5110-5113.1992; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Luster AD, 1997, J LEUKOCYTE BIOL, V62, P620, DOI 10.1002/jlb.62.5.620; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Matthews AN, 1998, P NATL ACAD SCI USA, V95, P6273, DOI 10.1073/pnas.95.11.6273; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MUELLER SG, 1995, J BIOL CHEM, V270, P10439, DOI 10.1074/jbc.270.18.10439; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rothenberg ME, 1997, J EXP MED, V185, P785, DOI 10.1084/jem.185.4.785; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; SAMANTA AK, 1990, J BIOL CHEM, V265, P183; Solari R, 1997, J BIOL CHEM, V272, P9617; Teixeira MM, 1997, J CLIN INVEST, V100, P1657, DOI 10.1172/JCI119690; Tenscher K, 1996, BLOOD, V88, P3195, DOI 10.1182/blood.V88.8.3195.bloodjournal8883195; Uguccioni M, 1997, J CLIN INVEST, V100, P1137, DOI 10.1172/JCI119624; UHING RJ, 1992, BIOCHEM BIOPH RES CO, V183, P1033, DOI 10.1016/S0006-291X(05)80294-3; WELLER PF, 1991, NEW ENGL J MED, V324, P1110	41	112	117	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12611	12618		10.1074/jbc.274.18.12611	http://dx.doi.org/10.1074/jbc.274.18.12611			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212240	hybrid			2022-12-27	WOS:000080056800060
J	Kim, DE; Shigesada, K; Patel, SS				Kim, DE; Shigesada, K; Patel, SS			Transcription termination factor rho contains three noncatalytic nucleotide binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-RHO; FUNCTIONAL INTERACTIONS; PHYSICAL-PROPERTIES; HELICASE ACTIVITY; LIGAND COFACTORS; CATALYTIC SITES; DNA HELICASE; RNA; F1-ATPASE; ATP	The active form of transcription termination factor rho from Escherichia coli is a homohexamer, but several studies suggest that the six subunits of the hexamer are not functionally identical. Rho has three tight and three weak ATP binding sites. Based on our findings, we propose that the tight nucleotide binding sites are noncatalytic and the weak sites are catalytic. In the presence of RNA, the rho-catalyzed ATPase rate is fast, close to 30 s(-1). However, under these conditions the three tightly bound nucleotides dissociate from the rho hexamer at a slow rate of 0.02 s(-1), indicating that the three tight nucleotide binding sites of rho do not participate in the fast ATPase turnover. These slowly exchanging nucleotide binding sites of rho are capable of hydrolyzing ATP, but the resulting products (ADP and pi) bind tightly and dissociate from rho about 1500 times slower than the fast ATPase turnover. Both RNA and excess ATP in solution are necessary for stabilizing nucleotide binding at these sites. In the absence of RNA or when solution ATP is hydrolyzed to ADP, a faster dissociation of nucleotides was observed. Based on these results, we pro pose that the rho hexamer is similar to the F-1-ATPase and T7 DNA helicase-containing noncatalytic sites that do not participate in the fast ATPase turnover. We propose that the three tight sites on rho are the noncatalytic sites and the three weak sites are the catalytic sites.	Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; Kyoto Univ, Inst Virus Res, Dept Genet & Mol Biol, Sakyo Ku, Kyoto 606, Japan	Ohio State University; Kyoto University	Patel, SS (corresponding author), Ohio State Univ, Dept Biochem, 484 W 12th Ave, Columbus, OH 43210 USA.		Kim, Dong-Eun/D-8304-2011	Kim, Dong-Eun/0000-0001-6545-8387	NIGMS NIH HHS [GM55310] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Allison TJ, 1998, NAT STRUCT BIOL, V5, P352, DOI 10.1038/nsb0598-352; BRENNAN CA, 1990, J BIOL CHEM, V265, P5440; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; BUJALOWSKI W, 1993, BIOCHEMISTRY-US, V32, P5888, DOI 10.1021/bi00073a023; CROSS RL, 1982, J BIOL CHEM, V257, P2874; DAS A, 1993, ANNU REV BIOCHEM, V62, P893; FINGER LR, 1982, J MOL BIOL, V156, P203, DOI 10.1016/0022-2836(82)90467-3; FINGER LR, 1981, BIOCHEMISTRY-US, V20, P1640, DOI 10.1021/bi00509a036; GALLUPPI GR, 1980, J MOL BIOL, V138, P513, DOI 10.1016/S0022-2836(80)80016-7; GEISELMANN J, 1993, P NATL ACAD SCI USA, V90, P7754, DOI 10.1073/pnas.90.16.7754; GEISELMANN J, 1992, BIOCHEMISTRY-US, V31, P121, DOI 10.1021/bi00116a018; GEISELMANN J, 1992, PROTEIN SCI, V1, P861, DOI 10.1002/pro.5560010704; GEISELMANN J, 1992, PROTEIN SCI, V1, P850, DOI 10.1002/pro.5560010703; GEISELMANN J, 1992, BIOCHEMISTRY-US, V31, P111, DOI 10.1021/bi00116a017; GOGOL EP, 1991, J MOL BIOL, V221, P1127, DOI 10.1016/0022-2836(91)80116-C; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; Horiguchi T, 1997, J MOL BIOL, V269, P514, DOI 10.1006/jmbi.1997.1059; MIWA Y, 1995, J MOL BIOL, V254, P815, DOI 10.1006/jmbi.1995.0658; MORI H, 1989, J MOL BIOL, V210, P39, DOI 10.1016/0022-2836(89)90289-1; PAGAN J, 1990, FEBS LETT, V273, P147, DOI 10.1016/0014-5793(90)81071-U; Richardson JP, 1996, J BIOL CHEM, V271, P1251, DOI 10.1074/jbc.271.3.1251; ROBERTS JW, 1969, NATURE, V224, P1168, DOI 10.1038/2241168a0; SEIFRIED SE, 1991, J MOL BIOL, V221, P1139; SEIFRIED SE, 1992, P NATL ACAD SCI USA, V89, P10454, DOI 10.1073/pnas.89.21.10454; SHIGESADA K, 1980, NUCLEIC ACIDS RES, V8, P3355, DOI 10.1093/nar/8.15.3355; STEINMETZ EJ, 1994, P NATL ACAD SCI USA, V91, P1401, DOI 10.1073/pnas.91.4.1401; Stitt BL, 1998, J BIOL CHEM, V273, P26477, DOI 10.1074/jbc.273.41.26477	28	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11623	11628		10.1074/jbc.274.17.11623	http://dx.doi.org/10.1074/jbc.274.17.11623			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206972	hybrid			2022-12-27	WOS:000079834800028
J	Masuyama, N; Hanafusa, H; Kusakabe, M; Shibuya, H; Nishida, E				Masuyama, N; Hanafusa, H; Kusakabe, M; Shibuya, H; Nishida, E			Identification of two Smad4 proteins in Xenopus - Their common and distinct properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MAD-RELATED PROTEIN; TUMOR-SUPPRESSOR SMAD4; SIGNAL-TRANSDUCTION; MESODERM INDUCTION; KINASE CASCADE; RECEPTOR; PHOSPHORYLATION; EMBRYO; GENE	Smad family proteins have been identified as mediators of intracellular signal transduction by the transforming growth factor-beta (TGF-beta) superfamily. Each member of the pathway-restricted, receptor-activated Smad family cooperates and synergizes with Smad4, called co-Smad, to transduce the signals. Only Smad4 has been shown able to function as a common partner of the various pathway-restricted Smads in mammals. Here we have identified a novel Smad4-like molecule in Xenopus (XSmad4 beta) as well as a Xenopus homolog of a well established Smad4 (XSmad4 alpha). XSmad4 beta is 70% identical to XSmad4 alpha in amino acid sequence. Both of the Xenopus Smad4s can cooperate with Smad1 and Smad2, the pathway-restricted Smads specific for bone morphogenetic protein and TGF-beta, respectively. However, they show distinct properties in terms of their developmental expression patterns, subcellular localizations, and phosphorylation states. Moreover, XSmad4 beta, but not XSmad4 alpha, has the potent ability to induce ventralization when microinjected into the dorsal marginal region of the 4-cell stage of the embryos. These results suggest that the two Xenopus Smad4s have overlapping but distinct functions.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; Natl Inst Basic Biol, Dept Dev Biol, Div Morphogenesis, Okazaki, Aichi 4448585, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Nishida, E (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.		Kusakabe, Minoru/Q-3258-2019					Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Attisano L, 1998, CURR OPIN CELL BIOL, V10, P188, DOI 10.1016/S0955-0674(98)80141-5; Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; Candia AF, 1997, DEVELOPMENT, V124, P4467; Chen Y, 1997, P NATL ACAD SCI USA, V94, P12938, DOI 10.1073/pnas.94.24.12938; DAWID IB, 1994, J BIOL CHEM, V269, P6259; deCaestecker MP, 1997, J BIOL CHEM, V272, P13690, DOI 10.1074/jbc.272.21.13690; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; GOTOH Y, 1995, EMBO J, V14, P2491, DOI 10.1002/j.1460-2075.1995.tb07246.x; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HARLAND RM, 1991, METHOD CELL BIOL, V36, P675; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heasman J, 1997, DEVELOPMENT, V124, P4179; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; KESSLER DS, 1994, SCIENCE, V266, P596, DOI 10.1126/science.7939714; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lechleider RJ, 1996, J BIOL CHEM, V271, P17617, DOI 10.1074/jbc.271.30.17617; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Meersseman G, 1997, MECH DEVELOP, V61, P127, DOI 10.1016/S0925-4773(96)00629-6; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Onichtchouk D, 1996, DEVELOPMENT, V122, P3045; Sasai Y, 1997, DEV BIOL, V182, P5, DOI 10.1006/dbio.1996.8445; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; SIVE HL, 1993, GENE DEV, V7, P1, DOI 10.1101/gad.7.1.1; SMITH JC, 1995, CURR OPIN CELL BIOL, V7, P856, DOI 10.1016/0955-0674(95)80070-0; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Suzuki A, 1997, DEV BIOL, V184, P402, DOI 10.1006/dbio.1997.8548; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Thomsen GH, 1996, DEVELOPMENT, V122, P2359; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; Yang X, 1998, P NATL ACAD SCI USA, V95, P3667, DOI 10.1073/pnas.95.7.3667; Yingling JM, 1996, P NATL ACAD SCI USA, V93, P8940, DOI 10.1073/pnas.93.17.8940; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhou SB, 1998, P NATL ACAD SCI USA, V95, P2412, DOI 10.1073/pnas.95.5.2412	53	85	90	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12163	12170		10.1074/jbc.274.17.12163	http://dx.doi.org/10.1074/jbc.274.17.12163			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207044	hybrid			2022-12-27	WOS:000079834800100
J	Schreiber, R; Nitschke, R; Greger, R; Kunzelmann, K				Schreiber, R; Nitschke, R; Greger, R; Kunzelmann, K			The cystic fibrosis transmembrane conductance regulator activates aquaporin 3 in airway epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-OOCYTES; NA+ CONDUCTANCE; WATER CHANNEL; COLLECTING DUCT; SODIUM-CHANNELS; RAT-KIDNEY; WILD-TYPE; CFTR; EXPRESSION; CL	Enhanced osmotic water permeability has been observed in Xenopus oocytes expressing cystic fibrosis transmembrane conductance regulator (CFTR) protein. Subsequent studies have shown that CFTR activates an endogenous water permeability in oocytes, but that CFTR itself is not the water channel. Here, we show CFTR dependent activation of endogenous water permeability in normal but not in cystic fibrosis human airway epithelial cells. Cell volume was measured by novel confocal x-z laser scanning microscopy, Glycerol uptake and antisense studies suggest CFTR-dependent regulation of aquaporin 3 (AQP3) water channels in airway epithelial cells. Regulatory interaction was confirmed by coexpression of CFTR and AQP3 cloned from human airways in Xenopus oocytes and of CFTR and rat AQP3 in Chinese hamster ovary cells. These findings indicate that CFTR is a regulator of AQP3 in airway epithelial cells.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany	University of Freiburg	Kunzelmann, K (corresponding author), Univ Freiburg, Inst Physiol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	kkunzel@sibm2.ruf.uni-freiburg.de	Nitschke, Roland/F-9525-2010; Schreiber, Robert/Q-7550-2019	Nitschke, Roland/0000-0002-9397-8475; Kunzelmann, Karl/0000-0002-4583-7037				BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Briel M, 1998, J PHYSIOL-LONDON, V508, P825, DOI 10.1111/j.1469-7793.1998.825bp.x; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; ECHEVARRIA M, 1993, J GEN PHYSIOL, V101, P827, DOI 10.1085/jgp.101.6.827; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; ENGELHARDT JF, 1994, J CLIN INVEST, V93, P737, DOI 10.1172/JCI117028; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Greger R, 1996, J MOL MED-JMM, V74, P527; HASEGAWA H, 1992, SCIENCE, V258, P1477, DOI 10.1126/science.1279809; HIPPER A, 1995, FEBS LETT, V374, P312, DOI 10.1016/0014-5793(95)01132-X; ISHIBASHI K, 1995, GENOMICS, V27, P352, DOI 10.1006/geno.1995.1055; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Ismailov II, 1996, J BIOL CHEM, V271, P4725; Jiang C, 1997, J PHYSIOL-LONDON, V501, P637, DOI 10.1111/j.1469-7793.1997.637bm.x; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; King LS, 1997, AM J PHYSIOL-CELL PH, V273, pC1541, DOI 10.1152/ajpcell.1997.273.5.C1541; KUNZELMANN K, 1995, PFLUG ARCH EUR J PHY, V431, P1, DOI 10.1007/BF00374371; Kunzelmann K, 1996, PFLUG ARCH EUR J PHY, V431, P578, DOI 10.1007/BF02191906; Kunzelmann K, 1997, FEBS LETT, V400, P341, DOI 10.1016/S0014-5793(96)01414-7; Lei DC, 1996, GENE THER, V3, P427; LITTLEWOOD JM, 1992, BRIT MED BULL, V48, P847, DOI 10.1093/oxfordjournals.bmb.a072581; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Mall M, 1996, FEBS LETT, V381, P47, DOI 10.1016/0014-5793(96)00079-8; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; McNicholas CM, 1996, P NATL ACAD SCI USA, V93, P8083, DOI 10.1073/pnas.93.15.8083; Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549; Nitschke R, 1997, PFLUG ARCH EUR J PHY, V434, P466, DOI 10.1007/s004240050422; RIORDAN JR, 1993, ANNU REV PHYSIOL, V55, P609, DOI 10.1146/annurev.ph.55.030193.003141; Schreiber R, 1997, PFLUG ARCH EUR J PHY, V434, P841, DOI 10.1007/s004240050473; Schwiebert EM, 1998, P NATL ACAD SCI USA, V95, P2674, DOI 10.1073/pnas.95.5.2674; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Stutts MJ, 1997, J BIOL CHEM, V272, P14037, DOI 10.1074/jbc.272.22.14037; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; WIDDICOMBE JH, 1995, RESP PHYSIOL, V99, P3, DOI 10.1016/0034-5687(94)00095-H; Zhang YL, 1996, AM J PHYSIOL-CELL PH, V270, pC1326, DOI 10.1152/ajpcell.1996.270.5.C1326	35	91	93	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11811	11816		10.1074/jbc.274.17.11811	http://dx.doi.org/10.1074/jbc.274.17.11811			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206998	hybrid			2022-12-27	WOS:000079834800054
J	Ueda, H; Yamauchi, J; Itoh, H; Morishita, R; Kaziro, Y; Kato, K; Asano, T				Ueda, H; Yamauchi, J; Itoh, H; Morishita, R; Kaziro, Y; Kato, K; Asano, T			Phosphorylation of F-actin-associating G protein gamma(12) subunit enhances fibroblast motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; KINASE-C; GROWTH-FACTOR; PHOSPHOLIPASE-C; ALPHA-SUBUNITS; CELL MOTILITY; BETA-SUBUNIT; PURIFICATION; CYTOSKELETON; CHEMOTAXIS	Eleven isoforms of G protein gamma subunit have been found thus far, but the precise roles of individual gamma subunits are not known. The gamma(12) subunit has two unique properties: phosphorylation by protein kinase C and association with F-actin. To elucidate the role of gamma(12), we overexpressed gamma(12) and other gamma subunits in NIH 3T3 cells together with the beta(1) subunit. The overexpressed gamma(12) as well as endogenous gamma(12), but not gamma(2), gamma(5), and gamma(7) subunits, associated with cytoskeletal components. Expression of gamma(12) induced remarkable changes including cell rounding, disruption of stress fibers, and enhancement of cell migration, but expression of other gamma subunits did not induce significant changes. Deletion of the N-terminal region of gamma(12) decreased the abilities of gamma(12) to associate with cytoskeletal fractions, to induce cell rounding, and to increase cell motility, Replacement by alanine of Ser(2) of gamma(12) (Ser(1) of a mature gamma(12) protein), a phosphorylation site for protein kinase C, eliminated these effects of y(12), whereas a mutant in which Ser(2) was replaced with glutamic acid showed effects equivalent to wild-type gamma(12), These results indicate that phosphorylation of gamma(12) at Ser(2) enhances the motility of cells.	Aichi Human Serv Ctr, Inst Dev Res, Dept Biochem, Aichi 4800392, Japan; Tokyo Inst Technol, Fac Biosci & Biotechnol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Asano, T (corresponding author), Aichi Human Serv Ctr, Inst Dev Res, Dept Biochem, Kamiya Cho, Aichi 4800392, Japan.							Anand-Apte B, 1997, J BIOL CHEM, V272, P30688, DOI 10.1074/jbc.272.49.30688; Arai H, 1997, P NATL ACAD SCI USA, V94, P14495, DOI 10.1073/pnas.94.26.14495; ASANO T, 1995, J NEUROCHEM, V64, P1267; ASANO T, 1993, J BIOL CHEM, V268, P20512; Asano T, 1998, EUR J BIOCHEM, V251, P314, DOI 10.1046/j.1432-1327.1998.2510314.x; Blobe GC, 1996, J BIOL CHEM, V271, P15823, DOI 10.1074/jbc.271.26.15823; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; CALI JJ, 1992, J BIOL CHEM, V267, P24023; CHIBA K, 1995, DEV BIOL, V169, P415, DOI 10.1006/dbio.1995.1157; CUNNINGHAM CC, 1991, SCIENCE, V251, P1233, DOI 10.1126/science.1848726; DAVIET I, 1990, FEBS LETT, V259, P315, DOI 10.1016/0014-5793(90)80035-H; Derman MP, 1997, J BIOL CHEM, V272, P6465, DOI 10.1074/jbc.272.10.6465; FISHER KJ, 1992, MOL CELL BIOL, V12, P1585, DOI 10.1128/MCB.12.4.1585; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; GAUTAM N, 1989, SCIENCE, V244, P971, DOI 10.1126/science.2499046; GRONDIN P, 1991, J BIOL CHEM, V266, P15705; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; IBARRONDO J, 1995, P NATL ACAD SCI USA, V92, P8413, DOI 10.1073/pnas.92.18.8413; Iniguez-Lluhi Jorge, 1993, Trends in Cell Biology, V3, P230, DOI 10.1016/0962-8924(93)90122-H; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Lin HC, 1998, P NATL ACAD SCI USA, V95, P5057, DOI 10.1073/pnas.95.9.5057; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; MORISHITA R, 1988, EUR J BIOCHEM, V174, P87, DOI 10.1111/j.1432-1033.1988.tb14066.x; MORISHITA R, 1995, J BIOL CHEM, V270, P29469, DOI 10.1074/jbc.270.49.29469; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Nern A, 1998, NATURE, V391, P195, DOI 10.1038/34458; PAYRASTRE B, 1991, J CELL BIOL, V115, P121, DOI 10.1083/jcb.115.1.121; SA G, 1994, J BIOL CHEM, V269, P3219; SARNDAHL E, 1993, P NATL ACAD SCI USA, V90, P6552, DOI 10.1073/pnas.90.14.6552; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Ueda H, 1997, J CELL SCI, V110, P1503; UEDA N, 1994, J BIOL CHEM, V269, P4388; YAMAUCHI J, 1995, BIOCHEM BIOPH RES CO, V214, P694, DOI 10.1006/bbrc.1995.2341; Yasuda H, 1998, J BIOL CHEM, V273, P21958, DOI 10.1074/jbc.273.34.21958	35	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12124	12128		10.1074/jbc.274.17.12124	http://dx.doi.org/10.1074/jbc.274.17.12124			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207039	hybrid			2022-12-27	WOS:000079834800095
J	Bousquet, C; Melmed, S				Bousquet, C; Melmed, S			Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PROOPIOMELANOCORTIN GENE-EXPRESSION; CORTICOTROPIN-RELEASING-FACTOR; ONCOSTATIN-M; FACTOR-RECEPTOR; TRANSCRIPTIONAL SYNERGY; INTERFERON-GAMMA; GROWTH-HORMONE; ADRENAL AXIS; LIF RECEPTOR	Leukemia inhibitory factor (LIF) is a pleiotropic neuroimmune cytokine that promotes corticotroph cell differentiation and induces proopiomelanocortin (POMC) mRNA expression and adrenocorticotropin hormone (ACTH) secretion. However, molecular mechanisms for this induction remain elusive. We therefore developed ACTH-secreting AtT20 transformants for wild-type or mutated STAT3, a cytokine signaling molecule, to address whether STAT3 is a determinant of LIF-mediated ACTH regulation. We show that these mutants act in a dominant negative manner by blocking endogenous STAT3 tyrosine phosphorylation or STAT3 DNA binding. Attenuation of STAT3 activity in the dominant negative AtT20 clones prevented LIF from promoting transcriptional activation of the POMC promoter (2.1-fold), whereas this LIF action was enhanced (7.7-fold; p < 0.05) in wild-type STAT3-overexpressing clones in comparison to mock-transfected cells (4.5-fold). However, wildtype or dominant negative STAT3-overexpressing clones showed comparable (4-fold) POMC induction after treatment with cyclic adenosine monophosphate (cAMP), an alternate inducer of POMC transcription, indicating the STAT3 specificity for LIF signaling. Moreover, dominant negative inactivation of STAT3 activity resulted in abrogation of LIF-induced POMC mRNA levels and ACTH secretion, confirming the in vivo role of STAT3 in LIF-mediated corticotroph action. Chemical or molecular blockade of the mitogen-activated protein kinase pathway did not affect LIF-mediated corticotroph function. These results indicate that STAT3 is a critical intrapituitary component of the LIF-mediated neuroimmunoendocrine interface in corticotroph cells.	Univ Calif Los Angeles, Sch Med, Cedars Sinai Res Inst, Dept Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Melmed, S (corresponding author), Cedars Sinai Med Ctr, 8700 Beverly Blvd,2015, Los Angeles, CA 90048 USA.		Bousquet, Corinne/P-2917-2014	Bousquet, Corinne/0000-0002-2501-0593	NIDDK NIH HHS [DK33802] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033802] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKITA S, 1995, J CLIN INVEST, V95, P1288, DOI 10.1172/JCI117779; ARGETSINGER LS, 1995, J BIOL CHEM, V270, P14685, DOI 10.1074/jbc.270.24.14685; Auernhammer CJ, 1998, MOL ENDOCRINOL, V12, P954, DOI 10.1210/me.12.7.954; BESEDOVSKY HO, 1992, FRONT NEUROENDOCRIN, V13, P61; Boeuf H, 1997, J CELL BIOL, V138, P1207, DOI 10.1083/jcb.138.6.1207; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; Bousquet C, 1997, J BIOL CHEM, V272, P10551; Boutillier A L, 1998, Pituitary, V1, P33, DOI 10.1023/A:1009966808106; BOUTILLIER AL, 1995, MOL ENDOCRINOL, V9, P745, DOI 10.1210/me.9.6.745; BOUTILLIER AL, 1991, MOL ENDOCRINOL, V5, P1301, DOI 10.1210/mend-5-9-1301; Chesnokova V, 1998, ENDOCRINOLOGY, V139, P2209, DOI 10.1210/en.139.5.2209; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; Davis S, 1993, CURR OPIN CELL BIOL, V5, P281, DOI 10.1016/0955-0674(93)90117-9; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Horvath CM, 1997, CURR OPIN CELL BIOL, V9, P233, DOI 10.1016/S0955-0674(97)80067-1; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Kojima H, 1996, ONCOGENE, V12, P547; Liu B, 1995, BIOCHEM J, V312, P827, DOI 10.1042/bj3120827; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; NAKAJIMA K, 1996, EMBO J, V15, P3951; PATTERSON PH, 1994, P NATL ACAD SCI USA, V91, P7833, DOI 10.1073/pnas.91.17.7833; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; Ray D, 1997, ENDOCR REV, V18, P206, DOI 10.1210/er.18.2.206; Ray DW, 1996, J CLIN INVEST, V97, P1852, DOI 10.1172/JCI118615; Sacerdote Paola, 1994, Neuroimmunomodulation, V1, P357, DOI 10.1159/000097188; SCHIEMANN WP, 1994, J BIOL CHEM, V269, P6376; Schiemann WP, 1997, J BIOL CHEM, V272, P16631, DOI 10.1074/jbc.272.26.16631; SCHIEMANN WP, 1995, P NATL ACAD SCI USA, V92, P5361, DOI 10.1073/pnas.92.12.5361; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; SPANGELO BL, 1989, ENDOCRINOLOGY, V125, P575, DOI 10.1210/endo-125-1-575; STAHL N, 1993, CELL, V74, P587, DOI 10.1016/0092-8674(93)90506-L; Stancato LF, 1998, J BIOL CHEM, V273, P18701, DOI 10.1074/jbc.273.30.18701; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; SUDA T, 1989, ENDOCRINOLOGY, V124, P1444, DOI 10.1210/endo-124-3-1444; THOMA B, 1994, J BIOL CHEM, V269, P6215; VALE W, 1983, RECENT PROG HORM RES, V39, P245; Wang ZY, 1996, ENDOCRINOLOGY, V137, P2947, DOI 10.1210/en.137.7.2947; Winston LA, 1995, J BIOL CHEM, V270, P30837, DOI 10.1074/jbc.270.52.30837	45	43	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10723	10730		10.1074/jbc.274.16.10723	http://dx.doi.org/10.1074/jbc.274.16.10723			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196143	hybrid			2022-12-27	WOS:000079751900011
J	Chen, Y; Morrow, JD; Roberts, LJ				Chen, Y; Morrow, JD; Roberts, LJ			Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; PROSTAGLANDIN-D SYNTHASE; INTRACELLULAR GLUTATHIONE; GROWTH-INHIBITION; METABOLITE; MECHANISM; J(2); 9-DEOXY-DELTA-9,DELTA-12-13,14-DIHYDROPROSTAGLANDIN-D2; 9-DEOXY-DELTA-9,DELTA-12(E)-PROSTAGLANDIN-D2; DELTA-12-PROSTAGLANDIN-J2	Cyclopentenone prostaglandins A(2) and J(2) are reactive compounds that possess unique biological activities. However, the extent to which they are formed in vivo remains unclear. In this study, we explored whether D-2/E-2-isoprostanes undergo dehydration in vivo to form A(2)/J(2)-isoprostanes. Oxidation of arachidonic acid in vitro generated a series of compounds that were confirmed to be A(2)/J(2)-isoprostanes by mass spectrometric analyses. A(2)/J(2)-isoprostanes were detected in vivo esterified to lipids in livers from normal rats at a level of 5.1 +/- 2.3 ng/g, and levels increased dramatically by a mean of 24-fold following administration of CCl4. An A(2)-isoprostane, 15-A(2t)-isoprostane, was obtained and found to readily undergo Michael addition with glutathione and to adduct covalently to protein. A(2)/J(2)-isoprostanes could not be detected in the circulation, even following CCl4 administration, which we hypothesized might be explained by rapid formation of adducts. This was supported by finding that essentially all the radioactivity excreted into the urine following infusion of radiolabaled 15-A(2t)-isoprostane into a human volunteer was in the form of a polar conjugate(s). These data identify a new class of reactive compounds that are produced in vivo as products of the isoprostane pathway that can exert biological effects relevant to the pathobiology of oxidant injury.	Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Roberts, LJ (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	jack.roberts@mcmail.vanderbilt.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P01GM015431] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK48831] Funding Source: Medline; NIGMS NIH HHS [GM15431, GM42057] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATSMON J, 1990, CANCER RES, V50, P1879; ATSMON J, 1990, BIOCHEMISTRY-US, V29, P3760, DOI 10.1021/bi00467a023; ATTALLAH A, 1974, PROSTAG OTH LIPID M, V5, P69, DOI 10.1016/S0090-6980(74)80133-4; BOYLAND E, 1968, BIOCHEM J, V109, P651, DOI 10.1042/bj1090651; Bui T, 1998, BBA-GENE STRUCT EXPR, V1397, P31, DOI 10.1016/S0167-4781(97)00214-5; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; FUKUSHIMA M, 1989, ADV PROSTAG THROMB L, V19, P415; FUKUSHIMA M, 1990, EICOSANOIDS, V3, P189; FUKUSHIMA M, 1982, BIOCHEM BIOPH RES CO, V109, P626, DOI 10.1016/0006-291X(82)91986-6; FUKUSHIMA M, 1992, PROSTAG LEUKOTR ESS, V47, P1, DOI 10.1016/0952-3278(92)90178-L; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; HIRATA Y, 1988, J BIOL CHEM, V263, P16619; HONN KV, 1985, BIOCHEM BIOPH RES CO, V129, P34, DOI 10.1016/0006-291X(85)91398-1; JONSSON HT, 1976, J LIPID RES, V17, P1; KIKAWA Y, 1984, P NATL ACAD SCI-BIOL, V81, P1317, DOI 10.1073/pnas.81.5.1317; Kim HS, 1996, PROSTAGLANDINS, V51, P413, DOI 10.1016/0090-6980(96)00047-0; KIM IK, 1993, FEBS LETT, V321, P209, DOI 10.1016/0014-5793(93)80110-G; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; LONGMIRE AW, 1994, BIOCHEM PHARMACOL, V47, P1173, DOI 10.1016/0006-2952(94)90389-1; MARINEZCAYUELA M, 1995, BIOCHIMIE PARIS, V77, P147; Melegos DN, 1996, CLIN CHEM, V42, P1984; MIDDLEDITCH BS, 1975, PROSTAGLANDINS, V9, P409, DOI 10.1016/0090-6980(75)90147-1; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; MORROW JD, 1994, J BIOL CHEM, V269, P4317; MORROW JD, 1991, ANAL BIOCHEM, V193, P142, DOI 10.1016/0003-2697(91)90054-W; NARUMIYA S, 1987, J PHARMACOL EXP THER, V242, P306; NARUMIYA S, 1986, J PHARMACOL EXP THER, V239, P506; PACEASCIAK CR, 1989, ADV PROSTAG THROMB L, V18, P1; Parker J, 1995, PROSTAGLANDINS, V50, P359, DOI 10.1016/0090-6980(95)00136-0; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; ROSELLO J, 1978, J CHROMATOGR SCI, V16, P177, DOI 10.1093/chromsci/16.5.177; Santoro MG, 1997, TRENDS MICROBIOL, V5, P276, DOI 10.1016/S0966-842X(97)01066-4; SHAHABI NA, 1987, EXP CELL BIOL, V55, P18; STEHLE RG, 1977, J PHARM SCI-US, V66, P1590, DOI 10.1002/jps.2600661123; Taber DF, 1997, PROSTAGLANDINS, V53, P63, DOI 10.1016/S0090-6980(97)00005-1; Tokugawa Y, 1998, BIOL REPROD, V58, P600, DOI 10.1095/biolreprod58.2.600	39	137	139	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10863	10868		10.1074/jbc.274.16.10863	http://dx.doi.org/10.1074/jbc.274.16.10863			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196163	hybrid			2022-12-27	WOS:000079751900031
J	Biberstine-Kinkade, KJ; Yu, LX; Dinauer, MC				Biberstine-Kinkade, KJ; Yu, LX; Dinauer, MC			Mutagenesis of an arginine- and lysine-rich domain in the gp91(phox) subunit of the phagocyte NADPH-oxidase flavocytochrome b(558)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; GTP-BINDING PROTEIN; RESPIRATORY BURST ACTIVITY; SITE-DIRECTED MUTAGENESIS; SRC HOMOLOGY-3 DOMAINS; MEDIATED GENE-TRANSFER; BONE-MARROW CELLS; HUMAN-NEUTROPHILS; CYTOCHROME B(558); SUPEROXIDE PRODUCTION	Site-directed mutagenesis was used to generate a series of mutants harboring point or multiple substitutions within the hydrophilic, polybasic domain of gp91(phox) encompassed by residues 86-102, which was previously identified as a site of interaction with p47(phox) during phagocyte NADPH oxidase assembly. Recombinant wild-type or mutant gp91(phox) was expressed in a human myeloid leukemia cell line in which the endogenous gp91(phox) gene was disrupted by gene targeting. NADPH oxidase activity was measured in a cytochrome c reduction assay following granulocytic differentiation of cells that expressed recombinant gp91(phox), Expression of a gp91(phox) mutant in which amino acids 89-97 were replaced with nine alternate amino acids abolished NADPH oxidase activity. Expression of gp91(phox) mutants R89T, D95A, D95R, R96A, R96E, or K102T did not significantly affect NADPH oxidase activity. However, mutations of individual or paired arginine residues at positions 91 and 92 had substantial effects on superoxide generation. The R91E/R92E mutation completely abolished both NADPH oxidase activity and membrane-translocation of the cytosolic oxidase proteins p47(phox), P67(phox), Rac1, and Rac2, The phorbol 12-myristate 13-acetate-induced rate of superoxide production was reduced by similar to 75% in cells expressing R91T/R92A, R91E, or R92E gp91(phox) along with an increased lag time to the maximal rates of superoxide production relative to cells expressing wild-type gp91(phox), Taken together, these results demonstrate that Arg(91) and Arg(92) of gp91(phox) are essential for flavocytochrome b(558) function in granulocytes and suggest that these residues participate in the interaction of gp91(phox) with the cytosolic oxidase proteins.	Indiana Univ, James Whitcomb Riley Hosp Children, Sch Med,Dept Pediat Hematol Oncol, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; Indiana Univ, James Whitcomb Riley Hosp Children, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children	Dinauer, MC (corresponding author), Indiana Univ, Sch Med, Canc Res Inst, Herman B Wells Ctr Pediat Res, 1044 W Walnut, Indianapolis, IN 46202 USA.	mdinauer@iupui.edu						ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Bjorgvinsdottir H, 1997, BLOOD, V89, P41, DOI 10.1182/blood.V89.1.41.41_41_48; BOKOCH GM, 1994, CURR OPIN CELL BIOL, V6, P212, DOI 10.1016/0955-0674(94)90138-4; DeLeo FR, 1996, J IMMUNOL METHODS, V198, P35, DOI 10.1016/0022-1759(96)00144-5; DELEO FR, 1995, J BIOL CHEM, V270, P26246, DOI 10.1074/jbc.270.44.26246; DeLeo FR, 1996, J LEUKOCYTE BIOL, V60, P677, DOI 10.1002/jlb.60.6.677; DELEO FR, 1995, P NATL ACAD SCI USA, V92, P7110, DOI 10.1073/pnas.92.15.7110; DEMENDEZ I, 1994, J BIOL CHEM, V269, P16326; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; DINAUER M, 1998, HEMATOLOGY INFANCY C, P889; DINAUER MC, 1987, NATURE, V327, P717, DOI 10.1038/327717a0; Ding CJ, 1996, BLOOD, V88, P1834; DORSEUIL O, 1995, J LEUKOCYTE BIOL, V58, P108, DOI 10.1002/jlb.58.1.108; Dorseuil O, 1996, J BIOL CHEM, V271, P83, DOI 10.1074/jbc.271.1.83; Downey G P, 1995, Curr Opin Hematol, V2, P76; Downey GP, 1998, J IMMUNOL, V160, P434; Dusi S, 1996, BIOCHEM J, V314, P409, DOI 10.1042/bj3140409; DUSI S, 1995, BIOCHEM J, V308, P991, DOI 10.1042/bj3080991; Freeman JL, 1996, J BIOL CHEM, V271, P22578, DOI 10.1074/jbc.271.37.22578; FUJITA I, 1987, BIOCHIM BIOPHYS ACTA, V931, P41, DOI 10.1016/0167-4889(87)90048-6; GREEN SP, 1994, J LEUKOCYTE BIOL, V55, P530, DOI 10.1002/jlb.55.4.530; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P261, DOI 10.1091/mbc.4.3.261; HEYWORTH PG, 1990, BIOCHIM BIOPHYS ACTA, V1052, P299, DOI 10.1016/0167-4889(90)90225-3; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; KLEINBERG ME, 1994, BIOCHEMISTRY-US, V33, P2490, DOI 10.1021/bi00175a018; KLEINBERG ME, 1992, BIOCHEMISTRY-US, V31, P2686, DOI 10.1021/bi00125a008; KLEINBERG ME, 1990, J BIOL CHEM, V265, P15577; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; Koshkin V, 1996, J BIOL CHEM, V271, P30326, DOI 10.1074/jbc.271.48.30326; KUME A, 1994, BLOOD, V84, P3311; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; LEUSEN JHW, 1994, J CLIN INVEST, V93, P2120, DOI 10.1172/JCI117207; LEUSEN JHW, 1994, J EXP MED, V180, P2329, DOI 10.1084/jem.180.6.2329; LEVY R, 1994, BBA-MOL CELL RES, V1220, P253, DOI 10.1016/0167-4889(94)90146-5; Maniatis T., 1982, MOL CLONING; NAUSEEF WM, 1993, EUR J HAEMATOL, V51, P301; NAUSEEF WM, 1993, J BIOL CHEM, V268, P23646; Nisimoto Y, 1997, J BIOL CHEM, V272, P18834, DOI 10.1074/jbc.272.30.18834; Park MY, 1997, BIOCHEM BIOPH RES CO, V234, P531, DOI 10.1006/bbrc.1997.6672; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; PRIGMORE E, 1995, J BIOL CHEM, V270, P10717, DOI 10.1074/jbc.270.18.10717; QUINN MT, 1993, J BIOL CHEM, V268, P20983; QUINN MT, 1992, BLOOD, V79, P1563; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Roos D, 1996, IMMUNOL TODAY, V17, P517; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; TOSI MF, 1992, AM J CLIN PATHOL, V97, P566, DOI 10.1093/ajcp/97.4.566; VERHOEVEN AJ, 1989, BLOOD, V73, P1686; Wallach TM, 1997, BIOCHEM J, V321, P583, DOI 10.1042/bj3210583; WIENTJES FB, 1993, BIOCHEM J, V296, P557, DOI 10.1042/bj2960557; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; Zhen L, 1998, J BIOL CHEM, V273, P6575, DOI 10.1074/jbc.273.11.6575; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	57	42	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10451	10457		10.1074/jbc.274.15.10451	http://dx.doi.org/10.1074/jbc.274.15.10451			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187835	hybrid			2022-12-27	WOS:000079663500074
J	Di Fiore, B; Guarguaglini, G; Palena, A; Kerkhoven, RM; Bernards, R; Lavia, P				Di Fiore, B; Guarguaglini, G; Palena, A; Kerkhoven, RM; Bernards, R; Lavia, P			Two E2F sites control growth-regulated and cell cycle-regulated transcription of the Htf9-a/RanBP1 gene through functionally distinct mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-MYB TRANSCRIPTION; PROTEIN FAMILY MEMBERS; RETINOBLASTOMA PROTEIN; NUCLEAR-LOCALIZATION; SUBCELLULAR-LOCALIZATION; HOUSEKEEPING PROMOTER; SUBUNIT COMPOSITION; BINDING-SITE; HTF9-C GENES; IN-VIVO	The gene encoding Ran-binding protein 1 (RanBP1) is transcribed in a cell cycle-dependent manner. The RanBP1 promoter contains two binding sites for E2F factors, named E2F-c, located proximal to the transcription start, and E2F-b, falling in a more distal promoter region, We have now induced site-directed mutagenesis in both sites. We have found that the distal E2F-b site, together with a neighboring Spl element, actively controls up-regulation of transcription in S phase. The proximal E2F-c site plays no apparent role in cycling cells yet is required for transcriptional repression upon growth arrest. Protein binding studies suggest that each E2F site mediates specific interactions with individual E2F family members. In addition, transient expression assays with mutagenized promoter constructs indicate that the functional role of each site is also dependent on its position relative to other regulatory elements in the promoter context. Thus, the two E2F sites play opposite genetic functions and control RanBP1 transcription through distinct molecular mechanisms.	Univ Rome La Sapienza, CNR, Ctr Evolutionary Genet, I-00185 Rome, Italy; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands	Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; Netherlands Cancer Institute	Lavia, P (corresponding author), Univ Rome La Sapienza, CNR, Ctr Evolutionary Genet, Via Apuli 4, I-00185 Rome, Italy.	lavia@axrma.uniroma1.it	Lavia, Patrizia/J-5793-2019; Lavia, Patrizia/AAL-3982-2021	Lavia, Patrizia/0000-0003-3310-6701; Bernards, Rene/0000-0001-8677-3423				Allen KE, 1997, J CELL SCI, V110, P2819; Battistoni A, 1997, J CELL SCI, V110, P2345; Beijersbergen RL, 1996, BBA-REV CANCER, V1287, P103, DOI 10.1016/0304-419X(96)00002-9; BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; Bennett JD, 1996, ONCOGENE, V13, P1073; Bernards R, 1997, BBA-REV CANCER, V1333, pM33, DOI 10.1016/S0304-419X(97)00027-9; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Botz J, 1996, MOL CELL BIOL, V16, P3401; BRESSAN A, 1991, GENE, V103, P201, DOI 10.1016/0378-1119(91)90274-F; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P157; COUTAVAS E, 1993, NATURE, V366, P585, DOI 10.1038/366585a0; COUTAVAS EE, 1994, MAMM GENOME, V5, P623, DOI 10.1007/BF00411457; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; delaLuna S, 1996, J CELL SCI, V109, P2443; Di Matteo G, 1998, J BIOL CHEM, V273, P495, DOI 10.1074/jbc.273.1.495; DIMATTEO G, 1995, CELL GROWTH DIFFER, V6, P1213; Fry CJ, 1997, MOL CELL BIOL, V17, P1966, DOI 10.1128/MCB.17.4.1966; Geng Y, 1996, ONCOGENE, V12, P1173; GINSBERG D, 1994, GENE DEV, V8, P2665, DOI 10.1101/gad.8.22.2665; Guarguaglini G, 1997, BIOCHEM J, V325, P277, DOI 10.1042/bj3250277; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; HIJMANS EM, 1995, MOL CELL BIOL, V15, P3082; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Ikeda M, 1996, P NATL ACAD SCI USA, V93, P3215, DOI 10.1073/pnas.93.8.3215; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; LAIMINS LA, 1982, P NATL ACAD SCI-BIOL, V79, P6453, DOI 10.1073/pnas.79.21.6453; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Lindeman GJ, 1997, P NATL ACAD SCI USA, V94, P5095, DOI 10.1073/pnas.94.10.5095; Liu NS, 1996, NUCLEIC ACIDS RES, V24, P2905, DOI 10.1093/nar/24.15.2905; Magae J, 1996, J CELL SCI, V109, P1717; MAYOL X, 1998, FRONT BIOSCI, V3, P11; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Muller H, 1997, MOL CELL BIOL, V17, P5508; NEUMAN E, 1994, MOL CELL BIOL, V14, P6607, DOI 10.1128/MCB.14.10.6607; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Pu RT, 1997, MOL BIOL CELL, V8, P1955, DOI 10.1091/mbc.8.10.1955; Rush MG, 1996, BIOESSAYS, V18, P103, DOI 10.1002/bies.950180206; Sazer S, 1996, TRENDS CELL BIOL, V6, P81, DOI 10.1016/0962-8924(96)80992-5; SCHULZE A, 1995, P NATL ACAD SCI USA, V92, P11264, DOI 10.1073/pnas.92.24.11264; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; Smith EJ, 1996, MOL CELL BIOL, V16, P6965; SOMMA MP, 1991, NUCLEIC ACIDS RES, V19, P2817, DOI 10.1093/nar/19.11.2817; STAPLETON G, 1993, NUCLEIC ACIDS RES, V21, P2465, DOI 10.1093/nar/21.10.2465; Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994; Tommasi S, 1997, J BIOL CHEM, V272, P30483, DOI 10.1074/jbc.272.48.30483; Tsuneoka M, 1997, ONCOGENE, V14, P2301, DOI 10.1038/sj.onc.1201067; VAIRO G, 1995, GENE DEV, V9, P869, DOI 10.1101/gad.9.7.869; vanGinkel PR, 1997, J BIOL CHEM, V272, P18367, DOI 10.1074/jbc.272.29.18367; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; XU GF, 1995, P NATL ACAD SCI USA, V92, P1357, DOI 10.1073/pnas.92.5.1357; ZHU LG, 1995, MOL CELL BIOL, V15, P3552	54	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10339	10348		10.1074/jbc.274.15.10339	http://dx.doi.org/10.1074/jbc.274.15.10339			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187822	Green Published, hybrid			2022-12-27	WOS:000079663500061
J	Firestein, BL; Bredt, DS				Firestein, BL; Bredt, DS			Interaction of neuronal nitric-oxide synthase and phosphofructokinase-M	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY PROTEIN PSD-95; CENTRAL-NERVOUS-SYSTEM; NEONATAL RAT-BRAIN; 6-PHOSPHOFRUCTO-1-KINASE ISOENZYMES; CORTICAL CULTURES; SKELETAL-MUSCLE; PDZ DOMAINS; FRUCTOSE-1,6-BISPHOSPHATE; ENZYME; NEUROTOXICITY	Neurons that express neuronal nitric-oxide synthase (nNOS) are resistant to NO-induced neurotoxicity; however, the mechanism by which these neurons are protected is not clear. To identify proteins possibly involved in this process, we performed affinity chromatography with the nNOS PDZ domain, a N-terminal motif that mediates protein interactions. Using this method to fractionate soluble tissue extracts, we identified the muscle isoform of phosphofructokinase (PFK-M) as a protein that binds to nNOS both in brain and skeletal muscle. PFK-RI interacts with the PDZ domain of nNOS, and nNOS-PFK-M binding can be competed by peptides that bind to the PDZ domain of nNOS, We found that nNOS is significantly associated with PFK-M in skeletal muscle because nNOS can be immunodepleted from cytosolic skeletal muscle extracts using an antibody directed against PFK-M, In brain, nNOS and PFK-M are both enriched in synaptosomes, and specifically, in the synaptic vesicle fraction, where they can interact. At the cellular level, PFK-M is enriched in neurons that express nNOS protein. As fructose-1,6-bisphosphate, the product of PFK activity, is neuroprotective, the interaction of nNOS and PFK may contribute to neuroprotection of nNOS positive cells.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Firestein, BL (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444,513 Parnassus Ave, San Francisco, CA 94143 USA.	bonfire@itsa.ucsf.edu	Bredt, David/J-4872-2012	Firestein, Bonnie/0000-0002-1679-3565	NINDS NIH HHS [R01-NS36017] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036017] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoki C, 1997, BRAIN RES, V750, P25, DOI 10.1016/S0006-8993(96)01147-X; Bedard S, 1997, BIOCHEM J, V325, P487, DOI 10.1042/bj3250487; BERNASCONI C, 1983, RES COMMUN CHEM PATH, V42, P281; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Brenman JE, 1997, CURR OPIN NEUROBIOL, V7, P374, DOI 10.1016/S0959-4388(97)80065-7; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1996, J NEUROSCI, V16, P7407; BROWN GC, 1995, FEBS LETT, V369, P136, DOI 10.1016/0014-5793(95)00763-Y; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Dawson VL, 1996, J NEUROSCI, V16, P2479; de la Torre JC, 1998, BRAIN RES, V779, P285, DOI 10.1016/S0006-8993(97)01169-4; DUNAWAY GA, 1985, J BIOL CHEM, V260, P4180; DUNAWAY GA, 1987, BIOCHEM J, V242, P667, DOI 10.1042/bj2420667; ERECINSKA M, 1995, J NEUROCHEM, V65, P2765; Espanol MT, 1998, ANESTHESIOLOGY, V88, P461, DOI 10.1097/00000542-199802000-00025; FOE LG, 1985, J BIOL CHEM, V260, P726; Garner JA, 1996, J NEUROCHEM, V67, P845; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; Gracy KN, 1997, BRAIN RES, V747, P259, DOI 10.1016/S0006-8993(96)01249-8; HASSINEN IE, 1991, CIRCULATION, V83, P584, DOI 10.1161/01.CIR.83.2.584; Hawkins RD, 1996, NEURON, V16, P465, DOI 10.1016/S0896-6273(00)80064-1; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Kendrick KM, 1997, NATURE, V388, P670, DOI 10.1038/41765; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIRTLEY ME, 1977, MOL CELL BIOCHEM, V18, P141, DOI 10.1007/BF00280279; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Li XJ, 1996, P NATL ACAD SCI USA, V93, P4839, DOI 10.1073/pnas.93.10.4839; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Meffert MK, 1996, NEURON, V16, P1229, DOI 10.1016/S0896-6273(00)80149-X; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; Moazed D, 1996, CELL, V86, P667, DOI 10.1016/S0092-8674(00)80139-7; PARDUCZ A, 1994, NEUROSCIENCE, V62, P93, DOI 10.1016/0306-4522(94)90317-4; RIGOBELLO MP, 1982, FARMACO-ED SCI, V37, P459; Roberts CK, 1997, AM J PHYSIOL-ENDOC M, V273, pE220, DOI 10.1152/ajpendo.1997.273.1.E220; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Schepens J, 1997, FEBS LETT, V409, P53, DOI 10.1016/S0014-5793(97)00481-X; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Sola A, 1996, BRAIN RES, V741, P294, DOI 10.1016/S0006-8993(96)00984-5; Son H, 1996, CELL, V87, P1015, DOI 10.1016/S0092-8674(00)81796-1; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; TORRES J, 1995, BIOCHEM J, V312, P169, DOI 10.1042/bj3120169; Zeitschel U, 1996, J NEUROCHEM, V67, P2573; Zhao SM, 1997, BIOCHEMISTRY-US, V36, P8318, DOI 10.1021/bi962814r	51	61	63	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10545	10550		10.1074/jbc.274.15.10545	http://dx.doi.org/10.1074/jbc.274.15.10545			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187848	hybrid			2022-12-27	WOS:000079663500087
J	Hong, SP; Piper, MD; Sinclair, DA; Dawes, IW				Hong, SP; Piper, MD; Sinclair, DA; Dawes, IW			Control of expression of one-carbon metabolism genes of Saccharomyces cerevisiae is mediated by a tetrahydrofolate-responsive protein binding to a glycine regulatory region including a core 5 '-CTTCTT-3 ' motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; LIPOAMIDE DEHYDROGENASE; NUCLEOTIDE-SEQUENCE; CLEAVAGE SYSTEM; CARRIER PROTEIN; LPD1 GENE; SITES; DECARBOXYLASE; SYNTHETASE; REPRESSION	Expression of yeast genes involved in one-carbon metabolism is controlled by glycine, by L-methionine, and by nitrogen sources. Here we report a novel control element containing a core CTTCTT moth mediating the glycine response, demonstrating that a protein binds this element, that binding is modulated by tetrahydrofolate, and that folate is required for the in vivo glycine response. In an heterologous CYC1 promoter the region needed for the glycine response of GCV2 (encoding the P-subunit of glycine decarboxylase) mediated repression that was relieved by glycine. It was also responsible for L-methionine control but not nitrogen repression. GCV1 and GCV3 have an homologous region in their promoters. The GCV1 region conferred a glycine response on an heterologous promoter acting as a repressor or activator depending on promoter context. A protein was identified that bound to the glycine regulatory regions of GCV1 and GCV2 only if the CTTCTT motif was intact. This protein protected a 17-base pair CATCN(7)CTTCTT region of GCV2 that is conserved between GCV1 and GCV2. Protein binding was increased by tetrahydrofolate, and use of a foil deletion mutant indicated the involvement of a folate in the in vivo glycine response. Tetrahydrofolate or a derivative may act as a Ligand for the transcription factor controlling expression of one-carbon metabolism genes.	Univ New S Wales, Sch Biochem & Mol Genet, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Dawes, IW (corresponding author), Univ New S Wales, Sch Biochem & Mol Genet, Sydney, NSW 2052, Australia.	i.dawes@unsw.edu.au	Piper, Matthew/C-1714-2008	Piper, Matthew/0000-0003-3245-7219; Sinclair, David/0000-0002-9936-436X				Blakley R.L., 1969, N HOLLAND RES MONOGR, P1; CICHOWICZ DJ, 1987, BIOCHEMISTRY-US, V26, P504, DOI 10.1021/bi00376a024; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; COSSINS EA, 1966, BIOCHEM J, V101, P542, DOI 10.1042/bj1010542; CUNNINGHAM TS, 1993, J BACTERIOL, V175, P5851, DOI 10.1128/JB.175.18.5851-5861.1993; DAUGHERTY JR, 1993, J BACTERIOL, V175, P64, DOI 10.1128/JB.175.1.64-73.1993; DICKINSON JR, 1986, MOL GEN GENET, V204, P103; DICKINSON JR, 1992, J GEN MICROBIOL, V138, P2029, DOI 10.1099/00221287-138-10-2029; GHRIST AC, 1995, J BACTERIOL, V177, P4980, DOI 10.1128/jb.177.17.4980-4984.1995; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GUARENTE L, 1984, P NATL ACAD SCI-BIOL, V81, P7860, DOI 10.1073/pnas.81.24.7860; HIRAGA K, 1980, J BIOL CHEM, V255, P1671; Kaiser C., 1994, METHODS YEAST GENETI; KOICHI H, 1974, J BIOCHEM-TOKYO, V75, P1113; LIN BF, 1994, J BIOL CHEM, V269, P9705; LOR KL, 1972, BIOCHEM J, V130, P773, DOI 10.1042/bj1300773; Maxam A M, 1980, Methods Enzymol, V65, P499; MCKENZIE KQ, 1977, GENETICS, V86, P85; McNeil JB, 1997, GENE, V186, P13, DOI 10.1016/S0378-1119(96)00670-1; MIKAELIAN I, 1992, NUCLEIC ACIDS RES, V20, P376, DOI 10.1093/nar/20.2.376; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Nagarajan L, 1997, J BIOL CHEM, V272, P4444, DOI 10.1074/jbc.272.7.4444; OGUR M, 1977, J BACTERIOL, V129, P926, DOI 10.1128/JB.129.2.926-933.1977; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; ROSS J, 1988, J GEN MICROBIOL, V134, P1131; RUET A, 1984, EMBO J, V3, P343, DOI 10.1002/j.1460-2075.1984.tb01809.x; SAGERS RD, 1961, J BACTERIOL, V81, P541, DOI 10.1128/JB.81.4.541-549.1961; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHIRCH V, 1989, ARCH BIOCHEM BIOPHYS, V269, P371, DOI 10.1016/0003-9861(89)90120-3; SHANE B, 1989, VITAM HORM, V45, P263; Sinclair DA, 1996, MOL MICROBIOL, V19, P611, DOI 10.1046/j.1365-2958.1996.419947.x; SINCLAIR DA, 1994, MOL CELL BIOL, V14, P214, DOI 10.1128/MCB.14.1.214; SINCLAIR DA, 1995, GENETICS, V140, P1213; STABEN C, 1986, J BIOL CHEM, V261, P4629; STANWAY C, 1987, NUCLEIC ACIDS RES, V15, P6855, DOI 10.1093/nar/15.17.6855; ULANE R, 1972, J BACTERIOL, V109, P34, DOI 10.1128/JB.109.1.34-43.1972; YOSHIDA T, 1972, J BIOCHEM, V72, P1503, DOI 10.1093/oxfordjournals.jbchem.a130042	37	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10523	10532		10.1074/jbc.274.15.10523	http://dx.doi.org/10.1074/jbc.274.15.10523			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187845	hybrid			2022-12-27	WOS:000079663500084
J	Juge-Aubry, CE; Hammar, E; Siegrist-Kaiser, C; Pernin, A; Takeshita, A; Chin, WW; Burger, AG; Meier, CA				Juge-Aubry, CE; Hammar, E; Siegrist-Kaiser, C; Pernin, A; Takeshita, A; Chin, WW; Burger, AG; Meier, CA			Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a dependent trans-activating domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; RETINOID-X RECEPTOR; KINASE-MEDIATED PHOSPHORYLATION; NUCLEAR RECEPTOR; PROTEIN-KINASE; ESTROGEN-RECEPTOR; SIGNALING PATHWAYS; CO-REPRESSOR; GAMMA; BINDING	The peroxisome proliferator-activated receptors (PPARs) are a subgroup of nuclear receptors activated by fatty acids and eicosanoids, In addition, they are subject to phosphorylation by insulin, resulting in the activation of PPAR alpha, while inhibiting PPAR gamma under certain conditions. However, it was hitherto unclear whether the stimulatory effect of insulin on PPAR alpha was direct and by which mechanism it occurs. We now demonstrate that amino acids 1-92 of hPPAR alpha contain an activation function (AF)-1-like domain, which is further activated by insulin through a pathway involving the mitogen-activated protein kinases p42 and p44, Further analysis of the amino-terminal region of PPAR alpha revealed that the insulin-induced trans-activation occurs through the phosphorylation of two mitogen-activated protein kinase sites at positions 12 and 21, both of which are conserved across evolution. The characterization of a strong AF-1 region in PPAR alpha, stimulating transcription one-fourth as strongly as the viral protein VP16, is compatible with the marked basal transcriptional activity of this isoform in transfection experiments. However, it is intriguing that the activity of this AF-1 region is modulated by the phosphorylation of two serine residues, both of which must be phosphorylated in order to activate transcription. This is in contrast to PPAR gamma 2, which was previously shown to be phosphorylated at a single site in a motif that is not homologous to the sites now described in PPAR alpha. Although the molecular details involved in the phosphorylation-dependent enhancement of the transcriptional activity of PPAR alpha remain to be elucidated, we demonstrate that the effect of insulin on the AF-1 region of PPAR alpha can be mimicked by the addition of triiodothyronine receptor beta 1, a strong binder of corepressor proteins. In addition, a triiodothyronine receptor beta 1 mutant deficient in interacting with corepressors is unable to activate PPAR alpha, These observations suggest that the AF-1 region of PPAR alpha is partially silenced by corepressor proteins, which might interact in a phosphorylation-dependent manner.	Univ Hosp Geneva, Div Endocrinol & Diabet, CH-1211 Geneva 14, Switzerland; Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; Univ Hosp Geneva, Dept Med, Med Clin 2, CH-1211 Geneva, Switzerland	University of Geneva; Harvard University; Brigham & Women's Hospital; University of Geneva	Meier, CA (corresponding author), Univ Hosp Geneva, Div Endocrinol & Diabet, CH-1211 Geneva 14, Switzerland.	cameier@genet.ch		Hammar, Eva/0000-0002-3267-2202				Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; BHAT MK, 1994, P NATL ACAD SCI USA, V91, P7927, DOI 10.1073/pnas.91.17.7927; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Camp HS, 1997, J BIOL CHEM, V272, P10811; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; DENNER LA, 1990, SCIENCE, V250, P1740, DOI 10.1126/science.2176746; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; JUGEAUBRY CE, 1995, J BIOL CHEM, V270, P18117, DOI 10.1074/jbc.270.30.18117; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KUIPER GGJM, 1994, MOL CELL ENDOCRINOL, V100, P103, DOI 10.1016/0303-7207(94)90287-9; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lemberger T, 1996, ANN NY ACAD SCI, V804, P231, DOI 10.1111/j.1749-6632.1996.tb18619.x; MEIER CA, 1993, J CLIN INVEST, V92, P1986, DOI 10.1172/JCI116793; NAGPAL S, 1993, EMBO J, V12, P2349, DOI 10.1002/j.1460-2075.1993.tb05889.x; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; ORTI E, 1992, ENDOCR REV, V13, P105, DOI 10.1210/er.13.1.105; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; SHER T, 1993, BIOCHEMISTRY-US, V32, P5598, DOI 10.1021/bi00072a015; STEINEGER HH, 1994, EUR J BIOCHEM, V225, P967, DOI 10.1111/j.1432-1033.1994.0967b.x; SUGAWARA A, 1994, J BIOL CHEM, V269, P433; Willson TM, 1997, CURR OPIN CHEM BIOL, V1, P235, DOI 10.1016/S1367-5931(97)80015-4; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771	32	149	154	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10505	10510		10.1074/jbc.274.15.10505	http://dx.doi.org/10.1074/jbc.274.15.10505			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187842	hybrid			2022-12-27	WOS:000079663500081
J	Merritt, SE; Mata, M; Nihalani, D; Zhu, CX; Hu, XP; Holzman, LB				Merritt, SE; Mata, M; Nihalani, D; Zhu, CX; Hu, XP; Holzman, LB			The mixed lineage kinase DLK utilizes MKK7 and not MKK4 as substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; ZIPPER-BEARING KINASE; SIGNAL-TRANSDUCTION PATHWAY; GLUTATHIONE-S-TRANSFERASE; N-TERMINAL KINASE; C-JUN; MOLECULAR-CLONING; INDUCED APOPTOSIS; FUSION PROTEINS; STRESS	Mixed lineage kinases DLK (dual leucine zipper-bearing kinase) and MLK3 have been proposed to function as mitogen-activated protein kinase kinase kinases in pathways leading to stress-activated protein kinase/c-Jun NH2-terminal kinase activation. Differences in primary protein structure place these MLK (mixed Lineage kinase) enzymes in separate subfamilies and suggest that they perform distinct functional roles. Both DLK and MLK3 associated with, phosphorylated, and activated MKK7 in vitro. Unlike MLK3, however, DLK did not phosphorylate or activate recombinant MKK4 in vitro, In confirmatory experiments performed in vivo, DLK both associated with and activated MKK7, The relative localization of endogenous DLK, MLK3, MKK4, and MKK7 was determined in cells of the nervous system. Distinct from MLK3, which was identified in non-neuronal cells, DLK and MKK7 were detected predominantly in neurons in sections of adult rat cortex by immunocytochemistry. Subcellular fractionation experiments of cerebral cortex identified DLK and MKK7 in similar nuclear and extranuclear subcellular compartments. Concordant with biochemical experiments, however, MKK4 occupied compartments distinct from that of DLK and MKK7, That DLK and MKK7 occupied subcellular compartments distinct from MKK4 was confirmed by immunocytochemistry in primary neuronal culture. The dissimilar cellular specificity of DLK and MLK3 and the specific substrate utilization and subcellular compartmentation of DLK suggest that specific mixed Lineage kinases participate in unique signal transduction events.	Univ Michigan, Sch Med, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; Dept Vet Affairs, Ann Arbor, MI 48105 USA; Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15213 USA; Dept Vet Affairs, Pittsburgh, PA 15213 USA	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Holzman, LB (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Nephrol, 1560 Med Sci Res Bldg 2, Ann Arbor, MI 48109 USA.	lholzman@umich.edu	nihalani, deepak/AAK-9453-2020	Holzman, Lawrence/0000-0002-8961-234X				BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; DOROW DS, 1993, EUR J BIOCHEM, V213, P701, DOI 10.1111/j.1432-1033.1993.tb17810.x; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Fan G, 1996, J BIOL CHEM, V271, P24788, DOI 10.1074/jbc.271.40.24788; Fanger GR, 1997, CURR OPIN GENET DEV, V7, P67, DOI 10.1016/S0959-437X(97)80111-6; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GAO B, 1995, NEUROSCIENCE, V65, P101, DOI 10.1016/0306-4522(94)00480-S; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hirai S, 1997, J BIOL CHEM, V272, P15167, DOI 10.1074/jbc.272.24.15167; Hirai S, 1996, ONCOGENE, V12, P641; Holland PM, 1997, J BIOL CHEM, V272, P24994, DOI 10.1074/jbc.272.40.24994; HOLZMAN LB, 1994, J BIOL CHEM, V269, P30808; Kenney AM, 1998, J NEUROSCI, V18, P1318; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; Mizukami Y, 1997, J BIOL CHEM, V272, P16657, DOI 10.1074/jbc.272.26.16657; Moriguchi T, 1997, EMBO J, V16, P7045, DOI 10.1093/emboj/16.23.7045; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rana A, 1996, J BIOL CHEM, V271, P19025, DOI 10.1074/jbc.271.32.19025; Sakuma H, 1997, J BIOL CHEM, V272, P28622, DOI 10.1074/jbc.272.45.28622; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yao ZB, 1997, J BIOL CHEM, V272, P32378, DOI 10.1074/jbc.272.51.32378; Zhang Y, 1998, P NATL ACAD SCI USA, V95, P2586, DOI 10.1073/pnas.95.5.2586; ZHENG CF, 1993, J BIOL CHEM, V268, P11435; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	36	84	94	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10195	10202		10.1074/jbc.274.15.10195	http://dx.doi.org/10.1074/jbc.274.15.10195			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187804	hybrid			2022-12-27	WOS:000079663500043
J	Bai, RL; Ewell, JB; Nguyen, NY; Hamel, E				Bai, RL; Ewell, JB; Nguyen, NY; Hamel, E			Direct photoaffinity labeling of cysteine 211 or a nearby amino acid residue of beta-tubulin by guanosine 5 '-diphosphate bound in the exchangeable site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP; BINDING; BRAIN	Tubulin with [8-C-14]GDP bound in the exchangeable site was exposed to ultraviolet light, and radiolabel was cross-linked to two peptide regions of the beta-subunit. Following enrichment for peptides cross-linked to guanosine by boronate chromatography, we confirmed that the cysteine 12 residue was the major site of crosslinking. However, significant radiolabel was also incorporated into a peptide containing amino acid residues 206 through 224. Although every amino acid in this peptide except cysteine 211 was identified by sequential Edman degradation, implying that this was the amino acid residue cross-linked to guanosine, radiolabel at C-8 was usually lost during peptide processing (probably during chromatography at pH 10). Consequently, the radiolabeled amino acid could not be unambiguously identified.	NCI, Frederick Canc Res & Dev Ctr, Sci Applicat Int Corp, NIH, Frederick, MD 21702 USA; US FDA, Ctr Biol Evaluat & Res, Facil Biotechnol Resources, Bethesda, MD 20892 USA; NCI, Frederick Canc Res & Dev Ctr, Lab Drug Discovery Res & Dev,NIH, Dev Therapeut Program,Div Canc Treatment & Diag, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Hamel, E (corresponding author), NIH, Lab Drug Discovery Res & Dev, Bldg 37,Rm 5D02,37 Convent Dr, Bethesda, MD 20892 USA.							BAI R, 1988, J BIOL CHEM, V273, P9894; GEAHLEN RL, 1977, P NATL ACAD SCI USA, V74, P4375, DOI 10.1073/pnas.74.10.4375; GROVER S, 1994, EUR J BIOCHEM, V222, P163, DOI 10.1111/j.1432-1033.1994.tb18854.x; HAMEL E, 1984, BIOCHEMISTRY-US, V23, P4173, DOI 10.1021/bi00313a026; KOBAYASH.T, 1974, J BIOCHEM-TOKYO, V76, P201, DOI 10.1093/oxfordjournals.jbchem.a130546; KRAUHS E, 1981, P NATL ACAD SCI-BIOL, V78, P4156, DOI 10.1073/pnas.78.7.4156; LEVI A, 1974, BIOCHIM BIOPHYS ACTA, V365, P450, DOI 10.1016/0005-2795(74)90022-1; LITTLE M, 1987, BIOCHIM BIOPHYS ACTA, V912, P28, DOI 10.1016/0167-4838(87)90243-3; LUDUENA RF, 1991, PHARMACOL THERAPEUT, V49, P133, DOI 10.1016/0163-7258(91)90027-J; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; PENNINGROTH SM, 1977, J MOL BIOL, V115, P643, DOI 10.1016/0022-2836(77)90108-5; SHEARWIN KE, 1994, BIOCHEMISTRY-US, V33, P885, DOI 10.1021/bi00170a006; SHIVANNA BD, 1993, J BIOL CHEM, V268, P127; SPIEGELMAN BM, 1977, CELL, V12, P587, DOI 10.1016/0092-8674(77)90259-8; Stephens R.E., 1967, SCIENCE, V156, P1606; WEISENBERG RC, 1968, BIOCHEMISTRY-US, V7, P4466, DOI 10.1021/bi00852a043; WEISENBERG RC, 1976, BIOCHEMISTRY-US, V15, P4248, DOI 10.1021/bi00664a018	17	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12710	12714		10.1074/jbc.274.18.12710	http://dx.doi.org/10.1074/jbc.274.18.12710			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212253	hybrid			2022-12-27	WOS:000080056800073
J	Marino, M; Zheng, G; McCluskey, RT				Marino, M; Zheng, G; McCluskey, RT			Megalin (gp330) is an endocytic receptor for thyroglobulin on cultured Fisher rat thyroid cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; HEPARAN-SULFATE PROTEOGLYCANS; HEYMANN NEPHRITIS; LDL RECEPTOR; MEDIATES ENDOCYTOSIS; POTENTIAL ROLE; GENE FAMILY; PROTEIN; BINDING; INTERNALIZATION	We recently reported that megalin (gp330), an endocytic receptor found on the apical surface of thyroid cells, binds thyroglobulin (Tg) with high affinity in solid phase assays. Megalin-bound Tg was releasable by heparin, Here we show that Fisher rat thyroid (FRTL-5) cells, a differentiated rat thyroid cell line, can bind and endocytose Tg via megalin, We first demonstrated that FRTL-5 cells express megalin in a thyroid-stimulating hormone-dependent manner. Evidence of Tg binding to megalin on FRTL-5 cells and on an immortalized rat renal proximal tubule cell line (IRPT cells), was obtained by incubating the cells with I-125-Tg, followed by chemical cross-linking and immunoprecipitation of I-125-Tg with antibodies against megalin, To investigate cell binding further, we developed an assay in which cells were incubated with unlabeled Tg at 4 degrees C, followed by incubation with heparin, which released almost all of the cell-bound Tg into the medium. In solid phase experiments designed to illuminate the mechanism of heparin release, we demonstrated that Tg is a heparin-binding protein, as are several megalin ligands, The amount of Tg released by heparin from FRTL-5 and IRPT cells, measured by enzyme-linked immunosorbent assay (ELISA), was markedly reduced by two megalin competitors, receptor-associated protein (RAP) and 1H2 (monoclonal antibody against megalin), indicating that much of the Tg released by heparin had been bound to megalin (similar to 60-80%). The amount inhibited by RAP was considered to represent specific binding to megalin, which was saturable and of high affinity (K(d)similar to 11.2 nM), Tg endocytosis by FRTL-5 and IRPT cells was demonstrated in experiments in which cells were incubated with unlabeled Tg at 37 degrees C, followed by heparin to remove cell-bound Tg, The amount of Tg internalized (measured by ELISA in the cell lysates) was reduced by RAP and 1H2, indicating that Tg endocytosis is partially mediated by megalin.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Pathol Res Lab, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	McCluskey, RT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Pathol Res Lab, 149 13th St, Charlestown, MA 02129 USA.				NIDDK NIH HHS [DK 46301] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046301] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; ARGRAVES KM, 1995, J BIOL CHEM, V270, P26550, DOI 10.1074/jbc.270.44.26550; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; BERNIERVALENTIN F, 1990, J BIOL CHEM, V265, P17373; BERNIERVALENTIN F, 1991, ENDOCRINOLOGY, V129, P2194, DOI 10.1210/endo-129-4-2194; BIDEY SP, 1984, J ENDOCRINOL, V101, P269, DOI 10.1677/joe.0.1010269; CONSIGLIO E, 1981, J BIOL CHEM, V256, P592; CONSIGLIO E, 1979, J BIOL CHEM, V254, P5065; DUNN A, 1996, WERNER INGBARS THYRO, P81; EMOTO N, 1994, ENDOCRINOL METAB, V1, P123; ESQUIVEL PS, 1977, J EXP MED, V145, P1250, DOI 10.1084/jem.145.5.1250; FARQUHAR MG, 1994, ANN NY ACAD SCI, V737, P96, DOI 10.1111/j.1749-6632.1994.tb44304.x; Giraud A, 1997, ENDOCRINOLOGY, V138, P2325, DOI 10.1210/en.138.6.2325; GOLDSTEIN JL, 1976, CELL, V7, P85, DOI 10.1016/0092-8674(76)90258-0; GUTMANN EJ, 1989, AM J PHYSIOL, V257, pC397, DOI 10.1152/ajpcell.1989.257.2.C397; HERZ J, 1991, J BIOL CHEM, V266, P21232; JI ZS, 1993, J BIOL CHEM, V268, P10160; Jung FF, 1998, KIDNEY INT, V53, P358, DOI 10.1046/j.1523-1755.1998.00766.x; KOSTROUCH Z, 1993, ENDOCRINOLOGY, V132, P2645, DOI 10.1210/en.132.6.2645; KOUNNAS MZ, 1994, ANN NY ACAD SCI, V737, P114, DOI 10.1111/j.1749-6632.1994.tb44305.x; LEMANSKY P, 1992, EUR J BIOCHEM, V209, P111, DOI 10.1111/j.1432-1033.1992.tb17267.x; LIMBIRD LE, 1996, CELL SURFACE RECEPTO; Lundgren S, 1997, J HISTOCHEM CYTOCHEM, V45, P383, DOI 10.1177/002215549704500306; MAHLEY RW, 1994, ANN NY ACAD SCI, V737, P39, DOI 10.1111/j.1749-6632.1994.tb44300.x; MIQUELIS R, 1987, J BIOL CHEM, V262, P15291; MOESTRUP SK, 1995, J CLIN INVEST, V96, P1404, DOI 10.1172/JCI118176; MOESTRUP SK, 1993, J BIOL CHEM, V268, P16564; MULDER M, 1993, J BIOL CHEM, V268, P9369; Mziaut H, 1996, ENDOCRINOLOGY, V137, P1370, DOI 10.1210/en.137.4.1370; RAYCHOWDHURY R, 1989, SCIENCE, V244, P1163, DOI 10.1126/science.2786251; Raychowdhury R, 1996, AM J PATHOL, V148, P1613; ROITT IM, 1984, CLIN EXP IMMUNOL, V56, P129; ROUSSET B, 1991, MOL CELL ENDOCRINOL, V78, P89; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; SAXENA U, 1990, J BIOL CHEM, V265, P12880; STEFANSSON S, 1995, J CELL SCI, V108, P2361; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; TANG SS, 1994, EXP NEPHROL, V2, P127; VANDENHOVE MF, 1982, EUR J BIOCHEM, V122, P415; Weaver AM, 1997, J LIPID RES, V38, P1841; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172; Zheng G, 1998, ENDOCRINOLOGY, V139, P1462, DOI 10.1210/en.139.3.1462; ZHENG G, 1994, ANN NY ACAD SCI, V737, P154, DOI 10.1111/j.1749-6632.1994.tb44309.x; ZHENG G, 1994, J HISTOCHEM CYTOCHEM, V42, P531, DOI 10.1177/42.4.7510321	44	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12898	12904		10.1074/jbc.274.18.12898	http://dx.doi.org/10.1074/jbc.274.18.12898			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212279	hybrid			2022-12-27	WOS:000080056800099
J	Borgne, A; Ostvold, AC; Flament, S; Meijer, L				Borgne, A; Ostvold, AC; Flament, S; Meijer, L			Intra-M phase-promoting factor phosphorylation of cyclin B at the prophase/metaphase transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CELL-CYCLE; FISSION YEAST; TYROSINE PHOSPHORYLATION; DEPENDENT KINASES; NUCLEAR-LOCALIZATION; OOCYTE MATURATION; STARFISH OOCYTES; CDC2; ACTIVATION	Activation of Cdc2-cyclin B (or M phase-promoting factor (MPF)) at the prophase/metaphase transition proceeds in two steps: dephosphorylation of Cdc2 and phosphorylation of cyclin B, We here investigated the regulation of cyclin B phosphorylation using the starfish oocyte model. Cyclin B phosphorylation is not required for Cdc2 kinase activity; both the prophase complex dephosphorylated on Cdc2 with Cdc25 and the metaphase complex dephosphorylated on cyclin B with protein phosphatase 2A display high kinase activities. An in vitro assay of cyclin B kinase activity closely mimics in vivo phosphorylation as shown by phosphopeptide maps of in vivo and in vitro phosphorylated cyclin B. We demonstrate that Cdc2 itself is the cyclin B kinase; cyclin B phosphorylation requires Cdc2 activity both in vivo (sensitivity to vitamin K-3, a Cdc25 inhibitor) and in vitro (copurification with Cdc2-cyclin B, requirement of Cdc2 dephosphorylation, and sensitivity to chemical inhibitors of cyclin-dependent kinases), Furthermore, cyclin B phosphorylation occurs as an intra-M phase-promoting factor reaction as shown by the following: 1) active Cdc2 is unable to phosphorylate cyclin B associated to phosphorylated Cdc2, and 2) cyclin B phosphorylation is insensitive to enzyme/substrate dilution. We conclude that, at the prophase/metaphase transition, cyclin B is mostly phosphorylated by its own associated Cdc2 subunit.	CNRS, Biol Stn, F-29682 Roscoff, France; Univ Oslo, Neurochem Lab, N-0317 Oslo, Norway; Univ Lille 1, Dev Biol Lab, F-59655 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); University of Oslo; Universite de Lille - ISITE; Universite de Lille	Meijer, L (corresponding author), CNRS, Biol Stn, BP 74, F-29682 Roscoff, France.	meijer@sb-roscoff.fr		, laurent/0000-0003-3511-4916				ARION D, 1988, CELL, V55, P371, DOI 10.1016/0092-8674(88)90060-8; AZZI L, 1994, J BIOL CHEM, V269, P13279; BOOHER RN, 1989, CELL, V58, P485, DOI 10.1016/0092-8674(89)90429-7; Borgne A, 1996, J BIOL CHEM, V271, P27847, DOI 10.1074/jbc.271.44.27847; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Derua R, 1997, EXP CELL RES, V230, P310, DOI 10.1006/excr.1996.3436; DRAETTA G, 1987, CELL, V50, P319, DOI 10.1016/0092-8674(87)90227-3; DUCOMMUN B, 1991, EMBO J, V10, P3311, DOI 10.1002/j.1460-2075.1991.tb04895.x; DUNPHY WG, 1997, METHOD ENZYMOL, V283, P677; ELLEDGE SJ, 1992, P NATL ACAD SCI USA, V89, P2907, DOI 10.1073/pnas.89.7.2907; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; GAUTIER J, 1991, EMBO J, V10, P177, DOI 10.1002/j.1460-2075.1991.tb07934.x; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; GOULD KL, 1991, EMBO J, V10, P3297, DOI 10.1002/j.1460-2075.1991.tb04894.x; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; IZUMI T, 1991, MOL CELL BIOL, V11, P3860, DOI 10.1128/MCB.11.8.3860; KERNS J, 1995, BIOORG CHEM, V23, P101, DOI 10.1006/bioo.1995.1008; KISHIMOTO T, 1994, INT J DEV BIOL, V38, P185; KORNBLUTH S, 1994, MOL BIOL CELL, V5, P273, DOI 10.1091/mbc.5.3.273; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; LABBE JC, 1988, NATURE, V335, P251, DOI 10.1038/335251a0; LEE MS, 1994, J BIOL CHEM, V269, P30530; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; LI JK, 1995, MOL BIOL CELL, V6, P1111, DOI 10.1091/mbc.6.9.1111; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; MEIJER L, 1989, EMBO J, V8, P2275, DOI 10.1002/j.1460-2075.1989.tb08353.x; MEIJER L, 1991, EMBO J, V10, P1545, DOI 10.1002/j.1460-2075.1991.tb07674.x; Meijer L., 1995, PROGR CELL CYCLE RES, V1; MEIJER L, 1997, PROGR CELL CYCLE RES, V3; Meijer L., 1996, PROGR CELL CYCLE RES, V2; Meijer Laurent, 1994, Seminars in Developmental Biology, V5, P165, DOI 10.1006/sedb.1994.1022; MILLAR JBA, 1992, EMBO J, V11, P4933, DOI 10.1002/j.1460-2075.1992.tb05600.x; MILLAR JBA, 1992, CELL, V68, P407, DOI 10.1016/0092-8674(92)90177-E; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Nigg E A, 1991, Semin Cell Biol, V2, P261; NURSE P, 1981, NATURE, V292, P558, DOI 10.1038/292558a0; OOKATA K, 1992, EMBO J, V11, P1763, DOI 10.1002/j.1460-2075.1992.tb05228.x; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; PONDAVEN P, 1990, GENE DEV, V4, P9, DOI 10.1101/gad.4.1.9; ROY LM, 1990, CELL, V61, P825, DOI 10.1016/0092-8674(90)90192-H; Shapiro H, 1941, J CELL COMPAR PHYSL, V18, P61, DOI 10.1002/jcp.1030180108; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; TASSAN JP, 1995, EMBO J, V14, P5608, DOI 10.1002/j.1460-2075.1995.tb00248.x; VESELY J, 1994, EUR J BIOCHEM, V224, P771, DOI 10.1111/j.1432-1033.1994.00771.x; WALAAS SI, 1989, FEBS LETT, V258, P106, DOI 10.1016/0014-5793(89)81626-6; XU WL, 1992, P NATL ACAD SCI USA, V89, P4573, DOI 10.1073/pnas.89.10.4573; YAMASHITA M, 1995, DEV BIOL, V168, P62, DOI 10.1006/dbio.1995.1061	53	57	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11977	11986		10.1074/jbc.274.17.11977	http://dx.doi.org/10.1074/jbc.274.17.11977			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207019	hybrid			2022-12-27	WOS:000079834800075
J	Gong, LM; Yeh, ETH				Gong, LM; Yeh, ETH			Identification of the activating and conjugating enzymes of the NEDD8 conjugation pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEIN; CELLULAR-REGULATION; HOMOLOG; SENTRIN; SYSTEM; ROLES; CDNA	NEDD8 is a ubiquitin-like molecule that can be covalently conjugated to a limited number of cellular proteins, such as Cdc53/cullin. We have previously reported that the C terminus of NEDD8 is efficiently processed to expose Gly-76, which is required for conjugation to target proteins. A combination of data base searches and polymerase chain reaction cloning was used to identify a cDNA encoding human UBA3, which is 38% identical to the yeast homologue, 22% identical to human UBA2, and 19% identical to the C-terminal region of human UBE1, The human UBA3 gene is located on chromosome 3p13 and gave rise to a 2.2-kilobase pair transcript that was detected in all tissues. Human UBA3 could be precipitated with glutathione S-transferase (GST)-NEDD8, but not with GST-ubiquitin or GST-sentrin-1. Moreover, human UBA3 could form a beta-mercaptoethanol-sensitive conjugate with NEDD8 in the presence of APP-BP1, a protein with sequence homology to the N-terminal half of ubiquitin-activating enzyme. We have also cloned human UBC12 and demonstrated that it could form a thiol ester linkage with NEDD8 in the presence of the activating enzyme complex. Identification of the activating and conjugating enzymes of the NEDD8 conjugation pathway should allow for a more detailed study of the role of NEDD8 modification in health and disease.	Univ Texas, Hlth Sci Ctr, Dept Internal Med, Div Mol Med, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Inst Mol Med Prevent Human Dis, Res Ctr Cardiovasc Dis, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Yeh, ETH (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Internal Med, Div Mol Med, 6431 Fannin,Suite 4200, Houston, TX 77030 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045851] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-45851] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chow NW, 1996, J BIOL CHEM, V271, P11339, DOI 10.1074/jbc.271.19.11339; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Haas AL, 1997, FASEB J, V11, P1053, DOI 10.1096/fasebj.11.13.9367340; HAAS AL, 1987, J BIOL CHEM, V262, P11315; HANDLEYGEARHART PM, 1994, J BIOL CHEM, V269, P33171; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; LOEB KR, 1992, J BIOL CHEM, V267, P7806; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; Narasimhan J, 1996, J BIOL CHEM, V271, P324, DOI 10.1074/jbc.271.1.324; Okura T, 1996, J IMMUNOL, V157, P4277; WILKINSON KD, 1995, ANNU REV NUTR, V15, P161, DOI 10.1146/annurev.nu.15.070195.001113	19	208	219	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12036	12042		10.1074/jbc.274.17.12036	http://dx.doi.org/10.1074/jbc.274.17.12036			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207026	hybrid			2022-12-27	WOS:000079834800082
J	Schweizer-Groyer, G; Jibard, N; Neau, E; Fortin, D; Cadepond, F; Baulieu, EE; Groyer, A				Schweizer-Groyer, G; Jibard, N; Neau, E; Fortin, D; Cadepond, F; Baulieu, EE; Groyer, A			The glucocorticoid response element II is functionally homologous in rat and human insulin-like growth factor-binding protein-1 promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOZOTOCIN-DIABETIC RATS; TRANS-ACTING FACTORS; HUMAN GENE; HEPATOMA-CELLS; IGFBP-1 PROMOTER; MAMMALIAN-CELLS; MESSENGER-RNA; CIS-ELEMENTS; EXPRESSION; TRANSCRIPTION	In vivo, insulin-like growth factor-binding protein-1 (IGFBP-1) modulates the IGFs' bioavailability and may contribute to their delivery to peripheral tissues. In rat and human hepatocytes, glucocorticoids stimulate IG-FBP-1 gene transcription through homologous glucocorticoid response units (GRU). Transfection experiments have shown that one of these, GRUB (nucleotide (nt) -121 to -85 and nt -111 to -74 in human and rat promoters, respectively), was on its own able to mediate the glucocorticoid response in rat but not in human species (Suwanichkul, A., Allander, S., Morris, S. L. & Powell, D. R. (1994) J. Biol. Chem. 269, 30835-30841, Goswami, a, Lacson, R., Yang, E,, Sam, R. & Unterman, T. (1994) Endocrinology 134, 736-743, and Sub, D. S., Ooi, G. T, & Rechler, M. M. (1994) Mob Endocrinol. 8, 794-805), A close comparison of GRUB sequences has pointed out a C to A transition in the underlying GREII, which creates a GATC tetranucleotide in rat species. This tetranucleotide is submitted to adenosyl methylation (dam methylation) in most Escherichia coli bacterial strains, but not in eucaryotic cells. We showed (i) that on its own, the unmethylated rat GRUB (propagated in dam E. coli strains) was inactive, as is the case for its human counterpart (nonsignificant glucocorticoid inductions, 1.48 +/- 0.23 and 1.7 +/- 0.35-fold in Chinese hamster ovary cells, respectively) and (ii) that its adenosyl methylation in standard dam(+) bacterial strains yielded a functional GRU (6.5 +/- 1.1 and 13.1 +/- 3.9-fold glucocorticoid inductions in Chinese hamster ovary and HepG2 cells, respectively). Transient transfection in HepG2 hepatoma cells clearly showed that the interaction of liver-enriched trans-acting factor(s) with the 5'-overlapping insulin response element does not enable the unmethylated rat GRU2 or the human GRUB to become responsive to glucocorticoids (nonsignificant 2.21 +/- 0.48 and 1.20 +/- 0.06-fold induction, respectively). Furthermore, we have correlated these functional data with in vitro DNA-protein interaction studies: the dam methylated rat GREII displayed a 2.8-fold higher affinity for the glucocorticoid receptor than its unmethylated counterpart.	INSERM, U488, Lab Hormones, F-94276 Le Kremlin Bicetre, France; Hop St Antoine, INSERM, U142, F-75571 Paris 12, France; Univ Paris 07, INSERM, U327, F-75870 Paris 18, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Schweizer-Groyer, G (corresponding author), INSERM, U488, Lab Hormones, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France.	groyer@kb.inserm.fr						BABAJKO S, 1993, P NATL ACAD SCI USA, V90, P272, DOI 10.1073/pnas.90.1.272; BABAJKO S, 1993, BIOCHEM BIOPH RES CO, V196, P480, DOI 10.1006/bbrc.1993.2275; BABAJKO S, 1993, ENDOCRINOLOGY, V132, P2586, DOI 10.1210/en.132.6.2586; BABAJKO S, 1993, GROWTH REGULAT, V3, P17; BAGCHI MK, 1992, ENDOCR REV, V13, P525, DOI 10.1210/er.13.3.525; BAR RS, 1990, ENDOCRINOLOGY, V127, P497, DOI 10.1210/endo-127-1-497; BARRAS F, 1989, TRENDS GENET, V5, P139, DOI 10.1016/0168-9525(89)90054-1; BAXTER RC, 1987, J CLIN ENDOCR METAB, V65, P432, DOI 10.1210/jcem-65-3-432; CADEPOND F, 1994, J STEROID BIOCHEM, V48, P361, DOI 10.1016/0960-0760(94)90076-0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLEMMONS DR, 1992, GROWTH REGULAT, V2, P80; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; ELLISTON JF, 1990, MOL CELL BIOL, V10, P6607, DOI 10.1128/MCB.10.12.6607; ERDOS T, 1970, ANAL BIOCHEM, V37, P244, DOI 10.1016/0003-2697(70)90044-8; GOSWAMI R, 1994, ENDOCRINOLOGY, V134, P736, DOI 10.1210/en.134.2.736; GRAHAM MW, 1995, TRANSGENIC RES, V4, P324, DOI 10.1007/BF01972529; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MURPHY LJ, 1991, ENDOCRINOLOGY, V128, P689, DOI 10.1210/endo-128-2-689; Nan XS, 1998, CIBA F SYMP, V214, P6; Neau Eric, 1995, Progress in Growth Factor Research, V6, P103, DOI 10.1016/0955-2235(95)00039-9; OBRIEN RM, 1995, MOL CELL BIOL, V15, P1747; OOI GT, 1992, MOL ENDOCRINOL, V6, P2219, DOI 10.1210/me.6.12.2219; OOI GT, 1993, J BIOL CHEM, V268, P16664; OOI GT, 1990, MOL ENDOCRINOL, V4, P321, DOI 10.1210/mend-4-2-321; ORLOWSKI CC, 1990, MOL ENDOCRINOL, V4, P1592, DOI 10.1210/mend-4-10-1592; PAO CI, 1992, MOL ENDOCRINOL, V6, P969, DOI 10.1210/me.6.6.969; POWELL DR, 1991, J BIOL CHEM, V266, P18868; POWELL DR, 1993, DNA CELL BIOL, V12, P283, DOI 10.1089/dna.1993.12.283; PRICE WA, 1992, ENDOCRINOLOGY, V130, P1424, DOI 10.1210/en.130.3.1424; Pristas P, 1998, J BASIC MICROB, V38, P283; Reik W, 1998, CURR OPIN GENET DEV, V8, P154, DOI 10.1016/S0959-437X(98)80136-6; ROBERTSON DG, 1994, BIOCHEM BIOPH RES CO, V200, P226, DOI 10.1006/bbrc.1994.1438; SCHULLER AGP, 1994, MOL CELL ENDOCRINOL, V104, P57, DOI 10.1016/0303-7207(94)90051-5; SchweizerGroyer G, 1997, BIOCHEM J, V324, P823, DOI 10.1042/bj3240823; SegardMaurel I, 1996, BIOCHEMISTRY-US, V35, P1634, DOI 10.1021/bi951369h; SLEIGH MJ, 1986, ANAL BIOCHEM, V156, P251, DOI 10.1016/0003-2697(86)90180-6; Suh DS, 1996, MOL ENDOCRINOL, V10, P1227, DOI 10.1210/me.10.10.1227; SUH DS, 1994, MOL ENDOCRINOL, V8, P794, DOI 10.1210/me.8.6.794; SUWANICHKUL A, 1993, J BIOL CHEM, V268, P9730; SUWANICHKUL A, 1994, J BIOL CHEM, V269, P30835; SUWANICKUL A, 1993, J BIOL CHEM, V268, P17063; TAJIMA S, 1998, J BIOCHEM-TOKYO, V123, P998; TRONCHE F, 1989, MOL CELL BIOL, V9, P4759, DOI 10.1128/MCB.9.11.4759; TRUSS M, 1992, NUCLEIC ACIDS RES, V20, P1483, DOI 10.1093/nar/20.7.1483; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; UNTERMAN TG, 1994, BIOCHEM BIOPH RES CO, V203, P1835, DOI 10.1006/bbrc.1994.2401; UNTERMAN TG, 1991, ENDOCRINOLOGY, V128, P2693, DOI 10.1210/endo-128-6-2693; UNTERMAN TG, 1990, ENDOCRINOLOGY, V126, P2614, DOI 10.1210/endo-126-5-2614; UNTERMAN TG, 1993, ENDOCRINOLOGY, V133, P2531, DOI 10.1210/en.133.6.2531	52	4	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11679	11686		10.1074/jbc.274.17.11679	http://dx.doi.org/10.1074/jbc.274.17.11679			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206981	hybrid			2022-12-27	WOS:000079834800037
J	Toshima, J; Tanaka, T; Mizuno, K				Toshima, J; Tanaka, T; Mizuno, K			Dual specificity protein kinase activity of testis-specific protein kinase 1 and its regulation by autophosphorylation of serine-215 within the activation loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; TYROSINE RESIDUES; PHOSPHORYLATION SITES; CONSERVED FEATURES; THREONINE KINASES; MAMMALIAN-CELLS; IDENTIFICATION; FAMILY; TESK1; TRANSFORMATION	TESK1 (testis-specific protein kinase 1) is a protein kinase with a structure composed of an N-terminal protein kinase domain and a C-terminal proline-rich domain. Whereas the 3.6-kilobase TESK1 mRNA is expressed predominantly in the testis, a faint 2.5-kilobase TESK1 mRNA is expressed ubiquitously. The kinase domain of TESK1 contains in the catalytic loop in subdomain VIE an unusual DLTSKN sequence, which is not related to the consensus sequence of either serine/threonine kinases or tyrosine kinases, In this study, we show that TESK1 has kinase activity with dual specificity on both serine/threonine and tyrosine residues. In an in vitro kinase reaction, the kinase domain of TESK1 underwent autophosphorylation on serine and tyrosine residues and catalyzed phosphorylation of histone H3 and myelin basic protein on serine, threonine, and tyrosine residues. Site-directed mutagenesis analyses revealed that Ser-215 within the "activation loop" of the kinase domain is the site of serine autophosphorylation of TESK1. Replacement of Ser-215 by alanine almost completely abolished serine autophosphorylation and histone H3 kinase activities. In contrast, replacement of Ser-215 by glutamic acid abolished serine autophosphorylation activity but retained histone H3 kinase activity. These results suggest that autophosphorylation of Ser-215 is an important step to positively regulate the kinase activity of TESK1.	Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan	Kyushu University	Mizuno, K (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan.	kmizuscb@mbox.nc.kyushu-u.ac.jp	Mizuno, Kensaku/G-8631-2015					ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; BENDAVID Y, 1991, EMBO J, V10, P317, DOI 10.1002/j.1460-2075.1991.tb07952.x; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DOUVILLE E, 1994, CANCER METAST REV, V13, P1, DOI 10.1007/BF00690414; DOUVILLE EMJ, 1992, MOL CELL BIOL, V12, P2681, DOI 10.1128/MCB.12.6.2681; GOULD KL, 1991, EMBO J, V10, P3297, DOI 10.1002/j.1460-2075.1991.tb04894.x; Guesdon F, 1997, J BIOL CHEM, V272, P30017, DOI 10.1074/jbc.272.48.30017; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Hiraoka J, 1996, FEBS LETT, V399, P117, DOI 10.1016/S0014-5793(96)01303-8; HOWELL BW, 1991, MOL CELL BIOL, V11, P568, DOI 10.1128/MCB.11.1.568; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kentrup H, 1996, J BIOL CHEM, V271, P3488; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Lawler S, 1997, J BIOL CHEM, V272, P14850, DOI 10.1074/jbc.272.23.14850; LINDBERG RA, 1992, TRENDS BIOCHEM SCI, V17, P114, DOI 10.1016/0968-0004(92)90248-8; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MIZUNO K, 1994, ONCOGENE, V9, P1605; NUNOUE K, 1995, ONCOGENE, V11, P701; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; ORR JW, 1994, J BIOL CHEM, V269, P27715; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PROSCHEL C, 1995, ONCOGENE, V11, P1271; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Toshima J, 1998, BIOCHEM BIOPH RES CO, V249, P107, DOI 10.1006/bbrc.1998.9099; Toshima J, 1995, J BIOL CHEM, V270, P31331, DOI 10.1074/jbc.270.52.31331; Toshima J, 1998, GENE, V206, P237, DOI 10.1016/S0378-1119(97)00591-X; WANG QM, 1994, J BIOL CHEM, V269, P14566; WU J, 1991, P NATL ACAD SCI USA, V88, P9508, DOI 10.1073/pnas.88.21.9508; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x	39	24	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12171	12176		10.1074/jbc.274.17.12171	http://dx.doi.org/10.1074/jbc.274.17.12171			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207045	hybrid			2022-12-27	WOS:000079834800101
J	Beall, A; Bagwell, D; Woodrum, D; Stoming, TA; Kato, K; Suzuki, A; Rasmussen, H; Brophy, CM				Beall, A; Bagwell, D; Woodrum, D; Stoming, TA; Kato, K; Suzuki, A; Rasmussen, H; Brophy, CM			The small heat shock-related protein, HSP20, is phosphorylated on serine 16 during cyclic nucleotide-dependent relaxation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; 20-KDA PROTEIN; ELECTROPHORESIS; VASORELAXATION; RESOLUTION; PEPTIDE; KINASE	The small heat shock-related protein 20 (HSP20) is present in four isoforms in bovine carotid artery smooth muscles. Three of the isoforms are phosphorylated and one is not. Increases in the phosphorylation of two isoforms of HSP20 (isoform 3, pI 5.9; and 8, pI 5.7) are associated with cyclic nucleotide-dependent relaxation of bovine carotid artery smooth muscles. Increases in the phosphorylation of another isoform (isoform 4, pI 6.0) are associated with phorbol ester-induced contraction of bovine carotid artery smooth muscles. In this investigation we determined that isoforms 3 and 8 are phosphorylated on Ser(16) of the HSP20 molecule during activation of cAMP-dependent signaling pathways. Phosphorylation state-specific antibodies produced against a peptide containing phosphorylated Ser(16) recognized isoforms 3 and 8 but not isoform 4. In human vascular tissue, only isoform 3 is present. Incubation of transiently permeabilized strips of bovine carotid artery smooth muscle with synthetic peptides in which Ser(16) is phosphorylated, inhibits contractile responses to high extracellular KCl and to serotonin, These data suggest that phosphorylation of HSP20 on Ser(16) modulates cAMP-dependent vasorelaxation.	Med Coll Georgia, Dept Surg, Augusta, GA 30912 USA; Med Coll Georgia, Dept Med, Inst Mol Med & Genet, Augusta, GA 30912 USA; Med Coll Georgia, Dept Cell Biol & Anat, Augusta, GA 30912 USA; Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; Augusta Vet Adm Med Ctr, Augusta, GA 30912 USA; Inst Dev Res, Human Serv Ctr, Dept Biochem, Kasugai, Aichi 48003, Japan; Yokohama City Univ, Sch Med, Dept Mol Biol, Yokohama, Kanagawa 236, Japan	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Yokohama City University	Brophy, CM (corresponding author), Med Coll Georgia, Dept Surg, 1120 15th St, Augusta, GA 30912 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058027] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL58027-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beall A, 1999, BBA-MOL CELL RES, V1449, P41, DOI 10.1016/S0167-4889(98)00169-4; Beall AC, 1997, J BIOL CHEM, V272, P11283; BERGH CM, 1995, AM J PHYSIOL-HEART C, V268, pH202, DOI 10.1152/ajpheart.1995.268.1.H202; Brophy CM, 1997, J VASC SURG, V25, P390, DOI 10.1016/S0741-5214(97)70361-6; Brophy CM, 1997, BIOL REPROD, V57, P1354, DOI 10.1095/biolreprod57.6.1354; Brophy CM, 1999, J VASC SURG, V29, P326, DOI 10.1016/S0741-5214(99)70385-X; Brophy CM, 1998, J VASC SURG, V27, P963, DOI 10.1016/S0741-5214(98)70279-4; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P424, DOI 10.1016/0003-2697(88)90209-6; Inaguma Y, 1996, GENE, V178, P145, DOI 10.1016/0378-1119(96)00356-3; Jerius H, 1999, J VASC SURG, V29, P678, DOI 10.1016/S0741-5214(99)70314-9; KATO K, 1994, J BIOL CHEM, V269, P15302; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSEN JK, 1997, AM J PHYSIOL, V273, P930; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; MORGAN JP, 1984, J PHYSIOL-LONDON, V351, P155, DOI 10.1113/jphysiol.1984.sp015239; MORGAN JP, 1982, PFLUG ARCH EUR J PHY, V395, P75, DOI 10.1007/BF00584972; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Rosales OR, 1997, BIOCHEM J, V326, P385, DOI 10.1042/bj3260385; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; TAKUWA Y, 1988, MOL CELL ENDOCRINOL, V60, P71, DOI 10.1016/0303-7207(88)90121-9; TAKUWA Y, 1987, J CLIN INVEST, V80, P248, DOI 10.1172/JCI113055	24	120	123	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11344	11351		10.1074/jbc.274.16.11344	http://dx.doi.org/10.1074/jbc.274.16.11344			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196226	hybrid			2022-12-27	WOS:000079751900094
J	Ben Mamoun, C; Beckerich, JM; Gaillardin, C; Kepes, F				Ben Mamoun, C; Beckerich, JM; Gaillardin, C; Kepes, F			Disruption of YHC8, a member of the TSR1 gene family, reveals its direct involvement in yeast protein translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; PREPRO-ALPHA-FACTOR; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; DIPEPTIDYL AMINOPEPTIDASE; SIGNAL SEQUENCE; RECOGNITION; TRANSPORT; COMPLEX; POLYPEPTIDE	Genetic studies of Saccharomyces cerevisiae have identified many components acting to deliver specific proteins to their cellular locations. Genome analysis, however, has indicated that additional genes may also participate in such protein trafficking. The product of the yeast Yarrowia lipolytica TSR1 gene promotes the signal recognition particle-dependent translocation of secretory proteins through the endoplasmic reticulum. Here we describe the identification of a new gene family of proteins that is well conserved among different yeast species. The TSR1 genes encode polypeptides that share the same protein domain distribution and, like Tsr1p, may play an important role in the early steps of the signal recognition particle-dependent translocation pathway. We have identified five homologues of the TSR1 gene, four of them from the yeast Saccharomyces cerevisiae and the other from Hansenula polymorpha. We generated a null mutation in the S. cerevisiae YHC8 gene, the closest homologue to Y. lipolytica TSR1, and used different soluble (carboxypeptidase Y, LY-factor, invertase) and membrane (dipeptidyl-aminopeptidase) secretory proteins to study its phenotype. A large accumulation of soluble protein precursors was detected in the mutant strain. Immunofluorescence experiments show that Yhc8p is localized in the endoplasmic reticulum. We propose that the YHC8 gene is a new and important component of the S. cerevisiae endoplasmic reticulum membrane and that it functions in protein translocation/insertion of secretory proteins through or into this compartment.	Inst Natl Agron Paris Grignon, Ctr Biotechnol Agroind, CNRS, INRA,Lab Genet Mol & Cellulaire, F-78850 Thiverval Grignon, France; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; CEA Saclay, DSV, DBCM, Serv Biochim & Genet Mol, F-91191 Gif Sur Yvette, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Washington University (WUSTL); Washington University (WUSTL); CEA; UDICE-French Research Universities; Universite Paris Saclay	Ben Mamoun, C (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave,Box 8230, St Louis, MO 63110 USA.	choukri@borcim.wustl.edu						AGAPHONOV MO, 1994, YEAST, V10, P509, DOI 10.1002/yea.320100410; AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; BenMamoun C, 1997, J BIOL CHEM, V272, P24594, DOI 10.1074/jbc.272.39.24594; BENMAMOUN C, 1996, J BIOL CHEM, V271, P23895; BRAKE AJ, 1983, MOL CELL BIOL, V3, P1440, DOI 10.1128/MCB.3.8.1440; Bryant NJ, 1997, J CELL BIOL, V136, P287, DOI 10.1083/jcb.136.2.287; CARLSON M, 1983, MOL CELL BIOL, V3, P439, DOI 10.1128/MCB.3.3.439; CULLIN C, 1994, YEAST, V10, P105, DOI 10.1002/yea.320100110; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; DUNTZE W, 1970, SCIENCE, V168, P1472, DOI 10.1126/science.168.3938.1472; ESMON PC, 1987, J BIOL CHEM, V262, P4387; ESNAULT Y, 1993, EMBO J, V12, P4083, DOI 10.1002/j.1460-2075.1993.tb06092.x; FANG H, 1994, MOL BIOL CELL, V5, P933, DOI 10.1091/mbc.5.9.933; FELDHEIM D, 1993, MOL BIOL CELL, V4, P931, DOI 10.1091/mbc.4.9.931; FELDHEIM D, 1994, J CELL BIOL, V126, P935, DOI 10.1083/jcb.126.4.935; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; GREEN R, 1986, J BIOL CHEM, V261, P7558; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HE F, 1992, J BIOL CHEM, V267, P1932; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JULIUS D, 1983, CELL, V32, P839, DOI 10.1016/0092-8674(83)90070-3; JULIUS D, 1984, CELL, V36, P309, DOI 10.1016/0092-8674(84)90224-1; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KURIHARA T, 1993, MOL BIOL CELL, V4, P919, DOI 10.1091/mbc.4.9.919; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; Maftahi M, 1996, YEAST, V12, P859, DOI 10.1002/(SICI)1097-0061(199607)12:9<859::AID-YEA978>3.0.CO;2-Q; Maniatis T., 1982, MOL CLONING; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; PERLMAN D, 1982, P NATL ACAD SCI-BIOL, V79, P781, DOI 10.1073/pnas.79.3.781; Pilon M, 1998, MOL BIOL CELL, V9, P3455, DOI 10.1091/mbc.9.12.3455; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; RISLER JL, 1988, J MOL BIOL, V204, P1019, DOI 10.1016/0022-2836(88)90058-7; ROBERTS CJ, 1989, J CELL BIOL, V108, P1363, DOI 10.1083/jcb.108.4.1363; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; SINGH A, 1983, NUCLEIC ACIDS RES, V11, P4049, DOI 10.1093/nar/11.12.4049; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; TOYN J, 1988, EMBO J, V7, P4347, DOI 10.1002/j.1460-2075.1988.tb03333.x; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; WATERS MG, 1986, J CELL BIOL, V102, P1543, DOI 10.1083/jcb.102.5.1543; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107	43	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11296	11302		10.1074/jbc.274.16.11296	http://dx.doi.org/10.1074/jbc.274.16.11296			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196219	Green Published, hybrid			2022-12-27	WOS:000079751900087
J	Pettigrew, GW; Prazeres, S; Costa, C; Palma, N; Krippahl, L; Moura, I; Moura, JJG				Pettigrew, GW; Prazeres, S; Costa, C; Palma, N; Krippahl, L; Moura, I; Moura, JJG			The structure of an electron transfer complex containing a cytochrome c and a peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARACOCCUS-DENITRIFICANS; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; CROSS-LINKING; LOW-AFFINITY; BINDING; RESOLUTION; SITE; NONCOVALENT; ASSIGNMENT	Efficient biological electron transfer may require a fluid association of redox partners. Two noncrystallographic methods (a new molecular docking program and H-1 NMR spectroscopy) have been used to study the electron transfer complex formed between the cytochrome c peroxidase (CCP) of Paracoccus denitrificans and cytochromes c, For the natural redox partner, cytochrome c(550), the results are consistent with a complex in which the heme of a single cytochrome lies above the exposed electron-transferring heme of the peroxidase. In contrast, two molecules of the nonphysiological but kinetically competent horse cytochrome bind between the two hemes of the peroxidase. These dramatically different patterns are consistent with a redox active surface on the peroxidase that may accommodate more than one cytochrome and allow lateral mobility.	Univ Edinburgh, Royal Dick Sch Vet Studies, Dept Preclin Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Ctr Quim Fina & Biotecnol, P-2825 Monte De Caparica, Portugal; Inst Super Ciencias Saude, P-2825 Monte De Caparica, Portugal	University of Edinburgh; Universidade Nova de Lisboa	Pettigrew, GW (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Dept Preclin Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland.		Costa, Cristina/A-9966-2012; Moura, Isabel/D-6339-2013; Moura, José J G/D-6426-2013	Costa, Cristina/0000-0002-8611-9023; Moura, Isabel/0000-0003-0971-4977; Moura, José J G/0000-0002-4726-2388; Palma, Nuno/0000-0002-9396-2131; Krippahl, Ludwig/0000-0002-3774-8624				BENNING MM, 1994, ARCH BIOCHEM BIOPHYS, V310, P460, DOI 10.1006/abbi.1994.1193; BERATAN DN, 1987, J CHEM PHYS, V86, P4488, DOI 10.1063/1.452723; BETTS JN, 1992, J AM CHEM SOC, V114, P4043, DOI 10.1021/ja00037a004; BOSSHARD HR, 1991, PEROXIDASES CHEM BIO, V2, P52; Boswell AP, 1980, BIOCHEM SOC T, V8, P637, DOI 10.1042/bst0080637b; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; CHEN LY, 1994, SCIENCE, V264, P86, DOI 10.1126/science.8140419; ELLFOLK N, 1984, BIOCHIM BIOPHYS ACTA, V784, P62, DOI 10.1016/0167-4838(84)90173-0; Erman JE, 1997, BIOCHEMISTRY-US, V36, P4054, DOI 10.1021/bi962632x; FOOTE N, 1984, BIOCHEM J, V223, P369, DOI 10.1042/bj2230369; FULOP V, 1995, STRUCTURE, V3, P1225, DOI 10.1016/S0969-2126(01)00258-1; GILMOUR R, 1993, BIOCHEM J, V294, P745, DOI 10.1042/bj2940745; GUPTA RK, 1973, BIOCHIM BIOPHYS ACTA, V292, P502, DOI 10.1016/0005-2728(73)90056-X; Hu W, 1997, BIOCHEMISTRY-US, V36, P7958, DOI 10.1021/bi963131e; KANG CH, 1977, J BIOL CHEM, V252, P919; KELLER RM, 1978, BIOCHIM BIOPHYS ACTA, V533, P195, DOI 10.1016/0005-2795(78)90564-0; MATSUURA Y, 1982, J MOL BIOL, V156, P389, DOI 10.1016/0022-2836(82)90335-7; MAUK MR, 1994, BIOCHEMISTRY-US, V33, P12609, DOI 10.1021/bi00208a011; MOENCH SJ, 1992, BIOCHEMISTRY-US, V31, P3661, DOI 10.1021/bi00129a015; NORTHRUP SH, 1988, SCIENCE, V241, P67, DOI 10.1126/science.2838904; Pappa HS, 1996, BIOCHEMISTRY-US, V35, P4837, DOI 10.1021/bi952935b; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; PETTIGREW GW, 1991, BIOCHIM BIOPHYS ACTA, V1058, P25, DOI 10.1016/S0005-2728(05)80261-0; STEMP EDA, 1993, BIOCHEMISTRY-US, V32, P10848, DOI 10.1021/bi00091a041; Sukits SF, 1997, BIOCHEMISTRY-US, V36, P5251, DOI 10.1021/bi970072b; TIMKOVICH R, 1984, BIOCHEMISTRY-US, V23, P3526, DOI 10.1021/bi00310a022; TIMKOVICH R, 1981, J MOL BIOL, V153, P95; WALDMEYER B, 1985, J BIOL CHEM, V260, P5184; WANG J, 1996, BIOCHEMISTRY-US, V335, P15107	29	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11383	11389		10.1074/jbc.274.16.11383	http://dx.doi.org/10.1074/jbc.274.16.11383			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196231	hybrid			2022-12-27	WOS:000079751900099
J	Yamamoto, H; Kishida, S; Kishida, M; Ikeda, S; Takada, S; Kikuchi, A				Yamamoto, H; Kishida, S; Kishida, M; Ikeda, S; Takada, S; Kikuchi, A			Phosphorylation of Axin, a Wnt signal negative regulator, by glycogen synthase kinase-3 beta regulates its stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOMATOUS POLYPOSIS-COLI; MAMMARY EPITHELIAL-CELLS; APC TUMOR-SUPPRESSOR; MOUSE FUSED LOCUS; BETA-CATENIN; XENOPUS EMBRYOS; POLARITY GENE; PROTEIN; PATHWAY; DROSOPHILA	Axin forms a complex with glycogen synthase kinase-3 beta (GSK-3 beta) and beta-catenin and promotes GSK-3 beta-dependent phosphorylation of beta-catenin, thereby stimulating the degradation of beta-catenin. Because GSH-3 beta also phosphorylates Axin in the complex, the physiological significance of the phosphorylation of Axin was examined. Treatment of COS cells with LiCl, a GSK-3 beta inhibitor, and okadaic acid, a protein phosphatase inhibitor, decreased and increased, respectively, the cellular protein level of Axin. Pulse-chase analyses showed that the phosphorylated form of Axin was more stable than the unphosphorylated form and that an Axin mutant, in which the possible phosphorylation sites for GSK-3 beta were mutated, exhibited a shorter half-life than wild type Axin, Dvl-1, which was genetically shown to function upstream of GSK-3 beta, inhibited the phosphorylation of Axin by GSK-3 beta in vitro. Furthermore, Wnt-3a-containing conditioned medium down-regulated Axin and accumulated beta-catenin in L cells and expression of DV1-1(Delta PDZ), in which the PDZ domain was deleted, suppressed this action of Wnt-3a, These results suggest that the phosphorylation of Axin is important for the regulation of its stability and that Wnt down-regulates Axin through Dv1.	Hiroshima Univ, Sch Med, Dept Biochem, Minami Ku, Hiroshima 7348551, Japan; Japan Sci & Technol Corp, Hiroshima 7348551, Japan; Kyoto Univ, Fac Sci, Ctr Mol & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan	Hiroshima University; Japan Science & Technology Agency (JST); Kyoto University	Kikuchi, A (corresponding author), Hiroshima Univ, Sch Med, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	akikuchi@mcai.med.hiroshima-u.ac.jp		Takada, Shinji/0000-0003-4125-6056; kishida, shosei/0000-0003-0405-851X				Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BRADLEY RS, 1995, MOL CELL BIOL, V15, P4616; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; Dale TC, 1998, BIOCHEM J, V329, P209; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Feig LA, 1996, TRENDS BIOCHEM SCI, V21, P438, DOI 10.1016/S0968-0004(96)10058-X; GLUECKSOHNSCHOENHEIMER S, 1949, J EXP ZOOL, V110, P47, DOI 10.1002/jez.1401100105; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Kishida M, 1999, ONCOGENE, V18, P979, DOI 10.1038/sj.onc.1202388; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Klingensmith J, 1996, MECH DEVELOP, V58, P15, DOI 10.1016/S0925-4773(96)00549-7; Matsubara K, 1997, FEBS LETT, V410, P169, DOI 10.1016/S0014-5793(97)00633-9; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Murai H, 1996, FEBS LETT, V392, P153, DOI 10.1016/0014-5793(96)00806-X; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; PERRY WL, 1995, GENETICS, V141, P321; Pizzuti A, 1996, HUM MOL GENET, V5, P953, DOI 10.1093/hmg/5.7.953; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Shibamoto S, 1998, GENES CELLS, V3, P659; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Wagner U, 1997, FEBS LETT, V411, P369, DOI 10.1016/S0014-5793(97)00733-3; WONG GT, 1994, MOL CELL BIOL, V14, P6278, DOI 10.1128/MCB.14.9.6278; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867, DOI 10.1128/MCB.18.5.2867; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	41	297	308	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10681	10684		10.1074/jbc.274.16.10681	http://dx.doi.org/10.1074/jbc.274.16.10681			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196136	hybrid			2022-12-27	WOS:000079751900004
J	Liu, HG; Maurice, DH				Liu, HG; Maurice, DH			Phosphorylation-mediated activation and translocation of the cyclic AMP-specific phosphodiesterase PDE4D3 by cyclic AMP-dependent protein kinase and mitogen-activated protein kinases - A potential mechanism allowing for the coordinated regulation of PDE4D activity and targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-SPECIFIC PHOSPHODIESTERASE; VASCULAR SMOOTH-MUSCLE; NUCLEOTIDE PHOSPHODIESTERASES; SELECTIVE-INHIBITION; MESSENGER-RNA; C INHIBITOR; CELLS; FAMILY; GENE; STIMULATION	In this study, we describe a novel mechanism by which a protein kinase C (PKC)-mediated activation of the Raf-extracellular signal-regulated kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) cascade regulates the activity and membrane targeting of members of the cyclic AMP-specific phosphodiesterase D family (PDE4D), Using a combination of pharmacological and biochemical approaches, we show that increases in intracellular cAMP cause a protein kinase A-mediated phosphorylation and activation of the two PDE4D variants expressed in vascular smooth muscle cells, namely PDE4D3 and PDE4D5. In addition, we show that stimulation of PKC via the associated activation of the Raf-MEK-ERK cascade results in the phosphorylation and activation of PDE4D3 in these cells. Furthermore, our studies demonstrate that simultaneous activation of both the protein kinase A and PKC-Raf-MEK-ERK pathways allows for a coordinated activation of PDE4D3 and for the translocation of the particulate PDE4D3 to the cytosolic fraction of these cells. These data are presented and discussed in the context of the activation of the Raf-MEK-ERK cascade acting to modulate the activation and subcellular targeting of PDE4D gene products mediated by cAMP.	Queens Univ, Pharmaceut Mfg Assoc Canada, Hlth Res Fdn,Med Res Council Canada, Dept Pathol, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Pharmacol & Toxicol, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Maurice, DH (corresponding author), Queens Univ, Pharmaceut Mfg Assoc Canada, Hlth Res Fdn,Med Res Council Canada, Dept Pathol, Botterell Hall,A221, Kingston, ON K7L 3N6, Canada.	Mauriced@post.queensu.ca	Maurice, Donald/AAE-9332-2019					ALVAREZ R, 1995, MOL PHARMACOL, V48, P616; BEAVO JA, 1990, TRENDS PHARMACOL SCI, V11, P150, DOI 10.1016/0165-6147(90)90066-H; Beltman J, 1996, J BIOL CHEM, V271, P27018, DOI 10.1074/jbc.271.43.27018; BOLGER G, 1993, MOL CELL BIOL, V13, P6558, DOI 10.1128/MCB.13.10.6558; Bolger GB, 1997, BIOCHEM J, V328, P539; DAVIS CW, 1979, J CYCLIC NUCL PROT, V5, P65; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Erdogan S, 1997, BIOCHEM J, V321, P165, DOI 10.1042/bj3210165; FINDIK D, 1995, J CELL BIOCHEM, V57, P12, DOI 10.1002/jcb.240570103; Gekeler V, 1996, BRIT J CANCER, V74, P897, DOI 10.1038/bjc.1996.454; Ho PD, 1998, J BIOL CHEM, V273, P21730, DOI 10.1074/jbc.273.34.21730; Houslay MD, 1998, ADV PHARMACOL, V44, P225, DOI 10.1016/S1054-3589(08)60128-3; KOMAS N, 1991, BRIT J PHARMACOL, V104, P495, DOI 10.1111/j.1476-5381.1991.tb12457.x; Lenhard JM, 1996, BIOCHEM J, V316, P751, DOI 10.1042/bj3160751; LOUGHNEY K, 1996, HANDB IMMUNOPHARM, P1; MANGANIELLO VC, 1995, CELL SIGNAL, V7, P445, DOI 10.1016/0898-6568(95)00017-J; Manning CD, 1996, J PHARMACOL EXP THER, V276, P810; Maurice D. H., 1998, Cell Biochemistry and Biophysics, V29, P35, DOI 10.1007/BF02737827; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Palmer D, 1998, CIRC RES, V82, P852; Polson JB, 1996, ANNU REV PHARMACOL, V36, P403, DOI 10.1146/annurev.pa.36.040196.002155; Rose RJ, 1997, BRIT J PHARMACOL, V122, P233, DOI 10.1038/sj.bjp.0701376; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Schulman H, 1993, CURR OPIN CELL BIOL, V5, P247, DOI 10.1016/0955-0674(93)90111-3; Scott JD, 1997, SOC GEN PHY, V52, P227; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; SETTE C, 1994, J BIOL CHEM, V269, P9245; SWINNEN JV, 1989, P NATL ACAD SCI USA, V86, P8197, DOI 10.1073/pnas.86.21.8197; TETSUKA T, 1995, AM J PHYSIOL-RENAL, V268, pF808, DOI 10.1152/ajprenal.1995.268.5.F808; TORPHY TJ, 1992, J PHARMACOL EXP THER, V263, P1195; TORPHY TJ, 1995, J BIOL CHEM, V270, P23598, DOI 10.1074/jbc.270.40.23598; VERGHESE MW, 1995, MOL PHARMACOL, V47, P1164	32	76	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10557	10565		10.1074/jbc.274.15.10557	http://dx.doi.org/10.1074/jbc.274.15.10557			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187850	hybrid			2022-12-27	WOS:000079663500089
J	Read, JA; Wilkinson, KW; Tranter, R; Sessions, RB; Brady, RL				Read, JA; Wilkinson, KW; Tranter, R; Sessions, RB; Brady, RL			Chloroquine binds in the cofactor binding site of Plasmodium falciparum lactate dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMALARIAL DRUG; IDENTIFICATION; ERYTHROCYTES; PROTEINS; TARGET; DESIGN	Although the molecular mechanism by which chloroquine exerts its effects on the malarial parasite Plasmodium falciparum remains unclear, the drug has previously been found to interact specifically with the glycolytic enzyme lactate dehydrogenase from the parasite. In this study we have determined the crystal structure of the complex between chloroquine and P. falciparum lactate dehydrogenase. The bound chloroquine is clearly seen within the NADH binding pocket of the enzyme, occupying a position similar to that of the adenyl ring of the cofactor. Chloroquine hence competes with NADH for binding to the enzyme, acting as a competitive inhibitor for this critical glycolytic enzyme. Specific interactions between the drug and amino acids unique to the malarial form of the enzyme suggest this binding is selective. Inhibition studies confirm that chloroquine acts as a weak inhibitor of lactate dehydrogenase, with mild selectivity for the parasite enzyme. As chloroquine has been shown to accumulate to millimolar concentrations within the food vacuole in the gut of the parasite, even low levels of inhibition may contribute to the biological efficacy of the drug, The structure of this enzyme-inhibitor complex provides a template from which the quinoline moiety might be modified to develop more efficient inhibitors of the enzyme.	Univ Bristol, Dept Biochem, Bristol BS8 1TD, Avon, England; Univ Bristol, Ctr Mol Recognit, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol	Brady, RL (corresponding author), Univ Bristol, Dept Biochem, Bristol BS8 1TD, Avon, England.		Conners, Rebecca/C-2608-2013	Conners, Rebecca/0000-0002-8653-1771; Sessions, Richard/0000-0003-0320-0895				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1992, X PLOR VERSION 3 1; CHOU AC, 1980, BIOCHEMISTRY-US, V19, P1543, DOI 10.1021/bi00549a600; Dunn CR, 1996, NAT STRUCT BIOL, V3, P912, DOI 10.1038/nsb1196-912; FITCH CD, 1972, P HELM SOC WASH, V39, P265; FOLEY M, 1994, J BIOL CHEM, V269, P6955; GINSBURG H, 1987, BIOCHEM PHARMACOL, V36, P1567, DOI 10.1016/0006-2952(87)90038-4; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Menting JG, 1997, MOL BIOCHEM PARASIT, V88, P215, DOI 10.1016/S0166-6851(97)00095-9; MUSICK WDL, 1979, J BIOL CHEM, V254, P7611; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETERS W, 1970, CHEMOTHERAPY DRUG RE, P540; PIONTEK K, 1990, PROTEINS, V7, P74, DOI 10.1002/prot.340070108; SINGH J, 1985, FEBS LETT, V191, P1, DOI 10.1016/0014-5793(85)80982-0; VANDERJAGT DL, 1990, MOL BIOCHEM PARASIT, V42, P277, DOI 10.1016/0166-6851(90)90171-H; WHITE JL, 1976, J MOL BIOL, V102, P759, DOI 10.1016/0022-2836(76)90290-4; WILKS HM, 1992, BIOCHEMISTRY-US, V31, P7802, DOI 10.1021/bi00149a009; YAYON A, 1984, EMBO J, V3, P2695, DOI 10.1002/j.1460-2075.1984.tb02195.x	20	73	77	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10213	10218		10.1074/jbc.274.15.10213	http://dx.doi.org/10.1074/jbc.274.15.10213			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187806	hybrid			2022-12-27	WOS:000079663500045
J	Varvas, K; Jarving, I; Koljak, R; Valmsen, K; Brash, AR; Samel, N				Varvas, K; Jarving, I; Koljak, R; Valmsen, K; Brash, AR; Samel, N			Evidence of a cyclooxygenase-related prostaglandin synthesis in coral - The allene oxide pathway is not involved in prostaglandin biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID; PLEXAURA-HOMOMALLA; 15-HYDROXYEICOSATETRAENOIC ACID; ENDOPEROXIDE SYNTHASE; MARINE PROSTANOIDS; GERSEMIA-FRUTICOSA; LIPOXYGENASE; IDENTIFICATION; EICOSANOIDS; CONVERSION	Certain corals are rich natural sources of prostaglandins, the metabolic origin of which has remained undefined. By analogy with the lipoxygenase/allene oxide synthase pathway to jasmonic acid in plants, the presence of (8R)-lipoxygenase and allene oxide synthase in the coral Plexaura homomalla suggested a potential metabolic route to prostaglandins (Brash, A. R., Baertshi, S. W., Ingram, C.D., and Harris, T. M. (1987) J. Biol. Chem. 262, 15829-15839). Other evidence, from the Arctic coral Gersemia fruticosa, has indicated a cyclooxygenase intermediate in the biosynthesis (Varvas, K., Koljak, R., Jarving, I., Pehk, T., and Samel, N. (1994) Tetrahedron Lett. 35, 8267-8270). In the present study, active preparations of G. fruticosa have been used to identify both types of arachidonic acid metabolism and specific inhibitors were used to establish the enzyme type involved in the prostaglandin biosynthesis. The synthesis of prostaglandins and (11R)-hydroxyeicosatetraenoic acid was inhibited by mammalian cyclooxygenase inhibitors (indomethacin, aspirin, and tolfenamic acid), while the formation of the products of the 8-lipoxygenase/allene oxide pathway was not affected or was increased. The specific cyclooxygenase-a inhibitor, nimesulide, did not inhibit the synthesis of prostaglandins in coral. We conclude that coral uses two parallel routes for the initial oxidation of polyenoic acids: the cyclooxygenase route, which leads to optically active prostaglandins, and the lipoxygenase/allene oxide synthase metabolism, the role of which remains to be established. An enzyme related to mammalian cyclooxygenases is the key to prostaglandin synthesis in coral. Based on our inhibitor data, the catalytic site of this evolutionary early cyclooxygenase appears to differ significantly from both known mammalian cyclooxygenases.	Tallinn Univ Technol, Inst Chem, Dept Bioorgan Chem, EE-12618 Tallinn, Estonia; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	Tallinn University of Technology; Vanderbilt University	Varvas, K (corresponding author), Tallinn Univ Technol, Inst Chem, Dept Bioorgan Chem, Akad Tee 15, EE-12618 Tallinn, Estonia.	kylli@boc.ic.ee	Samel, Nigulas/A-1420-2019	Valmsen, Karin/0000-0001-5303-6654	FOGARTY INTERNATIONAL CENTER [R03TW000404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053638] Funding Source: NIH RePORTER; FIC NIH HHS [11 RO3 TW00404-01] Funding Source: Medline; NIGMS NIH HHS [GM 53638] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BILD GS, 1978, J BIOL CHEM, V253, P21; BRASH AR, 1989, ADV PROSTAG THROMB L, V19, P70; BRASH AR, 1990, METHOD ENZYMOL, V187, P187; BRASH AR, 1989, J AM CHEM SOC, V111, P1891, DOI 10.1021/ja00187a060; BRASH AR, 1987, J BIOL CHEM, V262, P15829; BRYANT RW, 1982, J BIOL CHEM, V257, P6050; BUNDY GL, 1985, ADV PROSTAG THROMB L, V14, P229; BUNDY GL, 1986, J BIOL CHEM, V261, P747; COREY EJ, 1987, J AM CHEM SOC, V109, P289, DOI 10.1021/ja00235a053; COREY EJ, 1975, J CHEM SOC CHEM COMM, P277, DOI 10.1039/c39750000277; COREY EJ, 1987, TETRAHEDRON LETT, V28, P4247, DOI 10.1016/S0040-4039(00)96476-1; COREY EJ, 1988, TETRAHEDRON LETT, V29, P2555, DOI 10.1016/S0040-4039(00)86110-9; DIMARZO V, 1993, BIOCHEM J, V295, P23, DOI 10.1042/bj2950023; GERWICK WH, 1993, TOP CURR CHEM, V167, P117; Gierse JK, 1996, J BIOL CHEM, V271, P15810, DOI 10.1074/jbc.271.26.15810; GROWEISS A, 1990, J NAT PROD, V53, P222, DOI 10.1021/np50067a039; Guo QP, 1996, J BIOL CHEM, V271, P19134, DOI 10.1074/jbc.271.32.19134; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; HAMBERG M, 1980, BIOCHEM BIOPH RES CO, V95, P1090, DOI 10.1016/0006-291X(80)91584-3; HAMBERG M, 1992, BIOCHIM BIOPHYS ACTA, V1165, P1, DOI 10.1016/0005-2760(92)90069-8; HAWKINS DJ, 1987, J BIOL CHEM, V262, P7629; HEMLER ME, 1978, BIOCHEMISTRY-US, V17, P1772, DOI 10.1021/bi00602a031; HUBBARD WC, 1980, PROSTAGLANDINS, V20, P431; KIEFER HC, 1975, ANAL BIOCHEM, V68, P336, DOI 10.1016/0003-2697(75)90714-9; LATYSHEV NA, 1988, CHEM NAT PROD, V3, P447; LIGHT RJ, 1972, EUR J BIOCHEM, V28, P232, DOI 10.1111/j.1432-1033.1972.tb01906.x; MANCINI JA, 1994, FEBS LETT, V342, P33, DOI 10.1016/0014-5793(94)80579-2; MEADE EA, 1993, J BIOL CHEM, V268, P6610; PANOSSIAN AG, 1987, PROSTAG OTH LIPID M, V33, P363, DOI 10.1016/0090-6980(87)90019-0; PEERS KE, 1983, CHEM PHYS LIPIDS, V32, P49, DOI 10.1016/0009-3084(83)90069-5; POWELL WS, 1982, J BIOL CHEM, V257, P9457; SETTY BNY, 1985, BIOCHIM BIOPHYS ACTA, V833, P484, DOI 10.1016/0005-2760(85)90106-7; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; SONG WC, 1991, ARCH BIOCHEM BIOPHYS, V290, P427, DOI 10.1016/0003-9861(91)90562-W; VANOS CPA, 1981, BIOCHIM BIOPHYS ACTA, V663, P177, DOI 10.1016/0005-2760(81)90204-6; VARVAS K, 1994, TETRAHEDRON LETT, V35, P8267, DOI 10.1016/0040-4039(94)88299-1; VARVAS K, 1993, TETRAHEDRON LETT, V34, P3643, DOI 10.1016/S0040-4039(00)73658-6; WEINHEIMER AJ, 1969, TETRAHEDRON LETT, P5185	39	39	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					9923	9929		10.1074/jbc.274.15.9923	http://dx.doi.org/10.1074/jbc.274.15.9923			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187766	hybrid			2022-12-27	WOS:000079663500005
J	Carty, SM; Sreekumar, KR; Raetz, CRH				Carty, SM; Sreekumar, KR; Raetz, CRH			Effect of cold shock on lipid A biosynthesis in Escherichia coli - Induction at 12 degrees C of an acyltransferase specific for palmitoleoyl-acyl carrier protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPERATURE REQUIREMENT GENE; ACID-DEFICIENT MUTANT; SALMONELLA-TYPHIMURIUM; 3-DEOXY-D-MANNO-OCTULOSONIC ACID; FATTY-ACID; 3-DEOXY-D-MANNOOCTULOSONATE-8-PHOSPHATE SYNTHETASE; ENDOTOXIN BIOSYNTHESIS; MULTICOPY SUPPRESSOR; MEMBRANE LIPIDS; A PRECURSORS	Palmitoleate is not present in lipid A isolated from Escherichia coli grown at 30 degrees C or higher, but it comprises similar to 11% of the fatty acyl chains of lipid A in cells grown at 12 degrees C. The appearance of palmitoleate at 12 degrees C is accompanied by a decline in laurate from -18% to similar to 5.5%. We now report that wild-type E. coli shifted from 30 degrees C to 12 degrees C acquire a novel palmitoleoyl-acyl carrier protein (ACP)-dependent acyltransferase that acts on the key lipid A precursor Kdo(2)-lipid IVA. The palmitoleoyl transferase is induced more than 30-fold upon cold shock, as judged by assaying extracts of cells shifted to 12 degrees C. The induced activity is maximal after 2 h of cold shock, and then gradually declines but does not disappear. Strains harboring an insertion mutation in the lpxL(htrB) gene, which encodes the enzyme that normally transfers laurate from lauroyl-ACP to Kdo(2)-lipid IVA (Clementz, T., Bednarski, J. J., and Raetz, C. R. H. (1996) J. Biol. Chem. 271, 12095-12102) are not defective in the cold-induced palmitoleoyl transferase. Recently, a gene displaying 54% identity and 73% similarity at the protein level to lpxL was found in the genome off. coli. This lpxL homologue, designated lpxP, encodes the cold shock-induced palmitoleoyl transferase. Extracts of cells containing lpxP on the multicopy plasmid pSK57 exhibit a 10-fold increase in the specific activity of the cold-induced palmitoleoyl transferase compared with cells lacking the plasmid. The elevated specific activity of the palmitoleoyl transferase under conditions of cold shock is attributed to greatly increased levels of lpxP mRNA. The replacement of laurate with palmitoleate in lipid A may reflect the desirability of maintaining the optimal outer membrane fluidity at 12 degrees C.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Duke University; Tufts University	Raetz, CRH (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051310, T32GM008558] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-51310, GM-34123, GM08558] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguilar PS, 1998, J BACTERIOL, V180, P2194, DOI 10.1128/JB.180.8.2194-2200.1998; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; Ausubel FM, 1988, MOL REPROD DEV; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BROZEK KA, 1989, J BIOL CHEM, V264, P6956; BROZEK KA, 1987, J BIOL CHEM, V262, P5170; BROZEK KA, 1990, J BIOL CHEM, V265, P15410; Carty SM, 1997, FASEB J, V11, pA1423; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; CLEMENTZ T, 1995, FASEB J, V9, pA1311; CRONAN JE, 1975, BACTERIOL REV, V39, P232, DOI 10.1128/MMBR.39.3.232-256.1975; CRONAN JE, 1987, ESCHERICHIA COLI SAL, V1, P474; DIN ZZ, 1993, BIOCHEMISTRY-US, V32, P4579, DOI 10.1021/bi00068a014; DIRIENZO JM, 1983, EUR J BIOCHEM, V135, P351, DOI 10.1111/j.1432-1033.1983.tb07661.x; Fang L, 1997, MOL MICROBIOL, V23, P355, DOI 10.1046/j.1365-2958.1997.2351592.x; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; GARWIN JL, 1980, J BIOL CHEM, V255, P3263; Goldenberg D, 1997, MOL GEN GENET, V256, P282, DOI 10.1007/s004380050571; Goldenberg D, 1996, MOL MICROBIOL, V19, P241, DOI 10.1046/j.1365-2958.1996.363898.x; GREEN PR, 1981, J BIOL CHEM, V256, P1151; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; HAMPTON RY, 1988, J BIOL CHEM, V263, P14802; HOFER M, 1991, CHEM PHYS LIPIDS, V59, P167, DOI 10.1016/0009-3084(91)90005-V; JONES PG, 1994, MOL MICROBIOL, V11, P811, DOI 10.1111/j.1365-2958.1994.tb00359.x; Kadrmas JL, 1998, J BIOL CHEM, V273, P26432, DOI 10.1074/jbc.273.41.26432; KAROW M, 1992, J BACTERIOL, V174, P702, DOI 10.1128/jb.174.3.702-710.1992; KAROW M, 1991, MOL MICROBIOL, V5, P2285, DOI 10.1111/j.1365-2958.1991.tb02159.x; KAROW M, 1991, J BACTERIOL, V173, P741, DOI 10.1128/jb.173.2.741-750.1991; KELLY TM, 1993, J BIOL CHEM, V268, P19866; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; Lands W E, 1988, Prog Clin Biol Res, V282, P11; LIPKA G, 1988, CHEM PHYS LIPIDS, V48, P267, DOI 10.1016/0009-3084(88)90097-7; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Miller J.H., 1972, EXPT MOL GENETICS; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; MORRISON DC, 1992, BACTERIAL ENDOTOXIC, V1; Murphy NR, 1996, BIOTECHNIQUES, V21, P934; Odegaard TJ, 1997, J BIOL CHEM, V272, P19688, DOI 10.1074/jbc.272.32.19688; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; QUINN PJ, 1980, CRC CR REV BIOCH MOL, V8, P1, DOI 10.3109/10409238009105466; Raetz C. R. H., 1996, ESCHERICHIA COLI SAL, V1, P1035; RAETZ CRH, 1993, J BACTERIOL, V175, P5745, DOI 10.1128/JB.175.18.5745-5753.1993; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; RAETZ CRH, 1985, J BIOL CHEM, V260, P6080; Raetz CRH, 1998, PROG CLIN BIOL RES, V397, P1; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; RICK PD, 1977, J BIOL CHEM, V252, P4904; RICK PD, 1977, J BIOL CHEM, V252, P4895; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; SARMIENTOS P, 1983, CELL, V32, P1337, DOI 10.1016/0092-8674(83)90314-8; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; SILBERT DF, 1975, ANNU REV BIOCHEM, V44, P315, DOI 10.1146/annurev.bi.44.070175.001531; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; SMALL DM, 1986, PHYSICAL CHEM LIPIDS, V4; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sorensen PG, 1996, J BIOL CHEM, V271, P25898, DOI 10.1074/jbc.271.42.25898; STRAIN SM, 1985, J BIOL CHEM, V260, P6089; Thieringer HA, 1998, BIOESSAYS, V20, P49; Tiku PE, 1996, SCIENCE, V271, P815, DOI 10.1126/science.271.5250.815; VANALPHEN L, 1979, EUR J BIOCHEM, V101, P571; Vigh L, 1998, TRENDS BIOCHEM SCI, V23, P369, DOI 10.1016/S0968-0004(98)01279-1; WOLLENWEBER HW, 1983, EUR J BIOCHEM, V130, P167; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	75	123	133	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9677	9685		10.1074/jbc.274.14.9677	http://dx.doi.org/10.1074/jbc.274.14.9677			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092655	hybrid			2022-12-27	WOS:000079451800074
J	Maatta, A; Jaakkola, P; Jalkanen, M				Maatta, A; Jaakkola, P; Jalkanen, M			Extracellular matrix-dependent activation of syndecan-1 expression in keratinocyte growth factor-treated keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CELL-SURFACE; FIBROBLAST GROWTH; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; GENE-EXPRESSION; FIBRONECTIN; PROTEIN; RECEPTOR; BINDING	Syndecan-1 is a major heparan sulfate proteoglycan of the epidermis. Its expression is strongly induced in migrating and proliferating keratinocytes during wound healing and, on the other hand, diminished or lost in invasive squamous cell carcinoma. We have recently found in the syndecan-1 gene an enhancer (fibroblast growth factor-inducible response element (FIRE)) that activates gene expression in wound edge keratinocytes (Jaakkola, P., Kontusaari, S., Kauppi, T., Maatta, A., and Jalkanen, M. (1998) FASEB J. 12, 959-969). Now, we demonstrate that the activation of this enhancer by keratinocyte growth factor (KGF) is modulated by the components of the extracellular matrix (ECM), MCA-3D mouse immortal keratinocytes growing on fibrillar collagen failed to activate FiRE and subsequently to induce syndecan-1 in response to KGF, The same cells growing on fibronectin or laminin, however, increased FiRE-dependent reporter gene expression upon KGF treatment. The inhibition of the KGF induction by collagen appears to be specific for signaling to FiRE, as the increase in cell proliferation by KGF was not affected. The effect was selective to KGF, as EGF-induction was independent on ECM composition. Changes in the transcription factor binding were not involved in the differential activation of FiRE, as the levels and composition of the AP-1 complexes were unchanged. However, application of anisomycin, an activator of Jun amino-terminal kinase, resulted in a lower response in cells growing on collagen compared with fibronectin, These results indicate that the composition of ECM and availability of growth factors can play a role in the epidermal regulation of syndecan-1 expression and that FiRE is a novel target for gene regulation by the extracellular matrix.	Univ Turku, Ctr Biotechnol, FIN-20521 Turku, Finland; Abo Akad Univ, FIN-20521 Turku, Finland	University of Turku; Abo Akademi University	Maatta, A (corresponding author), Imperial Canc Res Fund, Keratinocyte Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	a.maatta@icrf.icnet.uk	Jaakkola, Panu M/B-4355-2012	Jaakkola, Panu/0000-0002-2365-4985; Maatta, Arto/0000-0003-3759-1310				AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; CLARK RAF, 1985, J INVEST DERMATOL, V84, P378, DOI 10.1111/1523-1747.ep12265466; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; ELENIUS K, 1994, J CELL SCI, V107, P2975; ELENIUS K, 1992, J BIOL CHEM, V267, P6435; ELENIUS K, 1991, J CELL BIOL, V114, P585, DOI 10.1083/jcb.114.3.585; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; Gallo R, 1996, J INVEST DERMATOL, V107, P676, DOI 10.1111/1523-1747.ep12365571; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; HAYASHI K, 1987, J HISTOCHEM CYTOCHEM, V35, P1079, DOI 10.1177/35.10.2957423; HUHTALA P, 1995, J CELL BIOL, V129, P867, DOI 10.1083/jcb.129.3.867; INKI P, 1991, AM J PATHOL, V139, P1333; INKI P, 1992, LAB INVEST, V66, P314; INKI P, 1994, EUR J CELL BIOL, V63, P43; Jaakkola P, 1997, MOL CELL BIOL, V17, P3210, DOI 10.1128/MCB.17.6.3210; Jaakkola P, 1998, ONCOGENE, V17, P1279, DOI 10.1038/sj.onc.1202002; Jaakkola P, 1998, FASEB J, V12, P959, DOI 10.1096/fasebj.12.11.959; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; KATO M, 1995, MOL BIOL CELL, V6, P559, DOI 10.1091/mbc.6.5.559; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; KULESZMARTIN M, 1983, CARCINOGENESIS, V4, P1367, DOI 10.1093/carcin/4.11.1367; KURKINEN M, 1980, LAB INVEST, V43, P47; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEPPA S, 1992, P NATL ACAD SCI USA, V89, P932, DOI 10.1073/pnas.89.3.932; Lin TH, 1997, J BIOL CHEM, V272, P8849; MALI M, 1993, J BIOL CHEM, V268, P24215; MALI M, 1994, J BIOL CHEM, V269, P27795; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; NAKATO H, 1995, DEVELOPMENT, V121, P3687; OKEEFE EJ, 1985, J INVEST DERMATOL, V85, P125, DOI 10.1111/1523-1747.ep12276531; PIERCE GF, 1994, J EXP MED, V179, P831, DOI 10.1084/jem.179.3.831; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; SANDERSON RD, 1988, P NATL ACAD SCI USA, V85, P9562, DOI 10.1073/pnas.85.24.9562; SAUNDERS S, 1989, J CELL BIOL, V107, P1199; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; STAIANNOCOICO L, 1994, J EXP MED, V178, P865; SUDBECK BD, 1994, J BIOL CHEM, V269, P30022; VIHINEN T, 1993, J BIOL CHEM, V268, P17261; Vihinen T, 1996, J BIOL CHEM, V271, P12532, DOI 10.1074/jbc.271.21.12532; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	49	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9891	9898		10.1074/jbc.274.14.9891	http://dx.doi.org/10.1074/jbc.274.14.9891			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092681	hybrid			2022-12-27	WOS:000079451800100
J	Long, WP; Chen, X; Perdew, GH				Long, WP; Chen, X; Perdew, GH			Protein kinase C modulates aryl hydrocarbon receptor nuclear translocator protein-mediated transactivation potential in a dimer context	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR USF; HELIX-LOOP-HELIX; AH RECEPTOR; SIGNAL-TRANSDUCTION; FUNCTIONAL DOMAINS; ACTIVATION DOMAINS; GENE-EXPRESSION; SIM GENE; ARNT; DNA	Protein kinase C (PKC)- and protein kinase A (PKA)mediated modulation of the transactivation potential of human aryl hydrocarbon receptor nuclear translocator (hARNT), a basic helix-loop-helix (bHLH)-PAS transcription factor, and the bHLH-ZIP transcription factors USF-1 (for upstream regulatory factor 1) and c-Myc were examined, An 81 nM dose of the PKC activator phorbol-12-myristate-13-acetate (PMA), shown here to specifically activate PKC in COS-l cells, or a 1 nM dose of the PKA activator 8-bromoadenosine-3',5'-cyclic monophosphate (8-Br-cAMP) results in 2.6- and 1.9-fold enhancements, respectively, in hARNT-mediated transactivation of the class B, E-box-driven reporter pMyc3E1bLuc relative to identically transfected, carrier solvent-treated COS-l cells. In contrast, 81 nM PMA and 1 nM 8-Br-cAMP did not enhance transactivation of pMyc3E1bLuc-driven by USF-1 and c-Myc expression relative to identically transfected, carrier-treated COS-1 cells. Co-transfection of pcDNA3/ARNT-474-Flag, expressing a hARNT carboxyl-terminal transactivation domain deletion, and pMyc3E1bLuc does not result in induction of reporter activity, suggesting PMA's effects do not involve formation of unknown hARNT-protein heterodimers. Additionally, PMA had no effect on hARNT expression relative to Me2SO-treated cells. Metabolic P-32 labeling of hARNT in cells treated with carrier solvent or 81 nM PMA demonstrates that PMA does not increase the overall phosphorylation level of hARNT. These results demonstrate, for the first time, that the transactivation potential of ARNT in a dimer context can be specifically modulated by PKC or PKA stimulation and that the bHLH-PAS and bHLH-ZIP transcription factors are differentially regulated by these pathways in COS-1 cells.	Penn State Univ, Ctr Mol Toxicol, Dept Vet Sci, University Pk, PA 16802 USA; Penn State Univ, Grad Program Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Perdew, GH (corresponding author), Penn State Univ, Ctr Mol Toxicol, Dept Vet Sci, 115 Henning Bldg, University Pk, PA 16802 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009272, R01ES004869, R29ES004869] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES04869, ES09272] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; ANTONSSON C, 1995, J BIOL CHEM, V270, P13968, DOI 10.1074/jbc.270.23.13968; Blackwood EM, 1992, CURR OPIN GENET DEV, V2, P227, DOI 10.1016/S0959-437X(05)80278-3; Chen YH, 1996, J BIOL CHEM, V271, P26261, DOI 10.1074/jbc.271.42.26261; COGSWELL JP, 1995, MOL CELL BIOL, V15, P2782; CZERNIECKI BJ, 1989, CANCER LETT, V48, P29, DOI 10.1016/0304-3835(89)90199-7; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; DIFAGAGNA FD, 1995, J VIROL, V69, P2765, DOI 10.1128/JVI.69.5.2765-2775.1995; DOLWICK KM, 1993, P NATL ACAD SCI USA, V90, P8566, DOI 10.1073/pnas.90.18.8566; Ema M, 1996, MOL CELL BIOL, V16, P5865; Galibert MD, 1997, J IMMUNOL, V159, P6176; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GUPTA S, 1993, P NATL ACAD SCI USA, V90, P3216, DOI 10.1073/pnas.90.8.3216; HEI YJ, 1991, MOL PHARMACOL, V39, P233; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; HORD NG, 1994, MOL PHARMACOL, V46, P618; Ko HSP, 1996, MOL CELL BIOL, V16, P430; Kobayashi A, 1997, J BIOCHEM, V122, P703; Kobayashi M, 1996, BIOTECHNIQUES, V21, P398; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; Long WP, 1998, MOL PHARMACOL, V53, P691, DOI 10.1124/mol.53.4.691; Luo X, 1996, MOL CELL BIOL, V16, P1367; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; PACKHAM G, 1995, BBA-REV CANCER, V1242, P11, DOI 10.1016/0304-419X(94)00015-T; REISMAN D, 1993, NUCLEIC ACIDS RES, V21, P345, DOI 10.1093/nar/21.2.345; REISZPORSZASZ S, 1994, MOL CELL BIOL, V14, P6075, DOI 10.1128/MCB.14.9.6075; SALMINEN M, 1994, MOL CELL BIOL, V14, P6797, DOI 10.1128/MCB.14.10.6797; SAWADOGO M, 1988, J BIOL CHEM, V263, P11985; SETH A, 1992, J BIOL CHEM, V267, P24796; SOGAWA K, 1995, P NATL ACAD SCI USA, V92, P1936, DOI 10.1073/pnas.92.6.1936; SOGAWA K, 1995, J CANCER RES CLIN, V121, P612, DOI 10.1007/BF01197779; SOGAWA K, 1989, EUR J BIOCHEM, V181, P539, DOI 10.1111/j.1432-1033.1989.tb14757.x; SWANSON HI, 1995, J BIOL CHEM, V270, P26292, DOI 10.1074/jbc.270.44.26292; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WILSON C, 1998, J SOC TOXICOL, V42, P247; Yamaki A, 1996, GENOMICS, V35, P136, DOI 10.1006/geno.1996.0332	37	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12391	12400		10.1074/jbc.274.18.12391	http://dx.doi.org/10.1074/jbc.274.18.12391			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212212	hybrid			2022-12-27	WOS:000080056800032
J	Marcinkiewicz, C; Calvete, JJ; Marcinkiewicz, MM; Raida, M; Vijay-Kumar, S; Huang, ZW; Lobb, RR; Niewiarowski, S				Marcinkiewicz, C; Calvete, JJ; Marcinkiewicz, MM; Raida, M; Vijay-Kumar, S; Huang, ZW; Lobb, RR; Niewiarowski, S			EC3, a novel heterodimeric disintegrin from Echis carinatus venom, inhibits alpha 4 and alpha 5 integrins in an RGD-independent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE-1; PLATELET-AGGREGATION INHIBITOR; SNAKE-VENOM; STRUCTURAL REQUIREMENTS; LIGAND-BINDING; VIPER VENOMS; RECEPTOR; IIIA; FIBRONECTIN; PEPTIDE	EC3, a heterodimeric disintegrin (M-r = 14,762) isolated from Echis carinatus venom is a potent antagonist of alpha 4 integrins, Two subunits called EC3A and EC3B were isolated from reduced and alkylated EC3 by reverse phase high performance liquid chromatography, Each subunit contained 67 residues, including 10 cysteines, and displayed a high degree of homology to each other and to other disintegrins, EC3 inhibited adhesion of cells expressing alpha 4 beta 1 and alpha 4 beta 7 integrins to natural ligands vascular cell adhesion molecule 1 (VCAM-1) and mucosal addressin cell adhesion molecule 1 (MadCAM-1) with IC50 = 630 nM, adhesion of K562 cells (alpha 5 beta 1) to fibronectin with IC50 = 150 nM, and adhesion of alpha IIb beta 3 Chinese hamster ovary cells to fibrinogen with IC50 500 nM; it did not inhibit adhesion of alpha v beta 3 Chinese hamster ovary cells to vitronectin, Ethylpyridylethylated EC3B inhibited adhesion of Jurkat cells to immobilized VCAM-1 (IC50 = 6 mu M), whereas EC3A was inactive in this system. The MLDG motif appeared to be essential for activity of EC3B, Linear MLDG peptide inhibited the adhesion of Jurkat to VCAM-1 in a dose-dependent manner (IC50 = 4 mM), whereas RGDS peptide was not active at the same concentration. MLDG partially inhibited adhesion of K562 cells to fibronectin (5-10 mM) in contrast to RGDS peptide (IC50 = 3 mM), inhibiting completely at 10 mM.	Temple Univ, Sch Med, Dept Physiol, Sol Sherry Thrombosis Res Ctr,Fels Canc Res Inst, Philadelphia, PA 19140 USA; Biogen Inc, Cambridge, MA 02142 USA; Inst Peptide Res, D-30559 Hannover, Germany; CSIC, Inst Biomed, E-46010 Valencia, Spain; Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Inst, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Biogen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Jefferson University	Niewiarowski, S (corresponding author), Temple Univ, Sch Med, Dept Physiol, Sol Sherry Thrombosis Res Ctr,Fels Canc Res Inst, 3400 N Broad St, Philadelphia, PA 19140 USA.		Calvete, Juan J/K-9619-2014; Calvete, Juan/P-2555-2019	Calvete, Juan J/0000-0001-5026-3122; Calvete, Juan/0000-0001-5026-3122	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE011844] Funding Source: NIH RePORTER; NIDCR NIH HHS [R03 DE11844] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ADLER M, 1992, BIOCHEMISTRY-US, V31, P1031, DOI 10.1021/bi00119a011; BJARNASON JB, 1995, METHOD ENZYMOL, V248, P345; Briskin MJ, 1996, J IMMUNOL, V156, P719; CALVETE JJ, 1992, FEBS LETT, V309, P316, DOI 10.1016/0014-5793(92)80797-K; CALVETE JJ, 1991, BIOCHEMISTRY-US, V30, P5225, DOI 10.1021/bi00235a016; CHAO BH, 1989, P NATL ACAD SCI USA, V86, P8050, DOI 10.1073/pnas.86.20.8050; CLARK EA, 1994, J BIOL CHEM, V269, P21940; DENNIS MS, 1990, P NATL ACAD SCI USA, V87, P2471, DOI 10.1073/pnas.87.7.2471; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; GAN ZR, 1988, J BIOL CHEM, V263, P19827; GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168, DOI 10.3181/00379727-195-43129B; HUANG TF, 1989, BIOCHEMISTRY-US, V28, P661, DOI 10.1021/bi00428a037; HUANG TF, 1987, J BIOL CHEM, V262, P16157; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 1996, DEV BIOL, V180, P402, DOI 10.1006/dbio.1996.0314; IRIE A, 1995, EMBO J, V14, P5550, DOI 10.1002/j.1460-2075.1995.tb00242.x; Jia LG, 1997, J BIOL CHEM, V272, P13094, DOI 10.1074/jbc.272.20.13094; KAMATA T, 1995, BIOCHEM J, V305, P945, DOI 10.1042/bj3050945; Lobb RR, 1995, CELL ADHES COMMUN, V3, P385, DOI 10.3109/15419069509081293; LOBB RR, 1994, J CLIN INVEST, V94, P1722, DOI 10.1172/JCI117519; MADSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Marcinkiewicz C, 1997, BLOOD, V90, P1565, DOI 10.1182/blood.V90.4.1565.1565_1565_1575; MARCINKIEWICZ C, 1996, BIOCHEM J, V371, P118; MCLANE MA, 1994, BIOCHEM J, V301, P429, DOI 10.1042/bj3010429; McMurray RW, 1996, SEMIN ARTHRITIS RHEU, V25, P215, DOI 10.1016/S0049-0172(96)80034-5; MOULD AP, 1994, J BIOL CHEM, V269, P27224; Moyano JV, 1997, J BIOL CHEM, V272, P24832, DOI 10.1074/jbc.272.40.24832; Munoz M, 1996, J BIOL CHEM, V271, P2696, DOI 10.1074/jbc.271.5.2696; MUSIAL J, 1990, CIRCULATION, V82, P261, DOI 10.1161/01.CIR.82.1.261; NIEWIAROWSKI S, 1994, SEMIN HEMATOL, V31, P289; OTOOLE TE, 1990, CELL REGUL, V1, P883, DOI 10.1091/mbc.1.12.883; RENZ ME, 1994, J CELL BIOL, V125, P1395, DOI 10.1083/jcb.125.6.1395; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Satoh T, 1997, J BIOL CHEM, V272, P12175, DOI 10.1074/jbc.272.18.12175; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P7369, DOI 10.1021/bi00244a003; SENN H, 1993, J MOL BIOL, V232, P907, DOI 10.1006/jmbi.1993.1439; Siigur E, 1996, BIOCHEM BIOPH RES CO, V224, P229, DOI 10.1006/bbrc.1996.1012; TRIKHA M, 1994, CANCER RES, V54, P4993; Tselepis VH, 1997, J BIOL CHEM, V272, P21341, DOI 10.1074/jbc.272.34.21341; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321	40	94	100	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12468	12473		10.1074/jbc.274.18.12468	http://dx.doi.org/10.1074/jbc.274.18.12468			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212222	hybrid			2022-12-27	WOS:000080056800042
J	Petersen, F; Brandt, E; Lindahl, U; Spillmann, D				Petersen, F; Brandt, E; Lindahl, U; Spillmann, D			Characterization of a neutrophil cell surface glycosaminoglycan that mediates binding of platelet factor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; FACTOR-IV; POLYMORPHONUCLEAR NEUTROPHILS; PROTEOGLYCAN CARRIER; CHONDROITIN SULFATE; CHEMOKINES; PLATELET-FACTOR-4; CLEAVAGE; PROTEINS; RESIDUES	Platelet factor 4 (PF-4) is a platelet-derived alpha-chemokine that binds to and activates human neutrophils to undergo specific functions like exocytosis or adhesion. PF-4 binding has been shown to be independent of interleukin-8 receptors and could be inhibited by soluble chondroitin sulfate type glycosaminoglycans or by pretreatment of cells with chondroitinase ABC. Here we present evidence that surface-expressed neutrophil glycosaminoglycans are of chondroitin sulfate type and that this species binds to the tetrameric form of PF-4, The glycosaminoglycans consist of a single type of chain with an average molecular mass of similar to 23 kDa and are composed of similar to 85-90% chondroitin 8-sulfate disaccharide units type CSA (-->4GlcA beta 1-->3GalNAc(4-O-sulfate)beta 1-->) and of similar to 10-15% di-O-sulfated disaccharide units. A major part of these di-O-sulfated disaccharide units are CSE units (-->4GlcA beta 1-->3GaLNAc(4,6-O-sulfate)beta 1-->). Binding studies revealed that the interaction of chondroitin sulfate with PF-4 required at least 20 monosaccharide units for significant binding. The di-O-sulfated disaccharide units in neutrophil glycosaminoglycans clearly promoted the affinity to PF-4, which showed a K-d similar to 0.8 mu M as the affinities of bovine cartilage chondroitin sulfate A, porcine skin dermatan sulfate, or bovine cartilage chondroitin sulfate C, all consisting exclusively of monosulfated disaccharide units, were found to be 3-5-fold lower. Taken together, our data indicate that chondroitin sulfate chains function as physiologically relevant binding sites for PF-4 on neutrophils and that the affinity of these chains for PF-4 is controlled by their degree of sulfation.	Univ Uppsala, Ctr Biomed, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; Res Ctr Borstel, Dept Immunol & Cell Biol, D-23845 Borstel, Germany	Uppsala University; Forschungszentrum Borstel	Spillmann, D (corresponding author), Univ Uppsala, Ctr Biomed, Dept Med Biochem & Microbiol, Box 575, S-75123 Uppsala, Sweden.							BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BARBER AJ, 1972, BIOCHIM BIOPHYS ACTA, V286, P312, DOI 10.1016/0304-4165(72)90267-X; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BOURIN MC, 1990, J BIOL CHEM, V265, P15424; BRANDT E, 1991, CYTOKINE, V3, P311, DOI 10.1016/1043-4666(91)90499-4; CASU B, 1988, TRENDS BIOCHEM SCI, V13, P221, DOI 10.1016/0968-0004(88)90088-6; CLORE GM, 1995, FASEB J, V9, P57, DOI 10.1096/fasebj.9.1.7821760; Dudek AZ, 1997, J BIOL CHEM, V272, P31785, DOI 10.1074/jbc.272.50.31785; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; FILES JC, 1981, BLOOD, V58, P607; GARDINER EE, 1994, EUR J BIOCHEM, V221, P871, DOI 10.1111/j.1432-1033.1994.tb18802.x; GARDINER EE, 1992, BIOCHEM J, V288, P577, DOI 10.1042/bj2880577; GUO Y, 1989, ANAL BIOCHEM, V176, P96, DOI 10.1016/0003-2697(89)90278-9; HANDIN RI, 1976, J BIOL CHEM, V251, P4273; HOOK M, 1982, ANAL BIOCHEM, V119, P236, DOI 10.1016/0003-2697(82)90580-2; HUANG SS, 1982, J BIOL CHEM, V257, P1546; Kolset SO, 1996, J LEUKOCYTE BIOL, V59, P545, DOI 10.1002/jlb.59.4.545; LEVINE SP, 1977, THROMB RES, V11, P673, DOI 10.1016/0049-3848(77)90025-1; LEVITT D, 1986, MOL IMMUNOL, V23, P1125, DOI 10.1016/0161-5890(86)90011-8; LIDHOLT K, 1995, BIOCHEM J, V311, P233, DOI 10.1042/bj3110233; LINDAHL U, 1965, J BIOL CHEM, V240, P2817; LORTAT-JACOB H, 1995, BIOCHEM J, V310, P497, DOI 10.1042/bj3100497; LOSCALZO J, 1985, ARCH BIOCHEM BIOPHYS, V240, P446, DOI 10.1016/0003-9861(85)90049-9; LUDWIGS U, 1987, BIOCHEM J, V245, P795, DOI 10.1042/bj2450795; MACCARANA M, 1993, GLYCOBIOLOGY, V3, P271, DOI 10.1093/glycob/3.3.271; MAYO KH, 1989, BIOCHEMISTRY-US, V28, P9469, DOI 10.1021/bi00450a034; MAYO KH, 1995, BIOCHEM J, V312, P357, DOI 10.1042/bj3120357; MCLAREN KM, 1982, THROMB RES, V19, P293; OLSSON I, 1967, BIOCHIM BIOPHYS ACTA, V141, P348, DOI 10.1016/0304-4165(67)90109-2; OLSSON I, 1968, BIOCHIM BIOPHYS ACTA, V165, P309, DOI 10.1016/0304-4165(68)90209-2; Petersen F, 1996, J IMMUNOL, V156, P1954; PETERSEN F, 1994, J IMMUNOL, V152, P2467; Petersen F, 1998, J IMMUNOL, V161, P4347; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; SHAKLEE PN, 1984, BIOCHEM J, V217, P187, DOI 10.1042/bj2170187; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Stringer SE, 1997, J BIOL CHEM, V272, P20508, DOI 10.1074/jbc.272.33.20508; STUCKEY JA, 1992, PROTEINS, V14, P277, DOI 10.1002/prot.340140213; WITT DP, 1994, CURR BIOL, V4, P394, DOI 10.1016/S0960-9822(00)00088-9; ZHANG XH, 1994, BIOCHEMISTRY-US, V33, P8361, DOI 10.1021/bi00193a025	41	88	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12376	12382		10.1074/jbc.274.18.12376	http://dx.doi.org/10.1074/jbc.274.18.12376			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212210	hybrid			2022-12-27	WOS:000080056800030
J	Graf, GA; Connell, PM; van der Westhuyzen, DR; Smart, EJ				Graf, GA; Connell, PM; van der Westhuyzen, DR; Smart, EJ			The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol ethers into caveolae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE CAVEOLAE; APOPROTEIN-A-I; SR-BI; RAT; TRANSPORT; PROTEIN; CELLS; INTERNALIZATION; METABOLISM; EXPRESSION	The uptake of cholesterol esters from high density lipoproteins (HDLs) is characterized by the initial movement of cholesterol esters into a reversible plasma membrane pool. Cholesterol esters are subsequently internalized to a nonreversible pool. Unlike the uptake of cholesterol from low density lipoproteins, cholesterol ester uptake from HDL does not involve the internalization and degradation of the particle and is therefore termed selective. The class B, type I scavenger receptor (SR-BI) has been identified as an HDL receptor and shown to mediate selective cholesterol ester uptake. SR-BI is localized to cholesterol- and sphingomyelin-rich microdomains called caveolae, Caveolae are directly involved in cholesterol trafficking. Therefore, we tested the hypothesis that caveolae are accepters for HDL-derived cholesterol ether (CE), Our studies demonstrate that in Chinese hamster ovary cells expressing SR-BI, >80% of the plasma membrane associated CE is present in caveolae after 7.5 min of selective cholesterol ether uptake. We also show that excess, unlabeled HDL can extract the radiolabeled CE from caveolae, demonstrating that caveolae constitute a reversible plasma membrane pool of CE. Furthermore, 50% of the caveolae-associated CE can be chased into a nonreversible pool. We conclude that caveolae are accepters for HDL-derived cholesterol ethers, and that caveolae constitute a reversible, plasma membrane pool of cholesterol ethers.	Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Smart, EJ (corresponding author), Univ Kentucky, Dept Physiol, 800 Rose St,MSC 508C, Lexington, KY 40536 USA.		Eckhardt, Erik/G-1567-2010	Graf, Gregory/0000-0002-0130-9929	NHLBI NIH HHS [R01HL59376, R26HL58475] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL058475, R01HL058475, R01HL059376] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; ANDERSEN JM, 1978, J BIOL CHEM, V253, P9024; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Dorahy DJ, 1996, BIOCHEM J, V319, P67, DOI 10.1042/bj3190067; FIELDING CJ, 1995, J LIPID RES, V36, P211; FIELDING PE, 1995, BIOCHEMISTRY-US, V34, P14288, DOI 10.1021/bi00044a004; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; GLASS C, 1985, J BIOL CHEM, V260, P744; GRUNDY SM, 1986, JAMA-J AM MED ASSOC, V256, P2849, DOI 10.1001/jama.256.20.2849; GWYNNE JT, 1989, J BIOL CHEM, V264, P8141; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; KNETCH TP, 1989, BIOCHIM BIOPHYS ACTA, V1002, P365; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Murao K, 1997, J BIOL CHEM, V272, P17551, DOI 10.1074/jbc.272.28.17551; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; MURPHY BD, 1985, ENDOCRINOLOGY, V116, P1587, DOI 10.1210/endo-116-4-1587; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Reaven E, 1998, ENDOCRINOLOGY, V139, P2847, DOI 10.1210/en.139.6.2847; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; RINNINGER F, 1993, BIOCHIM BIOPHYS ACTA, V1166, P275, DOI 10.1016/0005-2760(93)90108-L; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Smart EJ, 1995, COLD SPRING HARB SYM, V60, P243, DOI 10.1101/SQB.1995.060.01.028; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; SMART EJ, 1995, J CELL BIOL, V131, P929, DOI 10.1083/jcb.131.4.929; SMART EJ, 1994, J CELL BIOL, V124, P307, DOI 10.1083/jcb.124.3.307; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; STRACHAN AF, 1988, BIOCHEM J, V250, P203, DOI 10.1042/bj2500203; TALL AR, 1990, J CLIN INVEST, V86, P379, DOI 10.1172/JCI114722; Tao NB, 1996, J BIOL CHEM, V271, P22315, DOI 10.1074/jbc.271.37.22315; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Webb NR, 1998, J BIOL CHEM, V273, P15241, DOI 10.1074/jbc.273.24.15241; Webb NR, 1997, J LIPID RES, V38, P1490	46	150	154	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12043	12048		10.1074/jbc.274.17.12043	http://dx.doi.org/10.1074/jbc.274.17.12043			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207027	hybrid			2022-12-27	WOS:000079834800083
J	Topham, MK; Prescott, SM				Topham, MK; Prescott, SM			Mammalian diacylglycerol kinases, a family of lipid kinases with signaling functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BIOLOGICALLY-ACTIVE LIPIDS; PLECKSTRIN HOMOLOGY DOMAIN; ROD OUTER SEGMENTS; MOLECULAR-CLONING; PHOSPHATIDIC-ACID; PHOSPHOLIPASE-C; LYSOPHOSPHATIDIC ACID; INDUCED TRANSLOCATION; TRANSFORMED CELLS; ENDOTHELIAL-CELLS		Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Prescott, SM (corresponding author), Univ Utah, Huntsman Canc Inst, 15 N 2030 E,Rm 4220, Salt Lake City, UT 84112 USA.	stephen.prescott@hci.utah.edu						AHMED S, 1993, J BIOL CHEM, V268, P10709; Badola P, 1997, J BIOL CHEM, V272, P24176, DOI 10.1074/jbc.272.39.24176; BANFIC H, 1993, BIOCHEM J, V290, P633, DOI 10.1042/bj2900633; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; BESTERMAN JM, 1986, P NATL ACAD SCI USA, V83, P9378, DOI 10.1073/pnas.83.24.9378; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; BOONEN GJJC, 1993, BIOCHIM BIOPHYS ACTA, V1178, P97, DOI 10.1016/0167-4889(93)90114-5; BRTVA TR, 1995, J BIOL CHEM, V270, P9809, DOI 10.1074/jbc.270.17.9809; Bunting M, 1996, J BIOL CHEM, V271, P10230, DOI 10.1074/jbc.271.17.10230; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; Chang JS, 1997, CANCER RES, V57, P5465; CHUANG TH, 1993, J BIOL CHEM, V268, P26206; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; DEBOSCHERO MGI, 1992, BIOCHIM BIOPHYS ACTA, V1127, P105, DOI 10.1016/0005-2760(92)90265-W; Ding L, 1998, J BIOL CHEM, V273, P32746, DOI 10.1074/jbc.273.49.32746; Ding L, 1997, P NATL ACAD SCI USA, V94, P5519, DOI 10.1073/pnas.94.11.5519; Ding L, 1998, FEBS LETT, V429, P109, DOI 10.1016/S0014-5793(98)00490-6; DIVECHA N, 1993, CELL, V74, P405, DOI 10.1016/0092-8674(93)80041-C; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; Flores I, 1996, J BIOL CHEM, V271, P10334, DOI 10.1074/jbc.271.17.10334; Goto K, 1996, P NATL ACAD SCI USA, V93, P11196, DOI 10.1073/pnas.93.20.11196; GOTO K, 1993, P NATL ACAD SCI USA, V90, P7598, DOI 10.1073/pnas.90.16.7598; GULBINS E, 1994, MOL CELL BIOL, V14, P4749, DOI 10.1128/MCB.14.7.4749; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARDEN N, 1993, BIOCHEM J, V289, P439, DOI 10.1042/bj2890439; HAYASHI F, 1985, BIOCHEM BIOPH RES CO, V128, P954, DOI 10.1016/0006-291X(85)90139-1; Hodgkin MN, 1998, TRENDS BIOCHEM SCI, V23, P200, DOI 10.1016/S0968-0004(98)01200-6; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; Houssa B, 1997, J BIOL CHEM, V272, P10422; Hurley JH, 1997, PROTEIN SCI, V6, P477; INOUE H, 1989, J BIOL CHEM, V264, P5996; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; ISHITOYA J, 1987, BIOCHEM BIOPH RES CO, V144, P1025, DOI 10.1016/S0006-291X(87)80066-9; KAI M, 1994, J BIOL CHEM, V269, P18492; Kalhammer G, 1997, FEBS LETT, V414, P599, DOI 10.1016/S0014-5793(97)01076-4; KANOH H, 1990, TRENDS BIOCHEM SCI, V15, P47, DOI 10.1016/0968-0004(90)90172-8; KANOH H, 1989, BIOCHEM J, V258, P455, DOI 10.1042/bj2580455; Katagiri T, 1996, PLANT MOL BIOL, V30, P647, DOI 10.1007/BF00049339; KATO H, 1988, BIOCHEM BIOPH RES CO, V154, P959, DOI 10.1016/0006-291X(88)90233-1; KATO M, 1987, J BIOL CHEM, V262, P5696; KELLEHER JA, 1989, J NEUROSCI RES, V23, P87, DOI 10.1002/jnr.490230112; Klauck TM, 1996, J BIOL CHEM, V271, P19781, DOI 10.1074/jbc.271.33.19781; KNAUSS TC, 1990, J BIOL CHEM, V265, P14457; KohyamaKoganeya A, 1997, FEBS LETT, V409, P258, DOI 10.1016/S0014-5793(97)00526-7; LIPPE IT, 1989, EUR J PHARMACOL, V159, P1, DOI 10.1016/0014-2999(89)90037-X; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; MARONEY AC, 1989, J BIOL CHEM, V264, P2537; Masai I, 1997, J NEUROBIOL, V32, P695, DOI 10.1002/(SICI)1097-4695(19970620)32:7<695::AID-NEU5>3.0.CO;2-#; MASAI I, 1993, P NATL ACAD SCI USA, V90, P11157, DOI 10.1073/pnas.90.23.11157; MASAI I, 1992, P NATL ACAD SCI USA, V89, P6030, DOI 10.1073/pnas.89.13.6030; MUID RE, 1987, BIOCHEM BIOPH RES CO, V143, P630, DOI 10.1016/0006-291X(87)91400-8; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; OHANIAN J, 1994, BIOCHEM J, V300, P51, DOI 10.1042/bj3000051; PREISS J, 1986, J BIOL CHEM, V261, P8597; PRESCOTT SM, 1981, J BIOL CHEM, V256, P579; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; RAO KVR, 1994, J NEUROCHEM, V63, P1454; Reddy BS, 1996, CANCER RES, V56, P2314; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Sakane F, 1996, BIOCHEM J, V318, P583, DOI 10.1042/bj3180583; SAKANE F, 1989, FEBS LETT, V255, P409, DOI 10.1016/0014-5793(89)81134-2; SAKANE F, 1990, NATURE, V344, P345, DOI 10.1038/344345a0; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; SCHAAP D, 1993, BIOCHEM J, V289, P875, DOI 10.1042/bj2890875; SCHAAP D, 1990, FEBS LETT, V275, P151, DOI 10.1016/0014-5793(90)81461-V; SCHAAP D, 1994, BIOCHEM J, V304, P661, DOI 10.1042/bj3040661; SCHMIDT SY, 1983, J BIOL CHEM, V258, P6863; SETTY BNY, 1987, J BIOL CHEM, V262, P17613; SOLING HD, 1989, J BIOL CHEM, V264, P10643; Takeuchi H, 1997, BBA-MOL CELL RES, V1359, P275, DOI 10.1016/S0167-4889(97)00109-2; Tang W, 1996, J BIOL CHEM, V271, P10237, DOI 10.1074/jbc.271.17.10237; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; TRAN K, 1994, BBA-LIPID LIPID MET, V1212, P193, DOI 10.1016/0005-2760(94)90253-4; Udovichenko IP, 1997, J BIOL CHEM, V272, P7952, DOI 10.1074/jbc.272.12.7952; VAIDYANATHAN VV, 1994, NEUROSCI LETT, V179, P171, DOI 10.1016/0304-3940(94)90961-X; VANCORVEN EJ, 1992, BIOCHEM J, V281, P163, DOI 10.1042/bj2810163; VANDERBEND RL, 1994, J BIOL CHEM, V269, P4098; WALSH JP, 1995, J BIOL CHEM, V270, P28647, DOI 10.1074/jbc.270.48.28647; WOLFMAN A, 1987, J BIOL CHEM, V262, P16546; Yamada K, 1997, BIOCHEM J, V321, P59, DOI 10.1042/bj3210059; YOUNES A, 1992, J BIOL CHEM, V267, P842; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	84	246	253	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11447	11450		10.1074/jbc.274.17.11447	http://dx.doi.org/10.1074/jbc.274.17.11447			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206945	hybrid			2022-12-27	WOS:000079834800001
J	Wang, WY; Poovaiah, BW				Wang, WY; Poovaiah, BW			Interaction of plant chimeric calcium/calmodulin-dependent protein kinase with a homolog of eukaryotic elongation factor-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; AMINOACYL-TRANSFER-RNA; FACTOR 1-ALPHA; SIGNAL-TRANSDUCTION; BINDING-PROTEIN; TRANSLATIONAL ELONGATION; CALCIUM-CALMODULIN; TYROSINE KINASE; PHOSPHORYLATION; DOMAIN	A chimeric Ca2+/calmodulin-dependent protein kinase (CCaMK) was previously cloned and characterized in this laboratory. To investigate the biological functions of CCaMK, the yeast two-hybrid system was used to isolate genes encoding proteins that interact with CCaMK, One of the cDNA clones obtained from the screening (LlEF-1 alpha 1) has high similarity with the eukaryotic elongation factor-1 alpha (EF-1 alpha). CCaMK phosphorylated LlEF-1 alpha 1 in a Ca2+/calmodulin-dependent manner. The phosphorylation site for CCaMK (Thr-257) was identified by site-directed mutagenesis. Interestingly, Thr-257 is located in the putative tRNA-binding region of LlEF-1 alpha 1. An isoform of Ca2+-dependent protein kinase (CDPK) phosphorylated multiple sites of LlEF-1 alpha 1 in a Ca2+-dependent but calmodulin-independent manner. Unlike CDPK, CCaMK phosphorylated only one site, and this site is different from CDPK phosphorylation sites, This suggests that the phosphorylation of EF-1 alpha by these two kinases may have different functional significance. Although the phosphorylation of LlEF-1 alpha 1 by CCaMK is Ca2+/calmodulin-dependent, in vitro binding assays revealed that CCaMK binds to LlEF-1 alpha 1 in a Ca2+-independent manner. This was further substantiated by coimmunoprecipitation of CCaMK and EF-1 alpha using the protein extract from lily anthers. Dissociation of CCaMK from EF-1 alpha by Ca2+ and phosphorylation of EF-1 alpha by CCaMK in a Ca2+/calmodulin-dependent manner suggests that these interactions may play a role in regulating the biological functions of EF-1 alpha.	Washington State Univ, Dept Hort, Lab Plant Mol Biol & Physiol, Pullman, WA 99164 USA	Washington State University	Poovaiah, BW (corresponding author), Washington State Univ, Dept Hort, Lab Plant Mol Biol & Physiol, Pullman, WA 99164 USA.							BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; Chang YWE, 1997, J BIOL CHEM, V272, P28252, DOI 10.1074/jbc.272.45.28252; Clore AM, 1996, PLANT CELL, V8, P2003, DOI 10.2307/3870408; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; DURSO NA, 1994, PLANT CELL, V6, P893, DOI 10.1105/tpc.6.6.893; DURSO NA, 1994, PROTOPLASMA, V180, P99, DOI 10.1007/BF01507846; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; HARPER JF, 1991, SCIENCE, V252, P951, DOI 10.1126/science.1852075; HYATT SL, 1994, BIOCHEMISTRY-US, V33, P1223, DOI 10.1021/bi00171a023; KAUR KJ, 1994, J BIOL CHEM, V269, P23045; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; Kumagai F, 1995, BOT ACTA, V108, P467, DOI 10.1111/j.1438-8677.1995.tb00523.x; Kurasawa Y, 1996, J BIOCHEM-TOKYO, V119, P791; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; Lu YT, 1996, PLANTA, V199, P18; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Moore RC, 1998, CELL MOTIL CYTOSKEL, V41, P168, DOI 10.1002/(SICI)1097-0169(1998)41:2<168::AID-CM7>3.0.CO;2-A; Murray JW, 1996, J CELL BIOL, V135, P1309, DOI 10.1083/jcb.135.5.1309; NAIRN AC, 1994, SEMIN CANCER BIOL, V5, P295; Negrutskii BS, 1996, FEBS LETT, V382, P18, DOI 10.1016/0014-5793(96)00128-7; PATIL S, 1995, P NATL ACAD SCI USA, V92, P4897, DOI 10.1073/pnas.92.11.4897; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; POOVAIAH BW, 1993, CRIT REV PLANT SCI, V12, P185, DOI 10.1080/713608046; PROUD CG, 1992, CURR TOP CELL REGUL, V32, P243; Ramachandiran S, 1997, J BIOCHEM-TOKYO, V121, P984; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; ROBERTS DM, 1992, ANNU REV PLANT PHYS, V43, P375, DOI 10.1146/annurev.pp.43.060192.002111; Sambrook J., 2002, MOL CLONING LAB MANU; Schulman H, 1993, CURR OPIN CELL BIOL, V5, P247, DOI 10.1016/0955-0674(93)90111-3; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Takezawa D, 1996, J PLANT PHYSIOL, V149, P329, DOI 10.1016/S0176-1617(96)80130-1; Takezawa D, 1996, J BIOL CHEM, V271, P8126, DOI 10.1074/jbc.271.14.8126; TANG WJY, 1993, METHOD CELL BIOL, V37, P95, DOI 10.1016/S0091-679X(08)60245-9; VELAZQUEZ L, 1995, J BIOL CHEM, V270, P3327, DOI 10.1074/jbc.270.7.3327; VENEMA RC, 1991, J BIOL CHEM, V266, P12574; WANG CS, 1992, AM J BOT, V79, P118, DOI 10.2307/2445097; WATANABE Y, 1995, J BIOL CHEM, V270, P456, DOI 10.1074/jbc.270.1.456; WATILLON B, 1993, PLANT PHYSIOL, V101, P1381, DOI 10.1104/pp.101.4.1381; White RR, 1998, J BIOL CHEM, V273, P3166, DOI 10.1074/jbc.273.6.3166; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; YANG W, 1994, J BIOL CHEM, V269, P3852; ZHU JK, 1994, PLANT CELL, V6, P393, DOI 10.1105/tpc.6.3.393; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697	45	28	33	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12001	12008		10.1074/jbc.274.17.12001	http://dx.doi.org/10.1074/jbc.274.17.12001			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207022	hybrid			2022-12-27	WOS:000079834800078
J	Chaves-Olarte, E; Low, P; Freer, E; Norlin, T; Weidmann, M; von Eichel-Streiber, C; Thelestam, M				Chaves-Olarte, E; Low, P; Freer, E; Norlin, T; Weidmann, M; von Eichel-Streiber, C; Thelestam, M			A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SORDELLII LETHAL TOXIN; R-RAS; RHO-PROTEINS; BINDING; GLUCOSYLATION; CELLS	The large clostridial cytotoxins (LCTs) constitute a group of high molecular weight clostridial cytotoxins that inactivate cellular small GTP-binding proteins. We demonstrate that a novel LCT (TcdB-1470) from Clostridium difficile strain 1470 is a functional hybrid between "reference" TcdB-10463 and Clostridium sordellii TcsL-1522. It bound to the same specific receptor as TcdB-10463 but glucosylated the same GTP-binding proteins as TcsL-1522. Ah three toxins had equal enzymatic potencies but were equally cytotoxic only when micro injected. When applied extracellularly TcdB-1470 and TcdB-10463 were considerably more potent cytotoxins than TcsL-1522. The small GTP-binding protein R-Ras was identified as a target for TcdB-1470 and also for Test-1522 but not for TcdB-10463. R-Ras is known to control integrin-extracellular matrix interactions from inside the cell. Its glucosylation may be a major determinant for the cell rounding and detachment induced by the two R-Ras-attacking toxins. In contrast, fibroblasts treated with TcdB-10463 were arborized and remained attached, with phosphotyrosine containing structures located at the cell-to-cell contacts and beta(3)-integrin remaining at the tips of cellular protrusions. These components were absent from cells treated with the R-Ras-inactivating toxins. The novel hybrid toxin will broaden the utility of the LCTs for clarifying the functions of several small GTPases, now including also R-Ras.	Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden; Univ Costa Rica, Unidad Microscopia Elect, San Jose, Costa Rica; Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, S-17177 Stockholm, Sweden; Johannes Gutenberg Univ Mainz, Inst Med Mikrobiol & Hyg, Verfugungagebaude Forsch & Entwicklung, D-55101 Mainz, Germany	Karolinska Institutet; Universidad Costa Rica; Karolinska Institutet; Johannes Gutenberg University of Mainz	Thelestam, M (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, Box 280, S-17177 Stockholm, Sweden.	monica.thelestam@mtc.ki.se	Weidmann, Manfred/G-1817-2015	Weidmann, Manfred/0000-0002-7063-7491				AKTORIES K, 1995, TRENDS CELL BIOL, V5, P441, DOI 10.1016/S0962-8924(00)89107-2; ChavesOlarte E, 1997, J CLIN INVEST, V100, P1734, DOI 10.1172/JCI119698; ChavesOlarte E, 1996, J BIOL CHEM, V271, P6925, DOI 10.1074/jbc.271.12.6925; DEPITRE C, 1993, J MED MICROBIOL, V38, P434, DOI 10.1099/00222615-38-6-434; EICHELSTREIBER CV, 1995, MOL MICROBIOL, V17, P313; GIRY M, 1995, INFECT IMMUN, V63, P4063, DOI 10.1128/IAI.63.10.4063-4071.1995; Hofmann F, 1996, BIOCHEM BIOPH RES CO, V227, P77, DOI 10.1006/bbrc.1996.1470; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Huff SY, 1997, ONCOGENE, V14, P133, DOI 10.1038/sj.onc.1200815; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWE DG, 1987, CELL, V48, P137, DOI 10.1016/0092-8674(87)90364-3; O'Farrell P H, 1977, Methods Cell Biol, V16, P407; POPOFF MR, 1987, INFECT IMMUN, V55, P35, DOI 10.1128/IAI.55.1.35-43.1987; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; Sauerborn M, 1997, FEMS MICROBIOL LETT, V155, P45, DOI 10.1016/S0378-1097(97)00365-0; THELESTAM M, 1997, BACTERIAL TOXINS TOO, P141; VONEICHELSTREIBER C, 1987, MICROB PATHOGENESIS, V2, P307, DOI 10.1016/0882-4010(87)90073-8; vonEichelStreiber C, 1996, TRENDS MICROBIOL, V4, P375, DOI 10.1016/0966-842X(96)10061-5; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	21	92	98	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11046	11052		10.1074/jbc.274.16.11046	http://dx.doi.org/10.1074/jbc.274.16.11046			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196187	hybrid			2022-12-27	WOS:000079751900055
J	Druillennec, S; Caneparo, A; de Rocquigny, H; Roques, BP				Druillennec, S; Caneparo, A; de Rocquigny, H; Roques, BP			Evidence of interactions between the nucleocapsid protein NCp7 and the reverse transcriptase of HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RNASE-H ACTIVITY; MURINE LEUKEMIA-VIRUS; TERMINAL ZINC-FINGER; PRIMER BINDING-SITE; DNA STRAND TRANSFER; IN-VITRO; RIBONUCLEASE-H; ANNEALING ACTIVITIES; DOMAIN	The human immunodeficiency virus (HIV-1) nucleocapsid protein NCp7 containing two CX2CX4HX4C-type zinc fingers was proposed to be involved in reverse transcriptase (RT)-catalyzed proviral DNA synthesis through promotion of tRNA(3)(LYS) annealing to the RNA primer binding site, improvement of DNA strand transfers, and enhancement of RT processivity. The NCp7 structural characteristics are crucial because mutations altering the finger domain conformation led to noninfectious viruses characterized by defects in provirus integration. These findings prompted us to study a putative RT/NCp7 protein-protein interaction. Binding as says using far Western analysis or RT immobilized on beads clearly showed the formation of a complex between NCp7 and RT. The affinity of NCp7 for p66/p51RT was 0.60 mu M with a 1:1 stoichiometry. This interaction was confirmed by chemical cross-linking and co-immunoprecipitation of the two proteins in a viral environment. Competition experiments using different NCp7 mutants showed that alteration of the finger structure disrupted RT recognition giving insights into the loss of infectivity of corresponding HIV-1 mutants. Together with structural data on RT, these results suggest that the role of NCp7 could be to enhance RT processivity through stabilization of a p51-induced active form of the p66 subunit and open the way for designing new antiviral agents.	UFR Sci Pharmaceut & Biol 4, Dept Pharmacochim Mol & Struct, CNRS, UMR 8600,INSERM,U266, F-75270 Paris 06, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Roques, BP (corresponding author), UFR Sci Pharmaceut & Biol 4, Dept Pharmacochim Mol & Struct, CNRS, UMR 8600,INSERM,U266, 4 Ave Observ, F-75270 Paris 06, France.		DRUILLENNEC, Sabine/B-2572-2019	DRUILLENNEC, Sabine/0000-0003-0237-1465				ALDOVINI A, 1990, J VIROL, V64, P1920, DOI 10.1128/JVI.64.5.1920-1926.1990; BARAT C, 1993, J MOL BIOL, V231, P185, DOI 10.1006/jmbi.1993.1273; BARAT C, 1989, EMBO J, V8, P3279, DOI 10.1002/j.1460-2075.1989.tb08488.x; Cameron CE, 1997, P NATL ACAD SCI USA, V94, P6700, DOI 10.1073/pnas.94.13.6700; Coffin JM, 1990, VIROLOGY, V2, P1437; DARLIX JL, 1993, CR ACAD SCI III-VIE, V316, P763; DARLIX JL, 1995, J MOL BIOL, V254, P523, DOI 10.1006/jmbi.1995.0635; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; de Rocquigny H, 1997, J BIOL CHEM, V272, P30753, DOI 10.1074/jbc.272.49.30753; DEMENE H, 1994, BIOCHEMISTRY-US, V33, P11707, DOI 10.1021/bi00205a006; DEROCQUIGNY H, 1992, P NATL ACAD SCI USA, V89, P6472, DOI 10.1073/pnas.89.14.6472; DeStefano JJ, 1996, J BIOL CHEM, V271, P16350; DORFMAN T, 1993, J VIROL, V67, P6159, DOI 10.1128/JVI.67.10.6159-6169.1993; Drummond JE, 1997, AIDS RES HUM RETROV, V13, P533, DOI 10.1089/aid.1997.13.533; GORELICK RJ, 1990, J VIROL, V64, P3207, DOI 10.1128/JVI.64.7.3207-3211.1990; Guo JH, 1997, J VIROL, V71, P5178, DOI 10.1128/JVI.71.7.5178-5188.1997; HOSTOMSKY Z, 1991, P NATL ACAD SCI USA, V88, P1148, DOI 10.1073/pnas.88.4.1148; Ji XD, 1996, BIOCHEMISTRY-US, V35, P132, DOI 10.1021/bi951707e; KANAYA S, 1991, J BIOL CHEM, V266, P11621; KARPEL RL, 1987, J BIOL CHEM, V262, P4961; KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.bi.63.070194.001025; Keck JL, 1996, J BIOL CHEM, V271, P19883, DOI 10.1074/jbc.271.33.19883; KECK JL, 1995, P NATL ACAD SCI USA, V92, P2740, DOI 10.1073/pnas.92.7.2740; KHAN R, 1992, J BIOL CHEM, V267, P6689; Lee BM, 1998, J MOL BIOL, V279, P633, DOI 10.1006/jmbi.1998.1766; Li XG, 1996, J VIROL, V70, P4996, DOI 10.1128/JVI.70.8.4996-5004.1996; MORELLET N, 1992, EMBO J, V11, P3059, DOI 10.1002/j.1460-2075.1992.tb05377.x; MORELLET N, 1994, J MOL BIOL, V235, P287, DOI 10.1016/S0022-2836(05)80033-6; OTTMANN M, 1995, J VIROL, V69, P1778, DOI 10.1128/JVI.69.3.1778-1784.1995; PELISKA JA, 1994, BIOCHEMISTRY-US, V33, P13817, DOI 10.1021/bi00250a036; POWERS R, 1992, BIOCHEMISTRY-US, V31, P9150, DOI 10.1021/bi00153a006; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Remy E, 1998, J BIOL CHEM, V273, P4819, DOI 10.1074/jbc.273.9.4819; RODRIGUEZRODRIGUEZ L, 1995, J BIOL CHEM, V270, P15005, DOI 10.1074/jbc.270.25.15005; SCHWARTZ O, 1995, J VIROL, V69, P528, DOI 10.1128/JVI.69.1.528-533.1995; SOUTH TL, 1991, BIOCHEMISTRY-US, V30, P6342, DOI 10.1021/bi00239a036; SUMMERS MF, 1992, PROTEIN SCI, V1, P563, DOI 10.1002/pro.5560010502; TANCHOU V, 1994, AIDS RES HUM RETROV, V10, P983, DOI 10.1089/aid.1994.10.983; Tanchou V, 1998, J VIROL, V72, P4442, DOI 10.1128/JVI.72.5.4442-4447.1998; TANCHOU V, 1995, J MOL BIOL, V252, P563, DOI 10.1006/jmbi.1995.0520; Wu WX, 1996, J VIROL, V70, P7132, DOI 10.1128/JVI.70.10.7132-7142.1996; Yu QA, 1996, J VIROL, V70, P5791, DOI 10.1128/JVI.70.9.5791-5798.1996	43	77	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11283	11288		10.1074/jbc.274.16.11283	http://dx.doi.org/10.1074/jbc.274.16.11283			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196217	hybrid			2022-12-27	WOS:000079751900085
J	Heimann, K; Percival, JM; Weinberger, R; Gunning, P; Stow, JL				Heimann, K; Percival, JM; Weinberger, R; Gunning, P; Stow, JL			Specific isoforms of actin-binding proteins on distinct populations of Golgi-derived vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-II; COATED VESICLES; TROPOMYOSIN ISOFORMS; TRANSPORT VESICLES; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE PROTEIN; VESICULAR TRANSPORT; ENDOCYTIC PATHWAY; EPITHELIAL-CELLS	Golgi membranes and Golgi-derived vesicles are associated with multiple cytoskeletal proteins and motors, the diversity and distribution of which have not yet been defined. Carrier vesicles were separated from Golgi membranes, using an in vitro budding assay, and different populations of vesicles were separated using sucrose density gradients. Three main populations of vesicles labeled with beta-COP, gamma-adaptin, or p200/myosin II were separated and analyzed for the presence of actin/actin-binding proteins, beta-Actin was bound to Golgi cisternae and to all populations of newly budded vesicles. Centractin was selectively associated with vesicles co-distributing with beta-COP-vesicles, while p200/myosin II (non-muscle myosin IIA) and non-muscle myosin IIB were found on different vesicle populations. Isoforms of the Tm5 tropomyosins were found on selected Golgi-derived vesicles, while other Tm isoforms did not colocalize with Tm5 indicating the association of specialized actin filaments with Golgi-derived vesicles. Golgi-derived vesicles were shown to bind to F-actin polymerized from cytosol with Jasplakinolide. Thus, newly budded, coated vesicles derived from Golgi membranes can bind to actin and are customized for differential interactions with microfilaments by the presence of selective arrays of actin-binding proteins.	Univ Queensland, Ctr Cellular & Mol Biol, Brisbane, Qld 4072, Australia; Univ Sydney, Dept Paediat & Child Hlth, Westmead, NSW 2145, Australia; New Childrens Hosp, Oncol Res Unit, Westmead, NSW, Australia	University of Queensland; University of Sydney; University of Sydney	Stow, JL (corresponding author), Univ Queensland, Ctr Cellular & Mol Biol, Brisbane, Qld 4072, Australia.	j.stow@cmcb.uq.edu.au	Stow, Jennifer L/I-4723-2013; Heimann, Kirsten/M-4814-2019; Heimann, Kirsten/C-4539-2012; Gunning, Peter W/E-9058-2010; Heimann, Kirsten/N-1512-2013	Stow, Jennifer L/0000-0002-5409-9101; Heimann, Kirsten/0000-0003-2691-9659; Heimann, Kirsten/0000-0003-2691-9659; Gunning, Peter/0000-0003-0833-3128				BECK KA, 1994, J CELL BIOL, V127, P707, DOI 10.1083/jcb.127.3.707; Beck KA, 1997, J CELL SCI, V110, P1239; Bock JB, 1996, J BIOL CHEM, V271, P17961, DOI 10.1074/jbc.271.30.17961; Burkhardt JK, 1998, BBA-MOL CELL RES, V1404, P113, DOI 10.1016/S0167-4889(98)00052-4; CLARK SW, 1994, MOL BIOL CELL, V5, P1301, DOI 10.1091/mbc.5.12.1301; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; De Matteis MA, 1998, CURR OPIN CELL BIOL, V10, P542, DOI 10.1016/S0955-0674(98)80071-9; DEALMEIDA JB, 1993, J CELL SCI, V106, P1239; DeOca GM, 1997, ARCH MED RES, V28, P321; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Evans LL, 1997, J CELL SCI, V110, P439; FANNING AS, 1994, CELL MOTIL CYTOSKEL, V29, P29, DOI 10.1002/cm.970290104; FATH KR, 1993, J CELL BIOL, V120, P117, DOI 10.1083/jcb.120.1.117; FATH KR, 1994, J CELL BIOL, V126, P661, DOI 10.1083/jcb.126.3.661; Fath KR, 1997, J CELL BIOL, V139, P1169, DOI 10.1083/jcb.139.5.1169; Gleeson PA, 1996, J CELL SCI, V109, P2811; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; GRIFFITHS G, 1995, J CELL SCI, V108, P2839; Gunning P, 1998, ANNU REV CELL DEV BI, V14, P339, DOI 10.1146/annurev.cellbio.14.1.339; Gunning P, 1997, ANAT EMBRYOL, V195, P311, DOI 10.1007/s004290050050; HEUSER J, 1989, CELL BIOL INT REP, V13, P1063, DOI 10.1016/0309-1651(89)90020-9; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Ikonen E, 1997, J CELL SCI, V110, P2155; Ikonen E, 1996, MOL BIOL CELL, V7, P961, DOI 10.1091/mbc.7.6.961; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kelley CA, 1996, J CELL BIOL, V134, P675, DOI 10.1083/jcb.134.3.675; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEELAVATHI DE, 1970, BIOCHIM BIOPHYS ACTA, V211, P124, DOI 10.1016/0005-2736(70)90087-8; LIU HP, 1992, J CELL BIOL, V118, P285, DOI 10.1083/jcb.118.2.285; Lowe M, 1998, BBA-MOL CELL RES, V1404, P53, DOI 10.1016/S0167-4889(98)00046-9; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; MAUPIN P, 1994, J CELL SCI, V107, P3077; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Mulholland J, 1997, MOL BIOL CELL, V8, P1481, DOI 10.1091/mbc.8.8.1481; Musch A, 1997, J CELL BIOL, V138, P291, DOI 10.1083/jcb.138.2.291; NARULA N, 1995, P NATL ACAD SCI USA, V92, P2874, DOI 10.1073/pnas.92.7.2874; NARULA N, 1992, J CELL BIOL, V117, P27, DOI 10.1083/jcb.117.1.27; Nickel W, 1997, P NATL ACAD SCI USA, V94, P11393, DOI 10.1073/pnas.94.21.11393; NOVY RE, 1993, CELL MOTIL CYTOSKEL, V25, P267, DOI 10.1002/cm.970250307; Odorizzi G, 1998, TRENDS CELL BIOL, V8, P282, DOI 10.1016/S0962-8924(98)01295-1; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; PoucellHatton S, 1997, GASTROENTEROLOGY, V113, P649, DOI 10.1053/gast.1997.v113.pm9247487; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119; Santos B, 1997, J CELL BIOL, V136, P95, DOI 10.1083/jcb.136.1.95; SCHEVZOV G, 1992, J CELL BIOL, V117, P775, DOI 10.1083/jcb.117.4.775; SERAFINI T, 1992, METHOD ENZYMOL, V219, P286; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; Shpetner HS, 1996, J BIOL CHEM, V271, P13, DOI 10.1074/jbc.271.1.13; Shurety W, 1998, MOL BIOL CELL, V9, P957, DOI 10.1091/mbc.9.4.957; Simon JP, 1998, P NATL ACAD SCI USA, V95, P1073, DOI 10.1073/pnas.95.3.1073; Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239; Stow JL, 1998, TRENDS CELL BIOL, V8, P138, DOI 10.1016/S0962-8924(98)01238-0; Stow JL, 1998, BBA-MOL CELL RES, V1404, P161, DOI 10.1016/S0167-4889(98)00055-X; TANG BL, 1993, J CELL BIOL, V120, P325, DOI 10.1083/jcb.120.2.325; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Weinberger R, 1996, J NEUROSCI, V16, P238; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967	61	94	96	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10743	10750		10.1074/jbc.274.16.10743	http://dx.doi.org/10.1074/jbc.274.16.10743			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196146	hybrid			2022-12-27	WOS:000079751900014
J	Rittershaus, CW; Thomas, LJ; Miller, DP; Picard, MD; Geoghegan-Barek, KM; Scesney, SM; Henry, LD; Sen, AC; Bertino, AM; Hannig, G; Adari, H; Mealey, RA; Gosselin, ML; Couto, M; Hayman, EG; Levin, JL; Reinhold, VN; Marsh, HC				Rittershaus, CW; Thomas, LJ; Miller, DP; Picard, MD; Geoghegan-Barek, KM; Scesney, SM; Henry, LD; Sen, AC; Bertino, AM; Hannig, G; Adari, H; Mealey, RA; Gosselin, ML; Couto, M; Hayman, EG; Levin, JL; Reinhold, VN; Marsh, HC			Recombinant glycoproteins that inhibit complement activation and also bind the selectin adhesion molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SENSITIVE FLUORESCENCE DETECTION; IONIZATION MASS-SPECTROMETRY; REPERFUSION INJURY; QUANTITATIVE-DETERMINATION; CELL-SURFACE; LUNG INJURY; RECEPTOR-TYPE-1; PROTECTS; CR-1	Soluble human complement receptor type 1 (sCR1, TP10) has been expressed in Chinese hamster ovary (CHO) DUKX-B11 cells and shown to inhibit the classical and alternative complement pathways in vitro and in vivo, A truncated version of sCR1 lacking the long homologous repeat-A domain (LHR-A) containing the C4b binding site has similarly been expressed and designated sCR1[desLHR-A]. sCR1[desLHR-A] was shown to be a selective inhibitor of the alternative complement pathway in vitro and to function in vivo, In this study, sCR1 and sCR1[desLHR-A] were expressed in CHO LEC11 cells with an active alpha(1,3)-fucosyltransferase, which makes possible the biosynthesis of the sialyl-Lewis(x) (sLe(x)) tetrasaccharide (NeuNAc alpha 2-3Gal beta 1-4 (Fuc alpha 1-3)GlcNAc) during post-translational glycosylation, The resulting glycoproteins, designated sCRlsLe(x) and sCR1[desLHR-A]sLe(x), respectively, retained the complement regulatory activities of their DUKX B11 counterparts, which lack alpha(1-3)-fucose. Carbohydrate analysis of purified sCRlsLe(x) and sCR1[desLHR-A]sLe(x) indicated an average incorporation of 10 and 8 mol of sLe(x)/mol of glycoprotein, respectively. sLe(x) is a carbohydrate ligand for the selectin adhesion molecules, sCR1sLe(x) was shown to specifically bind CHO cells expressing cell surface E-selectin. sCR1[desLHR-A]sLe(x) inhibited the binding of the monocytic cell line U937 to human aortic endothelial cells, which had been activated with tumor necrosis factor-alpha to up-regulate the expression of E-selectin. sCR1sLe(x) inhibited the binding of U937 cells to surface-adsorbed P-selectin-IgG, sCR1sLe(x) and sCR1[desLHR-A]sLe(x) have thus demonstrated both complement regulatory activity and the capacity to bind selectins and to inhibit selectin-mediated cell adhesion in vitro.	Avant Immunotherapeut Inc, Needham, MA 02494 USA; Univ New Hampshire, Dept Chem, Durham, NH USA	University System Of New Hampshire; University of New Hampshire	Marsh, HC (corresponding author), Avant Immunotherapeut Inc, Needham, MA 02494 USA.			Marsh, Henry/0000-0001-5637-6013				ANUMULA KR, 1995, ANAL BIOCHEM, V230, P24, DOI 10.1006/abio.1995.1432; ANUMULA KR, 1994, ANAL BIOCHEM, V220, P275, DOI 10.1006/abio.1994.1338; ARUFFO A, 1991, CELL, V67, P35, DOI 10.1016/0092-8674(91)90570-O; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BUERKE M, 1994, J CLIN INVEST, V93, P1140, DOI 10.1172/JCI117066; CAMPBELL C, 1984, J BIOL CHEM, V259, P1208; CARSON GR, 1991, J BIOL CHEM, V266, P7883; CHAVEZCARTAYA RE, 1995, TRANSPLANTATION, V59, P1047, DOI 10.1097/00007890-199504150-00023; Diacovo TG, 1996, SCIENCE, V273, P252, DOI 10.1126/science.273.5272.252; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Gralinski MR, 1996, IMMUNOPHARMACOLOGY, V34, P79, DOI 10.1016/0162-3109(96)00105-1; Lennon PF, 1996, AM J PHYSIOL-HEART C, V270, pH1924, DOI 10.1152/ajpheart.1996.270.6.H1924; LINSLEY KB, 1994, ANAL BIOCHEM, V219, P207, DOI 10.1006/abio.1994.1259; MAKRIDES SC, 1992, J BIOL CHEM, V267, P24754; MULLIGAN MS, 1992, J IMMUNOL, V148, P1479; MULLIGAN MS, 1993, J EXP MED, V178, P623, DOI 10.1084/jem.178.2.623; MULLIGAN MS, 1993, NATURE, V364, P149, DOI 10.1038/364149a0; MUROHARA T, 1995, METHOD FIND EXP CLIN, V17, P499; Nickells M, 1998, CLIN EXP IMMUNOL, V112, P27; PICARD MD, 1996, GLYCOBIOLOGY, V6, P766; Piddlesden SJ, 1996, J NEUROIMMUNOL, V71, P173, DOI 10.1016/S0165-5728(96)00144-0; PIDDLESDEN SJ, 1994, J IMMUNOL, V152, P5477; PRUITT SK, 1994, TRANSPLANTATION, V57, P363, DOI 10.1097/00007890-199402150-00009; REINHOLD BB, 1992, J AM SOC MASS SPECTR, V3, P207, DOI 10.1016/1044-0305(92)87004-I; REINHOLD VN, 1995, ANAL CHEM, V67, P1772, DOI 10.1021/ac00107a005; Reinhold VN, 1996, METHOD ENZYMOL, V271, P377; Scesney SM, 1996, EUR J IMMUNOL, V26, P1729, DOI 10.1002/eji.1830260810; SIMONSEN CC, 1983, P NATL ACAD SCI-BIOL, V80, P2495, DOI 10.1073/pnas.80.9.2495; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Weiser MR, 1996, J EXP MED, V183, P2343, DOI 10.1084/jem.183.5.2343; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; WELPLY JK, 1994, GLYCOBIOLOGY, V4, P259, DOI 10.1093/glycob/4.3.259; Witte K, 1997, J AM CHEM SOC, V119, P2114, DOI 10.1021/ja961846z	33	44	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11237	11244		10.1074/jbc.274.16.11237	http://dx.doi.org/10.1074/jbc.274.16.11237			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196211	hybrid			2022-12-27	WOS:000079751900079
J	Feltkamp, D; Wiebel, FF; Alberti, S; Gustafsson, JA				Feltkamp, D; Wiebel, FF; Alberti, S; Gustafsson, JA			Identification of a novel DNA binding site for nuclear orphan receptor OR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; PROLIFERATOR-ACTIVATED RECEPTOR; THYROID-HORMONE RECEPTORS; ACID RECEPTORS; DIRECT REPEATS; LIGAND-BINDING; S14 GENE; TRANSCRIPTIONAL ACTIVATION; RESPONSE ELEMENTS; ESTROGEN-RECEPTOR	The nuclear orphan receptor OR1 has been shown to bind as a heterodimer with retinoid X receptor (RXR) to direct repeat 4 (DR4) response elements. It remained unclear, however, whether this represents the only or the optimal binding site for this receptor, Therefore, we performed a DNA binding site selection assay that allows the identification of novel DNA binding sites for OR1 in an unbiased manner. While ORI alone was not able to select a specific sequence from the pool of oligonucleotides, the OR1/RXR heterodimer selected a highly conserved DR1 element, termed DR1s, with two AG-GTCA motifs spaced by one adenosine, The functional activity of the consensus binding site was verified in transient transfection assays and corroborated by in vitro studies. Based on the sequence of the consensus DR1s, we located putative natural binding sites in the 5'-promoter flanking regions of the rat S14 gene and the rat cholecystokinin type A receptor gene. Furthermore, we could show that although the OR1/RXR heterodimer has a distinct binding orientation on a DR4 element, it is able to bind in both orientations to the DR1s element. The OR1 paralog LXR alpha does not bind as a heterodimer with RXR to the DR1s element, indicating that these receptors, despite their homology, are involved in the regulation of different sets of genes.	Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden; Karolinska Inst, Dept Med Nutr, S-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet	Feltkamp, D (corresponding author), Karolinska Inst, Novum, Dept Biosci, Halsovogen 7, S-14157 Huddinge, Sweden.							ALEX R, 1992, NUCLEIC ACIDS RES, V20, P2257, DOI 10.1093/nar/20.9.2257; APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Castelein H, 1996, MOL CELL ENDOCRINOL, V119, P11, DOI 10.1016/0303-7207(96)03794-X; CHEN ZP, 1994, J BIOL CHEM, V269, P25770; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; CRAWLEY JN, 1994, PEPTIDES, V15, P731, DOI 10.1016/0196-9781(94)90104-X; DiRenzo J, 1997, MOL CELL BIOL, V17, P2166, DOI 10.1128/MCB.17.4.2166; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; FORMAN BM, 1989, MOL ENDOCRINOL, V3, P1610, DOI 10.1210/mend-3-10-1610; FREAKE HC, 1987, P NATL ACAD SCI USA, V84, P3070, DOI 10.1073/pnas.84.9.3070; FREEDMAN LP, 1992, ENDOCR REV, V13, P129, DOI 10.1210/er.13.2.129; GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; GLASS CK, 1991, MOL ASPECTS CELLULAR; Gronemeyer H, 1995, PROTEIN PROFILE, V2, P1173; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; JORPES JE, 1966, ACTA PHYSIOL SCAND, V66, P196; JUMP DB, 1990, J BIOL CHEM, V265, P3474; Kainu T, 1996, J MOL NEUROSCI, V7, P29, DOI 10.1007/BF02736846; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; LEE MS, 1993, SCIENCE, V260, P1117, DOI 10.1126/science.8388124; Lee SK, 1998, MOL ENDOCRINOL, V12, P325, DOI 10.1210/me.12.3.325; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; LUCAS PC, 1992, ANNU REV BIOCHEM, V61, P1131; LUETJOHANN D, 1996, P NATL ACAD SCI USA, V93, P9799; LUND E, 1995, ACCOUNTS CHEM RES, V28, P241, DOI 10.1021/ar00054a001; MADER S, 1993, EMBO J, V12, P5029, DOI 10.1002/j.1460-2075.1993.tb06196.x; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; NAGPAL S, 1992, CELL, V70, P1007, DOI 10.1016/0092-8674(92)90250-G; ONATE SA, 1995, SCIENCE, V270, P1354; Ota Y, 1997, MOL CELL ENDOCRINOL, V126, P75, DOI 10.1016/S0303-7207(96)03971-8; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; PERLMANN T, 1995, GEN DEV, V9, P796; Ren B, 1997, J BIOL CHEM, V272, P26827, DOI 10.1074/jbc.272.43.26827; SCHRADER M, 1994, DNA CELL BIOL, V13, P333, DOI 10.1089/dna.1994.13.333; SEOL WG, 1995, MOL ENDOCRINOL, V9, P72, DOI 10.1210/me.9.1.72; SHINAR DM, 1994, GENE, V147, P273, DOI 10.1016/0378-1119(94)90080-9; SILVER AJ, 1991, PROG NEUROBIOL, V36, P23, DOI 10.1016/0301-0082(91)90035-Y; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; SONG C, 1994, P NATL ACAD SCI USA, V91, P10809, DOI 10.1073/pnas.91.23.10809; SPENCER TA, 1985, J BIOL CHEM, V260, P3391; TAKATA Y, 1995, BIOCHEM BIOPH RES CO, V213, P958, DOI 10.1006/bbrc.1995.2222; TEBOUL M, 1995, P NATL ACAD SCI USA, V92, P2096, DOI 10.1073/pnas.92.6.2096; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; VANDERHAEGHEN JJ, 1975, NATURE, V221, P557; Wiebel FF, 1997, MOL CELL BIOL, V17, P3977, DOI 10.1128/MCB.17.7.3977; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Willy PJ, 1997, GENE DEV, V11, P289, DOI 10.1101/gad.11.3.289; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; WILSON TE, 1992, SCIENCE, V256, P107, DOI 10.1126/science.1314418; Yan ZH, 1997, J BIOL CHEM, V272, P10565; ZECHEL C, 1994, EMBO J, V13, P1425, DOI 10.1002/j.1460-2075.1994.tb06396.x; ZHANG XK, 1991, NEW BIOL, V3, P169; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0	63	14	14	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10421	10429		10.1074/jbc.274.15.10421	http://dx.doi.org/10.1074/jbc.274.15.10421			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187832	hybrid			2022-12-27	WOS:000079663500071
J	Miranti, CK; Ohno, S; Brugge, JS				Miranti, CK; Ohno, S; Brugge, JS			Protein kinase C regulates integrin-induced activation of the extracellular regulated kinase pathway upstream of Shc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR ACTIVATION; T-CELL ACTIVATION; NIH 3T3 CELLS; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; MEDIATED ACTIVATION; MAP KINASE; DIFFERENTIAL TRANSLOCATION; SERINE PHOSPHORYLATION; DEPENDENT MECHANISM	Adhesion of fibroblasts to extracellular matrices via integrin receptors is accompanied by extensive cytoskeletal rearrangements and intracellular signaling events. The protein kinase C (PKC) family of serine/threonine kinases has been implicated in several integrin-mediated events including focal adhesion formation, cell spreading, cell migration, and cytoskeletal rearrangements. However, the mechanism by which PKC regulates integrin function is not known. To characterize the role of PKC family kinases in mediating integrin-induced signaling, we monitored the effects of PKC inhibition on fibronectin-induced signaling events in Cos7 cells using pharmacological and genetic approaches. We found that inhibition of classical and novel isoforms of PKC by down-regulation with 12-O-tetradeconoyl-phorbol-13-acetate or overexpression of dominant-negative mutants of PKC significantly reduced extracellular regulated kinase 2 (Erk2) activation by fibronectin receptors in Cos7 cells. Furthermore, overexpression of constitutively active PKC alpha, PKC delta, or PKC epsilon was sufficient to rescue 12-O-tetradeconoyl-phorbol-13-acetate-mediated down-regulation of Erk2 activation, and all three of these PKC isoforms were activated following adhesion. PKC was required for maximal activation of mitogen-activated kinase kinase 1, Raf-1, and Ras, tyrosine phosphorylation of Shc, and Shc association with Grb2. PKC inhibition does not appear to have a generalized effect on integrin signaling, because it does not block integrin-induced focal adhesion kinase or paxillin tyrosine phosphorylation. These results indicate that PKC activity enhances Erk2 activation in response to fibronectin by stimulating the Erk/mitogen-activated protein kinase pathway at an early step upstream of Shc.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Yokohama City Univ, Sch Med, Dept Mol Biol, Kanazawa Ku, Yokohama, Kanagawa 236, Japan	Harvard University; Harvard Medical School; Yokohama City University	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.		Miranti, Cindy/AAJ-3783-2020; Ohno, Shigeo/B-1768-2010	Ohno, Shigeo/0000-0002-1294-5269	NCI NIH HHS [CA72203, CA27951, CA 78773] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078773, R01CA027951, F32CA072203, R37CA027951] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALESSI DR, 1995, METHOD ENZYMOL, V255, P279; Anand-Apte B, 1997, J BIOL CHEM, V272, P30688, DOI 10.1074/jbc.272.49.30688; Aplin AE, 1998, PHARMACOL REV, V50, P197; Asano T, 1998, EUR J BIOCHEM, V251, P314, DOI 10.1046/j.1432-1327.1998.2510314.x; Banno Y, 1996, J BIOL CHEM, V271, P14989, DOI 10.1074/jbc.271.25.14989; BARRY ST, 1994, J CELL SCI, V107, P2033; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; BERTI L, 1994, J BIOL CHEM, V269, P3381; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; Blobe GC, 1996, CANCER SURV, V27, P213; Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5; Brumell JH, 1997, J BIOL CHEM, V272, P875, DOI 10.1074/jbc.272.2.875; BURGERING BMT, 1993, MOL CELL BIOL, V13, P7248, DOI 10.1128/MCB.13.12.7248; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chapline C, 1998, J BIOL CHEM, V273, P19482, DOI 10.1074/jbc.273.31.19482; Chen P, 1996, MOL BIOL CELL, V7, P871, DOI 10.1091/mbc.7.6.871; Chen Y, 1998, J BIOL CHEM, V273, P19809, DOI 10.1074/jbc.273.31.19809; CHUN JS, 1993, MOL BIOL CELL, V4, P271; Chun JS, 1996, J BIOL CHEM, V271, P13008, DOI 10.1074/jbc.271.22.13008; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Clark EA, 1996, J BIOL CHEM, V271, P14814, DOI 10.1074/jbc.271.25.14814; CYBULSKY AV, 1993, AM J PHYSIOL, V264, P323; Dabrowski A, 1996, J BIOL CHEM, V271, P27125, DOI 10.1074/jbc.271.43.27125; Daulhac L, 1997, BIOCHEM J, V325, P383, DOI 10.1042/bj3250383; Defilippi P, 1997, J BIOL CHEM, V272, P21726, DOI 10.1074/jbc.272.35.21726; DeNichilo MO, 1996, J BIOL CHEM, V271, P11016, DOI 10.1074/jbc.271.18.11016; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Downward J, 1996, CANCER SURV, V27, P87; Duckworth BC, 1997, J BIOL CHEM, V272, P27665, DOI 10.1074/jbc.272.44.27665; GARTON AJ, 1994, EMBO J, V13, P3763, DOI 10.1002/j.1460-2075.1994.tb06687.x; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; HABIB T, 1994, J BIOL CHEM, V269, P25243; Haimovich B, 1996, BLOOD, V87, P152, DOI 10.1182/blood.V87.1.152.bloodjournal871152; Haller H, 1998, CIRC RES, V82, P157; Howe AK, 1998, J BIOL CHEM, V273, P27268, DOI 10.1074/jbc.273.42.27268; Huang XZ, 1998, J CELL SCI, V111, P2189; HUNDLE B, 1995, J BIOL CHEM, V270, P30134; HYATT SL, 1994, BIOCHEMISTRY-US, V33, P1223, DOI 10.1021/bi00171a023; JAKEN S, 1989, J CELL BIOL, V109, P697, DOI 10.1083/jcb.109.2.697; Keenan C, 1998, CELL SIGNAL, V10, P225, DOI 10.1016/S0898-6568(97)00121-6; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Ktistakis NT, 1998, BIOESSAYS, V20, P495; Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323; LI WQ, 1994, MOL CELL BIOL, V14, P6727, DOI 10.1128/MCB.14.10.6727; LI WQ, 1994, J BIOL CHEM, V269, P2349; LIAO L, 1993, CELL GROWTH DIFFER, V4, P309; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Lin TH, 1997, J CELL BIOL, V136, P1385, DOI 10.1083/jcb.136.6.1385; Lin XY, 1996, J BIOL CHEM, V271, P28430, DOI 10.1074/jbc.271.45.28430; MAINIERO F, 1995, EMBO J, V14, P4470, DOI 10.1002/j.1460-2075.1995.tb00126.x; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; Miki H, 1997, CELL GROWTH DIFFER, V8, P195; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Myat MM, 1997, CURR BIOL, V7, P611, DOI 10.1016/S0960-9822(06)00262-4; NAKAMURA S, 1994, J BIOCHEM, V115, P1029, DOI 10.1093/oxfordjournals.jbchem.a124451; NORI M, 1992, MOL CELL BIOL, V12, P936, DOI 10.1128/MCB.12.3.936; Ohtsuka T, 1996, BBA-MOL CELL RES, V1310, P223, DOI 10.1016/0167-4889(95)00172-7; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592; REUTER CWM, 1995, METHOD ENZYMOL, V255, P245; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Schubert C, 1996, J BIOL CHEM, V271, P15311, DOI 10.1074/jbc.271.26.15311; Shanmugam M, 1998, ONCOGENE, V16, P1649, DOI 10.1038/sj.onc.1201684; Smithgall TE, 1998, PHARMACOL REV, V50, P1; Song JS, 1998, ONCOGENE, V16, P3357, DOI 10.1038/sj.onc.1201886; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; VAILLANCOURT RR, 1994, METHOD ENZYMOL, V238, P255; vanBiesen T, 1996, J BIOL CHEM, V271, P1266, DOI 10.1074/jbc.271.3.1266; VUORI K, 1993, J BIOL CHEM, V268, P21459; WADZINSKI BE, 1992, J BIOL CHEM, V267, P16883; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wei JY, 1998, J BIOL CHEM, V273, P5903, DOI 10.1074/jbc.273.10.5903; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; WOODS A, 1992, J CELL SCI, V101, P277; Zang Q, 1997, J BIOL CHEM, V272, P13275, DOI 10.1074/jbc.272.20.13275; Zhao H, 1997, J BIOL CHEM, V272, P21625, DOI 10.1074/jbc.272.34.21625; Zheng LM, 1996, P NATL ACAD SCI USA, V93, P8431, DOI 10.1073/pnas.93.16.8431	87	97	100	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10571	10581		10.1074/jbc.274.15.10571	http://dx.doi.org/10.1074/jbc.274.15.10571			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187852	hybrid			2022-12-27	WOS:000079663500091
J	Chen, G; Yuan, SSF; Liu, W; Xu, Y; Trujillo, K; Song, BW; Cong, F; Goff, SP; Wu, Y; Arlinghaus, R; Baltimore, D; Gasser, PJ; Park, MS; Sung, P; Lee, EYHP				Chen, G; Yuan, SSF; Liu, W; Xu, Y; Trujillo, K; Song, BW; Cong, F; Goff, SP; Wu, Y; Arlinghaus, R; Baltimore, D; Gasser, PJ; Park, MS; Sung, P; Lee, EYHP			Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; DOUBLE-STRAND BREAKS; ATAXIA-TELANGIECTASIA CELLS; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; IONIZING-RADIATION; TYROSINE KINASE; GENE-PRODUCT; REPAIR; PHOSPHORYLATION	Cells from individuals with the recessive cancer-prone disorder ataxia telangiectasia (A-T) are hypersensitive to ionizing radiation (I-R). ATM (mutated in A-T) is a protein kinase whose activity is stimulated by I-R. c-Abl, a nonreceptor tyrosine kinase, interacts with ATM and is activated by ATM following I-R. Rad51 is a homologue of bacterial RecA protein required for DNA recombination and repair. Here we demonstrate that there is an I-R-induced Rad51 tyrosine phosphorylation, and this induction is dependent on both ATM and c-Abl. ATM, c-Abl, and Rad51 can be co-immunoprecipitated from cell extracts. Consistent with the physical interaction, c-Abl phosphorylates Rad51 in vitro and in vivo. In assays using purified components, phosphorylation of Rad51 by c-Abl enhances complex formation between Rad51 and Rad52, which cooperates with Rad51 in recombination and repair. After I-R, an increase in association between Rad51 and Rad52 occurs in wild-type cells but not in cells with mutations that compromise ATM or c-Abl. Our data suggest signaling mediated through ATM, and c-Abl is required for the correct posttranslational modification of Rad51, which is critical for the assembly of Rad51 repair protein complex following I-R.	Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Univ Texas, MD Anderson Cancer Ctr, Dept Mol Pathol, Houston, TX 77030 USA; Univ Calif Los Alamos Natl Lab, Div Life Sci, Los Alamos, NM 87545 USA	University of Texas System; University of Texas Health San Antonio; Massachusetts Institute of Technology (MIT); Columbia University; Howard Hughes Medical Institute; University of Texas System; UTMD Anderson Cancer Center; United States Department of Energy (DOE); Los Alamos National Laboratory	Lee, EYHP (corresponding author), Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, 7703 Floyd Curl Dr, San Antonio, TX 78245 USA.		Park, Min Sung/HCH-2207-2022; Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547; Xu, Yang/0000-0001-5574-921X; yuan, shyng-shiou/0000-0002-4753-788X; Gasser, Paul/0000-0002-2092-6068	NINDS NIH HHS [1RO1NS378381-01] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andoniou CE, 1996, ONCOGENE, V12, P1981; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barlow C, 1998, DEVELOPMENT, V125, P4007; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; BLOCHER D, 1991, INT J RADIAT BIOL, V60, P791, DOI 10.1080/09553009114552601; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen G, 1996, J BIOL CHEM, V271, P33693, DOI 10.1074/jbc.271.52.33693; COX R, 1982, ATAXIA TELANGIECTASI; Dar ME, 1997, MUTAT RES-DNA REPAIR, V384, P169, DOI 10.1016/S0921-8777(97)00021-9; Foray N, 1997, INT J RADIAT BIOL, V71, P449; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; Kanaar Roland, 1997, Genes and Function, V1, P165; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Lakin ND, 1996, ONCOGENE, V13, P2707; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Luo CM, 1996, J BIOL CHEM, V271, P4497; MEYN MS, 1993, SCIENCE, V260, P1327, DOI 10.1126/science.8493577; MEYN MS, 1995, CANCER RES, V55, P5991; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shen ZY, 1996, J BIOL CHEM, V271, P148, DOI 10.1074/jbc.271.1.148; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; SHINOHARA A, 1995, TRENDS BIOCHEM SCI, V20, P387, DOI 10.1016/S0968-0004(00)89085-4; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; THACKER J, 1994, INT J RADIAT BIOL, V66, P87; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Van Dyck E, 1998, J MOL BIOL, V284, P1027, DOI 10.1006/jmbi.1998.2203; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yuan ZM, 1996, NATURE, V382, P272, DOI 10.1038/382272a0; Yuan ZM, 1998, J BIOL CHEM, V273, P3799, DOI 10.1074/jbc.273.7.3799	40	216	222	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12748	12752		10.1074/jbc.274.18.12748	http://dx.doi.org/10.1074/jbc.274.18.12748			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212258	Green Accepted, hybrid			2022-12-27	WOS:000080056800078
J	Laderoute, KR; Mendonca, HL; Calaoagan, JM; Knapp, AM; Giaccia, AJ; Stork, PJS				Laderoute, KR; Mendonca, HL; Calaoagan, JM; Knapp, AM; Giaccia, AJ; Stork, PJS			Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironments - A candidate MKP for the inactivation of hypoxia-inducible stress-activated protein kinase/c-Jun N-terminal protein kinase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; DUAL-SPECIFICITY PHOSPHATASE; NECROSIS-FACTOR-ALPHA; RAT MESANGIAL CELLS; C-JUN; TYROSINE-PHOSPHATASE; FACTOR-I; KAPPA-B; TRANSCRIPTION FACTORS; SIGNALING PATHWAY	Pathophysiological hypoxia is an important modulator of gene expression in solid tumors and other pathologic conditions. We observed that transcriptional activation of the c-jun proto oncogene in hypoxic tumor cells correlates with phosphorylation of the ATF2 transcription factor. This finding suggested that hypoxic signals transmitted to c-jun involve protein kinases that target AP-1 complexes (c-Jun and ATF2) that bind to its promoter region, Stress-inducible protein kinases capable of activating c-jun expression include stress-activated protein kinase/c-Jun N-terminal protein kinase (SAPK/JNK) and p38 members of the mitogen-activated protein kinase (MAPK) superfamily of signaling molecules. To investigate the potential role of MAPKs in the regulation of c-jun by tumor hypoxia, we focused on the activation SAPK/JNKs in SiHa human squamous carcinoma cells. Here, we describe the transient activation of SAPK/JNKs by tumor-like hypoxia, and the concurrent transcriptional activation of MKP-1, a stress-inducible member of the MAPK phosphatase (MKP) family of dual specificity protein-tyrosine phosphatases. MKP-1 antagonizes SAPK/JNK activation in response to diverse environmental stresses. Together, these findings identify MKP-1 as a hypoxia-responsive gene and suggest a critical role in the regulation of SAPK/JNK activity in the tumor microenvironment.	SRI Int, Div Pharmaceut Discovery, Menlo Park, CA 94025 USA; Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; Oregon Hlth Sci Univ, Dept Pathol, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	SRI International; Stanford University; Oregon Health & Science University; Oregon Health & Science University	Laderoute, KR (corresponding author), SRI Int, Div Pharmaceut Discovery, 333 Ravenswood Ave, Menlo Park, CA 94025 USA.			, Keith/0000-0002-5121-8072	NATIONAL CANCER INSTITUTE [R01CA020329, R37CA020329, R01CA073807, P01CA067166] Funding Source: NIH RePORTER; NCI NIH HHS [CA67166, CA20329, CA73807] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Anderson GR, 1995, J SURG RES, V59, P666, DOI 10.1006/jsre.1995.1221; AUSSERER WA, 1994, MOL CELL BIOL, V14, P5032, DOI 10.1128/MCB.14.8.5032; Beitner-Johnson D, 1998, J BIOL CHEM, V273, P19834, DOI 10.1074/jbc.273.31.19834; BENJAMIN IJ, 1990, P NATL ACAD SCI USA, V87, P6263, DOI 10.1073/pnas.87.16.6263; Bogoyevitch MA, 1996, CIRC RES, V79, P162, DOI 10.1161/01.RES.79.2.162; Bokemeyer D, 1996, J BIOL CHEM, V271, P639, DOI 10.1074/jbc.271.2.639; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Brown JM, 1998, CANCER RES, V58, P1408; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Bunn HF, 1998, J EXP BIOL, V201, P1197; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Chan ED, 1997, P NATL ACAD SCI USA, V94, P13169, DOI 10.1073/pnas.94.24.13169; CHARLES CH, 1993, P NATL ACAD SCI USA, V90, P5292, DOI 10.1073/pnas.90.11.5292; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Cook SJ, 1997, J BIOL CHEM, V272, P13309, DOI 10.1074/jbc.272.20.13309; Discher DJ, 1998, J BIOL CHEM, V273, P26087, DOI 10.1074/jbc.273.40.26087; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; Guo YL, 1998, J BIOL CHEM, V273, P10362, DOI 10.1074/jbc.273.17.10362; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hirsch DD, 1997, J BIOL CHEM, V272, P4568, DOI 10.1074/jbc.272.7.4568; Horiuchi M, 1997, J BIOL CHEM, V272, P19022, DOI 10.1074/jbc.272.30.19022; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Kimura H, 1996, CANCER RES, V56, P5522; KOONG AC, 1994, CANCER RES, V54, P1; KOROMA BM, 1995, J CELL BIOCHEM, V59, P123, DOI 10.1002/jcb.240590114; KWAK SP, 1994, J BIOL CHEM, V269, P3596; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Laderoute KR, 1996, INT J ONCOL, V8, P875; Laderoute KR, 1997, CIRC RES, V80, P336, DOI 10.1161/01.RES.80.3.336; LADEROUTE KR, 1992, INT J CANCER, V42, P1; Leav I, 1996, LAB INVEST, V75, P361; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; Loda M, 1996, AM J PATHOL, V149, P1553; Magi-Galluzzi C, 1998, VIRCHOWS ARCH, V432, P407, DOI 10.1007/s004280050184; MagiGalluzzi C, 1997, LAB INVEST, V76, P37; Mazure NM, 1996, CANCER RES, V56, P3436; Mazure NM, 1997, BLOOD, V90, P3322, DOI 10.1182/blood.V90.9.3322; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Mizukami Y, 1997, J BIOL CHEM, V272, P16657, DOI 10.1074/jbc.272.26.16657; Muda M, 1997, J BIOL CHEM, V272, P5141, DOI 10.1074/jbc.272.8.5141; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; Muller JN, 1997, J BIOL CHEM, V272, P23435, DOI 10.1074/jbc.272.37.23435; NOGUCHI T, 1993, MOL CELL BIOL, V13, P5195, DOI 10.1128/MCB.13.9.5195; POMBO CM, 1994, J BIOL CHEM, V269, P26546; Reynolds TY, 1996, CANCER RES, V56, P5754; RUPEC RA, 1995, EUR J BIOCHEM, V234, P632, DOI 10.1111/j.1432-1033.1995.632_b.x; SACHSENMAIER C, 1994, CELL, V78, P963, DOI 10.1016/0092-8674(94)90272-0; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Scimeca JC, 1997, ONCOGENE, V15, P717, DOI 10.1038/sj.onc.1201231; Stein B, 1997, J BIOL CHEM, V272, P19509, DOI 10.1074/jbc.272.31.19509; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; SUN H, 1994, SCIENCE, V266, P285, DOI 10.1126/science.7939666; Sutherland RM, 1996, SEMIN RADIAT ONCOL, V6, P59, DOI 10.1016/S1053-4296(96)80036-1; TONKS NK, 1996, INTRACELLULAR SIGNAL, P91; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; WANG GL, 1995, BIOCHEM BIOPH RES CO, V216, P669, DOI 10.1006/bbrc.1995.2674; WEBSTER KA, 1993, J BIOL CHEM, V268, P16852; Weinbrenner C, 1997, J MOL CELL CARDIOL, V29, P2383, DOI 10.1006/jmcc.1997.0473; Wenger RH, 1997, BIOL CHEM, V378, P609; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Woodgett JR, 1996, CANCER SURV, V27, P127; YANG DD, 1998, SCIENCE, V389, P865; Yin TG, 1997, J BIOL CHEM, V272, P19943, DOI 10.1074/jbc.272.32.19943	78	115	119	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12890	12897		10.1074/jbc.274.18.12890	http://dx.doi.org/10.1074/jbc.274.18.12890			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212278	hybrid			2022-12-27	WOS:000080056800098
J	Waldow, A; Schmidt, B; Dierks, T; von Bulow, R; von Figura, K				Waldow, A; Schmidt, B; Dierks, T; von Bulow, R; von Figura, K			Amino acid residues forming the active site of arylsulfatase A - Role in catalytic activity and substrate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN MODIFICATION; FORMYLGLYCINE; SULFATASE; GENE; CONVERSION; CYSTEINE; CLONING	Arylsulfatase A belongs to the sulfatase family whose members carry a C alpha-formylglycine that is post-translationally generated by oxidation of a conserved cysteine or serine residue. The formylglycine acts as an aldehyde hydrate with two geminal hydroxyls being involved in catalysis of sulfate ester cleavage. In arylsulfatase A and N-acetylgalactosamine 4-sulfatase this formylglycine was found to form the active site together with a divalent cation and a number of polar residues, tightly interconnected by a net of hydrogen bonds. Most of these putative active site residues are highly conserved among the eukaryotic and prokaryotic members of the sulfatase family. To analyze their function in binding and cleaving sulfate esters, we substituted a total of nine putative active site residues of human ASA by alanine (Asp(29), Asp(30), Asp(281), Asn(282), His(125), His(229), Lys(123), Lys(302), and Ser(150)). In addition the Mg2+-complexing residues (Asp(29), Asp(30), Asp(281), and Asn(282)) were substituted conservatively by either asparagine or aspartate, In all mutants V-max was decreased to 1-26% of wild type activity. The K-m was more than 10-fold increased in K123A and K302A and up to B-fold in the other mutants, In all mutants the pH optimum was increased from 4.5 by 0.2-0.8 units. These results indicate that each of the nine residues examined is critical for catalytic activity, Lys(123) and Lys(302) by binding the substrate and the others by direct (His(125) and Asp(281)) Or indirect participation in catalysis. The shift in the pH optimum is explained by two deprotonation steps that have been proposed for sulfate ester cleavage.	Univ Gottingen, Biochem Abt 2, Zentrum Biochem & Mol Zellbiol, D-37073 Gottingen, Germany	University of Gottingen	Schmidt, B (corresponding author), Univ Gottingen, Biochem Abt 2, Zentrum Biochem & Mol Zellbiol, Gosslerstr 12D, D-37073 Gottingen, Germany.	bschmidt@uni-bc2.gwdg.de	Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339				Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Haag ES, 1998, DEV GENES EVOL, V208, P188, DOI 10.1007/s004270050173; Kasper D, 1996, J CELL BIOL, V134, P615, DOI 10.1083/jcb.134.3.615; Knaust A, 1998, BIOCHEMISTRY-US, V37, P13941, DOI 10.1021/bi9810205; Kyte J., 1995, STRUCTURE PROTEIN CH; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Miech C, 1998, J BIOL CHEM, V273, P4835, DOI 10.1074/jbc.273.9.4835; Osteras M, 1998, P NATL ACAD SCI USA, V95, P11394, DOI 10.1073/pnas.95.19.11394; PAIETTA JV, 1989, MOL CELL BIOL, V9, P3630, DOI 10.1128/MCB.9.9.3630; Parenti G, 1997, CURR OPIN GENET DEV, V7, P386, DOI 10.1016/S0959-437X(97)80153-0; Recksiek R, 1998, J BIOL CHEM, V273, P6096, DOI 10.1074/jbc.273.11.6096; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Selmer T, 1996, EUR J BIOCHEM, V238, P341, DOI 10.1111/j.1432-1033.1996.0341z.x; STEIN C, 1989, J BIOL CHEM, V264, P1252; von Figura K, 1998, BIOESSAYS, V20, P505, DOI 10.1002/(SICI)1521-1878(199806)20:6<505::AID-BIES9>3.0.CO;2-K	17	57	65	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12284	12288		10.1074/jbc.274.18.12284	http://dx.doi.org/10.1074/jbc.274.18.12284			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212197	hybrid			2022-12-27	WOS:000080056800017
J	Wang, DH; Sun, LZ; Zborowska, E; Willson, JKV; Gong, JG; Verraraghavan, J; Brattain, MG				Wang, DH; Sun, LZ; Zborowska, E; Willson, JKV; Gong, JG; Verraraghavan, J; Brattain, MG			Control of type II transforming growth factor-beta receptor expression by integrin ligation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CARCINOMA-CELLS; BREAST-CANCER CELLS; MCF-7 CELLS; TGF-BETA; DIFFERENTIAL SENSITIVITY; DNA-SYNTHESIS; FET CELLS; ALPHA(5)BETA(1); ADENOCARCINOMA; PHENOTYPE	Ectopic expression of the alpha(5) integrin subunit in cancer cells with little or no endogenous expression of this integrin often results in reduced proliferation as well as reduced malignancy, We now show that inhibition resulting from ectopic expression of alpha(5) integrin is due to induction of autocrine negative transforming growth factor-beta (TGF-beta) activity. MCF-7 breast cancer cells do not express either alpha(5) integrin or type II TGF-beta receptor and hence are unable to generate TGF-beta signal transduction. Ectopic expression of cy,integrin expression enhanced cell adhesion to fibronectin, reduced proliferation, and increased the expression of type II TGF-beta receptor mRNA and cell surface protein. Receptor expression was increased to a higher level in alpha(5) transfectants by growth on fibronectin-coated plates. Induction of type II TGF-beta receptor expression also resulted in the generation of autocrine negative TGF-beta activity because colony formation was increased after TGF-beta neutralizing antibody treatment. Transient transfection with a TGF-beta promoter response element in tandem with a luciferase cDNA into cells stably transfected with cu, integrin resulted in basal promoter activities 5-10-fold higher than those of control cells. Moreover, when alpha(5) transfectants were treated with a neutralizing antibody to either TGF-beta or integrin alpha(5), this increased basal promoter activity was blocked, Autocrine TGF-beta activity also induced 3-fold higher endogenous fibronectin expression in alpha(5) transfectants relative to that of control cells, Re-expression of type II receptor by alpha(5) transfection also restored the ability of the cells to respond to exogenous TGF-beta and led to reduced tumor growth in athymic nude mice. Taken together, these results show for the first time that TGF-beta type II receptor expression can be controlled by alpha(5)beta(1) ligation and integrin signal transduction, Moreover, TGF-beta and integrin signal transduction appear to cooperate in their tumor-suppressive functions.	Univ Texas, Hlth Sci Ctr, Dept Surg, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA; Univ Kentucky, Dept Pharmacol, Lexington, KY 40536 USA; Case Western Reserve Univ, Ireland Canc Ctr, Dept Med, Cleveland, OH 44106 USA; Sch Med, Cleveland, OH 44106 USA; Med Coll Ohio, Dept Biochem, Toledo, OH 43699 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Kentucky; Case Western Reserve University	Brattain, MG (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Surg, 7703 Floyd Curl Dr, San Antonio, TX 78284 USA.		, LuZhe/AAW-4095-2021		NATIONAL CANCER INSTITUTE [R37CA038173, R01CA038173, R01CA072001, R01CA050457] Funding Source: NIH RePORTER; NCI NIH HHS [CA 72001, CA 50457, CA 38173] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ammanamanchi S, 1998, J BIOL CHEM, V273, P16527, DOI 10.1074/jbc.273.26.16527; ARTEAGA CL, 1990, CELL GROWTH DIFFER, V1, P367; Brattain MG, 1996, J MAMMARY GLAND BIOL, V1, P365, DOI 10.1007/BF02017392; CARMICHAEL J, 1987, CANCER RES, V47, P936; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; ELLIOTT B, 1992, J CELL PHYSIOL, V152, P292, DOI 10.1002/jcp.1041520210; FENG XH, 1995, J BIOL CHEM, V270, P24237, DOI 10.1074/jbc.270.41.24237; GEISER AG, 1992, J BIOL CHEM, V267, P2588; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; GIANCOTTI FG, 1994, BBA-REV CANCER, V1198, P47, DOI 10.1016/0304-419X(94)90005-1; Gong JG, 1998, J BIOL CHEM, V273, P1662, DOI 10.1074/jbc.273.3.1662; Guilherme A, 1998, J BIOL CHEM, V273, P22899, DOI 10.1074/jbc.273.36.22899; HOOSEIN NM, 1989, EXP CELL RES, V181, P442, DOI 10.1016/0014-4827(89)90101-8; Jones Peter Lloyd, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P137; KALKHOVEN E, 1995, CELL GROWTH DIFFER, V6, P1151; Ko Y, 1998, J CELL PHYSIOL, V176, P424, DOI 10.1002/(SICI)1097-4652(199808)176:2<424::AID-JCP21>3.3.CO;2-N; KORETZ K, 1991, AM J PATHOL, V138, P741; Lee M, 1997, AM J PHYSIOL-LUNG C, V273, pL374, DOI 10.1152/ajplung.1997.273.2.L374; MANNING AM, 1991, ONCOGENE, V6, P1471; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; MULDER KM, 1989, MOL ENDOCRINOL, V3, P1215, DOI 10.1210/mend-3-8-1215; NATALI PG, 1992, BRIT J CANCER, V66, P318, DOI 10.1038/bjc.1992.263; ROBERTS AB, 1985, P NATL ACAD SCI USA, V82, P119, DOI 10.1073/pnas.82.1.119; RUFF E, 1986, BIOCHEM BIOPH RES CO, V138, P714, DOI 10.1016/S0006-291X(86)80555-1; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; SCHWARTZ MA, 1993, CANCER RES, V53, P1503; SEGARINI PR, 1987, J BIOL CHEM, V262, P14655; SUN LZ, 1994, J BIOL CHEM, V269, P26449; SYMINGTON BE, 1992, J BIOL CHEM, V267, P25744; SYMINGTON BE, 1990, CELL REGUL, V1, P637, DOI 10.1091/mbc.1.9.637; WANG DH, 1995, J BIOL CHEM, V270, P14154, DOI 10.1074/jbc.270.23.14154; WANG DH, 1995, J CELL PHYSIOL, V164, P499, DOI 10.1002/jcp.1041640308; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; WEINEL RJ, 1992, INT J CANCER, V52, P827, DOI 10.1002/ijc.2910520526; WESTERGRENTHORSSON G, 1991, J CELL PHYSIOL, V147, P523, DOI 10.1002/jcp.1041470319; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wu GF, 1998, J BIOL CHEM, V273, P7749, DOI 10.1074/jbc.273.13.7749; WU SP, 1993, CELL GROWTH DIFFER, V4, P115; WU SP, 1992, J CELL BIOL, V116, P187, DOI 10.1083/jcb.116.1.187; ZUTTER MM, 1993, AM J PATHOL, V142, P1439; ZUTTER MM, 1990, AM J PATHOL, V137, P863	43	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12840	12847		10.1074/jbc.274.18.12840	http://dx.doi.org/10.1074/jbc.274.18.12840			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212271	hybrid			2022-12-27	WOS:000080056800091
J	Lai, MC; Teh, BH; Tarn, WY				Lai, MC; Teh, BH; Tarn, WY			A human papillomavirus E2 transcriptional activator - The interactions with cellular splicing factors and potential function in pre-mRNA processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CARBOXY-TERMINAL DOMAIN; MESSENGER-RNA; SR PROTEINS; CONSERVED FAMILY; GENE; CTD; PHOSPHORYLATION; LOCALIZATION; COACTIVATOR	The human papillomavirus (HPV) E2 protein plays an important role in transcriptional regulation of viral genes as well as in viral DNA replication. Unlike most types of HPV, the E2 protein of epidermodysplasia verruciformis (EV)-associated HPVs harbors a relatively long hinged region between the terminal, conserved transactivation and DNA binding/dimerization domains. The sequence of EV-HPV E2 hinge contains multiple arginine/serine (RS) dipeptide repeats which are characteristic of a family of pre-messenger RNA splicing factors, called SR proteins. Here we show that the HPV-5 (an EV-HPV) E2 protein can specifically interact with cellular splicing factors including a set of prototypical SR proteins and two snRNP-associated proteins. Transiently expressed HPV-5 E2 protein colocalizes with a nuclear matrix associated-splicing coactivator in nuclear speckled domains. The RS-rich hinge is essential for E2 transactivator interaction with splicing factors and for its subnuclear localization. Moreover, we present functional evidence for the HPV-B E2 transactivator, which shows that the RS-rich hinge domain of the E2 protein can facilitate the splicing of precursor messenger RNA made via transactivation by E2 itself. Our results, therefore, suggest that a DNA binding transactivator containing an RS-rich sequence can play a dual role in gene expression.	Acad Sinica, Inst Biomed Sci, Taipei 11526, Taiwan	Academia Sinica - Taiwan	Tarn, WY (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 11526, Taiwan.				NHLBI NIH HHS [DOH88-HR-812] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARKSDALE SK, 1995, J VIROL, V69, P6553, DOI 10.1128/JVI.69.10.6553-6556.1995; BLENCOWE BJ, 1994, J CELL BIOL, V127, P593, DOI 10.1083/jcb.127.3.593; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; BRIDGE E, 1995, J VIROL, V69, P281, DOI 10.1128/JVI.69.1.281-290.1995; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; Corden JL, 1997, TRENDS BIOCHEM SCI, V22, P413, DOI 10.1016/S0968-0004(97)01125-0; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Du L, 1997, J CELL BIOL, V136, P5, DOI 10.1083/jcb.136.1.5; Fetzer S, 1997, RNA, V3, P344; FORTES P, 1995, J GEN VIROL, V76, P1001, DOI 10.1099/0022-1317-76-4-1001; FU XD, 1995, RNA, V1, P663; FUCHS PG, 1994, INTERVIROLOGY, V37, P159, DOI 10.1159/000150374; HAM J, 1991, TRENDS BIOCHEM SCI, V16, P440, DOI 10.1016/0968-0004(91)90172-R; Harlow E., 1988, ANTIBODIES LAB MANUA; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; HOWLEY PM, 1990, VIROLOGY, P1625; KILEDJIAN M, 1994, RNA PROTEIN INTERACT, P127; Kim E, 1997, J CELL BIOL, V136, P19, DOI 10.1083/jcb.136.1.19; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; LEE CG, 1993, J BIOL CHEM, V268, P13472; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; NEUGEBAUER KM, 1995, J CELL BIOL, V129, P899, DOI 10.1083/jcb.129.4.899; Neugebauer KM, 1997, GENE DEV, V11, P3279, DOI 10.1101/gad.11.24.3279; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002; Pfister H, 1992, Semin Cancer Biol, V3, P263; PHELAN A, 1993, P NATL ACAD SCI USA, V90, P9056, DOI 10.1073/pnas.90.19.9056; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; ROTH MB, 1991, J CELL BIOL, V115, P587, DOI 10.1083/jcb.115.3.587; Schoneich J, 1997, J IMMUNOL, V158, P4788; SHUMAN S, 1997, P NATL ACAD SCI USA, V94, P12898; Singer RH, 1997, CELL, V91, P291, DOI 10.1016/S0092-8674(00)80411-0; Skiadopoulos MH, 1996, J VIROL, V70, P1117, DOI 10.1128/JVI.70.2.1117-1124.1996; SOLNICK D, 1985, CELL, V42, P157, DOI 10.1016/S0092-8674(85)80111-2; Steinmetz EJ, 1997, CELL, V89, P491, DOI 10.1016/S0092-8674(00)80230-5; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Tanner S, 1997, BIOL CHEM, V378, P565; TARN WY, 1995, RNA, V1, P644; Teigelkamp S, 1997, RNA, V3, P1313; USHIKAI M, 1994, J VIROL, V68, P6655, DOI 10.1128/JVI.68.10.6655-6666.1994; Valcarcel J, 1996, TRENDS BIOCHEM SCI, V21, P296, DOI 10.1016/0968-0004(96)10039-6; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A; Zheng ZM, 1997, J VIROL, V71, P9096, DOI 10.1128/JVI.71.12.9096-9107.1997	53	83	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11832	11841		10.1074/jbc.274.17.11832	http://dx.doi.org/10.1074/jbc.274.17.11832			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207001	hybrid			2022-12-27	WOS:000079834800057
J	McPhee, I; Yarwood, SJ; Scotland, G; Huston, E; Beard, MB; Ross, AH; Houslay, ES; Houslay, MD				McPhee, I; Yarwood, SJ; Scotland, G; Huston, E; Beard, MB; Ross, AH; Houslay, ES; Houslay, MD			Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B - Consequences for rolipram inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMP-SPECIFIC PHOSPHODIESTERASE; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; TERMINAL SPLICE REGION; MEMBRANE ASSOCIATION; MOLECULAR-CLONING; PROTEIN-KINASE; CHIMERIC CONSTRUCTS; RPDE-6 RNPDE4A5; SH3 DOMAIN; COS7 CELLS	The cAMP-specific phosphodiesterase (PDE) HSPDE 4A4B(pde46) selectively bound SH3 domains of SRC family tyrosyl kinases. Such an interaction profoundly changed the inhibition of PDE4 activity caused by the PDE4-selective inhibitor rolipram and mimicked the enhanced rolipram inhibition seen for particulate, compared with cytosolic pde46 expressed in COS7 cells. Particulate pde46 co-localized with LYN kinase in COS7 cells. The unique N-terminal and LR2 regions of pde46 contained the sites for SH3 binding. Altered rolipram inhibition was triggered by SH3 domain interaction with the LR2 region. Purified LYN SH3 and human PDE4A LR2 could be co immunoprecipitated, indicating a direct interaction. Protein kinase A-phosphorylated pde46 remained able to bind LYN SH3, pde46 was found to be associated with SRC kinase in the cytosol of COS1 cells, leading to aberrant kinetics of rolipram inhibition. It is suggested that pde46 may be associated with SRC family tyrosyl kinases in intact cells and that the ensuing SH3 domain interaction with the LR2 region of pde46 alters the conformation of the PDE catalytic unit, as detected by altered rolipram inhibition. Interaction between pde46 and SRC family tyrosyl kinases highlights a potentially novel regulatory system and point of signaling system cross-talk.	Univ Glasgow, IBLS, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Houslay, MD (corresponding author), Univ Glasgow, IBLS, Div Biochem & Mol Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	M.Kouslay@bio.gla.ac.uk	Houslay, Miles/AAM-5281-2020; Houslay, Miles D/A-6825-2011	Houslay, Miles/0000-0002-3826-8091; Yarwood, Stephen/0000-0001-9489-9253				ALVAREZ R, 1995, MOL PHARMACOL, V48, P616; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Atienza JM, 1999, J BIOL CHEM, V274, P4839, DOI 10.1074/jbc.274.8.4839; Barnette MS, 1998, J PHARMACOL EXP THER, V284, P420; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; BOLGER G, 1993, MOL CELL BIOL, V13, P6558, DOI 10.1128/MCB.13.10.6558; Bolger GB, 1997, BIOCHEM J, V328, P539; BOLGER GB, 1994, CELL SIGNAL, V6, P851, DOI 10.1016/0898-6568(94)90018-3; Bolger GB, 1996, J BIOL CHEM, V271, P1065, DOI 10.1074/jbc.271.2.1065; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; CONTI M, 1995, ENDOCR REV, V16, P370, DOI 10.1210/er.16.3.370; ERPEL T, 1995, CURR OPIN CELL BIOL, V7, P176, DOI 10.1016/0955-0674(95)80025-5; Faux MC, 1996, TRENDS BIOCHEM SCI, V21, P312, DOI 10.1016/0968-0004(96)10040-2; Giembycz MA, 1996, TRENDS PHARMACOL SCI, V17, P331, DOI 10.1016/0165-6147(96)10039-0; HERRERAVELIT PRN, J IMMUNOL, V156, P1157; Hoffmann R, 1998, BIOCHEM J, V333, P139, DOI 10.1042/bj3330139; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Houslay MD, 1998, ADV PHARMACOL, V44, P225, DOI 10.1016/S1054-3589(08)60128-3; Huston E, 1997, BIOCHEM J, V328, P549, DOI 10.1042/bj3280549; Huston E, 1996, J BIOL CHEM, V271, P31334, DOI 10.1074/jbc.271.49.31334; Jacobitz S, 1996, MOL PHARMACOL, V50, P891; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARCHMONT RJ, 1980, BIOCHEM J, V187, P381, DOI 10.1042/bj1870381; MCPHEE I, 1995, BIOCHEM J, V310, P965, DOI 10.1042/bj3100965; OConnell JC, 1996, BIOCHEM J, V318, P255, DOI 10.1042/bj3180255; Owens RJ, 1997, CELL SIGNAL, V9, P575, DOI 10.1016/S0898-6568(97)00072-7; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PILLAI R, 1994, J BIOL CHEM, V269, P30676; PILLAI R, 1993, P NATL ACAD SCI USA, V90, P11970, DOI 10.1073/pnas.90.24.11970; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; SCHUDT C, 1995, EUR RESPIR J, V8, P1179, DOI 10.1183/09031936.95.08071179; SCOTLAND G, 1995, BIOCHEM J, V308, P673, DOI 10.1042/bj3080673; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; SETTE C, 1994, J BIOL CHEM, V269, P9245; SHAKUR Y, 1993, BIOCHEM J, V292, P677, DOI 10.1042/bj2920677; SHAKUR Y, 1995, BIOCHEM J, V306, P801, DOI 10.1042/bj3060801; Smith KJ, 1996, J BIOL CHEM, V271, P16703, DOI 10.1074/jbc.271.28.16703; SOUNESS JE, 1991, BIOCHEM PHARMACOL, V42, P937, DOI 10.1016/0006-2952(91)90056-B; Souness JE, 1997, CELL SIGNAL, V9, P227, DOI 10.1016/S0898-6568(96)00173-8; SOUNESS JE, 1993, BIOCHEM J, V291, P389, DOI 10.1042/bj2910389; SULLIVAN M, 1994, CELL SIGNAL, V6, P793, DOI 10.1016/0898-6568(94)00039-5; Sullivan M, 1998, BIOCHEM J, V333, P693, DOI 10.1042/bj3330693; THOMPSON WJ, 1971, BIOCHEMISTRY-US, V10, P311; TORPHY TJ, 1993, AGENT ACTION SUPPL, V43, P51; TORPHY TJ, 1992, J BIOL CHEM, V267, P1798; TORPHY TJ, 1994, ENVIRON HEALTH PERSP, V102, P79, DOI 10.2307/3432220; WILSON M, 1994, BIOCHEM J, V304, P407, DOI 10.1042/bj3040407; YI TL, 1991, MOL CELL BIOL, V11, P2391, DOI 10.1128/MCB.11.5.2391	51	99	103	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11796	11810		10.1074/jbc.274.17.11796	http://dx.doi.org/10.1074/jbc.274.17.11796			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206997	hybrid			2022-12-27	WOS:000079834800053
J	Rajavashisth, TB; Liao, JK; Galis, ZS; Tripathi, S; Laufs, U; Tripathi, J; Chai, NN; Xu, XP; Jovinge, S; Shah, PK; Libby, P				Rajavashisth, TB; Liao, JK; Galis, ZS; Tripathi, S; Laufs, U; Tripathi, J; Chai, NN; Xu, XP; Jovinge, S; Shah, PK; Libby, P			Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE CELLS; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; GENE-EXPRESSION; CDNA LIBRARY; MT-MMPS; ACTIVATION; INTERLEUKIN-1; MT1-MMP	We investigated whether inflammatory cytokines or oxidized low density lipoproteins (Ox-LDL) present in human atheroma modulate extracellular matrix degradation by inducing membrane type 1-matrix metalloproteinase (MT1-MMP) expression. Cultured human endothelial cells (EC) constitutively expressed MT1-MMP mRNA and protein with enzymatic activity, Tumor necrosis factor-alpha (TNF-alpha), interleukin-1 alpha, or interleukin-1 beta caused a time dependent increase in the steady-state MT1-MMP mRNA levels within 4 h of exposure, peaking about 4-fold by 6 h, and remaining elevated for 12 h, Increased MT1-MMP mRNA correlated with a 2.5-fold increase in MT1-MMP protein in EC membranes. Ox-LDL also increased MT1-MMP mRNA levels that varied with the duration of exposure and degree of LDL oxidation, The increase in MT1-MMP mRNA occurred within 6 h of exposure to Ox-LDL and peaked over 3 fold by 6 h, Ox-LDL, but not native LDL, increased MT1-MMP protein by a-fold in EC membranes. A combination of TNF-alpha and Ox-LDL was additive in increasing MT1-MMP expression. Nuclear run-on assays showed that TNF-alpha or Ox-LDL augmented steady-state mRNA levels by increased transcription of the MT1-MMP gene. These findings indicate that activation of EC by inflammatory cytokines and/or Ox-LDL increase MT1-MMP expression. Since MT1-MMP promotes matrix degradation by activating pro-MMP-2, these results suggest a novel mechanism whereby cytokines or Ox-LDL may influence extracellular matrix remodeling.	Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Atherosclerosis Res Ctr, Los Angeles, CA 90048 USA; Harbor UCLA Med Ctr, Torrance, CA 90502 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Vasc Med & Atherosclerosis Unit, Boston, MA 02115 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Rajavashisth, TB (corresponding author), Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Atherosclerosis Res Ctr, Los Angeles, CA 90048 USA.	rajavashisth@cshs.org	Libby, Peter/AAY-6404-2021; Rajavashisth, Tripathi/ABB-6379-2020	Libby, Peter/0000-0002-1502-502X; 	NHLBI NIH HHS [HL51980, HL58555, HL52233] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052233, R01HL058555, R29HL051980, R01HL051980] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; BERLINER JA, 1990, J CLIN INVEST, V85, P1260, DOI 10.1172/JCI114562; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; HANEMAAIJER R, 1993, BIOCHEM J, V296, P803, DOI 10.1042/bj2960803; Harlow E., 1988, ANTIBODIES LAB MANUA; HENNEY AM, 1991, P NATL ACAD SCI USA, V88, P8154, DOI 10.1073/pnas.88.18.8154; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Imai K, 1996, CANCER RES, V56, P2707; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Knauper V, 1997, EUR J BIOCHEM, V248, P369, DOI 10.1111/j.1432-1033.1997.00369.x; Kolodgie FD, 1998, J AM COLL CARDIOL, V31, p419A, DOI 10.1016/S0735-1097(97)85524-6; LIAO JK, 1992, CIRC RES, V70, P1018, DOI 10.1161/01.RES.70.5.1018; LIBBY P, 1986, AM J PATHOL, V124, P179; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; LIBBY P, 1996, ATHEROSCLEROSIS CORO, V1, P585; Lichte A, 1996, FEBS LETT, V397, P277, DOI 10.1016/S0014-5793(96)01206-9; Lin CY, 1997, J BIOL CHEM, V272, P9147; MARZLUFF WF, 1985, TRANSCRIPTION TRANSL, P89; NAVAB M, 1988, J CLIN INVEST, V82, P1853, DOI 10.1172/JCI113802; PENG HB, 1995, J BIOL CHEM, V270, P17050, DOI 10.1074/jbc.270.28.17050; RAJAVASHISTH TB, 1987, P NATL ACAD SCI USA, V84, P1157, DOI 10.1073/pnas.84.5.1157; RAJAVASHISTH TB, 1997, ENCY HUMAN BIOL, V1, P565; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sang Q X, 1998, Cell Res, V8, P171; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Shofuda K, 1997, J BIOL CHEM, V272, P9749; Springer TA., 1996, ATHEROSCLEROSIS CORO, VVol 1, P511; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; TAKINO T, 1995, J BIOL CHEM, V270, P23013, DOI 10.1074/jbc.270.39.23013; Tanaka M, 1997, FEBS LETT, V402, P219, DOI 10.1016/S0014-5793(96)01537-2; TIPPING PG, 1993, AM J PATHOL, V142, P1721; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; ZEMPO N, 1994, J VASC SURG, V20, P209, DOI 10.1016/0741-5214(94)90008-6	44	163	170	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11924	11929		10.1074/jbc.274.17.11924	http://dx.doi.org/10.1074/jbc.274.17.11924			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207013	hybrid			2022-12-27	WOS:000079834800069
J	Vishnivetskiy, SK; Paz, CL; Schubert, C; Hirsch, JA; Sigler, PB; Gurevich, VV				Vishnivetskiy, SK; Paz, CL; Schubert, C; Hirsch, JA; Sigler, PB; Gurevich, VV			How does arrestin respond to the phosphorylated state of rhodopsin?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENTS; VISUAL ARRESTIN; 48-KDA PROTEIN; PHOTOEXCITED RHODOPSIN; BINDING; RECOGNITION; SELECTIVITY; ACTIVATION; ROLES	Visual arrestin quenches light-induced signaling by binding to light-activated, phosphorylated rhodopsin (P-Rh*). Here are present structure-function data, which in conjunction with the refined crystal structure of arrestin (Hirsch, J. A., Schubert, C., Gurevich, V. V., and Sigler, P.B. (1999) Cell, in press), support a model for the conversion of a basal or "inactive" conformation of free arrestin to one that can bind to and inhibit the light activated receptor. The trigger for this transition is an interaction of the phosphorylated COOH-terminal segment of the receptor with arrestin that disrupts intramolecular interactions, including a hydrogen-bonded network of buried, charged side chains, referred to as the "polar core." This disruption permits structural adjustments that allow arrestin to bind to the receptor. Our mutational survey identifies residues in arrestin (Arg(175), Asp(30), Asp(296), ASp(303), Arg(382)), which when altered bypass the need for the interaction with the receptor's phosphopeptide, enabling arrestin to bind to activated, nonphosphorylated rhodopsin (Rh*), These mutational changes disrupt interactions and substructures which the crystallographic model and previous biochemical studies have shown are responsible for maintaining the inactive state, The molecular basis for these disruptions was confirmed by successfully introducing structure-based second site substitutions that restored the critical interactions. The nearly absolute conservation of the mutagenically sensitive residues throughout the arrestin family suggests that this mechanism is likely to be applicable to arrestin-mediated desensitization of most G-protein-coupled receptors.	Sun Hlth Res Inst, Ralph & Muriel Roberts Lab Vis Sci, Sun City, AZ 85372 USA; Yale Univ, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA	Banner Research; Banner Health; Banner Sun Health Research Institute; Howard Hughes Medical Institute; Yale University	Gurevich, VV (corresponding author), Sun Hlth Res Inst, Ralph & Muriel Roberts Lab Vis Sci, 10515 W Santa Fe Dr, Sun City, AZ 85372 USA.		Hirsch, Joel/AAC-8000-2021; Gurevich, Vsevolod/A-3236-2008	Hirsch, Joel/0000-0001-7544-8668; Gurevich, Vsevolod/0000-0002-3950-5351	NEI NIH HHS [EY11500] Funding Source: Medline; NIGMS NIH HHS [GM22324] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022324] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNETT N, 1988, BIOCHEMISTRY-US, V27, P1710, DOI 10.1021/bi00405a049; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; GrayKeller MP, 1997, BIOCHEMISTRY-US, V36, P7058, DOI 10.1021/bi963110k; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; HIRSCH JA, 1999, IN PRESS CELL; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; OHGURO H, 1994, PROTEIN SCI, V3, P2428, DOI 10.1002/pro.5560031226; PALCZEWSKI K, 1989, J BIOL CHEM, V264, P15770; SCHERTLER GFX, 1995, P NATL ACAD SCI USA, V92, P11578, DOI 10.1073/pnas.92.25.11578; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; SHINOHARA T, 1987, P NATL ACAD SCI USA, V84, P6975, DOI 10.1073/pnas.84.20.6975; Smith WC, 1999, BIOCHEMISTRY-US, V38, P2752, DOI 10.1021/bi982643l; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174	20	141	145	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11451	11454		10.1074/jbc.274.17.11451	http://dx.doi.org/10.1074/jbc.274.17.11451			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206946	hybrid			2022-12-27	WOS:000079834800002
J	Basar, T; Havlicek, V; Bezouskova, S; Halada, P; Hackett, M; Sebo, P				Basar, T; Havlicek, V; Bezouskova, S; Halada, P; Hackett, M; Sebo, P			The conserved lysine 860 in the additional fatty-acylation site of Bordetella pertussis adenylate cyclase is crucial for toxin function independently of its acylation status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HEMOLYSIN; CELL-INVASIVE ACTIVITY; MASS-SPECTROMETRY; ACTIVATION; PROTEIN; HLYA; PENETRATION; EXPRESSION; RESOLUTION; INFECTION	The Bordetella pertussis RTX (repeat in toxin family protein) adenylate cyclase toxin-hemolysin (ACT) acquires biological activity upon a single amide-linked palmitoylation of the E-amino group of lysine 983 (Lys(983)) by the accessory fatty-acyltransferase CyaC. However, an additional conserved RTX acylation site can be identified in ACT at lysine 860 (Lys(860)), and this residue becomes palmitoylated when recombinant ACT (r-Ec-ACT) is produced together with CyaC in Escherichia coli K12. We have eliminated this additional acylation site by replacing Lys(860) Of ACT with arginine, leucine, and cysteine residues. Two-dimensional gel electrophoresis and microcapillary high performance liquid chromatography/tandem mass spectrometric analyses of mutant proteins confirmed that the two sites are acylated independently in vivo and that mutations of Lys860 did not affect the quantitative acylation of Lys983 by palmitoyl (C16:0) and palmitoleil (cis Delta 9 C16:1) fatty-acyl groups. Nevertheless, even the most conservative substitution of lysine 860 by an arginine residue caused a 10-fold decrease of toxin activity. This resulted from a B-fold reduction of cell association capacity and a further 2-fold reduction in cell penetration efficiency of the membrane-bound K860R toxin, These results suggest that lysine 860 plays by itself a crucial structural role in membrane insertion and translocation of the toxin, independently of its acylation status.	Acad Sci Czech Republ, Inst Microbiol, CZ-14220 Prague 4, Czech Republic; Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Washington; University of Washington Seattle	Sebo, P (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Videnska 1083, CZ-14220 Prague 4, Czech Republic.		Basar, Tamer/V-6613-2019; Halada, Petr/H-3330-2014; SEBO, Peter/N-2043-2019; SEBO, Peter/F-7423-2011; Havlicek, Vladimir/H-2626-2014	Halada, Petr/0000-0002-7229-3450; SEBO, Peter/0000-0002-9755-7715; SEBO, Peter/0000-0002-9755-7715; Havlicek, Vladimir/0000-0002-8614-7059	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046440] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK46440-06] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARRY EM, 1991, J BACTERIOL, V173, P720, DOI 10.1128/jb.173.2.720-726.1991; Beaver W.L., 1991, CLIN J SPORT MED, V1, P27; BELLALOU J, 1990, INFECT IMMUN, V58, P3242, DOI 10.1128/IAI.58.10.3242-3247.1990; BENZ R, 1994, J BIOL CHEM, V269, P27231; BETSOU F, 1995, INFECT IMMUN, V63, P3309, DOI 10.1128/IAI.63.9.3309-3315.1995; BETSOU F, 1993, INFECT IMMUN, V61, P3583, DOI 10.1128/IAI.61.9.3583-3589.1993; BIEMANN K, 1992, ANNU REV BIOCHEM, V61, P977, DOI 10.1146/annurev.bi.61.070192.004553; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; Ducret A, 1998, PROTEIN SCI, V7, P706, DOI 10.1002/pro.5560070320; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GLASER P, 1988, MOL MICROBIOL, V2, P19, DOI 10.1111/j.1365-2958.1988.tb00003.x; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; GORDON VM, 1989, J BIOL CHEM, V264, P14792; Gray M, 1998, J BIOL CHEM, V273, P18260, DOI 10.1074/jbc.273.29.18260; GuzmanVerri C, 1997, J BACTERIOL, V179, P5959, DOI 10.1128/jb.179.18.5959-5962.1997; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; HACKETT M, 1995, J BIOL CHEM, V270, P20250, DOI 10.1074/jbc.270.35.20250; HANSKI E, 1989, TRENDS BIOCHEM SCI, V14, P459, DOI 10.1016/0968-0004(89)90106-0; HANSKI E, 1985, J BIOL CHEM, V260, P5526; Hanski E, 1991, SOURCEBOOK BACTERIAL, P349; HEWLETT EL, 1983, CLIN RES, V31, pA365; HEWLETT EL, 1991, J BIOL CHEM, V266, P17503; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; IWAKI M, 1995, MOL MICROBIOL, V17, P1015, DOI 10.1111/j.1365-2958.1995.mmi_17061015.x; KHELEF N, 1992, MICROB PATHOGENESIS, V12, P227, DOI 10.1016/0882-4010(92)90057-U; KHELEF N, 1995, FEMS MICROBIOL LETT, V134, P27, DOI 10.1016/0378-1097(95)00375-F; LEPAGE G, 1986, J LIPID RES, V27, P114; Ludwig A, 1996, J BACTERIOL, V178, P5422, DOI 10.1128/jb.178.18.5422-5430.1996; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Pellett S, 1996, INFECT IMMUN, V64, P3081, DOI 10.1128/IAI.64.8.3081-3087.1996; ROGEL A, 1992, J BIOL CHEM, V267, P22599; ROSE T, 1995, J BIOL CHEM, V270, P26370, DOI 10.1074/jbc.270.44.26370; SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598; Sambrook J., 2002, MOL CLONING LAB MANU; SEBO P, 1991, GENE, V104, P19, DOI 10.1016/0378-1119(91)90459-O; STANLEY P, 1994, SCIENCE, V266, P1992, DOI 10.1126/science.7801126; SZABO G, 1994, J BIOL CHEM, V269, P22496; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Wang HL, 1998, ANAL CHEM, V70, P205, DOI 10.1021/ac971036l; Wang HL, 1997, ANAL BIOCHEM, V250, P162, DOI 10.1006/abio.1997.2214; WEISS AA, 1986, ANNU REV MICROBIOL, V40, P661, DOI 10.1146/annurev.micro.40.1.661; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; WOLFF J, 1980, P NATL ACAD SCI-BIOL, V77, P3841, DOI 10.1073/pnas.77.7.3841	43	53	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10777	10783		10.1074/jbc.274.16.10777	http://dx.doi.org/10.1074/jbc.274.16.10777			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196151	hybrid			2022-12-27	WOS:000079751900019
J	DeGraff, JL; Gagnon, AW; Benovic, JL; Orsini, MJ				DeGraff, JL; Gagnon, AW; Benovic, JL; Orsini, MJ			Role of arrestins in endocytosis and signaling of alpha(2)-adrenergic receptor subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; EPIDERMAL GROWTH-FACTOR; BETA-ARRESTIN; ALPHA-2-ADRENERGIC RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; OPIOID RECEPTOR; KINASE PATHWAY; ACTIVATION; DESENSITIZATION	We investigated the role of arrestins in the trafficking of human alpha(2)-adrenergic receptors (alpha(2)-ARs) and the effect of receptor trafficking on p42/p44 RAP kinase activation. alpha(2)-ARs expressed in COS-1 cells demonstrated a modest level of agonist-mediated internalization, with alpha(2c) > alpha(2b) > alpha(2a). However, upon coexpression of arrestin-2 (beta-arrestin-1) or arrestin-3 (beta-arrestin-2), internalization of the alpha(2b) AR was dramatically enhanced and redistribution of receptors to clathrin coated vesicles and endosomes was observed. Internalization of the alpha 2c AR was selectively promoted by coexpression of arrestin-3, while alpha 2a AR internalization was only slightly stimulated by coexpression of either arrestin. Coexpression of GRK2 had no effect on the internalization of any alpha 2-AR subtype, either in the presence or absence of arrestins. Internalization of the alpha 2b and alpha 2c ARs was inhibited by coexpression of dominant negative dynamin-K44A However, alpha 2-AR-mediated activation of either endogenous or cotransfected p42/p44 mitogen-activated protein (IMAP) kinase was not affected by either dynamin-K44A or arrestin-3. Moreover, activation of p42/ p44 MAP kinase by endogenous epidermal growth factor, lysophosphatidic acid, and beta(2)-adrenergic receptors was also unaltered by dynamin-K44A. In summary, our data suggest that internalization of the alpha(2b), alpha(2c), and to a lesser extent alpha(2a) ARs, is both arrestin- and dynamin de pendent. However, endocytosis does not appear to be required for alpha(2)-adrenergic, epidermal growth factor, lysophosphatidic acid, or beta(2)-adrenergic receptor-mediated p42/p44 MAP kinase activation in COS-1 cells.	Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University	Benovic, JL (corresponding author), Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, 233 S 10th St, Philadelphia, PA 19107 USA.	benovic@lac.jci.tju.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007705] Funding Source: NIH RePORTER; NIAID NIH HHS [5-T32-AI07523] Funding Source: Medline; NIDDK NIH HHS [5-T32-DK07705] Funding Source: Medline; NIGMS NIH HHS [GM47419] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBLAS J, 1993, J BIOL CHEM, V268, P22235; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; BYLUND DB, 1992, FASEB J, V6, P832, DOI 10.1096/fasebj.6.3.1346768; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; EASON MG, 1992, J BIOL CHEM, V267, P25473; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; JewellMotz EA, 1996, J BIOL CHEM, V271, P18082, DOI 10.1074/jbc.271.30.18082; JEWELLMOTZ EA, 1995, BIOCHEMISTRY-US, V34, P11946, DOI 10.1021/bi00037a036; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; KUROSE H, 1994, J BIOL CHEM, V269, P10093; LAMAZE C, 1993, MOL BIOL CELL, V4, P715, DOI 10.1091/mbc.4.7.715; LAMAZE C, 1995, J CELL BIOL, V129, P47, DOI 10.1083/jcb.129.1.47; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LI JG, 1999, IN PRESS J BIOL CHEM, V274; LOMASNEY JW, 1990, P NATL ACAD SCI USA, V87, P5094, DOI 10.1073/pnas.87.13.5094; Luttrell LM, 1997, J BIOL CHEM, V272, P31648, DOI 10.1074/jbc.272.50.31648; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Murray SR, 1998, J BIOL CHEM, V273, P24987, DOI 10.1074/jbc.273.39.24987; Nakamura K, 1998, J BIOL CHEM, V273, P24346, DOI 10.1074/jbc.273.38.24346; Polakiewicz RD, 1998, J BIOL CHEM, V273, P12402, DOI 10.1074/jbc.273.20.12402; Rao AW, 1998, J BIOL CHEM, V273, P25450, DOI 10.1074/jbc.273.39.25450; REGAN JW, 1988, P NATL ACAD SCI USA, V85, P6301, DOI 10.1073/pnas.85.17.6301; VONZASTROW M, 1993, J BIOL CHEM, V268, P763; Wozniak M, 1996, J BIOL CHEM, V271, P5017; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	39	117	118	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11253	11259		10.1074/jbc.274.16.11253	http://dx.doi.org/10.1074/jbc.274.16.11253			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196213	hybrid			2022-12-27	WOS:000079751900081
J	Iida, SI; Yamamoto, K; Irimura, T				Iida, SI; Yamamoto, K; Irimura, T			Interaction of human macrophage C-type lectin with O-linked N-acetylgalactosamine residues on mucin glycopeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAINS; SURFACE-PLASMON RESONANCE; HELICAL COILED-COIL; ASIALOGLYCOPROTEIN RECEPTOR; MOLECULAR-CLONING; ANIMAL LECTINS; BINDING; EXPRESSION; AFFINITY; CDNA	A fluorescein-labeled synthetic peptide, PTTTPITTTT-TK, was converted into O-glycosylated glycopeptides with various numbers of attached N-acetyl-D-galactosamines (GalNAcs) by in vitro glycosylation with UDP-Gal-NAc and a microsomal fraction of LS174T human colon carcinoma cells, Glycopeptides with 1, 3, 5, and 6 GalNAc residues (G1, G3, G5, and G6) were obtained, and their sizes were confirmed by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, Their sequences were determined by a peptide sequencer to be PTTTGalNAcPITTTTK for G1, PTGalNAcTTPITGalNAc TGalNAcTTK for G3, PTTGalNAcTGalNAcPITGalNAcTGalNAc- TGalNAcTK for G5, and PTGalNAcTGalNAcTGalNAcPITGalNAc. TGalNAcTGalNAcTK for G6, A calcium-type human macrophage lectin (HML) was prepared in a recombinant form, and its interaction with these glycopeptides was investigated by surface plasmon resonance (SPR) spectroscopy and fluorescence polarization. The affinity of recombinant HML (rHML) for immobilized glycopeptides increased, as revealed by SPR, in parallel with the number of GalNAc. The highest affinity was obtained when the G6-peptide was immobilized at high density, Fluorescence polarization equilibrium-binding assays also revealed that the affinity of rHML for soluble glycopeptides increased, depending on the number of attached GalNAcs. Carbohydrate recognition domain (CRD) fragments of HML were prepared, and their affinity for these four glycopeptides was also determined, this affinity was apparently lower than that of rHML, Affinity constants of rHML for the G3- and G5-peptides were 11- and 38-fold higher, respectively, than for the G1-peptide, whereas those of CRD fragments were only 2- and 6-fold higher, respectively. A chemical cross-linking study revealed that rHML but not recombinant CRD forms trimers in an aqueous solution. Thus, preferential binding of densely glycosylated O-linked glycopeptides should be due to the trimer formation of rHML.	Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Irimura, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.							ADLER P, 1995, J BIOL CHEM, V270, P5164, DOI 10.1074/jbc.270.10.5164; BEAVIL AJ, 1992, P NATL ACAD SCI USA, V89, P753, DOI 10.1073/pnas.89.2.753; BOVIN NV, 1993, GLYCOCONJUGATE J, V10, P142, DOI 10.1007/BF00737711; BYRD JC, 1988, CANCER RES, V48, P6678; CHECOVICH WJ, 1995, NATURE, V375, P254, DOI 10.1038/375254a0; DIERKS SE, 1993, J IMMUNOL, V150, P2372; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; Gabius HJ, 1997, EUR J BIOCHEM, V243, P543, DOI 10.1111/j.1432-1033.1997.t01-1-00543.x; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; Gerken TA, 1997, J BIOL CHEM, V272, P9709; GUM JR, 1994, J BIOL CHEM, V269, P2440; Hosoi T, 1998, GLYCOBIOLOGY, V8, P791, DOI 10.1093/glycob/8.8.791; IMAI Y, 1994, J IMMUNOL METHODS, V171, P23, DOI 10.1016/0022-1759(94)90224-0; Imai Y, 1995, IMMUNOLOGY, V86, P591; Iobst ST, 1996, J BIOL CHEM, V271, P6686, DOI 10.1074/jbc.271.12.6686; KAWAKAMI K, 1994, JPN J CANCER RES, V85, P744, DOI 10.1111/j.1349-7006.1994.tb02423.x; Kim YS, 1996, GLYCOCONJUGATE J, V13, P693, DOI 10.1007/BF00702333; LEE RT, 1987, GLYCOCONJUGATE J, V4, P317, DOI 10.1007/BF01048365; LEE YC, 1992, FASEB J, V6, P3193, DOI 10.1096/fasebj.6.13.1397841; LODISH HF, 1991, TRENDS BIOCHEM SCI, V16, P374, DOI 10.1016/0968-0004(91)90154-N; MacKenzie CR, 1996, J BIOL CHEM, V271, P1527, DOI 10.1074/jbc.271.3.1527; Mizuochi S, 1997, GLYCOBIOLOGY, V7, P137, DOI 10.1093/glycob/7.1.137; OZAKI K, 1992, J BIOL CHEM, V267, P9229; Reddish MA, 1997, GLYCOCONJUGATE J, V14, P549, DOI 10.1023/A:1018576224062; RINI JM, 1995, ANNU REV BIOPH BIOM, V24, P551, DOI 10.1146/annurev.biophys.24.1.551; RUSSELL ME, 1994, J CLIN INVEST, V94, P722, DOI 10.1172/JCI117391; SAKAMAKI T, 1995, J LEUKOCYTE BIOL, V57, P407, DOI 10.1002/jlb.57.3.407; Schuck P, 1996, ANAL BIOCHEM, V240, P262, DOI 10.1006/abio.1996.0356; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789; Suzuki N, 1996, J IMMUNOL, V156, P128; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301	32	75	79	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10697	10705		10.1074/jbc.274.16.10697	http://dx.doi.org/10.1074/jbc.274.16.10697			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196140	hybrid			2022-12-27	WOS:000079751900008
J	Kitayama, S; Ikeda, T; Mitsuhata, C; Sato, T; Morita, K; Dohi, T				Kitayama, S; Ikeda, T; Mitsuhata, C; Sato, T; Morita, K; Dohi, T			Dominant negative isoform of rat norepinephrine transporter produced by alternative RNA splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DOPAMINE TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; NORADRENALINE TRANSPORTER; H-3 NISOXETINE; MESSENGER-RNA; UPTAKE SITES; GENE; EXPRESSION; RECEPTOR	We have cloned from rat brain a family of alternatively spliced cDNAs from a single gene, which encodes a norepinephrine transporter (NET) having variations at the 3'-region including both coding and noncoding regions. This produces two transporter isoforms, rNETa and rNETb, which differ at their COOH termini, The rNETa isoform reveals a COOH terminus homologous to human NET and transports norepinephrine. In contrast, rNETb revealed no detectable transport function but reduced functional expression of rNETa when both isoforms were expressed in the same cell. Thus, rNETb potentially functions as a dominant negative inhibitor of rNETa activity. Go-expression of rNETb with a gamma-aminobutyric acid transporter (rGAT1), a serotonin transporter (rSERT), and a dopamine transporter (rDAT) reduced their transport activity. No reduction was found with the glutamate/aspartate transporter (rGLAST), Alternative RNA splicing of NET suggests a novel mechanism for the regulation of synaptic transmission.	Hiroshima Univ, Sch Dent, Dept Pharmacol, Minami Ku, Hiroshima 734, Japan	Hiroshima University	Kitayama, S (corresponding author), Hiroshima Univ, Sch Dent, Dept Pharmacol, Minami Ku, Kasumi 1-2-3, Hiroshima 734, Japan.							Amara S G, 1991, Curr Opin Neurobiol, V1, P84, DOI 10.1016/0959-4388(91)90014-X; BAUER ME, 1992, BRAIN RES, V582, P208, DOI 10.1016/0006-8993(92)90134-U; BOROWSKY B, 1993, NEURON, V10, P851, DOI 10.1016/0896-6273(93)90201-2; CEBELLS JF, 1995, J NEUROCHEM, V65, P502; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Fritz JD, 1998, J NEUROCHEM, V70, P2241; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Hecht K, 1997, J BIOL CHEM, V272, P26659, DOI 10.1074/jbc.272.42.26659; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; JURSKY F, 1994, J EXP BIOL, V196, P283; Kitayama S, 1996, JPN J PHARMACOL, V72, P195, DOI 10.1254/jjp.72.195; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LACROIX D, 1991, J PHARMACOL EXP THER, V257, P1081; LANGER SZ, 1988, PROG NEURO-PSYCHOPH, V12, P193, DOI 10.1016/0278-5846(88)90037-1; Lee FJS, 1996, J BIOL CHEM, V271, P20885, DOI 10.1074/jbc.271.34.20885; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; LINGEN B, 1994, FEBS LETT, V342, P235, DOI 10.1016/0014-5793(94)80508-3; MILNER HE, 1994, BBA-BIOMEMBRANES, V1190, P185, DOI 10.1016/0005-2736(94)90051-5; Nagai M, 1998, NEUROSCI LETT, V244, P165, DOI 10.1016/S0304-3940(98)00158-X; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; Perego C, 1997, J BIOL CHEM, V272, P6584, DOI 10.1074/jbc.272.10.6584; PORZGEN P, 1995, BIOCHEM BIOPH RES CO, V215, P1145, DOI 10.1006/bbrc.1995.2582; RAMACHANDRAN B, 1993, J BIOL CHEM, V268, P23891; Sairam MR, 1996, BIOCHEM BIOPH RES CO, V226, P717, DOI 10.1006/bbrc.1996.1419; SCHAEFFER JC, 1991, MOL BRAIN RES, V9, P271; SZOT P, 1993, BRAIN RES, V618, P308, DOI 10.1016/0006-8993(93)91281-V; TEJANIBUTT SM, 1990, EUR J PHARMACOL, V191, P239, DOI 10.1016/0014-2999(90)94155-Q; UHL GR, 1992, TRENDS NEUROSCI, V15, P265, DOI 10.1016/0166-2236(92)90068-J; WANG YL, 1991, MOL ENDOCRINOL, V5, P1707, DOI 10.1210/mend-5-11-1707; WATANABE K, 1995, J BIOL CHEM, V270, P13733, DOI 10.1074/jbc.270.23.13733	33	45	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10731	10736		10.1074/jbc.274.16.10731	http://dx.doi.org/10.1074/jbc.274.16.10731			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196144	hybrid			2022-12-27	WOS:000079751900012
J	Maziarz, KM; Monaco, HL; Shen, F; Ratnam, M				Maziarz, KM; Monaco, HL; Shen, F; Ratnam, M			Complete mapping of divergent amino acids responsible for differential ligand binding of folate receptors alpha and beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED KB CELLS; GLYCOSYL-PHOSPHATIDYLINOSITOL; MEMBRANE-TRANSPORT; LEUKEMIA-CELLS; MEDIATED ENDOCYTOSIS; INCREASED EXPRESSION; MURINE L1210; TUMOR-CELLS; MA104 CELLS; PROTEIN	The folate receptor (FR) type alpha may be distinguished from FR-beta by its higher affinity for the circulating folate coenzyme, (GS)-5-methyltetrahydrofolate (B-CH(3)H(4)folate), and its opposite stereospecificity for reduced folate coenzymes, Previous studies showed that a single leucine to alanine substitution at position 49 of the mature protein sequence is responsible for the functional divergence of FR-beta (Shen, F,, Zheng, X, Wang, H,, and Ratnam, M. (1997) Biochemistry 36, 6157-6163); however, the results also indicated that the minimum requirement for conversion of FR-beta to the functional equivalent of FR-alpha should include amino acid substitution(s) downstream of residue 92 in addition to mutation of L49A. To pinpoint those residues, chimeric FR-beta(L49A)/FR-alpha constructs including progressively shorter segments of FR-alpha downstream of position 92 as well as selected point mutants were studied, Simultaneous substitution of Leu-49, Phe-104, and Gly-166 in FR-beta with the corresponding FR-alpha residues Ala, Val, and Glu, respectively, reconstituted the ligand binding characteristics of FR-alpha. The results also exclude a role for other residues in FR-alpha in determining its functional divergence, A homology model of FR-alpha based on the three-dimensional structure of the chicken riboflavin-binding protein is used to show the position of residues 49, 104, and 166 in relation to the hydrophobic cleft corresponding to the riboflavin-binding pocket.	Med Coll Ohio, Dept Biochem & Mol Biol, Toledo, OH 43614 USA; Univ Pavia, Dept Genet, I-27100 Pavia, Italy	University of Pavia	Ratnam, M (corresponding author), Med Coll Ohio, Dept Biochem & Mol Biol, Toledo, OH 43614 USA.			Monaco, Hugo L./0000-0002-2067-0365	NCI NIH HHS [R29 CA57598] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA057598] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTONY AC, 1992, BLOOD, V79, P2807; BIRN H, 1993, AM J PHYSIOL, V264, pC302, DOI 10.1152/ajpcell.1993.264.2.C302; BRIGLE KE, 1991, J BIOL CHEM, V266, P17243; BRIGLE KE, 1994, BIOCHEM PHARMACOL, V47, P337, DOI 10.1016/0006-2952(94)90025-6; BRUGER AT, 1992, X PLOR VERSION 3 1 S; CAMPBELL IG, 1991, CANCER RES, V51, P5329; CONEY LR, 1991, CANCER RES, V51, P6125; Douglas JT, 1996, NAT BIOTECHNOL, V14, P1574, DOI 10.1038/nbt1196-1574; ELWOOD PC, 1989, J BIOL CHEM, V264, P14893; HAMAZUME Y, 1987, J BIOCHEM-TOKYO, V101, P217, DOI 10.1093/oxfordjournals.jbchem.a121894; HENDERSON GB, 1990, BIOCHEM PHARMACOL, V39, P2019, DOI 10.1016/0006-2952(90)90624-T; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; JANSEN G, 1990, CANCER RES, V50, P7544; JANSEN G, 1991, CANCER CHEMOTH PHARM, V28, P115, DOI 10.1007/BF00689699; JANSEN G, 1989, CANCER RES, V49, P2455; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAMEN BA, 1988, J BIOL CHEM, V263, P13602; LACEY SW, 1989, J CLIN INVEST, V84, P715, DOI 10.1172/JCI114220; Ladino CA, 1997, INT J CANCER, V73, P859; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEAMON CP, 1994, J DRUG TARGET, V2, P101, DOI 10.3109/10611869409015898; LEAMON CP, 1991, P NATL ACAD SCI USA, V88, P5572, DOI 10.1073/pnas.88.13.5572; LEAMON CP, 1993, BIOCHEM J, V291, P855, DOI 10.1042/bj2910855; LEAMON CP, 1992, J BIOL CHEM, V267, P24966; LEAMON CP, 1993, J BIOL CHEM, V268, P24847; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEE RJ, 1994, J BIOL CHEM, V269, P3198; LEE RJ, 1995, BBA-BIOMEMBRANES, V1233, P134, DOI 10.1016/0005-2736(94)00235-H; LUHRS CA, 1989, J BIOL CHEM, V264, P21446; Mathias CJ, 1998, J NUCL MED, V39, P1579; Mathias CJ, 1996, J NUCL MED, V37, P1003; Mathias CJ, 1998, NUCL MED BIOL, V25, P585, DOI 10.1016/S0969-8051(98)00030-4; Monaco HL, 1997, EMBO J, V16, P1475, DOI 10.1093/emboj/16.7.1475; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NORIOKA N, 1985, J BIOCHEM-TOKYO, V97, P19, DOI 10.1093/oxfordjournals.jbchem.a135044; RATNAM M, 1989, BIOCHEMISTRY-US, V28, P8249, DOI 10.1021/bi00446a042; Ross JF, 1999, CANCER-AM CANCER SOC, V85, P348, DOI 10.1002/(SICI)1097-0142(19990115)85:2<348::AID-CNCR12>3.0.CO;2-4; ROSS JF, 1994, CANCER-AM CANCER SOC, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SHEN F, 1995, BIOCHEMISTRY-US, V34, P5660, DOI 10.1021/bi00016a042; SHEN F, 1994, BIOCHEMISTRY-US, V33, P1209, DOI 10.1021/bi00171a021; Shen F, 1997, BIOCHEM J, V327, P759, DOI 10.1042/bj3270759; Shen F, 1997, BIOCHEMISTRY-US, V36, P6157, DOI 10.1021/bi9626564; Smart EJ, 1996, J CELL BIOL, V134, P1169, DOI 10.1083/jcb.134.5.1169; TUREK JJ, 1993, J CELL SCI, V106, P423; VERMA RS, 1992, J BIOL CHEM, V267, P4119; WANG S, 1995, P NATL ACAD SCI USA, V92, P3318, DOI 10.1073/pnas.92.8.3318; Wang S, 1997, BIOCONJUGATE CHEM, V8, P673, DOI 10.1021/bc9701297; WANG X, 1992, BIOCHEM PHARMACOL, V44, P1898; WEITMAN SD, 1992, CANCER RES, V52, P3396; WESTERHOF GR, 1991, CANCER RES, V51, P5507; WESTERHOF GR, 1995, MOL PHARMACOL, V48, P459; Wu M, 1997, J MEMBRANE BIOL, V159, P137, DOI 10.1007/s002329900277; YAN W, 1995, BIOCHEMISTRY-US, V34, P14594, DOI 10.1021/bi00044a039	54	53	56	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11086	11091		10.1074/jbc.274.16.11086	http://dx.doi.org/10.1074/jbc.274.16.11086			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196192	hybrid			2022-12-27	WOS:000079751900060
J	Desterro, JMP; Rodriguez, MS; Kemp, GD; Hay, RT				Desterro, JMP; Rodriguez, MS; Kemp, GD; Hay, RT			Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; NUCLEAR-PORE COMPLEX; AFFINITY PURIFICATION; CONJUGATING ENZYME; SYSTEM; DEGRADATION; PML; TERMINUS; HOMOLOG; RANGAP1	The ubiquitin-like protein SUMO-1 is conjugated to a variety of proteins including Ran GTPase-activating protein 1 (RanGAP1), I kappa B alpha, and PML, SUMO-1-modified proteins display altered subcellular targeting and/or stability. We have purified the SUMO-1-activating enzyme from human cells and shown that it contains two subunits of 38 and 72 kDa, Isolation of cDNAs for each subunit indicates that they are homologous to ubiquitin-activating enzymes and to the Saccharomyces cerevisiae enzymes responsible for conjugation of Smt3p and Rub-1p, In vitro, recombinant SAE1/SAE2 (SUMO-1-activating enzyme) was capable of catalyzing the ATP-dependent formation of a thioester linkage between SUMO-1 and SAE2. The addition of the SUMO-1-conjugating enzyme Ubch9 resulted in efficient transfer of the thioester-linked SUMO-1 from SAE2 to Ubch9, In the presence of SAE1/SAE2, Ubch9, and ATP, SUMO-1 was efficiently conjugated to the protein substrate I kappa B alpha. As SAE1/SAE2, Ubch9, SUMO-1, and I kappa B alpha are all homogeneous, recombinant proteins, it appears that SUMO-1 conjugation of I kappa B alpha in vitro does not require the equivalent of an E3 ubiquitin protein ligase activity.	Univ St Andrews, Sch Biomed Sci, St Andrews KY16 9ST, Fife, Scotland	University of St Andrews	Hay, RT (corresponding author), Univ St Andrews, Sch Biomed Sci, BMS Bldg, St Andrews KY16 9ST, Fife, Scotland.		Hay, Ronald T/F-9338-2011	Hay, Ronald T/0000-0001-7113-9024; Desterro, Joana/0000-0002-6359-7233				Boddy MN, 1996, ONCOGENE, V13, P971; BRADBURY EM, 1992, BIOESSAYS, V14, P9; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1987, J BIOL CHEM, V262, P11315; HANDLEY PM, 1991, P NATL ACAD SCI USA, V88, P258, DOI 10.1073/pnas.88.1.258; HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; JAFFRAY E, 1995, MOL CELL BIOL, V15, P2166; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kamitani T, 1997, J BIOL CHEM, V272, P14001, DOI 10.1074/jbc.272.22.14001; Kroll M, 1997, ONCOGENE, V15, P1841, DOI 10.1038/sj.onc.1201560; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Narasimhan J, 1996, J BIOL CHEM, V271, P324, DOI 10.1074/jbc.271.1.324; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Schwarz SE, 1998, P NATL ACAD SCI USA, V95, P560, DOI 10.1073/pnas.95.2.560; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shen ZY, 1996, GENOMICS, V36, P271, DOI 10.1006/geno.1996.0462; Sternsdorf T, 1997, J CELL BIOL, V139, P1621, DOI 10.1083/jcb.139.7.1621; Wada H, 1998, BIOCHEM BIOPH RES CO, V251, P688, DOI 10.1006/bbrc.1998.9532; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543	34	278	292	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10618	10624		10.1074/jbc.274.15.10618	http://dx.doi.org/10.1074/jbc.274.15.10618			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187858	hybrid			2022-12-27	WOS:000079663500097
J	Liou, ML; Liou, HC				Liou, ML; Liou, HC			The ubiquitin-homology protein, DAP-1, associates with tumor necrosis factor receptor (p60) death domain and induces apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-DEATH; TNF-RECEPTOR; SPHINGOMYELIN PATHWAY; SIGNAL-TRANSDUCTION; KINASE COMPLEX; DNA-REPAIR; ACTIVATION; INTERACTS; CYCLE	The tumor necrosis factor receptor, p60 (TNF-R1), transduces death signals via the association of its cytoplasmic domain with several intracellular proteins. By screening a mammalian cDNA library using the yeast two-hybrid cloning technique, we isolated a ubiquitin-homology protein, DAP-1, which specifically interacts with the cytoplasmic death domain of TNF-R1. Sequence analysis reveals that DAP-1 shares striking sequence homology with the yeast SMT3 protein that is essential for the maintenance of chromosome integrity during mitosis (Meluh, P. B., and Koshland, D. (1995) Mel. Biol. Cell 6, 793-807). DAP-1 is nearly identical to PIC1, a protein that interacts with the PML tumor suppressor implicated in acute promyelocytic leukemia (Boddy, M. N., Howe, K., Etkin, L. D., Solomon, E., and Freemont, P. S. (1996) Oncogene 13, 971-982), and the sentrin protein, which associates with the Fas death receptor (Okura, T., Gong, L., Kamitani, T., Wada, T., Okura, I., Wei, C. F., Chang, H. M., and Yeh, E. T. (1996) J. Immunol. 157, 4277-4281). The in vivo interaction between DAP-1 and TNF-R1 was further confirmed in mammalian cells. In transient transfection assays, overexpression of DAP-1 suppresses NF-kappa B/Rel activity in 293T cells, a human kidney embryonic carcinoma cell line. Overexpression of either DAP-1 or sentrin causes apoptosis of TNF-sensitive L929 fibroblast cell line, as well as TNF-resistant osteosarcoma cell line, U20S. Furthermore, the dominant negative Fas-associated death domain protein (FADD) protein blocks the cell death induced by either DAP-1 or FADD. Collectively, these observations highly suggest a role for DAP-1 in mediating TNF-induced cell death signaling pathways, presumably through the recruitment of FADD death effector.	Cornell Univ, Coll Med, Dept Med, Div Immunol, New York, NY 10021 USA; Cornell Univ, Coll Med, Grad Sch Med Sci, New York, NY 10021 USA	Cornell University; Cornell University	Liou, HC (corresponding author), Cornell Univ, Coll Med, Dept Med, Div Immunol, New York, NY 10021 USA.				NATIONAL CANCER INSTITUTE [R01CA068155] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA68155] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Andjelic S, 1998, EUR J IMMUNOL, V28, P570, DOI 10.1002/(SICI)1521-4141(199802)28:02<570::AID-IMMU570>3.0.CO;2-M; AUSUBEL FM, 1989, CURRENT PROTOCOS MOL; Boddy MN, 1996, ONCOGENE, V13, P971; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; DARNAY BG, 1995, J BIOL CHEM, V270, P14867, DOI 10.1074/jbc.270.25.14867; Dunbar JD, 1997, J IMMUNOL, V158, P4252; GARRETT KP, 1995, P NATL ACAD SCI USA, V92, P7172, DOI 10.1073/pnas.92.16.7172; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hochstrasser M, 1998, GENE DEV, V12, P901, DOI 10.1101/gad.12.7.901; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; Lee SY, 1997, J EXP MED, V185, P1275, DOI 10.1084/jem.185.7.1275; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Maniatis T, 1997, SCIENCE, V278, P818, DOI 10.1126/science.278.5339.818; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Mendelsohn Andrew R., 1994, Current Opinion in Biotechnology, V5, P482, DOI 10.1016/0958-1669(94)90061-2; Okura T, 1996, J IMMUNOL, V157, P4277; Orr-Weaver TL, 1998, NATURE, V392, P223, DOI 10.1038/32520; Pena LA, 1997, BIOCHEM PHARMACOL, V53, P615, DOI 10.1016/S0006-2952(96)00834-9; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Schievella AR, 1997, J BIOL CHEM, V272, P12069, DOI 10.1074/jbc.272.18.12069; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Speiser DE, 1997, J EXP MED, V185, P1777, DOI 10.1084/jem.185.10.1777; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; WATKINS JF, 1993, MOL CELL BIOL, V13, P7757, DOI 10.1128/MCB.13.12.7757; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	39	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10145	10153		10.1074/jbc.274.15.10145	http://dx.doi.org/10.1074/jbc.274.15.10145			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187798	hybrid			2022-12-27	WOS:000079663500037
J	Graca-Souza, AV; Silva-Neto, MAC; Oliveira, PL				Graca-Souza, AV; Silva-Neto, MAC; Oliveira, PL			Urate synthesis in the blood-sucking insect Rhodnius prolixus - Stimulation by hemin is mediated by protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URIC-ACID; CELLULAR-REGULATION; OKADAIC ACID; ACTIVATION; CELLS; PHOSPHORYLATION; INHIBITION; PROTECTION; COMPOUND; POTENT	Hemin is a catalyst of the formation of reactive oxygen species. We proposed that hematophagous insects are exposed to intense oxidative stress because of hemoglobin hydrolysis in their midgut (Petretsky, NI. D., Ribeiro, J.M.C., Atella, G. C., Masuda, H., and Oliveira, P. L. (1995) J. Biol. Chem. 270, 10893-10896). We have shown that hemin stimulates urate synthesis in the blood-sucking insect Rhodnius prolixus (Graca-Souza, A. V., Petretsky, J. H., Demasi, M., Bechara, E. J. H,, and Oliveira, P. L. (1997) Free Radical Biol. Med. 22, 209-214). Once released by fat body cells, urate accumulates in the hemolymph, where this radical scavenger constitutes an important defense against blood-feeding derived oxidative stress. Incubation of Rhodnius fat bodies with okadaic acid raises the level of urate synthesis, suggesting that urate production can be controlled by protein phosphorylation/dephosphorylation. Urate synthesis is stimulated by dibutyryl cAMP and inhibited by N(2((p-bromocinnamil) amino)ethyl)-5-isoquinolinesulfonamide (H-89), an inhibitor of protein kinase A, as well as activated by the protein kinase C activator phorbol 12-myristate 13-acetate. In the presence of hemin, however, inhibition of urate synthesis by H-89 does not occur, suggesting that the hemin stimulatory effect is not mediated by protein kinase A Calphostin C completely inhibits the hemin-induced urate production, suggesting that the triggering of urate antioxidant response depends on protein kinase C activation. This conclusion is reinforced by the observation that in fat bodies exposed to hemin, both protein kinase C activity and phosphorylation of specific endogenous polypeptides are significantly increased.	Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Dept Bioquim Med, BR-21910590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Graca-Souza, AV (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Dept Bioquim Med, BR-21910590 Rio De Janeiro, Brazil.	avsouza@server.bioqmed.ufrj.br	Silva-Neto, Mario A C/C-1211-2013; L. Oliveira, Pedro/A-9438-2010	Silva-Neto, Mario A C/0000-0003-2273-194X; L. Oliveira, Pedro/0000-0003-0307-354X				AFT RL, 1983, J BIOL CHEM, V258, P2069; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BRAWN MK, 1995, FREE RADICAL RES, V22, P23, DOI 10.3109/10715769509147525; BURSELL E, 1965, ADV INSECT PHYSL, V9, P33; CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Cochran D. G., 1975, INSECT BIOCH FUNCTIO, P177; COCHRAN DG, 1985, ANNU REV ENTOMOL, V30, P29, DOI 10.1146/annurev.en.30.010185.000333; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; de Meis L, 1974, Biochemistry, V13, P2057, DOI 10.1021/bi00707a009; DOMAGK GF, 1968, ANAL BIOCHEM, V22, P219, DOI 10.1016/0003-2697(68)90309-6; FEENER EP, 1994, BIOCHEM J, V303, P43, DOI 10.1042/bj3030043; GOPALAKRISHNA R, 1991, ARCH BIOCHEM BIOPHYS, V285, P382, DOI 10.1016/0003-9861(91)90377-U; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; GRACASOUZA AV, 1997, FREE RADICAL BIO MED, V22, P209; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HILLIKER AJ, 1992, P NATL ACAD SCI USA, V89, P4343, DOI 10.1073/pnas.89.10.4343; KASS GEN, 1989, BIOCHEM J, V260, P499, DOI 10.1042/bj2600499; KIKKAWA U, 1983, METHOD ENZYMOL, V99, P288; Klann E, 1998, J BIOL CHEM, V273, P4516, DOI 10.1074/jbc.273.8.4516; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; KUO ML, 1995, BBA-MOL CELL RES, V1268, P229, DOI 10.1016/0167-4889(95)00076-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu YS, 1996, FREE RADICAL BIO MED, V21, P771, DOI 10.1016/0891-5849(96)00176-1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MADDRELL SH, 1969, J EXP BIOL, V51, P71; Maia J.C., 1983, GENES ANTIGENS PARAS, P144; MATSUSHITA S, 1963, ARCH BIOCHEM BIOPHYS, V102, P446, DOI 10.1016/0003-9861(63)90253-4; MEADOWS J, 1986, ARCH BIOCHEM BIOPHYS, V246, P838, DOI 10.1016/0003-9861(86)90340-1; NEMANI R, 1993, ARCH BIOCHEM BIOPHYS, V300, P24, DOI 10.1006/abbi.1993.1004; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; ODONNELL MJ, 1983, J EXP BIOL, V103, P169; OLIVEIRA PL, 1995, J BIOL CHEM, V270, P10897, DOI 10.1074/jbc.270.18.10897; PETRETSKI MD, 1995, J BIOL CHEM, V270, P10893; QIU ZH, 1994, J BIOL CHEM, V269, P19480; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; TAPPEL AL, 1955, J BIOL CHEM, V217, P721; VINCENT SH, 1988, ARCH BIOCHEM BIOPHYS, V265, P539, DOI 10.1016/0003-9861(88)90159-2; WIGGLESWORTH VB, 1931, J EXP BIOL, V8, P448; YAMAGUCHI K, 1995, BIOCHEM BIOPH RES CO, V210, P639, DOI 10.1006/bbrc.1995.1708	50	17	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9673	9676		10.1074/jbc.274.14.9673	http://dx.doi.org/10.1074/jbc.274.14.9673			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092654	hybrid			2022-12-27	WOS:000079451800073
J	Heck, S; Lezoualc'h, F; Engert, S; Behl, C				Heck, S; Lezoualc'h, F; Engert, S; Behl, C			Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CELL-DEATH; FACTOR-I; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; HIPPOCAMPAL-NEURONS; HYPOTHALAMIC CELLS; INDUCED APOPTOSIS; BINDING-PROTEINS; INHIBITION; ALPHA	The role of insulin-like growth factor 1 (IGF-I) for the treatment of neurodegenerative disorders, such as Alzheimer's disease, has recently gained attention. The present study demonstrates that IGF-1 promotes the survival of rat primary cerebellar neurons and of immortalized hypothalamic rat GT1-7 cells after challenge with oxidative stress induced by hydrogen peroxide (H2O2). Neuroprotective concentrations of IGF-1 specifically induce the transcriptional activity and the DNA binding activity of nuclear factor kappa B (NF-kappa B), a transcription factor that has been suggested to play a neuroprotective role. This induction is associated with increased nuclear translocation of the p65 subunit of NF-kappa B and with degradation of the NP-kappa B inhibitory protein I kappa B alpha. IGF-1-mediated protection of GT1-7 cells against oxidative challenges was mimicked by overexpression of the NF-kappa B subunit c-Rel. Partial inhibition of NF-kappa B baseline activity by overexpression of a dominant-negative I kappa B alpha mutant enhanced the toxicity of H2O2 in GT1-7 cells. The pathway by which IGF-1 promotes neuronal survival and activation of NF-kappa B involves the phosphoinositol (PI) 3-kinase, because both effects of IGF-1 are blocked by LY294002 and wortmannin, two specific PI 3-kinase inhibitors. Taken together, our results provide evidence for a novel molecular link between IGF-l-mediated neuroprotection and induction of NF-kappa B that is dependent on the PI 3-kinase pathway.	Max Planck Inst Psychiat, D-80804 Munich, Germany	Max Planck Society	Behl, C (corresponding author), Max Planck Inst Psychiat, Kraepelinstr 2-10, D-80804 Munich, Germany.	chris@mpipsykl.mpg.de	Lezoualc'h, Frank/E-5031-2016	Behl, Christian/0000-0001-8453-2378				ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Behl C, 1997, ENDOCRINOLOGY, V138, P101, DOI 10.1210/en.138.1.101; Bertrand F, 1998, J BIOL CHEM, V273, P2931, DOI 10.1074/jbc.273.5.2931; BERTRAND F, 1995, J BIOL CHEM, V270, P24435, DOI 10.1074/jbc.270.41.24435; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crowder RJ, 1998, J NEUROSCI, V18, P2933; DEPABLO F, 1995, TRENDS NEUROSCI, V18, P143, DOI 10.1016/0166-2236(95)93892-2; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dore S, 1997, TRENDS NEUROSCI, V20, P326; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; ISRAEL A, 1995, TRENDS GENET, V11, P203, DOI 10.1016/S0168-9525(00)89045-9; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Lezoualc'h F, 1998, MOL PSYCHIATR, V3, P15, DOI 10.1038/sj.mp.4000295; Lezoualc'h F, 1998, J NEUROSCI, V18, P3224; Lipton SA, 1997, NAT MED, V3, P20, DOI 10.1038/nm0197-20; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Loddick SA, 1998, P NATL ACAD SCI USA, V95, P1894, DOI 10.1073/pnas.95.4.1894; MURPHY MF, 1995, ANN NEUROL, V38, P335; OLSON BR, 1995, NEUROENDOCRINOLOGY, V62, P155, DOI 10.1159/000127000; Parrizas M, 1997, J BIOL CHEM, V272, P154; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Sagara Y, 1996, J NEUROSCI, V16, P497; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; Sortino MA, 1996, ENDOCRINOLOGY, V137, P1418, DOI 10.1210/en.137.4.1418; Sparapani M, 1997, GLIA, V20, P203, DOI 10.1002/(SICI)1098-1136(199707)20:3<203::AID-GLIA4>3.0.CO;2-8; Taglialatela G, 1998, NEUROREPORT, V9, P489, DOI 10.1097/00001756-199802160-00024; Taglialatela G, 1997, J NEUROSCI RES, V47, P155; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; TORRESALEMAN I, 1990, NEUROSCIENCE, V35, P601, DOI 10.1016/0306-4522(90)90332-X; TORRESALEMAN I, 1994, J NEUROSCI RES, V39, P117, DOI 10.1002/jnr.490390202; TSAI PS, 1995, ENDOCRINOLOGY, V136, P3831, DOI 10.1210/en.136.9.3831; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x; Yuen EC, 1996, ANN NEUROL, V40, P346, DOI 10.1002/ana.410400304	51	186	190	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9828	9835		10.1074/jbc.274.14.9828	http://dx.doi.org/10.1074/jbc.274.14.9828			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092673	hybrid			2022-12-27	WOS:000079451800092
J	Steegborn, C; Clausen, T; Sondermann, P; Jacob, U; Worbs, M; Marinkovic, S; Huber, R; Wahl, MC				Steegborn, C; Clausen, T; Sondermann, P; Jacob, U; Worbs, M; Marinkovic, S; Huber, R; Wahl, MC			Kinetics and inhibition of recombinant human cystathionine gamma-lyase - Toward the rational control of transsulfuration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT-BINDING INHIBITORS; ESCHERICHIA-COLI; BETA-LYASE; SLOW-BINDING; ENZYMATIC AMPLIFICATION; X-RAY; INACTIVATION; MECHANISM; PROPARGYLGLYCINE; PURIFICATION	The gene encoding human cystathionine gamma-lyase was cloned from total cellular Rep G2 RNA. Fusion to a T7 promoter allowed expression in Escherichia coli, representing the first mammalian cystathionine gamma-lyase overproduced in a bacterial system. About 90% of the heterologous gene product was insoluble, and renaturation experiments from purified inclusion bodies met with limited success. About 5 mg/liter culture of human cystathionine gamma-lyase could also be extracted from the soluble lysis fraction, employing a three-step native procedure. While the enzyme showed high gamma-lyase activity toward L-cystathionine (K-m = 0.5 mM, V-max = 2.5 units/mg) with an optimum pH of 8.2, no residual cystathionine beta-lyase behavior and only marginal reactivity toward L-cystine and L-cysteine were detected. Inhibition studies were performed with the mechanism-based inactivators propargylglycine, trifluoroalanine, and aminoethoxyvinylglycine. Propargylglycine inactivated human cystathionine gamma-lyase much more strongly than trifluoroalanine, in agreement with the enzyme's preference for C-gamma-S bonds. Aminoethoxyvinylglycine showed slow and tight binding characteristics with a K-i of 10.5 mu M, comparable with its effect on cystathionine beta-lyase, The results have important implications for the design of specific inhibitors for transsulfuration components.	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Planegg Martinsried, Germany	Max Planck Society	Wahl, MC (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, Klopferspitz 18A, D-82152 Planegg Martinsried, Germany.		Wahl, Markus C./D-6365-2017	Wahl, Markus C./0000-0002-2811-5307; Clausen, Tim/0000-0003-1582-6924				ABELES RH, 1973, J AM CHEM SOC, V95, P6124, DOI 10.1021/ja00799a053; ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; ALSTON AT, 1981, FEBS LETT, V128, P293; ALTING AC, 1995, APPL ENVIRON MICROB, V61, P4037, DOI 10.1128/AEM.61.11.4037-4042.1995; BRZOVIC P, 1990, BIOCHEMISTRY-US, V29, P442, DOI 10.1021/bi00454a020; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2177, DOI 10.1016/0006-2952(75)90050-7; CHA S, 1976, BIOCHEM PHARMACOL, V25, P2695, DOI 10.1016/0006-2952(76)90259-8; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHURCHICH JE, 1975, J BIOL CHEM, V250, P7722; Clausen T, 1998, EMBO J, V17, P6827, DOI 10.1093/emboj/17.23.6827; Clausen T, 1996, J MOL BIOL, V262, P202, DOI 10.1006/jmbi.1996.0508; Clausen T, 1997, BIOCHEMISTRY-US, V36, P12633, DOI 10.1021/bi970630m; Dudman NPB, 1996, J NUTR, V126, pS1295, DOI 10.1093/jn/126.suppl_4.1295S; Eadie GS, 1942, J BIOL CHEM, V146, P85; FEARON CW, 1982, BIOCHEMISTRY-US, V21, P3790, DOI 10.1021/bi00259a011; FLAVIN M, 1964, J BIOL CHEM, V239, P2212; FLAVIN M, 1971, METHODS ENZYMOL B, V17, P416; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; GLODE LM, 1981, BIOCHEMISTRY-US, V20, P1306, DOI 10.1021/bi00508a041; GRIFFITH OW, 1987, METHOD ENZYMOL, V143, P367; HOFSTEE BHJ, 1959, NATURE, V184, P1296, DOI 10.1038/1841296b0; JOHNSTON M, 1979, BIOCHEMISTRY-US, V18, P4691; KITZ R, 1962, J BIOL CHEM, V237, P3245; KREFT BD, 1994, PLANT PHYSIOL, V104, P1215, DOI 10.1104/pp.104.4.1215; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LU Y, 1992, BIOCHEM BIOPH RES CO, V189, P749, DOI 10.1016/0006-291X(92)92265-Y; MARTEL A, 1987, BIOCH VITAMIN B6, P341; MATSUO Y, 1958, J BIOL CHEM, V230, P545; MATSUO Y, 1958, J BIOL CHEM, V230, P561; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; NAGASAWA T, 1984, J BIOL CHEM, V259, P10398; OWENS LD, 1968, BIOCHIM BIOPHYS ACTA, V158, P219, DOI 10.1016/0304-4165(68)90134-7; PRUESS DL, 1974, J ANTIBIOT, V27, P229, DOI 10.7164/antibiotics.27.229; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SILVERMAN RB, 1995, METHOD ENZYMOL, V249, P240; SILVERMAN RB, 1977, BIOCHEMISTRY-US, V16, P5515, DOI 10.1021/bi00644a019; SILVERMAN RB, 1976, BIOCHEMISTRY-US, V15, P4718, DOI 10.1021/bi00666a028; SILVERMAN RB, 1988, MECH BASED ENZYME IN, V2; STURMAN JA, 1980, J BIOL CHEM, V255, P4763; SZEDLACSEK SE, 1995, METHOD ENZYMOL, V249, P144; UREN JR, 1978, BIOCHEM PHARMACOL, V27, P2807, DOI 10.1016/0006-2952(78)90194-6; UREN JR, 1987, METHOD ENZYMOL, V143, P483; Wahl MC, 1997, FEBS LETT, V414, P492, DOI 10.1016/S0014-5793(97)01057-0; WASHTIEN W, 1977, BIOCHEMISTRY-US, V16, P2485, DOI 10.1021/bi00630a026; YAMAGATA S, 1993, J BACTERIOL, V175, P4800, DOI 10.1128/JB.175.15.4800-4808.1993; [No title captured]	49	78	94	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12675	12684		10.1074/jbc.274.18.12675	http://dx.doi.org/10.1074/jbc.274.18.12675			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212249	hybrid			2022-12-27	WOS:000080056800069
J	Murphy, MP; Hickman, LJ; Eckman, CB; Uljon, SN; Wang, R; Golde, TE				Murphy, MP; Hickman, LJ; Eckman, CB; Uljon, SN; Wang, R; Golde, TE			gamma-Secretase, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid beta peptides of varying length	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; TRANSMEMBRANE DOMAIN; CULTURED-CELLS; SENILE PLAQUES; A-BETA; CLEAVAGE; A-BETA-42(43); MUTATION; RELEASE	gamma-Secretase activity is the final cleavage event that releases the amyloid beta peptide (A beta) from the beta-secretase cleaved carboxyl-terminal fragment of the amyloid beta protein precursor (APP). No protease responsible for this highly unusual, purportedly intramembranous, cleavage has been definitively identified, We examined the substrate specificity of gamma-secretase by mutating various residues within or adjacent to the transmembrane domain of the APP and then analyzing A beta production from cells transfected with these mutant APPs by enzyme-linked immunosorbent assay and mass spectrometry. A beta production was also analyzed from a subset of transmembrane domain APP mutants that showed dramatic shifts in gamma-secretase cleavage in the presence or absence of pepstatin, an inhibitor of gamma-secretase activity. These studies demonstrate that gamma-secretase's cleavage specificity is primarily determined by location of the gamma-secretase cleavage site of APP with respect to the membrane, and that gamma-secretase activity is due to the action of multiple proteases exhibiting both a pepstatin-sensitive activity and a pepstatin-insensitive activity. Given that gamma-secretase is a major therapeutic target in Alzheimer's disease these studies provide important information with respect to the mechanism of A beta production that will direct efforts to isolate the gamma-secretases and potentially to develop effective therapeutic inhibitors of pathologically relevant gamma-secretase activities.	Mayo Clin Jacksonville, Dept Pharmacol, Jacksonville, FL 32224 USA; Univ Penn, Dept Neurosci, Philadelphia, PA 19010 USA; Rockefeller Univ, Lab Mass Spectrometry, New York, NY 10021 USA	Mayo Clinic; University of Pennsylvania; Rockefeller University	Golde, TE (corresponding author), Mayo Clin Jacksonville, Dept Pharmacol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.		Wang, Rong/A-8721-2009		NATIONAL INSTITUTE ON AGING [R03AG016065] Funding Source: NIH RePORTER; NIA NIH HHS [AG-16065] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BROMME D, 1986, ARCH BIOCHEM BIOPHYS, V244, P439, DOI 10.1016/0003-9861(86)90611-9; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DEAN RT, 1979, BIOCHEM J, V180, P339, DOI 10.1042/bj1800339; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; FELSENSTEIN KM, 1994, NEUROSCI LETT, V174, P173, DOI 10.1016/0304-3940(94)90014-0; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; HIGAKI J, 1995, NEURON, V14, P651, DOI 10.1016/0896-6273(95)90322-4; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; Klafki HW, 1996, J BIOL CHEM, V271, P28655, DOI 10.1074/jbc.271.45.28655; Klafki HW, 1995, NEUROSCI LETT, V201, P29, DOI 10.1016/0304-3940(95)12122-K; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; Lichtenthaler SF, 1997, BIOCHEMISTRY-US, V36, P15396, DOI 10.1021/bi971071m; Paganetti PA, 1996, J NEUROSCI RES, V46, P283, DOI 10.1002/(SICI)1097-4547(19961101)46:3<283::AID-JNR1>3.0.CO;2-G; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tischer E, 1996, J BIOL CHEM, V271, P21914, DOI 10.1074/jbc.271.36.21914; USAMI M, 1993, J NEUROCHEM, V61, P239, DOI 10.1111/j.1471-4159.1993.tb03560.x; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; WHITTAKER RG, 1994, ANAL BIOCHEM, V220, P238, DOI 10.1006/abio.1994.1333; WIEDEMANN A, 1989, CELL, V57, P115; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b	46	149	160	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11914	11923		10.1074/jbc.274.17.11914	http://dx.doi.org/10.1074/jbc.274.17.11914			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207012				2022-12-27	WOS:000079834800068
J	Page, S; Fischer, C; Baumgartner, B; Haas, M; Kreusel, U; Loidl, G; Hayn, M; Ziegler-Heitbrock, HWL; Neumeier, D; Brand, K				Page, S; Fischer, C; Baumgartner, B; Haas, M; Kreusel, U; Loidl, G; Hayn, M; Ziegler-Heitbrock, HWL; Neumeier, D; Brand, K			4-hydroxynonenal prevents NF-kappa B activation and tumor necrosis factor expression by inhibiting I kappa B phosphorylation and subsequent proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; LIPID-PEROXIDATION; KINASE COMPLEX; OXIDIZED LDL; CELL-LINE; ATHEROSCLEROTIC LESION; SIGNAL-TRANSDUCTION; CYTOKINE PRODUCTION; MONOCYTIC CELLS; MESSENGER-RNA	Extensively oxidized low density lipoprotein (ox-LDL), a modulator of atherogenesis, down-regulates the lipopolysaccharide (LPS)-induced activation of transcription factor NF-kappa B. We investigated whether 4-hydroxynonenal (HNE), a prominent aldehyde component of on-LDL, represents one of the inhibitory substances. NF-kappa B activation by stimuli such as LPS, interleukin (IL)-1 beta, and phorbol ester, but not tumor necrosis factor (TNF), was reversibly inhibited by HNE in a dose-dependent manner in human monocytic cells, whereas AP-1 binding was unaffected. Using similar HNE concentrations, LPS-induced kappa B- and TNF or IL-8 promoter-dependent transcription was prevented. Furthermore, pretreatment with HNE suppressed TNF production but not lactate dehydrogenase levels. Under these conditions the binding of LPS to monocytic cells was not significantly affected, However, induced proteolysis of the inhibitory proteins I kappa B-alpha, I kappa B-beta, and, at a later time point, I kappa B-epsilon was prevented. This is not due to inhibition of the proteasome, the major proteolytic activities of which remain unaffected, but rather to a specific prevention of the activation-dependent phosphorylation of I kappa B-alpha. This is the first report which demonstrates that HNE specifically inhibits the NF-kappa B/Rel system. Downmodulation of NF-kappa B-regulated gene expression may contribute at certain stages of atherosclerosis to low levels of chronic inflammation and may also be involved in other inflammatory/degenerative diseases.	Tech Univ Munich, Klinikum Rechts Isar, Inst Clin Chem & Pathobiochem, D-81675 Munich, Germany; Max Planck Inst Biochem, Dept Bioorgan Chem, D-82152 Martinsried, Germany; Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; Univ Munich, Inst Immunol, D-80336 Munich, Germany	Technical University of Munich; Max Planck Society; Graz University of Technology; University of Munich	Brand, K (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Clin Chem & Pathobiochem, Ismaninger Str 22, D-81675 Munich, Germany.			Page, Sharon/0000-0003-0228-3609				ARES MPS, 1995, ARTERIOSCL THROM VAS, V15, P1584, DOI 10.1161/01.ATV.15.10.1584; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; Blanc EM, 1997, J NEUROCHEM, V69, P570; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; BRAND K, 1993, J CLIN INVEST, V91, P2031, DOI 10.1172/JCI116425; BRAND K, 1994, ARTERIOSCLER THROMB, V14, P790, DOI 10.1161/01.ATV.14.5.790; Brand K, 1997, ARTERIOSCL THROM VAS, V17, P1901, DOI 10.1161/01.ATV.17.10.1901; Brand K, 1997, EXP PHYSIOL, V82, P297, DOI 10.1113/expphysiol.1997.sp004025; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Camandola S, 1997, BIOFACTORS, V6, P173, DOI 10.1002/biof.5520060211; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; COLLINS T, 1993, LAB INVEST, V68, P499; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; ESTERBAUER H, 1987, J LIPID RES, V28, P495; FONG LG, 1991, J LIPID RES, V32, P1899; GRILLI M, 1993, INT REV CYTOL, V143, P1; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Haas M, 1998, J LEUKOCYTE BIOL, V63, P395, DOI 10.1002/jlb.63.3.395; HAMILTON TA, 1990, J IMMUNOL, V144, P2343; Heinemann M, 1996, INFECT IMMUN, V64, P4872, DOI 10.1128/IAI.64.11.4872-4875.1996; Hilt W, 1996, TRENDS BIOCHEM SCI, V21, P96, DOI 10.1016/S0968-0004(96)10012-8; INGALLS RR, 1995, INFECT IMMUN, V63, P3125, DOI 10.1128/IAI.63.8.3125-3130.1995; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kol A, 1998, TRENDS CARDIOVAS MED, V8, P191, DOI 10.1016/S1050-1738(98)00010-3; Kruman I, 1997, J NEUROSCI, V17, P5089; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Leonarduzzi G, 1997, FASEB J, V11, P851, DOI 10.1096/fasebj.11.11.9285483; LIBBY P, 1991, LAB INVEST, V64, P5; MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mattila KJ, 1998, CLIN INFECT DIS, V26, P719, DOI 10.1086/514570; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Muller K, 1996, FEBS LETT, V388, P165, DOI 10.1016/0014-5793(96)00559-5; Napoli C, 1997, J CLIN INVEST, V100, P2680, DOI 10.1172/JCI119813; O'Connell MA, 1998, J BIOL CHEM, V273, P30410, DOI 10.1074/jbc.273.46.30410; Ohlsson BG, 1996, J CLIN INVEST, V98, P78, DOI 10.1172/JCI118780; Paradis V, 1997, HEPATOLOGY, V26, P135; Parthasarathy Sampath, 1994, Current Opinion in Lipidology, V5, P371, DOI 10.1097/00041433-199410000-00009; PEDRON T, 1995, J IMMUNOL, V155, P1460; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Schmidt M, 1997, FASEB J, V11, P1235, DOI 10.1096/fasebj.11.14.9409542; Schouten GJ, 1997, EMBO J, V16, P3133, DOI 10.1093/emboj/16.11.3133; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SHACKELFORD RE, 1995, J BIOL CHEM, V270, P3475, DOI 10.1074/jbc.270.8.3475; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Sonoda Y, 1997, J BIOL CHEM, V272, P15366, DOI 10.1074/jbc.272.24.15366; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; THAI SF, 1995, J LEUKOCYTE BIOL, V57, P427, DOI 10.1002/jlb.57.3.427; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; UCHIDA K, 1994, BIOCHEMISTRY-US, V33, P12487, DOI 10.1021/bi00207a016; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wulczyn FG, 1996, J MOL MED, V74, P749, DOI 10.1007/s001090050078; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	67	137	142	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11611	11618		10.1074/jbc.274.17.11611	http://dx.doi.org/10.1074/jbc.274.17.11611			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206970	hybrid			2022-12-27	WOS:000079834800026
J	Sastry, S; Linderoth, N				Sastry, S; Linderoth, N			Molecular mechanisms of peptide loading by the tumor rejection antigen heat shock chaperone gp96 (GRP94)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CONFORMATIONAL CHANGE; PYRENE EXCIMER FLUORESCENCE; CYTOTOXIC T-LYMPHOCYTES; STRESS-INDUCED PROTEINS; ENDOPLASMIC-RETICULUM; IMMUNE-RESPONSE; IN-VIVO; BINDING; CANCER; TAP	Complexes of gp96/GRP94 and peptides have been shows to elicit immunogenicity. We used fluorescence to understand peptide association with gp96, A pyrene-peptide conjugate was complexed with gp96 under a variety of conditions. At room temperature in low salt (20 mM NaCl), the peptide binds gp96 with a strong affinity (similar to 100-150 nM) and forms pyrene excimers, suggesting that the peptides were assembled as dimers. In high salt (2.2 at NaCl), although peptide binding was stronger (K-a approximate to 55 nM) than in low salt, pyrene excimers were absent, implying that peptides were farther apart in the complex. Heat shock-activated peptide binding exhibited characteristics of both low salt and high salt modes of binding. Anisotropy and average lifetime of the bound pyrene suggested that peptides were probably located in a solvent-accessible hydrophobic binding pocket in low salt, whereas in high salt, the peptide may be buried in a less hydrophobic (more hydrophilic) environment. These results suggested that peptide-gp96 complexes were assembled in several different ways, depending on the assembly conditions. Resonance energy transfer between the intrinsic tryptophan(s) in gp96 and pyrene suggested that one or more tryptophan residues were within the critical Forster distance of 27-30 Angstrom from the pyrene in the bound peptide. It is proposed that peptides are assembled within higher order gp96 complexes (dimers, etc.) in a hydrophobic pocket and that there may be a conformational change in gp96 leading to an open configuration for peptide loading.	Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA	Rockefeller University	Sastry, S (corresponding author), Rockefeller Univ, Mol Genet Lab, 1230 York Ave, New York, NY 10021 USA.	sastrys@rockvax.rockefeller.edu						ANDERSON SL, 1994, J EXP MED, V180, P1565, DOI 10.1084/jem.180.4.1565; Arnold D, 1997, J EXP MED, V186, P461, DOI 10.1084/jem.186.3.461; BARRANTES FJ, 1975, P NATL ACAD SCI USA, V72, P3097, DOI 10.1073/pnas.72.8.3097; BLACHERE NE, 1993, J IMMUNOTHER, V14, P352, DOI 10.1097/00002371-199311000-00016; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; Boniface JJ, 1996, J EXP MED, V183, P119, DOI 10.1084/jem.183.1.119; Breloer M, 1998, EUR J IMMUNOL, V28, P1016, DOI 10.1002/(SICI)1521-4141(199803)28:03<1016::AID-IMMU1016>3.0.CO;2-G; Ciupitu AMT, 1998, J EXP MED, V187, P685, DOI 10.1084/jem.187.5.685; CREIGHTON, 1993, PROTEINS STRUCTURE M, P270; EGUSA S, 1985, MACROMOLECULES, V18, P882, DOI 10.1021/ma00147a011; ENGELKE M, 1994, CHEM PHYS LIPIDS, V72, P35, DOI 10.1016/0009-3084(94)90015-9; Engelke M, 1996, J MEMBRANE BIOL, V153, P117, DOI 10.1007/s002329900115; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GOROVITS BM, 1995, J BIOL CHEM, V270, P13057, DOI 10.1074/jbc.270.22.13057; Grosso VN, 1998, PHOTOCHEM PHOTOBIOL, V68, P481, DOI 10.1111/j.1751-1097.1998.tb02503.x; HAUGLAND RA, 1996, HDB FLUORESCENT PROB, P36; Heikema A, 1997, IMMUNOL LETT, V57, P69, DOI 10.1016/S0165-2478(97)00048-5; Janetzki S, 1998, J IMMUNOTHER, V21, P269, DOI 10.1097/00002371-199807000-00004; KNOPP JA, 1969, J BIOL CHEM, V244, P6309; LAKOWICZ JR, 1983, PRINCIPLES FLUORESCE, P75; Lammert E, 1997, EUR J IMMUNOL, V27, P923, DOI 10.1002/eji.1830270418; Lehrer S S, 1995, Subcell Biochem, V24, P115; Lehrer SS, 1997, METHOD ENZYMOL, V278, P286; LI ZH, 1993, EMBO J, V12, P3143, DOI 10.1002/j.1460-2075.1993.tb05983.x; Marusina K, 1997, BIOCHEMISTRY-US, V36, P856, DOI 10.1021/bi9619738; Nicchitta CV, 1998, CURR OPIN IMMUNOL, V10, P103, DOI 10.1016/S0952-7915(98)80039-3; Nieland TJF, 1996, P NATL ACAD SCI USA, V93, P6135, DOI 10.1073/pnas.93.12.6135; PAP EHW, 1995, J BIOL CHEM, V270, P1254, DOI 10.1074/jbc.270.3.1254; Przepiorka D, 1998, MOL MED TODAY, V4, P478, DOI 10.1016/S1357-4310(98)01345-8; Roman E, 1996, IMMUNOLOGY, V88, P487, DOI 10.1046/j.1365-2567.1996.d01-697.x; Spee P, 1997, EUR J IMMUNOL, V27, P2441, DOI 10.1002/eji.1830270944; Srivastava P K, 1991, Semin Immunol, V3, P57; Srivastava P. K., 1993, ADV CANCER RES, V62, P154; SRIVASTAVA PK, 1991, CURR TOP MICROBIOL, V167, P109; SRIVASTAVA PK, 1994, EXPERIENTIA, V50, P1054, DOI 10.1007/BF01923461; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; Srivastava PK, 1997, METHODS, V12, P165, DOI 10.1006/meth.1997.0464; STANFIELD RL, 1995, CURR OPIN STRUC BIOL, V5, P103, DOI 10.1016/0959-440X(95)80015-S; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; TURRO NJ, 1991, MODERN MOL PHOTOCHEM, P141; UDONO H, 1994, P NATL ACAD SCI USA, V91, P3077, DOI 10.1073/pnas.91.8.3077; UDONO H, 1994, J IMMUNOL, V152, P5398; VONHIPPEL PH, 1989, BIOL MACROMOL, P417; Wearsch PA, 1998, BIOCHEMISTRY-US, V37, P5709, DOI 10.1021/bi9801006; Wearsch PA, 1996, BIOCHEMISTRY-US, V35, P16760, DOI 10.1021/bi962068q; Wearsch PA, 1997, J BIOL CHEM, V272, P5152, DOI 10.1074/jbc.272.8.5152; WINNIK FM, 1993, CHEM REV, V93, P587, DOI 10.1021/cr00018a001	50	40	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12023	12035		10.1074/jbc.274.17.12023	http://dx.doi.org/10.1074/jbc.274.17.12023			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207025	hybrid			2022-12-27	WOS:000079834800081
J	Sato, H; Tamba, M; Ishii, T; Bannai, S				Sato, H; Tamba, M; Ishii, T; Bannai, S			Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-TRANSPORT; HUMAN-DIPLOID FIBROBLASTS; MOUSE PERITONEAL-MACROPHAGES; XENOPUS-LAEVIS OOCYTES; HEAVY-CHAIN; CYSTINE; GLUTAMATE; INDUCTION; ANTIGEN; IDENTIFICATION	Transport system x(c)(-) found in plasma membrane of cultured mammalian cells is an exchange agency for anionic amino acids with high specificity for anionic form of cystine and glutamate, We have isolated cDNA encoding the transporter for system x(c)(-) from mouse activated macrophages by expression in Xenopus oocytes. The expression of system x(c)(-) activity in oocytes required two cDNA transcripts, and the sequence analysis revealed that one is identical with the heavy chain of 4F2 cell surface antigen (4F2hc) and the other is a novel protein of 502 amino acids with 12 putative transmembrane domains. The latter protein, named xCT, showed a significant homology with those recently reported to mediate cationic or zwitterionic amino acid transport when co-expressed with 4F2hc, Thus xCT is a new member of a family of amino acid transporters that form heteromultimeric complex with 4F2hc, with a striking difference in substrate specificity. The expression of system x(c)(-) was highly regulated, and Northern blot analysis demonstrated that the expression of both 4F2hc and xCT was enhanced in macrophages stimulated by lipopolysaccharide or an electrophilic agent. However, the expression of xCT was more directly correlated with the system x(c)(-), activity.	Univ Tsukuba, Inst Basic Med Sci, Dept Biochem, Tsukuba, Ibaraki 3058575, Japan	University of Tsukuba	Bannai, S (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Dept Biochem, Tsukuba, Ibaraki 3058575, Japan.							BANNAI S, 1989, J BIOL CHEM, V264, P18480; BANNAI S, 1980, J BIOL CHEM, V255, P2372; BANNAI S, 1984, NATURE, V311, P308; BANNAI S, 1986, J BIOL CHEM, V261, P2256; BANNAI S, 1982, J CELL PHYSIOL, V112, P265, DOI 10.1002/jcp.1041120216; BANNAI S, 1981, J BIOL CHEM, V256, P5770; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5606, DOI 10.1073/pnas.89.12.5606; Chillaron J, 1996, J BIOL CHEM, V271, P17761, DOI 10.1074/jbc.271.30.17761; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; DEVES R, 1992, J PHYSIOL-LONDON, V454, P491, DOI 10.1113/jphysiol.1992.sp019275; Droge W, 1997, FASEB J, V11, P1077, DOI 10.1096/fasebj.11.13.9367343; Estevez R, 1998, FASEB J, V12, P1319, DOI 10.1096/fasebj.12.13.1319; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; Herzenberg LA, 1997, P NATL ACAD SCI USA, V94, P1967, DOI 10.1073/pnas.94.5.1967; ISHII T, 1992, ANN NY ACAD SCI, V663, P497, DOI 10.1111/j.1749-6632.1992.tb38714.x; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; SATO H, 1995, BIOCHEM J, V310, P547, DOI 10.1042/bj3100547; TAYLOR MA, 1987, DEV BIOL, V124, P287, DOI 10.1016/0012-1606(87)90480-5; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; WATANABE H, 1987, J EXP MED, V165, P628, DOI 10.1084/jem.165.3.628; WELLS RG, 1992, J BIOL CHEM, V267, P15285	23	689	728	8	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11455	11458		10.1074/jbc.274.17.11455	http://dx.doi.org/10.1074/jbc.274.17.11455			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206947	hybrid			2022-12-27	WOS:000079834800003
J	Yao, I; Hata, Y; Ide, N; Hirao, K; Deguchi, M; Nishioka, H; Mizoguchi, A; Takai, Y				Yao, I; Hata, Y; Ide, N; Hirao, K; Deguchi, M; Nishioka, H; Mizoguchi, A; Takai, Y			MAGUIN, a novel neuronal membrane-associated guanylate kinase-interacting protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; TUMOR-SUPPRESSOR PROTEIN; POSTSYNAPTIC DENSITY; PDZ DOMAIN; BINDING; FAMILY; PSD-95; RAS; RECOGNITION; NETWORKS	Postsynaptic density (PSD)-95/Synapse-associated protein (SAP) 90 and synaptic scaffolding molecule (S-SCAM) are neuronal membrane-associated guanylate kinases. Because PSD-95/SAP90 and S-SCAM function as synaptic scaffolding proteins, identification of ligands for these proteins is important to elucidate the structure of synaptic junctions. Here, we report a novel protein interacting with the PDZ domains of PSD-95/SAP90 and S-SCAM and named it MAGUIN-1 (membrane-associated guanylate kinase-interacting protein-1). MAGUIN-1 has one sterile alpha motif, one PDZ, and one plekstrin homology domain. MAGUIN-1 is localized at the plasma membrane via the plekstrin homology domain and the C-terminal region and interacts with PSD-95/SAP90 and S-SCAM via a C-terminal PDZ domain-binding moth, MAGUIN-1 has a short isoform, MAGUIN-2, which lacks a PDZ domain-binding motif, MAGUINs are expressed in neurons and localized in the cell body and neurites and are coimmunoprecipitated with PSD-95/SAP90 and S-SCAM hom rat crude synaptosome. MAGUIN-1 may play an important role with PSD-95/SAP90 and S-SCAM to assemble the components of synaptic junctions.	JCR Pharmaceut Co Ltd, Japan Sci & Technol Corp, Takai Biotimer Project Exploratory Res Adv Techno, Nishi Ku, Kobe, Hyogo 6512241, Japan; Kyoto Univ, Grad Sch, Dept Anat & Neurobiol, Kyoto 6068315, Japan; Osaka Univ, Sch Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan	Japan Science & Technology Agency (JST); Kyoto University; Osaka University	Takai, Y (corresponding author), JCR Pharmaceut Co Ltd, Japan Sci & Technol Corp, Takai Biotimer Project Exploratory Res Adv Techno, Nishi Ku, 2-2-10 Murotani, Kobe, Hyogo 6512241, Japan.							Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Deguchi M, 1998, J BIOL CHEM, V273, P26269, DOI 10.1074/jbc.273.41.26269; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fanning AS, 1996, CURR BIOL, V6, P1385, DOI 10.1016/S0960-9822(96)00737-3; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; GARNER C, 1996, TRENDS CELL BIOL, V19, P429; HAMMOND C, 1996, CELLULAR MOL NEUROBI, P20; Hata Y, 1998, NEUROSCI RES, V32, P1, DOI 10.1016/S0168-0102(98)00069-8; Hata Y, 1996, J NEUROSCI, V16, P2488; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Kennedy M B, 1993, Curr Opin Neurobiol, V3, P732, DOI 10.1016/0959-4388(93)90145-O; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KOMAU HC, 1995, SCIENCE, V269, P1737; Kurachi H, 1997, J BIOL CHEM, V272, P28081, DOI 10.1074/jbc.272.44.28081; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P102, DOI 10.1016/S0968-0004(00)88973-2; PONTING CP, 1995, PROTEIN SCI, V4, P1928, DOI 10.1002/pro.5560040927; RAMEZANI RM, 1992, MOL GEN GENET, V236, P145; Satoh K, 1997, GENES CELLS, V2, P415, DOI 10.1046/j.1365-2443.1997.1310329.x; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schultz J, 1997, PROTEIN SCI, V6, P249; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Telemenakis I, 1997, EUR J CELL BIOL, V74, P143; Therrien M, 1998, CELL, V95, P343, DOI 10.1016/S0092-8674(00)81766-3; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; WANG Y, 1991, MOL CELL BIOL, V11, P3554, DOI 10.1128/MCB.11.7.3554; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	47	61	68	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11889	11896		10.1074/jbc.274.17.11889	http://dx.doi.org/10.1074/jbc.274.17.11889			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207009	hybrid			2022-12-27	WOS:000079834800065
J	Easton, JB; Moody, NM; Zhu, XY; Middlemas, DS				Easton, JB; Moody, NM; Zhu, XY; Middlemas, DS			Brain-derived neurotrophic factor induces phosphorylation of fibroblast growth factor receptor substrate 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRK PROTOONCOGENE PRODUCT; TYROSINE KINASE-ACTIVITY; EAR SENSORY NEURONS; PROTEIN-KINASE; AUTOPHOSPHORYLATION SITES; PHEOCHROMOCYTOMA CELLS; SIGNAL-TRANSDUCTION; ADAPTER PROTEINS; SNT PROTEIN; HIPPOCAMPAL	Brain-derived neurotrophic factor (BDNF) promotes neuronal survival. Gaining an understanding of how BDNF, via the tropomyosin-related kinase B (TRKB) receptor, elicits specific cellular responses is of contemporary interest. Expression of mutant TrkB in fibroblasts, where tyrosine 484 was changed to phenylalanine, abrogated Shc association with TrkB, but only attenuated and did not block BDNF-induced phosphorylation of mitogen-activated protein kinase (MAPK), This suggests there is another BDNF-induced signaling mechanism for activating MAPK, which compelled a search for other TrkB substrates. BDNF induces phosphorylation of fibroblast growth factor receptor substrate 2 (FRS2) in both fibroblasts engineered to express TrkB and human neuroblastoma (NB) cells that naturally express TrkB, Additionally, BDNF induces phosphorylation of FRS2 in primary cultures of cortical neurons, thus showing that FRS2 is a physiologically relevant substrate of TrkB. Data are presented demonstrating that BDNF induces association of FRS2 with growth factor receptor-binding protein 2 (GRB2) in cortical neurons, fibroblasts, and NE cells, which in turn could activate the RAS/MAPK pathway. This is not dependent on Shc, since BDNF does not induce association of Shc and FRS2. Finally, the experiments suggest that FRS2 and sue-associated neurotrophic factor-induced tyrosine-phosphorylated target are the same protein.	St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Middlemas, DS (corresponding author), St Jude Childrens Res Hosp, Dept Mol Pharmacol, 332 N Lauderdale,POB 318, Memphis, TN 38101 USA.			Easton, John/0000-0003-4503-6608	NATIONAL CANCER INSTITUTE [R29CA071628, P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [CA 21765, 1 R29 CA 71628] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BASU T, 1994, ONCOGENE, V9, P3483; BUTLER WB, 1984, ANAL BIOCHEM, V141, P70, DOI 10.1016/0003-2697(84)90426-3; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; FURSHPAN EJ, 1989, NEURON, V3, P199, DOI 10.1016/0896-6273(89)90033-0; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Harlow E., 1988, ANTIBODIES LAB MANUA; HUFF K, 1981, J CELL BIOL, V88, P189, DOI 10.1083/jcb.88.1.189; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1994, FASEB J, V8, P738, DOI 10.1096/fasebj.8.10.8050673; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kwon YW, 1996, J NEUROBIOL, V29, P503; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MIDDLEMAS DS, 1994, J BIOL CHEM, V269, P5458; MIDDLEMAS DS, 1993, METHODS NEUROSCI, V12, P139; Minichiello L, 1995, DEVELOPMENT, V121, P4067; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; Novikov L, 1997, NEUROSCIENCE, V79, P765, DOI 10.1016/S0306-4522(96)00665-3; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; Ong SH, 1997, BIOCHEM BIOPH RES CO, V238, P261, DOI 10.1006/bbrc.1997.7272; Ong SH, 1996, BIOCHEM BIOPH RES CO, V225, P1021, DOI 10.1006/bbrc.1996.1288; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PENG X, 1995, NEURON, V15, P395, DOI 10.1016/0896-6273(95)90043-8; Pinon LGP, 1996, DEVELOPMENT, V122, P3255; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; RABIN SJ, 1993, MOL CELL BIOL, V13, P2203, DOI 10.1128/MCB.13.4.2203; Sawai H, 1996, J NEUROSCI, V16, P3887; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Schimmang T, 1997, MECH DEVELOP, V64, P77, DOI 10.1016/S0925-4773(97)00047-6; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; VANDERGEER P, 1995, CURR BIOL, V5, P404, DOI 10.1016/S0960-9822(95)00081-9; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xu H, 1998, J BIOL CHEM, V273, P17987, DOI 10.1074/jbc.273.29.17987; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324	50	29	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11321	11327		10.1074/jbc.274.16.11321	http://dx.doi.org/10.1074/jbc.274.16.11321			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196222	hybrid			2022-12-27	WOS:000079751900090
J	Goldsmith, PK; Fan, GF; Ray, K; Shiloach, J; McPhie, P; Rogers, KV; Spiegel, AM				Goldsmith, PK; Fan, GF; Ray, K; Shiloach, J; McPhie, P; Rogers, KV; Spiegel, AM			Expression, purification, and biochemical characterization of the amino-terminal extracellular domain of the human calcium receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE PHEROMONE RECEPTORS; HUMAN CA2+ RECEPTOR; SENSING RECEPTOR; CELL-SURFACE; CA2+-SENSING RECEPTOR; SIGNAL-TRANSDUCTION; GLUTAMATE RECEPTORS; CIRCULAR-DICHROISM; BINDING-PROTEINS; MULTIGENE FAMILY	We purified the extracellular domain (ECD) of the human calcium receptor (hCaR) from the medium of HEK-293 cells stably transfected with a hCaR cDNA containing an isoleucine 599 nonsense mutation. A combination of lectin, anion exchange, and gel permeation chromatography yielded milligram quantities of >95% pure protein from 15 liters of starting culture medium. The purified ECD ran as an similar to 78-kDa protein on SDS-polyacrylamide gel electrophoresis and was found to be a disulfide-linked dimer. Its NH2-terminal sequence, carbohydrate content, and CD spectrum were defined. Tryptic proteolysis studies showed two major sites accessible to cleavage. These studies provide new insights into the structure of the hCaR ECD. Availability of purified ECD protein should permit further structural studies to help define the mechanism of Ca2+ activation of this G protein-coupled receptor.	NIDDK, Metab Dis Branch, NIH, Bethesda, MD 20892 USA; NIDDK, Biotechnol Unit, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA; NPS Pharmaceut, Salt Lake City, UT 84108 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Spiegel, AM (corresponding author), NIDDK, Metab Dis Branch, NIH, 10-9N-222, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK043011] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 1998, ANNU REV MED, V49, P15, DOI 10.1146/annurev.med.49.1.15; Chattopadhyay N, 1997, BIOL CHEM, V378, P759; CONKLIN BR, 1994, NATURE, V367, P22, DOI 10.1038/367022a0; Fan GF, 1997, ENDOCRINOLOGY, V138, P1916, DOI 10.1210/en.138.5.1916; Fan GF, 1998, FEBS LETT, V436, P353, DOI 10.1016/S0014-5793(98)01165-X; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; GOLDSMITH P, 1987, J BIOL CHEM, V262, P14683; Goldsmith PK, 1997, J BONE MINER RES, V12, P1780, DOI 10.1359/jbmr.1997.12.11.1780; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MCPHIE P, 1992, ARCH BIOCHEM BIOPHYS, V293, P46, DOI 10.1016/0003-9861(92)90363-2; MITHAL A, 1995, ENDOCRINOLOGY, V136, P3087, DOI 10.1210/en.136.7.3087; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Ward DT, 1998, J BIOL CHEM, V273, P14476, DOI 10.1074/jbc.273.23.14476	25	56	56	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11303	11309		10.1074/jbc.274.16.11303	http://dx.doi.org/10.1074/jbc.274.16.11303			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196220	hybrid			2022-12-27	WOS:000079751900088
J	van den Berghe, N; Cool, RH; Wittinghofer, A				van den Berghe, N; Cool, RH; Wittinghofer, A			Discriminatory residues in Ras and Rap for guanine nucleotide exchange factor recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE ACTIVATION; H-RAS; SACCHAROMYCES-CEREVISIAE; DISSOCIATION STIMULATOR; DEPENDENT ACTIVATION; MOLECULAR MECHANISM; CATALYTIC DOMAIN; STRUCTURAL BASIS; ONCOGENIC RAS; AMINO-ACIDS	The inability of the S17N mutant of Rap1A to sequester the catalytic domain of the Rap guanine nucleotide exchange factor C3G (van den Berghe, N., Cool, R, H., Horn, G., and Wittinghofer, A. (1997) Oncogene 15, 845-850) prompted us to study possible fundamental differences in the way Rap1 interacts with C3G compared with the interaction of Ras with the catalytic domain of the mouse Ras guanine nucleotide exchange factor Cdc25(Mm), A variety of mutants in both Ras and Rap1A were designed, and both the C3G and Cdc25(Mm) catalyzed release of guanine nucleotide from these mutants was studied. In addition, we could identify regions in Rap2A that are responsible for the lack of recognition by C3G and induce high C3G activity by replacement of these residues with the corresponding Rap1A residues. The different Ras and Rap mutants showed that many residues were equally important for both C3G and Cdc25(Mm), suggesting that they interact similarly with their substrates, However, several residues were also identified to be important for the exchange reaction with only C3G (Leu(70)) or only Cdc25(Mm) (Gln(61) and Tyr(40)). These results are discussed in the light of the structure of the Ras-Sos complex and suggest that some important differences in the interaction of Rap1 with C3G and Ras with Cdc25(Mm) indeed exist and that marker residues have been identified for the different structural requirements.	Max Planck Inst Mol Physiol, Abt Strukt Biol, D-44139 Dortmund, Germany	Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Abt Strukt Biol, Rheinlanddamm 201, D-44139 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.d		Cool, Robbert/0000-0002-9845-2202				Akasaka K, 1996, J BIOL CHEM, V271, P5353, DOI 10.1074/jbc.271.10.5353; ALTSCHULER DL, 1995, J BIOL CHEM, V270, P10373, DOI 10.1074/jbc.270.18.10373; Altschuler DL, 1998, P NATL ACAD SCI USA, V95, P7475, DOI 10.1073/pnas.95.13.7475; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; Carrera V, 1998, FEBS LETT, V440, P291, DOI 10.1016/S0014-5793(98)01481-1; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DOWNWARD J, 1990, P NATL ACAD SCI USA, V87, P5998, DOI 10.1073/pnas.87.15.5998; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; HOWE LR, 1993, ONCOGENE, V8, P2583; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Ichiba T, 1997, J BIOL CHEM, V272, P22215, DOI 10.1074/jbc.272.35.22215; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Leonardsen L, 1996, ONCOGENE, V13, P2177; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; MARSHALL MS, 1991, MOL CELL BIOL, V11, P3997, DOI 10.1128/MCB.11.8.3997; MARTEGANI E, 1992, EMBO J, V11, P2151, DOI 10.1002/j.1460-2075.1992.tb05274.x; MEDEMA RH, 1993, CRIT REV ONCOGENESIS, V4, P615; MISTOU MY, 1992, EMBO J, V11, P2391, DOI 10.1002/j.1460-2075.1992.tb05303.x; MOSTELLER RD, 1994, MOL CELL BIOL, V14, P1104, DOI 10.1128/MCB.14.2.1104; MOSTELLER RD, 1995, METHOD ENZYMOL, V255, P135; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; NODA M, 1989, P NATL ACAD SCI USA, V86, P162, DOI 10.1073/pnas.86.1.162; Okada S, 1998, EMBO J, V17, P2554, DOI 10.1093/emboj/17.9.2554; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; POULLET P, 1995, EUR J BIOCHEM, V227, P537, DOI 10.1111/j.1432-1033.1995.tb20421.x; POWERS S, 1989, MOL CELL BIOL, V9, P390, DOI 10.1128/MCB.9.2.390; Quilliam LA, 1996, J BIOL CHEM, V271, P11076, DOI 10.1074/jbc.271.19.11076; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; SEGAL M, 1993, P NATL ACAD SCI USA, V90, P5564, DOI 10.1073/pnas.90.12.5564; SHIROUZU M, 1992, ONCOGENE, V7, P475; STACEY DW, 1991, MOL CELL BIOL, V11, P4053, DOI 10.1128/MCB.11.8.4053; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; vandenBerghe N, 1997, ONCOGENE, V15, P845, DOI 10.1038/sj.onc.1201407; VERROTTI AC, 1992, EMBO J, V11, P2855, DOI 10.1002/j.1460-2075.1992.tb05353.x; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; White MA, 1996, J BIOL CHEM, V271, P16439, DOI 10.1074/jbc.271.28.16439; WILLUMSEN BM, 1991, MOL CELL BIOL, V11, P6026, DOI 10.1128/MCB.11.12.6026; WITTINGHOFER A, 1995, FEBS LETT, V369, P52, DOI 10.1016/0014-5793(95)00667-X; Wolthuis RMF, 1997, EMBO J, V16, P6748, DOI 10.1093/emboj/16.22.6748; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; ZHANG K, 1991, SCIENCE, V254, P1630, DOI 10.1126/science.1749934; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	57	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11078	11085		10.1074/jbc.274.16.11078	http://dx.doi.org/10.1074/jbc.274.16.11078			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196191	hybrid			2022-12-27	WOS:000079751900059
J	Ayyoub, M; Mazarguil, H; Monsarrat, B; Van den Eynde, B; Gairin, JE				Ayyoub, M; Mazarguil, H; Monsarrat, B; Van den Eynde, B; Gairin, JE			A structure-based approach to designing non-natural peptides that can activate anti-melanoma cytotoxic T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CYTOLYTIC LYMPHOCYTES-T; CLASS-I MOLECULES; HIGH-AFFINITY; SYNTHETIC PEPTIDES; DRUG DEVELOPMENT; GENE MAGE-3; MHC; BINDING; STABILITY	Tumor antigens presented by major histocompatibility complex (MHC) class I molecules and recognized by CD8(+) cytotoxic T lymphocytes (CTLs) may generate an efficient antitumor immune response after appropriate immunization. Antigenic peptides can be used in vivo to induce antitumor or antiviral immunity. The efficiency of naked peptides may be greatly limited by their degradation in the biological fluids. We present a rational, structure-based approach to design structurally modified, peptidase-resistant and biologically active analogues of human tumor antigen MAGE-1.A1. This approach is based on our understanding of the peptide interaction with the MHC and the T cell receptor and its precise degradation pathway. Knowledge of these mechanisms led to the design of a non-natural, minimally modified analogue of MAGE-1.A1, [Aib(2),MMe-Ser(8)]MAGE-1.A1, which was highly peptidase-resistant and bound to MHC and activated MAGE-1.A1-specific anti-melanoma CTLs. Thus, we showed that it is possible to structurally modify peptide epitopes to obtain analogues that are still specifically recognized by CTLs. Such analogues may represent interesting leads for antitumor synthetic vaccines.	Inst Pharmacol & Biol Struct, CNRS, UPR 9062, F-31400 Toulouse, France; Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Ludwig Institute for Cancer Research	Gairin, JE (corresponding author), Inst Pharmacol & Biol Struct, CNRS, UPR 9062, 205 Route Narbonne, F-31400 Toulouse, France.	gairin@ipbs.fr	Ayyoub, Maha/G-2778-2013; Ayyoub, Maha/A-2074-2017	Ayyoub, Maha/0000-0003-2022-0898				AICHELE P, 1995, J EXP MED, V182, P261, DOI 10.1084/jem.182.1.261; BARINAGA M, 1992, SCIENCE, V257, P880, DOI 10.1126/science.1502554; BOON T, 1993, INT J CANCER, V54, P177, DOI 10.1002/ijc.2910540202; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Chen WS, 1996, J IMMUNOL, V157, P1000; DIBRINO M, 1994, J IMMUNOL, V152, P620; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; Fairchild PJ, 1996, IMMUNOL TODAY, V17, P80, DOI 10.1016/0167-5699(96)80584-6; FALO LD, 1992, P NATL ACAD SCI USA, V89, P8347, DOI 10.1073/pnas.89.17.8347; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; GUICHARD G, 1995, J BIOL CHEM, V270, P26057, DOI 10.1074/jbc.270.44.26057; GUICHARD G, 1994, P NATL ACAD SCI USA, V91, P9765, DOI 10.1073/pnas.91.21.9765; Guichard G, 1996, J MED CHEM, V39, P2030, DOI 10.1021/jm9509511; Herve M, 1997, MOL IMMUNOL, V34, P157, DOI 10.1016/S0161-5890(97)00004-7; Hu XY, 1996, CANCER RES, V56, P2479; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; HUDRISIER D, 1995, MOL IMMUNOL, V32, P895, DOI 10.1016/0161-5890(95)00043-E; Hudrisier D, 1996, J BIOL CHEM, V271, P17829, DOI 10.1074/jbc.271.30.17829; Hudrisier D, 1998, CURR TOP MICROBIOL, V232, P75; Jaeger E, 1996, INT J CANCER, V66, P162; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; Kondo A, 1997, IMMUNOGENETICS, V45, P249, DOI 10.1007/s002510050200; KOZLOWSKI S, 1992, J EXP MED, V175, P1417, DOI 10.1084/jem.175.6.1417; KOZLOWSKI S, 1993, J IMMUNOL, V151, P4033; LAMONT AG, 1990, J IMMUNOL, V144, P2493; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Maillere B, 1995, MOL IMMUNOL, V32, P1073, DOI 10.1016/0161-5890(95)00073-9; MALARKANNAN S, 1995, J IMMUNOL, V154, P585; MANDELBOIM O, 1995, NAT MED, V1, P1179, DOI 10.1038/nm1195-1179; Marchand M, 1995, INT J CANCER, V63, P883, DOI 10.1002/ijc.2910630622; Melief CJM, 1996, CURR OPIN IMMUNOL, V8, P651, DOI 10.1016/S0952-7915(96)80081-1; OJCIUS DM, 1994, J IMMUNOL, V152, P2798; POWELL MF, 1992, J PHARM SCI, V81, P731, DOI 10.1002/jps.2600810802; POWELL MF, 1993, PHARMACEUT RES, V10, P1268, DOI 10.1023/A:1018953309913; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; ROGNAN D, 1995, P NATL ACAD SCI USA, V92, P753, DOI 10.1073/pnas.92.3.753; ROMERO P, 1995, J EXP MED, V182, P1019, DOI 10.1084/jem.182.4.1019; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; SCHULZ M, 1991, P NATL ACAD SCI USA, V88, P991, DOI 10.1073/pnas.88.3.991; Toes REM, 1996, P NATL ACAD SCI USA, V93, P7855, DOI 10.1073/pnas.93.15.7855; TRAVERSARI C, 1992, J EXP MED, V176, P1453, DOI 10.1084/jem.176.5.1453; TRAVERSARI C, 1992, IMMUNOGENETICS, V35, P145, DOI 10.1007/BF00185107; Valmori D, 1998, J IMMUNOL, V160, P1750; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Verdoliva A, 1995, J BIOL CHEM, V270, P30422, DOI 10.1074/jbc.270.51.30422; WIDMANN C, 1991, J IMMUNOL, V147, P3745	48	13	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10227	10234		10.1074/jbc.274.15.10227	http://dx.doi.org/10.1074/jbc.274.15.10227			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187808	hybrid			2022-12-27	WOS:000079663500047
J	Higashi, S; Miyazaki, K				Higashi, S; Miyazaki, K			Reactive site-modified tissue inhibitor of metalloproteinases-2 inhibits the cell-mediated activation of progelatinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-TYPE-1 MATRIX METALLOPROTEINASE; IV COLLAGENASE; EXTRACELLULAR-MATRIX; CATALYTIC DOMAIN; TIMP-2; SURFACE; GELATINASE; PURIFICATION; FIBROBLASTS; EXPRESSION	Tissue inhibitor of metalloproteinases-a (TIMP-2) is supposed to play a regulatory role in the cell-mediated activation of progelatinase A To investigate the mechanism of the regulation, we prepared and characterized a chemically modified TIMP-2, and examined its effects on the activation of progelatinase A. We found that treatment of TIMP-2 with cyanate ion led to loss of inhibitory activity toward matrilysin or gelatinase A Structural and functional analyses of the modified TIMP-2 showed that carbamylation of the alpha-amino group of the NH2-terminal Cys(1) of TIMP-2 led to complete loss of the inhibitory activity. When the reactive-site modified TIMP-2 was added to culture medium of concanavalin A-stimulated HT1080 cells, the conversion of endogenous progelatinase A to the intermediate form was partially inhibited, whereas that of the intermediate form to the mature one was strongly inhibited. The reactive site-modified TIMP-2 also prevented an accumulation of active gelatinase A on the cell surface. We speculate that occupation of the hemopexin-like domain of gelatinase A by the reactive site-modified TIMP-2 makes it unable for gelatinase A to be retained on the cell surface, thus preventing the autocatalytic conversion of the intermediate fern of gelatinase A to its mature form.	Yokohama City Univ, Kihara Inst Biol Res, Div Cell Biol, Totsuka Ku, Yokohama, Kanagawa 244, Japan	Yokohama City University	Higashi, S (corresponding author), Yokohama City Univ, Kihara Inst Biol Res, Div Cell Biol, Totsuka Ku, Maioka Cho 641-12, Yokohama, Kanagawa 244, Japan.	shigashi@cserv2.yokohama-cu.ac.jp						Atkinson SJ, 1995, J BIOL CHEM, V270, P30479, DOI 10.1074/jbc.270.51.30479; AZZAM HS, 1992, CANCER RES, V52, P4540; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; BROWN PD, 1990, CANCER RES, V50, P6184; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; DOCHERTY AJP, 1992, TRENDS BIOTECHNOL, V10, P200, DOI 10.1016/0167-7799(92)90214-G; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Kinoshita T, 1996, CANCER RES, V56, P2535; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; Lichte A, 1996, FEBS LETT, V397, P277, DOI 10.1016/S0014-5793(96)01206-9; LIOTTA LA, 1986, CANCER RES, V46, P1; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; MIYAZAKI K, 1990, CANCER RES, V50, P7758; MIYAZAKI K, 1993, J BIOL CHEM, V268, P14387; OVERALL CM, 1990, J BIOL CHEM, V265, P21141; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato H, 1996, FEBS LETT, V385, P238, DOI 10.1016/0014-5793(96)00389-4; Shofuda K, 1998, J BIOCHEM-TOKYO, V124, P462, DOI 10.1093/oxfordjournals.jbchem.a022136; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; WARD RV, 1991, BIOCHIM BIOPHYS ACTA, V1079, P242, DOI 10.1016/0167-4838(91)90132-J; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; WILLIAMSON RA, 1993, BIOCHIM BIOPHYS ACTA, V1203, P147, DOI 10.1016/0167-4838(93)90049-W	28	44	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10497	10504		10.1074/jbc.274.15.10497	http://dx.doi.org/10.1074/jbc.274.15.10497			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187841	hybrid			2022-12-27	WOS:000079663500080
J	Messner, KR; Imlay, JA				Messner, KR; Imlay, JA			The identification of primary sites of superoxide and hydrogen peroxide formation in the aerobic respiratory chain and sulfite reductase complex of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE; XANTHINE-OXIDASE; FLAVOPROTEIN COMPONENT; FLAVIN MONONUCLEOTIDE; PROSTHETIC GROUPS; DNA-DAMAGE; HEMOFLAVOPROTEIN; ENTEROBACTERIA; DISMUTASE; RADICALS	The fitness of organisms depends upon the rate at which they generate superoxide (O-2(radical anion)) and hydrogen peroxide (H2O2) as toxic by-products of aerobic metabolism. In Escherichia coli these oxidants arise primarily from the autoxidation of components of its respiratory chain. Inverted vesicles that were incubated with NADH generated O-2(radical anion) and H2O2 at accelerated rates either when treated with cyanide or when devoid of quinones, implicating an NADH dehydrogenase as their source. Null mutations in the gene encoding NADH dehydrogenase II averted autoxidation of vesicles, and its overproduction accelerated it. Thus NADH dehydrogenase II but not NADH dehydrogenase I, respiratory quinones, or cytochrome oxidases formed substantial O2(radical) (anion) and H2O2. NADH dehydrogenase II that was purified from both wild-type and quinone-deficient cells generated similar to 130 H2O2 and 15 O-2(radical anion) min(-1) by autoxidation of its reduced FAD cofactor, Sulfite reductase is a second autoxidizable electron transport chain of E, coli, containing FAD, FMN, [4Fe-4S], and siroheme moieties, Purified flavoprotein that contained only the FAD and FMN cofactors had about the same oxidation turnover number as did the holoenzyme, 7 min(-1) FAD(-1). Oxidase activity was largely lost upon FMN removal. Thus the autoxidation of sulfite reductase, like that of the respiratory chain, occurs primarily by autoxidation of an exposed flavin cofactor. Great variability in the oxidation turnover numbers of these and other flavoproteins suggests that endogenous oxidants will be predominantly formed by only a few oxidizable enzymes. Thus the degree of oxidative stress in a cell may depend upon the titer of such enzymes and accordingly may vary with growth conditions and among different cell types. Furthermore, the chemical nature of these reactions was manifested by their acceleration at high temperatures and oxygen concentrations. Thus these environmental parameters may also directly affect the O2(radical anion) and H2O2 loads that organisms must bear.	Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Imlay, JA (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.		Messner, Kevin/J-2242-2014; Messner, Kevin/ABC-8801-2020	Messner, Kevin/0000-0003-2516-0695; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049640, T32GM007283, R37GM049640] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM07283-20, GM49640, R01 GM049640] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AU DCT, 1984, J BACTERIOL, V157, P122, DOI 10.1128/JB.157.1.122-125.1984; BOEHME DE, 1976, NATURE, V262, P418, DOI 10.1038/262418a0; BOVERIS A, 1984, METHOD ENZYMOL, V105, P429; BRANDT R, 1965, ANAL BIOCHEM, V11, P6, DOI 10.1016/0003-2697(65)90035-7; CALHOUN MW, 1993, J BACTERIOL, V175, P3013, DOI 10.1128/JB.175.10.3013-3019.1993; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Coves J, 1997, BIOCHEMISTRY-US, V36, P5921, DOI 10.1021/bi9623744; ESCHENBRENNER M, 1995, J BIOL CHEM, V270, P20550, DOI 10.1074/jbc.270.35.20550; FAEDER EJ, 1974, J BIOL CHEM, V249, P1599; FARR SB, 1986, P NATL ACAD SCI USA, V83, P8268, DOI 10.1073/pnas.83.21.8268; FLINT D H, 1990, P285; FLINT DH, 1993, J BIOL CHEM, V268, P22369; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; Fridovich I., 1982, SUPEROXIDE DISMUTASE, V1, P69; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GAUDU P, 1994, J BIOL CHEM, V269, P8182; GONZALEZFLECHA B, 1995, J BIOL CHEM, V270, P13681, DOI 10.1074/jbc.270.23.13681; Gort AS, 1998, J BACTERIOL, V180, P1402, DOI 10.1128/JB.180.6.1402-1410.1998; HILLE R, 1987, J BIOL CHEM, V262, P10914; HILLE R, 1981, J BIOL CHEM, V256, P9090; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; IMLAY JA, 1987, J BACTERIOL, V169, P2967, DOI 10.1128/jb.169.7.2967-2976.1987; IMLAY JA, 1995, J BIOL CHEM, V270, P19767; JAWOROWSKI A, 1981, BIOCHEMISTRY-US, V20, P3621, DOI 10.1021/bi00515a049; KESTON AS, 1965, ANAL BIOCHEM, V11, P1, DOI 10.1016/0003-2697(65)90034-5; KEYER K, 1995, J BACTERIOL, V177, P6782, DOI 10.1128/jb.177.23.6782-6790.1995; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; KUO CF, 1987, J BIOL CHEM, V262, P4724; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9; LIOCHEV SI, 1992, P NATL ACAD SCI USA, V89, P5892, DOI 10.1073/pnas.89.13.5892; LOEWEN PC, 1984, J BACTERIOL, V157, P622, DOI 10.1128/JB.157.2.622-626.1984; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MASSEY V, 1969, BIOCHEM BIOPH RES CO, V36, P891, DOI 10.1016/0006-291X(69)90287-3; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCCORD JM, 1971, P NATL ACAD SCI USA, V68, P1024, DOI 10.1073/pnas.68.5.1024; Miller J. H., 1972, EXPT MOL GENETICS, P432; MINGHETTI KC, 1988, BIOCHEM BIOPH RES CO, V155, P243; MISRA HP, 1977, ANAL BIOCHEM, V79, P553, DOI 10.1016/0003-2697(77)90429-8; MULLER F, 1987, FREE RADICAL BIO MED, V3, P215, DOI 10.1016/0891-5849(87)90009-8; OSTROWSKI J, 1989, J BIOL CHEM, V264, P15796; SAMBROOK J, 1989, MOL CLONING LAB MANU, pA6; SHAW DJ, 1981, MOL GEN GENET, V181, P95, DOI 10.1007/BF00339011; SIEGEL LM, 1974, J BIOL CHEM, V249, P1587; SIEGEL LM, 1973, J BIOL CHEM, V248, P251; SIEGEL LM, 1974, J BIOL CHEM, V249, P1572; SPIRO S, 1989, MOL MICROBIOL, V3, P601, DOI 10.1111/j.1365-2958.1989.tb00207.x; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P75, DOI 10.1016/0005-2728(77)90070-6; WU JY, 1991, J BACTERIOL, V173, P325, DOI 10.1128/jb.173.1.325-333.1991; YOUNG IG, 1976, BIOCHIM BIOPHYS ACTA, V449, P376, DOI 10.1016/0005-2728(76)90149-3; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	54	205	211	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10119	10128		10.1074/jbc.274.15.10119	http://dx.doi.org/10.1074/jbc.274.15.10119			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187794	hybrid			2022-12-27	WOS:000079663500033
J	Mizutani, K; Yamashita, H; Kurokawa, H; Mikami, B; Hirose, M				Mizutani, K; Yamashita, H; Kurokawa, H; Mikami, B; Hirose, M			Alternative structural state of transferrin - The crystallographic analysis of iron-loaded but domain-opened ovotransferrin N-lobe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL CHANGE; TERMINAL HALF-MOLECULE; HUMAN LACTOFERRIN; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; X-RAY; DUCK OVOTRANSFERRIN; HEN OVOTRANSFERRIN; SERUM TRANSFERRIN; OPEN FORM	Transferrins bind Fe3+ very tightly in a closed interdomain cleft by the coordination of four protein ligands (Asp(60), Tyr(92) Tyr(191) and His(250) in ovotransferrin N-lobe) and of a synergistic anion, physiologically bidentate CO32-. Upon Fe3+ uptake, transferrins undergo a large scale conformational transition: the apo structure with an opening of the interdomain cleft is transformed into the closed hole structure, implying initial Fe3+ binding in the open form. To solve the Fe3+-loaded, domain-opened structure, an ovotransferrin N-lobe crystal that had been grown as the apo form was soaked with Fe3+ -nitrilotriacetate, and its structure was solved at 2.1 Angstrom resolution. The Fe3+-soaked form showed almost exactly the same overall open structure as the iron-free apo form. The electron density map unequivocally proved the presence of an iron atom with the coordination by the two protein ligands of Tyr(92)-OH and Tyr(191)-OH. Other Fe3+ coordination sites are occupied by a nitrilotriacetate anion, which is stabilized through the hydrogen bonds with the peptide NH groups of Ser(122), Ala(123), and Gly(124) and a side chain group of Thr(117). There is, however, no clear interaction between the nitrilotriacetate anion and the synergistic anion binding site, Arg(121).	Kyoto Univ, Food Sci Res Inst, Uji, Kyoto 6110011, Japan	Kyoto University	Hirose, M (corresponding author), Kyoto Univ, Food Sci Res Inst, Uji, Kyoto 6110011, Japan.		Kurokawa, Hirofumi/A-7231-2010	Hirose, Masaaki/0000-0003-2672-4384				AISEN P, 1980, ANNU REV BIOCHEM, V49, P357, DOI 10.1146/annurev.bi.49.070180.002041; ANDERSON BF, 1990, NATURE, V344, P784, DOI 10.1038/344784a0; ANDERSON BF, 1989, J MOL BIOL, V209, P711, DOI 10.1016/0022-2836(89)90602-5; BAKER EN, 1992, J INORG BIOCHEM, V47, P147, DOI 10.1016/0162-0134(92)84061-Q; BAKER EN, 1987, TRENDS BIOCHEM SCI, V12, P350, DOI 10.1016/0968-0004(87)90163-0; BRUNGER AT, 1993, XPLOR VERSION 3 1 SY; DAY CL, 1993, J MOL BIOL, V232, P1084, DOI 10.1006/jmbi.1993.1462; DEWAN JC, 1993, BIOCHEMISTRY-US, V32, P11963, DOI 10.1021/bi00096a004; Faber HR, 1996, BIOCHEMISTRY-US, V35, P14473, DOI 10.1021/bi961729g; Faber HR, 1996, J MOL BIOL, V256, P352; GERSTEIN M, 1993, J MOL BIOL, V234, P357, DOI 10.1006/jmbi.1993.1592; GROSSMANN JG, 1993, J MOL BIOL, V229, P585, DOI 10.1006/jmbi.1993.1063; GROSSMANN JG, 1992, J MOL BIOL, V225, P811, DOI 10.1016/0022-2836(92)90402-6; Grossmann JG, 1998, J MOL BIOL, V279, P461, DOI 10.1006/jmbi.1998.1787; Jeffrey PD, 1998, BIOCHEMISTRY-US, V37, P13978, DOI 10.1021/bi9812064; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUROKAWA H, 1995, J MOL BIOL, V254, P196, DOI 10.1006/jmbi.1995.0611; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LINDLEY PF, 1993, ACTA CRYSTALLOGR D, V49, P292, DOI 10.1107/S0907444992012101; MacGillivray RTA, 1998, BIOCHEMISTRY-US, V37, P7919, DOI 10.1021/bi980355j; Mecklenburg SL, 1997, J MOL BIOL, V270, P739, DOI 10.1006/jmbi.1997.1126; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moore SA, 1997, J MOL BIOL, V274, P222, DOI 10.1006/jmbi.1997.1386; Nicholson H, 1997, BIOCHEMISTRY-US, V36, P341, DOI 10.1021/bi961908y; OE H, 1988, J BIOCHEM-TOKYO, V103, P1066, DOI 10.1093/oxfordjournals.jbchem.a122381; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; Rawas A, 1997, ACTA CRYSTALLOGR D, V53, P464, DOI 10.1107/S0907444997000838; SARRA R, 1990, ACTA CRYSTALLOGR B, V46, P763, DOI 10.1107/S0108768190006450; SCHLABACH MR, 1975, J BIOL CHEM, V250, P2182	29	56	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10190	10194		10.1074/jbc.274.15.10190	http://dx.doi.org/10.1074/jbc.274.15.10190			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187803	hybrid			2022-12-27	WOS:000079663500042
J	Muller, JMM; Meyer, HH; Ruhrberg, C; Stamp, GW; Warren, G; Shima, DT				Muller, JMM; Meyer, HH; Ruhrberg, C; Stamp, GW; Warren, G; Shima, DT			The mouse p97 (CDC48) gene - Genomic structure, definition of transcriptional regulatory sequences, gene expression, and characterization of a pseudogene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING PROTEIN; MEMBRANE-FUSION; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; TYROSINE PHOSPHORYLATION; MAMMALIAN HOMOLOG; ATPASE; VCP; LOCALIZATION; HYBRIDIZATION	Here we present the first description of the genomic organization, transcriptional regulatory sequences, and adult and embryonic gene expression for the mouse p97(CDC48) AAA ATPase. Clones representing two distinct p97 genes were isolated in a genomic library screen, one of them likely representing a non-functional processed pseudogene. The coding region of the gene encoding the functional mRNA is interrupted by 16 introns and encompasses 20.4 kilobase pairs. Definition of the transcriptional initiation site and sequence analysis showed that the gene contains a TATA-less, CC-rich promoter region with an initiator element spanning the transcription start site. Cis-acting elements necessary for basal transcription activity reside within 410 base pairs of the flanking region as determined by transient transfection assays. In immunohistological analyses, p97 was widely expressed in embryos and adults, but protein levels were tightly controlled in a cell type- and cell differentiation-dependent manner. A remarkable heterogeneity in p97 immunostaining was found on a cellular level within a given tissue, and protein amounts in the cytoplasm and nucleus varied widely, suggesting a highly regulated and intermittent function for p97, This study provides the basis for a detailed analysis of the complex regulation of p97 and the reagents required for assessing its functional significance using targeted gene manipulation in the mouse.	Imperial Canc Res Fund, Cell Biol Lab 624, London WC2A 3PX, England; Natl Inst Med Res, London NW7 1AA, England; Hammersmith Hosp, Imperial Coll, Sch Med, Dept Histopathol, London W12 0HS, England	Cancer Research UK; MRC National Institute for Medical Research; Imperial College London	Shima, DT (corresponding author), Imperial Canc Res Fund, Cell Biol Lab 624, 44 Lincolns Inn Fields, London WC2A 3PX, England.	shima@icrf.icnet.uk	Ruhrberg, Christiana/C-6404-2009; Meyer, Hemmo/GNH-5784-2022	Ruhrberg, Christiana/0000-0002-3212-9381; Meyer, Hemmo/0000-0003-1883-1796				ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; BERG K, 1983, GEOTEKTONISCHE FORSC, V66, P1; CONFALONIERI F, 1994, J MOL BIOL, V235, P396, DOI 10.1016/S0022-2836(05)80047-6; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; DUBIEL W, 1995, MOL BIOL REP, V21, P27, DOI 10.1007/BF00990967; EGERTON M, 1992, EMBO J, V11, P3533, DOI 10.1002/j.1460-2075.1992.tb05436.x; FEILER HS, 1995, EMBO J, V14, P5626, DOI 10.1002/j.1460-2075.1995.tb00250.x; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hoyle J, 1997, MAMM GENOME, V8, P778, DOI 10.1007/s003359900566; KOLLER KJ, 1987, NATURE, V325, P542, DOI 10.1038/325542a0; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; MOIR D, 1982, GENETICS, V100, P547; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; Pinter M, 1998, INSECT BIOCHEM MOLEC, V28, P91, DOI 10.1016/S0965-1748(97)00095-7; PLEASURE IT, 1993, NATURE, V365, P459, DOI 10.1038/365459a0; Poulsom R, 1998, EUR J HISTOCHEM, V42, P121; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Richardson MP, 1998, GENE, V206, P145, DOI 10.1016/S0378-1119(97)00586-6; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SCHULTE RJ, 1994, J IMMUNOL, V153, P5465; SENIOR PV, 1988, DEVELOPMENT, V104, P431; SHIBUYA H, 1992, NATURE, V357, P700, DOI 10.1038/357700a0; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; TOMOYASU T, 1993, J BACTERIOL, V175, P1352, DOI 10.1128/JB.175.5.1352-1357.1993; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; ZHANG L, 1994, J CELL BIOL, V127, P1871, DOI 10.1083/jcb.127.6.1871	32	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10154	10162		10.1074/jbc.274.15.10154	http://dx.doi.org/10.1074/jbc.274.15.10154			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187799	hybrid			2022-12-27	WOS:000079663500038
J	Shearstone, JR; Baneyx, F				Shearstone, JR; Baneyx, F			Biochemical characterization of the small heat shock protein IbpB from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; MOLECULAR CHAPERONE ACTIVITY; QUATERNARY STRUCTURE; A-CRYSTALLIN; IN-VITRO; 1,1'-BI(4-ANILINO)NAPHTHALENE-5,5'-DISULFONIC ACID; CELLULAR THERMORESISTANCE; GUANIDINE-HYDROCHLORIDE; H-1-NMR SPECTROSCOPY; HYDROPHOBIC SURFACES	Escherichia coli IbpB was overexpressed in a strain carrying a deletion in the chromosomal ibp operon and purified by refolding, Under our experimental conditions, IbpB exhibited pronounced size heterogeneity, Basic oligomers, roughly spherical and approximately 15 nn in diameter, interacted to form larger particles in the 100-200-nm range, which themselves associated to yield loose aggregates of micrometer size. IbpB suppressed the thermal aggregation of model proteins in a concentration-dependent manner, and its CD spectrum was consistent with a mostly P-pleated secondary structure. Incubation at high temperatures led to a partial loss of secondary structure, the progressive exposure of tryptophan residues to the solvent, the dissociation of high molecular mass aggregates into approximate to 600-kDa oligomers, and an increase in surface hydrophobicity, Structural changes were reversible between 37 and 55 degrees C, and, up to 55 degrees C, hydrophobic sites were reburied upon cooling. IbpB exhibited a biphasic unfolding trend upon guanidine hydrochloride (GdnHCl) treatment and underwent comparable conformational changes upon melting and during the first GdnHCl-induced transition. However, hydrophobicity decreased with increasing GdnHCl concentrations, suggesting that efficient exposure of structured hydrophobic sites involves denaturant-sensitive structural features. By contrast, IbpB hydrophobicity rose at high NaCl concentrations and increased further at high temperatures. Our results support a model in which temperature-driven conformational changes lead to the reversible exposure of normally shielded binding sites for nonnative proteins and suggest that both hydrophobicity and charge context may determine substrate binding to IbpB.	Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Baneyx, F (corresponding author), Univ Washington, Dept Chem Engn, Box 351750, Seattle, WA 98195 USA.			Shearstone, Jeffrey/0000-0002-6875-1826				ALLEN SP, 1992, J BACTERIOL, V174, P6938, DOI 10.1128/JB.174.21.6938-6947.1992; Arrigo AP, 1994, BIOL HEAT SHOCK PROT, P335; Ayling A, 1996, PROTEIN SCI, V5, P478; BEHLKE J, 1991, FEBS LETT, V288, P119, DOI 10.1016/0014-5793(91)81016-2; BOND U, 1987, ADV GENET, V24, P1, DOI 10.1016/S0065-2660(08)60005-X; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; CARVER JA, 1992, FEBS LETT, V311, P143, DOI 10.1016/0014-5793(92)81386-Z; CARVER JA, 1995, FEBS LETT, V369, P305, DOI 10.1016/0014-5793(95)00770-A; Chang ZY, 1996, J BIOL CHEM, V271, P7218, DOI 10.1074/jbc.271.12.7218; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; CHUANG SE, 1993, GENE, V134, P1, DOI 10.1016/0378-1119(93)90167-2; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; GERNOLD M, 1993, DEV GENET, V14, P103, DOI 10.1002/dvg.1020140204; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; HANSEN JE, 1994, J BIOL CHEM, V269, P6286; HANSEN JE, 1993, J BIOL CHEM, V268, P21632; HOROWITZ PM, 1995, J BIOL CHEM, V270, P1535, DOI 10.1074/jbc.270.4.1535; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jones PG, 1996, MOL MICROBIOL, V21, P1207, DOI 10.1111/j.1365-2958.1996.tb02582.x; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kim R, 1998, P NATL ACAD SCI USA, V95, P9129, DOI 10.1073/pnas.95.16.9129; KLEMENZ R, 1993, J CELL BIOL, V120, P639, DOI 10.1083/jcb.120.3.639; KNAUF U, 1994, EMBO J, V13, P54, DOI 10.1002/j.1460-2075.1994.tb06234.x; KOENIG SH, 1992, BIOPHYS J, V61, P776, DOI 10.1016/S0006-3495(92)81882-9; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; Laskowska E, 1996, BIOCHIMIE, V78, P117, DOI 10.1016/0300-9084(96)82643-5; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; Lee GJ, 1995, METHOD CELL BIOL, V50, P325, DOI 10.1016/S0091-679X(08)61040-7; LEE GJ, 1995, J BIOL CHEM, V270, P10432, DOI 10.1074/jbc.270.18.10432; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Leroux MR, 1997, J BIOL CHEM, V272, P12847, DOI 10.1074/jbc.272.19.12847; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; MERCK KB, 1993, J BIOL CHEM, V268, P1046; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; Muchowski PJ, 1998, P NATL ACAD SCI USA, V95, P1004, DOI 10.1073/pnas.95.3.1004; Muchowski PJ, 1997, J BIOL CHEM, V272, P2578; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; RAMAN B, 1994, J BIOL CHEM, V269, P27264; ROSENBERG HF, 1993, J BIOL CHEM, V268, P4499; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; SCHIRMER EC, 1994, PLANT CELL, V6, P1899, DOI 10.1105/tpc.6.12.1899; SEALE JW, 1995, BIOCHEMISTRY-US, V34, P7443, DOI 10.1021/bi00022a018; Seale JW, 1998, METHOD ENZYMOL, V290, P318, DOI 10.1016/S0076-6879(98)90028-3; SHAKOORI AR, 1992, J CELL BIOCHEM, V48, P277, DOI 10.1002/jcb.240480308; Sharma KK, 1998, J BIOL CHEM, V273, P15474, DOI 10.1074/jbc.273.25.15474; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; SIEZEN RJ, 1982, EXP EYE RES, V34, P969, DOI 10.1016/0014-4835(82)90077-X; SINGH M, 1970, J BIOL CHEM, V245, P4636; SPECTOR A, 1971, BIOCHEM J, V124, P337, DOI 10.1042/bj1240337; Sun TX, 1997, J BIOL CHEM, V272, P6220, DOI 10.1074/jbc.272.10.6220; TARDIEU A, 1986, J MOL BIOL, V192, P711, DOI 10.1016/0022-2836(86)90023-9; TAURA T, 1989, BIOCHEM BIOPH RES CO, V163, P438, DOI 10.1016/0006-291X(89)92155-4; Thomas JG, 1996, J BIOL CHEM, V271, P11141, DOI 10.1074/jbc.271.19.11141; Thomas JG, 1998, J BACTERIOL, V180, P5165, DOI 10.1128/JB.180.19.5165-5172.1998; TIFFANY ML, 1973, BIOPOLYMERS, V12, P575, DOI 10.1002/bip.1973.360120310; VANDENIJSSEL PRLA, 1994, FEBS LETT, V355, P54, DOI 10.1016/0014-5793(94)01175-3; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; ZHU X, 1996, NATURE, V272, P1606	64	88	91	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					9937	9945		10.1074/jbc.274.15.9937	http://dx.doi.org/10.1074/jbc.274.15.9937			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187768	hybrid			2022-12-27	WOS:000079663500007
J	Sweeney, G; Somwar, R; Ramlal, T; Volchuk, A; Ueyama, A; Klip, A				Sweeney, G; Somwar, R; Ramlal, T; Volchuk, A; Ueyama, A; Klip, A			An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-TRANSPORT; RAT ADIPOSE-CELLS; SKELETAL-MUSCLE CELLS; N-TERMINAL KINASE; GROWTH-FACTOR-I; MAP KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; INTRINSIC ACTIVITY; GLUT4-CONTAINING VESICLES; GLUT4 TRANSLOCATION	The precise mechanisms underlying insulin-stimulated glucose transport still require investigation. Here we assessed the effect of SB203580, an inhibitor of the p38 MAP kinase family, on insulin-stimulated glucose transport in 3T3-L1 adipocytes and L6 myotubes, We found that SB203580, but not its inactive analogue (SB202474), prevented insulin-stimulated glucose transport in both cell types with an IC50 similar to that for inhibition of p38 MAP kinase (0.6 mu M). Basal glucose uptake was not affected. Moreover, SB203580 added only during the transport assay did not inhibit basal or insulin-stimulated transport. SB203580 did not inhibit insulin-stimulated translocation of the glucose transporters GLUT1 or GLUT4 in 3T3-L1 adipocytes as assessed by immunoblotting of subcellular fractions or by immunofluorescence of membrane lawns. L6 muscle cells expressing GLUT4 tagged on an extracellular domain with a Myc epitope (GLUT4myc) were used to assess the functional insertion of GLUT4 into the plasma membrane. SB203580 did not affect the insulin-induced gain in GLUT4myc exposure at the cell surface but largely reduced the stimulation of glucose uptake. SB203580 had no effect on insulin-dependent insulin receptor substrate-1 phosphorylation, association of the p85 subunit of phosphatidylinositol 3-kinase with insulin receptor substrate-1, nor on pho sphatidylinositol 3-kinase, Akt1, Akt2, or Akt3 activities in 3T3-L1 adipocytes, In conclusion, in the presence of SB203580, insulin caused normal translocation and cell surface membrane insertion of glucose transporters without stimulating glucose transport. We propose that insulin stimulates two independent signals contributing to stimulation of glucose transport: phosphatidylinositol 3-kinase leads to glucose transporter translocation and a pathway involving p38 MAP kinase leads to activation of the recruited glucose transporter at the membrane.	Hosp Sick Children, Cell Biol Programme, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Klip, A (corresponding author), Hosp Sick Children, Cell Biol Programme, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.							Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; ARMONI M, 1995, ENDOCRINOLOGY, V136, P3292, DOI 10.1210/en.136.8.3292; Baldwin SA, 1995, BIOSCIENCE REP, V15, P419, DOI 10.1007/BF01204346; Barros LF, 1997, J PHYSIOL-LONDON, V504, P517, DOI 10.1111/j.1469-7793.1997.517bd.x; BASHAN N, 1993, AM J PHYSIOL, V264, pC430, DOI 10.1152/ajpcell.1993.264.2.C430; BILAN PJ, 1992, FEBS LETT, V298, P285, DOI 10.1016/0014-5793(92)80078-U; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Carel K, 1996, DIABETES, V45, P666; Clerk A, 1998, FEBS LETT, V426, P93, DOI 10.1016/S0014-5793(98)00324-X; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DENTON RM, 1995, EUR J BIOCHEM, V227, P597, DOI 10.1111/j.1432-1033.1995.tb20179.x; GOULD GW, 1995, BIOCHEM J, V311, P735, DOI 10.1042/bj3110735; Guo JH, 1998, J BIOL CHEM, V273, P16487, DOI 10.1074/jbc.273.26.16487; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; HARRISON SA, 1991, J BIOL CHEM, V266, P19438; Heidenreich KA, 1996, J BIOL CHEM, V271, P9891, DOI 10.1074/jbc.271.17.9891; HellerHarrison RA, 1996, J BIOL CHEM, V271, P10200, DOI 10.1074/jbc.271.17.10200; Holman GD, 1997, DIABETOLOGIA, V40, P991, DOI 10.1007/s001250050780; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; JOOST HG, 1987, MOL PHARMACOL, V31, P279; KARNIELI E, 1993, ENDOCRINOLOGY, V133, P2943, DOI 10.1210/en.133.6.2943; Katagiri H, 1997, AM J PHYSIOL-ENDOC M, V272, pE326, DOI 10.1152/ajpendo.1997.272.2.E326; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; KLIP A, 1988, BIOCHEM J, V255, P1023, DOI 10.1042/bj2551023; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee-Kwon W, 1998, BIOCHEMISTRY-US, V37, P15747, DOI 10.1021/bi9805947; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Meier R, 1996, EUR J BIOCHEM, V236, P796, DOI 10.1111/j.1432-1033.1996.00796.x; MITSUMOTO Y, 1992, J BIOL CHEM, V267, P4957; Moriguchi T, 1996, Adv Pharmacol, V36, P121, DOI 10.1016/S1054-3589(08)60579-7; Morris AJ, 1996, P NATL ACAD SCI USA, V93, P8401, DOI 10.1073/pnas.93.16.8401; Moxham CM, 1996, J BIOL CHEM, V271, P30765, DOI 10.1074/jbc.271.48.30765; Moyers JS, 1996, J BIOL CHEM, V271, P23111, DOI 10.1074/jbc.271.38.23111; Paul A, 1997, CELL SIGNAL, V9, P403, DOI 10.1016/S0898-6568(97)00042-9; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; Sharma PM, 1997, MOL CELL BIOL, V17, P7386, DOI 10.1128/MCB.17.12.7386; Shimizu Y, 1998, BIOCHEM J, V330, P397, DOI 10.1042/bj3300397; Somwar R, 1998, AM J PHYSIOL-ENDOC M, V275, pE618, DOI 10.1152/ajpendo.1998.275.4.E618; Somwar R, 1998, CLIN THER, V20, P125, DOI 10.1016/S0149-2918(98)80040-4; Sutherland C, 1997, DIABETES, V46, P17, DOI 10.2337/diabetes.46.1.17; Taha C, 1997, AM J PHYSIOL-ENDOC M, V273, pE68, DOI 10.1152/ajpendo.1997.273.1.E68; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; TSAKIRIDIS T, 1995, ENDOCRINOLOGY, V136, P4315, DOI 10.1210/en.136.10.4315; VANNUCCI SJ, 1992, BIOCHEM J, V288, P325, DOI 10.1042/bj2880325; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhou LX, 1997, J BIOL CHEM, V272, P29829, DOI 10.1074/jbc.272.47.29829; Zierler K, 1998, DIABETOLOGIA, V41, P724, DOI 10.1007/s001250050975	55	262	276	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10071	10078		10.1074/jbc.274.15.10071	http://dx.doi.org/10.1074/jbc.274.15.10071			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187787	hybrid			2022-12-27	WOS:000079663500026
J	Thome, M; Martinon, F; Hofmann, K; Rubio, V; Steiner, V; Schneider, P; Mattmann, C; Tschopp, J				Thome, M; Martinon, F; Hofmann, K; Rubio, V; Steiner, V; Schneider, P; Mattmann, C; Tschopp, J			Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-kappa B transcription factor and c-Jun N-terminal kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JNK/SAPK ACTIVATION; CYTOCHROME-C; APOPTOSIS; DEATH; PROTEINS; RECEPTOR; ADAPTER; MYD88; SEQUENCE; CASPASES	We have previously reported on the death effector domain containing E8 gene product from equine herpesvirus-a, designated FLICE inhibitory protein (v-FLIP), and on its cellular homologue, c-FLIP, which inhibit the activation of caspase-8 by death receptors, Here we report on the structure and function of the E10 gene product of equine herpesvirus-a, designated v-CARMEN, and on its cellular homologue, c-CARMEN, which contain a caspase-recruiting domain (CARD) motif, c-CARMEN is highly homologous to the viral protein in its N-terminal CARD motif but differs in its C-terminal extension. v-CARMEN and c-CARMEN interact directly in a CARD-dependent manner yet reveal different binding specificities toward members of the tumor necrosis factor receptor-associated factor (TRAF) family. v-CARMEN binds to TRAF6 and weakly to TRAF3 and, upon overexpression, potently induces the c-Jun N-terminal kinase (JNK), p38, and nuclear factor (NF)-kappa B transcriptional pathways. c-CARMEN or truncated versions thereof do not appear to induce JNK and NF-kappa B activation by themselves, nor do they affect the JNK and NF-kappa B activating potential of v-CARMEN, Thus, in contrast to the cellular homologue, v-CARMEN may have additional properties in its unique C terminus that allow for an autonomous activator effect on NF-B kappa and JNK, Through activation of NF-kappa B, V-CARMEN may regulate the expression of the cellular and viral genes important for viral replication.	Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland; Swiss Canc Res Inst, BIL Biomed Res Ctr, CH-1066 Epalinges, Switzerland	University of Lausanne	Tschopp, J (corresponding author), Univ Lausanne, Inst Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.		Martinon, Fabio/A-5575-2009; Hofmann, Kay/D-6714-2011; Thome, Margot/F-8167-2011	Martinon, Fabio/0000-0002-6969-822X; Hofmann, Kay/0000-0002-2289-9083; Thome, Margot/0000-0002-5656-2139; Schneider, Pascal/0000-0003-0677-9409				Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Bertin J, 1997, P NATL ACAD SCI USA, V94, P1172, DOI 10.1073/pnas.94.4.1172; BLAKESLEE JR, 1975, CAN J MICROBIOL, V21, P1940, DOI 10.1139/m75-281; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Hu SM, 1997, J BIOL CHEM, V272, P9621; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; McFadden G, 1998, SEMIN CELL DEV BIOL, V9, P359, DOI 10.1006/scdb.1998.0245; Mosialos G, 1997, SEMIN CANCER BIOL, V8, P121, DOI 10.1006/scbi.1997.0063; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Scheidereit C, 1998, NATURE, V395, P225, DOI 10.1038/26121; TELFORD EAR, 1995, J MOL BIOL, V249, P520, DOI 10.1006/jmbi.1995.0314; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tschopp J, 1998, CURR OPIN GENET DEV, V8, P82, DOI 10.1016/S0959-437X(98)80066-X; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	29	89	95	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					9962	9968		10.1074/jbc.274.15.9962	http://dx.doi.org/10.1074/jbc.274.15.9962			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187771	hybrid, Green Published			2022-12-27	WOS:000079663500010
J	Alvarez-Dominguez, C; Stahl, PD				Alvarez-Dominguez, C; Stahl, PD			Increased expression of Rab5a correlates directly with accelerated maturation of Listeria monocytogenes phagosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY ENDOCYTIC PATHWAY; GAMMA-INTERFERON; FUSION; CELLS; YEAST; MACROPHAGES; MECHANISMS; ACTIVATION; ENDOSOMES; ISOFORMS	Previous studies have shown that Listeria monocytogenes (LM) modulates phagocytic membrane traffic. Here we explore whether Rab5a, a GTPase associated with phagosome-endosome fusion, is related to phagosome maturation and to the intracellular survival of LM. Stable transfection of Rab5a cDNA into macrophages accelerates intracellular degradation of LM. Morphological studies confirmed that phagosome maturation and phagosome-lysosome fusion is enhanced by overexpression of Rab5a. Down-regulation experiments using antisense oligonucleotides targeted to the Rab5a mRNA efficiently reduced RabBa synthesis, reduced phagosome-endosome traffic, blocked phagosome-lysosome fusion, and extended intraphagosomal survival of LM. Down-regulation of Rab5a had no effect on LM internalization. Down-regulation of Rab5c had no effect on phagosome maturation and phagosome-lysosome fusion. The results indicate that RabBa controls early phagosome-endosome interactions and governs the maturation of the early phagosome leading to phagosome-lysosome fusion.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Stahl, PD (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.		Alvarez-Dominguez, Carmen/J-4675-2014	Alvarez-Dominguez, Carmen/0000-0002-4585-6959				Akhtar S, 1992, Trends Cell Biol, V2, P139, DOI 10.1016/0962-8924(92)90100-2; Alvarez-Dominguez C., 1995, Immunology and Infectious Diseases (Oxford), V5, P127; Alvarez-Dominguez C, 1998, J BIOL CHEM, V273, P33901, DOI 10.1074/jbc.273.51.33901; ALVAREZDOMINGUE.C, 1998, PHAGOCYTOSIS PATHOGE; AlvarezDominguez C, 1996, J BIOL CHEM, V271, P13834, DOI 10.1074/jbc.271.23.13834; AlvarezDominguez C, 1997, J CELL SCI, V110, P731; BARBIERI MA, 1994, J BIOL CHEM, V269, P18720; BERMUDEZ LE, 1993, CLIN EXP IMMUNOL, V91, P277; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; BUCCI C, 1994, P NATL ACAD SCI USA, V91, P5061, DOI 10.1073/pnas.91.11.5061; CHIANG MY, 1991, J BIOL CHEM, V266, P18162; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Field H, 1998, J BIOL CHEM, V273, P32102, DOI 10.1074/jbc.273.48.32102; HARDING CV, 1992, EUR J IMMUNOL, V22, P1865, DOI 10.1002/eji.1830220728; HIGGINBOTHAM JN, 1992, CLIN EXP IMMUNOL, V88, P492; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x; Jahraus A, 1998, J BIOL CHEM, V273, P30379, DOI 10.1074/jbc.273.46.30379; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; MAYORGA LS, 1991, J BIOL CHEM, V266, P6511; Pontow SE, 1996, J BIOL CHEM, V271, P30736, DOI 10.1074/jbc.271.48.30736; PORTNOY DA, 1992, CURR OPIN IMMUNOL, V4, P20, DOI 10.1016/0952-7915(92)90118-X; PORTNOY DA, 1989, J EXP MED, V170, P2141, DOI 10.1084/jem.170.6.2141; Scorneaux B, 1996, ANTIMICROB AGENTS CH, V40, P1225, DOI 10.1128/AAC.40.5.1225; SINGERKRUGER B, 1995, J CELL SCI, V108, P3509; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; STEINC A, 1989, OLIGODEOXYNUCLEOTIDE, P97; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Zerlauth G, 1996, INFECT IMMUN, V64, P2666, DOI 10.1128/IAI.64.7.2666-2672.1996	30	68	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11459	11462		10.1074/jbc.274.17.11459	http://dx.doi.org/10.1074/jbc.274.17.11459			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206948	hybrid			2022-12-27	WOS:000079834800004
J	Rudolph, AE; Stuckey, JA; Zhao, Y; Matthews, HR; Patton, WA; Moss, J; Dixon, JE				Rudolph, AE; Stuckey, JA; Zhao, Y; Matthews, HR; Patton, WA; Moss, J; Dixon, JE			Expression, characterization, and mutagenesis of the Yersinia pestis murine toxin, a phospholipase D superfamily member	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; D DEFINES; PHOSPHATASE; PHOSPHATIDYLCHOLINE; FAMILY; GENE; PHOSPHOHISTIDINE; IDENTIFICATION; INTERMEDIATE; PURIFICATION	A phospholipase D (PLD) superfamily was recently identified that contains proteins of highly diverse functions with the conserved motif HXKX(4)DX(6)G(G/S). The superfamily includes a bacterial nuclease, human and plant PLD enzymes, cardiolipin synthases, phosphatidylserine synthases, and the murine toxin from Yersinia pestis (Ymt), Ymt is particularly effective as a prototype for family members containing two conserved motifs, because it is smaller than many other two-domain superfamily enzymes, and it can be overexpressed, Large quantities of pure recombinant Ymt allowed the formation of diffraction-quality crystals for x-ray structure determination, Dimeric Ymt was shown to have PLD-like activity as demonstrated by the hydrolysis of phosphatidylcholine. Ymt also used bis(para-nitrophenol) phosphate as a substrate. Using these substrates, the amino acids essential for Ymt function were determined. Specifically, substitution of histidine or lysine in the conserved motifs reduced the turnover rate of bis(para-nitrophenol) phosphate by a factor of 10(4) and phospholipid turnover to an undetectable level. The role of the conserved residues in catalysis was further defined by the isolation of a radiolabeled phosphoenzyme intermediate, which identified a conserved histidine residue as the nucleophile in the catalytic reaction. Based on these data, a unifying two-step catalytic mechanism is proposed for this diverse family of enzymes.	Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA; Univ Calif Davis, Sch Med, Dept Biol Chem, Davis, CA 95616 USA; NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Dixon, JE (corresponding author), Univ Michigan, Dept Biol Chem, Sch Med, M5416 Med Sci Bldg I, Ann Arbor, MI 48109 USA.	jedixon@umich.edu			NIDDK NIH HHS [NIDDKD 18849] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018849] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOYER PD, 1962, J BIOL CHEM, V237, P3306; Brubaker R R, 1972, Curr Top Microbiol Immunol, V57, P111; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; BRUZIK K, 1984, BIOCHEMISTRY-US, V23, P1656, DOI 10.1021/bi00303a012; BURLAND V, 1995, NUCLEIC ACIDS RES, V23, P2105, DOI 10.1093/nar/23.12.2105; Butler T, 1983, PLAGUE OTHER YERSINI; Cao JX, 1997, VIRUS RES, V48, P11, DOI 10.1016/S0168-1702(96)01422-0; Cherepanov P A, 1991, Mol Gen Mikrobiol Virusol, P19; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; DUCLOS B, 1991, METHOD ENZYMOL, V201, P10; Exton JH, 1997, J BIOL CHEM, V272, P15579, DOI 10.1074/jbc.272.25.15579; Gottlin EB, 1998, P NATL ACAD SCI USA, V95, P9202, DOI 10.1073/pnas.95.16.9202; GUAN KL, 1991, J BIOL CHEM, V266, P17026; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; HIRAOKA S, 1991, J BIOCHEM, V110, P443, DOI 10.1093/oxfordjournals.jbchem.a123600; HULTQUIS.DE, 1968, BIOCHIM BIOPHYS ACTA, V153, P329, DOI 10.1016/0005-2728(68)90078-9; HULTQUIST DE, 1966, BIOCHEMISTRY-US, V5, P322, DOI 10.1021/bi00865a041; Koonin EV, 1996, TRENDS BIOCHEM SCI, V21, P242, DOI 10.1016/0968-0004(96)30024-8; Li LW, 1997, J BIOL CHEM, V272, P29403, DOI 10.1074/jbc.272.47.29403; POHLMAN RF, 1993, NUCLEIC ACIDS RES, V21, P4867, DOI 10.1093/nar/21.21.4867; Ponting CP, 1996, PROTEIN SCI, V5, P914; RAETZ CRH, 1987, BIOCHEMISTRY-US, V26, P4022, DOI 10.1021/bi00387a042; Rudge SA, 1998, J CELL BIOL, V140, P81, DOI 10.1083/jcb.140.1.81; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; TROPP BE, 1995, J BACTERIOL, V177, P5155, DOI 10.1128/jb.177.17.5155-5157.1995; VANETTEN RL, 1978, P NATL ACAD SCI USA, V75, P4784; WANG XM, 1994, J BIOL CHEM, V269, P20312; WEI YF, 1991, METHOD ENZYMOL, V200, P388; Xie Z, 1998, J BIOL CHEM, V273, P34679, DOI 10.1074/jbc.273.52.34679; YANG SF, 1967, J BIOL CHEM, V242, P477; ZHANG ZY, 1991, J BIOL CHEM, V266, P1516; Zhao Y, 1997, PROTEIN SCI, V6, P2655	34	93	104	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11824	11831		10.1074/jbc.274.17.11824	http://dx.doi.org/10.1074/jbc.274.17.11824			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207000	hybrid			2022-12-27	WOS:000079834800056
J	Schmidt, BZ; Fowler, NL; Hidvegi, T; Perlmutter, DH; Colten, HR				Schmidt, BZ; Fowler, NL; Hidvegi, T; Perlmutter, DH; Colten, HR			Disruption of disulfide bonds is responsible for impaired secretion in human complement factor H deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM DEGRADATION; CONSENSUS REPEAT UNITS; HOMOZYGOUS FACTOR-H; CYSTEINE RESIDUES; MENINGOCOCCAL DISEASE; REGULATORY PROTEINS; MEMBRANE-PROTEIN; HUMAN LYSOZYME; C2 DEFICIENCY; CDNA SEQUENCE	Factor H, a secretory glycoprotein composed of 20 short consensus repeat modules, is an inhibitor of the complement system. Previous studies of inherited factor H deficiency revealed single amino acid substitutions at conserved cysteine residues, on one allele arginine for cysteine 518 (C518R) and on the other tyrosine for cysteine 941 (C941Y) (Ault, B. H,, Schmidt, B, Z,, Fowler, N, L., Kashtan, C, E,, Ahmed, A. E,, Vogt, B, A., and Colten, H, R, (1997) J, Biol. Chem, 272, 25168-25175), To ascertain if the phenotype, impaired secretion of factor H, is due to the C518R substitution or the C941Y substitution and to ascertain the mechanism by which secretion is impaired, we studied COS-1 and HepG2 cells transfected with wild type and several mutant factor H molecules, The results showed markedly impaired secretion of both C518R and C941Y factor H as well as that of factor H molecules bearing alanine or arginine substitutions at the Cys(518)-Cys(546) disulfide bond (C518A, C546A, C546R, C518A-C546A), In each case, mutant factor H was retained in the endoplasmic reticulum and degraded relatively slowly as compared with most other mutant secretory and membrane proteins that are retained in the endoplasmic reticulum, These data indicate that impaired secretion of the naturally occurring C518R and C941Y mutant factor H proteins is due to disruption of framework-specific disulfide bonds in factor H short consensus repeat modules.	Washington Univ, Sch Med, Childrens Hosp, Dept Pediat,Div Gastroenterol & Nutr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Childrens Hosp, Dept Cell Biol,Div Gastroenterol & Nutr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Childrens Hosp, Dept Physiol,Div Gastroenterol & Nutr, St Louis, MO 63110 USA	St. Louis Children's Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL)	Perlmutter, DH (corresponding author), Washington Univ, Sch Med, Childrens Hosp, Dept Pediat,Div Gastroenterol & Nutr, 1 Childrens Pl, St Louis, MO 63110 USA.		Hidvegi, Tunda/A-8041-2008	Schmidt, Bela Z/0000-0003-1085-9372	NHLBI NIH HHS [HL37784] Funding Source: Medline; NIAID NIH HHS [AI24836] Funding Source: Medline; NIDDK NIH HHS [DK52526] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052526] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ault BH, 1997, J BIOL CHEM, V272, P25168, DOI 10.1074/jbc.272.40.25168; Ausubel FM., 2006, ENZYMATIC MANIPULATI; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; BARON M, 1991, TRENDS BIOCHEM SCI, V16, P13, DOI 10.1016/0968-0004(91)90009-K; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; BRAI M, 1988, J CLIN IMMUNOL, V8, P50, DOI 10.1007/BF00915156; DAY AJ, 1988, IMMUNOGENETICS, V27, P211, DOI 10.1007/BF00346588; DISCIPIO RG, 1992, J IMMUNOL, V149, P2592; Eikenboom JCJ, 1996, BLOOD, V88, P2433, DOI 10.1182/blood.V88.7.2433.bloodjournal8872433; Ernst SC, 1996, J IMMUNOL, V157, P405; FIJEN CAP, 1989, LANCET, V2, P585; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; FURUHASHI M, 1994, J BIOL CHEM, V269, P25543; GUENZI S, 1994, EUR J IMMUNOL, V24, P2477, DOI 10.1002/eji.1830241033; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Harlow E, 1988, ANTIBODIES LAB MANUA, P418; HASHIGUCHI T, 1995, J CLIN INVEST, V95, P1002, DOI 10.1172/JCI117744; HAVILAND DL, 1991, J IMMUNOL, V146, P362; HOGASEN K, 1995, J CLIN INVEST, V95, P1054, DOI 10.1172/JCI117751; Horton R M, 1997, Methods Mol Biol, V67, P141; JANATOVA J, 1989, BIOCHEMISTRY-US, V28, P4754, DOI 10.1021/bi00437a036; KULICS J, 1994, IMMUNOLOGY, V82, P509; LEVY M, 1986, KIDNEY INT, V30, P949, DOI 10.1038/ki.1986.278; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; LOPEZLARREA C, 1987, BIOCHEM SOC T, V15, P648, DOI 10.1042/bst0150648; MCCORMACK AL, 1995, J BIOL CHEM, V270, P3212, DOI 10.1074/jbc.270.7.3212; MIYAZAKI JI, 1986, P NATL ACAD SCI USA, V83, P757, DOI 10.1073/pnas.83.3.757; Nabil K, 1997, BIOCHEM J, V326, P377, DOI 10.1042/bj3260377; NAKANO Y, 1992, BIOCHIM BIOPHYS ACTA, V1116, P235, DOI 10.1016/0304-4165(92)90016-N; NIELSEN HE, 1989, SCAND J IMMUNOL, V30, P711, DOI 10.1111/j.1365-3083.1989.tb02480.x; NILSSON UR, 1965, J EXP MED, V122, P277, DOI 10.1084/jem.122.2.277; OMURA F, 1992, EUR J BIOCHEM, V205, P551, DOI 10.1111/j.1432-1033.1992.tb16812.x; PICHETTE V, 1994, AM J KIDNEY DIS, V24, P936, DOI 10.1016/S0272-6386(12)81065-1; Reddy P, 1996, EMBO J, V15, P2077, DOI 10.1002/j.1460-2075.1996.tb00561.x; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Sambrook J., 2002, MOL CLONING LAB MANU; SCHULZ TF, 1986, EUR J IMMUNOL, V16, P1351, DOI 10.1002/eji.1830161107; SEGAL MS, 1992, J CELL BIOL, V118, P227, DOI 10.1083/jcb.118.2.227; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; Soames CJ, 1997, BIOCHEM J, V326, P553, DOI 10.1042/bj3260553; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; SUGAHARA Y, 1994, THROMB HAEMOSTASIS, V72, P814; TANIYAMA Y, 1988, BIOCHEM BIOPH RES CO, V152, P962, DOI 10.1016/S0006-291X(88)80377-2; TARTAKOFF AM, 1983, J CELL BIOL, V97, P1243, DOI 10.1083/jcb.97.4.1243; Teckman JH, 1996, J BIOL CHEM, V271, P13215, DOI 10.1074/jbc.271.22.13215; THOMPSON RA, 1981, CLIN EXP IMMUNOL, V46, P110; Tran K, 1998, J BIOL CHEM, V273, P7244, DOI 10.1074/jbc.273.13.7244; TSAO YS, 1992, J CELL BIOL, V116, P57, DOI 10.1083/jcb.116.1.57; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; VIK DP, 1989, CURR TOP MICROBIOL I, V153, P147; VOGT BA, 1995, PEDIATR NEPHROL, V9, P11, DOI 10.1007/BF00858956; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Warwicker P, 1997, IMMUNOGENETICS, V46, P437, DOI 10.1007/s002510050300; Wetsel RA, 1996, J BIOL CHEM, V271, P5824, DOI 10.1074/jbc.271.10.5824; WU Y, 1994, P NATL ACAD SCI USA, V91, P9014, DOI 10.1073/pnas.91.19.9014; YUK MH, 1995, J BIOL CHEM, V270, P20169, DOI 10.1074/jbc.270.34.20169; ZIPFEL PF, 1994, IMMUNOL TODAY, V15, P121, DOI 10.1016/0167-5699(94)90155-4	58	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11782	11788		10.1074/jbc.274.17.11782	http://dx.doi.org/10.1074/jbc.274.17.11782			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206995	hybrid			2022-12-27	WOS:000079834800051
J	Taylor, VC; Buckley, CD; Douglas, M; Cody, AJ; Simmons, DL; Freeman, SD				Taylor, VC; Buckley, CD; Douglas, M; Cody, AJ; Simmons, DL; Freeman, SD			The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOGENOUS LEUKEMIA; IMMUNOGLOBULIN SUPERFAMILY; INHIBITORY RECEPTOR; CRYSTAL-STRUCTURE; PROGENITOR CELLS; SH2 DOMAIN; ANTIBODY; ANTIGEN; FAMILY; SIALOADHESIN	The myeloid restricted membrane glycoprotein, CD33, is a member of the recently characterized "sialic acid-binding immunoglobulin-related lectin" family. Although CD33 can mediate sialic acid-dependent cell interactions as a recombinant protein, its function in myeloid cells has yet to be determined. Since CD33 contains two potential immunoreceptor tyrosine-based inhibition motifs in its cytoplasmic tail, we investigated whether it might act as a signaling receptor in myeloid cells. Tyrosine phosphorylation of CD33 in myeloid cell lines was stimulated by cell surface cross-linking or by pervanadate, and inhibited by PP2, a specific inhibitor of Src family tyrosine kinases, Phosphorylated CD33 recruited both the protein-tyrosine phosphatases, SHP-1 and SHP-8. CD33 was dephosphorylated in vitro by the co-immunoprecipitated tyrosine phosphatases, suggesting that it might also be an in vivo substrate. The first CD33 phosphotyrosine motif is dominant in CD33-SHP-1/SHP-2 interactions, since mutating tyrosine 340 in a CD33-cytoplasmic tail fusion protein significantly reduced binding to SHP-1 and SHP-2 in THP-1 lysates, while mutation of tyrosine 358 had no effect. Furthermore, the NH2-terminal Src homology 2 domain of SHP-1 and SHP-8, believed to be essential for phosphatase activation, selectively bound a CD33 phosphopeptide containing tyrosine 340 but not one containing tyrosine 358, Finally, mutation of tyrosine 340 increased red blood cell binding by CD33 expressed in COS cells. Hence, CD33 signaling through selective recruitment of SHP-1/SHP-8 may modulate its ligand(s) binding activity.	John Radcliffe Hosp, Inst Mol Med, Cell Adhes Lab, Oxford OX3 9DU, England; Univ Birmingham, Dept Rheumatol, Birmingham B15 2TT, W Midlands, England; SmithKline Beecham Pharmaceut, Dept Neurosci, Harlow CM19 5AW, Essex, England	University of Oxford; University of Birmingham; GlaxoSmithKline	Freeman, SD (corresponding author), John Radcliffe Hosp, Inst Mol Med, Cell Adhes Lab, Oxford OX3 9DU, England.	freemans@icrf.icnet.uk		Cody, Alison/0000-0002-2868-6580; Freeman, Sylvie/0000-0003-1869-180X				APPELBAUM FR, 1992, TRANSPLANTATION, V54, P829, DOI 10.1097/00007890-199211000-00012; Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6; Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; Burshtyn DN, 1997, J BIOL CHEM, V272, P13066, DOI 10.1074/jbc.272.20.13066; Burshtyn DN, 1997, TRENDS CELL BIOL, V7, P473, DOI 10.1016/S0962-8924(97)01167-7; CARON PC, 1994, CANCER, V73, P1049, DOI 10.1002/1097-0142(19940201)73:3+<1049::AID-CNCR2820731344>3.0.CO;2-1; Cornish AL, 1998, BLOOD, V92, P2123, DOI 10.1182/blood.V92.6.2123.418k20_2123_2132; FREEMAN SD, 1995, BLOOD, V85, P2005, DOI 10.1182/blood.V85.8.2005.bloodjournal8582005; GRIFFIN JD, 1984, LEUKEMIA RES, V8, P521, DOI 10.1016/0145-2126(84)90001-8; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Huyer G, 1998, BIOCHEMISTRY-US, V37, P2741, DOI 10.1021/bi9722913; Kelm S, 1996, GLYCOCONJUGATE J, V13, P913, DOI 10.1007/BF01053186; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kuroiwa A, 1998, J BIOL CHEM, V273, P1070, DOI 10.1074/jbc.273.2.1070; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; Le Drean E, 1998, EUR J IMMUNOL, V28, P264, DOI 10.1002/(SICI)1521-4141(199801)28:01<264::AID-IMMU264>3.0.CO;2-O; MATUTES E, 1985, HEMATOL ONCOL, V3, P179, DOI 10.1002/hon.2900030306; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; ROBERTSON MJ, 1992, BLOOD, V79, P2229; SIMMONS D, 1988, J IMMUNOL, V141, P2797; Takei Y, 1997, CYTOGENET CELL GENET, V78, P295, DOI 10.1159/000134676; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; vanderMerwe PA, 1996, J BIOL CHEM, V271, P9273, DOI 10.1074/jbc.271.16.9273; Vely F, 1997, EUR J IMMUNOL, V27, P1994, DOI 10.1002/eji.1830270825; Vinson M, 1996, J BIOL CHEM, V271, P9267, DOI 10.1074/jbc.271.16.9267; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; Wu YJ, 1998, CURR BIOL, V8, P1009, DOI 10.1016/S0960-9822(07)00421-6	30	132	141	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11505	11512		10.1074/jbc.274.17.11505	http://dx.doi.org/10.1074/jbc.274.17.11505			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206955	Green Published, hybrid			2022-12-27	WOS:000079834800011
J	Bi, L; Okabe, I; Bernard, DJ; Wynshaw-Boris, A; Nussbaum, RL				Bi, L; Okabe, I; Bernard, DJ; Wynshaw-Boris, A; Nussbaum, RL			Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110 alpha subunit of phosphoinositide 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; REGULATORY SUBUNIT; P85-ALPHA GENE; INHIBITION; GROWTH; 3,4,5-TRISPHOSPHATE; WORTMANNIN; PATHWAYS; KINASES; CROSS	Phosphatidylinositol 3,4,5-trisphosphate is a phospholipid signaling molecule involved in many cellular functions including growth factor receptor signaling, cytoskeletal organization, chemotaxis, apoptosis, and protein trafficking. Phosphorylation at the 3 position of the inositol ring is catalyzed by many different 3-kinases (classified as types I-A, I-B, II, and III), but the physiological roles played by each of the different 3-kinase isozymes during embryonic development and in homeostasis in animals is incompletely understood, Mammalian type I-A kinase isozymes are heterodimers that are active at 37 degrees C when the catalytic 110-kDa subunit interacts through an amino-terminal binding domain with a regulatory 85- or 55-kDa subunit, Using gene targeting in embryonic stem cells, we deleted this binding domain in the gene encoding the alpha isoform of the 110-kDa catalytic subunit (Pik3ca) of the alpha isozyme of the type I-A kinases, leading to loss of expression of the p110 catalytic subunit. We show that Pik3ca(del/del) embryos are developmentally delayed at embryonic day (E) 9.5 and die between E9.5 and E10.5. E9.5 Pik3ca(del/del) embryos have a profound proliferative defect but no increase in apoptosis, A proliferative defect is supported by the observation that fibroblasts from Pik3ca(del/del) embryos fail to replicate in Dulbecco's modified Eagle's medium and fetal calf serum, even with supplemental growth factors.	NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Nussbaum, RL (corresponding author), NHGRI, Genet Dis Res Branch, NIH, 49 Convent Dr MSC 4472, Bethesda, MD 20892 USA.							ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Batty IH, 1997, BIOCHEM SOC T, V25, P1132, DOI 10.1042/bst0251132; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; CARPENTER CL, 1996, BIOCH BIOPHYS ACTA R, V1288, P11; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 1996, GENOMICS, V37, P113, DOI 10.1006/geno.1996.0527; FRY MJ, 1993, PHILOS T ROY SOC B, V340, P337, DOI 10.1098/rstb.1993.0076; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Harlow E, 1988, ANTIBODIES LABORATOR, P471; Hawkins PT, 1997, BIOCHEM SOC T, V25, P1147, DOI 10.1042/bst0251147; Inukai K, 1996, J BIOL CHEM, V271, P5317, DOI 10.1074/jbc.271.10.5317; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; KLIPPEL A, 1994, MOL CELL BIOL, V14, P2675, DOI 10.1128/MCB.14.4.2675; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LACY ER, 1991, GASTROENTEROLOGY, V100, P259, DOI 10.1016/0016-5085(91)90610-W; Marte BM, 1997, CURR BIOL, V7, P63, DOI 10.1016/S0960-9822(06)00028-5; Nave BT, 1996, BIOCHEM J, V318, P203, DOI 10.1042/bj3180203; OAKEY RJ, 1995, GENETICS, V141, P667; Oikawa T, 1996, EUR J PHARMACOL, V318, P93, DOI 10.1016/S0014-2999(96)00864-3; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RUGH R, 1993, MOUSE; Sambrook J., 2002, MOL CLONING LAB MANU; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; VANHAESEBROECK B, 1997, TRENDS BIOCHEM SCI, V22, P233; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WOSCHOLSKI R, 1994, J BIOL CHEM, V269, P25067; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	36	361	407	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10963	10968		10.1074/jbc.274.16.10963	http://dx.doi.org/10.1074/jbc.274.16.10963			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196176	hybrid			2022-12-27	WOS:000079751900044
J	Li, BL; Li, XL; Duan, ZJ; Lee, O; Lin, S; Ma, ZM; Chang, CCY; Yang, XY; Park, JP; Mohandas, TK; Noll, W; Chan, L; Chang, TY				Li, BL; Li, XL; Duan, ZJ; Lee, O; Lin, S; Ma, ZM; Chang, CCY; Yang, XY; Park, JP; Mohandas, TK; Noll, W; Chan, L; Chang, TY			Human acyl-CoA : cholesterol acyltransferase-1 (ACAT-1) gene organization and evidence that the 4.3-kilobase ACAT-1 mRNA is produced from two different chromosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; MESSENGER-RNA LEVELS; C-MYB PROTOONCOGENE; COENZYME-A; MOLECULAR-CLONING; INTERMOLECULAR RECOMBINATION; CODING SEQUENCES; MAMMALIAN-CELLS; HUMAN MONOCYTES; POINT MUTATION	Acyl-CoA:cholesterol acyltransferase (ACAT) plays important roles in cellular cholesterol homeostasis. Four human ACAT-1 mRNAs (7.0, 4.3, 3.6, and 2.8 kilobases (kb)) share the same short 5'-untranslated region (exon 1) and coding sequence (exons 2-15). The 4.3-kb mRNA contains an additional 5'-untranslated region (1289 nucleotides in length; exons X-a and X-b) immediately upstream from the exon 1 sequence. One ACAT-1 genomic DNA insert covers exons 1-16 and a promoter (the P1 promoter). A separate insert covers exon X-a (1277 base pairs) and a different promoter (the P7 promoter). Gene mapping shows that exons 1-16 and the P1 promoter sequences are located in chromosome 1, while exon X-a and the P7 promoter sequence are located in chromosome 7. RNase protection assays demonstrate three different protected fragments, corresponding to the 4.3 kb mRNA and the two other mRNAs transcribed from the two promoters. These results are consistent with the interpretation that the 4.3-kb mRNA is produced from two different chromosomes, by a novel RNA recombination mechanism involving trans-splicing of two discontinuous precursor RNAs.	Shanghai Inst Biochem, Shanghai, Peoples R China; Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03756 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Dartmouth College; Baylor College of Medicine; Baylor College of Medicine; Dartmouth College	Chang, TY (corresponding author), Shanghai Inst Biochem, Shanghai, Peoples R China.			Chang, Ta-Yuan/0000-0002-3249-0468	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036709, R01HL060306, R37HL036709, R37HL016512, R01HL016512] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 36709, HL 60306, HL 16512] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; BASU A, 1993, J BIOL CHEM, V268, P4188; BONEN L, 1993, FASEB J, V7, P40, DOI 10.1096/fasebj.7.1.8422973; CADIGAN KM, 1989, J CELL BIOL, V108, P2201, DOI 10.1083/jcb.108.6.2201; CADIGAN KM, 1988, J BIOL CHEM, V263, P274; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Caudevilla C, 1998, P NATL ACAD SCI USA, V95, P12185, DOI 10.1073/pnas.95.21.12185; CHANG CCY, 1995, J BIOL CHEM, V270, P29532; CHANG CCY, 1986, BIOCHEMISTRY-US, V25, P1693, DOI 10.1021/bi00355a038; Chang CCY, 1998, J BIOL CHEM, V273, P35132, DOI 10.1074/jbc.273.52.35132; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; CHANG CCY, 1994, SOMAT CELL MOLEC GEN, V20, P71, DOI 10.1007/BF02257489; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; CHEN JY, 1992, BIOCHEMISTRY-US, V31, P2400, DOI 10.1021/bi00123a027; CHENG D, 1995, J BIOL CHEM, V270, P685, DOI 10.1074/jbc.270.2.685; CHENG WL, 1995, AM J PHYSIOL-ENDOC M, V269, pE642, DOI 10.1152/ajpendo.1995.269.4.E642; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; DEANDRADE M, 1995, AM J HUM GENET, V56, P1379; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; DODGSON JB, 1983, J BIOL CHEM, V258, P4623; EDWARDS JBDM, 1991, NUCLEIC ACIDS RES, V19, P5227, DOI 10.1093/nar/19.19.5227; EUL J, 1995, EMBO J, V14, P3226, DOI 10.1002/j.1460-2075.1995.tb07325.x; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; HASAN MT, 1991, SOMAT CELL MOLEC GEN, V17, P513, DOI 10.1007/BF01233175; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; HUANG DH, 1988, J BIOL CHEM, V263, P12596; KING CR, 1983, CELL, V32, P707, DOI 10.1016/0092-8674(83)90056-9; KRAUSE BR, 1995, ACAT INHIBITORS PHYS, P173; Lee O, 1998, J LIPID RES, V39, P1722; Matsuda H, 1996, BBA-LIPID LIPID MET, V1301, P76, DOI 10.1016/0005-2760(96)00020-3; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Miyazaki A, 1998, ARTERIOSCL THROM VAS, V18, P1568, DOI 10.1161/01.ATV.18.10.1568; MULLICK J, 1995, BIOCHEMISTRY-US, V34, P13729, DOI 10.1021/bi00042a003; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; OHLSSON H, 1986, CELL, V45, P35, DOI 10.1016/0092-8674(86)90535-0; OSBORNE TF, 1987, P NATL ACAD SCI USA, V84, P3614, DOI 10.1073/pnas.84.11.3614; PAPE ME, 1995, J LIPID RES, V36, P823; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Sambrook J., 2002, MOL CLONING LAB MANU; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; SMITH JD, 1988, J BIOL CHEM, V263, P8300; SUCHI M, 1995, GENOMICS, V29, P98, DOI 10.1006/geno.1995.1219; SUCKLING KE, 1985, J LIPID RES, V26, P647; SULLIVAN PM, 1991, J BIOL CHEM, V266, P143; SUREAU A, 1991, CR ACAD SCI III-VIE, V312, P323; TABAS I, 1995, CURR OPIN LIPIDOL, V6, P260, DOI 10.1097/00041433-199510000-00004; TROUTT AB, 1992, P NATL ACAD SCI USA, V89, P9823, DOI 10.1073/pnas.89.20.9823; UELMEN PJ, 1995, J BIOL CHEM, V270, P26192, DOI 10.1074/jbc.270.44.26192; VELLARD M, 1992, P NATL ACAD SCI USA, V89, P2511, DOI 10.1073/pnas.89.7.2511; VELLARD M, 1991, ONCOGENE, V6, P505; Wang HX, 1996, ARTERIOSCL THROM VAS, V16, P809, DOI 10.1161/01.ATV.16.6.809; WILSON MD, 1994, J LIPID RES, V35, P943; WOOD KV, 1991, BIOLUMINESCENCE CHEM; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yu CJ, 1996, J BIOL CHEM, V271, P24157, DOI 10.1074/jbc.271.39.24157	57	102	111	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11060	11071		10.1074/jbc.274.16.11060	http://dx.doi.org/10.1074/jbc.274.16.11060			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196189	hybrid			2022-12-27	WOS:000079751900057
J	Li, J; Lin, ML; Wiepz, GJ; Guadarrama, AG; Bertics, PJ				Li, J; Lin, ML; Wiepz, GJ; Guadarrama, AG; Bertics, PJ			Integrin-mediated migration of murine B82L fibroblasts is dependent on the expression of an intact epidermal growth factor receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; FOCAL ADHESION KINASE; UROKINASE PLASMINOGEN-ACTIVATOR; CARCINOMA-CELLS A-431; EGF RECEPTOR; SELF-PHOSPHORYLATION; SIGNAL-TRANSDUCTION; CARBOXYL TERMINUS; PROTEIN-KINASE; FACTOR-ALPHA	To evaluate the mechanisms by which epidermal growth factor (EGF) regulates actin-based cellular processes such as cell migration, we first examined the effects of EGF on cell adhesion, which is essential for cell migration. In mouse B82L fibroblasts transfected with the full-length EGF receptor, EGF promotes cell Pounding and attenuates cell spreading on fibronectin, laminin, and vitronectin, and thus appears to reduce the strength of cell adhesion. Moreover, EGF synergizes with multiple extracellular matrix (ECM) components in the promotion of integrin-mediated cell migration of several different cell types, including fibroblasts and various carcinoma and osteosarcoma cell lilies. Interestingly, co-presentation (co-positioning) of EGF with laminin or fibronectin is essential for EGF-stimulated migration. When EGF is mixed with the cells instead of the ECM components, it has little effect on cell migration. These results suggest that co-presentation of EGF with ECM components can enhance the polarization events required for directional cell movement. To identify the EGF receptor elements critical for the EGF stimulation of cell migration, B82L fibroblasts were transfected with either mutated or wild-type EGF receptors, Surprisingly, we found that B82L-Parental cells that lack the EGF receptor are not able to migrate to fibronectin, even though they can adhere to fibronectin. However, the introduction of wild-type EGF receptors into these fibroblasts enables them to migrate toward fibronectin even in the absence of EGF, The requirement of the EGF receptor for cell migration does not appear to result from the secretion of EGF or TGF-alpha by the cells transfected with the EGF receptor. Furthermore, cells expressing EGF receptors that are kinase-inactive, or C-terminally truncated, exhibit little migration toward fibronectin, indicating that an intact EGF receptor kinase is required for fibronectin-induced cell migration. In addition, neutralizing anti-EGF receptor antibodies attenuate cell migration in the presence of EGF, and inhibit migration to fibronectin or laminin alone. These results further suggest that the EGF receptor is downstream of integrin activation in the signal transduction pathways leading to fibroblast migration.	Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Bertics, PJ (corresponding author), Univ Wisconsin, Dept Biomol Chem, 1300 Univ Ave, Madison, WI 53706 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053271] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD07259] Funding Source: Medline; NIGMS NIH HHS [R01 GM53271] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTFELD NS, 1993, J BIOL CHEM, V268, P17270; BASSON MD, 1992, J CLIN INVEST, V90, P15, DOI 10.1172/JCI115828; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BERTICS PJ, 1985, J BIOL CHEM, V260, P4642; BERTICS PJ, 1988, J BIOL CHEM, V263, P3610; BERTICS PJ, 1985, J CELL BIOCHEM, V29, P195, DOI 10.1002/jcb.240290304; BLAY J, 1985, J CELL PHYSIOL, V124, P107, DOI 10.1002/jcp.1041240117; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; CAMPOSGONZALEZ R, 1992, J BIOL CHEM, V267, P14535; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CASTRONOVO V, 1993, INVAS METAST, V13, P1; CHANG CP, 1991, J BIOL CHEM, V266, P23467; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; CHEN JD, 1993, EXP CELL RES, V209, P216, DOI 10.1006/excr.1993.1304; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; CHEN P, 1994, J CELL BIOL, V124, P547, DOI 10.1083/jcb.124.4.547; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; CHINKERS M, 1981, J CELL BIOL, V88, P422, DOI 10.1083/jcb.88.2.422; CHINKERS M, 1979, J CELL BIOL, V83, P260, DOI 10.1083/jcb.83.1.260; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DEDHAR S, 1996, CURR OPIN CELL BIOL, V8, P667; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; DUBAND JL, 1991, J CELL SCI, V98, P517; DUNLEVY JR, 1995, J CELL SCI, V108, P311; DUNLEVY JR, 1993, J CELL SCI, V105, P489; ENHENEGOUWEN PMPV, 1992, EXP CELL RES, V199, P90, DOI 10.1016/0014-4827(92)90465-K; EPPSTEIN DA, 1989, J CELL PHYSIOL, V141, P420, DOI 10.1002/jcp.1041410224; FUJII K, 1995, EXP CELL RES, V216, P261, DOI 10.1006/excr.1995.1032; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; GRONOWSKI AM, 1993, ENDOCRINOLOGY, V133, P2838, DOI 10.1210/en.133.6.2838; GRONOWSKI AM, 1995, ENDOCRINOLOGY, V136, P2198, DOI 10.1210/en.136.5.2198; HAAFUSA H, 1977, COMPREHENSIVE VIROL, V10, P401; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; KEELY PJ, 1995, J CELL SCI, V108, P595; KESSLER TL, 1991, SEMIN THROMB HEMOST, V17, P217, DOI 10.1055/s-2007-1002612; KLEMKE RL, 1994, J CELL BIOL, V127, P859, DOI 10.1083/jcb.127.3.859; KUIJPERS TW, 1993, J EXP MED, V178, P279, DOI 10.1084/jem.178.1.279; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; LIN ML, 1995, J CELL PHYSIOL, V164, P593, DOI 10.1002/jcp.1041640318; MATTHAY MA, 1993, J CELL SCI, V106, P869; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; NIEDBALA MJ, 1990, CANCER COMMUN, V2, P317; PANAYOTOU G, 1989, CELL, V56, P93, DOI 10.1016/0092-8674(89)90987-2; REGEN CM, 1992, J CELL BIOL, V119, P1347, DOI 10.1083/jcb.119.5.1347; RIJKEN PJ, 1991, AVIAT SPACE ENVIR MD, V62, P32; RORTH P, 1990, NUCLEIC ACIDS RES, V18, P5009, DOI 10.1093/nar/18.17.5009; ROY LM, 1989, J CELL PHYSIOL, V140, P295, DOI 10.1002/jcp.1041400215; SACHSENMAIER C, 1994, CELL, V78, P963, DOI 10.1016/0092-8674(94)90272-0; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Sastry SK, 1993, CURR OPIN CELL BIOL, V5, P819, DOI 10.1016/0955-0674(93)90031-K; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHLESSINGER J, 1981, EXP CELL RES, V134, P273, DOI 10.1016/0014-4827(81)90426-2; SCHMIDT CE, 1993, J CELL BIOL, V123, P977, DOI 10.1083/jcb.123.4.977; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; SIMONSEN CC, 1983, P NATL ACAD SCI USA, V80, P2485; Tryggvason K, 1993, CURR OPIN CELL BIOL, V5, P877, DOI 10.1016/0955-0674(93)90038-R; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANBELZEN N, 1990, J CELL PHYSIOL, V145, P365, DOI 10.1002/jcp.1041450223; VUORI K, 1994, SCIENCE, V266, P1575; WALTON GM, 1990, J BIOL CHEM, V265, P1750; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; WESTERMARK K, 1991, ENDOCRINOLOGY, V129, P2180, DOI 10.1210/endo-129-4-2180; WILSON LK, 1989, MOL CELL BIOL, V9, P1536, DOI 10.1128/MCB.9.4.1536; WU DY, 1993, J CELL BIOL, V123, P653, DOI 10.1083/jcb.123.3.653; Xie H, 1998, J CELL SCI, V111, P615; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3; YOSHIDA K, 1990, JPN J CANCER RES, V81, P793, DOI 10.1111/j.1349-7006.1990.tb02647.x	80	65	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11209	11219		10.1074/jbc.274.16.11209	http://dx.doi.org/10.1074/jbc.274.16.11209			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196208	hybrid			2022-12-27	WOS:000079751900076
J	Strausak, D; La Fontaine, S; Hill, J; Firth, SD; Lockhart, PJ; Mercer, JFB				Strausak, D; La Fontaine, S; Hill, J; Firth, SD; Lockhart, PJ; Mercer, JFB			The role of GMXCXXC metal binding sites in the copper-induced redistribution of the Menkes protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; TRANS-GOLGI NETWORK; LOW-COPY-NUMBER; DISEASE PROTEIN; FUNCTIONAL EXPRESSION; CANDIDATE GENE; INTRACELLULAR-LOCALIZATION; TRANSPORTING ATPASE; TRAFFICKING; ENCODES	The Menkes protein (MNK or ATP7A) is a transmembrane, copper-transporting CPX-type ATPase, a subgroup of the extensive family of P-type ATPases, A striking feature of the protein is the presence of six metal binding sites (MBSs) in the N-terminal region with the highly conserved consensus sequence GMXCXXC, MNK is normally located in the trans-Golgi network (TGN) but has been shown to relocalize to the plasma membrane when cells are cultured in media containing high concentrations of copper, The experiments described in this report test the hypothesis that the six MBSs are required for this copper-induced trafficking of MNR, Site-directed mutagenesis was used to convert both cysteine residues in the conserved MBS motifs to serines, Mutation of MBS 1, MBS 6, and MBSs 1-3 resulted in a molecule that appeared to relocalize normally with copper, but when MBSs 4-6 or MBSs 1-6 were mutated, MNK remained in the TGN, even when cells were exposed to 300 mu M copper, Furthermore, the ability of the MNK variants to relocalize corresponded well with their ability to confer copper resistance, To further define the critical motifs, MBS 5 and MBS 6 were mutated, and these changes abolished the response to copper. The region from amino acid 8 to amino acid 485 was deleted, resulting in mutant MNK that lacked 478 amino acids from the N-terminal region, including the first four MBSs. This truncated molecule responded normally to copper. Moreover, when either one of the remaining MBS 5 and MBS 6 was mutated to GMXSXXS, the resulting proteins were localized to the TGN in low copper and relocalized in response to elevated copper. These experiments demonstrated that the deleted N-terminal region from amino acid 8 to amino acid 485 was not essential for copper-induced trafficking and that one MBS close to the membrane channel of MNK was necessary and sufficient for the copper-induced redistribution.	Deakin Univ, Ctr Cellular & Mol Biol, Sch Biol & Chem Sci, Burwood, Vic 3125, Australia; Royal Childrens Hosp, Murdoch Inst Res Birth Defects, Parkville, Vic 3052, Australia	Deakin University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Mercer, JFB (corresponding author), Deakin Univ, Ctr Cellular & Mol Biol, Sch Biol & Chem Sci, Burwood Campus,221 Burwood Highway, Burwood, Vic 3125, Australia.		Lockhart, Paul J/E-7753-2011; Mercer, Julian/R-8583-2019; La Fontaine, Sharon/G-7113-2018	Lockhart, Paul J/0000-0003-2531-8413; La Fontaine, Sharon/0000-0002-9948-074X				BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; CAMAKARIS J, 1995, HUM MOL GENET, V4, P2117, DOI 10.1093/hmg/4.11.2117; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; DiDonato M, 1997, J BIOL CHEM, V272, P33279, DOI 10.1074/jbc.272.52.33279; Dierick HA, 1997, HUM MOL GENET, V6, P409, DOI 10.1093/hmg/6.3.409; Francis MJ, 1998, HUM MOL GENET, V7, P1245, DOI 10.1093/hmg/7.8.1245; FU DD, 1995, YEAST, V11, P283, DOI 10.1002/yea.320110310; Iida M, 1998, FEBS LETT, V428, P281, DOI 10.1016/S0014-5793(98)00546-8; JOHNSTONE A, 1987, IMMUNOCYTOCHEMISTRY, P50; Klomp LWJ, 1997, J BIOL CHEM, V272, P9221, DOI 10.1074/jbc.272.14.9221; La Fontaine S, 1998, HUM MOL GENET, V7, P1293, DOI 10.1093/hmg/7.8.1293; La Fontaine S, 1998, PLASMID, V39, P245, DOI 10.1006/plas.1997.1334; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; Lutsenko S, 1998, P NATL ACAD SCI USA, V95, P6004, DOI 10.1073/pnas.95.11.6004; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; ODERMATT A, 1993, J BIOL CHEM, V268, P12775; Payne AS, 1998, P NATL ACAD SCI USA, V95, P10854, DOI 10.1073/pnas.95.18.10854; Payne AS, 1998, J BIOL CHEM, V273, P3765, DOI 10.1074/jbc.273.6.3765; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Petris MJ, 1998, HUM MOL GENET, V7, P2063, DOI 10.1093/hmg/7.13.2063; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; Sambongi Y, 1997, J BIOCHEM-TOKYO, V121, P1169, DOI 10.1093/oxfordjournals.jbchem.a021711; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Tumer Z, 1997, AM J HUM GENET, V60, P63; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; VULPE CD, 1995, ANNU REV NUTR, V15, P293, DOI 10.1146/annurev.nu.15.070195.001453; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Yamaguchi Y, 1996, P NATL ACAD SCI USA, V93, P14030, DOI 10.1073/pnas.93.24.14030; Yang XL, 1997, BIOCHEM J, V326, P897, DOI 10.1042/bj3260897	32	138	138	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11170	11177		10.1074/jbc.274.16.11170	http://dx.doi.org/10.1074/jbc.274.16.11170			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196202	hybrid, Green Published			2022-12-27	WOS:000079751900070
J	Weisburg, JH; Roepe, PD; Dzekunov, S; Scheinberg, DA				Weisburg, JH; Roepe, PD; Dzekunov, S; Scheinberg, DA			Intracellular pH and multidrug resistance regulate complement-mediated cytotoxicity of nucleated human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; EXPRESSING DIFFERENT LEVELS; CYTOSOLIC PH; CHLORIDE CHANNELS; ALTERED PH(I); MDR PROTEIN; TUMOR-CELLS; GLYCOPROTEIN; TRANSPORTER; ATP	In previous work (Weisburg, J. H., Curcio, M., Caron, P. C., Raghi, G., Meehetner, E. B., Roepe, P. D., and Scheinberg, D, A. (1996) J. Exp. Med. 183, 2699-2704), we showed that multidrug resistance (MDR) cells created by continuous selection with the vinca alkaloid vincristine (HL60 RV+) or by retroviral infection (K562/human MDR 1 cells) exhibited significant resistance to complement-mediated cytotoxicity (CMC). This resistance was due to the presence of overexpressed P-glycoprotein (P-GP). In this paper, we probe the molecular mechanism of this phenomenon. We test whether the significant elevated intracellular pH (pH(i)) that accompanies P-GP overexpression is sufficient to confer resistance to CMC and whether this resistance is related to effects on complement function in the cell membrane. Control HL60 cells not expressing P-GP, but comparably elevated in cytosolic pH(i) by two independent methods (CO2 "conditioning" or isotonic Cl- substitution), are tested for CMC using two different antibody-antigen systems (human IgG and murine IgM; protein and carbohydrate) and two complement sources (rabbit and human). Elevation of pH, by either of these methods or by expression of P-GP confers resistance to CMC, Resistance is not observed when the alkalinization mediated by reverse Cl-/HCO3- exchange upon Cl- substitution is blocked by treatment with dihydro-4,4'-diisothiocyanostilbene-2,2'-disulfonate. Continuous photometric monitoring of 2',7'-bis(carboxyethyl)-5,6-carboxyfluorescein (BCECF), to assess changes in pH(i) or efflux of the probe through MAC pores, in single cells or cell populations, respectively, verifies changes in pH(i) upon CO2 conditioning and Cl- substitution and release of BCECF upon formation of MAC pores. Antibody binding and internalization kinetics are similar in both the parental and resistant cell lines as measured by radioimmunoassay, but flow cytometric data showed that net complement deposition in the cell membrane is both delayed and reduced in magnitude in the MDR cells and in the cells with increased pH(i). This interpretation is supported by comparison of BCECF release data for the different cells, Dual isotopic labeling of key complement components shows no significant change in molecular stoichiometry of the MACs formed at different pH(i). The results are relevant to understanding clinical implications of MDR, the physiology of P-GP, and the biochemistry of the complement cascade and further suggest that the "drug pump" model of P-GP action cannot account for all of its effects.	Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Therapeut, New York, NY 10021 USA; Georgetown Univ, Dept Chem, Washington, DC 20057 USA; Georgetown Univ, Lombardi Canc Ctr, Program Tumor Biol, Washington, DC 20057 USA	Memorial Sloan Kettering Cancer Center; Georgetown University; Georgetown University	Scheinberg, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Therapeut, 1275 York Ave, New York, NY 10021 USA.				NATIONAL CANCER INSTITUTE [R01CA055349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054516] Funding Source: NIH RePORTER; NCI NIH HHS [CA55349] Funding Source: Medline; NIGMS NIH HHS [GM54516] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM EH, 1993, P NATL ACAD SCI USA, V90, P312, DOI 10.1073/pnas.90.1.312; ALAWQATI Q, 1995, SCIENCE, V269, P805, DOI 10.1126/science.7543697; ANDREWS NW, 1990, CELL, V61, P1277, DOI 10.1016/0092-8674(90)90692-8; ASSHAR SS, 1984, PHARMACOL REV, V36, P223; CARON PC, 1992, CANCER RES, V52, P6761; ESSER AF, 1982, BIOL MEMBR, V4, P277; ESSER AF, 1979, P NATL ACAD SCI USA, V76, P1410, DOI 10.1073/pnas.76.3.1410; GILL DR, 1992, CELL, V71, P223; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; HARDY SP, 1995, EMBO J, V14, P68, DOI 10.1002/j.1460-2075.1995.tb06976.x; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Hoffman MM, 1997, BIOCHEMISTRY-US, V36, P11153, DOI 10.1021/bi970530g; Hoffman MM, 1996, J GEN PHYSIOL, V108, P295, DOI 10.1085/jgp.108.4.295; HUANG NN, 1992, BIOCHEM BIOPH RES CO, V182, P836, DOI 10.1016/0006-291X(92)91808-4; JACKSON MB, 1981, P NATL ACAD SCI-BIOL, V78, P6421, DOI 10.1073/pnas.78.10.6421; KEIZER HG, 1989, J NATL CANCER I, V81, P706, DOI 10.1093/jnci/81.9.706; LAW SKA, 1988, COMPLEMENT, P1; LUZ JG, 1994, BIOCHEMISTRY-US, V33, P7239, DOI 10.1021/bi00189a028; MIYAZAWA K, 1990, J IMMUNOL, V145, P650; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; RAMM LE, 1982, J IMMUNOL, V129, P1143; RESTREPO D, 1988, J GEN PHYSIOL, V92, P489, DOI 10.1085/jgp.92.4.489; REUTZ S, 1994, J BIOL CHEM, V269, P12277; Robinson LJ, 1997, BIOCHEMISTRY-US, V36, P11169, DOI 10.1021/bi9627830; Roepe PD, 1996, J BIOENERG BIOMEMBR, V28, P541, DOI 10.1007/BF02110444; ROEPE PD, 1994, BIOCHEMISTRY-US, V33, P11008, DOI 10.1021/bi00202a021; ROEPE PD, 1993, BIOCHEMISTRY-US, V32, P11042, DOI 10.1021/bi00092a014; ROEPE PD, 1992, BIOCHEMISTRY-US, V31, P12555, DOI 10.1021/bi00165a003; SCHEINBERG DA, 1989, LEUKEMIA, V3, P440; SIEGEL J, 1974, J EXP MED, V140, P631, DOI 10.1084/jem.140.3.631; TANIMOTO M, 1989, LEUKEMIA, V3, P339; THIEBAUT F, 1990, J HISTOCHEM CYTOCHEM, V38, P685, DOI 10.1177/38.5.1692055; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; TSCHOPP J, 1984, J BIOL CHEM, V259, P1922; VALVERDE MA, 1992, NATURE, V355, P830, DOI 10.1038/355830a0; VOLANAKIS JE, 1981, J IMMUNOL, V126, P1820; Wadkins RM, 1997, INT REV CYTOL, V171, P121; WARE CF, 1981, MOL IMMUNOL, V18, P521, DOI 10.1016/0161-5890(81)90130-9; Wei LY, 1997, AM J PHYSIOL-CELL PH, V272, pC1642, DOI 10.1152/ajpcell.1997.272.5.C1642; Weisburg JH, 1996, J EXP MED, V183, P2699, DOI 10.1084/jem.183.6.2699	41	45	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10877	10888		10.1074/jbc.274.16.10877	http://dx.doi.org/10.1074/jbc.274.16.10877			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196165	hybrid			2022-12-27	WOS:000079751900033
J	Pan, ZK; Christiansen, SC; Ptasznik, A; Zuraw, BL				Pan, ZK; Christiansen, SC; Ptasznik, A; Zuraw, BL			Requirement of phosphatidylinositol 3-kinase activity for bradykinin stimulation of NF-kappa B activation in cultured human epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PHOSPHOINOSITIDE 3-KINASE; TYROSINE PHOSPHORYLATION; SIGNALING PATHWAY; ADP-RIBOSYLATION; GENE-EXPRESSION; RHO; ZETA; RECEPTORS; 3,4,5-TRISPHOSPHATE	The signaling mechanisms utilized by bradykinin (BK) to activate the transcription factor nuclear factor kappa B (NF-kappa B) are poorly defined. We previously demonstrated that BK-stimulated NF-kappa B activation requires the small GTPase RhoA, We present evidence that BK-induced NF-kappa B activation both activates and requires phosphatidylinositol 3-kinase (PI 3-kinase) in A549 human epithelial cells. Pre-treatment with the PI 3-kinase-specific inhibitors, wortmannin, and LY294002 effectively blocked BK-induced PI 3-kinase activity. Wortmannin and LY294002 also abolished BK-induced NF-kappa B activation, as did transient transfection with a dominant negative mutant of the p85 subunit, BR-stimulated PI 3-kinase activity and NF-kappa B activation were sensitive to pertussis but not cholera toxin, suggesting that the B2 BK receptors transducing the response were coupled to G alpha i or G alpha o heterotrimeric G proteins. Tumor necrosis factor alpha (TNF alpha) also stimulated increased PI 3-kinase activity, however TNF alpha-stimulated NF-kappa B activation was not affected by the PI 3-kinase inhibitors or the p85 dominant negative mutant. These findings provide evidence that BK-induced NF-kappa B activation utilizes a signaling pathway that requires activity of both RhoA and PI 3-kinase and is distinct from the signaling pathway utilized by TNF alpha, Furthermore, we show that the p85 regulatory subunit is required for activation of PI 3-kinase activity by this G protein-coupled receptor.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Pediat, La Jolla, CA 92037 USA	Scripps Research Institute; University of California System; University of California San Diego	Zuraw, BL (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	zuraw@scripps.edu		Zuraw, Bruce/0000-0003-0640-6768	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036220, U19AI042244] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR00833] Funding Source: Medline; NIAID NIH HHS [AI42244, AI36220] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; BURNETTE WN, 1994, STRUCTURE, V2, P151, DOI 10.1016/S0969-2126(00)00017-4; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; DIAZMECO MT, 1994, EMBO J, V13, P2842, DOI 10.1002/j.1460-2075.1994.tb06578.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; Duronio V, 1998, CELL SIGNAL, V10, P233, DOI 10.1016/S0898-6568(97)00129-0; Edmead CE, 1996, J IMMUNOL, V157, P3290; FRY MJ, 1994, BBA-MOL BASIS DIS, V1226, P237, DOI 10.1016/0925-4439(94)90036-1; Gomez J, 1997, J IMMUNOL, V158, P1516; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HESS JF, 1992, BIOCHEM BIOPH RES CO, V184, P260, DOI 10.1016/0006-291X(92)91187-U; Hu ZW, 1996, J BIOL CHEM, V271, P8977, DOI 10.1074/jbc.271.15.8977; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KowalskiChauvel A, 1996, J BIOL CHEM, V271, P26356, DOI 10.1074/jbc.271.42.26356; KUMAGAI N, 1993, J BIOL CHEM, V268, P24535; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Musacchio A, 1996, P NATL ACAD SCI USA, V93, P14373, DOI 10.1073/pnas.93.25.14373; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NAKANISHI S, 1995, CELL SIGNAL, V7, P545, DOI 10.1016/0898-6568(95)00033-L; Pan ZK, 1996, J CLIN INVEST, V98, P2042, DOI 10.1172/JCI119009; Pan ZXK, 1998, J IMMUNOL, V160, P3038; Ptasznik A, 1996, J BIOL CHEM, V271, P25204, DOI 10.1074/jbc.271.41.25204; PTASZNIK A, 1995, J BIOL CHEM, V270, P19969, DOI 10.1074/jbc.270.34.19969; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Ren XD, 1998, CURR OPIN GENET DEV, V8, P63, DOI 10.1016/S0959-437X(98)80063-4; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Sontag E, 1997, EMBO J, V16, P5662, DOI 10.1093/emboj/16.18.5662; STEPHENS L, 1994, CURR BIOL, V4, P203, DOI 10.1016/S0960-9822(00)00049-X; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; TOKER A, 1994, J BIOL CHEM, V269, P32358; Virbasius JV, 1996, J BIOL CHEM, V271, P13304, DOI 10.1074/jbc.271.23.13304; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; Yanagihara Y, 1997, CELL IMMUNOL, V176, P66, DOI 10.1006/cimm.1996.1071; ZHANG J, 1995, J BIOL CHEM, V270, P6589, DOI 10.1074/jbc.270.12.6589; Zuraw BL, 1998, LUNG BIOL HEALTH DIS, V117, P783	40	52	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					9918	9922		10.1074/jbc.274.15.9918	http://dx.doi.org/10.1074/jbc.274.15.9918			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187765	hybrid			2022-12-27	WOS:000079663500004
J	Redding, K; Cournac, L; Vassiliev, IR; Golbeck, JH; Peltier, G; Rochaix, JD				Redding, K; Cournac, L; Vassiliev, IR; Golbeck, JH; Peltier, G; Rochaix, JD			Photosystem I is indispensable for photoautotrophic growth, CO2 fixation, and H-2 photoproduction in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOBACTERIUM OSCILLATORIA-LIMNETICA; FACULTATIVE ANOXYGENIC PHOTOSYNTHESIS; REACTION CENTERS; ELECTRON-TRANSFER; CROSS-LINKING; AMINO-ACIDS; PSAC GENE; CHLOROPLAST; DEFICIENT; MUTANTS	Certain Chlamydomonas reinhardtii mutants deficient in photosystem I due to defects in psaA mRNA maturation have been reported to be capable of CO2 fixation, H-2 photoevolution, and photoautotrophic growth (Greenbaum, E,, Lee, J. W,, Tevault, C, V., Blankinship, S, L,, and Mets, L, J, (1995) Nature 376, 438-441 and Lee, J, W., Tevault, C, V., Owens, T, G.; Greenbaum, E. (1996) Science 273, 364-367), We have generated deletions of photosystem I core subunits in both wild type and these mutant strains and have analyzed their abilities to grow photoautotrophically, to fix CO2, and to photoevolve O-2 or H-2 (using mass spectrometry) as well as their photosystem I content (using immunological and spectroscopic analyses). We find no instance of a strain that can perform photosynthesis in the absence of photosystem I. The F8 strain harbored a small amount of photosystem I, and it could fix CO2 and grow slowly, but it lost these abilities after deletion of either psaA or psaC; these activities could be restored to the F8-psaA Delta mutant by reintroduction of psaA, We observed limited O-2 photoevolution in mutants lacking photosystem I; use of O-18(2) indicated that this O-2 evolution is coupled to O-2 uptake (i.e. respiration) rather than CO2 fixation or H-2 evolution. We conclude that the reported instances of CO2 fixation, H-2 photoevolution, and photoautotrophic growth of photosystem I-deficient mutants result from the presence of unrecognized photosystem I.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Plant Biol, CH-1211 Geneva 4, Switzerland; CEA, CEN Cadarache, Dept Ecophysiol Vegetale & Microbiol, Lab Ecophysiol Photosynth, F-13108 St Paul Les Durance, France; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Geneva; University of Geneva; CEA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Redding, K (corresponding author), Univ Alabama, Dept Chem, 120 Lloyd Hall,6th Ave, Tuscaloosa, AL 35487 USA.	Kevin.Redding@mail.ua.edu	PELTIER, Gilles/ABD-4484-2021; Cournac, Laurent/G-2564-2010; Rochaix, Jean-David/ABC-5243-2020	PELTIER, Gilles/0000-0002-2226-3931; Redding, Kevin/0000-0003-2819-4022; Cournac, Laurent/0000-0003-0371-938X				ALBERTSSON PA, 1983, P NATL ACAD SCI-BIOL, V80, P3971, DOI 10.1073/pnas.80.13.3971; Arnon DI, 1995, PHOTOSYNTH RES, V46, P47, DOI 10.1007/BF00020416; ARNON DI, 1990, P NATL ACAD SCI USA, V87, P5930, DOI 10.1073/pnas.87.15.5930; BENNOUN P, 1977, MOL GEN GENET, V153, P343, DOI 10.1007/BF00431600; BENNOUN P, 1976, GENETICS BIOGENESIS, P33; Boichenko VA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P164; Boichenko VA, 1996, PHOTOSYNTH RES, V47, P291, DOI 10.1007/BF02184289; Brettel K, 1997, BBA-BIOENERGETICS, V1318, P322, DOI 10.1016/S0005-2728(96)00112-0; CHOQUET Y, 1988, CELL, V52, P903, DOI 10.1016/0092-8674(88)90432-1; COHEN Y, 1975, NATURE, V257, P489, DOI 10.1038/257489a0; COHEN Y, 1975, J BACTERIOL, V123, P855, DOI 10.1128/JB.123.3.855-861.1975; Cournac L, 1997, FEBS LETT, V416, P65, DOI 10.1016/S0014-5793(97)01170-8; DUYSENS LN, 1961, NATURE, V190, P510, DOI 10.1038/190510a0; EMERSON R, 1958, ANNU REV PLANT PHYS, V9, P1, DOI 10.1146/annurev.pp.09.060158.000245; FARAH J, 1995, EMBO J, V14, P4976, DOI 10.1002/j.1460-2075.1995.tb00180.x; FENTON JM, 1990, PHOTOSYNTH RES, V26, P59, DOI 10.1007/BF00048977; Fischer N, 1997, BIOCHEMISTRY-US, V36, P93, DOI 10.1021/bi962244v; Fischer N, 1996, MOL GEN GENET, V251, P373, DOI 10.1007/s004380050179; Gaffron Hans, 1942, JOUR GEN PHYSIOL, V26, P219, DOI 10.1085/jgp.26.2.219; GARLICK S, 1977, J BACTERIOL, V129, P623, DOI 10.1128/JB.129.2.623-629.1977; GIRARD J, 1980, CURR GENET, V2, P215, DOI 10.1007/BF00435689; GIRARDBASCOU J, 1987, CURR GENET, V12, P489, DOI 10.1007/BF00419557; GIRARDBASCOU J, 1987, CURR GENET, V12, P483, DOI 10.1007/BF00419556; GOLBECK JH, 1991, CURR TOP BIOENERG, V16, P83; GOLDSCHMIDTCLERMONT M, 1990, MOL GEN GENET, V223, P417, DOI 10.1007/BF00264448; GREENBAUM E, 1995, NATURE, V376, P438, DOI 10.1038/376438a0; GREENE EVARTS BOUTELL, 1898, P 1998 HYDR PROGR AN, P1; Hanley J, 1996, BIOCHEMISTRY-US, V35, P8563, DOI 10.1021/bi960399x; HARBINSON J, 1987, PLANT CELL ENVIRON, V10, P131, DOI 10.1111/j.1365-3040.1987.tb02089.x; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HILL R, 1960, NATURE, V186, P136, DOI 10.1038/186136a0; HOOBER JK, 1984, CHLOROPLASTS CELLULA; KLIMOV VV, 1982, BIOFIZIKA+, V27, P179; KLIMOV VV, 1977, FEBS LETT, V82, P183, DOI 10.1016/0014-5793(77)80580-2; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; KUCK U, 1987, EMBO J, V6, P2185, DOI 10.1002/j.1460-2075.1987.tb02489.x; Lee JW, 1996, SCIENCE, V273, P364, DOI 10.1126/science.273.5273.364; LELONG C, 1994, J BIOL CHEM, V269, P10034; LEVINE RP, 1968, SCIENCE, V162, P768, DOI 10.1126/science.162.3855.768; MYERS J, 1971, ANN REV PLANT PHYSIO, V22, P289, DOI 10.1146/annurev.pp.22.060171.001445; NICKELSEN J, 1994, EMBO J, V13, P3182, DOI 10.1002/j.1460-2075.1994.tb06617.x; PELTIER G, 1988, BIOCHIM BIOPHYS ACTA, V936, P319, DOI 10.1016/0005-2728(88)90007-2; Redding K, 1998, EMBO J, V17, P50, DOI 10.1093/emboj/17.1.50; SMART LB, 1991, EMBO J, V10, P3289, DOI 10.1002/j.1460-2075.1991.tb04893.x; STAEHELIN LA, 1984, J CELL BIOCHEM, V24, P261, DOI 10.1002/jcb.240240307; STIEHL HH, 1969, Z NATURFORSCH PT B, VB 24, P1588; STRYER L, 1995, BIOCHEMISTRY-US, P653; STUART TS, 1972, PLANTA, V106, P91, DOI 10.1007/BF00383989; STUART TS, 1972, PLANTA, V106, P101, DOI 10.1007/BF00383990; TAKAHASHI Y, 1994, PLANT MOL BIOL, V24, P779, DOI 10.1007/BF00029859; TAKAHASHI Y, 1991, EMBO J, V10, P2033, DOI 10.1002/j.1460-2075.1991.tb07733.x; TOELGE M, 1991, BIOCHIM BIOPHYS ACTA, V1060, P233, DOI 10.1016/S0005-2728(09)91011-8; TOGASAKI RK, 1986, PHOTOSYNTH RES, V10, P415, DOI 10.1007/BF00118307; TREBST A, 1974, ANNU REV PLANT PHYS, V25, P423, DOI 10.1146/annurev.pp.25.060174.002231; TRISSL HW, 1993, TRENDS BIOCHEM SCI, V18, P415, DOI 10.1016/0968-0004(93)90136-B	55	51	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10466	10473		10.1074/jbc.274.15.10466	http://dx.doi.org/10.1074/jbc.274.15.10466			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187837	Green Published, hybrid			2022-12-27	WOS:000079663500076
J	Sonoda, Y; Watanabe, S; Matsumoto, Y; Aizu-Yokota, E; Kasahara, T				Sonoda, Y; Watanabe, S; Matsumoto, Y; Aizu-Yokota, E; Kasahara, T			FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; GROWTH-FACTOR; BCL-2; HOMOLOG; DEATH; BAX; PHOSPHORYLATION; STIMULATION; FAMILY	Protein phosphorylation in a human glioblastoma cell line, T98G, was examined after exposure to oxidative stress in vitro. Hydrogen peroxide (1 mM) markedly induced tyrosine phosphorylation of focal adhesion kinase (FAK) and serine phosphorylation of Akt at 1 h after stimulation. Concommitantly, the association of FAK with phosphatidylinositide 3'-OH-kinase (PI 3-kinase) was also observed by the hydrogen peroxide stimulation. When T98G cells were incubated with wortmannin, a PI 3-kinase inhibitor, both PI 3-kinase activity and phosphorylation of Akt were inhibited, whereas apoptosis by oxidative stress was accelerated. Concomitant with apoptosis, elevated level of CPP32 protease activity (caspase-3) was observed, with decreases in Bcl-2 protein and increases in Pax protein. These results suggested that in the signal transduction pathway from FAR to PI 3-kinase, Akt promotes survival. Thus, it became apparent that FAK is the upstream signal protein of the PI 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis in T98G cells.	Kyoritsu Coll Pharm, Dept Biochem, Minato Ku, Tokyo 1058512, Japan	Keio University	Kasahara, T (corresponding author), Kyoritsu Coll Pharm, Dept Biochem, Minato Ku, Shibakoen 1-5-30, Tokyo 105, Japan.	kasahara-td@kyoritsu-ph.ac.jp	Aizu-Yokota, Eriko/AAH-1318-2020					Aritomi M, 1997, J BIOL CHEM, V272, P27886, DOI 10.1074/jbc.272.44.27886; Boersma AWM, 1997, CYTOMETRY, V27, P275, DOI 10.1002/(SICI)1097-0320(19970301)27:3<275::AID-CYTO10>3.0.CO;2-Q; CHEN HC, 1994, J BIOL CHEM, V269, P31229; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Motyl T, 1998, EUR J CELL BIOL, V75, P367, DOI 10.1016/S0171-9335(98)80070-8; NAKAMURA K, 1993, ONCOGENE, V8, P3133; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Qin SF, 1996, EUR J BIOCHEM, V236, P443, DOI 10.1111/j.1432-1033.1996.00443.x; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V91, P9931; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; SCHIEVEN GL, 1993, J BIOL CHEM, V268, P16688; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Sonoda Y, 1997, BIOCHEM BIOPH RES CO, V241, P769, DOI 10.1006/bbrc.1997.7895; Sonoda Y, 1997, J BIOL CHEM, V272, P15366, DOI 10.1074/jbc.272.24.15366; Suzuki Y, 1996, IMMUNOLOGY, V87, P396, DOI 10.1046/j.1365-2567.1996.431546.x; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; YANG E, 1995, CELL, V80, P585; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324	23	219	223	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10566	10570		10.1074/jbc.274.15.10566	http://dx.doi.org/10.1074/jbc.274.15.10566			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187851	hybrid			2022-12-27	WOS:000079663500090
J	Xu, PA; Winston, JH; Datta, SK; Kellems, RE				Xu, PA; Winston, JH; Datta, SK; Kellems, RE			Regulation of forestomach-specific expression of the murine adenosine deaminase gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INVOLUCRIN PROMOTER; DIFFERENTIATION-SPECIFIC EXPRESSION; KRUPPEL-LIKE FACTOR; ETS TRANSCRIPTION FACTORS; PROTEIN-KINASE-C; TRANSGENIC MICE; EPIDERMAL KERATINOCYTE; FLANKING SEQUENCES; SQUAMOUS EPITHELIA; PROXIMAL PROMOTER	The maturation of stratified squamous epithelium of the upper gastrointestinal tract is a highly ordered process of development and differentiation. Information on the molecular basis of this process is, however, limited. Here we report the identification of the first murine forestomach regulatory element using the murine adenosine deaminase (Ada) gene as a model. In the adult mouse, Ada is highly expressed in the terminally differentiated epithelial layer of upper gastrointestinal tract tissues. The data reported here represent the identification and detailed analysis of a 1.1-kilobase (kb) sequence located 3,4-kb upstream of the transcription initiation site of the murine Ada gene, which is sufficient to target caf reporter gene expression to the forestomach in transgenic mice. This 1.1-kb fragment is capable of directing caf reporter gene expression mainly to the forestomach of transgenic mice, with a level comparable to the endogenous Ada gene. This expression is localized to the appropriate cell types, confers copy number dependence, and shows the same developmental regulation. Mutational analysis revealed the functional importance of multiple transcription factor-binding sites.	Univ Texas, Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Kellems, RE (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	rkellems@bmb.med.uth.tmc.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046207] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46207] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBECHT U, 1997, MOL CELLULAR METHODS, P23; ARONOW B, 1989, GENE DEV, V3, P1384, DOI 10.1101/gad.3.9.1384; ARONOW BJ, 1995, MOL CELL BIOL, V15, P1123; ARONOW BJ, 1992, MOL CELL BIOL, V12, P4170, DOI 10.1128/MCB.12.9.4170; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; Bernerd Francoise, 1993, Gene Expression, V3, P187; BLACKBURN MR, 1995, J BIOL CHEM, V270, P23891, DOI 10.1074/jbc.270.41.23891; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; BYRNE C, 1993, MOL CELL BIOL, V13, P3176, DOI 10.1128/MCB.13.6.3176; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CARROLL JM, 1993, P NATL ACAD SCI USA, V90, P10270, DOI 10.1073/pnas.90.21.10270; CASATORRES J, 1994, J BIOL CHEM, V269, P20489; CHINSKY JM, 1990, DIFFERENTIATION, V42, P172, DOI 10.1111/j.1432-0436.1990.tb00759.x; Crish JF, 1998, J BIOL CHEM, V273, P30460, DOI 10.1074/jbc.273.46.30460; CRISH JF, 1993, DIFFERENTIATION, V53, P191, DOI 10.1111/j.1432-0436.1993.tb00708.x; DISEPIO D, 1995, J BIOL CHEM, V270, P10792, DOI 10.1074/jbc.270.18.10792; Dusing MR, 1997, J BIOL CHEM, V272, P26634, DOI 10.1074/jbc.272.42.26634; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; ECKERT RL, 1989, PHYSIOL REV, V69, P1316, DOI 10.1152/physrev.1989.69.4.1316; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; FRANKFURT OS, 1967, EXP CELL RES, V46, P603, DOI 10.1016/0014-4827(67)90387-4; FREDERIK.S, 1966, ARCH BIOCHEM BIOPHYS, V113, P383, DOI 10.1016/0003-9861(66)90202-5; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; FUCHS E, 1993, J CELL SCI, P197; GREEN H, 1981, COLD SPRING HARB SYM, V46, P293; HUFF CA, 1993, J BIOL CHEM, V268, P377; HUMMEL KP, 1966, BIOL LABORATORY MOUS, P263; Jenkins TD, 1997, J BIOL CHEM, V272, P24433, DOI 10.1074/jbc.272.39.24433; Jenkins TD, 1998, J BIOL CHEM, V273, P10747, DOI 10.1074/jbc.273.17.10747; JUAN TSC, 1993, P NATL ACAD SCI USA, V90, P2584, DOI 10.1073/pnas.90.7.2584; LaPres JJ, 1996, J BIOL CHEM, V271, P23154, DOI 10.1074/jbc.271.38.23154; LEASK A, 1991, P NATL ACAD SCI USA, V88, P7948, DOI 10.1073/pnas.88.18.7948; LEASK A, 1990, GENE DEV, V4, P1985, DOI 10.1101/gad.4.11.1985; Lee JH, 1996, J BIOL CHEM, V271, P4561; LopezBayghen E, 1996, J BIOL CHEM, V271, P512, DOI 10.1074/jbc.271.1.512; LU B, 1994, J BIOL CHEM, V269, P7443; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Moser M, 1997, DEV DYNAM, V208, P115, DOI 10.1002/(SICI)1097-0177(199701)208:1<115::AID-AJA11>3.0.CO;2-5; MOSER M, 1995, DEVELOPMENT, V121, P2779; Nakagawa H, 1997, ONCOGENE, V14, P1185, DOI 10.1038/sj.onc.1200937; Nakagawa H, 1997, J BIOL CHEM, V272, P16688, DOI 10.1074/jbc.272.26.16688; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oh HS, 1998, J INVEST DERMATOL, V110, P939, DOI 10.1046/j.1523-1747.1998.00199.x; Ohtsuki Mamitaro, 1993, Gene Expression, V3, P201; OuladAbdelghani M, 1996, EXP CELL RES, V225, P338, DOI 10.1006/excr.1996.0184; Pennisi E, 1997, SCIENCE, V275, P155, DOI 10.1126/science.275.5297.155; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rossi A, 1998, J INVEST DERMATOL, V110, P34, DOI 10.1046/j.1523-1747.1998.00071.x; ROWDEN G, 1967, J INVEST DERMATOL, V48, P571, DOI 10.1038/jid.1967.90; Sark MWJ, 1998, J BIOL CHEM, V273, P24683, DOI 10.1074/jbc.273.38.24683; SCHWEIZER J, 1988, CELL TISSUE RES, V253, P221; Shi DQ, 1997, J BIOL CHEM, V272, P2334, DOI 10.1074/jbc.272.4.2334; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Welter JF, 1996, J BIOL CHEM, V271, P11034; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; WINSTON JH, 1992, J BIOL CHEM, V267, P13472; Winston JH, 1996, SOMAT CELL MOLEC GEN, V22, P261, DOI 10.1007/BF02369566; YAMADA K, 1994, BIOCHEM MOL BIOL INT, V34, P827; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; YONEDA K, 1993, P NATL ACAD SCI USA, V90, P10754, DOI 10.1073/pnas.90.22.10754; ZHANG Y, 1993, MOL CELL BIOL, V13, P3831, DOI 10.1128/MCB.13.6.3831	64	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10316	10323		10.1074/jbc.274.15.10316	http://dx.doi.org/10.1074/jbc.274.15.10316			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187819	hybrid			2022-12-27	WOS:000079663500058
J	Guo, LN; Fatig, RO; Orr, GL; Schafer, BW; Strickland, JA; Sukhapinda, K; Woodsworth, AT; Petell, JK				Guo, LN; Fatig, RO; Orr, GL; Schafer, BW; Strickland, JA; Sukhapinda, K; Woodsworth, AT; Petell, JK			Photorhabdus luminescens W-14 insecticidal activity consists of at least two similar but distinct proteins - Purification and characterization of toxin A and toxin B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENORHABDUS-NEMATOPHILUS; BACILLUS-THURINGIENSIS; GALLERIA-MELLONELLA; HETERORHABDITIS-BACTERIOPHORA; ENTOMOPATHOGENIC NEMATODES; SYMBIOTIC BACTERIA; LARVAL GROWTH; BUSH LUPINE; GEN-NOV; ENTEROBACTERIACEAE	Both the bacterium Photorhabdus luminescens alone and its symbiotic Photorhabdus-nematode complex are known to be highly pathogenic to insects, The nature of the insecticidal activity of Photorhabdus bacteria was investigated for its potential application as an insect control agent. It was found that in the fermentation broth of P. luminescens strain W-14, at least two proteins, toxin A and toxin B, independently contributed to the oral insecticidal activity against Southern corn rootworm, Purified toxin A and toxin B exhibited single bands on native polyacrylamide gel electrophoresis and two peptides of 208 and 63 kDa on SDS-polyacrylamide gel electrophoresis. The native molecular weight of both the toxin A and toxin B was determined to be approximately 860 kDa, suggesting that they are tetrameric, NH2-terminal amino acid sequencing and Western analysis using monospecific antibodies to each toxin demonstrated that the two toxins were distinct but homologous, The oral potency (LD,,) of toxin A and toxin B against Southern corn rootworm larvae was determined to be similar to that observed with highly potent Bt toxins against lepidopteran pests, In addition, it was found that the two peptides present in toxin B could be processed in vitro from a 281-kDa protoxin by endogenous P. luminescens proteases. Proteolytic processing was shown to enhance insecticidal activity.	Dow AgroSci LLC, Input Agr Gene Discovery, Biotechnol, Indianapolis, IN 46268 USA	Dow Chemical Company	Petell, JK (corresponding author), Dow AgroSci LLC, Input Agr Gene Discovery, Biotechnol, Indianapolis, IN 46268 USA.							AKHURST R, 1993, NEMATODES AND THE BIOLOGICAL CONTROL OF INSECT PESTS, P127; Akhurst R., 2012, PARASITES PATHOGENS, P1; Akhurst R. J., 1990, Entomopathogenic nematodes in biological control., P75; AKHURST RJ, 1988, J GEN MICROBIOL, V134, P1835; AKHURST RJ, 1993, ENTOMOPATHOGENIC NEM, V2, P75; BALCERZAK M, 1991, Acta Parasitologica Polonica, V36, P175; Bintrim SB, 1998, J BACTERIOL, V180, P1261, DOI 10.1128/JB.180.5.1261-1269.1998; Boemare N, 1996, BIOCONTROL SCI TECHN, V6, P333, DOI 10.1080/09583159631316; BOEMARE NE, 1993, INT J SYST BACTERIOL, V43, P249, DOI 10.1099/00207713-43-2-249; Bovien P., 1937, Videnskabelige Meddelelser fra Dansk Naturhistorisk Forening i Kjobenhavn, V101, P1; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; BOWEN D, 1995, THESIS U WISCONSIN M; BOWEN D, 1987, P M AM SOC MICROBIOL, V183, P1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carlton BC., 1993, ADV ENG PESTICIDES, P43; CHRISPEELS MJ, 1991, PLANT CELL, V3, P1, DOI 10.1105/tpc.3.1.1; CLARKE DJ, 1995, J INVERTEBR PATHOL, V66, P149, DOI 10.1006/jipa.1995.1078; COUCHE GA, 1987, J BACTERIOL, V169, P5279, DOI 10.1128/jb.169.11.5279-5288.1987; DUNPHY GB, 1988, J GEN MICROBIOL, V134, P1017; DUNPHY GB, 1991, J INVERTEBR PATHOL, V58, P40, DOI 10.1016/0022-2011(91)90160-R; Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389; FARMER JJ, 1989, J CLIN MICROBIOL, V27, P1594, DOI 10.1128/JCM.27.7.1594-1600.1989; Forst S, 1996, MICROBIOL REV, V60, P21, DOI 10.1128/MMBR.60.1.21-43.1996; Gaertner F.H., 1993, ADV ENG PESTICIDES, P73; GERRITSEN LJM, 1993, FUND APPL NEMATOL, V16, P367; GOTZ P, 1981, PROC R SOC SER B-BIO, V212, P333, DOI 10.1098/rspb.1981.0043; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; Hilder V.A., 1993, TRANSGENIC PLANTS, V1, P317; HOFTE H, 1989, MICROBIOL REV, V53, P242; JAROSZ J, 1991, ENTOMOPHAGA, V36, P361, DOI 10.1007/BF02377940; Klein M. G., 1990, Entomopathogenic nematodes in biological control., P195; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOBO AL, 1994, METHOD ENZYMOL, V235, P667; MIDDLEBROOK JL, 1984, MICROBIOL REV, V48, P199, DOI 10.1128/MMBR.48.3.199-221.1984; MILSTEAD JE, 1979, J INVERTEBR PATHOL, V33, P324, DOI 10.1016/0022-2011(79)90033-8; Nealson K. H., 1990, Entomopathogenic nematodes in biological control., P271; ORR GL, 1994, J INSECT PHYSIOL, V40, P893, DOI 10.1016/0022-1910(94)90023-X; POINAR GO, 1967, J INVERTEBR PATHOL, V9, P510, DOI 10.1016/0022-2011(67)90131-0; POINAR GO, 1966, NEMATOLOGICA, V12, P105, DOI 10.1163/187529266X00068; PURCELL JP, 1993, BIOCHEM BIOPH RES CO, V196, P1406, DOI 10.1006/bbrc.1993.2409; Qin X. X. (et al.), 1988, Forest Research, V1, P179; ROSE RI, 1973, J ECON ENTOMOL, V66, P398, DOI 10.1093/jee/66.2.398; RUPAR MJ, 1991, APPL ENVIRON MICROB, V57, P3337, DOI 10.1128/AEM.57.11.3337-3344.1991; SCHMIDT TM, 1988, APPL ENVIRON MICROB, V54, P2793, DOI 10.1128/AEM.54.11.2793-2797.1988; SHUKLE RH, 1983, ENVIRON ENTOMOL, V12, P787, DOI 10.1093/ee/12.3.787; Strong DR, 1996, OECOLOGIA, V108, P167, DOI 10.1007/BF00333228; STRONG DR, 1995, OECOLOGIA, V104, P85, DOI 10.1007/BF00365566; Szallas E, 1997, INT J SYST BACTERIOL, V47, P402, DOI 10.1099/00207713-47-2-402; THOMAS GM, 1979, INT J SYST BACTERIOL, V29, P352, DOI 10.1099/00207713-29-4-352; VONEICHELSTREIBER C, 1992, MOL GEN GENET, V233, P260, DOI 10.1007/BF00587587; WANG J X, 1987, Revue de Nematologie, V10, P483; Yamamoto T, 1993, ADV ENG PESTICIDES, P1; Yu CG, 1997, APPL ENVIRON MICROB, V63, P532, DOI 10.1128/AEM.63.2.532-536.1997	53	49	62	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9836	9842		10.1074/jbc.274.14.9836	http://dx.doi.org/10.1074/jbc.274.14.9836			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092674	hybrid			2022-12-27	WOS:000079451800093
J	Labrecque, J; Mc Nicoll, N; Marquis, M; De Lean, A				Labrecque, J; Mc Nicoll, N; Marquis, M; De Lean, A			A disulfide-bridged mutant of natriuretic peptide receptor-A displays constitutive activity - Role of receptor dimerization in signal transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE GUANYLATE-CYCLASE; HUMAN GROWTH-HORMONE; EXTRACELLULAR DOMAIN; MUTATIONAL ANALYSIS; FACTOR-R1 RECEPTOR; ACTIVITY REQUIRES; ZONA GLOMERULOSA; BINDING ACTIVITY; ENZYME SUBUNITS; ACTIVATION	Natriuretic peptide receptor-A (NPR-A), a particulate guanylyl cyclase receptor, is composed of an extracellular domain (ECD) with a ligand binding site, a transmembrane spanning, a kinase homology domain (KHD), and a guanylyl cyclase domain. Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), the natural agonists, bind and activate the receptor leading to cyclic GMP production. This receptor has been reported to be spontaneously dimeric or oligomeric. In response to agonists, the KI-ID-mediated guanylate cyclase repression is removed, and it is assumed that. ATP binds to the KHD. Since NPR-A displays a pair of juxtamembrane cysteines separated by 8 residues, we hypothesized that the removal of one of those cysteines would leave the other unpaired and reactive, thus susceptible to form an interchain disulfide bridge and to favor the dimeric interactions. Here we show that NPR-A(C423S) mutant, expressed mainly as a covalent dimer, increases the affinity of pBNP for this receptor by enhancing a high affinity binding component, Dimerization primarily depends on ECD since a secreted NPB-A C423S soluble ectodomain (EGD(C423S)) also documents a covalent dimer, ANP binding to the unmutated ECD yields up to 80-fold affinity loss as compared with the membrane receptor. However, the ECD C423S mutation restores a high binding affinity. Furthermore, C423S mutation leads to cellular constitutive activation (20-40-fold) of basal catalytic production of cyclic GMP by the full-length mutant. In vitro particulate guanylyl cyclase assays demonstrate that NPR-A(C423S) displays an increased sensitivity to ATP treatment alone and that the effect of ANP + ATP joint treatment is cumulative instead of synergistic, Finally, the cellular and particulate guanylyl cyclase assays indicate that the receptor is desensitized to agonist stimulation. We conclude the following: I) dimers are functional units of NPR-A guanylyl cyclase activation; and 2) agonists are inducing dimeric contact of the juxtamembranous region leading to the removal of the KHD-mediated guanylyl cyclase repression, hence allowing catalytic activation.	Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	De Lean, A (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, CP 6128,Ctr Ville, Montreal, PQ H3C 3J7, Canada.							AnandSrivastava MB, 1996, J BIOL CHEM, V271, P19324, DOI 10.1074/jbc.271.32.19324; ASAI N, 1995, MOL CELL BIOL, V15, P1613; BUECHLER WA, 1991, BIOCHEM BIOPH RES CO, V174, P351, DOI 10.1016/0006-291X(91)90527-E; CHINKERS M, 1991, ANNU REV BIOCHEM, V60, P553, DOI 10.1146/annurev.bi.60.070191.003005; CHINKERS M, 1992, J BIOL CHEM, V267, P18589; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; Cohen D, 1996, J BIOL CHEM, V271, P9863, DOI 10.1074/jbc.271.16.9863; d'Avis PY, 1998, CELL GROWTH DIFFER, V9, P71; DELEAN A, 1982, MOL PHARMACOL, V21, P5; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DUQUESNOY P, 1994, EMBO J, V13, P1386, DOI 10.1002/j.1460-2075.1994.tb06392.x; ESPINER EA, 1995, ENDOCRIN METAB CLIN, V24, P481, DOI 10.1016/S0889-8529(18)30028-8; FALKE JJ, 1988, J BIOL CHEM, V263, P14850; FETHIERE J, 1989, MOL PHARMACOL, V35, P584; HARDMAN JG, 1971, ANN NY ACAD SCI, V185, P27; HARTENECK C, 1990, FEBS LETT, V272, P221, DOI 10.1016/0014-5793(90)80489-6; ITAKURA M, 1994, J BIOL CHEM, V269, P8314; IWASHINA M, 1994, J BIOCHEM-TOKYO, V115, P563, DOI 10.1093/oxfordjournals.jbchem.a124376; IWATA T, 1991, J BIOCHEM-TOKYO, V110, P35, DOI 10.1093/oxfordjournals.jbchem.a123539; JEWETT JRS, 1993, EMBO J, V12, P769, DOI 10.1002/j.1460-2075.1993.tb05711.x; Lia F, 1996, J BIOL CHEM, V271, P28287, DOI 10.1074/jbc.271.45.28287; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; LOWE DG, 1992, BIOCHEMISTRY-US, V31, P10421, DOI 10.1021/bi00158a001; MANGASARIAN K, 1997, J CELL PHYSL, V172, P177; MARQUIS M, 1999, IN PRESS MOL CELL BI; MELOCHE S, 1988, BIOCHEMISTRY-US, V27, P8151, DOI 10.1021/bi00421a025; MIZUNO T, 1993, J BIOL CHEM, V268, P5162; NAKANE M, 1990, J BIOL CHEM, V265, P16841; NAKAO K, 1992, J HYPERTENS, V10, P907; POTTER LR, 1992, J BIOL CHEM, V267, P14531; POTTER LR, 1994, J BIOL CHEM, V269, P14636; Potter LR, 1998, MOL CELL BIOL, V18, P2164, DOI 10.1128/MCB.18.4.2164; RONDEAU JJ, 1995, BIOCHEMISTRY-US, V34, P2130, DOI 10.1021/bi00007a005; SOROKIN A, 1994, J BIOL CHEM, V269, P9752; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; THOMPSON DK, 1995, J BIOL CHEM, V270, P425, DOI 10.1074/jbc.270.1.425; WATOWICH SS, 1992, P NATL ACAD SCI USA, V89, P2140, DOI 10.1073/pnas.89.6.2140; Wedel BJ, 1997, P NATL ACAD SCI USA, V94, P459, DOI 10.1073/pnas.94.2.459; WILSON EM, 1995, BIOCHEMISTRY-US, V34, P4696, DOI 10.1021/bi00014a025	41	62	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9752	9759		10.1074/jbc.274.14.9752	http://dx.doi.org/10.1074/jbc.274.14.9752			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092664	hybrid			2022-12-27	WOS:000079451800083
J	Cociancich, SO; Park, SS; Fidock, DA; Shahabuddin, M				Cociancich, SO; Park, SS; Fidock, DA; Shahabuddin, M			Vesicular ATPase-overexpressing cells determine the distribution of malaria parasite oocysts on the midguts of mosquitoes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; B-SUBUNIT; PLASMODIUM-GALLINACEUM; PROTON PUMP; CLONING; TUBULES; FAMILY	In Plasmodium-infected mosquitoes, oocysts are preferentially located at the posterior half of the posterior midgut, Because mosquitoes rest vertically after feeding, the effect of gravity on the ingested blood has been proposed as the cause of such a biased distribution. In this paper, we examined the oocyst distribution on the midguts of mosquitoes that were continuously rotated to nullify the effect of gravity and found that the typical pattern of oocyst distribution did not change, Invasion of the midgut epithelium by ookinetes was similarly found to be biased toward the posterior part of the posterior midgut, We examined whether the distribution of oocysts depends on the distribution of vesicular ATPase (V-ATPase)-overexpressing cells that Plasmodium ookinetes preferentially use to cross the midgut epithelium. An antiserum raised against recombinant Aedes aegypti V-ATPase B subunit indicated that the majority of VATPase-overexpressing cells in Ae. aegypti and Anopheles gambiae are localized at the posterior part of the posterior midgut, We propose that the typical distribution of oocysts on the mosquito midgut is attributable to the presence and the spatial distribution of the V-ATPase-overexpressing cells in the midgut epithelium.	NIAID, Parasit Dis Lab, Malaria Genet Sect, NIH, Bethesda, MD 20892 USA; NIAID, Parasit Dis Lab, Med Entomol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shahabuddin, M (corresponding author), NIAID, Parasit Dis Lab, Malaria Genet Sect, NIH, 9000 Rockville Pike,Bldg 4,Rm B2-39, Bethesda, MD 20892 USA.		COCIANCICH, Stéphane/C-4267-2014	COCIANCICH, Stéphane/0000-0001-8601-3598; Fidock, David/0000-0001-6753-8938	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000811] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CLEMENTS AN, 1992, BIOL MOSQUITOES, V1, P304; CLEMENTS AN, 1992, BIOL MOSQUITOES, V1, P263; Davies SA, 1996, J BIOL CHEM, V271, P30677, DOI 10.1074/jbc.271.48.30677; DUFFY PE, 1993, J EXP MED, V177, P505, DOI 10.1084/jem.177.2.505; Filippova M, 1998, INSECT MOL BIOL, V7, P223, DOI 10.1111/j.1365-2583.1998.00069.x; Finbow ME, 1997, BIOCHEM J, V324, P697, DOI 10.1042/bj3240697; GILL SS, 1991, ARCH BIOCHEM BIOPHYS, V291, P92, DOI 10.1016/0003-9861(91)90109-V; Huff CG, 1934, AM J HYG, V19, P123, DOI 10.1093/oxfordjournals.aje.a117980; HUFF CG, 1965, EXP PARASITOL, V16, P107, DOI 10.1016/0014-4894(65)90036-6; LICHKO LP, 1985, FEBS LETT, V187, P349, DOI 10.1016/0014-5793(85)81274-6; MADDRELL SHP, 1992, J EXP BIOL, V172, P417; Neumann R. O., 1908, Archiv fuer Protistenkunde, V13; NOVAK FJS, 1992, BIOCHIM BIOPHYS ACTA, V1132, P67, DOI 10.1016/0167-4781(92)90053-3; Shahabuddin M, 1998, P NATL ACAD SCI USA, V95, P3385, DOI 10.1073/pnas.95.7.3385; SHAHABUDDIN M, 1993, P NATL ACAD SCI USA, V90, P4266, DOI 10.1073/pnas.90.9.4266; Shahabuddin M, 1998, PARASITOLOGY, V116, pS83, DOI 10.1017/S0031182000084973; Shute P. G., 1938, Archives Roumaines de Pathologie Experimentale et de Microbiologie, V11, P351; SIEBER KP, 1991, EXP PARASITOL, V72, P145, DOI 10.1016/0014-4894(91)90132-G; WATERS AP, 1991, P NATL ACAD SCI USA, V88, P3140, DOI 10.1073/pnas.88.8.3140; WIECZOREK H, 1989, J BIOL CHEM, V264, P11143	20	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12650	12655		10.1074/jbc.274.18.12650	http://dx.doi.org/10.1074/jbc.274.18.12650			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212245	hybrid			2022-12-27	WOS:000080056800065
J	Goncharov, I; Palfi, Z; Bindereif, A; Michaeli, S				Goncharov, I; Palfi, Z; Bindereif, A; Michaeli, S			Purification of the spliced leader ribonucleoprotein particle from Leptomonas collosoma revealed the existence of an Sm protein in trypanosomes - Cloning the SmE homologue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEAR RIBONUCLEOPROTEINS; SNRNP E-PROTEIN; MESSENGER-RNA; BRUCEI; GENE; U2; U6; IDENTIFICATION; COMPONENTS; SEQUENCE	Trans-splicing in trypanosomes involves the addition of a common spliced leader (SL) sequence, which is derived from a small RNA, the SL RNA, to all mRNA precursors. The SL RNA is present in the cell in the form of a ribonucleoprotein, the SL RNP, Using conventional chromatography and affinity selection with 2'-O-methylated RNA oligonucleotides at high ionic strength, five proteins of 70, 16, 13, 12, and 8 kDa were co-selected with the SL RNA from Leptomonas collosoma, representing the SL RNP core particle. Under conditions of lower ionic strength, additional proteins of 28 and 20 kDa were revealed. On the basis of peptide sequences, the gene coding for a protein with a predicted molecular weight of 11.9 kDa was cloned and identified as homologue of the cis-spliceosomal SmE. The protein carries the Sm motifs 1 and 2 characteristic of Sm antigens that bind to all known cis-spliceosomal uridylic acid-rich small nuclear RNAs (U snRNAs), suggesting the existence of Sm proteins in trypanosomes, This finding is of special interest because trypanosome snRNPs are the only snRNPs examined to date that are not recognized by anti-Sm antibodies. Because of the early divergence of trypanosomes from the eukaryotic lineage, the trypanosome SmE protein represents one of the primordial Sm proteins in nature.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Humboldt Univ, Inst Biochem, D-10117 Berlin, Germany	Weizmann Institute of Science; Humboldt University of Berlin	Michaeli, S (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.		Michaeli, Shulamit/AAC-8255-2022					AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; Bordonne R, 1996, GENE, V176, P111, DOI 10.1016/0378-1119(96)00230-2; BRANLANT C, 1982, EMBO J, V1, P1259, DOI 10.1002/j.1460-2075.1982.tb00022.x; Camasses A, 1998, MOL CELL BIOL, V18, P1956, DOI 10.1128/MCB.18.4.1956; COOPER M, 1995, EMBO J, V14, P2066, DOI 10.1002/j.1460-2075.1995.tb07198.x; CROSS M, 1991, MOL CELL BIOL, V11, P5516, DOI 10.1128/MCB.11.11.5516; CROSS M, 1993, EMBO J, V12, P1239, DOI 10.1002/j.1460-2075.1993.tb05765.x; Dungan JM, 1996, EMBO J, V15, P4016, DOI 10.1002/j.1460-2075.1996.tb00775.x; FAUTSCH MP, 1992, GENOMICS, V14, P883, DOI 10.1016/S0888-7543(05)80109-0; GOLDRING A, 1995, GENE, V156, P139, DOI 10.1016/0378-1119(95)00048-B; GOLDRING A, 1995, EXPT PARASITOLOGY, V80, P333; HERMANN H, 1995, EMBO J, V14, P2076, DOI 10.1002/j.1460-2075.1995.tb07199.x; Judd R C, 1994, Methods Mol Biol, V32, P49; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Lucke S, 1997, EMBO J, V16, P4433, DOI 10.1093/emboj/16.14.4433; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; MICHAELI S, 1990, J BIOL CHEM, V265, P10582; MOTTRAM J, 1989, MOL CELL BIOL, V9, P1212, DOI 10.1128/MCB.9.3.1212; PALFI Z, 1992, J BIOL CHEM, V267, P20159; PALFI Z, 1991, P NATL ACAD SCI USA, V88, P9097, DOI 10.1073/pnas.88.20.9097; SERAPHIN B, 1995, EMBO J, V14, P2089, DOI 10.1002/j.1460-2075.1995.tb07200.x; STANFORD DR, 1988, NUCLEIC ACIDS RES, V16, P10593, DOI 10.1093/nar/16.22.10593; TSCHUDI C, 1986, NUCLEIC ACIDS RES, V14, P8893, DOI 10.1093/nar/14.22.8893; TSCHUDI C, 1990, CELL, V61, P459, DOI 10.1016/0092-8674(90)90527-L; ULLU E, 1995, J BIOL CHEM, V270, P20365, DOI 10.1074/jbc.270.35.20365; ULLU E, 1995, MOL BIOL PARASITIC P, P115; Xu YX, 1997, P NATL ACAD SCI USA, V94, P8473, DOI 10.1073/pnas.94.16.8473	28	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12217	12221		10.1074/jbc.274.18.12217	http://dx.doi.org/10.1074/jbc.274.18.12217			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212187	hybrid			2022-12-27	WOS:000080056800007
J	Jourdan-Le Saux, C; Tronecker, H; Bogic, L; Bryant-Greenwood, GD; Boyd, CD; Csiszar, K				Jourdan-Le Saux, C; Tronecker, H; Bogic, L; Bryant-Greenwood, GD; Boyd, CD; Csiszar, K			The LOXL2 gene encodes a new lysyl oxidase-like protein and is expressed at high levels in reproductive tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAS RECISION GENE; MESSENGER-RNA; AMINE OXIDASES; IN-SITU; H-RAS; LOCALIZATION; SEQUENCE; IDENTIFICATION; REVERTANTS; ASSIGNMENT	We have reported in this paper the complete cDNA sequence, gene structure, and tissue-specific expression of LOXL2, a new amine oxidase and a member of an emerging family of human lysyl oxidases, The predicted amino acid sequence, from several overlapping cDNA clones isolated from placenta and spleen cDNA libraries, shared extensive sequence homology with the conserved copper-binding and catalytic domains of both lysyl oxidase (LOX) and the lysyl oxidase-like (LOXL) protein. These conserved domains are encoded by five consecutive exons within the LOX, LOXL, and LOXL2 genes that also maintained exon-intron structure conservation. In contrast, six exons encoding the aminoterminal domains diverged both in sequence and structure. Exon 1 of the LOXL2 gene does not encode a signal sequence that is present in LOX and LOXL, suggesting a different processing and intracellular localization for this new protein. Expression of the LOXL2 gene was detected in almost all tissues with the highest steady state mRNA levels in the reproductive tissues, placenta, uterus and prostate. In situ hybridization identified placental syncytial and cytotrophoblasts responsible for the synthesis of LOXL2 mRNA and demonstrated a spatial and temporal expression pattern unique to the LOXL2 gene.	Univ Hawaii, Pacific Biomed Res Ctr, Honolulu, HI 96822 USA	University of Hawaii System	Csiszar, K (corresponding author), Univ Hawaii, Pacific Biomed Res Ctr, 1960 E West Rd, Honolulu, HI 96822 USA.	kciszar@aol.com			NCI NIH HHS [CA766580] Funding Source: Medline; NCRR NIH HHS [RR03061] Funding Source: Medline; NICHD NIH HHS [HD24314] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024314] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BACCARANICONTRI M, 1990, MATRIX, V9, P428, DOI 10.1016/S0934-8832(11)80011-9; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BOGIC LV, 1995, J CLIN ENDOCR METAB, V80, P130, DOI 10.1210/jc.80.1.130; BOYD CD, 1995, MOL BIOL REP, V21, P95, DOI 10.1007/BF00986499; BUTLER E, 1987, EXP CELL RES, V173, P174, DOI 10.1016/0014-4827(87)90343-0; Casey ML, 1997, J CLIN ENDOCR METAB, V82, P167, DOI 10.1210/jc.82.1.167; CONTENTE S, 1990, SCIENCE, V249, P796, DOI 10.1126/science.1697103; Csiszar K, 1996, MOL BIOL REP, V23, P97, DOI 10.1007/BF00424435; Di Donato A, 1997, FEBS LETT, V419, P63, DOI 10.1016/S0014-5793(97)01420-8; Dove JE, 1996, FEBS LETT, V398, P231, DOI 10.1016/S0014-5793(96)01245-8; HAJNAL A, 1993, CANCER RES, V53, P4670; HAMALAINEN ER, 1991, GENOMICS, V11, P508, DOI 10.1016/0888-7543(91)90057-L; JANES SM, 1992, BIOCHEMISTRY-US, V31, P12147, DOI 10.1021/bi00163a025; Jourdan-Le Saux C, 1998, GENOMICS, V51, P305, DOI 10.1006/geno.1998.5356; KAGAN HM, 1994, MOL BIOL PATHOL ELAS; KENYON K, 1993, J BIOL CHEM, V268, P18435; KENYON K, 1991, SCIENCE, V253, P802, DOI 10.1126/science.1678898; Kim YH, 1999, J CELL BIOCHEM, V72, P181, DOI 10.1002/(SICI)1097-4644(19990201)72:2<181::AID-JCB3>3.0.CO;2-D; KIM YH, 1995, J BIOL CHEM, V270, P7176, DOI 10.1074/jbc.270.13.7176; KREBS CJ, 1993, BIOCHIM BIOPHYS ACTA, V1202, P7, DOI 10.1016/0167-4838(93)90056-W; KUIVANIEMI H, 1984, J BIOL CHEM, V259, P6996; Li WD, 1997, P NATL ACAD SCI USA, V94, P12817, DOI 10.1073/pnas.94.24.12817; Lyles GA, 1996, INT J BIOCHEM CELL B, V28, P259, DOI 10.1016/1357-2725(95)00130-1; MARIANI TJ, 1992, MATRIX, V12, P242, DOI 10.1016/S0934-8832(11)80067-3; MELLO MLS, 1995, EXP CELL RES, V220, P374, DOI 10.1006/excr.1995.1328; OBERHUBER H, 1995, MOL CARCINOGEN, V12, P198, DOI 10.1002/mc.2940120404; Peyrol S, 1997, AM J PATHOL, V150, P497; Ren CZ, 1998, CANCER RES, V58, P1285; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; Saito H, 1997, J BIOL CHEM, V272, P8157, DOI 10.1074/jbc.272.13.8157; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Szabo Z, 1997, HUM GENET, V101, P198, DOI 10.1007/s004390050613; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; WAKASAKI H, 1990, LAB INVEST, V63, P377	34	81	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12939	12944						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212285				2022-12-27	WOS:000080056800105
J	Szabo, K; Szakacs, G; Hegedus, T; Sarkadi, B				Szabo, K; Szakacs, G; Hegedus, T; Sarkadi, B			Nucleotide occlusion in the human cystic fibrosis transmembrane conductance regulator - Different patterns in the two nucleotide binding domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN ATPASE ACTIVITY; HUMAN MULTIDRUG TRANSPORTER; P-GLYCOPROTEIN; CHLORIDE CHANNELS; INSECT CELLS; CL CHANNELS; CFTR; HYDROLYSIS; SITES; EXPRESSION	The function of the human cystic fibrosis transmembrane conductance regulator (CFTR) protein as a chloride channel or transport regulator involves cellular ATP binding and cleavage. Here we describe that human CFTR expressed in insect (Sf9) cell membranes shows specific, Mg2+-dependent nucleotide occlusion, detected by covalent labeling with 8-azido-[alpha-P-32]ATP. Nucleotide occlusion in CFTR requires incubation at 37 degrees C, and the occluded nucleotide can not be removed by repeated washings of the membranes with cold MgATP-containing medium. By using limited tryptic digestion of the labeled CFTR protein we found that the adenine nucleotide occlusion preferentially occurred in the N-terminal nucleotide binding domain (NBD). Addition of the ATPase inhibitor vanadate, which stabilizes an open state of the CFTR chloride channel, produced an increased nucleotide occlusion and resulted in the labeling of both the N-terminal and C-terminal NBDs, Protein modification with N-ethylmaleimide prevented both vanadate-dependent and -independent nucleotide occlusion in CFTR, The pattern of nucleotide occlusion indicates significant differences in the ATP hydrolyzing activities of the two NBDs, which may explain their different roles in the CFTR channel regulation.	Hungarian Acad Sci, Natl Inst Haematol & Immunol, Membrane Res Grp, H-1113 Budapest, Hungary; Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Sarkadi, B (corresponding author), Hungarian Acad Sci, Natl Inst Haematol & Immunol, Membrane Res Grp, Daroczi U24, H-1113 Budapest, Hungary.		Sarkadi, Balazs/I-5024-2013; Szakacs, Gergely/A-2580-2009; Hegedus, Tamas/P-8625-2015	Szakacs, Gergely/0000-0002-9311-7827; Hegedus, Tamas/0000-0002-5195-749X				ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; BAUKROWITZ T, 1994, NEURON, V12, P473, DOI 10.1016/0896-6273(94)90206-2; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Cotten JF, 1997, J BIOL CHEM, V272, P25617, DOI 10.1074/jbc.272.41.25617; GABRIEL SE, 1992, AM J PHYSIOL, V263, pC708, DOI 10.1152/ajpcell.1992.263.3.C708; GADSBY DC, 1994, TRENDS BIOCHEM SCI, V19, P513, DOI 10.1016/0968-0004(94)90141-4; GERMANN UA, 1990, BIOCHEMISTRY-US, V29, P2295, DOI 10.1021/bi00461a013; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hrycyna CA, 1998, J BIOL CHEM, V273, P16631, DOI 10.1074/jbc.273.27.16631; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; ISKANDER II, 1996, J BIOL CHEM, V271, P4725; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Larsen EH, 1996, PFLUG ARCH EUR J PHY, V432, P528, DOI 10.1007/s004240050166; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Ma JJ, 1997, J BIOL CHEM, V272, P28133, DOI 10.1074/jbc.272.44.28133; RIORDAN JR, 1989, SCIENCE, V245, P1066; RIORDAN JR, 1993, ANNU REV PHYSIOL, V55, P609, DOI 10.1146/annurev.ph.55.030193.003141; Sankaran B, 1997, ARCH BIOCHEM BIOPHYS, V341, P160, DOI 10.1006/abbi.1997.9944; SARKADI B, 1992, J BIOL CHEM, V267, P2087; SARKADI B, 1992, J BIOL CHEM, V267, P4854; SARKADI B, 1994, EUR CYST FIBR C; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Senior AE, 1998, BIOCHEMISTRY-US, V37, P831, DOI 10.1021/bi9719962; Senior AE, 1997, SEMIN CANCER BIOL, V8, P143, DOI 10.1006/scbi.1997.0065; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Szabo K, 1998, J BIOL CHEM, V273, P10132, DOI 10.1074/jbc.273.17.10132; Ueda K, 1997, J BIOL CHEM, V272, P22983, DOI 10.1074/jbc.272.37.22983; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Urbatsch IL, 1998, BIOCHEMISTRY-US, V37, P4592, DOI 10.1021/bi9728001; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; WELSH MJ, 1992, NEURON, V8, P821, DOI 10.1016/0896-6273(92)90196-K; YOUNG HK, 1995, J BIOL CHEM, V270, P22093	39	78	79	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12209	12212		10.1074/jbc.274.18.12209	http://dx.doi.org/10.1074/jbc.274.18.12209			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212185	hybrid			2022-12-27	WOS:000080056800005
J	Rietveld, A; Neutz, S; Simons, K; Eaton, S				Rietveld, A; Neutz, S; Simons, K; Eaton, S			Association of sterol- and glycosylphosphatidylinositol-linked proteins with Drosophila raft lipid microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; EPITHELIAL-CELLS; PHASE-SEPARATION; CHOLESTEROL; HEDGEHOG; IDENTIFICATION; TRANSPORT; GLYCOSPHINGOLIPIDS; SPHINGOMYELIN; MONOLAYERS	In vertebrates, the formation of raft lipid microdomains plays an important part in both polarized protein sorting and signal transduction, To establish a system in which raft-dependent processes could be studied genetically, we have analyzed the protein and lipid composition of these microdomains in Drosophila melanogaster, Using mass spectrometry, we identified the phospholipids, sphingolipids, and sterols present in Drosophila membranes. Despite chemical differences between Drosophila and mammalian lipids, their structure suggests that the biophysical properties that allow raft formation have been preserved. Consistent with this, we have identified a detergent-insoluble fraction of Drosophila membranes that, like mammalian rafts, is rich in sterol, sphingolipids, and glycosylphosphatidylinositol-linked proteins. We show that the sterol-linked Hedgehog N-terminal fragment associates specifically with this detergent-insoluble membrane fraction. Our findings demonstrate that raft formation is preserved across widely separated phyla in organisms with different lipid structures. They further suggest sterol modification as a novel mechanism for targeting proteins to raft membranes and raise the possibility that signaling and polarized intracellular transport of Hedgehog are based on raft association.	European Mol Biol Lab, Cell Biol Programme, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Eaton, S (corresponding author), European Mol Biol Lab, Cell Biol Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Eaton, Suzanne/D-7698-2017	Eaton, Suzanne/0000-0002-8319-284X; Simons, Kai/0000-0002-9231-9996				Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; BITTMAN R, 1994, BIOCHEMISTRY-US, V33, P11776, DOI 10.1021/bi00205a013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BONDARENKO L V, 1989, Ontogenez, V20, P141; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; FIEDLER K, 1993, BIOCHEMISTRY-US, V32, P6365, DOI 10.1021/bi00076a009; FOLCH J, 1957, J BIOL CHEM, V226, P497; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; HORTSCH M, 1990, J BIOL CHEM, V265, P15104; Huang CF, 1997, MOL BIOL CELL, V8, P2365, DOI 10.1091/mbc.8.12.2365; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; KLENK HD, 1970, VIROLOGY, V40, P939, DOI 10.1016/0042-6822(70)90140-6; KLENK HD, 1969, VIROLOGY, V38, P255, DOI 10.1016/0042-6822(69)90367-5; Kubler E, 1996, J BIOL CHEM, V271, P32975, DOI 10.1074/jbc.271.51.32975; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Melkonian KA, 1995, BIOCHEMISTRY-US, V34, P16161, DOI 10.1021/bi00049a031; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; SANKARAM MB, 1990, BIOCHEMISTRY-US, V29, P10670, DOI 10.1021/bi00499a014; SANKARAM MB, 1991, P NATL ACAD SCI USA, V88, P8686, DOI 10.1073/pnas.88.19.8686; SCHNAAR RL, 1994, METHOD ENZYMOL, V230, P371; SCHULER I, 1990, BIOCHIM BIOPHYS ACTA, V1028, P82, DOI 10.1016/0005-2736(90)90268-S; SHAFFER CD, 1994, METHOD CELL BIOL, V44, P99, DOI 10.1016/S0091-679X(08)60908-5; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; SILBERKANG M, 1983, J BIOL CHEM, V258, P8503; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; SLOTTE JP, 1992, BIOCHEMISTRY-US, V31, P5472, DOI 10.1021/bi00139a008; SUGITA M, 1989, J BIOL CHEM, V264, P15028; SVOBODA JA, 1995, LIPIDS, V30, P91, DOI 10.1007/BF02537047; URBINA JA, 1995, BBA-BIOMEMBRANES, V1238, P163, DOI 10.1016/0005-2736(95)00117-L; VANHELVOORT A, 1995, FEBS LETT, V369, P18, DOI 10.1016/0014-5793(95)00616-H; WIEGANDT H, 1992, BIOCHIM BIOPHYS ACTA, V1123, P117, DOI 10.1016/0005-2760(92)90101-Z; Xiao Z, 1997, MOL BIOL CELL, V8, P855, DOI 10.1091/mbc.8.5.855	43	237	245	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12049	12054		10.1074/jbc.274.17.12049	http://dx.doi.org/10.1074/jbc.274.17.12049			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207028	hybrid			2022-12-27	WOS:000079834800084
J	Saxena, M; Williams, S; Brockdorff, J; Gilman, J; Mustelin, T				Saxena, M; Williams, S; Brockdorff, J; Gilman, J; Mustelin, T			Inhibition of T cell signaling by mitogen-activated protein kinase-targeted hematopoietic tyrosine phosphatase (HePTP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN RECEPTOR; MAP KINASE; TRANSCRIPTIONAL REGULATION; NEGATIVE REGULATION; GENETIC-EVIDENCE; FAMILY KINASES; IL-2 GENE; LC-PTP; TRANSDUCTION; PHOSPHORYLATION	Activation of T lymphocytes to produce cytokines is regulated by the counterbalance of protein-tyrosine kinases and protein-tyrosine phosphatases, many of which have a high degree of substrate specificity because of physical association with their targets. Overexpression of hematopoietic protein-tyrosine phosphatase (HePTP) results in suppression of T lymphocyte activation as measured by T cell antigen receptor-induced activation of transcription factors binding to the 5' promoter of the interleukin-2 gene. Efforts to pinpoint the exact site of action and specificity of HePTP in the signaling cascade revealed that HePTP acts directly on the mitogen-activated protein (MAP) kinases Erk1 and 2 and consequently reduces the magnitude and duration of their catalytic activation in intact T cells. In contrast, HePTP had no effects on N-terminal c-Jun kinase or on events upstream of the MAP kinases, The specificity of HePTP correlated with its physical association through its noncatalytic N terminus with Erk and another MAP kinase, p38, but not Jnk or other proteins. We propose that HePTP plays a negative role in antigen receptor signaling by specifically regulating MAP kinases in the cytosol and at early time points of T cell activation before the activation-induced expression of nuclear dual-specific MAP kinase phosphatases.	La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Mustelin, T (corresponding author), Sidney Kimmel Canc Ctr, Lab Signal Transduct, 10835 Altman Row, San Diego, CA 92121 USA.			Mustelin, Tomas/0000-0001-5912-8840	NIAID NIH HHS [AI35603, AI41481] Funding Source: Medline; NIGMS NIH HHS [GM48960] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035603, R01AI041481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM048960] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI M, 1992, BIOCHEM BIOPH RES CO, V186, P1607, DOI 10.1016/S0006-291X(05)81592-X; ADACHI M, 1994, FEBS LETT, V338, P47, DOI 10.1016/0014-5793(94)80114-2; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; Altman A, 1990, Adv Immunol, V48, P227, DOI 10.1016/S0065-2776(08)60756-7; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; Couture C, 1996, J BIOL CHEM, V271, P24880, DOI 10.1074/jbc.271.40.24880; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; Egerton M, 1996, EUR J IMMUNOL, V26, P2279, DOI 10.1002/eji.1830261002; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; FONATSCH C, 1991, CANCER GENET CYTOGEN, V56, P243, DOI 10.1016/0165-4608(91)90177-V; Gopalbhai K, 1998, J CELL PHYSIOL, V174, P35, DOI 10.1002/(SICI)1097-4652(199801)174:1<35::AID-JCP5>3.0.CO;2-H; Hata D, 1998, J BIOL CHEM, V273, P10979, DOI 10.1074/jbc.273.18.10979; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; IZQUIERDO M, 1994, J EXP MED, V180, P401, DOI 10.1084/jem.180.1.401; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Jascur T, 1997, J BIOL CHEM, V272, P14483, DOI 10.1074/jbc.272.22.14483; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Keyse SM, 1998, SEMIN CELL DEV BIOL, V9, P143, DOI 10.1006/scdb.1997.0219; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; LUO K, 1990, ONCOGENE, V5, P921; MAMAEV N, 1988, CANCER GENET CYTOGEN, V35, P21, DOI 10.1016/0165-4608(88)90116-1; MITELMAN F, 1991, CYTOGENET CELL GENET, V58, P1503; MUSTELIN T, 1994, IMMUNITY, V1, P351, DOI 10.1016/1074-7613(94)90065-5; MUSTELIN T, 1990, SCIENCE, V247, P1584, DOI 10.1126/science.2138816; MUSTELIN T, 1998, FRONT BIOSCI, V3, P1066; Pani G, 1996, J EXP MED, V184, P839, DOI 10.1084/jem.184.3.839; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; Saxena M, 1998, J BIOL CHEM, V273, P15340, DOI 10.1074/jbc.273.25.15340; SESILVA DR, 1998, J IMMUNOL, V160, P4175; SHARMA E, 1995, J BIOL CHEM, V270, P49, DOI 10.1074/jbc.270.1.49; SHIOZUKA K, 1995, GENE, V162, P279, DOI 10.1016/0378-1119(95)00306-Q; SIEGEL JN, 1990, J BIOL CHEM, V265, P18472; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SWEITER M, 1995, J BIOL CHEM, V270, P21902; Whitehurst CE, 1996, J IMMUNOL, V156, P1020; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Williams S, 1997, EUR J BIOCHEM, V245, P84, DOI 10.1111/j.1432-1033.1997.00084.x; ZANKE B, 1994, LEUKEMIA, V8, P236; ZANKE B, 1992, EUR J IMMUNOL, V22, P235, DOI 10.1002/eji.1830220134; Zhan XL, 1997, GENE DEV, V11, P1690, DOI 10.1101/gad.11.13.1690; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x	49	124	127	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11693	11700		10.1074/jbc.274.17.11693	http://dx.doi.org/10.1074/jbc.274.17.11693			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206983	hybrid			2022-12-27	WOS:000079834800039
J	Avisar, N; Shiftan, L; Ben-Dror, I; Havazelet, N; Vardimon, L				Avisar, N; Shiftan, L; Ben-Dror, I; Havazelet, N; Vardimon, L			A silencer element in the regulatory region of glutamine synthetase controls cell type-specific repression of gene induction by glucocorticoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC NEURAL RETINA; RECEPTOR TRANSCRIPTIONAL ACTIVITY; SODIUM-CHANNEL GENE; MAMMALIAN-CELLS; TARGET GENES; EXPRESSION; IDENTIFICATION; LOCALIZATION; INDUCIBILITY; INVOLVEMENT	Glutamine synthetase is a key enzyme in the recycling of the neurotransmitter glutamate, Expression of this enzyme is regulated by glucocorticoids, which induce a high level of glutamine synthetase in neural but not in various non-neural tissues, This is despite the fact that non-neural cells express functional glucocorticoid receptor molecules capable of inducing other target genes. Sequencing and functional analysis of the upstream region of the glutamine synthetase gene identified, 5' to the glucocorticoid response element (GRE), a 21-base pair glutamine synthetase silencer element (GSSE), which showed considerable homology with the neural restrictive silencer element NRSE. The GSSE was able to markedly repress the induction of gene transcription by glucocorticoids in non-neural cells and in embryonic neural retina. The repressive activity of the GSSE could be conferred on a heterologous GRE promoter and was orientation- and position-independent with respect to the transcriptional start site, but appeared to depend on a location proximal to the GRE, Gel-shift assays revealed that non-neural cells and cells of early embryonic retina contain a high level of GSSE binding activity and that this level declines progressively with age. Our results suggest that the GSSE might be involved in the restriction of glutamine synthetase induction by glucocorticoids to differentiated neural tissues.	Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel	Tel Aviv University	Vardimon, L (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.							BENDROR I, 1993, P NATL ACAD SCI USA, V90, P1117, DOI 10.1073/pnas.90.3.1117; BENOR S, 1993, MOL CELL BIOL, V13, P331, DOI 10.1128/MCB.13.1.331; BERKOFLINT Y, 1994, EMBO J, V13, P646, DOI 10.1002/j.1460-2075.1994.tb06303.x; BESSIS A, 1995, NEUROSCIENCE, V69, P807, DOI 10.1016/0306-4522(95)00303-Z; BULMER M, 1987, MOL BIOL EVOL, V4, P395; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Dieffenbach C.W., 1995, PCR PRIMER LAB MANUA; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GOROVITS R, 1994, P NATL ACAD SCI USA, V91, P4786, DOI 10.1073/pnas.91.11.4786; Gorovits R, 1996, MOL BRAIN RES, V43, P321, DOI 10.1016/S0169-328X(96)00213-6; GROSSMAN R, 1994, MOL BRAIN RES, V21, P312, DOI 10.1016/0169-328X(94)90262-3; KALLUNKI P, 1995, J BIOL CHEM, V270, P21291, DOI 10.1074/jbc.270.36.21291; KENNEDY AJ, 1974, NATURE, V252, P50, DOI 10.1038/252050a0; Kimura M., 1983, NEUTRAL THEORY MOL E; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; LI LA, 1993, P NATL ACAD SCI USA, V90, P1460, DOI 10.1073/pnas.90.4.1460; LINSER P, 1979, P NATL ACAD SCI USA, V76, P6476, DOI 10.1073/pnas.76.12.6476; LINSER PJ, 1981, DEV BRAIN RES, V1, P103, DOI 10.1016/0165-3806(81)90097-3; MAGNUSON SR, 1988, DEV BIOL, V130, P536, DOI 10.1016/0012-1606(88)90348-X; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; Mieda M, 1996, J BIOL CHEM, V271, P5177; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; Moran D, 1997, GENE, V194, P201, DOI 10.1016/S0378-1119(97)00148-0; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; MOSCONA AA, 1983, PROGR RETINAL RES, P111; MOSCONA M, 1979, DIFFERENTIATION, V13, P165, DOI 10.1111/j.1432-0436.1979.tb01579.x; PATEJUNAS G, 1987, MOL CELL BIOL, V7, P1070, DOI 10.1128/MCB.7.3.1070; PATEJUNAS G, 1990, J BIOL CHEM, V265, P15280; PU HF, 1990, GENE, V89, P259, DOI 10.1016/0378-1119(90)90014-I; PUPKO T, 1999, IN PRESS J MOL EVOL, V48; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; SHARP PM, 1987, MOL BIOL EVOL, V4, P222; VANDENBERG CJ, 1970, HDB NEUROCHEMISTRY, P355; VANDERBILT JN, 1987, MOL ENDOCRINOL, V1, P68, DOI 10.1210/mend-1-1-68; VARDIMON L, 1988, P NATL ACAD SCI USA, V85, P5981, DOI 10.1073/pnas.85.16.5981; Wood IC, 1996, J BIOL CHEM, V271, P14221, DOI 10.1074/jbc.271.24.14221; ZHANG HY, 1993, J BIOL CHEM, V268, P2850; ZHANG HY, 1991, J BIOL CHEM, V266, P24332	43	25	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11399	11407		10.1074/jbc.274.16.11399	http://dx.doi.org/10.1074/jbc.274.16.11399			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196233	hybrid			2022-12-27	WOS:000079751900101
J	Frutos, S; Moscat, J; Diaz-Meco, MT				Frutos, S; Moscat, J; Diaz-Meco, MT			Cleavage of zeta PKC but not lambda/iota PKC by caspase-3 during UV-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NF-KAPPA-B; HYDROLYZING PHOSPHOLIPASE-C; XENOPUS-LAEVIS OOCYTES; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEOLYTIC ACTIVATION; SIGNAL-TRANSDUCTION; TNF-ALPHA; SUBSPECIES BLOCKS; CELL-DEATH	The stimulation of caspases is a critical event in apoptotic cell death. Several kinases critically involved in cell proliferation pathways have been shown to be cleaved by caspase-mediated mechanisms, Thus, the degradation of delta protein kinase C (PKC) and MEKK-1 by caspase-3 generates activated fragments corresponding to their catalytic domains, consistent with the observations that both enzymes are important for apoptosis. In contrast, other kinases reported to have anti-apoptotic properties, such as Raf-1 and Akt, are inactivated by proteolytic degradation by the caspase system. Since the atypical PKCs have been shown to play critical roles in cell survival, in the study reported here we have addressed the potential degradation of these PKCs by the caspase system in UV-irradiated HeLa cells. Herein we show that although zeta PKC and lambda/iota PKC are both inhibited in UV-treated cells, only zeta PKC but not lambda/iota PKC is cleaved by a caspase-mediated process. This cleavage generates a fragment that corresponds to its catalytic domain that is enzymatically inactive, The sequence where caspase-3 cleaves zeta PKC was mapped, and a mutant resistant to degradation was shown to protect cells from apoptosis more efficiently than the wild-type enzyme.	Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Lab Glaxo Wellcome, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); GlaxoSmithKline	Diaz-Meco, MT (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Lab Glaxo Wellcome, Canto Blanco, E-28049 Madrid, Spain.		Moscat, Jorge/A-7011-2009	Diaz-Meco, Maria/0000-0003-0147-0998				Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BERRA E, 1993, CELL, V74, P555, DOI 10.1016/0092-8674(93)80056-K; Berra E, 1997, MOL CELL BIOL, V17, P4346, DOI 10.1128/MCB.17.8.4346; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; Berra E, 1998, J BIOL CHEM, V273, P10792, DOI 10.1074/jbc.273.17.10792; Bjorkoy G, 1997, J BIOL CHEM, V272, P11557; BJORKOY G, 1995, J BIOL CHEM, V270, P21299; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Deak JC, 1998, P NATL ACAD SCI USA, V95, P5595, DOI 10.1073/pnas.95.10.5595; Denning MF, 1998, J BIOL CHEM, V273, P29995, DOI 10.1074/jbc.273.45.29995; DiazMeco MT, 1996, MOL CELL BIOL, V16, P105; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; DIAZMECO MT, 1993, MOL CELL BIOL, V13, P4770, DOI 10.1128/MCB.13.8.4770; DIAZMECO MT, 1994, J BIOL CHEM, V269, P31706; DOMINGUEZ I, 1993, MOL CELL BIOL, V13, P1290, DOI 10.1128/MCB.13.2.1290; DOMINGUEZ I, 1992, MOL CELL BIOL, V12, P3776, DOI 10.1128/MCB.12.9.3776; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Folgueira L, 1996, J VIROL, V70, P223, DOI 10.1128/JVI.70.1.223-231.1996; Gardner AM, 1996, J BIOL CHEM, V271, P14560, DOI 10.1074/jbc.271.24.14560; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; Hemmings BA, 1997, SCIENCE, V275, P628, DOI 10.1126/science.275.5300.628; Huang CS, 1996, J BIOL CHEM, V271, P31262, DOI 10.1074/jbc.271.49.31262; Kampfer S, 1998, EMBO J, V17, P4046, DOI 10.1093/emboj/17.14.4046; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; Limatola C, 1997, BIOCHEM J, V321, P497, DOI 10.1042/bj3210497; LOZANO J, 1994, J BIOL CHEM, V269, P19200; Mendez R, 1997, MOL CELL BIOL, V17, P5184, DOI 10.1128/MCB.17.9.5184; MULLER G, 1995, EMBO J, V14, P1961, DOI 10.1002/j.1460-2075.1995.tb07188.x; Murray NR, 1997, J BIOL CHEM, V272, P27521, DOI 10.1074/jbc.272.44.27521; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; ORR JW, 1994, J BIOL CHEM, V269, P27715; Parrizas M, 1997, J BIOL CHEM, V272, P154; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sells SF, 1997, MOL CELL BIOL, V17, P3823, DOI 10.1128/MCB.17.7.3823; SELLS SF, 1994, CELL GROWTH DIFFER, V5, P457; Sontag E, 1997, EMBO J, V16, P5662, DOI 10.1093/emboj/16.18.5662; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; vanDijk MCM, 1997, BIOCHEM J, V323, P693, DOI 10.1042/bj3230693; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Wooten MW, 1996, J NEUROCHEM, V67, P1023; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yuan ZM, 1997, J BIOL CHEM, V272, P23485, DOI 10.1074/jbc.272.38.23485; Zundel W, 1998, GENE DEV, V12, P1941, DOI 10.1101/gad.12.13.1941	61	82	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10765	10770		10.1074/jbc.274.16.10765	http://dx.doi.org/10.1074/jbc.274.16.10765			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196149	hybrid			2022-12-27	WOS:000079751900017
J	Netzer, KO; Leinonen, A; Boutaud, A; Borza, DB; Todd, P; Gunwar, S; Langeveld, JPM; Hudson, BG				Netzer, KO; Leinonen, A; Boutaud, A; Borza, DB; Todd, P; Gunwar, S; Langeveld, JPM; Hudson, BG			The Goodpasture autoantigen - Mapping the major conformational epitope(s) of alpha 3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; IV COLLAGEN; SYNTHETIC PEPTIDES; GBM ANTIBODIES; ALPHA-CHAINS; AMINO-ACID; ANTIGEN; IDENTIFICATION; PROTEINS; AUTOANTIBODIES	The Goodpasture (GP) autoantigen has been identified as the alpha 3(IV) collagen chain, one of six homologous chains designated alpha 1-alpha 6 that comprise type IV collagen (Hudson, B. G., Reeders, S. T., and Tryggvason, K. (1993) J. Biol. Chem. 268, 26033-26036). In this study, chimeric proteins were used to map the location of the major conformational, disulfide bond-dependent GP autoepitope(s) that has been previously localized to the non-collagenous (NC1) domain of alpha 3(IV) chain. Fourteen alpha 1/alpha 3 NC1 chimeras were constructed by substituting one or more short sequences of alpha 3(IV)NC1 at the corresponding positions in the non-immunoreactive alpha 1(IV)NC1 domain and expressed in mammalian cells for proper folding. The interaction between the chimeras and eight GP sera was assessed by both direct and inhibition enzyme-linked immunosorbent assay. Two chimeras, C2 containing residues 17-31 of alpha 3(IV)NC1 and C6 containing residues 127-141 of alpha 3(IV)NC1, bound autoantibodies, as did combination chimeras containing these regions. The epitope(s) that encompasses these sequences is immunodominant, showing strong reactivity with all GP sera and accounting for 50-90% of the autoantibody reactivity toward alpha 3(IV)NC1. The conformational nature of the epitope(s) in the C2 and C6 chimeras was established by reduction of the disulfide bonds and by PEPSCAN analysis of overlapping 12-mer peptides derived from alpha 1- and alpha 3(IV)NC1 sequences. The amino acid sequences 17-31 and 127-141 in alpha 3(IV)NC1 have thus been shown to contain the critical residues of one or two disulfide bond-dependent conformational autoepitopes that bind GP autoantibodies.	Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; DLO, ID, Inst Anim Sci & Hlth, NL-8200 AB Lelystad, Netherlands	University of Kansas; University of Kansas Medical Center	Hudson, BG (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.		Borza, Dorin-Bogdan/AAF-2156-2020	Borza, Dorin-Bogdan/0000-0003-4568-279X; Hudson, Billy/0000-0002-5420-4100	NIDDK NIH HHS [DK 18381] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK018381, R01DK018381] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; Dehan P, 1996, NEPHROL DIAL TRANSPL, V11, P2215, DOI 10.1093/oxfordjournals.ndt.a027139; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GUNWAR S, 1991, J BIOL CHEM, V266, P15318; Gunwar S, 1998, J BIOL CHEM, V273, P8767, DOI 10.1074/jbc.273.15.8767; HELLMARK T, 1994, KIDNEY INT, V46, P823, DOI 10.1038/ki.1994.338; Hellmark T, 1996, CLIN EXP IMMUNOL, V105, P504, DOI 10.1046/j.1365-2249.1996.119808.x; Henriksson EW, 1997, J AUTOIMMUN, V10, P559, DOI 10.1006/jaut.1997.0163; Hsia RC, 1996, MOL MICROBIOL, V19, P53, DOI 10.1046/j.1365-2958.1996.351878.x; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KALLURI R, 1991, J BIOL CHEM, V266, P24018; Kalluri R, 1996, J BIOL CHEM, V271, P9062, DOI 10.1074/jbc.271.15.9062; KALLURI R, 1995, J AM SOC NEPHROL, V6, P1178; KEFALIDES NA, 1993, KIDNEY INT, V43, P94, DOI 10.1038/ki.1993.16; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVER WG, 1990, CELL, V61, P553, DOI 10.1016/0092-8674(90)90464-P; Levy JB, 1996, CLIN EXP IMMUNOL, V106, P79, DOI 10.1046/j.1365-2249.1996.d01-815.x; Levy JB, 1997, J AM SOC NEPHROL, V8, P1698; MARIYAMA M, 1994, J BIOL CHEM, V269, P23013; MAYER U, 1994, EUR J BIOCHEM, V225, P573, DOI 10.1111/j.1432-1033.1994.00573.x; Meyers KEC, 1998, KIDNEY INT, V53, P402, DOI 10.1046/j.1523-1755.1998.00827.x; NEILSON EG, 1993, J BIOL CHEM, V268, P8402; Netzer KO, 1998, PROTEIN SCI, V7, P1340, DOI 10.1002/pro.5560070610; PENADES JR, 1995, EUR J BIOCHEM, V229, P754, DOI 10.1111/j.1432-1033.1995.tb20524.x; PUSEY CD, 1987, LAB INVEST, V56, P23; Ryan JJ, 1998, CLIN EXP IMMUNOL, V113, P17, DOI 10.1046/j.1365-2249.1998.00623.x; Sado Y, 1998, KIDNEY INT, V53, P664, DOI 10.1046/j.1523-1755.1998.00795.x; SAMBROOK J, 1989, MOL CLONING LAB MANU, V3; SAUS J, 1988, J BIOL CHEM, V263, P13374; SCHWAB C, 1993, PROTEIN SCI, V2, P175; TZARTOS SJ, 1991, MOL NEUROBIOL, V5, P1, DOI 10.1007/BF02935610; WIESLANDER J, 1984, P NATL ACAD SCI-BIOL, V81, P1544, DOI 10.1073/pnas.81.5.1544; WIESLANDER J, 1987, CLIN EXP IMMUNOL, V69, P332; WILSON CB, 1986, KIDNEY, P800; Yurchenco PD, 1997, P NATL ACAD SCI USA, V94, P10189, DOI 10.1073/pnas.94.19.10189	38	123	130	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11267	11274		10.1074/jbc.274.16.11267	http://dx.doi.org/10.1074/jbc.274.16.11267			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196215	hybrid			2022-12-27	WOS:000079751900083
J	van den Brink, MRM; Kapeller, R; Pratt, JC; Chang, JH; Burakoff, SJ				van den Brink, MRM; Kapeller, R; Pratt, JC; Chang, JH; Burakoff, SJ			The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAS-LIGAND EXPRESSION; NIH 3T3 CELLS; PROTEIN-KINASE; INDUCED APOPTOSIS; ANTIGEN RECEPTOR; TYROSINE KINASE; HYBRIDOMAS; LYMPHOCYTES; INHIBITOR; DIFFERENTIATION	T cells can undergo activation-induced cell death (AICD) upon stimulation of the T cell receptor-CD3 complex. We found that the extracellular signal-regulated kinase (ERK) pathway is activated during AICD, Transient transfection of a dominant interfering mutant of mitogen-activated/extracellular signal-regulated receptor protein kinase kinase (MEK1) demonstrated that down-regulation of the ERK pathway inhibited Fast expression during AICD, whereas activation of the ERK pathway with a constitutively active MEK1 resulted in increased expression of Fast. We also found that pretreatment with the specific MEK1 inhibitor PD98059 prevented the induction of Fast expression during AICD and inhibited AICD. However, PD98059 had no effect on other apoptotic stimuli. We found only very weak ERK activity during Fas-mediated apoptosis (induced by Fas cross-linking). Furthermore, preincubation with the MEK1 inhibitor did not inhibit Fas-mediated apoptosis, Finally, we also demonstrated that pretreatment with the MEK1 inhibitor could delay and decrease the expression of the orphan nuclear steroid receptor Nur77, which has been shown to be essential for AICD. In conclusion, this study demonstrates that the ERK pathway is required for AICD of T cells and appears to regulate the induction of Nur77 and Fast expression during AICD.	Dana Farber Canc Inst, Div Pediat Oncol, Dept Pediat Oncol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Hematol & Oncol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center	van den Brink, MRM (corresponding author), Dana Farber Canc Inst, Div Pediat Oncol, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.		van den Brink, Marcel R. M./HGB-9434-2022	van den Brink, Marcel/0000-0003-0696-4401	NATIONAL CANCER INSTITUTE [T32CA009382, P30CA008748, P01CA039542] Funding Source: NIH RePORTER; NCI NIH HHS [CA09382, 5PO1 CA39542, P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Alessandrini A, 1996, J BIOL CHEM, V271, P31612, DOI 10.1074/jbc.271.49.31612; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ANEL A, 1994, EUR J IMMUNOL, V24, P2469, DOI 10.1002/eji.1830241032; ASHWELL JD, 1987, J EXP MED, V165, P173, DOI 10.1084/jem.165.1.173; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; CHAN FKM, 1995, MOL CELL BIOL, V15, P2682; Chauhan D, 1997, BLOOD, V89, P227, DOI 10.1182/blood.V89.1.227.227_227_234; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Eischen CM, 1997, J IMMUNOL, V159, P1135; Faris M, 1998, MOL CELL BIOL, V18, P5414, DOI 10.1128/MCB.18.9.5414; Goillot E, 1997, P NATL ACAD SCI USA, V94, P3302, DOI 10.1073/pnas.94.7.3302; GonzalezGarcia A, 1997, J IMMUNOL, V158, P4104; GREEN DR, 1994, CURR OPIN IMMUNOL, V6, P476, DOI 10.1016/0952-7915(94)90130-9; GULBINS E, 1995, IMMUNITY, V2, P341, DOI 10.1016/1074-7613(95)90142-6; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Juo P, 1997, MOL CELL BIOL, V17, P24, DOI 10.1128/MCB.17.1.24; KAPPLER J, 1982, P NATL ACAD SCI-BIOL, V79, P3604, DOI 10.1073/pnas.79.11.3604; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Latinis KM, 1997, J IMMUNOL, V158, P4602; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; OYAIZU N, 1995, BIOCHEM BIOPH RES CO, V213, P994, DOI 10.1006/bbrc.1995.2227; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; Sahuquillo AG, 1998, J EXP MED, V187, P1179, DOI 10.1084/jem.187.8.1179; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Sutherland CL, 1996, J IMMUNOL, V157, P3381; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Weih F, 1996, P NATL ACAD SCI USA, V93, P5533, DOI 10.1073/pnas.93.11.5533; Wilson DJ, 1996, EUR J IMMUNOL, V26, P989, DOI 10.1002/eji.1830260505; Winoto A, 1997, Semin Immunol, V9, P51, DOI 10.1006/smim.1996.0053; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	41	89	89	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11178	11185		10.1074/jbc.274.16.11178	http://dx.doi.org/10.1074/jbc.274.16.11178			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196203	hybrid			2022-12-27	WOS:000079751900071
J	Varnai, P; Rother, KI; Balla, T				Varnai, P; Rother, KI; Balla, T			Phosphatidylinositol 3-kinase-dependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; PH DOMAIN; SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; INOSITOL TRISPHOSPHATE; ACTIVATION; 3-KINASE; MUTATION; TRANSLOCATION; SPECIFICITY	Phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P-3) has been proposed to act as a second messenger to recruit regulatory proteins to the plasma membrane via their pleckstrin homology (PH) domains. The PH domain of Bruton's tyrosine kinase (Btk), which is mutated in the human disease X-linked agammaglobulinemia, has been shown to interact with PI(3,4,5)P-3 in vitro. In this study, a fusion protein containing the PH domain of Btk and the enhanced green fluorescent protein (BtkPH-GFP) was constructed and utilized to study the ability of this PH domain to interact with membrane inositol phospholipids inside living cells. The localization of expressed BtkPH-GFP in quiescent NIH 3T3 cells was indistinguishable from that of GFP alone, both being cytosolic as assessed by confocal microscopy. In NIH 3T3 cells coexpressing BtkPH-GFP and the epidermal growth factor receptor, activation of epidermal growth factor or endogenous platelet-derived growth factor receptors caused a rapid (<3 min) translocation of the cytosolic fluorescence to ruffle-like membrane structures. This response was not observed in cells expressing GFP only and was completely inhibited by treatment with the PI 3-kinase inhibitors wortmannin and LY 292004, Membrane-targeted PI 3-kinase also caused membrane localization of BtkPH-GFP that was slowly reversed by wortmannin. When the R28C mutation of the Btk PH domain, which causes X-linked agammaglobulinemia, was introduced into the fluorescent construct, no translocation was observed after stimulation. Tn contrast, the E41K mutation, which confers transforming activity to native Btk, caused significant membrane localization of BtkPH-GFP with characteristics indicating its possible binding to PI(4,5)P-2. This mutant, but not wild-type BtkPH-GFP, interfered with agonist-induced PI(4,5)P-2 hydrolysis in COS-7 cells. These results show in intact cells that the PH domain of Btk binds selectively to 3-phosphorylated lipids after activation of PI 3-kinase enzymes and that losing such binding ability or specificity results in gross abnormalities in the function of the enzyme. Therefore, the interaction with PI(3,4,5)P-3 is likely to be an important determinant of the physiological regulation of Btk and can be utilized to visualize the dynamics and spatiotemporal organization of changes in this phospholipid in living cells.	NICHD, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA; NICHD, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Balla, T (corresponding author), NICHD, Endocrinol & Reprod Res Branch, NIH, Bldg 49,Rm 6A35,49 Convent Dr, Bethesda, MD 20892 USA.	tambal@box-t.nih.gov		Balla, Tamas/0000-0002-9077-3335	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000196] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABRAMS CS, 1995, J BIOL CHEM, V270, P14485, DOI 10.1074/jbc.270.24.14485; BALLA T, 1994, MOL BIOL CELL, V5, P17, DOI 10.1091/mbc.5.1.17; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Bromann PA, 1997, J BIOL CHEM, V272, P16240, DOI 10.1074/jbc.272.26.16240; Chen RH, 1997, EMBO J, V16, P1351, DOI 10.1093/emboj/16.6.1351; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fukuda M, 1996, J BIOL CHEM, V271, P30303, DOI 10.1074/jbc.271.48.30303; HUNYADY L, 1994, J BIOL CHEM, V269, P24798; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; JACKSON TR, 1992, J BIOL CHEM, V267, P16627; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kontos CD, 1998, MOL CELL BIOL, V18, P4131, DOI 10.1128/MCB.18.7.4131; LI TJ, 1995, IMMUNITY, V2, P451, DOI 10.1016/1074-7613(95)90026-8; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Mochly-Rosen D, 1998, FASEB J, V12, P35; Nagel WG, 1998, MOL BIOL CELL, V9, P1981, DOI 10.1091/mbc.9.8.1981; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Rawlings D J, 1995, Semin Immunol, V7, P237, DOI 10.1006/smim.1995.0028; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Rother KI, 1998, J BIOL CHEM, V273, P17491, DOI 10.1074/jbc.273.28.17491; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Shirai Y, 1998, J CELL BIOL, V143, P511, DOI 10.1083/jcb.143.2.511; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TSUKADA S, 1994, P NATL ACAD SCI USA, V91, P11256, DOI 10.1073/pnas.91.23.11256; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Venkateswarlu K, 1998, BIOCHEM J, V335, P139, DOI 10.1042/bj3350139; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Vihinen M, 1996, NUCLEIC ACIDS RES, V24, P160, DOI 10.1093/nar/24.1.160; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175; Yao LB, 1997, J BIOL CHEM, V272, P13033, DOI 10.1074/jbc.272.20.13033	42	242	251	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10983	10989		10.1074/jbc.274.16.10983	http://dx.doi.org/10.1074/jbc.274.16.10983			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196179	hybrid			2022-12-27	WOS:000079751900047
J	Anderson, RA; Boronenkov, IV; Doughman, SD; Kunz, J; Loijens, JC				Anderson, RA; Boronenkov, IV; Doughman, SD; Kunz, J; Loijens, JC			Phosphatidylinositol phosphate kinases, a multifaceted family of signaling enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PHOSPHOLIPASE-C ISOZYMES; PROTEIN-KINASE; PHOSPHOINOSITIDE KINASES; SACCHAROMYCES-CEREVISIAE; 4-PHOSPHATE 5-KINASE; DIACYLGLYCEROL KINASE; FACTOR RECEPTOR; HUMAN PLATELETS; 4-KINASE; PHOSPHORYLATION		Univ Wisconsin, Sch Med, Dept Pharmacol, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Anderson, RA (corresponding author), Univ Wisconsin, Sch Med, Dept Pharmacol, Mol & Cellular Pharmacol Program, 1300 Univ Ave, Madison, WI 53706 USA.	raanders@facstaff.wisc.edu		Anderson, Richard/0000-0001-6265-8359				AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BAZENET CE, 1990, J BIOL CHEM, V265, P18012; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; BORONENKOV IV, 1995, J BIOL CHEM, V270, P2881, DOI 10.1074/jbc.270.7.2881; BOSSEMEYER D, 1994, TRENDS BIOCHEM SCI, V19, P201, DOI 10.1016/0968-0004(94)90022-1; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Castellino AM, 1997, J BIOL CHEM, V272, P5861, DOI 10.1074/jbc.272.9.5861; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; COCHET C, 1991, J BIOL CHEM, V266, P637; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; DIVECHA N, 1995, BIOCHEM J, V309, P715, DOI 10.1042/bj3090715; DIVECHA N, 1993, CELL, V74, P405, DOI 10.1016/0092-8674(93)80041-C; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Exton JH, 1997, J BIOL CHEM, V272, P15579, DOI 10.1074/jbc.272.25.15579; FLANAGAN CA, 1993, SCIENCE, V262, P1444, DOI 10.1126/science.8248783; GARCIABUSTOS JF, 1994, EMBO J, V13, P2352, DOI 10.1002/j.1460-2075.1994.tb06519.x; Gehrmann T, 1998, EUR J BIOCHEM, V253, P357, DOI 10.1046/j.1432-1327.1998.2530357.x; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Hinchliffe KA, 1996, EMBO J, V15, P6516, DOI 10.1002/j.1460-2075.1996.tb01042.x; HOKIN LE, 1964, BIOCHIM BIOPHYS ACTA, V84, P563, DOI 10.1016/0926-6542(64)90126-X; HOKIN LE, 1989, BIOCHIM BIOPHYS ACTA, V1000, P465, DOI 10.1016/S0006-3002(89)80041-1; HOKIN LE, 1955, BIOCHIM BIOPHYS ACTA, V18, P102, DOI 10.1016/0006-3002(55)90013-5; Hokin M.R., 1964, METABOLISM PHYSL SIG, P423; HOKIN MR, 1953, J BIOL CHEM, V203, P967; Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Itoh T, 1998, J BIOL CHEM, V273, P20292, DOI 10.1074/jbc.273.32.20292; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; LING LE, 1989, J BIOL CHEM, V264, P5080; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; PAYRASTRE B, 1992, J BIOL CHEM, V267, P5078; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; RANA RS, 1990, PHYSIOL REV, V70, P115, DOI 10.1152/physrev.1990.70.1.115; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Roth MG, 1997, CURR OPIN CELL BIOL, V9, P519, DOI 10.1016/S0955-0674(97)80028-2; SATTERLEE JS, 1998, PLANT PHYSIOL, V115, P864; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Staeheli Peter, 1993, Trends in Cell Biology, V3, P268, DOI 10.1016/0962-8924(93)90055-6; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525; YAMAMOTO K, 1990, BIOCHEM BIOPH RES CO, V168, P466, DOI 10.1016/0006-291X(90)92344-Y; YAMAMOTO K, 1990, J BIOL CHEM, V265, P22086; YOSHIDA S, 1994, MOL GEN GENET, V242, P631, DOI 10.1007/BF00283416; YOSHIDA S, 1994, J BIOL CHEM, V269, P1166; Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756	63	223	228	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					9907	9910		10.1074/jbc.274.15.9907	http://dx.doi.org/10.1074/jbc.274.15.9907			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187762	hybrid			2022-12-27	WOS:000079663500001
J	Huang, YS; Chuang, DT				Huang, YS; Chuang, DT			Mechanisms for GroEL/GroES-mediated folding of a large 86-kDa fusion polypeptide in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KETOACID DEHYDROGENASE COMPLEX; MALTOSE-BINDING-PROTEIN; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; CELLULAR PROTEIN; IN-VITRO; GROEL; RELEASE; ALPHA-2-BETA-2; RECONSTITUTION	Our understanding of mechanisms for GroEL/GroES-assisted protein folding to date has been derived mostly from studies with small proteins. Little is known concerning the interaction of these chaperonins with large multidomain polypeptides during folding. In the present study, we investigated chaperonin-dependent folding of a large 86-kDa fusion polypeptide, in which the mature maltose-binding protein (MBP) sequence was linked to the N terminus of the alpha subunit of the decarboxylase (E1) component of the human mitochondrial branched-chain alpha-ketoacid dehydrogenase complex. The fusion polypeptide, MBP-alpha, when co-expressed with the beta subunit of E1, produced a chimeric protein MBP-E1 with an (MBP-alpha)(2)beta(2) structure, similar to the alpha(2)beta(2) structure in native E1, Reactivation of MBP-E1 denatured in 8 M urea was absolutely dependent on GroEL/GroES and Mg2+-ATP, and exhibited strikingly slow kinetics with a rate constant of 376 M-1 s(-1), analogous to denatured untagged E1. Chaperonin-mediated refolding of the MBP-alpha fusion polypeptide showed that the folding of the MBP moiety was about 7-fold faster than that of the cu moiety on the same chain with rate constants of 1.9 x 10(-3) s(-1) and 2.95 x 10(-4) s(-1), respectively. This explained the occurrence of an MBP-alpha.GroEL binary complex that was isolated with amylose resin from the refolding mixture and transformed Escherichia coli lysates. The data support the thesis that distinct functional sequences in a large polypeptide exhibit different folding characteristics on the same GroEL scaffold. Moreover, we show that when the alpha.GroEL complex (molar ratio 1:1) was incubated with GroES, the latter was capable of capping either the very ring that harbored the 48-kDa (His)(6)-alpha polypeptide (in cis) or the opposite unoccupied cavity (in trans). In contrast, the MBP-alpha.GroEL (1:1) complex was capped by GroES exclusively in the trans configuration. These findings suggest that the productive folding of a large multidomain polypeptide can only occur in the GroEL cavity that is not sequestered by GroES.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Biochem & Mol Biol Grad Program, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Chuang, DT (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.		Huang, Yi-Shuian/P-2824-2018	Huang, Yi-Shuian/0000-0001-9000-7748	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026758] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-26758] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BLOND S, 1986, Proteins Structure Function and Genetics, V1, P247, DOI 10.1002/prot.340010307; BLONDELGUINDI S, 1990, BIOCHEMISTRY-US, V29, P2409, DOI 10.1021/bi00461a026; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Chuang JL, 1999, J BIOL CHEM, V274, P10395, DOI 10.1074/jbc.274.15.10395; CHUN SY, 1993, J BIOL CHEM, V268, P20855; DAUTRYVARSAT A, 1981, BIOCHEMISTRY-US, V20, P1396, DOI 10.1021/bi00508a056; DAVIE JR, 1992, J BIOL CHEM, V267, P16601; DEVILLEBONNE D, 1989, BIOCHEMISTRY-US, V28, P1917, DOI 10.1021/bi00430a073; ELLIS J, 1992, NATURE, V358, P191, DOI 10.1038/358191a0; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; FERENCI T, 1978, FEBS LETT, V94, P213, DOI 10.1016/0014-5793(78)80940-5; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FRIEDEN C, 1990, P NATL ACAD SCI USA, V87, P4413, DOI 10.1073/pnas.87.12.4413; GAREL JR, 1980, P NATL ACAD SCI-BIOL, V77, P3379, DOI 10.1073/pnas.77.6.3379; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GORDON CL, 1994, J BIOL CHEM, V269, P27941; GRIMM R, 1993, J BIOL CHEM, V268, P5220; Hartl F U, 1991, Semin Immunol, V3, P5; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HARTMAN DJ, 1992, P NATL ACAD SCI USA, V89, P3394, DOI 10.1073/pnas.89.8.3394; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; JAENICKE R, 1979, BIOCHEMISTRY-US, V18, P1217, DOI 10.1021/bi00574a016; KIM S, 1994, TRENDS BIOCHEM SCI, V19, P543, DOI 10.1016/0968-0004(94)90058-2; LEGNAME G, 1995, FEBS LETT, V361, P211, DOI 10.1016/0014-5793(95)00184-B; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MENDOZA JA, 1994, J BIOL CHEM, V269, P2447; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PARK SH, 1988, SCIENCE, V239, P1033, DOI 10.1126/science.3278378; Richarme G, 1997, J BIOL CHEM, V272, P15607, DOI 10.1074/jbc.272.25.15607; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; Sambrook J., 2002, MOL CLONING LAB MANU; SCHWARZ E, 1994, BBA-BIOENERGETICS, V1187, P270, DOI 10.1016/0005-2728(94)90125-2; SINCLAIR JF, 1994, NAT STRUCT BIOL, V1, P320, DOI 10.1038/nsb0594-320; Sparrer H, 1996, J MOL BIOL, V258, P74, DOI 10.1006/jmbi.1996.0235; STUART RA, 1994, TRENDS BIOCHEM SCI, V19, P87, DOI 10.1016/0968-0004(94)90041-8; Voet D VJ, 1990, BIOCHEMISTRY; WALDINGER D, 1988, BIOL CHEM H-S, V369, P1185, DOI 10.1515/bchm3.1988.369.2.1185; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; WYNN RM, 1992, J BIOL CHEM, V267, P12400; Wynn RM, 1998, J BIOL CHEM, V273, P13110, DOI 10.1074/jbc.273.21.13110; WYNN RM, 1994, BIOCHEMISTRY-US, V33, P8962, DOI 10.1021/bi00196a014; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625	50	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10405	10412		10.1074/jbc.274.15.10405	http://dx.doi.org/10.1074/jbc.274.15.10405			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187830	hybrid			2022-12-27	WOS:000079663500069
J	Lee, RCH; Walters, JA; Reyland, ME; Anderson, SM				Lee, RCH; Walters, JA; Reyland, ME; Anderson, SM			Constitutive activation of the prolactin receptor results in the induction of growth factor-independent proliferation and constitutive activation of signaling molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; FMS PROTO-ONCOGENE; TYROSINE KINASE JAK2; BREAST-CANCER-CELLS; COMMON BETA-SUBUNIT; PHOSPHATIDYLINOSITOL 3-KINASE; POINT MUTATION; MAP KINASE; NB2 CELLS; INTERLEUKIN-3 DEPENDENCE	The ability to induce the oncogenic activation of the human prolactin receptor (PRLR) was examined by deleting 178 amino acids of the extracellular ligand-binding domain. Expression of this deletion mutant in the interleukin-3 (IL-3)-dependent murine myeloid cell line 32Dc13 resulted in the induction of growth factor-independent proliferation. Parental 32Dc13 cells proliferated only in the presence of exogenous murine IL-3 (mIL-3), while 32Dc13 cells transfected with the long form of the human PRLR were able to proliferate in response to mIL-3, ovine prolactin, or human PRL, Cells expressing the Delta 178 deletion mutant contained numerous phosphotyrosine-containing proteins in the absence of stimulation with either mIL-3 or ovine prolactin, Growth factor stimulation increased the number of proteins phosphorylated and the intensity of phosphorylation, These proteins included constitutively phosphorylated Janus kinase 2, signal transducer and activator of transcription 5, and SHC. Activated extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2) were observed in unstimulated 32Dc13 cells expressing the Delta 178 mutant. Likewise, transfection of Nb2 cells with the Delta 178 deletion mutant induced growth factor-independent proliferation and constitutive activation of Janus kinase 2, ERK1, and ERK2, In addition to the induction of a growth factor-independent state, the expression of the Delta 178 deletion mutant also suppressed the apoptosis that occurs when 32Dc13 cells are cultured in the absence of growth factors such as IL-3, These data suggest that the constitutive activation of the PRLR can be achieved by deletion of the ligand binding domain and that this mutation leads to the oncogenic activation of the receptor as determined by the ability of the receptor to induce growth factor-independent proliferation of factor-dependent hematopoietic cells.	Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Pathol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Sch Dent, Dept Basic Sci & Oral Biol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Anderson, SM (corresponding author), Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Pathol, Box B-216,4200 E 9th Ave, Denver, CO 80262 USA.	steve.anderson@uchsc.edu			NCI NIH HHS [CA46934] Funding Source: Medline; NIDDK NIH HHS [DK48879] Funding Source: Medline; NIGMS NIH HHS [GM08497] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AlSakkaf KA, 1996, BIOCHEM BIOPH RES CO, V221, P779, DOI 10.1006/bbrc.1996.0673; ANDERSON SM, 1995, J IMMUNOL, V155, P1660; Anderson SM, 1997, J BIOL CHEM, V272, P739, DOI 10.1074/jbc.272.2.739; ANDERSON SM, 1990, ONCOGENE, V5, P317; ASKEW DS, 1991, ONCOGENE, V6, P1915; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; Berlanga JJ, 1997, J BIOL CHEM, V272, P2050; BISWAS R, 1987, CANCER RES, V47, P3509; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BUCKLEY AR, 1994, BIOCHEM BIOPH RES CO, V204, P1158, DOI 10.1006/bbrc.1994.2584; Burton EA, 1997, J BIOL CHEM, V272, P16189, DOI 10.1074/jbc.272.26.16189; CAREY GB, 1995, ARCH BIOCHEM BIOPHYS, V316, P179, DOI 10.1006/abbi.1995.1026; CLEVELAND JL, 1989, MOL CELL BIOL, V9, P5685, DOI 10.1128/MCB.9.12.5685; CLEVELAND JL, 1994, ONCOGENE, V9, P2217; CLEVENGER CV, 1994, MOL ENDOCRINOL, V8, P674, DOI 10.1210/me.8.6.674; CUTLER RL, 1993, J BIOL CHEM, V268, P21463; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; DANDREA R, 1994, BLOOD, V83, P2802, DOI 10.1182/blood.V83.10.2802.2802; DAndrea RJ, 1996, BLOOD, V87, P2641, DOI 10.1182/blood.V87.7.2641.bloodjournal8772641; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVID M, 1994, P NATL ACAD SCI USA, V91, P7174, DOI 10.1073/pnas.91.15.7174; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; ERWIN RA, 1995, ENDOCRINOLOGY, V136, P3512, DOI 10.1210/en.136.8.3512; GINSBURG E, 1995, CANCER RES, V55, P2591; Goffin V, 1997, J MAMMARY GLAND BIOL, V2, P7, DOI 10.1023/A:1026313211704; Gonda TJ, 1997, BLOOD, V89, P355, DOI 10.1182/blood.V89.2.355; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Gourdou I, 1996, MOL ENDOCRINOL, V10, P45, DOI 10.1210/me.10.1.45; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; HANNEMANN J, 1995, MOL CELL BIOL, V15, P2402; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Hunter S, 1997, MOL ENDOCRINOL, V11, P1213, DOI 10.1210/me.11.9.1213; ISFORT R, 1988, J BIOL CHEM, V263, P19203; ISFORT RJ, 1988, P NATL ACAD SCI USA, V85, P7982, DOI 10.1073/pnas.85.21.7982; Jenkins BJ, 1996, J BIOL CHEM, V271, P29707, DOI 10.1074/jbc.271.47.29707; JENKINS BJ, 1995, EMBO J, V14, P4276, DOI 10.1002/j.1460-2075.1995.tb00102.x; LAX I, 1985, EMBO J, V4, P3179, DOI 10.1002/j.1460-2075.1985.tb04062.x; LEBRUN JJ, 1994, J BIOL CHEM, V269, P14021; LINNEKIN D, 1990, BIOCHEM J, V27, P317; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; LONGMORE GD, 1991, CELL, V67, P1089, DOI 10.1016/0092-8674(91)90286-8; METCALF D, 1985, BLOOD, V65, P357; OKUDA K, 1992, BLOOD, V79, P2880; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; PICCOLETTI R, 1994, BIOCHEM J, V303, P429, DOI 10.1042/bj3030429; ROUSSEL MF, 1988, CELL, V55, P979, DOI 10.1016/0092-8674(88)90243-7; ROVERA G, 1987, ONCOGENE, V1, P29; RUI H, 1992, J BIOL CHEM, V267, P24076; RUI H, 1994, J BIOL CHEM, V269, P5364; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SHIU RPC, 1983, ENDOCRINOLOGY, V113, P159, DOI 10.1210/endo-113-1-159; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; SOMMERS W, 1994, NATURE, V372, P478; SOUYRI M, 1990, CELL, V63, P1137, DOI 10.1016/0092-8674(90)90410-G; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Ware MD, 1996, BLOOD, V88, P2833, DOI 10.1182/blood.V88.8.2833.bloodjournal8882833; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1; WENDLING F, 1986, VIROLOGY, V149, P242, DOI 10.1016/0042-6822(86)90125-X; WILLIAMS DE, 1990, CELL, V63, P167, DOI 10.1016/0092-8674(90)90297-R; WOOLFORD J, 1988, CELL, V55, P965, DOI 10.1016/0092-8674(88)90242-5; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	66	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10024	10034		10.1074/jbc.274.15.10024	http://dx.doi.org/10.1074/jbc.274.15.10024			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187780	hybrid			2022-12-27	WOS:000079663500019
J	Sadhukhan, R; Santhamma, KR; Reddy, P; Peschon, JJ; Black, RA; Sen, I				Sadhukhan, R; Santhamma, KR; Reddy, P; Peschon, JJ; Black, RA; Sen, I			Unaltered cleavage and secretion of angiotensin-converting enzyme in tumor necrosis factor-alpha-converting enzyme-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; PROTEIN; METALLOPROTEASE; ECTODOMAIN; PRECURSOR; DISINTEGRIN; EXPRESSION; FERTILITY; RELEASE	Mammalian angiotensin-converting enzyme (ACE) is one of several biologically important ectoproteins that exist in both membrane-bound and soluble forms as a result of a post-translational proteolytic cleavage. It has been suggested that a common proteolytic system is responsible for the cleavage of a diverse group of membrane ectoproteins, and tumor necrosis factor-alpha-converting enzyme (TACE), a recently purified disintegrin-metalloprotease, has been implicated in the proteolytic cleavage of several cell surface proteins. Mice devoid of TACE have been developed by gene targeting. Such mice could provide a useful system to determine if TACE is responsible for the cleavage of other ectoproteins, Cultured fibroblasts without TACE activity, when transfected with cDNA encoding for the testicular isozyme of ACE (ACE(T)), synthesized and secreted ACE(T) normally after a proteolytic cleavage near the C terminus. In addition, similar quantities of the soluble, C-terminally truncated somatic isozyme of ACE (ACE(P)) were present in the serum of wild-type and TACE-deficient mice. These results demonstrate that TACE is not essential in the generation of soluble ACE under physiological conditions. Finally, we also report solubilization of ACE-secretase, the enzyme that cleaves ACE, from mouse ACE89 cells and from rabbit lung. We demonstrate that soluble ACE-secretase from both sources failed to cleave its substrate in solution, suggesting a requirement for anchoring to the membrane.	Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; Immunex Res & Dev Corp, Seattle, WA 98101 USA	Cleveland Clinic Foundation	Sen, I (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.				NHLBI NIH HHS [HL54297] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054297] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arribas J, 1997, J BIOL CHEM, V272, P17160, DOI 10.1074/jbc.272.27.17160; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; BELDENT V, 1993, J BIOL CHEM, V268, P26428; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; EHLERS MRW, 1991, P NATL ACAD SCI USA, V88, P1009, DOI 10.1073/pnas.88.3.1009; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P10065, DOI 10.1021/bi00106a001; HOOPER NM, 1991, INT J BIOCHEM, V23, P641, DOI 10.1016/0020-711X(91)90032-I; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; KASTURI S, 1994, BIOCHEMISTRY-US, V33, P6228, DOI 10.1021/bi00186a024; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Merlos-Suarez A, 1998, J BIOL CHEM, V273, P24955, DOI 10.1074/jbc.273.38.24955; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; MULLBERG J, 1995, J IMMUNOL, V155, P5198; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Ramaraj P, 1998, J CLIN INVEST, V102, P371, DOI 10.1172/JCI3545; RAMCHANDRAN R, 1995, BIOCHEMISTRY-US, V34, P12645, DOI 10.1021/bi00039a021; Ramchandran R, 1996, AM J PHYSIOL-HEART C, V271, pH744, DOI 10.1152/ajpheart.1996.271.2.H744; RAMCHANDRAN R, 1994, J BIOL CHEM, V269, P2125; Sadhukhan R, 1998, P NATL ACAD SCI USA, V95, P138, DOI 10.1073/pnas.95.1.138; SEN I, 1991, J BIOL CHEM, V266, P21985; SEN I, 1993, J BIOL CHEM, V268, P25748; WEI L, 1991, J BIOL CHEM, V266, P5540	23	46	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10511	10516		10.1074/jbc.274.15.10511	http://dx.doi.org/10.1074/jbc.274.15.10511			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187843	hybrid			2022-12-27	WOS:000079663500082
J	Xing, MZ; Post, S; Ostrom, RS; Samardzija, M; Insel, PA				Xing, MZ; Post, S; Ostrom, RS; Samardzija, M; Insel, PA			Inhibition of phospholipase A(2)-mediated arachidonic acid release by cyclic AMP defines a negative feedback loop for P-2Y receptor activation in Madin-Darby canine kidney D-1 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ALPHA(1)-ADRENERGIC RECEPTORS; EPITHELIAL-CELLS; CAMP PRODUCTION; PHORBOL ESTER; PATHWAY; PROSTAGLANDIN-E2; STIMULATION; HYDROLYSIS; ALPHA	In Madin-Darby canine kidney D-1 cells extracellular nucleotides activate P-2Y receptors that couple to several signal transduction pathways, including stimulation of multiple phospholipases and adenylyl cyclase, For one class of P-2Y receptors, P-2Y2 receptors, this stimulation of adenylyl cyclase and increase in cAMP occurs via the conversion of phospholipase A(2) (PLA(2))-generated arachidonic acid (AA) to prostaglandins (e.g. PGE(2)). These prostaglandins then stimulate adenylyl cyclase activity, presumably via activation of prostanoid receptors, In the current study we show that agents that increase cellular cAMP levels (including PGE(2), forskolin, and the beta-adrenergic agonist isoproterenol) can inhibit P-2Y receptor-promoted AA release. The protein kinase A (PKA) inhibitor H89 blocks this effect, suggesting that this feedback inhibition occurs via activation of PKA. Studies with PGE(2) indicate that inhibition of AA release is attributable to inhibition of mitogen-activated protein kinase activity and in turn of P-2Y receptor stimulated PLA(2) activity. Although cAMP/PKA-mediated inhibition occurs for P-2Y receptor-promoted AA release, we did not find such inhibition for epinephrine (alpha(1)-adrenergic) or bradykinin-mediated AA release. Taken together, these results indicate that negative feedback regulation via cAMP/PKA-mediated inhibition of mitogen-activated protein kinase occurs for some, but not all, classes of receptors that promote PLA(2) activation and AA release. We speculate that receptor-selective feedback inhibition occurs because PLA(2) activation by different receptors in Madin-Darby canine kidney D-1 cells involves the utilization of different signaling components that are differentially sensitive to increases in cAMP or, alternatively, because of compartmentation of signaling components.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Greater Baltimore Med Ctr, Dept Med, Baltimore, MD 21204 USA	University of California System; University of California San Diego; Greater Baltimore Medical Center	Insel, PA (corresponding author), Univ Calif San Diego, Dept Pharmacol, 0636, La Jolla, CA 92093 USA.			Ostrom, Rennolds/0000-0002-7204-0357	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031987] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL35847] Funding Source: Medline; NIGMS NIH HHS [GM31987] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balboa MA, 1998, MOL PHARMACOL, V53, P221, DOI 10.1124/mol.53.2.221; BALBOA MA, 1994, J BIOL CHEM, V269, P10511; CHABOT MC, 1986, J CRAN GENET DEV BIO, V6, P223; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; KENNEDY CRJ, 1995, BBA-LIPID LIPID MET, V1258, P206, DOI 10.1016/0005-2760(95)00049-I; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Mallat A, 1996, J CLIN INVEST, V98, P2771, DOI 10.1172/JCI119103; NIELSON CP, 1992, J IMMUNOL, V149, P4036; Post SR, 1998, J BIOL CHEM, V273, P23093, DOI 10.1074/jbc.273.36.23093; Post SR, 1996, J BIOL CHEM, V271, P2029, DOI 10.1074/jbc.271.4.2029; SLIVKA SR, 1987, J BIOL CHEM, V262, P4200; SLIVKA SR, 1988, J BIOL CHEM, V263, P14640; TAKENAWA T, 1986, J BIOL CHEM, V261, P1092; WEISS BA, 1991, J BIOL CHEM, V266, P2126; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Xing MB, 1996, J CLIN INVEST, V97, P1302, DOI 10.1172/JCI118546; Xing MZ, 1997, AM J PHYSIOL-CELL PH, V272, pC1380, DOI 10.1152/ajpcell.1997.272.4.C1380; Xing MZ, 1997, J CLIN INVEST, V99, P805, DOI 10.1172/JCI119227	18	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10035	10038		10.1074/jbc.274.15.10035	http://dx.doi.org/10.1074/jbc.274.15.10035			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187781	hybrid			2022-12-27	WOS:000079663500020
J	Schurmann, A; Schmidt, M; Asmus, M; Bayer, S; Fliegert, F; Koling, S; Massmann, S; Schilf, C; Subauste, MC; Voss, M; Jakobs, KH; Joost, HG				Schurmann, A; Schmidt, M; Asmus, M; Bayer, S; Fliegert, F; Koling, S; Massmann, S; Schilf, C; Subauste, MC; Voss, M; Jakobs, KH; Joost, HG			The ADP-ribosylation factor (ARF)-related GTPase ARF-related protein binds to the ARF-specific guanine nucleotide exchange factor cytohesin and inhibits the ARF-dependent activation of phospholipase D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-HYBRID SYSTEM; RAT-BRAIN; HOMOLOGY DOMAINS; SEC7 DOMAIN; FACTOR ARNO; FAMILY; CLONING; IDENTIFICATION; STIMULATION; PLECKSTRIN	ADP-ribosylation factor-related protein (ARP) is a membrane-associated GTPase with remote similarity to the family of ADP-ribosylation factors (ARF). In a yeast two-hybrid screen designed to identify proteins interacting with ARP, we isolated a partial cDNA of the ARF-specific guanine nucleotide exchange factor msec7-1/cytohesin encoding its N terminus and most of the See? domain (codons 1-200). ARP and ARP-Q79L (GTPase-negative ARP) exhibited a higher affinity to mSec7-1-(1-200) than ARP-T31N (nucleotide exchange-defective ARP) in the two-hybrid assay. Similarly, full-length [S-35]mSec7-1/cytohesin was specifically adsorbed to glutathione-Sepharose loaded with glutathione S-transferase (GST)-ARP-Q79L, GST-ARP, or GST-ARP-T31N, the latter exhibiting the lowest binding affinity. Overexpression of ARP-Q79L, but not of ARP-T31N, in COS-7 cells reduced the fluorescence from co-expressed green fluorescent protein fused with mSea7-1/cytohesin or mSec7-2/ARNO in plasma membranes as detected by deconvolution microscopy, Recombinant ARP and ARP-Q79L, but not ARP-T31N, inhibited the phospholipase D (PLD) activity stimulated by mSec7-2/ARNO and ARF in a system of isolated membranes. Furthermore, transfection of HEK-293 cells with ARP or ARP-Q79L, but not ARP-T31N, inhibited the muscarinic acetylcholine receptor-3 induced PLD stimulation and translocation of ARF from cytosol to membranes. These data suggest that the GTP-bound form of ARP specifically binds mSec7-1/cytohesin, and that ARP may be involved in a pathway inhibiting the ARF-controlled activity of PLD.	Rhein Westfal TH Aachen, Fak Med, Inst Pharmakol & Toxikol, D-52057 Aachen, Germany; Univ Essen Gesamthsch Klinikum, Inst Pharmakol, D-45122 Essen, Germany; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	RWTH Aachen University; University of Duisburg Essen; Scripps Research Institute	Joost, HG (corresponding author), Rhein Westfal TH Aachen, Fak Med, Inst Pharmakol & Toxikol, Wendlingweg 2, D-52057 Aachen, Germany.	joost@rwth-aachen.de	Joost, Hans-Georg/J-4462-2013	Joost, Hans-Georg/0000-0002-5860-606X; Schurmann, Annette/0000-0002-4113-4377				Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Bi K, 1997, CURR BIOL, V7, P301, DOI 10.1016/S0960-9822(06)00153-9; BOMAN AL, 1995, TRENDS BIOCHEM SCI, V20, P147, DOI 10.1016/S0968-0004(00)88991-4; Breiner M, 1996, BBA-GENE STRUCT EXPR, V1308, P1, DOI 10.1016/0167-4781(96)00081-4; Brown FD, 1998, CURR BIOL, V8, P835, DOI 10.1016/S0960-9822(98)70326-4; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Castleman K. R., 1996, DIGITAL IMAGE PROCES; CAVENAGH MM, 1994, J BIOL CHEM, V269, P18937; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Chen YG, 1997, J CELL BIOL, V138, P495, DOI 10.1083/jcb.138.3.495; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; COCKCROFT S, 1997, PROG LIPID RES, V35, P345; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; HATA Y, 1995, J BIOL CHEM, V270, P13022, DOI 10.1074/jbc.270.22.13022; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; JANOUEIXLEROSEY I, 1995, J BIOL CHEM, V270, P14801, DOI 10.1074/jbc.270.24.14801; KAHN RA, 1991, J BIOL CHEM, V266, P2606; Klarlund JK, 1998, J BIOL CHEM, V273, P1859, DOI 10.1074/jbc.273.4.1859; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kodaki T, 1997, J BIOL CHEM, V272, P11408; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; Meacci E, 1997, P NATL ACAD SCI USA, V94, P1745, DOI 10.1073/pnas.94.5.1745; MOSS J, 1995, J BIOL CHEM, V270, P12327, DOI 10.1074/jbc.270.21.12327; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Park SK, 1997, J BIOL CHEM, V272, P29263, DOI 10.1074/jbc.272.46.29263; Provost JJ, 1996, BIOCHEM J, V319, P285, DOI 10.1042/bj3190285; Rose M, 1990, LAB COURSE MANUAL ME; Rumenapp U, 1997, EUR J BIOCHEM, V248, P407, DOI 10.1111/j.1432-1033.1997.00407.x; RUMENAPP U, 1995, EUR J BIOCHEM, V234, P240, DOI 10.1111/j.1432-1033.1995.240_c.x; Schmidt M, 1996, J BIOL CHEM, V271, P2422, DOI 10.1074/jbc.271.5.2422; SCHMIDT M, 1994, EUR J BIOCHEM, V225, P667, DOI 10.1111/j.1432-1033.1994.00667.x; SCHURMANN A, 1994, J BIOL CHEM, V269, P15683; Schurmann A, 1995, J BIOL CHEM, V270, P30657, DOI 10.1074/jbc.270.51.30657; Telemenakis I, 1997, EUR J CELL BIOL, V74, P143; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C	44	27	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9744	9751		10.1074/jbc.274.14.9744	http://dx.doi.org/10.1074/jbc.274.14.9744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092663	hybrid			2022-12-27	WOS:000079451800082
J	Hasegawa, M; Cuenda, A; Spillantini, MG; Thomas, GM; Buee-Scherrer, V; Cohen, P; Goedert, M				Hasegawa, M; Cuenda, A; Spillantini, MG; Thomas, GM; Buee-Scherrer, V; Cohen, P; Goedert, M			Stress-activated protein kinase-3 interacts with the PDZ domain of alpha 1-syntrophin - A mechanism for specific substrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEGANS VULVAR INDUCTION; DYSTROPHIN-ASSOCIATED PROTEIN; MAP KINASE; CELLULAR STRESSES; SKELETAL-MUSCLE; MOLECULAR-CLONING; MAMMALIAN-CELLS; SODIUM-CHANNELS; SAP KINASES; P38 GROUP	Mechanisms for selective targeting to unique subcellular sites play an important role in determining the substrate specificities of protein kinases, Here we show that stress-activated protein kinase-3 (SAPK3, also called ERK6 and p38 gamma), a member of the mitogen-activated protein kinase family that is abundantly expressed in skeletal muscle, binds through its carboxyl-terminal sequence -KETXL to the PDZ domain of alpha 1-syntrophin, SAPK3 phosphorylates alpha 1-syntrophin at serine residues 193 and 201 in vitro and phosphorylation is dependent on binding 60 the PDZ domain of alpha 1-syntrophin, In skeletal muscle SAPK3 and alpha 1-syntrophin co-localize at the neuromuscular junction, and both proteins can be co-immunoprecipitated from transfected COS cell lysates, Phosphorylation of a PDZ domain-containing protein by an associated protein kinase is a novel mechanism for determining both the localization and the substrate specificity of a protein kinase.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Dundee, Dept Biochem, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; Univ Cambridge, Dept Neurol, Cambridge CB2 2PY, England	MRC Laboratory Molecular Biology; University of Dundee; University of Cambridge	Goedert, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Buee-Scherrer, Valerie/0000-0002-6107-1289				ADAMS ME, 1995, J BIOL CHEM, V270, P25859, DOI 10.1074/jbc.270.43.25859; ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; AHN AH, 1994, P NATL ACAD SCI USA, V91, P4446, DOI 10.1073/pnas.91.10.4446; AROIAN RV, 1990, NATURE, V348, P693, DOI 10.1038/348693a0; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Clifton AD, 1996, FEBS LETT, V392, P209, DOI 10.1016/0014-5793(96)00816-2; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FROEHNER SC, 1987, J CELL BIOL, V104, P1633, DOI 10.1083/jcb.104.6.1633; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Gee SH, 1998, J NEUROSCI, V18, P128; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Gum RJ, 1998, J BIOL CHEM, V273, P15605, DOI 10.1074/jbc.273.25.15605; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hoskins R, 1996, DEVELOPMENT, V122, P97; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; Mertens S, 1996, FEBS LETT, V383, P273, DOI 10.1016/0014-5793(96)00255-4; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Parker CG, 1998, BIOCHEM BIOPH RES CO, V249, P791, DOI 10.1006/bbrc.1998.9250; PETERS MF, 1994, NEUROREPORT, V5, P1577, DOI 10.1097/00001756-199408150-00009; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; Wang XS, 1997, J BIOL CHEM, V272, P23668, DOI 10.1074/jbc.272.38.23668; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909	51	133	139	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12626	12631		10.1074/jbc.274.18.12626	http://dx.doi.org/10.1074/jbc.274.18.12626			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212242	hybrid			2022-12-27	WOS:000080056800062
J	Hunter, GA; Ferreira, GC				Hunter, GA; Ferreira, GC			Pre-steady-state reaction of 8-aminolevulinate synthase - Evidence for a rate-determining product release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDOXAL 5'-PHOSPHATE COFACTOR; AMINO-ACID AMINOTRANSFERASE; 5-AMINOLEVULINATE SYNTHASE; ASPARTATE-AMINOTRANSFERASE; HEME-BIOSYNTHESIS; ESCHERICHIA-COLI; AMINOLEVULINATE SYNTHASE; CRYSTAL-STRUCTURES; BINDING; CATALYSIS	5-Aminolevulinate synthase (ALAS) is the first enzyme of the heme biosynthetic pathway in non-plant eukaryotes and the a-subclass of purple bacteria. The pyridoxal 5'-phosphate cofactor at the active site undergoes changes in absorptive properties during substrate binding and catalysis that have allowed us to study the kinetics of these reactions spectroscopically, Rapid scanning stopped-flow experiments of murine erythroid B-aminolevulinate synthase demonstrate that reaction with glycine plus succinyl-CoA results in a pre-steady-state burst of quinonoid intermediate formation. Thus, a step following binding of substrates and initial quinonoid intermediate formation is rate-determining. The steady-state spectrum of the enzyme is similar to that formed in the presence of Ei-aminolevulinate, suggesting that release of this product limits the overall rate. Reaction of either glycine or B-aminolevulinate with ALAS is slow (k(f) = 0.15 s(-1)) and approximates k(cat). The rate constant for reaction with glycine is increased at least 90-fold in the presence of succinyl-CoA and most likely represents a slow conformational change of the enzyme that is accelerated by succinyl-CoA The slow rate of reaction of B-aminolevulinate with ALAS is 8-aminolevulinate-independent, suggesting that it also represents a slow isomerization of the enzyme. Reaction of succinyl-CoA with the enzyme-glycine complex to form a quinonoid intermediate is a biphasic process and may be irreversible. Taken together, the data suggest that turnover is limited by release of 5-aminolevulinate or a conformational change associated with B-aminolevulinate release.	Univ S Florida, Coll Med, Dept Biochem & Mol Biol, Tampa, FL 33612 USA; Univ S Florida, Inst Biomol Sci, Tampa, FL 33612 USA; Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Ferreira, GC (corresponding author), Univ S Florida, Coll Med, Dept Biochem & Mol Biol, Tampa, FL 33612 USA.		Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052053] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK52053] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABBOUD MM, 1974, J CHEM SOC CHEM COMM, P643, DOI 10.1039/c39740000643; AHKTAR M, 1979, COMPREHENSIVE ORGANI, V5, P1121; ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; Berndt MC, 1996, BBA-PROTEIN STRUCT M, V1298, P159, DOI 10.1016/S0167-4838(96)00117-3; BOTTOMLEY SS, 1995, J BIOENERG BIOMEMBR, V27, P161, DOI 10.1007/BF02110031; DURBIN J, 1950, BIOMETRIKA, V37, P409, DOI 10.1093/biomet/37.3-4.409; FANICAGA.M, 1973, EUR J BIOCHEM, V40, P19, DOI 10.1111/j.1432-1033.1973.tb03164.x; FERREIRA GC, 1993, PROTEIN SCI, V2, P1959, DOI 10.1002/pro.5560021117; FERREIRA GC, 1995, J BIOENERG BIOMEMBR, V27, P151, DOI 10.1007/BF02110030; FERREIRA GC, 1993, J BIOL CHEM, V268, P584; FERREIRA GC, 1995, PROTEIN SCI, V4, P1001; Gong J, 1998, BIOCHEMISTRY-US, V37, P3509, DOI 10.1021/bi9719298; HUNTER GA, 1995, ANAL BIOCHEM, V226, P221, DOI 10.1006/abio.1995.1217; JAGER J, 1994, J MOL BIOL, V239, P285, DOI 10.1006/jmbi.1994.1368; Jordan PM, 1990, BIOSYNTHESIS HEME CH, P55; KIKUCHI G, 1958, J BIOL CHEM, V233, P1214; KIRSCH JF, 1966, BIOCHEMISTRY-US, V5, P783, DOI 10.1021/bi00866a053; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGHAI A, 1977, BIOCHEM SOC T, V5, P299, DOI 10.1042/bst0050299; MAY BK, 1995, PROG NUCLEIC ACID RE, V51, P1, DOI 10.1016/S0079-6603(08)60875-2; MCPHALEN CA, 1992, J MOL BIOL, V227, P197, DOI 10.1016/0022-2836(92)90691-C; MILES EW, 1994, ADV LIF SCI-SERIES, P113; NANDI DL, 1978, J BIOL CHEM, V253, P8872; OKAMOTO A, 1994, J BIOCHEM, V116, P95, DOI 10.1093/oxfordjournals.jbchem.a124509; Peisach D, 1998, BIOCHEMISTRY-US, V37, P4958, DOI 10.1021/bi972884d; PICOT D, 1991, EUR J BIOCHEM, V196, P329, DOI 10.1111/j.1432-1033.1991.tb15821.x; Rhee S, 1997, J BIOL CHEM, V272, P17293, DOI 10.1074/jbc.272.28.17293; SCHIRCH V, 1991, J BIOL CHEM, V266, P759; ShoolinginJordan PM, 1997, METHOD ENZYMOL, V281, P309; Tan DW, 1996, BIOCHEMISTRY-US, V35, P8934, DOI 10.1021/bi952918m; Tan DW, 1998, PROTEIN SCI, V7, P1208, DOI 10.1002/pro.5560070516; Tan DW, 1998, BIOCHEMISTRY-US, V37, P1478, DOI 10.1021/bi971928f; Wang W, 1997, BIOCHEMISTRY-US, V36, P8479, DOI 10.1021/bi970226n; YONAHA K, 1975, J BIOL CHEM, V250, P6983; ZAMAN Z, 1973, BIOCHEM J, V135, P257, DOI 10.1042/bj1350257; ZHANG ZY, 1991, BIOCHEMISTRY-US, V30, P8954, DOI 10.1021/bi00101a006	36	56	56	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12222	12228		10.1074/jbc.274.18.12222	http://dx.doi.org/10.1074/jbc.274.18.12222			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212188	hybrid			2022-12-27	WOS:000080056800008
J	Kao, R; Davies, J				Kao, R; Davies, J			Molecular dissection of mitogillin reveals that the fungal ribotoxins are a family of natural genetically engineered ribonucleases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA IDENTITY ELEMENTS; AMINO-ACID-SEQUENCE; ALPHA-SARCIN; EUKARYOTIC RIBOSOMES; TOXIN RESTRICTOCIN; SPECIFICITY; CLEAVAGE; RICIN; SITE; RECOGNITION	Mitogillin and the related fungal ribotoxins are highly specific ribonucleases which inactivate the ribosome enzymatically by cleaving the 23-28 S RNA of the large ribosomal subunit at a single phosphodiester bond. The site of cleavage occurs between G(4325) and A(4326) (rat ribosome numbering) which are present in one of the most conserved sequences (the alpha-sarcin loop) among the large subunit ribosomal RNAs of all living species. Amino acid sequence comparison of ribotoxins and guanyl/purine ribonucleases have identified domains or residues likely involved in ribonucleolytic activity or cleavage specificity. Fifteen deletion mutants (each 4 to 8 amino acid deletions) in motifs of mitogillin showing little amino acid sequence homology with guanyl/purine ribonucleases were constructed by site-directed mutagenesis, Analyses of the purified mutant proteins identified those regions in fungal ribotoxins contributing to ribosome targeting and modulating the catalytic activity of the toxin; some of the identified motifs are homologous to sequences in ribosomal proteins and elongation factors. This mutational study of mitogillin together with the recently published x-ray structure of restrictocin (a close relative of mitogillin) supports the hypothesis that the specific cleavage properties of ribotoxins are the result of natural genetic engineering in which the ribosomal targeting elements of ribosome-associated proteins were inserted into nonessential regions of T1-like ribonucleases.	Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Kao, R (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 6174 Univ Blvd, Vancouver, BC V6T 1Z3, Canada.		Kao, Richard Yi Tsun/C-4289-2009	Kao, Richard Y/0000-0001-8703-4980				ARNI R, 1988, J BIOL CHEM, V263, P15358; BETTER M, 1992, J BIOL CHEM, V267, P16712; BLANK A, 1982, ANAL BIOCHEM, V120, P267, DOI 10.1016/0003-2697(82)90347-5; CamposOlivas R, 1996, FEBS LETT, V399, P163, DOI 10.1016/S0014-5793(96)01320-8; CONDE FP, 1989, EUR J BIOCHEM, V178, P795, DOI 10.1111/j.1432-1033.1989.tb14511.x; ENDO Y, 1982, J BIOL CHEM, V257, P9054; ENDO Y, 1988, J BIOL CHEM, V263, P7917; FANDO JL, 1985, EUR J BIOCHEM, V149, P29, DOI 10.1111/j.1432-1033.1985.tb08888.x; FERNANDEZLUNA JL, 1985, BIOCHEMISTRY-US, V24, P861, DOI 10.1021/bi00325a008; Gluck A, 1996, J MOL BIOL, V256, P838, DOI 10.1006/jmbi.1996.0130; GLUCK A, 1994, NUCLEIC ACIDS RES, V22, P321, DOI 10.1093/nar/22.3.321; GLUCK A, 1992, J MOL BIOL, V226, P411, DOI 10.1016/0022-2836(92)90956-K; Kao R, 1998, MOL MICROBIOL, V29, P1019, DOI 10.1046/j.1365-2958.1998.00987.x; Kao R, 1995, BIOCHEM CELL BIOL, V73, P1151, DOI 10.1139/o95-124; Lacadena J, 1998, FEBS LETT, V424, P46, DOI 10.1016/S0014-5793(98)00137-9; Lamy B., 1992, GENETICALLY ENG TOXI, P237; LOPEZOTIN C, 1984, EUR J BIOCHEM, V143, P621, DOI 10.1111/j.1432-1033.1984.tb08415.x; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; OLSON BH, 1965, APPL MICROBIOL, V13, P322, DOI 10.1128/AEM.13.3.322-326.1965; OLSON BH, 1965, APPL MICROBIOL, V13, P314, DOI 10.1128/AEM.13.3.314-321.1965; ORLANDI R, 1988, CANC IMMUNOL IMMUNOT, V26, P1714; RODRIGUEZ R, 1982, BIOCHEM BIOPH RES CO, V108, P315, DOI 10.1016/0006-291X(82)91868-X; SACCO G, 1983, J BIOL CHEM, V258, P5811; SCHINDLER DG, 1977, NUCLEIC ACIDS RES, V4, P1097, DOI 10.1093/nar/4.4.1097; Shapiro R, 1998, BIOCHEMISTRY-US, V37, P6847, DOI 10.1021/bi9800146; TAKEDA E, 1997, NUCL ACIDS S SER, V37, P131; WAWRZYNCZAK EJ, 1991, EUR J BIOCHEM, V196, P203, DOI 10.1111/j.1432-1033.1991.tb15805.x; Yang XJ, 1996, STRUCTURE, V4, P837, DOI 10.1016/S0969-2126(96)00090-1	28	42	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12576	12582		10.1074/jbc.274.18.12576	http://dx.doi.org/10.1074/jbc.274.18.12576			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212236	hybrid			2022-12-27	WOS:000080056800056
J	Li, SS; Smerdon, MJ				Li, SS; Smerdon, MJ			Base excision repair of N-methylpurines in a yeast minichromosome - Effects of transcription, DNA sequence, and nucleosome positioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; NUCLEOTIDE LEVEL; DAMAGE; GENE; STRAND; METHYLATION; ENZYME	Base excision repair of dimethyl sulfate induced N-methylpurines (NMPs) was measured in a yeast minichromosome that has a galactose-inducible GAL1: URA3 fusion gene, a constitutively expressed HIS3 gene, and varied regions of chromatin structure. Removal rates of NMPs varied dramatically (>20-fold) at different sites along three selected fragments encompassing a total length of 1775 base pairs. Repair of NMPs was not coupled to transcription, because the transcribed strands of HIS3 and induced GAL1:URA3 were not repaired faster than the nontranscribed strands. However, the repair rate of NMPs was significantly affected by the nearest neighbor nucleotides, Slow repair occurred at NMPs between purines, especially guanines, whereas fast repair occurred at NMPs between pyrimidines. NMPs between a purine and pyrimidine were repaired at moderate rates. Moreover, a rough correlation between nucleosome positions and repair rates exists in some but not all regions that were analyzed.	Washington State Univ, Dept Biochem & Biophys, Pullman, WA 99164 USA	Washington State University	Smerdon, MJ (corresponding author), Washington State Univ, Dept Biochem & Biophys, Pullman, WA 99164 USA.	smerdon@mail.wsu.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004106] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES04106] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABANOBI SE, 1980, BIOCHEMISTRY-US, V19, P1382, DOI 10.1021/bi00548a018; CHEN J, 1989, P NATL ACAD SCI USA, V86, P7961, DOI 10.1073/pnas.86.20.7961; FRIEDMAN RA, 1995, BIOPHYS J, V69, P1528, DOI 10.1016/S0006-3495(95)80023-8; Krokan HE, 1997, BIOCHEM J, V325, P1; Labahn J, 1996, CELL, V86, P321, DOI 10.1016/S0092-8674(00)80103-8; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; LEADON SA, 1992, J BIOL CHEM, V267, P23175; LEADON SA, 1993, P NATL ACAD SCI USA, V90, P10499, DOI 10.1073/pnas.90.22.10499; LEDOUX SP, 1990, J BIOL CHEM, V265, P14875; LI S, 1999, IN PRESS METHODS COM; Li SS, 1996, CARCINOGENESIS, V17, P1549, DOI 10.1093/carcin/17.8.1549; Maxam A M, 1980, Methods Enzymol, V65, P499; Mullen GP, 1997, BIOCHEMISTRY-US, V36, P4713, DOI 10.1021/bi962363a; OMARI S, 1990, THESIS SWISS FEDERAL; Pieper RO, 1998, CONT CANC RES, P33; RYDBERG B, 1982, EMBO J, V1, P211, DOI 10.1002/j.1460-2075.1982.tb01149.x; SCICCHITANO DA, 1989, P NATL ACAD SCI USA, V86, P3050, DOI 10.1073/pnas.86.9.3050; SCICCHITANO DA, 1990, MUTAT RES, V233, P31, DOI 10.1016/0027-5107(90)90148-W; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; SMERDON MJ, 1993, ALFRED BENZON SYMP S, V35, P258; SMERDON MJ, 1990, CELL, V61, P675, DOI 10.1016/0092-8674(90)90479-X; Smerdon MJ, 1998, CONT CANC RES, P199; WASSERMANN K, 1990, J BIOL CHEM, V265, P13906; Xiao W, 1998, CURR GENET, V33, P92, DOI 10.1007/s002940050313; Yamagata Y, 1996, CELL, V86, P311, DOI 10.1016/S0092-8674(00)80102-6; Ye N, 1998, J MOL BIOL, V284, P269, DOI 10.1006/jmbi.1998.2138	26	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12201	12204		10.1074/jbc.274.18.12201	http://dx.doi.org/10.1074/jbc.274.18.12201			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212183	hybrid			2022-12-27	WOS:000080056800003
J	Morimoto, T; Hasegawa, K; Kaburagi, S; Kakita, T; Masutani, H; Kitsis, RN; Matsumori, A; Sasayama, S				Morimoto, T; Hasegawa, K; Kaburagi, S; Kakita, T; Masutani, H; Kitsis, RN; Matsumori, A; Sasayama, S			GATA-5 is involved in leukemia inhibitory factor-responsive transcription of the beta-myosin heavy chain gene in cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSDUCING RECEPTOR COMPONENT; PROTEIN-KINASE-C; MYOCARDIAL-CELL HYPERTROPHY; MUSCLE-SPECIFIC EXPRESSION; ATRIAL-NATRIURETIC-FACTOR; IL-6 SIGNAL TRANSDUCER; ENHANCER FACTOR-I; M-CAT; INDUCIBLE EXPRESSION; DEPENDENT PATHWAYS	Leukemia inhibitory factor is a member of a family of structurally related cytokines sharing the receptor component gp130, Activation of gp130 by leukemia inhibitory factor is sufficient to induce myocardial cell hypertrophy accompanied by specific changes in the pattern of gene expression. However, the molecular mechanisms that link gp130 activation to these changes have not been clarified. The present study investigated the transcriptional pathways by which leukemia inhibitory factor activates P-myosin heavy chain expression during myocardial cell hypertrophy. Mutation of the GATA motif in the P-myosin heavy chain promoter totally abolished leukemia inhibitory factor-responsive transcription without changing basal transcriptional activity. In contrast, endothelin-l responsiveness was unaffected by the GATA mutation. Among members of the cardiac GATA transcription factor subfamily (GATA-4, -5, and -6), GATA-5 was the sole and potent transactivator for the beta-myosin heavy chain promoter. This transactivation was dependent on sequence-specific binding of GATA-5 to the beta-myosin heavy chain GATA element, Cardiac nuclear factors that bind to to the beta-myosin heavy chain GATA element were induced by leukemia inhibitory factor stimulation. Last, leukemia inhibitory factor stimulation markedly increased transcripts of cardiac GATA-5, the expression of which is normally restricted to the early embryo. Thus, GATA-5 may be involved in gp130 signaling in cardiac myocytes.	Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Dept Biol Responses, Inst Virus Res, Kyoto 6068507, Japan; Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Kyoto University; Kyoto University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Hasegawa, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, 54 Kawara Cho, Kyoto 6068507, Japan.	koj@kuhp.kyoto-u.ac.jp	Masutani, Hiroshi/B-5114-2014	Masutani, Hiroshi/0000-0001-7633-2827				AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ARDATI A, 1993, EMBO J, V12, P5131, DOI 10.1002/j.1460-2075.1993.tb06208.x; BUTTRICK PM, 1993, CIRC RES, V72, P1211, DOI 10.1161/01.RES.72.6.1211; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Cooper G, 1997, ANNU REV MED, V48, P13, DOI 10.1146/annurev.med.48.1.13; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; FLINK IL, 1992, J BIOL CHEM, V267, P9917; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; Hasegawa K, 1997, J BIOL CHEM, V272, P20049, DOI 10.1074/jbc.272.32.20049; Hasegawa K, 1997, CIRCULATION, V96, P3943; HASEGAWA K, 1997, MOL BIOL CARDIOVASCU, P67; HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206; Heim MH, 1996, EUR J CLIN INVEST, V26, P1, DOI 10.1046/j.1365-2362.1996.103248.x; Herzig TC, 1997, P NATL ACAD SCI USA, V94, P7543, DOI 10.1073/pnas.94.14.7543; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; HUNTER JJ, 1995, J BIOL CHEM, V270, P23173, DOI 10.1074/jbc.270.39.23173; IP HS, 1994, MOL CELL BIOL, V14, P7517, DOI 10.1128/MCB.14.11.7517; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; Ishikawa M, 1996, BIOCHEM BIOPH RES CO, V219, P377, DOI 10.1006/bbrc.1996.0241; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; KARIYA K, 1993, J BIOL CHEM, V268, P26658; KARIYA K, 1994, J BIOL CHEM, V269, P3775; KARNS LR, 1995, J BIOL CHEM, V270, P410, DOI 10.1074/jbc.270.1.410; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KITSIS RN, 1991, P NATL ACAD SCI USA, V88, P4138, DOI 10.1073/pnas.88.10.4138; KNOTTS S, 1994, J BIOL CHEM, V269, P31275; KNOWLTON KU, 1991, J BIOL CHEM, V266, P7759; KRAFT R, 1989, NUCLEIC ACIDS RES, V17, P7529, DOI 10.1093/nar/17.18.7529; KURABAYASHI M, 1990, JPN CIRC J, V54, P1192, DOI 10.1253/jcj.54.1192; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; LEE RT, 1988, J CLIN INVEST, V81, P431, DOI 10.1172/JCI113337; MACLELLAN WR, 1997, MOL BIOL CARDIOVASCU, P327; MagnaghiJaulin L, 1996, FEBS LETT, V391, P247, DOI 10.1016/0014-5793(96)00745-4; McGrew MJ, 1996, MOL CELL BIOL, V16, P4524; MERCADIER JJ, 1993, B ACAD NAT MED PARIS, V177, P917; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P5056, DOI 10.1128/MCB.14.8.5056; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1997, DEV BIOL, V183, P21, DOI 10.1006/dbio.1996.8485; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; ORDAHL CP, 1992, CURR TOP DEV BIOL, V26, P145, DOI 10.1016/S0070-2153(08)60444-5; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Sheng ZL, 1997, J BIOL CHEM, V272, P5783, DOI 10.1074/jbc.272.9.5783; SHIMIZU N, 1992, NUCLEIC ACIDS RES, V20, P1793, DOI 10.1093/nar/20.7.1793; SHIMIZU N, 1993, NUCLEIC ACIDS RES, V21, P4103, DOI 10.1093/nar/21.17.4103; Shioi T, 1996, CIRCULATION, V94, P2930, DOI 10.1161/01.CIR.94.11.2930; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; TAGA T, 1992, P NATL ACAD SCI USA, V89, P10998, DOI 10.1073/pnas.89.22.10998; Taga T, 1996, J NEUROCHEM, V67, P1; THOMPSON WR, 1991, J BIOL CHEM, V266, P22678; THORBURN A, 1993, J BIOL CHEM, V268, P2244; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; Wollert KC, 1996, J BIOL CHEM, V271, P9535, DOI 10.1074/jbc.271.16.9535; YIN TG, 1993, J IMMUNOL, V151, P2555; ZHU H, 1991, MOL CELL BIOL, V11, P2273, DOI 10.1128/MCB.11.4.2273	63	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12811	12818		10.1074/jbc.274.18.12811	http://dx.doi.org/10.1074/jbc.274.18.12811			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212267	Green Submitted, hybrid			2022-12-27	WOS:000080056800087
J	Zamir, LO; Nikolakakis, A; Huang, LR; St-Pierre, P; Sauriol, F; Sparace, S; Mamer, O				Zamir, LO; Nikolakakis, A; Huang, LR; St-Pierre, P; Sauriol, F; Sparace, S; Mamer, O			Biosynthesis of 3-acetyldeoxynivalenol and sambucinol - Identification of the two oxygenation steps after trichodiene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSARIUM-CULMORUM; POST-TRICHODIENE; TRICHOTHECENE 3-ACETYLDEOXYNIVALENOL; ISOTRICHODERMIN; PRECURSOR; INTERMEDIATE; METABOLITES; MYCOTOXINS; COMPLEXES	The first two oxygenation steps post-trichodiene in the biosyntheses of the trichothecenes 3-acetyldeoxynivalenol and sambucinol were investigated. The plausible intermediates 2-hydroxytrichodiene (2 alpha- and 2 beta-) and 12,13-epoxytrichodiene and the dioxygenated compounds 12,13-epoxy-9,10-trichoene-2-ol (2 alpha- and 2 beta-) were prepared specifically labeled with stable isotopes. They were then fed separately and/or together to Fusarium culmorum cultures, and the derived trichothecenes were isolated, purified, and analyzed. The stable isotopes enable easy localization of the labels in the products by H-2 NMR, C-13 MMR, and mass spectrometry. We found that 2 alpha-hydroxytrichodiene is the first oxygenated step in the biosynthesis of both 3-acetyldeoxynivalenol and sambucinol. The stereoisomer 2 beta-hydroxytrichodiene and 12,13-epoxytrichodiene are not biosynthetic intermediates and have not been isolated as metabolites. We also demonstrated that the dioxygenated 12,13-epoxy-9,10-trichoene-2 alpha-ol is a biosynthetic precursor to trichothecenes as had been suggested in a preliminary work. Its stereoisomer was not found in the pathway. A further confirmation of our results was the isolation of both oxygenated trichodiene derivatives 2 alpha-hydroxytrichodiene and 12,13-epoxy-9,10-trichoene-2 alpha-ol as natural metabolites in F. culmorum cultures.	Univ Quebec, Inst Armand Frappier, Ctr Rech Microbiol Appl, Laval, PQ H7N 4Z3, Canada; McGill Univ, Dept Chem, Montreal, PQ H3Z 2K6, Canada; McGill Univ, Dept Plant Sci, St Anne De Bellevue, PQ H9X 3V9, Canada; McGill Univ, Biomed Mass Spectrometry Unit, Montreal, PQ H3A 1A3, Canada	University of Quebec; McGill University; McGill University; McGill University	Zamir, LO (corresponding author), Univ Quebec, Inst Armand Frappier, Ctr Rech Microbiol Appl, 531 Blvd Prairies, Laval, PQ H7N 4Z3, Canada.							COLVIN EW, 1973, J CHEM SOC PERK T, V18, P1989; DeNijs M, 1997, J FOOD SAFETY, V17, P161; GREENHALGH R, 1984, J AGR FOOD CHEM, V32, P945, DOI 10.1021/jf00124a060; HESKETH AR, 1990, J CHEM SOC CHEM COMM, P1184, DOI 10.1039/c39900001184; HESKETH AR, 1993, PHYTOCHEMISTRY, V32, P93, DOI 10.1016/0031-9422(92)80113-S; HESKETH AR, 1991, PHYTOCHEMISTRY, V30, P2237, DOI 10.1016/0031-9422(91)83621-Q; HUFFMAN JW, 1983, SYNTHETIC COMMUN, V13, P553, DOI 10.1080/00397918308059528; KAZLAUSKAS RJ, 1991, J ORG CHEM, V56, P2656, DOI 10.1021/jo00008a016; Liu WZ, 1997, EUR J PLANT PATHOL, V103, P589, DOI 10.1023/A:1008693213656; MARASAAS WFD, 1984, TOXIGENIC FUSARIUMS, P147; MCCORMICK SP, 1990, APPL ENVIRON MICROB, V56, P702, DOI 10.1128/AEM.56.3.702-706.1990; Muller HM, 1997, MYCOPATHOLOGIA, V137, P185, DOI 10.1023/A:1006805717043; PEARSON AJ, 1989, J ORG CHEM, V54, P4663, DOI 10.1021/jo00280a039; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Sharpless K. B., 1979, ALDRICHIM ACTA, V12, P63; SHARPLESS KB, 1972, J AM CHEM SOC, V94, P6538, DOI 10.1021/ja00773a045; THOMPSON DJ, 1976, J ORGANOMET CHEM, V108, P381, DOI 10.1016/S0022-328X(00)92017-5; ZAMIR LO, 1992, J LABELLED COMPD RAD, V31, P915, DOI 10.1002/jlcr.2580311110; ZAMIR LO, 1989, J CHEM SOC CHEM COMM, P598, DOI 10.1039/c39890000598; Zamir LO, 1996, J BIOL CHEM, V271, P27353, DOI 10.1074/jbc.271.44.27353; ZAMIR LO, 1991, J BIOL CHEM, V266, P14992; ZAMIR LO, 1990, J BIOL CHEM, V265, P6713; ZAMIR LO, 1987, J BIOL CHEM, V262, P15348; ZAMIR LO, 1991, J CHEM SOC CHEM COMM, P1033, DOI 10.1039/c39910001033; ZAMIR LO, 1999, IN PRESS J AGR FOOD	25	10	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12269	12277		10.1074/jbc.274.18.12269	http://dx.doi.org/10.1074/jbc.274.18.12269			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212195	hybrid			2022-12-27	WOS:000080056800015
J	Gardiner, EE; D'Souza, SE				Gardiner, EE; D'Souza, SE			Sequences within fibrinogen and intercellular adhesion molecule-1 (ICAM-1) modulate signals required for mitogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; LYN TYROSINE KINASE; LEUKOCYTE ADHESION; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; REGULATED KINASE; CROSS-LINKING; IN-VIVO; PATHWAY; PHOSPHORYLATION	The interaction of fibrinogen (Fg) with intercellular adhesion molecule-1 (ICAM) on B-lymphoid Raji cells results in mitogenesis (Gardiner, E. E., and D'Souza, S. E. (1997) J. Biol. Chem, 272, 15474-15480). Incubation of Raji with Fg resulted in the increased tyrosine phosphorylation of the receptor-associated tyrosine kinase, pp60(Src) and extracellular signal-regulated kinase-1 (ERK), The increase in ERK-1 phosphorylation was blocked by a peptide with sequence matching ICAM-1 (8-22) and corresponded to a decrease in ERK-1 enzymatic activity. 100 mu M amounts of Fg peptide gamma-(117-133) caused an increase in tyrosine phosphorylation of ERK-1, These results are consistent with our previous report wherein ICAM-1-(8-22) blocked Fg-induced mitogenesis and Fg-gamma-(117-133) induced proliferation in Raji, The specific inhibitor of MEK, PD98059 (25 mu M), abrogated the increased phosphorylation of ERK-1 and blocked Raji mitogenesis by >50%, Inhibitors of pp60(Src), geldanamycin (62 nm), and herbimycin A (2.5 mu M) blocked >50% of Raji proliferation. These results indicate that the proliferation induced by Fg interactions with ICAM-1 is mediated in part by receptor-associated tyrosine kinases and ERK-1, and that the recognition sequences within Fg and ICAM-1 participate in the signaling process.	Cleveland Clin Fdn, Lerner Res Inst, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	D'Souza, SE (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.		Gardiner, Elizabeth/E-7774-2011; Gardiner, Elizabeth/P-8716-2019	Gardiner, Elizabeth/0000-0001-9453-9688	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043721, R29HL043721] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 43721] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTIERI DC, 1995, J BIOL CHEM, V270, P696, DOI 10.1074/jbc.270.2.696; ALTIERI DC, 1993, J BIOL CHEM, V268, P1847; BLAGOSKLONNY MV, 1995, ONCOGENE, V11, P933; Bokemeyer D, 1997, J CLIN INVEST, V100, P582, DOI 10.1172/JCI119568; Bornfeldt KE, 1997, J CLIN INVEST, V100, P875, DOI 10.1172/JCI119603; BUDZYNSK.AZ, 1974, J BIOL CHEM, V249, P2294; CARPEN O, 1992, J CELL BIOL, V118, P1223, DOI 10.1083/jcb.118.5.1223; CHIRATHAWORN C, 1995, J IMMUNOL, V155, P5479; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DOOLITTLE RF, 1967, ARCH BIOCHEM BIOPHYS, V118, P456, DOI 10.1016/0003-9861(67)90374-8; DSouza SE, 1996, J BIOL CHEM, V271, P24270, DOI 10.1074/jbc.271.39.24270; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; DURIEUTRAUTMANN O, 1994, J BIOL CHEM, V269, P12536; Gardiner EE, 1997, J BIOL CHEM, V272, P15474, DOI 10.1074/jbc.272.24.15474; Hicks RCJ, 1996, NATURE, V379, P818, DOI 10.1038/379818a0; Holland J, 1997, J BIOL CHEM, V272, P9108; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lai KH, 1996, J CLIN INVEST, V98, P1560, DOI 10.1172/JCI118949; LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LEVESQUE JP, 1986, P NATL ACAD SCI USA, V83, P6494, DOI 10.1073/pnas.83.17.6494; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Nadal F, 1997, J BIOL CHEM, V272, P22381, DOI 10.1074/jbc.272.36.22381; PAZDRAK K, 1995, J EXP MED, V181, P1827, DOI 10.1084/jem.181.5.1827; POUDRIER J, 1994, J EXP MED, V179, P1417, DOI 10.1084/jem.179.5.1417; REILLY PL, 1995, J IMMUNOL, V155, P529; ROTHLEIN R, 1994, J IMMUNOL, V152, P2488; SCHNUR RC, 1995, J MED CHEM, V38, P3806, DOI 10.1021/jm00019a010; Shainoff JR, 1996, J BIOL CHEM, V271, P24129, DOI 10.1074/jbc.271.39.24129; SPORN LA, 1995, BLOOD, V86, P1802, DOI 10.1182/blood.V86.5.1802.bloodjournal8651802; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Sriramarao P, 1996, BLOOD, V88, P3416, DOI 10.1182/blood.V88.9.3416.bloodjournal8893416; Takahashi M, 1996, J CLIN INVEST, V98, P2623, DOI 10.1172/JCI119083; UEHARA Y, 1989, CANCER RES, V49, P780; VANHORSSEN M, 1995, EUR J IMMUNOL, V25, P154, DOI 10.1002/eji.1830250126; VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Xu QB, 1996, J CLIN INVEST, V97, P508, DOI 10.1172/JCI118442	40	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11930	11936		10.1074/jbc.274.17.11930	http://dx.doi.org/10.1074/jbc.274.17.11930			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207014	hybrid			2022-12-27	WOS:000079834800070
J	Peloponese, JM; Collette, Y; Gregoire, C; Bailly, C; Campese, D; Meurs, EF; Olive, D; Loret, EP				Peloponese, JM; Collette, Y; Gregoire, C; Bailly, C; Campese, D; Meurs, EF; Olive, D; Loret, EP			Full peptide synthesis, purification, and characterization of six Tat variants - Differences observed between HIV-1 isolates from Africa and other continents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DEPENDENT PROTEIN-KINASE; CIRCULAR-DICHROISM; TRANS-ACTIVATION; RNA; TYPE-1; GENE; PKR; LYMPHOCYTES; INDUCTION	AIDS in Africa is characterized by the equal distribution of mortality between the two genders because of highly virulent human immunodeficiency virus type I (HIV-1) strains. The viral protein Tat trans-activates viral gene expression and is essential for HIV-1 replication. We chemically synthesized six different Tat proteins, with sizes ranging from 86 to 101 residues, from HIV-1 isolates located in different parts of the world including highly virulent African strains. Protein purification, mass spectroscopy, and amino acid analysis showed that the synthesis was successful in each case but with different yields. We show that all have the ability to bind the HIV long terminal repeat (LTR) RNA trans-activation response element (TAR) region, involved in Tat-mediated trans-activation, but structural heterogeneities are revealed by circular dichroism. These Tat synthetic proteins cross membranes but differ in their ability to trans-activate an HIV LTR-reporter gene in stably transfected HeLa cells. Two Tat proteins from virulent African HIV-1 strains were much more active than those from Europe and the United States. The interferon-induced kinase (PKR), involved in cell antiviral defense, phosphorylates only Tat variants corresponding to less or nonvirulent HIV-1 isolates. Our results indicate that the high virulence of some African HN-I strains could be related to Tat activity.	Inst Biol Struct & Microbiol, Lab Ingn Syst Macromol, CNRS,UPR 9027, F-13402 Marseille, France; INSERM, U119, Unite Cancerol Expt, F-13009 Marseille, France; Inst Rech Canc, INSERM, U124, F-59045 Lille, France; Inst Pasteur, Unite Virol & Immunol Cellulaire, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Loret, EP (corresponding author), Inst Biol Struct & Microbiol, Lab Ingn Syst Macromol, CNRS,UPR 9027, 31 Chem Joseph Aiguier, F-13402 Marseille, France.		COLLETTE, Yves/F-2270-2013	COLLETTE, Yves/0000-0001-5359-7099; Peloponese, Jean-Marie/0000-0002-9677-9703				ALIZON M, 1986, CELL, V46, P63, DOI 10.1016/0092-8674(86)90860-3; BARANY G, 1980, PEPTIDES ANAL SYNTHE, V2, P1; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; BERKHOUT B, 1990, CELL, V62, P7257; Brand SR, 1997, J BIOL CHEM, V272, P8388, DOI 10.1074/jbc.272.13.8388; CHUN R, 1990, J VIROL, V64, P3074, DOI 10.1128/JVI.64.6.3074-3077.1990; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; Efthymiadis A, 1998, J BIOL CHEM, V273, P1623, DOI 10.1074/jbc.273.3.1623; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; GarciaMartinez LF, 1997, EMBO J, V16, P2836, DOI 10.1093/emboj/16.10.2836; Gregoire CJ, 1996, J BIOL CHEM, V271, P22641, DOI 10.1074/jbc.271.37.22641; Harrich D, 1997, EMBO J, V16, P1224, DOI 10.1093/emboj/16.6.1224; HOWCROFT TK, 1993, SCIENCE, V260, P1320, DOI 10.1126/science.8493575; HUET T, 1989, AIDS, V3, P707, DOI 10.1097/00002030-198911000-00004; Jeang K., 1996, HUMAN RETROVIRUSES A, P3; JEYAPAUL J, 1990, P NATL ACAD SCI USA, V87, P7030, DOI 10.1073/pnas.87.18.7030; JOHNSON WC, 1985, METHOD BIOCHEM ANAL, V31, P61, DOI 10.1002/9780470110522.ch2; LAURENT AG, 1985, P NATL ACAD SCI USA, V82, P4341, DOI 10.1073/pnas.82.13.4341; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; LORET EP, 1991, BIOCHEMISTRY-US, V30, P6013, DOI 10.1021/bi00238a027; LORET EP, 1992, P NATL ACAD SCI USA, V89, P9734, DOI 10.1073/pnas.89.20.9734; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MCMILLAN NAJ, 1995, VIROLOGY, V213, P413, DOI 10.1006/viro.1995.0014; OBRIEN WA, 1990, NATURE, V348, P69, DOI 10.1038/348069a0; PETERLIN BM, 1986, P NATL ACAD SCI USA, V83, P9734, DOI 10.1073/pnas.83.24.9734; ROSEN CA, 1986, NATURE, V319, P555, DOI 10.1038/319555a0; ROY S, 1990, SCIENCE, V247, P1216, DOI 10.1126/science.2180064; URRY DW, 1972, BIOCHIM BIOPHYS ACTA, V265, P115, DOI 10.1016/0304-4157(72)90021-4; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	34	61	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11473	11478		10.1074/jbc.274.17.11473	http://dx.doi.org/10.1074/jbc.274.17.11473			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206951	hybrid			2022-12-27	WOS:000079834800007
J	Roymoulik, I; Chen, HP; Marsh, ENG				Roymoulik, I; Chen, HP; Marsh, ENG			The reaction of the substrate analog 2-ketoglutarate with adenosylcobalamin-dependent glutamate mutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-ATOM ABSTRACTION; METHYLMALONYL-COA MUTASE; CARBON BOND HOMOLYSIS; CLOSTRIDIUM-COCHLEARIUM; ESCHERICHIA-COLI; ENZYME; REARRANGEMENT; PURIFICATION; CATALYSIS; MECHANISM	Glutamate mutase is one of several adenosylcobalamin-dependent enzymes that catalyze unusual rearrangements that proceed through a mechanism involving free radical intermediates. The enzyme exhibits remarkable specificity, and so far no molecules other than L-glutamate and L-threo-3-methylaspartate have been found to be substrates. Here we describe the reaction of glutamate mutase with the substrate analog, 2-ketoglutarate. Binding of 2-ketoglutarate (or its hydrate) to the holoenzyme elicits a change in the UV-visible spectrum consistent with the formation of cob(II)alamin on the enzyme, 2-ketoglutarate undergoes rapid exchange of tritium between the 5'-position of the coenzyme and C-4 of 2-ketoglutarate, consistent with the formation of a 2-ketoglutaryl radical analogous to that formed with glutamate, Under aerobic conditions this leads to the slow inactivation of the enzyme, presumably through reaction of free radical species with oxygen. Despite the formation of a substrate-like radical, no rearrangement of 2-ketoglutarate to 3-methyloxalacetate could be detected. The results indicate that formation of the C-4 radical of 2-ketoglutarate is a facile process but that it does not undergo further reactions, suggesting that this may be a useful substrate analog with which to investigate the mechanism of coenzyme homolysis.	Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Marsh, ENG (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.		Chen, Hao-Ping/Q-3283-2019; Marsh, Neil/G-7553-2016	Chen, Hao-Ping/0000-0002-6491-2178; Marsh, Neil/0000-0003-1713-1683	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM055163] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 55163] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banerjee R, 1997, CHEM BIOL, V4, P175, DOI 10.1016/S1074-5521(97)90286-6; BARKER HA, 1964, J BIOL CHEM, V239, P3260; BEATRIX B, 1994, EUR J BIOCHEM, V266, P577; Bothe H, 1998, BIOCHEMISTRY-US, V37, P4105, DOI 10.1021/bi971393q; BUCKEL W, 1996, CHEM SOC REV, P329; Chen HP, 1997, BIOCHEMISTRY-US, V36, P7884, DOI 10.1021/bi970169y; CHEN HP, 1997, BIOCHEMISTRY-US, V36, P14393; FINKE RG, 1990, MOLECULAR MECHANISMS IN BIOORGANIC PROCESSES, P244; HALPERN J, 1985, SCIENCE, V227, P869, DOI 10.1126/science.2857503; HARTZOULAKIS B, 1994, P INDIAN AS-CHEM SCI, V106, P1165; HAY BP, 1986, J AM CHEM SOC, V108, P4820, DOI 10.1021/ja00276a020; HOLLOWAY DE, 1994, J BIOL CHEM, V269, P20425; HSIANG MW, 1967, J BIOL CHEM, V242, P3079; LEUTBECHER U, 1992, EUR J BIOCHEM, V205, P759, DOI 10.1111/j.1432-1033.1992.tb16840.x; MARSH ENG, 1995, BIOCHEMISTRY-US, V34, P7542, DOI 10.1021/bi00022a030; Marsh ENG, 1998, BIOCHEMISTRY-US, V37, P11864, DOI 10.1021/bi980512e; MARSH ENG, 1995, BIOESSAYS, V17, P431, DOI 10.1002/bies.950170511; MICHENFELDER M, 1986, ANGEW CHEM INT EDIT, V25, P366, DOI 10.1002/anie.198603661; Padmakumar R, 1997, BIOCHEMISTRY-US, V36, P3713, DOI 10.1021/bi962503g; SWITZER RL, 1969, J BIOL CHEM, V244, P5263; ZELDER O, 1994, EUR J BIOCHEM, V226, P577, DOI 10.1111/j.1432-1033.1994.tb20083.x	21	15	15	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11619	11622		10.1074/jbc.274.17.11619	http://dx.doi.org/10.1074/jbc.274.17.11619			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206971	hybrid			2022-12-27	WOS:000079834800027
J	Zucker, SD; Goessling, W; Hoppin, AG				Zucker, SD; Goessling, W; Hoppin, AG			Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION UPTAKE; PERFUSED-RAT-LIVER; PLASMA-MEMBRANE; UDP-GLUCURONOSYLTRANSFERASE; BINDING-PROTEIN; HEPATIC-UPTAKE; SERUM-ALBUMIN; FATTY-ACIDS; PHOSPHOLIPID-BILAYERS; FLIP-FLOP	The liver is responsible for the clearance and metabolism of unconjugated bilirubin, the hydrophobic end-product of heme catabolism. Although several putative bilirubin transporters have been described, it has been alternatively proposed that bilirubin enters the hepatocyte by passive diffusion through the plasma membrane. In order to elucidate the mechanism of bilirubin uptake, we measured the rate of bilirubin transmembrane diffusion (flip-flop) using stopped-flow fluorescence techniques. Unconjugated bilirubin rapidly diffuses through model phosphatidylcholine vesicles, with a first-order rate constant of 5.3 s(-1) (t(1/2) = 130 ms). The flip-flop rate is independent of membrane cholesterol content, phospholipid acyl saturation, and lipid packing, consistent with thermodynamic analyses demonstrating minimal steric constraint to bilirubin transmembrane diffusion. The coincident decrease in pH of the entrapped vesicle volume supports a mechanism whereby the bilirubin molecule crosses the lipid bilayer as the uncharged diacid. Transport of bilirubin by native rat hepatocyte membranes exhibits kinetics comparable with that in model vesicles, suggesting that unconjugated bilirubin crosses cellular membranes by passive diffusion through the hydrophobic lipid core. In contrast, there is no demonstrable flip-flop of bilirubin diglucuronide or bilirubin ditaurate in phospholipid vesicles, yet these compounds rapidly traverse isolated rat hepatocyte membranes, confirming the presence of a facilitated uptake system(s) for hydrophilic bilirubin conjugates.	Univ Cincinnati, Med Ctr, Div Digest Dis, Cincinnati, OH 45267 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Div Pediat Gastroenterol, Boston, MA 02114 USA	University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Zucker, SD (corresponding author), Univ Cincinnati, Med Ctr, Div Digest Dis, 231 Bethesda Ave,ML 0595, Cincinnati, OH 45267 USA.		Zucker, Stephen/AAJ-3359-2020	Zucker, MD, Stephen/0000-0003-1451-905X; Goessling, Wolfram/0000-0001-9972-1569	NIDDK NIH HHS [DK-51679] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051679] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANCHORDOGUY TJ, 1992, BIOCHIM BIOPHYS ACTA, V1104, P117, DOI 10.1016/0005-2736(92)90139-D; BALDINI G, 1996, BIOCHIM BIOPHYS ACTA, V856, P1; Banhegyi G, 1996, BIOCHEM J, V315, P171, DOI 10.1042/bj3150171; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; BERK PD, 1994, SEMIN LIVER DIS, V14, P331; BERK PD, 1997, SEMIN LIVER DIS, V7, P165; BONNETT R, 1978, PROC R SOC SER B-BIO, V202, P249, DOI 10.1098/rspb.1978.0066; BRATLID D, 1990, CLIN PERINATOL, V17, P449, DOI 10.1016/S0095-5108(18)30578-5; BRODERSEN R, 1979, J BIOL CHEM, V254, P2364; DEAMER DW, 1983, P NATL ACAD SCI-BIOL, V80, P165, DOI 10.1073/pnas.80.1.165; ELFERINK RPJO, 1995, BBA-REV BIOMEMBRANES, V1241, P215, DOI 10.1016/0304-4157(95)00006-D; GARTNER U, 1982, GASTROENTEROLOGY, V83, P1163; GHERSIEGEA JF, 1988, LIFE SCI, V42, P2515, DOI 10.1016/0024-3205(88)90351-7; GOESSLING W, 1997, HEPATOLOGY, V26, P385; HAYWARD D, 1986, BIOCHIM BIOPHYS ACTA, V860, P149, DOI 10.1016/0005-2736(86)90509-2; IGA T, 1979, AM J PHYSIOL, V236, pC9, DOI 10.1152/ajpcell.1979.236.1.C9; JANSEN PLM, 1992, HEPATOLOGY, V15, P532, DOI 10.1002/hep.1840150328; KAMP F, 1993, BIOCHEMISTRY-US, V32, P11074, DOI 10.1021/bi00092a017; KAMP F, 1992, P NATL ACAD SCI USA, V89, P11367, DOI 10.1073/pnas.89.23.11367; Kanai N, 1996, AM J PHYSIOL-RENAL, V270, pF319, DOI 10.1152/ajprenal.1996.270.2.F319; Kleinfeld AM, 1997, BIOCHEMISTRY-US, V36, P14146, DOI 10.1021/bi971440e; KREMER JMH, 1977, BIOCHEMISTRY-US, V16, P3932, DOI 10.1021/bi00636a033; KULLAKUBLICK GA, 1994, HEPATOLOGY, V20, P411; LEININGERMULLER B, 1994, NEUROSCI LETT, V175, P37, DOI 10.1016/0304-3940(94)91072-3; LEONARD M, 1989, J BIOL CHEM, V264, P5648; MEIER PJ, 1990, METHOD ENZYMOL, V192, P534; NICHOLS JW, 1982, BIOCHEMISTRY-US, V21, P1720, DOI 10.1021/bi00537a003; NOGALES D, 1995, J BIOL CHEM, V270, P73, DOI 10.1074/jbc.270.1.73; NOY N, 1992, BIOPHYS CHEM, V42, P177, DOI 10.1016/0301-4622(92)85007-Q; OSTROW JD, 1994, J LIPID RES, V35, P1715; Pascolo L, 1996, BIOCHEM J, V316, P999, DOI 10.1042/bj3160999; PAUMGARTNER G, 1976, CLIN SCI MOL MED, V51, P169, DOI 10.1042/cs0510169; REED RG, 1977, J BIOL CHEM, V252, P7483; SCHARSCHMIDT BF, 1975, J CLIN INVEST, V56, P1280, DOI 10.1172/JCI108204; SCHMID R, 1972, NEW ENGL J MED, V287, P703, DOI 10.1056/NEJM197210052871407; Seppen J, 1996, BIOCHEM J, V314, P477, DOI 10.1042/bj3140477; SHEPHERD SRP, 1989, BIOCHEM J, V259, P617, DOI 10.1042/bj2590617; Sottocasa GL, 1996, J HEPATOL, V24, P36; SOTTOCASA GL, 1979, FUNCTION MOL ASPECTS, P451; SPIVAK W, 1985, BIOCHEM J, V225, P787, DOI 10.1042/bj2250787; STOLLMAN YR, 1983, J CLIN INVEST, V72, P718, DOI 10.1172/JCI111021; STREMMEL W, 1986, J CLIN INVEST, V78, P822, DOI 10.1172/JCI112646; STREMMEL W, 1990, J HEPATOL, V10, P99, DOI 10.1016/0168-8278(90)90079-7; TIRIBELLI C, 1993, HEPATOLOGY, V17, P715, DOI 10.1002/hep.1840170428; TORRES AM, 1993, P NATL ACAD SCI USA, V90, P8136, DOI 10.1073/pnas.90.17.8136; WEISIGER RA, 1985, P NATL ACAD SCI USA, V82, P1563, DOI 10.1073/pnas.82.5.1563; WENNBERG RP, 1988, PEDIATR RES, V23, P443, DOI 10.1203/00006450-198804000-00021; WISHART GJ, 1978, BIOCHEM J, V174, P485, DOI 10.1042/bj1740485; Wolkoff AW, 1996, SEMIN LIVER DIS, V16, P121, DOI 10.1055/s-2007-1007225; YANG BJ, 1991, BIOCHEMISTRY-US, V30, P688, DOI 10.1021/bi00217a015; ZUCKER SD, 1994, J BIOL CHEM, V269, P19262; ZUCKER SD, 1995, J BIOL CHEM, V270, P1074, DOI 10.1074/jbc.270.3.1074; ZUCKER SD, 1992, BIOCHEMISTRY-US, V31, P3184, DOI 10.1021/bi00127a020; Zuckert C, 1996, POLIT THEORY, V24, P132, DOI 10.1177/0090591796024001009	54	103	105	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10852	10862		10.1074/jbc.274.16.10852	http://dx.doi.org/10.1074/jbc.274.16.10852			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196162	hybrid			2022-12-27	WOS:000079751900030
J	Etchegaray, JP; Inouye, M				Etchegaray, JP; Inouye, M			Translational enhancement by an element downstream of the initiation codon in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; RIBOSOMAL-RNA; BOX; EXPRESSION; PROTEIN; REGION; CSPA	The translation initiation of Escherichia coli mRNAs is known to be facilitated by a cis element upstream of the initiation codon, called the Shine-Dalgarno (SD) sequence. This sequence complementary to the 3' end of 16 S rRNA enhances the formation of the translation initiation complex of the 30 S ribosomal subunit with mRNAs, It has been debated that a cis element called the downstream box downstream of the initiation codon, in addition to the SD sequence, facilitates formation of the translation initiation complex; however, conclusive evidence remains elusive. Here, we show evidence that the downstream box plays a major role in the enhancement of translation initiation in concert with SD.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Inouye, M (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	inouye@rwja.umdnj.edu			NIGMS NIH HHS [GM19043] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019043, R01GM019043] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DAMMEL CS, 1995, GENE DEV, V9, P626, DOI 10.1101/gad.9.5.626; Etchegaray JP, 1998, MOL MICROBIOL, V27, P873, DOI 10.1046/j.1365-2958.1998.00730.x; ETCHEGARAY JP, 1999, IN PRESS; FAXEN M, 1991, NUCLEIC ACIDS RES, V19, P5247, DOI 10.1093/nar/19.19.5247; HARLOCKER SL, 1993, J BACTERIOL, V175, P1956, DOI 10.1128/JB.175.7.1956-1960.1993; INOUYE M, 1983, EXPT MANIPULATION GE, P15; INOUYE S, 1991, DIRECTED MUTAGENESIS, P202; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; ITO K, 1993, P NATL ACAD SCI USA, V90, P302, DOI 10.1073/pnas.90.1.302; Jiang WN, 1996, J BACTERIOL, V178, P4919, DOI 10.1128/jb.178.16.4919-4925.1996; Jones PG, 1996, P NATL ACAD SCI USA, V93, P76, DOI 10.1073/pnas.93.1.76; MCCARTHY JEG, 1994, TRENDS GENET, V10, P402, DOI 10.1016/0168-9525(94)90057-4; Miller J. H, 1972, EXPT MOL GENETICS; Mitta M, 1997, MOL MICROBIOL, V26, P321, DOI 10.1046/j.1365-2958.1997.5771943.x; NAGAI H, 1991, P NATL ACAD SCI USA, V88, P10515, DOI 10.1073/pnas.88.23.10515; POWERS T, 1988, J MOL BIOL, V201, P697, DOI 10.1016/0022-2836(88)90468-8; Resch A, 1996, EMBO J, V15, P4740, DOI 10.1002/j.1460-2075.1996.tb00851.x; RINGQUIST S, 1995, BIOCHEMISTRY-US, V34, P3640, DOI 10.1021/bi00011a019; RON EZ, 1966, SCIENCE, V153, P1119, DOI 10.1126/science.153.3740.1119; SARMIENTOS P, 1983, CELL, V32, P1337, DOI 10.1016/0092-8674(83)90314-8; SHEAN CS, 1992, CELL, V70, P513, DOI 10.1016/0092-8674(92)90175-C; Sprengart ML, 1997, MOL MICROBIOL, V24, P19, DOI 10.1046/j.1365-2958.1997.3161684.x; Sprengart ML, 1996, EMBO J, V15, P665, DOI 10.1002/j.1460-2075.1996.tb00399.x; SPRENGART ML, 1990, NUCLEIC ACIDS RES, V18, P1719, DOI 10.1093/nar/18.7.1719; VIND J, 1993, J MOL BIOL, V231, P678, DOI 10.1006/jmbi.1993.1319; Winzeler E, 1997, J BACTERIOL, V179, P3981, DOI 10.1128/jb.179.12.3981-3988.1997; Wu XQ, 1996, EMBO J, V15, P4734, DOI 10.1002/j.1460-2075.1996.tb00850.x; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	28	83	91	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10079	10085		10.1074/jbc.274.15.10079	http://dx.doi.org/10.1074/jbc.274.15.10079			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187788	hybrid			2022-12-27	WOS:000079663500027
J	Bogerd, HP; Benson, RE; Truant, R; Herold, A; Phingbodhipakkiya, M; Cullen, BR				Bogerd, HP; Benson, RE; Truant, R; Herold, A; Phingbodhipakkiya, M; Cullen, BR			Definition of a consensus transportin-specific nucleocytoplasmic transport signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PROTEIN IMPORT; RNA-BINDING-PROTEIN; HNRNP A1; EXPORT SIGNAL; IDENTIFICATION; CYTOPLASM; RECEPTOR; PATHWAY; RANGTP	The low cytoplasmic and high nuclear concentration of the GTP-bound form of Ran provides directionality for both nuclear protein import and export. Both import and export factors bind RanGTP directly, yet this interaction produces opposite effects; in the former case, RanGTP binding induces nuclear cargo release, whereas in the latter, RanGTP binding induces nuclear cargo assembly. Therefore, nuclear import and export receptors and their protein recognition sites are predicted to be distinct. Nevertheless, the similar to 38-amino acid M9 sequence present in heterogeneous nuclear ribonucleoprotein Al has been reported to serve as both a nuclear localization signal and a nuclear export signal, even though only one protein, the nuclear import factor transportin, has been shown to bind M9 directly. We have used a combination of mutational randomization followed by selection for transportin binding to exhaustively define amino acids in M9 that are critical for transportin binding in vivo, As expected, the resultant similar to 12-amino acid transportin-binding consensus sequence is also predictive of nuclear localization signal activity. Surprisingly, however, this extensive mutational analysis failed to dissect M9 nuclear localization signal and nuclear export signal function. Nevertheless, transportin appears unlikely to be the M9 export receptor, as RanGTP can be shown to block M9 binding by transportin not only in vitro, but also in the nucleus in vivo, This analysis therefore predicts the existence of a nuclear export receptor distinct from transportin that nevertheless shares a common protein-binding site on heterogeneous nuclear ribonucleoprotein A1.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Genet, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.							BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Blair WS, 1997, MOL CELL BIOL, V17, P2888, DOI 10.1128/MCB.17.5.2888; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fridell RA, 1997, J CELL SCI, V110, P1325; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; HARPER JW, 1993, CELL, V75, P805; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Izaurralde E, 1998, RNA, V4, P351; Koepp DM, 1996, CELL, V87, P1, DOI 10.1016/S0092-8674(00)81315-X; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MICHAEL WM, 1995, CELL, V83, P415; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Truant R, 1998, MOL CELL BIOL, V18, P1449, DOI 10.1128/MCB.18.3.1449; WEIGHARDT F, 1995, J CELL SCI, V108, P545; Weis K, 1998, TRENDS BIOCHEM SCI, V23, P185, DOI 10.1016/S0968-0004(98)01204-3	23	60	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9771	9777		10.1074/jbc.274.14.9771	http://dx.doi.org/10.1074/jbc.274.14.9771			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092666	hybrid			2022-12-27	WOS:000079451800085
J	Tobiason, DM; Lenich, AG; Glasgow, AC				Tobiason, DM; Lenich, AG; Glasgow, AC			Multiple DNA binding activities of the novel site-specific recombinase, Piv, from Moraxella lacunata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MU-DNA; HIN RECOMBINASE; PILIN GENES; PROTEIN; TRANSPOSITION; INVERSION; COMPLEX; CLEAVAGE; PROMOTER	The recombinase, Piv, is essential for site-specific DNA inversion of the type IV pilin DNA segment in Moraxella lacunata and Moraxella bovis. Piv shows significant homology with the transposases of the IS110/IS492 family of insertion elements, but, surprisingly, Piv contains none of the conserved amino acid motifs of the lambda Int or Hin/Res families of site-specific recombinases. Therefore, Piv may mediate site-specific recombination by a novel mechanism, To begin to determine how Piv may assemble a synaptic nucleoprotein structure for DNA cleavage and strand exchange, we have characterized the interaction of Piv with the DNA inversion region of M. lacunata, Gel shift and nuclease/chemical protection assays, competition and dissociation rate analyses, and cooperativity studies indicate that Piv binds two distinct recognition sequences. Cine recognition sequence, found at multiple sites within and outside of the invertible segment, is bound by Piv protomers with high affinity. The second recognition sequence is located at the recombination cross-over sites at the ends of the invertible element; Piv interacts with this sequence as an oligomer with apparent low affinity. A model is proposed for the role of the different Piv binding sites of the M. lacunata inversion region in the formation of an active synaptosome.	Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University	Glasgow, AC (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, 1510 Clifton Rd, Atlanta, GA 30322 USA.				NIGMS NIH HHS [GM49794-05, R01 GM049794] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049794, R29GM049794] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM., 2006, ENZYMATIC MANIPULATI; BAKER TA, 1992, GENE DEV, V6, P2221, DOI 10.1101/gad.6.11.2221; Craig N., 1996, ESCHERICHIA COLI SAL, V2, P2339; CRAIGIE R, 1987, CELL, V51, P493, DOI 10.1016/0092-8674(87)90645-3; DIGUAN C, 1988, GENE, V67, P21, DOI 10.1016/0378-1119(88)90004-2; DREW HR, 1984, CELL, V37, P491, DOI 10.1016/0092-8674(84)90379-9; FULKS KA, 1990, J BACTERIOL, V172, P310, DOI 10.1128/JB.172.1.310-316.1990; GLASGOW AC, 1989, J BIOL CHEM, V264, P10072; Hallet B, 1997, FEMS MICROBIOL REV, V21, P157, DOI 10.1016/S0168-6445(97)00055-7; KIM SH, 1990, CELL, V63, P773, DOI 10.1016/0092-8674(90)90143-3; KOO HS, 1990, BIOCHEMISTRY-US, V29, P4227, DOI 10.1021/bi00469a027; Kristensen HH, 1996, J MOL BIOL, V260, P113, DOI 10.1006/jmbi.1996.0385; KUWABARA MD, 1987, BIOCHEMISTRY-US, V26, P7234, DOI 10.1021/bi00397a006; LANDY A, 1993, CURR OPIN GENET DEV, V3, P699, DOI 10.1016/S0959-437X(05)80086-3; LENICH AG, 1994, J BACTERIOL, V176, P4160, DOI 10.1128/JB.176.13.4160-4164.1994; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; MARRS CF, 1990, J BACTERIOL, V172, P4370, DOI 10.1128/jb.172.8.4370-4377.1990; Maxam A M, 1980, Methods Enzymol, V65, P499; Merickel SK, 1998, GENE DEV, V12, P2803, DOI 10.1101/gad.12.17.2803; MIZUUCHI M, 1992, CELL, V70, P303, DOI 10.1016/0092-8674(92)90104-K; RICHET E, 1988, CELL, V52, P9, DOI 10.1016/0092-8674(88)90526-0; ROSS W, 1983, CELL, V33, P261, DOI 10.1016/0092-8674(83)90355-0; ROZSA FW, 1991, J BACTERIOL, V173, P4000, DOI 10.1128/jb.173.13.4000-4006.1991; Sambrook J., 2002, MOL CLONING LAB MANU; SURETTE MG, 1992, CELL, V68, P1101, DOI 10.1016/0092-8674(92)90081-M; SURETTE MG, 1987, CELL, V49, P253, DOI 10.1016/0092-8674(87)90566-6; THOMPSON JF, 1987, J MOL BIOL, V195, P481, DOI 10.1016/0022-2836(87)90177-X	28	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9698	9706		10.1074/jbc.274.14.9698	http://dx.doi.org/10.1074/jbc.274.14.9698			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092658	hybrid			2022-12-27	WOS:000079451800077
J	Andrejewski, N; Punnonen, EL; Guhde, G; Tanaka, Y; Lullmann-Rauch, R; Hartmann, D; von Figura, K; Saftig, P				Andrejewski, N; Punnonen, EL; Guhde, G; Tanaka, Y; Lullmann-Rauch, R; Hartmann, D; von Figura, K; Saftig, P			Normal lysosomal morphology and function in LAMP-1-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; HAMSTER-KIDNEY CELLS; ASN-LINKED OLIGOSACCHARIDES; POLY-N-ACETYLLACTOSAMINE; MEMBRANE-GLYCOPROTEINS; ACID-PHOSPHATASE; CATHEPSIN-D; KDA SIALOGLYCOPROTEIN; EXON ORGANIZATION; CULTURED-CELLS	Lysosomal membranes contain two highly glycosylated proteins, designated LAMP-1 and LAMP-2, as major components. LAMP-1 and LAMP-S are structurally related, To investigate the physiological role of LAMP-1, we have generated mice deficient for this protein. LAMP-l-deficient mice are viable and fertile. In LAMP-1-deficient brain, a mild regional astrogliosis and altered immunoreactivity against cathepsin-D was observed. Histological and ultrastructural analyses of all other tissues did not reveal abnormalities. Lysosomal properties, such as enzyme activities, lysosomal pH, osmotic stability, density, shape, and subcellular distribution were not changed in comparison with controls. Western blot analyses of LAMP-1-deficient and heterozygote tissues revealed an up-regulation of the LAR IP-S protein pointing to a compensatory effect of LAMP-S in response to the LAMP-1 deficiency. The increase of LAMP-2 was neither correlated with an increase in the level of lamp-2 mRNAs nor with increased half-life time of LAMP-2, This findings suggest a translational regulation of LAMP-2 expression.	Univ Gottingen, Zentrum Biochem & Mol Zellbiol, Biochem Abt 2, D-37073 Gottingen, Germany; Univ Helsinki, Inst Biochem & Electron Microscopy, FIN-00014 Helsinki, Finland; Univ Kiel, Inst Anat, D-24043 Kiel, Germany	University of Gottingen; University of Helsinki; University of Kiel	Saftig, P (corresponding author), Univ Gottingen, Zentrum Biochem & Mol Zellbiol, Biochem Abt 2, Gosslerstr 12D, D-37073 Gottingen, Germany.		Saftig, Paul/A-7966-2010					AcevedoSchermerhorn C, 1997, EXP CELL RES, V236, P510, DOI 10.1006/excr.1997.3752; Bresciani R, 1996, EUR J BIOCHEM, V238, P669, DOI 10.1111/j.1432-1033.1996.0669w.x; CARLSSON SR, 1989, J BIOL CHEM, V264, P20526; CHA Y, 1990, J BIOL CHEM, V265, P5008; CHEN JW, 1985, ARCH BIOCHEM BIOPHYS, V239, P574, DOI 10.1016/0003-9861(85)90727-1; CHEN JW, 1988, J BIOL CHEM, V263, P8754; DAHLGREN C, 1995, BIOCHEM J, V311, P667, DOI 10.1042/bj3110667; DOCHERTY K, 1979, BIOCHEM J, V178, P361, DOI 10.1042/bj1780361; FAMBROUGH DM, 1988, J CELL BIOL, V106, P61, DOI 10.1083/jcb.106.1.61; FEBBRAIO M, 1990, J BIOL CHEM, V265, P18531; FUKUDA M, 1988, J BIOL CHEM, V263, P18920; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; GIESELMANN V, 1985, J BIOL CHEM, V260, P3215; GRANGER BL, 1990, J BIOL CHEM, V265, P12036; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; HEFFERNAN M, 1989, CANCER RES, V49, P6077; HIMENO M, 1989, FEBS LETT, V244, P351, DOI 10.1016/0014-5793(89)80561-7; HONING S, 1995, J CELL BIOL, V128, P464; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; HOWE CL, 1988, P NATL ACAD SCI USA, V85, P7577, DOI 10.1073/pnas.85.20.7577; ISBRANDT D, 1994, AM J HUM GENET, V54, P454; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; KORNFELD S, 1989, ANN REV CELL BIOL, V5, P488; KOSTER A, 1994, EUR J BIOCHEM, V224, P685, DOI 10.1111/j.1432-1033.1994.00685.x; KOSTER A, 1993, EMBO J, V12, P5219, DOI 10.1002/j.1460-2075.1993.tb06217.x; LAFERTE S, 1989, BIOCHEM J, V259, P569, DOI 10.1042/bj2590569; LEE N, 1990, J BIOL CHEM, V265, P20476; LEHMANN LE, 1992, EMBO J, V11, P4391, DOI 10.1002/j.1460-2075.1992.tb05539.x; LEMANSKY P, 1984, J BIOL CHEM, V259, P129; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYONS K, 1989, P NATL ACAD SCI USA, V86, P4554, DOI 10.1073/pnas.86.12.4554; MARSH M, 1987, J CELL BIOL, V104, P875, DOI 10.1083/jcb.104.4.875; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; OKAZAKI I, 1992, J BIOCHEM, V111, P763, DOI 10.1093/oxfordjournals.jbchem.a123833; PETERS C, 1994, FEBS LETT, V346, P108, DOI 10.1016/0014-5793(94)00499-4; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; PIERCE M, 1986, J BIOL CHEM, V261, P772; POHLMANN R, 1995, J BIOL CHEM, V270, P27311, DOI 10.1074/jbc.270.45.27311; PORTER MT, 1969, P NATL ACAD SCI USA, V62, P887, DOI 10.1073/pnas.62.3.887; Saftig P, 1997, J BIOL CHEM, V272, P18628, DOI 10.1074/jbc.272.30.18628; Saftig P, 1996, J BIOL CHEM, V271, P27241, DOI 10.1074/jbc.271.44.27241; SAWADA R, 1993, J BIOL CHEM, V268, P9014; SCHULZEGARG C, 1993, J CELL BIOL, V122, P541, DOI 10.1083/jcb.122.3.541; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; VIITALA J, 1988, P NATL ACAD SCI USA, V85, P3743, DOI 10.1073/pnas.85.11.3743; WAHEED A, 1988, EMBO J, V7, P2351, DOI 10.1002/j.1460-2075.1988.tb03079.x; YAMASHITA K, 1984, J BIOL CHEM, V259, P834; YOUAKIM A, 1989, CANCER RES, V49, P6889; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772; ZOT AS, 1990, J BIOL CHEM, V265, P20988	50	136	141	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12692	12701		10.1074/jbc.274.18.12692	http://dx.doi.org/10.1074/jbc.274.18.12692			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212251	hybrid			2022-12-27	WOS:000080056800071
J	Leisner, TM; Wencel-Drake, JD; Wang, W; Lam, SCT				Leisner, TM; Wencel-Drake, JD; Wang, W; Lam, SCT			Bidirectional transmembrane modulation of integrin alpha(IIb)beta(3) conformations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE GLYCOPROTEIN-IIB; GROWTH-FACTOR RECEPTOR; PLATELET GPIIB-IIIA; CYTOPLASMIC DOMAIN; SIGNAL-TRANSDUCTION; MONOCLONAL-ANTIBODY; LIGAND-BINDING; CHEMICAL SYNTHESIS; STRUCTURAL MODEL; CELL-ADHESION	Activation of blood platelets by physiological stimuli (e.g, thrombin, ADP) at sites of vascular injury induces inside-out signaling, resulting in a conformational change of the prototype integrin alpha(IIb)beta(3) from an inactive to an active state competent to bind soluble fibrinogen. Furthermore, ligand occupancy of alpha(IIb)beta(3) initiates outside-in signaling and additional conformational changes of the receptor, leading to the exposure of extracellular neoepitopes termed ligand-induced binding sites (LIBS), which are recognized by anti-LIES monoclonal antibodies. To date, the mechanism of bidirectional transmembrane signaling of alpha(IIb)beta(3) has not been established, In this study, using our newly developed anti-LIBS(cyt)1 monoclonal antibody, we showed that extracellular ligand binding to alpha(IIb)beta(3) on blood platelets induces a transmembrane conformational change in alpha(IIb)beta(3), thereby exposing the LIBS(cyt)1 epitope in the alpha(IIb), cytoplasmic sequence between Lys(994) and Asp(1003), In addition, a point mutation at this site (P998A/P999A) renders alpha(IIb)beta(3) constitutively active to bind extracellular ligands, resulting in fibrinogen-dependent cell-cell aggregation. Taken collectively, these results demonstrated that the extracellular ligand-binding site and a cytoplasmic LIBS epitope in integrin alpha(IIb)beta(3) are conformationally and functionally coupled. Such bidirectional modulation of alpha(IIb)beta(3) conformation across the cell membrane may play a key role in inside-out and outside-in signaling via this integrin.	Univ Illinois, Dept Pharmacol MC868, Chicago, IL 60612 USA; Univ Illinois, Sch Biomed & Hlth Informat Sci, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lam, SCT (corresponding author), Univ Illinois, Dept Pharmacol MC868, 835 S Wolcott Ave, Chicago, IL 60612 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052755, R01HL041793, R29HL041793] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-41793, HL-52755] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; BISHAYEE S, 1989, J BIOL CHEM, V264, P11699; BISHAYEE S, 1988, MOL CELL BIOL, V8, P3696, DOI 10.1128/MCB.8.9.3696; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; DU XP, 1993, J BIOL CHEM, V268, P23087; FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155; FILARDO EJ, 1994, J BIOL CHEM, V269, P4641; Fox JEB, 1996, J BIOL CHEM, V271, P7004, DOI 10.1074/jbc.271.12.7004; FRELINGER AL, 1988, J BIOL CHEM, V263, P12397; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Haas TA, 1996, J BIOL CHEM, V271, P6017, DOI 10.1074/jbc.271.11.6017; Haas TA, 1997, PROTEIN ENG, V10, P1395, DOI 10.1093/protein/10.12.1395; HARRISON P, 1989, J CLIN INVEST, V84, P1320, DOI 10.1172/JCI114300; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IUPAC-IUB commission on biochemical nomenclature, 1968, J BIOL CHEM, V243, P3557; KEATING MT, 1988, J BIOL CHEM, V263, P12805; KOUNS WC, 1990, J BIOL CHEM, V265, P20594; LAFLAMME SE, 1992, J CELL BIOL, V117, P437, DOI 10.1083/jcb.117.2.437; LAM SCT, 1992, J BIOL CHEM, V267, P5649; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; LOFTUS JC, 1988, J BIOL CHEM, V263, P11025; LOFTUS JC, 1987, P NATL ACAD SCI USA, V84, P7114, DOI 10.1073/pnas.84.20.7114; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; MUIR TW, 1994, BIOCHEMISTRY-US, V33, P7701, DOI 10.1021/bi00190a025; Nurden P, 1996, BLOOD, V88, P887, DOI 10.1182/blood.V88.3.887.bloodjournal883887; OTOOLE TE, 1990, CELL REGUL, V1, P883, DOI 10.1091/mbc.1.12.883; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; OTOOLE TE, 1989, BLOOD, V74, P14; PARISE LV, 1987, J BIOL CHEM, V262, P12597; PIDARD D, 1983, J BIOL CHEM, V258, P2582; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SHADLE PJ, 1984, J CELL BIOL, V99, P2056, DOI 10.1083/jcb.99.6.2056; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; SIMS PJ, 1991, J BIOL CHEM, V266, P7345; Tozer EC, 1996, J BIOL CHEM, V271, P21978, DOI 10.1074/jbc.271.36.21978; WencelDrake JD, 1996, BLOOD, V87, P602, DOI 10.1182/blood.V87.2.602.bloodjournal872602	42	59	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12945	12949		10.1074/jbc.274.18.12945	http://dx.doi.org/10.1074/jbc.274.18.12945			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212286	hybrid			2022-12-27	WOS:000080056800106
J	Maeda, N; Ichihara-Tanaka, K; Kimura, T; Kadomatsu, K; Muramatsu, T; Noda, M				Maeda, N; Ichihara-Tanaka, K; Kimura, T; Kadomatsu, K; Muramatsu, T; Noda, M			A receptor-like protein-tyrosine phosphatase PTP zeta/RPTP beta binds a heparin-binding growth factor midkine - Involvement of arginine 78 of midkine in the high affinity binding to PTP zeta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; MOLECULE HB-GAM; NEURITE OUTGROWTH; 6B4 PROTEOGLYCAN/PHOSPHACAN; EXTRACELLULAR VARIANT; PROMOTING ACTIVITY; CELL-ADHESION; BRAIN; CLONING; LIGAND	Midkine is a 13-kDa heparin-binding growth factor with 45% sequence identity to pleiotrophin. Pleiotrophin has been demonstrated to bind to protein-tyrosine phosphatase zeta (PTP zeta) with high affinity. In this study, we examined the binding of midkine to PTP zeta by solid-phase binding assay. Midkine and pleiotrophin binding to PTP zeta were equally inhibited by soluble pleiotrophin and also by some specific glycosaminoglycans. For both bindings, Scatchard analysis revealed low (3.0 nM) and high (0.58 nM) affinity binding sites. These results suggested that PTP zeta is a common receptor for midkine and pleiotrophin. Midkine is structurally divided into the N- and C-terminal halves, and the latter exhibited full activity for PTP zeta binding and neuronal migration induction. The C-terminal half contains two heparin-binding sites consisting of clusters of basic amino acids, Clusters I and II. A mutation at Arg(78) in Cluster I resulted in loss of the high affinity binding and reduced neuronal migration-inducing activity, while mutations at Lys(83) and Lys(84) in Cluster II showed almost no effect on either activity. Chondroitinase ABC-treated PTP zeta exhibited similar low affinity binding both to the native midkine and midkine mutants at Arg(78). These results suggested that Arg(78) in midkine plays an essential role in high affinity binding to PTP zeta by interacting with the chondroitin sulfate portion of this receptor.	Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Dept Mol Biomech, Okazaki, Aichi 4448585, Japan; Nagoya Univ, Sch Med, Dept Biochem, Showa Ku, Nagoya, Aichi 4668550, Japan; Peptide Inst Inc, Osaka 5620015, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Nagoya University	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, 38 Nishigonaka,Myodaiji Cho, Okazaki, Aichi 4448585, Japan.		Kadomatsu, Kenji/G-8083-2012; Noda, Masaharu/D-7146-2016	Noda, Masaharu/0000-0002-3796-524X				Akhter S, 1998, J BIOCHEM-TOKYO, V123, P1127; Asai T, 1997, BIOCHEM BIOPH RES CO, V236, P66, DOI 10.1006/bbrc.1997.6905; BARNEA G, 1994, J BIOL CHEM, V269, P14349; CHAUHAN AK, 1993, P NATL ACAD SCI USA, V90, P679, DOI 10.1073/pnas.90.2.679; FABRI L, 1993, J CHROMATOGR, V646, P213, DOI 10.1016/S0021-9673(99)87023-X; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; GRUMET M, 1994, J BIOL CHEM, V269, P12142; Inui T, 1996, J PEPT SCI, V2, P28; Iwasaki W, 1997, EMBO J, V16, P6936, DOI 10.1093/emboj/16.23.6936; KADOMATSU K, 1988, BIOCHEM BIOPH RES CO, V151, P1312, DOI 10.1016/S0006-291X(88)80505-9; Kadomatsu K, 1997, BRIT J CANCER, V75, P354, DOI 10.1038/bjc.1997.58; KOJIMA S, 1995, J BIOL CHEM, V270, P9590, DOI 10.1074/jbc.270.16.9590; Kojima T, 1996, J BIOL CHEM, V271, P5914, DOI 10.1074/jbc.271.10.5914; KRUEGER NX, 1992, P NATL ACAD SCI USA, V89, P7417, DOI 10.1073/pnas.89.16.7417; LEVY JB, 1993, J BIOL CHEM, V268, P10573; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; MAEDA N, 1995, NEUROSCIENCE, V67, P23, DOI 10.1016/0306-4522(94)00069-H; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; MAEDA N, 1994, FEBS LETT, V354, P67, DOI 10.1016/0014-5793(94)01093-5; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; Milev P, 1996, J BIOL CHEM, V271, P15716, DOI 10.1074/jbc.271.26.15716; MURAMATSU H, 1991, BIOCHEM BIOPH RES CO, V177, P652, DOI 10.1016/0006-291X(91)91838-4; MURAMATSU H, 1994, BIOCHEM BIOPH RES CO, V203, P1131, DOI 10.1006/bbrc.1994.2300; MURAMATSU T, 1994, DEV GROWTH DIFFER, V36, P1; Nadanaka S, 1998, J BIOL CHEM, V273, P3296, DOI 10.1074/jbc.273.6.3296; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; RAULO E, 1994, J BIOL CHEM, V269, P12999; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x	30	255	265	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12474	12479		10.1074/jbc.274.18.12474	http://dx.doi.org/10.1074/jbc.274.18.12474			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212223	hybrid			2022-12-27	WOS:000080056800043
J	Sinniger, V; Merton, RE; Fabregas, P; Felez, J; Longstaff, C				Sinniger, V; Merton, RE; Fabregas, P; Felez, J; Longstaff, C			Regulation of tissue plasminogen activator activity by cells - Domains responsible for binding and mechanism of stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-PA; FACTOR-X; CELLULAR RECEPTORS; KINETIC-PARAMETERS; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI; HIGH-AFFINITY; UROKINASE; CHAIN; SITE	A number of cell types have previously been shown to bind tissue plasminogen activator (tPA), which in some cases can remain active on the cell surface resulting in enhanced plasminogen activation kinetics. We have investigated several cultured cell lines, U937, THP1, K562, Molt4, and Nalm6 and shown that they bind both tPA and plasminogen and are able to act as promoters of plasminogen activation in kinetic assays. To understand what structural features of tPA are involved in cell surface interactions, we performed kinetic assays with a range of tPA domain deletion mutants consisting of full-length glycosylated and nonglycosylated tPA (F-G-K1-K2-P), Delta FtPA (G-K1-K2-P), K2-P tPA (BM 06.022 or Reteplase), and protease domain (P), Deletion variants were made in Escherichia coli and were nonglycosylated, Plasminogen activation rates were compared with and without cells, over a range of cell densities at physiological tPA concentrations, and produced maximum levels of stimulation up to 80-fold with full-length, glycosylated tPA, Stimulation for nonglycosylated full-length tPA dropped to 45-60% of this value. Loss of N-terminal domains as in Delta FtPA and K2P resulted in a further loss of stimulation to 15-30% of the full-length glycosylated value. The protease domain alone was stimulated at very low levels of up to a-fold. Thus, a number of different sites are involved in cell interactions especially within finger and kringle domains, which is similar to the regulation of tPA activity by fibrin, A model was developed to explain the mechanism of stimulation and compared with actual data collected with varying cell, plasminogen, or tPA concentrations and different tPA variants. Experimental data and model predictions were generally in good agreement and suggest that stimulation is well explained by the concentration of reactants by cells.	Natl Inst Biol Stand & Controls, Blanche Lane, S Mimms EN6 3QG, Herts, England; Hosp Duran Reynals, Inst Recersa Oncol, Barcelona 08907, Spain	National Institute for Biological Standards & Control; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals	Longstaff, C (corresponding author), Natl Inst Biol Stand & Controls, Blanche Lane, S Mimms EN6 3QG, Herts, England.	clongstaff@nibsc.ac.uk	Longstaff, Colin/D-2413-2013	Longstaff, Colin/0000-0001-7608-208X				BAKKER AHF, 1995, J BIOL CHEM, V270, P12355, DOI 10.1074/jbc.270.21.12355; BARNATHAN ES, 1988, J BIOL CHEM, V263, P7792; BEEBE DP, 1989, BLOOD, V74, P2034; BENNETT WF, 1991, J BIOL CHEM, V266, P5191; BU GJ, 1994, BLOOD, V83, P3427; CORNISHBOWDEN A, 1996, FUNDAMENTALS ENZYME, P112; CUMMINGS HS, 1985, ARCH BIOCHEM BIOPHYS, V236, P612, DOI 10.1016/0003-9861(85)90665-4; DEVRIES C, 1991, THROMB HAEMOSTASIS, V65, P280; Ellis V, 1997, BLOOD, V90, P2312, DOI 10.1182/blood.V90.6.2312.2312_2312_2322; FELEZ J, 1993, BLOOD, V82, P2433, DOI 10.1182/blood.V82.8.2433.bloodjournal8282433; Felez J, 1996, THROMB HAEMOSTASIS, V76, P577; FELEZ J, 1991, BLOOD, V78, P2318; FRIEDEN C, 1964, J BIOL CHEM, V239, P3522; GENNIS RB, 1989, BIOMEMBRANES MOL STR, P252; GENTRY R, 1995, BIOPHYS J, V69, P362, DOI 10.1016/S0006-3495(95)79908-8; GENTRY R, 1995, BIOPHYS J, V69, P356, DOI 10.1016/S0006-3495(95)79907-6; GEPPERT AG, 1992, ARCH BIOCHEM BIOPHYS, V297, P205, DOI 10.1016/0003-9861(92)90663-H; HAJJAR KA, 1994, J CLIN INVEST, V93, P703, DOI 10.1172/JCI117023; HAJJAR KA, 1995, THROMB HAEMOSTASIS, V74, P294; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; HIGGINS DL, 1990, ANNU REV PHARMACOL, V30, P91; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; Jardi M, 1996, THROMB HAEMOSTASIS, V76, P1009; JONES AJS, 1990, THROMB HAEMOSTASIS, V64, P455; KALYAN NK, 1988, J BIOL CHEM, V263, P3971; KOHNERT U, 1992, PROTEIN ENG, V5, P93, DOI 10.1093/protein/5.1.93; LEATHERBARROW RJ, 1998, GRAFT VERSION 4 0; LEVITZKI A, 1997, PROTEIN FUNCTION PRA, P104; LIJNEN HR, 1984, EUR J BIOCHEM, V144, P541, DOI 10.1111/j.1432-1033.1984.tb08499.x; LIM TK, 1977, BIOCHEMISTRY-US, V16, P4177, DOI 10.1021/bi00638a007; LONGSTAFF C, 1992, J BIOL CHEM, V267, P173; LONGSTAFF C, 1995, FIBRINOLYSIS, V9, P178, DOI 10.1016/S0268-9499(95)80009-3; Lu YF, 1996, BIOCHEMISTRY-US, V35, P8201, DOI 10.1021/bi960281g; Machovich R, 1997, THROMB HAEMOSTASIS, V77, P1041; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; NESHEIM ME, 1984, J BIOL CHEM, V259, P1447; NIEUWENHUIZEN W, 1988, EUR J BIOCHEM, V174, P163, DOI 10.1111/j.1432-1033.1988.tb14077.x; PLOW EF, 1991, THROMB HAEMOSTASIS, V66, P32; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; POWER RF, 1990, J BIOL CHEM, V265, P1419; RIJKEN DC, 1982, J BIOL CHEM, V257, P2920; Rijken DC, 1996, BLOOD COAGUL FIBRIN, V7, P561, DOI 10.1097/00001721-199607000-00008; SARMIENTOS P, 1989, BIO-TECHNOL, V7, P495, DOI 10.1038/nbt0589-495; Scandura JM, 1996, BIOCHEMISTRY-US, V35, P8903, DOI 10.1021/bi9525031; STOCKINGER H, 1992, THROMB RES, V67, P589, DOI 10.1016/0049-3848(92)90019-7; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; VANZONNEVELD AJ, 1986, P NATL ACAD SCI USA, V83, P4670; YE J, 1995, BIOCHEMISTRY-US, V34, P6448, DOI 10.1021/bi00019a026	50	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12414	12422		10.1074/jbc.274.18.12414	http://dx.doi.org/10.1074/jbc.274.18.12414			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212215	hybrid			2022-12-27	WOS:000080056800035
J	Amendt, BA; Sutherland, LB; Russo, AF				Amendt, BA; Sutherland, LB; Russo, AF			Transcriptional antagonism between Hmx1 and Nkx2.5 for a shared DNA-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEOBOX GENE; HOMEODOMAIN PROTEINS; EXPRESSION; RECOGNITION; NKX-2.5; SPECIFICITY; ACTIVATION; IDENTIFICATION; CONSERVATION; REPRESSION	The recently described Hmx family of homeodomain proteins is predominately expressed in discrete regions of developing sensory tissues. In this report, we have identified the preferred DNA-binding site of the murine Hmx3 homeodomain protein by the selection and amplification binding (SAAB) technique. The consensus Hmx-binding site contained the sequence 5'-CAAGTG-3', which differs from the 5'-TAAT-3' motif commonly associated with homeodomain proteins. Instead, the Hmx consensus is similar to the B'-CAAGTG-3'-binding sites of Nkx2.1 and Nkx2.5 homeodomain proteins. Based on mutation studies, both the 5'-CAAG-3' core and the 3'-TG dinucleotide are required for high affinity binding by Hmx3 and the homologous Hmx1 protein. A critical determinant of this specificity is the glutamine at position 50 in the third helix of the Hmx homeodomain. Hmx1 binds to the 5'-CAAGTG-3' element with an apparent dissociation constant of 20 nM. Unexpectedly, the human Hmx1 protein specifically repressed transcription from a luciferase reporter gene containing 3 copies of the 5'-CAAGTG-3' sequence. In contrast, the Nkx2.5 protein transactivated this luciferase reporter. Interestingly, co-expression of Hmx1 and Nkx2.5 attenuated each others activity, suggesting that genes containing the CAAGTG element can integrate signals from these proteins. Therefore, Hmx1 and Nkx2.5 proteins bind a unique DNA sequence and act as transcriptional antagonists.	Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa	Amendt, BA (corresponding author), Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	brad-amendt@uiowa.edu		Amendt, Brad A./0000-0001-6524-1006; Russo, Andrew/0000-0002-8156-5649	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE009170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NICHD NIH HHS [HD25969] Funding Source: Medline; NIDCR NIH HHS [DE09170] Funding Source: Medline; NIDDK NIH HHS [DK25295] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BOBER E, 1994, DEV BIOL, V162, P288, DOI 10.1006/dbio.1994.1086; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Chen YP, 1996, DEVELOPMENT, V122, P3035; Damante G, 1996, EMBO J, V15, P4992, DOI 10.1002/j.1460-2075.1996.tb00879.x; DAMANTE G, 1994, NUCLEIC ACIDS RES, V22, P3075, DOI 10.1093/nar/22.15.3075; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DEITCHER DL, 1994, J NEUROSCI, V14, P486; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Durocher D, 1996, MOL CELL BIOL, V16, P4648, DOI 10.1128/mcb.16.9.4648; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; Hadrys T, 1998, DEVELOPMENT, V125, P33; HAN KH, 1989, CELL, V56, P573, DOI 10.1016/0092-8674(89)90580-1; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; HAYASHI S, 1990, CELL, V63, P883, DOI 10.1016/0092-8674(90)90492-W; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; JAYNES JB, 1988, NATURE, V336, P744, DOI 10.1038/336744a0; KIM YS, 1989, P NATL ACAD SCI USA, V86, P7716, DOI 10.1073/pnas.86.20.7716; KORNBERG TB, 1993, J BIOL CHEM, V268, P26813; Lee Y, 1998, MOL CELL BIOL, V18, P3120, DOI 10.1128/MCB.18.6.3120; LINTS TJ, 1993, DEVELOPMENT, V119, P419; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MILLER CP, 1994, EMBO J, V13, P1145, DOI 10.1002/j.1460-2075.1994.tb06363.x; PERCIVALSMITH A, 1990, EMBO J, V9, P3967, DOI 10.1002/j.1460-2075.1990.tb07617.x; RINKWITZBRANDT S, 1995, MECH DEVELOP, V52, P371, DOI 10.1016/0925-4773(95)00414-V; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; STADLER HS, 1992, P NATL ACAD SCI USA, V89, P11579, DOI 10.1073/pnas.89.23.11579; STADLER HS, 1995, MAMM GENOME, V6, P383, DOI 10.1007/BF00355637; STADLER HS, 1994, DEV BIOL, V161, P251, DOI 10.1006/dbio.1994.1025; TREISMAN J, 1989, CELL, V59, P553; TVERBERG LA, 1993, J BIOL CHEM, V268, P15965; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; Wilson DS, 1996, P NATL ACAD SCI USA, V93, P6886, DOI 10.1073/pnas.93.14.6886; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	40	41	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11635	11642		10.1074/jbc.274.17.11635	http://dx.doi.org/10.1074/jbc.274.17.11635			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206974	hybrid			2022-12-27	WOS:000079834800030
J	Chan, WK; Yao, G; Gu, YZ; Bradfield, CA				Chan, WK; Yao, G; Gu, YZ; Bradfield, CA			Cross-talk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways - Demonstration of competition and compensation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DNA INTERACTIONS; AH-RECEPTOR; TRANSDUCTION PATHWAYS; NUCLEAR TRANSLOCATOR; TRANSCRIPTION FACTOR; GENE-EXPRESSION; HEPATOMA-CELLS; ARNT; 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN; DIFFERENTIATION	The aryl hydrocarbon receptor (AHR) and the alpha-class hypoxia inducible factors (HIF1 alpha, HIF2 alpha, and HIF3 alpha) are basic helix-loop-helix PAS (bHLH-PAS) proteins that heterodimerize with ARNT, In response to 2,3,7,8-tetrachlorodibenzo-p-dioxin, the AHR . ARNT complex binds to "dioxin responsive enhancers" (DREs) and activates genes involved in the metabolism of xenobiotics, e.g. cytochrome P4501A1 (Cyp1a1), The HIF1 alpha . ARNT complex binds to "hypoxia responsive enhancers" and activates the transcription of genes that regulate adaptation to low oxygen, e.g, erythropoietin (Epo), We postulated that activation of one pathway would inhibit the other due to competition for ARNT or other limiting cellular factors. Using pathway specific reporters in transient transfection assays, we observed that DRE driven transcription was markedly inhibited by hypoxia and that hypoxia responsive enhancer driven transcription was inhibited by AHR agonists, When we attempted to support this cross-talk model using endogenous loci, we observed that activation of the hypoxia pathway inhibited Cyp1a1 up-regulation, but that activation of the AHR actually enhanced the induction of Epo by hypoxia. To explain this unexpected additivity, we examined the Epo gene and found that its promoter harbors DREs immediately upstream of its transcriptional start site. These experiments outline conditions where inhibitory and additive cross-talk occur between the hypoxia and dioxin signal transduction pathways and identify Epo as an AHR-regulated gene.	Univ Wisconsin, Sch Med, McArdle Lab Canc Res, Madison, WI 53706 USA; Univ Pacific, Sch Pharm & Hlth Sci, Dept Pharmaceut & Med Chem, Stockton, CA 95211 USA	University of Wisconsin System; University of Wisconsin Madison; University of the Pacific	Bradfield, CA (corresponding author), Univ Wisconsin, Sch Med, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	bradfield@ontology.wisc.edu		, Guang/0000-0003-0167-777X	NATIONAL CANCER INSTITUTE [P30CA007175, R01CA098681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005703] Funding Source: NIH RePORTER; NCI NIH HHS [T32-CA098681, P30-CA07175] Funding Source: Medline; NIEHS NIH HHS [R01-ES05703] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		CARVER LA, 1994, NUCLEIC ACIDS RES, V22, P3038, DOI 10.1093/nar/22.15.3038; CARVER LA, 1996, THESIS; CHAN WK, 1994, J BIOL CHEM, V269, P26464; CHEN YH, 1995, J BIOL CHEM, V270, P22548, DOI 10.1074/jbc.270.38.22548; DENISON MS, 1989, J BIOL CHEM, V264, P16478; DENISON MS, 1995, J BIOL CHEM, V270, P18175, DOI 10.1074/jbc.270.31.18175; DEVORE J, 1986, STAT EXPLORATION ANA; DOLWICK KM, 1993, MOL PHARMACOL, V44, P911; DOLWICK KM, 1993, P NATL ACAD SCI USA, V90, P8566, DOI 10.1073/pnas.90.18.8566; ELFERINK CJ, 1990, J BIOL CHEM, V265, P20708; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gassmann M, 1997, KIDNEY INT, V51, P567, DOI 10.1038/ki.1997.81; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Gradin K, 1996, MOL CELL BIOL, V16, P5221; HANKINSON O, 1993, ARCH BIOCHEM BIOPHYS, V300, P1, DOI 10.1006/abbi.1993.1001; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; HURLIN PJ, 1994, COLD SPRING HARB SYM, V59, P109, DOI 10.1101/SQB.1994.059.01.014; KNUTSON JC, 1984, J CELL PHYSIOL, V121, P143, DOI 10.1002/jcp.1041210118; Kuil CW, 1998, J BIOL CHEM, V273, P8829, DOI 10.1074/jbc.273.15.8829; Li H, 1996, J BIOL CHEM, V271, P21262, DOI 10.1074/jbc.271.35.21262; LUSSKA A, 1993, J BIOL CHEM, V268, P6575; NEBERT DW, 1978, POLYCYCLIC HYDROCARB, V2, P345; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; POLLENZ RS, 1994, MOL PHARMACOL, V45, P428; POSTLIND H, 1993, TOXICOLOGY, V18, P255; RIDDICK DS, 1994, J BIOL CHEM, V269, P12118; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; SKEATH JB, 1994, FASEB J, V8, P714, DOI 10.1096/fasebj.8.10.8050670; SWANSON HI, 1993, PHARMACOGENETICS, V3, P213, DOI 10.1097/00008571-199310000-00001; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WHITLOCK JP, 1993, CHEM RES TOXICOL, V6, P754, DOI 10.1021/tx00036a003	34	170	173	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12115	12123		10.1074/jbc.274.17.12115	http://dx.doi.org/10.1074/jbc.274.17.12115			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207038	hybrid			2022-12-27	WOS:000079834800094
J	Lee, YC; Kaufmannn, M; Kitazume-Kawaguchi, S; Kono, M; Takashima, S; Kurosawa, N; Liu, H; Pircher, H; Tsujii, S				Lee, YC; Kaufmannn, M; Kitazume-Kawaguchi, S; Kono, M; Takashima, S; Kurosawa, N; Liu, H; Pircher, H; Tsujii, S			Molecular cloning and functional expression of two members of mouse NeuAc alpha 2,3Gal beta 1,3GalNAc GalNAc alpha 2,6-sialyltransferase family, ST6GalNAc III and IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAL-BETA-1,3GALNAC-SPECIFIC GALNAC ALPHA-2,6-SIALYLTRANSFERASE; BETA-GALACTOSIDE ALPHA-2,6-SIALYTRANSFERASE; DEVELOPMENTALLY-REGULATED MEMBER; SIALYLTRANSFERASE GENE FAMILY; N-LINKED OLIGOSACCHARIDES; POLYMERASE CHAIN-REACTION; CARBOHYDRATE STRUCTURES; G(D3) SYNTHASE; ACID-RESIDUES; ALPHA-2,3-SIALYLTRANSFERASE	Two cDNA clones encoding NeuAc alpha 2,3Gal beta 1,3GalNAc GalNAc alpha 2,6-sialyltransferase have been isolated from mouse brain cDNA libraries. One of the cDNA clones is a homologue of previously reported rat ST6GalNAc III according to the amino acid sequence identity (94.4%) and the substrate specificity of the expressed recombinant enzyme, while the other cDNA clone includes an open reading frame coding for 302 amino acids. The deduced amino acid sequence is not identical to those of other cloned mouse sialyltransferases, although it shows the highest sequence similarity with mouse ST6GalNAc III (43.0%). The expressed soluble recombinant enzyme exhibited activity toward NeuAc alpha 2, 3Gal beta 1,3GalNAc, fetuin, and GM1b, while no significant activity was detected toward Gal beta 1,3GalNAc or asialofetuin, or the other glycoprotein substrates tested. The sialidase sensitivity of the C-14-sialylated residue of fetuin, which was sialylated by this enzyme with CMP-[C-14]NeuAc, was the same as that of ST6GalNAc III. These results indicate that the expressed enzyme is a new type of GalNAc alpha 2,6-sialyltransferase, which requires sialic acid residues linked to Gal beta 1,3GalNAc residues for its activity; therefore, we designated it mouse ST6GalNAc TV. Although the substrate specificity of this enzyme is similar to that of ST6GalNAc III, ST6GalNAc IV prefers O-glycans to glycolipids, Glycolipids, however, are better substrates for ST6GalNAc III.	RIKEN, Inst Phys & Chem Res, Frontier Res Program, Wako, Saitama 3510198, Japan; Univ Freiburg, Inst Med Microbiol & Hyg, Dept Immunol, D-79104 Freiburg, Germany	RIKEN; University of Freiburg	Tsujii, S (corresponding author), RIKEN, Inst Phys & Chem Res, Frontier Res Program, Wako, Saitama 3510198, Japan.			Kono, Mari/0000-0003-2447-4350; Kurosawa, Nobuyuki/0000-0002-1548-4541				AASHEIM HC, 1993, EUR J BIOCHEM, V213, P467, DOI 10.1111/j.1432-1033.1993.tb17783.x; Ausubel FM, 1988, MOL REPROD DEV; BAST BJEG, 1992, J CELL BIOL, V116, P423, DOI 10.1083/jcb.116.2.423; CHANG ML, 1995, GLYCOBIOLOGY, V5, P319, DOI 10.1093/glycob/5.3.319; DRICKAMER K, 1993, GLYCOBIOLOGY, V3, P2, DOI 10.1093/glycob/3.1.2; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; FISHMAN PH, 1976, SCIENCE, V194, P906, DOI 10.1126/science.185697; FURUYA S, 1994, J BIOL CHEM, V269, P32418; Geremia RA, 1997, GLYCOBIOLOGY, V7, pR5; GILLESPIE W, 1992, J BIOL CHEM, V267, P21004; GRUNDMANN U, 1990, NUCLEIC ACIDS RES, V18, P667, DOI 10.1093/nar/18.3.667; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; Hamamoto T, 1993, Bioorg Med Chem, V1, P141, DOI 10.1016/S0968-0896(00)82111-2; HARAGUCHI M, 1994, P NATL ACAD SCI USA, V91, P10455, DOI 10.1073/pnas.91.22.10455; HARDY MR, 1994, METHOD ENZYMOL, V230, P208; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; ISHIKAWA D, 1995, GLYCOCONJUGATE J, V12, P523; Kim YJ, 1996, BIOCHEM BIOPH RES CO, V228, P324, DOI 10.1006/bbrc.1996.1660; Kim YJ, 1997, BIOCHEM BIOPH RES CO, V235, P327, DOI 10.1006/bbrc.1997.6725; KIMBER SJ, 1989, BIOCHEM SOC T, V17, P23, DOI 10.1042/bst0170023; Kitagawa H, 1996, J BIOL CHEM, V271, P931, DOI 10.1074/jbc.271.2.931; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; KITAZUME S, 1992, ANAL BIOCHEM, V202, P25, DOI 10.1016/0003-2697(92)90200-Q; KOJIMA N, 1995, FEBS LETT, V360, P1, DOI 10.1016/0014-5793(95)00059-I; KOJIMA N, 1994, BIOCHEMISTRY-US, V33, P5772, DOI 10.1021/bi00185a014; Kono M, 1996, J BIOL CHEM, V271, P29366, DOI 10.1074/jbc.271.46.29366; Kono M, 1997, GLYCOBIOLOGY, V7, P469, DOI 10.1093/glycob/7.4.469; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; KUROSAWA N, 1994, J BIOL CHEM, V269, P19048; Kurosawa N, 1996, J BIOL CHEM, V271, P15109, DOI 10.1074/jbc.271.25.15109; KUROSAWA N, 1994, J BIOL CHEM, V269, P1402; KUROSAWA N, 1995, BBA-GEN SUBJECTS, V1244, P216, DOI 10.1016/0304-4165(95)00012-Z; KUROSAWA N, 1994, EUR J BIOCHEM, V219, P375, DOI 10.1111/j.1432-1033.1994.tb19949.x; KUROSAWA N, 1999, IN PRESS J BIOCH TOK; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE YC, 1993, EUR J BIOCHEM, V216, P377, DOI 10.1111/j.1432-1033.1993.tb18155.x; LEE YC, 1994, J BIOL CHEM, V269, P10028; LIVINGSTON BD, 1993, J BIOL CHEM, V268, P11504; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; NARA K, 1994, P NATL ACAD SCI USA, V91, P7952, DOI 10.1073/pnas.91.17.7952; PAULSON JC, 1982, J BIOL CHEM, V257, P2734; SASAKI K, 1994, J BIOL CHEM, V269, P15950; SASAKI K, 1993, J BIOL CHEM, V268, P22782; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SCHNAAR R L, 1991, Glycobiology, V1, P477, DOI 10.1093/glycob/1.5.477; SIEBERT PD, 1992, NATURE, V359, P557, DOI 10.1038/359557a0; Sjoberg ER, 1996, J BIOL CHEM, V271, P7450, DOI 10.1074/jbc.271.13.7450; SPIRO RG, 1974, J BIOL CHEM, V249, P5704; Svennerholm L, 1980, Adv Exp Med Biol, V125, P533; SVENNERHOLM L, 1964, J LIPID RES, V5, P145; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; Tsuji S, 1996, J BIOCHEM-TOKYO, V120, P1; TSUJI T, 1986, CARBOHYD RES, V151, P391, DOI 10.1016/S0008-6215(00)90358-6; WASSARMAN PM, 1987, ANNU REV CELL BIOL, V3, P109, DOI 10.1146/annurev.cellbio.3.1.109; WEIGANDT H, 1967, J NEUROCHEM, V14, P671; WEN DX, 1992, J BIOL CHEM, V267, P21011; YOSHIDA Y, 1995, J BIOCHEM-TOKYO, V118, P658, DOI 10.1093/oxfordjournals.jbchem.a124960; YOSHIDA Y, 1995, J BIOL CHEM, V270, P14628, DOI 10.1074/jbc.270.24.14628; Zeng GC, 1997, GENE, V187, P131, DOI 10.1016/S0378-1119(96)00735-4; Zeng GC, 1996, BIOCHEM BIOPH RES CO, V226, P319, DOI 10.1006/bbrc.1996.1354	61	58	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11958	11967		10.1074/jbc.274.17.11958	http://dx.doi.org/10.1074/jbc.274.17.11958			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207017	hybrid			2022-12-27	WOS:000079834800073
J	Musante, L; Zegarra-Moran, O; Montaldo, PG; Ponzoni, M; Galietta, LJV				Musante, L; Zegarra-Moran, O; Montaldo, PG; Ponzoni, M; Galietta, LJV			Autocrine regulation of volume-sensitive anion channels in airway epithelial cells by adenosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; EXTRACELLULAR ATP; INTRACELLULAR CALCIUM; MOLECULAR-CLONING; ENDOTHELIAL-CELLS; ION-TRANSPORT; RECEPTORS; ANTAGONISTS; INHIBITION; MECHANISM	The activity of volume-sensitive Cl- channels was studied in human tracheal epithelial cells (9HTEo-) by taurine efflux experiments. The efflux elicited by a hypotonic shock was partially inhibited by adenosine receptor antagonists, by alpha,beta-methyleneadenosine 5'-diphosphate (alpha beta MeADP), an inhibitor of the 5'-ectonucleotidase, and by adenosine deaminase, On the other hand, dipyridamole, a nucleoside transporter inhibitor, increased the swelling-induced taurine efflux, Extracellular ATP and adenosine increased taurine efflux by potentiating the effect of hypotonic shock. alpha beta MeADP strongly inhibited the effect of extracellular ATP but not that of adenosine, These results suggest that anion channel activation involves the release of intracellular ATP, which is then degraded to adenosine by specific ectoenzymes. Adenosine then binds to purinergic receptors, causing the activation of the channels. To directly demonstrate ATP efflux, cells were loaded with [H-3]AMP, and the release of radiolabeled molecules was analyzed by high performance liquid chromatography, During hypotonic shock, cell supernatants showed the presence of ATP, ADP, and adenosine, alpha beta MeADP inhibited adenosine formation and caused the appearance of AMP. Under hypotonic conditions, elevation of intracellular Ca2+ by ionomycin caused an increase of ATP and adenosine in the extracellular solution. Our results demonstrate that volume-sensitive anion channels are regulated with an autocrine mechanism involving swelling-induced ATP release and then hydrolysis to adenosine.	Ist Giannina Gaslini, Genet Mol Lab, I-16148 Genoa, Italy; Ist Giannina Gaslini, Lab Oncol, I-16148 Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini	Galietta, LJV (corresponding author), Ist Giannina Gaslini, Genet Mol Lab, Largo Gerolamo Gaslini 5, I-16148 Genoa, Italy.		Ponzoni, Mirco/J-7713-2016; Galietta, Luis JV/HCG-8692-2022; Musante, Luciana/AAA-5726-2021	Ponzoni, Mirco/0000-0002-6164-4286; Musante, Luciana/0000-0002-2742-1484; Galietta, Luis/0000-0001-8686-3461	Telethon [E.0593] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; Basavappa S, 1996, MOL NEUROBIOL, V13, P137, DOI 10.1007/BF02740638; Cunha RA, 1998, J NEUROSCI, V18, P1987; Galietta LJV, 1997, AM J PHYSIOL-CELL PH, V273, pC57, DOI 10.1152/ajpcell.1997.273.1.C57; GALIETTA LJV, 1992, FEBS LETT, V304, P61, DOI 10.1016/0014-5793(92)80589-9; GARCIAPEREZ A, 1990, HYPERTENSION, V16, P595, DOI 10.1161/01.HYP.16.6.595; Griffiths M, 1997, BIOCHEM J, V328, P739, DOI 10.1042/bj3280739; GRUENERT DC, 1988, P NATL ACAD SCI USA, V85, P5951, DOI 10.1073/pnas.85.16.5951; Harris RA, 1997, AM J PHYSIOL-LUNG C, V273, pL363, DOI 10.1152/ajplung.1997.273.2.L363; HOFFMANN EK, 1991, ADV COMP ENV PHYSL, V9, P140; Kim HD, 1996, AM J PHYSIOL-CELL PH, V270, pC86, DOI 10.1152/ajpcell.1996.270.1.C86; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Kirk K, 1997, J MEMBRANE BIOL, V158, P1, DOI 10.1007/s002329900239; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; MCMANUS ML, 1995, NEW ENGL J MED, V333, P1260, DOI 10.1056/NEJM199511093331906; MEGHJI P, 1995, BIOCHEM J, V308, P725, DOI 10.1042/bj3080725; MEGHJI P, 1995, LIFE SCI, V57, P763, DOI 10.1016/0024-3205(95)02004-3; Mitchell CH, 1998, P NATL ACAD SCI USA, V95, P7174, DOI 10.1073/pnas.95.12.7174; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Ongini E, 1996, TRENDS PHARMACOL SCI, V17, P364, DOI 10.1016/S0165-6147(96)10045-6; Rugolo M, 1996, AM J PHYSIOL-LUNG C, V271, pL665, DOI 10.1152/ajplung.1996.271.4.L665; RUGOLO M, 1993, J BIOL CHEM, V268, P24779; SHIMADA J, 1992, J MED CHEM, V35, P924, DOI 10.1021/jm00083a018; SIEGFRIED G, 1995, ENDOCRINOLOGY, V136, P1267, DOI 10.1210/en.136.3.1267; Silver SM, 1997, KIDNEY INT, V51, P1237, DOI 10.1038/ki.1997.169; SMALLRIDGE RC, 1992, ENDOCRINOLOGY, V131, P1883, DOI 10.1210/en.131.4.1883; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; UKENA D, 1986, LIFE SCI, V39, P743, DOI 10.1016/0024-3205(86)90023-8; Vandenberg JI, 1996, CARDIOVASC RES, V32, P85, DOI 10.1016/S0008-6363(96)00048-X; Wang Y, 1996, P NATL ACAD SCI USA, V93, P12020, DOI 10.1073/pnas.93.21.12020; Wright AR, 1997, TRENDS PHARMACOL SCI, V18, P224, DOI 10.1016/S0165-6147(97)90627-1; Yao SYM, 1997, J BIOL CHEM, V272, P28423, DOI 10.1074/jbc.272.45.28423	32	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11701	11707		10.1074/jbc.274.17.11701	http://dx.doi.org/10.1074/jbc.274.17.11701			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206984	hybrid			2022-12-27	WOS:000079834800040
J	Pace, AJ; Gama, L; Breitwieser, GE				Pace, AJ; Gama, L; Breitwieser, GE			Dimerization of the calcium-sensing receptor occurs within the extracellular domain and is eliminated by Cys -> Ser mutations at Cys(101) and Cys(236)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PUTATIVE PHEROMONE RECEPTORS; CELL-SURFACE EXPRESSION; HUMAN CA2+ RECEPTOR; MUSCARINIC RECEPTORS; SIGNAL-TRANSDUCTION; MULTIGENE FAMILY; SF9 CELLS; BINDING; PHOSPHORYLATION	Calcium-sensing receptors are present in membranes as dimers that can be reduced to monomers with sufhydryl reagents. All studies were carried out on the human calcium-sensing receptor tagged at the carboxyl terminus with green fluorescent protein (hCaR-GFP) to permit identification and localization of expressed proteins. Truncations containing either the extracellular agonist binding domain plus transmembrane helix 1 (ECD/TMH1-GFP) or the transmembrane domain plus the intracellular carboxyl terminus (TMD/carboxyl terminus-GFP) were used to identify the dimerization domain. ECD/TMH1-GFP was a dimer in the absence of reducing reagents, whereas TMD/carboxyl-terminal GFP was a monomer in the absence or presence of reducing agents, suggesting that dimerization occurs via the ECD. To identify the residue(s) involved in dimerization within the ECD, cysteine --> serine point mutations were made in residues that are conserved between hCaR and metabotropic glutamate receptors. Mutations at positions 60 and 131 were expressed at levels comparable to wild type in HEK 293 cells, had minimal effects on hCaR function, and did not eliminate dimerization, whereas mutations at positions 101 and 236 greatly decreased receptor expression and resulted in significant amounts of monomer in the absence of reducing agents. The double point mutant hCaR(C101S/C236S)-GFP was expressed more robustly than either C101S or C236S and covalent dimerization was eliminated. hCaR(C101S/ C236S)-GFP had a decreased affinity for extracellular Ca2+ and slower response kinetics upon increases or decreases in agonist concentration. These results suggest that covalent, disulfide bond-mediated dimerization of the calcium-sensing receptor contributes to stabilization of the ECD and to acceleration of the transitions between inactive and active receptor conformations.	Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Breitwieser, GE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.			Gama, Lucio/0000-0001-9511-012X; Breitwieser, Gerda/0000-0001-9081-0362	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK044484] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-44484] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALI H, 1994, J BIOL CHEM, V269, P24557; AVISSAR S, 1983, P NATL ACAD SCI-BIOL, V80, P156, DOI 10.1073/pnas.80.1.156; Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; BROWN EM, 1991, J BONE MINER RES, V6, P1217; Chattopadhyay N, 1996, ENDOCR REV, V17, P289, DOI 10.1210/er.17.4.289; CONKLIN BR, 1994, NATURE, V367, P22, DOI 10.1038/367022a0; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Fan GF, 1997, ENDOCRINOLOGY, V138, P1916, DOI 10.1210/en.138.5.1916; Fan GF, 1998, FEBS LETT, V436, P353, DOI 10.1016/S0014-5793(98)01165-X; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Gama L, 1998, J BIOL CHEM, V273, P29712, DOI 10.1074/jbc.273.45.29712; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; GIANNINI E, 1995, J BIOL CHEM, V270, P19166, DOI 10.1074/jbc.270.32.19166; HARTIG P, 1990, NEUROPSYCHOPHARMACOL, V3, P335; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hebert TE, 1998, BIOCHEM J, V330, P287; Hermans E, 1998, J NEUROCHEM, V70, P1772; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; LEE TWT, 1986, BIOCHEMISTRY-US, V25, P7009, DOI 10.1021/bi00370a038; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MATTERA R, 1985, J BIOL CHEM, V260, P7410; Monnot C, 1996, J BIOL CHEM, V271, P1507, DOI 10.1074/jbc.271.3.1507; NG GYK, 1993, BIOCHEMISTRY-US, V32, P11727, DOI 10.1021/bi00094a032; Nimchinsky EA, 1997, J BIOL CHEM, V272, P29229, DOI 10.1074/jbc.272.46.29229; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; Pearce SHS, 1997, J ENDOCRINOL, V154, P371, DOI 10.1677/joe.0.1540371; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; POTTER LT, 1991, MOL PHARMACOL, V39, P211; Quinn SJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1315, DOI 10.1152/ajpcell.1997.273.4.C1315; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Ruat M, 1996, J BIOL CHEM, V271, P5972, DOI 10.1074/jbc.271.11.5972; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SCHREURS J, 1995, J NEUROCHEM, V64, P1622; VENTER JC, 1983, TRENDS PHARMACOL SCI, V4, P256; VIGNES M, 1992, NEUROCHEM INT, V21, P229, DOI 10.1016/0197-0186(92)90152-H; Ward DT, 1998, J BIOL CHEM, V273, P14476, DOI 10.1074/jbc.273.23.14476; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; WREGGETT KA, 1995, J BIOL CHEM, V270, P22488, DOI 10.1074/jbc.270.38.22488; Ye CP, 1997, J NEUROSCI RES, V47, P547, DOI 10.1002/(SICI)1097-4547(19970301)47:5<547::AID-JNR10>3.0.CO;2-V	44	98	104	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11629	11634		10.1074/jbc.274.17.11629	http://dx.doi.org/10.1074/jbc.274.17.11629			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206973	hybrid			2022-12-27	WOS:000079834800029
J	Artrip, JH; Kwiatkowski, P; Michler, RE; Wang, SF; Tugulea, S; Ankersmit, J; Chisholm, L; McKenzie, IFC; Sandrin, MS; Itescu, S				Artrip, JH; Kwiatkowski, P; Michler, RE; Wang, SF; Tugulea, S; Ankersmit, J; Chisholm, L; McKenzie, IFC; Sandrin, MS; Itescu, S			Target cell susceptibility to lysis by human natural killer cells is augmented by alpha(1,3)-galactosyltransferase and reduced by alpha(1,2)-fucosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-COMPLEMENT INHIBITOR; ANTI-PIG XENOANTIBODY; CARDIAC XENOTRANSPLANTATION; CARBOHYDRATE-RECOGNITION; INDEPENDENT ANTIGENS; XENOGRAFT REJECTION; MONONUCLEAR-CELLS; TRANSGENIC PIGS; HLA-C; ANTIBODIES	Susceptibility of porcine endothelial cells to human natural killer (NK) cell lysis was found to reflect surface expression of ligands containing Gal alpha(1,3)GlcNAc, the principal antigen on porcine endothelium recognized by xenoreactive human antibodies. Genetically modifying expression of this epitope on porcine endothelium by transfection with the alpha(1,2)-fucosyltransferase gene reduced susceptibility to human NK lysis, These results indicate that surface carbohydrate remodeling profoundly affects target cell susceptibility to NK lysis, and suggest that successful transgenic strategies to limit xenograft rejection by NK cells and xenoreactive antibodies will need to incorporate carbohydrate remodeling.	Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; Austin Hosp, Heidelberg, Vic 3084, Australia	Columbia University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Itescu, S (corresponding author), Columbia Presbyterian Med Ctr, Dept Surg, 630 W 168th St, New York, NY 10032 USA.			Ankersmit, Hendrik Jan/0000-0002-8761-3517	NHLBI NIH HHS [HL09744] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barber LD, 1996, J IMMUNOL, V156, P3275; BECKER JC, 1990, SCAND J IMMUNOL, V32, P153, DOI 10.1111/j.1365-3083.1990.tb02905.x; BEZOUSKA K, 1994, J BIOL CHEM, V269, P16945; BEZOUSKA K, 1994, NATURE, V372, P151; BLAKELY ML, 1994, TRANSPLANTATION, V58, P1059, DOI 10.1097/00007890-199411270-00001; BRENNAN J, 1995, J BIOL CHEM, V270, P9691, DOI 10.1074/jbc.270.17.9691; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Cohney S, 1996, IMMUNOGENETICS, V44, P76, DOI 10.1007/BF02602660; Coligan JE., 1994, CURRENT PROTOCOLS IM; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; DANIELS BF, 1994, IMMUNITY, V1, P785, DOI 10.1016/S1074-7613(94)80020-0; Diamond LE, 1996, TRANSPLANTATION, V61, P1241, DOI 10.1097/00007890-199604270-00021; FODOR WL, 1994, P NATL ACAD SCI USA, V91, P11153, DOI 10.1073/pnas.91.23.11153; GALILI U, 1988, J BIOL CHEM, V263, P17755; GALILI U, 1985, J EXP MED, V162, P573, DOI 10.1084/jem.162.2.573; GALILI U, 1988, INFECT IMMUN, V56, P1730, DOI 10.1128/IAI.56.7.1730-1737.1988; GUMPERZ JE, 1995, NATURE, V378, P245, DOI 10.1038/378245a0; HAYES CE, 1974, J BIOL CHEM, V249, P1904; INVERARDI L, 1997, TRANSPLANTATION, V63, P318; Itescu S, 1996, TRANSPLANTATION, V62, P1927, DOI 10.1097/00007890-199612270-00043; Itescu S, 1998, HUM IMMUNOL, V59, P275, DOI 10.1016/S0198-8859(98)00026-3; KAPLON RJ, 1995, TRANSPLANTATION, V59, P1, DOI 10.1097/00007890-199501150-00001; LARSEN RD, 1990, J BIOL CHEM, V265, P7055; MATSUMOT.I, 1969, BIOCHIM BIOPHYS ACTA, V194, P180, DOI 10.1016/0005-2795(69)90193-7; Michler RE, 1996, TRANSPLANT P, V28, P651; Minanov OP, 1997, TRANSPLANTATION, V63, P182, DOI 10.1097/00007890-199701270-00002; Minanov OP, 1998, J THORAC CARDIOV SUR, V115, P998, DOI 10.1016/S0022-5223(98)70397-6; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; MOND JJ, 1995, CURR OPIN IMMUNOL, V7, P349, DOI 10.1016/0952-7915(95)80109-X; Osman N, 1996, J BIOL CHEM, V271, P33105, DOI 10.1074/jbc.271.51.33105; PARHAM P, 1977, J BIOL CHEM, V252, P7555; PARKER W, 1994, J IMMUNOL, V153, P3791; PLATT JL, 1990, TRANSPLANTATION, V50, P817, DOI 10.1097/00007890-199011000-00015; ROSENGARD AM, 1995, TRANSPLANTATION, V59, P1325, DOI 10.1097/00007890-199505150-00018; SANDRIN MS, 1995, NAT MED, V1, P1261, DOI 10.1038/nm1295-1261; SANDRIN MS, 1994, IMMUNOL REV, V141, P169, DOI 10.1111/j.1600-065X.1994.tb00877.x; SANDRIN MS, 1993, P NATL ACAD SCI USA, V90, P11391, DOI 10.1073/pnas.90.23.11391; Sepp A, 1997, J BIOL CHEM, V272, P23104, DOI 10.1074/jbc.272.37.23104; Shinkel TA, 1997, TRANSPLANTATION, V64, P197, DOI 10.1097/00007890-199707270-00003; Snapper CM, 1996, J IMMUNOL, V157, P2229; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SNAPPER CM, 1993, J IMMUNOL, V151, P5251; STORKUS WJ, 1991, P NATL ACAD SCI USA, V88, P5989, DOI 10.1073/pnas.88.14.5989; VAUGHAN HA, 1994, TRANSPLANTATION, V58, P879, DOI 10.1097/00007890-199410270-00003; Watier H, 1996, TRANSPLANTATION, V62, P105, DOI 10.1097/00007890-199607150-00020; XU H, 1995, J THORAC CARDIOV SUR, V110, P1023, DOI 10.1016/S0022-5223(05)80170-9; XU H, 1995, TRANSPLANTATION, V59, P1189, DOI 10.1097/00007890-199504270-00019; YOKOYAMA WM, 1995, P NATL ACAD SCI USA, V92, P3081, DOI 10.1073/pnas.92.8.3081	48	48	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10717	10722		10.1074/jbc.274.16.10717	http://dx.doi.org/10.1074/jbc.274.16.10717			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196142	hybrid			2022-12-27	WOS:000079751900010
J	He, YP; Gaal, T; Karls, R; Donohue, TJ; Gourse, RL; Roberts, GP				He, YP; Gaal, T; Karls, R; Donohue, TJ; Gourse, RL; Roberts, GP			Transcription activation by CooA, the CO-sensing factor from Rhodospirillum rubrum - The interaction between CooA and the C-terminal domain of the alpha subunit of RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-DEPENDENT PROMOTERS; CARBON-MONOXIDE DEHYDROGENASE; ESCHERICHIA-COLI; RECEPTOR PROTEIN; DNA-BINDING; OPEN COMPLEX; RRNB P1; RECOGNITION; ELEMENT; CRP	CooA, a member of the cAMP receptor protein (CRP) family, is a CO-sensing transcription activator from Rhodospirillum rubrum that binds specific DNA sequences in response to CO. The location of the CooA-binding sites relative to the start sites of transcription suggested that the CooA-dependent promoters are analogous to class II CRP-dependent promoters. In this study, we developed an in vivo CooA reporter system in Escherichia coli and an in vitro transcription assay using RNA polymerases (RNAP) from E. coli and from Rhodobacter sphaeroides to study the transcription properties of CooA and the protein-protein interaction between CooA and RNAP. The ability of CooA to activate CO-dependent transcription in vivo in heterologous backgrounds suggested that CooA is sufficient to direct RNAP to initiate transcription and that no other factors are required. This hypothesis was confirmed in vitro with purified CooA and purified RNAP. Use of a mutant form of E. coli RNAP with cu subunits lacking their C-terminal domain (alpha-CTD) dramatically decreased CooA-dependent transcription of the CooA-regulated R. rubrum promoter P-cooF in vitro, which indicates that alpha-CTD plays an important role in this activation. DNase I footprinting analysis showed that CooA facilitates binding of wild-type RNAP, but not alpha-CTD-truncated RNAP, to P-cooF. This facilitated binding provides evidence for a direct contact between CooA and alpha-CTD of RNAP during activation of transcription. Mapping the CooA-contact site in alpha-CTD suggests that CooA is similar but not identical to GRP in terms of its contact sites to the alpha-CTD at class II promoters.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Roberts, GP (corresponding author), Univ Wisconsin, Dept Bacteriol, 106A EB Fred Hall,1550 Linden Dr, Madison, WI 53706 USA.		Donohue, Timothy/C-3273-2015	Donohue, Timothy/0000-0001-8738-2467; Karls, Russell/0000-0002-6474-6106	NIGMS NIH HHS [R01 GM037509, GM 37509, GM 37048, GM 53228] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037048, R01GM037048, R01GM053228, R01GM037509] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aono S, 1998, J BIOL CHEM, V273, P25757, DOI 10.1074/jbc.273.40.25757; BLATTER EE, 1994, CELL, V78, P889, DOI 10.1016/S0092-8674(94)90682-3; Bokal AJ, 1997, EMBO J, V16, P154, DOI 10.1093/emboj/16.1.154; BONAM D, 1989, J BACTERIOL, V171, P3102, DOI 10.1128/jb.171.6.3102-3107.1989; Busby S, 1997, MOL MICROBIOL, V23, P853, DOI 10.1046/j.1365-2958.1997.2771641.x; BUSBY S, 1994, CELL, V79, P743, DOI 10.1016/0092-8674(94)90063-9; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; EBRIGHT RH, 1993, MOL MICROBIOL, V8, P797, DOI 10.1111/j.1365-2958.1993.tb01626.x; EBRIGHT RH, 1995, CURR OPIN GENET DEV, V5, P197, DOI 10.1016/0959-437X(95)80008-5; Eichenberger P, 1996, BIOCHEMISTRY-US, V35, P15302, DOI 10.1021/bi961377d; Fox JD, 1996, J BACTERIOL, V178, P6200, DOI 10.1128/jb.178.21.6200-6208.1996; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Gaal T, 1996, GENE DEV, V10, P16, DOI 10.1101/gad.10.1.16; He YP, 1996, J BIOL CHEM, V271, P120, DOI 10.1074/jbc.271.1.120; HERBERT M, 1986, P NATL ACAD SCI USA, V83, P2807, DOI 10.1073/pnas.83.9.2807; ISHIHAMA A, 1992, MOL MICROBIOL, V6, P3283, DOI 10.1111/j.1365-2958.1992.tb02196.x; JEON YH, 1995, SCIENCE, V270, P1495, DOI 10.1126/science.270.5241.1495; KARLS RK, 1993, J BACTERIOL, V175, P7629, DOI 10.1128/JB.175.23.7629-7638.1993; KERBY RL, 1995, J BACTERIOL, V177, P2241, DOI 10.1128/jb.177.8.2241-2244.1995; KERBY RL, 1992, J BACTERIOL, V174, P5284, DOI 10.1128/JB.174.16.5284-5294.1992; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; LEIRMO S, 1991, J MOL BIOL, V220, P550; Miller JH., 1992, EXPT MOL GENETICS; Murakami K, 1996, EMBO J, V15, P4358, DOI 10.1002/j.1460-2075.1996.tb00809.x; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; RAO L, 1994, J MOL BIOL, V235, P1421, DOI 10.1006/jmbi.1994.1098; ROSS W, 1990, EMBO J, V9, P3733, DOI 10.1002/j.1460-2075.1990.tb07586.x; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Savery NJ, 1998, EMBO J, V17, P3439, DOI 10.1093/emboj/17.12.3439; SHELVER D, 1995, J BACTERIOL, V177, P2157, DOI 10.1128/jb.177.8.2157-2163.1995; Shelver D, 1999, BIOCHEMISTRY-US, V38, P2669, DOI 10.1021/bi982658j; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; TAGAMI H, 1995, NUCLEIC ACIDS RES, V23, P599, DOI 10.1093/nar/23.4.599; Tagami H, 1998, EMBO J, V17, P1759, DOI 10.1093/emboj/17.6.1759; TANG H, 1995, P NATL ACAD SCI USA, V92, P4902, DOI 10.1073/pnas.92.11.4902; ZHOU YH, 1994, EMBO J, V13, P4549, DOI 10.1002/j.1460-2075.1994.tb06776.x	37	39	39	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10840	10845		10.1074/jbc.274.16.10840	http://dx.doi.org/10.1074/jbc.274.16.10840			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196160	hybrid			2022-12-27	WOS:000079751900028
J	Luo, Y; Denker, BM				Luo, Y; Denker, BM			Interaction of heterotrimeric G protein G alpha(o) with Purkinje cell protein-2 - Evidence for a novel nucleotide exchange factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; GOLGI MEMBRANES; ALPHA-SUBUNITS; CDNA CLONING; MICE LACKING; EXPRESSION; CEREBELLUM; RECEPTOR; REGIONS; GAP-43	The heterotrimeric G protein G alpha(o) is ubiquitously expressed throughout the central nervous system, but many of its functions remain to be defined. To search for novel proteins that interact with G alpha(o) a mouse brain library was screened using the yeast two-hybrid interaction system. Pcp2 (Purkinje cell protein-2) was identified as a partner for G alpha(o) in this system. Pcp2 is expressed in cerebellar Purkinje cells and retinal bipolar neurons, two locations where G alpha(o) is also expressed. Pcp2 was first identified as a candidate gene to explain Purkinje cell degeneration in pcd mice (Nordquist, D. T., Kozak, C, A., and Orr, H. T, (1988) J, Neurosci, 8, 4780-4789), but its function remains unknown as Pcp2 knockout mice are normal (Mohn, A. R,, Feddersen, R, M,, Nguyen, M, S., and Koller, B, H, (1997) Mol. Cell. Neurosci, 9, 63-76), G alpha(o) and Pcp2 binding was confirmed in vitro using glutathione S-transferase-Pcp2 fusion proteins and in vitro translated [S-35]methionine-labeled G alpha(o). In addition, when G alpha(o) and Pcp2 were cotransfected into COS cells, G alpha(o) was detected in immunoprecipitates of Pcp2. To determine whether Pcp2 could modulate G alpha(o) function, kinetic constants k(cat) and k(off) of bovine brain G alpha(o) were determined in the presence and absence of Pcp2, Pcp2 stimulates GDP release from G alpha(o) more than 5-fold without affecting k(cat). These findings define a novel nucleotide exchange function for Pcpa and suggest that the interaction between Pcp2 and G alpha(o) is important to Purkinje cell function.	Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Denker, BM (corresponding author), Harvard Inst Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	bdenker@rics.bwh.harvard.edu						Althoefer H, 1997, J BIOL CHEM, V272, P24380, DOI 10.1074/jbc.272.39.24380; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Busconi L, 1997, BIOCHEM J, V328, P23, DOI 10.1042/bj3280023; DENKER BM, 1991, BIOCHEM J, V278, P341, DOI 10.1042/bj2780341; DENKER BM, 1992, J BIOL CHEM, V267, P6272; DENKER BM, 1995, BIOCHEMISTRY-US, V34, P5544, DOI 10.1021/bi00016a028; Denker BM, 1996, J BIOL CHEM, V271, P25750, DOI 10.1074/jbc.271.42.25750; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; GILLARDON F, 1995, J NEUROSCI RES, V41, P708, DOI 10.1002/jnr.490410517; HUFF RM, 1985, J BIOL CHEM, V260, P864; HUNT TW, 1994, J BIOL CHEM, V269, P29565; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Mohn AR, 1997, MOL CELL NEUROSCI, V9, P63, DOI 10.1006/mcne.1997.0606; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; NORDQUIST DT, 1988, J NEUROSCI, V8, P4780; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; PIMPLIKAR SW, 1993, NATURE, V362, P456, DOI 10.1038/362456a0; SENOGLES SE, 1990, J BIOL CHEM, V265, P4507; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; STRITTMATTER SM, 1990, NATURE, V344, P836, DOI 10.1038/344836a0; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Valenzuela D, 1997, P NATL ACAD SCI USA, V94, P1727, DOI 10.1073/pnas.94.5.1727; VANDAELE S, 1991, GENE DEV, V5, P1136, DOI 10.1101/gad.5.7.1136; Vassileva G, 1997, MOL BRAIN RES, V46, P333, DOI 10.1016/S0169-328X(97)00081-8; Yamatsuji T, 1996, SCIENCE, V272, P1349, DOI 10.1126/science.272.5266.1349	29	76	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10685	10688		10.1074/jbc.274.16.10685	http://dx.doi.org/10.1074/jbc.274.16.10685			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196137	hybrid			2022-12-27	WOS:000079751900005
J	Subbaramaiah, K; Altorki, N; Chung, WJ; Mestre, JR; Sampat, A; Dannenberg, AJ				Subbaramaiah, K; Altorki, N; Chung, WJ; Mestre, JR; Sampat, A; Dannenberg, AJ			Inhibition of cyclooxygenase-2 gene expression by p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLON-CANCER; WILD-TYPE P53; INTESTINAL EPITHELIAL-CELLS; PHORBOL ESTER; GROWTH; TRANSCRIPTION; APOPTOSIS; PROTEIN; CARCINOMA; MICE	Oncogenes enhance the expression of cyclooxygenase (Cox)-2, but interactions between tumor suppressor genes and Cox-a have not been studied. In the present work, we have compared the levels of Cox-2 and the production of prostaglandin E-2 in mouse embryo fibroblasts that do not express any p53 ((10)1) versus the same cell line ((10.1)Val5) engineered to overexpress wild-type (wt) p53 at 32 degrees C or mutant p53 at 39 degrees C. Cells expressing wt p53 showed about a 10-fold decrease in synthesis of prostaglandin E-2 compared with those expressing mutant p53. Levels of Cox-2 protein and mRNA were markedly suppressed by wt p53 but not by mutant p53. Nuclear run-offs revealed decreased rates of Cox-2 transcription in cells expressing wt p53. The activity of the Cox-2 promoter was reduced by 85% in cells expressing wt p53 but was reduced only by 30% in cells express ing mutant p53 compared with cells null for p53. The effect of p53 on the suppression of Cox-2 promoter activity was localized to the first 40 base pairs 5' from the transcription start site. Electrophoretic mobility shift assay revealed that p53 competed with TATA-binding protein for binding to mouse Cox-2 or human Cox-2 promoter extending from -50 to +52 base pairs. The results of this study suggest that interactions between p53 and Cox-2 could be important for understanding why levels of Cox-2 are undetectable in normal cells and increased in many tumors.	Cornell Univ, New York Presbyterian Hosp, Dept Med, Div Gastroenterol, New York, NY 10021 USA; Cornell Univ, New York Presbyterian Hosp, Dept Surg, New York, NY 10021 USA; Cornell Univ, New York Presbyterian Hosp, Dept Cardiothorac Surg, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, Head & Neck Serv, New York, NY 10021 USA; Strang Canc Prevent Ctr, New York, NY 10021 USA	Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center	Dannenberg, AJ (corresponding author), Cornell Univ, New York Presbyterian Hosp, Dept Med, Div Gastroenterol, Room F-231,1300 York Ave, New York, NY 10021 USA.	ajdannen@mail.med.cornell.edu			NCI NIH HHS [CA68136] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068136] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Ballif BA, 1996, P NATL ACAD SCI USA, V93, P5544, DOI 10.1073/pnas.93.11.5544; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bouvet M, 1998, CANCER RES, V58, P2288; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DEB SP, 1994, ONCOGENE, V9, P1341; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; DUBOIS RN, 1994, J CLIN INVEST, V93, P493, DOI 10.1172/JCI116998; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; GINSBERG D, 1991, P NATL ACAD SCI USA, V88, P9979, DOI 10.1073/pnas.88.22.9979; GOODWIN JS, 1983, J CLIN IMMUNOL, V3, P295, DOI 10.1007/BF00915791; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Herschman HR, 1996, BBA-LIPID LIPID MET, V1299, P125, DOI 10.1016/0005-2760(95)00194-8; Huang M, 1998, CANCER RES, V58, P1208; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; JONES DA, 1993, J BIOL CHEM, V268, P9049; KARGMAN SL, 1995, CANCER RES, V55, P2556; Kawamori T, 1998, CANCER RES, V58, P409; Kelley DJ, 1997, CARCINOGENESIS, V18, P795, DOI 10.1093/carcin/18.4.795; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MACK DH, 1993, NATURE, V363, P281, DOI 10.1038/363281a0; Mestre JR, 1997, CANCER RES, V57, P2890; MULLERDECKER K, 1995, MOL CARCINOGEN, V12, P31, DOI 10.1002/mc.2940120106; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Parrett ML, 1997, INT J ONCOL, V10, P503; RAGIMOV N, 1993, ONCOGENE, V8, P1183; RIMARACHIN JA, 1994, ARTERIOSCLER THROMB, V14, P1021, DOI 10.1161/01.ATV.14.7.1021; Ristimaki A, 1997, CANCER RES, V57, P1276; SANO H, 1995, CANCER RES, V55, P3785; SETO E, 1992, P NATL ACAD SCI USA, V89, P12028, DOI 10.1073/pnas.89.24.12028; SHEN YQ, 1994, P NATL ACAD SCI USA, V91, P8940, DOI 10.1073/pnas.91.19.8940; Sheng GG, 1997, GASTROENTEROLOGY, V113, P1883, DOI 10.1016/S0016-5085(97)70007-6; Sheng HM, 1998, CANCER RES, V58, P362; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Subbaramaiah K, 1996, CANCER RES, V56, P4424; TIANO H, 1997, P AM ASSOC CANC RES, V38, P1727; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Zhang F, 1998, J BIOL CHEM, V273, P2424, DOI 10.1074/jbc.273.4.2424	52	300	320	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10911	10915		10.1074/jbc.274.16.10911	http://dx.doi.org/10.1074/jbc.274.16.10911			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196169	hybrid			2022-12-27	WOS:000079751900037
J	Ning, Q; Liu, MF; Kongkham, P; Lai, MMC; Marsden, PA; Tseng, J; Pereira, B; Belyavskyi, M; Leibowitz, J; Phillips, MJ; Levy, G				Ning, Q; Liu, MF; Kongkham, P; Lai, MMC; Marsden, PA; Tseng, J; Pereira, B; Belyavskyi, M; Leibowitz, J; Phillips, MJ; Levy, G			The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA RECOMBINATION; STRAIN-3 INFECTION; LIVER; CORONAVIRUSES; EXPRESSION; INDUCTION; SEQUENCE; PROMOTER; ELEMENT; PATTERN	Using a set of parental and recombinant murine hepatitis virus strains, we demonstrate that the nucleocapsid protein induces transcription of the novel fg12 prothrombinase gene and elevated procoagulant activity in those strains that produce fulminant hepatitis. Chinese hamster ovary cells cotransfected with a construct expressing nucleocapsid protein from susceptible strains and with a luciferase reporter construct containing the fg12 promoter showed a B-fold increase in luciferase activity compared with nontransfected cells or cells cotransfected with a construct expressing nucleocapsid protein from resistant strains. Two deletions found at coding sites 111-123 and 1143-1145 of structural domains I and III, respectively, of the nucleocapsid gene may account for the differences between pathogenic and nonpathogenic strains. Preliminary mapping of the fg12 promoter has defined a region from -372 to -306 upstream from the ATG translation initiation site to be responsive to nucleocapsid protein. Hence, mapping of genetic determinants in parental and recombinant strains demonstrates that the nucleocapsid protein of strains that induce fulminant hepatitis is responsible for transcription of the fg12 prothrombinase gene. These studies provide new insights into the role of the nucleocapsid gene in the pathogenesis of viral hepatitis.	Toronto Hosp, Multiorgan Transplant Program, Toronto, ON M5G 2C4, Canada; Toronto Hosp, Dept Med, Toronto, ON M5G 2C4, Canada; Toronto Hosp, Dept Pathol, Toronto, ON M5G 2C4, Canada; St Michaels Hosp, Toronto, ON M5G 2C4, Canada; Univ Toronto, Toronto, ON M5G 2C4, Canada; Univ So Calif, Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90033 USA; Univ So Calif, Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; Texas A&M Univ, Dept Pathol, College Stn, TX 77843 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Howard Hughes Medical Institute; University of Southern California; University of Southern California; Texas A&M University System; Texas A&M University College Station	Levy, G (corresponding author), Toronto Hosp, Multiorgan Transplant Program, 621 Univ Ave,10th Floor,Rm 151, Toronto, ON M5G 2C4, Canada.	fgl2@msn.com	Lai, Michael M. C./I-7001-2012; Marsden, Philip A/B-1441-2012	Kongkham, Paul/0000-0002-1047-9305	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019244, R29AI030169] Funding Source: NIH RePORTER; NIAID NIH HHS [AI19244, AI30169] Funding Source: Medline; NINDS NIH HHS [NS18146] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CATTRAL MC, 1995, NEW ENGL J MED, V331, P268; CHISARI FV, 1995, SPRINGER SEMIN IMMUN, V17, P261, DOI 10.1007/BF00196169; CITARELLA F, 1993, BIOCHIM BIOPHYS ACTA, V1172, P197, DOI 10.1016/0167-4781(93)90294-N; CROSSLEY M, 1992, SCIENCE, V257, P377, DOI 10.1126/science.1631558; DAVIES SE, 1991, HEPATOLOGY, V13, P150, DOI 10.1002/hep.1840130122; Ding JW, 1997, J VIROL, V71, P9223, DOI 10.1128/JVI.71.12.9223-9230.1997; EVANS R, 1990, BIOTECHNIQUES, V8, P357; FICKENSCHER H, 1989, J GEN VIROL, V70, P107, DOI 10.1099/0022-1317-70-1-107; GASSON JC, 1991, BLOOD, V77, P1131, DOI 10.1182/blood.V77.6.1131.1131; KECK HJG, 1997, VIROLOGY, V156, P331; KECK JG, 1988, J VIROL, V62, P1989, DOI 10.1128/JVI.62.6.1989-1998.1988; KOYAMA T, 1987, P NATL ACAD SCI USA, V84, P1609, DOI 10.1073/pnas.84.6.1609; LAI MMC, 1978, J VIROL, V26, P236, DOI 10.1128/JVI.26.2.236-242.1978; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; LAVI E, 1990, LAB INVEST, V62, P570; LEVY GA, 1981, J EXP MED, V154, P1150, DOI 10.1084/jem.154.4.1150; LEVY GA, 1983, HEPATOLOGY, V3, P964; LI C, 1992, J EXP MED, V176, P689, DOI 10.1084/jem.176.3.689; MACKMAN N, 1990, P NATL ACAD SCI USA, V87, P2254, DOI 10.1073/pnas.87.6.2254; MACPHEE PJ, 1985, HEPATOLOGY, V5, P649, DOI 10.1002/hep.1840050422; MAKINO S, 1986, J VIROL, V57, P729, DOI 10.1128/JVI.57.3.729-737.1986; MAKINO S, 1989, P NATL ACAD SCI USA, V84, P6569; MASTERS PS, 1990, ADV EXP MED BIOL, V276, P235; MIAO CH, 1992, J BIOL CHEM, V267, P7395; Ning Q, 1998, J IMMUNOL, V160, P3487; PARLER MM, 1990, VIROLOGY, V179, P463; PARR RL, 1995, J VIROL, V69, P5033, DOI 10.1128/JVI.69.8.5033-5038.1995; POPE M, 1995, J VIROL, V69, P5252, DOI 10.1128/JVI.69.9.5252-5260.1995; RUSSELL NH, 1992, BLOOD REV, V6, P149, DOI 10.1016/0268-960X(92)90026-M; SIDWELL RW, 1977, ANN NY ACAD SCI, V284, P239, DOI 10.1111/j.1749-6632.1977.tb21956.x	31	43	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					9930	9936		10.1074/jbc.274.15.9930	http://dx.doi.org/10.1074/jbc.274.15.9930			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187767	hybrid			2022-12-27	WOS:000079663500006
J	Qiao, LY; Goldberg, JL; Russell, JC; Sun, XJ				Qiao, LY; Goldberg, JL; Russell, JC; Sun, XJ			Identification of enhanced serine kinase activity in insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SUBSTRATE-1 TYROSINE PHOSPHORYLATION; LA/N CORPULENT RAT; RECEPTOR SUBSTRATE-1; PHOSPHATIDYLINOSITOL 3-KINASE; 3T3-L1 ADIPOCYTES; SKELETAL-MUSCLE; OKADAIC ACID; PHOSPHOTYROSINE PROTEIN; GLUCOSE-METABOLISM	Insulin receptor substrate (IRS) proteins play a crucial role as signaling molecules in insulin action. Serine phosphorylation of IRS proteins has been hypothesized as a cause of attenuating insulin signaling. The current study investigated serine kinase activity toward IRS-1 in several models of insulin resistance. An in vitro kinase assay was developed that used partially purified cell lysates as a kinase and glutathione S-transferase fusion proteins that contained various of IRS-1 fragments as substrates. Elevated serine kinase activity was detected in Chinese hamster ovary/insulin receptor (IR)/IRS-1 cells and 3T3-L1 adipocytes chronically treated with insulin, and in liver and muscle of obese JCR:LA-cp rats. It phosphorylated the 526-859 amino acid region of IRS-1, whereas phosphorylation of the 2-516 and 900-1235 amino acid regions was not altered. Phosphopeptide mapping of the 526-859 region of IRS-1 showed three major phosphopeptides (P1, P2, and P3) with different patterns of phosphorylation depending on the source of serine kinase activity. P1 and P2 were strongly phosphorylated when the kinase activity was prepared from insulin-resistant Chinese hamster ovary/IR/IRS-1 cells, weakly phosphorylated by the kinase activity from insulin-resistant 3T3-L1 adipocytes, and barely phosphorylated when the extract was derived from insulin-resistant liver. In contrast, P3 was phosphorylated by the serine kinase activity prepared from all insulin-resistant cells and tissues of animals. P1 and P2 phosphorylation can be explained by mitogen-activated protein kinase activity based on the phosphopeptide map generated by recombinant ERK2. In contrast, mitogen-activated protein kinase failed to phosphorylate the P3 peptide, suggesting that another serine kinase regulates this modification of IRS-1 in insulin-resistant state.	Univ Vermont, Coll Med, Div Endocrinol, Burlington, VT 05405 USA; Univ Alberta, Dept Surg, Edmonton, AB T6G 2S2, Canada	University of Vermont; University of Alberta	Sun, XJ (corresponding author), Univ Vermont, Coll Med, Div Endocrinol, Given Bldg C-350, Burlington, VT 05405 USA.	xsun@zoo.uvm.edu			NIAID NIH HHS [AI41426-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI041426] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Anai M, 1998, DIABETES, V47, P13, DOI 10.2337/diabetes.47.1.13; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; CHANG PY, 1995, J BIOL CHEM, V270, P29928; CHIN JE, 1994, MOL ENDOCRINOL, V8, P51, DOI 10.1210/me.8.1.51; Craparo A, 1997, J BIOL CHEM, V272, P11663; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; delPeso L, 1997, SCIENCE, V278, P687; DELPRATO S, 1994, DIABETOLOGIA, V37, P1025, DOI 10.1007/BF00400466; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; EldarFinkelman H, 1997, P NATL ACAD SCI USA, V94, P9660, DOI 10.1073/pnas.94.18.9660; FEENER EP, 1993, J BIOL CHEM, V268, P11256; FEINSTEIN R, 1993, J BIOL CHEM, V268, P26055; FREUND GG, 1995, BIOCHEM BIOPH RES CO, V206, P272, DOI 10.1006/bbrc.1995.1038; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; KAHN CR, 1993, RECENT PROG HORM RES, V48, P291; KANETY H, 1995, J BIOL CHEM, V270, P23780, DOI 10.1074/jbc.270.40.23780; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kolter T, 1997, AM J PHYSIOL-ENDOC M, V273, pE59, DOI 10.1152/ajpendo.1997.273.1.E59; Koopmans SJ, 1997, DIABETES, V46, P1572, DOI 10.2337/diabetes.46.10.1572; Kosaki A, 1998, J BIOL CHEM, V273, P940, DOI 10.1074/jbc.273.2.940; Kroder G, 1996, J CLIN INVEST, V97, P1471, DOI 10.1172/JCI118569; LAM K, 1994, J BIOL CHEM, V269, P20648; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; LAWRENCE JC, 1990, J BIOL CHEM, V265, P19768; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; RICE KM, 1992, J BIOL CHEM, V267, P10163; Ricort JM, 1997, J BIOL CHEM, V272, P19814, DOI 10.1074/jbc.272.32.19814; RICORT JM, 1995, DIABETOLOGIA, V38, P1148, DOI 10.1007/s001250050406; RUSSELL JC, 1987, ARTERIOSCLEROSIS, V7, P620, DOI 10.1161/01.ATV.7.6.620; RUSSELL JC, 1986, CAN J PHYSIOL PHARM, V64, P750, DOI 10.1139/y86-127; RUSSELL JC, 1994, METABOLISM, V43, P538, DOI 10.1016/0026-0495(94)90192-9; Russell JC, 1998, DIABETES, V47, P770, DOI 10.2337/diabetes.47.5.770; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Sun XJ, 1996, J BIOL CHEM, V271, P10583, DOI 10.1074/jbc.271.18.10583; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; SUN XJ, 1992, J BIOL CHEM, V267, P22662; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; TANASIJEVIC MJ, 1993, J BIOL CHEM, V268, P18157; TANTI JF, 1991, J BIOL CHEM, V266, P2099; TANTI JF, 1994, J BIOL CHEM, V269, P6051; TANTI JF, 1994, BIOCHEM J, V304, P17, DOI 10.1042/bj3040017; Thomson MJ, 1997, J BIOL CHEM, V272, P7759, DOI 10.1074/jbc.272.12.7759; WANG LM, 1993, P NATL ACAD SCI USA, V90, P4032, DOI 10.1073/pnas.90.9.4032; Whelchel A, 1997, AM J RESP CELL MOL, V16, P589, DOI 10.1165/ajrcmb.16.5.9160841; White MF, 1996, PHILOS T ROY SOC B, V351, P181, DOI 10.1098/rstb.1996.0015; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116	60	88	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10625	10632		10.1074/jbc.274.15.10625	http://dx.doi.org/10.1074/jbc.274.15.10625			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187859	hybrid			2022-12-27	WOS:000079663500098
J	Henkel, JR; Popovich, JL; Gibson, GA; Watkins, SC; Weisz, OA				Henkel, JR; Popovich, JL; Gibson, GA; Watkins, SC; Weisz, OA			Selective perturbation of early endosome and/or trans-Golgi network pH but not lysosome pH by dose-dependent expression of influenza M2 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL ACTIVITY; MANNOSE 6-PHOSPHATE RECEPTOR; PLAGUE VIRUS HEMAGGLUTININ; VACUOLAR PROTON PUMP; H+-ATPASES; M(2) PROTEIN; CATHEPSIN-D; A VIRUS; SECRETORY PATHWAY; RAT HEPATOCYTES	Many sorting stations along the biosynthetic and endocytic pathways are acidified, suggesting a role for pH regulation in protein traffic, However, the function of acidification in individual compartments has been difficult to examine because global pH perturbants affect all acidified organelles in the cell and also have numerous side effects, To circumvent this problem, we have developed a method to selectively perturb the pH of a subset of acidified compartments, We infected HeLa cells with a recombinant adenovirus encoding influenza virus M2 protein (an acid-activated ion channel that dissipates proton gradients across membranes) and measured the effects on various steps in protein transport, Al low multiplicity of infection (m.o.i.), delivery of influenza hemagglutinin from the trans-Golgi network to the cell surface was blocked, but there was almost no effect on the rate of recycling of internalized transferrin, At higher m.o.i., transferrin recycling was inhibited, suggesting increased accumulation of M2 in endosomes, Interestingly, even at the higher m.o.i., M2 expression had no effect on lysosome morphology or on EGF degradation, suggesting that lysosomal pH was not compromised by M2 expression. However, delivery of newly synthesized cathepsin D to lysosomes was slowed in cells expressing active M2, suggesting that acidification of the TGN and endosomes is important for efficient delivery of lysosomal hydrolases, Fluorescence labeling using a pH-sensitive dye confirmed the reversible effect of M2 on the pH of a subset of acidified compartments in the cell, The ability to dissect the role of acidification in individual steps of a complex pathway should be useful for numerous other studies on protein processing and transport.	Univ Pittsburgh, Renal Electrolyte Div, Lab Epithelial Cell Biol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weisz, OA (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Lab Epithelial Cell Biol, 978 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15213 USA.	weisz@med1.dept-med.pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552	PHS HHS [R01DL54407] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; CHATTERJEE D, 1992, P NATL ACAD SCI USA, V89, P6257, DOI 10.1073/pnas.89.14.6257; Chizhmakov IV, 1996, J PHYSIOL-LONDON, V494, P329, DOI 10.1113/jphysiol.1996.sp021495; CIAMPOR F, 1992, VIROLOGY, V188, P14, DOI 10.1016/0042-6822(92)90730-D; DIMENT S, 1988, J BIOL CHEM, V263, P6901; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; GIESELMANN V, 1983, J CELL BIOL, V97, P1, DOI 10.1083/jcb.97.1.1; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; GRAMBAS S, 1992, VIROLOGY, V191, P541, DOI 10.1016/0042-6822(92)90229-I; GRAMBAS S, 1992, VIROLOGY, V190, P11, DOI 10.1016/0042-6822(92)91187-Y; Harada M, 1997, LIVER, V17, P244; Harada M, 1996, J HEPATOL, V24, P594, DOI 10.1016/S0168-8278(96)80146-2; HASILIK A, 1980, J BIOL CHEM, V255, P4937; Henkel JR, 1998, MOL BIOL CELL, V9, P2477, DOI 10.1091/mbc.9.9.2477; Henkel JR, 1998, J BIOL CHEM, V273, P6518, DOI 10.1074/jbc.273.11.6518; HOFLACK B, 1987, J BIOL CHEM, V262, P123; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; IMORT M, 1983, BIOCHEM J, V214, P671, DOI 10.1042/bj2140671; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kasper D, 1996, J CELL BIOL, V134, P615, DOI 10.1083/jcb.134.3.615; LUDWIG T, 1991, J CELL BIOL, V115, P1561, DOI 10.1083/jcb.115.6.1561; Matsuoka K, 1997, PLANT CELL, V9, P533; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; MUROI M, 1993, CELL STRUCT FUNCT, V18, P139, DOI 10.1247/csf.18.139; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V262, P159, DOI 10.1016/0003-9861(88)90178-6; ODA K, 1991, BIOCHEM BIOPH RES CO, V178, P369, DOI 10.1016/0006-291X(91)91823-U; OHUCHI M, 1994, J VIROL, V68, P920, DOI 10.1128/JVI.68.2.920-926.1994; PALOKANGAS H, 1994, J BIOL CHEM, V269, P17577; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; POHLMANN R, 1995, J BIOL CHEM, V270, P27311, DOI 10.1074/jbc.270.45.27311; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; RICHO GR, 1994, J BIOL CHEM, V269, P14806; RIJNBOUTT S, 1992, J BIOL CHEM, V267, P15665; ROSENFELD MG, 1982, J CELL BIOL, V93, P135, DOI 10.1083/jcb.93.1.135; Sakaguchi T, 1997, P NATL ACAD SCI USA, V94, P5000, DOI 10.1073/pnas.94.10.5000; Sakaguchi T, 1996, J CELL BIOL, V133, P733, DOI 10.1083/jcb.133.4.733; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; TAKEUCHI K, 1994, J VIROL, V68, P911, DOI 10.1128/JVI.68.2.911-919.1994; Temesvari LA, 1996, J CELL SCI, V109, P1479; Tu Q, 1996, J VIROL, V70, P4246, DOI 10.1128/JVI.70.7.4246-4252.1996; vanWeert AWM, 1997, EUR J CELL BIOL, V74, P417; VANWEERT AWM, 1995, J CELL BIOL, V130, P821, DOI 10.1083/jcb.130.4.821; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; WANG C, 1995, BIOPHYS J, V69, P1363, DOI 10.1016/S0006-3495(95)80003-2; XU HX, 1994, J BIOL CHEM, V269, P22875; YILLA M, 1993, J BIOL CHEM, V268, P19092; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	47	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9854	9860		10.1074/jbc.274.14.9854	http://dx.doi.org/10.1074/jbc.274.14.9854			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092677	hybrid			2022-12-27	WOS:000079451800096
J	Harpur, AG; Layton, MJ; Das, P; Bottomley, MJ; Panayotou, G; Driscoll, PC; Waterfield, MD				Harpur, AG; Layton, MJ; Das, P; Bottomley, MJ; Panayotou, G; Driscoll, PC; Waterfield, MD			Intermolecular interactions of the p85 alpha regulatory subunit of phosphatidylinositol 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASES; PHOSPHOINOSITIDE 3-KINASE; SH3 DOMAIN; P85 SUBUNIT; CATALYTIC SUBUNIT; BETA-RECEPTOR; PI 3-KINASE; ACTIVATION; BINDING; PROTEINS	The regulatory subunit of phosphatidylinositol 3-kinase, p85, contains a number of well defined domains involved in protein-protein interactions, including an SH3 domain and two SH2 domains. In order to investigate in detail the nature of the interactions of these domains with each other and with other binding partners, a series of deletion and point mutants was constructed, and their binding characteristics and apparent molecular masses under native conditions were analyzed. The SH3 domain and the first proline-rich motif bound each other, and variants of p85 containing the SH3 and BH domains and the first proline-rich motif were dimeric, Analysis of the apparent molecular mass of the deletion mutants indicated that each of these domains contributed residues to the dimerization interface, and competition experiments revealed that there were intermolecular SH3 domain-proline-rich motif interactions and BH-BH domain interactions mediating dimerization of p85 alpha both in vitro and in vivo. Binding of SH2 domain ligands did not affect the dimeric state of p85a. Recently, roles for the p85 subunit have been postulated that do not involve the catalytic subunit, and if p85 exists on its own we propose that it would be dimeric.	Ludwig Inst Canc Res, London W1P 8BT, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England; Biomed Sci Res Ctr A Fleming, Inst Mol Oncol, Vari 16672, Greece	Ludwig Institute for Cancer Research; University of London; University College London; Alexander Fleming Biomedical Sciences Research Center	Harpur, AG (corresponding author), Imperial Canc Res Fund, Cell Biophys Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	A.Harpur@icrf.icnet.uk	Layton, Meredith/E-9171-2014; Driscoll, Paul C/B-8007-2010	Driscoll, Paul C/0000-0002-4124-6950				Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Antonetti DA, 1996, MOL CELL BIOL, V16, P2195; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BOOKER GW, 1993, CELL, V73, P813, DOI 10.1016/0092-8674(93)90259-S; CHEN JK, 1994, BIOORG MED CHEM LETT, V4, P1755, DOI 10.1016/S0960-894X(00)80375-3; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; END P, 1993, J BIOL CHEM, V268, P10066; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Fruman DA, 1996, GENOMICS, V37, P113, DOI 10.1006/geno.1996.0527; GOUT I, 1992, BIOCHEM J, V288, P395, DOI 10.1042/bj2880395; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; Inukai K, 1997, J BIOL CHEM, V272, P7873, DOI 10.1074/jbc.272.12.7873; Inukai K, 1996, J BIOL CHEM, V271, P5317, DOI 10.1074/jbc.271.10.5317; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; Luo ZJ, 1996, NATURE, V383, P181, DOI 10.1038/383181a0; Musacchio A, 1996, P NATL ACAD SCI USA, V93, P14373, DOI 10.1073/pnas.93.25.14373; NOBES CD, 1995, J CELL SCI, V108, P225; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; PANAYOTOU G, 1993, MOL CELL BIOL, V13, P3567, DOI 10.1128/MCB.13.6.3567; PANAYOTOU G, 1993, BIOESSAYS, V15, P171, DOI 10.1002/bies.950150305; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; PONS S, 1995, MOL CELL BIOL, V15, P4453; RICKLES RJ, 1994, EMBO J, V13, P5598, DOI 10.1002/j.1460-2075.1994.tb06897.x; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; Shepherd PR, 1997, J BIOL CHEM, V272, P19000, DOI 10.1074/jbc.272.30.19000; SHIBASAKI F, 1993, BIOCHEM J, V289, P227, DOI 10.1042/bj2890227; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; Yin YX, 1998, NATURE, V391, P707, DOI 10.1038/35648; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zvelebil MJ, 1996, PHILOS T R SOC B, V351, P217, DOI 10.1098/rstb.1996.0019	44	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12323	12332		10.1074/jbc.274.18.12323	http://dx.doi.org/10.1074/jbc.274.18.12323			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212202	hybrid			2022-12-27	WOS:000080056800022
J	Heitmeier, MR; Scarim, AL; Corbett, JA				Heitmeier, MR; Scarim, AL; Corbett, JA			Double-stranded RNA inhibits beta-cell function and induces islet damage by stimulating beta-cell production of nitric oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; BB RAT; SYNTHASE EXPRESSION; DIABETES-MELLITUS; LANGERHANS; INTERFERON; INTERLEUKIN-1-BETA; MACROPHAGES; DESTRUCTION; ACTIVATION	Viral infection has been implicated as a triggering event that may initiate beta-cell damage during the development of autoimmune diabetes. In this study, the effects of the viral replicative intermediate, double-stranded RNA (dsRNA) (in the form of synthetic polyinosinic-polycytidylic acid (poly IC)) on islet expression of inducible nitric oxide synthase (iNOS), production of nitric oxide, and islet function and viability were investigated. Treatment of rat islets with poly(IC) + interferon-gamma (IFN-gamma) stimulates the time- and concentration-dependent expression of iNOS and production of nitrite by rat islets, iNOS expression and nitrite production by rat islets in response to poly(IC) + IFN-gamma correlate with an inhibition of insulin secretion and islet degeneration, effects that are prevented by the iNOS inhibitor aminoguanidine (AG), We have previously shown that poly(IC) + IFN-gamma activates resident macrophages, stimulating iNOS expression, nitric oxide production and interleukin-1 (IL-1) release. In addition, in response to tumor necrosis factor-alpha (TNF-alpha) + lipopolysaccharide, activated resident macrophages mediate beta-cell damage via intraislet IL-1 release followed by IL-1-induced iNOS expression by p-cells, The inhibitory and destructive effects of poly(IC) + IFN-gamma, however, do not appear to require resident macrophages. Treatment of macrophage-depleted rat islets for 40 h with poly(IC) + IFN-gamma results in the expression of iNOS, production of nitrite, and inhibition of insulin secretion. The destructive effects of dsRNA + IFN-gamma on islets appear to be mediated by a direct interaction with beta-cells. Poly IC + IFN-gamma stimulates iNOS expression and inhibits insulin secretion by primary beta-cells purified by fluorescence-activated cell sorting. In addition, AG prevents the inhibitory effects of poly(IC) + IFN-gamma on glucose-stimulated insulin secretion by beta-cells, These results indicate that dsRNA + IFN-gamma interacts directly with beta-cells stimulating iNOS expression and inhibiting insulin secretion in a nitric oxide-dependent manner. These findings provide biochemical evidence for a novel mechanism by which viral infection may directly mediate the initial destruction of beta-cells during the development of autoimmune diabetes.	St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Corbett, JA (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, 1402 S Grand Blvd, St Louis, MO 63104 USA.				NIAID NIH HHS [AI44458] Funding Source: Medline; NIDDK NIH HHS [DK-52194] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052194] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALEXANDER P, 1971, NATURE-NEW BIOL, V232, P76, DOI 10.1038/newbio232076a0; Arnush M, 1998, J IMMUNOL, V160, P2684; BURD PR, 1989, J EXP MED, V170, P245, DOI 10.1084/jem.170.1.245; CORBETT JA, 1992, BIOCHEM J, V287, P229, DOI 10.1042/bj2870229; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1995, J EXP MED, V181, P559, DOI 10.1084/jem.181.2.559; CORBETT JA, 1994, AM J PHYSIOL, V267, pC48, DOI 10.1152/ajpcell.1994.267.1.C48; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; CORBETT JA, 1995, DIABET ANN, V9, P265; EWEL CH, 1992, DIABETES, V41, P1016, DOI 10.2337/diabetes.41.8.1016; Faruqi TR, 1997, AM J PHYSIOL-HEART C, V273, pH2490, DOI 10.1152/ajpheart.1997.273.5.H2490; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Heitmeier MR, 1997, J BIOL CHEM, V272, P13697, DOI 10.1074/jbc.272.21.13697; Heitmeier MR, 1998, J BIOL CHEM, V273, P15301, DOI 10.1074/jbc.273.24.15301; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; Hirasawa K, 1996, J GEN VIROL, V77, P737, DOI 10.1099/0022-1317-77-4-737; HOPCROFT DW, 1985, IN VITRO CELL DEV B, V21, P421; HUANG XJ, 1994, IMMUNITY, V1, P469, DOI 10.1016/1074-7613(94)90089-2; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; KERR IM, 1992, J INTERFERON RES, V12, P237, DOI 10.1089/jir.1992.12.237; LACY PE, 1991, AM J PATHOL, V138, P1183; LENGYEL P, 1987, J INTERFERON RES, V7, P511, DOI 10.1089/jir.1987.7.511; MCDANIEL ML, 1983, METHOD ENZYMOL, V98, P182; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; NEURP J, 1994, DIABETOLOG, V37, P82; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806; SAMUEL CE, 1991, VIROLOGY, V183, P1, DOI 10.1016/0042-6822(91)90112-O; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; SELDEN RF, 1991, CURRENT PROTOCOLS MO, V1; Snell JC, 1997, J LEUKOCYTE BIOL, V62, P369, DOI 10.1002/jlb.62.3.369; SOBEL DO, 1992, DIABETES, V41, P515, DOI 10.2337/diabetes.41.4.515; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; Takamura T, 1998, J BIOL CHEM, V273, P2493, DOI 10.1074/jbc.273.5.2493; vonHerrath MG, 1996, IMMUNOL REV, V152, P111; vonHerrath MG, 1997, BIOCHEM SOC T, V25, P630, DOI 10.1042/bst0250630; WANG JL, 1993, J BIOL CHEM, V268, P7785; WELSH N, 1991, ENDOCRINOLOGY, V129, P3167, DOI 10.1210/endo-129-6-3167; WRIGHT PH, 1971, DIABETES, V20, P33, DOI 10.2337/diab.20.1.33; YOON JW, 1995, DIABETES METAB REV, V11, P83, DOI 10.1002/dmr.5610110202; YOON JW, 1997, TXB DIABETES; YOON JW, 1996, DIABETES MELLITUS, P3339	43	27	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12531	12536		10.1074/jbc.274.18.12531	http://dx.doi.org/10.1074/jbc.274.18.12531			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212230	hybrid			2022-12-27	WOS:000080056800050
J	Norcum, MT; Dignam, JD				Norcum, MT; Dignam, JD			Immunoelectron microscopic localization of glutamyl-/prolyl-tRNA synthetase within the eukaryotic multisynthetase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; STRUCTURAL ORGANIZATION; COMPONENT; SUBUNIT; FORM	A high molecular mass complex of aminoacyl-tRNA synthetases is readily isolated from a variety of eukaryotes. Although its composition is well characterized, knowledge of its structure and organization is still quite limited. This study uses antibodies directed against prolyl-tRNA synthetase for immunoelectron microscopic localization of the bifunctional glutamyl-/prolyl-tRNA synthetase. This is the first visualization of a specific site within the multisynthetase complex. Images of immunocomplexes are presented in the characteristic views of negatively stained multisynthetase complex from rabbit reticulocytes. As described in terms of a three domain working model of the structure, in "front" views of the particle and "intermediate" views, the primary antibody binding site is near the intersection between the "base" and one "arm," In "side" views, where the particle is rotated about its long axis, the binding site is near the midpoint. "Top" and "bottom" views, which appear as square projections, are also consistent with the central location of the binding site. These data place the glutamyl-/prolyl-tRNA synthetase polypeptide in a defined area of the particle, which encompasses portions of two domains, yet is consistent with the previous structural model.	Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; Med Coll Ohio, Dept Biochem & Mol Biol, Toledo, OH 43699 USA	University of Mississippi; University of Mississippi Medical Center	Norcum, MT (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, 2500 N State St, Jackson, MS 39216 USA.							BIANCHI C, 1992, BIOCHEM BIOPH RES CO, V187, P1071, DOI 10.1016/0006-291X(92)91306-B; DANG CV, 1979, J BIOL CHEM, V254, P5350; FILONENKO VV, 1994, J BIOL CHEM, V269, P17375; GODAR DE, 1988, BIOCHEMISTRY-US, V27, P6921, DOI 10.1021/bi00418a038; KERJAN P, 1992, BIOCHIMIE, V74, P195, DOI 10.1016/0300-9084(92)90046-H; KISSELEV LL, 1994, PROG NUCLEIC ACID RE, V48, P83, DOI 10.1016/S0079-6603(08)60854-5; NORCUM MT, 1989, J BIOL CHEM, V264, P15043; Norcum MT, 1998, PROTEIN SCI, V7, P79, DOI 10.1002/pro.5560070108; NORCUM MT, 1991, J BIOL CHEM, V266, P15398; Quevillon S, 1996, FEBS LETT, V395, P63, DOI 10.1016/0014-5793(96)01005-8; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Rho SB, 1996, P NATL ACAD SCI USA, V93, P10128, DOI 10.1073/pnas.93.19.10128; Rho SB, 1998, J BIOL CHEM, V273, P11267, DOI 10.1074/jbc.273.18.11267; Schimmel P, 1998, FASEB J, V12, P1599, DOI 10.1096/fasebj.12.15.1599; TARGOFF IN, 1994, RHEUM DIS CLIN N AM, V20, P857; TING SM, 1992, J BIOL CHEM, V267, P17701; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Yang DCH, 1996, CURR TOP CELL REGUL, V34, P101, DOI 10.1016/S0070-2137(96)80004-5	18	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12205	12208		10.1074/jbc.274.18.12205	http://dx.doi.org/10.1074/jbc.274.18.12205			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212184	hybrid			2022-12-27	WOS:000080056800004
J	Ogata, M; Takada, T; Mori, Y; Oh-hora, M; Uchida, Y; Kosugi, A; Miyake, K; Hamaoka, T				Ogata, M; Takada, T; Mori, Y; Oh-hora, M; Uchida, Y; Kosugi, A; Miyake, K; Hamaoka, T			Effects of overexpression of PTP36, a putative protein tyrosine phosphatase, on cell adhesion, cell growth, and cytoskeletons in HeLa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; INTEGRIN-MEDIATED ADHESION; SEQUENCE HOMOLOGY; MOLECULAR-CLONING; BAND-4.1 FAMILY; KINASE-ACTIVITY; EXPRESSION; DOMAIN; BINDING; MEMBER	Non-receptor-type putative protein tyrosine phosphatase-36 (PTP36), also known as PTPD2/Pez, possesses a domain homologous to the N-terminal half of band 4.1 protein. To gain insight into the biological function of PTP36, we established a HeLa cell line, HtTA/P36-9, in which the overexpression of PTP36 was inducible. PTP36 expressed in HeLa cells was enriched in the cytoskeleton near the plasma membrane. There was little endogenous PTP36 detectable in uninduced HtTA/P36-9 cells or in the parental HeLa cells. Upon induction of PTP36 overexpression, HtTA/P36-9 cells spread less well, grew more slowly, and adhered to the extracellular matrix proteins less well than uninduced cells. Moreover, decreases in the actin stress fibers and the number of focal adhesions were observed. The tyrosine phosphorylation of the focal adhesion kinase induced by lysophosphatidic acid was suppressed in the HtTA/P36-9 cells overexpressing PTP36. These results indicate that PTP36 affects cytoskeletons, cell adhesion, and cell growth, thus suggesting that PTP36 is involved in their regulatory processes.	Osaka Univ, Sch Med C6, Ctr Biomed Res, Dept Oncol, Suita, Osaka 5650871, Japan; Osaka Univ, Fac Med, Sch Allied Hlth Sci, Suita, Osaka 5650871, Japan; Saga Med Sch, Dept Immunol, Saga 849, Japan	Osaka University; Osaka University; Saga University	Ogata, M (corresponding author), Osaka Univ, Sch Med C6, Ctr Biomed Res, Dept Oncol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							ARAI M, 1994, J NEUROSCI RES, V38; Arregui CO, 1998, J CELL BIOL, V143, P861, DOI 10.1083/jcb.143.3.861; Balsamo J, 1998, J CELL BIOL, V143, P523, DOI 10.1083/jcb.143.2.523; BANVILLE D, 1994, J BIOL CHEM, V269, P22320; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gu MX, 1996, J BIOL CHEM, V271, P27751, DOI 10.1074/jbc.271.44.27751; GU MX, 1991, P NATL ACAD SCI USA, V88, P5867, DOI 10.1073/pnas.88.13.5867; Gu MX, 1996, P NATL ACAD SCI USA, V93, P12980, DOI 10.1073/pnas.93.23.12980; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HIGASHITSUJI H, 1995, ONCOGENE, V10, P407; JINNO Y, 1989, J BIOL CHEM, V264, P15953; LABBE D, 1994, FEBS LETT, V356, P351, DOI 10.1016/0014-5793(94)01305-5; MAEKAWA K, 1994, FEBS LETT, V337, P200, DOI 10.1016/0014-5793(94)80273-4; MIYAKE K, 1992, J CELL BIOL, V119, P653, DOI 10.1083/jcb.119.3.653; MOLLER NPH, 1994, P NATL ACAD SCI USA, V91, P7477, DOI 10.1073/pnas.91.16.7477; OGATA M, 1997, KINASES PHOSPHATASES, P322; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; Roach T, 1997, CURR BIOL, V7, P408, DOI 10.1016/S0960-9822(06)00188-6; ROMER LH, 1994, MOL BIOL CELL, V5, P349, DOI 10.1091/mbc.5.3.349; SARAS J, 1994, J BIOL CHEM, V269, P24082; SAWADA M, 1994, BIOCHEM BIOPH RES CO, V203, P479, DOI 10.1006/bbrc.1994.2207; SMITH AL, 1995, BIOCHEM BIOPH RES CO, V209, P959, DOI 10.1006/bbrc.1995.1591; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Tonks N K, 1996, Adv Pharmacol, V36, P91, DOI 10.1016/S1054-3589(08)60578-5; TOYAMASORIMACHI N, 1993, EUR J IMMUNOL, V23, P439, DOI 10.1002/eji.1830230221; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949	34	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12905	12909		10.1074/jbc.274.18.12905	http://dx.doi.org/10.1074/jbc.274.18.12905			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212280	hybrid			2022-12-27	WOS:000080056800100
J	Smas, CM; Chen, L; Zhao, L; Latasa, MJ; Sul, HS				Smas, CM; Chen, L; Zhao, L; Latasa, MJ; Sul, HS			Transcriptional repression of pref-1 by glucocorticoids promotes 3T3-L1 adipocyte differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING-PROTEIN; EPIDERMAL-GROWTH-FACTOR; PPAR-GAMMA; GENE-EXPRESSION; OXIDIZED LDL; CELLS; PREADIPOCYTE; ALPHA; ADIPOGENESIS; ACTIVATION	Pref-1 is an epidermal growth factor-like domain-containing transmembrane protein that is cleaved to generate a soluble factor. It is abundant in 3T3-L1 preadipocytes but absent in mature adipocytes, Constitutive expression of pref-1 or the addition of its ectodomain inhibits adipogenesis, We find that the pref-1 gene is an early target of dexamethasone, a component of the dexamethasone/methylisobutylxanthine differentiation mixture used routinely for adipoconversion. The time course of the decrease in pref-1 mRNA by dexamethasone reflected the pref-1 mRNA half-life determined by actinomycin D treatment. Nuclear run-on assays showed that dexamethasone attenuates pref-1 transcription. We demonstrate a correlation between pref-1 down regulation and adipoconversion by varying the time period and concentration of dexamethasone, Increasing the dexamethasone treatment from 2 to 4 days resulted in a time-dependent pref-1 down-regulation and increased differentiation as measured by adipocyte marker mRNAs, The dexamethasone concentration between 1 and 10 nM showed a dose-dependent decrease in pref-1 mRNA and an enhancement of adipogenesis. To test the hypothesis that dexamethasone initiation of adipoconversion may be via down-regulation of pref-1, we lowered endogenous pref-1 mRNA levels by stably transfecting 3T3-L1 preadipocytes with antisense pref-1, At 1 mu M, antisense cells had enhanced adipose conversion; a similar degree of differentiation occurred with 2 nM dexamethasone, a concentration that does not support differentiation of control 3T3-L1 cells. We conclude that dexamethasone-mediated repression of pref-1 contributes to the mechanisms whereby glucocorticoids promote adipogenesis.	Univ Calif Berkeley, Dept Nutr Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sul, HS (corresponding author), Univ Calif Berkeley, Dept Nutr Sci, Berkeley, CA 94720 USA.		Han, Zaiqi/AAI-2233-2019; Latasa, Maria-Jesus/M-8704-2014	Latasa, Maria-Jesus/0000-0003-2840-8692	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050828] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK50828] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ailhaud G, 1996, BIOCHEM SOC T, V24, P400, DOI 10.1042/bst0240400; Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; Boney CM, 1996, ENDOCRINOLOGY, V137, P2923, DOI 10.1210/en.137.7.2923; Brun RP, 1996, CURR OPIN CELL BIOL, V8, P826, DOI 10.1016/S0955-0674(96)80084-6; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Cui Q, 1997, J BONE JOINT SURG AM, V79A, P1054, DOI 10.2106/00004623-199707000-00012; Elbrecht A, 1996, BIOCHEM BIOPH RES CO, V224, P431, DOI 10.1006/bbrc.1996.1044; FRIEDMAN AD, 1990, GENE DEV, V4, P1416, DOI 10.1101/gad.4.8.1416; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139; Hansen LH, 1998, MOL ENDOCRINOL, V12, P1140, DOI 10.1210/me.12.8.1140; Hanson R W, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P203; HELMAN LJ, 1990, NUCLEIC ACIDS RES, V18, P685; JENSEN CH, 1994, EUR J BIOCHEM, V225, P83, DOI 10.1111/j.1432-1033.1994.00083.x; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3467, DOI 10.1073/pnas.95.7.3467; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; MASSAGUE J, 1990, J BIOL CHEM, V265, P21393; Micheal LF, 1997, ENDOCRINOLOGY, V138, P3695, DOI 10.1210/en.138.9.3695; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; SADOWSKI HB, 1992, J BIOL CHEM, V267, P4722; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; SHUGART EC, 1995, CELL GROWTH DIFFER, V6, P1541; Smas CM, 1996, INT J OBESITY, V20, pS65; Smas CM, 1998, J BIOL CHEM, V273, P31751, DOI 10.1074/jbc.273.48.31751; Smas CM, 1997, MOL CELL BIOL, V17, P977, DOI 10.1128/MCB.17.2.977; SMAS CM, 1994, BIOCHEMISTRY-US, V33, P9257, DOI 10.1021/bi00197a029; SMAS CM, 1995, BIOCHEM J, V309, P697, DOI 10.1042/bj3090697; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smas CM, 1997, CRIT REV EUKAR GENE, V7, P281, DOI 10.1615/CritRevEukarGeneExpr.v7.i4.10; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; YOUNG HE, 1995, DEV DYNAM, V202, P137, DOI 10.1002/aja.1002020205	42	127	132	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12632	12641		10.1074/jbc.274.18.12632	http://dx.doi.org/10.1074/jbc.274.18.12632			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212243	hybrid			2022-12-27	WOS:000080056800063
J	Koenderink, JB; Swarts, HGP; Hermsen, HPH; De Pont, JJHHM				Koenderink, JB; Swarts, HGP; Hermsen, HPH; De Pont, JJHHM			The beta-subunits of Na+,K+-ATPase and gastric H+,K+-ATPase have a high preference for their own alpha-subunit and affect the K+ affinity of these enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/K+-ATPASE COMPLEXES; AMINO-ACID-SEQUENCE; FUNCTIONAL EXPRESSION; INTRACELLULAR-TRANSPORT; EXTRACELLULAR DOMAIN; DISULFIDE BONDS; INSECT CELLS; H+/K+-ATPASE; NA,K-ATPASE; H,K-ATPASE	The alpha- and beta-subunits of Na+,K+-ATPase and H+,K+ ATPase were expressed in Sf9 cells in different combinations. Immunoprecipitation of the alpha-subunits resulted in coprecipitation of the accompanying beta-subunit independent of the type of beta-subunit, This indicates cross-assembly of the subunits of the different ATPases, The hybrid ATPase with the catalytic subunit of Na+,K+- ATPase and the beta-subunit of H+,K+-ATPase (NaK alpha HK beta) showed an ATPase activity, which was only 12 +/- 4% of the activity of the Na+,K+-ATPase with its own beta-subunit. Likewise, the complementary hybrid ATPase with the catalytic subunit of H+,K+-ATPase and the beta-subunit of Na+,K+-ATPase (HK alpha NaK beta) showed an ATPase activity which was 9 +/- 2% of that of the recombinant H+,K+ ATPase, In addition, the apparent K+ affinity of hybrid NaK alpha HK beta was decreased, while the apparent K+ affinity of the opposite hybrid HK alpha NaK beta was increased. The hybrid NaK alpha HK beta could be phosphorylated by ATP to a level of 21 +/- 7% of that of Na+,K+-ATPase, These values, together with the ATPase activity gave turnover numbers for NaK alpha beta and NaK alpha HK beta of 8800 +/- 310 min(-1) and 4800 +/- 160 min(-1), respectively. Measurements of phosphorylation of the HK alpha NaK beta and HK alpha beta enzymes are consistent with a higher turnover of the former. These findings suggest a role of the beta-subunit in the catalytic turnover. In conclusion, although both Na+,K+-ATPase and H+,K+-ATPase have a high preference for their own beta-subunit, they can function with the beta-subunit of the other enzyme, in which case the K+ affinity and turnover number are modified.	Catholic Univ Nijmegen, Dept Biochem, Inst Cellular Signaling, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	De Pont, JJHHM (corresponding author), Catholic Univ Nijmegen, Dept Biochem, Inst Cellular Signaling, POB 9101, NL-6500 HB Nijmegen, Netherlands.	J.dePont@bioch.kun.nl	Koenderink, Jan/N-3578-2014					ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Beggah AT, 1997, J BIOL CHEM, V272, P10318; BEGGAH AT, 1993, BIOCHEMISTRY-US, V32, P14117, DOI 10.1021/bi00214a007; Caplan MJ, 1997, AM J PHYSIOL-GASTR L, V272, pG1304, DOI 10.1152/ajpgi.1997.272.6.G1304; CHOW DC, 1993, AM J PHYSIOL, V265, pC1562, DOI 10.1152/ajpcell.1993.265.6.C1562; CHOW DC, 1992, AM J PHYSIOL, V263, pC39, DOI 10.1152/ajpcell.1992.263.1.C39; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; CourtoisCoutry N, 1997, CELL, V90, P501, DOI 10.1016/S0092-8674(00)80510-3; DEPONT JJHHM, 1992, ANN NY ACAD SCI, V671, P446; DETOMASO AW, 1993, J BIOL CHEM, V268, P1470; Dunbar LA, 1997, ANN NY ACAD SCI, V834, P514, DOI 10.1111/j.1749-6632.1997.tb52309.x; EAKLE KA, 1994, J BIOL CHEM, V269, P6550; EAKLE KA, 1992, P NATL ACAD SCI USA, V89, P2834, DOI 10.1073/pnas.89.7.2834; EAKLE KA, 1995, J BIOL CHEM, V270, P13937, DOI 10.1074/jbc.270.23.13937; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; GEERING K, 1993, AM J PHYSIOL, V265, pC1169, DOI 10.1152/ajpcell.1993.265.4.C1169; GOTTARDI CJ, 1993, J CELL BIOL, V121, P283, DOI 10.1083/jcb.121.2.283; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; HAMRICK M, 1993, J BIOL CHEM, V268, P24367; Hermsen HPH, 1998, BIOCHEM J, V331, P465, DOI 10.1042/bj3310465; HORISBERGER JD, 1991, J BIOL CHEM, V266, P19131; HOROWITZ B, 1990, J BIOL CHEM, V265, P4189; JAUNIN P, 1993, J CELL BIOL, V123, P1751, DOI 10.1083/jcb.123.6.1751; KIRLEY TL, 1990, J BIOL CHEM, V265, P4227; KLAASSEN CHW, 1995, BIOCHEM BIOPH RES CO, V210, P907, DOI 10.1006/bbrc.1995.1743; Klaassen CHW, 1997, BIOCHEM J, V321, P419, DOI 10.1042/bj3210419; KLAASSEN CHW, 1993, FEBS LETT, V329, P277, DOI 10.1016/0014-5793(93)80237-O; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMAS MV, 1992, J BIOL CHEM, V267, P20987; Liu JY, 1997, BBA-GEN SUBJECTS, V1336, P370, DOI 10.1016/S0304-4165(96)00153-5; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; Melle-Milovanovic D, 1998, J BIOL CHEM, V273, P11075, DOI 10.1074/jbc.273.18.11075; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; NING G, 1993, FEBS LETT, V336, P521, DOI 10.1016/0014-5793(93)80868-U; NOGUCHI S, 1994, FEBS LETT, V341, P233, DOI 10.1016/0014-5793(94)80463-X; NOGUCHI S, 1992, BIOCHEM BIOPH RES CO, V182, P659, DOI 10.1016/0006-291X(92)91783-M; NOGUCHI S, 1987, FEBS LETT, V225, P27, DOI 10.1016/0014-5793(87)81125-0; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; RABON EC, 1990, ANNU REV PHYSIOL, V52, P321; SHULL GE, 1986, NATURE, V321, P429, DOI 10.1038/321429a0; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; SUN Y, 1992, AM J PHYSIOL, V262, pC1491, DOI 10.1152/ajpcell.1992.262.6.C1491; SWARTS HGP, 1995, J BIOL CHEM, V270, P7890, DOI 10.1074/jbc.270.14.7890; Swarts HGP, 1998, EMBO J, V17, P3029, DOI 10.1093/emboj/17.11.3029; SWARTS HGP, 1991, BIOCHIM BIOPHYS ACTA, V1070, P283, DOI 10.1016/0005-2736(91)90068-J; SWARTS HGP, 1994, BBA-BIOMEMBRANES, V1189, P143, DOI 10.1016/0005-2736(94)90059-0; TYAGARAJAN K, 1995, BBA-BIOMEMBRANES, V1236, P105, DOI 10.1016/0005-2736(95)00044-4; Ueno S, 1997, BBA-BIOMEMBRANES, V1330, P217, DOI 10.1016/S0005-2736(97)00167-3; UENO S, 1995, J BIOCHEM, V117, P591, DOI 10.1093/oxfordjournals.jbchem.a124749; Wang SG, 1997, AM J PHYSIOL-CELL PH, V272, pC923, DOI 10.1152/ajpcell.1997.272.3.C923	54	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11604	11610		10.1074/jbc.274.17.11604	http://dx.doi.org/10.1074/jbc.274.17.11604			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206969	Green Published, hybrid			2022-12-27	WOS:000079834800025
J	Miyamoto, A; Yang, SX; Laufs, U; Ruan, XL; Liao, JK				Miyamoto, A; Yang, SX; Laufs, U; Ruan, XL; Liao, JK			Activation of guanine nucleotide-binding proteins and induction of endothelial tissue-type plasminogen activator gene transcription by alcohol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; RELAXING FACTOR; CORONARY-DISEASE; PHORBOL ESTER; NITRIC-OXIDE; PC12 CELLS; ETHANOL; EXPRESSION; RELEASE; CONSUMPTION	The mechanism by which moderate alcohol ingestion lowers the risk of cardiovascular disease is unknown but may be due, in part, to the ability of alcohol to increase the level of tissue-type plasminogen activator (t-PA), Human endothelial cells were treated with low concentrations of ethanol (0.25-25 mM, 0-24 h), which are associated with moderate alcohol consumption. Although treatment with ethanol alone did not affect t-PA gene transcription or mRNA expression, it augmented isoproterenol (LSO)-stimulated t-PA gene transcription and mRNA levels by 3.4- and 2.8-fold, respectively, and decreased plasminogen activator inhibitor-1 mRNA levels by 65%. These effects of ethanol correlated with 2.5- and 6.9-fold increases in ISO-stimulated cyclic AMP levels and 4x-cyclic AMP response element heterologous promoter activity, respectively. To determine whether alcohol-induced changes in agonist-stimulated cyclic AMP levels were because of modulation of guanine nucleotide-binding proteins (G proteins), we assessed the effects of ethanol on G alpha(s) and G alpha(i2). Although ethanol did not affect the expression of G alpha(s) or G alpha(i2), it increased ISO-stimulated G alpha(s) GTPase and GTP binding activity by 2.2 and 2.9-fold and decreased UK14304-stimulated G alpha(i2) GTPase and GTP binding activity by 38 and 80%, These results indicate that treatment with relatively low concentrations of ethanol enhances agonist-stimulated cyclic AMP-dependent t-PA gene transcription in vascular endothelial cells through differential modulation of G protein.	Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Kagoshima Univ, Dept Vet Pharmacol, Kagoshima 8900065, Japan	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Kagoshima University	Liao, JK (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, 221 Longwood Ave,LMRC-322, Boston, MA 02115 USA.	jliao@rics.bwh.harvard.edu			NHLBI NIH HHS [HL-52233] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052233] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77; DE CR, 1995, J CLIN INVEST, V96, P60; Gorinstein S, 1997, J INTERN MED, V241, P47, DOI 10.1046/j.1365-2796.1997.77888000.x; Grenett HE, 1998, ALCOHOL CLIN EXP RES, V22, P849, DOI 10.1111/j.1530-0277.1998.tb03878.x; HOFFMAN PL, 1990, FASEB J, V4, P2612, DOI 10.1096/fasebj.4.9.2161371; HU G, 1993, J BIOL CHEM, V268, P23441; LAUG WE, 1983, JAMA-J AM MED ASSOC, V250, P772, DOI 10.1001/jama.250.6.772; LIAO JK, 1992, CIRC RES, V70, P1018, DOI 10.1161/01.RES.70.5.1018; LIAO JK, 1993, J CLIN INVEST, V92, P2168, DOI 10.1172/JCI116818; LIAO JK, 1993, J BIOL CHEM, V268, P19528; LIAO JK, 1994, J BIOL CHEM, V269, P12987; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; MEDCALF RL, 1991, MOL ENDOCRINOL, V5, P1773, DOI 10.1210/mend-5-12-1773; MEDCALF RL, 1990, J BIOL CHEM, V265, P14618; MOCHLYROSEN D, 1988, NATURE, V333, P848, DOI 10.1038/333848a0; NAGAMINE Y, 1985, P NATL ACAD SCI USA, V82, P4606, DOI 10.1073/pnas.82.14.4606; NAKAGAWA J, 1988, J BIOL CHEM, V263, P2460; Pellegrini N, 1996, EUR J CLIN NUTR, V50, P209; PENG HB, 1995, J BIOL CHEM, V270, P17050, DOI 10.1074/jbc.270.28.17050; RABE CS, 1990, BIOCHEM PHARMACOL, V40, P565, DOI 10.1016/0006-2952(90)90557-2; RABIN RA, 1988, J NEUROCHEM, V51, P1148, DOI 10.1111/j.1471-4159.1988.tb03080.x; Ramanathan R, 1996, J CELL BIOL, V133, P381, DOI 10.1083/jcb.133.2.381; RASBAND W, 1993, NIH IMAGE PROGRAM VE; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; RIDKER PM, 1993, LANCET, V341, P1165, DOI 10.1016/0140-6736(93)90998-V; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; SANTELL L, 1988, J BIOL CHEM, V263, P16802; Sloan LS, 1998, BIOCHEMISTRY-US, V37, P7113, DOI 10.1021/bi972009s; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; Sumpio BE, 1997, AM J PHYSIOL-CELL PH, V273, pC1441, DOI 10.1152/ajpcell.1997.273.5.C1441; Uno S, 1998, J BIOCHEM, V123, P806; WAND GS, 1993, J BIOL CHEM, V268, P2595; WIGLER M, 1976, NATURE, V259, P232, DOI 10.1038/259232a0	33	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12055	12060		10.1074/jbc.274.17.12055	http://dx.doi.org/10.1074/jbc.274.17.12055			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207029	hybrid			2022-12-27	WOS:000079834800085
J	VanValkenburgh, C; Chen, XM; Mullins, C; Fang, H; Green, N				VanValkenburgh, C; Chen, XM; Mullins, C; Fang, H; Green, N			The catalytic mechanism of endoplasmic reticulum signal peptidase appears to be distinct from most eubacterial signal peptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI LEADER PEPTIDASE; POTENTIAL ACTIVE-SITE; SACCHAROMYCES-CEREVISIAE; BACILLUS-SUBTILIS; SHUTTLE VECTORS; AMINO-ACIDS; YEAST; PROTEIN; GENE; IDENTIFICATION	Many type I signal peptidases from eubacterial cells appear to contain a serine/lysine catalytic dyad. In contrast, our data show that the signal peptidase complex from the endoplasmic reticulum lacks an apparent catalytic lysine. Instead, a serine, histidine, and two aspartic acids are important for signal peptidase activity by the Sec11p subunit of the yeast signal peptidase complex. Amino acids critical to the eubacterial signal peptidases and Sec11p are, however, positioned similarly along their primary sequences, suggesting the presence of a common structural element(s) near the catalytic sites of these enzymes.	Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University	VanValkenburgh, C (corresponding author), Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37232 USA.				NCI NIH HHS [2 T32 CA09385-11] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009385] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUSUBEL FM, 1987, CURRENT PROTOCOLS MO, V2; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3018; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; BLACK MT, 1993, J BACTERIOL, V175, P4957, DOI 10.1128/JB.175.16.4957-4961.1993; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BOHNI PC, 1988, J CELL BIOL, V106, P1035, DOI 10.1083/jcb.106.4.1035; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; DALBEY RE, 1992, TRENDS BIOCHEM SCI, V17, P474, DOI 10.1016/0968-0004(92)90492-R; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; Fang H, 1996, J BIOL CHEM, V271, P16460, DOI 10.1074/jbc.271.28.16460; Fang H, 1997, J BIOL CHEM, V272, P13152, DOI 10.1074/jbc.272.20.13152; GREEN N, 1992, MOL CELL BIOL, V12, P276, DOI 10.1128/MCB.12.1.276; HANSEN W, 1986, CELL, V45, P397, DOI 10.1016/0092-8674(86)90325-9; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; LINGAPPA VR, 1984, P NATL ACAD SCI-BIOL, V81, P456, DOI 10.1073/pnas.81.2.456; Meyer HA, 1997, J BIOL CHEM, V272, P13159, DOI 10.1074/jbc.272.20.13159; Mullins C, 1996, J BIOL CHEM, V271, P29094, DOI 10.1074/jbc.271.46.29094; MULLINS C, 1995, J BIOL CHEM, V270, P17139, DOI 10.1074/jbc.270.29.17139; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; Paetzel M, 1997, J BIOL CHEM, V272, P9994; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; SANDERSON CM, 1991, J BIOL CHEM, V266, P13423; SHELNESS GS, 1990, J BIOL CHEM, V265, P9512; SIKORSKI RS, 1989, GENETICS, V122, P19; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; SUNG M, 1992, J BIOL CHEM, V267, P13154; TALMADGE K, 1980, P NATL ACAD SCI-BIOL, V77, P3988, DOI 10.1073/pnas.77.7.3988; Tjalsma H, 1997, J BIOL CHEM, V272, P25983, DOI 10.1074/jbc.272.41.25983; Tjalsma H, 1998, GENE DEV, V12, P2318, DOI 10.1101/gad.12.15.2318; TSCHANTZ WR, 1993, J BIOL CHEM, V268, P27349; VANDIJL JM, 1992, EMBO J, V11, P2819, DOI 10.1002/j.1460-2075.1992.tb05349.x; VANDIJL JM, 1995, J BIOL CHEM, V270, P3611, DOI 10.1074/jbc.270.8.3611; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WEI YY, 1995, NAT STRUCT BIOL, V2, P218, DOI 10.1038/nsb0395-218; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4	39	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11519	11525		10.1074/jbc.274.17.11519	http://dx.doi.org/10.1074/jbc.274.17.11519			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206957	hybrid			2022-12-27	WOS:000079834800013
J	Kakuta, Y; Sueyoshi, T; Negishi, M; Pedersen, LC				Kakuta, Y; Sueyoshi, T; Negishi, M; Pedersen, LC			Crystal structure of the sulfotransferase domain of human heparan sulfate N-deacetylase/N-sulfotransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN SULFOTRANSFERASE; REFINEMENT	Heparan sulfate N-deacetylase/N-sulfotransferase (HSNST) catalyzes the first and obligatory step in the biosynthesis of heparan sulfates and heparin, The crystal structure of the sulfotransferase domain (NST1) of human HSNST-1 has been determined at 2.3-Angstrom resolution in a binary complex with 3'-phosphoadenosine 5'-phosphate (PAP), NST1 is approximately spherical with an open cleft, and consists of a single alpha/beta fold with a central five-stranded parallel beta-sheet and a three-stranded anti-parallel beta-sheet bearing an interstrand disulfide bond. The structural regions alpha 1, alpha 6, beta 1, beta 7, 5'-phosphosulfate binding loop (between beta 1 and alpha 1), and a random coil (between beta 8 and alpha 13) constitute the PAP binding site of NST1, The alpha 6 and random coil (between beta 2 and alpha 2), which form an open cleft near the 5'-phosphate of the PAP molecule, may provide interactions for substrate binding. The conserved residue Lys-614 is in position to form a hydrogen bond with the bridge oxygen of the 5'-phosphate.	NIEHS, Reprod & Dev Toxicol Lab, Pharmacogenet Sect, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), NIEHS, Reprod & Dev Toxicol Lab, Pharmacogenet Sect, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019; Pedersen, Lars/C-6173-2019	Negishi, Masahiko/0000-0002-2076-8928; Pedersen, Lars/0000-0002-4488-4077				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berninsone P, 1998, J BIOL CHEM, V273, P25556, DOI 10.1074/jbc.273.40.25556; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Cumberledge S, 1997, TRENDS GENET, V13, P421, DOI 10.1016/S0168-9525(97)01275-4; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; ERIKSSON I, 1994, J BIOL CHEM, V269, P10438; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Hacker U, 1997, DEVELOPMENT, V124, P3565; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kakuta Y, 1998, TRENDS BIOCHEM SCI, V23, P129, DOI 10.1016/S0968-0004(98)01182-7; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; Kakuta Y, 1998, J BIOL CHEM, V273, P27325, DOI 10.1074/jbc.273.42.27325; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; SHELDRICK GM, 1993, ACTA CRYSTALLOGR D, V49, P18, DOI 10.1107/S0907444992007364; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Sueyoshi T, 1998, FEBS LETT, V433, P211, DOI 10.1016/S0014-5793(98)00913-2; WEI Z, 1993, P NATL ACAD SCI USA, V90, P3885, DOI 10.1073/pnas.90.9.3885	23	111	117	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10673	10676		10.1074/jbc.274.16.10673	http://dx.doi.org/10.1074/jbc.274.16.10673			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196134	hybrid			2022-12-27	WOS:000079751900002
J	Krylov, DM; Niemi, GA; Dizhoor, AM; Hurley, JB				Krylov, DM; Niemi, GA; Dizhoor, AM; Hurley, JB			Mapping sites in guanylyl cyclase activating protein-1 required for regulation of photoreceptor membrane guanylyl cyclases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT CONE DYSTROPHY; CALCIUM SENSOR; RECOVERIN; CLONING; EXPRESSION; MUTANT; VISION; RETGC	Guanylyl cyclase activating protein (GCAP)-1 regulates photoreceptor membrane guanylyl cyclase, RetGC, in a Ca2+-sensitive manner. It contains four Ca2+-binding motifs, EF-hands, three of which are capable of binding Ca2+. GCAP-1 activates RetGC in low Ca2+ and inhibits it in high Ca2+, In this study we used deletion and substitution analysis to identify regions of GCAP-1 sequence that are specifically required for inhibition and activation. A COOH-terminal sequence within Met(157) to Arg(182) is required for activation but not for inhibition of RetGC, We localized one essential stretch to 5 residues from Arg(178) to Arg(182). Another sequence essential for activation is within the N-terminal residues Trp(21) to Thr(27). The region between EF-hands 1 and 3 of GCAP-1 also contains elements needed for activation of RetGC, Finally, we found that inhibition of RetGC requires the first 9 amino-terminal residues of GCAP-1, but none of the residues from Gln(33) to the COOH-terminal Gly(205) are specifically required for inhibition. The ability of GCAP-1 mutants to regulate RetGC was tested on total guanylyl cyclase activity present in rod outer segments. In addition, the key mutants were also shown to produce similar effects on recombinant bovine outer segment cyclases GC1 and GC2.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Wayne State Univ, Kresge Eye Inst, Dept Ophthalmol, Sch Med, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Wayne State University; Wayne State University	Hurley, JB (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.			Dizhoor, Alexander/0000-0001-6770-9186	NEI NIH HHS [EY06614, EY11522, R01 EY006641] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006641, R01EY011522] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMES JB, 1994, BIOCHEMISTRY-US, V33, P10743, DOI 10.1021/bi00201a023; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; DURONIO RJ, 1991, J BIOL CHEM, V266, P10498; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; GORACZNIAK RM, 1994, BIOCHEM J, V302, P455, DOI 10.1042/bj3020455; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; HORTON RM, 1991, DIRECTED MUTAGENESIS; HURLEY JB, 1993, SCIENCE, V260, P740, DOI 10.1126/science.8097896; KAWAMURA S, 1994, BIOCHEM BIOPH RES CO, V203, P121, DOI 10.1006/bbrc.1994.2157; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; OttoBruc A, 1997, BIOCHEMISTRY-US, V36, P4295, DOI 10.1021/bi963000d; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; POZDNYAKOV N, 1995, BIOCHEMISTRY-US, V34, P14279, DOI 10.1021/bi00044a002; RAY S, 1992, P NATL ACAD SCI USA, V89, P5705, DOI 10.1073/pnas.89.13.5705; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; YARFITZ S, 1994, J BIOL CHEM, V269, P14329	24	53	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10833	10839		10.1074/jbc.274.16.10833	http://dx.doi.org/10.1074/jbc.274.16.10833			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196159	hybrid			2022-12-27	WOS:000079751900027
J	Forbes, JR; Hsi, G; Cox, DW				Forbes, JR; Hsi, G; Cox, DW			Role of the copper-binding domain in the copper transport function of ATP7B, the P-type ATPase defective in Wilson disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MENKES DISEASE; CANDIDATE GENE; IRON UPTAKE; EXPRESSION; PROTEIN; YEAST; TRAFFICKING; ENCODES; IDENTIFICATION	We have analyzed the functional effect of site directed mutations and deletions in the copper-binding domain of ATP7B (the copper transporting P-type ATPase defective in Wilson disease) using a yeast complementation assay. We have shown that the sixth copper-binding motif alone is sufficient, but not essential, for normal ATP7B function. The N-terminal two or three copper-binding motifs alone are not sufficient for ATP7B function. The first two or three N-terminal motifs of the copper-binding domain are not equivalent to, and cannot replace, the C-terminal motifs when placed in the same sequence position with respect to the transmembrane channel. From our data, we propose that the copper-binding motifs closest to the channel are required for the copper-transport function of ATP7B. We propose that cooperative copper binding to the copper-binding domain of ATP7B is not critical for copper transport function, but that cooperative copper binding involving the N-terminal two or three copper-binding motifs may be involved in initiating copper-dependent intracellular trafficking. Our data also suggest a functional difference between the copper-binding domains of ATP7A and ATP7B.	Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada	University of Alberta	Cox, DW (corresponding author), Univ Alberta, Dept Med Genet, 8-39 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	diane.cox@ualberta.ca						[Anonymous], 1995, METABOLIC BASIS INHE; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Bingham MJ, 1996, AM J PHYSIOL-GASTR L, V271, pG741, DOI 10.1152/ajpgi.1996.271.5.G741; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; BULL PC, 1994, TRENDS GENET, V10, P246, DOI 10.1016/0168-9525(94)90172-4; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DiDonato M, 1997, J BIOL CHEM, V272, P33279, DOI 10.1074/jbc.272.52.33279; DIJKSTRA M, 1995, J CLIN INVEST, V95, P412, DOI 10.1172/JCI117670; Dijkstra M, 1996, J HEPATOL, V25, P37, DOI 10.1016/S0168-8278(96)80325-4; EIBLE R, 1992, BIOTECHNIQUES, V13, P18; Forbes JR, 1998, AM J HUM GENET, V63, P1663, DOI 10.1086/302163; Gitschier J, 1998, NAT STRUCT BIOL, V5, P47, DOI 10.1038/nsb0198-47; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; Iida M, 1998, FEBS LETT, V428, P281, DOI 10.1016/S0014-5793(98)00546-8; Klomp LWJ, 1997, J BIOL CHEM, V272, P9221, DOI 10.1074/jbc.272.14.9221; La Fontaine S, 1998, J BIOL CHEM, V273, P31375; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Payne AS, 1998, P NATL ACAD SCI USA, V95, P10854, DOI 10.1073/pnas.95.18.10854; Payne AS, 1998, J BIOL CHEM, V273, P3765, DOI 10.1074/jbc.273.6.3765; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; SCHENA M, 1991, METHOD ENZYMOL, V194, P389; SOLIOZ M, 1998, ADV MOL CEL A&B, V23, P167; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Theophilos MB, 1996, HUM MOL GENET, V5, P1619, DOI 10.1093/hmg/5.10.1619; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Voskoboinik I, 1998, FEBS LETT, V435, P178, DOI 10.1016/S0014-5793(98)01059-X; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; Yuan DS, 1997, J BIOL CHEM, V272, P25787, DOI 10.1074/jbc.272.41.25787; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632; ZUBENKO GS, 1980, GENETICS, V96, P137	37	129	135	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12408	12413		10.1074/jbc.274.18.12408	http://dx.doi.org/10.1074/jbc.274.18.12408			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212214	hybrid			2022-12-27	WOS:000080056800034
J	Jamieson, ER; Jacobson, MP; Barnes, CM; Chow, CS; Lippard, SJ				Jamieson, ER; Jacobson, MP; Barnes, CM; Chow, CS; Lippard, SJ			Structural and kinetic studies of a cisplatin-modified DNA icosamer binding to HMG1 domain B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; ANTICANCER DRUG CISPLATIN; DOUBLE-STRANDED DNA; EQUILIBRIUM BINDING; CRYSTAL-STRUCTURE; MAJOR ADDUCT; DUPLEX DNA; PROTEIN; CROSS; JUNCTION	The high mobility group (HMG) domain is a DNA-binding motif found in the non-histone chromosomal proteins, HMG1 and HMG2, and some transcription factors. Experimental evidence has demonstrated that HMG-domain proteins can play a role in sensitizing cells to the anticancer drug cisplatin. Fluorescence resonance energy transfer (FRET) experiments were performed in the present study to investigate structural changes that accompany complex formation between the HMG domain B of HMG1 and a cisplatin-modified, 20-base pair double-stranded DNA probe containing fluorescein and rhodamine tethered at its two ends. The binding affinity of HMG1 domain B for the cisplatin-modified DNA probe was investigated in fluorescence titration experiments, and a value of 60 +/- 30 nM was determined for the dissociation constant. Single photon counting methods were employed to measure the fluorescence lifetime of the fluorescein donor in the presence and absence of HMG1 domain B. These FRET experiments revealed a distance change that was used to estimate a bend angle of 80-95 degrees for the cisplatin-modified DNA upon protein binding. Stopped-flow fluorescence spectroscopic experiments afforded kinetic parameters for HMG1 domain B binding to the cisplatin-modified DNA probe, with k(on) = 1.1 +/- 0.1 x 10(9) m(-1) s(-1) and k(off) = 30 +/- 4 s(-1).	MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lippard, SJ (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Jacobson, Matthew/Y-5161-2018	Jacobson, Matthew/0000-0001-6262-655X	NCI NIH HHS [CA34992] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA034992, R01CA034992] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BELLON SF, 1990, BIOPHYS CHEM, V35, P179, DOI 10.1016/0301-4622(90)80007-T; BELLON SF, 1991, BIOCHEMISTRY-US, V30, P8026, DOI 10.1021/bi00246a021; BROWN SJ, 1993, SCIENCE, V261, P603, DOI 10.1126/science.8342024; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; CARDULLO RA, 1988, P NATL ACAD SCI USA, V85, P8790, DOI 10.1073/pnas.85.23.8790; CHOW CS, 1995, BIOCHEMISTRY-US, V34, P2956, DOI 10.1021/bi00009a027; CHOW CS, 1994, BIOCHEMISTRY-US, V33, P15124, DOI 10.1021/bi00254a023; CLEGG RM, 1993, P NATL ACAD SCI USA, V90, P2994, DOI 10.1073/pnas.90.7.2994; CLEGG RM, 1992, BIOCHEMISTRY-US, V31, P4846, DOI 10.1021/bi00135a016; Dunham SU, 1997, BIOCHEMISTRY-US, V36, P11428, DOI 10.1021/bi9709452; EIS PS, 1993, BIOCHEMISTRY-US, V32, P13852, DOI 10.1021/bi00213a014; Gelasco A, 1998, BIOCHEMISTRY-US, V37, P9230, DOI 10.1021/bi973176v; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; GOHLKE C, 1994, P NATL ACAD SCI USA, V91, P11660, DOI 10.1073/pnas.91.24.11660; Heyduk E, 1997, J BIOL CHEM, V272, P19763, DOI 10.1074/jbc.272.32.19763; HEYDUK T, 1992, BIOCHEMISTRY-US, V31, P5165, DOI 10.1021/bi00137a011; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P10394, DOI 10.1073/pnas.91.22.10394; JaresErijman EA, 1996, J MOL BIOL, V257, P597, DOI 10.1006/jmbi.1996.0188; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; LEPRE CA, 1990, NUCL ACIDS MOL BIOL, V4, P9, DOI [DOI 10.1007/978-3-642-84150-7-2, DOI 10.1007/978-3-642-84150-7]; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Mahtab R, 1996, J AM CHEM SOC, V118, P7028, DOI 10.1021/ja961602e; McANulty MM, 1996, MUTAT RES-DNA REPAIR, V362, P75, DOI 10.1016/0921-8777(95)00037-2; MURCHIE AIH, 1989, NATURE, V341, P763, DOI 10.1038/341763a0; O'Connor D. V., 1984, TIME CORRELATED SING; Ozaki H, 1997, BIOCHEM BIOPH RES CO, V231, P553, DOI 10.1006/bbrc.1997.6138; Parkhurst KM, 1996, BIOCHEMISTRY-US, V35, P7459, DOI 10.1021/bi9530301; Patrick SM, 1998, BIOCHEMISTRY-US, V37, P8808, DOI 10.1021/bi9730590; PEREZHOWARD GM, 1995, BIOCHEMISTRY-US, V34, P8005, DOI 10.1021/bi00025a006; PIL P, 1997, ENCY CANC, V1, P392; PIL PM, 1992, SCIENCE, V256, P234, DOI 10.1126/science.1566071; Poklar N, 1996, P NATL ACAD SCI USA, V93, P7606, DOI 10.1073/pnas.93.15.7606; Press W., 1992, NUMERICAL RECIPES FO; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; SHA M, 1995, J BIOL CHEM, V270, P19325, DOI 10.1074/jbc.270.33.19325; TAKAHARA PM, 1995, NATURE, V377, P649, DOI 10.1038/377649a0; Takahara PM, 1996, J AM CHEM SOC, V118, P12309, DOI 10.1021/ja9625079; TONEY JH, 1989, P NATL ACAD SCI USA, V86, P8328, DOI 10.1073/pnas.86.21.8328; TUSCHL T, 1994, SCIENCE, V266, P785, DOI 10.1126/science.7973630; URBANKE C, 1990, BIOCHEMISTRY-US, V29, P1744, DOI 10.1021/bi00459a012; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; YANG DZ, 1995, BIOCHEMISTRY-US, V34, P12912, DOI 10.1021/bi00039a054	42	66	70	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12346	12354		10.1074/jbc.274.18.12346	http://dx.doi.org/10.1074/jbc.274.18.12346			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212205	hybrid, Green Published			2022-12-27	WOS:000080056800025
J	Sayegh, R; Auerbach, SD; Li, X; Loftus, RW; Husted, RF; Stokes, JB; Thomas, CP				Sayegh, R; Auerbach, SD; Li, X; Loftus, RW; Husted, RF; Stokes, JB; Thomas, CP			Glucocorticoid induction of epithelial sodium channel expression in lung and renal epithelia occurs via trans-activation of a hormone response element in the 5 '-flanking region of the human epithelial sodium channel alpha subunit gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	31st Congress of the American-Society-of-Nephrology	OCT 25-28, 1998	PHILADELPHIA, PENNSYLVANIA	Amer Soc Nephrol			MEDULLARY COLLECTING DUCT; SENSITIVE NA+ CHANNEL; MINERALOCORTICOID HORMONES; HOMOLOGOUS SUBUNITS; LIQUID CLEARANCE; RECEPTOR; ALDOSTERONE; ENHANCEMENT; MECHANISM; CULTURE	In airway and renal epithelia, the glucocorticoid-mediated stimulation of amiloride-sensitive Na+ transport is associated with increased expression of the epithelial Na+ channel Lu subunit (alpha ENaC), In H441 lung cells, 100 nM dexamethasone increases amiloride-sensitive short-circuit current (3.3 mu A/cm(2) to 7.5 mu A/cm(2)), correlating with a 5-fold increase in aENaC mRNA expression that could be blocked by actinomycin D, To explore transcriptional regulation of alpha ENaC, the human alpha ENaC 5'-flanking region was cloned and tested in H441 cells. By deletion analysis, a similar to 150-base pair region 5' to the upstream promoter was identified that, when stimulated with 100 nM dexamethasone, increased luciferase expression 15-fold. This region, which contains two imperfect GREs, also functioned when coupled to a heterologous promoter. When individually tested, only the downstream GRE functioned in cis and bound GR in a gel mobility shift assay. In the M-l collecting duct line Na+ transport, m alpha ENaC expression and luciferase expression from alpha ENaC genomic fragments were also increased by 100 nM dexamethasone. In a colonic cell line, HT29, trans-activation via a heterologously expressed glucocorticoid receptor restored glucocorticoid-stimulated alpha ENaC gene transcription. We conclude that glucocorticoids stimulate alpha ENaC expression in kidney and lung via activation of a hormone response element in the 5'-flanking region of h alpha ENaC and this response, in part, is the likely basis for the up-regulation of Na+ transport in these sites.	Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52246 USA; Vet Affairs Med Ctr, Iowa City, IA 52246 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Thomas, CP (corresponding author), Univ Iowa Hosp & Clin, Dept Internal Med, Div Nephrol, 200 Hawkins Dr, Iowa City, IA 52242 USA.			Thomas, Christie/0000-0002-5989-9685	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK052617] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 52617] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asher C, 1996, AM J PHYSIOL-CELL PH, V271, pC605, DOI 10.1152/ajpcell.1996.271.2.C605; Aumais JP, 1996, J BIOL CHEM, V271, P12568, DOI 10.1074/jbc.271.21.12568; Barbry P, 1997, AM J PHYSIOL-GASTR L, V273, pG571, DOI 10.1152/ajpgi.1997.273.3.G571; Barker PM, 1998, J CLIN INVEST, V102, P1634, DOI 10.1172/JCI3971; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CHALEPAKIS G, 1988, CELL, V53, P371, DOI 10.1016/0092-8674(88)90157-2; CHAMPIGNY G, 1994, EMBO J, V13, P2177, DOI 10.1002/j.1460-2075.1994.tb06494.x; Escoubet B, 1997, AM J PHYSIOL-CELL PH, V272, pC1482, DOI 10.1152/ajpcell.1997.272.5.C1482; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; GarayRojas E, 1996, GENE, V170, P173, DOI 10.1016/0378-1119(95)00896-9; GOMEZSANCHEZ EP, 1990, AM J PHYSIOL, V258, pE649, DOI 10.1152/ajpendo.1990.258.4.E649; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; HUSTED RF, 1990, J CLIN INVEST, V86, P498, DOI 10.1172/JCI114736; Jenster G, 1997, P NATL ACAD SCI USA, V94, P7879, DOI 10.1073/pnas.94.15.7879; LAPLACE JR, 1992, J CLIN INVEST, V90, P1370, DOI 10.1172/JCI116003; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; LINGUEGLIA E, 1994, J BIOL CHEM, V269, P13736; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McDonald FJ, 1999, P NATL ACAD SCI USA, V96, P1727, DOI 10.1073/pnas.96.4.1727; PEARCE D, 1993, SCIENCE, V259, P1161, DOI 10.1126/science.8382376; ROSS ME, 1990, J NEUROSCI, V10, P520; Shibata H, 1997, RECENT PROG HORM RES, V52, P141; Stokes JB, 1998, AM J PHYSIOL-CELL PH, V274, pC1699, DOI 10.1152/ajpcell.1998.274.6.C1699; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; TCHEPICHEV S, 1995, AM J PHYSIOL-CELL PH, V269, pC805, DOI 10.1152/ajpcell.1995.269.3.C805; Thomas CP, 1998, AM J PHYSIOL-CELL PH, V274, pC1312, DOI 10.1152/ajpcell.1998.274.5.C1312; Thomas CP, 1996, J BIOL CHEM, V271, P26062, DOI 10.1074/jbc.271.42.26062; Venkatesh VC, 1997, AM J PHYSIOL-LUNG C, V273, pL227, DOI 10.1152/ajplung.1997.273.1.L227; Volk KA, 1995, J CLIN INVEST, V96, P2748, DOI 10.1172/JCI118344	30	127	129	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12431	12437		10.1074/jbc.274.18.12431	http://dx.doi.org/10.1074/jbc.274.18.12431			7	Biochemistry & Molecular Biology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212217	hybrid			2022-12-27	WOS:000080056800037
J	Wang, GQ; Li, SS; Lin, HN; Brumbaugh, EE; Huang, CH				Wang, GQ; Li, SS; Lin, HN; Brumbaugh, EE; Huang, CH			Effects of various numbers and positions of cis double bonds in the sn-2 acyl chain of phosphatidylethanolamine on the chain-melting temperature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE-TRANSITION TEMPERATURES; MOLECULAR MECHANICS; HETEROACID PHOSPHATIDYLCHOLINES; UNSATURATION; HYDROCARBONS; BILAYERS; SERIES; GEL	In an attempt to investigate systematically the effects of various single and multiple cis carbon-carbon double bonds in the sn-2 acyl chains of natural phospholipids on membrane properties, we have de novo synthesized unsaturated C-20 fatty acids comprised of single or multiple methylene-interrupted cis double bonds. Subsequently, 15 molecular species of phosphatidylethanolamine (PE) with sn-l C-20-saturated and sn-2 C-20-unsaturated acyl chains were semi-synthesized by acylation of C-20-lysophosphatidylcholine with unsaturated C-20 fatty acids followed by phospholipase D-catalyzed base-exchange reaction in the presence of excess ethanolamine, The gel-to-liquid crystalline phase transitions of these 15 mixed-chain PE, in excess H2O, were investigated by high resolution differential scanning calorimetry. In addition, the energy-minimized structures of these sn-l C-20-saturated/sn-2 C-20-unsaturated PE were simulated by molecular mechanics calculations. It is shown that the successive introduction of cis double bonds into the sn-2 acyl chain of C(20):C(20)PE can affect the gel-to-liquid crystalline phase transition temperature, T-m, of the lipid bilayer in some characteristic ways; moreover, the effect depends critically on the position of cis double bonds in the sn-2 acyl chain. Specifically, we have constructed a novel T-m diagram for the 15 species of unsaturated PE, from which the effects of the number and the position of cis double bonds on T-m can be examined simultaneously in a simple, direct, and unifying manner. Interestingly, the characteristic T-m profiles exhibited by different series of mixed-chain PE with increasing degree of unsaturation can be interpreted in terms of structural changes associated with acyl chain unsaturation.	Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Huang, CH (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Biochem, Box 440, Charlottesville, VA 22908 USA.				NIGMS NIH HHS [GM-17452] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017452] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLINGER NL, 1989, J AM CHEM SOC, V111, P8551, DOI 10.1021/ja00205a001; BATTA AK, 1984, J CHROMATOGR, P284; Christie W.W., 1967, CHEM PHYS LIPIDS, V1, P407; COMFURIUS P, 1977, BIOCHIM BIOPHYS ACTA, V488, P36, DOI 10.1016/0005-2760(77)90120-5; COOLBEAR KP, 1983, BIOCHEMISTRY-US, V22, P1466, DOI 10.1021/bi00275a022; HITCHCOCK PB, 1974, P NATL ACAD SCI USA, V71, P3036, DOI 10.1073/pnas.71.8.3036; HUANG C, 1994, BBA-BIOMEMBRANES, V1189, P7, DOI 10.1016/0005-2736(94)90273-9; Huang C, 1998, BBA-BIOMEMBRANES, V1373, P282, DOI 10.1016/S0005-2736(98)00092-3; HUANG C, 1998, CELL PHYSL SOURCE BO, P39; Huang CH, 1997, J BIOL CHEM, V272, P21917, DOI 10.1074/jbc.272.35.21917; Huang CH, 1996, ARCH BIOCHEM BIOPHYS, V334, P135, DOI 10.1006/abbi.1996.0438; KEOUGH KMW, 1987, BIOCHIM BIOPHYS ACTA, V902, P1, DOI 10.1016/0005-2736(87)90129-5; KEOUGH KMW, 1990, BIOCHEM SOC T, V18, P835, DOI 10.1042/bst0180835; Li SS, 1996, J COMPUT CHEM, V17, P1013, DOI 10.1002/(SICI)1096-987X(199606)17:8<1013::AID-JCC10>3.0.CO;2-F; Li SS, 1998, J BIOL CHEM, V273, P19009, DOI 10.1074/jbc.273.30.19009; LI SS, 1994, BIOPHYS J, V66, P2005, DOI 10.1016/S0006-3495(94)80993-2; LIN HN, 1990, BIOCHEMISTRY-US, V29, P7063, DOI 10.1021/bi00482a017; NIEBYLSKI CD, 1994, BIOPHYS J, V67, P2387, DOI 10.1016/S0006-3495(94)80725-8; OSBOND JM, 1961, J CHEM SOC, P2779, DOI 10.1039/jr9610002779; SanchezMigallon M, 1996, BBA-BIOMEMBRANES, V1279, P251; VALICENTI AJ, 1985, LIPIDS, V20, P234, DOI 10.1007/BF02534194; Wang GQ, 1997, BIOPHYS J, V73, P283, DOI 10.1016/S0006-3495(97)78069-X; WANG ZQ, 1994, J BIOL CHEM, V269, P23491	23	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12289	12299		10.1074/jbc.274.18.12289	http://dx.doi.org/10.1074/jbc.274.18.12289			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212198	hybrid			2022-12-27	WOS:000080056800018
J	Madiai, F; Hackshaw, KV; Chiu, IM				Madiai, F; Hackshaw, KV; Chiu, IM			Characterization of the entire transcription unit of the mouse fibroblast growth factor 1 (FGF-1) gene - Tissue-specific expression of the FGF-1.A mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MESSENGER-RNA; SMOOTH-MUSCLE CELLS; FACTOR FAMILY; FACTOR-I; DIFFERENTIAL EXPRESSION; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; CARCINOMA-CELLS; NERVOUS-SYSTEM; C-MYB	Fibroblast growth factor 1 (FGF-1, also known as acidic FGF) is a mitogen for a variety of mesoderm- and neuroectoderm-derived cells, as well as an angiogenic factor in vivo. It has been implicated in angiogenic diseases including atherosclerosis, cancer and inflammatory diseases. In the present study, the entire transcriptional unit of the mouse FGF-1 gene, including four promoters, is characterized. By nucleotide sequence and RNase protection analyses, we have determined that its 3'-end resides 3.2 kilobase pairs downstream from the stop codon. We have previously cloned and characterized the mouse homologue of the human 1B promoter, as well as a novel upstream untranslated exon. In order to elucidate the regulatory mechanism of FGF-I gene expression, the mouse promoter containing TATA and CAAT consensus sequences (FGF-1.A) was isolated from a P1 library and characterized. We further determined that the mouse heart is the most abundant source for the FGF-1.A mRNA. Finally, via both RNase protection analysis and 5'-rapid amplification of cDNA ends, we determined the transcription start site of the FGF-1.A mRNA.	Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Chiu, IM (corresponding author), Ohio State Univ, Dept Internal Med, 480 W 9th Ave, Columbus, OH 43210 USA.	chiu.1@osu.edu	Chiu, Ing-Ming/B-1534-2008		NCI NIH HHS [R01CA45611] Funding Source: Medline; NIAID NIH HHS [K11AI01048] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA045611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K11AI001048] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam KY, 1996, J BIOL CHEM, V271, P30263, DOI 10.1074/jbc.271.47.30263; ANDREWS DF, 1990, ONCOGENE, V5, P441; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; BOVI PD, 1987, CELL, V50, P729, DOI 10.1016/0092-8674(87)90331-X; Burgess W. H., 1996, P154; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CHIU IM, 1990, FID RES FDN, V3, P57; CHIU IM, 1990, ONCOGENE, V5, P755; Chotani MA, 1997, CELL GROWTH DIFFER, V8, P999; CHOTANI MA, 1995, NUCLEIC ACIDS RES, V23, P434, DOI 10.1093/nar/23.3.434; COULIER F, 1991, ANN NY ACAD SCI, V638, P53, DOI 10.1111/j.1749-6632.1991.tb49017.x; CRUMLEY G, 1990, BIOCHEM BIOPH RES CO, V171, P7, DOI 10.1016/0006-291X(90)91348-V; CURATOLA AM, 1990, MOL CELL BIOL, V10, P2475, DOI 10.1128/MCB.10.6.2475; DICKSON C, 1987, NATURE, V326, P833, DOI 10.1038/326833a0; FISHEL RS, 1995, J CLIN INVEST, V95, P377, DOI 10.1172/JCI117666; Fulton GJ, 1997, J VASC SURG, V25, P453, DOI 10.1016/S0741-5214(97)70255-6; GOODRICH SP, 1989, NUCLEIC ACIDS RES, V17, P2867, DOI 10.1093/nar/17.7.2867; Gunn J, 1997, CIRC RES, V80, P520, DOI 10.1161/01.RES.80.4.520; Hackshaw KV, 1996, GENE, V180, P131, DOI 10.1016/S0378-1119(96)00433-7; Hicks K K, 1996, P R Health Sci J, V15, P179; Hoshikawa M, 1998, BIOCHEM BIOPH RES CO, V244, P187, DOI 10.1006/bbrc.1998.8239; HUGHES SE, 1993, LAB INVEST, V69, P173; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; KAN M, 1989, P NATL ACAD SCI USA, V86, P7432, DOI 10.1073/pnas.86.19.7432; Liu Y, 1998, J BIOL CHEM, V273, P19269, DOI 10.1074/jbc.273.30.19269; LU DL, 1994, EUR J BIOCHEM, V222, P753, DOI 10.1111/j.1432-1033.1994.tb18921.x; Madiai F, 1996, GENE, V179, P231, DOI 10.1016/S0378-1119(96)00365-4; McWhirter JR, 1997, DEVELOPMENT, V124, P3221; Mehta VB, 1998, J BIOL CHEM, V273, P4197, DOI 10.1074/jbc.273.7.4197; Miyake A, 1998, BIOCHEM BIOPH RES CO, V243, P148, DOI 10.1006/bbrc.1998.8073; MIYAMOTO M, 1993, MOL CELL BIOL, V13, P4251, DOI 10.1128/MCB.13.7.4251; MYERS RL, 1995, ONCOGENE, V11, P785; MYERS RL, 1995, J BIOL CHEM, V270, P8257, DOI 10.1074/jbc.270.14.8257; MYERS RL, 1993, ONCOGENE, V8, P341; PAYSON RA, 1993, NUCLEIC ACIDS RES, V21, P489, DOI 10.1093/nar/21.3.489; Philippe JM, 1996, DNA CELL BIOL, V15, P703, DOI 10.1089/dna.1996.15.703; PIERCE JC, 1992, MAMM GENOME, V3, P550, DOI 10.1007/BF00350620; PIERCE JC, 1992, P NATL ACAD SCI USA, V89, P2056, DOI 10.1073/pnas.89.6.2056; PIRVOLA U, 1995, P NATL ACAD SCI USA, V92, P9269, DOI 10.1073/pnas.92.20.9269; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ray SK, 1997, J BIOL CHEM, V272, P7546, DOI 10.1074/jbc.272.11.7546; RENAUD F, 1994, J CELL PHYSIOL, V158, P435, DOI 10.1002/jcp.1041580307; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shin JT, 1996, BBA-MOL CELL RES, V1312, P27, DOI 10.1016/0167-4889(96)00013-4; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; TANAKA A, 1992, P NATL ACAD SCI USA, V89, P8928, DOI 10.1073/pnas.89.19.8928; THOMAS D, 1991, DEV BRAIN RES, V59, P117, DOI 10.1016/0165-3806(91)90091-V; WANG WP, 1991, ONCOGENE, V6, P1521; WANG WP, 1991, DNA CELL BIOL, V10, P771, DOI 10.1089/dna.1991.10.771; WANG WP, 1989, MOL CELL BIOL, V9, P2387, DOI 10.1128/MCB.9.6.2387; WEINER HL, 1989, P NATL ACAD SCI USA, V86, P2683, DOI 10.1073/pnas.86.8.2683; Yamasaki M, 1996, J BIOL CHEM, V271, P15918, DOI 10.1074/jbc.271.27.15918; YOSHIDA T, 1987, P NATL ACAD SCI USA, V84, P7305, DOI 10.1073/pnas.84.20.7305; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487	61	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11937	11944		10.1074/jbc.274.17.11937	http://dx.doi.org/10.1074/jbc.274.17.11937			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207015	hybrid			2022-12-27	WOS:000079834800071
J	Takasaki, A; Hayashi, N; Matsubara, M; Yamauchi, E; Taniguchi, H				Takasaki, A; Hayashi, N; Matsubara, M; Yamauchi, E; Taniguchi, H			Identification of the calmodulin-binding domain of neuron-specific protein kinase C substrate protein CAP-22/NAP-22 - Direct involvement of protein myristoylation in calmodulin-target protein interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-MYRISTOYLATION; CATALYTIC SUBUNIT; BOVINE BRAIN; MARCKS; PEPTIDES; PHOSPHORYLATION; MYRISTYLATION; RECOVERIN; COMPLEX; PURIFICATION	Various proteins in the signal transduction pathways as well as those of viral origin have been shown to be myristoylated, Although the modification is often essential for the proper functioning of the modified protein, the mechanism by which the modification exerts its effects is still largely unknown. Brain-specific protein kinase C substrate, CAP-23/NAP-22, which is involved in the synaptogenesis and neuronal plasticity, binds calmodulin, but the protein lacks any canonical calmodulin-binding domain. In the present report, we show that CAP-23/NAP-22 isolated from rat brain is myristoylated and that the modification is directly involved in its interaction with calmodulin. Myristoylated and non-myristoylated recombinant proteins were produced in Escherichia coli, and their calmodulin-binding properties were examined. Only the former bound to calmodulin, Synthetic peptides based on the N-terminal sequence showed similar binding properties to calmodulin, only when they were myristoylated, The calmodulin-binding site narrowed down to the myristoyl moiety together with a nine-amino acid N-terminal basic domain. Phosphorylation of a single serine residue in the N-terminal domain (Ser(5)) by protein kinase C abolished the binding. Furthermore, phosphorylation of CAP-23/NAP-22 by protein kinase C was also found myristoylation-dependent, suggesting the importance of myristoylation in protein-protein interactions.	Fujita Hlth Univ, Inst Comprehens Med Sci, Div Biomed Polymer Sci, Aichi 4701192, Japan	Fujita Health University	Taniguchi, H (corresponding author), Fujita Hlth Univ, Inst Comprehens Med Sci, Div Biomed Polymer Sci, Aichi 4701192, Japan.		Taniguchi, Hisaaki/I-9171-2012; Hayashi, Nobuhiro/F-6088-2011; Matsubara, Mamoru/AAP-4016-2021	Hayashi, Nobuhiro/0000-0002-9950-094X; Matsubara, Mamoru/0000-0002-8893-0485				AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; BLUMENTHAL DK, 1985, P NATL ACAD SCI USA, V82, P3187, DOI 10.1073/pnas.82.10.3187; Caroni P, 1997, J CELL BIOL, V136, P679, DOI 10.1083/jcb.136.3.679; CARR SA, 1982, P NATL ACAD SCI-BIOL, V79, P6128, DOI 10.1073/pnas.79.20.6128; CHOW M, 1987, NATURE, V327, P482, DOI 10.1038/327482a0; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; GARBER EA, 1987, P NATL ACAD SCI USA, V84, P80, DOI 10.1073/pnas.84.1.80; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; JOHNSON JD, 1983, BIOCHEM J, V211, P473, DOI 10.1042/bj2110473; KAWAMURA S, 1994, BIOCHEM BIOPH RES CO, V203, P121, DOI 10.1006/bbrc.1994.2157; Kennedy MT, 1996, J BIOL CHEM, V271, P26517, DOI 10.1074/jbc.271.43.26517; KIM JY, 1994, BIOPHYS J, V67, P227, DOI 10.1016/S0006-3495(94)80473-4; KNOLL LJ, 1995, METHOD ENZYMOL, V250, P405; MAEKAWA S, 1993, J BIOL CHEM, V268, P13703; MAEKAWA S, 1994, J BIOL CHEM, V269, P19462; MAEKAWA S, 1994, BBA-GENE STRUCT EXPR, V1218, P119, DOI 10.1016/0167-4781(94)90113-9; MANENTI S, 1993, J BIOL CHEM, V268, P6878; MANENTI S, 1992, J BIOL CHEM, V267, P22310; Matsubara M, 1998, FEBS LETT, V421, P203, DOI 10.1016/S0014-5793(97)01557-3; Matsubara M, 1997, J BIOL CHEM, V272, P23050, DOI 10.1074/jbc.272.37.23050; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; OBRIAN CA, 1990, BIOCHEM PHARMACOL, V39, P49, DOI 10.1016/0006-2952(90)90647-4; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Resh MD, 1996, CELL SIGNAL, V8, P403, DOI 10.1016/S0898-6568(96)00088-5; SENIN II, 1995, FEBS LETT, V376, P87, DOI 10.1016/0014-5793(95)01187-2; TANIGUCHI H, 1993, J BIOL CHEM, V268, P9960; TANIGUCHI H, 1994, J BIOL CHEM, V269, P18299; TANIGUCHI H, 1994, J BIOL CHEM, V269, P22481; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; WARD NE, 1993, BIOCHEMISTRY-US, V32, P11903, DOI 10.1021/bi00095a020; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; WIDMER F, 1990, J CELL BIOL, V111, P3035, DOI 10.1083/jcb.111.6.3035; YONEMOTO W, 1993, J BIOL CHEM, V268, P2348; Zaliani A, 1998, PROTEIN ENG, V11, P803, DOI 10.1093/protein/11.9.803; ZHU DH, 1995, J BIOL CHEM, V270, P24831, DOI 10.1074/jbc.270.42.24831	41	57	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11848	11853		10.1074/jbc.274.17.11848	http://dx.doi.org/10.1074/jbc.274.17.11848			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207003	hybrid			2022-12-27	WOS:000079834800059
J	Yang, ZY; Mendoza, AR; Welch, TR; Zipf, WB; Yu, CY				Yang, ZY; Mendoza, AR; Welch, TR; Zipf, WB; Yu, CY			Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module) - A mechanism for gene deletions and disease associations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; EXTRACELLULAR-MATRIX PROTEIN; EXON-INTRON STRUCTURE; ENDOGENOUS RETROVIRUSES; ANTIGENIC DETERMINANTS; MOLECULAR-GENETICS; 4TH COMPONENT; NULL ALLELES; FACTOR-B; CLASS-I	The frequent variations of human complement component C4 gene size and gene numbers, plus the extensive polymorphism of the proteins, render C4 an excellent marker for major histocompatibility complex disease associations. As shown by definitive RFLPs, the tandemly arranged genes RP, C4, CYP21, and TNX are duplicated together as a discrete genetic unit termed the RCCX module. Duplications of the RCCX modules occurred by the addition of genomic fragments containing a long (L) or a short (S) C4 gene, a CYP21A or a CYP21B gene, and the gene fragments TNXA and RP2, Four major RCCX structures with bimodular L-L, bimodular LS, monomodular L, and monomodular S are present in the Caucasian population. These modules are readily detectable by TaqI RFLPs, The RCCX modular variations appear to be a root cause for the acquisition of deleterious mutations from pseudogenes or gene segments in the RCCX to their corresponding functional genes. In a patient with congenital adrenal hyperplasia, we discovered a TNXB-TNXA recombinant with the deletion of RP2-C4B-CYP21B. Elucidation of the DNA sequence for the recombination breakpoint region and sequence analyses yielded definitive proof for an unequal crossover between TNXA om a bimodular chromosome and TNXB from a monomodular chromosome.	Childrens Hosp Res Fdn, Columbus, OH 43205 USA; Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; Ohio State Univ, Dept Med Microbiol & Immunol, Columbus, OH 43210 USA; Univ Cincinnati, Med Ctr, Cincinnati, OH 45229 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; University of Cincinnati	Yu, CY (corresponding author), Childrens Hosp Res Fdn, Room W208,700 Childrens Dr, Columbus, OH 43205 USA.		Yu, Chack-Yung/E-4360-2011	Welch, Thomas/0000-0002-5893-4020; Yu, Chack-Yung/0000-0002-5218-7503	NCRR NIH HHS [1P41 RR06009] Funding Source: Medline; NIAMS NIH HHS [R01 AR43969] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043969] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aguado B, 1996, HLA MHC GENES MOL FU, P39; AHMED AR, 1991, P NATL ACAD SCI USA, V88, P5056, DOI 10.1073/pnas.88.11.5056; APPLE RJ, 1996, HLA MHC GENES MOL FU, P97; AWDEH ZL, 1980, P NATL ACAD SCI-BIOL, V77, P3576, DOI 10.1073/pnas.77.6.3576; BARBA G, 1993, J CLIN INVEST, V91, P1681, DOI 10.1172/JCI116377; BELT KT, 1984, CELL, V36, P907; BRISTOW J, 1993, J CELL BIOL, V122, P265, DOI 10.1083/jcb.122.1.265; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; CARROLL MC, 1985, EMBO J, V4, P2547, DOI 10.1002/j.1460-2075.1985.tb03969.x; CARROLL MC, 1984, NATURE, V307, P237, DOI 10.1038/307237a0; CARROLL MC, 1990, P NATL ACAD SCI USA, V87, P6868, DOI 10.1073/pnas.87.17.6868; Chiquet-Ehrismann Ruth, 1993, P93; CHU XL, 1992, EXP CLIN IMMUNOGENET, V9, P80; CHU XL, 1995, EXP CLIN IMMUNOGENET, V12, P74; DANGEL AW, 1994, IMMUNOGENETICS, V40, P425; DEGLIESPOSTI MA, 1992, IMMUNOGENETICS, V36, P345; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; DONOHOUE PA, 1995, TISSUE ANTIGENS, V46, P163, DOI 10.1111/j.1399-0039.1995.tb03115.x; FIELDER AHL, 1983, BMJ-BRIT MED J, V286, P425, DOI 10.1136/bmj.286.6363.425; *GEN COMP GROUP, 1991, GCG SEQ AN SOFTW PAC; GILES CM, 1988, IMMUNOGENETICS, V27, P442, DOI 10.1007/BF00364431; GITELMAN SE, 1992, MOL CELL BIOL, V12, P2124, DOI 10.1128/MCB.12.5.2124; Gomez-Escobar N, 1998, J BIOL CHEM, V273, P30954, DOI 10.1074/jbc.273.47.30954; HARDA F, 1987, P NATL ACAD SCI USA, V84, P8091; Hauptmann G, 1988, Immunodefic Rev, V1, P3; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; HOWE HS, 1991, CLIN EXP IMMUNOL, V83, P387; JENHANI F, 1992, J AUTOIMMUN, V5, P149, DOI 10.1016/0896-8411(92)90196-W; JONES FS, 1988, P NATL ACAD SCI USA, V85, P2186, DOI 10.1073/pnas.85.7.2186; JOSPE N, 1987, BIOCHEM BIOPH RES CO, V142, P798, DOI 10.1016/0006-291X(87)91484-7; KAWAGUCHI H, 1991, MOL EVOLUTION MAJOR, P357; LAITINEN T, 1991, HUM REPROD, V6, P1384, DOI 10.1093/oxfordjournals.humrep.a137273; LEVISTRAUSS M, 1988, SCIENCE, V240, P201, DOI 10.1126/science.3353717; LEWIN B, 1995, CELL, V80, P1, DOI 10.1016/0092-8674(95)90442-5; Lokki ML, 1999, J IMMUNOL, V162, P3687; MATSUKI K, 1985, J CLIN INVEST, V76, P2078, DOI 10.1172/JCI112211; MATSUMOTO K, 1992, GENOMICS, V12, P485, DOI 10.1016/0888-7543(92)90438-X; MAUFF G, 1990, COMPLEMENT INFLAMMAT, V7, P193, DOI 10.1159/000463148; MILLER WL, 1989, ANNU REV GENET, V23, P371, DOI 10.1146/annurev.ge.23.120189.002103; MOREL Y, 1989, P NATL ACAD SCI USA, V86, P6582, DOI 10.1073/pnas.86.17.6582; Porter R R, 1983, Mol Biol Med, V1, P161; Rathjen Fritz G., 1993, P87; RAUM D, 1984, AM J HUM GENET, V36, P72; RODRIGUES NR, 1987, EMBO J, V6, P1653, DOI 10.1002/j.1460-2075.1987.tb02414.x; RUPERT KL, 1999, IN PRESS EXP CLIN IM; Saiki R. K., 1990, PCR PROTOCOLS GUIDE, P13; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARGENT CA, 1994, HUM MOL GENET, V3, P481, DOI 10.1093/hmg/3.3.481; SCHAFFER FM, 1989, P NATL ACAD SCI USA, V86, P8015, DOI 10.1073/pnas.86.20.8015; Schneider P.M., 1997, COMPLEMENT PRACTICAL, P165; SCHNEIDER PM, 1986, J CLIN INVEST, V78, P650, DOI 10.1172/JCI112623; SCHNEIDER PM, 1989, EUR J PEDIATR, V149, P170, DOI 10.1007/BF01958273; SHEN LM, 1994, J BIOL CHEM, V269, P8466; SIM E, 1986, BIOCHEM J, V239, P763, DOI 10.1042/bj2390763; Simon S, 1997, HUM IMMUNOL, V57, P27, DOI 10.1016/S0198-8859(97)00177-8; SINNOTT P, 1990, P NATL ACAD SCI USA, V87, P2107, DOI 10.1073/pnas.87.6.2107; TASSABEHJI M, 1994, NUCLEIC ACIDS RES, V22, P5211, DOI 10.1093/nar/22.24.5211; Taylor JE, 1998, EUR J HUM GENET, V6, P467, DOI 10.1038/sj.ejhg.5200210; TEE MK, 1995, GENOMICS, V28, P171, DOI 10.1006/geno.1995.1128; TUSIELUNA MT, 1995, P NATL ACAD SCI USA, V92, P10796, DOI 10.1073/pnas.92.23.10796; VENNEKER GT, 1992, J INVEST DERMATOL, V99, P853, DOI 10.1111/1523-1747.ep12614826; WARREN RP, 1992, IMMUNOGENETICS, V36, P203, DOI 10.1007/BF00215048; WegRemers S, 1997, HUM GENET, V100, P548, DOI 10.1007/s004390050550; WELCH TR, 1989, HUM IMMUNOL, V26, P353, DOI 10.1016/0198-8859(89)90012-8; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; Yang ZY, 1998, GENOMICS, V53, P338, DOI 10.1006/geno.1998.5499; Yu CY, 1998, EXP CLIN IMMUNOGENET, V15, P213, DOI 10.1159/000019075; YU CY, 1986, EMBO J, V5, P2873, DOI 10.1002/j.1460-2075.1986.tb04582.x; YU CY, 1988, IMMUNOGENETICS, V27, P399, DOI 10.1007/BF00364425; YU CY, 1991, J IMMUNOL, V146, P1057; YU CY, 1987, IMMUNOGENETICS, V25, P384; YU CY, 1992, METHOD ENZYMOL, P378; ZU X, 1998, NUCLEIC ACIDS RES, V26, P4068	74	136	138	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12147	12156		10.1074/jbc.274.17.12147	http://dx.doi.org/10.1074/jbc.274.17.12147			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207042	hybrid			2022-12-27	WOS:000079834800098
J	Baskakov, IV; Kumar, R; Srinivasan, G; Ji, YS; Bolen, DW; Thompson, EB				Baskakov, IV; Kumar, R; Srinivasan, G; Ji, YS; Bolen, DW; Thompson, EB			Trimethylamine N-oxide-induced cooperative folding of an intrinsically unfolded transcription-activating fragment of human glucocorticoid receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSACTIVATION DOMAIN; STRUCTURAL CHARACTERIZATION; SECONDARY STRUCTURE; GENE-REGULATION; BETA-SHEET; TRIFLUOROETHANOL; DNA; MECHANISM; PROTEINS; CELLS	A number of biologically important proteins or protein domains identified recently are fully or partially unstructured (unfolded), Methods that allow studies of the propensity of such proteins to fold naturally are valuable. The traditional biophysical approaches using alcohols to drive alpha-helix formation raise serious questions of the relevance of alcohol-induced structure to the biologically important conformations. Recently we illustrated the extraordinary capability of the naturally occurring solute, trimethylamine N-oxide (TMAO), to force two unfolded proteins to fold to native-like species with significant functional activity. In the present work we apply this technique to recombinant human glucocorticoid receptor fragments consisting of residues 1-500 and residues 77-262. CD and fluorescence spectroscopy showed that both were largely disordered in aqueous solution. TMAO induced a condensed structure in the large fragment, indicated by the substantial enhancement in intrinsic fluorescence and blue shift of fluorescent maxima, CD spectroscopy demonstrated that the TMAO-induced structure is different from the alpha-helix-rich conformation driven by trifluoroethanol (TFE), In contrast to TFE, the conformational transition of the 1-500 fragment induced by TMAO is cooperative, a condition characteristic of proteins with unique structures.	Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Thompson, EB (corresponding author), Univ Texas, Med Branch, Dept Human Biol Chem & Genet, 301 Univ Blvd,605 Basic Sci Bldg, Galveston, TX 77555 USA.	bthompso@utmb.edu			NATIONAL CANCER INSTITUTE [R01CA041407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049760] Funding Source: NIH RePORTER; NCI NIH HHS [CA41407] Funding Source: Medline; NIGMS NIH HHS [GM 49760] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALMLOF T, 1995, J BIOL CHEM, V270, P17535, DOI 10.1074/jbc.270.29.17535; Almlof T, 1997, MOL CELL BIOL, V17, P934, DOI 10.1128/MCB.17.2.934; Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; Baskakov I, 1998, BIOPHYS J, V74, P2666, DOI 10.1016/S0006-3495(98)77972-X; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BUCK M, 1995, BIOCHEMISTRY-US, V34, P13219, DOI 10.1021/bi00040a038; CammersGoodwin A, 1996, J AM CHEM SOC, V118, P3082, DOI 10.1021/ja952900z; DAHLMANWRIGHT K, 1995, P NATL ACAD SCI USA, V92, P1699, DOI 10.1073/pnas.92.5.1699; DONALDSON L, 1992, J BIOL CHEM, V267, P1411; FAN P, 1993, BIOCHEMISTRY-US, V32, P1573, DOI 10.1021/bi00057a023; FRANKEL AD, 1991, CELL, V65, P717, DOI 10.1016/0092-8674(91)90378-C; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAHN S, 1993, CELL, V72, P481, DOI 10.1016/0092-8674(93)90064-W; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HOY MV, 1993, CELL, V72, P587; LEUTHER KK, 1993, CELL, V72, P575, DOI 10.1016/0092-8674(93)90076-3; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Luo YZ, 1998, J MOL BIOL, V279, P49, DOI 10.1006/jmbi.1998.1774; MASON SA, 1993, J BIOL CHEM, V268, P21501; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Rahmoune H, 1998, J BIOL CHEM, V273, P7303, DOI 10.1074/jbc.273.13.7303; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHMITZ ML, 1994, J BIOL CHEM, V269, P25613; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; SRINIVASAN G, 1990, MOL ENDOCRINOL, V4, P209, DOI 10.1210/mend-4-2-209; Wang AJ, 1997, BIOCHEMISTRY-US, V36, P9101, DOI 10.1021/bi970247h; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87	30	141	144	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10693	10696		10.1074/jbc.274.16.10693	http://dx.doi.org/10.1074/jbc.274.16.10693			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196139	hybrid			2022-12-27	WOS:000079751900007
J	Brown, BK; Li, C; Cheng, PC; Song, WX				Brown, BK; Li, C; Cheng, PC; Song, WX			Trafficking of the Ig alpha/Ig beta heterodimer with membrane Ig and bound antigen to the major histocompatibility complex class II peptide-loading compartment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; HLA-DM; INTRACELLULAR-TRANSPORT; INVARIANT CHAIN; B-LYMPHOCYTES; RECEPTOR; IMMUNOGLOBULIN; MOLECULES; CELLS; INTERNALIZATION	The binding of antigen to the B cell antigen receptor (BCR) initiates two major cellular events. First, upon cross linking by antigen, the BCR induces signal transduction cascades leading to the transcription of a number of genes associated with B cell activation. Second, the BCR internalizes and delivers antigens to processing compartments, where processed antigenic peptides are loaded onto major histocompatibility complex (MHC) class II molecules for presentation to T helper cells. The BCR consists of membrane Ig (mIg) and Ig alpha/ Ig beta heterodimer (Ig alpha/Ig beta). The Ig alpha/Ig beta, the signal transducing component of the BCR, has been indicated to play a role in antigen processing. In order to understand the function of the Ig alpha/Ig beta in antigen transport, we studied the intracellular trafficking pathway of the Ig alpha/Ig beta. We show that in the absence of antigen binding, the Ig alpha/Ig beta constitutively traffics with mig from the plasma membrane, through the early endosomes, to the MHC class II peptide-loading compartment. Cross-linking the BCR does not alter the trafficking pathway; however, it accelerates the transport of the Ig alpha/Ig beta to the MHC class II peptide-loading compartment. This suggests that the Ig alpha/Ig beta heterodimer is involved in BCR-mediated antigen transport through the entire antigen transport pathway.	Univ Maryland, Dept Cell Biol & Mol Genet, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	University System of Maryland; University of Maryland College Park; Northwestern University	Song, WX (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA.				NIAID NIH HHS [R29AI42093] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI042093] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; Aluvihare VR, 1997, EMBO J, V16, P3553, DOI 10.1093/emboj/16.12.3553; AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BARNES KA, 1995, J EXP MED, V181, P1715, DOI 10.1084/jem.181.5.1715; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; BONNEROT C, 1995, IMMUNITY, V3, P335, DOI 10.1016/1074-7613(95)90118-3; CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457; Cassard S, 1998, J IMMUNOL, V160, P1767; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; CASTEN LA, 1988, J IMMUNOL, V140, P404; CASTEN LA, 1985, P NATL ACAD SCI USA, V82, P5890, DOI 10.1073/pnas.82.17.5890; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1997, SCIENCE, V278, P106, DOI 10.1126/science.278.5335.106; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; GREEN JM, 1995, J IMMUNOL, V155, P3759; HARDING CV, 1993, J IMMUNOL, V151, P3988; HAUGHTON G, 1986, IMMUNOL REV, V93, P35, DOI 10.1111/j.1600-065X.1986.tb01501.x; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; HOMBACH J, 1988, EMBO J, V7, P3451, DOI 10.1002/j.1460-2075.1988.tb03219.x; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; JELACHICH ML, 1984, P NATL ACAD SCI-BIOL, V81, P5537, DOI 10.1073/pnas.81.17.5537; Kleijmeer MJ, 1997, J CELL BIOL, V139, P639, DOI 10.1083/jcb.139.3.639; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Lankar D, 1998, J EXP MED, V188, P819, DOI 10.1084/jem.188.5.819; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MITCHELL RN, 1995, J EXP MED, V181, P1705, DOI 10.1084/jem.181.5.1705; OZATO K, 1980, J IMMUNOL, V124, P533; PATEL KJ, 1993, CELL, V74, P939, DOI 10.1016/0092-8674(93)90473-4; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; QIU Y, 1994, J CELL BIOL, V125, P595, DOI 10.1083/jcb.125.3.595; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; RUDENSKY AY, 1994, IMMUNITY, V1, P585, DOI 10.1016/1074-7613(94)90048-5; Schafer PH, 1996, J IMMUNOL, V157, P5487; SHAW AC, 1990, CELL, V63, P381, DOI 10.1016/0092-8674(90)90171-A; Siemasko K, 1998, J IMMUNOL, V160, P5203; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SONG WX, 1994, J BIOL CHEM, V269, P29474; SONG WX, 1995, J IMMUNOL, V155, P4255; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; WOLF PR, 1995, NATURE, V376, P464, DOI 10.1038/376464a0; Xu XX, 1996, INT IMMUNOL, V8, P1867, DOI 10.1093/intimm/8.12.1867; XU XX, 1995, J IMMUNOL, V155, P2984	52	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11439	11446		10.1074/jbc.274.16.11439	http://dx.doi.org/10.1074/jbc.274.16.11439			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196238	hybrid			2022-12-27	WOS:000079751900106
J	Nagai, Y; Aoki, J; Sato, T; Amano, R; Matsuda, Y; Arai, H; Inoue, K				Nagai, Y; Aoki, J; Sato, T; Amano, R; Matsuda, Y; Arai, H; Inoue, K			An alternative splicing form of phosphatidylserine-specific phospholipase A(1) that exhibits lysophosphatidylserine-specific lysophospholipase activity in humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PANCREATIC LIPASE; ACTIVATED PLATELETS; LIPOPROTEIN-LIPASE; CYTOSOLIC PHOSPHOLIPASE-A(2); HEPATIC LIPASE; ANNEXIN-V; CELLS; MEMBRANE; BINDING; TRANSLOCATION	Phosphatidylserine-specific phospholipase A(1) (PS-PLA(1)), which acts specifically on phosphatidylserine (PS) and 1-acyl-2-lysophosphatidylserine (lyso-PS) to hydrolyze fatty acids at the sn-l position of these phospholipids, was first identified in rat platelets (Sato, T., Aoki, J., Nagai, Y., Dohmae, N., Takio, K., Doi, T., Arai, H., and Inoue, K. (1997) J. Biol. Chem. 272, 2192-2198). In this study we isolated and sequenced cDNA clones encoding human PS-PLA(1), which showed 80% homology with rat PS-PLA(1) at the amino acid level. In addition to an mRNA encoding a 456-amino acid product (PS-PLA(1)), an mRNA with four extra bases inserted at the boundary of the exon-intron junction was detected in human tissues and various human cell lines. This mRNA is most probably produced via an alternative use of the 5'-splicing site (two consensus sequences for RNA splicing occur at the boundary of the exon-intron junction) and encodes a 376-amino acid product (PS-PLA(1)Delta C) that lacks two-thirds of the C-terminal domain of PS PLA(1). Unlike PS-PLA(1), PS-PLA(1)Delta C hydrolyzed exclusively lyso-PS but not PS appreciably. Any other phospholipids such as phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidic acid (PA), and their lyse derivatives were not hydrolyzed at all. These data demonstrated that PS-PLA(1)Delta C exhibits lyso-PS-specific lysophospholipase activity and that the C-terminal domain of PS-PLA(1) is responsible for recognizing diacylphospholipids. In addition, human PS-PLA(1) gene was mapped to chromosome 3q13.13-13.2 and was unexpectedly identical to the nmd gene, which is highly expressed in nonmetastatic melanoma cell lines but poorly expressed in metastatic cell lines (van Groningen, J. J., Bloemers, H. P., and Swart, G. W. (1995) Cancer Res. 55, 6237-6243).	Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Bunkyo Ku, Tokyo 1130033, Japan; Nagoya Univ, Sch Agr Sci, Lab Anim Genet, Chikusa Ku, Nagoya, Aichi 4640814, Japan	University of Tokyo; Nagoya University	Aoki, J (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	jaoki@mol.f.u-tokyo.ac.jp		Aoki, Junken/0000-0001-9435-1896				BASSE F, 1993, BIOCHEMISTRY-US, V32, P2337, DOI 10.1021/bi00060a027; BELLINI F, 1993, FEBS LETT, V316, P1, DOI 10.1016/0014-5793(93)81724-E; BITBOL M, 1988, P NATL ACAD SCI USA, V85, P6783, DOI 10.1073/pnas.85.18.6783; BOHN E, 1992, FEBS LETT, V296, P237, DOI 10.1016/0014-5793(92)80294-Q; BRUNI A, 1984, AGENTS ACTIONS, V14, P619, DOI 10.1007/BF01978896; Bruni A, 1988, Prog Clin Biol Res, V282, P165; CALDERON C, 1994, J EXP MED, V180, P945, DOI 10.1084/jem.180.3.945; CONNOR J, 1994, J BIOL CHEM, V269, P2399; DUGI KA, 1995, J BIOL CHEM, V270, P25396, DOI 10.1074/jbc.270.43.25396; FADOK VA, 1993, J IMMUNOL, V151, P4274; FUJIMORI Y, 1993, EUR J BIOCHEM, V218, P629, DOI 10.1111/j.1432-1033.1993.tb18416.x; GASSAMADIAGNE A, 1991, METHOD ENZYMOL, V197, P316; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; GILLETT MPT, 1993, INT J BIOCHEM, V25, P449, DOI 10.1016/0020-711X(93)90639-V; Grant KA, 1997, INFECT IMMUN, V65, P1172, DOI 10.1128/IAI.65.4.1172-1180.1997; HIDE WA, 1992, J LIPID RES, V33, P167; HJORTH A, 1993, BIOCHEMISTRY-US, V32, P4702, DOI 10.1021/bi00069a003; HORIGOME K, 1987, J BIOCHEM-TOKYO, V101, P53, DOI 10.1093/oxfordjournals.jbchem.a121907; HORIGOME K, 1986, J BIOCHEM-TOKYO, V100, P571, DOI 10.1093/oxfordjournals.jbchem.a121748; JENNENS ML, 1994, J BIOL CHEM, V269, P25470; Liliom K, 1998, AM J PHYSIOL-CELL PH, V274, pC1065, DOI 10.1152/ajpcell.1998.274.4.C1065; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; PLUCKTHUN A, 1982, BIOCHEMISTRY-US, V21, P1743; RAVANAT C, 1992, BIOCHEM J, V282, P7, DOI 10.1042/bj2820007; REYNOLDS LJ, 1993, BIOCHIM BIOPHYS ACTA, V1167, P272, DOI 10.1016/0005-2760(93)90229-3; SAITO K, 1991, METHOD ENZYMOL, V197, P446; SAKANE F, 1991, J BIOL CHEM, V266, P7096; SANTAMARINAFOJO S, 1994, INT J CLIN LAB RES, V24, P143, DOI 10.1007/BF02592444; Sato T, 1997, J BIOL CHEM, V272, P2192; SATTA N, 1994, J IMMUNOL, V153, P3245; STOCKERT M, 1992, ADV EXP MED BIOL, V318, P325; TAKAHASHI E, 1990, HUM GENET, V86, P14; THIAGARAJAN P, 1990, J BIOL CHEM, V265, P17420; TUMA PL, 1993, J BIOL CHEM, V268, P17240; vanGroningen JJM, 1997, FEBS LETT, V404, P82, DOI 10.1016/S0014-5793(97)00098-7; VANTILBEURGH H, 1994, J BIOL CHEM, V269, P4626; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; YOKOYAMA K, 1995, J BIOCHEM-TOKYO, V117, P1280, DOI 10.1093/oxfordjournals.jbchem.a124856; ZWAAL RFA, 1989, MOL CELL BIOCHEM, V91, P23, DOI 10.1007/BF00228075	41	51	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11053	11059		10.1074/jbc.274.16.11053	http://dx.doi.org/10.1074/jbc.274.16.11053			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196188	hybrid			2022-12-27	WOS:000079751900056
J	Yang, W; Wang, DZ; Richmond, A				Yang, W; Wang, DZ; Richmond, A			Role of clathrin-mediated endocytosis in CXCR2 sequestration, resensitization, and signal transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; HUMAN INTERLEUKIN-8 RECEPTOR; COATED VESICLE FORMATION; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; CHEMOTACTIC CYTOKINES; HUMAN NEUTROPHILS; DYNAMIN; CHEMOKINES; FAMILY	CXCR2 is a seven-transmembrane receptor that transduces intracellular signals in response to the chemokines interleukin-8, melanoma growth-stimulatory activity/growth-regulatory protein, and other ELR motif-containing CXC chemokines by coupling to heterotrimeric GTP-binding proteins. In this study, we explored the mechanism responsible for ligand-induced CXCR2 endocytosis. Here, we demonstrate that dynamin, a component of clathrin-mediated endocytosis, is essential for CXCR2 endocytosis and resensitization. In HEK293 cells, dynamin I K44A, a dominant-negative mutant of dynamin that inhibits the clathrin-mediated endocytosis, blocks the ligand-stimulated CXCR2 sequestration. Furthermore, co-expression of dynamin I K44A significantly delays dephosphorylation of CXCR2 after ligand stimulation, suggesting that clathrin-mediated endocytosis plays an important role in receptor dephosphorylation and resensitization. In addition, ligand-mediated receptor down-regulation is attenuated when receptor internalization is inhibited by dynamin I K44A. Interestingly, inhibition of receptor endocytosis by dynamin I K44A does not affect the CXCR2-mediated stimulation of mitogen-activated protein kinase. Most significantly, our data indicate that the ligand-stimulated receptor endocytosis is required for CXCR2-mediated chemotaxis in HEK293 cells. Taken together, our findings suggest that clathrin-mediated CXCR2 internalization is crucial for receptor endocytosis, resensitization, and chemotaxis.	Vanderbilt Univ, Sch Med, Dept Cell Biol, Nashville, TN 37232 USA; Vet Affairs Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Richmond, A (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.		Richmond, Ann/A-3048-2014	RICHMOND, ANN/0000-0002-9580-900X	NATIONAL CANCER INSTITUTE [R01CA034590, R23CA034590, P30CA068485] Funding Source: NIH RePORTER; NCI NIH HHS [CA34590, CA68485] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aragay AM, 1998, P NATL ACAD SCI USA, V95, P2985, DOI 10.1073/pnas.95.6.2985; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BAGGIOLINI M, 1995, INT J IMMUNOPHARMACO, V17, P103, DOI 10.1016/0192-0561(94)00088-6; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; Cesarman E, 1996, J VIROL, V70, P8218, DOI 10.1128/JVI.70.11.8218-8223.1996; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; HOPKINS CR, 1994, J CELL BIOL, V125, P1265, DOI 10.1083/jcb.125.6.1265; Knall C, 1996, J BIOL CHEM, V271, P2832, DOI 10.1074/jbc.271.5.2832; Knall C, 1997, P NATL ACAD SCI USA, V94, P3052, DOI 10.1073/pnas.94.7.3052; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Krueger KM, 1997, J BIOL CHEM, V272, P5; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MUELLER SG, 1994, J BIOL CHEM, V269, P1973; Mueller SG, 1997, J BIOL CHEM, V272, P8207, DOI 10.1074/jbc.272.13.8207; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; OPPENHEIM JJ, 1993, ADV EXP MED BIOL, V351, P183; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; Richardson RM, 1998, J BIOL CHEM, V273, P23830, DOI 10.1074/jbc.273.37.23830; SHPETNER HS, 1992, NATURE, V355, P733, DOI 10.1038/355733a0; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; WANG LH, 1995, J BIOL CHEM, V270, P10079, DOI 10.1074/jbc.270.17.10079; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; Yang W, 1997, BIOCHEMISTRY-US, V36, P15193, DOI 10.1021/bi971594u; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	35	110	112	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11328	11333		10.1074/jbc.274.16.11328	http://dx.doi.org/10.1074/jbc.274.16.11328			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196223	hybrid			2022-12-27	WOS:000079751900091
J	Jerome, LJ; Frost, LS				Jerome, LJ; Frost, LS			In vitro analysis of the interaction between the FinO protein and FinP antisense RNA of F-like conjugative plasmids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REV-RESPONSE ELEMENT; COPY NUMBER CONTROL; MESSENGER-RNA; FERTILITY INHIBITION; STRUCTURAL-ANALYSIS; ROM PROTEIN; BINDING; RECOGNITION; EXPRESSION; SEQUENCES	The FinO protein regulates the transfer potential of F-like conjugative plasmids through its interaction with FinP antisense RNA and its target, traJ mRNk FinO binds to and protects FinP from degradation and promotes duplex formation between FinP and traJ mRNA in vitro. The FinP secondary structure consists of two stem-loop domains separated by a 4-base spacer and terminated by a B-base tail. Previous studies suggested FinO bound to the smooth 14-base pair helix of stem-loop II. In this investigation, RNA mobility shift analysis was used to study the interaction between a glutathione S-transferase (GST)-FinO fusion protein and a series of synthetic FinP and traJ mRNA variants. Mutations in 16 of the 28 bases in stem II of FinP that are predicted to disrupt base pairing did not significantly alter the GST-FinO binding affinity. Removal of the single-stranded regions on either side of stem-loop II led to a dramatic decrease in GST-FinO binding to FinP and to the complementary region of the traJ mRNA leader. While no evidence for sequence-specific contacts was found, the results suggest that FinO recognizes the overall shape of the RNA and is influenced by the length of the single-stranded regions flanking the stem-loop.	Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Alberta	Frost, LS (corresponding author), Univ Alberta, Dept Biol Sci, CW405 Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.		Frost, Laura/A-2639-2014	Frost, Laura/0000-0002-8433-8230				Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P9983, DOI 10.1021/bi9607259; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CHANDLER M, 1983, J MOL BIOL, V170, P61, DOI 10.1016/S0022-2836(83)80227-7; CHEAH KC, 1986, J GEN MICROBIOL, V132, P3269; DEMPSEY WB, 1987, MOL GEN GENET, V209, P533, DOI 10.1007/BF00331160; DRAPER DE, 1995, ANNU REV BIOCHEM, V64, P593, DOI 10.1146/annurev.bi.64.070195.003113; EGUCHI Y, 1991, J MOL BIOL, V220, P831, DOI 10.1016/0022-2836(91)90356-B; FINLAY BB, 1986, J BACTERIOL, V167, P754, DOI 10.1128/jb.167.2.754-757.1986; FINNEGAN D, 1973, MOL GEN GENET, V127, P307, DOI 10.1007/BF00267101; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; GREGORIAN RS, 1995, J MOL BIOL, V248, P968, DOI 10.1006/jmbi.1995.0275; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; HELMERCITTERICH M, 1988, EMBO J, V7, P557, DOI 10.1002/j.1460-2075.1988.tb02845.x; IWAI S, 1992, NUCLEIC ACIDS RES, V20, P6465, DOI 10.1093/nar/20.24.6465; Jerome LJ, 1999, J MOL BIOL, V285, P1457, DOI 10.1006/jmbi.1998.2404; KJEMS J, 1991, P NATL ACAD SCI USA, V88, P683, DOI 10.1073/pnas.88.3.683; Koraimann G, 1996, MOL MICROBIOL, V21, P811, DOI 10.1046/j.1365-2958.1996.361401.x; KORAIMANN G, 1991, MOL MICROBIOL, V5, P77, DOI 10.1111/j.1365-2958.1991.tb01828.x; LEE SH, 1992, MOL GEN GENET, V235, P131, DOI 10.1007/BF00286190; MALIM MH, 1991, CELL, V65, P241, DOI 10.1016/0092-8674(91)90158-U; MATTAJ IW, 1993, CELL, V73, P837, DOI 10.1016/0092-8674(93)90265-R; MULLINEAUX P, 1985, PLASMIDS BACTERIA, P605; PREDKI PF, 1995, CELL, V80, P41, DOI 10.1016/0092-8674(95)90449-2; Sandercock JR, 1998, MOL GEN GENET, V259, P622, DOI 10.1007/s004380050856; Sozhamannan S, 1997, J MOL BIOL, V268, P689, DOI 10.1006/jmbi.1997.1004; STEITZ TA, 1993, RNA WORLD, P219; TAMM J, 1983, NUCLEIC ACIDS RES, V11, P6381, DOI 10.1093/nar/11.18.6381; TOMIZAWA J, 1984, CELL, V38, P871, DOI 10.1016/0092-8674(84)90282-4; TSAI MM, 1990, J BACTERIOL, V172, P4603, DOI 10.1128/jb.172.8.4603-4609.1990; VANBIESEN T, 1993, MOL MICROBIOL, V10, P35; VANBIESEN T, 1992, MOL MICROBIOL, V6, P771, DOI 10.1111/j.1365-2958.1992.tb01527.x; VANBIESEN T, 1994, MOL MICROBIOL, V14, P427, DOI 10.1111/j.1365-2958.1994.tb02177.x; VARANI G, 1994, RNA PROTEIN INTERACT, P1; WILLETTS N, 1986, GENET RES, V47, P1, DOI 10.1017/S0016672300024447; WILLIAMS AS, 1995, NUCLEIC ACIDS RES, V23, P654, DOI 10.1093/nar/23.4.654; YOSHIOKA Y, 1987, J BACTERIOL, V169, P619, DOI 10.1128/jb.169.2.619-623.1987	36	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10356	10362		10.1074/jbc.274.15.10356	http://dx.doi.org/10.1074/jbc.274.15.10356			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187824	hybrid			2022-12-27	WOS:000079663500063
J	Shaw, AL; Hochkoeppler, A; Bonora, P; Zannoni, D; Hanson, GR; McEwan, AG				Shaw, AL; Hochkoeppler, A; Bonora, P; Zannoni, D; Hanson, GR; McEwan, AG			Characterization of DorC from Rhodobacter capsulatus, a c-type cytochrome involved in electron transfer to dimethyl sulfoxide reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; DIMETHYLSULFOXIDE REDUCTASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DMSO REDUCTASE; IDENTIFICATION; MOLYBDOENZYME; RESOLUTION; PROTEIN; HEMES	The dorC gene of the dimethyl sulfoxide respiratory (dor) operon of Rhodobacter capsulatus encodes a pentaheme c-type cytochrome that is involved in electron transfer from ubiquinol to periplasmic dimethyl sulfoxide reductase, DorC was expressed as a C-terminal fusion to an 8-amino acid FLAG epitope and was purified from detergent-solubilized membranes by ion exchange chromatography and immunoaffinity chromatography, The DorC protein had a subunit M-r = 46,000, and pyridine hemochrome analysis indicated that it contained 5 mol heme c/mol DorC polypeptide, as predicted from the derived amino acid sequence of the dorC gene. The reduced form of DorC exhibited visible absorption maxima at 551.5 nm (alpha-band), 522 nm (beta-band), and 419 nm (Soret band). Redox potentiometry of the heme centers of DorC identified five components (n = 1) with midpoint potentials of -34, -128, -184, -185, and -276 mV, Despite the low redox potentials of the heme centers, DorC was reduced by duroquinol and was oxidized by dimethyl sulfoxide reductase.	Univ Queensland, Dept Microbiol, Brisbane, Qld 4072, Australia; Univ Queensland, Ctr Magnet Resonance, Brisbane, Qld 4072, Australia; Univ Bologna, Dipartimento Biol, I-40126 Bologna, Italy	University of Queensland; University of Queensland; University of Bologna	McEwan, AG (corresponding author), Univ Queensland, Dept Microbiol, Brisbane, Qld 4072, Australia.	mcewan@biosci.uq.edu.au	/C-3940-2008	/0000-0003-0306-4360; ZANNONI, DAVIDE/0000-0002-7291-4253; McEwan, Alastair/0000-0002-2419-1003				Berks BC, 1995, BBA-BIOENERGETICS, V1232, P97, DOI 10.1016/0005-2728(95)00092-5; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BERTRAND P, 1994, BIOCHIMIE, V76, P524, DOI 10.1016/0300-9084(94)90176-7; Dutton P L, 1978, Methods Enzymol, V54, P411; GAYDA JP, 1988, EUR J BIOCHEM, V177, P199, DOI 10.1111/j.1432-1033.1988.tb14362.x; HATTON AD, 1994, ARCH MICROBIOL, V162, P148; HOPP TP, 1988, BIOTECHNOLOGY, V6, P1205; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATTHEWS CK, 1995, BIOCHEMISTRY-US, P524; McAlpine AS, 1997, J BIOL INORG CHEM, V2, P690, DOI 10.1007/s007750050185; MCEWAN AG, 1991, BIOCHEM J, V274, P305, DOI 10.1042/bj2740305; McEwan AG, 1998, BIOCHEM SOC T, V26, P390, DOI 10.1042/bst0260390; MCEWAN AG, 1989, BIOCHIM BIOPHYS ACTA, V973, P308, DOI 10.1016/S0005-2728(89)80437-2; MEJEAN V, 1994, MOL MICROBIOL, V11, P1169, DOI 10.1111/j.1365-2958.1994.tb00393.x; MOORE GR, 1987, CYTOCHROMES C BIOL A; Mouncey NJ, 1997, J BACTERIOL, V179, P7617, DOI 10.1128/jb.179.24.7617-7624.1997; RICHARDSON DJ, 1988, ARCH MICROBIOL, V150, P130; SANTOS H, 1984, EUR J BIOCHEM, V141, P283, DOI 10.1111/j.1432-1033.1984.tb08190.x; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; Schneider F, 1996, J MOL BIOL, V263, P53, DOI 10.1006/jmbi.1996.0555; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; WEAVER PF, 1975, ARCH MICROBIOL, V105, P207, DOI 10.1007/BF00447139; WEINER JH, 1992, BIOCHIM BIOPHYS ACTA, V1102, P1, DOI 10.1016/0167-4838(92)90493-W	25	42	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					9911	9914		10.1074/jbc.274.15.9911	http://dx.doi.org/10.1074/jbc.274.15.9911			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187763	hybrid			2022-12-27	WOS:000079663500002
J	Umayahara, Y; Billiard, J; Ji, CH; Centrella, M; McCarthy, TL; Rotwein, P				Umayahara, Y; Billiard, J; Ji, CH; Centrella, M; McCarthy, TL; Rotwein, P			CCAAT enhancer-binding protein delta is a critical regulator of insulin-like growth factor-I gene transcription in osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FETAL-RAT BONE; CAMP RESPONSE ELEMENT; ENRICHED CULTURES; PROSTAGLANDIN E(2); C/EBP; IDENTIFICATION; PROMOTER; FAMILY; CELLS; LIVER	Insulin-like growth factor-I (IGF-I) plays a major role in promoting skeletal growth by stimulating bone cell replication and differentiation. Prostaglandin E-2 and other agents that induce cAMP production enhance IGF-I gene transcription in cultured rat osteoblasts through a DNA element termed HS3D, located in the proximal part of the major rat IGF-I promoter. We previously determined that CCAAT/enhancer-binding protein delta (C/EBP delta) is the key cAMP-stimulated regulator of IGF-I transcription in these cells and showed that it transactivates the rat IGF-I promoter through the HS3D site. We now have defined the physical-chemical properties and functional consequences of the interactions between C/EBP delta and HS3D. C/EBP delta, expressed in COS-7 cells or purified as a recombinant protein from Escherichia coli, bound to HS3D with an affinity at least equivalent to that of the albumin D-site, a known high affinity C/EBP binding sequence, and both DNA elements competed equally for C/EBP delta, C/EBP delta bound to HS3D as a dimer, with protein-DNA contact points located on guanine residues on both DNA strands within and just adjacent to the core C/EBP half-site, GCAAT, as determined by methylation interference footprinting, C/EBP delta also formed protein-protein dimers in the absence of interactions with its DNA binding site, as indicated by results of glutaraldehyde cross-linking studies, As established by competition gel-mobility shift experiments, the conserved HS3D sequence from rat, human, and chicken also bound C/EBP delta with similar affinity. We also found that prostaglandin E-2-induced expression of reporter genes containing human IGF-I promoter 1 or four tandem copies of the human HS3D element fused to a minimal promoter and show that these effects were enhanced by a co-transfected C/EBP delta expression plasmid, Taken together, our results provide evidence that C/EBP delta is a critical activator of IGF-I gene transcription in osteoblasts and potentially in other cell types and species.	Oregon Hlth Sci Univ, Dept Med, Div Mol Med, Portland, OR 97201 USA; Yale Univ, Sch Med, Sect Plast Surg, New Haven, CT 06520 USA	Oregon Health & Science University; Yale University	Rotwein, P (corresponding author), Oregon Hlth Sci Univ, Dept Med, Div Mol Med, 3181 SW Sam Jackson Pk Rd,NRC3, Portland, OR 97201 USA.	rotweinp@ohsu.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	NICHD NIH HHS [5-PO1-HD20805] Funding Source: Medline; NIDDK NIH HHS [T32 DK007674, 5-RO1-DK37449] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD020805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037449, T32DK007674] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BICHELL DP, 1993, ENDOCRINOLOGY, V133, P1020, DOI 10.1210/en.133.3.1020; Boudreaux JM, 1996, J BIOL CHEM, V271, P7508, DOI 10.1074/jbc.271.13.7508; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Habener JF, 1995, VITAM HORM, V51, P1, DOI 10.1016/S0083-6729(08)61037-7; HALL LJ, 1992, DNA CELL BIOL, V11, P301, DOI 10.1089/dna.1992.11.301; HAYDEN JM, 1995, BONE, V17, P93; Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Jux C, 1998, ENDOCRINOLOGY, V139, P3296, DOI 10.1210/en.139.7.3296; KAJIMOTO Y, 1991, J BIOL CHEM, V266, P9724; KAVSAN VM, 1993, DNA CELL BIOL, V12, P729, DOI 10.1089/dna.1993.12.729; KIM SW, 1991, MOL ENDOCRINOL, V5, P1964, DOI 10.1210/mend-5-12-1964; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Lean JM, 1996, AM J PHYSIOL-ENDOC M, V270, pE937, DOI 10.1152/ajpendo.1996.270.6.E937; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; MCCARTHY TL, 1990, J BIOL CHEM, V265, P15353; MCCARTHY TL, 1995, ENDOCRINOLOGY, V136, P3901, DOI 10.1210/en.136.9.3901; MCCARTHY TL, 1990, ENDOCRINOLOGY, V126, P1569, DOI 10.1210/endo-126-3-1569; MCCARTHY TL, 1988, J BONE MINER RES, V3, P401; MCCARTHY TL, 1991, ENDOCRINOLOGY, V128, P2895, DOI 10.1210/endo-128-6-2895; MCCARTHY TL, 1989, ENDOCRINOLOGY, V124, P1247, DOI 10.1210/endo-124-3-1247; MCCARTHY TL, 1993, ADV EXP MED BIOL, V343, P407; Osada S, 1996, J BIOL CHEM, V271, P3891; PASH JM, 1995, ENDOCRINOLOGY, V136, P33, DOI 10.1210/en.136.1.33; POLL V, 1990, CELL, V63, P643; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; THOMAS MJ, 1994, ENDOCRINOLOGY, V135, P1584, DOI 10.1210/en.135.4.1584; THOMAS MJ, 1995, ENDOCRINOLOGY, V136, P562, DOI 10.1210/en.136.2.562; Thomas MJ, 1996, J BIOL CHEM, V271, P21835, DOI 10.1074/jbc.271.36.21835; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; Umayahara Y, 1997, J BIOL CHEM, V272, P31793, DOI 10.1074/jbc.272.50.31793; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; WEDEL A, 1995, IMMUNOBIOLOGY, V193, P171, DOI 10.1016/S0171-2985(11)80541-3	39	53	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10609	10617		10.1074/jbc.274.15.10609	http://dx.doi.org/10.1074/jbc.274.15.10609			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187857	hybrid			2022-12-27	WOS:000079663500096
J	Vichi, P; Whelchel, A; Posada, J				Vichi, P; Whelchel, A; Posada, J			Transmembrane helix 7 of the endothelin B receptor regulates downstream signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; TERNARY COMPLEX MODEL; CONSTITUTIVE ACTIVATION; RHODOPSIN; KINASES; EXPRESSION; CLONING; CELLS; AP-1; PROLIFERATION	Endothelin is a al-amino acid peptide with a striking diversity of important biological responses, including, vasoconstriction, bronchoconstriction, and mitogenesis, Endothelin-l binding to the endothelin B receptor (ETB), a member of the superfamily of G-protein-coupled receptors, was associated with catalytic activation of the extracellular-regulated kinase 2 (ERK2) and stimulation of AP-1 transcriptional reporter activity. A panel of single point mutations in transmembrane helix 6 (TM6), intracellular loop 3, and transmembrane helix 7 (TM7) were developed to study the structural requirements for ETB activation. Point mutations within highly conserved regions of TM6 and intracellular loop 3 were without effect on agonist-stimulated ERK activation. However, mutations within TM7 of the ETB significantly impacted ligand-stimulated downstream signaling. For example, nine point mutations within TM7 of the ETB were identified that prevented endothelin-stimulated ERK activation. Interestingly, the TM7 mutants fell into two classes; several exhibited greatly decreased AP-1 activity, relative to wild type ETB, whereas others displayed augmented endothelin-stimulated AP-1 transcriptional activity relative to wild type ETB, Our results suggest that TM7 of the ETB is involved in its activation mechanism and regulates agonist-stimulated ERK activation.	Univ Vermont, Sch Allied Hlth, Dept Biomed Technol, Burlington, VT 05405 USA; Univ Vermont, Coll Med, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Vichi, P (corresponding author), Univ Vermont, Sch Allied Hlth, Dept Biomed Technol, Burlington, VT 05405 USA.			Posada, James/0000-0003-3582-9612	NHLBI NIH HHS [HL55327, HL49570] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049570, R29HL055327] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADACHI M, 1993, J CARDIOVASC PHAR S8, V22, P121; Aquilla E, 1996, J BIOL CHEM, V271, P31572, DOI 10.1074/jbc.271.49.31572; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; BOGOYEVITCH MA, 1995, J BIOL CHEM, V270, P26303, DOI 10.1074/jbc.270.44.26303; CAZAUBON SM, 1994, J BIOL CHEM, V269, P24805; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DRATZ EA, 1983, TRENDS BIOCHEM SCI, V8, P128, DOI 10.1016/0968-0004(83)90235-9; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; HASHIDO K, 1993, CELL MOL BIOL RES, V39, P3; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; LIN HY, 1991, P NATL ACAD SCI USA, V88, P3185, DOI 10.1073/pnas.88.8.3185; Rincon M, 1996, MOL CELL BIOL, V16, P1074; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Shapiro PS, 1996, J BIOL CHEM, V271, P5750, DOI 10.1074/jbc.271.10.5750; SIMONSON MS, 1992, J BIOL CHEM, V267, P8643; Simonson MS, 1996, J BIOL CHEM, V271, P77, DOI 10.1074/jbc.271.1.77; SIMONSON MS, 1993, J BIOL CHEM, V268, P9347; Spalding TA, 1997, BIOCHEMISTRY-US, V36, P10109, DOI 10.1021/bi970565g; UNGER VM, 1995, BIOPHYS J, V68, P1776, DOI 10.1016/S0006-3495(95)80354-1; Whelchel A, 1997, AM J RESP CELL MOL, V16, P589, DOI 10.1165/ajrcmb.16.5.9160841; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	26	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10331	10338		10.1074/jbc.274.15.10331	http://dx.doi.org/10.1074/jbc.274.15.10331			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187821	hybrid			2022-12-27	WOS:000079663500060
J	Nikolaev, I; Lenouvel, F; Felenbok, B				Nikolaev, I; Lenouvel, F; Felenbok, B			Unique DNA binding specificity of the binuclear zinc AlcR activator of the ethanol utilization pathway in Aspergillus nidulans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ALCR; CRYSTAL-STRUCTURE; CLUSTER PROTEINS; RECOGNITION; SEQUENCE; COMPLEX; DOMAIN; REGION; FAMILY; MOTIF	AlcR is the transcriptional activator in Aspergillus nidulans, necessary for the induction of the ale gene cluster. It belongs to the Zn(2)Cys(6) zinc cluster protein family, but contains some striking differences compared with other proteins of this group. In this report, we show that no dimerization element is present in the entire AlcR protein which occurs in solution as a monomer and binds also to its cognate sites as a monomer. Another important feature of AlcR is its unique specificity for single sites occurring naturally as inverted or direct repeats and sharing a common motif, 5'-(T/A)GCGG-S', Like most other Zn(2)Cys(6) proteins, AlcR contacts directly with the CGG triplet and, in addition, the upstream adjacent guanine is required for high affinity binding. We also establish that the flanking regions outside the core play an essential role in tight binding. From our in vitro analysis, we propose an optimal AlcR-binding site which is 5'-PuNGCGG-AT rich 3'.	Univ Paris 11, CNRS, UMR 8621, Ctr Univ Orsay,Inst Genet & Microbiol, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Felenbok, B (corresponding author), Univ Paris 11, CNRS, UMR 8621, Ctr Univ Orsay,Inst Genet & Microbiol, Batiment 409, F-91405 Orsay, France.							Ascone I, 1997, BBA-PROTEIN STRUCT M, V1343, P211, DOI 10.1016/S0167-4838(97)00112-X; BATTAGLIA PA, 1994, BIOCHEM BIOPH RES CO, V201, P701, DOI 10.1006/bbrc.1994.1757; CASTAGNOLI L, 1994, J MOL BIOL, V237, P378, DOI 10.1006/jmbi.1994.1241; Cerdan R, 1997, FEBS LETT, V408, P235, DOI 10.1016/S0014-5793(97)00430-4; CERDAN R, 1997, THESIS U PARIS SUD F; Felenbok B, 1994, Prog Ind Microbiol, V29, P141; Fillinger S, 1996, MOL MICROBIOL, V20, P475, DOI 10.1046/j.1365-2958.1996.5301061.x; FILLINGER S, 1996, THESIS U PARIS SUD F; HU JC, 1990, SCIENCE, V250, P1400, DOI 10.1126/science.2147779; JOHNSTON M, 1987, P NATL ACAD SCI USA, V84, P2401, DOI 10.1073/pnas.84.8.2401; KULMBURG P, 1992, J BIOL CHEM, V267, P21146; KULMBURG P, 1991, FEBS LETT, V280, P11, DOI 10.1016/0014-5793(91)80193-7; KULMBURG P, 1992, MOL CELL BIOL, V12, P1932, DOI 10.1128/MCB.12.5.1932; Lenouvel F, 1997, J BIOL CHEM, V272, P15521, DOI 10.1074/jbc.272.24.15521; LENOUVEL F, 1996, THESIS U PARIS SUD F; Liang SD, 1996, MOL CELL BIOL, V16, P3773; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; MARCHETTI A, 1995, J MOL BIOL, V248, P541, DOI 10.1006/jmbi.1995.0241; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; MARMORSTEIN R, 1994, GENE DEV, V8, P2504, DOI 10.1101/gad.8.20.2504; MATHIEU M, 1994, EMBO J, V13, P4022, DOI 10.1002/j.1460-2075.1994.tb06718.x; MAXAM AM, 1980, METHOD ENZYMOL, V65, P497; Nikolaev I, 1999, MOL MICROBIOL, V31, P1115, DOI 10.1046/j.1365-2958.1999.01250.x; Panozzo C, 1997, J BIOL CHEM, V272, P22859, DOI 10.1074/jbc.272.36.22859; Poch O, 1997, GENE, V184, P229, DOI 10.1016/S0378-1119(96)00602-6; REECE RJ, 1993, SCIENCE, V261, P909, DOI 10.1126/science.8346441; SCAZZOCCHIO C, 1994, ASPERGILLUS 50 YEARS, V29, P259; Schjerling P, 1996, NUCLEIC ACIDS RES, V24, P4599, DOI 10.1093/nar/24.23.4599; SEQUEVAL D, 1994, MOL GEN GENET, V242, P33, DOI 10.1007/BF00277345; Strauss J, 1998, MOL CELL BIOL, V18, P1339, DOI 10.1128/MCB.18.3.1339; Swaminathan K, 1997, NAT STRUCT BIOL, V4, P751, DOI 10.1038/nsb0997-751; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; Walters KJ, 1997, NAT STRUCT BIOL, V4, P744, DOI 10.1038/nsb0997-744	33	26	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9795	9802		10.1074/jbc.274.14.9795	http://dx.doi.org/10.1074/jbc.274.14.9795			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092669	hybrid			2022-12-27	WOS:000079451800088
J	Wuytens, G; Verschueren, K; de Winter, JP; Gajendran, N; Beek, L; Devos, K; Bosman, F; de Waele, P; Andries, M; van den Eijnden-van Raaij, AJM; Smith, JC; Huylebroeck, D				Wuytens, G; Verschueren, K; de Winter, JP; Gajendran, N; Beek, L; Devos, K; Bosman, F; de Waele, P; Andries, M; van den Eijnden-van Raaij, AJM; Smith, JC; Huylebroeck, D			Identification of two amino acids in activin A that are important for biological activity and binding to the activin type II receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-2; OSTEOGENIC PROTEIN-1; FUNCTIONAL-ANALYSIS; MESODERM INDUCTION; CYSTEINE RESIDUES; CRYSTAL-STRUCTURE; NEURAL INDUCTION; XENOPUS-LAEVIS; SUPERFAMILY	Activins are members of the transforming growth factor-beta family of growth and differentiation factors. In this paper, we report the results of a structure-function analysis of activin A. The primary targets for directed mutagenesis were charged, individual amino acids located in accessible domains of the protein, concentrating on those that differ from transforming growth factor-beta 2, the x-ray crystal structure of which is known. Based on the activities of the recombinant activin mutants in two bioassays, 4 out of 39 mutant proteins (D27K, K102A, K102E, and K102R) produced in a vaccinia virus system were selected for further investigation. After production in insect cells and purification of these four mutants to homogeneity, they were studied in bioassays and in cross-linking experiments involving transfected receptor combinations. Mutant D27K has a 2-fold higher specific bio-activity and binding affinity to an ActRIIA/ALK-4 activin receptor complex than wild type activin, whereas mutant K102E had no detectable biological activity and did not bind to any of the activin receptors. Mutant K102R and wild type activin bound to all the activin receptor combinations tested and were equipotent in bioassays. Our results with the Lys-102 mutants indicate that the positive charge of amino acid 102 is important for biological activity and type II receptor binding of activins.	Catholic Univ Louvain, Mol Biol Lab, CELGEN, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol VIB, Dept Cell Growth Differentiat & Dev VIB07, B-3000 Louvain, Belgium; Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Innogenet SA, B-9052 Zwijnaarde, Belgium; Catholic Univ Louvain, Lab Cell Pharmacol, B-3000 Louvain, Belgium; Natl Inst Med Res, Div Dev Biol, London NW7 1AA, England	Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Innogenetics NV; Universite Catholique Louvain; MRC National Institute for Medical Research	Huylebroeck, D (corresponding author), Catholic Univ Louvain, Mol Biol Lab, CELGEN, Herestr 49, B-3000 Louvain, Belgium.	dhu@sgi.celgen.kuleuven.ac.be		Smith, Jim/0000-0003-2413-9392; , Nadesan/0000-0002-7463-4220; Huylebroeck, Danny/0000-0003-4862-1079				ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; BRUNNER AM, 1992, MOL ENDOCRINOL, V6, P1691, DOI 10.1210/me.6.10.1691; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; DENEF C, 1989, METHOD ENZYMOL, V168, P47; ENGSTROM U, 1992, J BIOL CHEM, V267, P16581; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Huang SS, 1997, J BIOL CHEM, V272, P27155, DOI 10.1074/jbc.272.43.27155; HUYLEBROECK D, 1990, MOL ENDOCRINOL, V4, P1153, DOI 10.1210/mend-4-8-1153; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; INAGAKI M, 1993, P NATL ACAD SCI USA, V90, P5359, DOI 10.1073/pnas.90.11.5359; JONES CM, 1995, DEVELOPMENT, V121, P3651; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Leal SM, 1997, J BIOL CHEM, V272, P20572, DOI 10.1074/jbc.272.33.20572; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; Liu QJ, 1997, J BIOL CHEM, V272, P18891, DOI 10.1074/jbc.272.30.18891; MASON AJ, 1994, MOL ENDOCRINOL, V8, P325, DOI 10.1210/me.8.3.325; Mason AJ, 1996, MOL ENDOCRINOL, V10, P1055, DOI 10.1210/me.10.9.1055; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MATHEWS LS, 1994, ENDOCR REV, V15, P310, DOI 10.1210/er.15.3.310; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Nishitoh H, 1997, Kokubyo Gakkai Zasshi, V64, P24; Qian SW, 1996, J BIOL CHEM, V271, P30656, DOI 10.1074/jbc.271.48.30656; Roberts AB, 1990, PEPTIDE GROWTH FACTO, P419; ROEBROEK AJM, 1993, EMBO J, V12, P1853, DOI 10.1002/j.1460-2075.1993.tb05834.x; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; SCHNEYER AL, 1994, ENDOCRINOLOGY, V135, P667, DOI 10.1210/en.135.2.667; SLACK JMW, 1984, J EMBRYOL EXP MORPH, V80, P289; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; SMITH JC, 1983, J EMBRYOL EXP MORPH, V78, P299; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; SYMES K, 1987, DEVELOPMENT, V101, P339; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; WITTBRODT J, 1994, GENE DEV, V8, P1448, DOI 10.1101/gad.8.12.1448; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217	42	35	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9821	9827		10.1074/jbc.274.14.9821	http://dx.doi.org/10.1074/jbc.274.14.9821			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092672	hybrid			2022-12-27	WOS:000079451800091
J	Hoidal, HK; Ertesvag, H; Skjak-Braek, G; Stokke, BT; Valla, S				Hoidal, HK; Ertesvag, H; Skjak-Braek, G; Stokke, BT; Valla, S			The recombinant Azotobacter vinelandii mannuronan C-5-epimerase AlgE4 epimerizes alginate by a nonrandom attack mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; CHEMICAL-COMPOSITION; NMR-SPECTROSCOPY; SEQUENCE; ACID; CLONING; PATTERN; STRAINS; GELS; GENE	The Ca2+-dependent mannuronan C-5-epimerase AlgE4 is a representative of a family of Azotobacter vinelandii enzymes catalyzing the polymer level epimerization of beta-D-mannuronic acid (M) to alpha-L-guluronic acid (G) in the commercially important polysaccharide alginate. The reaction product of recombinantly produced AlgE4 is predominantly characterized by an alternating sequence distribution of the M and Gr residues (MG blocks). AlgE4 was purified after intracellular overexpression in Escherichia coli, and the activity was shown to be optimal at pH values between 6.5 and 7.0, in the presence of 1-3 mM Ca2+, and at temperatures near 37 degrees C, Sr2+ was found to substitute reasonably well for Ca2+ in activation, whereas Zn2+ strongly inhibited the activity. During epimerization of alginate, the fraction of GMG blocks increased linearly as a function of the total fraction of Gr residues and comparably much faster than that of MMG blocks. These experimental data could not be accounted for by a random attack mechanism, suggesting that the enzyme either slides along the alginate chain during catalysis or recognizes a pre-existing G; residue as a preferred substrate in its consecutive attacks.	Norwegian Univ Sci & Technol, UNIGEN Ctr Mol Biol, N-7849 Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Biotechnol, N-7849 Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Phys, N-7849 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Valla, S (corresponding author), Norwegian Univ Sci & Technol, UNIGEN Ctr Mol Biol, N-7849 Trondheim, Norway.		Stokke, Bjørn T/C-4957-2009	Stokke, Bjørn T/0000-0003-2991-8088; Ertesvag, helga/0000-0001-9437-9469				BAYER AS, 1992, INFECT IMMUN, V60, P3979, DOI 10.1128/IAI.60.10.3979-3985.1992; BOYD A, 1994, APPL ENVIRON MICROB, V60, P2355, DOI 10.1128/AEM.60.7.2355-2359.1994; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CORNISHB.A, 1974, BIOCHEM J, V139, P721, DOI 10.1042/bj1390721; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DRAGET KI, 1994, CARBOHYD POLYM, V25, P31, DOI 10.1016/0144-8617(94)90159-7; Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8; DUBOIS M, 1956, ANAL CHEM, V28, P356; ERTESVAG H, 1995, MOL MICROBIOL, V16, P719, DOI 10.1111/j.1365-2958.1995.tb02433.x; ERTESVAG H, 1994, J BACTERIOL, V176, P2846; FETT WF, 1989, PLANT PHYSIOL, V89, P5, DOI 10.1104/pp.89.1.5; FUJIHARA M, 1992, CARBOHYD RES, V224, P343, DOI 10.1016/0008-6215(92)84123-A; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7; GRASDALEN H, 1979, CARBOHYD RES, V68, P23, DOI 10.1016/S0008-6215(00)84051-3; GRASDALEN H, 1981, CARBOHYD RES, V89, P179, DOI 10.1016/S0008-6215(00)85243-X; GRASDALEN H, 1983, CARBOHYD RES, V118, P255, DOI 10.1016/0008-6215(83)88053-7; Grasdalen H, 1996, CARBOHYD RES, V289, P105, DOI 10.1016/0008-6215(96)00079-1; HAUG A, 1967, ACTA CHEM SCAND, V21, P768, DOI 10.3891/acta.chem.scand.21-0768; HAUG A, 1974, CARBOHYD RES, V32, P217, DOI 10.1016/S0008-6215(00)82100-X; HAUG A, 1969, BIOCHIM BIOPHYS ACTA, V192, P557, DOI 10.1016/0304-4165(69)90414-0; HAUG A, 1962, ACTA CHEM SCAND, V16, P1908, DOI 10.3891/acta.chem.scand.16-1908; HAUG A, 1971, CARBOHYD RES, V17, P297, DOI 10.1016/S0008-6215(00)82537-9; HAUG A, 1964, 30 NORW I SEAW RES N, P116; JOHANSEN HK, 1994, INFECT IMMUN, V62, P3146, DOI 10.1128/IAI.62.8.3146-3155.1994; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSEN B, 1981, CARBOHYD RES, V92, P163, DOI 10.1016/S0008-6215(00)85994-7; LARSEN B, 1971, CARBOHYD RES, V17, P287, DOI 10.1016/S0008-6215(00)82536-7; LARSEN B, 1971, CARBOHYD RES, V20, P225, DOI 10.1016/S0008-6215(00)81375-0; LIN LP, 1968, J BACTERIOL, V95, P2336, DOI 10.1128/JB.95.6.2336-2343.1968; MARTINOU A, 1998, IN PRESS CARBOHYDR R; MINGOS DMP, 1995, ESSENTIALS INORGANIC, V1; MITCHELL ED, 1973, BIOCHIM BIOPHYS ACTA, V295, P314, DOI 10.1016/0005-2795(73)90099-8; Ofstad R., 1981, P 11 INT SEAW S GOET, P485; Onsoyen E, 1996, CARBOHYDR EUR, V46, P26; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; OTTERLEI M, 1991, J IMMUNOTHER, V10, P286, DOI 10.1097/00002371-199108000-00007; Rehm BH, 1996, J BACTERIOL, V178, P5884, DOI 10.1128/jb.178.20.5884-5889.1996; ROBYT JF, 1967, ARCH BIOCHEM BIOPHYS, V122, P8, DOI 10.1016/0003-9861(67)90118-X; SADOFF HL, 1975, BACTERIOL REV, V39, P516, DOI 10.1128/MMBR.39.4.516-539.1975; Sambrook J., 2002, MOL CLONING LAB MANU; SHERBROCKCOX V, 1984, CARBOHYD RES, V135, P147, DOI 10.1016/0008-6215(84)85012-0; SIMPSON JA, 1988, J GEN MICROBIOL, V134, P29; Skjak-Braek G, 1991, SEAWEED RESOURCES EU, P219; Skjak-Braek G, 1996, CARBOHYDR EUR, V14, P19; SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239; SKJAKBRAEK G, 1982, CARBOHYD RES, V103, P133, DOI 10.1016/S0008-6215(82)80013-X; SMIDSROD O, 1972, ACTA CHEM SCAND, V26, P79, DOI 10.3891/acta.chem.scand.26-0079; STOKKE BT, 1995, CAN J CHEM, V78, P1972; Svanem BIG, 1999, J BACTERIOL, V181, P68, DOI 10.1128/JB.181.1.68-77.1999; Varum KM, 1996, BBA-GEN SUBJECTS, V1291, P5, DOI 10.1016/0304-4165(96)00038-4; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	53	65	67	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12316	12322		10.1074/jbc.274.18.12316	http://dx.doi.org/10.1074/jbc.274.18.12316			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212201	hybrid			2022-12-27	WOS:000080056800021
J	Isshiki, S; Togayachi, A; Kudo, T; Nishihara, S; Watanabe, M; Kubota, T; Kitajima, M; Shiraishi, N; Sasaki, K; Andoh, T; Narimatsu, H				Isshiki, S; Togayachi, A; Kudo, T; Nishihara, S; Watanabe, M; Kubota, T; Kitajima, M; Shiraishi, N; Sasaki, K; Andoh, T; Narimatsu, H			Cloning, expression, and characterization of a novel UDP-galactose :beta-N-acetylglucosamine beta 1,3-galactosyltransferase (beta 3Gal-T5) responsible for synthesis of type 1 chain in colorectal and pancreatic epithelia and tumor cells derived therefrom	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALYL-LEWIS-X; CARBOHYDRATE ANTIGENS; PROGNOSTIC FACTOR; CANCER PATIENTS; GASTRIC-CANCER; LINES; GENE; ALPHA-1,3-FUCOSYL-TRANSFERASE; BIOSYNTHESIS; GANGLIOSIDE	The sialyl Lewis a antigen is a well known tumor marker, CA19-9, which is frequently elevated in the serum in gastrointestinal and pancreatic cancers. UDP-galactose:N-acetylglucosamine pl,3-galactosyltransferase(s) (beta 3Gal-Ts) are required for the synthesis of the sialyl Lewis a epitope, In the present study, a novel beta 3Gal-T, named beta 3Gal-T5, was isolated from a Colo205 cDNA library using a degenerate primer strategy based on the amino acid sequences of the four human beta 3Gal-T genes cloned to date. Transfection experiments demonstrated that HCT-15 cells transfected with the beta 3Gal-T5 gene expressed all the type 1 Lewis antigens. In gastrointestinal and pancreatic cancer cell lines, the amounts of beta 3Gal-T5 transcripts were quite well correlated with the amounts of the sialyl Lewis a antigens. The beta 1,3Gal-T activity toward agalacto-lacto-N-neotetraose was also well correlated with the amounts of beta 3Gal-T5 transcripts in a series of cultured cancer cells, and in Namalwa and HCT-15 cells transfected with the beta 3Gal-T5 gene. Thus, the beta 3Gal-T5 gene is the most probable candidate responsible for the synthesis of the type 1 Lewis antigens in gastrointestinal and pancreatic epithelia and tumor cells derived therefrom. In addition, beta 3Gal-T5 is a key enzyme that determines the amounts of the type 1 Lewis antigens including the sialyl Lewis a antigen.	Soka Univ, Inst Life Sci, Div Cell Biol, Hachioji, Tokyo 1928577, Japan; Soka Univ, Fac Engn, Dept Bioengn, Hachioji, Tokyo 1928577, Japan; Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 1608282, Japan; Kyowa Hakko Kogyo Co Ltd, Tokyo Res Labs, Machida, Tokyo 1948533, Japan	Soka University; Soka University; Keio University; Kyowa Kirin Ltd	Narimatsu, H (corresponding author), Soka Univ, Inst Life Sci, Div Cell Biol, 1-236 Tangi Cho, Hachioji, Tokyo 1928577, Japan.	hisashi@scc1.t.soka.ac.jp	Kubota, Tomomi/J-1492-2018	Kubota, Tomomi/0000-0002-0723-135X; Nishihara, Shoko/0000-0002-1668-2603				Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FRUMKIN A, 1993, DEVELOPMENT, V118, P553; HAMANAKA Y, 1994, FEBS LETT, V353, P48, DOI 10.1016/0014-5793(94)01004-8; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hennet T, 1998, J BIOL CHEM, V273, P58, DOI 10.1074/jbc.273.1.58; HOLMES EH, 1989, ARCH BIOCHEM BIOPHYS, V270, P630, DOI 10.1016/0003-9861(89)90546-8; HROMAS R, 1995, CANCER RES, V55, P3610; Kolbinger F, 1998, J BIOL CHEM, V273, P433, DOI 10.1074/jbc.273.1.433; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Kudo T, 1998, J BIOL CHEM, V273, P26729, DOI 10.1074/jbc.273.41.26729; Kudo T, 1998, LAB INVEST, V78, P797; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MAGNANI JL, 1982, J BIOL CHEM, V257, P4365; MAGNANI JL, 1983, CANCER RES, V43, P5489; Miyazaki H, 1997, J BIOL CHEM, V272, P24794, DOI 10.1074/jbc.272.40.24794; Nakamori S, 1997, J CLIN ONCOL, V15, P816, DOI 10.1200/JCO.1997.15.2.816; NAKAYAMA T, 1995, CANCER, V75, P2051, DOI 10.1002/1097-0142(19950415)75:8<2051::AID-CNCR2820750804>3.0.CO;2-4; Nakayama T, 1997, ANTICANCER RES, V17, P1379; Narimatsu H, 1998, CANCER RES, V58, P512; Narimatsu H, 1996, CANCER RES, V56, P330; NGUYEN M, 1993, NATURE, V365, P267, DOI 10.1038/365267a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SASAKI K, 1994, J BIOL CHEM, V269, P14730; SASAKI K, 1994, Patent No. 0618759; TAKADA A, 1993, CANCER RES, V53, P354; TORRADO J, 1992, GASTROENTEROLOGY, V102, P424, DOI 10.1016/0016-5085(92)90086-E; Valli M, 1998, EUR J BIOCHEM, V256, P494, DOI 10.1046/j.1432-1327.1998.2560494.x; YAGO K, 1993, CANCER RES, V53, P5559	30	113	138	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12499	12507		10.1074/jbc.274.18.12499	http://dx.doi.org/10.1074/jbc.274.18.12499			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212226	hybrid			2022-12-27	WOS:000080056800046
J	Raya, A; Revert, F; Navarro, S; Saus, J				Raya, A; Revert, F; Navarro, S; Saus, J			Characterization of a novel type of serine/threonine kinase that specifically phosphorylates the human goodpasture antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; KAPPA-B-ALPHA; PROTEIN-KINASE; IDENTIFICATION; AUTOANTIGEN; EXPRESSION; SITE; DEGRADATION; DATABASE; COMPLEX	Goodpasture disease is an autoimmune disorder that occurs naturally only in humans. Also exclusive to humans is the phosphorylation process that targets the unique N terminal region of the Goodpasture antigen. Here we report the molecular cloning of GPBP (Goodpasture antigen-binding protein), a previously unknown 624-residue polypeptide. Although the predicted sequence does not meet the conventional structural requirements for a protein kinase, its recombinant counterpart specifically binds to and phosphorylates the exclusive N-terminal region of the human Goodpasture antigen in vitro, This novel kinase is widely expressed in human tissues but shows preferential expression in the histological structures that are targets of common autoimmune responses. The work presented in this report highlights a novel gene to be explored in human autoimmunity.	Inst Invest Citological Caja Ahorros Valencia, Fdn Valenciana Invest Biomed, Valencia 46010, Spain; Univ Valencia, Fac Med, Dept Patol, Valencia 46010, Spain	University of Valencia	Saus, J (corresponding author), Inst Invest Citological Caja Ahorros Valencia, Fdn Valenciana Invest Biomed, C Amadeo de Saboya 4, Valencia 46010, Spain.	jsaus@ochoa.fib.es	Raya, Angel/E-6205-2010; REVERT, FERNANDO/ABF-8171-2021	Raya, Angel/0000-0003-2189-9775; REVERT, FERNANDO/0000-0002-7304-5846; Saus, Juan/0000-0003-2082-1597				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; BEELER JF, 1994, MOL CELL BIOL, V14, P982, DOI 10.1128/MCB.14.2.982; BERNAL D, 1993, J BIOL CHEM, V268, P12090; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Coligan JE, 1996, CURRENT PROTOCOLS PR; Cote GP, 1997, J BIOL CHEM, V272, P6846, DOI 10.1074/jbc.272.11.6846; CSERMELY P, 1991, J BIOL CHEM, V266, P4943; CSERMELY P, 1995, J BIOL CHEM, V270, P6381, DOI 10.1074/jbc.270.11.6381; Dikstein R, 1996, CELL, V84, P781, DOI 10.1016/S0092-8674(00)81055-7; Eichinger L, 1996, EMBO J, V15, P5547, DOI 10.1002/j.1460-2075.1996.tb00939.x; ERLICH H, 1998, MHC DIS ASS ENCY IMM, P1690; FENG LL, 1994, J BIOL CHEM, V269, P2342; FERRELL JE, 1991, METHOD ENZYMOL, V200, P430; Fraser RA, 1998, J BIOL CHEM, V273, P16199, DOI 10.1074/jbc.273.26.16199; Henderson RD, 1998, ACTA NEUROL SCAND, V98, P134; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Langelier Y, 1998, J BIOL CHEM, V273, P1435, DOI 10.1074/jbc.273.3.1435; LEINONEN A, 1994, J BIOL CHEM, V269, P26172; Lemmon MA, 1998, CURR TOP MICROBIOL, V228, P39; Lemmon MA, 1997, TRENDS CELL BIOL, V7, P237, DOI 10.1016/S0962-8924(97)01065-9; LITERSKY JM, 1992, J BIOL CHEM, V267, P1563; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; MARU Y, 1991, CELL, V67, P459, DOI 10.1016/0092-8674(91)90521-Y; PENADES JR, 1995, EUR J BIOCHEM, V229, P754, DOI 10.1111/j.1432-1033.1995.tb20524.x; Phelps RG, 1998, J BIOL CHEM, V273, P11440, DOI 10.1074/jbc.273.19.11440; Phelps RG, 1996, J BIOL CHEM, V271, P18549, DOI 10.1074/jbc.271.31.18549; QUINONES S, 1992, J BIOL CHEM, V267, P19780; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; REVERT F, 1995, J BIOL CHEM, V270, P13254, DOI 10.1074/jbc.270.22.13254; ROITT I, 1994, AUTOIMMUNE DIS, P383; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAUS J, 1998, GOODPASTURES SYNDROM, P1005; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334	41	71	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12642	12649		10.1074/jbc.274.18.12642	http://dx.doi.org/10.1074/jbc.274.18.12642			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212244	hybrid			2022-12-27	WOS:000080056800064
J	Valentinis, B; Romano, G; Peruzzi, F; Morrione, A; Prisco, M; Soddu, S; Cristofanelli, B; Sacchi, A; Baserga, R				Valentinis, B; Romano, G; Peruzzi, F; Morrione, A; Prisco, M; Soddu, S; Cristofanelli, B; Sacchi, A; Baserga, R			Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; HEMATOPOIETIC-CELLS; IGF-I; MYOBLAST DIFFERENTIATION; RETROVIRAL VECTORS; NEURITE FORMATION; NON-SH2 DOMAINS; SOMATOMEDIN-C; SHC PROTEINS	The type 1 insulin-like growth factor receptor (IGF-IR) plays an important role in the growth of cells both in vivo and in vitro. The IGF-IR is also capable of inducing differentiation in a number of cell types, raising the question of how the same receptor can send two seemingly contradictory signals, one for growth and one for differentiation. Using 32D cells, which are murine hemopoietic cells, we show that the activated IGF-IR can induce differentiation along the granulocytic pathway in a manner similar to the granulocyte colony-stimulating factor. We find that one of the major substrates of the IGF-IR, the insulin receptor substrate-1 inhibits IGF-I-mediated differentiation of 32D cells. In the absence of insulin receptor substrate-1, functional impairment of another major substrate of the IGF-IR, the Shc proteins, is associated with a decrease in the extent of differentiation. Although the end points of the respective pathways remain to be defined, these results show for the first time that IGF-I-mediated growth or differentiation of hemopoietic cells may depend on a balance between two of its substrates.	Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Ctr Ricersa Sperimentale, Inst Regina Elena, Lab Oncogenesi Mol, I-00158 Rome, Italy	Jefferson University; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Baserga, R (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, 233 S 10th St,624 BLSB, Philadelphia, PA 19107 USA.	rbaserga@lac.jci.tju.edu	Soddu, Silvia/K-2467-2018; Soddu, Silvia/ABH-6774-2020; Peruzzi, Francesca/M-9804-2014	Soddu, Silvia/0000-0001-8526-0044; Soddu, Silvia/0000-0001-8526-0044; 	NCI NIH HHS [CA 53484] Funding Source: Medline; NIGMS NIH HHS [GM 33694] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA053484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033694] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHULER D, 1994, MOL ENDOCRINOL, V8, P1139, DOI 10.1210/me.8.9.1139; ASKEW DS, 1991, ONCOGENE, V6, P1915; BALDARI CT, 1995, ONCOGENE, V10, P1141; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; CRAPARO A, 1995, J BIOL CHEM, V270, P15639, DOI 10.1074/jbc.270.26.15639; DAmbrosio C, 1997, CANCER RES, V57, P3264; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dews M, 1997, RECEPT SIGNAL TRANS, V7, P231; Dumenil G, 1997, BIOCHEM BIOPH RES CO, V234, P748, DOI 10.1006/bbrc.1997.6702; Fei ZL, 1997, ONCOGENE, V15, P961, DOI 10.1038/sj.onc.1201265; FLORINI JR, 1986, AM J PHYSIOL, V250, pC771, DOI 10.1152/ajpcell.1986.250.5.C771; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; GIORGETTI S, 1993, J BIOL CHEM, V268, P7358; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; HAWLEY RG, 1994, GENE THER, V1, P136; HE WM, 1995, J BIOL CHEM, V270, P23258, DOI 10.1074/jbc.270.40.23258; Hill RJ, 1996, CELL GROWTH DIFFER, V7, P1125; Hongo A, 1996, ONCOGENE, V12, P1231; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kulik G, 1998, MOL CELL BIOL, V18, P6711, DOI 10.1128/MCB.18.11.6711; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; LANFRANCONE L, 1995, ONCOGENE, V10, P907; LI SW, 1994, J BIOL CHEM, V269, P32558; Maruoka Y, 1997, BIOCHEM BIOPH RES CO, V238, P886, DOI 10.1006/bbrc.1997.7405; MCCUE JL, 1991, BRIT J SURG, V78, P921, DOI 10.1002/bjs.1800780808; MCMORRIS FA, 1986, P NATL ACAD SCI USA, V83, P822, DOI 10.1073/pnas.83.3.822; MERCHAV S, 1988, J CLIN INVEST, V81, P791, DOI 10.1172/JCI113385; METCALF D, 1985, BLOOD, V65, P357; MILL JF, 1985, P NATL ACAD SCI USA, V82, P7126, DOI 10.1073/pnas.82.20.7126; MISCHAK H, 1993, J BIOL CHEM, V268, P20110; Miura M, 1997, BIOCHEM BIOPH RES CO, V239, P182, DOI 10.1006/bbrc.1997.7449; MYERS MG, 1994, J BIOL CHEM, V269, P28783; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; OConnor R, 1997, MOL CELL BIOL, V17, P427, DOI 10.1128/MCB.17.1.427; OUWENS DM, 1994, J BIOL CHEM, V269, P33116; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Prisco M, 1999, HORM METAB RES, V31, P80, DOI 10.1055/s-2007-978703; Prisco M, 1997, MOL CELL BIOL, V17, P1084, DOI 10.1128/MCB.17.3.1084; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; PRUETT W, 1995, MOL CELL BIOL, V15, P1778; RECIOPINTO E, 1984, P NATL ACAD SCI-BIOL, V81, P2562, DOI 10.1073/pnas.81.8.2562; RODRIGUEZTARDUCHY G, 1992, J IMMUNOL, V149, P535; Romano G, 1999, J CELL BIOCHEM, V72, P294, DOI 10.1002/(SICI)1097-4644(19990201)72:2<294::AID-JCB14>3.0.CO;2-0; Romano G, 1997, VIROLOGY, V237, P23, DOI 10.1006/viro.1997.8764; ROSE DW, 1994, P NATL ACAD SCI USA, V91, P797, DOI 10.1073/pnas.91.2.797; Rubini M, 1997, EXP CELL RES, V230, P284, DOI 10.1006/excr.1996.3430; SCHMID C, 1983, FEBS LETT, V161, P117, DOI 10.1016/0014-5793(83)80742-X; SCHMID C, 1984, FEBS LETT, V173, P48, DOI 10.1016/0014-5793(84)81015-7; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; TARTAREDECKERT S, 1995, J BIOL CHEM, V270, P23456, DOI 10.1074/jbc.270.40.23456; Valentinis, 1997, BIOCHIM BIOPHYS ACTA, V1332, P105; Valentinis B, 1999, ONCOGENE, V18, P1827, DOI 10.1038/sj.onc.1202471; Valentinis B, 1997, MOL CELL BIOL, V17, P3744, DOI 10.1128/MCB.17.7.3744; VALTIERI M, 1987, J IMMUNOL, V138, P3829; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WATERS SB, 1993, J BIOL CHEM, V268, P22231; WENG QP, 1995, P NATL ACAD SCI USA, V92, P5744, DOI 10.1073/pnas.92.12.5744; YAMAUCHI K, 1994, MOL CELL BIOL, V14, P4427, DOI 10.1128/MCB.14.7.4427; Yao R, 1996, ONCOGENE, V13, P343; Yenush L, 1996, MOL CELL BIOL, V16, P2509; Zamorano J, 1996, J IMMUNOL, V157, P4926	63	119	129	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12423	12430		10.1074/jbc.274.18.12423	http://dx.doi.org/10.1074/jbc.274.18.12423			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212216	hybrid, Green Published			2022-12-27	WOS:000080056800036
J	Williams, JR; Sharp, JW; Kumari, VG; Wilson, M; Payne, JA				Williams, JR; Sharp, JW; Kumari, VG; Wilson, M; Payne, JA			The neuron-specific K-Cl cotransporter, KCC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN CORTICAL-NEURONS; CEREBELLAR GRANULE CELLS; SHARK RECTAL GLAND; KCL CO-TRANSPORT; MONOCLONAL-ANTIBODIES; GABA(A) RECEPTOR; FUNCTIONAL EXPRESSION; RAT-BRAIN; SUBCELLULAR-LOCALIZATION; MOLECULAR-CLONING	The neuron-specific K-Cl cotransporter (KCC2) is hypothesized to function as an active Cl- extrusion pathway important in postsynaptic inhibition mediated by ligand-gated anion channels, like gamma-aminobutyric acid type A (GABA(A)) and glycine receptors, To understand better the functional role of KCC2 in the nervous system, we developed polyclonal antibodies to a KCC2 fusion protein and used these antibodies 60 characterize and localize KCC2 in the rat cerebellum. The antibodies specifically recognized the KCC2 protein which is an similar to 140-kDa glycoprotein detectable only within the central nervous system. The KCC2 protein displayed a robust and punctate distribution in primary cultured retinal amacrine cells known to form exclusively GABA(A)ergic synapses in culture. In immunolocalization studies, KCC2 was absent from axons and glia but was highly expressed at neuronal somata and dendrites, indicating a specific postsynaptic distribution of the protein. In the granule cell layer, KCC2 exhibited a distinct colocalization with the beta(2)/beta(3)-subunits of the GABA(A) receptor at the plasma membrane of granule cell somata and at cerebellar glomeruli, KCC2 lightly labeled the plasma membrane of Purkinje cell somata. Within the molecular layer, KCC2 exhibited a distinctly punctate distribution along dendrites, indicating it may be highly localized at inhibitory synapses along these processes. The distinct postsynaptic localization of KCC2 and its colocalization with GABA(A) receptor in the cerebellum are consistent with the putative role of KCC2 in neuronal Cl- extrusion and postsynaptic inhibition.	Univ Calif Davis, Sch Med, Dept Human Physiol, Davis, CA 95616 USA; Univ Calif Davis, Sch Med, Dept Human Anat & Cell Biol, Davis, CA 95616 USA; Univ Calif Davis, Div Biol Sci, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Payne, JA (corresponding author), Univ Calif Davis, Sch Med, Dept Human Physiol, 1 Shields Ave, Davis, CA 95616 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036296, R29NS036296] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-36296] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AICKIN CC, 1984, NEUROSCI LETT, V47, P239, DOI 10.1016/0304-3940(84)90520-2; AICKIN CC, 1982, J PHYSIOL-LONDON, V329, P319, DOI 10.1113/jphysiol.1982.sp014305; ALVAREZLEEFMANS FJ, 1990, CHLORIDE CHANNELS AND CARRIERS IN NERVE, MUSCLE, AND GLIAL CELLS, P109; ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P1138, DOI 10.1152/jn.1964.27.6.1138; BISHOP GA, 1993, ANAT EMBRYOL, V188, P287; DEBLAS AL, 1988, J NEUROSCI, V8, P602; DUNHAM PB, 1990, REGULATION POTASSIUM, P331; ECCLES JC, 1966, EXP BRAIN RES, V1, P161; EWERT M, 1992, BRAIN RES, V569, P57, DOI 10.1016/0006-8993(92)90368-J; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; GABBOTT PLA, 1986, J COMP NEUROL, V251, P474, DOI 10.1002/cne.902510404; GAO B, 1995, DEV BRAIN RES, V88, P1, DOI 10.1016/0165-3806(95)00062-I; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; GLEASON E, 1993, J NEUROSCI, V13, P2359, DOI 10.1523/JNEUROSCI.13-06-02359.1993; GLEASON E, 1992, VISUAL NEUROSCI, V8, P315, DOI 10.1017/S0952523800005058; GUTIERREZ A, 1994, J NEUROSCI, V14, P7168; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; KING JS, 1993, ANAT EMBRYOL, V188, P299; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; LLANO I, 1988, P NATL ACAD SCI USA, V85, P3221, DOI 10.1073/pnas.85.9.3221; LYTLE C, 1992, AM J PHYSIOL, V262, pC1009, DOI 10.1152/ajpcell.1992.262.4.C1009; LYTLE C, 1992, J BIOL CHEM, V267, P25428; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; Nusser Z, 1998, J NEUROSCI, V18, P1693; PAYNE JA, 1995, J BIOL CHEM, V270, P17977, DOI 10.1074/jbc.270.30.17977; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; REUSS L, 1983, NATURE, V305, P723, DOI 10.1038/305723a0; RICHARDS JG, 1987, J NEUROSCI, V7, P1866; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rohrbough J, 1996, J NEUROSCI, V16, P82; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; SAITO K, 1974, P NATL ACAD SCI USA, V71, P269, DOI 10.1073/pnas.71.2.269; SASAKI S, 1988, J CLIN INVEST, V81, P194, DOI 10.1172/JCI113294; SOMOGYI P, 1989, J NEUROSCI, V9, P2197; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; THOMPSON SM, 1988, J NEUROPHYSIOL, V60, P105, DOI 10.1152/jn.1988.60.1.105; THOMPSON SM, 1988, NEUROSCI LETT, V89, P49, DOI 10.1016/0304-3940(88)90479-X; Wisden W, 1996, NEUROPHARMACOLOGY, V35, P1139, DOI 10.1016/S0028-3908(96)00076-7; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201	41	183	184	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12656	12664		10.1074/jbc.274.18.12656	http://dx.doi.org/10.1074/jbc.274.18.12656			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212246	hybrid			2022-12-27	WOS:000080056800066
J	Brock, TG; McNish, RW; Peters-Golden, M				Brock, TG; McNish, RW; Peters-Golden, M			Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); TUMOR-NECROSIS-FACTOR; RAT PERITONEAL-MACROPHAGES; BASOPHILIC LEUKEMIA-CELLS; NUCLEAR-ENVELOPE; MAST-CELLS; SUBCELLULAR-LOCALIZATION; ENDOPEROXIDE SYNTHASE-1; SIGNAL-TRANSDUCTION; INDUCTION	The two cyclooxygenase isoforms, cyclooxygenase-1 and cyclooxygenase-2, both metabolize arachidonic acid to prostaglandin H-2, which is subsequently processed by downstream enzymes to the various prostanoids. In the present study, we asked if the two isoforms differ in the profile of prostanoids that ultimately arise from their action on arachidonic acid. Resident peritoneal macrophages contained only cyclooxygenase-1 and synthesized (from either endogenous or exogenous arachidonic acid) a balance of four major prostanoids: prostacyclin, thromboxane A(2), prostaglandin D-2, and 12-hydroxyheptadecatrienoic acid. Prostaglandin E-2 was a minor fifth product, although these cells efficiently converted exogenous prostaglandin H-2 to prostaglandin E-2. By contrast, induction of cyclooxygenase-a with lipopolysaccharide resulted in the preferential production of prostacyclin and prostaglandin E-2. This shift in product profile was accentuated if cyclooxygenase-1 was permanently inactivated with aspirin before cyclooxygenase-2 induction. The conversion of exogenous prostaglandin H-2 to prostaglandin E-2 was only modestly increased by lipopolysaccharide treatment. Thus, cyclooxygenase-a induction leads to a shift in arachidonic acid metabolism from the production of several prostanoids with diverse effects as mediated by cyclooxygenase-1 to the preferential synthesis of two prostanoids, prostacyclin and prostaglandin E-2, which evoke common effects at the cellular level.	Univ Michigan, Med Ctr, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Brock, TG (corresponding author), Univ Michigan, Med Ctr, Div Pulm & Crit Care Med, 6301 MSRB 3, Ann Arbor, MI 48109 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL046487, T32HL007749, R01HL047391] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL07749, R01 HL47391, P50 HL46487] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; BETZ M, 1991, J IMMUNOL, V146, P108; BishopBailey D, 1997, ARTERIOSCL THROM VAS, V17, P1644, DOI 10.1161/01.ATV.17.9.1644; Bjorkman David J., 1998, American Journal of Medicine, V105, p8S, DOI 10.1016/S0002-9343(98)00069-2; BROCK T, 1997, EICOSANOIDS ASPIRIN, P91; BROCK TG, 1994, J BIOL CHEM, V269, P22059; Bustos M, 1997, J CLIN INVEST, V100, P1150, DOI 10.1172/JCI119626; CHANDLER DB, 1983, AM REV RESPIR DIS, V128, P71, DOI 10.1164/arrd.1983.128.1.71; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Fedyk ER, 1997, ADV EXP MED BIOL, V407, P237; FLETCHER JR, 1993, ANN SURG, V217, P668, DOI 10.1097/00000658-199306000-00008; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; HELBIG H, 1990, CURR EYE RES, V9, P501, DOI 10.3109/02713689008999616; HERTELENDY F, 1993, AM J REPROD IMMUNOL, V30, P49, DOI 10.1111/j.1600-0897.1993.tb00601.x; HILKENS CMU, 1995, EUR J IMMUNOL, V25, P59, DOI 10.1002/eji.1830250112; KUNKEL SL, 1984, ADV INFLAMMAT RES, V7, P93; MASFERRER JL, 1994, P NATL ACAD SCI USA, V91, P3228, DOI 10.1073/pnas.91.8.3228; Matsumoto H, 1997, BIOCHEM BIOPH RES CO, V230, P110, DOI 10.1006/bbrc.1996.5894; Modeer T, 1996, J CLIN PERIODONTOL, V23, P927, DOI 10.1111/j.1600-051X.1996.tb00513.x; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; MUKHERJEE E, 1989, PROSTAGLANDINS, V38, P557, DOI 10.1016/0090-6980(89)90149-4; MURAKAMI M, 1994, J BIOL CHEM, V269, P22269; MURAKAMI M, 1995, J BIOL CHEM, V270, P3239, DOI 10.1074/jbc.270.7.3239; Naraba H, 1998, J IMMUNOL, V160, P2974; PETERSGOLDEN M, 1990, J IMMUNOL, V144, P263; PetersGolden M, 1996, BIOCHEM J, V318, P797, DOI 10.1042/bj3180797; PETERSGOLDEN M, 1997, LUNG MACROPHAGES DEN, P151; PHIPPS RP, 1991, IMMUNOL TODAY, V12, P349, DOI 10.1016/0167-5699(91)90064-Z; REDDY ST, 1994, J BIOL CHEM, V269, P15473; Reddy ST, 1997, J BIOL CHEM, V272, P3231, DOI 10.1074/jbc.272.6.3231; RIEDO FX, 1990, J IMMUNOL, V144, P3506; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; SMITH WL, 1982, METHOD ENZYMOL, V86, P213; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; UJIHARA M, 1988, ARCH BIOCHEM BIOPHYS, V260, P521, DOI 10.1016/0003-9861(88)90477-8; URADE Y, 1989, J IMMUNOL, V143, P2982; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; WHEELER AP, 1992, AM REV RESPIR DIS, V145, P632, DOI 10.1164/ajrccm/145.3.632; WILBORN J, 1995, AM J PHYSIOL-LUNG C, V268, pL294, DOI 10.1152/ajplung.1995.268.2.L294; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Zhang Y, 1998, J IMMUNOL, V160, P1053	41	230	241	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11660	11666		10.1074/jbc.274.17.11660	http://dx.doi.org/10.1074/jbc.274.17.11660			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206978	hybrid			2022-12-27	WOS:000079834800034
J	Fischle, W; Emiliani, S; Hendzel, MJ; Nagase, T; Nomura, N; Voelter, W; Verdin, E				Fischle, W; Emiliani, S; Hendzel, MJ; Nagase, T; Nomura, N; Voelter, W; Verdin, E			A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION; IN-VIVO; CHROMATIN STRUCTURE; YEAST GCN5P; N-COR; COMPLEX; ACETYLATION; RPD3; ACTIVATION; COREPRESSOR	Histone deacetylases are the catalytic subunits of multiprotein complexes that are targeted to specific pro meters through their interaction with sequence-specific DNA-binding factors. We have cloned and characterized a new human cDNA, HDAC-A, with homology to the yeast HDA1 family of histone deacetylases. Analysis of the predicted amino acid sequence of HDAC-A revealed an open reading frame of 967 amino acids containing two domains: a NH2-terminal domain with no homology to known proteins and a COOH-terminal domain with homology to known histone deacetylases (42% similarity to RPD3, 60% similarity to HDA1), Three additional human cDNAs with high homology to HDAC-A were identified in sequence data bases, indicating that HDAC-A itself is a member of a new family of human histone deacetylases. The mRNA encoding HDAC-A was differentially expressed in a variety of human tissues. The expressed protein, HDAC-Ap, exhibited histone deacetylase activity and this activity mapped to the COOH-terminal region (amino acids 495-967) with homology to HDA1p, in immunoprecipitation experiments, HDAC-A interacted specifically with several cellular proteins, indicating that it might be part of a larger multiprotein complex.	Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Univ Alberta, Dept Oncol, Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; Kazusa DNA Res Inst, Chiba 2920812, Japan; Univ Tubingen, Inst Physiol Chem, D-72076 Tubingen, Germany	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Alberta; Kazusa DNA Research Institute; Eberhard Karls University of Tubingen	Verdin, E (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, POB 419100, San Francisco, CA 94141 USA.		Verdin, Eric/AAB-7999-2019; Hendzel, Michael/C-3391-2009; Emiliani, Stéphane/O-2454-2017	Hendzel, Michael/0000-0002-9603-7945; Emiliani, Stéphane/0000-0001-7344-8429; Verdin, Eric/0000-0003-3703-3183	PHS HHS [R016M516] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; AUSIO J, 1992, J CELL SCI, V102, P1; Ausubel FM, 1995, CURRENT PROTOCOLS MO, V1; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Dangond F, 1998, BIOCHEM BIOPH RES CO, V242, P648, DOI 10.1006/bbrc.1997.8033; Davie JR, 1996, J CELL BIOCHEM, V62, P149, DOI 10.1002/(SICI)1097-4644(199608)62:2<149::AID-JCB2>3.0.CO;2-S; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Ferreira R, 1998, P NATL ACAD SCI USA, V95, P10493, DOI 10.1073/pnas.95.18.10493; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hendzel MJ, 1998, MOL BIOL CELL, V9, P2491, DOI 10.1091/mbc.9.9.2491; Imhof A, 1998, CURR BIOL, V8, pR422, DOI 10.1016/S0960-9822(98)70268-4; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kasten MM, 1997, MOL CELL BIOL, V17, P4852, DOI 10.1128/MCB.17.8.4852; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; LOIDL P, 1994, CHROMOSOMA, V103, P441; LOIDL P, 1988, FEBS LETT, V227, P91, DOI 10.1016/0014-5793(88)80874-3; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Lusser A, 1997, SCIENCE, V277, P88, DOI 10.1126/science.277.5322.88; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Mizzen CA, 1998, CELL MOL LIFE SCI, V54, P6, DOI 10.1007/s000180050121; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Ohara O, 1997, DNA Res, V4, P53, DOI 10.1093/dnares/4.1.53; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sambrook J., 2002, MOL CLONING LAB MANU; Scanlan MJ, 1998, INT J CANCER, V76, P652, DOI 10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.3.CO;2-9; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sundqvist A, 1998, FEBS LETT, V429, P183, DOI 10.1016/S0014-5793(98)00588-2; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; VanLint C, 1996, GENE EXPRESSION, V5, P245; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Verdel A, 1999, J BIOL CHEM, V274, P2440, DOI 10.1074/jbc.274.4.2440; VIDAL M, 1991, MOL CELL BIOL, V11, P6317, DOI 10.1128/MCB.11.12.6317; VIDAL M, 1991, MOL CELL BIOL, V11, P6306, DOI 10.1128/MCB.11.12.6306; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang L, 1998, GENE DEV, V12, P640, DOI 10.1101/gad.12.5.640; Wolffe AP, 1997, NATURE, V387, P16, DOI 10.1038/387016a0; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1	64	206	224	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11713	11720		10.1074/jbc.274.17.11713	http://dx.doi.org/10.1074/jbc.274.17.11713			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206986	hybrid			2022-12-27	WOS:000079834800042
J	Mathur, R; Zhou, J; Babila, T; Koren, G				Mathur, R; Zhou, J; Babila, T; Koren, G			Ile-177 and Ser-180 in the S1 segment are critically important in Kv1.1 channel function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIRST TRANSMEMBRANE SEGMENT; GATED POTASSIUM CHANNELS; SHAKER K+ CHANNEL; LONG-QT SYNDROME; ENDOPLASMIC-RETICULUM; EXPRESSION; GENE; CONFORMATIONS; MUTATIONS; PROTEINS	Ile-177 and Ser-180 are conserved residues in the first transmembrane segment (S1) of the Shaker, Shab, Show, and Shal subfamilies of voltage-gated K+ channels. Here we report that the mutation of these residues in Kv1.1 to leucine, proline, or arginine abolished the expression of outward potassium currents in Xenopus oocytes. Go-injection of these mutant cRNAs and wild type Kv1.1 cRNA into Xenopus oocytes exerted a potent dominant negative effect resulting in the suppression of Kv1.1-encoded currents. Transient transfection experiments of COS-7 cells revealed that the S1 mutants directed the synthesis of Kv1.1 polypeptides. Quantitative co-immunoprecipitation assays revealed that most of the S1 mutants coassembled and formed both homo- and heteromultimeric complexes. Furthermore, the mutated polypeptides could reach the plasma membranes of transfected Sol8 cells. We conclude that mutations of Ile-177 and Ser-180 do not interfere with either the assembly of multimeric channel complexes or the targeting of these complexes to the plasma membrane. It is likely that these residues are involved in helix-helix interactions that are critical to the proper functioning of voltage-gated potassium channels.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Koren, G (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	Koren@calvin.bwh.harvard.edu			NHLBI NIH HHS [HL46005] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL146005, R01HL046005] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BABILA T, 1994, NEURON, V12, P615, DOI 10.1016/0896-6273(94)90217-8; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Bibi E, 1998, TRENDS BIOCHEM SCI, V23, P51, DOI 10.1016/S0968-0004(97)01134-1; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; CHANDY KG, 1994, LIGAND VOLTAGE GATED, P1; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; Durell SR, 1998, J STRUCT BIOL, V121, P263, DOI 10.1006/jsbi.1998.3962; Folco E, 1997, J BIOL CHEM, V272, P26505, DOI 10.1074/jbc.272.42.26505; GUY HR, 1994, SOC GEN PHY, V49, P197; Harlow E, 1988, ANTIBODIES LABORATOR, P359; Hille B., 1992, IONIC CHANNELS EXCIT; HOPKINS WF, 1994, J NEUROSCI, V14, P1385, DOI 10.1523/JNEUROSCI.14-03-01385.1994; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Keating MT, 1996, CURR OPIN GENET DEV, V6, P326, DOI 10.1016/S0959-437X(96)80010-4; KIM JW, 1991, NATURE, V352, P725, DOI 10.1038/352725a0; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; LEE TE, 1994, BIOPHYS J, V66, P667, DOI 10.1016/S0006-3495(94)80840-9; LEVIN G, 1995, J BIOL CHEM, V270, P14611, DOI 10.1074/jbc.270.24.14611; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PeledZehavi H, 1996, BIOCHEMISTRY-US, V35, P6828, DOI 10.1021/bi952988t; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Ribera AB, 1996, J NEUROSCI, V16, P1123; Ribera AB, 1996, NEUROPHARMACOLOGY, V35, P1007, DOI 10.1016/0028-3908(96)00098-6; Roden DM, 1996, CIRCULATION, V94, P1996, DOI 10.1161/01.CIR.94.8.1996; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHEN NV, 1993, NEURON, V11, P67; Stuhmer W., 1995, SINGLE CHANNEL RECOR, P341, DOI DOI 10.1007/978-1-4419-1229-9_15; Thornhill WB, 1996, J BIOL CHEM, V271, P19093, DOI 10.1074/jbc.271.32.19093; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; TU LW, 1995, BIOPHYS J, V68, P147, DOI 10.1016/S0006-3495(95)80169-4; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761	37	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11487	11493		10.1074/jbc.274.17.11487	http://dx.doi.org/10.1074/jbc.274.17.11487			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206953	hybrid			2022-12-27	WOS:000079834800009
J	van der Sman, J; Thomas, NSB; Lam, EWF				van der Sman, J; Thomas, NSB; Lam, EWF			Modulation of E2F complexes during G(0) to S phase transition in human primary B-lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; RETINOBLASTOMA SUSCEPTIBILITY GENE; TRANSCRIPTION FACTOR; IN-VIVO; MYB TRANSCRIPTION; ALPHA-INTERFERON; PROTEIN FAMILY; PHORBOL ESTER; GROWTH-FACTOR; P130	The pocket protein-E2F complexes are convergence points for cell cycle signaling. In the present report, we identified and monitored the pocket protein-E2F complexes in human primary B-lymphocytes after activation by phorbol 12-myristate 13-acetate, Consistent with previous data from human and mouse fibroblasts and T-lymphocytes, E2F4 and DP1 form the predominant E2F heterodimers both in G(0) and G(1) phases of the human B-lymphocyte cell cycle, whereas E2F1 and -3 are first detected in late G(1), and their expression levels increase towards S phase. Intriguingly, the major E2F complex that we detected in quiescent human B-lymphocytes is consisted of pRB, E2F4, and DP1, Though the levels of DP1 and -2 increase when cells progress from G(0) to S, the proportion of DP1 to DP2 remains relatively constant during the cell cycle. We also observed an increase in electrophoretic mobility of the predominant E2F components, DP1 and E2F4, as B-lymphocytes progressed from G(0) into early G(1). This increase in mobility was attributable to dephosphorylation, as lambda phosphatase treatment could convert the slower migrating fortes into the corresponding faster mobility forms. We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity. This modulation of DNA binding activity mediated through the dephosphorylation of DP1 and E2F4 could help to explain the lack of in vivo DNA footprinting in late G(1) and S phases of gene promoters negatively regulated through E2F sites and suggests a novel mechanism for controlling E2F transcriptional activity during the transition from quiescence to proliferation.	Univ London Imperial Coll Sci Technol & Med, Sch Med St Marys, Ludwig Inst Canc Res, London W2 1PG, England; Univ London Imperial Coll Sci Technol & Med, Sch Med St Marys, Sect Virol & Cell Biol, London W2 1PG, England; UCL, Sch Med, Dept Haematol, London WC1E 6HX, England	Imperial College London; Ludwig Institute for Cancer Research; Imperial College London; University of London; University College London; UCL Medical School	Lam, EWF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med St Marys, Ludwig Inst Canc Res, London W2 1PG, England.	eric.lam@ic.ac.uk						BANDARA LR, 1994, EMBO J, V13, P3104, DOI 10.1002/j.1460-2075.1994.tb06609.x; Beijersbergen RL, 1996, BBA-REV CANCER, V1287, P103, DOI 10.1016/0304-419X(96)00002-9; BEIJERSBERGEN RL, 1995, GENE DEV, V9, P1340, DOI 10.1101/gad.9.11.1340; BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; Belbrahem A, 1996, EXP CELL RES, V225, P286, DOI 10.1006/excr.1996.0178; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; Cartwright P, 1998, ONCOGENE, V17, P611, DOI 10.1038/sj.onc.1201975; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; DALTON S, 1992, EMBO J, V11, P1797, DOI 10.1002/j.1460-2075.1992.tb05231.x; DARZYNKIEWICZ Z, 1982, J CELL PHYSIOL, V113, P465, DOI 10.1002/jcp.1041130316; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DEFRANCE T, 1992, EUR J IMMUNOL, V22, P2831, DOI 10.1002/eji.1830221112; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; Geng Y, 1996, ONCOGENE, V12, P1173; GINSBERG D, 1994, GENE DEV, V8, P2665, DOI 10.1101/gad.8.22.2665; HIJMANS EM, 1995, MOL CELL BIOL, V15, P3082; Huet X, 1996, MOL CELL BIOL, V16, P3789; Ikeda M, 1996, P NATL ACAD SCI USA, V93, P3215, DOI 10.1073/pnas.93.8.3215; JOHNSON DG, 1995, ONCOGENE, V11, P1685; KATO J, 1993, GENE DEV, V7, P331; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; LAM EWF, 1994, EMBO J, V13, P871, DOI 10.1002/j.1460-2075.1994.tb06330.x; LAM EWF, 1995, GENE, V160, P277, DOI 10.1016/0378-1119(95)00184-8; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; LAM EWF, 1994, CURR OPIN CELL BIOL, V6, P859; Lam EWF, 1998, J BIOL CHEM, V273, P10051, DOI 10.1074/jbc.273.16.10051; LARSSON LG, 1987, P NATL ACAD SCI USA, V84, P223, DOI 10.1073/pnas.84.1.223; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; MAYOL X, 1993, ONCOGENE, V8, P2561; MAYOL X, 1995, ONCOGENE, V11, P801; MEANS AL, 1992, MOL CELL BIOL, V12, P1054, DOI 10.1128/MCB.12.3.1054; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Morkel M, 1997, NATURE, V390, P567, DOI 10.1038/37507; MUDRYJ M, 1991, CELL, V65, P1243, DOI 10.1016/0092-8674(91)90019-U; Mulligan GJ, 1998, MOL CELL BIOL, V18, P206, DOI 10.1128/MCB.18.1.206; MURPHY JJ, 1993, LEUKEMIA RES, V17, P657, DOI 10.1016/0145-2126(93)90070-2; NEUMAN E, 1994, MOL CELL BIOL, V14, P6607, DOI 10.1128/MCB.14.10.6607; NEVINS JR, 1992, NATURE, V358, P375, DOI 10.1038/358375a0; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; QIAN YY, 1992, MOL CELL BIOL, V12, P5363, DOI 10.1128/MCB.12.12.5363; Rogers KT, 1996, P NATL ACAD SCI USA, V93, P7594, DOI 10.1073/pnas.93.15.7594; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; SCHWARZ JK, 1993, EMBO J, V12, P1013, DOI 10.1002/j.1460-2075.1993.tb05742.x; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Smith EJ, 1996, MOL CELL BIOL, V16, P6965; THOMAS NSB, 1989, J BIOL CHEM, V264, P13697; Thomas NSB, 1998, J BIOL CHEM, V273, P23659, DOI 10.1074/jbc.273.37.23659; TOMMASI S, 1995, MOL CELL BIOL, V15, P6901; Trimarchi JM, 1998, P NATL ACAD SCI USA, V95, P2850, DOI 10.1073/pnas.95.6.2850; VAIRO G, 1995, GENE DEV, V9, P869, DOI 10.1101/gad.9.7.869; WADE M, 1992, MOL CELL BIOL, V12, P4364, DOI 10.1128/MCB.12.10.4364; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Williams CD, 1997, BRIT J HAEMATOL, V96, P688, DOI 10.1046/j.1365-2141.1997.d01-2086.x; Williams CD, 1997, BLOOD, V90, P194; ZAMANIAN M, 1993, MOL BIOL CELL, V4, P389, DOI 10.1091/mbc.4.4.389; Zetterberg A, 1996, APOPTOSIS CELL CYCLE, P17; Zwicker J, 1996, SCIENCE, V271, P1595, DOI 10.1126/science.271.5255.1595	60	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12009	12016		10.1074/jbc.274.17.12009	http://dx.doi.org/10.1074/jbc.274.17.12009			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207023	hybrid			2022-12-27	WOS:000079834800079
J	Gibson, S; Widmann, C; Johnson, GL				Gibson, S; Widmann, C; Johnson, GL			Differential involvement of MEK kinase 1 (MEKK1) in the induction of apoptosis in response to microtubule-targeted drugs versus DNA damaging agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACLITAXEL-INDUCED APOPTOSIS; PROGRAMMED CELL-DEATH; CARCINOMA-CELLS; CANCER CELLS; TAXOL; ACTIVATION; BCL-2; PHOSPHORYLATION; CISPLATIN; CASPASES	MEK kinase 1 (MEKK1) is a 196-kDa enzyme that is involved in the regulation of the c-Jun N-terminal kinase (JNK) pathway and apoptosis, In cells exposed to genotoxic agents including etoposide and cytosine arabinoside, MEKK1 is cleaved at Asp(874) by caspases. The cleaved kinase domain of MEKK1, itself, stimulates caspase activity leading to apoptosis. Kinase-inactive MEKK1 expressed in HEK293 cells effectively blocks genotoxin-induced apoptosis. Treatment of cells with taxol, a microtubule stabilizing agent, did not induce MEKK1 cleavage in cells, and kinase-inactive MEKK1 expression failed to block taxol-induced apoptosis, MEKK1 became activated in HEK293 cells exposed to taxol, but in contrast to etoposide-treatment, taxol failed to increase JNK activity. Taxol treatment of cells, therefore, dissociates MEKK1 activation from the regulation of the JNK pathway. Overexpression of anti-apoptotic Bcl2 blocked MEKK1 and taxol-induced apoptosis but did not block the caspase-dependent cleavage of MEKX1 in response to etoposide. This indicates Bcl2 inhibition of apoptosis is, therefore, downstream of caspase dependent MEKK1 cleavage. The results define the involvement of MEKK1 in the induction of apoptosis by genotoxins but not microtubule altering drugs.	Natl Jewish Med & Res Ctr, Program Mol Signal Transduct, Div Basic Sci, Denver, CO 80206 USA; Univ Colorado, Sch Med, Dept Pharmacol, Denver, CO 80262 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Gibson, S (corresponding author), Natl Jewish Med & Res Ctr, Program Mol Signal Transduct, Div Basic Sci, 1400 Jackson St, Denver, CO 80206 USA.		Widmann, Christian/N-9851-2013	Widmann, Christian/0000-0002-6881-0363; Gibson, Spencer/0000-0003-0119-732X	NIDDK NIH HHS [DK 37871, DK 48845] Funding Source: Medline; NIGMS NIH HHS [GM 30324] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048845, R01DK037871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030324, R01GM030324] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen RT, 1998, CELL MOL LIFE SCI, V54, P427, DOI 10.1007/s000180050171; BHALLA K, 1993, LEUKEMIA, V7, P563; Capranico G, 1997, CANCER CHEMOTHER BIO, V17, P114; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Correa P, 1998, BRIT MED BULL, V54, P151; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; DONALDSON KL, 1994, CELL GROWTH DIFFER, V5, P1041; Fanger GR, 1997, CURR OPIN GENET DEV, V7, P67, DOI 10.1016/S0959-437X(97)80111-6; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; GONG M, 1994, VIROLOGY, V204, P38, DOI 10.1006/viro.1994.1508; GU Y, 1995, J BIOL CHEM, V270, P18715, DOI 10.1074/jbc.270.32.18715; HALDAR S, 1995, P NATL ACAD SCI USA, V92, P4507, DOI 10.1073/pnas.92.10.4507; Haldar S, 1996, CANCER RES, V56, P1253; Haldar S, 1997, CANCER RES, V57, P229; Ibrado AM, 1996, CELL GROWTH DIFFER, V7, P1087; Ibrado AM, 1997, CANCER RES, V57, P1109; Jensen PB, 1997, BIOCHEM PHARMACOL, V54, P755; Johnson NL, 1996, J BIOL CHEM, V271, P3229, DOI 10.1074/jbc.271.6.3229; Jones NA, 1998, MOL PHARMACOL, V53, P819; Karin M, 1998, P NATL ACAD SCI USA, V95, P9067, DOI 10.1073/pnas.95.16.9067; Kroning R, 1998, LEUKEMIA RES, V22, P275, DOI 10.1016/S0145-2126(97)00170-7; Kuan NK, 1998, ARCH SURG-CHICAGO, V133, P773, DOI 10.1001/archsurg.133.7.773; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; Lee LF, 1998, J BIOL CHEM, V273, P28253, DOI 10.1074/jbc.273.43.28253; Lokich J, 1998, EUR J CANCER, V34, P664, DOI 10.1016/S0959-8049(97)10108-3; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Reed JC, 1998, CANCER J, V4, pS8; Shen SC, 1998, CELL GROWTH DIFFER, V9, P23; Staunton MJ, 1998, ARCH PATHOL LAB MED, V122, P310; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vaux DL, 1997, CELL, V90, P389, DOI 10.1016/S0092-8674(00)80497-3; Wang TH, 1998, J BIOL CHEM, V273, P4928, DOI 10.1074/jbc.273.9.4928; Widmann C, 1997, ONCOGENE, V15, P2439, DOI 10.1038/sj.onc.1201421; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; Zaffaroni N, 1998, BRIT J CANCER, V77, P1378, DOI 10.1038/bjc.1998.230; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	38	65	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10916	10922		10.1074/jbc.274.16.10916	http://dx.doi.org/10.1074/jbc.274.16.10916			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196170	hybrid			2022-12-27	WOS:000079751900038
J	Krishnan, P; Hocking, AM; Scholtz, JM; Pace, CN; Holik, KK; McQuillan, DJ				Krishnan, P; Hocking, AM; Scholtz, JM; Pace, CN; Holik, KK; McQuillan, DJ			Distinct secondary structures of the leucine-rich repeat proteoglycans decorin and biglycan - Glycosylation-dependent conformational stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; HUMAN ARTICULAR-CARTILAGE; CIRCULAR-DICHROISM; COLLAGEN FIBRILLOGENESIS; EXTRACELLULAR-MATRIX; FACTOR RECEPTOR; CORE PROTEIN; INHIBITOR; SULFATE; PROTEODERMATAN	Biglycan and decorin have been overexpressed in eukaryotic cells and two major glycoforms isolated under native conditions: a proteoglycan substituted with glycosaminoglycan chains; and a core protein form secreted devoid of glycosaminoglycans (Hocking, A. M,, Strugnell, R. A., Ramamurthy, P., and McQuillan, D. J. (1996) J. Biol. Chem. 271, 19571-19577; Ramamurthy, P., Hocking, A. M., and McQuillan, D, J, (1996) J. Biol. Chem. 271, 19578-19584). Far-UV CD spectroscopy of decorin and biglycan proteoglycans indicates that, although they are predominantly beta-sheet, biglycan has a significantly higher content of alpha-helical structure, Decorin proteoglycan and core protein are very similar, whereas the biglycan core protein exhibits closer similarity to the decorin glycoforms than to the biglycan proteoglycan form. However, enzymatic removal of the chondroitin sulfate chains from biglycan proteoglycan does not induce a shift to the core protein structure, suggesting that the final form is influenced by polysaccharide addition only during biosynthesis. Fluorescence emission spectroscopy demonstrated that the single tryptophan residue, which is at a conserved position at the C-terminal domain of both biglycan and decorin, is found in similar microenvironments. This indicates that in this specific domain the different glycoforms do exhibit apparent conservation of structure. Exposure of decorin and biglycan to 10 M urea resulted in an increase in fluorescent intensity, which indicates that the emission from tryptophan in the native state is quenched. Comparison of urea-induced protein unfolding curves provide further evidence that decorin and biglycan assume different structures in solution. Decorin proteoglycan and core protein unfold in a manner similar to a classic two-state model, in which there is a steep transition to an unfolded state between 1 and 2 an urea. The biglycan core protein also shows a similar steep transition. However, biglycan proteoglycan shows a broad unfolding transition between 1 and 6 M urea, probably indicating the presence of stable unfolding intermediates.	Inst Biosci & Technol, Ctr Extracellular Matrix Biol, Houston, TX 77030 USA; Texas A&M Univ, Hlth Sci Ctr, Dept Med Biochem & Genet, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	McQuillan, DJ (corresponding author), Inst Biosci & Technol, Ctr Extracellular Matrix Biol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.			Hocking, Anne/0000-0003-2130-3732	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042826] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR42826] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; FLEISCHMAJER R, 1991, J STRUCT BIOL, V106, P82, DOI 10.1016/1047-8477(91)90065-5; Font B, 1998, EUR J BIOCHEM, V254, P580, DOI 10.1046/j.1432-1327.1998.2540580.x; GLOSSL J, 1984, J BIOL CHEM, V259, P4144; HARPER JR, 1994, METHODS ENZYMOL, V245, P241; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hocking AM, 1998, MATRIX BIOL, V17, P1; Hocking AM, 1996, J BIOL CHEM, V271, P19571, DOI 10.1074/jbc.271.32.19571; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Isaka Y, 1996, NAT MED, V2, P418, DOI 10.1038/nm0496-418; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; NEAME PJ, 1989, J BIOL CHEM, V264, P8653; PACE CN, 1989, BIOCHEMISTRY-US, V28, P2520, DOI 10.1021/bi00432a026; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Patel S, 1998, J BIOL CHEM, V273, P3121, DOI 10.1074/jbc.273.6.3121; PATTHY L, 1987, J MOL BIOL, V198, P567, DOI 10.1016/0022-2836(87)90200-2; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; PTITSYN OB, 1995, CURR OPIN STRUC BIOL, V5, P74, DOI 10.1016/0959-440X(95)80011-O; Ramamurthy P, 1996, J BIOL CHEM, V271, P19578, DOI 10.1074/jbc.271.32.19578; ROUGHLEY PJ, 1993, BIOCHEM J, V295, P421, DOI 10.1042/bj2950421; RUOSLAHTI E, 1992, COLD SPRING HARB SYM, V57, P309, DOI 10.1101/SQB.1992.057.01.035; SAMPAIO LD, 1988, BIOCHEM J, V254, P757; Scott JE, 1996, BIOCHEMISTRY-US, V35, P8795, DOI 10.1021/bi960773t; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; TOUMADJE A, 1992, ANAL BIOCHEM, V200, P321, DOI 10.1016/0003-2697(92)90473-K; VOGEL KG, 1987, BIOCHEM BIOPH RES CO, V148, P658, DOI 10.1016/0006-291X(87)90927-2; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767	34	27	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10945	10950		10.1074/jbc.274.16.10945	http://dx.doi.org/10.1074/jbc.274.16.10945			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196174	hybrid			2022-12-27	WOS:000079751900042
J	Trivedi, A; Young, LS; Ouyang, C; Johnson, DL; Sprague, KU				Trivedi, A; Young, LS; Ouyang, C; Johnson, DL; Sprague, KU			A TATA element is required for tRNA promoter activity and confers TATA-binding protein responsiveness in Drosophila Schneider-2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA GENE; POLYMERASE-III PROMOTERS; IN-VIVO EXPRESSION; SEQUENCE ELEMENTS; TRANSCRIPTIONAL PROPERTIES; SACCHAROMYCES-CEREVISIAE; INVITRO TRANSCRIPTION; DNA INTERACTIONS; BOMBYX-MORI; BASE-PAIRS	In contrast to yeast and mammalian systems, which depend principally on internal promoter elements for tRNA gene transcription, insect systems require additional upstream sequences. To understand the function of the upstream sequences, we have asked whether the Bombyx mori tRNA(C)(Ala) and tRNA(SG)(Ala) genes, which are absolutely dependent on these sequences in vitro, also require them for transcription in vivo, We introduced wild-type and mutant versions of the Bombyx tRNA(Ala) genes into Drosophila Schneider-2 cells and found that the tRNA(C)(Ala) gene is efficiently transcribed and that its transcription depends strongly on the distal segment of its upstream promoter. In contrast, the tRNA(SG)(Ala) gene is inefficiently transcribed, and this inefficiency results from lack of a specific sequence within the distal tRNA(C)(Ala) upstream promoter. This sequence, 5'-TTTATAT-3', is sufficient to increase the activity of the tRNA(SG)(Ala) promoter to that of the tRNA(C)(Ala) promoter. Moreover, promoters containing the 5'-TTTATAT-3' element are stimulated by increased levels of cellular TATA-binding protein. Together these results indicate that, in insect cells, a TATA-like element is specifically required to form functional TATA-binding protein-containing complexes that promote efficient transcription of tRNA genes.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Phys, Eugene, OR 97403 USA; Univ So Calif, Sch Pharm, Dept Mol Pharmacol, Los Angeles, CA 90033 USA; Univ So Calif, Sch Pharm, Dept Biochem, Los Angeles, CA 90033 USA; Univ So Calif, Sch Med, Dept Biochem, Los Angeles, CA 90033 USA; Univ So Calif, Sch Med, Dept Mol Pharmacol, Los Angeles, CA 90033 USA	University of Oregon; University of Oregon; University of Oregon; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Sprague, KU (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.		ouyang, chuying/K-9577-2017	ouyang, chuying/0000-0001-8891-1682	NATIONAL CANCER INSTITUTE [R01CA074138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025388] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA074138, CA74138] Funding Source: Medline; NIGMS NIH HHS [GM25388] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROWN DD, 1985, CELL, V42, P759, DOI 10.1016/0092-8674(85)90272-7; DINGERMANN T, 1981, NUCLEIC ACIDS RES, V9, P3907, DOI 10.1093/nar/9.16.3907; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; FOURNIER A, 1984, EMBO J, V3, P1547, DOI 10.1002/j.1460-2075.1984.tb02009.x; FRANCIS MA, 1990, MOL CELL BIOL, V10, P4486, DOI 10.1128/MCB.10.9.4486; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Joazeiro CAP, 1996, GENE DEV, V10, P725, DOI 10.1101/gad.10.6.725; KASSAVETIS GA, 1994, TRANSCRIPTION MECHAN, P107; KELLER HJ, 1990, MOL CELL BIOL, V10, P5166, DOI 10.1128/MCB.10.10.5166; KURJAN J, 1980, CELL, V20, P701, DOI 10.1016/0092-8674(80)90316-5; LOFQUIST AK, 1988, MOL CELL BIOL, V8, P4441, DOI 10.1128/MCB.8.10.4441; MORTON DG, 1984, P NATL ACAD SCI-BIOL, V81, P5519, DOI 10.1073/pnas.81.17.5519; NAKAAR V, 1994, MOL CELL BIOL, V14, P6736, DOI 10.1128/MCB.14.10.6736; PALIDA FA, 1993, NUCLEIC ACIDS RES, V21, P5875, DOI 10.1093/nar/21.25.5875; RAYMOND GJ, 1983, NUCLEIC ACIDS RES, V11, P5969, DOI 10.1093/nar/11.17.5969; SAJJADI FG, 1987, MOL GEN GENET, V206, P279, DOI 10.1007/BF00333585; Sambrook J., 1989, MOL CLONING LAB MANU, P412; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SCHAACK J, 1984, J BIOL CHEM, V259, P1461; SCHULTZ MC, 1992, CELL, V69, P697, DOI 10.1016/0092-8674(92)90233-3; Sethy-Coraci I, 1998, NUCLEIC ACIDS RES, V26, P2344, DOI 10.1093/nar/26.10.2344; SHARP SJ, 1985, CRC CR REV BIOCH MOL, V19, P107, DOI 10.3109/10409238509082541; SHARP SJ, 1988, MOL CELL BIOL, V8, P1266, DOI 10.1128/MCB.8.3.1266; SHAW KJ, 1984, MOL CELL BIOL, V4, P657, DOI 10.1128/MCB.4.4.657; SPRAGUE KU, 1994, TRANSCRIPTION EUKARY; STRABY KB, 1988, NUCLEIC ACIDS RES, V16, P2841, DOI 10.1093/nar/16.7.2841; TANEJA R, 1992, P NATL ACAD SCI USA, V89, P1070, DOI 10.1073/pnas.89.3.1070; TAPPING RI, 1993, NUCLEIC ACIDS RES, V21, P4476, DOI 10.1093/nar/21.19.4476; Trivedi A, 1996, MOL CELL BIOL, V16, P6909; ULMASOV B, 1995, PLANT CELL, V7, P1723, DOI 10.1105/tpc.7.10.1611; WHITE RJ, 1998, RNA POLYM 3 TRANSCRI; WILSON ET, 1988, MOL CELL BIOL, V8, P624, DOI 10.1128/MCB.8.2.624; WOLFFE AP, 1990, J BIOL CHEM, V265, P4592; WONG JM, 1994, NUCLEIC ACIDS RES, V22, P1890, DOI 10.1093/nar/22.10.1890; Young LS, 1996, MOL CELL BIOL, V16, P1256; YOUNG LS, 1986, P NATL ACAD SCI USA, V83, P374, DOI 10.1073/pnas.83.2.374	36	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11369	11375		10.1074/jbc.274.16.11369	http://dx.doi.org/10.1074/jbc.274.16.11369			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196229	hybrid			2022-12-27	WOS:000079751900097
J	Colasanti, M; Persichini, T; Cavalieri, E; Fabrizi, C; Mariotto, S; Menegazzi, M; Lauro, GM; Suzuki, H				Colasanti, M; Persichini, T; Cavalieri, E; Fabrizi, C; Mariotto, S; Menegazzi, M; Lauro, GM; Suzuki, H			Rapid inactivation of NOS-I by lipopolysaccharide plus interferon-gamma-induced tyrosine phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; KINASE INHIBITORS; EXPRESSION; INDUCTION; CELLS; SUPPRESSION	Human astrocytoma T67 cells constitutively express a neuronal NO synthase (NOS-I) and, following administration of lipopolysaccharide (LPS) plus interferon-gamma (IFN gamma), an inducible NOS isoform (NOS-II). Previous results indicated that a treatment of T67 cells with the combination of LPS plus IFN gamma, by affecting NOS-I activity, also inhibited NO production in a very short time. Here, we report that under basal conditions, a NOS-I protein of about 150 kDa was weakly and partially tyrosine-phosphorylated, as verified by immunoprecipitation and Western blotting. Furthermore, LPS plus IFN gamma increased the tyrosine phosphorylation of NOS-I, with a concomitant inhibition of its enzyme activity. The same effect was observed in the presence of vanadate, an inhibitor of phosphotyrosine-specific phosphatases. On the contrary, genistein, an inhibitor of protein-tyrosine kinases, reduced tyrosine phosphorylation of NOS-I, enhancing its enzyme activity. Finally, using reverse transcriptase-polymerase chain reaction, we have observed that a suboptimal induction of NOS-II mRNA expression in T67 cells was enhanced by vanadate (or L-NAME) and inhibited by genistein. Because exogenous NO has been found to suppress NOS-II expression, the decrease of NO production that we have obtained from the inactivation of NOS-I by LPS/IFN gamma-induced tyrosine phosphorylation provides the best conditions for NOS-II expression in human astrocytoma T67 cells.	Univ Verona, Dipartimento Sci Neurol & Vis, Sez Chim Biol, Biol Chem Lab, I-37134 Verona, Italy; Univ Rome, Dept Biol, Roma TRE, I-00146 Rome, Italy	University of Verona	Suzuki, H (corresponding author), Univ Verona, Dipartimento Sci Neurol & Vis, Sez Chim Biol, Biol Chem Lab, Str Le Grazie 8, I-37134 Verona, Italy.		Menegazzi, Marta/AAE-7079-2019; fabrizi, cinzia/G-2379-2012; COLASANTI, MARCO/A-5616-2010; mariotto, sofia/AAH-5473-2019	Menegazzi, Marta/0000-0003-1310-9227; COLASANTI, MARCO/0000-0002-5752-4943; PERSICHINI, TIZIANA/0000-0001-8291-6706				AKARASEREENONT P, 1994, BRIT J PHARMACOL, V113, P1522, DOI 10.1111/j.1476-5381.1994.tb17169.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Colasanti M, 1998, BIOCHEM BIOPH RES CO, V246, P453, DOI 10.1006/bbrc.1998.8642; Colasanti M, 1997, J BIOL CHEM, V272, P7582, DOI 10.1074/jbc.272.12.7582; COLASANTI M, 1995, J BIOL CHEM, V270, P26731, DOI 10.1074/jbc.270.45.26731; Faure V, 1998, AM J PHYSIOL-CELL PH, V275, pC208, DOI 10.1152/ajpcell.1998.275.1.C208; FEINSTEIN DL, 1994, ANN NY ACAD SCI, V738, P325; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; Geller DA, 1998, CANCER METAST REV, V17, P7, DOI 10.1023/A:1005940202801; GENG Y, 1995, J CELL PHYSIOL, V163, P545, DOI 10.1002/jcp.1041630315; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; Kong LY, 1996, BRAIN RES, V729, P102, DOI 10.1016/0006-8993(96)00417-9; LAURO GM, 1986, ACTA NEUROPATHOL, V69, P278, DOI 10.1007/BF00688305; MARIOTTO S, 1995, BRIT J PHARMACOL, V114, P1105, DOI 10.1111/j.1476-5381.1995.tb13320.x; Marletta MA, 1998, CURR OPIN CHEM BIOL, V2, P656, DOI 10.1016/S1367-5931(98)80098-7; Moncada S, 1997, PHARMACOL REV, V49, P137; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; PAUL A, 1995, BRIT J PHARMACOL, V114, P482, DOI 10.1111/j.1476-5381.1995.tb13252.x; SIMMONS ML, 1994, GLIA, V11, P227, DOI 10.1002/glia.440110303; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; TETSUKA T, 1995, AM J PHYSIOL-CELL PH, V269, pC55, DOI 10.1152/ajpcell.1995.269.1.C55; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779	24	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					9915	9917		10.1074/jbc.274.15.9915	http://dx.doi.org/10.1074/jbc.274.15.9915			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187764	hybrid			2022-12-27	WOS:000079663500003
J	Hossain, MZ; Jagdale, AB; Ao, P; Kazlauskas, A; Boynton, AL				Hossain, MZ; Jagdale, AB; Ao, P; Kazlauskas, A; Boynton, AL			Disruption of gap junctional communication by the platelet-derived growth factor is mediated via multiple signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PHOSPHOLIPASE-C-GAMMA; RECEPTOR TYROSINE KINASE; TO-CELL COMMUNICATION; RAT-LIVER CELLS; INTERCELLULAR COMMUNICATION; BETA-RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; PDGF RECEPTOR; PHORBOL-ESTER	The platelet-derived growth factor (PDGF) mediates its cellular functions via activation of its receptor tyrosine kinase followed by the recruitment and activation of several signaling molecules. These signaling molecules then initiate specific signaling cascades, finally resulting in distinct physiological effects. To delineate the PDGF signaling pathway responsible for the disruption of gap junctional communication (GJC), wild-type PDGF receptor beta (PDGFR beta) and a series of PDGFR beta mutants were expressed in T51B rat liver epithelial cells. In cells expressing wild-type PDGFR beta, PDGF induced disruption of GJC and phosphorylation of a gap junctional protein, connexin-43 (Cx43), which required activation of mitogen-activated protein kinase, although involvement of additional factors was also evident. In the F5 mutant lacking binding sites for phosphatidylinositol 3-kinase, GTPase-activating protein, SHP-2, and phospholipase C gamma 1 (PLC gamma 1), PDGF induced mitogen-activated protein kinase, but failed to affect GJC or Cx43, indicating involvement of additional signals presumably initiated by one or more of the mutated binding sites. Examination of the single-site mutants revealed that PDGF effects were not mediated via a single signaling component. This was confirmed by the "add-back" mutants, which showed that restoration of either SHP-2 or PLC gamma 1 binding was sufficient to propagate the GJC inhibitory actions of PDGF. Further analysis showed that activation of PLC gamma 1 is involved in Cx43 phosphorylation, which surprisingly failed to correlate with GJC blockade. The results of our study demonstrate that PDGF-induced disruption of GJC can be mediated by multiple signaling pathways and requires participation of multiple components.	Northwest Hosp, Seattle, WA 98125 USA; Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute	Hossain, MZ (corresponding author), Northwest Hosp, 120 Northgate Plaza,Suite 230, Seattle, WA 98125 USA.	mhossain@nwhsea.org			NCI NIH HHS [CA 57064] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057064, R55CA057064] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; BERTHOUD VM, 1993, EUR J CELL BIOL, V62, P384; BOYNTON AL, 1984, CANCER LETT, V21, P293, DOI 10.1016/0304-3835(84)90008-9; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; BURGERING BMT, 1994, CELL GROWTH DIFFER, V5, P341; Calero G, 1998, CIRC RES, V82, P929, DOI 10.1161/01.RES.82.9.929; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cook SJ, 1997, J BIOL CHEM, V272, P13309, DOI 10.1074/jbc.272.20.13309; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; Cruciani VR, 1997, INT J CANCER, V73, P240, DOI 10.1002/(SICI)1097-0215(19971009)73:2<240::AID-IJC14>3.3.CO;2-D; Delmar M, 1998, GAP JUNCTIONS, P8; DeMali KA, 1997, J BIOL CHEM, V272, P9011; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; EkVitorin JF, 1996, BIOPHYS J, V71, P1273, DOI 10.1016/S0006-3495(96)79328-1; ELDARFINKELMAN H, 1995, J BIOL CHEM, V270, P987, DOI 10.1074/jbc.270.3.987; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Fanger GR, 1997, MOL CELL BIOL, V17, P89, DOI 10.1128/MCB.17.1.89; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Gotoh N, 1997, MOL CELL BIOL, V17, P1824, DOI 10.1128/MCB.17.4.1824; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hossain MZ, 1998, J CELL PHYSIOL, V176, P332, DOI 10.1002/(SICI)1097-4652(199808)176:2<332::AID-JCP11>3.3.CO;2-O; HOSSAIN MZ, 1989, CARCINOGENESIS, V10, P1743, DOI 10.1093/carcin/10.9.1743; Hossain MZ, 1998, J CELL PHYSIOL, V174, P66; Huang RP, 1996, J CELL BIOL, V133, P211, DOI 10.1083/jcb.133.1.211; Jansen LAM, 1996, CARCINOGENESIS, V17, P333, DOI 10.1093/carcin/17.2.333; Kanemitsu MY, 1997, J BIOL CHEM, V272, P22824, DOI 10.1074/jbc.272.36.22824; KANEMITSU MY, 1993, MOL BIOL CELL, V4, P837, DOI 10.1091/mbc.4.8.837; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KAZLAUSKAS A, 1994, CURR OPIN GENET DEV, V4, P5, DOI 10.1016/0959-437X(94)90085-X; KAZLAUSKAS A, 1991, CELL REGUL, V2, P413, DOI 10.1091/mbc.2.6.413; Klarlund JK, 1996, J BIOL CHEM, V271, P16674, DOI 10.1074/jbc.271.28.16674; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; KURATA WE, 1994, ONCOGENE, V9, P329; LANGLOIS WJ, 1995, J BIOL CHEM, V270, P25320, DOI 10.1074/jbc.270.43.25320; Lau AF, 1996, J BIOENERG BIOMEMBR, V28, P359, DOI 10.1007/BF02110112; LAU AF, 1992, MOL BIOL CELL, V3, P865, DOI 10.1091/mbc.3.8.865; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Loewenstein W R, 1992, Semin Cell Biol, V3, P59; MA YH, 1994, J BIOL CHEM, V269, P30734; MALDONADO PE, 1988, J MEMBRANE BIOL, V106, P203, DOI 10.1007/BF01872158; MATESIC DF, 1994, MOL CARCINOGEN, V10, P226, DOI 10.1002/mc.2940100407; Montmayeur JP, 1997, J BIOL CHEM, V272, P32670, DOI 10.1074/jbc.272.51.32670; Moriya S, 1996, P NATL ACAD SCI USA, V93, P151, DOI 10.1073/pnas.93.1.151; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; MunariSilem Y, 1996, EUR J ENDOCRINOL, V135, P251, DOI 10.1530/eje.0.1350251; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; OH SY, 1991, BIOCHIM BIOPHYS ACTA, V1094, P243, DOI 10.1016/0167-4889(91)90016-Q; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; PELLETIER DB, 1994, J CELL PHYSIOL, V158, P427, DOI 10.1002/jcp.1041580306; Potempa S, 1998, MOL BIOL CELL, V9, P2185, DOI 10.1091/mbc.9.8.2185; Proulx A, 1997, DEV GENET, V20, P133, DOI 10.1002/(SICI)1520-6408(1997)20:2<133::AID-DVG6>3.0.CO;2-8; Ridefelt P, 1998, ANTICANCER RES, V18, P1819; RIVARD N, 1995, J BIOL CHEM, V270, P11017, DOI 10.1074/jbc.270.18.11017; Robinson CJM, 1996, BIOCHEM J, V320, P123, DOI 10.1042/bj3200123; Roche S, 1996, EMBO J, V15, P4940, DOI 10.1002/j.1460-2075.1996.tb00874.x; RONNSTRAND L, 1992, EMBO J, V11, P3911, DOI 10.1002/j.1460-2075.1992.tb05484.x; SATOH T, 1993, MOL CELL BIOL, V13, P3706, DOI 10.1128/MCB.13.6.3706; SEEDORF K, 1994, J BIOL CHEM, V269, P16009; ShiokawaSawada M, 1997, J BONE MINER RES, V12, P1165, DOI 10.1359/jbmr.1997.12.8.1165; SMITH MR, 1990, SCIENCE, V247, P1074, DOI 10.1126/science.2408147; SWENSON KI, 1990, CELL REGUL, V1, P989, DOI 10.1091/mbc.1.13.989; Swierenga S H, 1980, Ann N Y Acad Sci, V349, P294; TATRAI A, 1994, BBA-MOL CELL RES, V1224, P575, DOI 10.1016/0167-4889(94)90296-8; TenBroek E, 1998, GAP JUNCTIONS, P215; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; VAILLANCOURT RR, 1995, MOL CELL BIOL, V15, P3644; VALIUS M, 1995, MOL CELL BIOL, V15, P3058; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; vanDijk MCM, 1997, BIOCHEM J, V325, P303, DOI 10.1042/bj3250303; Warn-Cramer BJ, 1998, J BIOL CHEM, V273, P9188, DOI 10.1074/jbc.273.15.9188; WarnCramer BJ, 1996, J BIOL CHEM, V271, P3779; Warner A., 1992, Seminars in Cell Biology, V3, P81; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yamasaki H, 1996, CARCINOGENESIS, V17, P1199, DOI 10.1093/carcin/17.6.1199; ZHANG LX, 1991, CARCINOGENESIS, V12, P2109, DOI 10.1093/carcin/12.11.2109	81	51	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10489	10496		10.1074/jbc.274.15.10489	http://dx.doi.org/10.1074/jbc.274.15.10489			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187840	hybrid			2022-12-27	WOS:000079663500079
J	Calvo, PA; Frank, DW; Bieler, BM; Berson, JF; Marks, MS				Calvo, PA; Frank, DW; Bieler, BM; Berson, JF; Marks, MS			A cytoplasmic sequence in human tyrosinase defines a second class of Di-leucine-based sorting signals for late endosomal and lysosomal delivery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II INVARIANT CHAIN; TRANS-GOLGI NETWORK; MEMBRANE-PROTEIN; ENDOCYTIC PATHWAY; OCULOCUTANEOUS ALBINISM; STRUCTURAL REQUIREMENTS; PLASMA-MEMBRANE; DOWN-REGULATION; CELL-SURFACE; LIMP-II	Distinct cytoplasmic sorting signals target integral membrane proteins to late endosomal compartments, but it is not known whether different signals direct targeting by different pathways. The availability of multiple pathways may permit some cell types to divert proteins to specialized compartments, such as the melanosome of pigmented cells. To address this issue, we characterized sorting determinants of tyrosinase, a tissue-specific resident protein of the melanosome. The cytoplasmic domain of tyrosinase was both necessary and sufficient for internalization and steady state localization to late endosomes and lysosomes in HeLa cells. Mutagenesis of two leucine residues within a conventional di leucine motif ablated late endosomal localization. However, the properties of this di-leucine-based signal were distinguished from that of CD3 gamma by overexpression studies; overexpression of the tyrosinase signal, but not the well characterized CD3 gamma signal, induced a 4-fold enlargement of late endosomes and lysosomes and interfered with endosomal sorting mediated by both tyrosine- and other di-leucine-based signals. These properties suggest that the tyrosinase and CD3 gamma dileucine signals are distinctly recognized and sorted by distinct pathways to late endosomes in non-pigmented cells. We speculate that melanocytic cells utilize the second pathway to divert proteins to the melanosome.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Marks, MS (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 277 John Morgan Bldg6082,36th & Hamilton Walk, Philadelphia, PA 19104 USA.		Marks, Michael S/Q-7223-2019	Marks, Michael S/0000-0001-7435-7262	NATIONAL CANCER INSTITUTE [T32CA009671] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI009946] Funding Source: NIH RePORTER; NCI NIH HHS [T32-CA09671] Funding Source: Medline; NEI NIH HHS [T32-EY07131-06] Funding Source: Medline; NIAID NIH HHS [1F32-AI09946] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARUNACHALAM B, 1994, INT IMMUNOL, V6, P439, DOI 10.1093/intimm/6.3.439; BEERMANN F, 1995, EXP EYE RES, V61, P599, DOI 10.1016/S0014-4835(05)80053-3; Bonifacino JS, 1996, P ASSOC AM PHYSICIAN, V108, P285; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; Borovansky J, 1997, ARCH DERMATOL RES, V289, P145, DOI 10.1007/s004030050170; BOUCHARD B, 1989, J EXP MED, V169, P2029, DOI 10.1084/jem.169.6.2029; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; CHEN YT, 1995, P NATL ACAD SCI USA, V92, P8125, DOI 10.1073/pnas.92.18.8125; Cooper AA, 1996, J CELL BIOL, V133, P529, DOI 10.1083/jcb.133.3.529; COWLES CR, 1997, EMBO J, V16, P2768; Darsow T, 1998, J CELL BIOL, V142, P913, DOI 10.1083/jcb.142.4.913; delMarmol V, 1996, FEBS LETT, V381, P165, DOI 10.1016/0014-5793(96)00109-3; DIETRICH J, 1994, EMBO J, V13, P2156, DOI 10.1002/j.1460-2075.1994.tb06492.x; Dietrich J, 1997, J CELL BIOL, V138, P271, DOI 10.1083/jcb.138.2.271; DIMENT S, 1995, J BIOL CHEM, V270, P4213, DOI 10.1074/jbc.270.9.4213; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; FUKUDA M, 1988, J BIOL CHEM, V263, P18920; Geisler C, 1998, J BIOL CHEM, V273, P21316, DOI 10.1074/jbc.273.33.21316; GIEBEL LB, 1991, AM J HUM GENET, V48, P1159; Glickman JN, 1996, J CELL BIOL, V132, P769, DOI 10.1083/jcb.132.5.769; Gut A, 1998, EMBO J, V17, P1919, DOI 10.1093/emboj/17.7.1919; Hansen HJ, 1996, BIOCHEM J, V320, P293, DOI 10.1042/bj3200293; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; Jackson IJ, 1997, HUM MOL GENET, V6, P1613, DOI 10.1093/hmg/6.10.1613; JIMENEZ M, 1991, J BIOL CHEM, V266, P1147; JOHNSON KF, 1992, J BIOL CHEM, V267, P17110; Kang S, 1998, J BIOL CHEM, V273, P20644, DOI 10.1074/jbc.273.32.20644; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Karlsson K, 1998, J BIOL CHEM, V273, P18966, DOI 10.1074/jbc.273.30.18966; Keller P, 1997, J CELL SCI, V110, P3001; KING RA, 1991, MOL BIOL MED, V8, P19; KING RA, 1995, METABOLIC MOL BASES, V3, P4353; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Kondoh H, 1996, ZOOL SCI, V13, P825, DOI 10.2108/zsj.13.825; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; LAMB CA, 1992, J IMMUNOL, V148, P3478; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; ODORIZZI CG, 1994, J CELL BIOL, V126, P317, DOI 10.1083/jcb.126.2.317; Odorizzi G, 1997, J BIOL CHEM, V272, P11757, DOI 10.1074/jbc.272.18.11757; Odorizzi G, 1998, TRENDS CELL BIOL, V8, P282, DOI 10.1016/S0962-8924(98)01295-1; ORLOW SJ, 1995, J INVEST DERMATOL, V105, P3, DOI 10.1111/1523-1747.ep12312291; ORLOW SJ, 1993, J INVEST DERMATOL, V100, P55, DOI 10.1111/1523-1747.ep12354138; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; PIETERS J, 1993, J CELL SCI, V106, P831; Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Robinson MS, 1997, TRENDS CELL BIOL, V7, P99, DOI 10.1016/S0962-8924(96)10048-9; ROCHE PA, 1992, EMBO J, V11, P2841, DOI 10.1002/j.1460-2075.1992.tb05351.x; ROMAGNOLI P, 1993, J EXP MED, V177, P583, DOI 10.1084/jem.177.3.583; RUTLEDGE T, 1992, EMBO J, V11, P3245, DOI 10.1002/j.1460-2075.1992.tb05402.x; SANDOVAL IV, 1994, J BIOL CHEM, V269, P6622; Santini F, 1998, MOL BIOL CELL, V9, P1177, DOI 10.1091/mbc.9.5.1177; SCHRAERMEYER U, 1995, PIGM CELL RES, V8, P209, DOI 10.1111/j.1600-0749.1995.tb00665.x; Schraermeyer U, 1996, HISTOL HISTOPATHOL, V11, P445; SEIJI M, 1961, J INVEST DERMATOL, V36, P243, DOI 10.1038/jid.1961.42; SEYMOUR AS, 1997, MOL BIOL CELL, V8, P227; SIMONSEN A, 1993, INT IMMUNOL, V5, P903, DOI 10.1093/intimm/5.8.903; Song WX, 1997, INT IMMUNOL, V9, P1709, DOI 10.1093/intimm/9.11.1709; Tan PK, 1996, J CELL BIOL, V135, P1789, DOI 10.1083/jcb.135.6.1789; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; VIJAYASARADHI S, 1995, J CELL BIOL, V130, P807, DOI 10.1083/jcb.130.4.807; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x; Vowels JJ, 1998, EMBO J, V17, P2482, DOI 10.1093/emboj/17.9.2482; Warren RA, 1997, J BIOL CHEM, V272, P2116; Warren RA, 1998, J BIOL CHEM, V273, P17056, DOI 10.1074/jbc.273.27.17056; Wilson JM, 1997, J CELL BIOL, V136, P319, DOI 10.1083/jcb.136.2.319; Xu YQ, 1997, J INVEST DERMATOL, V109, P788, DOI 10.1111/1523-1747.ep12340971; Yoshimori T, 1996, J CELL BIOL, V133, P247, DOI 10.1083/jcb.133.2.247	74	96	96	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12780	12789		10.1074/jbc.274.18.12780	http://dx.doi.org/10.1074/jbc.274.18.12780			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212263	hybrid			2022-12-27	WOS:000080056800083
J	Ishii, TM; Takano, M; Xie, LH; Noma, A; Ohmori, H				Ishii, TM; Takano, M; Xie, LH; Noma, A; Ohmori, H			Molecular characterization of the hyperpolarization-activated cation channel in rabbit heart sinoatrial node	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINO-ATRIAL NODE; CURRENT IF; CELLS; IDENTIFICATION; DEPOLARIZATION; FAMILY; BLOCK; CLAMP; BRAIN; NA+	We cloned a cDNA (HAC4) that encodes the hyperpolarization-activated cation channel (I-f or I-h) by screening a rabbit sinoatrial (SA) node cDNA library using a fragment of rat brain I-f cDNA. HAC I is composed of 1150 amino acid residues, and its cytoplasmic N- and C-terminal regions are longer than those of HAC1-3. The transmembrane region of HAC4 was most homologous to partially cloned mouse I-f BCNG-3 (96%), whereas the C-terminal region of HAC4 showed low homology to all HAC family members so far cloned. Northern blotting revealed that HAC4 mRNA was the most highly expressed in the SA node among the rabbit cardiac tissues examined. The electrophysiological properties of HAC4 were examined using the whole cell patch-clamp technique. In COS-7 cells transfected with HAC4 cDNA, hyperpolarizing voltage steps activated slowly developing inward currents. The half-maximal activation was obtained at -87.2 +/- 2.8 mV under control conditions and at -64.4 +/- 2.6 mV in the presence of intracellular 0.3 mM cAMP. The reversal potential was -34.2 +/- 0.9 mV in 140 mM Na-o(+) and 5 mM K-o(+) versus 10 mM Na-i(+) and 145 mM K-i(+). These results indicate that HAC4 forms I-f in rabbit heart SA node.	Kyoto Univ, Fac Med, Dept Physiol, Kyoto 6068501, Japan	Kyoto University	Ohmori, H (corresponding author), Kyoto Univ, Fac Med, Dept Physiol, Kyoto 6068501, Japan.			Ohmori, Harunori/0000-0002-4319-4947				Clapham DE, 1998, NEURON, V21, P5, DOI 10.1016/S0896-6273(00)80508-5; DENYER JC, 1990, J PHYSIOL-LONDON, V429, P401, DOI 10.1113/jphysiol.1990.sp018264; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; DIFRANCESCO D, 1980, J PHYSIOL-LONDON, V308, P353, DOI 10.1113/jphysiol.1980.sp013475; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DOERR T, 1989, PFLUG ARCH EUR J PHY, V413, P599, DOI 10.1007/BF00581808; FRACE AM, 1992, PFLUG ARCH EUR J PHY, V421, P97; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; GINNEKEN ACG, 1991, J PHYSIOL-LONDON, V434, P57; GUO JQ, 1995, J PHYSIOL-LONDON, V483, P1; HO WK, 1994, PFLUG ARCH EUR J PHY, V426, P68, DOI 10.1007/BF00374672; ISHII T, 1993, J BIOL CHEM, V268, P2836; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; MARUOKA F, 1994, J PHYSIOL-LONDON, V477, P423, DOI 10.1113/jphysiol.1994.sp020204; NOMA A, 1983, PFLUG ARCH EUR J PHY, V397, P190, DOI 10.1007/BF00584356; ONO K, 1994, PFLUG ARCH EUR J PHY, V427, P437, DOI 10.1007/BF00374258; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; WATANABE E, 1995, AM J PHYSIOL, V269, pH1753; YANAGIHARA K, 1980, JPN J PHYSIOL, V30, P841; YANAGIHARA K, 1980, PFLUG ARCH EUR J PHY, V385, P11, DOI 10.1007/BF00583909; YANAGIHARA K, 1980, PFLUG ARCH EUR J PHY, V388, P255, DOI 10.1007/BF00658491	23	218	237	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12835	12839		10.1074/jbc.274.18.12835	http://dx.doi.org/10.1074/jbc.274.18.12835			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212270	hybrid			2022-12-27	WOS:000080056800090
J	Le Gouill, C; Parent, JL; Caron, CA; Gaudreau, R; Volkov, L; Rola-Pleszczynski, M; Stankova, J				Le Gouill, C; Parent, JL; Caron, CA; Gaudreau, R; Volkov, L; Rola-Pleszczynski, M; Stankova, J			Selective modulation of wild type receptor functions by mutants of G-protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; TRANSMEMBRANE DOMAIN; BETA(2)-ADRENERGIC RECEPTOR; MUSCARINIC RECEPTORS; SIGNAL-TRANSDUCTION; PHOSPHORYLATION; DIMERIZATION; MUTATIONS; IDENTIFICATION; EXPRESSION	Members of the G-protein-coupled receptor (GPCR) family are involved in most aspects of higher eukaryote biology, and mutations in their coding sequence have been linked to several diseases. In the present study, we report that mutant GPCR can affect the functional properties of the co-expressed wild type (WT) receptor. Mutants of the human platelet-activating factor receptor that fail to show any detectable ligand binding (N285I and K298stop) or coupling to a G-protein (D63N, D289A, and Y293A) were co-expressed with the WT receptor in Chinese hamster ovary and COS-7 cells. In this context, N285I and K298stop mutant receptors inhibited H-3-WEB2086 binding and surface expression. Co-transfection with D63N resulted in a constitutively active receptor phenotype. Platelet-activating factor-induced inositol phosphate production in cells transfected with a 1:1 ratio of WT:D63N was higher than with the WT cDNA alone but was abolished with a 1:3 ratio. We confirmed that these findings could be extended to other GPCRs by showing that co-expression of the WT C-C chemokine receptor 2b with a carboxyl-terminal deletion mutant (K311stop), resulted in a decreased affinity and responsiveness to MCP-1. A better understanding of this phenomenon could lead to important tools for the prevention or treatment of certain diseases.	Univ Sherbrooke, Fac Med, Div Immunol, Dept Pediat, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Stankova, J (corresponding author), Univ Sherbrooke, Fac Med, Div Immunol, Dept Pediat, 3001 N 12th Ave, Sherbrooke, PQ J1H 5N4, Canada.							ALBLAS J, 1995, J BIOL CHEM, V270, P8944, DOI 10.1074/jbc.270.15.8944; ALI H, 1994, J BIOL CHEM, V269, P24557; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; BIRNBAUMER M, 1995, J RECEPT SIGNAL TR R, V15, P131, DOI 10.3109/10799899509045213; Ciruela F, 1995, J NEUROSCI RES, V42, P818, DOI 10.1002/jnr.490420610; COUGHLIN SR, 1994, CURR OPIN CELL BIOL, V6, P191, DOI 10.1016/0955-0674(94)90135-X; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; FAR DF, 1994, CYTOMETRY, V15, P327, DOI 10.1002/cyto.990150408; GIANNINI E, 1995, J BIOL CHEM, V270, P19166, DOI 10.1074/jbc.270.32.19166; Grosse R, 1997, MOL ENDOCRINOL, V11, P1305, DOI 10.1210/me.11.9.1305; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hebert TE, 1998, BIOCHEM J, V330, P287; Horan TP, 1997, J BIOCHEM-TOKYO, V121, P370; HWANG SB, 1990, J LIPID MEDIATOR, V2, P123; Ishii I, 1998, J BIOL CHEM, V273, P9878, DOI 10.1074/jbc.273.16.9878; Izumi T, 1995, BBA-LIPID LIPID MET, V1259, P317, DOI 10.1016/0005-2760(95)00171-9; KOTANI M, 1995, MOL PHARMACOL, V48, P869; Kuang YN, 1996, J BIOL CHEM, V271, P3975; LeGouill C, 1997, J BIOL CHEM, V272, P21289, DOI 10.1074/jbc.272.34.21289; LEMON MA, 1997, EMBO J, V16, P281; LIU K, 1994, J BIOL CHEM, V269, P29220; Maclennan KM, 1996, PROG NEUROBIOL, V50, P585, DOI 10.1016/S0301-0082(96)00047-0; Maggio R, 1996, J BIOL CHEM, V271, P31055, DOI 10.1074/jbc.271.49.31055; MAGGIO R, 1993, FEBS LETT, V319, P195, DOI 10.1016/0014-5793(93)80066-4; Monnot C, 1996, J BIOL CHEM, V271, P1507, DOI 10.1074/jbc.271.3.1507; Naville D, 1996, J CLIN ENDOCR METAB, V81, P1442, DOI 10.1210/jc.81.4.1442; Nimchinsky EA, 1997, J BIOL CHEM, V272, P29229, DOI 10.1074/jbc.272.46.29229; OkudaAshitaka E, 1996, J BIOL CHEM, V271, P31255, DOI 10.1074/jbc.271.49.31255; Parent JL, 1996, BIOCHEM BIOPH RES CO, V219, P968, DOI 10.1006/bbrc.1996.0341; Parent JL, 1996, J BIOL CHEM, V271, P23298, DOI 10.1074/jbc.271.38.23298; PARMA J, 1995, MOL ENDOCRINOL, V9, P725, DOI 10.1210/me.9.6.725; Paschke R, 1996, EXP CLIN ENDOCR DIAB, V104, P129, DOI 10.1055/s-0029-1211720; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Schoneberg T, 1996, EMBO J, V15, P1283, DOI 10.1002/j.1460-2075.1996.tb00470.x; SHUKLA SD, 1997, ADV EXP MED BIOL, V416, P153; SNYDER F, 1982, ANNU REP MED CHEM, V517, P243; Spiegel AM, 1997, J INHERIT METAB DIS, V20, P113, DOI 10.1023/A:1005393501786; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Watson S., 1994, G PROTEIN LINKED REC; WREGGETT KA, 1995, J BIOL CHEM, V270, P22488, DOI 10.1074/jbc.270.38.22488; Yano K, 1996, BIOCHEM BIOPH RES CO, V220, P1036, DOI 10.1006/bbrc.1996.0528	44	47	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12548	12554		10.1074/jbc.274.18.12548	http://dx.doi.org/10.1074/jbc.274.18.12548			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212233	hybrid			2022-12-27	WOS:000080056800053
J	Felinski, EA; Quinn, PG				Felinski, EA; Quinn, PG			The CREB constitutive activation domain interacts with TATA-binding protein-associated factor 110 (TAF110) through specific hydrophobic residues in one of the three subdomains required for both activation and TAF110 binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CAMP RESPONSE ELEMENT; MEDIATES TRANSCRIPTIONAL ACTIVATION; THYROID-HORMONE RECEPTORS; DROSOPHILA TFIID-COMPLEX; ALPHA-SUBUNIT GENE; DTAF(II)110 COMPONENT; SOMATOSTATIN GENE; HUMAN TAF(II)135; COACTIVATORS	The cAMP response element-binding protein (CREB) mediates both basal and PKA-inducible transcription through two separate and independently active domains, the constitutive activation domain (CAD) and the kinase-inducible domain, respectively. The CREB CAD interacts with the general transcription factor TFIID through one or more of the TATA-binding protein-associated factors (TAFs), one of which is TAF110, The CAD is composed of three subdomains, rich in either serine, hydrophobic amino acids, or glutamine, In the present study, analysis of deletion mutants of the CAD showed that all three CAD subdomains were required for effective interaction with TAF110 in a yeast two-hybrid assay, Therefore, a library of random point mutations within the CAD was analyzed in a reverse two-hybrid screen to identify amino acids that are essential for interaction with the TAF. Interaction defects resulted solely from mutations of hydrophobic amino acid residues within the hydrophobic cluster to charged amino acid residues. Together, the deletion and mutation analyses suggest that the entire CAD provides an environment for a specific hydrophobic interaction with TAF110 that is crucial for interaction. Our results provide further evidence for a model of basal activation by CREB involving interaction with TAF110 that promotes recruitment or stabilization of TFIID binding to the promoter, which facilitates pre-initiation complex assembly.	Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; Penn State Univ, Coll Med, Cell & Mol Biol Program, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Quinn, PG (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA.	pquinn@psu.edu						Bjorklund S, 1996, TRENDS BIOCHEM SCI, V21, P335, DOI 10.1016/0968-0004(96)10051-7; BRINDLE P, 1993, NATURE, V364, P821, DOI 10.1038/364821a0; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; CHEN JL, 1994, CELL, V79, P93, DOI 10.1016/0092-8674(94)90403-0; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Coustry F, 1998, BIOCHEM J, V331, P291, DOI 10.1042/bj3310291; CRESS WD, 1991, SCIENCE, V251, P87, DOI 10.1126/science.1846049; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; FERRERI K, 1994, P NATL ACAD SCI USA, V91, P1210, DOI 10.1073/pnas.91.4.1210; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HIMMELFARB HJ, 1990, CELL, V63, P1299, DOI 10.1016/0092-8674(90)90425-E; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; KIM KS, 1993, J BIOL CHEM, V268, P15689; KOLESKE AJ, 1995, TRENDS BIOCHEM SCI, V20, P113, DOI 10.1016/S0968-0004(00)88977-X; LEE CQ, 1990, EMBO J, V9, P4455, DOI 10.1002/j.1460-2075.1990.tb07896.x; Mazzarelli JM, 1997, J VIROL, V71, P7978, DOI 10.1128/JVI.71.10.7978-7983.1997; Mengus G, 1997, GENE DEV, V11, P1381, DOI 10.1101/gad.11.11.1381; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; Nakajima T, 1997, GENE DEV, V11, P738, DOI 10.1101/gad.11.6.738; NASMYTH KM, 1986, P NATL ACAD SCI USA, V77, P2119; NILSON JH, 1989, ANN NY ACAD SCI, V564, P77, DOI 10.1111/j.1749-6632.1989.tb25889.x; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Parker D, 1996, MOL CELL BIOL, V16, P694; Petty KJ, 1996, MOL ENDOCRINOL, V10, P1632, DOI 10.1210/me.10.12.1632; PUGH BF, 1992, J BIOL CHEM, V267, P679; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; QUINN PG, 1988, MOL CELL BIOL, V8, P3467, DOI 10.1128/MCB.8.8.3467; QUINN PG, 1993, J BIOL CHEM, V268, P16999; Saluja D, 1998, MOL CELL BIOL, V18, P5734, DOI 10.1128/MCB.18.10.5734; SAUER F, 1995, SCIENCE, V270, P1783, DOI 10.1126/science.270.5243.1783; Sauer F, 1996, CELL, V87, P1271, DOI 10.1016/S0092-8674(00)81822-X; SCHENA M, 1988, SCIENCE, V241, P965, DOI 10.1126/science.3043665; SCHULTZ LD, 1987, GENE, V61, P123, DOI 10.1016/0378-1119(87)90107-7; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; VANDYKE MW, 1989, MOL CELL BIOL, V9, P342, DOI 10.1128/MCB.9.1.342; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Walker SS, 1996, NATURE, V383, P185, DOI 10.1038/383185a0; WANG JC, 1993, BIOCHIM BIOPHYS ACTA, V1216, P73, DOI 10.1016/0167-4781(93)90039-G; WEIL PA, 1979, CELL, V18, P469; WEINZIERL ROJ, 1993, NATURE, V362, P511, DOI 10.1038/362511a0; XING LP, 1995, J BIOL CHEM, V270, P17488, DOI 10.1074/jbc.270.29.17488; XING LP, 1993, MOL ENDOCRINOL, V7, P1484, DOI 10.1210/me.7.11.1484; XING LP, 1994, J BIOL CHEM, V269, P28732; Yamit-Hezi A, 1998, EMBO J, V17, P5161, DOI 10.1093/emboj/17.17.5161; ZAWEL L, 1995, ANNU REV BIOCHEM, V64, P533; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964; ZHOU YH, 1991, NUCLEIC ACIDS RES, V19, P6052, DOI 10.1093/nar/19.21.6052	62	44	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11672	11678		10.1074/jbc.274.17.11672	http://dx.doi.org/10.1074/jbc.274.17.11672			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206980	hybrid			2022-12-27	WOS:000079834800036
J	Qian, YM; Varlamov, O; Fricker, LD				Qian, YM; Varlamov, O; Fricker, LD			Glu(300) of rat carboxypeptidase E is essential for enzymatic activity but not substrate binding or routing to the regulated secretory pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PITUITARY CELL-LINE; B VIRUS-PARTICLES; C-TERMINAL REGION; GENE FAMILY; MOLECULAR-CLONING; CPE(FAT)/CPE(FAT) MICE; SEQUENCE-ANALYSIS; SORTING RECEPTOR; MEMBRANE-BINDING; CDNA CLONING	Several recently discovered members of the carboxypeptidase E (CPE) gene family lack critical active site residues that are conserved in other family members. For example, three CPE-like proteins contain a Tyr in place of Glu(300) (equivalent to Glu(270) Of carboxypeptidase A and B). To investigate the importance of this position, Glu(300) Of rat CPE was converted into Gin, Lys, or Tyr, and the proteins expressed in Sf9 cells using the baculovirus system. All three mutants were secreted from the cells, but the media showed no enzyme activity above background levels. Wild-type CPE and the Gln(300) point mutant bound to ap-aminobenzoyl-Arg-Sepharose affinity resin, and this binding was competed by an active site-directed inhibitor, guanidinoethylmercaptosuccinic acid. The affinity purified mutant CPE protein showed no detectable enzyme activity (<0.004% of wildtype CPE) toward dansyl-Phe-Ala-Arg. Expression of the Gln(300) and Lys(300) mutant CPE proteins in the NIT3 mouse pancreatic beta-cell line showed that these mutants are routed into secretory vesicles and secreted via the regulated pathway. Taken together, these results indicate that Glu(300) Of CPE is essential for enzyme activity, but not required for substrate binding or for routing into the regulated secretory pathway.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	fricker@aecom.yu.edu			NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494, K02DA000194] Funding Source: NIH RePORTER; NCI NIH HHS [CA13330] Funding Source: Medline; NIDA NIH HHS [DA-00194, R01 DA-04494] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		[Anonymous], 1995, METH NEUROSCI; Battey, 1986, BASIC METHODS MOL BI; Bauerfeind R, 1993, CURR OPIN CELL BIOL, V5, P628, DOI 10.1016/0955-0674(93)90132-A; BRADSHAW RA, 1969, P NATL ACAD SCI USA, V63, P1389, DOI 10.1073/pnas.63.4.1389; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; CHRISTIANSON DW, 1991, ADV PROTEIN CHEM, V42, P281; CONE RI, 1982, NEUROPEPTIDES, V3, P97, DOI 10.1016/0143-4179(82)90005-1; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; DEVI L, 1989, MOL ENDOCRINOL, V3, P1852, DOI 10.1210/mend-3-11-1852; DEVI L, 1989, J NEUROENDOCRINOL, V1, P363, DOI 10.1111/j.1365-2826.1989.tb00130.x; EATON DL, 1991, J BIOL CHEM, V266, P21833; Eng FJ, 1998, J BIOL CHEM, V273, P8382, DOI 10.1074/jbc.273.14.8382; FRICKER LD, 1986, NATURE, V323, P461, DOI 10.1038/323461a0; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; FRICKER LD, 1983, BIOCHEM BIOPH RES CO, V111, P994, DOI 10.1016/0006-291X(83)91398-0; GARDELL SJ, 1988, J BIOL CHEM, V263, P17828; GEBHARD W, 1989, EUR J BIOCHEM, V178, P603, DOI 10.1111/j.1432-1033.1989.tb14488.x; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; Irminger JC, 1997, J BIOL CHEM, V272, P27532, DOI 10.1074/jbc.272.44.27532; KUROKI K, 1995, J BIOL CHEM, V270, P15022, DOI 10.1074/jbc.270.25.15022; Layne MD, 1998, J BIOL CHEM, V273, P15654, DOI 10.1074/jbc.273.25.15654; Lei YH, 1999, DNA CELL BIOL, V18, P175, DOI 10.1089/104454999315565; MITRA A, 1994, J BIOL CHEM, V269, P19876; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; NALAMACHU SR, 1994, J BIOL CHEM, V269, P11192; Normant E, 1998, ENDOCRINOLOGY, V139, P2137, DOI 10.1210/en.139.4.2137; Philippon A, 1998, CELL MOL LIFE SCI, V54, P341, DOI 10.1007/s000180050161; REYNOLDS DS, 1989, J BIOL CHEM, V264, P20094; ROBERTS RM, 1995, ADV EXP MED BIOL, V362, P231; Sagane K, 1998, BIOCHEM J, V334, P93, DOI 10.1042/bj3340093; SONG LX, 1995, J BIOL CHEM, V270, P7963, DOI 10.1074/jbc.270.14.7963; Song LX, 1997, J BIOL CHEM, V272, P10543; SONG LX, 1995, J BIOL CHEM, V270, P25007, DOI 10.1074/jbc.270.42.25007; Song LX, 1997, BIOCHEM J, V323, P265, DOI 10.1042/bj3230265; TAN FL, 1989, J BIOL CHEM, V264, P13165; TITANI K, 1975, P NATL ACAD SCI USA, V72, P1666, DOI 10.1073/pnas.72.5.1666; van Huijsduijnen RH, 1998, GENE, V206, P273, DOI 10.1016/S0378-1119(97)00597-0; Varlamov O, 1996, J BIOL CHEM, V271, P6077, DOI 10.1074/jbc.271.11.6077; Varlamov O, 1997, ENDOCRINOLOGY, V138, P4883, DOI 10.1210/en.138.11.4883; Varlamov O, 1996, J BIOL CHEM, V271, P13981, DOI 10.1074/jbc.271.24.13981; Xie S, 1997, P NATL ACAD SCI USA, V94, P12809, DOI 10.1073/pnas.94.24.12809; Xin XN, 1997, DNA CELL BIOL, V16, P897, DOI 10.1089/dna.1997.16.897; Xin XN, 1998, DNA CELL BIOL, V17, P897, DOI 10.1089/dna.1998.17.897; ZHANG FM, 1991, J BIOL CHEM, V266, P24606; Zhang ZY, 1997, CURR TOP CELL REGUL, V35, P21, DOI 10.1016/S0070-2137(97)80002-7	46	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11582	11586		10.1074/jbc.274.17.11582	http://dx.doi.org/10.1074/jbc.274.17.11582			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206965	hybrid			2022-12-27	WOS:000079834800021
J	Edwards, DC; Gill, GN				Edwards, DC; Gill, GN			Structural features of LIM kinase that control effects on the actin cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; FILAMENT-BINDING PROTEIN; DEPOLYMERIZING FACTOR; DOMAIN PROTEINS; ZINC-FINGER; C-SRC; COFILIN; PHOSPHORYLATION; IDENTIFICATION; SEQUENCE	LIM kinase phosphorylates and inactivates the actin binding/depolymerizing factor cofilin and induces actin cytoskeletal changes. Several unique structural features within LIM kinase were investigated for their roles in regulation of LIM kinase activity. Disruption of the second LIM domain or the PDZ domain or deletion of the entire amino terminus increased activity in vivo measured as increasing aggregation of the actin cytoskeleton. A kinase deleted alternate splice product was identified and characterized. This alternate splice product and a kinase inactive mutant inhibited LIM kinase in vivo, indicating that the amino terminus suppresses activity of the kinase domain. Mutation of threonine 508 in the activation loop to valine abolished activity whereas replacement with 2 glutamic acid residues resulted in a fully active enzyme. Dephosphorylation of LIM kinase inhibited cofilin phosphorylation. Mutation of the basic insert in the activation loop inhibited activity in vivo, but not in vitro. These results indicate phosphorylation is an essential regulatory feature of LIM kinase and indicate that threonine 508 and the adjacent basic insert sequences of the activation loop are required for this process. A combination of structural features are thus involved in receiving upstream signals that regulate LIM kinase-induced actin cytoskeletal reorganization.	Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Chem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Gill, GN (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, 9500 Gilman Dr 0650, La Jolla, CA 92093 USA.	ggill@ucsd.edu			NIDDK NIH HHS [DK13149] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK013149, R01DK013149] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; ADAMS ME, 1990, BIOCHEMISTRY-US, V29, P7414, DOI 10.1021/bi00484a009; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; BENDAVID Y, 1991, EMBO J, V10, P317, DOI 10.1002/j.1460-2075.1991.tb07952.x; BERNARD O, 1994, CELL GROWTH DIFFER, V5, P1159; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHENG AK, 1995, MECH DEVELOP, V52, P187, DOI 10.1016/0925-4773(95)00400-U; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; DAWID IB, 1995, CR ACAD SCI III-VIE, V318, P295; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; Herberg FW, 1997, PROTEIN SCI, V6, P569; Hiraoka J, 1996, FEBS LETT, V399, P117, DOI 10.1016/S0014-5793(96)01303-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HORTON RM, 1990, J IMMUNOL, V145, P1782; HUANG WD, 1995, MOL BIOL CELL, V6, P237, DOI 10.1091/mbc.6.3.237; Ikebe C, 1998, BIOCHEM BIOPH RES CO, V246, P307, DOI 10.1006/bbrc.1998.8609; Jiang Y, 1997, J BIOL CHEM, V272, P11096; Johnson LN, 1996, CURR OPIN STRUC BIOL, V6, P762, DOI 10.1016/S0959-440X(96)80005-4; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Jurata LW, 1998, CURR TOP MICROBIOL, V228, P75; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; KAGEN A, 1979, METHOD HORM RADIOIMM, P328; KOSA JL, 1994, BIOCHEMISTRY-US, V33, P468, DOI 10.1021/bi00168a011; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; LIU XQ, 1993, ONCOGENE, V8, P1119; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; MIZUNO K, 1994, ONCOGENE, V9, P1605; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Mori T, 1997, MOL BRAIN RES, V45, P247, DOI 10.1016/S0169-328X(96)00257-4; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; ORR JW, 1994, J BIOL CHEM, V269, P27715; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PEREZALVARADO GC, 1994, NAT STRUCT BIOL, V1, P388, DOI 10.1038/nsb0694-388; Pomies P, 1997, J CELL BIOL, V139, P157, DOI 10.1083/jcb.139.1.157; PROSCHEL C, 1995, ONCOGENE, V11, P1271; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; SADLER I, 1992, J CELL BIOL, V119, P1573, DOI 10.1083/jcb.119.6.1573; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Theriot JA, 1997, J CELL BIOL, V136, P1165, DOI 10.1083/jcb.136.6.1165; TURNER CE, 1994, J CELL SCI, V107, P1583; Wu RY, 1996, J BIOL CHEM, V271, P15934, DOI 10.1074/jbc.271.27.15934; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; YONEZAWA N, 1989, EUR J BIOCHEM, V183, P235, DOI 10.1111/j.1432-1033.1989.tb14918.x; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	62	70	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11352	11361		10.1074/jbc.274.16.11352	http://dx.doi.org/10.1074/jbc.274.16.11352			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196227	hybrid			2022-12-27	WOS:000079751900095
J	Kirby, JR; Saulmon, MM; Kristich, CJ; Ordal, GW				Kirby, JR; Saulmon, MM; Kristich, CJ; Ordal, GW			CheY-dependent methylation of the asparagine receptor, McpB, during chemotaxis in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CHEMOTAXIS; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; PROTEIN-PHOSPHORYLATION; FLAGELLAR SWITCH; SALMONELLA-TYPHIMURIUM; PROMOTES ADAPTATION; GROUP TURNOVER; GENES; METHYLESTERASE	For the Gram-positive organism Bacillus subtilis, chemotaxis to the attractant asparagine is mediated by the chemoreceptor McpB. In this study, we show that rapid net demethylation of B. subtilis McpB results in the immediate production of methanol, presumably due to the action of CheB. We also show that net demethylation of McpB occurs upon both addition and removal of asparagine. After each demethylation event, McpB is remethylated to nearly prestimulus levels. Both remethylation events are attributable to CheR using S-adenosylmethionine as a substrate. Therefore, no methyl transfer to an intermediate carrier need be postulated to occur during chemotaxis in B. subtilis as was previously suggested. Furthermore, we show that the remethylation of asparagine-bound McpB requires the response regulator, CheY-P, suggesting that CheY-P acts in a feedback mechanism to facilitate adaptation to positive stimuli during chemotaxis in B. subtilis, This hypothesis is supported by two observations: a cheRBCD mutant is capable of transient excitation and subsequent oscillations that bring the flagellar rotational bias below the prestimulus value in the tethered cell assay, and the cheRBCD mutant is capable of swarming in a Tryptone swarm plate.	Univ Illinois, Coll Med, Dept Biochem, Urbana, IL 61801 USA; Univ Illinois, Coll Liberal Arts & Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Ordal, GW (corresponding author), Univ Illinois, Coll Med, Dept Biochem, 190 Med Sci Bldg,506 S Mathews, Urbana, IL 61801 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054365, R56GM054365] Funding Source: NIH RePORTER; NIAID NIH HHS [AI20336] Funding Source: Medline; NIGMS NIH HHS [GM54365] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHLGREN JA, 1983, BIOCHEM J, V213, P759, DOI 10.1042/bj2130759; Appleby JL, 1996, CELL, V86, P845, DOI 10.1016/S0092-8674(00)80158-0; BEDALE WA, 1988, J BACTERIOL, V170, P223, DOI 10.1128/jb.170.1.223-227.1988; Bibikov SI, 1997, J BACTERIOL, V179, P4075, DOI 10.1128/jb.179.12.4075-4079.1997; BISCHOFF DS, 1993, BIOCHEMISTRY-US, V32, P9256, DOI 10.1021/bi00086a035; BISCHOFF DS, 1991, J BIOL CHEM, V266, P12301; Blat Y, 1996, J BIOL CHEM, V271, P1232, DOI 10.1074/jbc.271.2.1232; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; BORKOVICH KA, 1990, CELL, V63, P1339, DOI 10.1016/0092-8674(90)90429-I; BOURRET RB, 1991, ANNU REV BIOCHEM, V60, P401, DOI 10.1146/annurev.bi.60.070191.002153; Bren A, 1996, P NATL ACAD SCI USA, V93, P10090, DOI 10.1073/pnas.93.19.10090; BURGESSCASSLER A, 1982, J BIOL CHEM, V257, P8412; Cochran AG, 1996, SCIENCE, V271, P1113, DOI 10.1126/science.271.5252.1113; FERRARI E, 1981, J BACTERIOL, V146, P430, DOI 10.1128/JB.146.1.430-432.1981; FREDRICK KL, 1994, J BACTERIOL, V176, P2727, DOI 10.1128/JB.176.9.2727-2735.1994; FUHRER DK, 1991, J BACTERIOL, V173, P7443, DOI 10.1128/jb.173.23.7443-7448.1991; Garrity LF, 1997, MICROBIOL-UK, V143, P2945, DOI 10.1099/00221287-143-9-2945; GOLDMAN DJ, 1984, BIOCHEMISTRY-US, V23, P675, DOI 10.1021/bi00299a014; GOY MF, 1977, P NATL ACAD SCI USA, V74, P4964, DOI 10.1073/pnas.74.11.4964; HANLON DW, 1992, J BIOL CHEM, V267, P12055; HANLON DW, 1992, J BACTERIOL, V174, P4218, DOI 10.1128/JB.174.13.4218-4222.1992; HANLON DW, 1994, J BIOL CHEM, V269, P14038; HANLON DW, 1994, MICROBIOL-SGM, V140, P1847, DOI 10.1099/13500872-140-8-1847; HENNER DJ, 1990, METHOD ENZYMOL, V185, P223; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; KEHRY MR, 1984, J BIOL CHEM, V259, P1828; KIHARA M, 1989, J BACTERIOL, V171, P3247, DOI 10.1128/jb.171.6.3247-3257.1989; Kirby JR, 1997, MOL MICROBIOL, V24, P869, DOI 10.1046/j.1365-2958.1997.3941759.x; KIRSCH ML, 1993, J BIOL CHEM, V268, P18610; KIRSCH ML, 1993, J BIOL CHEM, V268, P25350; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LIU JD, 1989, P NATL ACAD SCI USA, V86, P8703, DOI 10.1073/pnas.86.22.8703; Liu Y, 1997, EMBO J, V16, P7231, DOI 10.1093/emboj/16.24.7231; Muller J, 1997, MICROBIOL-UK, V143, P3231, DOI 10.1099/00221287-143-10-3231; NINFA EG, 1991, J BIOL CHEM, V266, P9764; NORDMANN B, 1994, J BIOL CHEM, V269, P16449; ORDAL GW, 1983, J BACTERIOL, V154, P1088, DOI 10.1128/JB.154.3.1088-1097.1983; ORDAL GW, 1977, J BACTERIOL, V129, P156, DOI 10.1128/JB.129.1.156-165.1977; ORDAL GW, 1975, SCIENCE, V189, P802, DOI 10.1126/science.808854; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; Rosario MML, 1996, MOL MICROBIOL, V21, P511, DOI 10.1111/j.1365-2958.1996.tb02560.x; ROSARIO MML, 1995, BIOCHEMISTRY-US, V34, P3823, DOI 10.1021/bi00011a040; ROSARIO MML, 1994, J BACTERIOL, V176, P2736, DOI 10.1128/JB.176.9.2736-2739.1994; Satir B.H., 1991, MODERN CELL BIOL, P137; SLACK FJ, 1995, MOL MICROBIOL, V15, P689, DOI 10.1111/j.1365-2958.1995.tb02378.x; SMIBERT RM, 1994, METHODS GEN MOL BACT, V1, P603; SOCKETT H, 1992, J BACTERIOL, V174, P793, DOI 10.1128/jb.174.3.793-806.1992; SPRINGER MS, 1979, NATURE, V280, P279, DOI 10.1038/280279a0; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; STOCK JB, 1991, ANNU REV BIOPHYS BIO, V20, P109, DOI 10.1146/annurev.bb.20.060191.000545; STOCK JB, 1996, ESCHERICHIA COLI SAL, V2, P1103; Surette MG, 1996, J BIOL CHEM, V271, P17966, DOI 10.1074/jbc.271.30.17966; THOELKE MS, 1990, J BIOL CHEM, V265, P1928; THOELKE MS, 1988, BIOCHEMISTRY-US, V27, P8453, DOI 10.1021/bi00422a024; THOELKE MS, 1987, J BIOL CHEM, V262, P2811; THOELKE MS, 1990, J BACTERIOL, V172, P1148, DOI 10.1128/jb.172.2.1148-1150.1990; THOELKE MS, 1989, BIOCHEMISTRY-US, V28, P5585, DOI 10.1021/bi00439a037; TOEWS ML, 1979, P NATL ACAD SCI USA, V81, P5544; ULLAH AHJ, 1981, J BACTERIOL, V145, P958, DOI 10.1128/JB.145.2.958-965.1981; Wang H, 1996, MOL MICROBIOL, V19, P695, DOI 10.1046/j.1365-2958.1996.393934.x; WEINRAUCH Y, 1991, J BACTERIOL, V173, P5685, DOI 10.1128/jb.173.18.5685-5693.1991; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8787, DOI 10.1073/pnas.90.19.8787; WONG LS, 1995, J BACTERIOL, V177, P4342, DOI 10.1128/jb.177.15.4342-4349.1995	66	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11092	11100		10.1074/jbc.274.16.11092	http://dx.doi.org/10.1074/jbc.274.16.11092			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196193	hybrid			2022-12-27	WOS:000079751900061
J	Makihira, S; Yan, WQ; Ohno, S; Kawamoto, T; Fujimoto, K; Okimura, A; Yoshida, E; Noshiro, M; Hamada, T; Kato, Y				Makihira, S; Yan, WQ; Ohno, S; Kawamoto, T; Fujimoto, K; Okimura, A; Yoshida, E; Noshiro, M; Hamada, T; Kato, Y			Enhancement of cell adhesion and spreading by a cartilage-specific noncollagenous protein, cartilage matrix protein (CMP/matrilin-1), via integrin alpha(1)beta(1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; EXTRACELLULAR-MATRIX; OSTEOARTHRITIC CARTILAGE; ARTICULAR CHONDROCYTES; VONWILLEBRAND-FACTOR; SUBSTRATE ADHESION; DIVALENT-CATIONS; EXPRESSION; RECEPTOR; ALPHA-3-BETA-1	Cartilage matrix protein (CMP; also known as matrilin-1), one of the major noncollagenous proteins in most cartilages, binds to aggrecan and type II collagen. We examined the effect of CMP on the adhesion of chondrocytes and fibroblasts using CMP-coated dishes. The CMP coating at 10-20 mu g/ml enhanced the adhesion and spreading of rabbit growth plate, resting and articular chondrocytes, and fibroblasts and human epiphyseal chondrocytes and MRC5 fibroblasts. The effect of CMP on the spreading of chondrocytes was synergistically increased by native, but not heated, type II collagen (gelatin). The monoclonal antibody to integrin alpha(1) or beta(1) abolished CMP-induced cell adhesion and spreading, whereas the antibody to integrin alpha(2), alpha(3), alpha(5), beta(2), alpha(5)beta(1), or alpha(v)beta(5) had little effect on cell adhesion or spreading. The antibody to integrin alpha(1), but not to other subunits, coprecipitated I-125-CMP that was added to MRC5 cell lysates, indicating the association of CMP with the integrin a, subunit. Unlabeled CMP competed for the binding to integrin alpha(1), with I-125-CMP. These findings suggest that CMP is a potent adhesion factor for chondrocytes, particularly in the presence of type II collagen, and that integrin alpha(1)beta(1) is involved in CMP-mediated cell adhesion and spreading, Since CMP is expressed almost exclusively in cartilage, this adhesion factor, unlike fibronectin or laminin, may play a special role in the development and remodeling of cartilage.	Hiroshima Univ, Sch Dent, Dept Biochem, Minami Ku, Hiroshima 7348553, Japan; Hiroshima Univ, Sch Dent, Dept Prosthet Dent, Minami Ku, Hiroshima 7348553, Japan; Hiroshima Univ, Sch Dent, Dept Orthodont, Minami Ku, Hiroshima 7348553, Japan; Norman Bethune Univ Med Sci, Inst Endem Dis, Dept Biochem, Changchun 130021, Peoples R China	Hiroshima University; Hiroshima University; Hiroshima University; Jilin University	Kato, Y (corresponding author), Hiroshima Univ, Sch Dent, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	ykato@ipc.hiroshima-u.ac.jp	, 河本健/D-7938-2015	, 河本健/0000-0003-3337-1775				ARGRAVES WS, 1987, P NATL ACAD SCI USA, V84, P464, DOI 10.1073/pnas.84.2.464; Belluoccio D, 1997, FEBS LETT, V415, P212, DOI 10.1016/S0014-5793(97)01126-5; BERGELSON JM, 1993, J CLIN INVEST, V92, P232, DOI 10.1172/JCI116555; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; CARTER WG, 1990, J CELL BIOL, V110, P1387, DOI 10.1083/jcb.110.4.1387; CHEN Q, 1995, MOL BIOL CELL, V6, P1743, DOI 10.1091/mbc.6.12.1743; COLOMBATTI A, 1991, BLOOD, V77, P2305; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Deak F, 1997, J BIOL CHEM, V272, P9268; ELICES MJ, 1991, J CELL BIOL, V112, P169, DOI 10.1083/jcb.112.1.169; Hauser N, 1996, J BIOL CHEM, V271, P32247, DOI 10.1074/jbc.271.50.32247; HAUSER N, 1994, J BIOL CHEM, V269, P25747; Hauser N, 1995, ACTA ORTHOP SCAND, V66, P19, DOI 10.3109/17453679509157641; JENKINS RN, 1990, J BIOL CHEM, V265, P19624; KATO Y, 1993, J CLIN INVEST, V92, P2323, DOI 10.1172/JCI116836; KISS I, 1989, J BIOL CHEM, V264, P8126; LOESER RF, 1995, EXP CELL RES, V217, P248, DOI 10.1006/excr.1995.1084; LUQUE A, 1994, FEBS LETT, V346, P278, DOI 10.1016/0014-5793(94)00490-0; Meulenbelt I, 1997, ARTHRITIS RHEUM, V40, P1760, DOI 10.1002/art.1780401006; OKADA Y, 1992, LAB INVEST, V66, P680; Okimura A, 1997, ARTHRITIS RHEUM, V40, P1029, DOI 10.1002/art.1780400606; Pattaramalai S, 1996, EXP CELL RES, V222, P281, DOI 10.1006/excr.1996.0036; PAULSSON M, 1979, BIOCHEM J, V183, P539, DOI 10.1042/bj1830539; PAULSSON M, 1982, BIOCHEM J, V207, P207, DOI 10.1042/bj2070207; PAULSSON M, 1984, BIOCHEM J, V221, P623, DOI 10.1042/bj2210623; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SALTER DM, 1995, J HISTOCHEM CYTOCHEM, V43, P447, DOI 10.1177/43.4.7897185; Shen M, 1997, BIOCHEM BIOPH RES CO, V236, P294, DOI 10.1006/bbrc.1997.6960; STIRPE NS, 1989, DEVELOPMENT, V107, P23; Towbin H, 1992, Biotechnology, V24, P145; TSONIS PA, 1988, EXP EYE RES, V46, P753, DOI 10.1016/S0014-4835(88)80061-7; Wagener R, 1997, FEBS LETT, V413, P129, DOI 10.1016/S0014-5793(97)00895-8; WAYNER EA, 1988, J CELL BIOL, V107, P1881, DOI 10.1083/jcb.107.5.1881; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; WAYNER EA, 1993, J CELL BIOL, V121, P1141, DOI 10.1083/jcb.121.5.1141; WOODS VL, 1994, ARTHRITIS RHEUM, V37, P537, DOI 10.1002/art.1780370414; Wu JJ, 1998, J BIOL CHEM, V273, P17433, DOI 10.1074/jbc.273.28.17433; YAMAGATA M, 1989, J BIOL CHEM, V264, P8012	38	60	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11417	11423		10.1074/jbc.274.16.11417	http://dx.doi.org/10.1074/jbc.274.16.11417			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196235	hybrid			2022-12-27	WOS:000079751900103
J	Miura, R; Aspberg, A; Ethell, IM; Hagihara, K; Schnaar, RL; Ruoslahti, E; Yamaguchi, Y				Miura, R; Aspberg, A; Ethell, IM; Hagihara, K; Schnaar, RL; Ruoslahti, E; Yamaguchi, Y			The proteoglycan lectin domain binds sulfated cell surface glycolipids and promotes cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE; NERVOUS-SYSTEM; CARBOHYDRATE-BINDING; CORE PROTEIN; TENASCIN-R; L-SELECTIN; RAT-BRAIN; L2/HNK-1 CARBOHYDRATE; EXPRESSION CLONING; NEURITE OUTGROWTH	The lecticans are a group of chondroitin sulfate proteoglycans characterized by the presence of C-type lectin domains. Despite the suggestion that their lectin domains interact with carbohydrate ligands, the identity of such ligands has not been elucidated. We previously showed that brevican, a nervous system-specific lectican, binds the surface of B28 glial cells (Yamada, H., Fredette, B., Shitara, K., Hagihara, K., Miura, R., Ranscht, B., Stallcup, W, B., and Yamaguchi, Y. (1997) J. Neurosci, 17, 7784-7795), In this paper, we demonstrate that two classes of sulfated glycolipids, sulfatides and HNK-1-reactive sulfoglucuronylglycolipids (SGGLs), act as cell surface receptors for brevican. The lectin domain of brevican binds sulfatides and SGGLs in a calcium-dependent manner as expected of a C-type lectin domain. Intact, full-length brevican also binds both sulfatides and SGGLs. The lectin domain immobilized as a substrate supports adhesion of cells expressing SGGLs or sulfatides, which was inhibited by monoclonal antibodies against these glycolipids or by treatment of the substrate with SGGLs or sulfatides, Our findings demonstrate that the interaction between the lectin domains of lecticans and sulfated glycolipids comprises a novel cell substrate recognition system, and suggest that lecticans in extracellular matrices serve as substrate for adhesion and migration of cells expressing these glycolipids in vivo.	Burnham Inst, La Jolla, CA 92037 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Neurosci, Baltimore, MD 21205 USA	Sanford Burnham Prebys Medical Discovery Institute; Johns Hopkins University	Yamaguchi, Y (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Schnaar, Ronald L/S-8967-2016	Schnaar, Ronald L/0000-0002-7701-5484; Ethell, Iryna/0000-0002-1324-6611; Aspberg, Anders/0000-0002-6588-6944	NCI NIH HHS [CA28896] Funding Source: Medline; NICHD NIH HHS [HD25938] Funding Source: Medline; NINDS NIH HHS [NS32717] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA028896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032717] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARUFFO A, 1991, CELL, V67, P35, DOI 10.1016/0092-8674(91)90570-O; ASPBERG A, 1995, P NATL ACAD SCI USA, V92, P10590, DOI 10.1073/pnas.92.23.10590; Aspberg A, 1997, P NATL ACAD SCI USA, V94, P10116, DOI 10.1073/pnas.94.19.10116; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BIGNAMI A, 1993, J NEUROSCI RES, V34, P97, DOI 10.1002/jnr.490340110; BodeLesniewska B, 1996, J HISTOCHEM CYTOCHEM, V44, P303, DOI 10.1177/44.4.8601689; Chou DKH, 1998, J BIOL CHEM, V273, P8508, DOI 10.1074/jbc.273.14.8508; COOLING LLW, 1995, GLYCOBIOLOGY, V5, P571, DOI 10.1093/glycob/5.6.571; Courel MN, 1998, J NEUROCYTOL, V27, P27, DOI 10.1023/A:1006982802778; CROSSIN KL, 1992, J NEUROSCI RES, V33, P631, DOI 10.1002/jnr.490330416; DOEGE K, 1987, J BIOL CHEM, V262, P17757; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; FRYXELL KJ, 1980, J NEUROCHEM, V35, P1461, DOI 10.1111/j.1471-4159.1980.tb09026.x; GERSTEN DM, 1978, J IMMUNOL METHODS, V24, P305, DOI 10.1016/0022-1759(78)90133-3; GRIFFITH LS, 1992, J NEUROSCI RES, V33, P639, DOI 10.1002/jnr.490330417; HALBERG DF, 1988, J BIOL CHEM, V263, P9486; HALL H, 1995, GLYCOBIOLOGY, V5, P435, DOI 10.1093/glycob/5.4.435; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; ITO K, 1995, J BIOL CHEM, V270, P958, DOI 10.1074/jbc.270.2.958; Jahnke W, 1997, ANGEW CHEM INT EDIT, V36, P2603, DOI 10.1002/anie.199726031; JUNGALWALA FB, 1994, NEUROCHEM RES, V19, P945, DOI 10.1007/BF00968704; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; LASKY LA, 1995, ANNU REV BIOCHEM, V64, P113, DOI 10.1146/annurev.bi.64.070195.000553; Lebaron RG, 1996, PERSPECT DEV NEUROBI, V3, P261; Li H, 1996, MOL BRAIN RES, V36, P309, DOI 10.1016/0169-328X(95)00269-X; MCEVER RP, 1995, J BIOL CHEM, V270, P1125; MeyerPuttlitz B, 1996, J COMP NEUROL, V366, P44, DOI 10.1002/(SICI)1096-9861(19960226)366:1<44::AID-CNE4>3.0.CO;2-K; Milev P, 1998, BIOCHEM BIOPH RES CO, V247, P207, DOI 10.1006/bbrc.1998.8759; Miura Y, 1997, BIOCHEM BIOPH RES CO, V241, P698, DOI 10.1006/bbrc.1997.7876; Nair SM, 1997, J NEUROCHEM, V68, P1286; NEEDHAM LK, 1993, J CELL BIOL, V121, P397, DOI 10.1083/jcb.121.2.397; NEEDHAM LK, 1993, P NATL ACAD SCI USA, V90, P1339; NIIMURA Y, 1990, BIOCHIM BIOPHYS ACTA, V1052, P248, DOI 10.1016/0167-4889(90)90218-3; Norton WT., 1984, MYELIN, P147, DOI DOI 10.1007/978-1-4757-1830-0_5; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; OOHIRA A, 1994, NEUROSCIENCE, V60, P145, DOI 10.1016/0306-4522(94)90210-0; PESHEVA P, 1989, J CELL BIOL, V109, P1765, DOI 10.1083/jcb.109.4.1765; Pesheva P, 1997, J NEUROSCI, V17, P4642; PODUSLO SE, 1985, NEUROCHEM RES, V10, P1285, DOI 10.1007/BF00964847; PURI KD, 1995, J CELL BIOL, V131, P261, DOI 10.1083/jcb.131.1.261; RAUCH U, 1992, J BIOL CHEM, V267, P19536; RAUCH U, 1991, J BIOL CHEM, V266, P14785; ROBERTS DD, 1985, J BIOL CHEM, V260, P9405; ROBERTS DD, 1985, P NATL ACAD SCI USA, V82, P1306, DOI 10.1073/pnas.82.5.1306; ROBERTS DD, 1986, J BIOL CHEM, V261, P3306; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; SALEQUE S, 1993, GLYCOBIOLOGY, V3, P185, DOI 10.1093/glycob/3.2.185; SCHACHNER M, 1995, TRENDS NEUROSCI, V18, P183, DOI 10.1016/0166-2236(95)93899-9; Schwartz NB, 1996, PERSPECT DEV NEUROBI, V3, P291; SEIDENBECHER CI, 1995, J BIOL CHEM, V270, P27206, DOI 10.1074/jbc.270.45.27206; Seidenbecher CI, 1998, EUR J NEUROSCI, V10, P1621, DOI 10.1046/j.1460-9568.1998.00166.x; STALLCUP WB, 1976, EXP CELL RES, V98, P285, DOI 10.1016/0014-4827(76)90440-7; TAKI T, 1991, CANCER RES, V51, P1701; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; UJITA M, 1994, J BIOL CHEM, V269, P27603; Wong CH, 1997, J AM CHEM SOC, V119, P8152, DOI 10.1021/ja970920q; YAMADA H, 1995, BIOCHEM BIOPH RES CO, V216, P957, DOI 10.1006/bbrc.1995.2713; Yamada H, 1997, J NEUROSCI, V17, P7784; YAMADA H, 1994, J BIOL CHEM, V269, P10119; Yamaguchi Y, 1996, PERSPECT DEV NEUROBI, V3, P307; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	63	96	98	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11431	11438		10.1074/jbc.274.16.11431	http://dx.doi.org/10.1074/jbc.274.16.11431			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196237	hybrid			2022-12-27	WOS:000079751900105
J	Nemes, Z; Marekov, LN; Steinert, PM				Nemes, Z; Marekov, LN; Steinert, PM			Involucrin cross-linking by transglutaminase 1 - Binding to membranes directs residue specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNIFIED CELL-ENVELOPE; PROLINE-RICH PROTEINS; LAMELLAR ICHTHYOSIS; KERATINOCYTE TRANSGLUTAMINASE; EPIDERMAL-KERATINOCYTES; TERMINAL DIFFERENTIATION; SUBSTRATE PROPERTIES; CALCIUM REGULATION; ENZYME; COMPONENTS	The transglutaminase 1 (TGase 1) enzyme is essential for the assembly of the cell envelope barrier in stratified squamous epithelia, It is usually bound to membranes, but to date most studies with it have involved solution assays. Here we describe an in vitro model system for characterizing the function of TGase 1 on the surface of synthetic lipid vesicles (SLV) of composition similar to eukaryote plasma membranes. Recombinant baculovirus-expressed human TGase 1 readily binds to SLV and becomes active in cross-linking above 10 mu M Ca2+, in comparison to above 100 mu M in solution assays, suggesting that the membrane surface is important for enzyme function. Involucrin also binds to SLV containing 12-18% phosphatidylserine and at Ca2+ concentrations above 1 mu M. In reactions of involucrin with TGase 1 enzyme in solution, 80 of its 150 glutamines serve as donor residues. However, on SLV carrying both involucrin and TGase 1, only five glutamines serve as donors, of which glutamine 496 was the most favored, As controls, there was no change in specificity toward the glutamines of other substrates used by free or SLV-bound TGase 1 enzyme. We propose a model in which involucrin and TGase 1 bind to membranes shortly after expression in differentiating keratinocytes, but cross-linking begins only later as intracellular Ca2+ levels increase. Furthermore, the data suggest that the membrane surface regulates the steric interaction of TGase 1 with substrates such as involucrin to permit specific cross linking for initiation of cell envelope barrier formation.	NIAMS, Skin Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Steinert, PM (corresponding author), NIAMS, Skin Biol Lab, NIH, Bldg 6,Rm 425, Bethesda, MD 20892 USA.	pemast@helix.nih.gov			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041086, Z01AR041087] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aeschlimann D, 1998, J BIOL CHEM, V273, P3452, DOI 10.1074/jbc.273.6.3452; BERS DM, 1994, METHOD CELL BIOL, V40, P1; Candi E, 1998, J BIOL CHEM, V273, P13693, DOI 10.1074/jbc.273.22.13693; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; Candi E, 1999, J BIOL CHEM, V274, P7226, DOI 10.1074/jbc.274.11.7226; CHAKRAVARTY R, 1989, J BIOL CHEM, V264, P625; CRISH JF, 1993, DIFFERENTIATION, V53, P191, DOI 10.1111/j.1432-0436.1993.tb00708.x; DEVIRAGH PA, 1994, J INVEST DERMATOL, V103, P815, DOI 10.1111/1523-1747.ep12413482; ECKERT RL, 1986, CELL, V46, P583, DOI 10.1016/0092-8674(86)90884-6; ETOH Y, 1986, BIOCHEM BIOPH RES CO, V136, P51, DOI 10.1016/0006-291X(86)90875-2; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; FOLK JE, 1983, ADV ENZYMOL RAMB, V54, P1; FORSLIND B, 1984, SCAN ELECTRON MICROS, P755; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Hauser H, 1991, STRUCTURE BIOL MEMBR, P3; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Jarnik M, 1998, J CELL SCI, V111, P1051; KIM HC, 1990, J BIOL CHEM, V265, P21971; KIM HC, 1991, J BIOL CHEM, V266, P536; KIM SY, 1995, J BIOL CHEM, V270, P18026, DOI 10.1074/jbc.270.30.18026; KIM SY, 1994, J BIOL CHEM, V269, P27979; KONIGSBERG WH, 1983, METHOD ENZYMOL, V91, P254; LEE MH, 1989, J BIOL CHEM, V264, P14797; LI LW, 1995, CELL GROWTH DIFFER, V6, P1171; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; Marekov LN, 1998, J BIOL CHEM, V273, P17763, DOI 10.1074/jbc.273.28.17763; MATOLTSY AG, 1966, J INVEST DERMATOL, V46, P127, DOI 10.1038/jid.1966.19; MCLAUGHLIN S, 1988, J PHYSIOL-LONDON, V396, P189, DOI 10.1113/jphysiol.1988.sp016958; MCLAUGHLIN S, 1981, J GEN PHYSIOL, V77, P445, DOI 10.1085/jgp.77.4.445; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; MOISOR M, 1994, J BOIL CHEM, V269, P13798; MOSIOR M, 1993, BIOCHEMISTRY-US, V32, P65, DOI 10.1021/bi00052a010; Parmentier L, 1996, HUM MOL GENET, V5, P555, DOI 10.1093/hmg/5.4.555; PHILLIPS MA, 1993, BIOCHEMISTRY-US, V32, P11057, DOI 10.1021/bi00092a015; PILLAI S, 1990, J CELL PHYSIOL, V143, P294, DOI 10.1002/jcp.1041430213; Reichert Uwe, 1993, P107; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; Robinson NA, 1997, J BIOL CHEM, V272, P12035, DOI 10.1074/jbc.272.18.12035; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; SIMON M, 1988, J BIOL CHEM, V263, P18093; SIMON M, 1984, CELL, V36, P827, DOI 10.1016/0092-8674(84)90032-1; SIMON M, 1994, KERATINOCYTE HDB, P275; Song HJ, 1999, GENOMICS, V55, P28, DOI 10.1006/geno.1998.5607; Steinert PM, 1996, J BIOL CHEM, V271, P26242, DOI 10.1074/jbc.271.42.26242; Steinert PM, 1998, J BIOL CHEM, V273, P11758, DOI 10.1074/jbc.273.19.11758; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Steinert PM, 1997, J BIOL CHEM, V272, P2021, DOI 10.1074/jbc.272.3.2021; SUN TT, 1976, CELL, V9, P511, DOI 10.1016/0092-8674(76)90033-7; Tarcsa E, 1998, J BIOL CHEM, V273, P23297, DOI 10.1074/jbc.273.36.23297; Tarcsa E, 1997, J BIOL CHEM, V272, P27893, DOI 10.1074/jbc.272.44.27893; THOMAS MV, 1991, CELLULAR CALCIUM, P115; THOMSON JM, 1985, BLOOD COAGULATION HA, P301; TSENG H, 1988, CELL, V54, P491, DOI 10.1016/0092-8674(88)90070-0; Vicanova J, 1998, J INVEST DERMATOL, V111, P97, DOI 10.1046/j.1523-1747.1998.00251.x; WATT FM, 1983, J INVEST DERMATOL, V81, pS100, DOI 10.1111/1523-1747.ep12540786; WATT FM, 1981, J CELL BIOL, V90, P738, DOI 10.1083/jcb.90.3.738; YAFFE MB, 1993, J INVEST DERMATOL, V100, P3, DOI 10.1111/1523-1747.ep12349857; YAFFE MB, 1992, J BIOL CHEM, V267, P12233	59	45	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11013	11021		10.1074/jbc.274.16.11013	http://dx.doi.org/10.1074/jbc.274.16.11013			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196183	hybrid			2022-12-27	WOS:000079751900051
J	Kimura, S; Tokishita, S; Ohta, T; Kobayashi, M; Yamagata, H				Kimura, S; Tokishita, S; Ohta, T; Kobayashi, M; Yamagata, H			Heterogeneity and differential expression under hypoxia of two-domain hemoglobin chains in the water flea, Daphnia magna	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; 2-DOMAIN HEMOGLOBIN; BARBATIA-LIMA; PROTEINS; GLOBIN; CDNA; CLONING	Hemoglobin (Hb) purified from the water flea, Daphnia magna, reared under hypoxia was analyzed by two dimensional gel electrophoresis. The Hb was shown to be composed of six major subunit chain species (designated as DHbA to DHbF). The NH2-terminal amino acid sequences of DHbA, DHbB, DHbC, and DHbF are different from one another, indicating that at least four Hb genes are present in D. magna. The NH2-terminal amino acid sequences of DHbD and DHbE are the same as those of DHbA and DHbB, respectively. The six Hb chains were also found in the animal reared under normoxia in small amounts and with altered composition; the extent of decrease under normoxia was higher in the amounts of DHbC, DHbD, and DHbF than those of others. These results indicate that the Hb genes are differentially regulated by the ambient oxygen concentration. Four Hb genes constituting a cluster in the order, dhb4, dhb3, dhb1, and dhb2, were found on the chromosome of D. magna, The complete nucleotide sequences of the dhb1, dhb2, and dhb3 genes and their cDNAs showed that the genes have a seven-exon, six-intron structure. The structure consists of an intron separating an exon encoding a secretory signal sequence, two large repeated regions of a three-exon, two-intron structure that encode each a domain containing a heme-binding site, and an intron bridging the two repeated regions. The deduced amino acid sequences of the gene products showed higher than 79% identity to one another and showed unique features conserved in D. magna Hb chains. The analysis also suggested that DHbB (or DHbE), DHbF, and DHbC are encoded by the dhb1, dhb2, and dhb3 genes, respectively.	Tokyo Univ Pharm & Life Sci, Sch Life Sci, Div Environm Sci, Lab Environm & Mol Biol, Tokyo 1920392, Japan; Niigata Univ, Fac Sci, Dept Biol, Niigata 9502181, Japan	Tokyo University of Pharmacy & Life Sciences; Niigata University	Yamagata, H (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Div Environm Sci, Lab Environm & Mol Biol, Tokyo 1920392, Japan.							BAERE DE, 1992, P NATL ACAD SCI USA, V89, P4638; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; BUNN HF, 1986, HEMOGLOBIN MOL GENET, P126; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CAVINS JF, 1970, ANAL BIOCHEM, V35, P489, DOI 10.1016/0003-2697(70)90211-3; DIXON B, 1991, P NATL ACAD SCI USA, V88, P5655, DOI 10.1073/pnas.88.13.5655; EDMAN P, 1956, ACTA CHEM SCAND, V10, P761, DOI 10.3891/acta.chem.scand.10-0761; ILAN E, 1982, BIOCHEM J, V207, P297, DOI 10.1042/bj2070297; IWAASA H, 1989, J MOL BIOL, V208, P355, DOI 10.1016/0022-2836(89)90395-1; KAPP OH, 1995, PROTEIN SCI, V4, P2179, DOI 10.1002/pro.5560041024; KOBAYASHI M, 1984, ZOOL SCI, V1, P523; KOBAYASHI M, 1988, PHYSIOL ZOOL, V61, P415, DOI 10.1086/physzool.61.5.30161263; KOBAYASHI M, 1990, COMP BIOCHEM PHYS A, V97, P513; KOBAYASHI M, 1985, PHYSIOL ZOOL, V58, P190, DOI 10.1086/physzool.58.2.30158566; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANIATIS T, 1980, ANNU REV GENET, V14, P45; Mashiko K., 1951, Japanese Journal of Limnology, V15, P88; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MINNING DM, 1995, J BIOL CHEM, V270, P22248, DOI 10.1074/jbc.270.38.22248; MOENS L, 1990, J BIOL CHEM, V265, P14285; NAITO Y, 1991, P NATL ACAD SCI USA, V88, P6672, DOI 10.1073/pnas.88.15.6672; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Sambrook J., 2002, MOL CLONING LAB MANU; SUGANO H, 1971, BIOCHIM BIOPHYS ACTA, V229, P349, DOI 10.1016/0005-2795(71)90194-2; SUZUKI T, 1989, ZOOL SCI, V6, P269; SUZUKI T, 1995, J PROTEIN CHEM, V14, P499, DOI 10.1007/BF01886875; SWOFFORD DL, 1993, PAUP PHYLOGENETIC AN; Tokishita S, 1997, GENE, V189, P73, DOI 10.1016/S0378-1119(96)00836-0; URICH K, 1990, COMP ANIMAL BIOCH, P249; VINOGRADOV SN, 1993, COMP BIOCHEM PHYS B, V106, P1, DOI 10.1016/0305-0491(93)90002-M	31	52	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10649	10653		10.1074/jbc.274.15.10649	http://dx.doi.org/10.1074/jbc.274.15.10649			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187862	hybrid			2022-12-27	WOS:000079663500101
J	Minamisawa, S; Gu, YS; Ross, J; Chien, KR; Chen, J				Minamisawa, S; Gu, YS; Ross, J; Chien, KR; Chen, J			A post-transcriptional compensatory pathway in heterozygous ventricular myosin light chain 2-deficient mice results in lack of gene dosage effect during normal cardiac growth or hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; SKELETAL-MUSCLE; ALPHA-TROPOMYOSIN; HEART; ABLATION; PHOSPHORYLATION; MORPHOGENESIS; CONTRACTION; REQUIREMENT; DROSOPHILA	Our previous study of homozygous mutants of the ventricular specific isoform of myosin light chain 2 (mlc-2v) demonstrated that mlc-ev plays an essential role in murine heart development (Chen, J,, Kubalak, S, W,, Minamisawa, S,, Price, R, L,, Becker, K, D., Hickey, R,, Ross, J,, Jr,, and Chien, K, R, (1998) J. Biol. Chem. 273, 1252-1256), As gene dosage of some myofibrillar proteins can affect muscle function, we have analyzed heterozygous mutants in depth. Ventricles of heterozygous mutants displayed a 50% reduction in mlc-2v mRNA, yet expressed normal levels of protein both under basal conditions and following induction of cardiac hypertrophy by aortic constriction. Heterozygous mutants exhibited cardiac function comparable to that of wild-type littermate controls both prior to and following aortic constriction. There were no significant differences in contractility and responses to calcium between wild-type and heterozygous unloaded cardiomyocytes, We conclude that heterozygous mutants show neither a molecular nor a physiological cardiac phenotype either at base line or following hypertrophic stimuli, These results suggest that post-transcriptional compensatory mechanisms play a major role in maintaining the level of MLC-SV protein in murine hearts, In addition, as our mlc-2v knockout mutants were created by a knock-in of Cre recombinase into the endogenous mlc-ev locus, this study demonstrates that heterozygous mlc-ev cre knock-in mice are appropriate for ventricular specific gene targeting.	Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Chen, J (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Chen, Ju/E-5579-2011; gu, yu/GSD-4507-2022	Minamisawa, Susumu/0000-0003-4728-2116	NHLBI NIH HHS [HL-46345] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046345] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLEN BG, 1994, TRENDS BIOCHEM SCI, V19, P362, DOI 10.1016/0968-0004(94)90112-0; BEALL CJ, 1989, GENE DEV, V3, P131, DOI 10.1101/gad.3.2.131; Blanchard EM, 1997, CIRC RES, V81, P1005; Chen J, 1998, J BIOL CHEM, V273, P1252, DOI 10.1074/jbc.273.2.1252; Chen J, 1998, DEVELOPMENT, V125, P1943; DIFFEE GM, 1995, BIOPHYS J, V68, P1443, DOI 10.1016/S0006-3495(95)80317-6; HIROTA H, 1999, IN PRESS CELL; IKEBE M, 1985, BIOCHEMISTRY-US, V24, P2380, DOI 10.1021/bi00330a038; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406; LOWEY S, 1993, NATURE, V365, P454, DOI 10.1038/365454a0; MOUSSAVI RS, 1993, MOL CELL BIOCHEM, V128, P219, DOI 10.1007/BF01076773; Palermo J, 1996, CIRC RES, V78, P504, DOI 10.1161/01.RES.78.3.504; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Rethinasamy P, 1998, CIRC RES, V82, P116; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sata M, 1996, CIRCULATION, V93, P310, DOI 10.1161/01.CIR.93.2.310; SOLARO RJ, 1971, BIOCHIM BIOPHYS ACTA, V245, P259, DOI 10.1016/0005-2728(71)90033-8; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Szczesna D, 1996, J BIOL CHEM, V271, P5246; Tanaka N, 1996, CIRCULATION, V94, P1109, DOI 10.1161/01.CIR.94.5.1109; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; WARMKE J, 1992, J CELL BIOL, V119, P1523, DOI 10.1083/jcb.119.6.1523	27	34	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10066	10070		10.1074/jbc.274.15.10066	http://dx.doi.org/10.1074/jbc.274.15.10066			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187786	hybrid			2022-12-27	WOS:000079663500025
J	Tirosh, A; Potashnik, R; Bashan, N; Rudich, A				Tirosh, A; Potashnik, R; Bashan, N; Rudich, A			Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes - A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; RAT ADIPOSE-CELLS; SIGNAL-TRANSDUCTION; GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; GLUCOSE-TRANSPORT; GLUCOSE-TRANSPORTER-4 TRANSLOCATION; GLUT4-CONTAINING VESICLES; STIMULATED TRANSLOCATION; MOLECULAR-CLONING	In a recent study we have demonstrated that 3T3-L1 adipocytes exposed to low micromolar H2O2 concentrations display impaired insulin stimulated GLUT4 translocation from internal membrane pools to the plasma membrane (Rudich, A., Tirosh, A., Potashnik, R., Hemi, R., Kannety, H., and Bashan, N, (1998) Diabetes 47, 1562-1569), In this study we further characterize the cellular mechanisms responsible for this observation, Two-hour exposure to similar to 25 mu M H2O2 (generated by adding glucose oxidase to the medium) resulted in disruption of the normal insulin stimulated insulin receptor substrate (IRS)-1 and phosphatidylinositol (PI) 3-kinase cellular redistribution between the cytosol and an internal membrane pool (low density microsomal fraction (LDM)). This was associated with reduced insulin-stimulated IRS-1 and p85 associated PI 3-kinase activities in the LDM (84 and 96% inhibition, respectively). The effect of this finding on the downstream insulin signal was demonstrated by a 90% reduction in insulin stimulated protein kinase B (PKB) serine 473 phosphorylation and impaired activation of PKB alpha and PKB gamma. Both control and oxidized cells exposed to heat shock displayed a wortmannin insensitive PKB serine phosphorylation and activity. These data suggest that activation of PKB and GLUT4 translocation are insulin signaling events dependent upon a normal insulin induced cellular compartmentalization of PI 3-kinase and IRS-1, which is oxidative stress-sensitive. These findings represent a novel cellular mechanism for the induction of insulin resistance in response to changes in the extracellular environment.	Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, IL-84103 Beer Sheva, Israel; Soroka Med Ctr, IL-84101 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Soroka Medical Center	Bashan, N (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, IL-84105 Beer Sheva, Israel.			Rudich, Assaf/0000-0002-1366-1444; Tirosh, Amir/0000-0003-2210-5906				Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Caro Jose F., 1996, P519; Chen D, 1997, J BIOL CHEM, V272, P27401, DOI 10.1074/jbc.272.43.27401; CLANCY BM, 1990, J BIOL CHEM, V265, P12434; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; Cohen P, 1997, FEBS LETT, V410, P3, DOI 10.1016/S0014-5793(97)00490-0; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; CZECH MP, 1974, P NATL ACAD SCI USA, V71, P4173, DOI 10.1073/pnas.71.10.4173; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; EldarFinkelman H, 1997, P NATL ACAD SCI USA, V94, P9660, DOI 10.1073/pnas.94.18.9660; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Frevert EU, 1997, MOL CELL BIOL, V17, P190, DOI 10.1128/MCB.17.1.190; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; HADARI YR, 1992, J BIOL CHEM, V267, P17483; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; HELLERHARRISON RA, 1995, J BIOL CHEM, V270, P24442, DOI 10.1074/jbc.270.41.24442; HellerHarrison RA, 1996, J BIOL CHEM, V271, P10200, DOI 10.1074/jbc.271.17.10200; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Inoue G, 1998, J BIOL CHEM, V273, P11548, DOI 10.1074/jbc.273.19.11548; JAMES DE, 1988, BIOCHEM J, V256, P725, DOI 10.1042/bj2560725; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; KELLY KL, 1992, J BIOL CHEM, V267, P3423; KELLY KL, 1993, J BIOL CHEM, V268, P4391; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; KRIEGERBRAUER HI, 1995, BIOCHEM J, V307, P549, DOI 10.1042/bj3070549; KRIEGERBRAUER HI, 1992, J CLIN INVEST, V89, P1006, DOI 10.1172/JCI115641; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; Martin SS, 1996, ENDOCRINOLOGY, V137, P5045, DOI 10.1210/en.137.11.5045; Matsuzaki H, 1996, FEBS LETT, V396, P305, DOI 10.1016/0014-5793(96)01120-9; MAY JM, 1979, J BIOL CHEM, V254, P9017; Nave BT, 1996, BIOCHEM J, V318, P55, DOI 10.1042/bj3180055; NOUROOZZADEH J, 1995, DIABETES, V44, P1054, DOI 10.2337/diabetes.44.9.1054; NouroozZadeh J, 1997, DIABETOLOGIA, V40, P647, DOI 10.1007/s001250050729; Palmer HJ, 1997, NUTR REV, V55, P353, DOI 10.1111/j.1753-4887.1997.tb01561.x; PAOLISSO G, 1994, METABOLISM, V43, P1426, DOI 10.1016/0026-0495(94)90039-6; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; PAZ K, 1998, 7 INT S INS REC INS, P66; Ricort JM, 1996, EUR J BIOCHEM, V239, P17, DOI 10.1111/j.1432-1033.1996.0017u.x; Rudich A, 1997, AM J PHYSIOL-ENDOC M, V272, pE935, DOI 10.1152/ajpendo.1997.272.5.E935; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; SALONEN JT, 1995, BRIT MED J, V311, P1124, DOI 10.1136/bmj.311.7013.1124; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Slein M.W., 1965, METHODS ENZYMATIC AN, P117, DOI 10.1016/B978-0-12-395630-9.50023-2; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; Tanti JF, 1996, J BIOL CHEM, V271, P25227, DOI 10.1074/jbc.271.41.25227; TANTI JF, 1994, J BIOL CHEM, V269, P6051; Tanti JF, 1997, ENDOCRINOLOGY, V138, P2005, DOI 10.1210/en.138.5.2005; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Walker KS, 1998, BIOCHEM J, V331, P299, DOI 10.1042/bj3310299; Wang QH, 1998, BIOCHEM J, V331, P917, DOI 10.1042/bj3310917; WHITE MF, 1994, J BIOL CHEM, V269, P1; WILDEN PA, 1995, J CELL BIOCHEM, V58, P279, DOI 10.1002/jcb.240580303; WOLFF SP, 1991, FREE RADICAL BIO MED, V10, P339, DOI 10.1016/0891-5849(91)90040-A; Yang J, 1996, BIOCHEM J, V313, P125, DOI 10.1042/bj3130125	67	243	256	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10595	10602		10.1074/jbc.274.15.10595	http://dx.doi.org/10.1074/jbc.274.15.10595			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187855	hybrid			2022-12-27	WOS:000079663500094
J	Ueba, T; Kaspar, B; Zhao, XY; Gage, FH				Ueba, T; Kaspar, B; Zhao, XY; Gage, FH			Repression of human fibroblast growth factor 2 by a novel transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; DNA METHYLTRANSFERASE; CELLS; SEQUENCE; PROTEINS; PROMOTER; RECEPTOR; CLONING; DISEASE; VARIANT	Here we describe the cloning of the regulator of fibroblast growth factor 2 (FGF-2) transcription (RFT) using a yeast one-hybrid screening with a defined motif in FGF-S promoter as a target sequence. Overexpression of human RFT (RFT-A) reduces FGF-2 RNA and protein levels in both normal and tumor cell lines. Its splice variants, RFT-A' and RFT-B, have deletions in the putative DNA binding domain and fail to bind FGF-S promoter and repress FGF-2 gene expression. The ratios of RFT isoforms differ between normal and tumor cells, with the splice variants dominating in tumor cells. Overexpression of RFT-A induces glioma cell death. Our data suggest that regulation of FGF-2 by RFT is important for cellular functions and may be impaired in certain tumors.	Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Gage, FH (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	fgage@salk.edu	Kaspar, Brian/E-6490-2010; Ueba, Tetsuya/AFL-6434-2022; Kaspar, Brian/E-3349-2011; Ueba, Tetsuya/AAG-6548-2022		NINDS NIH HHS [N01-NS-6-23438] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; Baird Andrew, 1994, Current Opinion in Neurobiology, V4, P78, DOI 10.1016/0959-4388(94)90035-3; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Biesiada E, 1996, J BIOL CHEM, V271, P18576, DOI 10.1074/jbc.271.31.18576; Care A, 1996, MOL CELL BIOL, V16, P4842; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; COTMAN CW, 1991, ANN NY ACAD SCI, V638, P221, DOI 10.1111/j.1749-6632.1991.tb49033.x; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; FOULKES NS, 1992, CELL, V68, P411, DOI 10.1016/0092-8674(92)90178-F; GOSPODAROWICZ D, 1989, J INVEST DERMATOL, V93, P39; Grabowski PJ, 1998, CELL, V92, P709, DOI 10.1016/S0092-8674(00)81399-9; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; ISHII S, 1985, SCIENCE, V230, P1378, DOI 10.1126/science.2999983; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; Moffett J, 1996, P NATL ACAD SCI USA, V93, P2470, DOI 10.1073/pnas.93.6.2470; Murai N, 1996, J NEUROSURG, V85, P1072, DOI 10.3171/jns.1996.85.6.1072; PESCINI R, 1994, J BIOL CHEM, V269, P1159; Shibata F, 1991, GROWTH FACTORS, V4, P277, DOI 10.3109/08977199109043913; Skerjanc IS, 1996, J BIOL CHEM, V271, P3555, DOI 10.1074/jbc.271.7.3555; Snyder RO, 1997, HUM GENE THER, V8, P1891, DOI 10.1089/hum.1997.8.16-1891; STACHOWIAK MK, 1994, J CELL BIOL, V127, P203, DOI 10.1083/jcb.127.1.203; SUZUKI M, 1989, J MOL BIOL, V207, P61, DOI 10.1016/0022-2836(89)90441-5; TAKAHASHI JA, 1990, P NATL ACAD SCI USA, V87, P5710, DOI 10.1073/pnas.87.15.5710; Tashiro K, 1997, P NATL ACAD SCI USA, V94, P7862, DOI 10.1073/pnas.94.15.7862; TOOYAMA I, 1993, BRAIN RES, V610, P1, DOI 10.1016/0006-8993(93)91209-B; UEBA T, 1994, P NATL ACAD SCI USA, V91, P9009, DOI 10.1073/pnas.91.19.9009; Wang D, 1997, ONCOGENE, V14, P2291, DOI 10.1038/sj.onc.1201069; ZAGZAG D, 1990, CANCER RES, V50, P7393; ZELEZNIKLE NJ, 1994, P NATL ACAD SCI USA, V91, P10610, DOI 10.1073/pnas.91.22.10610; ZHOU SZ, 1994, J EXP MED, V179, P1867, DOI 10.1084/jem.179.6.1867	33	11	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10382	10387		10.1074/jbc.274.15.10382	http://dx.doi.org/10.1074/jbc.274.15.10382			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187827	hybrid			2022-12-27	WOS:000079663500066
J	Ernst, M; Novak, U; Nicholson, SE; Layton, JE; Dunn, AR				Ernst, M; Novak, U; Nicholson, SE; Layton, JE; Dunn, AR			The carboxyl-terminal domains of gp130-related cytokine receptors are necessary for suppressing embryonic stem cell differentiation - Involvement of STAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; LEUKEMIA INHIBITORY FACTOR; CILIARY NEUROTROPHIC FACTOR; SIGNAL TRANSDUCER GP130; TYROSINE PHOSPHORYLATION; TARGETED DISRUPTION; CYTOPLASMIC DOMAIN; DISTINCT REGIONS; CSF RECEPTOR; ONCOSTATIN-M	Cell type-specific responses to the leukemia inhibitory factor (LIF)/interleukin 6 cytokine family are mediated by dimerization of the LIF receptor alpha-chain (LIFR alpha) with the signal transducer gp130 or of two gp130 molecules followed by activation of the JAK/STAT and Ras/mitogen-activated protein kinase cascades. In order to dissect the contribution of gp130 and LIFR alpha individually, chimeric molecules consisting of the extracellular domain of the granulocyte colony stimulating factor receptor (GCSF-R) and various mutant forms of the cytoplasmic domains of gp130 or LIFR alpha were expressed in embryonic stem (ES) cells to test for suppression of differentiation, or in a factor-dependent plasma cytoma cell line to assess for induction of proliferation. Carboxyl-terminal domains downstream of the phosphatase (SHP2)-binding sites were dispensable for mitogen-activated protein kinase activation and the transduction of proliferative signals. Moreover, carboxyl-terminal truncation mutants which lacked intact Box 3 homology domains showed decreased STAT3 activation, failed to induce Hck kinase activity and suppress ES cell differentiation. Moreover, STAT3 antisense oligonucleotides impaired LIF-dependent inhibition of differentiation. Substitution of the tyrosine residue within the Box 3 region of the GSCF-R abolished receptor-mediated suppression of differentiation without affecting the transduction of proliferative signals. Thus, distinct cytoplasmic domains within the LIFR alpha, gp130, and GCSF-R transduce proliferative and differentiation suppressing signals.	Ludwig Inst Canc Res, Melbourne Tumour Biol Branch, Melbourne, Vic 3050, Australia; Univ Melbourne, Dept Med, Melbourne, Vic 3050, Australia	Ludwig Institute for Cancer Research; University of Melbourne	Ernst, M (corresponding author), Ludwig Inst Canc Res, Melbourne Tumour Biol Branch, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.	matthias.ernst@ludwig.edu.au	Ernst, Matthias/D-5111-2012	Ernst, Matthias/0000-0002-6399-1177; , Sandra/0000-0002-1314-2134				ALEXANDER WS, 1995, ONCOGENE, V10, P795; ARGETSINGER LS, 1995, J BIOL CHEM, V270, P14685, DOI 10.1074/jbc.270.24.14685; BAUMANN H, 1994, MOL CELL BIOL, V14, P138, DOI 10.1128/MCB.14.1.138; BAUMANN H, 1993, J BIOL CHEM, V268, P8414; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; Drachman JG, 1997, P NATL ACAD SCI USA, V94, P2350, DOI 10.1073/pnas.94.6.2350; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Ernst M, 1996, J BIOL CHEM, V271, P30136, DOI 10.1074/jbc.271.47.30136; ERNST M, 1994, EMBO J, V13, P1574, DOI 10.1002/j.1460-2075.1994.tb06420.x; Friedman MC, 1996, P NATL ACAD SCI USA, V93, P2077, DOI 10.1073/pnas.93.5.2077; Fujitani Y, 1997, ONCOGENE, V14, P751, DOI 10.1038/sj.onc.1200907; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Gerhartz C, 1996, J BIOL CHEM, V271, P12991, DOI 10.1074/jbc.271.22.12991; Giordano V, 1997, J IMMUNOL, V158, P4097; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; HILTON DJ, 1992, TRENDS BIOCHEM SCI, V17, P72, DOI 10.1016/0968-0004(92)90505-4; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; JOHNSTON JA, 1995, J BIOL CHEM, V270, P28527, DOI 10.1074/jbc.270.48.28527; Karras JG, 1997, J EXP MED, V185, P1035, DOI 10.1084/jem.185.6.1035; LAI CF, 1995, J BIOL CHEM, V270, P23254, DOI 10.1074/jbc.270.40.23254; LAI CF, 1995, J BIOL CHEM, V270, P14847, DOI 10.1074/jbc.270.25.14847; LIU W, 1997, GENE DEV, V11, P179; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Nicholson SE, 1996, J BIOL CHEM, V271, P26947, DOI 10.1074/jbc.271.43.26947; NICHOLSON SE, 1995, BLOOD, V86, P3698, DOI 10.1182/blood.V86.10.3698.bloodjournal86103698; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; ONEAL KD, 1993, LYMPHOKINE CYTOK RES, V12, P309; SADOWSKI HB, 1993, SCIENCE, V26, P1749; SATO N, 1993, EMBO J, V12, P4181, DOI 10.1002/j.1460-2075.1993.tb06102.x; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1995, SCIENCE, V267, P1701; Starr R, 1997, J BIOL CHEM, V272, P19982, DOI 10.1074/jbc.272.32.19982; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; TWEARDY DJ, 1995, BLOOD, V86, P4409, DOI 10.1182/blood.V86.12.4409.bloodjournal86124409; UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938; Yamanaka Y, 1996, EMBO J, V15, P1557, DOI 10.1002/j.1460-2075.1996.tb00500.x; YOSHIKAWA A, 1995, EMBO J, V14, P5288, DOI 10.1002/j.1460-2075.1995.tb00213.x; ZIEGLER SF, 1993, MOL CELL BIOL, V13, P2384, DOI 10.1128/MCB.13.4.2384	47	64	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9729	9737		10.1074/jbc.274.14.9729	http://dx.doi.org/10.1074/jbc.274.14.9729			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092661	hybrid			2022-12-27	WOS:000079451800080
J	Joshi, L; St Leger, RJ				Joshi, L; St Leger, RJ			Cloning, expression, and substrate specificity of MeCPA, a zinc carboxypeptidase that is secreted into infected tissues by the fungal entomopathogen Metarhizium anisopliae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PROCARBOXYPEPTIDASE A2; ULTRASTRUCTURAL-LOCALIZATION; SERINE CARBOXYPEPTIDASES; RAT CARBOXYPEPTIDASE; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; GENE FAMILY; ACTIVATION; PROTEASE; CDNA	To date zinc carboxypeptidases have only been found in animals and actinomycete bacteria. A cDNA clone (MeCPA) for a novel fungal (Metarhizium anisopliae) carboxypeptidase (MeCPA) was obtained by using reverse transcription differential display polymerase chain reaction to identify pathogenicity genes. MeCPA resembles pancreatic carboxypeptidases in being synthesized as a precursor species (418 amino acids) containing a large amino-terminal fragment (99 amino acids). The mature (secreted) form of MeCPA shows closest amino acid identity to human carboxypeptidases Al (35%) and A2 (37%). MeCPA was expressed in an insect cell line yielding an enzyme with dual A1 + A2 specificity for branched aliphatic and aromatic COOH-terminal amino acids. However, in contrast to the very broad spectrum A + B-type bacterial enzymes, MeCPA lacks B-type activity against charged amino acids. This is predictable as key catalytic residues determining the specificity of MeCPA are conserved with those of mammalian A-type carboxypeptidases. Thus, in evolutionary terms the fungal enzyme is an intermediate between the divergence of A and B forms and the differentiation of the A form into A1 and A2 isoforms, Ultrastructural immunocytochemistry of infected host (Manduca sexta) cuticle demonstrated that MeCPA participates with the concurrently produced endoproteases in procuring nutrients; an equivalent function to digestive pancreatic enzymes.	Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14853 USA	University System of Maryland; University of Maryland College Park; Cornell University; Boyce Thompson Institute for Plant Research	St Leger, RJ (corresponding author), Univ Maryland, Dept Entomol, 4112 Plant Sci Bldg, College Pk, MD 20742 USA.	rl106@umailsrv0.umd.edu	St. Leger, Raymond/N-3219-2013					AVILES FX, 1993, EUR J BIOCHEM, V211, P381, DOI 10.1111/j.1432-1033.1993.tb17561.x; BREDDAM K, 1988, CARLSBERG RES COMMUN, V53, P309, DOI 10.1007/BF02904436; BREDDAM K, 1986, CARLSBERG RES COMMUN, V51, P83, DOI 10.1007/BF02907561; CATASUS L, 1995, J BIOL CHEM, V270, P6651, DOI 10.1074/jbc.270.12.6651; CLAUSER E, 1988, J BIOL CHEM, V263, P17837; CUENI LB, 1980, ANAL BIOCHEM, V107, P341, DOI 10.1016/0003-2697(80)90394-2; DALDEGAN F, 1992, APPL ENVIRON MICROB, V58, P2144, DOI 10.1128/AEM.58.7.2144-2152.1992; DISANTO ME, 1992, J BACTERIOL, V174, P447, DOI 10.1128/jb.174.2.447-455.1992; Garcia-Saez I, 1997, EMBO J, V16, P6906, DOI 10.1093/emboj/16.23.6906; GARDELL SJ, 1988, J BIOL CHEM, V263, P17828; GROEBE DR, 1990, NUCLEIC ACIDS RES, V18, P4033, DOI 10.1093/nar/18.13.4033; HAMBLIN M, 1990, APPL ENVIRON MICROB, V56, P3057, DOI 10.1128/AEM.56.10.3057-3062.1990; JOHNSTON M, 1994, SCIENCE, V265, P2077, DOI 10.1126/science.8091229; Joshi L, 1997, GENE, V197, P1, DOI 10.1016/S0378-1119(97)00132-7; LEHUEROU I, 1991, BIOCHEM BIOPH RES CO, V175, P110, DOI 10.1016/S0006-291X(05)81207-0; Luckow Verne A., 1995, P51; NEURATH H, 1986, J CELL BIOCHEM, V32, P35, DOI 10.1002/jcb.240320105; OPPEZZO O, 1994, EUR J BIOCHEM, V222, P55, DOI 10.1111/j.1432-1033.1994.tb18841.x; OSTERMAN AL, 1992, J PROTEIN CHEM, V11, P561, DOI 10.1007/BF01025034; Phillips MA, 1996, BIOCHEMISTRY-US, V35, P6771, DOI 10.1021/bi960113o; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Reverter D, 1998, J BIOL CHEM, V273, P3535, DOI 10.1074/jbc.273.6.3535; StLeger RJ, 1996, APPL ENVIRON MICROB, V62, P1257, DOI 10.1128/AEM.62.4.1257-1264.1996; StLeger RJ, 1996, P NATL ACAD SCI USA, V93, P6349, DOI 10.1073/pnas.93.13.6349; STLEGER RJ, 1992, EUR J BIOCHEM, V204, P991, DOI 10.1111/j.1432-1033.1992.tb16721.x; STLEGER RJ, 1987, ARCH BIOCHEM BIOPHYS, V253, P221, DOI 10.1016/0003-9861(87)90655-2; STLEGER RJ, 1995, CAN J BOT, V73, pS1119, DOI 10.1139/b95-367; STLEGER RJ, 1989, EXP MYCOL, V13, P274, DOI 10.1016/0147-5975(89)90049-2; StLeger RJ, 1996, APPL ENVIRON MICROB, V62, P907, DOI 10.1128/AEM.62.3.907-912.1996; WOOD HA, 1977, J INVERTEBR PATHOL, V29, P304, DOI 10.1016/S0022-2011(77)80035-9; ZHANG FM, 1991, J BIOL CHEM, V266, P24606	31	36	43	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9803	9811		10.1074/jbc.274.14.9803	http://dx.doi.org/10.1074/jbc.274.14.9803			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092670	hybrid			2022-12-27	WOS:000079451800089
J	Bertin, J; Nir, WJ; Fischer, CM; Tayber, OV; Errada, PR; Grant, JR; Keilty, JJ; Gosselin, ML; Robison, KE; Wong, GHW; Glucksmann, MA; DiStefano, PS				Bertin, J; Nir, WJ; Fischer, CM; Tayber, OV; Errada, PR; Grant, JR; Keilty, JJ; Gosselin, ML; Robison, KE; Wong, GHW; Glucksmann, MA; DiStefano, PS			Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; RECEPTOR; ELEGANS; KINASE	The nematode CED-4 protein and its human homolog Apaf-1 play a central role in apoptosis by functioning as direct activators of death-inducing caspases. A novel human CED-4/Apaf-1 family member called CARD4 was identified that has a domain structure strikingly similar to the cytoplasmic, receptor-like proteins that mediate disease resistance in plants. CARD4 interacted with the serine-threonine kinase RICK and potently induced NF-kappa B activity through TRAF-6 and NIK signaling molecules. In addition, coexpression of CARD4 augmented caspase-9-induced apoptosis. Thus, CARD4 coordinates downstream NF-kappa B and apoptotic signaling pathways and may be a component of the host innate immune response.	Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Bertin, J (corresponding author), Millennium Pharmaceut Inc, 640 Med Dr, Cambridge, MA 02139 USA.	bertin@mpi.com						Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Chin KC, 1997, P NATL ACAD SCI USA, V94, P2501, DOI 10.1073/pnas.94.6.2501; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; INOHARA N, 1998, P NATL ACAD SCI USA, V273, P12296; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	16	302	324	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	1999	274	19					12955	12958		10.1074/jbc.274.19.12955	http://dx.doi.org/10.1074/jbc.274.19.12955			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	194NL	10224040	hybrid			2022-12-27	WOS:000080200400002
J	Fagan, KA; Rich, TC; Tolman, S; Schaack, J; Karpen, JW; Cooper, DMF				Fagan, KA; Rich, TC; Tolman, S; Schaack, J; Karpen, JW; Cooper, DMF			Adenovirus-mediated expression of an olfactory cyclic nucleotide-gated channel regulates the endogenous Ca2+-inhibitable adenylyl cyclase in C6-2B glioma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CA2+ ENTRY; FUNCTIONAL EXPRESSION; LIGHT ADAPTATION; CALCIUM; NEURONS; CLONING; INHIBITION; METABOLISM; SYNAPSES; MUSCLE	Previous studies have established that Ca2+-sensitive adenylyl cyclases, whether endogenously or heterologously expressed, are preferentially regulated by capacitative Ca2+ entry, compared with other means of elevating cytosolic Ca2+ (Chiono, M,, Mahey, R,, Tate, G,, and Cooper, D, Ni. F. (1995) J. Biol. Chem, 270, 1149-1155; Fagan, K, A, Mahey, R,, and Cooper, D, M. F, (1996) J, Biol, Chem, 271, 12438-12444; Fagan, K, A., Mons, N,, and Cooper, D, M. F, (1998) J. Biol. Chem. 273, 9297-9305), These findings led to the suggestion that adenylyl cyclases and capacitative Ca2+ entry channels were localized in the same functional domain of the plasma membrane, In the present study, we have asked whether a heterologously expressed Ca2+-permeable channel could regulate the Ca2+-inhibitable adenylyl cyclase of C6-2B glioma cells. The cDNA coding for the rat olfactory cyclic nucleotide-gated channel was inserted into an adenovirus construct to achieve high levels of expression. Electrophysiological measurements confirmed the preservation of the properties of the expressed olfactory channel. Stimulation of the channel with cGMP analogs yielded a robust elevation in cytosolic Ca2+, which was associated with an inhibition of cAMP accumulation, comparable with that elicited by capacitative Ca2+ entry. These findings not only extend the means whereby Ca2+-sensitive adenylyl cyclases may be regulated, they also suggest that in tissues where they co-exist, cyclic nucleotidegated channels and Ca2+ sensitive adenylyl cyclases may reciprocally modulate each other's activity.	Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Physiol & Biophys, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Microbiol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Cooper, DMF (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Box C-236,4200 E 9th Ave, Denver, CO 80262 USA.				NHLBI NIH HHS [HL58344] Funding Source: Medline; NIGMS NIH HHS [GM 32483] Funding Source: Medline; NINDS NIH HHS [NS 28389] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028389] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANHOLT RRH, 1993, CRIT REV NEUROBIOL, V7, P1; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; BIEL M, 1994, P NATL ACAD SCI USA, V91, P3505, DOI 10.1073/pnas.91.9.3505; Bradley J, 1997, J NEUROSCI, V17, P1993; CHIONO M, 1995, J BIOL CHEM, V270, P1149, DOI 10.1074/jbc.270.3.1149; COOPER DMF, 1994, CELL SIGNAL, V6, P823, DOI 10.1016/0898-6568(94)90016-7; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; DEBERNARDI MA, 1993, BIOCHEM J, V293, P325, DOI 10.1042/bj2930325; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Ding CL, 1997, AM J PHYSIOL-CELL PH, V272, pC1335, DOI 10.1152/ajpcell.1997.272.4.C1335; EVANS T, 1984, MOL PHARMACOL, V26, P395; Fagan KA, 1998, J BIOL CHEM, V273, P9297, DOI 10.1074/jbc.273.15.9297; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Feng L, 1996, FEBS LETT, V395, P77, DOI 10.1016/0014-5793(96)01011-3; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; GOMEZFOIX AM, 1992, J BIOL CHEM, V267, P25129; Ishikawa Y, 1997, CIRC RES, V80, P297, DOI 10.1161/01.RES.80.3.297; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kingston PA, 1996, P NATL ACAD SCI USA, V93, P10440, DOI 10.1073/pnas.93.19.10440; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; MONS N, 1995, P NATL ACAD SCI USA, V92, P8473, DOI 10.1073/pnas.92.18.8473; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; Parent A, 1998, J NEUROPHYSIOL, V79, P3295, DOI 10.1152/jn.1998.79.6.3295; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; Ruiz ML, 1996, J MOL CELL CARDIOL, V28, P1453, DOI 10.1006/jmcc.1996.0136; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Savchenko A, 1997, NATURE, V390, P694, DOI 10.1038/37803; SCHAACK J, 1995, J VIROL, V69, P3920, DOI 10.1128/JVI.69.6.3920-3923.1995; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; YOSHIMURA M, 1992, P NATL ACAD SCI USA, V89, P6716, DOI 10.1073/pnas.89.15.6716	37	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12445	12453		10.1074/jbc.274.18.12445	http://dx.doi.org/10.1074/jbc.274.18.12445			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212219	hybrid			2022-12-27	WOS:000080056800039
J	Pizard, A; Blaukat, A; Muller-Esterl, W; Alhenc-Gelas, F; Rajerison, RM				Pizard, A; Blaukat, A; Muller-Esterl, W; Alhenc-Gelas, F; Rajerison, RM			Bradykinin-induced internalization of the human B-2 receptor requires phosphorylation of three serine and two threonine residues at its carboxyl tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; MEDIATED ENDOCYTOSIS; B2 RECEPTOR; SIGNAL-TRANSDUCTION; TYROSINE RESIDUE; BETA-ARRESTIN; AGONIST; DESENSITIZATION; SEQUESTRATION	The binding of bradykinin (BK) to B-2 receptor triggers the internalization of the agonist-receptor complex, To investigate the mechanisms and the receptor structures involved in this fundamental process of receptor regulation, the human B-2 receptor was mutated within its cytoplasmic tail by complementary strategies of truncation, deletion, and amino acid substitution. Ligand binding, signal transduction, internalization as well as phosphorylation were studied for the mutated receptors expressed in COS, CHO, and HEK 293 cells, Truncation of 44 out of 55 amino acid residues of the receptor's cytoplasmic tail corresponding to positions 321-364 did not alter the kinetics of BK binding and the receptor coupling to phospholipase C and phospholipase A(2). By contrast, truncations after positions 320 and 334, deletions within the segment covering positions 335-351, as well as alanine substitution of serine and threonine residues within segment 335-351 diminished the internalization capacity of the mutant receptors. Mutants with a markedly reduced internalization potential failed to produce BK-induced receptor phosphorylation suggesting that phosphorylation may be involved in receptor internalization. The mutagenesis approaches converged at the conclusion that three serines in positions 339, 346, and 348 and two threonines in positions 342 and 345, contained in a sequence segment that is highly conserved between species, have a critical role in the ligand-dependent internalization and phosphorylation of kinin receptors and can intervene in these processes iii an alternative manner. However, mutants lacking these residues were still sensitive to dominant-negative forms of p-arrestin and dynamin, suggesting the existence of additional receptor structure(s) involved in the receptor sequestration through clathrin-coated vesicles.	INSERM, U367, F-75005 Paris, France; Univ Mainz, Inst Physiol Chem & Pathobiochem, D-55099 Mainz, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); Johannes Gutenberg University of Mainz	Pizard, A (corresponding author), INSERM, U367, 17 Rue Fer Moulin, F-75005 Paris, France.		Pizard, Anne CM/P-4754-2016; Alhenc-Gelas, Francois/F-9511-2017	Pizard, Anne CM/0000-0003-2705-6365; 				Arora KK, 1997, MOL ENDOCRINOL, V11, P1203, DOI 10.1210/me.11.9.1203; BARAK LS, 1994, J BIOL CHEM, V269, P2790; BASCANDS JL, 1994, AM J PHYSIOL, V36, pF871; BENYA RV, 1993, J BIOL CHEM, V268, P20285; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Blaukat A, 1996, J BIOL CHEM, V271, P32366, DOI 10.1074/jbc.271.50.32366; Blaukat A, 1997, IMMUNOPHARMACOLOGY, V36, P115, DOI 10.1016/S0162-3109(97)00009-X; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; CHABRY J, 1995, J BIOL CHEM, V270, P2439, DOI 10.1074/jbc.270.6.2439; CHEN CC, 1995, MOL PHARMACOL, V39, P39; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; deWeerd WFC, 1997, J BIOL CHEM, V272, P17858, DOI 10.1074/jbc.272.28.17858; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Faussner A, 1998, J BIOL CHEM, V273, P2617, DOI 10.1074/jbc.273.5.2617; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Goldman PS, 1996, J BIOL CHEM, V271, P4215; Haasemann M, 1998, J CELL SCI, V111, P917; HAIGLER HT, 1980, J BIOL CHEM, V255, P1239; Hess J. F., 1993, MOL PHARMACOL, V45, P1; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hill AV, 1910, J PHYSIOL-LONDON, V40, piv; JAFFA AA, 1997, AM J PHYSIOL, V273, pF9126; LeGouill C, 1997, J BIOL CHEM, V272, P21289, DOI 10.1074/jbc.272.34.21289; LIAO JK, 1993, J CLIN INVEST, V92, P2168, DOI 10.1172/JCI116818; McConalogue K, 1998, MOL BIOL CELL, V9, P2305, DOI 10.1091/mbc.9.8.2305; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; MENKE JG, 1994, J BIOL CHEM, V269, P21583; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; Pizard A, 1998, J BIOL CHEM, V273, P1309, DOI 10.1074/jbc.273.3.1309; Pohl M, 1997, J BIOL CHEM, V272, P18179, DOI 10.1074/jbc.272.29.18179; Prado GN, 1997, J BIOL CHEM, V272, P14638, DOI 10.1074/jbc.272.23.14638; Rao RV, 1997, MOL PHARMACOL, V51, P185, DOI 10.1124/mol.51.2.185; REGOLI D, 1980, PHARMACOL REV, V32, P1; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Schroeder C, 1997, J BIOL CHEM, V272, P12475, DOI 10.1074/jbc.272.19.12475; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; Widmann C, 1997, MOL ENDOCRINOL, V11, P1094, DOI 10.1210/me.11.8.1094; WOLSING DH, 1991, J PHARMACOL EXP THER, V257, P621; YANG J, 1995, MOL PHARMACOL, V48, P477; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	43	87	89	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12738	12747		10.1074/jbc.274.18.12738	http://dx.doi.org/10.1074/jbc.274.18.12738			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212257	hybrid			2022-12-27	WOS:000080056800077
J	Rogers, GW; Richter, NJ; Merrick, WC				Rogers, GW; Richter, NJ; Merrick, WC			Biochemical and kinetic characterization of the RNA helicase activity of eukaryotic initiation factor 4A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX PROTEIN EIF4A; MESSENGER-RNA; SECONDARY STRUCTURE; ESCHERICHIA-COLI; TRANSLATION; BINDING; NUCLEOTIDE; MECHANISM; FAMILY; REGION	Eukaryotic initiation factor (eIF) 4A is the prototypic member of the DEAD box family of proteins and has been proposed to act as an RNA helicase to unwind secondary structure in the 5'-untranslated region of eukaryotic mRNAs, Previous studies have shown that the RNA helicase activity of eIF4A is dependent on the presence of a second initiation factor, eIF4B, In this report, eIF4A has been demonstrated to function independently of eIF4B as an ATP-dependent RNA helicase, The bio chemical and kinetic properties of this activity were examined. By using a family of RNA duplexes with an unstructured single-stranded region followed by a duplex region of increasing length and stability, it was observed that the initial rate of duplex unwinding decreased with increasing stability of the duplex. Furthermore, the maximum amount of duplex unwound also decreased with increasing stability. Results suggest that eIF4A acts in a non-processive manner. eIF4B and eIF4H were shown to stimulate the helicase activity of eIF4A, allowing eIF4A to unwind longer, more stable duplexes with both an increase in initial rate and maximum amount of duplex unwound. A simple kinetic model is proposed to explain the mechanism by which eIF4A unwinds RNA duplex structures in an ATP-dependent manner.	Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Merrick, WC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026796] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK07319] Funding Source: Medline; NIGMS NIH HHS [GM08056, GM26796] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMSON RD, 1988, J BIOL CHEM, V263, P6016; ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; ABRAMSON RD, 1988, J BIOL CHEM, V263, P5462; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; BORK P, 1993, NUCLEIC ACIDS RES, V21, P751, DOI 10.1093/nar/21.3.751; CARBERRY SE, 1992, BIOCHEMISTRY-US, V31, P1427, DOI 10.1021/bi00120a020; CONROY SC, 1990, ARCH BIOCHEM BIOPHYS, V282, P363, DOI 10.1016/0003-9861(90)90130-Q; FLORESROZAS H, 1993, J BIOL CHEM, V268, P21372; GOSS DJ, 1987, BIOCHEMISTRY-US, V26, P1551, DOI 10.1021/bi00380a009; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; JARAMILLO M, 1991, MOL CELL BIOL, V11, P5992, DOI 10.1128/MCB.11.12.5992; Jones PG, 1996, P NATL ACAD SCI USA, V93, P76, DOI 10.1073/pnas.93.1.76; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KOONIN EV, 1991, NATURE, V352, P290, DOI 10.1038/352290c0; LAWSON TG, 1989, BIOCHEMISTRY-US, V28, P4729, DOI 10.1021/bi00437a033; LAWSON TG, 1986, J BIOL CHEM, V261, P13979; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; Merrick WC., 1996, TRANSLATION CONTROL, P31; METHOT N, 1994, MOL CELL BIOL, V14, P2307, DOI 10.1128/MCB.14.4.2307; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; RAY BK, 1985, J BIOL CHEM, V260, P7651; Richter-Cook NJ, 1998, J BIOL CHEM, V273, P7579, DOI 10.1074/jbc.273.13.7579; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Sambrook J., 2002, MOL CLONING LAB MANU; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; SHUMAN S, 1993, J BIOL CHEM, V268, P11798; Tai CL, 1996, J VIROL, V70, P8477, DOI 10.1128/JVI.70.12.8477-8484.1996; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; WASSARMAN DA, 1991, NATURE, V349, P463, DOI 10.1038/349463a0; WETMUR JG, 1991, CRIT REV BIOCHEM MOL, V26, P227, DOI 10.3109/10409239109114069	37	244	248	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12236	12244		10.1074/jbc.274.18.12236	http://dx.doi.org/10.1074/jbc.274.18.12236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212190	hybrid			2022-12-27	WOS:000080056800010
J	Vezza, R; Habib, A; FitzGerald, GA				Vezza, R; Habib, A; FitzGerald, GA			Differential signaling by the thromboxane receptor isoforms via the novel GTP-binding protein, G(h)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	70th Scientific Session of the American-Heart-Association Meeting	NOV 09-13, 1997	ORLANDO, FLORIDA	Amer Heart Assoc			PHOSPHOLIPASE-C; HUMAN PLATELETS; A(2) RECEPTOR; TRANSGLUTAMINASE ACTIVITY; THROMBIN RECEPTORS; ALPHA-SUBUNITS; TERMINAL TAIL; KINASE-C; IN-VIVO; IDENTIFICATION	Thromboxane A(2) acts via G protein-coupled receptors; two splice variants of the thromboxane A(2) receptor (TP alpha and TP beta) have been cloned. It is unknown whether they differ in their capacity to activate intracellular signaling pathways. Recently, a high molecular weight G protein, G(h), that can also function as a tissue transglutaminase, has been described. We investigated whether G(h) functions as a signaling protein in association with thromboxane receptors, First, we sought G(h) expression in cells known to express TPs, Reverse transcription-polymerase chain reaction and immunoblotting demonstrated G(h) expression in platelets, megakaryocytic cell lines, and endothelial and vascular smooth muscle cells. Second, immunoprecipitation of both TP alpha and TP beta in transfected COS-7 cells resulted in the co-immunoprecipitation of G(h), indicating that TPs may associate G(h) in vice. Finally, agonist activation of TP alpha, but not of TP beta, resulted in stimulation of phospholipase C-mediated inositol phosphate production in cells cotransfected with G(h), By contrast, agonist activation of both TP iso forms resulted in G(h)-mediated inositol phosphate signaling. G(h) is expressed in platelets and vascular cells and may associate with both TP isoforms. However, stimulation of TP isoforms results in differential activation of downstream signaling pathways via this novel G protein.	Univ Penn, Ctr Expt Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania	FitzGerald, GA (corresponding author), Univ Penn, Ctr Expt Therapeut, 153 Johnson Pavil,3600 Hamilton Walk, Philadelphia, PA 19104 USA.		FitzGerald, Garret A/A-4222-2010; Habib, Aida/H-8647-2019	Habib, Aida/0000-0001-6027-0043	NHLBI NIH HHS [HL4500] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allan CJ, 1996, J PHARMACOL EXP THER, V277, P1132; BAEK KJ, 1993, J BIOL CHEM, V268, P27390; BRASS LF, 1991, J BIOL CHEM, V266, P958; BRASS LF, 1987, J CLIN INVEST, V79, P1269, DOI 10.1172/JCI112947; Chen SH, 1996, J BIOL CHEM, V271, P32385, DOI 10.1074/jbc.271.50.32385; DANGELO DD, 1994, J PHARMACOL EXP THER, V271, P1034; EASON MG, 1995, J BIOL CHEM, V270, P24753, DOI 10.1074/jbc.270.42.24753; Feng JF, 1996, J BIOL CHEM, V271, P16451, DOI 10.1074/jbc.271.28.16451; FITZGERALD GA, 1991, AM J CARDIOL, V68, pB11, DOI 10.1016/0002-9149(91)90379-Y; GENTILE V, 1991, J BIOL CHEM, V266, P478; HABIB A, 1993, J BIOL CHEM, V268, P23448; Habib A, 1999, J BIOL CHEM, V274, P2645, DOI 10.1074/jbc.274.5.2645; Habib A, 1997, J BIOL CHEM, V272, P7191, DOI 10.1074/jbc.272.11.7191; HALUSHKA PV, 1995, J LIPID MEDIAT CELL, V12, P361, DOI 10.1016/0929-7855(95)00023-J; HERRMANN HC, 1993, ARTERIOSCLER THROMB, V13, P924, DOI 10.1161/01.ATV.13.6.924; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; HIRATA T, 1994, J CLIN INVEST, V94, P1662, DOI 10.1172/JCI117510; HWANG KC, 1995, J BIOL CHEM, V270, P27058, DOI 10.1074/jbc.270.45.27058; IM JM, 1990, J BIOL CHEM, V265, P18944; Kinsella BT, 1997, J PHARMACOL EXP THER, V281, P957; KNEZEVIC I, 1993, J BIOL CHEM, V268, P26011; Lee MJ, 1996, J BIOL CHEM, V271, P11272, DOI 10.1074/jbc.271.19.11272; Liu J, 1996, J BIOL CHEM, V271, P8772, DOI 10.1074/jbc.271.15.8772; Melino G, 1998, FEBS LETT, V430, P59, DOI 10.1016/S0014-5793(98)00521-3; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; MORAN N, 1990, CIRCULATION, V82, P461; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; NUSING RM, 1993, J BIOL CHEM, V268, P25253; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; OHYAMA K, 1992, BIOCHEM BIOPH RES CO, V189, P677, DOI 10.1016/0006-291X(92)92254-U; OKUMA Y, 1992, J BIOL CHEM, V267, P14826; RAYCHOWDHURY MK, 1994, J BIOL CHEM, V269, P19256; Sano T, 1997, J BIOL CHEM, V272, P23631, DOI 10.1074/jbc.272.38.23631; SHENKER A, 1991, J BIOL CHEM, V266, P9309; Shibata T, 1996, BIOCHEM BIOPH RES CO, V218, P383, DOI 10.1006/bbrc.1996.0067; SHIRAI H, 1995, HYPERTENSION, V25, P726, DOI 10.1161/01.HYP.25.4.726; TAKIGAWA M, 1995, EUR J BIOCHEM, V228, P102, DOI 10.1111/j.1432-1033.1995.0102o.x; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; USHIKUBI F, 1994, MOL PHARMACOL, V46, P808; VANWILLIGEN G, 1995, BIOCHEM BIOPH RES CO, V214, P254, DOI 10.1006/bbrc.1995.2282; Vezza R, 1996, J BIOL CHEM, V271, P30028, DOI 10.1074/jbc.271.47.30028; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; WU DQ, 1995, J BIOL CHEM, V270, P16008, DOI 10.1074/jbc.270.27.16008; WU DQ, 1995, J BIOL CHEM, V270, P9828, DOI 10.1074/jbc.270.17.9828	46	111	113	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12774	12779		10.1074/jbc.274.18.12774	http://dx.doi.org/10.1074/jbc.274.18.12774			6	Biochemistry & Molecular Biology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212262	hybrid			2022-12-27	WOS:000080056800082
J	Yujiri, T; Fanger, GR; Garrington, TP; Schlesinger, TK; Gibson, S; Johnson, GL				Yujiri, T; Fanger, GR; Garrington, TP; Schlesinger, TK; Gibson, S; Johnson, GL			MEK kinase 1 (MEKK1) transduces c-Jun NH2-terminal kinase activation in response to changes in the microtubule cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUID SHEAR-STRESS; CELL-SHAPE CHANGE; PROTEIN-KINASE; ENDOTHELIAL-CELLS; GENE-EXPRESSION; JNK; PATHWAYS; RAC1; ERK; INTERLEUKIN-1	Cell shape change and the restructuring of the cytoskeleton are important regulatory responses that influence the growth, differentiation, and commitment to apoptosis of different cell types. MEK kinase 1 (MEKK1) activates the c-Jun NH2-terminal kinase (JNK) pathway in response to exposure of cells to microtubule toxins, including taxol, MEKK1 expression is elevated 3-fold in mitosis and microtubule toxin-treated cells accumulated at G(2)/M of the cell cycle. Targeted disruption of MEKK1 expression in embryonic stem cells resulted in the loss of JNK activation and increased apoptosis in response to taxol. Targeted disruption of the MEK kinase 2 gene had no effect on activation of the JNK pathway in response to microtubule toxins demonstrating a specific role of MEKK1 in this response. Cytochalasin D-mediated disruption of actin fibers activates JNK and stimulates apoptosis similarly in MEKK1(-/-) and wild type cells. The results show that MEKK1 is required for JNK activation in response to microtubule but not actin fiber toxins in embryonic stem cells. MEKK1 activation can protect cells from apoptosis in response to change in the integrity of the microtubule cytoskeleton.	Natl Jewish Med & Res Ctr, Div Basic Sci, Program Mol Signal Transduct, Denver, CO 80206 USA; Univ Colorado, Sch Med, Dept Pharmacol, Denver, CO 80262 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Johnson, GL (corresponding author), Natl Jewish Med & Res Ctr, Div Basic Sci, Program Mol Signal Transduct, 1400 Jackson St, Denver, CO 80206 USA.		Yujiri, Toshiaki/AAY-8150-2020	Yujiri, Toshiaki/0000-0001-6838-3456; Gibson, Spencer/0000-0003-0119-732X	NIDDK NIH HHS [DK37871, DK48845] Funding Source: Medline; NIGMS NIH HHS [GM30324] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048845, R01DK037871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030324, R01GM030324] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Best A, 1996, J BIOL CHEM, V271, P3756; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CLEVELAND DW, 1985, ANNU REV BIOCHEM, V54, P331, DOI 10.1146/annurev.bi.54.070185.001555; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; FERRUA B, 1990, CELL IMMUNOL, V131, P391, DOI 10.1016/0008-8749(90)90263-Q; FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Ishida T, 1997, ANN NY ACAD SCI, V811, P12, DOI 10.1111/j.1749-6632.1997.tb51984.x; Jalali S, 1998, ARTERIOSCL THROM VAS, V18, P227, DOI 10.1161/01.ATV.18.2.227; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Li YS, 1996, MOL CELL BIOL, V16, P5947; Malek AM, 1996, J CELL SCI, V109, P713; MANIE S, 1993, J BIOL CHEM, V268, P13675; MAROUDAS NG, 1973, EXP CELL RES, V81, P104, DOI 10.1016/0014-4827(73)90116-X; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; RESNICK N, 1993, P NATL ACAD SCI USA, V90, P4591, DOI 10.1073/pnas.90.10.4591; RIDLEY AJ, 1994, EMBO J, V13, P260; ROSETTE C, 1995, J CELL BIOL, V128, P1111, DOI 10.1083/jcb.128.6.1111; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911	25	109	113	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12605	12610		10.1074/jbc.274.18.12605	http://dx.doi.org/10.1074/jbc.274.18.12605			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212239	hybrid			2022-12-27	WOS:000080056800059
J	Iguchi, G; Okimura, Y; Takahashi, T; Mizuno, I; Fumoto, M; Takahashi, Y; Kaji, H; Abe, H; Chihara, K				Iguchi, G; Okimura, Y; Takahashi, T; Mizuno, I; Fumoto, M; Takahashi, Y; Kaji, H; Abe, H; Chihara, K			Cloning and characterization of the 5 '-flanking region of the human growth hormone-releasing hormone receptor gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-TYPES; EXPRESSION; PIT-1; SECRETION; RESPONSES; PROMOTER; BINDING; MOUSE; DNA	We cloned the 5'-flanking region of the human growth hormone-releasing hormone receptor (GHRH-R) gene and determined the nucleotide sequence of 2.7 kilobases upstream from the translation start site. RNase protection analysis showed the major transcription start site is 122 base pairs upstream from the translation start site. The 5'-end of the longest product of 5'-rapid amplification of cDNA ends was close to the site. There were no typical TATA homologies but several putative regulatory elements including Pit-1-binding site-like element. Transient transfection studies using a luciferase reporter gene demonstrated that 5'-flanking region had promoter activity in GH3 cells (derived from rat pituitary tumor) but not in nonpituitary cells, BeWo and HeLa cells. However, co-transfection of Pit-1 expression vector increased luciferase activity in BeWo cells. Deletion study showed that the regions from -310 to -130 and from -130 to -120 were important for the GHRH-R gene expression in GH3 cells, although the latter contributed less to the gene expression. In BeWo cells cotransfected with Pit-1 expression vector, the region from -310 to -130 was essential for the Pit-1-dependent expression of GHRH-R gene. The region from -310 to -120 has two putative Pit-1-binding sites, P1 and P2, located from -129 to -123 and from -171 to -160, respectively. Both mobility shift assay and DNase-I footprint analysis showed that P2 had much higher Pit-1 binding affinity than P1. Mutation of P2 decreased GHRH-R gene expression in GH3 cells. These findings were consistent with the results that the region from -310 to -130 is an important element for Pit-1-dependent expression of GHRH-R gene.	Kobe Univ, Sch Med, Dept Med, Div 3,Chuo Ku, Kobe, Hyogo 6500017, Japan	Kobe University	Okimura, Y (corresponding author), Kobe Univ, Sch Med, Dept Med, Div 3,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.							ANDERSEN B, 1994, J BIOL CHEM, V269, P29335; BANCROFT FC, 1969, J CELL BIOL, V43, P432, DOI 10.1083/jcb.43.3.432; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASANUEVA FF, 1990, J CLIN ENDOCR METAB, V70, P234, DOI 10.1210/jcem-70-1-234; CASTRILLO JL, 1991, SCIENCE, V253, P197, DOI 10.1126/science.1677216; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; GAYLINN BD, 1993, MOL ENDOCRINOL, V7, P77, DOI 10.1210/me.7.1.77; GILMAN M, 1993, CURRENT PROTOCOLS MO; Horikawa R, 1996, ENDOCRINOLOGY, V137, P2642, DOI 10.1210/en.137.6.2642; HSIUNG HM, 1993, NEUROPEPTIDES, V25, P1, DOI 10.1016/0143-4179(93)90062-F; IRANMANESH A, 1992, ENDOCRIN METAB CLIN, V21, P783, DOI 10.1016/S0889-8529(18)30189-0; Lam KSL, 1996, NEUROENDOCRINOLOGY, V63, P475, DOI 10.1159/000127075; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1743; OKIMURA Y, 1994, MOL ENDOCRINOL, V8, P1559, DOI 10.1210/me.8.11.1559; Petersenn S, 1998, MOL ENDOCRINOL, V12, P233, DOI 10.1210/me.12.2.233; PETERSENN S, 1996, 10 INT C END JUN 12, P623; SEHGAL A, 1988, MOL CELL BIOL, V8, P3160, DOI 10.1128/MCB.8.8.3160; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SREEDHARAN SP, 1995, P NATL ACAD SCI USA, V92, P2939, DOI 10.1073/pnas.92.7.2939; STEPHANOU A, 1992, J MOL ENDOCRINOL, V9, P273, DOI 10.1677/jme.0.0090273; TAKAHASHI T, 1996, 10 INT C END JUN 12, P621; TAKAHASHI T, 1997, 79 ANN M END SOC JUN, P527; TAKAHASHI T, 1995, ENDOCRINOLOGY, V136, P4271; VALE W, 1983, ENDOCRINOLOGY, V112, P1553, DOI 10.1210/endo-112-4-1553; Wajnrajch MP, 1996, NAT GENET, V12, P88, DOI 10.1038/ng0196-88	29	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12108	12114		10.1074/jbc.274.17.12108	http://dx.doi.org/10.1074/jbc.274.17.12108			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207037	hybrid			2022-12-27	WOS:000079834800093
J	Kimball, SR; Shantz, LM; Horetsky, RL; Jefferson, LS				Kimball, SR; Shantz, LM; Horetsky, RL; Jefferson, LS			Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR EIF-4E; MESSENGER-RNA TRANSLATION; ORNITHINE DECARBOXYLASE; AMINO-ACIDS; SIGNAL-TRANSDUCTION; SECONDARY STRUCTURE; CELL-PROLIFERATION; MAMMALIAN TARGET; RAT-LIVER; PHAS-I	Regulation of translation of mRNAs coding for specific proteins plays an important role in controlling cell growth, differentiation, and transformation. Two proteins have been implicated in the regulation of specific mRNA translation: eukaryotic initiation factor eIF4E and ribosomal protein S6. Increased phosphorylation of eIF4E as well as its overexpression are associated with stimulation of translation of mRNAs with highly structured 5'-untranslated regions. Similarly, phosphorylation of S6 results in preferential translation of mRNAs containing an oligopyrimidine tract at the 5'-end of the message, In the present study, leucine stimulated phosphorylation of the eIF4E-binding protein, 4E-BP1, in L6 myoblasts, resulting in dissociation of eIF4E from the inactive eIF4E 4E-BP1 complex. The increased availability of eIF4E was associated with a 1.6-fold elevation in ornithine decarboxylase relative to global protein synthesis. Leucine also stimulated phosphorylation of the ribosomal protein Se kinase, p70(S6k), resulting in increased phosphorylation of S6. Hyperphosphorylation of S6 was associated with a 4-fold increase in synthesis of elongation factor eEF1A Rapamycin, an inhibitor of the protein kinase mTOR, prevented all of the leucine-induced effects. Thus, leucine acting through an mTOR-dependent pathway stimulates the translation of specific mRNAs both by increasing the availability of eIF4E and by stimulating phosphorylation of S6.	Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kimball, SR (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, POB 850, Hershey, PA 17033 USA.	skimball@psu.edu		Shantz, Lisa/0000-0001-8814-4022	NIDDK NIH HHS [DK-15658] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015658] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; BOMMER UA, 1994, CELL MOL BIOL RES, V40, P633; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Coffer PJ, 1998, BIOCHEM J, V335, P1; COLEMAN CS, 1993, J BIOL CHEM, V268, P24572; De Benedetti Arrigo, 1994, Molecular and Cellular Differentiation, V2, P347; FLAIM KE, 1982, J BIOL CHEM, V257, P2939; Flynn A, 1996, CANCER SURV, V27, P293; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; JEFFERIES HBJ, 1996, COLD SPRING HARBOR M, V30, P389; KAHANA C, 1985, J BIOL CHEM, V260, P5390; Kawasome H, 1998, P NATL ACAD SCI USA, V95, P5033, DOI 10.1073/pnas.95.9.5033; KIMBALL SR, 1990, J BIOL CHEM, V265, P16794; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; KIMBALL SR, 1994, BBA-GEN SUBJECTS, V1201, P473, DOI 10.1016/0304-4165(94)90079-5; Kleijn M, 1998, EUR J BIOCHEM, V253, P531, DOI 10.1046/j.1432-1327.1998.2530531.x; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; MANZELLA JM, 1991, J BIOL CHEM, V266, P2383; MANZELLA JM, 1990, J BIOL CHEM, V265, P11817; Meyuhas Oded, 1996, V30, P363; MINICH WB, 1994, P NATL ACAD SCI USA, V91, P7668, DOI 10.1073/pnas.91.16.7668; NYGARD O, 1990, EUR J BIOCHEM, V191, P1, DOI 10.1111/j.1432-1033.1990.tb19087.x; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Shama Silvian, 1995, Gene Expression, V4, P241; SHANTZ LM, 1994, CANCER RES, V54, P2313; Shantz LM, 1996, CANCER RES, V56, P3265; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; VANVENRO.WJ, 1972, BIOCHIM BIOPHYS ACTA, V259, P127, DOI 10.1016/0005-2787(72)90480-7; VAUGHAN MH, 1973, J BIOL CHEM, V248, P7087; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Xu G, 1998, J BIOL CHEM, V273, P28178, DOI 10.1074/jbc.273.43.28178	43	282	290	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11647	11652		10.1074/jbc.274.17.11647	http://dx.doi.org/10.1074/jbc.274.17.11647			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206976	hybrid			2022-12-27	WOS:000079834800032
J	Chen, SC; Costa, CHRM; Nakamura, K; Ribeiro, RCJ; Gardner, DG				Chen, SC; Costa, CHRM; Nakamura, K; Ribeiro, RCJ; Gardner, DG			Vitamin D-dependent suppression of human atrial natriuretic peptide gene promoter activity requires heterodimer assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; D-RESPONSIVE ELEMENT; THYROID-HORMONE RECEPTOR; LIGAND-BINDING DOMAIN; 1,25-DIHYDROXYVITAMIN-D3 RECEPTOR; TRANSCRIPTIONAL REPRESSION; GLUCOCORTICOID RECEPTOR; NEGATIVE REGULATION; 5'-FLANKING REGION; OSTEOCALCIN GENE	Crystallographic structures of the ligand-binding domains for the retinoid X (RXR) and estrogen receptors have identified conserved surface residues that participate in dimer formation. Homologous regions have been identified in the human vitamin D receptor (hVDR). Mutating Lys-386 to Ala (K386A) in hVDR significantly reduced binding to glutathione S-transferase-RXR alpha in solution3 whereas binding of an I384R/Q385R VDR mutant was almost undetectable. The K386A mutant formed heterodimers with RXR alpha on DR-3 (a direct repeat of AG-GTCA spaced by three nucleotides), whereas the I384R/Q385R mutant completely eliminated heterodimer formation. Wild type hVDR effected a 3-fold induction of DR-3-dependent thymidine kinase-luciferase activity in cultured neonatal rat atrial myocytes, an effect that was increased to 8-9-fold by cotransfected hRXR alpha. Induction by K386A, in the presence or absence of RXRa, was only slightly lower than that seen with wild type VDR. On the other hand, I384R/Q385R alone displayed no stimulatory activity and less than 2-fold induction in the presence of hRXR alpha. Qualitatively similar findings were observed with the negative regulation of the human atrial natriuretic peptide gene promoter by these mutants. Collectively, these studies identify specific amino acids in hVDR that play a critical role in heterodimer formation and subsequent modulation of gene transcription.	Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Brasilia, Dept Pharmaceut Sci, BR-70910900 Brasilia, DF, Brazil	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade de Brasilia	Gardner, DG (corresponding author), Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035753] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-35753] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; BAUER RF, 1976, IN VITRO CELL DEV B, V12, P558; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CAO X, 1993, J BIOL CHEM, V268, P27371; CARLBERG C, 1993, NATURE, V361, P657, DOI 10.1038/361657a0; Chen SC, 1998, HYPERTENSION, V31, P1338, DOI 10.1161/01.HYP.31.6.1338; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; DEMAY MB, 1992, P NATL ACAD SCI USA, V89, P8097, DOI 10.1073/pnas.89.17.8097; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; DOKOH S, 1981, ANAL BIOCHEM, V116, P211, DOI 10.1016/0003-2697(81)90346-8; Falzon M, 1996, MOL ENDOCRINOL, V10, P672, DOI 10.1210/me.10.6.672; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; FORMAN BM, 1990, MOL ENDOCRINOL, V4, P1293, DOI 10.1210/mend-4-9-1293; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; Kremer R, 1996, J BIOL CHEM, V271, P16310, DOI 10.1074/jbc.271.27.16310; Lee SK, 1998, MOL ENDOCRINOL, V12, P325, DOI 10.1210/me.12.3.325; LI Q, 1994, J BIOL CHEM, V269, P4934; Liu SM, 1996, MOL ENDOCRINOL, V10, P206, DOI 10.1210/me.10.2.206; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MORRISON NA, 1989, SCIENCE, V246, P1158, DOI 10.1126/science.2588000; NAGAYA T, 1993, J BIOL CHEM, V268, P24278; NAKAJIMA S, 1994, MOL ENDOCRINOL, V8, P159, DOI 10.1210/me.8.2.159; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; NODA M, 1990, P NATL ACAD SCI USA, V87, P9995, DOI 10.1073/pnas.87.24.9995; OHYAMA Y, 1994, J BIOL CHEM, V269, P10545; OZONO K, 1990, J BIOL CHEM, V265, P21881; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; RIBEIRO RCJ, 1994, ENDOCRINOLOGY, V135, P2076, DOI 10.1210/en.135.5.2076; RIBEIRO RCJ, 1995, ANNU REV MED, V46, P443, DOI 10.1146/annurev.med.46.1.443; RIBEIRO RCJ, 1998, KEYST S NUCL REC GEN, P64; SCHRADER M, 1995, MOL CELL BIOL, V15, P1154; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; WHITFIELD GK, 1995, MOL ENDOCRINOL, V9, P1166, DOI 10.1210/me.9.9.1166; WU J, 1995, AM J PHYSIOL-ENDOC M, V268, pE1108, DOI 10.1152/ajpendo.1995.268.6.E1108; Wu JM, 1996, J CLIN INVEST, V97, P1577, DOI 10.1172/JCI118582; WU JP, 1989, J BIOL CHEM, V264, P6472	39	20	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11260	11266		10.1074/jbc.274.16.11260	http://dx.doi.org/10.1074/jbc.274.16.11260			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196214	hybrid			2022-12-27	WOS:000079751900082
J	Chin, BY; Petrache, I; Choi, AMK; Choi, ME				Chin, BY; Petrache, I; Choi, AMK; Choi, ME			Transforming growth factor beta(1) rescues serum deprivation-induced apoptosis via the mitogen-activated protein kinase (MAPK) pathway in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; TGF-BETA; EPITHELIAL-CELLS; IN-VITRO; FACTOR-BETA-1; INHIBITION; RECEPTORS; EXPRESSION; MECHANISMS; CASCADE	Cell death and cell survival are central components of normal development and pathologic states. Transforming growth factor beta(1) (TGF-beta(1)) is a pleiotropic cytokine that regulates both cell growth and cell death. To better understand the molecular mechanisms that control cell death or survival, we investigated the role of TGF-beta(1) in the apoptotic process by dominant-negative inhibition of both TGF-beta(1) and mitogen-activated protein kinase (MAPK) signaling pathways. Murine macrophages (RAW 264.7) undergo apoptosis following serum deprivation, as determined by DNA laddering assay. However, apoptosis is prevented in serum-deprived macrophages by the presence of exogenous TGF-beta(1). Using stably transfected RAW 264.7 cells with the kinase-deleted dominant-negative mutant of T beta R-II (T beta R-IIM) cDNA, we demonstrate that this protective effect by TGF-beta(1) is completely abrogated. To determine the downstream signaling pathways, we examined TGF-beta(1) effects on the MAPK pathway. We show that TGF-beta(1) induces the extracellular signal-regulated kinase (ERK) activity in a time-dependent manner up to 4 h after stimulation. Furthermore, TGF-beta(1) does not rescue serum deprivation-induced apoptosis in RAW 264.7 cells transfected with a dominant-negative mutant MAPK (ERK2) cDNA or in wild type RAW 264.7 cells in the presence of the MAPK kinase (MEK1) inhibitor. Taken together, our data demonstrate for the first time that TGF-beta(1) is an inhibitor of apoptosis in cultured macrophages and may serve as a cell survival factor via T beta R-II-mediated signaling and downstream intracellular MAPK signaling pathway.	Yale Univ, Sch Med, Nephrol Sect, Dept Internal Med, New Haven, CT 06520 USA; Vet Affairs Connecticut Healthcare Syst, New Haven, CT 06520 USA; Johns Hopkins Med Inst, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; Yale Univ, Sch Med, Pulm & Crit Care Med Sect, New Haven, CT 06520 USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Johns Hopkins University; Johns Hopkins Medicine; Yale University	Choi, ME (corresponding author), Yale Univ, Sch Med, Nephrol Sect, Dept Internal Med, 333 Cedar St,2073 LMP, New Haven, CT 06520 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010028, R29HL055330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042365] Funding Source: NIH RePORTER; NHLBI NIH HHS [R29 HL-55330, F32 HL010028] Funding Source: Medline; NIAID NIH HHS [R01 AI-42365] Funding Source: Medline; NIDDK NIH HHS [5-K12-DK0129809] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Andjelic S, 1997, J IMMUNOL, V158, P2527; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Attisano Liliana, 1996, Cytokine and Growth Factor Reviews, V7, P327, DOI 10.1016/S1359-6101(96)00042-1; CHOI ME, 1995, J BIOL CHEM, V270, P21144, DOI 10.1074/jbc.270.36.21144; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Duttaroy A, 1997, J CELL BIOCHEM, V64, P434; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Frey RS, 1997, CANCER RES, V57, P628; Hartsough MT, 1996, J BIOL CHEM, V271, P22368, DOI 10.1074/jbc.271.37.22368; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LOTEM J, 1992, BLOOD, V80, P1750; MADER S, 1993, P NATL ACAD SCI USA, V90, P5603, DOI 10.1073/pnas.90.12.5603; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; ROTELLO RJ, 1991, P NATL ACAD SCI USA, V88, P3412, DOI 10.1073/pnas.88.8.3412; Sheng ZL, 1997, J BIOL CHEM, V272, P5783, DOI 10.1074/jbc.272.9.5783; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; WIESER R, 1993, MOL CELL BIOL, V13, P7239, DOI 10.1128/MCB.13.12.7239; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	33	92	96	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11362	11368		10.1074/jbc.274.16.11362	http://dx.doi.org/10.1074/jbc.274.16.11362			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196228	hybrid			2022-12-27	WOS:000079751900096
J	Chuang, TL; Schleef, RR				Chuang, TL; Schleef, RR			Identification of a nuclear targeting domain in the insertion between helices C and D in protease inhibitor-10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-2; SERINE PROTEINASE-INHIBITOR; MOLECULAR CHARACTERIZATION; OVALBUMIN FAMILY; HUMAN SERPIN; CLONING; CELLS; DIFFERENTIATION; EXPRESSION; TRANSPORT	Protease inhibitor 10 (PI-10), an intracellular ovalbumin-serpin, contains a series of basic amino acids in the loop between helices C and D that exhibit homology to known nuclear targeting signals. Transfection of HeLa cells with plasmids encoding enhanced green fluorescent protein (EGFP) coupled to PI-10 revealed an intense fluorescence of the nucleus. Immunoblotting demonstrated a single M-r 80,000 EGFP . PI-10 complex in isolated nuclei. Mutation of four basic amino acids in the interhelical loop to alanines (i.e. K74A, K75A, R76A, K77A) resulted in the fluorescent complex being confined to the cytoplasm, Further evidence for a nuclear targeting signal in this region was provided by localization of the fluorescent label to the nucleus in cells transfected with a plasmid encoding EGFP fused to the 25 amino acids comprising the interhelical loop of PI-10 (i.e. Arg-63 to Glu-87), whereas a cytoplasmic distribution was noted for the construct encoding EGFP coupled to the mutated interhelical loop. These data raise the possibility that PI-10 may play a role in regulating protease activity within the nucleus, a property unique in the field of serpin biology.	Scripps Res Inst, Dept Vasc Biol VB1, La Jolla, CA 92037 USA	Scripps Research Institute	Schleef, RR (corresponding author), Scripps Res Inst, Dept Vasc Biol VB1, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049563, R01HL045954] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45954, HL49563] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENZ WC, 1975, P NATL ACAD SCI USA, V72, P2413, DOI 10.1073/pnas.72.6.2413; CARTER DB, 1976, BIOCHEMISTRY-US, V15, P180, DOI 10.1021/bi00646a028; CHONG MT, 1974, BIOCHEMISTRY-US, V13, P5128, DOI 10.1021/bi00722a012; COUGHLIN P, 1993, P NATL ACAD SCI USA, V90, P9417, DOI 10.1073/pnas.90.20.9417; DICKINSON JL, 1995, J BIOL CHEM, V270, P27894, DOI 10.1074/jbc.270.46.27894; GOMBAU L, 1994, J BIOL CHEM, V269, P3875; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Jensen PH, 1996, J BIOL CHEM, V271, P26892, DOI 10.1074/jbc.271.43.26892; JENSEN PH, 1994, J BIOL CHEM, V269, P15394; Meyer J, 1998, BLOOD, V91, P1901, DOI 10.1182/blood.V91.6.1901.1901_1901_1908; MORGENSTERN KA, 1994, BIOCHEMISTRY-US, V33, P3432, DOI 10.1021/bi00177a037; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; REMOLDODONNELL E, 1992, P NATL ACAD SCI USA, V89, P5635, DOI 10.1073/pnas.89.12.5635; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; Riewald M, 1998, BLOOD, V91, P1256, DOI 10.1182/blood.V91.4.1256; RIEWALD M, 1995, J BIOL CHEM, V270, P26754, DOI 10.1074/jbc.270.45.26754; Rivett AJ, 1998, CURR OPIN IMMUNOL, V10, P110, DOI 10.1016/S0952-7915(98)80040-X; SCHLEEF RR, 1989, J CLIN INVEST, V83, P1747, DOI 10.1172/JCI114076; SCHLEUNING WD, 1987, MOL CELL BIOL, V7, P4564, DOI 10.1128/MCB.7.12.4564; Scholtz B, 1996, DEV BIOL, V173, P420, DOI 10.1006/dbio.1996.0037; SILVER P, 1989, CRIT REV BIOCHEM MOL, V24, P419, DOI 10.3109/10409238909082557; SPRECHER CA, 1995, J BIOL CHEM, V270, P29854; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; SUMINAMI Y, 1991, BIOCHEM BIOPH RES CO, V181, P51, DOI 10.1016/S0006-291X(05)81380-4; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; TOKES ZA, 1989, J BIOL CHEM, V264, P15059; TRAPANI JA, 1994, J BIOL CHEM, V269, P18359; YE RD, 1989, J BIOL CHEM, V264, P5495; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	30	32	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11194	11198		10.1074/jbc.274.16.11194	http://dx.doi.org/10.1074/jbc.274.16.11194			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196205	hybrid			2022-12-27	WOS:000079751900073
J	Fukao, M; Mason, HS; Britton, FC; Kenyon, JL; Horowitz, B; Keef, KD				Fukao, M; Mason, HS; Britton, FC; Kenyon, JL; Horowitz, B; Keef, KD			Cyclic GMP-dependent protein kinase activates cloned BKCa channels expressed in mammalian cells by direct phosphorylation at serine 1072	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; CA2+-ACTIVATED K+ CHANNEL; PORCINE CORONARY-ARTERY; POTASSIUM CHANNELS; NITRIC-OXIDE; CA CHANNELS; VASORELAXATION; IDENTIFICATION; VASODILATION; STIMULATION	NO-induced activation of cGMP-dependent protein kinase (PKG) increases the open probability of large conductance Ca2+-activated K+ channels and results in smooth muscle relaxation, However, the molecular mechanism of channel regulation by the NO-PKG pathway has not been determined on cloned channels. The present study was designed to clarify PKG-mediated modulation of channels at the molecular level. The cDNA encoding the alpha-subunit of the large conductance Ca2+-activated K+ channel, cslo-alpha, was expressed in HER293 cells. Whole cell and single channel characteristics of cslo-alpha exhibited functional features of native large conductance Ca2+-activated K+ channels in smooth muscle cells. The NO-donor sodium nitroprusside increased outward current 2.3-fold in whole cell recordings. In cell-attached patches, sodium nitroprusside increased the channel open probability (NPo) of cslo-alpha channels 3.3-fold without affecting unitary conductance. The stimulatory effect of sodium nitroprusside was inhibited by the PKG-inhibitor KT5823. Direct application of PKG-I alpha to the cytosolic surface of inside-out patches increased NPo 3.2-fold only in the presence of ATP and cGMP without affecting unitary conductance. A point mutation of cslo-alpha in which Ser-1072 (the only optimal consensus sequence for PKG phosphorylation) was replaced by Ala abolished the PKG effect on NPo in inside-out patches and the effect of SNP in cell attached patches. These results indicate that PKG activates cslo-alpha by direct phosphorylation at serine 1072.	Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Keef, KD (corresponding author), Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA.		Britton, Fiona/Q-5338-2016	Britton, Fiona/0000-0002-3834-9940; Kenyon, James/0000-0001-8699-4680	NHLBI NIH HHS [HL40399] Funding Source: Medline; NIDDK NIH HHS [DK41315] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL040399, R01HL040399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041315] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; Alioua A, 1998, J BIOL CHEM, V273, P32950, DOI 10.1074/jbc.273.49.32950; ARCHER SL, 1994, P NATL ACAD SCI USA, V91, P7583, DOI 10.1073/pnas.91.16.7583; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BERS D, 1994, METHODS CELL BIOL PR, V40; BIALECKI RA, 1995, AM J PHYSIOL-LUNG C, V268, pL152, DOI 10.1152/ajplung.1995.268.1.L152; Bischof G, 1997, CELL CALCIUM, V21, P135, DOI 10.1016/S0143-4160(97)90037-3; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; BUTT E, 1993, NEUROCHEM RES, V18, P27, DOI 10.1007/BF00966920; Bychkov R, 1998, J PHARMACOL EXP THER, V285, P293; CARL A, 1989, AM J PHYSIOL, V257, pC470, DOI 10.1152/ajpcell.1989.257.3.C470; DINERMAN JL, 1994, NEUROPHARMACOLOGY, V33, P1245, DOI 10.1016/0028-3908(94)90023-X; DWORETZKY SI, 1994, MOL BRAIN RES, V27, P189, DOI 10.1016/0169-328X(94)90203-8; ESGUERRA M, 1994, NATURE, V369, P563, DOI 10.1038/369563a0; FUJINO K, 1991, J PHARMACOL EXP THER, V256, P371; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Goyal RK, 1998, AM J PHYSIOL-GASTR L, V275, pG1185, DOI 10.1152/ajpgi.1998.275.5.G1185; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Jiang F, 1998, BRIT J PHARMACOL, V123, P106, DOI 10.1038/sj.bjp.0701552; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Kaczorowski GJ, 1996, J BIOENERG BIOMEMBR, V28, P255, DOI 10.1007/BF02110699; KHAN SA, 1993, J PHARMACOL EXP THER, V267, P1327; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LECHLEITER JD, 1988, NEURON, V1, P227, DOI 10.1016/0896-6273(88)90143-2; LINCOLN TM, 1991, BLOOD VESSELS, V28, P129; MINAMI K, 1993, BIOCHEM BIOPH RES CO, V190, P263, DOI 10.1006/bbrc.1993.1040; Mistry DK, 1998, BRIT J PHARMACOL, V124, P1131, DOI 10.1038/sj.bjp.0701940; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; PEREZ G, 1994, BIOPHYS J, V66, P1022, DOI 10.1016/S0006-3495(94)80883-5; PREVARSKAYA NB, 1995, J BIOL CHEM, V270, P24292, DOI 10.1074/jbc.270.41.24292; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Sansom SC, 1996, CLIN EXP PHARMACOL P, V23, P76; Tanaka Y, 1998, N-S ARCH PHARMACOL, V357, P705, DOI 10.1007/PL00005228; TANIGUCHI J, 1993, PFLUG ARCH EUR J PHY, V423, P167, DOI 10.1007/BF00374390; Toro L, 1998, NEWS PHYSIOL SCI, V13, P112; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Vaali K, 1998, J PHARMACOL EXP THER, V286, P110; Vogalis F, 1996, AM J PHYSIOL-GASTR L, V271, pG629, DOI 10.1152/ajpgi.1996.271.4.G629; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; WHITE RE, 1993, NATURE, V361, P263, DOI 10.1038/361263a0; WILLIAMS DL, 1988, P NATL ACAD SCI USA, V85, P9360, DOI 10.1073/pnas.85.23.9360; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; Zhou XB, 1998, PFLUG ARCH EUR J PHY, V436, P725, DOI 10.1007/s004240050695; Zhou XB, 1996, J BIOL CHEM, V271, P19760, DOI 10.1074/jbc.271.33.19760; Zhu GY, 1998, J NEUROSCI METH, V81, P73, DOI 10.1016/S0165-0270(98)00019-3	49	156	168	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10927	10935		10.1074/jbc.274.16.10927	http://dx.doi.org/10.1074/jbc.274.16.10927			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196172	hybrid			2022-12-27	WOS:000079751900040
J	Reimers, L; Borras, AM; Kurdistani, SK; Garreau, JR; Chung, M; Aaronson, SA; Lee, SW				Reimers, L; Borras, AM; Kurdistani, SK; Garreau, JR; Chung, M; Aaronson, SA; Lee, SW			Altered regulation of cyclin G in human breast cancer and its specific localization at replication foci in response to DNA damage in p53+/+ cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; TUMOR-SUPPRESSOR PROTEIN; MESSENGER-RNA; GENE; GROWTH; OVEREXPRESSION; EXPRESSION; SITES; PCNA; PROLIFERATION	Cyclin G, a recent addition to the cyclin family, was initially identified in screens for new src kinase family members and soon thereafter by differential screening for transcriptional targets of the tumor suppressor gene, p53. We have identified cyclin G as being overexpressed in breast and prostate cancer cells using differential display polymerase chain reaction screening. We demonstrate here that cyclin G is overexpressed in human breast and prostate cancer cells and in cancer cells in sifu from tumor specimens. Cyclin G expression was tightly regulated throughout the cell cycle in normal breast cells, peaking at the S and G(2)/M phases of the cell cycle with lower levels in G(1). The cell cycle-dependent expression was absent in breast cancer cells. Following DNA damage in normal p53+/+ cells, cyclin G is triggered to cluster in discrete nuclear DNA replication foci that contain replication-associated proteins such as proliferating cell nuclear antigen (PCNA). While p53-/- cells displayed a faint cyclin G nuclear staining pattern, there was no increased expression and no change in distribution of the staining pattern after DNA damage. The specific subcellular localization of cyclin G at DNA replication foci provides an additional link between p53-mediated growth arrest and cell cycle regulation and suggests that cyclin G may act as an effector of p53-mediated events by functional association with replication foci protein(s).	Harvard Univ, Inst Med, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Boston, MA 02115 USA; CUNY Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Lee, SW (corresponding author), Harvard Univ, Inst Med, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Rm 921,77 Ave Louis Pasteur, Boston, MA 02115 USA.			Kurdistani, Siavash/0000-0003-3295-3511				BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; Bates S, 1996, ONCOGENE, V13, P1103; BRAVO R, 1986, EXP CELL RES, V163, P287, DOI 10.1016/0014-4827(86)90059-5; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; CARDOSO MC, 1993, CELL, V74, P979, DOI 10.1016/0092-8674(93)90721-2; Chen DS, 1997, HUM GENE THER, V8, P1667, DOI 10.1089/hum.1997.8.14-1667; Chen JD, 1996, MOL CELL BIOL, V16, P2445; EMERMAN JT, 1990, IN VITRO CELL DEV B, V26, P1186; ETHIER SP, 1993, CANCER RES, V53, P627; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050; HUNTER T, 1991, CELL, V66, P1071, DOI 10.1016/0092-8674(91)90028-W; JIANG W, 1992, CANCER RES, V52, P2980; KEOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112; KEYOMARSI K, 1991, CANCER RES, V51, P3602; KIYOKAWA N, 1995, P NATL ACAD SCI USA, V92, P1092, DOI 10.1073/pnas.92.4.1092; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lee SW, 1996, NAT MED, V2, P776, DOI 10.1038/nm0796-776; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; Okamoto K, 1996, MOL CELL BIOL, V16, P6593; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; SKOTZKO M, 1995, CANCER RES, V55, P5493; Smith ML, 1998, EXP CELL RES, V242, P235, DOI 10.1006/excr.1998.4078; Smith ML, 1997, EXP CELL RES, V230, P61, DOI 10.1006/excr.1996.3402; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; TAMURA K, 1993, ONCOGENE, V8, P2113; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WANG J, 1990, NATURE, V343, P555, DOI 10.1038/343555a0; WEINSTATSASLOW D, 1995, NAT MED, V1, P1257, DOI 10.1038/nm1295-1257; WOSIKOWSKI K, 1995, CELL GROWTH DIFFER, V6, P1395; WU LT, 1994, ONCOL REP, V1, P705; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; ZAUBERMAN A, 1995, ONCOGENE, V10, P2361	38	75	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11022	11029		10.1074/jbc.274.16.11022	http://dx.doi.org/10.1074/jbc.274.16.11022			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196184	hybrid			2022-12-27	WOS:000079751900052
J	Boensch, C; Huang, SS; Connolly, DT; Huang, JS				Boensch, C; Huang, SS; Connolly, DT; Huang, JS			Cell surface retention sequence binding protein-1 interacts with the v-sis gene product and platelet-derived growth factor beta-type receptor in simian sarcoma virus-transformed cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-A-CHAIN; ALTERNATIVELY SPLICED EXON; NIH 3T3 CELLS; AUTOCRINE TRANSFORMATION; EXTRACELLULAR-MATRIX; ONCOGENE PRODUCT; PDGF; IDENTIFICATION; MECHANISM; SURAMIN	The cell surface retention sequence (CRS) binding protein-1 (CRSBP-1) is a newly identified membrane glycoprotein which is hypothesized to be responsible for cell surface retention of the oncogene v-sis and c-sis gene products and other secretory proteins containing CRSs, In simian sarcoma virus-transformed NIH 3T3 cells (SSV-NIH 3T3 cells), a fraction of CRSBP-1 was demonstrated at the cell surface and underwent internalization/recycling as revealed by cell surface I-125 labeling and its resistance/sensitivity to trypsin digestion. However, the majority of CRSBP-1 was localized in intracellular compartments as evidenced by the resistance of most of the S-35-metabolically labeled CRSBP-1 to trypsin digestion, and by indirect immunofluorescent staining. CRSBP-1 appeared to form complexes with proteolytically processed forms (generated at and/or after the trans-Golgi network) of the v-sis gene product and with a similar to 140-kDa proteolytically cleaved form of the platelet-derived growth factor (PDGF) beta-type receptor, as demonstrated by metabolic labeling and co-immunoprecipitation. CRSBP-1, like the v-sis gene product and PDGF beta-type receptor, underwent rapid turnover which was blocked in the presence of 100 mu M suramin, In normal and other transformed NIH 3T3 cells, CRSBP-1 was relatively stable and did not undergo rapid turnover and internalization/recycling at the cell surface. These results suggest that in SSV-NIH 3T3 cells, CRSBP-1 interacts with and forms ternary and binary complexes with the newly synthesized v-sis gene product and PDGF P-type receptor at the trans-Golgi network and that the stable binary (CRSBP-1.v-sis gene product) complex is transported to the cell surface where it presents the v-sis gene product to unoccupied PDGF beta-type receptors during internalization/recycling.	St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; Monsanto Co, Atherosclerosis Res, St Louis, MO 63167 USA	Saint Louis University; Monsanto	Huang, JS (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, 1402 S Grand Blvd, St Louis, MO 63104 USA.				NCI NIH HHS [CA38808] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA038808] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baghdiguian S, 1996, EUR J CANCER, V32A, P525, DOI 10.1016/0959-8049(95)00588-9; BEJCEK BE, 1992, J BIOL CHEM, V267, P3289; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BETSHOLTZ C, 1986, P NATL ACAD SCI USA, V83, P6440, DOI 10.1073/pnas.83.17.6440; BOENSCH C, 1995, J BIOL CHEM, V270, P1807, DOI 10.1074/jbc.270.4.1807; BOENSCH C, 1998, THESIS ST LOUIS U; BONTHRON DT, 1988, P NATL ACAD SCI USA, V85, P1492, DOI 10.1073/pnas.85.5.1492; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; DEUEL TF, 1984, BLOOD, V64, P951; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; FLEMING TP, 1989, P NATL ACAD SCI USA, V86, P8063, DOI 10.1073/pnas.86.20.8063; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; HANNINK M, 1988, J CELL BIOL, V107, P287, DOI 10.1083/jcb.107.1.287; HELDIN CH, 1990, CELL REGUL, V1, P555, DOI 10.1091/mbc.1.8.555; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; HUANG JS, 1983, J CELL BIOL, V97, P383, DOI 10.1083/jcb.97.2.383; Huang SS, 1997, FEBS LETT, V416, P297, DOI 10.1016/S0014-5793(97)01213-1; HUANG SS, 1988, J BIOL CHEM, V263, P12608; HUBBARD AL, 1972, J CELL BIOL, V55, P390, DOI 10.1083/jcb.55.2.390; KEATING MT, 1988, SCIENCE, V239, P914, DOI 10.1126/science.2829358; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; KHACHIGIAN LM, 1992, J BIOL CHEM, V267, P7478; KHACHIGIAN LM, 1992, J BIOL CHEM, V267, P1660; KIEFER P, 1991, MOL CELL BIOL, V11, P5929, DOI 10.1128/MCB.11.12.5929; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; LAROCHELLE WJ, 1991, GENE DEV, V5, P1191, DOI 10.1101/gad.5.7.1191; LEAL F, 1985, SCIENCE, V230, P327, DOI 10.1126/science.2996133; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LOKESHWAR VB, 1990, J BIOL CHEM, V265, P1665; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; OSTMAN A, 1991, CELL REGUL, V2, P503, DOI 10.1091/mbc.2.7.503; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; RAINES EW, 1992, J CELL BIOL, V116, P533, DOI 10.1083/jcb.116.2.533; RORSMAN F, 1988, MOL CELL BIOL, V8, P571, DOI 10.1128/MCB.8.2.571; TISCHER E, 1991, J BIOL CHEM, V266, P11947; VALGEIRSDOTTIR S, 1995, J BIOL CHEM, V270, P10161, DOI 10.1074/jbc.270.17.10161; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0	38	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10582	10589		10.1074/jbc.274.15.10582	http://dx.doi.org/10.1074/jbc.274.15.10582			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187853	hybrid			2022-12-27	WOS:000079663500092
J	Kobayashi, M; Sugumaran, G; Liu, JA; Shworak, NW; Silbert, JE; Rosenberg, RD				Kobayashi, M; Sugumaran, G; Liu, JA; Shworak, NW; Silbert, JE; Rosenberg, RD			Molecular cloning and characterization of a human uronyl 2-sulfotransferase that sulfates iduronyl and glucuronyl residues in dermatan chondroitin sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-COFACTOR-II; D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE; N-DEACETYLASE/N-SULFOTRANSFERASE; HAMSTER OVARY CELLS; HIGH-AFFINITY; CDNA CLONING; EXPRESSION; SEQUENCE; BINDING; BIOSYNTHESIS	A partial-length human cDNA with a predicted amino acid sequence homologous to a previously described heparan sulfate iduronyl 2-sulfotransferase (Kobayashi, M., Habuchi, H,, Yoneda, M,, Habuchi, O,, and Kimata, K, (1997) J, Biol, Chem. 272, 13980-13985) was obtained by searching the expressed sequence-tagged data bank. Northern blot analysis was performed using this homologous cDNA as a probe, which demonstrated ubiquitous expression of messages of 5.1 and 2.0 kilobases in a number of human tissues and in several human cancer cell lines. Since the human lymphoma Raji cell line had the highest level of expression, it was used to isolate a full-length cDNA clone, The full-length cDNA was found to contain an open reading frame that predicted a type IT transmembrane protein composed of 406 amino acid residues. The cDNA in a baculovirus expression vector was expressed in Sf9 insect cells, and cell extracts were then incubated together with 3'-phosphoadenosine 5'phospho[S-35]sulfate and potential glycosaminoglycan accepters. This demonstrated substantial sulfotransferase activity with dermatan sulfate, a small degree of activity with chondroitin sulfate, but no sulfotransferase activity with desulfated N-resulfated heparin, Analysis of [S-35]sulfate-labeled disaccharide products of chondroitin ABC, chondroitin AC, and chondroitin B lyase treatment demonstrated that the enzyme only transferred sulfate to the a-position of uronyl residues, which were preponderantly iduronyl residues in dermatan sulfate, but some lesser transfer to glucuronyl residues of chondroitin sulfate.	MIT, Dept Biol, Cambridge, MA 02139 USA; Edith Nourse Rogers Mem Vet Adm Hosp, Bedford, MA 01730 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02215 USA; Beth Israel Hosp, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center	Rosenberg, RD (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave,68-480, Cambridge, MA 02139 USA.		Shworak, Nicholas/AAJ-6770-2020	Shworak, Nicholas/0000-0001-7783-4634	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041649] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-66385] Funding Source: Medline; NIAMS NIH HHS [AR-41649] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADAMS MD, 1995, NATURE, V377, P3; AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9; CELLA G, 1992, ANGIOLOGY, V43, P59, DOI 10.1177/000331979204300107; CHENG F, 1994, GLYCOBIOLOGY, V4, P685, DOI 10.1093/glycob/4.5.685; CLARKE D, 1995, CYTOKINE, V7, P325, DOI 10.1006/cyto.1995.0041; DAVIDSON S, 1990, J BIOL CHEM, V265, P12324; DIXON J, 1995, GENOMICS, V26, P239, DOI 10.1016/0888-7543(95)80206-2; ERIKSSON I, 1994, J BIOL CHEM, V269, P10438; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Fransson L.-A., 1993, DERMATAN SULPHATE PR, P11; FUKUTA M, 1995, J BIOL CHEM, V270, P18575, DOI 10.1074/jbc.270.31.18575; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; Habuchi H, 1998, J BIOL CHEM, V273, P9208, DOI 10.1074/jbc.273.15.9208; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; Kakuta Y, 1998, TRENDS BIOCHEM SCI, V23, P129, DOI 10.1016/S0968-0004(98)01182-7; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; Kobayashi M, 1997, J BIOL CHEM, V272, P13980, DOI 10.1074/jbc.272.21.13980; Kobayashi M, 1996, J BIOL CHEM, V271, P7645, DOI 10.1074/jbc.271.13.7645; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Liu J, 1996, J BIOL CHEM, V271, P27072, DOI 10.1074/jbc.271.43.27072; Lyon M, 1998, J BIOL CHEM, V273, P271, DOI 10.1074/jbc.273.1.271; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; MALMSTROM A, 1975, J BIOL CHEM, V250, P3419; MALMSTROM A, 1984, J BIOL CHEM, V259, P161; MARK M P, 1990, International Journal of Developmental Biology, V34, P191; MASCELLANI G, 1993, BIOCHEM J, V296, P639, DOI 10.1042/bj2960639; MCLEAN MW, 1984, EUR J BIOCHEM, V145, P607, DOI 10.1111/j.1432-1033.1984.tb08600.x; NAGASAWA K, 1979, J BIOCHEM-TOKYO, V86, P1323, DOI 10.1093/oxfordjournals.jbchem.a132648; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; POWERS PA, 1991, GENETICS, V129, P133; PRIGLINGER U, 1994, J BIOL CHEM, V269, P14705; SCULLY MF, 1988, BIOCHEM J, V254, P547, DOI 10.1042/bj2540547; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170; Silbert JE, 1996, GLYCOCONJUGATE J, V13, P907, DOI 10.1007/BF01053185; SILBERT JE, 1986, J BIOL CHEM, V261, P3397; SILBERT JE, 1993, DERMATAN SULFATE PRO, P147; Sueyoshi T, 1998, FEBS LETT, V433, P211, DOI 10.1016/S0014-5793(98)00913-2; SUGAHARA K, 1992, J BIOL CHEM, V267, P6027; SUGUMARAN G, 1989, METHOD ENZYMOL, V169, P428; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Walker A, 1996, BIOCHEM J, V317, P871, DOI 10.1042/bj3170871; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; ZHENG YQ, 1994, J BIOL CHEM, V269, P30313	49	119	123	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10474	10480		10.1074/jbc.274.15.10474	http://dx.doi.org/10.1074/jbc.274.15.10474			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187838	hybrid			2022-12-27	WOS:000079663500077
J	Pandey, P; Avraham, S; Kumar, S; Nakazawa, A; Place, A; Ghanem, L; Rana, A; Kumar, V; Majumder, PK; Avraham, H; Davis, RJ; Kharbanda, S				Pandey, P; Avraham, S; Kumar, S; Nakazawa, A; Place, A; Ghanem, L; Rana, A; Kumar, V; Majumder, PK; Avraham, H; Davis, RJ; Kharbanda, S			Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; N-TERMINAL KINASE; C-JUN; MAP KINASE; IONIZING-RADIATION; STRESS-RESPONSE; GENE-EXPRESSION; ABL; PHOSPHORYLATION; CALCIUM	The stress-activated p38 mitogen-activated protein kinase (p38 MAPK), a member of the subgroup of mammalian kinases, appears to play an important role in regulating inflammatory responses, including cytokine secretion and apoptosis, The upstream mediators that link extracellular signals with the p38 MAPK signaling pathway are currently unknown. Here we demonstrate that pp125 focal adhesion kinase-related tyrosine kinase RAFTK (also known as PYK2, CADTK) is activated specifically by methylmethane sulfonate (MMS) and hyperosmolarity but not by ultraviolet radiation, ionizing radiation, or cis-platinum. Overexpression of RAFTK leads to the activation of p38 MAPK, Furthermore, overexpression of a dominant-negative mutant of RAFTK (RAFTK K-M) inhibits MMS-induced p38 MAPK activation. MKK3 and MKK6 are known potential constituents of p38 MAPK signaling pathway, whereas SEK1 and MEK1 are upstream activators of SAPK/JNK and ERK pathways, respectively. We observe that the dominant-negative mutant of MKK3 but not of MKK6, SEK1, or MEK1 inhibits RAFTK-induced p38 MAPK activity. Furthermore, the results demonstrate that treatment of cells with 1,2-bis(2-aminophenoxy)ethane-N,N,N'.N'-tetraacetic acid, tetra(acetoxymethyl)-ester, a membrane-permeable calcium chelator, inhibits MMS-induced activation of RAFTK and p38 MAPK. Taken together, these findings indicate that RAFTK represents a stress-sensitive mediator of the p38 MAPK signaling pathway in response to certain cytotoxic agents.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Inst Med, Deaconess Med Ctr, Div Expt Med & Hematol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Mol Biol, Diabet Res Lab, Boston, MA 02114 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Howard Hughes Med Inst,Program Mol Med, Worcester, MA 01605 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Kharbanda, S (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.		Ghanem, Louis/R-3733-2016; Rana, Ajay/ABE-3739-2020	Ghanem, Louis/0000-0002-7723-5241; Rana, Ajay/0000-0003-0951-2566; Avraham, Hava/0000-0002-7545-3640; Kumar, Vijay/0000-0001-6477-8274	NATIONAL CANCER INSTITUTE [R01CA075216, R01CA065861] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055445] Funding Source: NIH RePORTER; NCI NIH HHS [CA75216, CA65861] Funding Source: Medline; NHLBI NIH HHS [R01 HL55445] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Kharbanda S, 1996, P NATL ACAD SCI USA, V93, P6898, DOI 10.1073/pnas.93.14.6898; KHARBANDA S, 1995, J BIOL CHEM, V270, P18871, DOI 10.1074/jbc.270.32.18871; Kharbanda S, 1997, NATURE, V386, P732, DOI 10.1038/386732a0; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Kharbanda S, 1995, J BIOL CHEM, V270, P30278, DOI 10.1074/jbc.270.51.30278; KHARBANDA S, 1994, P NATL ACAD SCI USA, V91, P5416, DOI 10.1073/pnas.91.12.5416; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; NARAHARA H, 1995, J CLIN ENDOCR METAB, V80, P3121, DOI 10.1210/jc.80.11.3121; Pandey P, 1996, J BIOL CHEM, V271, P23775, DOI 10.1074/jbc.271.39.23775; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; SALEEM A, 1995, J IMMUNOL, V154, P4150; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SCHWARTZ JL, 1986, CARCINOGENESIS, V7, P159, DOI 10.1093/carcin/7.1.159; SMITH GJ, 1986, AM J PATHOL, V122, P488; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; ZOHN IE, 1995, MOL CELL BIOL, V15, P6160	37	124	125	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10140	10144		10.1074/jbc.274.15.10140	http://dx.doi.org/10.1074/jbc.274.15.10140			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187797	hybrid			2022-12-27	WOS:000079663500036
J	Thakker, GD; Hajjar, DP; Muller, WA; Rosengart, TK				Thakker, GD; Hajjar, DP; Muller, WA; Rosengart, TK			The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE DOMAIN; FOCAL ADHESION KINASE; PERMEABILITY FACTOR; CATALYTIC SUBUNIT; RECEPTOR; ACTIVATION; PROTEIN; CELLS; KDR; PHOSPHORYLATION	Vascular endothelial growth factor (VEGF) receptor Flk-1/KDR in endothelial cells is activated during vasculogenesis and angiogenesis upon ligand-receptor interaction. Activated Flk-1/KDR has been shown to recruit Src homology 2 domain-containing signaling molecules that are known to serve as links to the activation of the mitogen-activated protein (MAP) kinase signaling pathway. To define the functional significance of phosphatidylinositol (PI) 3-kinase in VEGF signaling, we have examined its role in human umbilical vein endothelial cell (HUVEC) cycle progression. We show herein that p85, the regulatory subunit of PI 3-kinase, is constitutively associated with Flk-1/KDR. The treatment of HUVECs with VEGF promoted tyrosine autophosphorylation of Flk-1/KDR and also induced phosphorylation of p85, This was followed by an increase in the PI 3-kinase activity, which was sensitive to wortmannin, a potent PI 3-kinase inhibitor, VEGF also induced a striking activation of MAP kinase in a time-dependent manner. Inhibition studies with both a dominant-negative p85 mutant and the PI 3-kinase inhibitor, wortmannin, were employed to show for the first time that VEGF-stimulated PI 3-kinase modulates MAP kinase activation and nuclear events such as transcription from c-fos promoter and entry into the synthesis (S)-phase, Our data demonstrate the importance of PI 3-kinase as a necessary signaling component of VEGF-mediated cell cycle progression.	Cornell Univ, Weill Med Coll, Dept Cardiothorac Surg, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA	Cornell University; Cornell University	Rosengart, TK (corresponding author), Cornell Univ, Weill Med Coll, Dept Cardiothorac Surg, Rm F2103,1300 York Ave, New York, NY 10021 USA.	tkrosen@mail.med.cornell.edu						Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Brown LF, 1997, LAB INVEST, V76, P245; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; CUNNINGHAM SA, 1995, J BIOL CHEM, V270, P20254, DOI 10.1074/jbc.270.35.20254; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; DOUGHERVERMAZEN M, 1994, BIOCHEM BIOPH RES CO, V205, P728, DOI 10.1006/bbrc.1994.2726; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; HU P, 1994, MOL CELL BIOL, V14, P2577, DOI 10.1128/MCB.14.4.2577; Iwama A., 1995, Clinical and Experimental Pharmacology and Physiology, V22, pS318, DOI 10.1111/j.1440-1681.1995.tb02935.x; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; KLIPPEL A, 1993, MOL CELL BIOL, V13, P5560, DOI 10.1128/MCB.13.9.5560; KLIPPEL A, 1994, MOL CELL BIOL, V14, P2675, DOI 10.1128/MCB.14.4.2675; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Krook A, 1997, J BIOL CHEM, V272, P30208, DOI 10.1074/jbc.272.48.30208; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LI W, 1992, MOL CELL BIOL, V12, P5824, DOI 10.1128/MCB.12.12.5824; MALARKEY K, 1995, BIOCHEM J, V309, P361, DOI 10.1042/bj3090361; OBERG C, 1994, GROWTH FACTORS, V10, P115, DOI 10.3109/08977199409010985; Parenti A, 1998, J BIOL CHEM, V273, P4220, DOI 10.1074/jbc.273.7.4220; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PEPPER MS, 1992, BIOCHEM BIOPH RES CO, V189, P824, DOI 10.1016/0006-291X(92)92277-5; Phillips G D, 1994, In Vivo, V8, P961; PLOUET J, 1989, EMBO J, V8, P3801, DOI 10.1002/j.1460-2075.1989.tb08557.x; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; SEETHARAM L, 1995, ONCOGENE, V10, P135; SENGER DR, 1986, CANCER RES, V46, P5629; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shepherd PR, 1996, TRENDS CELL BIOL, V6, P92, DOI 10.1016/0962-8924(96)80998-6; TAKHASHI T, 1997, ONCOGENE, V14, P2079; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; TRIESMAN R, 1995, EMBO J, V14, P4905; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; VANDERGREER P, 1995, CURR BIOL, V5, P405; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; YUSOFF P, 1994, GROWTH FACTORS, V10, P181, DOI 10.3109/08977199409000236	46	206	216	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10002	10007		10.1074/jbc.274.15.10002	http://dx.doi.org/10.1074/jbc.274.15.10002			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187776	hybrid			2022-12-27	WOS:000079663500015
J	Fry, M; Loeb, LA				Fry, M; Loeb, LA			Human Werner syndrome DNA helicase unwinds tetrahelical structures of the fragile X syndrome repeat sequence d(CGG)(n)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME PROTEIN; HAIRPIN STRUCTURES; ESCHERICHIA-COLI; HUMAN GENOME; CGG REPEAT; INSTABILITY; FORM; RECOMBINATION; EXONUCLEASE; CELLS	Formation of hairpin and tetrahelical structures by a d(CGG) trinucleotide repeat sequence is thought to cause expansion of this sequence and to engender fragile X syndrome. Here we show that human Werner syndrome DNA helicase (WRN), a member of the RecQ family of helicases, efficiently unwinds G'2 bimolecular tetraplex structures of d(CGG),. Unwinding of d(CGG), by WRN requires hydrolyzable ATP and Mg2+ and is proportional to the amount of added helicase and to the time of incubation. The efficiencies of unwinding of G'2 d(CGG)(7) tetraplex with 7 nucleotide-long single-stranded tails at their 3' or 5' ends are, respectively, 3.5- and a-fold greater than that of double-stranded DNA. By contrast, WRN is unable to unwind a blunt-ended d(CGG), tetraplex, bimolecular tetraplex structures of a telomeric sequence 5'-d(TAGACATG(TTAGGG)(2)TTA)-3', or tetramolecular quadruplex forms of an IgG switch region sequence 5'-d(TACAGGGGAGCTGGGGTAGA)-3'. The ability of WRN to selectively unwind specific tetra-helices may reflect a specific role of this helicase in DNA metabolism.	Technion Israel Inst Technol, Bruce Rappaport Fac Med, Biochem Unit, IL-31096 Haifa, Israel; Univ Washington, Dept Pathol, Joseph Gottstein Canc Res Mem Lab, Seattle, WA 98195 USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Washington; University of Washington Seattle	Fry, M (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Biochem Unit, POB 9649, IL-31096 Haifa, Israel.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001751] Funding Source: NIH RePORTER; NCI NIH HHS [R35-CA-39909] Funding Source: Medline; NIAID NIH HHS [AI-01751] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baran N, 1997, NUCLEIC ACIDS RES, V25, P297, DOI 10.1093/nar/25.2.297; CHEN FM, 1995, J BIOL CHEM, V270, P23090, DOI 10.1074/jbc.270.39.23090; CHEN XA, 1995, P NATL ACAD SCI USA, V92, P5199, DOI 10.1073/pnas.92.11.5199; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; COURCELLE J, 1997, FASEB J, V11, P1358; Ellis NA, 1997, CURR OPIN GENET DEV, V7, P354, DOI 10.1016/S0959-437X(97)80149-9; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FRY M, 1988, NUCLEIC ACIDS RES, V16, P199, DOI 10.1093/nar/16.1.199; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; GACY AM, 1995, CELL, V81, P533; GEBHART E, 1988, HUM GENET, V80, P135, DOI 10.1007/BF00702855; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; HAN J, 1994, NUCLEIC ACIDS RES, V22, P1735, DOI 10.1093/nar/22.9.1735; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; HENDERSON E, 1995, TELOMERES, P11; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; KETTANI A, 1995, J MOL BIOL, V254, P638, DOI 10.1006/jmbi.1995.0644; Mangel L, 1998, J BIOL CHEM, V273, P30466, DOI 10.1074/jbc.273.46.30466; MITAS M, 1995, BIOCHEMISTRY-US, V34, P12803, DOI 10.1021/bi00039a041; NADEL Y, 1995, J BIOL CHEM, V270, P28970, DOI 10.1074/jbc.270.48.28970; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Ogburn CE, 1997, HUM GENET, V101, P121, DOI 10.1007/s004390050599; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; SALK D, 1981, CYTOGENET CELL GENET, V30, P92, DOI 10.1159/000131596; Sambrook J, 1989, MOL CLONING LAB MANU, VII; SEKI M, 1995, MOL CELL BIOL, V15, P165, DOI 10.1128/MCB.15.1.165; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VIJAYALAXMI H J E, 1983, Science (Washington D C), V221, P851; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7	41	302	313	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12797	12802		10.1074/jbc.274.18.12797	http://dx.doi.org/10.1074/jbc.274.18.12797			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212265	hybrid			2022-12-27	WOS:000080056800085
J	Grimm, SL; Nordeen, SK				Grimm, SL; Nordeen, SK			A composite enhancer element directing tissue-specific expression of mouse mammary tumor virus requires both ubiquitous and tissue-restricted factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG TERMINAL REPEAT; MULTIPLE REGULATORY ELEMENTS; BINDING-PROTEIN; GLUCOCORTICOID RECEPTOR; TRANSCRIPTION FACTORS; CELL-LINE; GLAND; PROMOTER; DNA; FAMILY	Mouse mammary tumor virus (MMTV) expression is restricted primarily to mammary epithelial cells. Sequences responsible for both the mammary-specific expression of MMTV and the activation of cellular oncogenes are located within two enhancer elements at the 5'-end of the long terminal repeat. Whereas the Ban2 enhancer (-1075 to -978) has been well characterized, the mammary-specific enhancer of MMTV from -956 to -862 has only recently been recognized as a key determinant of mammary-specific oncogene activation by MMTV. The present study identifies and characterizes three binding sites located within this element. Transient transfection of deletion and mutation constructs shows that all three sites contribute to the basal expression of MMTV in mammary cells. One of the binding activities (footprint I) is restricted to mammary cells, whereas the other two sites bind factors found in both mammary and nonmammary cells. The multimerized mammary-specific enhancer of MMTV on its own can enhance a minimal promoter in a mammary-specific fashion. However, the FpI binding site alone cannot mediate this effect. Thus, it is the binding of multiple factors in a combinatorial fashion that mediates the mammary-restricted expression of MMTV.	Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Program Mol Biol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Nordeen, SK (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pathol, 4200 E 9th Ave,Box B216, Denver, CO 80262 USA.	Steve.Nordeen@uchsc.edu						BORGMEYER U, 1984, NUCLEIC ACIDS RES, V12, P4295, DOI 10.1093/nar/12.10.4295; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOPPLER W, 1995, J BIOL CHEM, V270, P17962, DOI 10.1074/jbc.270.30.17962; Durocher D, 1998, DEV GENET, V22, P250, DOI 10.1002/(SICI)1520-6408(1998)22:3<250::AID-DVG7>3.0.CO;2-5; DYNAN WS, 1987, GENETIC ENG PRINCIPL, V9, P75; Golovkina TV, 1998, J VIROL, V72, P3066, DOI 10.1128/JVI.72.4.3066-3071.1998; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; Grimm SL, 1998, J VIROL, V72, P9428, DOI 10.1128/JVI.72.12.9428-9435.1998; GUNZBURG WH, 1992, BIOCHEM J, V283, P625; GUSTAFSSON JA, 1987, ENDOCR REV, V8, P185, DOI 10.1210/edrv-8-2-185; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; HENRARD D, 1988, J VIROL, V62, P3046, DOI 10.1128/JVI.62.8.3046-3049.1988; Kusk P, 1996, J BIOL CHEM, V271, P31269, DOI 10.1074/jbc.271.49.31269; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; LEFEBVRE P, 1991, MOL CELL BIOL, V11, P2529, DOI 10.1128/MCB.11.5.2529; MELLENTINMICHELOTTI J, 1994, J BIOL CHEM, V269, P31983; MINK S, 1990, NUCLEIC ACIDS RES, V18, P2017, DOI 10.1093/nar/18.8.2017; MINK S, 1992, MOL CELL BIOL, V12, P4906, DOI 10.1128/MCB.12.11.4906; MOK E, 1992, J VIROL, V66, P7529, DOI 10.1128/JVI.66.12.7529-7532.1992; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Moore D H, 1979, Adv Cancer Res, V29, P347, DOI 10.1016/S0065-230X(08)60850-7; MORRIS VL, 1977, J MOL BIOL, V114, P73, DOI 10.1016/0022-2836(77)90284-4; NANDI S, 1973, ADV CANCER RES, V17, P353; Nikolajczyk BS, 1997, MOL CELL BIOL, V17, P3527, DOI 10.1128/MCB.17.7.3527; NORDEEN SK, 1989, MOL ENDOCRINOL, V3, P1270, DOI 10.1210/mend-3-8-1270; NORDEEN SK, 1993, MOL ENDOCRINOL, V7, P731, DOI 10.1210/me.7.6.731; NORDEEN SK, 1987, DNA-J MOLEC CELL BIO, V6, P173, DOI 10.1089/dna.1987.6.173; Qin W, 1999, J VIROL, V73, P368, DOI 10.1128/JVI.73.1.368-376.1999; Rosen JM, 1998, BIOCHEM SOC SYMP, P101; Sabatakos G, 1998, BIOCHEM J, V334, P205, DOI 10.1042/bj3340205; SALMONS B, 1987, VIRUS RES, V8, P81, DOI 10.1016/0168-1702(87)90022-0; SCHEIDEREIT C, 1983, NATURE, V304, P749, DOI 10.1038/304749a0; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; VANLEEUWEN F, 1995, SEMIN CANCER BIOL, V6, P127, DOI 10.1006/scbi.1995.0018; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; WEDEL A, 1995, IMMUNOBIOLOGY, V193, P171, DOI 10.1016/S0171-2985(11)80541-3; WELTE T, 1994, EUR J BIOCHEM, V223, P997, DOI 10.1111/j.1432-1033.1994.tb19078.x; XANTHOPOULOS KG, 1993, EUR J BIOCHEM, V216, P353, DOI 10.1111/j.1432-1033.1993.tb18152.x; YANAGAWA S, 1991, J VIROL, V65, P526, DOI 10.1128/JVI.65.1.526-531.1991	40	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12790	12796		10.1074/jbc.274.18.12790	http://dx.doi.org/10.1074/jbc.274.18.12790			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212264	hybrid			2022-12-27	WOS:000080056800084
J	Hanna, AN; Chan, EYW; Xu, J; Stone, JC; Brindley, DN				Hanna, AN; Chan, EYW; Xu, J; Stone, JC; Brindley, DN			A novel pathway for tumor necrosis factor-alpha and ceramide signaling involving sequential activation of tyrosine kinase, p21(ras), and phosphatidylinositol 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PERMEABLE CERAMIDES; FOCAL ADHESION KINASE; SPHINGOMYELIN TURNOVER; PROTEIN-KINASE; TNF-ALPHA; PHOSPHOINOSITIDE 3-KINASE; ARACHIDONIC-ACID; PHOSPHOLIPASE-D; GLUCOSE-UPTAKE; DNA-SYNTHESIS	Treatment of confluent rata fibroblasts with C-2-ceramide (N-acetylsphingosine), sphingomyelinase, or tumor necrosis factor-alpha (TNF alpha) increased phosphatidylinositol (PI) 3-kinase activity by 3-6-fold after 10 min. This effect of C-2-ceramide depended on tyrosine kinase activity and an increase in Ras-GTP levels. Increased PI 3-kinase activity was also accompanied by its translocation to the membrane fraction, increases in tyrosine phosphorylation of the p85 subunit, and physical association with Pas, Activation of PI 3-kinase by TNF alpha, sphingomyelinase, and C-2-ceramide was inhibited by tyrosine kinase inhibitors (genistein and PP1). The stimulation of PI S-kinase by sphingomyelinase and C-2-ceramide was not observed in fibroblasts expressing dominant-negative Pas (N17) and the stimulation by TNF alpha was decreased by 70%. PI 3-kinase activation by C-2-ceramide was not modified by inhibitors of acidic and neutral ceramidases, and it was not observed with the relatively inactive analog, dihydro-C-2-ceramide It is proposed that activation of Pas and PI 3-kinase by ceramide can contribute to signaling effects of TNF alpha that occur downstream of sphingomyelinase activation and result in increased fibroblasts proliferation.	Univ Alberta, Signal Transduct Labs, Lipid & Lipoprot Res Grp, Heritage Med Res Ctr 357, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Brindley, DN (corresponding author), Univ Alberta, Signal Transduct Labs, Lipid & Lipoprot Res Grp, Heritage Med Res Ctr 357, Edmonton, AB T6G 2S2, Canada.		Chan, Edmond Y.W./A-1940-2013	Chan, Edmond Y.W./0000-0001-9777-0252				AGGARWAL BB, 1995, FEBS LETT, V364, P5, DOI 10.1016/0014-5793(95)00339-B; BATTEGAY EJ, 1995, J IMMUNOL, V154, P6040; BELKA C, 1995, EMBO J, V14, P1156, DOI 10.1002/j.1460-2075.1995.tb07099.x; Bielawska A, 1996, J BIOL CHEM, V271, P12646, DOI 10.1074/jbc.271.21.12646; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN WJ, 1995, J CELL BIOL, V130, P781, DOI 10.1083/jcb.130.4.781; BURGERING BMT, 1993, MOL CELL BIOL, V13, P7248, DOI 10.1128/MCB.13.12.7248; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; CIFONE MG, 1993, J EXP MED, V177, P1547; DAVIDSON HW, 1995, J CELL BIOL, V130, P797, DOI 10.1083/jcb.130.4.797; DBAIBO GS, 1993, J BIOL CHEM, V268, P17762; DeMaria R, 1996, J CLIN INVEST, V97, P316, DOI 10.1172/JCI118418; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; EVANS DA, 1989, AM J PHYSIOL, V257, pR1182, DOI 10.1152/ajpregu.1989.257.5.R1182; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FOLLI F, 1992, J BIOL CHEM, V267, P22171; Gerritsen ME, 1998, AM J PATHOL, V152, P505; GOMEZMUNOZ A, 1994, J BIOL CHEM, V269, P8937; GOMEZMUNOZ A, 1997, SPHINGOLIPID MEDIATE, P103; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; Guo DQ, 1996, J BIOL CHEM, V271, P615, DOI 10.1074/jbc.271.2.615; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HAUSER JML, 1994, J BIOL CHEM, V269, P6803; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Jobson TM, 1998, J CLIN INVEST, V101, P2650, DOI 10.1172/JCI1876; Jones SM, 1997, J CELL BIOL, V139, P339, DOI 10.1083/jcb.139.2.339; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; KIM MY, 1991, J BIOL CHEM, V266, P484; Klippel A, 1996, MOL CELL BIOL, V16, P4117; KOLESNICK R, 1995, J EXP MED, V181, P1949, DOI 10.1084/jem.181.6.1949; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU J, 1994, J BIOL CHEM, V269, P3047; LIU XQ, 1993, MOL CELL BIOL, V13, P5225, DOI 10.1128/MCB.13.9.5225; Lu G, 1997, NEUROCHEM INT, V30, P401, DOI 10.1016/S0197-0186(96)00075-7; MARTIN A, 1993, J BIOL CHEM, V268, P23924; MATHIAS S, 1993, SCIENCE, V259, P519, DOI 10.1126/science.8424175; McGowan KM, 1997, J BIOL CHEM, V272, P1331, DOI 10.1074/jbc.272.2.1331; MIYAZAKI Y, 1995, J CLIN INVEST, V96, P250, DOI 10.1172/JCI118029; MULLER G, 1995, EMBO J, V14, P1961, DOI 10.1002/j.1460-2075.1995.tb07188.x; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OHTA H, 1994, ANAL BIOCHEM, V222, P489, DOI 10.1006/abio.1994.1522; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OLIVERA A, 1992, J BIOL CHEM, V267, P26121; Philpott KL, 1997, J CELL BIOL, V139, P809, DOI 10.1083/jcb.139.3.809; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; PRASAD KVS, 1993, P NATL ACAD SCI USA, V90, P7366, DOI 10.1073/pnas.90.15.7366; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; SJOLANDER A, 1991, P NATL ACAD SCI USA, V88, P7908, DOI 10.1073/pnas.88.18.7908; SJOLANDER A, 1992, BIOCHEM BIOPH RES CO, V189, P1503, DOI 10.1016/0006-291X(92)90245-G; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; TOPP WC, 1981, VIROLOGY, V113, P408, DOI 10.1016/0042-6822(81)90168-9; VARTICOVSKI L, 1994, BBA-MOL BASIS DIS, V1226, P1, DOI 10.1016/0925-4439(94)90051-5; Wang CN, 1998, DIABETES, V47, P24, DOI 10.2337/diabetes.47.1.24; WARNER LC, 1993, ONCOGENE, V8, P3249; WYMANN M, 1994, BIOCHEM J, V298, P517, DOI 10.1042/bj2980517; YAO B, 1995, NATURE, V378, P307, DOI 10.1038/378307a0; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	67	44	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12722	12729		10.1074/jbc.274.18.12722	http://dx.doi.org/10.1074/jbc.274.18.12722			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212255	hybrid			2022-12-27	WOS:000080056800075
J	Tang, H; Zhao, ZZJ; Huang, XY; Landon, EJ; Inagami, T				Tang, H; Zhao, ZZJ; Huang, XY; Landon, EJ; Inagami, T			Fyn kinase-directed activation of SH2 domain-containing protein-tyrosine phosphatase SHP-2 by G(i) protein-coupled receptors in Madin-Darby canine kidney cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SRC FAMILY KINASE; PHOSPHOTYROSINE PHOSPHATASE; RAS ACTIVATION; MAP KINASE; PHOSPHORYLATION; INSULIN; ASSOCIATION; SH-PTP2; SHPTP2	SHP-2, an SH2 domain-containing protein-tyrosine phosphatase, plays an important role in receptor tyrosine kinase-regulated cell proliferation and differentiation, Little is known about the activation mechanisms and the participation of SHP-2 in the activity of G protein-coupled receptors lacking intrinsic tyrosine kinase activity. We show that the activity of SHP-2 (but not SHP-1) is specifically stimulated by the selective alpha(2A)-adrenergic receptor agonist UK14304 and by lysophosphatidic acid (LPA) in Madin-Darby canine kidney (MDCK) cells. UK14304 and LPA promote the tyrosine phosphorylation of SHP-2 and its association with Grb2, The agonist-induced direct interaction of Grb2 with SHP-2 is mediated by the SH2 domain of Grb2 and the tyrosine phosphorylation of SHP-2. Rapid activation of Src family kinase by UK14304 preceded the SHP-2 activation. Among the Src family members (Src, Fyn, Lck, Yes, and Lyn) present in MDCK cells, Fyn was the only one specifically associated with SHP-2, and the physical interaction between them, which requires the Src family kinase activity, was increased in response to the agonists, Pertussis toxin, PP1 (a selective Src family kinase inhibitor), or overexpression of a catalytically inactive mutant of Fyn blocked the UK14304- or LPA-stimulated activity of SHP-2, SHP-2 tyrosine phosphorylation, and SHP-2 association with Grb2. Therefore, we have demonstrated for the first time that the activation of SHP-2 by these G(i) protein-coupled receptors requires Fyn kinase and that there is a specific physical interaction of Fyn kinase with SHP-2 in MDCK cells.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Div Hematol, Nashville, TN 37232 USA; Cornell Univ, Coll Med, Dept Physiol, New York, NY 10021 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Cornell University	Inagami, T (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 663 Light Hall, Nashville, TN 37232 USA.				NHLBI NIH HHS [HL-57393, HL-58205] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058205, R01HL057393, R37HL058205] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adachi M, 1996, CELL, V85, P15; Ali MS, 1997, J BIOL CHEM, V272, P12373, DOI 10.1074/jbc.272.19.12373; Arrandale JM, 1996, J BIOL CHEM, V271, P21353, DOI 10.1074/jbc.271.35.21353; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; Byon JCH, 1997, P SOC EXP BIOL MED, V216, P1; CHEN YH, 1994, J BIOL CHEM, V269, P27372; CHENG HC, 1991, J BIOL CHEM, V266, P17919; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Gesbert F, 1998, J BIOL CHEM, V273, P18273, DOI 10.1074/jbc.273.29.18273; Gu HH, 1997, J BIOL CHEM, V272, P16421, DOI 10.1074/jbc.272.26.16421; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; KEEFER JR, 1994, J BIOL CHEM, V269, P16425; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; LORENZ U, 1994, MOL CELL BIOL, V14, P1824, DOI 10.1128/MCB.14.3.1824; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1997, J BIOL CHEM, V272, P31648, DOI 10.1074/jbc.272.50.31648; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; Qu CK, 1997, MOL CELL BIOL, V17, P5499, DOI 10.1128/MCB.17.9.5499; RIVARD N, 1995, J BIOL CHEM, V270, P11017, DOI 10.1074/jbc.270.18.11017; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; SCHLESSINGER J, 1993, TRENDS BIOCHEM SCI, V18, P273, DOI 10.1016/0968-0004(93)90031-H; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; SUGIMOTO S, 1994, J BIOL CHEM, V269, P13614; TAKATA M, 1995, FEBS LETT, V374, P407, DOI 10.1016/0014-5793(95)01160-G; Takeda H, 1998, ONCOGENE, V16, P3019, DOI 10.1038/sj.onc.1201839; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; WELHAM MJ, 1994, J BIOL CHEM, V269, P23764; YAMAUCHI K, 1995, J BIOL CHEM, V270, P17716, DOI 10.1074/jbc.270.30.17716; ZHAO ZZ, 1995, J BIOL CHEM, V270, P11765, DOI 10.1074/jbc.270.20.11765; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	39	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12401	12407		10.1074/jbc.274.18.12401	http://dx.doi.org/10.1074/jbc.274.18.12401			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212213	hybrid			2022-12-27	WOS:000080056800033
J	Volonte, D; Galbiati, F; Li, SW; Nishiyama, K; Okamoto, T; Lisanti, MP				Volonte, D; Galbiati, F; Li, SW; Nishiyama, K; Okamoto, T; Lisanti, MP			Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo - Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENICALLY TRANSFORMED-CELLS; PLASMA-MEMBRANE DOMAINS; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE CELLS; ROUS-SARCOMA VIRUS; TYROSINE KINASES; GENE FAMILY; RECOMBINANT EXPRESSION; BIOLOGICAL-MEMBRANES; SIGNAL-TRANSDUCTION	Caveolae are vesicular organelles that represent a subcompartment of the plasma membrane, Caveolins and flotillins are two families of mammalian caveolae-associated integral membrane proteins. However, it remains unknown whether flotillins interact with caveolin proteins to form a stable caveolar complex or if expression of flotillins can drive vesicle formation, Here, we examine the cell type and tissue-specific expression of the flotillin gene family. For this purpose, we generated a novel monoclonal antibody probe that recognizes only flotillin-1. A survey of cell and tissue types demonstrates that flotillins 1 and 2 have a complementary tissue distribution. At the cellular level, flotillin-2 was ubiquitously expressed, whereas flotillin-1 was most abundant in A498 kidney cells, muscle cell lines, and fibroblasts, Using three different models of cellular differentiation, we next examined the expression of flotillins 1 and 2, Taken together, our data suggest that the expression levels of flotillins 1 and 2 are independently regulated and does not strictly correlate with known expression patterns of caveolin family members. However, when caveolins and flotillins are co-expressed within the same cell, as in A498 cells, they form a stable hetero-oligomeric "caveolar complex." In support of these observations, we show that heterologous expression of murine flotillin-1 in Sf21 insect cells using baculovirus-based vectors is sufficient to drive the formation of caveolae-like vesicles. These results suggest that flotillins may participate functionally in the formation of caveolae or caveolae-like vesicles in vivo. Thus, flotillin-1 represents a new integral membrane protein marker for the slightly larger caveolae-related domains (50-200 nm) that are observed in cell types that fail to express caveolin-1, As a consequence of these findings, we propose the term "cavatellins" be used (instead of flotillins) to describe this gene family.	Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Harvard Medical School; Cleveland Clinic Foundation	Lisanti, MP (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lisanti@aecom.yu.edu	Li, Shengwen Calvin/H-1725-2012; Lisanti, Michael P/C-6866-2013; Galbiati, Ferruccio/AAF-3527-2020; Lisanti, Michael/B-6131-2018	Li, Shengwen Calvin/0000-0002-9699-9204; Lisanti, Michael/0000-0003-2034-1382	NATIONAL CANCER INSTITUTE [F32CA071326, R01CA080250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH056036] Funding Source: NIH RePORTER; NCI NIH HHS [CA-71326, F32 CA071326, R01-CA-80250] Funding Source: Medline; NIMH NIH HHS [MH-56036] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BRETSCHER MS, 1977, J ULTRA MOL STRUCT R, V61, P215, DOI 10.1016/S0022-5320(77)80088-9; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; COLE F, 1993, J BIOL CHEM, V268, P1580; Couet J, 1997, TRENDS CARDIOVAS MED, V7, P103, DOI 10.1016/S1050-1738(97)00001-7; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; FAN JY, 1983, J CELL SCI, V61, P219; FORBES MS, 1979, J ULTRA MOL STRUCT R, V67, P325, DOI 10.1016/S0022-5320(79)80032-5; Galbiati F, 1998, GENE, V210, P229, DOI 10.1016/S0378-1119(98)00064-X; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; GLENNEY JR, 1992, P NATL ACAD SCI USA, V89, P10517, DOI 10.1073/pnas.89.21.10517; GLENNEY JR, 1989, J BIOL CHEM, V264, P20163; GLENNEY JR, 1992, FEBS LETT, V314, P45, DOI 10.1016/0014-5793(92)81458-X; Harlow E., 1988, ANTIBODIES LAB MANUA; Jaiswal RK, 1996, J BIOL CHEM, V271, P23626, DOI 10.1074/jbc.271.39.23626; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; Kubler E, 1996, J BIOL CHEM, V271, P32975, DOI 10.1074/jbc.271.51.32975; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; Li SW, 1996, J BIOL CHEM, V271, P28647, DOI 10.1074/jbc.271.45.28647; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LISANTI MP, 1993, J CELL BIOL, V123, P595, DOI 10.1083/jcb.123.3.595; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Liu J, 1997, J BIOL CHEM, V272, P7211, DOI 10.1074/jbc.272.11.7211; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; Parolini I, 1996, BLOOD, V87, P3783, DOI 10.1182/blood.V87.9.3783.bloodjournal8793783; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; Puertollano R, 1997, J BIOL CHEM, V272, P18311, DOI 10.1074/jbc.272.29.18311; ROBBINS SM, 1995, MOL CELL BIOL, V15, P3507; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; SCHROEDER WT, 1994, J BIOL CHEM, V269, P19983; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; SIMIONESCU N, 1983, HISTOLOGY CELL TISSU, P371; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; SUMMERS MD, 1987, TEX AGR EXP STN B, V1555; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Tang ZL, 1997, J BIOL CHEM, V272, P2437, DOI 10.1074/jbc.272.4.2437; WAY M, 1995, FEBS LETT, V376, P108, DOI 10.1016/0014-5793(95)01256-7	53	177	192	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12702	12709		10.1074/jbc.274.18.12702	http://dx.doi.org/10.1074/jbc.274.18.12702			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212252	hybrid			2022-12-27	WOS:000080056800072
J	Harmer, SL; DeFranco, AL				Harmer, SL; DeFranco, AL			The Src homology domain 2-containing inositol phosphatase SHIP forms a ternary complex with Shc and Grb2 in antigen receptor-stimulated B lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHORYLATED PROTEINS; FC-GAMMA RECEPTORS; CROSS-LINKING; PHOSPHATIDYLINOSITOL 3-KINASE; POLYPHOSPHATE 5-PHOSPHATASE; SIGNAL-TRANSDUCTION; ADAPTER PROTEIN; CO-LIGATION; CELL; KINASE	The inositol phosphatase SHIP has been implicated in signaling events downstream of a variety of receptors and is thought to play an inhibitory role in stimulated B cells. we and others have reported that SHIP is rapidly tyrosine phosphorylated upon B cell antigen receptor (BCR) cross-linking and forms a complex with the adapter protein Shc. Here, we report that cross-linking of the BCR induces association between Grb2 and SHIP as well as association between Shc and SHIP. We made use of a Grb2-deficient B cell line to demonstrate both in vitro and in vivo that Grb2 expression is required for the efficient association between Shc and SHIP. The results indicate that SHIP, Shc, and Grb2 form a ternary complex in stimulated B cells, with Grb2 stabilizing the interaction between Shc and SHIP, The interactions between Shc, Grb2, and SHIP are therefore analogous to the interactions between Shc, Grb2, and SOS. Shc and Grb2 may help to localize SHIP to the cell membrane, regulating SHIP's inhibitory function following BCR stimulation.	Univ Calif San Francisco, George Williams Hooper Fdn, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	DeFranco, AL (corresponding author), Univ Calif San Francisco, George Williams Hooper Fdn, San Francisco, CA 94143 USA.		Harmer, Sarah/G-5572-2016	Harmer, Sarah/0000-0002-5627-5500; Harmer, Stacey/0000-0001-6813-6682				Chacko GW, 1996, J IMMUNOL, V157, P2234; CHARDIN P, 1995, FEBS LETT, V369, P47, DOI 10.1016/0014-5793(95)00578-W; CHOQUET D, 1993, J CELL BIOL, V121, P355, DOI 10.1083/jcb.121.2.355; Crowley MT, 1996, J BIOL CHEM, V271, P1145, DOI 10.1074/jbc.271.2.1145; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; CUSSAC D, 1994, EMBO J, V13, P4011, DOI 10.1002/j.1460-2075.1994.tb06717.x; DAmbrosio D, 1996, IMMUNOL LETT, V54, P77, DOI 10.1016/S0165-2478(96)02653-3; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; DEFRANCO AL, 1995, CURR OPIN CELL BIOL, V7, P163, DOI 10.1016/0955-0674(95)80024-7; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; DeuterReinhard M, 1997, MOL CELL BIOL, V17, P2559, DOI 10.1128/MCB.17.5.2559; Earl PL, 1998, CURRENT PROTOCOLS MO; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; FAHEY KA, 1987, J IMMUNOL, V138, P3935; Feng GS, 1996, J BIOL CHEM, V271, P12129, DOI 10.1074/jbc.271.21.12129; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; GOLD MR, 1992, BIOCHEM J, V287, P269, DOI 10.1042/bj2870269; GOLD MR, 1994, J IMMUNOL, V152, P42; GOLD MR, 1992, J IMMUNOL, V148, P2012; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; Gotoh N, 1996, EMBO J, V15, P6197, DOI 10.1002/j.1460-2075.1996.tb01008.x; Harmer SL, 1997, MOL CELL BIOL, V17, P4087, DOI 10.1128/MCB.17.7.4087; HARWOOD AE, 1993, J IMMUNOL, V151, P4513; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; Kavanaugh WM, 1996, CURR BIOL, V6, P438, DOI 10.1016/S0960-9822(02)00511-0; KAWAUCHI K, 1994, J IMMUNOL, V152, P3306; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kiener PA, 1997, J BIOL CHEM, V272, P3838, DOI 10.1074/jbc.272.6.3838; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Lamkin TD, 1997, J BIOL CHEM, V272, P10396; LANKESTER AC, 1994, EUR J IMMUNOL, V24, P2818, DOI 10.1002/eji.1830241136; LAZARUS AH, 1993, J EXP MED, V178, P1765, DOI 10.1084/jem.178.5.1765; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Liu L, 1997, J BIOL CHEM, V272, P8983; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; MOTTO DG, 1994, J BIOL CHEM, V269, P21608; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Okada H, 1998, J IMMUNOL, V161, P5129; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Osborne MA, 1996, J BIOL CHEM, V271, P29271, DOI 10.1074/jbc.271.46.29271; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PHILLIPS NE, 1984, J IMMUNOL, V132, P627; Pradhan M, 1997, J CELL BIOCHEM, V67, P32, DOI 10.1002/(SICI)1097-4644(19971001)67:1<32::AID-JCB4>3.0.CO;2-X; RAMEH LE, 1995, CELL, V83, P821, DOI 10.1016/0092-8674(95)90195-7; Richards JD, 1996, J BIOL CHEM, V271, P6458, DOI 10.1074/jbc.271.11.6458; SALCINI AE, 1994, ONCOGENE, V9, P2827; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Sarmay G, 1997, IMMUNOL LETT, V57, P159, DOI 10.1016/S0165-2478(97)00055-2; Sarmay G, 1996, J BIOL CHEM, V271, P30499; SAXTON TM, 1994, J IMMUNOL, V153, P623; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; SMIT L, 1994, J BIOL CHEM, V269, P20209; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; TORDAI A, 1994, J BIOL CHEM, V269, P7538; Tridandapani S, 1997, J IMMUNOL, V158, P1125; Tridandapani S, 1997, MOL CELL BIOL, V17, P4305, DOI 10.1128/MCB.17.8.4305; Trub T, 1997, J BIOL CHEM, V272, P894, DOI 10.1074/jbc.272.2.894; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8	61	48	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12183	12191		10.1074/jbc.274.17.12183	http://dx.doi.org/10.1074/jbc.274.17.12183			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207047	hybrid			2022-12-27	WOS:000079834800103
J	Oosterhuis, JH; van der Hoorn, FA				Oosterhuis, JH; van der Hoorn, FA			Testis-specific TTF-D binds to single-stranded DNA in the c-mos and Odf1 promoters and activates Odf1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H1T GENE; GERM-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR; NUCLEAR PROTEINS; TRANSGENIC MICE; PGK-2 GENE; SPERMATOGENESIS; CREM; EXPRESSION; ELEMENT	We recently identified testis-specific nuclear factor binding sites in the testis-specific promoters of the cmos gene and the Odf1 gene, which are 80% identical. Here we characterize a testis-specific nuclear factor, TTF-D, which is able to complex with both binding sites and stimulates Odf1 promoter activity. TTF-D is detectable in mouse testis as early as day 11 postpartum and contains three peptides of 22, 25, and 35 kDa in size. Surprisingly, TTF-D binds specifically to its cognate double-stranded DNA binding site as well as to its single-stranded DNA binding site. Both double-stranded and single-stranded binding site oligonucleotide DNA can specifically repress Odf1 promoter activity. Our results suggest that TTF-D is involved in positive transcription regulation of a pre-meiotic and a post-meiotic gene in the testis.	Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary	van der Hoorn, FA (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	fvdhoorn@ucalgary.ca						BARBERIS A, 1987, CELL, V50, P347, DOI 10.1016/0092-8674(87)90489-2; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; BOISSONNEAULT G, 1993, MOL CELL BIOL, V13, P4323, DOI 10.1128/MCB.13.7.4323; BRUNEL F, 1991, NUCLEIC ACIDS RES, V19, P5237, DOI 10.1093/nar/19.19.5237; BudhramMahadeo V, 1996, J BIOL CHEM, V271, P9108, DOI 10.1074/jbc.271.15.9108; CUNLIFFE V, 1990, GENOMICS, V8, P331, DOI 10.1016/0888-7543(90)90290-B; DavisSmyth T, 1996, J BIOL CHEM, V271, P31679, DOI 10.1074/jbc.271.49.31679; DEGROOT RP, 1993, EMBO J, V12, P3903, DOI 10.1002/j.1460-2075.1993.tb06068.x; DELMAS V, 1993, MOL ENDOCRINOL, V7, P1502, DOI 10.1210/me.7.11.1502; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; DENNY P, 1991, GENE, V106, P221, DOI 10.1016/0378-1119(91)90202-M; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; ERICKSON RP, 1990, TRENDS GENET, V6, P264, DOI 10.1016/0168-9525(90)90209-O; FOULKES NS, 1992, CELL, V68, P411, DOI 10.1016/0092-8674(92)90178-F; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; FOULKES NS, 1993, NATURE, V362, P264, DOI 10.1038/362264a0; GEBARA MM, 1992, MOL CELL BIOL, V12, P1422, DOI 10.1128/MCB.12.4.1422; GOTO M, 1993, NUCLEIC ACIDS RES, V21, P209, DOI 10.1093/nar/21.2.209; Graves JAM, 1998, BIOESSAYS, V20, P264, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;264::AID-BIES10&gt;3.0.CO;2-1; Grimes SR, 1997, MOL BIOL REP, V24, P175, DOI 10.1023/A:1006807716339; GRIMES SR, 1992, EXP CELL RES, V201, P216, DOI 10.1016/0014-4827(92)90366-G; GRIMES SR, 1992, ARCH BIOCHEM BIOPHYS, V296, P402, DOI 10.1016/0003-9861(92)90590-S; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; HIGGY NA, 1995, DEV GENET, V16, P190, DOI 10.1002/dvg.1020160211; HOWARD T, 1993, MOL CELL BIOL, V13, P18, DOI 10.1128/MCB.13.1.18; LILIENBAUM A, 1993, J BIOL CHEM, V268, P2180; Lindsey S, 1996, J ASSIST REPROD GEN, V13, P182, DOI 10.1007/BF02072542; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; NIKOLAJCZYK BS, 1995, BIOL REPROD, V52, P524, DOI 10.1095/biolreprod52.3.524; PESCHON JJ, 1989, ANN NY ACAD SCI, V564, P186, DOI 10.1111/j.1749-6632.1989.tb25897.x; PROPST F, 1988, TRENDS GENET, V4, P183, DOI 10.1016/0168-9525(88)90073-X; ROBINSON MO, 1989, P NATL ACAD SCI USA, V86, P8437, DOI 10.1073/pnas.86.21.8437; STEWART TA, 1988, MOL CELL BIOL, V8, P1748, DOI 10.1128/MCB.8.4.1748; TAMURA TA, 1992, J BIOL CHEM, V267, P4327; VANDERHOORN FA, 1987, J MOL BIOL, V193, P255, DOI 10.1016/0022-2836(87)90217-8; VANDERHOORN FA, 1992, ONCOGENE, V7, P1093; VANDERHOORN FA, 1992, P NATL ACAD SCI USA, V89, P703, DOI 10.1073/pnas.89.2.703; VANDERHOORN FA, 1990, DEV BIOL, V142, P147, DOI 10.1016/0012-1606(90)90158-F; WILLISON K, 1987, TRENDS GENET, V3, P351, DOI 10.1016/0168-9525(87)90296-4; Yiu GK, 1997, BIOL REPROD, V56, P1439, DOI 10.1095/biolreprod56.6.1439; Zambrano N, 1997, BIOCHEM J, V328, P293, DOI 10.1042/bj3280293	41	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11708	11712		10.1074/jbc.274.17.11708	http://dx.doi.org/10.1074/jbc.274.17.11708			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206985	hybrid			2022-12-27	WOS:000079834800041
J	Shimizu, H; Hosokawa, H; Ninomiya, H; Miner, JH; Masaki, T				Shimizu, H; Hosokawa, H; Ninomiya, H; Miner, JH; Masaki, T			Adhesion of cultured bovine aortic endothelial cells to laminin-1 mediated by dystroglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIN-ASSOCIATED GLYCOPROTEINS; CENTRAL-NERVOUS-SYSTEM; ADULT-MOUSE TISSUES; EXTRACELLULAR-MATRIX; ALPHA-DYSTROGLYCAN; BETA-DYSTROGLYCAN; PERIPHERAL-NERVE; MUSCULAR-DYSTROPHY; CONVERTING ENZYME; BINDING-PROTEIN	Expression of dystroglycan (DG) by cultured bovine aortic endothelial (BAE) cells was confirmed by cDNA cloning from a BAE cDNA library, Northern blotting of mRNA, Western blotting of membrane proteins, and double immunostaining with antibodies against beta DG and platelet endothelial cell adhesion molecule-1. Immunocytochemical analysis revealed localization of DG in multiple plaques on the basal side of resting cells. This patchy distribution was obscured in migrating cells, in which the most prominent staining was observed in the trailing edge anchoring the cells to the substratum. Biotin-labeled laminin-1 overlay assay of dissociated BAE membrane proteins indicated the interaction of laminin-l with alpha DG, The laminin alpha 5 globular domain fragment expressed in bacteria and labeled with biotin could also bind alpha DG on the membrane blot, and the unlabeled fragment disrupted the binding of biotin-laminin-1 to alpha DG. The interaction of biotin-laminin-1 with alpha DG was inhibited by soluble alpha DG contained in the conditioned medium from DG cDNA-transfected BAE cells and by a series of glycosaminoglycans (heparin, dextran sulfate, and fucoidan), Soluble alpha DG in the conditioned medium inhibited the adhesion of BAE cells to laminin-1-coated dishes, whereas it had no effect on their adhesion to fibronectin, All three glycosaminoglycans that disrupted the biotin-laminin-1 binding to alpha DG inhibited BAE cell adhesion to laminin-1, whereas they failed to inhibit the adhesion to fibronectin, These results indicate a role of DG as a non-integrin laminin receptor involved in vascular endothelial cell adhesion to the extracellular matrix.	Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Kyoto University; Washington University (WUSTL)	Masaki, T (corresponding author), Natl Cardiovasc Res Inst, 5-7-1 Fujishirodai, Osaka 5658565, Japan.							ALBELDA SM, 1989, J CLIN INVEST, V83, P1992, DOI 10.1172/JCI114109; AZIZKHAN RG, 1980, J EXP MED, V152, P931, DOI 10.1084/jem.152.4.931; BASSON CT, 1990, J CELL BIOL, V110, P789, DOI 10.1083/jcb.110.3.789; Belkin AM, 1996, CELL ADHES COMMUN, V4, P281, DOI 10.3109/15419069609010772; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; BRUCE GW, 1990, J NEUROSCI, V10, P3576; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; CHENG YF, 1989, J CELL PHYSIOL, V139, P275, DOI 10.1002/jcp.1041390209; Chiba A, 1997, J BIOL CHEM, V272, P2156; Cohen MW, 1997, J CELL BIOL, V136, P1047, DOI 10.1083/jcb.136.5.1047; Drenckhahn D, 1996, NEUROSCIENCE, V73, P605, DOI 10.1016/0306-4522(96)00069-3; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; Durbeej M, 1997, EXP LUNG RES, V23, P109, DOI 10.3109/01902149709074024; Frieser M, 1997, EUR J BIOCHEM, V246, P727, DOI 10.1111/j.1432-1033.1997.t01-1-00727.x; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; IKURA T, 1994, BIOCHEM BIOPH RES CO, V203, P1417, DOI 10.1006/bbrc.1994.2343; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; LANGUINO LR, 1989, J CELL BIOL, V109, P2455, DOI 10.1083/jcb.109.5.2455; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Matsumura K, 1997, J BIOL CHEM, V272, P13904, DOI 10.1074/jbc.272.21.13904; MINER JH, 1995, J BIOL CHEM, V270, P28523, DOI 10.1074/jbc.270.48.28523; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Osawa M, 1997, EUR J CELL BIOL, V72, P229; Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SAWAMURA T, 1990, BIOCHEM BIOPH RES CO, V169, P1138, DOI 10.1016/0006-291X(90)92014-Q; SOROKIN L, 1994, EUR J BIOCHEM, V223, P603, DOI 10.1111/j.1432-1033.1994.tb19031.x; Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668; Sugawara F, 1996, MOL PHARMACOL, V49, P447; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; SUZUKI A, 1994, EUR J BIOCHEM, V220, P283, DOI 10.1111/j.1432-1033.1994.tb18624.x; THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659; Tian M, 1996, EUR J NEUROSCI, V8, P2739, DOI 10.1111/j.1460-9568.1996.tb01568.x; Tressler R J, 1989, Cancer Commun, V1, P55; Uchino M, 1996, INTERNAL MED, V35, P189, DOI 10.2169/internalmedicine.35.189; Yamada H, 1996, J NEUROCHEM, V66, P1518; YAMADA H, 1994, FEBS LETT, V352, P49, DOI 10.1016/0014-5793(94)00917-1; Yamada H, 1996, J BIOL CHEM, V271, P23418, DOI 10.1074/jbc.271.38.23418; Yamamoto T, 1997, ACTA NEUROPATHOL, V94, P173, DOI 10.1007/s004010050690; YOSHIDA M, 1994, EUR J BIOCHEM, V222, P1055, DOI 10.1111/j.1432-1033.1994.tb18958.x	46	62	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11995	12000		10.1074/jbc.274.17.11995	http://dx.doi.org/10.1074/jbc.274.17.11995			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207021	hybrid, Green Submitted			2022-12-27	WOS:000079834800077
J	Muller, C; Yang, R; Beck-Von-Peccoz, L; Idos, G; Verbeek, W; Koeffler, HP				Muller, C; Yang, R; Beck-Von-Peccoz, L; Idos, G; Verbeek, W; Koeffler, HP			Cloning of the cyclin A1 genomic structure and characterization of the promoter region - GC boxes are essential for cell cycle-regulated transcription of the cyclin A1 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; MYELOID CELLS; S-PHASE; C-MYB; SP1; EXPRESSION; ACTIVATION; REPRESSION; MOUSE; BINDING	Cyclin A1 is a recently cloned cyclin with high level expression in meiotic cells in the testis, However, it is also frequently expressed at high levels in acute myeloid leukemia. To elucidate the regulation of cyclin A1 gene expression, we cloned and analyzed the genomic structure of cyclin. A1. It consists of 9 exons within 13 kilobase pairs. The TATA-less promoter initiates transcription from several start sites with the majority of transcripts beginning within a 4-base pair stretch. A construct containing a fragment from -190 to +145 showed the highest transcriptional activity. Transfection of cyclin A1 promoter constructs into S2 Drosophila cells demonstrated that Sp1 is essential for the activity of the promoter. Sp1, as well as Sp3, bound to four GC boxes between nucleotides -130 and -80 as observed by gel shift analysis. Mutations in two or more of the four GC boxes decreased promoter activity by >80%. The promoter was found to be cell cycle-regulated with highest activities found in late S and G(2)/M phase. Further analyses suggested that cell cycle regulation was accomplished by periodic repression of the GC boxes in G(1) phase. Taken together, our data show that cyclin A1 promoter activity critically depends on four GC boxes, and members of the Sp1 family appear to be involved in directing expression of cyclin A1 in both a tissue- and cell cycle-specific manner.	Univ Calif Los Angeles, Sch Med, Cedars Sinai Res Inst, Div Hematol Oncol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Muller, C (corresponding author), Univ Calif Los Angeles, Sch Med, Cedars Sinai Res Inst, Div Hematol Oncol, Davis Bldg,RM5066, Los Angeles, CA 90048 USA.	muellerc@CSMC.edu	Müller-Tidow, Carsten CMT/B-5257-2014; Müller-Tidow, Carsten/O-7207-2018	Müller-Tidow, Carsten/0000-0002-7166-5232				Apt D, 1996, VIROLOGY, V224, P281, DOI 10.1006/viro.1996.0530; Birnbaum MJ, 1995, BIOCHEMISTRY-US, V34, P16503, DOI 10.1021/bi00050a034; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; Block KL, 1996, BLOOD, V88, P2071, DOI 10.1182/blood.V88.6.2071.bloodjournal8862071; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; CARBONAROHALL D, 1993, ONCOGENE, V8, P1649; Chao Y, 1998, CANCER RES, V58, P985; CHEN HM, 1993, J BIOL CHEM, V268, P8230; CHUMAKOV AM, 1993, ONCOGENE, V8, P3005; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; GALLANT P, 1994, EMBO J, V13, P595, DOI 10.1002/j.1460-2075.1994.tb06297.x; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; Huet X, 1996, MOL CELL BIOL, V16, P3789; HWANG A, 1995, J BIOL CHEM, V270, P28419; Kumar AP, 1997, NUCLEIC ACIDS RES, V25, P2012, DOI 10.1093/nar/25.10.2012; LAM EWF, 1992, ONCOGENE, V7, P1885; LANS MS, 1994, J BIOL CHEM, V269, P14170; Liu NS, 1997, NUCLEIC ACIDS RES, V25, P4915, DOI 10.1093/nar/25.24.4915; Liu NS, 1998, ONCOGENE, V16, P2957, DOI 10.1038/sj.onc.1201838; Majello B, 1997, J BIOL CHEM, V272, P4021, DOI 10.1074/jbc.272.7.4021; Margana RK, 1997, J BIOL CHEM, V272, P3083, DOI 10.1074/jbc.272.5.3083; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; MULLER R, 1995, TRENDS GENET, V11, P173, DOI 10.1016/S0168-9525(00)89039-3; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Noti JD, 1996, MOL CELL BIOL, V16, P2940; OHNISHI H, 1990, LEUKEMIA RES, V14, P423, DOI 10.1016/0145-2126(90)90028-8; REDDY MA, 1994, J EXP MED, V180, P2309, DOI 10.1084/jem.180.6.2309; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; ROSENBERG AR, 1995, ONCOGENE, V10, P1501; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; SCHULZE A, 1995, P NATL ACAD SCI USA, V92, P11264, DOI 10.1073/pnas.92.24.11264; Sitzmann J, 1995, ONCOGENE, V11, P2273; Strassburg C. P., 1992, Neoplasma (Bratislava), V39, P343; Suzuki M, 1998, MOL CELL BIOL, V18, P3010, DOI 10.1128/MCB.18.5.3010; Sweeney C, 1996, DEVELOPMENT, V122, P53; TOMMASI S, 1995, MOL CELL BIOL, V15, P6901; WANG J, 1990, NATURE, V343, P555, DOI 10.1038/343555a0; Yang R, 1999, MOL CELL BIOL, V19, P2400; Yang R, 1997, CANCER RES, V57, P913; Yang R, 1999, BLOOD, V93, P2067; Zwicker J, 1997, NUCLEIC ACIDS RES, V25, P4926, DOI 10.1093/nar/25.24.4926; ZWICKER J, 1995, NUCLEIC ACIDS RES, V23, P3822, DOI 10.1093/nar/23.19.3822; ZWICKER J, 1995, EMBO J, V14, P4514, DOI 10.1002/j.1460-2075.1995.tb00130.x	47	41	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11220	11228		10.1074/jbc.274.16.11220	http://dx.doi.org/10.1074/jbc.274.16.11220			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196209	hybrid			2022-12-27	WOS:000079751900077
J	Rao, S; Matsumura, A; Yoon, J; Simon, MC				Rao, S; Matsumura, A; Yoon, J; Simon, MC			SPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN GENE ENHANCER; STIMULATING FACTOR-RECEPTOR; ETS-DOMAIN; REGULATES EXPRESSION; FACTORS INTERACT; CD11B PROMOTER; FAMILY MEMBER; T-CELLS; MACROPHAGE; COMPLEX	SPI-B is a B lymphocyte-specific Ets transcription factor that shares a high degree of similarity with PU.1/SPI-1. In direct contrast to PU.1(-/-) mice that die in utero and lack monocytes, neutrophils, B cells, and T cells, Spi-B-/- mice are viable and exhibit a severe B cell proliferation defect. Since PU.1 is expressed at wild type levels in Spi-B-/- B cells, the mutant mice provide genetic evidence that SPI-B and PU.1 have at least some non-redundant roles in B lymphocytes, To begin to understand the molecular basis for these defects, we delineated functional domains of SPI-B for comparison to those of PU.1. By using a heterologous co-transfection system, we identified two independent transactivation domains in the N terminus of SPI-B, Interestingly, only one of these domains (amino acids 31-61), a proline/serine/threonine-rich region, unique among Ets proteins, is necessary for transactivation of the immunoglobulin lambda light chain enhancer. This transactivation motif is in marked contrast to PU.1, which contains acidic and glutamine-rich domains. In addition, we describe a functional PU.1 site within the c-FES promoter which SPI-B fails to bind efficiently and transactivate. Finally, we show that SPI-B interacts with the PU.1 cofactors Pip, TBP, c-Jun and with lower affinity to nuclear factor interleukin-6 beta and retinoblastoma. Takes together, these data suggest that SPI-B binds DNA with a different affinity for certain sites than PU.1 and harbors different transactivation domains. We conclude that SPI-B may activate unique target genes in B lymphocytes and interact with unique, although currently unidentified, cofactors.	Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Dept Med & Mol Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Simon, MC (corresponding author), Univ Chicago, Howard Hughes Med Inst, 5841 S Maryland Ave,MC 1028, Chicago, IL 60637 USA.	csimon@medicine.bsd.uchicago.edu	Simon, Celeste/AAG-3941-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052094] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL5-2094] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bassuk AG, 1997, ADV IMMUNOL, V64, P65, DOI 10.1016/S0065-2776(08)60887-1; BASSUK AG, 1995, IMMUNITY, V3, P223, DOI 10.1016/1074-7613(95)90092-6; Basuyaux JP, 1997, J BIOL CHEM, V272, P26188, DOI 10.1074/jbc.272.42.26188; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Celada A, 1996, J EXP MED, V184, P61, DOI 10.1084/jem.184.1.61; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; CHEN HM, 1993, J BIOL CHEM, V268, P8230; Dang W, 1998, MOL CELL BIOL, V18, P1477, DOI 10.1128/MCB.18.3.1477; Eichbaum Q, 1997, BLOOD, V90, P4135, DOI 10.1182/blood.V90.10.4135; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Erman B, 1996, EMBO J, V15, P4665, DOI 10.1002/j.1460-2075.1996.tb00843.x; Erman B, 1998, MOL CELL BIOL, V18, P1322, DOI 10.1128/MCB.18.3.1322; FELDHAUS AL, 1992, MOL CELL BIOL, V12, P1126, DOI 10.1128/MCB.12.3.1126; GUNTHER CV, 1990, GENE DEV, V4, P667, DOI 10.1101/gad.4.4.667; HAGEMEIER C, 1993, P NATL ACAD SCI USA, V90, P1580, DOI 10.1073/pnas.90.4.1580; Henkel GW, 1996, BLOOD, V88, P2917, DOI 10.1182/blood.V88.8.2917.bloodjournal8882917; Heydemann A, 1996, MOL CELL BIOL, V16, P1676; Himmelmann A, 1997, BLOOD, V90, P3984, DOI 10.1182/blood.V90.10.3984; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; HROMAS R, 1993, BLOOD, V82, P2998; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Klemsz MJ, 1996, MOL CELL BIOL, V16, P390; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; KOMINATO Y, 1995, MOL CELL BIOL, V15, P58; LEPRINCE D, 1992, ONCOGENE, V7, P9; MACLEOD K, 1992, TRENDS BIOCHEM SCI, V17, P251, DOI 10.1016/0968-0004(92)90404-W; Mao C, 1996, ONCOGENE, V12, P863; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Morrisey EE, 1997, J BIOL CHEM, V272, P8515, DOI 10.1074/jbc.272.13.8515; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; NAGULAPALLI S, 1995, J IMMUNOL, V155, P4330; NELSEN B, 1993, SCIENCE, V261, P82, DOI 10.1126/science.8316859; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; ORKIN SH, 1995, CURR OPIN CELL BIOL, V7, P870, DOI 10.1016/0955-0674(95)80072-7; PAHL HL, 1993, J BIOL CHEM, V268, P5014; PARMACEK MS, 1994, MOL CELL BIOL, V14, P1870, DOI 10.1128/MCB.14.3.1870; Pio F, 1996, J BIOL CHEM, V271, P23329, DOI 10.1074/jbc.271.38.23329; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; Pongubala JMR, 1997, P NATL ACAD SCI USA, V94, P127, DOI 10.1073/pnas.94.1.127; PONGUBALA JMR, 1993, SCIENCE, V259, P1622, DOI 10.1126/science.8456286; Rao E, 1997, J BIOL CHEM, V272, P6722, DOI 10.1074/jbc.272.10.6722; RAY D, 1992, MOL CELL BIOL, V12, P4297, DOI 10.1128/MCB.12.10.4297; RAYGALLET D, 1995, ONCOGENE, V11, P303; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHIN MK, 1993, GENE DEV, V7, P2006, DOI 10.1101/gad.7.10.2006; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; StraussSoukup JK, 1997, J BIOL CHEM, V272, P31570, DOI 10.1074/jbc.272.50.31570; Su GH, 1996, J EXP MED, V184, P203, DOI 10.1084/jem.184.1.203; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Tang HK, 1998, J BIOL CHEM, V273, P7210, DOI 10.1074/jbc.273.13.7210; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373	57	44	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11115	11124		10.1074/jbc.274.16.11115	http://dx.doi.org/10.1074/jbc.274.16.11115			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196196	hybrid			2022-12-27	WOS:000079751900064
J	Valentine, AM; LeTadic-Biadatti, MH; Toy, PH; Newcomb, M; Lippard, SJ				Valentine, AM; LeTadic-Biadatti, MH; Toy, PH; Newcomb, M; Lippard, SJ			Oxidation of ultrafast radical clock substrate probes by the soluble methane monooxygenase from Methylococcus capsulatus (Bath)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONO-OXYGENASE; CYTOCHROME-P-450 ENZYMES; COMPONENT INTERACTIONS; CONCERTED MECHANISM; REGULATORY PROTEIN; CATALYTIC CYCLE; RING OPENINGS; DIIRON CENTER; HYDROXYLATION; ACTIVATION	Radical clock substrate probes were used to assess the viability of a discrete substrate radical species in the mechanism of hydrocarbon oxidation by the soluble methane monooxygenase (sMMO) from Methylococcus capsulatus (Bath). New substituted cyclopropane probes were used with very fast ring-opening rate constants and other desirable attributes, such as the ability to discriminate between radical and cationic intermediates. Oxidation of these substrates by a reconstituted sMMO system resulted in no rearranged products, allowing an upper limit of 150 fs to be placed on the lifetime of a putative radical species. This limit strongly suggests that there is no such substrate radical intermediate. The two enantiomers of trans-1-methyl-2-phenyl-cyclopropane were prepared, and the regioselectivity of their oxidation to the corresponding cyclopropylmethanol and cyclopropylphenol products was determined The results are consistent with selective orientation of the two enantiomeric substrates in the hydrophobic cavity at the active site of sMMO, specific models for which were examined by molecular modeling.	MIT, Dept Chem, Cambridge, MA 02139 USA; Wayne State Univ, Dept Chem, Detroit, MI 48202 USA	Massachusetts Institute of Technology (MIT); Wayne State University	Lippard, SJ (corresponding author), MIT, Dept Chem, Rm 18-590, Cambridge, MA 02139 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048722, R01GM032134, R37GM032134] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32134, GM48722] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATKINSON JK, 1994, BIOCHEMISTRY-US, V33, P10630, DOI 10.1021/bi00201a009; CASTELLINO AJ, 1988, J AM CHEM SOC, V110, P7512, DOI 10.1021/ja00230a039; Choi SY, 1996, J AM CHEM SOC, V118, P6547, DOI 10.1021/ja952226l; COLBY J, 1978, BIOCHEM J, V171, P461, DOI 10.1042/bj1710461; COLBY J, 1979, BIOCHEM J, V177, P903, DOI 10.1042/bj1770903; COLBY J, 1977, BIOCHEM J, V165, P395, DOI 10.1042/bj1650395; Collman JP, 1998, J AM CHEM SOC, V120, P425, DOI 10.1021/ja973111f; DALTON H, 1980, ADV APPL MICROBIOL, V26, P71; Deeth RJ, 1998, J BIOL INORG CHEM, V3, P302, DOI 10.1007/s007750050236; DEIGHTON N, 1991, J CHEM SOC CHEM COMM, P1086, DOI 10.1039/c39910001086; DEWITT JG, 1991, J AM CHEM SOC, V113, P9219, DOI 10.1021/ja00024a031; FEIG AL, 1994, CHEM REV, V94, P759, DOI 10.1021/cr00027a011; FOX BG, 1990, BIOCHEMISTRY-US, V29, P6419, DOI 10.1021/bi00479a013; GREEN J, 1989, J BIOL CHEM, V264, P17698; GREEN J, 1985, J BIOL CHEM, V260, P5795; GRILLER D, 1980, ACCOUNTS CHEM RES, V13, P317, DOI 10.1021/ar50153a004; Lee DW, 1998, J AM CHEM SOC, V120, P12153, DOI 10.1021/ja9831094; LEE SK, 1993, J BIOL CHEM, V268, P21569; LEE SK, 1993, J AM CHEM SOC, V115, P6450, DOI 10.1021/ja00067a086; LeTadicBiadatti MH, 1996, J CHEM SOC PERK T 2, P1467, DOI 10.1039/p29960001467; Lipscomb JD, 1998, J BIOL INORG CHEM, V3, P331, DOI 10.1007/s007750050241; LIU KE, 1994, J AM CHEM SOC, V116, P7465, DOI 10.1021/ja00095a083; LIU KE, 1995, J AM CHEM SOC, V117, P10174, DOI 10.1021/ja00146a002; LIU KE, 1993, J AM CHEM SOC, V115, P939, DOI 10.1021/ja00056a018; LIU KE, 1995, ADV INORG CHEM RAD, V42, P263; NEWCOMB M, 1993, TETRAHEDRON, V49, P1151, DOI 10.1016/S0040-4020(01)85808-7; NEWCOMB M, 1992, J AM CHEM SOC, V114, P10915, DOI 10.1021/ja00053a031; NEWCOMB M, 1995, J AM CHEM SOC, V117, P12085, DOI 10.1021/ja00154a008; NEWCOMB M, 1995, J AM CHEM SOC, V117, P3312, DOI 10.1021/ja00116a052; Nordlander E, 1998, J BIOL INORG CHEM, V3, P300; PRIESTLEY ND, 1992, J AM CHEM SOC, V114, P7561, DOI 10.1021/ja00045a037; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; ROSENZWEIG AC, 1994, ACCOUNTS CHEM RES, V27, P229, DOI 10.1021/ar00044a003; ROSENZWEIG AC, 1995, CHEM BIOL, V2, P409, DOI 10.1016/1074-5521(95)90222-8; Rosenzweig AC, 1997, PROTEINS, V29, P141, DOI 10.1002/(SICI)1097-0134(199710)29:2<141::AID-PROT2>3.3.CO;2-W; RUZICKA F, 1990, BIOCHEMISTRY-US, V29, P1696, DOI 10.1021/bi00459a005; Shteinman AA, 1998, J BIOL INORG CHEM, V3, P325, DOI 10.1007/s007750050240; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Siegbahn PEM, 1998, J BIOL INORG CHEM, V3, P314, DOI 10.1007/s007750050238; Siegbahn PEM, 1997, J AM CHEM SOC, V119, P3103, DOI 10.1021/ja963939m; Toy PH, 1997, J ORG CHEM, V62, P9114, DOI 10.1021/jo9712097; Valentine AM, 1997, J AM CHEM SOC, V119, P1818, DOI 10.1021/ja963971g; VALENTINE AM, 1997, J CHEM SOC DA, V21, P3925; VANNI R, 1995, TETRAHEDRON LETT, V36, P7999, DOI 10.1016/0040-4039(95)01666-6; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; Whittington DA, 1998, J BIOL INORG CHEM, V3, P307, DOI 10.1007/s007750050237; WHITTINGTON DA, 1998, ACS SYM SER, V692, P334; Willems JP, 1998, J AM CHEM SOC, V120, P9410, DOI 10.1021/ja980795y; WOODLAND MP, 1984, J BIOL CHEM, V259, P53; Yoshizawa K, 1998, ORGANOMETALLICS, V17, P2825, DOI 10.1021/om980067j; Yoshizawa K, 1998, J BIOL INORG CHEM, V3, P318, DOI 10.1007/s007750050239; Yoshizawa K, 1997, CHEM-EUR J, V3, P1160, DOI 10.1002/chem.19970030722	52	62	62	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10771	10776		10.1074/jbc.274.16.10771	http://dx.doi.org/10.1074/jbc.274.16.10771			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196150	hybrid			2022-12-27	WOS:000079751900018
J	Li, YT; Li, SC; Hasegawa, A; Ishida, H; Kiso, M; Bernardi, A; Brocca, P; Raimondi, L; Sonnino, S				Li, YT; Li, SC; Hasegawa, A; Ishida, H; Kiso, M; Bernardi, A; Brocca, P; Raimondi, L; Sonnino, S			Structural basis for the resistance of Tay-Sachs ganglioside GM2 to enzymatic degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXOSAMINIDASE-A; MOLECULAR MECHANICS; ACTIVATOR PROTEIN; CONFORMATIONAL PROPERTIES; OLIGOSACCHARIDE CHAIN; ENZYMIC-HYDROLYSIS; HUMAN-BRAIN; DYNAMICS; SPECTROSCOPY; PARAMETERS	To understand the reason why, in the absence of GM2 activator protein, the GaLNAc and the NeuAc in GM2 (GalNAc beta 1-->4(NeuAc alpha 2-->3)Gal beta 1-->4Glc beta 1-1'Cer) are refractory to beta-hexosaminidase A and sialidase, respectively, we have recently synthesized a linkage analogue of GM2 named 6'GM2 (GalNAc beta 1-->6(NeuAc alpha 2-->3)Gal beta 1-->4Glc beta 1-1'Cer). While GM2 has GalNAc beta 1-->4Gal linkage, 6'-GM2 has GalNAc beta 1-->6Gal linkage (Ishida, H., Ito, Y,, Tanahashi, E., Li, Y.-T., Kiso, M., and Hasegawa, A (1997) Carbohydr. Res. 302, 223-227). We have studied the enzymatic susceptibilities of GM2 and 6'GM2, as well as that of the oligosaccharides derived from GM2, asialo-GM2 (GalNAc beta 1-->4Gal beta 1-->4Glc beta 1-1'Cer) and 6'GM2. In addition, the conformational properties of both GM2 and 6'GM2 were analyzed using NMR spectroscopy and molecular mechanics computation. In sharp contrast to GM2, the GalNAc and the Neu5Ac of 6'GM2 were readily hydrolyzed by beta-hexosaminidase A and sialidase, respectively, without GM2 activator. Among the oligosaccharides derived from GM2, asialo-GM2, and 6'GM2, only the oligosaccharide from GM2 was resistant to p-hexosaminidase A. Conformational analyses revealed that while GM2 has a compact and rigid oligosaccharide head group, 6'GM2 has an open spatial arrangement of the sugar units, with the GalNAc and the Neu5Ac freely accessible to external interactions. These results strongly indicate that the resistance of GM2 to enzymatic hydrolysis is because of the specific rigid conformation of the GM2 oligosaccharide.	Tulane Univ, Sch Med, Dept Biochem, New Orleans, LA 70112 USA; Gifu Univ, Dept Bioorgan Chem, Gifu 50111, Japan; Univ Milan, Dept Organ & Ind Chem, I-20133 Milan, Italy; Univ Milan, Dept Med Chem & Biochem, I-20090 Segrate, Mi, Italy	Tulane University; Gifu University; University of Milan; University of Milan	Li, YT (corresponding author), Tulane Univ, Sch Med, Dept Biochem, 1430 Tulane Ave, New Orleans, LA 70112 USA.		Bernardi, Anna/A-1167-2012; Sonnino, Sandro/R-4154-2017; Raimondi, Laura M/A-1327-2012; BROCCA, PAOLA/E-3778-2018	Bernardi, Anna/0000-0002-1258-2007; Sonnino, Sandro/0000-0001-8180-5908; Raimondi, Laura M/0000-0002-7314-1387; BROCCA, PAOLA/0000-0002-9852-6056	NINDS NIH HHS [NS 09626] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009626] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACQUOTTI D, 1994, EUR J BIOCHEM, V225, P271, DOI 10.1111/j.1432-1033.1994.00271.x; ACQUOTTI D, 1990, J AM CHEM SOC, V112, P7772, DOI 10.1021/ja00177a043; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; BERNARDI A, 1995, J ORG CHEM, V60, P3370, DOI 10.1021/jo00116a021; Brocca P, 1998, BIOPHYS J, V74, P309, DOI 10.1016/S0006-3495(98)77788-4; CHANG G, 1989, J AM CHEM SOC, V111, P4379, DOI 10.1021/ja00194a035; CONZELMANN E, 1978, P NATL ACAD SCI USA, V75, P3979, DOI 10.1073/pnas.75.8.3979; CONZELMANN E, 1979, H-S Z PHYSIOL CHEM, V360, P1837, DOI 10.1515/bchm2.1979.360.2.1837; FARMER BT, 1987, J MAGN RESON, V72, P197, DOI 10.1016/0022-2364(87)90189-2; GOODMAN JM, 1991, J COMPUT CHEM, V12, P1110, DOI 10.1002/jcc.540120908; HARRIS G, 1954, CHEM IND-LONDON, P249; HECHTMAN P, 1982, PEDIATR RES, V16, P217, DOI 10.1203/00006450-198203000-00011; HECTMAN P, 1977, BIOCHEM J, V167, P693; HIRABAYASHI Y, 1983, J NEUROCHEM, V40, P168, DOI 10.1111/j.1471-4159.1983.tb12667.x; HOMANS SW, 1993, GLYCOBIOLOGY, V3, P551, DOI 10.1093/glycob/3.6.551; HULTBERG B, 1969, LANCET, V2, P1195; Ishida H, 1997, CARBOHYD RES, V302, P223, DOI 10.1016/S0008-6215(97)00120-1; LI SC, 1981, J BIOL CHEM, V256, P6234; LI YT, 1973, J BIOL CHEM, V248, P7512; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; PONDER JW, 1987, J COMPUT CHEM, V8, P1016, DOI 10.1002/jcc.540080710; POPPE L, 1994, BIOPHYS J, V66, P1642, DOI 10.1016/S0006-3495(94)80956-7; RUTHERFORD TJ, 1994, GLYCOBIOLOGY, V4, P59, DOI 10.1093/glycob/4.1.59; SABESAN S, 1984, CAN J CHEM, V62, P1034, DOI 10.1139/v84-172; SANDHOFF K, 1969, FEBS LETT, V4, P351, DOI 10.1016/0014-5793(69)80274-7; Senderowitz H, 1997, J ORG CHEM, V62, P1427, DOI 10.1021/jo9612483; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; SVENNERHOLM L, 1973, J BIOL CHEM, V248, P740; SVENNERHOLM L, 1972, METHODS CARBOHYD CHE, V6, P464; WU YY, 1994, J BIOL CHEM, V269, P16276; ZHOU B, 1989, J BIOL CHEM, V264, P12272	32	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10014	10018		10.1074/jbc.274.15.10014	http://dx.doi.org/10.1074/jbc.274.15.10014			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187778	hybrid			2022-12-27	WOS:000079663500017
J	Rui, LY; Herrington, J; Carter-Su, C				Rui, LY; Herrington, J; Carter-Su, C			SH2-B is required for nerve growth factor-induced neuronal differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE KINASE; INSULIN-RECEPTOR; SIGNAL-TRANSDUCTION; BINDING-SITES; PC12 CELLS; SHC; ACTIVATION; DOMAIN; IDENTIFICATION; ASSOCIATION	Nerve growth factor (NGF) is essential for the development and survival of sympathetic and sensory neurons. NGF binds to TrkA, activates the intrinsic kinase activity of TrkA, and promotes the differentiation of pheochromocytoma (PC12) cells into sympathetic-like neurons. Several signaling molecules and pathways are known to be activated by NGF, including phospholipase C gamma, phosphatidylinositol-3 kinase, and the mitogen-activated protein kinase cascade. However, the mechanism of NGF-induced neuronal differentiation remains unclear. In this study, we examined whether SH2-B beta, a recently identified pleckstrin homology and SH2 domain-containing signaling protein, is a critical signaling protein for NGF, TrkA bound to glutathione S-transferase fusion proteins containing SH2-B beta, and NGF stimulation dramatically increased that binding. In contrast, NGF was unable to stimulate the association of TrkA with a glutathione S-transferase fusion protein containing a mutant SH2-B beta(R555E) with a defective SH2 domain. When overexpressed in PC12 cells, SH2-B beta coimmunoprecipitated with TrkA in response to NGF. NGF stimulated tyrosyl phosphorylation of endogenous SH2-B beta as well as exogenously expressed GFP-SH2-B beta but not GFP-SH2-B beta(R555E). Overexpression of SH2-B beta(R555E) blocked NGF-induced neurite outgrowth of PC12 cells, whereas overexpression of wild type SH2-B beta enhanced NGF-induced neurite outgrowth. Overexpression of either wild type or mutant SH2-B beta(R555E) did not alter tyrosyl phosphorylation of TrkA, Shc, or phospholipase C gamma in response to NGF or NGF-induced activation of ERK1/2, suggesting that SH2-B beta may initiate a previously unknown pathway(s) that is essential for NGF-induced neurite outgrowth. Taken together, these data indicate that SH2-B beta is a novel signaling molecule required for NGF-induced neuronal differentiation.	Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Carter-Su, C (corresponding author), Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA.	cartersu@umich.edu			NIDDK NIH HHS [R01 DK034171, F32 DK009756, P60-DK-20572, DK 34171, F32-DK-09756] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034171, P60DK020572, F32DK009756, R01DK034171] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CLARY DO, 1994, P NATL ACAD SCI USA, V91, P11133, DOI 10.1073/pnas.91.23.11133; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DIKIC I, 1995, J BIOL CHEM, V270, P15125, DOI 10.1074/jbc.270.25.15125; DIKIC I, 1994, CURR BIOL, V4, P702, DOI 10.1016/S0960-9822(00)00155-X; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; OSBORNE MA, 1995, BIO-TECHNOL, V13, P1474, DOI 10.1038/nbt1295-1474; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; PENG X, 1995, NEURON, V15, P395, DOI 10.1016/0896-6273(95)90043-8; Riedel H, 1997, J BIOCHEM-TOKYO, V122, P1105; Rui LY, 1998, J BIOL CHEM, V273, P21239, DOI 10.1074/jbc.273.33.21239; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; VAILLANCOURT RR, 1995, MOL CELL BIOL, V15, P3644; Wang J, 1998, J BIOL CHEM, V273, P3136, DOI 10.1074/jbc.273.6.3136; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	24	73	82	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10590	10594		10.1074/jbc.274.15.10590	http://dx.doi.org/10.1074/jbc.274.15.10590			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187854	hybrid			2022-12-27	WOS:000079663500093
J	Dwyer, MA; Huang, AJ; Pan, CQ; Lazarus, RA				Dwyer, MA; Huang, AJ; Pan, CQ; Lazarus, RA			Expression and characterization of a DNase I-Fc fusion enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN DEOXYRIBONUCLEASE; SYSTEMIC LUPUS-ERYTHEMATOSUS; CYSTIC-FIBROSIS; BINDING; VARIANTS; IMMUNOADHESINS; RECOGNITION; DEPENDENCE; MECHANISM; CLEAVAGE	Recombinant human deoxyribonuclease I (DNase I) is an important clinical agent that is inhaled into the airways where it degrades DNA to lower molecular weight fragments, thus reducing the viscoelasticity of sputum and improving the lung function of cystic fibrosis patients, To investigate DNases with potentially improved properties, we constructed a molecular fusion of human DNase I with the hinge and Fe region of human IgG1 heavy chain, creating a DNase I-Fc fusion protein. Infection of Sf9 insect cells with recombinant baculovirus resulted in the expression and secretion of the DNase I-Fc fusion protein, The fusion protein was purified from the culture medium using protein A affinity chromatography followed by desalting by gel filtration and was characterized by amino-terminal sequence, amino acid composition, and a variety of enzyme-linked immunosorbent assays (ELISA) and activity assays. The purified fusion contains DNase I, as determined by a DNase I ELISA and an actin-binding ELISA, and an intact antibody Fc region, which was quantified by an Fc ELISA, in a 2:1 stoichiometric ratio, respectively. The dimeric DNase I-Fc fusion was functionally active in enzymatic DNA digestion assays, albeit about 10-fold less than monomeric DNase I. Cleavage of the DNase I-Fc fusion by papain resulted in a specific activity comparable to the monomeric enzyme. Salt was inhibitory for wild type monomeric DNase I but actually enhanced the activity of the dimeric DNase I-Fc fusion, The DNase I-Fc fusion protein was also less Ca2+-dependent than DNase I itself. These results are consistent with a higher affinity of the dimeric: fusion protein to DNA than monomeric DNase I, The engineered DNase I-Fc fusion protein described herein has properties that may have clinical benefits.	Genentech Inc, Dept Prot Engn, S San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, S San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Lazarus, RA (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, S San Francisco, CA 94080 USA.	lazarus.bob@gene.com						Ashkenazi A, 1997, CURR OPIN IMMUNOL, V9, P195, DOI 10.1016/S0952-7915(97)80135-5; CAMPBELL VW, 1980, J BIOL CHEM, V255, P3726; Chamow SM, 1996, TRENDS BIOTECHNOL, V14, P52, DOI 10.1016/0167-7799(96)80921-8; DREW HR, 1984, CELL, V37, P491, DOI 10.1016/0092-8674(84)90379-9; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; HENZEL WJ, 1987, J CHROMATOGR, V404, P41, DOI 10.1016/S0021-9673(01)86835-7; HOGAN ME, 1989, P NATL ACAD SCI USA, V86, P9273, DOI 10.1073/pnas.86.23.9273; HOGAN ME, 1987, NATURE, V329, P263, DOI 10.1038/329263a0; Hsu TA, 1996, PROTEIN EXPRES PURIF, V7, P281, DOI 10.1006/prep.1996.0040; KLEIN A, 1994, P NATL ACAD SCI USA, V91, P7782, DOI 10.1073/pnas.91.16.7782; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIAO TH, 1988, BIOCHEM J, V255, P781, DOI 10.1042/bj2550781; Macanovic M, 1996, CLIN EXP IMMUNOL, V106, P243, DOI 10.1046/j.1365-2249.1996.d01-839.x; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MOHLER M, 1993, DRUG METAB DISPOS, V21, P71; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; Pan CQ, 1998, J BIOL CHEM, V273, P18374, DOI 10.1074/jbc.273.29.18374; Pan CQ, 1998, J BIOL CHEM, V273, P11701, DOI 10.1074/jbc.273.19.11701; Pan CQ, 1997, BIOCHEMISTRY-US, V36, P6624, DOI 10.1021/bi962960x; Pan CQ, 1998, PROTEIN SCI, V7, P628, DOI 10.1002/pro.5560070312; PRICE PA, 1969, J BIOL CHEM, V244, P929; RAMSEY BW, 1993, AM REV RESPIR DIS, V148, P145, DOI 10.1164/ajrccm/148.1.145; Ramsey BW, 1996, NEW ENGL J MED, V335, P179, DOI 10.1056/NEJM199607183350307; Sambrook J., 2002, MOL CLONING LAB MANU; SHAK S, 1990, P NATL ACAD SCI USA, V87, P9188, DOI 10.1073/pnas.87.23.9188; SUCK D, 1988, NATURE, V332, P464, DOI 10.1038/332464a0; SUCK D, 1986, NATURE, V321, P620, DOI 10.1038/321620a0; Suck Dietrich, 1994, Journal of Molecular Recognition, V7, P65, DOI 10.1002/jmr.300070203; Tournay C, 1996, DNA CELL BIOL, V15, P617, DOI 10.1089/dna.1996.15.617; Ulmer JS, 1996, P NATL ACAD SCI USA, V93, P8225, DOI 10.1073/pnas.93.16.8225	31	10	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9738	9743		10.1074/jbc.274.14.9738	http://dx.doi.org/10.1074/jbc.274.14.9738			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092662	hybrid			2022-12-27	WOS:000079451800081
J	Banhegyi, G; Lusini, L; Puskas, F; Rossi, R; Fulceri, R; Braun, L; Mile, V; di Simplicio, P; Mandl, J; Benedetti, A				Banhegyi, G; Lusini, L; Puskas, F; Rossi, R; Fulceri, R; Braun, L; Mile, V; di Simplicio, P; Mandl, J; Benedetti, A			Preferential transport of glutathione versus glutathione disulfide in rat liver microsomal vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN; OXIDATION; DEHYDROASCORBATE; PERMEABILITY; GLUCOSE; SYSTEM; CELL	A bi directional, saturable transport of glutathione (GSH) was found in rat liver microsomal vesicles. GSH transport could be inhibited by the anion transport blockers flufenamic acid and 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid. A part of GSH taken up by the vesicles was metabolized to glutathione disulfide (GSSG) in the lumen. Microsomal membrane was virtually nonpermeable toward GSSG; accordingly, GSSG generated in the microsomal lumen could hardly exit. Therefore, GSH transport, contrary to previous assumptions, is preferred in the endoplasmic reticulum, and GSSG entrapped and accumulated in the lumen creates the oxidized state of its redox buffer.	Univ Siena, Inst Gen Pathol, I-53100 Siena, Italy; Semmelweis Univ, Dept Med Chem, H-1444 Budapest, Hungary; Univ Siena, Inst Nervous & Mental Dis, I-53100 Siena, Italy	University of Siena; Semmelweis University; University of Siena	Benedetti, A (corresponding author), Univ Siena, Inst Gen Pathol, Via Laterina 8, I-53100 Siena, Italy.	benedetti@unisi.it	Rossi, Ranieri/C-8743-2011; Bánhegyi, Gábor/A-1476-2014	Rossi, Ranieri/0000-0002-0187-4530; 				Banhegyi G, 1998, J BIOL CHEM, V273, P2758, DOI 10.1074/jbc.273.5.2758; Banhegyi G, 1997, J BIOL CHEM, V272, P13584, DOI 10.1074/jbc.272.21.13584; Banhegyi G, 1996, BIOCHEM J, V315, P171, DOI 10.1042/bj3150171; BURCHELL A, 1988, CLIN CHIM ACTA, V173, P183, DOI 10.1016/0009-8981(88)90256-2; COUSIN JL, 1982, BIOCHIM BIOPHYS ACTA, V687, P147, DOI 10.1016/0005-2736(82)90540-5; FARISS MW, 1987, METHOD ENZYMOL, V143, P101; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; FULCERI R, 1994, ARCH BIOCHEM BIOPHYS, V309, P43, DOI 10.1006/abbi.1994.1081; FULCERI R, 1992, BIOCHEM J, V286, P813, DOI 10.1042/bj2860813; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HENNE V, 1986, FEBS LETT, V202, P267, DOI 10.1016/0014-5793(86)80699-8; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; ISSACS J, 1977, BIOCHIM BIOPHYS ACTA, V497, P192; JANOLINO VG, 1987, ARCH BIOCHEM BIOPHYS, V258, P265, DOI 10.1016/0003-9861(87)90344-4; Marcolongo P, 1996, BIOCHEM BIOPH RES CO, V219, P916, DOI 10.1006/bbrc.1996.0333; MEISSNER G, 1988, METHOD ENZYMOL, V157, P417; MINOTTI G, 1991, J BIOL CHEM, V266, P20011; OJCIUS DM, 1991, TRENDS BIOCHEM SCI, V16, P225, DOI 10.1016/0968-0004(91)90090-I; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Puskas F, 1998, FEBS LETT, V430, P293, DOI 10.1016/S0014-5793(98)00678-4; SOLING HD, 1994, FALK SYMP, V74, P127; VERMEER C, 1990, BIOCHEM J, V266, P625, DOI 10.1042/bj2660625; WELLS WW, 1990, J BIOL CHEM, V265, P15361; ZIEGLER DM, 1977, TRENDS BIOCHEM SCI, V2, P79, DOI 10.1016/0968-0004(77)90042-1	24	104	107	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12213	12216		10.1074/jbc.274.18.12213	http://dx.doi.org/10.1074/jbc.274.18.12213			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212186	hybrid, Green Published			2022-12-27	WOS:000080056800006
J	Boiziau, C; Dausse, E; Yurchenko, L; Toulme, JJ				Boiziau, C; Dausse, E; Yurchenko, L; Toulme, JJ			DNA aptamers selected against the HIV-1 trans-activation-responsive RNA element form RNA-DNA kissing complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; HIGH-AFFINITY; TAR RNA; ANTISENSE OLIGONUCLEOTIDES; SECONDARY STRUCTURES; HAIRPIN COMPLEX; BINDING PROTEIN; INHIBITION; REGION; LOOP	In vitro selection was performed in a DNA library, made of oligonucleotides with a 30-nucleotide random sequence, to identify ligands of the human immunodeficiency virus type-1 trans-activation-responsive (TAR) RNA element. Aptamers, extracted after 15 rounds of selection-amplification, either from a classical library of sequences or from virtual combinatorial libraries, displayed an imperfect stem-loop structure and presented a consensus motif 5'ACTCCCAT in the apical loop. The six central bases of the consensus were complementary to the TAR apical region, giving rise to the formation of RNA-DNA kissing complexes, without disrupting the secondary structure of TAR. The RNA-DNA kissing complex was a poor substrate for Escherichia coli RNase H, likely due to steric and conformational constraints of the DNA/RNA heteroduplex, 2'-O-Methyl derivatives of a selected aptamer were binders of lower efficiency than the parent aptamer in contrast to regular sense/antisense hybrids, indicating that the RNA/DNA loop-loop region adopted a non-canonical heteroduplex structure. These results, which allowed the identification of a new type of complex, DNA-RNA kissing complex, demonstrate the interest of in vitro selection for identifying non antisense oligonucleotide ligands of RNA structures that are of potential value for artificially modulating gene expression.	Univ Victor Segalen, IFR Pathol Infect, INSERM U386, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Toulme, JJ (corresponding author), Univ Victor Segalen, IFR Pathol Infect, INSERM U386, 146 Rue Leo Saignat, F-33076 Bordeaux, France.		Boiziau, Claudine/AAM-3463-2021	Boiziau, Claudine/0000-0002-0475-2571; Toulme, Jean-jacques/0000-0002-8432-5034				Boiziau C, 1997, ANTISENSE NUCLEIC A, V7, P369, DOI 10.1089/oli.1.1997.7.369; CHANG KY, 1994, P NATL ACAD SCI USA, V91, P8705, DOI 10.1073/pnas.91.18.8705; Chang KY, 1997, J MOL BIOL, V269, P52, DOI 10.1006/jmbi.1997.1021; CHURCHER MJ, 1993, J MOL BIOL, V230, P90, DOI 10.1006/jmbi.1993.1128; ECKER DJ, 1992, SCIENCE, V257, P958, DOI 10.1126/science.1502560; FEDOROFF OY, 1993, J MOL BIOL, V233, P509, DOI 10.1006/jmbi.1993.1528; GAIT MJ, 1993, TRENDS BIOCHEM SCI, V18, P255, DOI 10.1016/0968-0004(93)90176-N; Gatignol A, 1996, GENE EXPRESSION, V5, P217; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; GRAEBLE MA, 1993, P NATL ACAD SCI USA, V90, P6184, DOI 10.1073/pnas.90.13.6184; HAASNOOT CAG, 1986, J BIOMOL STRUCT DYN, V3, P843, DOI 10.1080/07391102.1986.10508468; HELENE C, 1990, BIOCHIM BIOPHYS ACTA, V1049, P99, DOI 10.1016/0167-4781(90)90031-V; HJALT TAH, 1995, NUCLEIC ACIDS RES, V23, P580, DOI 10.1093/nar/23.4.580; HUE I, 1997, P NATL ACAD SCI USA, V94, P2106; INOUE H, 1987, NUCLEIC ACIDS RES, V15, P6131, DOI 10.1093/nar/15.15.6131; IRIBARREN AM, 1990, P NATL ACAD SCI USA, V87, P7747, DOI 10.1073/pnas.87.19.7747; JAEGER JA, 1989, P NATL ACAD SCI USA, V86, P7706, DOI 10.1073/pnas.86.20.7706; LARROUY B, 1995, NUCLEIC ACIDS RES, V23, P3434, DOI 10.1093/nar/23.17.3434; Le Tinevez R, 1998, NUCLEIC ACIDS RES, V26, P2273, DOI 10.1093/nar/26.10.2273; Lima WF, 1997, J BIOL CHEM, V272, P18191, DOI 10.1074/jbc.272.29.18191; Lima WF, 1997, J BIOL CHEM, V272, P27513, DOI 10.1074/jbc.272.44.27513; MARINO JP, 1995, SCIENCE, V268, P1448, DOI 10.1126/science.7539549; Mishra RK, 1996, P NATL ACAD SCI USA, V93, P10679, DOI 10.1073/pnas.93.20.10679; MORIKAWA K, 1998, CRYSTAL STRUCTURES R, P181; Paillart JC, 1996, BIOCHIMIE, V78, P639, DOI 10.1016/S0300-9084(96)80010-1; STRIPECKE R, 1994, MOL CELL BIOL, V14, P5898, DOI 10.1128/MCB.14.9.5898; TOMIZAWA J, 1986, CELL, V47, P89, DOI 10.1016/0092-8674(86)90369-7; Toulme JJ, 1996, BIOCHIMIE, V78, P663, DOI 10.1016/S0300-9084(96)80012-5; VONAHSEN U, 1995, SCIENCE, V267, P234, DOI 10.1126/science.7528943; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WU F, 1991, GENE DEV, V5, P2128, DOI 10.1101/gad.5.11.2128	33	95	122	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12730	12737		10.1074/jbc.274.18.12730	http://dx.doi.org/10.1074/jbc.274.18.12730			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212256	hybrid			2022-12-27	WOS:000080056800076
J	Dickinson, LA; Trauger, JW; Baird, EE; Dervan, PB; Graves, BJ; Gottesfeld, JM				Dickinson, LA; Trauger, JW; Baird, EE; Dervan, PB; Graves, BJ; Gottesfeld, JM			Inhibition of Ets-1 DNA binding and ternary complex formation between Ets-1, NF-kappa B, and DNA by a designed DNA-binding ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRROLE-IMIDAZOLE POLYAMIDES; MINOR-GROOVE; TRANSCRIPTION FACTORS; GENE-EXPRESSION; ALPHA-ENHANCER; PHYSICAL INTERACTIONS; CRYSTAL-STRUCTURE; VIRUS ENHANCER; MURINE ETS-1; HMG PROTEIN	Sequence-specific pyrrole-imidazole polyamides can be designed to interfere with transcription factor binding and to regulate gene expression, both in vitro and in living cells. Polyamides bound adjacent to the recognition sites for TBP, Ets-l, and LEF-1 in the human immunodeficiency virus, type 1 (HnT-1), long terminal repeat inhibited transcription in cell-free assays and viral rep lication in human peripheral blood lymphocytes. The DNA binding activity of the transcription factor Ets-l is specifically inhibited by a polyamide bound in the minor groove. Ets-l is a member of the winged-helix-turn-helix family of transcription factors and binds DNA through a recognition helix bound in the major groove with additional phosphate contacts on either side of this major groove interaction. The inhibitory polyamide possibly interferes with phosphate contacts made by Ets-l, by occupying the adjacent minor groove. Full-length Ets-l binds the HIV-1 enhancer through cooperative interactions with the p50 subunit of NF-kappa B, and the Ets-inhibitory polyamide also blocks formation of ternary Ets-1 NF-kappa B DNA complexes on the HIV-1 enhancer. A polyamide bound adjacent to the recognition site for NF-kappa B also inhibits NF-kappa B binding and ternary complex formation. These results broaden the application range of minor groove-binding polyamides and demonstrate that these DNA ligands are powerful inhibitors of DNA-binding proteins that predominantly use major groove contacts and of cooperative protein-DNA ternary complexes.	Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92087 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; CALTECH, Beckman Inst, Pasadena, CA 91125 USA; Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84132 USA	Scripps Research Institute; California Institute of Technology; California Institute of Technology; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Gottesfeld, JM (corresponding author), Scripps Res Inst, Dept Biol Mol, 10550 N Torrey Pines Rd, La Jolla, CA 92087 USA.			Gottesfeld, Joel/0000-0002-4643-5777	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057148, R01GM038663] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM038663, GM-57148] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baird EE, 1996, J AM CHEM SOC, V118, P6141, DOI 10.1021/ja960720z; Bassuk AG, 1997, J VIROL, V71, P3563, DOI 10.1128/JVI.71.5.3563-3573.1997; BASSUK AG, 1995, IMMUNITY, V3, P223, DOI 10.1016/1074-7613(95)90092-6; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Bradford AP, 1997, MOL CELL BIOL, V17, P1065, DOI 10.1128/MCB.17.3.1065; Bremer RE, 1998, CHEM BIOL, V5, P119, DOI 10.1016/S1074-5521(98)90057-6; Dickinson LA, 1998, P NATL ACAD SCI USA, V95, P12890, DOI 10.1073/pnas.95.22.12890; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Gottesfeld JM, 1997, NATURE, V387, P202, DOI 10.1038/387202a0; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; GUNTHER CV, 1994, MOL CELL BIOL, V14, P7569, DOI 10.1128/MCB.14.11.7569; JOHN S, 1995, MOL CELL BIOL, V15, P1786; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kielkopf CL, 1998, NAT STRUCT BIOL, V5, P104, DOI 10.1038/nsb0298-104; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; SHERIDAN PL, 1995, GENE DEV, V9, P2090, DOI 10.1101/gad.9.17.2090; STARR DB, 1995, J MOL BIOL, V250, P434; Trauger JW, 1996, NATURE, V382, P559, DOI 10.1038/382559a0; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Turner JM, 1998, J AM CHEM SOC, V120, P6219, DOI 10.1021/ja980147e; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Werner MH, 1997, J BIOMOL NMR, V10, P317, DOI 10.1023/A:1018399711996; White S, 1998, NATURE, V391, P468, DOI 10.1038/35106; White S, 1997, CHEM BIOL, V4, P569, DOI 10.1016/S1074-5521(97)90243-X	37	73	77	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12765	12773		10.1074/jbc.274.18.12765	http://dx.doi.org/10.1074/jbc.274.18.12765			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212261	hybrid, Green Accepted			2022-12-27	WOS:000080056800081
J	Ghose, S; Porzig, H; Baltensperger, K				Ghose, S; Porzig, H; Baltensperger, K			Induction of erythroid differentiation by altered G(alpha 16) activity as detected by a reporter gene assay in MB-02 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-DEFICIENT G-ALPHA(16); PROTEIN-COUPLED RECEPTORS; EMBRYONAL CARCINOMA-CELLS; SIGNAL-TRANSDUCTION; ERYTHROLEUKEMIA-CELLS; KINASE CASCADES; ALPHA-SUBUNITS; RETINOIC ACID; B-CELL; EXPRESSION	Heterotrimeric G proteins may assume modulatory roles in cellular proliferation and differentiation. The G protein alpha-subunit G(alpha 16) which is specifically expressed in hematopoietic cells, is highly regulated during differentiation of normal and leukemic cells. In human erythroleukemia cells, suppression of G(alpha 16) inhibited cellular growth rates. A reporter gene system was established to assess the role of G(alpha 16) on erythroid differentiation of MB-02 erythroleukemia cells. It is based on transient transfection with a plasmid that expresses green fluorescent protein under the control of the beta-globin promoter. Expression of G(alpha 16) led to a significant increase in green fluorescent protein-positive cells, as did transfection with a G(alpha 16) antisense plasmid (154 and 156% of controls, respectively). The GTPase-deficient, constitutively active mutant of G(alpha 16), G(alpha 16)R186C, further stimulated differentiation to 195% of control values. Because the effect of G(alpha 16) is triggered most efficiently by the GTP-bound protein, an indirect action through interference of overexpressed G(alpha 16) with G protein beta gamma-subunits can be excluded, The corresponding mutant of G(alpha q) (G(alpha q)R182C), the phylogenetically closest family member of G(alpha 16), had no effect. The data define a specific role for G(alpha 16)-dependent signal transduction in cellular differentiation: deviations from optimal levels of G(alpha 16) functional activity lead to reduced growth rates and promote differentiation in hematopoietic cells.	Univ Bern, Inst Pharmacol, CH-3010 Bern, Switzerland	University of Bern	Baltensperger, K (corresponding author), Univ Bern, Inst Pharmacol, Postfach 51,Friedbuhlstr 49, CH-3010 Bern, Switzerland.	kurt.baltensperger@pki.unibe.ch						AMATRUDA TT, 1995, J BIOL CHEM, V270, P28010; AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139; Baltensperger H, 1997, J BIOL CHEM, V272, P10151; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; BUHL AM, 1995, J BIOL CHEM, V270, P19828, DOI 10.1074/jbc.270.34.19828; Grant KR, 1997, IMMUNOLOGY, V90, P564, DOI 10.1046/j.1365-2567.1997.00196.x; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Heasley LE, 1996, J BIOL CHEM, V271, P349, DOI 10.1074/jbc.271.1.349; Heasley LE, 1996, MOL CELL BIOL, V16, P648; HOOPER WC, 1991, LEUKEMIA RES, V15, P753, DOI 10.1016/0145-2126(91)90079-9; HUPPERTZ C, 1993, EUR J BIOCHEM, V215, P611, DOI 10.1111/j.1432-1033.1993.tb18072.x; Jho EH, 1997, J BIOL CHEM, V272, P24468, DOI 10.1074/jbc.272.39.24468; Jho EH, 1997, J BIOL CHEM, V272, P24461, DOI 10.1074/jbc.272.39.24461; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Lippert E, 1997, FEBS LETT, V417, P292, DOI 10.1016/S0014-5793(97)01308-2; LOWNDES JM, 1991, J BIOL CHEM, V266, P14193; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; MAPARA MY, 1995, BLOOD, V85, P1836, DOI 10.1182/blood.V85.7.1836.bloodjournal8571836; NEEDHAM M, 1995, PROTEIN EXPRES PURIF, V6, P124, DOI 10.1006/prep.1995.1015; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; ORKIN SH, 1975, P NATL ACAD SCI USA, V72, P98, DOI 10.1073/pnas.72.1.98; PAPAYANNOPOULOU T, 1987, BLOOD, V70, P1764; Pfeilstocker M, 1996, LEUKEMIA, V10, P1117; Post GR, 1996, FASEB J, V10, P741, DOI 10.1096/fasebj.10.7.8635691; QIAN NX, 1994, J BIOL CHEM, V269, P17417; SPICHER K, 1994, BIOCHEM BIOPH RES CO, V198, P906, DOI 10.1006/bbrc.1994.1129; SU HL, 1993, AM J PHYSIOL, V265, pC1729, DOI 10.1152/ajpcell.1993.265.6.C1729; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Tenailleau S, 1997, EXP HEMATOL, V25, P927; WANG HY, 1992, NATURE, V358, P334, DOI 10.1038/358334a0; WATKINS DC, 1992, SCIENCE, V258, P1373, DOI 10.1126/science.1455234; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840	33	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12848	12854		10.1074/jbc.274.18.12848	http://dx.doi.org/10.1074/jbc.274.18.12848			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212272	hybrid			2022-12-27	WOS:000080056800092
J	Wang, J; White, AL				Wang, J; White, AL			6-aminohexanoic acid as a chemical chaperone for apolipoprotein(a)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA LIPOPROTEIN(A) CONCENTRATIONS; PRIMARY BABOON HEPATOCYTES; LOW-DENSITY-LIPOPROTEIN; APO(A) MESSENGER-RNA; MOLECULAR-BASIS; ENDOPLASMIC-RETICULUM; SIZE POLYMORPHISM; BINDING SITES; PROTEIN; PLASMINOGEN	Apolipoprotein (a) (apo(a)) is a component of the atherogenic lipoprotein, Lp(a), The efficiency with which apo(a) escapes the endoplasmic reticulum (ER) and is secreted by the liver is a major determinant of plasma Lp(a) levels. Apo(a) contains a series of domains homologous to plasminogen kringle (K) 4, each of which possesses a potential lysine-binding site. By using primary mouse hepatocytes expressing a 17K4 human apo(a) protein, we found that high concentrations (25-200 mM) of the lysine analog, 6-aminohexanoic acid (6AHA), increased apo(a) secretion 8-14-fold. This was accompanied by a decrease in apo(a) presecretory degradation. 6AHA inhibited accumulation of apo(a) in the ER induced by the proteasome inhibitor, lactacystin. Thus, 6AHA appeared to inhibit degradation by increasing apo(a) export from the ER. Significantly, 6AHA overcame the block in apo(a) secretion induced by the ER glucosidase inhibitor, castanospermine. 6AHA may therefore circumvent the requirement for calnexin and calreticulin interaction in apo(a) secretion. Sucrose gradients and a gel-based folding assay were unable to detect any influence of 6AHA on apo(a) folding. However, non-covalent or small, disulfide-dependent changes in apo(a) conformation would not be detected in these assays. Proline also increased the efficiency of apo(a) secretion. We propose that 6AHA and proline can act as chemical chaperones for apo(a).	Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	White, AL (corresponding author), Univ Texas, SW Med Ctr, Ctr Human Nutr, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059541, R29HL059541] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL59541] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AZROLAN N, 1991, J BIOL CHEM, V266, P13866; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Brown CR, 1997, J CLIN INVEST, V99, P1432, DOI 10.1172/JCI119302; CHIESA G, 1992, J BIOL CHEM, V267, P24369; COHEN JC, 1993, J CLIN INVEST, V91, P1630, DOI 10.1172/JCI116370; Cox LA, 1998, J LIPID RES, V39, P1319; ERNST A, 1995, J BIOL CHEM, V270, P6227, DOI 10.1074/jbc.270.11.6227; Fless GM, 1996, BIOCHEMISTRY-US, V35, P2289, DOI 10.1021/bi951792q; FUHRMANN U, 1985, BIOCHIM BIOPHYS ACTA, V825, P95, DOI 10.1016/0167-4781(85)90095-8; Gaubatz J W, 1986, Methods Enzymol, V129, P167; GETHING MJ, 1992, NATURE, V355, P3; GUEVARA J, 1993, BIOPHYS J, V64, P686, DOI 10.1016/S0006-3495(93)81428-0; GUEVARA J, 1993, ARTERIOSCLER THROMB, V13, P758, DOI 10.1161/01.ATV.13.5.758; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HARPEL PC, 1989, P NATL ACAD SCI USA, V86, P3847, DOI 10.1073/pnas.86.10.3847; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; HIXSON JE, 1989, J BIOL CHEM, V264, P6013; HOOVERPLOW JL, 1993, BIOCHEMISTRY-US, V32, P13681, DOI 10.1021/bi00212a037; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KRAFT HG, 1989, J CLIN INVEST, V83, P137, DOI 10.1172/JCI113849; KREMPLER F, 1980, J CLIN INVEST, V65, P1483, DOI 10.1172/JCI109813; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; LAPLAUD PM, 1988, J LIPID RES, V29, P1157; LINTON MF, 1993, J CLIN INVEST, V92, P3029, DOI 10.1172/JCI116927; MAKINO K, 1991, LIPIDS, V26, P679, DOI 10.1007/BF02535613; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; MORRISETT JD, 1990, LIPOPROTEIN A, P53; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Obermoeller LM, 1998, J BIOL CHEM, V273, P22374, DOI 10.1074/jbc.273.35.22374; RADER DJ, 1994, J CLIN INVEST, V93, P2758, DOI 10.1172/JCI117292; RAINWATER DL, 1989, BIOCHIM BIOPHYS ACTA, V1003, P30, DOI 10.1016/0005-2760(89)90094-5; ROUY D, 1992, BIOCHEMISTRY-US, V31, P6333, DOI 10.1021/bi00142a024; SANDHOLZER C, 1991, HUM GENET, V86, P607; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; SCANU AM, 1990, J CLIN INVEST, V85, P1709, DOI 10.1172/JCI114625; SOUSA M, 1995, EMBO J, V14, P4196, DOI 10.1002/j.1460-2075.1995.tb00093.x; Tatzelt J, 1996, EMBO J, V15, P6363, DOI 10.1002/j.1460-2075.1996.tb01027.x; TOMLINSON JE, 1989, J BIOL CHEM, V264, P5957; TRIEU VN, 1991, J BIOL CHEM, V266, P5480; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WHITE AL, 1994, J BIOL CHEM, V269, P9060; White AL, 1997, CLIN GENET, V52, P326; WHITE AL, 1993, J LIPID RES, V34, P509; WHITE AL, 1994, J BIOL CHEM, V269, P28716; WHITE AL, 1994, CHEM PHYS LIPIDS, V67-8, P123, DOI 10.1016/0009-3084(94)90131-7; White AL, 1999, J LIPID RES, V40, P275; White AL, 1997, J BIOL CHEM, V272, P5048, DOI 10.1074/jbc.272.8.5048; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; ZYSOW BR, 1995, ARTERIOSCL THROM VAS, V15, P58, DOI 10.1161/01.ATV.15.1.58	50	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12883	12889		10.1074/jbc.274.18.12883	http://dx.doi.org/10.1074/jbc.274.18.12883			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212277	hybrid			2022-12-27	WOS:000080056800097
J	Babenko, AP; Gonzalez, G; Bryan, J				Babenko, AP; Gonzalez, G; Bryan, J			Two regions of sulfonylurea receptor specify the spontaneous bursting and ATP inhibition of K-ATP channel isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC B-CELLS; POTASSIUM CHANNELS; INSULIN-SECRETION; SUBUNIT; SUR1; REGULATOR; DIAZOXIDE; BINDING; MGADP	K-ATP channels are heteromultimers of K(IR)6.2 and a sulfonylurea receptor, SUR, an ATP binding cassette (ABC) protein with several isoforms. K(IR)6.2 forms a channel pore whose spontaneous activity and ATP sensitivity are modulated by the receptor via an unknown interaction(s), Side by side comparison of single-channel kinetics and steady-state ATP inhibition of human beta-cell, SUR1/K(IR)6.2, versus cardiac, SUR2A/K(IR)6.2 channels demonstrate that the latter have a greater mean burst duration and open probability in the absence of nucleotides and similar to 4-fold higher IC50(ATP). We have used matched chimeras of SUR1 and SUR2A to show that the kinetics, which determine the maximal open probability (Po-max), and the ATP sensitivity are functionally separable and to identify the two segments of SUR responsible for these isoform differences. A region within the first five transmembrane domains specifies the interburst kinetics, whereas a C-terminal segment determines the sensitivity to inhibitory ATP, The separable effects of SUR on ATP inhibition and channel kinetics implies that the cytoplasmic C terminus of SUR either directly modulates the affinity of a weak ATP binding site on the inward rectifier or affects linkage between the binding site and the gate. This is the first identification of parts of an ABC protein that interact with an ion channel subunit to modulate the spontaneous activity and ATP sensitivity of the heteromeric channel.	Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	Baylor College of Medicine	Babenko, AP (corresponding author), Baylor Coll Med, Dept Cell Biol, 1 Baylor Plaza, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052771, R01DK044311] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK44311, DK52771] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguilar-Bryan L, 1998, PHYSIOL REV, V78, P227, DOI 10.1152/physrev.1998.78.1.227; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Babenko AP, 1999, FEBS LETT, V445, P131, DOI 10.1016/S0014-5793(99)00102-7; Babenko AP, 1998, CIRC RES, V83, P1132, DOI 10.1161/01.RES.83.11.1132; Babenko AP, 1999, BIOCHEM BIOPH RES CO, V255, P231, DOI 10.1006/bbrc.1999.0172; Bryan J, 1997, CURR OPIN CELL BIOL, V9, P553, DOI 10.1016/S0955-0674(97)80033-6; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; Drain P, 1998, P NATL ACAD SCI USA, V95, P13953, DOI 10.1073/pnas.95.23.13953; GILLIS KD, 1989, AM J PHYSIOL, V257, pC1119, DOI 10.1152/ajpcell.1989.257.6.C1119; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; John SA, 1998, J PHYSIOL-LONDON, V510, P333, DOI 10.1111/j.1469-7793.1998.333bk.x; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; SCHWAPPACH B, 1999, IN PRESS NEURON; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; TAKANO M, 1993, PROG NEUROBIOL, V41, P21, DOI 10.1016/0301-0082(93)90039-U; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; TRUBE G, 1984, PFLUG ARCH EUR J PHY, V401, P178, DOI 10.1007/BF00583879; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Ueda K, 1997, J BIOL CHEM, V272, P22983, DOI 10.1074/jbc.272.37.22983; ZILBERTER Y, 1988, PFLUG ARCH EUR J PHY, V411, P584, DOI 10.1007/BF00582382	26	65	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11587	11592		10.1074/jbc.274.17.11587	http://dx.doi.org/10.1074/jbc.274.17.11587			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206966	hybrid			2022-12-27	WOS:000079834800022
J	Davies, DR; Braam, LM; Reznikoff, WS; Rayment, I				Davies, DR; Braam, LM; Reznikoff, WS; Rayment, I			The three-dimensional structure of a Tn5 transposase-related protein determined to 2.9-angstrom resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA VIRUS INTEGRASE; RAY-DIFFRACTION DATA; CATALYTIC DOMAIN; MACROMOLECULAR STRUCTURES; ESCHERICHIA-COLI; HIV-1 INTEGRASE; ACTIVE-SITE; POLYNUCLEOTIDYL TRANSFER; RETROVIRAL INTEGRATION; CRYSTAL-STRUCTURE	Transposon Tn5 employs a unique means of self-regulation by expressing a truncated version of the transposase enzyme that acts as an inhibitor. The inhibitor protein differs from the full-length transposase only by the absence of the first 55 N-terminal amino acid residues. It contains the catalytic active site of transposase and a C-terminal domain involved in protein-protein interactions. The three-dimensional structure of Tn5 inhibitor determined to 2.9-Angstrom resolution is reported here. A portion of the protein fold of the catalytic core domain is similar to the folds of human immunodeficiency virus-1 integrase, avian sarcoma virus integrase, and bacteriophage Mu transposase, The Tn5 inhibitor contains an insertion that extends the beta-sheet of the catalytic core from 5 to 9 strands. All three of the conserved residues that make up the "DDE" motif of the active site are visible in the structure. An arginine residue that is strictly conserved among the IS4 family of bacterial transposases is present at the center of the active site, suggesting a catalytic motif of "DDRE," A novel C-terminal domain forms a dimer interface across a crystallographic 2-fold axis, Although this dimer represents the structure of the inhibited complex, it provides insight into the structure of the synaptic complex.	Univ Wisconsin, Inst Enzyme Res, Madison, WI 53705 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rayment, I (corresponding author), Univ Wisconsin, Inst Enzyme Res, 1710 Univ Ave, Madison, WI 53705 USA.	ivan@enzyme.wisc.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835	NIAMS NIH HHS [AR35186] Funding Source: Medline; NIGMS NIH HHS [GM50692, GM08349] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER TA, 1993, CELL, V74, P723, DOI 10.1016/0092-8674(93)90519-V; BAKER TA, 1994, GENE DEV, V8, P2416, DOI 10.1101/gad.8.20.2416; BERG DE, 1983, P NATL ACAD SCI-BIOL, V80, P792, DOI 10.1073/pnas.80.3.792; BERG DE, 1989, MOBILE DNA, P186; BERG DE, 1989, MOBILE DNA, P185; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bolland S, 1996, CELL, V84, P223, DOI 10.1016/S0092-8674(00)80977-0; Braam LAM, 1998, J BIOL CHEM, V273, P10908, DOI 10.1074/jbc.273.18.10908; Braam LAM, 1999, J BIOL CHEM, V274, P86, DOI 10.1074/jbc.274.1.86; Bujacz G, 1997, J BIOL CHEM, V272, P18161, DOI 10.1074/jbc.272.29.18161; BUJACZ G, 1995, J MOL BIOL, V253, P333, DOI 10.1006/jmbi.1995.0556; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; BUSHMAN FD, 1994, J VIROL, V68, P2215, DOI 10.1128/JVI.68.4.2215-2223.1994; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; CRAIG NL, 1995, SCIENCE, V270, P253, DOI 10.1126/science.270.5234.253; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; DELACRUZ NB, 1993, J BACTERIOL, V175, P6932, DOI 10.1128/jb.175.21.6932-6938.1993; DELONG A, 1991, P NATL ACAD SCI USA, V88, P6072, DOI 10.1073/pnas.88.14.6072; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; FISHER AJ, 1996, MOLDED; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Goryshin IY, 1998, J BIOL CHEM, V273, P7367, DOI 10.1074/jbc.273.13.7367; HANIFORD DB, 1989, CELL, V59, P385, DOI 10.1016/0092-8674(89)90299-7; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; HICKMAN AB, 1994, J BIOL CHEM, V269, P29279; JENKINS TM, 1995, P NATL ACAD SCI USA, V92, P6057, DOI 10.1073/pnas.92.13.6057; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; JONES TA, 1985, METHOD ENZYMOL, V115, P157; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; KATAYANAGI K, 1990, NATURE, V347, P306, DOI 10.1038/347306a0; Kennedy AK, 1998, CELL, V95, P125, DOI 10.1016/S0092-8674(00)81788-2; Kleckner N, 1996, CURR TOP MICROBIOL, V204, P49; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KULKOSKY J, 1995, VIROLOGY, V206, P448, DOI 10.1016/S0042-6822(95)80060-3; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; MILLER S, 1987, NATURE, V328, P834, DOI 10.1038/328834a0; MIZUUCHI K, 1992, J BIOL CHEM, V267, P21273; NAVAZA J, 1993, ACTA CRYSTALLOGR D, V49, P588, DOI 10.1107/S0907444993005141; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OTWINOWSKI Z, 1986, THESIS YALE U; POLARD P, 1995, MOL MICROBIOL, V15, P13, DOI 10.1111/j.1365-2958.1995.tb02217.x; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; REZNIKOFF WS, 1993, ANNU REV MICROBIOL, V47, P945, DOI 10.1146/annurev.mi.47.100193.004501; REZSOHAZY R, 1993, MOL MICROBIOL, V9, P1283, DOI 10.1111/j.1365-2958.1993.tb01258.x; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Rice P, 1996, CURR OPIN STRUC BIOL, V6, P76, DOI 10.1016/S0959-440X(96)80098-4; Rodgers DW, 1997, METHOD ENZYMOL, V276, P183, DOI 10.1016/S0076-6879(97)76059-2; ROSSMANN MG, 1975, J BIOL CHEM, V250, P7525; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; RYPNIEWSKI WR, 1991, BIOCHEMISTRY-US, V30, P4126, DOI 10.1021/bi00231a003; SCHALLER H, 1979, COLD SPRING HARB SYM, V43, P401, DOI 10.1101/SQB.1979.043.01.046; TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568; TERWILLIGER TC, 1983, ACTA CRYSTALLOGR A, V39, P813, DOI 10.1107/S0108767383001592; Terwilliger TC, 1997, METHOD ENZYMOL, V276, P530; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; WEINREICH MD, 1994, J MOL BIOL, V241, P166, DOI 10.1006/jmbi.1994.1486; WEINREICH MD, 1994, GENE DEV, V8, P2363, DOI 10.1101/gad.8.19.2363; WIEGAND TW, 1994, J MOL BIOL, V235, P486, DOI 10.1006/jmbi.1994.1008; WIEGAND TW, 1992, J BACTERIOL, V174, P1229, DOI 10.1128/jb.174.4.1229-1239.1992; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3; York D, 1996, NUCLEIC ACIDS RES, V24, P3790, DOI 10.1093/nar/24.19.3790; Yurieva O, 1996, BIOCHEM MOL BIOL INT, V38, P15; Zhou M, 1997, J MOL BIOL, V271, P362, DOI 10.1006/jmbi.1997.1188	71	60	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11904	11913		10.1074/jbc.274.17.11904	http://dx.doi.org/10.1074/jbc.274.17.11904			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207011	hybrid			2022-12-27	WOS:000079834800067
J	Esser, K; Nelson, T; Lupa-Kimball, V; Blough, E				Esser, K; Nelson, T; Lupa-Kimball, V; Blough, E			The CACC box and myocyte enhancer factor-2 sites within the myosin light chain 2 slow promoter cooperate in regulating nerve-specific transcription in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN GENE-EXPRESSION; TRANSGENIC MICE; FIBER-TYPE; LIGHT-CHAIN-2 GENE; ACTIN GENE; ELEMENTS; DIFFERENTIATION; MYOGENESIS; ACTIVATION; CELLS	Previous experiments showed that activity of the -800-base pair MLC2slow promoter was 75-fold higher in the innervated soleus (SOL) compared with the noninnervated SOL muscles, Using in vivo DNA injection of MLC2slow promoter-luciferase constructs, the aim of this project was to identify regulatory sites and potential transcription factors important for slow nerve-dependent gene expression. Three sites within the proximal promoter (myocyte enhancer factor-2 (MEF2), E-box, and CACC box) were individually mutated, and the effect on luciferase expression was determined. There was no change in luciferase expression in the SOL and extensor digitorum longus (EDL) muscles when the E-box was mutated. In contrast, the MEF2 mutation resulted in a 30-fold decrease in expression in the innervated SOL muscles (10.3 versus 0.36 normalized relative light units (RLUs)). Transactivation of the MLC2slow promoter by overexpressing MEF2 was only seen in the innervated SOL (676,340 versus 2,225,957 RLUs; p < 0.01) with no effect in noninnervated SOL or EDL muscles. These findings suggest that the active MLC2slow promoter is sensitive to MEF2 levels, but MEF2 levels alone do not determine nerve-dependent expression. Mutation of the CACC box resulted in a significant up-regulation in the EDL muscles (0.23 versus 4.08 normalized RLUs), With the CACC box mutated, overexpression of MEF2 was sufficient to transactivate the MLC2slow promoter in noninnervated SOL muscles (27,536 versus 1,605,797 RLUs), Results from electrophoretic mobility shift and supershift assays confirm MEF2 protein binding to the MEF2 site and demonstrate specific binding to the CACC sequence. These results suggest a model for nerve-dependent regulation of the MLC2slow promoter in which derepression occurs through the CACC box followed by quantitative expression through enhanced MEF2 activation.	Univ Illinois, Sch Kinesiol MC 194, Chicago, IL 60608 USA; Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60608 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Esser, K (corresponding author), Univ Illinois, Sch Kinesiol MC 194, 901 W Roosevelt Rd, Chicago, IL 60608 USA.	kryn.esser@uic.edu			NHLBI NIH HHS [HL07692-08] Funding Source: Medline; NIAMS NIH HHS [AR43349] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043349, R29AR043349] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; BANERJEEBASU S, 1993, MOL CELL BIOL, V13, P7019, DOI 10.1128/MCB.13.11.7019; BASSELDUBY R, 1994, MOL CELL BIOL, V14, P4596, DOI 10.1128/MCB.14.7.4596; BLACK BL, 1995, J BIOL CHEM, V270, P2889, DOI 10.1074/jbc.270.7.2889; Blough E, 1999, BIOTECHNIQUES, V26, P202, DOI 10.2144/99262bm05; BUCKINGHAM M, 1992, TRENDS GENET, V8, P144, DOI 10.1016/0168-9525(92)90373-C; BULLER AJ, 1965, J PHYSIOL-LONDON, V178, P343, DOI 10.1113/jphysiol.1965.sp007631; Calvo S, 1996, DEV GENET, V19, P169, DOI 10.1002/(SICI)1520-6408(1996)19:2<169::AID-DVG9>3.3.CO;2-T; CARLSON BM, 1981, PHYSIOL BOHEMOSLOV, V30, P505; CARSON J, 1996, AM J PHYSIOL, V39, pC1624; CARSON JA, 1995, AM J PHYSIOL-CELL PH, V268, pC918, DOI 10.1152/ajpcell.1995.268.4.C918; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; COHEN A, 1988, NUCLEIC ACIDS RES, V16, P10037, DOI 10.1093/nar/16.21.10037; CORIN SJ, 1995, P NATL ACAD SCI USA, V92, P6185, DOI 10.1073/pnas.92.13.6185; CSERJESI P, 1991, MOL CELL BIOL, V11, P4854, DOI 10.1128/MCB.11.10.4854; Dhar M, 1997, J BIOL CHEM, V272, P18490, DOI 10.1074/jbc.272.29.18490; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; ERNST H, 1991, MOL CELL BIOL, V11, P3735, DOI 10.1128/MCB.11.7.3735; ESSER K, 1993, DEV BIOL, V159, P173, DOI 10.1006/dbio.1993.1231; Grayson J, 1998, J CELL BIOCHEM, V70, P366, DOI 10.1002/(SICI)1097-4644(19980901)70:3<366::AID-JCB10>3.3.CO;2-T; GUNNING P, 1987, MOL CELL BIOL, V7, P4100, DOI 10.1128/MCB.7.11.4100; HAN TH, 1995, MOL CELL BIOL, V15, P2907; HENDERSON SA, 1989, J BIOL CHEM, V264, P18142; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; Jerkovic R, 1997, J MUSCLE RES CELL M, V18, P369, DOI 10.1023/A:1018630311208; KNOTTS S, 1994, J BIOL CHEM, V269, P31275; Krainc D, 1998, J BIOL CHEM, V273, P26218, DOI 10.1074/jbc.273.40.26218; Kraus W E, 1994, Exerc Sport Sci Rev, V22, P313; Lakich MM, 1998, J BIOL CHEM, V273, P15217, DOI 10.1074/jbc.273.24.15217; LEE KJ, 1994, MOL CELL BIOL, V14, P1220, DOI 10.1128/MCB.14.2.1220; LEVITT LK, 1995, DNA CELL BIOL, V14, P599, DOI 10.1089/dna.1995.14.599; Lupa-Kimball VA, 1998, AM J PHYSIOL-CELL PH, V274, pC229, DOI 10.1152/ajpcell.1998.274.1.C229; MAR JH, 1988, P NATL ACAD SCI USA, V85, P6404, DOI 10.1073/pnas.85.17.6404; MATHISEN PM, 1987, GENE DEV, V1, P1107, DOI 10.1101/gad.1.10.1107; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; MINTY A, 1986, MOL CELL BIOL, V6, P2137, DOI 10.1128/MCB.6.6.2137; Molkentin JD, 1996, J BIOL CHEM, V271, P17199, DOI 10.1074/jbc.271.29.17199; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; MURPHY S, 1992, MOL CELL BIOL, V12, P3247, DOI 10.1128/MCB.12.7.3247; Nakayama M, 1996, MOL CELL BIOL, V16, P2408; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; ONTELL MP, 1993, DEV DYNAM, V198, P203, DOI 10.1002/aja.1001980306; Ornatsky OI, 1996, J BIOL CHEM, V271, P24927, DOI 10.1074/jbc.271.40.24927; PARMACEK MS, 1994, MOL CELL BIOL, V14, P1870, DOI 10.1128/MCB.14.3.1870; PETTE D, 1985, MUSCLE NERVE, V8, P676, DOI 10.1002/mus.880080810; Pette D, 1990, Rev Physiol Biochem Pharmacol, V116, P1; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; ROSENTHAL N, 1989, P NATL ACAD SCI USA, V86, P7780, DOI 10.1073/pnas.86.20.7780; Sambrook J., 1989, MOL CLONING, pA1; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; SUTHERLAND CJ, 1993, DEV DYNAM, V196, P25, DOI 10.1002/aja.1001960104; SUTHERLAND CJ, 1991, DEV BIOL, V146, P167, DOI 10.1016/0012-1606(91)90457-E; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ZHU H, 1991, MOL CELL BIOL, V11, P2273, DOI 10.1128/MCB.11.4.2273	54	42	42	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12095	12102		10.1074/jbc.274.17.12095	http://dx.doi.org/10.1074/jbc.274.17.12095			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207035	hybrid			2022-12-27	WOS:000079834800091
J	Gotoh, I; Fukuda, M; Adachi, M; Nishida, E				Gotoh, I; Fukuda, M; Adachi, M; Nishida, E			Control of the cell morphology and the S phase entry by mitogen-activated protein kinase kinase - A regulatory role of its N-terminal region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT SIGNAL; NIH 3T3 CELLS; MAP-KINASE; MESODERM INDUCTION; PHOSPHORYLATION SITES; DNA-SYNTHESIS; RAS; CASCADE; TRANSFORMATION; PROLIFERATION	The mitogen-activated protein kinase kinase (MAPKK)/MAP kinase (MAPK) cascade plays an important role in the growth control of mammalian cells. We have found that expression of constitutively active MAPKK induces rapid morphological changes of fibroblastic cells, which are accompanied by disruption of stress fibers and disappearance of focal adhesions. These changes took place under the conditions that inhibited cellular Pas function, suggesting a linkage between the MAPK cascade and the control of cell morphology. We further show that constitutively active MAPKK can induce expression of endogenous Fos protein, an immediately early gene product, and cause the S phase entry of G(0)-arrested cells. Finally, expression of the N-terminal fragment of MAPKK which encompasses the nuclear export signal sequence and the MAPK-binding site blocked both the serum-induced S phase entry of quiescent cells and the oncogenic Ras induced morphological changes. All these results demonstrate that MAPKK is one of key molecules involved in the control of both cell morphology and cell proliferation and suggest an important role for the N-terminal region of MAPKK in the regulation of the MAPK signaling.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Nishida, E (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.		Fukuda, Makoto/S-9748-2019; Fukuda, Makoto/C-9745-2009; Fukuda, Makoto/I-7915-2014	Fukuda, Makoto/0000-0003-0112-9925; Fukuda, Makoto/0000-0003-0112-9925; Fukuda, Makoto/0000-0003-0112-9925				Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; FERAMISCO JR, 1984, CELL, V38, P109, DOI 10.1016/0092-8674(84)90531-2; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; GOTOH Y, 1995, EMBO J, V14, P2491, DOI 10.1002/j.1460-2075.1995.tb07246.x; GOTOH Y, 1994, ONCOGENE, V9, P1891; GOTOH Y, 1995, J BIOL CHEM, V270, P25898, DOI 10.1074/jbc.270.43.25898; HATTORI S, 1985, MOL CELL BIOL, V5, P1449, DOI 10.1128/MCB.5.6.1449; HUANG WD, 1995, MOL BIOL CELL, V6, P237, DOI 10.1091/mbc.6.3.237; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; KOSAKO H, 1993, EMBO J, V12, P787, DOI 10.1002/j.1460-2075.1993.tb05713.x; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LABONNE C, 1995, DEVELOPMENT, V121, P1475; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MORRIS JDH, 1989, ONCOGENE, V4, P27; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; SEGER R, 1994, J BIOL CHEM, V269, P25699; STACEY DW, 1984, NATURE, V310, P508, DOI 10.1038/310508a0; SUN H, 1994, SCIENCE, V266, P285, DOI 10.1126/science.7939666; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x	41	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11874	11880		10.1074/jbc.274.17.11874	http://dx.doi.org/10.1074/jbc.274.17.11874			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207007	hybrid			2022-12-27	WOS:000079834800063
J	Chandrasekaran, S; Guo, NH; Rodrigues, RG; Kaiser, J; Roberts, DD				Chandrasekaran, S; Guo, NH; Rodrigues, RG; Kaiser, J; Roberts, DD			Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cells are mediated by alpha(3)beta(1) integrin and regulated by insulin-like growth factor-1 and CD98	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEINS; HEPARIN-BINDING DOMAIN; CANCER CELLS; I REPEATS; PLATELET THROMBOSPONDIN; ENDOTHELIAL-CELLS; MELANOMA-CELLS; TUMOR-GROWTH; RECEPTOR; ANGIOGENESIS	Thrombospondin-1 (TSP1) is a matricellular protein that displays both pro- and anti-adhesive activities. Binding to sulfated glycoconjugates mediates most high affinity binding of soluble TSP1 to MDA-MB-435 cells, but attachment and spreading of these cells on immobilized TSP1 is primarily beta(1) integrin-dependent. The integrin alpha(3)beta(1) is the major mediator of breast carcinoma cell adhesion and chemotaxis to TSP1. This integrin is partially active in MDA-MB-435 cells but is mostly inactive in MDA-MB-231 and MCF-7 cells, which require beta(1) integrin activation to induce spreading on TSP1. Integrin-mediated cell spreading on TSP1 is accompanied by extension of filopodia containing beta(1) integrins. TSP1 binding activity of the alpha(3)beta(1) integrin is not stimulated by CD47-binding peptides from TSP1 or by protein kinase C activation, which activate alpha(v)beta(3) integrin function in the same cells. In MDA-MB-231 but not MDA-MB-435 cells, this integrin is activated by pertussis toxin, whereas serum, insulin, insulin-like growth factor-1, and ligation of CD98 increase activity of this integrin in both cell lines. Serum stimulation is accompanied by increased surface expression of CD98, whereas insulinlike growth factor-1 does not increase CD98 expression. Thus, the pro-adhesive activity of TSP1 for breast carcinoma cells is controlled by several signals that regulate activity of the alpha(3)beta(1) integrin.	NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roberts, DD (corresponding author), NCI, Pathol Lab, NIH, Bldg 10,Rm 2A33,10 Ctr Dr,MSC 1500, Bethesda, MD 20892 USA.		Roberts, David D./A-9699-2008	Roberts, David D./0000-0002-2481-2981				ADAMS JC, 1995, J CELL SCI, V108, P1977; AKIYAMA SK, 1985, J BIOL CHEM, V260, P4492; Berditchevski F, 1997, J BIOL CHEM, V272, P29174, DOI 10.1074/jbc.272.46.29174; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Chung J, 1997, J BIOL CHEM, V272, P14740, DOI 10.1074/jbc.272.23.14740; Coopman PJ, 1996, MOL BIOL CELL, V7, P1789, DOI 10.1091/mbc.7.11.1789; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; DEFREITAS MF, 1995, NEURON, V15, P333, DOI 10.1016/0896-6273(95)90038-1; Doerr ME, 1996, J BIOL CHEM, V271, P2443, DOI 10.1074/jbc.271.5.2443; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; Gao AG, 1996, J CELL BIOL, V135, P533, DOI 10.1083/jcb.135.2.533; Genersch E, 1996, J MOL MED-JMM, V74, P609, DOI 10.1007/s001090050064; GUO NH, 1992, J BIOL CHEM, V267, P19349; Guo NH, 1997, J PEPT RES, V50, P210; GUO NH, 1992, P NATL ACAD SCI USA, V89, P3040, DOI 10.1073/pnas.89.7.3040; GUO NH, 1992, J BIOL CHEM, V267, P17743; HEMLER ME, 1984, J IMMUNOL, V132, P3011; Hotchkiss KA, 1996, BIOCHEMISTRY-US, V35, P9761, DOI 10.1021/bi9603938; Hsu SC, 1996, CANCER RES, V56, P5684; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Incardona F, 1996, J CELL BIOCHEM, V62, P431, DOI 10.1002/(SICI)1097-4644(19960915)62:4<431::AID-JCB1>3.0.CO;2-N; IruelaArispe ML, 1997, THROMB HAEMOSTASIS, V78, P672; KAESBERG PR, 1989, J CLIN INVEST, V83, P994, DOI 10.1172/JCI113986; Kolanus W, 1997, CURR OPIN CELL BIOL, V9, P725, DOI 10.1016/S0955-0674(97)80127-5; Lasky LA, 1997, NATURE, V390, P15, DOI 10.1038/36204; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; MIKHAILENKO I, 1995, J BIOL CHEM, V270, P9543, DOI 10.1074/jbc.270.16.9543; PEYRAT JP, 1989, B CANCER, V76, P311; Roberts David D., 1994, Journal of Tissue Culture Methods, V16, P217, DOI 10.1007/BF01540654; ROBERTS DD, 1987, J CELL BIOL, V104, P131, DOI 10.1083/jcb.104.1.131; Roberts DD, 1996, FASEB J, V10, P1183, DOI 10.1096/fasebj.10.10.8751720; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; SHEIBANI N, 1995, P NATL ACAD SCI USA, V92, P6788, DOI 10.1073/pnas.92.15.6788; SUN X, 1992, J CELL BIOL, V118, P693, DOI 10.1083/jcb.118.3.693; Tachibana I, 1997, J BIOL CHEM, V272, P29181, DOI 10.1074/jbc.272.46.29181; TUSZYNSKI GP, 1991, J CLIN INVEST, V87, P1387, DOI 10.1172/JCI115144; van der Pluijm G, 1997, LAB INVEST, V77, P665; VOGEL T, 1993, J CELL BIOCHEM, V53, P74, DOI 10.1002/jcb.240530109; VOLPERT OV, 1995, BREAST CANCER RES TR, V36, P119, DOI 10.1007/BF00666034; VOURI K, 1994, SCIENCE, V266, P1576; Wang XQ, 1998, MOL BIOL CELL, V9, P865, DOI 10.1091/mbc.9.4.865; WEINSTATSASLOW DL, 1994, CANCER RES, V54, P6504; YABKOWITZ R, 1993, J IMMUNOL, V151, P149	45	107	109	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11408	11416		10.1074/jbc.274.16.11408	http://dx.doi.org/10.1074/jbc.274.16.11408			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196234	hybrid			2022-12-27	WOS:000079751900102
J	Li, S; Chen, PL; Subramanian, T; Chinnadurai, G; Tomlinson, G; Osborne, CK; Sharp, ZD; Lee, WH				Li, S; Chen, PL; Subramanian, T; Chinnadurai, G; Tomlinson, G; Osborne, CK; Sharp, ZD; Lee, WH			Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY EMBRYONIC LETHALITY; C-TERMINAL REGION; INTERACT IN-VIVO; CELL-CYCLE; DROSOPHILA CTBP; GENE-PRODUCT; PROTEIN; BREAST; MUTATION; REPAIR	Mutations in BRCA1 are responsible for nearly all of the hereditary ovarian and breast cancers, and about half of those in breast cancer-only kindreds. The ability of BRCA1 to transactivate the p21 promoter can be inactivated by mutation of the conserved BRCA1 C-terminal (BRCT) repeats. To explore the mechanisms of this BRCA1 function, the BRCT repeats were used as bait in a yeast two-hybrid screen. A known protein, CtIP, a co-repressor with CtBP, was found. CtIP interacts specifically with the BRCT repeats of BRCA1, both in vitro and in vivo, and tumor-derived mutations in this region abolished these interactions. The association of BRCA1 with CtIP was also abrogated in cells treated with DNA-damaging agents including UV, gamma-irradiation, and adriamycin, a response correlated with BRCA1 phosphorylation. The transactivation of the p21 promoter by BRCA1 was diminished by expression of exogenous CtIP and CtBP. These results suggest that the binding of the BRCT repeats of BRCA1 to CtIP/CtBP is critical in mediating transcriptional regulation of p21 in response to DNA damage.	Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78245 USA; St Louis Univ, Med Ctr, Inst Mol Virol, St Louis, MO 63110 USA; Univ Texas, SW Med Ctr, Dept Pediat, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75235 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Saint Louis University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Lee, WH (corresponding author), Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA.		Tomlinson, Gail/AAR-9776-2020; LI, SHANG/HII-4989-2022	LI, SHANG/0000-0002-6226-3362	NCI NIH HHS [CA58183, CA30195] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA058183, P01CA030195] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bertwistle D, 1998, CURR OPIN GENET DEV, V8, P14, DOI 10.1016/S0959-437X(98)80056-7; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen CF, 1996, J BIOL CHEM, V271, P32863, DOI 10.1074/jbc.271.51.32863; Chen YM, 1996, SCIENCE, V272, P125, DOI 10.1126/science.272.5258.125; Chen YM, 1996, CANCER RES, V56, P3168; Critchlow SE, 1997, CURR BIOL, V7, P588, DOI 10.1016/S0960-9822(06)00258-2; DURFEE T, 1994, J CELL BIOL, V127, P609, DOI 10.1083/jcb.127.3.609; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; EASTON DF, 1995, AM J HUM GENET, V56, P265; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Hakem R, 1997, NAT GENET, V16, P298, DOI 10.1038/ng0797-298; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Poortinga G, 1998, EMBO J, V17, P2067, DOI 10.1093/emboj/17.7.2067; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Sollerbrant K, 1996, NUCLEIC ACIDS RES, V24, P2578, DOI 10.1093/nar/24.13.2578; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Tomlinson GE, 1998, CANCER RES, V58, P3237; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388	37	162	168	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11334	11338		10.1074/jbc.274.16.11334	http://dx.doi.org/10.1074/jbc.274.16.11334			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196224	hybrid			2022-12-27	WOS:000079751900092
J	Martens, JS; Lougheed, M; Gomez-Munoz, A; Steinbrecher, UP				Martens, JS; Lougheed, M; Gomez-Munoz, A; Steinbrecher, UP			A modification of apolipoprotein B accounts for most of the induction of macrophage growth by oxidized low density lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING-FACTOR ACETYLHYDROLASE; COLONY-STIMULATING FACTOR; SMOOTH-MUSCLE CELLS; A TYPE I/II; SCAVENGER RECEPTOR; ENDOTHELIAL-CELLS; ATHEROSCLEROTIC LESIONS; HUMAN-PLASMA; IN-VITRO; OXIDATION	It has recently been shown that macrophage proliferation occurs during the progression of atherosclerotic lesions and that oxidized low density lipoprotein (LDL) stimulates macrophage growth. Possible mechanisms for this include the interaction of oxidized LDL with integral plasma membrane proteins coupled to signaling pathways, the release of growth factors and autocrine activation of growth factor receptors, or the potentiation of mitogenic signal transduction by a component of oxidized LDL after internalization. The present study was undertaken to further elucidate the mechanisms involved in the growth-stimulating effect of oxidized LDL in macrophages, Only extensively oxidized LDL caused significant growth stimulation, whereas mildly oxidized LDL, native LDL, and acetyl LDL were ineffective. LDL that had been methylated before oxidation (to block lysine derivatization by oxidation products and thereby prevent the formation of a scavenger receptor ligand) did not promote growth, even though extensive lipid peroxidation had occurred. The growth stimulation could not be attributed to lysophosphatidylcholine (lyso-PC) because incubation of oxidized LDL with fatty acid-free bovine serum albumin resulted in a 97% decrease in lyse-PC content but only a 20% decrease in mitogenic activity. Similarly, treatment of acetyl LDL with phospholipase A(2) converted more than 90% of the initial content of phosphatidylcholine (PC) to lyso-PC, but the phospholipase A(2)-treated acetyl LDL was nearly 10-fold less potent than oxidized LDL at stimulating growth. Platelet-activating factor receptor antagonists partly inhibited growth stimulation by oxidized LDL, but platelet-activating factor itself did not induce growth. Digestion of oxidized LDL with phospholipase A(2) resulted in the hydrolysis of PC and oxidized PC but did not attenuate growth induction. Native LDL, treated with autoxidized arachidonic acid under conditions that caused extensive modification of lysine residues by lipid peroxidation products but did not result in oxidation of LDL lipids, was equal to oxidized LDL in potency at stimulating macrophage growth. Albumin modified by arachidonic acid peroxidation products also stimulated growth, demonstrating that LDL lipids that oxidatively modified apolipoprotein B is the main growth-stimulating component of oxidized LDL, but that oxidized phospholipids may play a secondary role.	Univ British Columbia, Dept Med, Div Gastroenterol, Vancouver, BC V5Z 4E3, Canada	University of British Columbia	Steinbrecher, UP (corresponding author), Univ British Columbia, Dept Med, Div Gastroenterol, 3300-950 W 10th Ave, Vancouver, BC V5Z 4E3, Canada.			GOMEZ MUNOZ, ANTONIO/0000-0002-2539-016X				Antonov AS, 1997, J CLIN INVEST, V99, P2867, DOI 10.1172/JCI119480; BERLINER JA, 1990, J CLIN INVEST, V85, P1260, DOI 10.1172/JCI114562; BROWN MS, 1980, J SUPRAMOL STR CELL, V13, P67, DOI 10.1002/jss.400130107; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; Dentan C, 1996, BBA-LIPID LIPID MET, V1299, P353, DOI 10.1016/0005-2760(95)00226-X; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P335; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HEERY JM, 1995, J CLIN INVEST, V96, P2322, DOI 10.1172/JCI118288; KATSUDA S, 1993, AM J PATHOL, V142, P1787; KIM JA, 1994, ARTERIOSCLER THROMB, V14, P427, DOI 10.1161/01.ATV.14.3.427; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; LIAPIKOS TA, 1994, BBA-LIPID LIPID MET, V1212, P353, DOI 10.1016/0005-2760(94)90210-0; Ling WH, 1997, J CLIN INVEST, V100, P244, DOI 10.1172/JCI119528; Lougheed M, 1997, J BIOL CHEM, V272, P12938, DOI 10.1074/jbc.272.20.12938; Lougheed M, 1996, J BIOL CHEM, V271, P11798, DOI 10.1074/jbc.271.20.11798; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYNCH SM, 1994, J CLIN INVEST, V93, P998, DOI 10.1172/JCI117107; Martens JS, 1998, J BIOL CHEM, V273, P4915, DOI 10.1074/jbc.273.9.4915; Matsumura T, 1997, ARTERIOSCL THROM VAS, V17, P3013, DOI 10.1161/01.ATV.17.11.3013; PALINSKI W, 1994, ARTERIOSCLER THROMB, V14, P605, DOI 10.1161/01.ATV.14.4.605; QUINN MT, 1987, P NATL ACAD SCI USA, V84, P2995, DOI 10.1073/pnas.84.9.2995; RAJAVASHISTH TB, 1990, NATURE, V344, P254, DOI 10.1038/344254a0; REKHTER MD, 1995, AM J PATHOL, V147, P668; ROSENFELD ME, 1992, AM J PATHOL, V140, P291; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P336, DOI 10.1161/01.ATV.10.3.336; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sakai M, 1996, J BIOL CHEM, V271, P27346, DOI 10.1074/jbc.271.44.27346; SAKAI M, 1994, J BIOL CHEM, V269, P31430; SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396; SCHWARTZ D, 1994, J CLIN INVEST, V94, P1968, DOI 10.1172/JCI117548; SCUDIERO DA, 1988, CANCER RES, V48, P4827; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1989, J LIPID RES, V30, P305; STEINBRECHER UP, 1992, ARTERIOSCLER THROMB, V12, P608, DOI 10.1161/01.ATV.12.5.608; STEINBRECHER UP, 1987, J BIOL CHEM, V262, P3603; STEINBRECHER UP, 1987, ARTERIOSCLEROSIS, V7, P135, DOI 10.1161/01.ATV.7.2.135; STEINBRECHER UP, 1989, J BIOL CHEM, V264, P15216; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; STREMLER KE, 1989, J BIOL CHEM, V264, P5331; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; YLAHERTTUALA S, 1990, EUR HEART J, V11, P88, DOI 10.1093/eurheartj/11.suppl_E.88; YUI S, 1993, ARTERIOSCLER THROMB, V13, P331, DOI 10.1161/01.ATV.13.3.331; ZHANG H, 1993, CLIN CHEM ENZYMOL CO, V2, P142	44	41	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10903	10910		10.1074/jbc.274.16.10903	http://dx.doi.org/10.1074/jbc.274.16.10903			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196168	hybrid			2022-12-27	WOS:000079751900036
J	Moodie, SA; Alleman-Sposeto, J; Gustafson, TA				Moodie, SA; Alleman-Sposeto, J; Gustafson, TA			Identification of the APS protein as a novel insulin receptor substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION; FACTOR-I RECEPTORS; 3T3-L1 ADIPOCYTES; GLUCOSE-TRANSPORT; KINASE-B; GLUT4 TRANSLOCATION; DNA-SYNTHESIS; GLUCOSE-TRANSPORTER-4 TRANSLOCATION; PHOSPHOINOSITIDE 3-KINASE; SIGNALING PATHWAYS	In order to identify novel substrates involved in insulin receptor signaling, a yeast two-hybrid 3T3-L1 adipocyte cDNA library was screened with the cytoplasmic domain of the human insulin receptor as bait. Here we describe the isolation and characterization of an interacting protein, APS, which contains pleckstrin homology and Src homology 2 domains and several potential tyrosine phosphorylation sites. APS mRNA and protein are expressed primarily in skeletal muscle, heart, and adipose tissue, and in differentiated 3T3-L1 adipocytes, We show that APS associates with phosphotyrosines situated within the activation loop of the insulin receptor via the APS Src homology 2 domain. Insulin stimulation of 3T3-L1 adipocytes resulted in rapid tyrosine phosphorylation of endogenous APS on tyrosine 618, whereas platelet-derived growth factor treatment resulted in no APS phosphorylation, In summary, we have identified a new insulin receptor substrate that is primarily expressed in insulin-responsive tissues and in 3T3-L1 adipocytes whose phosphorylation shows insulin receptor specificity. These findings suggest a potential role for APS in insulin-regulated metabolic signaling pathways.	Metabolex Inc, Hayward, CA 94545 USA		Moodie, SA (corresponding author), Metabolex Inc, 3876 Bay Ctr Pl, Hayward, CA 94545 USA.							Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; BACKER JM, 1993, J BIOL CHEM, V268, P8204; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; Dong LQ, 1997, MOL ENDOCRINOL, V11, P1757, DOI 10.1210/me.11.12.1757; EBINA Y, 1985, P NATL ACAD SCI USA, V82, P8014, DOI 10.1073/pnas.82.23.8014; EVANS JL, 1995, CELL SIGNAL, V7, P365, DOI 10.1016/0898-6568(95)00007-C; Frevert EU, 1998, J BIOL CHEM, V273, P25480, DOI 10.1074/jbc.273.39.25480; Frevert EU, 1997, MOL CELL BIOL, V17, P190, DOI 10.1128/MCB.17.1.190; GOLEMIS EA, 1992, MOL CELL BIOL, V12, P3006, DOI 10.1128/MCB.12.7.3006; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HARUTA T, 1995, J BIOL CHEM, V270, P27991; HERBST JJ, 1995, J BIOL CHEM, V270, P26000, DOI 10.1074/jbc.270.43.26000; HUANG XM, 1995, P NATL ACAD SCI USA, V92, P11618, DOI 10.1073/pnas.92.25.11618; ISAKOFF SJ, 1995, P NATL ACAD SCI USA, V92, P10247, DOI 10.1073/pnas.92.22.10247; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; Katagiri H, 1997, AM J PHYSIOL-ENDOC M, V272, pE326, DOI 10.1152/ajpendo.1997.272.2.E326; Katagiri H, 1996, J BIOL CHEM, V271, P16987, DOI 10.1074/jbc.271.29.16987; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Morris AJ, 1996, P NATL ACAD SCI USA, V93, P8401, DOI 10.1073/pnas.93.16.8401; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; ONeill TJ, 1996, J BIOL CHEM, V271, P22506, DOI 10.1074/jbc.271.37.22506; ONEILL TJ, 1994, MOL CELL BIOL, V14, P6433, DOI 10.1128/MCB.14.10.6433; OSBORNE MA, 1995, BIO-TECHNOL, V13, P1474, DOI 10.1038/nbt1295-1474; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Riedel H, 1997, J BIOCHEM-TOKYO, V122, P1105; Rui LY, 1998, J BIOL CHEM, V273, P21239, DOI 10.1074/jbc.273.33.21239; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Shepherd PR, 1997, BIOCHEM SOC T, V25, P978, DOI 10.1042/bst0250978; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Takaki S, 1997, J BIOL CHEM, V272, P14562, DOI 10.1074/jbc.272.23.14562; Tanti JF, 1996, J BIOL CHEM, V271, P25227, DOI 10.1074/jbc.271.41.25227; Tanti JF, 1997, ENDOCRINOLOGY, V138, P2005, DOI 10.1210/en.138.5.2005; Wang J, 1998, J BIOL CHEM, V273, P3136, DOI 10.1074/jbc.273.6.3136; WIESE RJ, 1995, J BIOL CHEM, V270, P3442, DOI 10.1074/jbc.270.7.3442; YEH JI, 1995, J BIOL CHEM, V270, P2107, DOI 10.1074/jbc.270.5.2107; Yokouchi M, 1997, ONCOGENE, V15, P7, DOI 10.1038/sj.onc.1201163; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	44	82	83	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11186	11193		10.1074/jbc.274.16.11186	http://dx.doi.org/10.1074/jbc.274.16.11186			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196204	hybrid			2022-12-27	WOS:000079751900072
J	Okomoto, T; Minamikawa, T; Edward, G; Vakharia, V; Herman, E				Okomoto, T; Minamikawa, T; Edward, G; Vakharia, V; Herman, E			Posttranslational removal of the carboxyl-terminal KDEL of the cysteine protease SH-EP occurs prior to maturation of the enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUXIN-BINDING PROTEIN; LUMINAL ER PROTEINS; MUNG-BEAN SEEDLINGS; RAT PROCATHEPSIN-B; ENDOPLASMIC-RETICULUM; CATHEPSIN-L; VIGNA-MUNGO; MOLECULAR-CLONING; SULFHYDRYL-ENDOPEPTIDASE; VICILIN PEPTIDOHYDROLASE	SH-EP is a cysteine protease from germinating mung bean (Vigna mungo) that possesses a carboxyl-terminal endoplasmic reticulum (ER) retention sequence, KDEL. In order to examine the function of the ER retention sequence, we expressed a full-length cDNA of SH-EP and a minus-KDEL control in insect Sf-9 cells using the baculovirus system. Our observations on the synthesis, processing, and trafficking of SH-EP in Sf-9 cells suggest that the KDEL ER-retention sequence is posttranslationally removed either while the protein is still in the ER or immediately after its exit from the ER, resulting in the accumulation of proSH-EP minus its KDEL signal. It is this intermediate form that appears to progress through the endomembrane system and is subsequently processed to form mature active SH-EP, The removal of an ER retention may regulate protein delivery to a functional site and present an alternative role for ER retention sequences in addition to their well established role in maintaining the protein composition of the ER lumen.	Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan; Univ Maryland, Ctr Agr Biotechnol, College Pk, MD 20742 USA; ARS, Climate Stress Lab, USDA, Beltsville, MD 20705 USA	Tokyo Metropolitan University; University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA)	Okomoto, T (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Minami Osawa, Tokyo 1920397, Japan.			Vakharia, Vikram/0000-0002-0955-3010				AKASOFU H, 1989, NUCLEIC ACIDS RES, V17, P6733, DOI 10.1093/nar/17.16.6733; BAKER EN, 1977, J MOL BIOL, V115, P263, DOI 10.1016/0022-2836(77)90154-1; BAUMGARTNER B, 1978, J CELL BIOL, V79, P10, DOI 10.1083/jcb.79.1.10; BAUMGARTNER B, 1977, EUR J BIOCHEM, V77, P223, DOI 10.1111/j.1432-1033.1977.tb11661.x; BECKER C, 1995, EUR J BIOCHEM, V228, P456, DOI 10.1111/j.1432-1033.1995.tb20284.x; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; BOOTH C, 1989, CELL, V59, P729, DOI 10.1016/0092-8674(89)90019-6; BOYLAN MT, 1987, PLANTA, V170, P343, DOI 10.1007/BF00395026; BUSTOS MM, 1988, PLANT MOL BIOL, V10, P475, DOI 10.1007/BF00033603; Carmona E, 1996, BIOCHEMISTRY-US, V35, P8149, DOI 10.1021/bi952736s; CHRISPEELS MJ, 1976, P NATL ACAD SCI USA, V73, P3168, DOI 10.1073/pnas.73.9.3168; CHRISPEELS MJ, 1975, PLANT PHYSIOL, V55, P1031, DOI 10.1104/pp.55.6.1031; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; CUOZZO JW, 1995, J BIOL CHEM, V270, P15611, DOI 10.1074/jbc.270.26.15611; Cygler M, 1996, STRUCTURE, V4, P405, DOI 10.1016/S0969-2126(96)00046-9; DENECKE J, 1992, EMBO J, V11, P2345, DOI 10.1002/j.1460-2075.1992.tb05294.x; DENECKE J, 1991, PLANT CELL, V3, P1025, DOI 10.1105/tpc.3.9.1025; DRENTH J, 1968, NATURE, V218, P929, DOI 10.1038/218929a0; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; Guerrero C, 1998, PLANT MOL BIOL, V36, P565, DOI 10.1023/A:1005952005739; GUERRERO FD, 1990, PLANT MOL BIOL, V15, P11, DOI 10.1007/BF00017720; HARANISHIMURA I, 1991, FEBS LETT, V294, P89, DOI 10.1016/0014-5793(91)81349-D; HARANISHIMURA I, 1993, PLANT CELL, V5, P1651, DOI 10.1105/tpc.5.11.1651; HARDWICK KG, 1990, EMBO J, V9, P623, DOI 10.1002/j.1460-2075.1990.tb08154.x; Henderson J, 1997, PLANTA, V202, P313, DOI 10.1007/s004250050133; HERMAN EM, 1990, PLANTA, V182, P305, DOI 10.1007/BF00197126; HESSE T, 1989, EMBO J, V8, P2453, DOI 10.1002/j.1460-2075.1989.tb08380.x; HICKS GR, 1989, P NATL ACAD SCI USA, V86, P4948, DOI 10.1073/pnas.86.13.4948; HINK WF, 1970, NATURE, V226, P466, DOI 10.1038/226466b0; HIRANO H, 1992, J BIOCHEM-TOKYO, V111, P754, DOI 10.1093/oxfordjournals.jbchem.a123831; HOLWERDA BC, 1990, PLANT CELL, V2, P1091, DOI 10.1105/tpc.2.11.1091; HOLWERDA BC, 1992, PLANT CELL, V4, P307, DOI 10.1105/tpc.4.3.307; INOHARA N, 1989, P NATL ACAD SCI USA, V86, P3564, DOI 10.1073/pnas.86.10.3564; JONES AM, 1993, PLANT PHYSIOL, V101, P595, DOI 10.1104/pp.101.2.595; Jones CG, 1996, BBA-PROTEIN STRUCT M, V1296, P13, DOI 10.1016/0167-4838(96)00098-2; KALINSKI A, 1992, J BIOL CHEM, V267, P12068; Kalinski A, 1997, PLANT PHYSIOL BIOCH, V35, P795; KALINSKI AJ, 1994, PLANTA, V195, P611; Kardailsky IV, 1996, MOL PLANT MICROBE IN, V9, P689, DOI 10.1094/MPMI-9-0689; KASSELL B, 1973, SCIENCE, V180, P1022, DOI 10.1126/science.180.4090.1022; KOEHLER SM, 1990, PLANT CELL, V2, P769, DOI 10.1105/tpc.2.8.769; LEE HI, 1993, P NATL ACAD SCI USA, V90, P11433, DOI 10.1073/pnas.90.23.11433; LEWIS MJ, 1990, NATURE, V348, P162, DOI 10.1038/348162a0; LEWIS MJ, 1992, J MOL BIOL, V226, P913, DOI 10.1016/0022-2836(92)91039-R; MACDONALD H, 1994, PLANT PHYSIOL, V105, P1049, DOI 10.1104/pp.105.4.1049; MASON RW, 1992, BIOCHEM BIOPH RES CO, V189, P1659, DOI 10.1016/0006-291X(92)90268-P; MASON RW, 1987, BIOCHEM J, V248, P449, DOI 10.1042/bj2480449; MCINTYRE GF, 1993, P NATL ACAD SCI USA, V90, P10588, DOI 10.1073/pnas.90.22.10588; MITSUHASHI W, 1986, PLANT PHYSIOL, V80, P628, DOI 10.1104/pp.80.3.628; MITSUHASHI W, 1989, PLANT PHYSIOL, V89, P274, DOI 10.1104/pp.89.1.274; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Muntz K, 1996, J EXP BOT, V47, P605, DOI 10.1093/jxb/47.5.605; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; NAPIER RM, 1990, PLANTA, V182, P313, DOI 10.1007/BF00197128; NAPIER RM, 1992, J CELL SCI, V102, P261; NISHIMURA M, 1982, PLANT PHYSIOL, V70, P742, DOI 10.1104/pp.70.3.742; NONG VH, 1995, BBA-GENE STRUCT EXPR, V1261, P435, DOI 10.1016/0167-4781(95)00038-I; NORTH MJ, 1986, BIOCHEM J, V238, P623, DOI 10.1042/bj2380623; OKAMOTO T, 1994, FEBS LETT, V351, P31, DOI 10.1016/0014-5793(94)00809-4; OKAMOTO T, 1995, EUR J BIOCHEM, V231, P300, DOI 10.1111/j.1432-1033.1995.tb20700.x; Okamoto T, 1999, PLANT MOL BIOL, V39, P63, DOI 10.1023/A:1006170518002; Okita TW, 1996, ANNU REV PLANT PHYS, V47, P327, DOI 10.1146/annurev.arplant.47.1.327; Paris N, 1997, PLANT PHYSIOL, V115, P29, DOI 10.1104/pp.115.1.29; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; PUEYO JJ, 1995, PLANTA, V196, P586, DOI 10.1007/BF00203660; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; ROWAN AD, 1992, J BIOL CHEM, V267, P15993; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; SMITH SM, 1989, J BIOL CHEM, V264, P20487; TANAKA T, 1991, PLANT MOL BIOL, V16, P1083, DOI 10.1007/BF00016081; TAO K, 1994, ARCH BIOCHEM BIOPHYS, V311, P19, DOI 10.1006/abbi.1994.1203; VAUX D, 1990, NATURE, V345, P495, DOI 10.1038/345495a0; VERNET T, 1991, J BIOL CHEM, V266, P21451; VERNET T, 1995, J BIOL CHEM, V270, P10838, DOI 10.1074/jbc.270.18.10838; VITALE A, 1993, J EXP BOT, V44, P390; WANDELT CI, 1992, PLANT J, V2, P181; WEIST DL, 1995, EMBO J, V14, P3425; WEIST DL, 1997, P NATL ACAD SCI USA, V94, P1884; YAMAUCHI D, 1992, PLANT CELL PHYSIOL, V33, P789; YOSHIMORI T, 1990, J BIOL CHEM, V265, P15984	81	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11390	11398		10.1074/jbc.274.16.11390	http://dx.doi.org/10.1074/jbc.274.16.11390			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196232	hybrid			2022-12-27	WOS:000079751900100
J	Coscoy, S; de Weille, JR; Lingueglia, E; Lazdunski, M				Coscoy, S; de Weille, JR; Lingueglia, E; Lazdunski, M			The pre-transmembrane 1 domain of acid-sensing ion channels participates in the ion pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; SENSITIVE NA+ CHANNEL; MUTATIONS CAUSING NEURODEGENERATION; CAENORHABDITIS-ELEGANS; PSEUDOHYPOALDOSTERONISM TYPE-1; MEMBRANE TOPOLOGY; MOLECULAR-CLONING; SUBUNIT; IDENTIFICATION; RESIDUES	The acid-sensing ion channel (ASIC) subunits ASIC1, ASIC2, and ASIC3 are members of the amiloride-sensitive Na+ channel/degenerin family of ion channels. They form proton-gated channels that are expressed in the central nervous system and in sensory neurons, where they are thought to play an important role in pain accompanying tissue acidosis, A splice variant of ASIC2, ASIC2b, is not active on its own but modifies the properties of ASIC3, In particular, whereas most members of the amiloride-sensitive Na+ channel/degenerin family are highly selective for Na+ over K+, ASIC3/ASIC2b heteromultimers show a nonselective component, Chimeras of the two splice variants allowed identification of a 9-amino acid region preceding the first transmembrane (TM) domain (pre-TM1) of ASIC2 that is involved in ion permeation and is critical for Na+ selectivity. Three amino acids in this region (Ile-19, Phe-20, and Thr-25) appear to be particularly important, because channels mutated at these residues discriminate poorly between Na+ and K+. In addition, the pH dependences of the activity of the F20S and T25K mutants are changed as compared with that of wild-type ASIC2, A corresponding ASIC3 mutant (T26K) also has modified Na+ selectivity. Our results suggest that the pre-TM1 region of ASICs participates in the ion pore.	Inst Pharmacol Mol & Cellulaire, CNRS, UPR 411, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Lazdunski, M (corresponding author), Inst Pharmacol Mol & Cellulaire, CNRS, UPR 411, 660 Route Lucioles,Sophia Antipolis, F-06560 Valbonne, France.	ipmc@ipmc.cnrs.fr	LINGUEGLIA, Eric/F-5509-2013; de Weille, Jan R/F-8103-2014	LINGUEGLIA, Eric/0000-0003-3902-3405; de Weille, Jan R/0000-0002-0505-3166; Coscoy, Sylvie/0000-0003-3963-3609				BEVAN S, 1991, J PHYSIOL-LONDON, V433, P145, DOI 10.1113/jphysiol.1991.sp018419; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Champigny G, 1998, J BIOL CHEM, V273, P15418, DOI 10.1074/jbc.273.25.15418; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; FULLER CM, 1995, AM J PHYSIOL-CELL PH, V269, pC641, DOI 10.1152/ajpcell.1995.269.3.C641; Garcia-Anoveros J, 1998, NEURON, V20, P1231, DOI 10.1016/S0896-6273(00)80503-6; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Kosari F, 1998, J BIOL CHEM, V273, P13469, DOI 10.1074/jbc.273.22.13469; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; RENARD S, 1994, J BIOL CHEM, V269, P12981; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; WALDMANN R, 1995, J BIOL CHEM, V270, P11735, DOI 10.1074/jbc.270.20.11735; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411	27	67	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10129	10132		10.1074/jbc.274.15.10129	http://dx.doi.org/10.1074/jbc.274.15.10129			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187795	hybrid			2022-12-27	WOS:000079663500034
J	Li, HL; Davis, W; Pure, E				Li, HL; Davis, W; Pure, E			Suboptimal cross-linking of antigen receptor induces Syk-dependent activation of p70S6 kinase through protein kinase C and phosphoinositol 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED SIGNAL-TRANSDUCTION; BRUTONS TYROSINE KINASE; B-CELL DEVELOPMENT; S6 KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; RAPAMYCIN SENSITIVITY; INSULIN STIMULATION; INDEPENDENT PATHWAY; DOWN-REGULATION; LYMPHOCYTES-B	Ligation of the B cell antigen receptor (BCR) induces a cascade of signaling pathways that lead to clonal expansion, differentiation, or abortive activation-induced apoptosis of B lymphocytes, BCR-mediated cross-linking induces the sapid phosphorylation of protein tyrosine kinases. However, the pathways leading to the activation of downstream serine/threonine kinases such as mitogen-activated protein kinase, p90(Rsk), and p70S6 kinase (p70(S6k)) that mediate reorganization of the actin cytoskeleton, cell cycle progression, gene transcription, and protein synthesis have not been delineated. We recently demonstrated that cross-linking of BCR leads to activation of p70(S6k) in B lymphocytes, In this report, we demonstrate that multiple protein tyrosine kinase-dependent signal transduction pathways induced by BCR lead to the activation of p70(S6k). These distinct pathways exhibit different thresholds with respect Co the extent of receptor cross-linking required for their activation. Activation of p70S6k by suboptimal doses of anti-Ig is Syk-dependent and is mediated by protein kinase C and phosphoinositol 3-kinase. Moreover, the activation of p70(S6k) results in phosphorylation of S6. protein which is important for ribosomal protein synthesis and may be coupled to BCR-induced protein and DNA synthesis in primary murine B cells.	Wistar Inst, Philadelphia, PA 19104 USA	The Wistar Institute	Pure, E (corresponding author), Wistar Inst, 3601 Spruce St, Philadelphia, PA 19104 USA.		Li, Hsiu-Ling/C-3567-2011		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025185] Funding Source: NIH RePORTER; NIAID NIH HHS [AI25185] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AAGAARDTILLERY KM, 1994, CELL IMMUNOL, V156, P493, DOI 10.1006/cimm.1994.1193; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; BALLOU LM, 1991, NATURE, V349, P348, DOI 10.1038/349348a0; BJORBAEK C, 1995, J BIOL CHEM, V270, P18848, DOI 10.1074/jbc.270.32.18848; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; CALVO V, 1992, P NATL ACAD SCI USA, V89, P7571, DOI 10.1073/pnas.89.16.7571; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; CHANG PY, 1995, J BIOL CHEM, V270, P29928; Chang YWE, 1997, J BIOL CHEM, V272, P28252, DOI 10.1074/jbc.272.45.28252; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CHEATHAM L, 1995, P NATL ACAD SCI USA, V92, P11696, DOI 10.1073/pnas.92.25.11696; CHEN RH, 1991, MOL CELL BIOL, V11, P1861, DOI 10.1128/MCB.11.4.1861; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; CHOU MM, 1995, CURR OPIN CELL BIOL, V7, P806, DOI 10.1016/0955-0674(95)80064-6; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Cox D, 1996, J BIOL CHEM, V271, P16597, DOI 10.1074/jbc.271.28.16597; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Dumont F J, 1996, Life Sci, V58, P373; Edelmann HML, 1996, J BIOL CHEM, V271, P963, DOI 10.1074/jbc.271.2.963; Fulcher D A, 1997, Int Rev Immunol, V15, P33, DOI 10.3109/08830189709068170; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GSCHWENDT M, 1991, TRENDS BIOCHEM SCI, V16, P167, DOI 10.1016/0968-0004(91)90064-3; HAN JW, 1995, J BIOL CHEM, V270, P21396, DOI 10.1074/jbc.270.36.21396; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; IGARASHI H, 1994, J IMMUNOL, V153, P2381; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; JOHNSON SA, 1995, J IMMUNOL, V155, P4596; Jugloff LS, 1997, J IMMUNOL, V159, P1096; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Katsuta H, 1998, J IMMUNOL, V160, P1547; Kawasome H, 1998, P NATL ACAD SCI USA, V95, P5033, DOI 10.1073/pnas.95.9.5033; Kilgour E, 1996, BIOCHEM J, V315, P517, DOI 10.1042/bj3150517; KUO CJ, 1992, NATURE, V358, P70, DOI 10.1038/358070a0; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; Lenormand P, 1996, J BIOL CHEM, V271, P15762, DOI 10.1074/jbc.271.26.15762; Li HL, 1997, J BIOL CHEM, V272, P18200, DOI 10.1074/jbc.272.29.18200; LI TJ, 1995, IMMUNITY, V2, P451, DOI 10.1016/1074-7613(95)90026-8; Lin JJ, 1997, J IMMUNOL, V159, P4823; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Mahalingam M, 1996, MOL CELL BIOL, V16, P405; McIlroy J, 1997, MOL CELL BIOL, V17, P248, DOI 10.1128/MCB.17.1.248; Mishell B.B., 1980, SELECTED METHODS CEL; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; NOORCHASHM H, 1999, IN PRESS INT IMMUNOL; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; PAPKOFF J, 1994, MOL CELL BIOL, V14, P463, DOI 10.1128/MCB.14.1.463; Pearson R B, 1995, Prog Cell Cycle Res, V1, P21; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Reif K, 1997, J BIOL CHEM, V272, P14426, DOI 10.1074/jbc.272.22.14426; REINHARD C, 1994, EMBO J, V13, P1557, DOI 10.1002/j.1460-2075.1994.tb06418.x; SEGER R, 1995, J BIOL CHEM, V270, P28325; Seva C, 1997, BIOCHEM BIOPH RES CO, V238, P202, DOI 10.1006/bbrc.1997.7163; SILLMAN AL, 1995, J BIOL CHEM, V270, P11806, DOI 10.1074/jbc.270.20.11806; Stewart MJ, 1996, P NATL ACAD SCI USA, V93, P10791, DOI 10.1073/pnas.93.20.10791; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; TERADA N, 1992, BIOCHEM BIOPH RES CO, V186, P1315, DOI 10.1016/S0006-291X(05)81549-9; TERADA N, 1995, J IMMUNOL, V155, P3418; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Tudan C, 1998, BIOCHEM J, V331, P531, DOI 10.1042/bj3310531; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Watson KL, 1996, P NATL ACAD SCI USA, V93, P13694, DOI 10.1073/pnas.93.24.13694; WENG QP, 1995, P NATL ACAD SCI USA, V92, P5744, DOI 10.1073/pnas.92.12.5744; WENG QP, 1995, MOL CELL BIOL, V15, P2333; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903	77	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9812	9820		10.1074/jbc.274.14.9812	http://dx.doi.org/10.1074/jbc.274.14.9812			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092671	hybrid			2022-12-27	WOS:000079451800090
J	Fleming, IN; Elliott, CM; Buchanan, FG; Downes, CP; Exton, JH				Fleming, IN; Elliott, CM; Buchanan, FG; Downes, CP; Exton, JH			Ca2+/calmodulin-dependent protein kinase II regulates Tiam1 by reversible protein phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-FAMILY GTPASES; SWISS 3T3 CELLS; PLECKSTRIN HOMOLOGY DOMAINS; ACTIN STRESS FIBERS; PHOSPHOLIPASE-D; GROWTH-FACTOR; LYSOPHOSPHATIDIC ACID; RAS TRANSFORMATION; GDP/GTP EXCHANGE; CDC42 GTPASES	A number of guanine nucleotide exchange factors have been identified that activate Rho family GTPases, by promoting the binding of GTP to these proteins. We have recently demonstrated that lysophosphatidic acid and several other agonists stimulate phosphorylation of the Rac1-specific exchange factor Tiam1 in Swiss 3T3 fibroblasts, and that protein kinase C is involved in Tiam1 phosphorylation (Fleming, I. N,, Elliott, C, M,, Collard, J, G,, and Exton, J, H. (1997) J, BioA Chem. 272, 33105-33110), We now show, through manipulation of intracellular [Ca2+] and the use of protein kinase inhibitors, that both protein kinase C alpha and Ca2+/calmodulindependent protein kinase II are involved in the phosphorylation of Tiam1 in vivo, Furthermore, we show that Ca2+/calmodulin-dependent protein kinase II phosphorylates Tiam1 in vitro, producing an electrophoretic retardation on SDS-polyacrylamide gel electrophoresis, Significantly, phosphorylation of Tiam1 by Ca2+/calmodulin-dependent protein kinase II, but not by protein kinase C, enhanced its nucleotide exchange activity toward Rad, by approximately a-fold. Furthermore, Tiam1 was preferentially dephosphorylated by protein phosphatase 1 in vitro, and treatment with this phosphatase abolished the Ca2+/calmodulin-dependent protein kinase II activation of Tiam1, These data demonstrate that protein kinase Ca and Ca2+/calmodulin-dependent protein kinase II phosphorylate Tiam1 in vivo, and that the latter kinase plays a key role in regulating the activity of this exchange factor in vitro.	Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Univ Dundee, Inst Med Sci, Dept Biochem, Dundee DD1 4HN, Scotland	Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University; University of Dundee	Exton, JH (corresponding author), Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, 221 Kirkland Hall, Nashville, TN 37232 USA.			Fleming, Ian/0000-0001-9505-6418				BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Fleming IN, 1996, J BIOL CHEM, V271, P33067, DOI 10.1074/jbc.271.51.33067; Fleming IN, 1997, J BIOL CHEM, V272, P33105, DOI 10.1074/jbc.272.52.33105; Fleming IN, 1998, FEBS LETT, V429, P229, DOI 10.1016/S0014-5793(98)00566-3; FUJISAWA H, 1990, BIOESSAYS, V12, P27, DOI 10.1002/bies.950120106; GRAZIANI G, 1989, ONCOGENE, V4, P823; HABETS GGM, 1995, ONCOGENE, V10, P1371; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hess JA, 1997, J BIOL CHEM, V272, P1615, DOI 10.1074/jbc.272.3.1615; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; HORII Y, 1994, EMBO J, V13, P4776, DOI 10.1002/j.1460-2075.1994.tb06803.x; ISSANDOU M, 1990, J BIOL CHEM, V265, P11890; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; Malcolm KC, 1996, J BIOL CHEM, V271, P13135, DOI 10.1074/jbc.271.22.13135; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MIURA Y, 1993, J BIOL CHEM, V268, P510; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OLIVIER AR, 1992, J CELL PHYSIOL, V152, P240, DOI 10.1002/jcp.1041520204; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; SCHULMAN H, 1989, TRENDS BIOCHEM SCI, V14, P62, DOI 10.1016/0968-0004(89)90045-5; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Stam JC, 1998, EMBO J, V17, P4066, DOI 10.1093/emboj/17.14.4066; TAKUWA N, 1989, J BIOL CHEM, V264, P7856; YEO EJ, 1995, J BIOL CHEM, V270, P3980, DOI 10.1074/jbc.270.8.3980; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; ZHENG Y, 1995, J BIOL CHEM, V270, P9031, DOI 10.1074/jbc.270.16.9031	39	133	136	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12753	12758		10.1074/jbc.274.18.12753	http://dx.doi.org/10.1074/jbc.274.18.12753			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212259	hybrid			2022-12-27	WOS:000080056800079
J	Huang, CS; Ma, WY; Maxiner, A; Sun, Y; Dong, ZG				Huang, CS; Ma, WY; Maxiner, A; Sun, Y; Dong, ZG			p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; DNA-BINDING FUNCTION; ULTRAVIOLET-RADIATION; AP-1 TRANSACTIVATION; GAMMA-RADIATION; IN-VITRO; ACTIVATION; GROWTH; DAMAGE; PATHWAY	The p53 tumor suppressor protein is a transcription factor that plays a key role in the process of apoptosis and the cell's defense against tumor development. Activation of p53 occurs, at least in part, by phosphorylation of its protein. Very recently it has been reported that UV induced a functional activation of p53 via phosphorylation at serine 389. Here, we report that the UV-induced phosphorylation of p53 at serine 389 is mediated by p38 kinase. WC-induced phosphorylation of p53 at serine 389 was markedly impaired by either pretreatment of cells with p38 kinase inhibitor, SB202190, or stable expression of a dominant negative mutant of p38 kinase. In contrast, there was no inhibition observed in cells treated with specific MEK1 inhibitor, PD98059, or with stable expression of a dominant negative mutant of ERK2 or JNK1. Most importantly, p38 kinase could be co-immunoprecipitated with p53 by using antibodies against p53. Incubation of active p38 kinase with p53 protein caused the phosphorylation of p53 protein at serine 389 in. vitro, while no phosphorylation of p53 at serine 389 was observed when p53 was incubated with activated JNK2 or ERK2. Furthermore, pretreatment of cells with SB202190 blocked the p53 DNA binding activity and p53-dependent transcription. These results strongly suggest that the p38 kinase is at least one of the most important mediators of p53 phosphorylation at serine 389 induced by UVC radiation.	Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; Parke Davis Pharmaceut Res, Dept Biol Mol, Ann Arbor, MI 48105 USA	University of Minnesota System; Pfizer	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16Th Ave NE, Austin, MN 55912 USA.	zgdong@smig.net		Huang, Chuanshu/0000-0003-4133-5096	NCI NIH HHS [CA74916] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA074916] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADLER V, 1995, CELL GROWTH DIFFER, V6, P1437; Adler V, 1997, P NATL ACAD SCI USA, V94, P1686, DOI 10.1073/pnas.94.5.1686; Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; APPEL K, 1995, ONCOGENE, V11, P1971; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; Bian JH, 1996, CARCINOGENESIS, V17, P2559, DOI 10.1093/carcin/17.12.2559; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; HAFFNER R, 1995, CURR OPIN GENET DEV, V5, P84, DOI 10.1016/S0959-437X(95)90058-6; Harris CC, 1996, JNCI-J NATL CANCER I, V88, P1442, DOI 10.1093/jnci/88.20.1442; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HARVEY M, 1993, ONCOGENE, V8, P2457; Hecker D, 1996, ONCOGENE, V12, P953; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hu MCT, 1997, ONCOGENE, V15, P2277, DOI 10.1038/sj.onc.1201401; Huang CS, 1998, CANCER RES, V58, P4102; Huang CS, 1999, CARCINOGENESIS, V20, P237, DOI 10.1093/carcin/20.2.237; Huang CS, 1996, J BIOL CHEM, V271, P31262, DOI 10.1074/jbc.271.49.31262; Huang CS, 1997, P NATL ACAD SCI USA, V94, P11957, DOI 10.1073/pnas.94.22.11957; Huang CS, 1996, MOL CELL BIOL, V16, P6427; Huang CS, 1997, J BIOL CHEM, V272, P26325, DOI 10.1074/jbc.272.42.26325; Huang CS, 1998, P NATL ACAD SCI USA, V95, P156, DOI 10.1073/pnas.95.1.156; HUPP TR, 1993, NUCLEIC ACIDS RES, V21, P3167, DOI 10.1093/nar/21.14.3167; HUPP TR, 1994, COLD SPRING HARB SYM, V59, P195, DOI 10.1101/SQB.1994.059.01.024; Kapoor M, 1998, P NATL ACAD SCI USA, V95, P2834, DOI 10.1073/pnas.95.6.2834; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIU M, 1994, CARCINOGENESIS, V15, P1089, DOI 10.1093/carcin/15.6.1089; Lu H, 1998, P NATL ACAD SCI USA, V95, P6399, DOI 10.1073/pnas.95.11.6399; Martinez JD, 1997, ONCOGENE, V14, P2511, DOI 10.1038/sj.onc.1201095; MAYR GA, 1995, CANCER RES, V55, P2410; Meek DW, 1997, BIOCHEM SOC T, V25, P416, DOI 10.1042/bst0250416; MILNE DM, 1995, J BIOL CHEM, V270, P5511, DOI 10.1074/jbc.270.10.5511; MILNE DM, 1994, J BIOL CHEM, V269, P9253; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; REED M, 1995, P NATL ACAD SCI USA, V92, P9455, DOI 10.1073/pnas.92.21.9455; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Smith ML, 1997, P NATL ACAD SCI USA, V94, P12255, DOI 10.1073/pnas.94.23.12255; Sun Y, 1997, ONCOGENE, V14, P385, DOI 10.1038/sj.onc.1200834; SUN Y, 1993, MOL CARCINOGEN, V8, P49, DOI 10.1002/mc.2940080111; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; Wang XW, 1996, GENE DEV, V10, P1219, DOI 10.1101/gad.10.10.1219; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602	48	249	255	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12229	12235		10.1074/jbc.274.18.12229	http://dx.doi.org/10.1074/jbc.274.18.12229			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212189	hybrid			2022-12-27	WOS:000080056800009
J	Rao, GN; Madamanchi, NR; Lele, M; Gadiparthi, L; Gingras, AC; Eling, TE; Sonenberg, N				Rao, GN; Madamanchi, NR; Lele, M; Gadiparthi, L; Gingras, AC; Eling, TE; Sonenberg, N			A potential role for extracellular signal-regulated kinases in prostaglandin F-2 alpha-induced protein synthesis in smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 4E; P70 S6 KINASE; INSULIN-RECEPTOR SUBSTRATE-1; PHOSPHATIDYLINOSITOL 3-KINASE; GROWTH-FACTOR; TRANSLATION INITIATION; VENTRICULAR MYOCYTES; CARDIAC-HYPERTROPHY; MESSENGER-RNA; PHAS-I	To understand the mechanisms of prostaglandin F-2 alpha (PGF(2 alpha))-induced protein synthesis in vascular smooth muscle cells (VSMC), we have studied its effect on two major signal transduction pathways: mitogen-activated protein kinases and phosphatidylinositol 3-kinase (PI3-kinase) and their downstream targets ribosomal protein S6 kinase (p70(S6k)) and eukaryotic initiation factor eIF4E and its regulator 4E-BP1, PGF(2 alpha) induced the activities of extracellular signal-regulated kinase 2 (ERK2) and Jun N-terminal kinase 1 (JNK1) groups of mitogen-activated protein kinases, PI3-kinase, and p70(S6k) in a time-dependent manner in growth-arrested VSMC. PGF(2 alpha) also induced eIF4E and 4E-BP1 phosphorylation, global protein synthesis, and basic fibroblast growth factor-a (bFGF-2) expression in VSMC, Whereas inhibition of PI3-kinase by wortmannin completely blocked the p70(S6k) activation, it only partially decreased the ERK2 activity, and had no significant effect on global protein synthesis and bFGF-2 expression induced by PGF(2 alpha), Rapamycin, a potent inhibitor of p70(S6k), also failed to prevent PGF(2 alpha)-induced global protein synthesis and bFGF-2 expression, although it partially decreased ERK2 activity. In contrast, inhibition of ERK2 activity by PD 098059 led to a significant loss of PGF(2 alpha)-induced eIF4E and 4E-BP1 phosphorylation, global protein synthesis, and bFGF-2 expression. PGF(2 alpha)-induced phosphorylation of eIF4E and 4E-BP1 was also found to be sensitive to inhibition by both wortmannin and rapamycin, These findings demonstrate that 1) PI3-kinase-dependent and independent mechanisms appear to be involved in PGF(2 alpha)-induced activation of ERK2; 2) PGF(2 alpha)-induced eIF4E and 4E-BP1 phosphorylation appear to be mediated by both ERK-dependent and PI3-kinase-dependent rapamycin-sensitive mechanisms; and 3) ERK-dependent eIF4E phosphorylation but not PIS-kinase-dependent p70S6k activation correlates with PGF(2 alpha)-induced global protein synthesis and bFGF-2 expression in VSMC.	Univ Texas, Med Branch, Div Cardiol, Galveston, TX 77555 USA; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA	University of Texas System; University of Texas Medical Branch Galveston; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Rao, GN (corresponding author), Univ Texas, Med Branch, Old John Sealy Hosp 4 124B, 301 Univ Blvd,Route 0567, Galveston, TX 77555 USA.		Gingras, Anne-Claude/ABA-8341-2020	Gingras, Anne-Claude/0000-0002-6090-4437; Madamanchi, Nageswara/0000-0003-0590-0908				Adams JW, 1996, J BIOL CHEM, V271, P1179, DOI 10.1074/jbc.271.2.1179; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BANERJEE P, 1990, P NATL ACAD SCI USA, V87, P8550, DOI 10.1073/pnas.87.21.8550; BERK BC, 1989, HYPERTENSION, V13, P305, DOI 10.1161/01.HYP.13.4.305; BROWN EJ, 1995, NATURE, V377, P411; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; DORN GW, 1992, J BIOL CHEM, V267, P24897; Duckworth BC, 1997, J BIOL CHEM, V272, P27665, DOI 10.1074/jbc.272.44.27665; FERRARI S, 1994, CRIT REV BIOCHEM MOL, V29, P385, DOI 10.3109/10409239409083485; FLEMING JW, 1992, CIRCULATION, V85, P420, DOI 10.1161/01.CIR.85.2.420; Fleurent M, 1997, J BIOL CHEM, V272, P4006, DOI 10.1074/jbc.272.7.4006; FREDERICKSON RM, 1991, MOL CELL BIOL, V11, P2896, DOI 10.1128/MCB.11.5.2896; GIASSON E, 1995, J BIOL CHEM, V270, P5225, DOI 10.1074/jbc.270.10.5225; Gingras AC, 1996, P NATL ACAD SCI USA, V93, P5578, DOI 10.1073/pnas.93.11.5578; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; GRAVES LM, 1995, P NATL ACAD SCI USA, V92, P7222, DOI 10.1073/pnas.92.16.7222; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HORDIJK PL, 1994, J BIOL CHEM, V269, P3534; HU CB, 1994, P NATL ACAD SCI USA, V91, P3730, DOI 10.1073/pnas.91.9.3730; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KRIEG J, 1988, J BIOL CHEM, V263, P11473; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Mendez R, 1996, MOL CELL BIOL, V16, P2857; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MORLEY SJ, 1991, J BIOL CHEM, V266, P4669; MORLEY SJ, 1990, J BIOL CHEM, V265, P10611; Morley SJ, 1997, J BIOL CHEM, V272, P17887, DOI 10.1074/jbc.272.28.17887; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; MYERS MG, 1994, J BIOL CHEM, V269, P28783; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; RAO GN, 1994, J BIOL CHEM, V269, P7180; Rao GN, 1996, ONCOGENE, V13, P713; Rao GN, 1996, J BIOL CHEM, V271, P20805, DOI 10.1074/jbc.271.34.20805; REDPATH NT, 1994, BBA-MOL CELL RES, V1220, P147, DOI 10.1016/0167-4889(94)90130-9; Reif K, 1997, J BIOL CHEM, V272, P14426, DOI 10.1074/jbc.272.22.14426; RHOADS RE, 1988, TRENDS BIOCHEM SCI, V13, P52, DOI 10.1016/0968-0004(88)90028-X; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Servant MJ, 1996, J BIOL CHEM, V271, P16047, DOI 10.1074/jbc.271.27.16047; Seva C, 1997, BIOCHEM BIOPH RES CO, V238, P202, DOI 10.1006/bbrc.1997.7163; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; Tang XW, 1997, J BIOL CHEM, V272, P14193, DOI 10.1074/jbc.272.22.14193; VANMANTEUFFEL S, 1996, P NATL ACAD SCI USA, V93, P4076; VANMANTEUFFEL SR, 1997, MOL CELL BIOL, V17, P5426; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; WATANABE T, 1995, J BIOL CHEM, V270, P8984, DOI 10.1074/jbc.270.15.8984; WENG QP, 1995, P NATL ACAD SCI USA, V92, P5744, DOI 10.1073/pnas.92.12.5744; Whalen SG, 1996, J BIOL CHEM, V271, P11831, DOI 10.1074/jbc.271.20.11831	59	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12925	12932		10.1074/jbc.274.18.12925	http://dx.doi.org/10.1074/jbc.274.18.12925			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212283	hybrid			2022-12-27	WOS:000080056800103
J	Chaika, OV; Chaika, N; Volle, DJ; Hayashi, H; Ebina, Y; Wang, LM; Pierce, JH; Lewis, RE				Chaika, OV; Chaika, N; Volle, DJ; Hayashi, H; Ebina, Y; Wang, LM; Pierce, JH; Lewis, RE			Mutation of tyrosine 960 within the insulin receptor juxtamembrane domain impairs glucose transport but does not inhibit ligand-mediated phosphorylation of insulin receptor substrate-2 in 3T3-L1 adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE PROTEIN; SIGNAL-TRANSDUCTION; KINASE-ACTIVITY; CSF-1 RECEPTOR; CELLS; IRS-2; REGION; FAMILY; MICE; IDENTIFICATION	CSF-1 is equipotent to insulin in its ability to stimulate 2[H-3]deoxyglucose uptake in 3T3-L1 adipocytes expressing the colony stimulating factor-1 receptor/insulin receptor chimera (CSF1R/IR), However, CSF-1-stimulated glucose uptake and glycogen synthesis is reduced by 50% in comparison to insulin in 3T3-L1 cells expressing a CSF1R/IR mutated at Tyr(960) (CSF1R/IRA960), CSF-1-treated adipocytes expressing the CSF1R/IRA960 were impaired in their ability to phosphorylate insulin receptor substrate 1 (IRS-1) but not in their ability to phosphorylate IRS-2, Immunoprecipitation of IRS proteins followed by Western blotting revealed that the intact CSF1R/IR co-precipitates with IRS-2 from CSF-1-treated cells. In contrast, the CSF1R/IRA960 co-precipitates poorly with IRS-S, These observations suggest that Tyr(960) is important for interaction of the insulin receptor cytoplasmic domain with IRS-2, but it is not essential to the ability of the insulin receptor tyrosine kinase to use IRS-2 as a substrate. These observations also suggest that in 3T3-L1 adipocytes, tyrosine phosphorylation of IRS-2 by the insulin receptor tyrosine kinase is not sufficient for maximal stimulation of receptor-regulated glucose transport or glycogen synthesis.	Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; Univ Tokushima, Inst Enzyme Res, Dept Enzyme Genet, Tokushima 770, Japan; NCI, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Tokushima University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lewis, RE (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, 600 S 42nd St, Omaha, NE 68198 USA.		Lewis, Robert E./H-3404-2019	Hayashi, Hideki/0000-0003-4585-6542	NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052809] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA36727] Funding Source: Medline; NIDDK NIH HHS [DK52809] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; BACKER JM, 1991, BIOCHEMISTRY-US, V30, P6366, DOI 10.1021/bi00240a003; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BACKER JM, 1992, J CELL BIOL, V118, P831, DOI 10.1083/jcb.118.4.831; Boehm JE, 1998, J BIOL CHEM, V273, P7169, DOI 10.1074/jbc.273.12.7169; Chaika OV, 1997, J BIOL CHEM, V272, P11968, DOI 10.1074/jbc.272.18.11968; COUSSENS L, 1986, NATURE, V320, P277, DOI 10.1038/320277a0; CZECH MP, 1992, TRENDS BIOCHEM SCI, V17, P197, DOI 10.1016/0968-0004(92)90266-C; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; Fantin VR, 1998, J BIOL CHEM, V273, P10726, DOI 10.1074/jbc.273.17.10726; FEENER EP, 1993, J BIOL CHEM, V268, P11256; FROST SC, 1985, J BIOL CHEM, V260, P2646; GANDERTON RH, 1992, BIOCHEM J, V288, P195, DOI 10.1042/bj2880195; He WM, 1996, J BIOL CHEM, V271, P11641, DOI 10.1074/jbc.271.20.11641; HESS SL, 1991, J CELL BIOCHEM, V45, P374, DOI 10.1002/jcb.240450411; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HOSOMI Y, 1994, J BIOL CHEM, V269, P11498; Inoue G, 1998, J BIOL CHEM, V273, P11548, DOI 10.1074/jbc.273.19.11548; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; KABURAGI Y, 1995, ENDOCRINOLOGY, V136, P3437, DOI 10.1210/en.136.8.3437; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; MAEGAWA H, 1988, J BIOL CHEM, V263, P8912; Morris AJ, 1996, P NATL ACAD SCI USA, V93, P8401, DOI 10.1073/pnas.93.16.8401; SawkaVerhelle D, 1996, J BIOL CHEM, V271, P5980, DOI 10.1074/jbc.271.11.5980; SawkaVerhelle D, 1997, J BIOL CHEM, V272, P16414, DOI 10.1074/jbc.272.26.16414; Sharma PM, 1997, MOL CELL BIOL, V17, P7386, DOI 10.1128/MCB.17.12.7386; SHERR CJ, 1989, BLOOD, V73, P1786; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Sun XJ, 1997, MOL ENDOCRINOL, V11, P251, DOI 10.1210/me.11.2.251; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; TAVARE JM, 1988, BIOCHEM J, V252, P607, DOI 10.1042/bj2520607; TAVARE JM, 1993, BIOCHIM BIOPHYS ACTA, V1178, P21, DOI 10.1016/0167-4889(93)90106-Y; THEIS RS, 1989, J BIOL CHEM, V264, P12820; TORNQVIST HE, 1987, J BIOL CHEM, V262, P10212; TORNQVIST HE, 1988, J BIOL CHEM, V263, P350; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WANG LM, 1995, BLOOD, V86, P4218, DOI 10.1182/blood.V86.11.4218.bloodjournal86114218; WHITE MF, 1988, CELL, V54, P641, DOI 10.1016/S0092-8674(88)80008-4; WHITTAKER J, 1987, P NATL ACAD SCI USA, V84, P5237, DOI 10.1073/pnas.84.15.5237; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yeh TC, 1996, J BIOL CHEM, V271, P2921, DOI 10.1074/jbc.271.6.2921; YONEZAWA K, 1994, J BIOL CHEM, V269, P4634; Zhou LX, 1997, J BIOL CHEM, V272, P29829, DOI 10.1074/jbc.272.47.29829	44	12	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12075	12080		10.1074/jbc.274.17.12075	http://dx.doi.org/10.1074/jbc.274.17.12075			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207032	hybrid			2022-12-27	WOS:000079834800088
J	Deyrup, AT; Krishnan, S; Singh, B; Schwartz, NB				Deyrup, AT; Krishnan, S; Singh, B; Schwartz, NB			Activity and stability of recombinant bifunctional rearranged and monofunctional domains of ATP-sulfurylase and adenosine 5 '-phosphosulfate kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHASE BIENZYME COMPLEX; RAT CHONDROSARCOMA; BRACHYMORPHIC MICE; KINETIC MECHANISM; PROTEIN; DEFECT; MUTAGENESIS; ENZYMES; GENE	Murine adenosine 3'-phosphate 5'-phosphosulfate (PAPS) synthetase consists of a COOH-terminal ATP-sulfurylase domain covalently linked through a nonhomologous intervening sequence to an NH2-terminal adenosine 5'-phosphosulfate (APS) kinase domain forming a bifunctional fused protein. Possible advantages of bifunctionality were probed by separating the domains on the cDNA level and expressing them as monofunctional proteins. Expressed protein generated from the ATP-sulfurylase domain alone was fully active in both the forward and reverse sulfurylase assays. APS kinase-only recombinants exhibited no kinase activity. However, extension of the kinase domain at the COOH terminus by inclusion of the 36 residue linker region restored kinase activity. An equimolar mixture of the two monofunctional enzymes catalyzed the overall reaction (synthesis of PAPS from ATP + SO42-) comparably to the fused bifunctional enzyme. The importance of the domain order and organization was demonstrated by generation of a series of rearranged recombinants in which the order of the two active domains was reversed or altered relative to the linker region, The critical role of the linker region was established by generation of recombinants that had the linker deleted or rearranged relative to the two active domains. The intrinsic stability of the various recombinants was also investigated by measuring enzyme deactivation as a function of time of incubation at 25 or 37 degrees C, The expressed monofunctional ATP-sulfurylase, which was initially fully active, was unstable compared with the fused bifunctional wild type enzyme, decaying with a t(1/2) of 10 min at 37 degrees C, Progressive extension by addition of kinase sequence at the NH2-terminal side of the sulfurylase recombinant eventually stabilized sulfurylase activity. Sulfurylase activity was significantly destabilized in a time-dependent manner in the rearranged proteins as well. In contrast, no significant deactivation of any truncated kinase-containing recombinants or misordered kinase recombinants was observed at either temperature. It would therefore appear that fusion of the two enzymes enhances the intrinsic stability of the sulfurylase only.	Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Schwartz, NB (corresponding author), Univ Chicago, Dept Pediat, MC5058,5841 S Maryland Ave, Chicago, IL 60637 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD009402, R01HD017332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-17332, HD-09402] Funding Source: Medline; NIGMS NIH HHS [GM 07281] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALI SA, 1995, BIOTECHNIQUES, V18, P746; Beaucamp N, 1997, PROTEIN SCI, V6, P2159; BRZOVIC PS, 1992, BIOCHEMISTRY-US, V31, P3831, DOI 10.1021/bi00130a014; Deyrup AT, 1998, J BIOL CHEM, V273, P9450, DOI 10.1074/jbc.273.16.9450; DEYRUP AT, 1997, THESIS U CHICAGO CHI; FOSTER BA, 1994, J BIOL CHEM, V269, P19777; GELLER DH, 1987, J BIOL CHEM, V262, P7374; JULIEN D, 1997, MECH DEVELOP, V68, P179; KIRSCHNER K, 1991, BIOCHEMISTRY-US, V30, P472, DOI 10.1021/bi00216a024; LEYH TS, 1992, J BIOL CHEM, V267, P10405; LI H, 1995, J BIOL CHEM, V270, P29453, DOI 10.1074/jbc.270.49.29453; LYLE S, 1994, BIOCHEMISTRY-US, V33, P5920, DOI 10.1021/bi00185a032; LYLE S, 1994, BIOCHEM J, V301, P349, DOI 10.1042/bj3010349; LYLE S, 1994, BIOCHEMISTRY-US, V33, P6822, DOI 10.1021/bi00188a010; LYLE S, 1994, BIOCHEM J, V301, P355, DOI 10.1042/bj3010355; LYLE S, 1995, BIOCHEMISTRY-US, V34, P940, DOI 10.1021/bi00003a028; ROSENTHAL E, 1995, GENE, V165, P243, DOI 10.1016/0378-1119(95)00450-K; STOKES AM, 1973, BIOCHIM BIOPHYS ACTA, V302, P64, DOI 10.1016/0005-2744(73)90008-9; SUGAHARA K, 1982, ARCH BIOCHEM BIOPHYS, V214, P589, DOI 10.1016/0003-9861(82)90064-9; SUGAHARA K, 1979, P NATL ACAD SCI USA, V76, P6615, DOI 10.1073/pnas.76.12.6615; SUGAHARA K, 1982, ARCH BIOCHEM BIOPHYS, V214, P601; Yablonski MJ, 1996, J BIOL CHEM, V271, P10704, DOI 10.1074/jbc.271.18.10704	22	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10751	10757		10.1074/jbc.274.16.10751	http://dx.doi.org/10.1074/jbc.274.16.10751			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196147	hybrid			2022-12-27	WOS:000079751900015
J	Hashimoto, A; Hirose, K; Okada, H; Kurosaki, T; Iino, M				Hashimoto, A; Hirose, K; Okada, H; Kurosaki, T; Iino, M			Inhibitory modulation of B cell receptor-mediated Ca2+ mobilization by Src homology 2 domain-containing inositol 5 '-phosphatase (SHIP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-GAMMA-RIIB; POLYPHOSPHATE 5-PHOSPHATASE SHIP; TYROSINE-PHOSPHORYLATED PROTEIN; PHOSPHOLIPASE C-GAMMA; AFFINITY IGE RECEPTOR; ANTIGEN RECEPTOR; CALCIUM CURRENT; CROSS-LINKING; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; SIGNAL-TRANSDUCTION	Src homology 2 domain-containing inositol 5'-phosphatase (SHIP) mediates inhibitory signals that attenuate intracellular Ca2+ mobilization in B cells upon B cell receptor (BCR) stimulation. To clarify the mechanisms affected by SHIP, we analyzed Ca2+ mobilization in the DT40 B cell line in which the SHIP gene was disrupted. In SHIP-deficient cells, Ca2+ transient elicited by BCR stimulation was more prolonged than that in control cells both in the presence and absence of extracellular Ca2+, Inositol 1,4,5-trisphosphate production following BCR stimulation was enhanced in SHIP-deficient cells. In SHIP-deficient cells in comparison with the control cells, BCR stimulation in the absence of extracellular Ca2+ induced a greater degree of Ca2+ store depletion and the Ca2+ influx upon re-addition of extracellular Ca2+ was also greater. However, store-operated Ca2+ influx (SOC) elicited by thapsigargin-induced store depletion was not affected by SHIP. These results indicate that the primary target pathway of SHIP is the Ca2+ release from the stores, and that Ca2+ influx by the SOC mechanism is secondarily controlled by the level of Ca2+ in the stores without direct inhibition of SOC. In this way, SHIP may play an important role in ensuring the robust tuning of Ca2+ signaling in B cells.	Univ Tokyo, Fac Med, Dept Pharmacol, Bunkyo Ku, Tokyo 113, Japan; Japan Sci & Technol Corp, Tokyo 113, Japan; Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Moriguchi, Osaka 570, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kansai Medical University	Iino, M (corresponding author), Univ Tokyo, Fac Med, Dept Pharmacol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.		Kurosaki, Tomohiro/D-1306-2009; Okada, Hidetaka/AAP-7775-2020; okada, hidetaka/C-6990-2011	Kurosaki, Tomohiro/0000-0002-6352-304X; Hashimoto-Tane, Akiko/0000-0001-8519-266X				Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berridge MJ, 1997, NATURE, V386, P759, DOI 10.1038/386759a0; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P290; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; CAMBIER JC, 1987, IMMUNOL REV, V95, P37, DOI 10.1111/j.1600-065X.1987.tb00499.x; CHALLISS RAJ, 1988, BIOCHEM BIOPH RES CO, V157, P684, DOI 10.1016/S0006-291X(88)80304-8; CHEN CLH, 1982, J IMMUNOL, V129, P2580; CHOQUET D, 1993, J CELL BIOL, V121, P355, DOI 10.1083/jcb.121.2.355; Crowley MT, 1996, J BIOL CHEM, V271, P1145, DOI 10.1074/jbc.271.2.1145; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; DIEGEL ML, 1994, J BIOL CHEM, V269, P11409; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Giuriato S, 1997, J BIOL CHEM, V272, P26857, DOI 10.1074/jbc.272.43.26857; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Huang Y, 1998, J BIOL CHEM, V273, P19554, DOI 10.1074/jbc.273.31.19554; Kiener PA, 1997, J BIOL CHEM, V272, P3838, DOI 10.1074/jbc.272.6.3838; Kimura T, 1997, J BIOL CHEM, V272, P13991, DOI 10.1074/jbc.272.21.13991; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; LIU L, 1994, MOL CELL BIOL, V14, P6926, DOI 10.1128/MCB.14.10.6926; Liu QR, 1998, J EXP MED, V188, P1333, DOI 10.1084/jem.188.7.1333; Liu QR, 1998, BLOOD, V91, P2753, DOI 10.1182/blood.V91.8.2753.2753_2753_2759; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; Nadler MJS, 1997, J BIOL CHEM, V272, P20038, DOI 10.1074/jbc.272.32.20038; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Osborne MA, 1996, J BIOL CHEM, V271, P29271, DOI 10.1074/jbc.271.46.29271; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 1997, CELL, V89, P973, DOI 10.1016/S0092-8674(00)80282-2; POENIE M, 1986, SCIENCE, V233, P886, DOI 10.1126/science.3755550; RANSOM JT, 1988, J IMMUNOL, V140, P3150; RAVETCH JV, 1994, CELL, V78, P553, DOI 10.1016/0092-8674(94)90521-5; SAXTON TM, 1994, J IMMUNOL, V153, P623; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	42	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11203	11208		10.1074/jbc.274.16.11203	http://dx.doi.org/10.1074/jbc.274.16.11203			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196207	hybrid			2022-12-27	WOS:000079751900075
J	Krab, IM; Parmeggiani, A				Krab, IM; Parmeggiani, A			Functional-structural analysis of threonine 25, a residue coordinating the nucleotide-bound magnesium in elongation factor Tu	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; EF-TS COMPLEX; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; KIRROMYCIN RESISTANCE; EXCHANGE FACTOR; BINDING DOMAIN; ACTIVE-SITE; P21 RAS; GTP	Elongation factor (EF) Tu Thr-25 is a key residue binding the essential magnesium complexed to nucleotide. We have characterized mutations at this position to the related Ser and to Ala, which abolishes the bond to Mg2+, and a double mutation, H22Y/T25S. Nucleotide interaction was moderately destabilized in EF-Tu(T25S) but strongly in EF-Tu(T25A) and EF-Tu(H22Y/T25S), Binding Phe-tRNA(Phe) to poly(U) ribosome needed a higher magnesium concentration for the latter two mutants but was comparable at 10 mM MgCl2. Whereas EF-Tu(T25S) synthesized poly(Phe), as effectively as wild type, the rate was reduced to 50% for EF-Tu(H22Y/T25S) and was, surprisingly, still 10% for EF-Tu(T25A), In contrast, protection of Phe-tRNA(Phe) against spontaneous hydrolysis by the latter two mutants was very low. The intrinsic GTPase in EF-Tu(H22Y/T25S) and (T25A) was reduced, and the different responses to ribosomes and kirromycin suggest that stimulation by these two agents follows different mechanisms. Of the mutants, only EF-Tu(T25A) forms a more stable complex with EF-Ts than wild type. This implies that stabilization of the EF-Tu EF-Ts complex is related to the inability to bind Mg2+, rather than to a decreased nucleotide affinity. These results are discussed in the light of the three-dimensional structure. They emphasize the importance of the Thr-25-Mg2+ bond, although its absence is compatible with protein synthesis and thus with an active overall conformation of EF-Tu.	Ecole Polytech, Grp Biophys Equipe 2, F-91128 Palaiseau, France	Institut Polytechnique de Paris	Parmeggiani, A (corresponding author), Ecole Polytech, Grp Biophys Equipe 2, F-91128 Palaiseau, France.	andrea@poly.polytechnique.fr						ABDULKARIM F, 1994, FEBS LETT, V352, P118, DOI 10.1016/0014-5793(94)00937-6; Abel K, 1996, STRUCTURE, V4, P1153, DOI 10.1016/S0969-2126(96)00123-2; ANBORGH PH, 1991, EMBO J, V10, P779, DOI 10.1002/j.1460-2075.1991.tb08009.x; ANBORGH PH, 1993, J BIOL CHEM, V268, P24622; ANBORGH PH, 1993, THESIS LEIDEN U THE; ARAI K, 1980, P NATL ACAD SCI-BIOL, V77, P1326, DOI 10.1073/pnas.77.3.1326; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Cetin R, 1996, EMBO J, V15, P2604, DOI 10.1002/j.1460-2075.1996.tb00618.x; CHINALI G, 1977, EUR J BIOCHEM, V75, P55, DOI 10.1111/j.1432-1033.1977.tb11503.x; COOL RH, 1991, BIOCHEMISTRY-US, V30, P362, DOI 10.1021/bi00216a008; Crechet JB, 1996, J BIOL CHEM, V271, P17234, DOI 10.1074/jbc.271.29.17234; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; Farrar CT, 1997, STRUCTURE, V5, P1055, DOI 10.1016/S0969-2126(97)00257-8; FASANO O, 1982, ANAL BIOCHEM, V124, P53, DOI 10.1016/0003-2697(82)90218-4; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; HALKIDES CJ, 1994, BIOCHEMISTRY-US, V33, P4019, DOI 10.1021/bi00179a031; HWANG YW, 1989, ARCH BIOCHEM BIOPHYS, V274, P394, DOI 10.1016/0003-9861(89)90452-9; IVELL R, 1981, BIOCHEMISTRY-US, V20, P6852, DOI 10.1021/bi00527a017; JENSEN M, 1989, EUR J BIOCHEM, V182, P247, DOI 10.1111/j.1432-1033.1989.tb14824.x; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Kjeldgaard M, 1996, FASEB J, V10, P1347, DOI 10.1096/fasebj.10.12.8903506; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Krab IM, 1998, BBA-GENE STRUCT EXPR, V1443, P1, DOI 10.1016/S0167-4781(98)00169-9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MESTERS JR, 1994, EMBO J, V13, P4877, DOI 10.1002/j.1460-2075.1994.tb06815.x; Miller DL, 1977, MOL MECH PROTEIN BIO, P323; MISTOU MY, 1992, EUR J BIOCHEM, V204, P179, DOI 10.1111/j.1432-1033.1992.tb16621.x; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; PARLATO G, 1983, J BIOL CHEM, V258, P995; PARMEGGIANI A, 1981, MOL CELL BIOCHEM, V35, P129, DOI 10.1007/BF02357085; PARMEGGIANI A, 1971, METHODS ENZYMOLOGY C, V20, P291; PICONE D, 1983, BIOCHEMISTRY-US, V22, P4400, DOI 10.1021/bi00288a009; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; POULLET P, 1995, EUR J BIOCHEM, V227, P537, DOI 10.1111/j.1432-1033.1995.tb20421.x; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; STACEY DW, 1991, MOL CELL BIOL, V11, P4053, DOI 10.1128/MCB.11.8.4053; SWART GWM, 1987, BIOCHEMISTRY-US, V26, P2047, DOI 10.1021/bi00381a038; Wang Y, 1997, NAT STRUCT BIOL, V4, P650, DOI 10.1038/nsb0897-650	45	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11132	11138		10.1074/jbc.274.16.11132	http://dx.doi.org/10.1074/jbc.274.16.11132			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196198	hybrid			2022-12-27	WOS:000079751900066
J	Mueckler, M; Makepeace, C				Mueckler, M; Makepeace, C			Transmembrane segment 5 of the Glut1 glucose transporter is an amphipathic helix that forms part of the sugar permeation pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOFACIAL LIGAND-BINDING; XENOPUS-OOCYTES; AMINO-ACID; MEMBRANE; MUTAGENESIS; DOMAINS; FAMILY; HEPG2; SITE	Transmembrane segment 5 of the Glut1 glucose transporter has been proposed to form an amphipathic transmembrane helix that lines the substrate translocation pathway (Mueckler, M., Caruso, C., Baldwin, S. A. Panico, M., Blench, I., Morris, H. R., Allard, W. J., Lienhard, G. E., and Lodish, H. F. (1985) Science 229, 941-945). This hypothesis was tested using cysteine-scanning mutagenesis in conjunction with the membrane-impermeant, sulfhydryl-specific reagent, p-chloromercuribenzenesulfonate (pCMBS), A series of 21 mutants was created from a fully functional, cysteine-less, parental Glut1 molecule by changing each residue within putative transmembrane segment 5 to cysteine, Each mutant was then expressed in Xenopus oocytes and its steady-state protein level, alpha-deoxyglucose uptake activity, and sensitivity to pCMBS were measured. All 21 mutants exhibited measurable transport activity, although several of the mutants exhibited reduced activity due to a corresponding reduction in steady-state protein. Six of the amino acid side chains within transmembrane segment 5 were clearly accessible to pCMBS in the external medium, as determined by inhibition of transport activity, and a 7th residue showed inhibition that lacked statistical significance because of the extremely low transport activity of the corresponding mutant. All 7 of these residues were clustered along one face of a putative alpha-helix, proximal to the exoplasmic surface of the plasma membrane. These results comprise the first experimental evidence for the existence of an amphipathic transmembrane alpha-helix in a glucose transporter molecule and strongly suggest that transmembrane segment 5 of Glut1 forms part of the sugar permeation pathway.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Mueckler, M (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.		Mueckler, Mike M/F-6115-2012		NIDDK NIH HHS [DK 43695] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043695] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALDWIN SA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P17, DOI 10.1016/0304-4157(93)90015-G; CARRUTHERS A, 1990, PHYSIOL REV, V70, P1135, DOI 10.1152/physrev.1990.70.4.1135; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; HASHIRAMOTO M, 1992, J BIOL CHEM, V267, P17502; HRESKO RC, 1994, J BIOL CHEM, V269, P32110; HRESKO RC, 1994, J BIOL CHEM, V269, P20482; JUNG EKY, 1986, J BIOL CHEM, V261, P9155; Kaback HR, 1997, Q REV BIOPHYS, V30, P333, DOI 10.1017/S0033583597003387; KELLER K, 1989, J BIOL CHEM, V264, P18884; LOWE AG, 1989, RED BLOOD CELL MEMBR, V11, P597; MARSHALL BA, 1993, J BIOL CHEM, V268, P26193; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; Mueckler M, 1997, J BIOL CHEM, V272, P30141, DOI 10.1074/jbc.272.48.30141; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; PESSIN JE, 1992, ANNU REV PHYSIOL, V54, P911, DOI 10.1146/annurev.ph.54.030192.004403; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973	17	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10923	10926		10.1074/jbc.274.16.10923	http://dx.doi.org/10.1074/jbc.274.16.10923			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196171	hybrid			2022-12-27	WOS:000079751900039
J	Stratmann, A; Mahmud, T; Lee, S; Distler, J; Floss, HG; Piepersberg, W				Stratmann, A; Mahmud, T; Lee, S; Distler, J; Floss, HG; Piepersberg, W			The AcbC protein from Actinoplanes species is a C-7-cyclitol synthase related to 3-dehydroquinate synthases and is involved in the biosynthesis of the alpha-glucosidase inhibitor acarbose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; DEHYDROQUINATE SYNTHASE; STREPTOMYCES-GRISEUS; 2-DEOXY-SCYLLO-INOSOSE SYNTHASE; SHIKIMATE PATHWAY; ESCHERICHIA-COLI; CLONING; GENES; UNIT; DNA	The putative biosynthetic gene cluster for the a-glucosidase inhibitor acarbose was identified in the producer Actinoplanes sp, 50/110 by cloning a DNA segment containing the conserved gene for dTDP-D-glucose 4,6-dehydratase, acbB. The two flanking genes were acbA (dTDP-D-glucose synthase) and acbC, encoding a protein with significant similarity to 3-dehydroquinate synthases (AroB proteins). The acbC gene was overexpressed heterologously in Streptomyces lividans 66, and the product was shown to be a C-7-cyclitol synthase using sedo-heptulose 7-phosphate, but not ido-heptulose 7-phosphate, as its substrate. The cyclization product, 2-epi-5-epi-valiolone ((2S,3S,4S,5R)-5-(hydroxymethyl)cyclohexanon-2,3,4,5-tetrol), is a precursor of the valienamine moiety of acarbose. A possible five-step reaction mechanism is proposed for the cyclization reaction catalyzed by AcbC based on the recent analysis of the three-dimensional structure of a eukaryotic 3-dehydroquinate synthase domain (Carpenter, E. P., Hawkins, A. R., Frost, J. W., and Brown, K. A. (1998) Nature 394, 299-302).	Berg Univ Gesamthsch Wuppertal, D-42097 Wuppertal, Germany; Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Wuppertal; University of Washington; University of Washington Seattle	Piepersberg, W (corresponding author), Berg Univ Gesamthsch Wuppertal, Gauss Str 20, D-42097 Wuppertal, Germany.		Mahmud, Taifo/A-1492-2015	Mahmud, Taifo/0000-0001-9639-526X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BABCOCK MJ, 1988, J BACTERIOL, V170, P2802, DOI 10.1128/jb.170.6.2802-2808.1988; BENDER SL, 1989, BIOCHEMISTRY-US, V28, P7555, DOI 10.1021/bi00445a009; BIBB MJ, 1984, GENE, V30, P157, DOI 10.1016/0378-1119(84)90116-1; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Carpenter EP, 1998, NATURE, V394, P299, DOI 10.1038/28431; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Decker H, 1996, FEMS MICROBIOL LETT, V141, P195, DOI 10.1016/0378-1097(96)00221-2; DEGWERT U, 1987, J ANTIBIOT, V40, P855, DOI 10.7164/antibiotics.40.855; DISTLER J, 1987, NUCLEIC ACIDS RES, V15, P8041, DOI 10.1093/nar/15.19.8041; DISTLER J, 1985, FEMS MICROBIOL LETT, V30, P145; Drepper A, 1996, FEBS LETT, V388, P177, DOI 10.1016/0014-5793(96)00554-6; Floss HG, 1997, NAT PROD REP, V14, P433, DOI 10.1039/np9971400433; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HEMKER M, 1995, THESIS U MUNSTER; Hopwood D.A., 1985, GENETIC MANIPULATION; KAMEDA Y, 1984, J ANTIBIOT, V37, P1301, DOI 10.7164/antibiotics.37.1301; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee S, 1997, J ANTIBIOT, V50, P954, DOI 10.7164/antibiotics.50.954; LEE SS, 1999, IN PRESS J MOL CATAL; LIU HW, 1994, ANNU REV MICROBIOL, V48, P223, DOI 10.1146/annurev.micro.48.1.223; LOEWUS MW, 1980, J BIOL CHEM, V255, P1710; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; MULLER L, 1989, NOVEL MICROBIAL PROD, P109; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PIEPERSBERG W, 1994, CRIT REV BIOTECHNOL, V14, P251, DOI 10.3109/07388554409079835; Piepersberg W., 1997, BIOTECHNOLOGY ANTIBI, P81; PISSOWOTZKI K, 1991, MOL GEN GENET, V231, P113, DOI 10.1007/BF00293829; Rehm H. J., 1997, BIOTECHNOLOGY, P397; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sohng JK, 1996, J BIOCHEM MOL BIOL, V29, P183; STOCKMANN M, 1992, FEMS MICROBIOL LETT, V90, P185, DOI 10.1111/j.1574-6968.1992.tb05149.x; TAKANO E, 1995, GENE, V166, P133, DOI 10.1016/0378-1119(95)00545-2; TOYOKUNI T, 1987, J AM CHEM SOC, V109, P3481, DOI 10.1021/ja00245a061; TRUSCHEIT E, 1981, ANGEW CHEM INT EDIT, V20, P744, DOI 10.1002/anie.198107441; WIDLANSKI T, 1989, J AM CHEM SOC, V111, P2299, DOI 10.1021/ja00188a052; YAMAUCHI N, 1995, J ORG CHEM, V60, P5614, DOI 10.1021/jo00122a049; YAMAUCHI N, 1993, J ANTIBIOT, V46, P1916, DOI 10.7164/antibiotics.46.1916; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	41	60	71	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10889	10896		10.1074/jbc.274.16.10889	http://dx.doi.org/10.1074/jbc.274.16.10889			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196166	hybrid			2022-12-27	WOS:000079751900034
J	Chow, CW; Woodside, M; Demaurex, N; Yu, FH; Plant, P; Rotin, D; Grinstein, S; Orlowski, J				Chow, CW; Woodside, M; Demaurex, N; Yu, FH; Plant, P; Rotin, D; Grinstein, S; Orlowski, J			Proline-rich motifs of the Na+/H+ exchanger 2 isoform - Binding of Src homology domain 3 and role in apical targeting in epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; COLLECTING DUCT CELLS; THICK ASCENDING LIMB; AIRWAY ION-TRANSPORT; RAT NA/H EXCHANGER; SH3 DOMAIN; FUNCTIONAL EXPRESSION; TYROSINE KINASE; MAMMALIAN-CELLS; ATP DEPENDENCE	The NHE2 isoform of the Na+/H+ exchanger (NHE) displays two proline-rich sequences in its C-terminal region that resemble SH3 (Src homology 3)-binding domains. We investigated whether these regions ((PPS)-P-743-VTPAP(750), termed Pro-1, and (VPPKPPP792)-V-786, termed Pro-2) can bind to SH3 domains and whether they are essential for NHE2 function and targeting. A fusion protein containing the Pro-1 region showed promiscuous binding to SH3 domains of several proteins in vitro, whereas a Pro-2 fusion bound preferentially to domains derived from kinases. In contrast, cytoplasmic regions of NHE1, NHE3, or NHE4 failed to interact. When expressed in antiporter-deficient cells, truncated NHE2 lacking both Pro-rich regions catalyzed Na+/H+ exchange, retained sensitivity to intracellular ATP, and was activated by hyperosmolarity, resembling full-length NHE2, The role of the Pro-rich regions in subcellular targeting was examined by transfection of epitope-tagged forms of NHE2 in porcine renal epithelial LLC-PK1 cells. Both full-length and Pro-2-truncated NHE2 localized almost exclusively to the apical membrane. By contrast, a mutant devoid of both Pro-1 and Pro-2 was preferentially sorted to the basolateral surface but also accumulated intracellularly. These observations indicate that the region encompassing Pro-1 is essential for appropriate subcellular targeting of NHE2.	McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; Hosp Sick Children, Cell Biol Programme, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Med, Div Resp Med, Toronto, ON M5G 1X8, Canada	McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Orlowski, J (corresponding author), McGill Univ, Dept Physiol, 3655 Drummond St,McIntyre Med Sci Bldg, Montreal, PQ H3G 1Y6, Canada.	orlowski@physio.mcgill.ca	Chow, Chung-Wai/AAP-5533-2020	Chow, Chung-Wai/0000-0001-9344-8522; Yu, Frank/0000-0001-9306-1731; Demaurex, Nicolas/0000-0002-9933-6772; Orlowski, John/0000-0001-7371-175X				AMEMIYA M, 1995, KIDNEY INT, V48, P1206, DOI 10.1038/ki.1995.404; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; Biemesderfer D, 1998, J BIOL CHEM, V273, P12391, DOI 10.1074/jbc.273.20.12391; BOOKSTEIN C, 1994, J CLIN INVEST, V93, P106, DOI 10.1172/JCI116933; BOUCHER RC, 1994, AM J RESP CRIT CARE, V150, P581, DOI 10.1164/ajrccm.150.2.8049852; BOUCHER RC, 1994, AM J RESP CRIT CARE, V150, P271, DOI 10.1164/ajrccm.150.1.8025763; BRIGGS SD, 1995, J BIOL CHEM, V270, P14718, DOI 10.1074/jbc.270.24.14718; Broome MA, 1996, J BIOL CHEM, V271, P16798, DOI 10.1074/jbc.271.28.16798; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Chow CW, 1997, J GEN PHYSIOL, V110, P185, DOI 10.1085/jgp.110.2.185; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; COLLINS JF, 1993, P NATL ACAD SCI USA, V90, P3938, DOI 10.1073/pnas.90.9.3938; CUSSAC D, 1994, EMBO J, V13, P4011, DOI 10.1002/j.1460-2075.1994.tb06717.x; DEMAUREX N, 1994, J EXP BIOL, V196, P389; deMendez I, 1996, EMBO J, V15, P1211, DOI 10.1002/j.1460-2075.1996.tb00462.x; Erpel T, 1996, J BIOL CHEM, V271, P16807, DOI 10.1074/jbc.271.28.16807; GOSS GG, 1994, J BIOL CHEM, V269, P8741; Guerra L, 1998, KIDNEY INT, V53, P1269, DOI 10.1046/j.1523-1755.1998.00897.x; Holleran EA, 1998, TRENDS CELL BIOL, V8, P26, DOI 10.1016/S0962-8924(97)01195-1; KANDASAMY RK, 1995, J BIOL CHEM, V270, P29209, DOI 10.1074/jbc.270.49.29209; KAPUS A, 1994, J BIOL CHEM, V269, P23544; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; Nakamura R, 1998, EUR J BIOCHEM, V251, P583, DOI 10.1046/j.1432-1327.1998.2510583.x; Nath SK, 1996, AM J PHYSIOL-GASTR L, V270, pG431, DOI 10.1152/ajpgi.1996.270.3.G431; Noel J, 1996, J CELL SCI, V109, P929; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Pisabarro MT, 1996, BIOCHEMISTRY-US, V35, P10634, DOI 10.1021/bi960203t; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; ROTIN D, 1994, EMBO J, V13, P4440, DOI 10.1002/j.1460-2075.1994.tb06766.x; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Singh G, 1996, J MEMBRANE BIOL, V151, P261, DOI 10.1007/s002329900076; SOLEIMANI M, 1994, J BIOL CHEM, V269, P27973; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Sun AM, 1997, J MEMBRANE BIOL, V160, P85, DOI 10.1007/s002329900297; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; TSE CM, 1993, J BIOL CHEM, V268, P11917; TSE M, 1993, J MEMBRANE BIOL, V135, P93; VIGUERA AR, 1994, BIOCHEMISTRY-US, V33, P10925, DOI 10.1021/bi00202a011; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P13710; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P5583; WANG Z, 1993, J BIOL CHEM, V268, P11925; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; Wong L, 1996, J BIOL CHEM, V271, P20981, DOI 10.1074/jbc.271.35.20981; Wormmeester L, 1998, AM J PHYSIOL-CELL PH, V274, pC1261, DOI 10.1152/ajpcell.1998.274.5.C1261; Yoshioka S, 1997, J BIOCHEM-TOKYO, V122, P641; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	51	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10481	10488		10.1074/jbc.274.15.10481	http://dx.doi.org/10.1074/jbc.274.15.10481			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187839	hybrid			2022-12-27	WOS:000079663500078
J	Kumahara, E; Ebihara, T; Saffen, D				Kumahara, E; Ebihara, T; Saffen, D			Protein kinase inhibitor H7 blocks the induction of immediate-early genes zif268 and c-fos by a mechanism unrelated to inhibition of protein kinase C but possibly related to inhibition of phosphorylation of RNA polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; PC12 PHEOCHROMOCYTOMA CELLS; TRANSCRIPTION FACTOR TFIIH; RAS-DEPENDENT ACTIVATION; TUMOR-NECROSIS-FACTOR; MAP KINASE; CYCLIC-AMP; TYROSINE PHOSPHORYLATION; SIGNAL TRANSDUCTION; CALCIUM INFLUX	1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H7) has often been used in combination with protein kinase inhibitor (N-(2-guanidinoethyl)-5-isoquinolinesulfonamide) (HA1004) to assess the contribution of protein kinase C (PKC) to cellular processes, including the induction of gene expression. This use of H7 and HA1004 is based upon the fact that H7 inhibits PRC more potently than HA1004 in in vitro assays. Thus, although both compounds are broad spectrum protein kinase inhibitors, inhibition by H7, but not by HA1004, has often been interpreted as evidence for the involvement of PKC in the cellular process under study. Here we describe experiments that show that this interpretation is not correct with regard to the induction of two immediate early genes, zif268 and c-fos, in PC1SD cells. In these studies we confirmed that H7, but not HA1004, potently blocks the induction of zif268 and c-fos mRNA by nerve growth factor, carbachol, phorbol ester, Ca2+ ionophore, or forskolin, Surprisingly, however, H7 has no effect on the ability of these agents to activate mitogen-activated protein kinase (MAPK), an upstream activator of zif268 and c-fos gene expression. H7 also does not inhibit preactivated MAPK in vitro. Taken together, these results suggest that H7 blocks gene expression by acting at a site downstream from MAPK. H7 has previously been shown to block transcription in vitro by blocking the phosphorylation of the carboxyl-terminal domain of RNA polymerase II (Yankulov, K,, Yamashita, K,, Roy, R,, Egly, J,-M,, and Bentley, D, L,(1995) J, Biol, Chem, 270, 23922-23925). In this study, we show that pretreating PC12D cells with H7, but not with HA1004, significantly reduces levels of phosphorylated RNA polymerase II in vivo. These results suggest that H7 blocks gene expression by inhibiting the phosphorylation of RNA polymerase II, a step required for progression from transcription initiation to mRNA chain elongation.	Univ Tokyo, Fac Med, Dept Neurochem, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo	Kumahara, E (corresponding author), Univ Tokyo, Fac Med, Dept Neurochem, Bunkyo Ku, Hongo 7-3-1, Tokyo 113, Japan.	kumahara@m.u-tokyo.ac.jp	EBIHARA, TAKAE/M-9420-2019	EBIHARA, TAKAE/0000-0003-2325-7637				ABBOUD SL, 1995, J CELL PHYSIOL, V164, P434, DOI 10.1002/jcp.1041640224; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Angel P. E., 1994, FOS JUN FAMILIES TRA; ASANO T, 1984, J PHARMACOL EXP THER, V231, P141; BALBI D, 1994, MOL BRAIN RES, V23, P310, DOI 10.1016/0169-328X(94)90240-2; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; BERG MM, 1992, J BIOL CHEM, V267, P13; BETHEA JR, 1992, J CELL PHYSIOL, V152, P264, DOI 10.1002/jcp.1041520207; Boado RJ, 1996, NEUROSCI LETT, V220, P53, DOI 10.1016/S0304-3940(96)13237-7; CADENA DL, 1987, J BIOL CHEM, V262, P12468; CAO XM, 1992, J BIOL CHEM, V267, P1345; CHANGELIAN PS, 1989, P NATL ACAD SCI USA, V86, P377, DOI 10.1073/pnas.86.1.377; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CHODOSH LA, 1989, J BIOL CHEM, V264, P2250; CHRISTY B, 1989, MOL CELL BIOL, V9, P4889, DOI 10.1128/MCB.9.11.4889; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Ebihara T, 1997, J NEUROCHEM, V68, P1001; ENSLEN H, 1994, J BIOL CHEM, V269, P20872; ERHARDT P, 1995, MOL CELL BIOL, V15, P5524; FRODIN M, 1994, J BIOL CHEM, V269, P6207; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HAMA T, 1986, P NATL ACAD SCI USA, V83, P2353, DOI 10.1073/pnas.83.8.2353; HARBERS M, 1991, BIOCHEM J, V278, P305, DOI 10.1042/bj2780305; HEASLEY LE, 1989, J BIOL CHEM, V264, P8646; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HIPSKIND RA, 1994, MOL CELL BIOL, V14, P6219, DOI 10.1128/MCB.14.9.6219; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; JAMES RI, 1992, EUR J BIOCHEM, V209, P813, DOI 10.1111/j.1432-1033.1992.tb17352.x; Jenab S, 1998, ENDOCRINOLOGY, V139, P1883, DOI 10.1210/en.139.4.1883; Jenab S, 1997, ENDOCRINOLOGY, V138, P2740, DOI 10.1210/en.138.7.2740; Johnson CM, 1997, J NEUROSCI, V17, P6189; KAHLE P, 1994, J NEUROCHEM, V62, P479; KATOHSEMBA R, 1987, J NEUROSCI RES, V17, P36, DOI 10.1002/jnr.490170106; KNUSEL B, 1992, J NEUROCHEM, V59, P1987; KUMAHARA E, 1999, IN PRESS J BIOCH TOK, V125; MANTOVANI L, 1991, FEBS LETT, V280, P97, DOI 10.1016/0014-5793(91)80213-M; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MECHTI N, 1991, MOL CELL BIOL, V11, P2832, DOI 10.1128/MCB.11.5.2832; MEINKOTH JL, 1993, MOL CELL BIOCHEM, V128, P179, DOI 10.1007/BF01076769; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MORRIS CHT, 1988, NUCLEIC ACIDS RES, V16, P8835, DOI 10.1093/nar/16.18.8835; NAKAJIMA K, 1991, MOL CELL BIOL, V11, P1409, DOI 10.1128/MCB.11.3.1409; NAKAJIMA K, 1993, MOL CELL BIOL, V13, P3027, DOI 10.1128/MCB.13.5.3027; NORDEEN SK, 1987, DNA-J MOLEC CELL BIO, V6, P173, DOI 10.1089/dna.1987.6.173; NOSE K, 1991, EUR J BIOCHEM, V201, P99, DOI 10.1111/j.1432-1033.1991.tb16261.x; OHTSUKI M, 1992, MOL CELL BIOL, V12, P261, DOI 10.1128/MCB.12.1.261; PERALDI P, 1995, FEBS LETT, V357, P290, DOI 10.1016/0014-5793(94)01376-C; QUICK J, 1992, BIOCHEM BIOPH RES CO, V187, P657, DOI 10.1016/0006-291X(92)91245-L; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SERIZAWA H, 1993, J BIOL CHEM, V268, P17300; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; SLOOTWEG MC, 1991, J MOL ENDOCRINOL, V6, P179, DOI 10.1677/jme.0.0060179; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Suh Harold H., 1992, Biological Signals, V1, P257; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; TSAO H, 1990, J BIOL CHEM, V265, P15471; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YANKULOV K, 1995, J BIOL CHEM, V270, P23922, DOI 10.1074/jbc.270.41.23922; Yankulov KY, 1996, MOL CELL BIOL, V16, P3291; YIN TG, 1994, J BIOL CHEM, V269, P3731; YIN TG, 1993, CELL GROWTH DIFFER, V4, P603; Yu CW, 1997, FEBS LETT, V420, P69, DOI 10.1016/S0014-5793(97)01489-0	81	21	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10430	10438		10.1074/jbc.274.15.10430	http://dx.doi.org/10.1074/jbc.274.15.10430			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187833	hybrid			2022-12-27	WOS:000079663500072
J	Okamoto, K; Tanaka, H; Ogawa, H; Makino, Y; Eguchi, H; Hayashi, S; Yoshikawa, N; Poellinger, L; Umesono, K; Makino, I				Okamoto, K; Tanaka, H; Ogawa, H; Makino, Y; Eguchi, H; Hayashi, S; Yoshikawa, N; Poellinger, L; Umesono, K; Makino, I			Redox-dependent regulation of nuclear import of the glucocorticoid receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; THYROID-HORMONE RECEPTOR; PROLIFERATOR-ACTIVATED RECEPTOR; RETINOIC ACID RECEPTOR; NF-KAPPA-B; DNA-BINDING; PEROXISOME-PROLIFERATOR; TRANSCRIPTION FACTOR; ESTROGEN-RECEPTOR; GENE-EXPRESSION	A number of transcription factors including the glucocorticoid receptor (GR) are regulated in a redox-dependent fashion. We have previously reported that the functional activity of the GR is suppressed under oxidative conditions and restored in the presence of reducing reagents. In the present study, we have used a chimeric human GR fused to the Aequorea green fluorescent protein and demonstrated that both ligand-dependent and -independent nuclear translocation of the GR is impaired under oxidative conditions in living cells. Substitution of Cys-481 for Ser within NL1 of the human GR resulted in reduction of sensitivity to oxidative treatment, strongly indicating that Cys-481 is one of the target amino acids for redox regulation of the receptor. Taken together, we may conclude that redox-dependent regulation of nuclear translocation of the GR constitutes an important mechanism for modulation of glucocorticoid-dependent signal transduction.	Asahikawa Med Coll, Dept Internal Med 2, Asahikawa, Hokkaido 0788510, Japan; Kyoto Univ, Inst Virus Res, Dept Genet & Mol Biol, Kyoto 6068507, Japan; Saitama Canc Ctr, Res Inst, Dept Biochem, Ina, Saitama 3620800, Japan; Karolinska Inst, Nobel Med Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Asahikawa Medical College; Kyoto University; Karolinska Institutet	Tanaka, H (corresponding author), Asahikawa Med Coll, Dept Internal Med 2, Asahikawa, Hokkaido 0788510, Japan.	hirotnk@asahikawa-med.ac.jp	Ogawa, Hidesato/M-3778-2019; Ogawa, Hidesato/A-2079-2016; Eguchi, Hiromi/GWC-5633-2022	Ogawa, Hidesato/0000-0001-9740-9010; 				ALKSNIS M, 1991, J BIOL CHEM, V266, P10078; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BODWELL JE, 1984, BIOCHEMISTRY-US, V23, P1392, DOI 10.1021/bi00302a009; BOUMPAS DT, 1993, ANN INTERN MED, V119, P1198, DOI 10.7326/0003-4819-119-12-199312150-00007; BRESNICK EH, 1988, BIOCHEMISTRY-US, V27, P2866, DOI 10.1021/bi00408a030; Calleja C, 1998, NAT MED, V4, P92, DOI 10.1038/nm0198-092; Carey KL, 1996, J CELL BIOL, V133, P985, DOI 10.1083/jcb.133.5.985; CHALFIE M, 1995, PHOTOCHEM PHOTOBIOL, V62, P651, DOI 10.1111/j.1751-1097.1995.tb08712.x; CHANG C, 1988, BIOCHEM BIOPH RES CO, V155, P971, DOI 10.1016/S0006-291X(88)80591-6; CHARTIER FL, 1994, GENE, V147, P269, DOI 10.1016/0378-1119(94)90079-5; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Eguchi H, 1997, J BIOL CHEM, V272, P17640, DOI 10.1074/jbc.272.28.17640; Eudy JD, 1998, GENOMICS, V50, P382, DOI 10.1006/geno.1998.5345; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; Hayashi S, 1997, NUCLEIC ACIDS RES, V25, P4035, DOI 10.1093/nar/25.20.4035; HIROSE T, 1994, BIOCHEM BIOPH RES CO, V205, P1976, DOI 10.1006/bbrc.1994.2902; HIROSE T, 1994, MOL ENDOCRINOL, V8, P1667, DOI 10.1210/me.8.12.1667; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; HSU SC, 1992, EMBO J, V11, P3457, DOI 10.1002/j.1460-2075.1992.tb05425.x; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; HUTCHISON KA, 1991, J BIOL CHEM, V266, P10505; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; JEWELL CM, 1995, J STEROID BIOCHEM, V55, P135, DOI 10.1016/0960-0760(95)00174-X; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kapelle M, 1997, BBA-GENE STRUCT EXPR, V1352, P13, DOI 10.1016/S0167-4781(97)00043-2; KLEBANOFF SJ, 1986, J IMMUNOL, V136, P4220; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; Lambe KG, 1996, EUR J BIOCHEM, V239, P1, DOI 10.1111/j.1432-1033.1996.0001u.x; LEHMANN JM, 1991, NUCLEIC ACIDS RES, V19, P573, DOI 10.1093/nar/19.3.573; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; MADAN AP, 1993, P NATL ACAD SCI USA, V90, P3588, DOI 10.1073/pnas.90.8.3588; Makino Y, 1996, MOL PHARMACOL, V49, P612; Makino Y, 1996, J CLIN INVEST, V98, P2469, DOI 10.1172/JCI119065; Makino Y, 1999, J BIOL CHEM, V274, P3182, DOI 10.1074/jbc.274.5.3182; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MCGUIRE J, 1994, MOL CELL BIOL, V14, P2438, DOI 10.1128/MCB.14.4.2438; MISRAHI M, 1987, BIOCHEM BIOPH RES CO, V143, P740, DOI 10.1016/0006-291X(87)91416-1; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Oba K, 1996, BIOCHEM BIOPH RES CO, V226, P261, DOI 10.1006/bbrc.1996.1343; OGAWA H, 1995, P NATL ACAD SCI USA, V92, P11899, DOI 10.1073/pnas.92.25.11899; Ogawa S, 1998, BIOCHEM BIOPH RES CO, V243, P122, DOI 10.1006/bbrc.1997.7893; Ohkura N, 1996, BBA-GENE STRUCT EXPR, V1308, P205, DOI 10.1016/0167-4781(96)00101-7; OKABE T, 1995, J IMMUNOL, V154, P3871; Okamoto K, 1998, BIOCHEM PHARMACOL, V56, P79, DOI 10.1016/S0006-2952(98)00121-X; OPOKU J, 1994, J BIOL CHEM, V269, P503; Pariante CM, 1997, MOL PHARMACOL, V52, P571, DOI 10.1124/mol.52.4.571; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PFAHL M, 1987, NUCLEIC ACIDS RES, V15, P9613, DOI 10.1093/nar/15.22.9613; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PRATT WB, 1993, J BIOL CHEM, V268, P21455; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Sackey FNA, 1996, MOL ENDOCRINOL, V10, P1191, DOI 10.1210/me.10.10.1191; SCHENA M, 1989, GENE DEV, V3, P1590, DOI 10.1101/gad.3.10.1590; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; SCHRECK R, 1994, METHOD ENZYMOL, V234, P151; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Sen CK, 1998, BIOCHEM PHARMACOL, V55, P1747, DOI 10.1016/S0006-2952(97)00672-2; Shepherd V L, 1986, Semin Respir Infect, V1, P99; SHER T, 1993, BIOCHEMISTRY-US, V32, P5598, DOI 10.1021/bi00072a015; SIMONS SS, 1995, METHOD ENZYMOL, V251, P406; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Tanaka H, 1999, VITAM HORM, V57, P153; TANAKA H, 1995, MOL PHARMACOL, V48, P938; Tanaka H, 1996, J IMMUNOL, V156, P1601; Tang YT, 1996, MOL CELL BIOL, V16, P1989; Tang YT, 1997, MOL BIOL CELL, V8, P795, DOI 10.1091/mbc.8.5.795; TIENRUNGROJ W, 1987, J BIOL CHEM, V262, P6992; TSAN MF, 1977, BLOOD, V49, P437; TYRRELL JB, 1995, ENDOCRINOL METAB, P855; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Yang J, 1997, J CELL BIOL, V137, P523, DOI 10.1083/jcb.137.3.523; Yang J, 1996, MOL ENDOCRINOL, V10, P3, DOI 10.1210/me.10.1.3; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; ZILLIACUS J, 1992, J STEROID BIOCHEM, V42, P131, DOI 10.1016/0960-0760(92)90021-A	89	144	149	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10363	10371		10.1074/jbc.274.15.10363	http://dx.doi.org/10.1074/jbc.274.15.10363			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187825	hybrid			2022-12-27	WOS:000079663500064
J	Viljoen, M; Volschenk, H; Young, RA; van Vuuren, HJJ				Viljoen, M; Volschenk, H; Young, RA; van Vuuren, HJJ			Transcriptional regulation of the Schizosaccharomyces pombe malic enzyme gene, mae2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; L-MALATE; CAMP; EXPRESSION; PROTEIN; DNA; DIFFERENTIATION; IDENTIFICATION; METABOLISM; TRANSPORT	The NAD-dependent malic enzyme from Schizosaccharomyces pombe catalyzes the oxidative decarboxylation of L-malate to pyruvate and CO2. Transcription of the S, pombe malic enzyme gene, mae2, was studied to elucidate the regulatory mechanisms involved in the expression of the gene. No evidence for substrate-induced expression of mae2 was observed in the presence of 0.2% L-malate, However, transcription of mae2 was induced when cells were grown in high concentrations of glucose or under anaerobic conditions. The increased levels of malic enzyme may provide additional pyruvate or assist in maintaining the redox potential under fermentative conditions. Deletion and mutation analyses of the 5'-flanking region of the mae2 gene revealed the presence of three novel negative cis-acting elements, URS1, URS2, and URS3, that seem to function cooperatively to repress transcription of the mae2 gene. URS1 and URS2 are also present in the promoter region of the S, pombe malate transporter gene, suggesting co-regulation of their expression. Furthermore, two positive cis-acting elements in the mae2 promoter, UAS1 and UAS2, show homology with the DNA recognition sites of the cAMP-dependent transcription factors ADR1, AP-2, and ATF (activating transcription factor)/CREB (cAMP response element binding).	Univ Stellenbosch, Dept Microbiol, ZA-7600 Stellenbosch, South Africa; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Brock Univ, Cool Climate Oenol & Viticulture Inst, St Catharines, ON L2S 3A1, Canada	Stellenbosch University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Brock University	Viljoen, M (corresponding author), Univ Stellenbosch, Dept Microbiol, Private Bag X1, ZA-7602 Matieland, South Africa.	mv4@maties.sun.ac.za	Volschenk, Heinrich/L-8400-2015; Young, Richard A/F-6495-2012	Volschenk, Heinrich/0000-0001-9287-0975; Young, Richard A/0000-0001-8855-8647; Viljoen-Bloom, Marinda/0000-0002-4825-2392				ARTUS NN, 1985, FEBS LETT, V182, P225, DOI 10.1016/0014-5793(85)80305-7; Ausubel FM, 1994, CURRENT PROTOCOLS MO; BAGCHI S, 1987, J BIOL CHEM, V262, P1558; BARANOWSKI K, 1984, A VAN LEEUW J MICROB, V50, P329, DOI 10.1007/BF00394646; BERKOWITZ LA, 1990, P NATL ACAD SCI USA, V87, P5258, DOI 10.1073/pnas.87.14.5258; Boles E, 1998, J BACTERIOL, V180, P2875, DOI 10.1128/JB.180.11.2875-2882.1998; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BYRNE SM, 1993, J CELL SCI, V105, P1095; CHEN TH, 1985, IEEE T COMPUT AID D, V4, P3, DOI 10.1109/TCAD.1985.1270093; CHENG C, 1994, MOL CELL BIOL, V14, P3842, DOI 10.1128/MCB.14.6.3842; CHERRY JR, 1989, CELL, V56, P409, DOI 10.1016/0092-8674(89)90244-4; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Grobler J, 1995, YEAST, V11, P1485, DOI 10.1002/yea.320111503; GUILFOILE PG, 1992, J BACTERIOL, V174, P3651, DOI 10.1128/JB.174.11.3651-3658.1992; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HAYLES J, 1992, ANNU REV GENET, V26, P373, DOI 10.1146/annurev.ge.26.120192.002105; HOFFMAN CS, 1991, GENE DEV, V5, P561, DOI 10.1101/gad.5.4.561; HSU RY, 1992, BIOCHEM J, V284, P869, DOI 10.1042/bj2840869; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; Johnson B.F, 1989, MOL BIOL FISSION YEA, P243; Kratzer S, 1997, MOL MICROBIOL, V26, P631, DOI 10.1046/j.1365-2958.1997.5611937.x; KULKARNI G, 1993, ARCH BIOCHEM BIOPHYS, V300, P231, DOI 10.1006/abbi.1993.1032; MAGYAR I, 1989, AM J ENOL VITICULT, V40, P233; MAYER K, 1963, ARCH MIKROBIOL, V46, P321, DOI 10.1007/BF00422193; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; OSOTHSILP C, 1986, CAN J MICROBIOL, V32, P481, DOI 10.1139/m86-088; OSOTHSILP C, 1986, J BACTERIOL, V168, P1439, DOI 10.1128/jb.168.3.1439-1443.1986; PETERSON CL, 1991, CELL, V64, P1135, DOI 10.1016/0092-8674(91)90268-4; PRENTICE HL, 1992, NUCLEIC ACIDS RES, V20, P3383, DOI 10.1093/nar/20.13.3383; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; RODRIGUEZ SB, 1990, FEMS MICROBIOL LETT, V72, P17, DOI 10.1016/0378-1097(90)90337-P; RUPP RAW, 1990, NUCLEIC ACIDS RES, V18, P2607, DOI 10.1093/nar/18.9.2607; SIKORSKI RS, 1989, GENETICS, V122, P19; Singh MV, 1998, BBA-GENE STRUCT EXPR, V1398, P148, DOI 10.1016/S0167-4781(98)00037-2; TAILLANDIER P, 1991, APPL MICROBIOL BIOT, V35, P541; TEMPERLI A, 1965, BIOCHIM BIOPHYS ACTA, V110, P630, DOI 10.1016/S0926-6593(65)80080-7; VILJOEN M, 1994, YEAST, V10, P613, DOI 10.1002/yea.320100506; Yeagley D, 1998, J BIOL CHEM, V273, P18743, DOI 10.1074/jbc.273.30.18743	40	13	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					9969	9975		10.1074/jbc.274.15.9969	http://dx.doi.org/10.1074/jbc.274.15.9969			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187772	hybrid			2022-12-27	WOS:000079663500011
J	Wong, SC; Zhang, L; Witt, TL; Proefke, SA; Bhushan, A; Matherly, LH				Wong, SC; Zhang, L; Witt, TL; Proefke, SA; Bhushan, A; Matherly, LH			Impaired membrane transport in methotrexate-resistant CCRF-CEM cells involves early translation termination and increased turnover of a mutant reduced folate carrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; L1210 LEUKEMIA-CELLS; TUMOR-CELLS; FOLIC-ACID; CELLULAR PHARMACOLOGY; ANTIFOLATE RESISTANCE; PROTEIN-DEGRADATION; GENE; EXPRESSION; MECHANISM	The basis for impaired reduced folate carrier (RFC) activity in methotrexate-resistant CCRF-CEM (CEM/Mtx-1) cells was examined. Parental and CEM/Mtx-1 cells expressed identical levels of the 3.1-kilobase RFC transcript. A similar to 85-kDa RFC protein was detected in parental cells by photoaffinity labeling and on Western blots with RFC-specific antiserum. In CEM/Mtx-1 cells, RFC protein was undetectable. By reverse transcriptase-polymerase chain reaction and sequence analysis, G to A point mutations were identified in CEM/Mtx-1 transcripts at positions 130 (P-1; changes glycine 44 --> arginine) and 380 (P-2; changes serine 127 --> asparagine), A 4-base pair (CATG) insertion detected at position 191 (in 19-30% of cDNA clones) resulted in a frameshift and early translation termination. Wild-type RFC was also detected (0-9% of clones). Wild-type RFC and double-mutated RFC (RFCP1+P2) cDNAs mere transfected into transport-impaired K562 and Chinese hamster ovary cells. Although RFC transcripts paralleled wild-type protein, for the RFCP1+P2 transfectants, disproportionately low RFCP1+P2 protein was detected, This reflected an increased turnover of RFCP1+P2 over wild type RFC, RFCP1+P2 did not restore methotrexate transport; however, uptake was partially restored by constructs with single mutations at the P-1 or P-2 loci. Cumulatively, our results show that loss of transport function in CEM/Mtx-1 cells results from complete loss of RFC protein due to early translation termination and increased turnover of a mutant RFC protein.	Barbara Ann Karmanos Canc Inst, Expt & Clin Therapeut Program, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; Idaho State Univ, Dept Pharmaceut Sci, Pocatello, ID 83209 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Idaho; Idaho State University	Matherly, LH (corresponding author), Barbara Ann Karmanos Canc Inst, Expt & Clin Therapeut Program, Detroit, MI 48201 USA.	matherly@kci.wayne.edu			NCI NIH HHS [CA 53535] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BODANSKY O, 1963, J BIOL CHEM, V238, P3420; BRIGLE KE, 1995, J BIOL CHEM, V270, P22974, DOI 10.1074/jbc.270.39.22974; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; DUCH DS, 1993, CANCER RES, V53, P810; FLINTOFF WF, 1983, ARCH BIOCHEM BIOPHYS, V223, P433, DOI 10.1016/0003-9861(83)90607-0; FRY DW, 1982, J BIOL CHEM, V257, P1890; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Goldberg AL, 1997, BIOL CHEM, V378, P131; GOLDMAN ID, 1985, PHARMACOL THERAPEUT, V28, P77, DOI 10.1016/0163-7258(85)90083-X; Gong MK, 1997, BLOOD, V89, P2494, DOI 10.1182/blood.V89.7.2494; Gorlick R, 1997, BLOOD, V89, P1013, DOI 10.1182/blood.V89.3.1013; GREEN DE, 1955, J BIOL CHEM, V217, P551; HARLOWE E, 1988, ANTIBODIES LAB MANUA; HENDERSON GB, 1990, CANCER RES, V50, P1709; Jansen G, 1998, J BIOL CHEM, V273, P30189, DOI 10.1074/jbc.273.46.30189; JENTSCH S, 1995, CELL, V82, P881, DOI 10.1016/0092-8674(95)90021-7; Kumar CK, 1998, AM J PHYSIOL-CELL PH, V274, pC289, DOI 10.1152/ajpcell.1998.274.1.C289; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOO TW, 1994, J BIOL CHEM, V269, P28683; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1989, MOL CLONING LAB MANU; MATHERLY LH, 1993, BIOCHEM PHARMACOL, V46, P2185, DOI 10.1016/0006-2952(93)90608-Y; MATHERLY LH, 1992, J BIOL CHEM, V267, P23253; MATHERLY LH, 1991, CANCER RES, V51, P3420; MOSCOW JA, 1995, CANCER RES, V55, P3790; Murray RC, 1996, J BIOL CHEM, V271, P19174, DOI 10.1074/jbc.271.32.19174; ROSOWSKY A, 1980, BIOCHEM PHARMACOL, V29, P648, DOI 10.1016/0006-2952(80)90391-3; Roy K, 1998, J BIOL CHEM, V273, P2526, DOI 10.1074/jbc.273.5.2526; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUETZ JD, 1988, J BIOL CHEM, V263, P9840; Sierra EE, 1997, BIOCHEM PHARMACOL, V53, P223, DOI 10.1016/S0006-2952(96)00730-7; SIROTNAK FM, 1985, CANCER RES, V45, P3992; SIROTNAK FM, 1987, BIOCHEM PHARMACOL, V36, P1659, DOI 10.1016/0006-2952(87)90051-7; SIROTNAK FM, 1981, CANCER RES, V41, P4442; Tolner B, 1998, GENE, V211, P331, DOI 10.1016/S0378-1119(98)00123-1; Wong SC, 1997, BIOCHEM PHARMACOL, V53, P199, DOI 10.1016/S0006-2952(96)00710-1; WONG SC, 1995, J BIOL CHEM, V270, P17468, DOI 10.1074/jbc.270.29.17468; Wong SC, 1998, BIOCHEM PHARMACOL, V55, P1135, DOI 10.1016/S0006-2952(97)00639-4; Zhang L, 1998, BBA-GENE STRUCT EXPR, V1442, P389, DOI 10.1016/S0167-4781(98)00168-7; Zhao R, 1998, J BIOL CHEM, V273, P19065, DOI 10.1074/jbc.273.30.19065; Zhao RB, 1998, J BIOL CHEM, V273, P7873, DOI 10.1074/jbc.273.14.7873; Zhao RB, 1997, J BIOL CHEM, V272, P21207, DOI 10.1074/jbc.272.34.21207	42	73	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10388	10394		10.1074/jbc.274.15.10388	http://dx.doi.org/10.1074/jbc.274.15.10388			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187828	hybrid			2022-12-27	WOS:000079663500067
J	Narishige, T; Blade, KL; Ishibashi, Y; Nagai, T; Hamawaki, M; Menick, DR; Kuppuswamy, D; Cooper, G				Narishige, T; Blade, KL; Ishibashi, Y; Nagai, T; Hamawaki, M; Menick, DR; Kuppuswamy, D; Cooper, G			Cardiac hypertrophic and developmental regulation of the beta-tubulin multigene family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE DYSFUNCTION; MICROTUBULES; MYOCARDIUM; CARDIOCYTES; ISOTYPES; CELLS; MAP4	Increased microtubule density, through viscous loading of active myofilaments, causes contractile dysfunction of hypertrophied and failing pressure-overloaded myocardium, which is normalized by microtubule depolymerization. We have found this to be based on augmented tubulin synthesis and microtubule stability. We show here that increased tubulin synthesis is accounted for by marked transcriptional up-regulation of the beta 1- and beta 2-tubulin isoforms, that hypertrophic regulation of these genes recapitulates their developmental regulation, and that the greater proportion of beta 1-tubulin protein may have a causative role in the microtubule stabilization found in cardiac hypertrophy.	Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Dept Med, Charleston, SC 29403 USA; Vet Affairs Med Ctr, Charleston, SC 29403 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Cooper, G (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Dept Med, POB 250773, Charleston, SC 29403 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048788] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-48788] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARLOW S, 1994, J CELL BIOL, V126, P1017, DOI 10.1083/jcb.126.4.1017; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cooper G, 1997, ANNU REV MED, V48, P13, DOI 10.1146/annurev.med.48.1.13; COOPER G, 1986, CIRC RES, V58, P692, DOI 10.1161/01.RES.58.5.692; COOPER G, 1973, CIRC RES, V33, P213, DOI 10.1161/01.RES.33.2.213; HOYLE HD, 1990, J CELL BIOL, V111, P1009, DOI 10.1083/jcb.111.3.1009; LEE MG, 1983, CELL, V33, P477; LOPATA MA, 1987, J CELL BIOL, V105, P1707, DOI 10.1083/jcb.105.4.1707; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; Mangan ME, 1996, DEVELOPMENT, V122, P771; MANN DL, 1991, CIRC RES, V68, P402, DOI 10.1161/01.RES.68.2.402; OBLINGER MM, 1994, DEV BRAIN RES, V77, P45, DOI 10.1016/0165-3806(94)90212-7; OSTLUND RE, 1979, ANAL BIOCHEM, V96, P155, DOI 10.1016/0003-2697(79)90568-2; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Raff EC, 1997, SCIENCE, V275, P70, DOI 10.1126/science.275.5296.70; RENTHAL R, 1993, CELL MOTIL CYTOSKEL, V25, P19, DOI 10.1002/cm.970250104; Sato H, 1997, J CELL BIOL, V139, P963, DOI 10.1083/jcb.139.4.963; SULLIVAN KF, 1986, P NATL ACAD SCI USA, V83, P4327, DOI 10.1073/pnas.83.12.4327; Tagawa H, 1996, CIRCULATION, V93, P1230, DOI 10.1161/01.CIR.93.6.1230; Tagawa H, 1997, CIRC RES, V80, P281, DOI 10.1161/01.RES.80.2.281; TSUTSUI H, 1993, SCIENCE, V260, P682, DOI 10.1126/science.8097594; Wang XM, 1996, J CELL BIOL, V132, P345, DOI 10.1083/jcb.132.3.345; YEN TJ, 1988, NATURE, V334, P580, DOI 10.1038/334580a0	23	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9692	9697		10.1074/jbc.274.14.9692	http://dx.doi.org/10.1074/jbc.274.14.9692			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092657	hybrid			2022-12-27	WOS:000079451800076
J	Nishiya, N; Iwabuchi, Y; Shibanuma, M; Cote, JF; Tremblay, ML; Nose, K				Nishiya, N; Iwabuchi, Y; Shibanuma, M; Cote, JF; Tremblay, ML; Nose, K			Hic-5, a paxillin homologue, binds to the protein-tyrosine phosphatase PEST (PTP-PEST) through its LIM3 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CELL-ADHESION; MOTIF; EXPRESSION; SENESCENCE; INTEGRINS; VINCULIN; CLONING; GENES; PHOSPHORYLATION	The Hic-5 protein is encoded by a transforming growth factor-beta 1- and hydrogen peroxide-inducible gene, hic-5, and has striking similarity to paxillin, especially in their C-terminal LIM domains. Like paxillin, Hic-5 is localized in focal adhesion plaques in association with focal adhesion kinase in cultured fibroblasts. We carried out yeast two-hybrid screening to identify cellular factors that form a complex with Hic-5 using its LIM domains as a bait, and we identified a cytoplasmic tyrosine phosphatase (PTP-PEST) as one of the partners of Hic-5. These two proteins are associated in mammalian cells. From in vitro binding experiments using deletion and point mutations, it was demonstrated that the essential domain in Hic-5 for the binding was LIM 3, As for PTP-PEST, one of the five proline-rich sequences found on PTP-PEST, Pro-2, was identified as the binding site for Hic-5 in in vitro binding assays. Paxillin also binds to the Pro-a domain of PTP-PEST. In conclusion, Hic-5 may participate in the regulation of signaling cascade through its interaction with distinct tyrosine kinases and phosphatases.	Showa Univ, Sch Pharmaceut Sci, Dept Microbiol, Shinagawa Ku, Tokyo 142, Japan; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	Showa University; McGill University	Nose, K (corresponding author), Showa Univ, Sch Pharmaceut Sci, Dept Microbiol, Shinagawa Ku, Hatanodai 1-5-8, Tokyo 142, Japan.	knose@pharm.showa-u.ac.jp		Nishiya, Naoyuki/0000-0003-1575-9944				BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; BURRIDGE K, 1986, Cancer Reviews, V4, P18; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Charest A, 1996, J BIOL CHEM, V271, P8424, DOI 10.1074/jbc.271.14.8424; CHAREST A, 1995, BIOCHEM J, V308, P425, DOI 10.1042/bj3080425; Charest A, 1997, ONCOGENE, V14, P1643, DOI 10.1038/sj.onc.1201008; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Cote JF, 1998, BIOCHEMISTRY-US, V37, P13128, DOI 10.1021/bi981259l; Craig SW, 1996, CURR OPIN CELL BIOL, V8, P74, DOI 10.1016/S0955-0674(96)80051-2; DENHERTOG J, 1992, BIOCHEM BIOPH RES CO, V184, P1241, DOI 10.1016/S0006-291X(05)80015-4; FEUERSTEIN R, 1994, P NATL ACAD SCI USA, V91, P10655, DOI 10.1073/pnas.91.22.10655; Fujita H, 1998, J BIOL CHEM, V273, P26516, DOI 10.1074/jbc.273.41.26516; Giancotti FG, 1997, CURR OPIN CELL BIOL, V9, P691, DOI 10.1016/S0955-0674(97)80123-8; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HENIKOFF S, 1987, GENETICS, V117, P711; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Matsuya M, 1998, J BIOL CHEM, V273, P1003, DOI 10.1074/jbc.273.2.1003; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884, DOI 10.1128/MCB.17.7.3884; NAMBA M, 1985, INT J CANCER, V35, P275, DOI 10.1002/ijc.2910350221; Nishiya N, 1998, NUCLEIC ACIDS RES, V26, P4267, DOI 10.1093/nar/26.18.4267; Parsons JT, 1996, CURR OPIN CELL BIOL, V8, P146, DOI 10.1016/S0955-0674(96)80059-7; SANCHEZGARCIA I, 1994, TRENDS GENET, V10, P315, DOI 10.1016/0168-9525(94)90034-5; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; Shen Y, 1998, J BIOL CHEM, V273, P6474, DOI 10.1074/jbc.273.11.6474; Shibanuma M, 1997, MOL CELL BIOL, V17, P1224, DOI 10.1128/MCB.17.3.1224; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Shibanuma M, 1998, INT J BIOCHEM CELL B, V30, P39, DOI 10.1016/S1357-2725(97)00155-6; TAKEKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P1223, DOI 10.1016/0006-291X(92)92335-U; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; TURNER CE, 1994, J CELL SCI, V107, P1583; YANG Q, 1993, J BIOL CHEM, V268, P6622	42	76	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9847	9853		10.1074/jbc.274.14.9847	http://dx.doi.org/10.1074/jbc.274.14.9847			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092676	hybrid			2022-12-27	WOS:000079451800095
J	Blumenthal, SG; Aichele, G; Wirth, T; Czernilofsky, AP; Nordheim, A; Dittmer, J				Blumenthal, SG; Aichele, G; Wirth, T; Czernilofsky, AP; Nordheim, A; Dittmer, J			Regulation of the human interleukin-5 promoter by Ets transcription factors - Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax(1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-I; CREB BINDING-PROTEIN; NF-KAPPA-B; HORMONE-RELATED PROTEIN; GM-CSF PROMOTER; HUMAN T-CELLS; DNA-BINDING; C-JUN; TRANSACTIVATOR TAX; GENE-EXPRESSION	Interleukin-5 (IL-5), expressed primarily by type-2 T helper (Th2) cells, plays an important role in the development of allergic diseases, such as allergic asthma. Studying the regulation of IL-5 gene expression by Ets transcription factors, we found that Ets1 and Ets2, but not Elf-1, were able to activate the human IL-5 promoter in Jurkat T-cells. This required the presence of either phorbol 12-myristate acetate (PMA) plus ionomycin or PMA plus the viral protein HTLV-I Tax,. By mutation studies, it could be shown that Ets1 and Ets2 exerted their effects on the IL-5 promoter through a GGAA motif within the Cle0 element. In myeloid Kasumi cells, Ets1 and Ets2 failed to stimulate IL-5 promoter activity, unless the T-cell specific transcription factor GATA3 was added. These results show, for the first time, that Ets1 and Ets2 are able to cooperate with GATA3. Both ionomycin and Tax, increased the combined effect of GATA3 with Ets1 and Ets2 in the presence of PMA. The data further demonstrate that, in addition to Ets1, Ets2 is also able to functionally cooperate with Tax,. The synergism of GATA3 with either Ets1 or Ets2 may play an important role in calcium- or Tax(1)-dependent regulation of IL-5 expression in Th2 cells or in HTLV-I transformed adult T-cell leukemia cells, respectively.	Univ Tubingen, Inst Zellbiol, Mol Biol Abt, D-72076 Tubingen, Germany; Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany; Bender & Co Gesell MBH, A-1121 Vienna, Austria	Eberhard Karls University of Tubingen	Dittmer, J (corresponding author), Univ Tubingen, Inst Zellbiol, Mol Biol Abt, Morgenstelle 15, D-72076 Tubingen, Germany.		Dittmer, Juergen/G-1160-2011; Wirth, Thomas/X-7172-2019					ALEXANDRE C, 1991, ONCOGENE, V6, P543; ANNWEILER A, 1992, MOL CELL BIOL, V12, P3107, DOI 10.1128/MCB.12.7.3107; ARMSTRONG AP, 1993, P NATL ACAD SCI USA, V90, P7303, DOI 10.1073/pnas.90.15.7303; BARANGER AM, 1995, NATURE, V376, P606, DOI 10.1038/376606a0; BASSUK AG, 1995, IMMUNITY, V3, P223, DOI 10.1016/1074-7613(95)90092-6; BERGELSON S, 1994, BIOCHEM BIOPH RES CO, V200, P290, DOI 10.1006/bbrc.1994.1447; Bex F, 1998, MOL CELL BIOL, V18, P2392, DOI 10.1128/MCB.18.4.2392; BHAT NK, 1990, P NATL ACAD SCI USA, V87, P3723, DOI 10.1073/pnas.87.10.3723; BISCHOFF SC, 1990, J EXP MED, V172, P1577, DOI 10.1084/jem.172.6.1577; BOHJANEN PR, 1990, P NATL ACAD SCI USA, V87, P5283, DOI 10.1073/pnas.87.14.5283; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; BOSSELUT R, 1990, EMBO J, V9, P3137, DOI 10.1002/j.1460-2075.1990.tb07511.x; CARON C, 1993, EMBO J, V12, P4269, DOI 10.1002/j.1460-2075.1993.tb06111.x; Caron C, 1997, P NATL ACAD SCI USA, V94, P3662, DOI 10.1073/pnas.94.8.3662; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Clemens KE, 1996, MOL CELL BIOL, V16, P4656; Dittmer J, 1998, BBA-REV CANCER, V1377, pF1, DOI 10.1016/S0304-419X(97)00039-5; DITTMER J, 1994, J BIOL CHEM, V269, P21428; DITTMER J, 1993, J VIROL, V67, P6087, DOI 10.1128/JVI.67.10.6087-6095.1993; Dittmer J, 1997, J BIOL CHEM, V272, P4953, DOI 10.1074/jbc.272.8.4953; Fam NP, 1997, MOL CELL BIOL, V17, P1396, DOI 10.1128/MCB.17.3.1396; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; FLEISCHMAN LF, 1993, ONCOGENE, V8, P771; Foster PS, 1997, MEM I OSWALDO CRUZ, V92, P55, DOI 10.1590/S0074-02761997000800009; FUJII M, 1992, GENE DEV, V6, P2066, DOI 10.1101/gad.6.11.2066; GEGONNE A, 1992, NEW BIOL, V4, P512; GHYSDAEL J, 1997, ONCOGENES TRANSCRIPT, V1, P29; Giebler HA, 1997, MOL CELL BIOL, V17, P5156, DOI 10.1128/MCB.17.9.5156; Gitlin Scott D., 1993, P159; Good L, 1997, J BIOL CHEM, V272, P1425, DOI 10.1074/jbc.272.3.1425; GRUARTGOUILLEUX V, 1995, EUR J IMMUNOL, V25, P1431, DOI 10.1002/eji.1830250544; HASSANAIN HH, 1993, ANAL BIOCHEM, V213, P162, DOI 10.1006/abio.1993.1400; HIRAI H, 1994, P NATL ACAD SCI USA, V91, P3584, DOI 10.1073/pnas.91.9.3584; HIRAI K, 1990, J EXP MED, V172, P1525, DOI 10.1084/jem.172.5.1525; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; Hogan SP, 1998, AM J RESP CRIT CARE, V157, P210, DOI 10.1164/ajrccm.157.1.9702074; HOOPER WC, 1991, BIOCHEM BIOPH RES CO, V181, P976, DOI 10.1016/0006-291X(91)92032-F; JANKNECHT R, 1993, EUR J BIOCHEM, V216, P469, DOI 10.1111/j.1432-1033.1993.tb18165.x; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; KANNO T, 1994, MOL CELL BIOL, V14, P6443, DOI 10.1128/MCB.14.10.6443; KVANTA A, 1992, CELL SIGNAL, V4, P275, DOI 10.1016/0898-6568(92)90067-I; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Logan SK, 1996, J BIOL CHEM, V271, P774, DOI 10.1074/jbc.271.2.774; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; Luo C, 1996, MOL CELL BIOL, V16, P3955; MAJERUS MA, 1992, NUCLEIC ACIDS RES, V20, P2699, DOI 10.1093/nar/20.11.2699; MAKOVER D, 1991, ONCOGENE, V6, P455; MURATA K, 1992, CANCER, V69, P966, DOI 10.1002/1097-0142(19920215)69:4&lt;966::AID-CNCR2820690422&gt;3.0.CO;2-H; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; NOMA T, 1989, J EXP MED, V169, P1853, DOI 10.1084/jem.169.5.1853; Patton SE, 1998, CANCER RES, V58, P2253; PiseMasison CA, 1997, MOL CELL BIOL, V17, P1236, DOI 10.1128/MCB.17.3.1236; POGNONEC P, 1989, ONCOGENE, V4, P691; POGNONEC P, 1988, EMBO J, V7, P977, DOI 10.1002/j.1460-2075.1988.tb02904.x; RABAULT B, 1994, J BIOL CHEM, V269, P28143; RIMSKY L, 1988, NATURE, V335, P738, DOI 10.1038/335738a0; Rincon M, 1997, CURR BIOL, V7, pR729, DOI 10.1016/S0960-9822(06)00368-X; Rousset R, 1996, NATURE, V381, P328, DOI 10.1038/381328a0; RUBEN S M, 1989, New Biologist, V1, P275; SACCHI N, 1988, LEUKEMIA, V2, P12; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; Stranick KS, 1997, J BIOL CHEM, V272, P16453, DOI 10.1074/jbc.272.26.16453; SUN SC, 1994, MOL CELL BIOL, V14, P7377, DOI 10.1128/MCB.14.11.7377; Thomas RS, 1997, ONCOGENE, V14, P2845, DOI 10.1038/sj.onc.1201125; THOMAS RS, 1995, ONCOGENE, V11, P2135; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; TOMINAGA A, 1988, J IMMUNOL, V140, P1175; TSUCHIYA H, 1993, J VIROL, V67, P7001, DOI 10.1128/JVI.67.12.7001-7007.1993; WAGNER S, 1993, SCIENCE, V262, P395, DOI 10.1126/science.8211160; WANG CY, 1994, MOL CELL BIOL, V14, P1153, DOI 10.1128/MCB.14.2.1153; WARREN DJ, 1985, IMMUNOLOGY, V54, P615; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; Wasylyk C, 1997, ONCOGENE, V14, P899, DOI 10.1038/sj.onc.1200914; Yamagata T, 1997, MOL CELL BIOL, V17, P4272, DOI 10.1128/MCB.17.8.4272; YAMAGATA T, 1995, MOL CELL BIOL, V15, P3830; YAMAGUCHI Y, 1988, J EXP MED, V167, P1737, DOI 10.1084/jem.167.5.1737; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218; Yin MJ, 1996, MOL CELL BIOL, V16, P3156; Zhang M, 1997, CELL GROWTH DIFFER, V8, P179	86	86	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12910	12916		10.1074/jbc.274.18.12910	http://dx.doi.org/10.1074/jbc.274.18.12910			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212281	hybrid			2022-12-27	WOS:000080056800101
J	Yang, VWC; LaBrenz, SR; Rosenberg, LC; McQuillan, D; Hook, M				Yang, VWC; LaBrenz, SR; Rosenberg, LC; McQuillan, D; Hook, M			Decorin is a Zn2+ metalloprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE ARTICULAR-CARTILAGE; DERMATAN SULFATE PROTEOGLYCANS; GROWTH-FACTOR-BETA; CORE PROTEIN; MATRIX METALLOPROTEINASES; COLLAGEN FIBRILLOGENESIS; PROTEODERMATAN SULFATE; ESCHERICHIA-COLI; SKIN FRAGILITY; LINK PROTEIN	Decorin is ubiquitously distributed in the extracellular matrix of mammals and a member of the proteoglycan family characterized by a core protein dominated by leucine-rich repeat motifs. We show here that decorin extracted from bovine tissues under denaturing conditions or produced in recombinant "native" form by cultured mammalian cells has a high affinity for Zn2+ as demonstrated by equilibrium dialyses. The Zn2+-binding sites are localized to the N-terminal domain of the core protein that contains 4 Cys residues in a spacing reminiscent of a zinc finger. A recombinant 41-amino acid long peptide representing the N-terminal domain of decorin has full Zn2+ binding activity and binds two Zn2+ ions with an average H-D, of 3 x 10(-7) (M). Binding of Zn2+ to this peptide results in a change in secondary structure as shown by circular dichroism spectroscopy. Biglycan, a proteoglycan that is structurally closely related to decorin contains a similar high affinity Zn2+-binding segment, whereas the structurally more distantly related proteoglycans, epiphycan and osteoglycin, do not bind Zn2+ with high affinity.	Ctr Extracellular Matrix Biol, Albert B Alkek Inst Biosci & Technol, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; Texas A&M Univ, Dept Biochem & Biophys, Houston, TX 77030 USA; Montefiore Med Ctr, Orthopaed Res Lab, Bronx, NY 10467 USA	University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Hook, M (corresponding author), Ctr Extracellular Matrix Biol, Albert B Alkek Inst Biosci & Technol, Houston, TX 77030 USA.	mhook@ibt.tamu.edu			NIAMS NIH HHS [AR42919, AR42826] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042919, R01AR042826] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ancsin JB, 1996, J BIOL CHEM, V271, P6845, DOI 10.1074/jbc.271.12.6845; BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250; BROWN DC, 1990, MATRIX, V9, P468, DOI 10.1016/S0934-8832(11)80016-8; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; CHOI HU, 1989, J BIOL CHEM, V264, P2876; DAMLE SP, 1982, J BIOL CHEM, V257, P5523; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; EMONARD H, 1990, CELL MOL BIOL, V36, P131; FISHER LW, 1983, J BIOL CHEM, V258, P6588; FISHER LW, 1985, CHEM BIOL MINERALIZE, P188; FREIFELDER D, 1982, PHYSICAL BIOCH APPLI, P654; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hering TM, 1996, ANAL BIOCHEM, V240, P98, DOI 10.1006/abio.1996.0335; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hocking AM, 1996, J BIOL CHEM, V271, P19571, DOI 10.1074/jbc.271.32.19571; HUNT JB, 1984, J BIOL CHEM, V259, P4793; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; JACOBS GH, 1992, EMBO J, V11, P4507, DOI 10.1002/j.1460-2075.1992.tb05552.x; JEZOREK JR, 1979, ANAL CHEM, V51, P373, DOI 10.1021/ac50039a012; Johnson HJ, 1997, J BIOL CHEM, V272, P18709, DOI 10.1074/jbc.272.30.18709; LEWANDOWSKA K, 1987, J CELL BIOL, V105, P1443, DOI 10.1083/jcb.105.3.1443; LIU J, 1994, J BIOL CHEM, V269, P28366; MOSCATELLI D, 1988, BIOCHIM BIOPHYS ACTA, V948, P67, DOI 10.1016/0304-419X(88)90005-4; NAKAMURA T, 1983, BIOCHEM J, V213, P289, DOI 10.1042/bj2130289; NEAME PJ, 1989, J BIOL CHEM, V264, P8653; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; POOLE AR, 1986, J HISTOCHEM CYTOCHEM, V34, P619, DOI 10.1177/34.5.3701029; Ramamurthy P, 1996, J BIOL CHEM, V271, P19578, DOI 10.1074/jbc.271.32.19578; REINHARDT D, 1993, J BIOL CHEM, V268, P10881; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; ROSENBERG L, 1991, J BIOL CHEM, V266, P7016; ROSENBERG LC, 1985, J BIOL CHEM, V260, P6304; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMIDT G, 1987, J CELL BIOL, V104, P1683, DOI 10.1083/jcb.104.6.1683; SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776; TAKAHASHI T, 1993, J HISTOCHEM CYTOCHEM, V41, P1447, DOI 10.1177/41.10.8245404; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VARELAS JB, 1995, ARCH BIOCHEM BIOPHYS, V321, P21, DOI 10.1006/abbi.1995.1363; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; WINNEMOLLER M, 1991, EUR J CELL BIOL, V54, P10; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0	44	29	31	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12454	12460		10.1074/jbc.274.18.12454	http://dx.doi.org/10.1074/jbc.274.18.12454			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212220	Green Submitted, hybrid			2022-12-27	WOS:000080056800040
J	Salinas, M; Reyes, R; Lesage, F; Fosset, M; Heurteaux, C; Romey, G; Lazdunski, M				Salinas, M; Reyes, R; Lesage, F; Fosset, M; Heurteaux, C; Romey, G; Lazdunski, M			Cloning of a new mouse two-P domain channel subunit and a human homologue with a unique pore structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; LONG-QT SYNDROME; CALCIUM-MODULATED PROTEINS; RECTIFYING K+-CHANNEL; SENSITIVE NA+ CHANNEL; POTASSIUM CHANNEL; SULFONYLUREA RECEPTOR; ENDOPLASMIC-RETICULUM; CYTOPLASMIC DOMAIN; PLASMA-MEMBRANE	Mouse KCNK6 is a new subunit belonging to the TWIK channel family. This 335-amino acid polypeptide has four transmembrane segments, two pore-forming domains, and a Ca2+-binding EF-hand motif. Expression of KCNK6 transcripts is principally observed in eyes, lung, stomach and embryo. In the eyes, immunohistochemistry reveals protein expression only in some of the retina neurons. Although KCNK6 is able to dimerize as other functional two-P domain K+ channels when it is expressed in COS-7 cells, it remains in the endoplasmic reticulum and is unable to generate ionic channel activity. Deletions, mutations, and chimera constructions suggest that KCNK6 is not an intracellular channel but rather a subunit that needs to associate with a partner, which remains to be discovered, in order to reach the plasma membrane, A closely related human KCNK7-A subunit has been cloned. KCNK7 displays an intriguing GLE sequence in its filter region instead of the G(Y/F/L)G sequence, which is considered to be the K+ channel signature. This subunit is alternatively spliced and gives rise to the shorter forms KCNK7-B and -C, None of the KCNR7 structures can generate channel activity by itself. The KCNK7 gene is situated on chromosome 11, in the q13 region, where several candidate diseases have been identified.	CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Lazdunski, M (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	ipmc@ipmc.cnrs.fr	SALINAS, Miguel/N-6380-2016; Lesage, Florian/P-9780-2019; HEURTEAUX, Catherine/M-4947-2016; Lesage, Florian/D-5097-2011	SALINAS, Miguel/0000-0002-7445-123X; Lesage, Florian/0000-0002-4406-7106; HEURTEAUX, Catherine/0000-0002-9741-9777; Lesage, Florian/0000-0002-4406-7106				ADAMS GA, 1985, CELL, V41, P1007, DOI 10.1016/S0092-8674(85)80081-7; Attali B, 1996, NATURE, V384, P24, DOI 10.1038/384024a0; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Czempinski K, 1997, EMBO J, V16, P2565, DOI 10.1093/emboj/16.10.2565; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drici MD, 1998, CIRC RES, V83, P95, DOI 10.1161/01.RES.83.1.95; Duggal P, 1998, CIRCULATION, V97, P142, DOI 10.1161/01.CIR.97.2.142; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; DUPRAT F, 1995, BIOCHEM BIOPH RES CO, V212, P657, DOI 10.1006/bbrc.1995.2019; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Fink M, 1996, J BIOL CHEM, V271, P26341, DOI 10.1074/jbc.271.42.26341; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HAY M, 1994, NEUROSCI LETT, V167, P179, DOI 10.1016/0304-3940(94)91056-1; HEIZMANN CW, 1991, TRENDS BIOCHEM SCI, V16, P98, DOI 10.1016/0968-0004(91)90041-S; Hille B., 1992, IONIC CHANNELS EXCIT; Hille Bertil, 1994, P75; Hugnot JP, 1996, EMBO J, V15, P3322, DOI 10.1002/j.1460-2075.1996.tb00697.x; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; JAN LY, 1994, NATURE, V371, P119, DOI 10.1038/371119a0; Jaskiewicz E, 1997, ACTA BIOCHIM POL, V44, P173; John SA, 1998, J PHYSIOL-LONDON, V510, P333, DOI 10.1111/j.1469-7793.1998.333bk.x; JONES BG, 1995, EMBO J, V14, P5869, DOI 10.1002/j.1460-2075.1995.tb00275.x; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; Kolling R, 1997, EMBO J, V16, P2251, DOI 10.1093/emboj/16.9.2251; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; LECHLEITER J, 1990, EMBO J, V9, P4381, DOI 10.1002/j.1460-2075.1990.tb07888.x; Leonoudakis D, 1998, J NEUROSCI, V18, P868; LEPPERT M, 1994, NAT GENET, V7, P108, DOI 10.1038/ng0594-108; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; Lesage F, 1997, FEBS LETT, V402, P28, DOI 10.1016/S0014-5793(96)01491-3; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; LINGUEGLIA E, 1994, J BIOL CHEM, V269, P13736; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; Maingret F, 1999, J BIOL CHEM, V274, P1381, DOI 10.1074/jbc.274.3.1381; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; NAKAYAMA S, 1992, J MOL EVOL, V34, P416, DOI 10.1007/BF00162998; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Patel AJ, 1997, EMBO J, V16, P6615, DOI 10.1093/emboj/16.22.6615; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; Pedrazzini E, 1996, P NATL ACAD SCI USA, V93, P4207, DOI 10.1073/pnas.93.9.4207; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Post MA, 1996, FEBS LETT, V399, P177, DOI 10.1016/S0014-5793(96)01316-6; Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Salinas M, 1997, J BIOL CHEM, V272, P24371, DOI 10.1074/jbc.272.39.24371; Salinas M, 1997, J BIOL CHEM, V272, P8774, DOI 10.1074/jbc.272.13.8774; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Sather William A., 1994, Current Opinion in Neurobiology, V4, P313, DOI 10.1016/0959-4388(94)90091-4; SCHAFER W, 1995, EMBO J, V14, P2424, DOI 10.1002/j.1460-2075.1995.tb07240.x; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; SKRE H, 1974, CLIN GENET, V5, P196; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; STONE EM, 1992, NAT GENET, V1, P246, DOI 10.1038/ng0792-246; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; WONG SH, 1993, J BIOL CHEM, V268, P22853; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zhu ZL, 1996, J VIROL, V70, P6563, DOI 10.1128/JVI.70.10.6563-6575.1996	79	111	115	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11751	11760		10.1074/jbc.274.17.11751	http://dx.doi.org/10.1074/jbc.274.17.11751			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206991	hybrid			2022-12-27	WOS:000079834800047
J	Wilson, HA; Waldrip, JB; Nielson, KH; Judd, AM; Han, SK; Cho, WW; Sims, PJ; Bell, JD				Wilson, HA; Waldrip, JB; Nielson, KH; Judd, AM; Han, SK; Cho, WW; Sims, PJ; Bell, JD			Mechanisms by which elevated intracellular calcium induces S49 cell membranes to become susceptible to the action of secretory phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-II PHOSPHOLIPASE-A2; PLASMA-MEMBRANE; LAURDAN FLUORESCENCE; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; ARACHIDONIC-ACID; PALMITIC ACID; MAST-CELLS; IN-VITRO; LYSOPHOSPHATIDYLCHOLINE	Exposure of S49 lymphoma cells to exogenous group IIA or V secretory phospholipase A(2) (sPLA(2)) caused an initial release of fatty acid followed by resistance to further hydrolysis by the enzyme. This refractoriness was overcome by exposing cells to palmitoyl lysolecithin. This effect was specific in terms of lysophospholipid structure, Induction of membrane susceptibility by lysolecithin involved an increase in cytosolic calcium and was duplicated by incubating the cells with calcium ionophores such as ionomycin. Lysolecithin also activated cytosolic phospholipase A(2) (cPLA(2)). Inhibition of this enzyme attenuated the ability of lysolecithin (but not ionomycin) to induce susceptibility to sPLC(2). Lysolecithin or ionomycin caused concurrent hydrolysis of both phosphatidylethanolamine and phosphatidylcholine implying that transbilayer movement of phosphatidylethanolamine occurred upon exposure to these agents but that susceptibility is not simply due to exposure of a preferred substrate (i.e. phosphatidylethanolamine) to the enzyme. Microvesicles were apparently released from the cells upon addition of lysolecithin or ionomycin. Both these vesicles and the remnant cell membranes were susceptible to sPLA(2). Together these data suggest that lysolecithin induces susceptibility through both cPLA(2)-dependent and -independent pathways. Whereas elevated cytosolic calcium was required for both pathways, it was sufficient only for the cPLA(2)-independent pathway. This cPLA(2)-independent pathway involved changes in cell membrane structure associated with transbilayer phospholipid migration and microvesicle release.	Brigham Young Univ, Dept Zool, Provo, UT 84602 USA; Univ Illinois, Dept Chem, Chicago, IL 60607 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Brigham Young University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Scripps Research Institute	Bell, JD (corresponding author), Brigham Young Univ, Dept Zool, Provo, UT 84602 USA.	john_bell@byu.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049710, R01GM052598] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL36946] Funding Source: Medline; NIGMS NIH HHS [GM52598, GM49710] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANCIAN P, 1995, BIOCHEMISTRY-US, V34, P13146, DOI 10.1021/bi00040a028; ARNDTJOVIN DJ, 1989, METHOD CELL BIOL, V30, P417; ASAOKA Y, 1992, P NATL ACAD SCI USA, V89, P6447, DOI 10.1073/pnas.89.14.6447; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BASSE F, 1994, BBA-BIOMEMBRANES, V1190, P217, DOI 10.1016/0005-2736(94)90077-9; BELL JD, 1995, BIOCHEMISTRY-US, V34, P11551, DOI 10.1021/bi00036a031; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BURACK WR, 1995, BIOCHEMISTRY-US, V34, P14819, DOI 10.1021/bi00045a024; CHANG CP, 1993, J BIOL CHEM, V268, P7171; CHAP HJ, 1977, BIOCHIM BIOPHYS ACTA, V467, P146, DOI 10.1016/0005-2736(77)90192-4; Chen L, 1997, J LIPID RES, V38, P546; CHONG PLG, 1993, BIOCHIM BIOPHYS ACTA, V1149, P260, DOI 10.1016/0005-2736(93)90209-I; Cieslik K, 1998, J BIOL CHEM, V273, P14885, DOI 10.1074/jbc.273.24.14885; COMFURIUS P, 1990, BIOCHIM BIOPHYS ACTA, V1026, P153, DOI 10.1016/0005-2736(90)90058-V; COX DA, 1996, AM J PHYS, V40, pH1706; DUMASWALA UJ, 1984, TRANSFUSION, V24, P490, DOI 10.1046/j.1537-2995.1984.24685066807.x; Fang XJ, 1997, J BIOL CHEM, V272, P13683, DOI 10.1074/jbc.272.21.13683; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; GELB MH, 1995, ANNU REV BIOCHEM, V64, P653; GHERIANIGRUSZKA N, 1988, J BIOL CHEM, V263, P11808; Han SK, 1998, BIOCHEM J, V331, P353, DOI 10.1042/bj3310353; HARA S, 1993, J BIOCHEM-TOKYO, V114, P509, DOI 10.1093/oxfordjournals.jbchem.a124208; Henshaw JB, 1998, BIOCHEMISTRY-US, V37, P10709, DOI 10.1021/bi9728809; Honger T, 1996, BIOCHEMISTRY-US, V35, P9003, DOI 10.1021/bi960866a; Hoque ANE, 1997, CIRC RES, V80, P95, DOI 10.1161/01.RES.80.1.95; Huang Z., 1994, MEDIAT INFLAMM, V3, P307; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V980, P23, DOI 10.1016/0005-2736(89)90195-8; KIKUCHIYANOSHITA R, 1993, J BIOCHEM-TOKYO, V114, P33, DOI 10.1093/oxfordjournals.jbchem.a124135; Koumanov K, 1997, BIOCHEM J, V326, P227, DOI 10.1042/bj3260227; KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P217, DOI 10.1016/0005-2760(93)90003-R; Magishi K, 1996, PFLUG ARCH EUR J PHY, V432, P345, DOI 10.1007/s004240050142; MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839; MURAKAMI M, 1991, FEBS LETT, V294, P247, DOI 10.1016/0014-5793(91)81440-J; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; NAG MK, 1995, MEDIAT INFLAMM, V4, P90, DOI 10.1155/S0962935195000147; OGITA T, 1997, AM J PHYS, V41, pH17; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; PARASASSI T, 1994, BIOPHYS J, V66, P120, DOI 10.1016/S0006-3495(94)80763-5; Reddy ST, 1997, J BIOL CHEM, V272, P3231, DOI 10.1074/jbc.272.6.3231; RICHIERI GV, 1989, J IMMUNOL, V143, P2302; RICHIERI GV, 1995, ANAL BIOCHEM, V229, P256, DOI 10.1006/abio.1995.1410; Romano M, 1998, ARTERIOSCL THROM VAS, V18, P519, DOI 10.1161/01.ATV.18.4.519; RYBORG AK, 1995, BRIT J DERMATOL, V133, P398, DOI 10.1111/j.1365-2133.1995.tb02667.x; SCOLDING NJ, 1992, NEUROSCI LETT, V135, P95, DOI 10.1016/0304-3940(92)90144-V; SEVANIAN A, 1988, BIOCHIM BIOPHYS ACTA, V961, P316, DOI 10.1016/0005-2760(88)90079-3; Shander GS, 1996, J MOL CELL CARDIOL, V28, P743, DOI 10.1006/jmcc.1996.0069; Snitko Y, 1997, BIOCHEMISTRY-US, V36, P14325, DOI 10.1021/bi971200z; Spangelo BL, 1996, ENDOCRINOLOGY, V137, P4419, DOI 10.1210/en.137.10.4419; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; SWEETMAN LL, 1995, ARCH BIOCHEM BIOPHYS, V323, P97, DOI 10.1006/abbi.1995.0014; VADAS P, 1993, CIRC SHOCK, V39, P160; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; WIEDMER T, 1991, BLOOD, V78, P2880; Wilson HA, 1997, BBA-LIPID LIPID MET, V1349, P142, DOI 10.1016/S0005-2760(97)00089-1; WOLF A, 1991, LIPIDS, V26, P223, DOI 10.1007/BF02543975; Wong JT, 1998, J BIOL CHEM, V273, P6830, DOI 10.1074/jbc.273.12.6830; Wu RH, 1998, ARTERIOSCL THROM VAS, V18, P626, DOI 10.1161/01.ATV.18.4.626; Yu LP, 1998, J PHARMACOL EXP THER, V286, P1; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	61	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11494	11504		10.1074/jbc.274.17.11494	http://dx.doi.org/10.1074/jbc.274.17.11494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206954	hybrid			2022-12-27	WOS:000079834800010
J	Wu, MY; Wang, PY; Han, SH; Hsieh, SL				Wu, MY; Wang, PY; Han, SH; Hsieh, SL			The cytoplasmic domain of the lymphotoxin-beta receptor mediates cell death in HeLa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; PERIPHERAL LYMPHOID ORGANS; FACTOR TNF RECEPTOR; VIRUS CORE PROTEIN; KAPPA-B ACTIVATION; MONOCLONAL-ANTIBODIES; SIGNALING COMPLEX; APOPTOSIS; EXPRESSION; INTERACTS	Activation of lymphotoxin-beta receptor (LT-beta R) by conjugation with heterotrimeric lymphotoxin, LT-alpha 1/beta 2, or by cross-linking with anti-LT-beta R antibodies can trigger apoptosis. We have observed that overexpression of either LT-beta R or the cytoplasmic domain of LT-beta R (LT-beta R(CD)) also induces apoptosis, which may be attributed to the tendency of LT-beta R(CD) to self associate. The self-association domain of LT-beta R(CD) was mapped to amino acids 324-377, a region of the protein that is also essential for LT-beta R-induced apoptosis. Furthermore, we have shown that LT-beta R(CD)-induced apoptosis could be inhibited by a TRAF3 dominant negative mutant and by the caspase inhibitors Z-VAD-FMK, DEVD -FMK, and CrmA. The ligand-independent apoptosis induced by LT-beta R(CD) will help us to further dissect LT-beta R signaling pathway.	Natl Yang Ming Univ, Sch Med, Inst Microbiol & Immunol, Taipei 11221, Taiwan; Natl Yang Ming Univ, Sch Med, Immunol Res Ctr, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hsieh, SL (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Microbiol & Immunol, Taipei 11221, Taiwan.		Hsieh, Shie-Liang Edmond/ABA-9184-2021					BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Browning JL, 1996, J EXP MED, V183, P867, DOI 10.1084/jem.183.3.867; BROWNING JL, 1995, J IMMUNOL, V154, P33; Chen CM, 1997, J VIROL, V71, P9417, DOI 10.1128/JVI.71.12.9417-9426.1997; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; DegliEsposti MA, 1997, J IMMUNOL, V158, P1756; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; ESPEVIK T, 1990, J EXP MED, V171, P415, DOI 10.1084/jem.171.2.415; Force WR, 1997, J BIOL CHEM, V272, P30835, DOI 10.1074/jbc.272.49.30835; FORCE WR, 1995, J IMMUNOL, V155, P5280; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Haridas V, 1998, J IMMUNOL, V160, P3152; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Mackay F, 1996, J BIOL CHEM, V271, P24934, DOI 10.1074/jbc.271.40.24934; Matsumoto M, 1997, J VIROL, V71, P1301, DOI 10.1128/JVI.71.2.1301-1309.1997; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Ossina NK, 1997, J BIOL CHEM, V272, P16351, DOI 10.1074/jbc.272.26.16351; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; SONG HY, 1994, J BIOL CHEM, V269, P22492; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460; Vandevoorde V, 1997, J CELL BIOL, V137, P1627, DOI 10.1083/jcb.137.7.1627; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175; Wu MY, 1997, J BIOL CHEM, V272, P17154, DOI 10.1074/jbc.272.27.17154; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhai YF, 1998, J CLIN INVEST, V102, P1142, DOI 10.1172/JCI3492	41	38	41	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11868	11873		10.1074/jbc.274.17.11868	http://dx.doi.org/10.1074/jbc.274.17.11868			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207006	hybrid			2022-12-27	WOS:000079834800062
J	Butler, GS; Apte, SS; Willenbrock, F; Murphy, G				Butler, GS; Apte, SS; Willenbrock, F; Murphy, G			Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B - Regulation by polyanions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOPEXIN-LIKE DOMAIN; TIMP GENE FAMILY; PROGELATINASE-A; MATRIX METALLOPROTEINASES; 72-KDA GELATINASE; COMPLEX-FORMATION; IV COLLAGENASE; ACTIVATION; BINDING; CLONING	We compared the association constants of tissue inhibitor of metalloproteinases (TIMP)-3 with various matrix metalloproteinases with those for TIMP-1 and TIMP-2 using a continuous assay. TIMP-3 behaved more like TIMP-3 than TIMP-1, showing rapid association with gelatinases A and B. Experiments with the N-terminal domain of gelatinase A the isolated C-terminal domain, or an inactive progelatinase A mutant showed that the hemopexin domain of gelatinase A makes an important contribution to the interaction with TIMP-3. The exchange of portions of the gelatinase A hemopexin domain with that of stromelysin revealed that residues 568-631 of gelatinase A were required for rapid association with TIMP-3. The N-terminal domain of gelatinase B alone also showed slower association with TIMP-3, again implying significant C-domain interactions. The isolation of complexes between TIMP-3 and progelatinases A and B on gelatin-agarose demonstrated that TIMP-3 binds to both proenzymes. We analyzed the effect of various polyanions on the inhibitory activity of TIMP-3 in our soluble assay. The association rate was increased by dextran sulfate, heparin, and heparan sulfate, but not by dermatan sulfate or hyaluronic acid. Because TIMP-3 is sequestered in the extracellular matrix, the presence of certain heparan sulfate proteoglycans could enhance its inhibitory capacity.	Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Cleveland Clin Fdn, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; Queen Mary Univ London, Dept Biochem, Lab Struct & Mech Enzymol, London E1 4NS, England	University of East Anglia; Cleveland Clinic Foundation; University of London; Queen Mary University London	Murphy, G (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	g.murphy@uea.ac.uk	Butler, Georgina/GQP-7553-2022	Butler, Georgina/0000-0003-1172-1578; Apte, Suneel/0000-0001-8441-1226				ALTER SC, 1987, BIOCHEM J, V248, P821, DOI 10.1042/bj2480821; AnandApte B, 1997, INVEST OPHTH VIS SCI, V38, P817; APTE SS, 1994, GENOMICS, V19, P86, DOI 10.1006/geno.1994.1016; APTE SS, 1995, J BIOL CHEM, V270, P14313, DOI 10.1074/jbc.270.24.14313; Atkinson SJ, 1995, J BIOL CHEM, V270, P30479, DOI 10.1074/jbc.270.51.30479; Bigg HF, 1997, J BIOL CHEM, V272, P15496, DOI 10.1074/jbc.272.24.15496; BLENIS J, 1983, P NATL ACAD SCI-BIOL, V80, P770, DOI 10.1073/pnas.80.3.770; BOONE TC, 1990, P NATL ACAD SCI USA, V87, P2800, DOI 10.1073/pnas.87.7.2800; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Butler GS, 1997, EUR J BIOCHEM, V244, P653, DOI 10.1111/j.1432-1033.1997.t01-1-00653.x; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; CRABBE T, 1992, BIOCHEMISTRY-US, V31, P8500, DOI 10.1021/bi00151a017; CRABBE T, 1994, BIOCHEMISTRY-US, V33, P6684, DOI 10.1021/bi00187a039; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; DECLERCK YA, 1993, BIOCHEM J, V289, P65, DOI 10.1042/bj2890065; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; EVANS DL, 1992, BIOCHEMISTRY-US, V31, P12629, DOI 10.1021/bi00165a013; GALLAGHER JT, 1995, ADV EXP MED BIOL, V376, P125; GALLAGHER JT, 1986, BIOCHEM J, V236, P313, DOI 10.1042/bj2360313; Gohlke U, 1996, FEBS LETT, V378, P126, DOI 10.1016/0014-5793(95)01435-7; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Greene J, 1996, J BIOL CHEM, V271, P30375, DOI 10.1074/jbc.271.48.30375; HOOK M, 1984, ANNU REV BIOCHEM, V53, P847; HOWARD EW, 1991, J BIOL CHEM, V266, P17972; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; KISHNANI NS, 1995, MATRIX BIOL, V14, P479, DOI 10.1016/0945-053X(95)90005-5; KLEINER DE, 1992, BIOCHEMISTRY-US, V31, P1665, DOI 10.1021/bi00121a013; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; KOKLITIS PA, 1991, BIOCHEM J, V276, P217, DOI 10.1042/bj2760217; LELIEVRE Y, 1990, MATRIX, V10, P292, DOI 10.1016/S0934-8832(11)80184-8; LIBSON AM, 1995, NAT STRUCT BIOL, V2, P938, DOI 10.1038/nsb1195-938; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; MURPHY AN, 1993, J CELL PHYSIOL, V157, P351, DOI 10.1002/jcp.1041570219; MURPHY G, 1992, BIOCHEM J, V283, P637, DOI 10.1042/bj2830637; MURPHY G, 1981, BIOCHEM J, V199, P807, DOI 10.1042/bj1990807; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; MURPHY G, 1995, METHOD ENZYMOL, V248, P496; NGUYEN Q, 1994, BIOCHEMISTRY-US, V33, P2089, DOI 10.1021/bi00174a015; OCONNELL JP, 1994, J BIOL CHEM, V269, P14967; OKADA Y, 1986, J BIOL CHEM, V261, P14245; SILBIGER SM, 1994, GENE, V141, P293, DOI 10.1016/0378-1119(94)90588-6; URIA JA, 1994, CANCER RES, V54, P2091; WARD RV, 1991, BIOCHEM J, V278, P179, DOI 10.1042/bj2780179; WARD RV, 1994, BIOCHEM J, V304, P263, DOI 10.1042/bj3040263; WELGUS HG, 1985, J CLIN INVEST, V76, P219, DOI 10.1172/JCI111949; WICK M, 1994, J BIOL CHEM, V269, P18953; WILDE CG, 1994, DNA CELL BIOL, V13, P711, DOI 10.1089/dna.1994.13.711; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; WILLENBROCK F, 1993, BIOCHEMISTRY-US, V32, P4330, DOI 10.1021/bi00067a023; WILLIAMSON RA, 1990, BIOCHEM J, V268, P267, DOI 10.1042/bj2680267	51	105	107	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10846	10851		10.1074/jbc.274.16.10846	http://dx.doi.org/10.1074/jbc.274.16.10846			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196161	hybrid			2022-12-27	WOS:000079751900029
J	Penta, K; Varner, JA; Liaw, L; Hidai, C; Schatzman, R; Quertermous, T				Penta, K; Varner, JA; Liaw, L; Hidai, C; Schatzman, R; Quertermous, T			Del1 induces integrin signaling and angiogenesis by ligation of alpha V beta 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; IN-VITRO; BLOOD-VESSELS; ENDOTHELIAL-CELLS; FOCAL ADHESIONS; PROTEIN SHC; INTEGRIN-ALPHA-V-BETA-3; VITRONECTIN; OSTEOPONTIN; SPECIFICITY	Del1 is a novel extracellular matrix protein encoding three Notch-like epidermal growth factor repeats, an RGD motif, and two discoidin domains. Del1 is expressed in an endothelial cell-restricted pattern during early development, In studies reported here, recombinant baculovirus Del1 protein was shown to promote alpha v beta 3-dependent endothelial cell attachment and migration, Attachment of endothelial cells to Del1 was associated with clustering of alpha v beta 3, the formation of focal complexes, and recruitment of talin and vinculin into these complexes. These events were shown to be associated with phosphorylation of proteins in the focal complexes, including the time-dependent phosphorylation of p125(FAK), MAPK, and Shc. When recombinant Del1 was evaluated in an in ovo chick chorioallantoic membrane assay, it was found to have potent angiogenic activity. This angiogenic activity was inhibited by a monoclonal antibody directed against alpha v beta 3, and an RAD mutant Del1 protein was inactive. Thus Del1 provides a unique autocrine angiogenic pathway for the embryonic endothelium, and this function is mediated in part by productive ligation of integrin alpha v beta 3.	Stanford Univ, Sch Med, Div Cardiol, Falk CVRC, Stanford, CA 94305 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Maine Med Ctr, Res Inst, Ctr Mol Med, Portland, ME USA; Tokyo Womens Med Coll, Tokyo 162, Japan; Progenitor Inc, Menlo Pk, CA 94025 USA	Stanford University; University of California System; University of California San Diego; Maine Medical Center; Tokyo Women's Medical University	Quertermous, T (corresponding author), Stanford Univ, Sch Med, Div Cardiol, Falk CVRC, Falk Bldg,300 Pasteur Dr, Stanford, CA 94305 USA.	tomq1@leland.stanford.edu		Varner, Judith/0000-0002-9251-0600; Quertermous, Thomas/0000-0002-7645-9067	NATIONAL CANCER INSTITUTE [R01CA071619] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052168] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA71619] Funding Source: Medline; NHLBI NIH HHS [R01 HL52168] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; CAIXIA S, 1991, CELL IMMUNOL, V138, P216, DOI 10.1016/0008-8749(91)90146-3; CHERESH DA, 1987, J BIOL CHEM, V262, P17703; Chung J, 1997, J BIOL CHEM, V272, P14740, DOI 10.1074/jbc.272.23.14740; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; DRAKE CJ, 1995, J CELL SCI, V108, P2655; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Gao AG, 1996, J CELL BIOL, V135, P533, DOI 10.1083/jcb.135.2.533; Harlow E., 1988, ANTIBODIES LAB MANUA; Hidai C, 1998, GENE DEV, V12, P21, DOI 10.1101/gad.12.1.21; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 1996, DEV BIOL, V180, P402, DOI 10.1006/dbio.1996.0314; Juliano Rudy, 1996, Bioessays, V18, P911, DOI 10.1002/bies.950181110; LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163; LIAW L, 1995, CIRC RES, V77, P665, DOI 10.1161/01.RES.77.4.665; LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214; MACARAK EJ, 1983, J CELL PHYSIOL, V116, P76, DOI 10.1002/jcp.1041160112; MAHER PA, 1985, P NATL ACAD SCI USA, V82, P6576, DOI 10.1073/pnas.82.19.6576; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; NODEN DM, 1989, AM REV RESPIR DIS, V140, P1097, DOI 10.1164/ajrccm/140.4.1097; OTEY C, 1990, HYBRIDOMA, V9, P57, DOI 10.1089/hyb.1990.9.57; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; Qian XH, 1997, EXP CELL RES, V235, P403, DOI 10.1006/excr.1997.3681; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Stromblad S, 1996, J CLIN INVEST, V98, P426, DOI 10.1172/JCI118808; Stromblad S, 1996, TRENDS CELL BIOL, V6, P462, DOI 10.1016/0962-8924(96)84942-7; STUPACK DG, 1991, SCAND J IMMUNOL, V34, P761, DOI 10.1111/j.1365-3083.1991.tb01601.x; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; Weiner Michael P., 1995, P613; Zimrin AB, 1996, J BIOL CHEM, V271, P32499, DOI 10.1074/jbc.271.51.32499	39	132	139	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11101	11109		10.1074/jbc.274.16.11101	http://dx.doi.org/10.1074/jbc.274.16.11101			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196194	hybrid			2022-12-27	WOS:000079751900062
J	Pikkarainen, T; Brannstrom, A; Tryggvason, K				Pikkarainen, T; Brannstrom, A; Tryggvason, K			Expression of macrophage MARCO receptor induces formation of dendritic plasma membrane processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR; FOCAL ADHESIONS; IN-VIVO; BACTERIA; BINDING; LIPOPROTEIN; GTPASES; CELLS; HOST	MARCO is a novel macrophage-specific receptor structurally related to macrophage class A scavenger receptors. It is constitutively expressed in macrophages of the marginal zone of the spleen and in lymph nodes and is up-regulated in other tissues during systemic bacterial infections. In this study, we show that ectopic expression of MARCO in cell lines such as Chinese hamster ovary, HeLa, NIH3T3, and 293 induces dramatic cell shape changes, Typically these changes include formation of large lamellipodia-like structures and of long dendritic processes. The morphological changes are accompanied by disassembly of actin stress fibers and often also by complete loss of focal adhesions. The MARCO induced changes are dependent on cell adhesion and are inhibited, but not completely abolished, when the cells are plated on fibronectin-coated surfaces. Similarly, a dominant-negative mutant of the Rho family GTPase Rac1 partially inhibited the morphogenic effects of MARCO in Chinese hamster ovary cells, whereas a dominant-negative form of a related protein, Cdc42, did not. Expression studies with a variety of truncated MARCO forms indicated that the proximal segment of the cysteine-rich domain V is important for the morphoregulatory activity. The results indicate that expression of MARCO has a direct effect in generating the phenotype of activated macrophages necessary for the trapping and removal of pathogens and other foreign substances.	Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Tryggvason, K (corresponding author), Karolinska Inst, Dept Biochem Med, Div Matrix Biol, S-17177 Stockholm, Sweden.							Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Domanico SZ, 1997, MOL BIOL CELL, V8, P2253, DOI 10.1091/mbc.8.11.2253; DUNNE DW, 1994, P NATL ACAD SCI USA, V91, P1863, DOI 10.1073/pnas.91.5.1863; Elomaa O, 1998, J BIOL CHEM, V273, P4530, DOI 10.1074/jbc.273.8.4530; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; FAWCETT DW, 1994, TXB HIST, P150; FRASER I, 1993, NATURE, V364, P343, DOI 10.1038/364343a0; FREEMAN M, 1991, P NATL ACAD SCI USA, V88, P4931, DOI 10.1073/pnas.88.11.4931; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; KUBY J, 1997, IMMUNOLOGY, P64; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; ROHRER L, 1990, NATURE, V343, P570, DOI 10.1038/343570a0; SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; van der Laan LJW, 1999, J IMMUNOL, V162, P939; vanderLaan LJW, 1997, IMMUNOL LETT, V57, P203, DOI 10.1016/S0165-2478(97)00077-1	22	42	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10975	10982		10.1074/jbc.274.16.10975	http://dx.doi.org/10.1074/jbc.274.16.10975			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196178	hybrid			2022-12-27	WOS:000079751900046
J	Lux, A; Attisano, L; Marchuk, DA				Lux, A; Attisano, L; Marchuk, DA			Assignment of transforming growth factor beta 1 and beta 3 and a third new ligand to the type I receptor ALK-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; SERINE/THREONINE KINASE RECEPTOR; BINDING PROTEIN ENDOGLIN; OSTEOGENIC PROTEIN-1; HETEROMERIC COMPLEX; ENDOTHELIAL-CELLS; ACTIVIN RECEPTORS; MOLECULAR-CLONING; III RECEPTOR; GENE	Germ line mutations in one of two distinct genes, endoglin or ALK-1, cause hereditary hemorrhagic telangiectasia (HHT), an autosomal dominant disorder of localized angiodysplasia, Both genes encode endothelial cell receptors for the transforming growth factor beta (TGF-beta) ligand superfamily, Endoglin has homology to the type III receptor, betaglycan, although its exact role in TGF-beta signaling is unclear. Activin receptor-like kinase 1 (ALK-1) has homology to the type I receptor family, but its ligand and corresponding type II receptor are unknown, In order to identify the ligand and type II receptor for ALK-1 and to investigate the role of endoglin in ALK-1 signaling, we devised a chimeric receptor signaling assay by exchanging the kinase domain of ALK-1 with either the TCF-beta type I receptor or the activin type IB receptor, both of which can activate an inducible PAI-1 promoter. we show that TGF-beta 1 and TGF-beta 3, as well as a third unknown ligand present in serum, can activate chimeric ALK-1, HHT-associated missense mutations in the ALK-1 extracellular domain abrogate signaling. The ALK-l/ligand interaction is mediated by the type II TGF-beta receptor for TGF-beta and most likely through the activin type II or type IIB receptors for the serum ligand, Endoglin is a bifunctional receptor partner since it can bind to ALK-1 as well as to type I TGF-beta receptor. These data suggest that HHT pathogenesis involves disruption of a complex network of positive and negative angiogenic factors, involving TGF-beta, a new unknown ligand, and their corresponding receptors.	Duke Univ, Med Ctr, Dept Genet, Durham, NC 27710 USA; Univ Toronto, Dept Anat & Cell Biol, Toronto, ON M5S 1A8, Canada	Duke University; University of Toronto	Marchuk, DA (corresponding author), Duke Univ, Med Ctr, Dept Genet, Durham, NC 27710 USA.			Marchuk, Douglas/0000-0002-3110-6671	NHLBI NIH HHS [HL 49171] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049171] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anders RA, 1996, J BIOL CHEM, V271, P21758, DOI 10.1074/jbc.271.36.21758; ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; BELLON T, 1993, EUR J IMMUNOL, V23, P2340, DOI 10.1002/eji.1830230943; Berg JN, 1997, AM J HUM GENET, V61, P60, DOI 10.1086/513903; Caniggia I, 1997, ENDOCRINOLOGY, V138, P4977, DOI 10.1210/en.138.11.4977; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Derynck R, 1997, BIOCHIM BIOPHYS ACTA, V1333, P105; deWinter JP, 1996, EXP CELL RES, V224, P323, DOI 10.1006/excr.1996.0142; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Gallione CJ, 1998, HUM MUTAT, V11, P286, DOI 10.1002/(SICI)1098-1004(1998)11:4<286::AID-HUMU6>3.0.CO;2-B; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; KLAUS DJ, 1998, HUM MUTAT; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; LASTRES P, 1994, BIOCHEM J, V301, P765, DOI 10.1042/bj3010765; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Lebrun JJ, 1997, MOL CELL BIOL, V17, P1682, DOI 10.1128/MCB.17.3.1682; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Luo KX, 1996, EMBO J, V15, P4485, DOI 10.1002/j.1460-2075.1996.tb00826.x; Martens JWM, 1997, ENDOCRINOLOGY, V138, P2928, DOI 10.1210/en.138.7.2928; Matsuzaki K, 1996, IN VITRO CELL DEV-AN, V32, P345, DOI 10.1007/BF02722961; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; MCALLISTER KA, 1995, HUM MOL GENET, V4, P1983, DOI 10.1093/hmg/4.10.1983; MOREN A, 1992, BIOCHEM BIOPH RES CO, V189, P356, DOI 10.1016/0006-291X(92)91566-9; Muramatsu M, 1997, MOL BIOL CELL, V8, P469, DOI 10.1091/mbc.8.3.469; MUSSAGUE J, 1990, ANN REV CELL BIOL, V6, P597; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Panchenko MP, 1996, AM J PHYSIOL-LUNG C, V270, pL547, DOI 10.1152/ajplung.1996.270.4.L547; Pece N, 1997, J CLIN INVEST, V100, P2568, DOI 10.1172/JCI119800; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Pepper MS, 1996, ENZYME PROTEIN, V49, P138, DOI 10.1159/000468622; PEPPER MS, 1993, EXP CELL RES, V204, P356, DOI 10.1006/excr.1993.1043; Persson U, 1997, J BIOL CHEM, V272, P21187, DOI 10.1074/jbc.272.34.21187; Pichuantes S, 1997, TISSUE ANTIGENS, V50, P265, DOI 10.1111/j.1399-0039.1997.tb02870.x; ROBERTSON DM, 1995, J ENDOCRINOL, V144, P261, DOI 10.1677/joe.0.1440261; Roelen BAJ, 1997, DEV DYNAM, V209, P418, DOI 10.1002/(SICI)1097-0177(199708)209:4<418::AID-AJA9>3.0.CO;2-L; Ryden M, 1996, J BIOL CHEM, V271, P30603, DOI 10.1074/jbc.271.48.30603; SAMBROOK J, 1989, MOL CLONING LABORATO, V2, P16; Shovlin CL, 1997, AM J HUM GENET, V61, P68, DOI 10.1086/513906; SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017; STJACQUES S, 1994, ENDOCRINOLOGY, V134, P2645, DOI 10.1210/en.134.6.2645; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; TENDIJKE P, 1993, ONCOGENE, V8, P2879; Tsuchida K, 1996, MOL CELL NEUROSCI, V7, P467, DOI 10.1006/mcne.1996.0034; TSUCHIDA K, 1995, ENDOCRINOLOGY, V136, P5493, DOI 10.1210/en.136.12.5493; VIVIEN D, 1995, J BIOL CHEM, V270, P7134, DOI 10.1074/jbc.270.13.7134; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Willis SA, 1996, MOL ENDOCRINOL, V10, P367, DOI 10.1210/me.10.4.367; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yamaguchi H, 1997, THROMB HAEMOSTASIS, V77, P243; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; YAMASHITA H, 1994, J BIOL CHEM, V269, P1995; Zhang HW, 1996, J IMMUNOL, V156, P565	65	120	124	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					9984	9992		10.1074/jbc.274.15.9984	http://dx.doi.org/10.1074/jbc.274.15.9984			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187774	hybrid			2022-12-27	WOS:000079663500013
J	Miles, EW; Rhee, S; Davies, DR				Miles, EW; Rhee, S; Davies, DR			The molecular basis of substrate channeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE; SYNTHASE ALPHA(2)BETA(2) COMPLEX; REDUCTASE-THYMIDYLATE SYNTHASE; CARBAMOYL-PHOSPHATE SYNTHETASE; GLYCINAMIDE RIBONUCLEOTIDE SYNTHETASE; TRYPTOPHAN SYNTHASE; DIHYDROFOLATE-REDUCTASE; ESCHERICHIA-COLI; ACTIVE-SITES; PHYSIOLOGICAL SIGNIFICANCE		NIDDK, Lab Biochem & Genet, Enzyme Struct & Funct Sect, NIH, Bethesda, MD 20892 USA; NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Miles, EW (corresponding author), NIDDK, Lab Biochem & Genet, Enzyme Struct & Funct Sect, NIH, Bldg 8,Rm 225,8 Ctr Dr MSC 0830, Bethesda, MD 20892 USA.	EdithM@intra.niddk.nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK034002, ZIHDK034002, Z01DK024140, Z01DK034002] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON KS, 1995, J BIOL CHEM, V270, P29936; ANDERSON KS, 1991, J BIOL CHEM, V266, P8020; ANDERSON PM, 1966, BIOCHEMISTRY-US, V5, P3157, DOI 10.1021/bi00874a012; BANIK U, 1995, BIOCHEMISTRY-US, V34, P12704, DOI 10.1021/bi00039a029; BRZOVIC PS, 1992, BIOCHEMISTRY-US, V31, P3831, DOI 10.1021/bi00130a014; CREIGHTO.TE, 1970, EUR J BIOCHEM, V13, P1, DOI 10.1111/j.1432-1033.1970.tb00892.x; DAVIS BD, 1958, ARCH BIOCHEM BIOPHYS, V78, P497, DOI 10.1016/0003-9861(58)90374-6; DEMOSS JA, 1962, BIOCHIM BIOPHYS ACTA, V62, P279, DOI 10.1016/0006-3002(62)90041-0; DUNN MF, 1990, BIOCHEMISTRY-US, V29, P8598, DOI 10.1021/bi00489a015; Elcock AH, 1997, BIOCHEMISTRY-US, V36, P16049, DOI 10.1021/bi971709u; Elcock AH, 1996, J MOL BIOL, V262, P370, DOI 10.1006/jmbi.1996.0520; Holden HM, 1998, CURR OPIN STRUC BIOL, V8, P679, DOI 10.1016/S0959-440X(98)80086-9; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Irvine HS, 1997, EUR J BIOCHEM, V247, P1063, DOI 10.1111/j.1432-1033.1997.01063.x; Kim JH, 1996, J BIOL CHEM, V271, P15549, DOI 10.1074/jbc.271.26.15549; KISLIUK RL, 1974, J BIOL CHEM, V249, P4100; KNIGHTON DR, 1994, NAT STRUCT BIOL, V1, P186, DOI 10.1038/nsb0394-186; KNOWLES JR, 1991, J THEOR BIOL, V152, P53, DOI 10.1016/S0022-5193(05)80509-0; Krahn JM, 1997, BIOCHEMISTRY-US, V36, P11061, DOI 10.1021/bi9714114; LANE AN, 1991, BIOCHEMISTRY-US, V30, P479, DOI 10.1021/bi00216a025; Liang PH, 1998, BIOCHEMISTRY-US, V37, P12195, DOI 10.1021/bi9803168; MANNEY TR, 1970, J BACTERIOL, V102, P483, DOI 10.1128/JB.102.2.483-488.1970; MATCHETT WH, 1974, J BIOL CHEM, V249, P4041; MEEK TD, 1985, BIOCHEMISTRY-US, V24, P678, DOI 10.1021/bi00324a021; MESSENGER LJ, 1979, J BIOL CHEM, V254, P3382; Miles BW, 1998, BIOCHEMISTRY-US, V37, P16773, DOI 10.1021/bi982018g; Miles E W, 1995, Subcell Biochem, V24, P207; MILES EW, 1991, ADV ENZYMOL RAMB, V64, P93; Muchmore CRA, 1998, PROTEIN SCI, V7, P39, DOI 10.1002/pro.5560070104; OVADI J, 1991, J THEOR BIOL, V152, P1, DOI 10.1016/S0022-5193(05)80500-4; OVADI J, 1991, J THEOR BIOL, V152, P135, DOI 10.1016/S0022-5193(05)80528-4; Pan P, 1997, TRENDS BIOCHEM SCI, V22, P22, DOI 10.1016/S0968-0004(96)10066-9; PENVERNE B, 1994, ARCH BIOCHEM BIOPHYS, V309, P85, DOI 10.1006/abbi.1994.1089; Raushel FM, 1998, BIOCHEMISTRY-US, V37, P10272, DOI 10.1021/bi980753m; Raushel FM, 1998, CURR OPIN CHEM BIOL, V2, P624, DOI 10.1016/S1367-5931(98)80094-X; Rhee S, 1998, J BIOL CHEM, V273, P8553, DOI 10.1074/jbc.273.15.8553; Rhee S, 1998, BIOCHEMISTRY-US, V37, P10653, DOI 10.1021/bi980779d; Rhee S, 1997, BIOCHEMISTRY-US, V36, P7664, DOI 10.1021/bi9700429; Rhee S, 1996, BIOCHEMISTRY-US, V35, P4211, DOI 10.1021/bi952506d; RUDOLPH J, 1995, BIOCHEMISTRY-US, V34, P2241, DOI 10.1021/bi00007a019; Schneider TR, 1998, BIOCHEMISTRY-US, V37, P5394, DOI 10.1021/bi9728957; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; STROUD RM, 1994, NAT STRUCT BIOL, V1, P131, DOI 10.1038/nsb0394-131; Thoden JB, 1999, ACTA CRYSTALLOGR D, V55, P8, DOI 10.1107/S0907444998006234; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P6305, DOI 10.1021/bi970503q; Trujillo M, 1996, BIOCHEMISTRY-US, V35, P6366, DOI 10.1021/bi952923q; Wang WR, 1998, BIOCHEMISTRY-US, V37, P15647, DOI 10.1021/bi981405n; YANOFSKY C, 1972, ENZYMES, V7, P1; YANOFSKY C, 1958, BIOCHIM BIOPHYS ACTA, V28, P641; Zalkin H, 1998, ADV ENZYMOL RAMB, V72, P87	50	291	295	1	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12193	12196		10.1074/jbc.274.18.12193	http://dx.doi.org/10.1074/jbc.274.18.12193			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212181	hybrid			2022-12-27	WOS:000080056800001
J	Pacheco-Rodriguez, G; Patton, WA; Adamik, R; Yoo, HS; Lee, FJS; Zhang, GF; Moss, J; Vaughan, M				Pacheco-Rodriguez, G; Patton, WA; Adamik, R; Yoo, HS; Lee, FJS; Zhang, GF; Moss, J; Vaughan, M			Structural elements of ADP-ribosylation factor 1 required for functional interaction with cytohesin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; GTP-BINDING PROTEIN; SEC7 DOMAIN; CHOLERA-TOXIN; PHOSPHOLIPASE-D; GOLGI-COMPLEX; FACTOR ARNO; ARF GTPASE; ACTIVATION; TRANSPORT	ADP-ribosylation factor 1 (ARF1) is a 20-kDa guanine nucleotide-binding protein involved in vesicular trafficking. Conversion of inactive ARF-G;DP to active ARF-GTP is catalyzed by guanine nucleotide exchange proteins such as cytohesin-1. Cytohesin-1 and its Sec7 domain (C-1Sec7) exhibit guanine nucleotide exchange protein activity with ARF1 but not ARF-like protein 1 (ARL1), which is 57% identical in amino acid sequence. With chimeric proteins composed of ARF1 (F) and ARL1 (L) sequences we identified three structural elements responsible for this specificity. Cytohesin-1 increased [S-35]guanosine 5'-(gamma-thio)triphosphate binding to L28/F first 28 residues of L, remainder Fl and to a much lesser extent F139L, and mut13F139/L (F139/L with random sequence in the first 13 positions) but not Delta 13ARF1 that lacks the first 13 amino acids; therefore, a nonspecific ARF N terminus was required for cytohesin-1 action. The N terminus was not, however, required for that of C-1Sec7. Both C-1Sec7 and cytohesin-1 effectively released guanosine 5'-(gamma-thio)triphosphate from ARF1, but only C-1Sec7 displaced the nonhydrolyzable GTP analog bound to mut13F139/L, again indicating that structure in addition to the Sec7 domain is involved in cytohesin-1 interaction. Some element(s) of the C-terminal region is also involved, because replacement of the last 42 amino acids with ARL sequence in F139L decreased markedly the interaction with cytohesin-1. Participation of both termini is consistent with the crystallographic structure of ARF in which the two terminal a-helices are in close proximity. ARF1 residues 28-50 are also important in the interaction with cytohesin-1; replacement of Lys-38 with Gin, the corresponding residue in ARL1, abolished the ability to serve as substrate for cytohesin-1 or C-1Sec7. These studies have defined multiple structural elements in ARF1, including switch 1 and the N and C termini, that participate in functional interactions with cytohesin-1 (or its catalytic domain C-1Sec7), which were not apparent from crystallographic analysis.	NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Pacheco-Rodriguez, G (corresponding author), NHLBI, Pulm Crit Care Med Branch, NIH, Rm 5N-307,Bldg 10,10 Ctr Dr,MSC 1434, Bethesda, MD 20892 USA.		Pacheco, Gustavo/Q-6956-2019	LEE, FANG-JEN/0000-0002-2167-2426	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000638, ZIAHL000627, Z01HL000656, Z01HL000627] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Betz SF, 1998, P NATL ACAD SCI USA, V95, P7909, DOI 10.1073/pnas.95.14.7909; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DONALDSON JG, 1994, CURR OPIN CELL BIOL, V6, P527, DOI 10.1016/0955-0674(94)90072-8; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; GREASLEY SE, 1995, NAT STRUCT BIOL, V2, P797, DOI 10.1038/nsb0995-797; Hong JX, 1998, J BIOL CHEM, V273, P15872, DOI 10.1074/jbc.273.25.15872; HONG JX, 1994, J BIOL CHEM, V269, P9743; KAHN RA, 1992, J BIOL CHEM, V267, P13039; Klarlund JK, 1998, J BIOL CHEM, V273, P1859, DOI 10.1074/jbc.273.4.1859; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Lee FJS, 1997, J BIOL CHEM, V272, P30998, DOI 10.1074/jbc.272.49.30998; Li R, 1997, J BIOL CHEM, V272, P4671, DOI 10.1074/jbc.272.8.4671; Liang JO, 1997, J BIOL CHEM, V272, P33001, DOI 10.1074/jbc.272.52.33001; LIU L, 1992, BIOCHIM BIOPHYS ACTA, V1132, P75, DOI 10.1016/0167-4781(92)90055-5; Losonczi JA, 1998, BIOCHEMISTRY-US, V37, P706, DOI 10.1021/bi9717791; Lowe SL, 1996, J CELL SCI, V109, P209; MAKLER V, 1995, J BIOL CHEM, V270, P5232, DOI 10.1074/jbc.270.10.5232; Meacci E, 1997, P NATL ACAD SCI USA, V94, P1745, DOI 10.1073/pnas.94.5.1745; Morinaga N, 1997, P NATL ACAD SCI USA, V94, P12926, DOI 10.1073/pnas.94.24.12926; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; MOSTELLER RD, 1994, MOL CELL BIOL, V14, P1104, DOI 10.1128/MCB.14.2.1104; Nagel W, 1998, J BIOL CHEM, V273, P14853, DOI 10.1074/jbc.273.24.14853; NUOFFER C, 1994, ANNU REV BIOCHEM, V63, P949, DOI 10.1146/annurev.bi.63.070194.004505; Pacheco-Rodriguez G, 1998, J BIOL CHEM, V273, P26543, DOI 10.1074/jbc.273.41.26543; Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221; PATTON WA, 1997, BACTERIAL TOXINS TOO, P15; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Randazzo PA, 1997, J BIOL CHEM, V272, P7688; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sata M, 1998, P NATL ACAD SCI USA, V95, P4204, DOI 10.1073/pnas.95.8.4204; Schekman R, 1997, CELL, V90, P197, DOI 10.1016/S0092-8674(00)80326-8; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; TAMKUN JW, 1991, P NATL ACAD SCI USA, V88, P3120, DOI 10.1073/pnas.88.8.3120; TSUCHIYA M, 1991, J BIOL CHEM, V266, P2772; Vitale N, 1997, J BIOL CHEM, V272, P25077, DOI 10.1074/jbc.272.40.25077; ZHANG GF, 1995, J BIOL CHEM, V270, P21, DOI 10.1074/jbc.270.1.21	48	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12438	12444		10.1074/jbc.274.18.12438	http://dx.doi.org/10.1074/jbc.274.18.12438			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212218	hybrid			2022-12-27	WOS:000080056800038
J	Parsley, TB; Cornell, CT; Semler, BL				Parsley, TB; Cornell, CT; Semler, BL			Modulation of the RNA binding and protein processing activities of poliovirus polypeptide 3CD by the viral RNA polymerase domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC MUTAGENESIS; CLEAVAGE SITES; REPLICATION; PRECURSOR; POLYPROTEIN; MUTATIONS; COMPLEX; INVITRO; TRANSLATION; EXPRESSION	To study the role of the RNA polymerase domain (3D) in the proteinase substrate recognition and RNA binding properties of poliovirus polypeptide 3CD, we generated recombinant 3C and 3CD polypeptides and purified them to near homogeneity. By using these purified proteins in in vitro cleavage assays with structural and non-structural viral polyprotein substrates, we found that 3CD processes the poliovirus structural polyprotein precursor (P1) 100 to 1000 times more efficiently than 3C processes P1, We also found that trans-cleavage of other 3CD molecules and sites within the non-structural P3 precursor is more efficiently mediated by 3CD than 3C, However, 3C and 3CD appear to be equally efficient in the processing of a non-structural polyprotein precursor, 2C3AB, Four mutated 3CD polyproteins with site-directed lesions in the 3D domain of the proteinase were analyzed for their ability to process viral polyprotein precursors and to form a ternary complex with RNA sequences encoded in the 5' terminus of the viral genome. Analysis of mutated 3CD polypeptides revealed that specific mutations within the 3D amino acid sequences of 3CD confer differential effects on 3CD activity. All four mutated 3CD proteins tested were able to process the P1 structural precursor with wild type or near wild type efficiency. However, three of the mutated enzymes demonstrated an impaired ability to process some sites within the P3 non-structural precursor, relative to wild type 3CD, One of the mutant 3CD polypeptides, 3CD-3DK127A, also displayed a defect in its ability to form a ternary ribonucleoprotein complex with poliovirus 5' RNA sequences.	Univ Calif Irvine, Coll Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine	Semler, BL (corresponding author), Univ Calif Irvine, Coll Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA.	blsemler@uci.edu	Semler, Bert/AAV-8795-2020	Semler, Bert/0000-0002-2424-5155	NIAID NIH HHS [R01 AI022693, AI 22693] Funding Source: Medline; NIGMS NIH HHS [GM 07311] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022693] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDINO R, 1990, CELL, V63, P369, DOI 10.1016/0092-8674(90)90170-J; ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x; Barton DJ, 1996, VIROLOGY, V217, P459, DOI 10.1006/viro.1996.0140; Blair WS, 1998, RNA, V4, P215; Blair WS, 1996, VIROLOGY, V218, P1, DOI 10.1006/viro.1996.0160; BROWN BA, 1979, VIROLOGY, V97, P396, DOI 10.1016/0042-6822(79)90350-7; BURNS CC, 1992, VIROLOGY, V189, P568, DOI 10.1016/0042-6822(92)90580-I; BURNS CC, 1989, J VIROL, V63, P4866, DOI 10.1128/JVI.63.11.4866-4874.1989; DIAMOND SE, 1994, J VIROL, V68, P863, DOI 10.1128/JVI.68.2.863-876.1994; HANECAK R, 1982, P NATL ACAD SCI-BIOL, V79, P3973, DOI 10.1073/pnas.79.13.3973; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; HARRIS KS, 1994, J BIOL CHEM, V269, P27004; Hope DA, 1997, J VIROL, V71, P9490, DOI 10.1128/JVI.71.12.9490-9498.1997; JORE J, 1988, J GEN VIROL, V69, P1627, DOI 10.1099/0022-1317-69-7-1627; KITAMURA N, 1981, NATURE, V291, P547, DOI 10.1038/291547a0; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LARSEN GR, 1982, J VIROL, V41, P340, DOI 10.1128/JVI.41.1.340-344.1982; LAWSON MA, 1990, CURR TOP MICROBIOL, V161, P49; LAWSON MA, 1991, P NATL ACAD SCI USA, V88, P9919, DOI 10.1073/pnas.88.22.9919; MATTHEWS DA, 1994, CELL, V77, P761, DOI 10.1016/0092-8674(94)90059-0; Mosimann SC, 1997, J MOL BIOL, V273, P1032, DOI 10.1006/jmbi.1997.1306; NELSON M, 1992, METHOD ENZYMOL, V216, P279; NICKLIN MJH, 1988, J VIROL, V62, P4586, DOI 10.1128/JVI.62.12.4586-4593.1988; PALLANSCH MA, 1984, J VIROL, V49, P873, DOI 10.1128/JVI.49.3.873-880.1984; Parsley TB, 1997, RNA, V3, P1124; RICHARDS OC, 1990, CURR TOP MICROBIOL, V161, P89; SEMLER BL, 1987, J CELL BIOCHEM, V33, P39, DOI 10.1002/jcb.240330105; SEMLER BL, 1981, P NATL ACAD SCI-BIOL, V78, P3464, DOI 10.1073/pnas.78.6.3464; SEMLER BL, 1981, VIROLOGY, V114, P589, DOI 10.1016/0042-6822(81)90242-7; Todd S, 1997, VIROLOGY, V229, P90, DOI 10.1006/viro.1996.8416; Towner JS, 1998, J VIROL, V72, P7191, DOI 10.1128/JVI.72.9.7191-7200.1998; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Xiang WK, 1997, SEMIN VIROL, V8, P256, DOI 10.1006/smvy.1997.0128; YPMAWONG MF, 1988, VIROLOGY, V166, P265, DOI 10.1016/0042-6822(88)90172-9; YPMAWONG MF, 1988, J BIOL CHEM, V263, P17846	35	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12867	12876		10.1074/jbc.274.18.12867	http://dx.doi.org/10.1074/jbc.274.18.12867			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212275	hybrid			2022-12-27	WOS:000080056800095
J	Sternsdorf, T; Jensen, K; Reich, B; Will, H				Sternsdorf, T; Jensen, K; Reich, B; Will, H			The nuclear dot protein Sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; PRIMARY BILIARY-CIRRHOSIS; GTPASE-ACTIVATING PROTEIN; PML-RAR-ALPHA; NF-KAPPA-B; RETINOIC ACID; SUMO-1 MODIFICATION; COVALENT MODIFICATION; GROWTH-SUPPRESSOR; ARSENIC TRIOXIDE	The Sp100 and promyelocytic leukemia proteins (PML) are constituents of nuclear domains, known as nuclear dots (NDs) or PML bodies, and are both covalently modified by the small ubiquitin-related protein SUMO-1. NDs play a role in autoimmunity, virus infections, and in the etiology of acute promyelocytic leukemia. To date, little is known about the function of the Sp100 protein. Here we analyzed Sp100 domains that determine its subcellular localization, dimerization, and SUMOylation. A functional nuclear localization signal and an ND-targeting region that coincides with an Sp100 homodimerization domain were mapped. Sequences similar to the Sp100 homodimerization/ND-targeting region occur in several other proteins and constitute a novel protein motif, termed HSR domain. The lysine residue of the Sp100 protein, to which SUMO-1 is covalently linked, was mapped within and may therefore modulate the previously described HP1 protein-binding site. A consensus sequence for SUMOylation of proteins in general is suggested. SUMOylation strictly depended on a functional nuclear localization signal but was not necessary for nuclear import or ND targeting. A three-dimensional structure of Sp100, which supports the mapping data and provides additional information on Sp100 structure/function relationships, was generated by computer modeling. Taken together, our studies indicate the existence of well defined Sp100 domains with functions in ND targeting, nuclear import, nuclear SUMOylation, and protein-protein interaction.	Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany	Heinrich Pette Institute; University of Hamburg	Sternsdorf, T (corresponding author), Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Martinistr 52, D-20251 Hamburg, Germany.	sternsdo@hpi.uni-hamburg.de						Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; AHN MJ, 1995, ONCOGENE, V10, P2307; Altabef M, 1996, EMBO J, V15, P2707, DOI 10.1002/j.1460-2075.1996.tb00631.x; Andre C, 1996, EXP CELL RES, V229, P253, DOI 10.1006/excr.1996.0368; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; BERNSTEIN RM, 1984, CLIN EXP IMMUNOL, V55, P553; Bloch DB, 1996, J BIOL CHEM, V271, P29198, DOI 10.1074/jbc.271.46.29198; Boddy MN, 1996, ONCOGENE, V13, P971; Borden KLB, 1998, J VIROL, V72, P758, DOI 10.1128/JVI.72.1.758-766.1998; BRASCH K, 1992, EXP CELL RES, V202, P211, DOI 10.1016/0014-4827(92)90068-J; Brown D, 1997, P NATL ACAD SCI USA, V94, P2551, DOI 10.1073/pnas.94.6.2551; CARVALHO T, 1995, J CELL BIOL, V131, P45, DOI 10.1083/jcb.131.1.45; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Chen GQ, 1996, BLOOD, V88, P1052; DANIEL MT, 1993, BLOOD, V82, P1858; Day PM, 1998, J VIROL, V72, P142, DOI 10.1128/JVI.72.1.142-150.1998; Dent AL, 1996, BLOOD, V88, P1423, DOI 10.1182/blood.V88.4.1423.bloodjournal8841423; Desbois C, 1996, SCIENCE, V273, P951, DOI 10.1126/science.273.5277.951; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; ECKERT WA, 1991, MOL CELL BIOL, V11, P2229, DOI 10.1128/MCB.11.4.2229; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; Grotzinger T, 1996, MOL CELL BIOL, V16, P1150; Grotzinger T, 1996, EUR J BIOCHEM, V238, P554, DOI 10.1111/j.1432-1033.1996.0554z.x; GULDNER HH, 1992, J IMMUNOL, V149, P4067; Guldner HH, 1999, J CELL SCI, V112, P733; He LZ, 1997, P NATL ACAD SCI USA, V94, P5302, DOI 10.1073/pnas.94.10.5302; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; KADEREIT S, 1993, J BIOL CHEM, V268, P24432; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; KOKEN MHM, 1995, ONCOGENE, V10, P1315; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Korioth F, 1996, EXP CELL RES, V229, P155, DOI 10.1006/excr.1996.0353; Kwong YL, 1997, BLOOD, V89, P3487, DOI 10.1182/blood.V89.9.3487; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; LAVAU C, 1995, ONCOGENE, V11, P871; Le XF, 1996, J BIOL CHEM, V271, P130, DOI 10.1074/jbc.271.1.130; Lehming N, 1998, P NATL ACAD SCI USA, V95, P7322, DOI 10.1073/pnas.95.13.7322; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; MAUL GG, 1993, J GEN VIROL, V74, P2679, DOI 10.1099/0022-1317-74-12-2679; MU ZM, 1994, MOL CELL BIOL, V14, P6858, DOI 10.1128/MCB.14.10.6858; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Okura T, 1996, J IMMUNOL, V157, P4277; PLASS C, 1995, HEREDITAS, V122, P245, DOI 10.1111/j.1601-5223.1995.00245.x; POWELL F, 1984, LANCET, V1, P288; RASKA I, 1992, CELL BIOL INT REP, V16, P771, DOI 10.1016/S0309-1651(05)80021-9; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Saitoh H, 1997, TRENDS BIOCHEM SCI, V22, P374, DOI 10.1016/S0968-0004(97)01102-X; Sambrook J, 1989, MOL CLONING LAB MANU, V3; Seeler JS, 1998, P NATL ACAD SCI USA, V95, P7316, DOI 10.1073/pnas.95.13.7316; Shen ZY, 1996, GENOMICS, V36, P271, DOI 10.1006/geno.1996.0462; Sternsdorf T, 1997, J CELL BIOL, V138, P435, DOI 10.1083/jcb.138.2.435; Sternsdorf T, 1997, IMMUNOBIOLOGY, V198, P307, DOI 10.1016/S0171-2985(97)80051-4; STERNSDORF T, 1995, SCAND J IMMUNOL, V42, P257, DOI 10.1111/j.1365-3083.1995.tb03652.x; Sternsdorf T, 1997, J CELL BIOL, V139, P1621, DOI 10.1083/jcb.139.7.1621; STUURMAN N, 1992, J CELL SCI, V101, P773; Szekely L, 1996, J VIROL, V70, P2562, DOI 10.1128/JVI.70.4.2562-2568.1996; SZOSTECKI C, 1992, SCAND J IMMUNOL, V36, P555, DOI 10.1111/j.1365-3083.1992.tb03224.x; SZOSTECKI C, 1987, CLIN EXP IMMUNOL, V68, P108; SZOSTECKI C, 1990, J IMMUNOL, V145, P4338; Weichenhan D, 1998, CYTOGENET CELL GENET, V80, P226, DOI 10.1159/000014985; Weichenhan D, 1997, GENOMICS, V43, P298, DOI 10.1006/geno.1997.4834; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; XIE KW, 1993, MOL CELL BIOL, V13, P6170, DOI 10.1128/MCB.13.10.6170	73	215	220	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12555	12566		10.1074/jbc.274.18.12555	http://dx.doi.org/10.1074/jbc.274.18.12555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212234	hybrid			2022-12-27	WOS:000080056800054
J	Vogler, O; Nolte, B; Voss, M; Schmidt, M; Jakobs, KH; van Koppen, CJ				Vogler, O; Nolte, B; Voss, M; Schmidt, M; Jakobs, KH; van Koppen, CJ			Regulation of muscarinic acetylcholine receptor sequestration and function by beta-arrestin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; SYNERGISTIC REGULATION; NEUROBLASTOMA-CELLS; PLASMA-MEMBRANE; PROTEIN-KINASE; INTERNALIZATION; RESENSITIZATION; DYNAMIN; DESENSITIZATION; PHOSPHORYLATION	After activation, agonist-occupied G; protein-coupled receptors are phosphorylated by G protein-coupled receptor kinases and bind cytosolic beta-arrestins, which uncouple the receptors from their cognate G;proteins, Recent studies on the beta(2)-adrenerse receptor have demonstrated that beta-arrestin also targets the receptors to clathrin-coated pits for subsequent internalization and activation of mitogen-activated protein kinases, We and others have previously shown that muscarinic acetylcholine receptors (mAChRs) of the mi, m3, and m4 subtype require functional dynamin to sequester into HEK-293 tsA201 cells, whereas m2 mAChRs sequester in a dynamin-independent manner. To investigate the role of beta-arrestin in mAChR sequestration, we determined the effect of overexpressing beta-arrestin-1 and the dominant-negative inhibitor of beta-arrestin-mediated receptor sequestration, beta-arrestin-1 V53D, on mAChR sequestration and function. Sequestration of mi, m3, and m4 mAChRs was suppressed by 60-75% in cells overexpressing beta-arrestin-1 V53D, whereas m2 mAChR sequestration was affected by less than 10%. In addition, overexpression of beta-arrestin-1 V53D as well as dynamin K44A significantly suppressed mi mAChR-mediated activation of mitogen-activated protein kinases, Finally, we investigated whether mAChRs sequester into clathrin-coated vesicles by overexpressing Hub, a dominant-negative clathrin mutant. Although sequestration of mi, m3, and m4 mAChRs was inhibited by 50-70%, m2 mAChR sequestration was suppressed by less than 10%, We conclude that mi, m3, and m4 mAChRs expressed in HEK-293 tsA201 cells sequester into clathrin-coated vesicles in a beta-arrestin- and dynamin-dependent manner, whereas sequestration of m2 mAChRs in these cells is largely independent of these proteins.	Univ Essen Gesamthsch Klinikum, Inst Pharmakol, D-45122 Essen, Germany	University of Duisburg Essen	van Koppen, CJ (corresponding author), Univ Essen Gesamthsch Klinikum, Inst Pharmakol, D-45122 Essen, Germany.		Vögler, Oliver/D-7658-2011					Bogatkewitsch GS, 1996, MOL PHARMACOL, V50, P424; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Haga K, 1996, J BIOL CHEM, V271, P2776, DOI 10.1074/jbc.271.5.2776; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lee KB, 1998, J BIOL CHEM, V273, P12967, DOI 10.1074/jbc.273.21.12967; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; PALSRYLAARSDAM R, 1995, J BIOL CHEM, V270, P29004, DOI 10.1074/jbc.270.48.29004; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; PERALTA EG, 1987, SCIENCE, V236, P600, DOI 10.1126/science.3107123; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Schlador ML, 1997, J BIOL CHEM, V272, P18882, DOI 10.1074/jbc.272.30.18882; SHAPIRO RA, 1988, J BIOL CHEM, V263, P18397; Slowiejko DM, 1996, J NEUROCHEM, V66, P186; Szekeres PG, 1998, J NEUROCHEM, V70, P1694; Tolbert LM, 1996, J BIOL CHEM, V271, P17335, DOI 10.1074/jbc.271.29.17335; TSUGA H, 1994, J BIOL CHEM, V269, P32522; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; VANKOPPEN CJ, 1993, BIOCHIM BIOPHYS ACTA, V1173, P342, DOI 10.1016/0167-4781(93)90135-Z; Vogler O, 1998, J BIOL CHEM, V273, P12155, DOI 10.1074/jbc.273.20.12155; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; YANG J, 1995, MOL PHARMACOL, V48, P477; YU SS, 1993, J BIOL CHEM, V268, P337; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	35	98	103	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12333	12338		10.1074/jbc.274.18.12333	http://dx.doi.org/10.1074/jbc.274.18.12333			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212203	hybrid			2022-12-27	WOS:000080056800023
J	Gamper, M; Kim, E; Howard, PK; Ma, H; Hunter, T; Firtel, RA				Gamper, M; Kim, E; Howard, PK; Ma, H; Hunter, T; Firtel, RA			Regulation of Dictyostelium protein-tyrosine phosphatase-3 (PTP3) through osmotic shock and stress stimulation and identification of pp130 as a PTP3 substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATF1 TRANSCRIPTION FACTOR; MAP KINASE CASCADE; FISSION YEAST; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; MAMMALIAN-CELLS; AP-1 ACTIVITY; MYOSIN-II; PHOSPHORYLATION; DISCOIDEUM	Osmotic shock and growth-medium stimulation of Dictyostelium cells results in rapid cell rounding, a reduction in cell volume, and a rearrangement of the cytoskeleton that leads to resistance to osmotic shock. Osmotic shock induces the activation of guanylyl cyclase, a rise in cGMP mediating the phosphorylation of myosin II, and the tyrosine phosphorylation of actin and the similar to 130-kDa protein (p130), We present data suggesting that signaling pathways leading to these different responses are, at least in part, independent. We show that a variety of stresses induce the SerPThr phosphorylation of the protein-tyrosine phosphatase-3 (PTP3), This modification does not alter PTP3 catalytic activity but correlates with its translocation from the cytosol to subcellular structures that co-localize to endosomal vesicles. This translocation is independent of PTP3 activity. Mutation of the catalytically essential Cys to a Ser results in inactive PTP3 that forms a stable complex with tyrosine-phosphorylated p130 (pp130) in vivo and in vitro, suggesting that PTP3 has a substrate specificity for pp130. The data suggest that stresses activate several interacting signaling pathways controlled by Ser/Thr and Tyr phosphorylation, which, along with the activation of guanylyl cyclase, mediate the ability of this organism to respond to adverse changes in the external environment.	Univ Calif San Diego, Ctr Mol Genet, Dept Biol, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Mol Biol & Virol Lab, San Diego, CA 92186 USA	University of California System; University of California San Diego; Salk Institute	Firtel, RA (corresponding author), Univ Calif San Diego, Ctr Mol Genet, Dept Biol, Rm 225,9500 Gilman Dr, La Jolla, CA 92093 USA.	rafirtel@ucsd.edu						AbuElneel K, 1996, J BIOL CHEM, V271, P977, DOI 10.1074/jbc.271.2.977; Araki T, 1998, EMBO J, V17, P4018, DOI 10.1093/emboj/17.14.4018; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Cavigelli M, 1996, EMBO J, V15, P6269, DOI 10.1002/j.1460-2075.1996.tb01017.x; CHENG HC, 1992, J BIOL CHEM, V267, P9248; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Dembinsky A, 1996, J CELL BIOL, V134, P911, DOI 10.1083/jcb.134.4.911; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; FIRTEL RA, 1995, GENE DEV, V9, P1427, DOI 10.1101/gad.9.12.1427; FRANKE J, 1977, P NATL ACAD SCI USA, V74, P2157, DOI 10.1073/pnas.74.5.2157; Gamper M, 1996, MOL CELL BIOL, V16, P2431; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; GLENNEY JR, 1988, J IMMUNOL METHODS, V109, P277, DOI 10.1016/0022-1759(88)90253-0; GUAN KL, 1991, J BIOL CHEM, V266, P17026; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HOWARD PK, 1993, SCIENCE, V259, P241, DOI 10.1126/science.7678470; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; JENSEN RE, 1988, EMBO J, V7, P3863, DOI 10.1002/j.1460-2075.1988.tb03272.x; JUNGBLUTH A, 1994, J CELL SCI, V107, P117; JUNGBLUTH A, 1995, FEBS LETT, V375, P87, DOI 10.1016/0014-5793(95)01165-B; Karin M, 1996, PHILOS T ROY SOC B, V351, P127, DOI 10.1098/rstb.1996.0008; Kuwayama H, 1996, SCIENCE, V271, P207, DOI 10.1126/science.271.5246.207; KUWAYAMA H, 1993, J CELL BIOL, V123, P1453, DOI 10.1083/jcb.123.6.1453; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; LI RY, 1994, FEBS LETT, V343, P89, DOI 10.1016/0014-5793(94)80613-6; Ma H, 1997, EMBO J, V16, P4317, DOI 10.1093/emboj/16.14.4317; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MANN SKO, 1987, MOL CELL BIOL, V7, P458, DOI 10.1128/MCB.7.1.458; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MIZUNO T, 1982, J BIOL CHEM, V257, P13692; Oyama M, 1996, J BIOL CHEM, V271, P5574; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Schuster SC, 1996, EMBO J, V15, P3880, DOI 10.1002/j.1460-2075.1996.tb00762.x; SCHWEIGER A, 1992, J CELL SCI, V102, P601; Shifrin VI, 1997, J BIOL CHEM, V272, P2957, DOI 10.1074/jbc.272.5.2957; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Temesvari LA, 1996, J CELL SCI, V109, P663; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Woodgett JR, 1996, PHILOS T R SOC B, V351, P135, DOI 10.1098/rstb.1996.0009; ZHAO ZH, 1994, P NATL ACAD SCI USA, V91, P5007, DOI 10.1073/pnas.91.11.5007; Zhu QL, 1997, P NATL ACAD SCI USA, V94, P7308, DOI 10.1073/pnas.94.14.7308	48	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12129	12138		10.1074/jbc.274.17.12129	http://dx.doi.org/10.1074/jbc.274.17.12129			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207040	hybrid			2022-12-27	WOS:000079834800096
J	Kang, S; Lee, H; Han, JS; Hwang, DS				Kang, S; Lee, H; Han, JS; Hwang, DS			Interaction of SeqA and Dam methylase on the hemimethylated origin of Escherichia coli chromosomal DNA replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISMATCH CORRECTION; INITIATION; PROTEIN; METHYLTRANSFERASE; GENE; PROMOTER; MUTANTS; EXPRESSION; SEQUENCE; PREVENTS	Preferential binding of SeqA protein to hemimethylated oriC, the origin of Escherichia coli chromosomal replication, delays methylation by Dam methylase. Because the SeqA-oriC interaction appears to be essential in timing of chromosomal replication initiation, the biochemical functions of SeqA protein and Dam methylase at the 13-mer L, M, and R region containing 4 GATC sequences at the left end of oriC were examined. We found that SeqA protein preferentially bound hemimethylated 13-mers but not fully nor unmethylated 13-mers. Regardless of strand methylation, the binding of SeqA protein to the hemimethylated GATC sequence of 13-mer L was followed by additional binding to other hemimethylated GATC sequences of 13-mer M and R. On the other hand, Dam methylase did not discriminate binding of 13-mers in different methylation patterns and was not specific to GATC sequences. The binding specificity and higher affinity of SeqA protein over Dam methylase to the hemimethylated 13-mers along with the reported cellular abundance of this protein explains the dominant action of SeqA protein over Dam methylase to the newly replicated oriC for the sequestration of chromosomal replication. Furthermore, SeqA protein bound to hemimethylated 13-mers was not dissociated by Dam methylase, and most SeqA protein spontaneously dissociated 10 min after binding. Also, SeqA protein delayed the in vitro methylation of hemimethylated 13-mers by Dam methylase. These in vitro results suggest that the intrinsic binding instability of SeqA protein results in release of sequestrated hemimethylated oriC.	Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 151742, South Korea; Seoul Natl Univ, Dept Microbiol, Seoul 151742, South Korea; Seoul Natl Univ, Interdisciplinary Program Genet Engn, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Hwang, DS (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 151742, South Korea.			Kang, Sukhyun/0000-0002-7567-0231				BALE A, 1979, MUTAT RES, V59, P157, DOI 10.1016/0027-5107(79)90153-2; BARRAS F, 1989, TRENDS GENET, V5, P139, DOI 10.1016/0168-9525(89)90054-1; BOYE E, 1990, CELL, V62, P981, DOI 10.1016/0092-8674(90)90272-G; Boye E, 1996, P NATL ACAD SCI USA, V93, P12206, DOI 10.1073/pnas.93.22.12206; BOYE E, 1992, J BACTERIOL, V174, P1682, DOI 10.1128/jb.174.5.1682-1685.1992; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; BRAUN RE, 1986, MOL GEN GENET, V202, P246, DOI 10.1007/BF00331644; BRENDLER T, 1995, EMBO J, V14, P4083, DOI 10.1002/j.1460-2075.1995.tb00080.x; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; GEIER GE, 1979, J BIOL CHEM, V254, P1408; GLICKMAN BW, 1980, P NATL ACAD SCI-BIOL, V77, P1063, DOI 10.1073/pnas.77.2.1063; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HATTMAN S, 1982, P NATL ACAD SCI-BIOL, V79, P5518, DOI 10.1073/pnas.79.18.5518; HERMAN GE, 1982, J BIOL CHEM, V257, P2605; HWANG DS, 1990, CELL, V63, P325, DOI 10.1016/0092-8674(90)90165-B; HWANG DS, 1988, J BIOL CHEM, V263, P10633; KIMURA T, 1989, MOL GEN GENET, V219, P69, DOI 10.1007/BF00261159; Kornberg A., 1992, DNA REPLICATION; LANDOULSI A, 1990, CELL, V63, P1053, DOI 10.1016/0092-8674(90)90508-C; Lee YS, 1997, J BIOL CHEM, V272, P83; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; MARINUS MG, 1973, J BACTERIOL, V114, P1143, DOI 10.1128/JB.114.3.1143-1150.1973; MARINUS MG, 1996, ESCHERICHIA COLI SAL, V1, P782; MODRICH P, 1987, ANNU REV BIOCHEM, V56, P435, DOI 10.1146/annurev.biochem.56.1.435; NWOSU VU, 1992, BIOCHEM J, V283, P745, DOI 10.1042/bj2830745; Papavassiliou AG., 1994, DNA-protein interactions, P43, DOI 10.1385/0-89603-256-6:43; RUSSELL DW, 1987, CELL, V50, P1071, DOI 10.1016/0092-8674(87)90173-5; Sambrook J., 2002, MOL CLONING LAB MANU; SLASTER S, 1995, CELL, V82, P927; SMITH DW, 1985, EMBO J, V4, P1319, DOI 10.1002/j.1460-2075.1985.tb03779.x; VONMEYENBURG K, 1987, ESCHERICHIA COLI SAL, V2, P1555; WAGNER R, 1976, P NATL ACAD SCI USA, V73, P4135, DOI 10.1073/pnas.73.11.4135; Wold S, 1998, EMBO J, V17, P4158, DOI 10.1093/emboj/17.14.4158; ZYSKIND JW, 1986, CELL, V46, P489, DOI 10.1016/0092-8674(86)90873-1	34	59	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11463	11468		10.1074/jbc.274.17.11463	http://dx.doi.org/10.1074/jbc.274.17.11463			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206949	hybrid			2022-12-27	WOS:000079834800005
J	Theodorakis, NG; Drujan, D; De Maio, A				Theodorakis, NG; Drujan, D; De Maio, A			Thermotolerant cells show an attenuated expression of Hsp70 after heat shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; PROTEIN-SYNTHESIS; TRANSLATIONAL THERMOTOLERANCE; TRANSCRIPTION FACTOR; ESCHERICHIA-COLI; DNAK; HSP104; STABILIZATION; MECHANISMS; INHIBITION	Expression of heat shock proteins (hsps) results in the protection of cells from subsequent stresses. However, hsps are also toxic when present within cells for a prolonged time period, Thus, the expression of hsps should be tightly regulated. In the present study, the expression of Hsp70 after heat shock was compared between thermotolerant cells, which contain a large concentration of Hsp70, and nonthermotolerant cells (naive), Accumulation of Hsp70, assessed by Western blotting, was negligible when thermotolerant cells were heat-shocked a second time. Hsp70 transcription was similar between thermotolerant and naive cells during heat shock. However, Hsp70 transcription was attenuated more rapidly in thermotolerant than naive cells immediately upon return to non-heat shock conditions. In addition, Hsp70 mRNA stability was reduced in thermotolerant cells as compared with naive cells following the stress. New synthesis of Hsp70 and the efficiency of Hsp70 mRNA translation were similar between thermotolerant and naive cells during the post-stress period. These results suggest that thermotolerant cells limit Hsp70 expression by transcriptional and pretranslational mechanisms, perhaps to avoid the potential cytotoxic effect of these proteins.	Johns Hopkins Univ, Sch Med, Div Pediat Surg, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	De Maio, A (corresponding author), Johns Hopkins Univ, Sch Med, Div Pediat Surg, 720 Rutland Ave, Baltimore, MD 21205 USA.			Theodorakis, Nicholas/0000-0002-3119-4990	NIGMS NIH HHS [GM-50878] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050878] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; ANATHAN J, 1986, SCIENCE, V232, P252; BALER R, 1992, J CELL BIOL, V117, P1151, DOI 10.1083/jcb.117.6.1151; BECK SC, 1994, J BIOL CHEM, V269, P21803; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRAIG EA, 1991, TRENDS BIOCHEM SCI, V16, P135, DOI 10.1016/0968-0004(91)90055-Z; De Maio A, 1995, New Horiz, V3, P198; DECKER CJ, 1994, TRENDS BIOCHEM SCI, V19, P336, DOI 10.1016/0968-0004(94)90073-6; DEMAIO A, 1993, CIRC SHOCK, V40, P177; DEMAIO A, 1993, EUR J BIOCHEM, V218, P413; DIDOMENICO BJ, 1982, P NATL ACAD SCI-BIOL, V79, P6181, DOI 10.1073/pnas.79.20.6181; DIDOMENICO BJ, 1982, CELL, V31, P593, DOI 10.1016/0092-8674(82)90315-4; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Feder ME, 1996, J EXP BIOL, V199, P1837; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; HEADS RJ, 1994, J MOL CELL CARDIOL, V26, P695, DOI 10.1006/jmcc.1994.1084; JOHNSTON RN, 1988, SCIENCE, V242, P1551, DOI 10.1126/science.3201244; LAVOIE JN, 1993, J BIOL CHEM, V268, P3420; LIBEREK K, 1995, P NATL ACAD SCI USA, V92, P6224, DOI 10.1073/pnas.92.14.6224; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; MIZZEN LA, 1988, J CELL BIOL, V106, P1105, DOI 10.1083/jcb.106.4.1105; MORIMOTO RI, 1991, CANCER CELL-MON REV, V3, P295; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; MOSSER DD, 1993, MOL CELL BIOL, V13, P5427, DOI 10.1128/MCB.13.9.5427; MOSSER DD, 1988, MOL CELL BIOL, V8, P4736, DOI 10.1128/MCB.8.11.4736; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; RIABOWOL KT, 1988, SCIENCE, V242, P433, DOI 10.1126/science.3175665; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; THEODORAKIS NG, 1987, MOL CELL BIOL, V7, P4357, DOI 10.1128/MCB.7.12.4357; TILLY K, 1983, CELL, V34, P641, DOI 10.1016/0092-8674(83)90396-3; VIDAIR CA, 1995, J CELL PHYSIOL, V163, P194, DOI 10.1002/jcp.1041630122; VOGEL JL, 1995, CURR BIOL, V5, P306, DOI 10.1016/S0960-9822(95)00061-3; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; YOST HJ, 1991, MOL CELL BIOL, V11, P1062, DOI 10.1128/MCB.11.2.1062	38	53	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12081	12086		10.1074/jbc.274.17.12081	http://dx.doi.org/10.1074/jbc.274.17.12081			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207033	hybrid			2022-12-27	WOS:000079834800089
J	Wood, LC; Ashby, MN; Grunfeld, C; Feingold, KR				Wood, LC; Ashby, MN; Grunfeld, C; Feingold, KR			Cloning of murine translation initiation factor 6 and functional analysis of the homologous sequence YPR016c in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REV ACTIVATION DOMAIN; CAP-BINDING PROTEIN; CELL-PROLIFERATION; SUBUNIT BIOGENESIS; BARRIER DISRUPTION; GROWTH-FACTOR; DNA-SYNTHESIS; YEAST; GENE; EXPRESSION	The cDNA sequence of a murine gene whose expression was up-regulated after epidermal injury was cloned utilizing differential display. The full-length cDNA was isolated by 3' and 5' rapid amplification of cDNA ends from mouse liver. The predicted protein is >97% identical to the human sequence for eukaryotic translation initiation factor (eIF) 6, thus identifying the gene as murine eIF6, Functional studies of the yeast eIF6 homolog, YPR016c, were initiated in Saccharomyces cerevisiae to determine the cellular role(s) of eIF6. Complete deletion of the YPR016c coding sequence was lethal. Viability was restored in the presence of either YPR016c of murine eIF6, when either was expressed as aminoterminal green fluorescent protein fusion protein. Moreover, both fusion proteins localized to nuclear/perinuclear compartments in their respective yeast strains. When the expression of YPR016c-green fluorescent protein was repressed, there was a dramatic reduction in the 60 S ribosomal subunit and polysome content and decreased 80S monosome content. Additionally, the YPR016c-depleted cells arrested in G(1). These studies show that YPR016c, which encodes yeast eIF6, is necessary for maximal polysome formation and plays an important role in determining free 60 S ribosomal subunit content.	Dept Vet Affairs Med Ctr, Dermatol Serv, San Francisco, CA 94121 USA; Dept Vet Affairs Med Ctr, Med Serv, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA; Acacia Biosci Inc, Richmond, CA 94806 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wood, LC (corresponding author), Dept Vet Affairs Med Ctr, Dermatol Serv, 4150 Clement St,111F, San Francisco, CA 94121 USA.				NIAMS NIH HHS [AR 39639] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039639] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Agrawal D, 1996, MOL CELL BIOL, V16, P4327; AUSUBEL FM, 1996, CURRENT PROTOCOLS MO, V2; Benard L, 1998, MOL CELL BIOL, V18, P2688, DOI 10.1128/MCB.18.5.2688; BENNE R, 1978, J BIOL CHEM, V253, P3078; BRENNER C, 1988, MOL CELL BIOL, V8, P3556, DOI 10.1128/MCB.8.8.3556; BURKE DJ, 1991, MOL CELL BIOL, V11, P3691, DOI 10.1128/MCB.11.7.3691; CALLARD D, 1994, BIOTECHNIQUES, V16, P1096; Denda M, 1996, ARCH DERMATOL RES, V288, P230, DOI 10.1007/BF02530090; ELIAS PM, 1991, ADV LIPID RES, V24, P1; FEINGOLD KR, 1991, ADV LIPID RES, V24, P57; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; HANICJOYCE PJ, 1987, EXP CELL RES, V172, P134, DOI 10.1016/0014-4827(87)90100-5; HANICJOYCE PJ, 1987, J BIOL CHEM, V262, P2845; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KANG HA, 1994, J BIOL CHEM, V269, P3934; Kovarik P, 1998, CURR GENET, V33, P100, DOI 10.1007/s002940050314; LEJBKOWICZ F, 1992, P NATL ACAD SCI USA, V89, P9612, DOI 10.1073/pnas.89.20.9612; Liou A, 1997, J INVEST DERMATOL, V108, P73, DOI 10.1111/1523-1747.ep12285638; LODISH HF, 1974, NATURE, V251, P385, DOI 10.1038/251385a0; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; MOLL R, 1995, BBA-GENE STRUCT EXPR, V1261, P315, DOI 10.1016/0167-4781(95)00024-B; NICKOLOFF BJ, 1994, J AM ACAD DERMATOL, V30, P535, DOI 10.1016/S0190-9622(94)70059-1; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; POPOLO L, 1982, EXP CELL RES, V142, P69, DOI 10.1016/0014-4827(82)90410-4; PROKSCH E, 1993, BRIT J DERMATOL, V128, P473, DOI 10.1111/j.1365-2133.1993.tb00222.x; PROKSCH E, 1991, J CLIN INVEST, V87, P1668, DOI 10.1172/JCI115183; RAYCHAUDHURI P, 1984, J BIOL CHEM, V259, P1930; REED SI, 1992, ANNU REV CELL BIOL, V8, P529, DOI 10.1146/annurev.cb.08.110192.002525; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; RUHL M, 1993, J CELL BIOL, V123, P1309, DOI 10.1083/jcb.123.6.1309; SACHS AB, 1990, SCIENCE, V247, P1077, DOI 10.1126/science.2408148; Si K, 1997, P NATL ACAD SCI USA, V94, P14285, DOI 10.1073/pnas.94.26.14285; SIKORSKI RS, 1989, GENETICS, V122, P19; Verlhac MH, 1997, EMBO J, V16, P6812, DOI 10.1093/emboj/16.22.6812; Wood L C, 1994, Exp Dermatol, V3, P56, DOI 10.1111/j.1600-0625.1994.tb00047.x; WOOD LC, 1992, J CLIN INVEST, V90, P482, DOI 10.1172/JCI115884; Wood LC, 1996, J INVEST DERMATOL, V106, P397, DOI 10.1111/1523-1747.ep12343392; Zanchin NIT, 1997, MOL CELL BIOL, V17, P5001, DOI 10.1128/MCB.17.9.5001	42	34	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11653	11659		10.1074/jbc.274.17.11653	http://dx.doi.org/10.1074/jbc.274.17.11653			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206977	hybrid			2022-12-27	WOS:000079834800033
J	Chow, JC; Young, DW; Golenbock, DT; Christ, WJ; Gusovsky, F				Chow, JC; Young, DW; Golenbock, DT; Christ, WJ; Gusovsky, F			Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA TOLL; KAPPA-B; BACTERIAL-ENDOTOXIN; GENE; ACTIVATION; PATHWAY; PROTEIN; FAMILY; RESPONSIVENESS; EXPRESSION	TLR4 is a member of the recently identified Toll-like receptor family of proteins and has been putatively identified as Lps, the gene necessary for potent responses to lipopolysaccharide in mammals. In order to determine whether TLR4 is involved in lipopolysaccharide-induced activation of the nuclear factor-kappa B (NF-kappa B) pathway, HEK 293 cells were transiently transfected with human TLR4 cDNA and an NF-kappa B-dependent luciferase reporter plasmid followed by stimulation with lipopolysaccharide/CD14 complexes. The results demonstrate that lipopolysaccharide stimulates NF-kappa B-mediated gene expression in cells transfected with the TLR4 gene in a dose- and time-dependent fashion. Furthermore, E5531, a lipopolysaccharide antagonist, blocked TLR4-mediated transgene activation in a dose-dependent manner (IC50 similar to 30 nM). These data demonstrate that TLR4 is involved in lipopolysaccharide signaling and serves as a cell-surface co-receptor for CD14, leading to lipopolysaccharide-mediated NF-kappa B activation and subsequent cellular events.	Eisai Res Inst, Div Inflammatory Dis, Andover, MA 01810 USA; Eisai Res Inst, Div Synthet Chem, Andover, MA 01810 USA; Boston Univ, Boston Med Ctr, Sch Med, Maxwell Finland Lab Infect Dis, Boston, MA 02118 USA	Eisai Co Ltd; Eisai Co Ltd; Boston Medical Center; Boston University	Chow, JC (corresponding author), Eisai Res Inst, 100 Res Dr, Wilmington, MA 01887 USA.							Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Chaudhary PM, 1998, BLOOD, V91, P4020, DOI 10.1182/blood.V91.11.4020.411a44_4020_4027; CHRIST WJ, 1995, SCIENCE, V268, P80, DOI 10.1126/science.7701344; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; GOLENBOCK DT, 1993, J BIOL CHEM, V268, P22055; Huang JN, 1997, P NATL ACAD SCI USA, V94, P12829, DOI 10.1073/pnas.94.24.12829; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; KUWATA T, 1995, BACTERIAL ENDOTOXINS, V392, P499; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rossignol DP, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P699; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	23	1557	1633	0	95	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10689	10692		10.1074/jbc.274.16.10689	http://dx.doi.org/10.1074/jbc.274.16.10689			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196138	hybrid			2022-12-27	WOS:000079751900006
J	Furge, KA; Cheng, QC; Jwa, M; Shin, SJ; Song, KW; Albright, CF				Furge, KA; Cheng, QC; Jwa, M; Shin, SJ; Song, KW; Albright, CF			Regions of Byr4, a regulator of septation in fission yeast, that bind Spg1 or Cdc16 and form a two-component GTPase-activating protein with Cdc16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOSAGE-DEPENDENT REGULATOR; SCHIZOSACCHAROMYCES-POMBE; SEPTUM FORMATION; SACCHAROMYCES-CEREVISIAE; S-POMBE; CYTOKINESIS; KINASE; DOMAIN; CDC42; GENE	In the fission yeast Schizosaccharomyces pombe, septation and constriction of the actomyosin ring for cell division are positively regulated by the Spg1. GTPase, a member of the Ras superfamily. Spg1 is negatively regulated by Byr4 and Cdc16, which together form a two-component GTPase-activating protein for the Spg1 GTPase. To better understand how Byr4 regulates septation, Byr4 mutants were tested for in vitro functions. This analysis revealed that Byr4 contained one Cdc16-binding site and four Spg1-binding sites (SBS), designated SBS1-SBS4. Although mutants with a single SBS bound Spg1 and inhibited GTP dissociation, the equilibrium binding affinity of these mutants was 28-280-fold weaker than Byr4. Because some Byr4 mutants with multiple SBSs bound Spg1 tighter than the corresponding mutants with a single SBS, multiple SBSs probably interact to cause the high affinity binding of Byr4 to Spg1. A region of Byr4 that bound Spg1, SBS4, and the region that bound Cdc16, Cdc16-binding site, was necessary and sufficient to form Cdc16-dependent Spg1GAP activity that was similar to that of wild-type Byr4 with Cdc16.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Yonsei Univ, Coll Sci, Dept Biochem, Seoul 120749, South Korea	Vanderbilt University; Yonsei University	Albright, CF (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 655 Light Hall, Nashville, TN 37232 USA.				NCI NIH HHS [T32-CA09582] Funding Source: Medline; NIGMS NIH HHS [GM-51952] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051952] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balasubramanian MK, 1998, GENETICS, V149, P1265; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; FANKHAUSER C, 1993, EMBO J, V12, P2697, DOI 10.1002/j.1460-2075.1993.tb05931.x; FANKHAUSER C, 1994, EMBO J, V13, P3011, DOI 10.1002/j.1460-2075.1994.tb06600.x; Furge KA, 1998, CURR BIOL, V8, P947, DOI 10.1016/S0960-9822(98)70394-X; Gould KL, 1997, GENE DEV, V11, P2939, DOI 10.1101/gad.11.22.2939; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; JOCHOVA J, 1991, CELL BIOL INT REP, V15, P607, DOI 10.1016/0309-1651(91)90007-6; JOHNSON BF, 1973, J BACTERIOL, V115, P358, DOI 10.1128/JB.115.1.358-366.1973; Jwa M, 1998, MOL CELLS, V8, P240; Kitayama C, 1997, J CELL BIOL, V137, P1309, DOI 10.1083/jcb.137.6.1309; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MCCOLLUM D, 1995, J CELL BIOL, V130, P1; MINET M, 1979, J BACTERIOL, V137, P440, DOI 10.1128/JB.137.1.440-446.1979; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P243, DOI 10.1016/S0968-0004(97)01073-6; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schmidt S, 1997, GENE DEV, V11, P1519, DOI 10.1101/gad.11.12.1519; SHIRAYAMA M, 1994, MOL CELL BIOL, V14, P7476, DOI 10.1128/MCB.14.11.7476; Sohrmann M, 1998, GENE DEV, V12, P84, DOI 10.1101/gad.12.1.84; Song KW, 1996, J CELL BIOL, V133, P1307, DOI 10.1083/jcb.133.6.1307; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0	27	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11339	11343		10.1074/jbc.274.16.11339	http://dx.doi.org/10.1074/jbc.274.16.11339			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196225	hybrid			2022-12-27	WOS:000079751900093
J	Lohmann, V; Overton, H; Bartenschlager, R				Lohmann, V; Overton, H; Bartenschlager, R			Selective stimulation of hepatitis C virus and pestivirus NS5B RNA polymerase activity by GTP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLIOVIRUS PROTEIN 3AB; RIBOSOME ENTRY SITE; NUCLEOTIDE-BINDING; NONSTRUCTURAL PROTEIN-3; HELICASE ACTIVITY; ESCHERICHIA-COLI; GENOME RNA; IDENTIFICATION; INITIATION; 3'-TERMINUS	NS5B of the hepatitis C virus is an RNA template-dependent RNA polymerase and therefore the key player of the viral replicase complex. Using a highly purified enzyme expressed with recombinant baculoviruses in insect cells, we demonstrate a stimulation of RNA synthesis up to 2 orders of magnitude by high concentrations of GTP but not with ATP, CTP, UTP, GDP, or C;Mg, Enhancement of RNA synthesis was found with various heteropolymeric RNA templates, with poly(C)-oligo(G)(12) but not with poly(A)-oligo(U)(12). Several amino acid substitutions in polymerase motifs B, C, and D previously shown to be crucial for RdRp activity were tested for GTP stimulation of RNA synthesis. Most of these mutations, in particular those affecting the GDD motif (motif C) strongly reduced or completely abolished activation by GTP, suggesting that the same NTP-binding site is used for stimulation and RNA synthesis. Since GTP did not affect the overall RNA binding properties or the elongation rate, high concentrations of GTP appear to accelerate a rate-limiting step at the level of initiation of RNA synthesis, Finally, enhancement of RNA synthesis by high GTP concentrations was also found with NS5B of the pestivirus classical swine fever virus, but not with the 3D polymerase of poliovirus, Thus, stimulation of RdRp activity by GTP is evolutionarily conserved between the closely related hepaciviruses and pestiviruses but not between these and the more distantly related picornaviruses.	Univ Mainz, Inst Virol, D-55131 Mainz, Germany; Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England	Johannes Gutenberg University of Mainz; Roche Holding	Bartenschlager, R (corresponding author), Univ Mainz, Inst Virol, Obere Zahlbacher Str 67, D-55131 Mainz, Germany.		Lohmann, Volker/H-4211-2019; Bartenschlager, Ralf/L-2582-2015	Lohmann, Volker/0000-0001-8719-7608; Bartenschlager, Ralf/0000-0001-5601-9307				Al RH, 1998, VIRUS RES, V53, P141, DOI 10.1016/S0168-1702(97)00147-0; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; Bartenschlager R, 1997, INTERVIROLOGY, V40, P378, DOI 10.1159/000150570; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Blight KJ, 1997, J VIROL, V71, P7345, DOI 10.1128/JVI.71.10.7345-7352.1997; Booth JCL, 1998, J VIRAL HEPATITIS, V5, P213, DOI 10.1046/j.1365-2893.1998.00115.x; CHO MW, 1993, J VIROL, V67, P3010, DOI 10.1128/JVI.67.6.3010-3018.1993; Clarke B, 1997, J GEN VIROL, V78, P2397, DOI 10.1099/0022-1317-78-10-2397; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; HIJIKATA M, 1993, P NATL ACAD SCI USA, V90, P10773, DOI 10.1073/pnas.90.22.10773; HIJIKATA M, 1991, P NATL ACAD SCI USA, V88, P5547, DOI 10.1073/pnas.88.13.5547; Hong Z, 1996, J VIROL, V70, P4261, DOI 10.1128/JVI.70.7.4261-4268.1996; HOUGHTON M, 1996, VIROLOGY, P1035; JOYCE CM, 1995, J BACTERIOL, V177, P6321, DOI 10.1128/jb.177.22.6321-6329.1995; Kao CC, 1996, J VIROL, V70, P6826, DOI 10.1128/JVI.70.10.6826-6830.1996; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Kolykhalov AA, 1996, J VIROL, V70, P3363, DOI 10.1128/JVI.70.6.3363-3371.1996; LAMA J, 1994, J BIOL CHEM, V269, P66; LAMA J, 1995, J BIOL CHEM, V270, P14430, DOI 10.1074/jbc.270.24.14430; LIN C, 1994, J VIROL, V68, P5063, DOI 10.1128/JVI.68.8.5063-5073.1994; Lohmann V, 1998, VIROLOGY, V249, P108, DOI 10.1006/viro.1998.9311; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; MILLER WA, 1986, J MOL BIOL, V187, P537, DOI 10.1016/0022-2836(86)90332-3; MIZUSHIMA H, 1994, J VIROL, V68, P6215, DOI 10.1128/JVI.68.10.6215-6222.1994; MOLLA A, 1994, J BIOL CHEM, V269, P27015; MURPHY FA, 1995, CLASSIFICATION NOMEN, P424; PATA JD, 1995, RNA, V1, P466; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; PAUL AV, 1994, J BIOL CHEM, V269, P29173; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; REDDY PS, 1994, EUR J BIOCHEM, V225, P737, DOI 10.1111/j.1432-1033.1994.00737.x; RICE CM, 1996, VIROLOGY, P931; Richards OC, 1996, J VIROL, V70, P8564, DOI 10.1128/JVI.70.12.8564-8570.1996; RICHARDS OC, 1992, J BIOL CHEM, V267, P17141; RICHARDS OC, 1995, BIOCHEMISTRY-US, V34, P6288, DOI 10.1021/bi00019a005; Richards OC, 1997, J BIOL CHEM, V272, P23261, DOI 10.1074/jbc.272.37.23261; Ruggli N, 1996, J VIROL, V70, P3478, DOI 10.1128/JVI.70.6.3478-3487.1996; SELBY MJ, 1993, J GEN VIROL, V74, P1103, DOI 10.1099/0022-1317-74-6-1103; Sun JH, 1997, VIROLOGY, V236, P348, DOI 10.1006/viro.1997.8742; Sun JH, 1997, VIROLOGY, V233, P63, DOI 10.1006/viro.1997.8583; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Tai CL, 1996, J VIROL, V70, P8477, DOI 10.1128/JVI.70.12.8477-8484.1996; TAKAMIZAWA A, 1991, J VIROL, V65, P1105, DOI 10.1128/JVI.65.3.1105-1113.1991; TANAKA T, 1995, BIOCHEM BIOPH RES CO, V215, P744, DOI 10.1006/bbrc.1995.2526; Tanaka T, 1996, J VIROL, V70, P3307, DOI 10.1128/JVI.70.5.3307-3312.1996; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; TSUKIYAMAKOHARA K, 1992, J VIROL, V66, P1476, DOI 10.1128/JVI.66.3.1476-1483.1992; Wang C, 1995, CURR TOP MICROBIOL, V203, P99; WANG CY, 1993, J VIROL, V67, P3338, DOI 10.1128/JVI.67.6.3338-3344.1993; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; Yuan ZH, 1997, BIOCHEM BIOPH RES CO, V232, P231, DOI 10.1006/bbrc.1997.6249	52	83	101	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10807	10815		10.1074/jbc.274.16.10807	http://dx.doi.org/10.1074/jbc.274.16.10807			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196156	hybrid			2022-12-27	WOS:000079751900024
J	Majerus, PW; Kisseleva, MV; Norris, FA				Majerus, PW; Kisseleva, MV; Norris, FA			The role of phosphatases in inositol signaling reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							POLYPHOSPHATE 5-PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; HUMAN-PLATELETS; PHOSPHOINOSITIDE 3-KINASE; MOLECULAR-CLONING; SALMONELLA-DUBLIN; TUMOR-SUPPRESSOR; LOWE-SYNDROME; PROTEIN; EXPRESSION		Washington Univ, Sch Med, Dept Internal Med, Div Hematol, St Louis, MO 63110 USA; Iowa State Univ, Ames, IA 50011 USA	Washington University (WUSTL); Iowa State University	Majerus, PW (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Hematol, 660 S Euclid Ave,Campus Box 8125, St Louis, MO 63110 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016634, T32HL007088, R37HL016634] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 3289, HL 16634, HL 07088] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acharya JK, 1998, NEURON, V20, P1219, DOI 10.1016/S0896-6273(00)80502-4; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; Auethavekiat V, 1997, J BIOL CHEM, V272, P1786, DOI 10.1074/jbc.272.3.1786; Campbell JK, 1997, BIOCHEMISTRY-US, V36, P15363, DOI 10.1021/bi9708085; CHARNAS L, 1995, METABOLIC BASIS INHE, V3, P3705; Chung JK, 1997, J BIOL CHEM, V272, P15980, DOI 10.1074/jbc.272.25.15980; CONNOLLY TM, 1985, J BIOL CHEM, V260, P7868; Craxton A, 1997, BIOCHEM J, V328, P75, DOI 10.1042/bj3280075; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DeSmedt F, 1996, J BIOL CHEM, V271, P10419, DOI 10.1074/jbc.271.17.10419; Drayer AL, 1996, BIOCHEM SOC T, V24, P1001, DOI 10.1042/bst0241001; Eckmann L, 1997, P NATL ACAD SCI USA, V94, P14456, DOI 10.1073/pnas.94.26.14456; Galyov EE, 1997, MOL MICROBIOL, V25, P903, DOI 10.1111/j.1365-2958.1997.mmi525.x; Habib T, 1998, J BIOL CHEM, V273, P18605, DOI 10.1074/jbc.273.29.18605; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hopkin K, 1998, SCIENCE, V282, P1027, DOI 10.1126/science.282.5391.1027; JACKSON SP, 1995, EMBO J, V14, P4490, DOI 10.1002/j.1460-2075.1995.tb00128.x; Janne PA, 1998, J CLIN INVEST, V101, P2042, DOI 10.1172/JCI2414; Jefferson AB, 1996, BIOCHEMISTRY-US, V35, P7890, DOI 10.1021/bi9602627; JEFFERSON AB, 1995, J BIOL CHEM, V270, P9370, DOI 10.1074/jbc.270.16.9370; Kavanaugh WM, 1996, CURR BIOL, V6, P438, DOI 10.1016/S0960-9822(02)00511-0; LAXMINARAYAN KM, 1994, J BIOL CHEM, V269, P17305; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majerus PW, 1996, GENE DEV, V10, P1051, DOI 10.1101/gad.10.9.1051; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; MCPHERSON PS, 1994, P NATL ACAD SCI USA, V91, P6486, DOI 10.1073/pnas.91.14.6486; MCPHERSON PS, 1994, J BIOL CHEM, V269, P30132; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Mitchell CA, 1996, BIOCHEM SOC T, V24, P994, DOI 10.1042/bst0240994; MITCHELL CA, 1989, J BIOL CHEM, V264, P8873; Nemoto Y, 1997, J BIOL CHEM, V272, P30817, DOI 10.1074/jbc.272.49.30817; NORRIS FA, 1994, J BIOL CHEM, V269, P8716; NORRIS FA, 1995, J BIOL CHEM, V270, P16128, DOI 10.1074/jbc.270.27.16128; Norris FA, 1997, J BIOL CHEM, V272, P10987; Norris FA, 1997, J BIOL CHEM, V272, P23859, DOI 10.1074/jbc.272.38.23859; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Osborne MA, 1996, J BIOL CHEM, V271, P29271, DOI 10.1074/jbc.271.46.29271; Pesesse X, 1997, BIOCHEM BIOPH RES CO, V239, P697, DOI 10.1006/bbrc.1997.7538; ROSS TS, 1991, J BIOL CHEM, V266, P20283; Seet LF, 1998, BIOCHEM BIOPH RES CO, V247, P116, DOI 10.1006/bbrc.1998.8564; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Speed CJ, 1996, EMBO J, V15, P4852, DOI 10.1002/j.1460-2075.1996.tb00866.x; SPEED CJ, 1995, EUR J BIOCHEM, V234, P216, DOI 10.1111/j.1432-1033.1995.216_c.x; Steen VM, 1998, PHARMACOGENETICS, V8, P259; Stolz LE, 1998, GENETICS, V148, P1715; SUCHY SF, 1995, HUM MOL GENET, V4, P2245, DOI 10.1093/hmg/4.12.2245; VERJANS B, 1994, BIOCHEM J, V300, P85, DOI 10.1042/bj3000085; YORK JD, 1995, P NATL ACAD SCI USA, V92, P5149, DOI 10.1073/pnas.92.11.5149; YORK JD, 1990, P NATL ACAD SCI USA, V87, P9548, DOI 10.1073/pnas.87.24.9548; Zhang XL, 1998, J BIOL CHEM, V273, P1574, DOI 10.1074/jbc.273.3.1574; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P15266, DOI 10.1021/bi00255a007; ZHOU GC, 1994, J BIOL CHEM, V269, P28084	57	177	183	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10669	10672		10.1074/jbc.274.16.10669	http://dx.doi.org/10.1074/jbc.274.16.10669			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196133	hybrid			2022-12-27	WOS:000079751900001
J	Sakuragi, S; Liu, QL; Craig, E				Sakuragi, S; Liu, QL; Craig, E			Interaction between the nucleotide exchange factor Mge1 and the mitochondrial Hsp70 Ssc1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI GRPE; MOLECULAR CHAPERONE DNAK; SACCHAROMYCES-CEREVISIAE; PROTEIN IMPORT; ATPASE DOMAIN; TRANSLOCATION; GENE; MEMBRANE; BINDING; PURIFICATION	Function of Hsp70s such as DnaK of the Escherichia coli cytoplasm and Ssc1 of the mitochondrial matrix of Saccharomyces cerevisiae requires the nucleotide release factors, GrpE and Mge1, respectively. A loop, which protrudes from domain IA of the DnaK ATPase domain, is one of six sites of interaction revealed in the GrpE:DnaK co-crystal structure and has been implicated as a functionally important site in both DnaK and Ssc1, Alanine substitutions for the amino acids (Lys-108 and Arg-213 of Mge1) predicted to interact with the Hsp70 loop were analyzed. Mge1 having both substitutions was able to support growth in the absence of the essential wild-type protein. K108A/R213A Mge1 was able to stimulate nucleotide release from Ssc1 and function in refolding of denatured luciferase, albeit higher concentrations of mutant protein than wild-type protein were required. In vitro and in vivo assays using K108A/R213A Mge1 and Ssc1 indicated that the disruption of contact at this site destabilized the interaction between the two proteins. We propose that the direct interaction between the loop of Ssc1 and Mge1 is not required to effect nucleotide release but plays a role in stabilization of the Mge1-Ssc1 interaction. The robust growth of the K108A/R213A MGE1 mutant suggests that the interaction between Mge1 and Ssc1 is tighter than required for function in vivo.	Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Craig, E (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA.	ecraig@facstaff.wisc.edu			NIGMS NIH HHS [GM27870] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027870] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANG D, 1986, J BACTERIOL, V167, P25, DOI 10.1128/jb.167.1.25-29.1986; ANG D, 1989, J BACTERIOL, V171, P2748, DOI 10.1128/jb.171.5.2748-2755.1989; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; BOLLIGER L, 1994, EMBO J, V13, P1998, DOI 10.1002/j.1460-2075.1994.tb06469.x; Bomer U, 1997, EMBO J, V16, P2205, DOI 10.1093/emboj/16.9.2205; BUCHBERGER A, 1994, NAT STRUCT BIOL, V1, P95, DOI 10.1038/nsb0294-95; CORMACK B, 1994, CURRENT PROTOCOLS MO, V1; Dekker PJT, 1997, J MOL BIOL, V270, P321, DOI 10.1006/jmbi.1997.1131; Deloche O, 1997, J BACTERIOL, V179, P6066, DOI 10.1128/jb.179.19.6066-6075.1997; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Horst M, 1996, PROTEIN SCI, V5, P759; Horst M, 1997, EMBO J, V16, P1842, DOI 10.1093/emboj/16.8.1842; IKEDA E, 1994, FEBS LETT, V339, P265, DOI 10.1016/0014-5793(94)80428-1; Johnson JL, 1997, CELL, V90, P201, DOI 10.1016/S0092-8674(00)80327-X; JONES EW, 1991, METHOD ENZYMOL, V194, P428; KAMATHLOEB AS, 1995, J BIOL CHEM, V270, P30051; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; MCKAY DB, 1994, BIOL HEAT SHOCK PROT, P153; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l; Rose MD., 1990, METHODS YEAST GENETI; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Voos W, 1996, EMBO J, V15, P2668, DOI 10.1002/j.1460-2075.1996.tb00627.x; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; WU B, 1994, J BACTERIOL, V176, P6965, DOI 10.1128/JB.176.22.6965-6973.1994; ZYLICZ M, 1987, J BIOL CHEM, V262, P17437; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591	33	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11275	11282		10.1074/jbc.274.16.11275	http://dx.doi.org/10.1074/jbc.274.16.11275			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196216	hybrid			2022-12-27	WOS:000079751900084
J	Seyama, K; Osborne, WRA; Ochs, HD				Seyama, K; Osborne, WRA; Ochs, HD			CD40 ligand mutants responsible for X-linked hyper-IgM syndrome associate with wild type CD40 ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR NECROSIS FACTOR; HUMAN FAS LIGAND; CELL-SURFACE; DEFECTIVE EXPRESSION; HETEROMERIC COMPLEX; CRYSTAL-STRUCTURE; SOLUBLE CD40; GENE; RECEPTOR; TNF	CD40 ligand (CD40L) is a 33-kDa type II membrane glycoprotein mainly expressed on activated CD4(+) T cells in trimeric form. When it is mutated, the clinical consequences are X-linked hyper-IgM syndrome (XHIM), a primary immunodeficiency disorder characterized by low levels of IgG, IgA, and elevated or normal levels of IgM. Mutated CD40L can no longer bind CD40 nor provide signals for B cells to proliferate and to switch from IgM to other immunoglobulin isotypes. When considering gene therapy for XHIM, it is important to address the possibility that the mutated CD40L associates with transduced wild type CD40L, and as a consequence, immune reconstitution is not attained. In this study, we demonstrate that the various mutated CD40L species we have identified in patients with XHIM, including both full-length and truncated mutants, associate with wild type CD40L on the cell surface of co-transfected COS cells. The association between wild type and mutated CD40L was also observed in CD4(+) T cell lines established from XHIM patients with leaky splice site mutations. The clinical phenotype of these patients suggests that this association between wild type and mutated CD40L species may result in less efficient cross-linking of CD40.	Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Juntendo Univ, Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Washington; University of Washington Seattle; Juntendo University	Ochs, HD (corresponding author), Univ Washington, Sch Med, Dept Pediat, Box 356320, Seattle, WA 98195 USA.				NIAID NIH HHS [AI40102] Funding Source: Medline; NICHD NIH HHS [HD17427] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017427, R37HD017427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040102] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ANDROLEWICZ MJ, 1992, J BIOL CHEM, V267, P2542; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; BAJORATH J, 1995, BIOCHEMISTRY-US, V34, P9884, DOI 10.1021/bi00031a009; BAJORATH J, 1995, BIOCHEMISTRY-US, V34, P1833, DOI 10.1021/bi00006a003; Bajorath J, 1996, PROTEIN SCI, V5, P531; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BEUTLER B, 1994, SCIENCE, V264, P667, DOI 10.1126/science.8171316; BJORCK P, 1994, IMMUNOLOGY, V83, P430; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; CLARK EA, 1986, P NATL ACAD SCI USA, V83, P4494, DOI 10.1073/pnas.83.12.4494; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; ECK MJ, 1992, J BIOL CHEM, V267, P2119; ECK MJ, 1989, J BIOL CHEM, V264, P17595; FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Grewal IS, 1996, IMMUNOL TODAY, V17, P410, DOI 10.1016/0167-5699(96)10030-X; HOLLENBAUGH D, 1992, EMBO J, V11, P4313, DOI 10.1002/j.1460-2075.1992.tb05530.x; Hsu YM, 1997, J BIOL CHEM, V272, P911, DOI 10.1074/jbc.272.2.911; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; KARPUSAS M, 1995, STRUCTURE, V3, P1031, DOI 10.1016/S0969-2126(01)00239-8; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; MAZZEI GJ, 1995, J BIOL CHEM, V270, P7025, DOI 10.1074/jbc.270.13.7025; Notarangelo LD, 1996, IMMUNOL TODAY, V17, P511, DOI 10.1016/0167-5699(96)30059-5; Pietravalle F, 1996, J BIOL CHEM, V271, P5965, DOI 10.1074/jbc.271.11.5965; Schwabe RF, 1997, HYBRIDOMA, V16, P217, DOI 10.1089/hyb.1997.16.217; Seyama K, 1998, BLOOD, V92, P2421, DOI 10.1182/blood.V92.7.2421.2421_2421_2434; Seyama K, 1996, HUM GENET, V97, P180, DOI 10.1007/BF02265262; SMITH CA, 1993, CELL, V73, P1349, DOI 10.1016/0092-8674(93)90361-S; SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543; Stout RD, 1996, IMMUNOL TODAY, V17, P487, DOI 10.1016/0167-5699(96)10060-I; TAKAHASHI T, 1994, INT IMMUNOL, V6, P1567, DOI 10.1093/intimm/6.10.1567; VILLA A, 1994, P NATL ACAD SCI USA, V91, P2110, DOI 10.1073/pnas.91.6.2110; WAGNER DH, 1994, EUR J IMMUNOL, V24, P3148, DOI 10.1002/eji.1830241235	37	20	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11310	11320		10.1074/jbc.274.16.11310	http://dx.doi.org/10.1074/jbc.274.16.11310			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196221	hybrid			2022-12-27	WOS:000079751900089
J	Bemark, M; Martensson, A; Liberg, D; Leanderson, T				Bemark, M; Martensson, A; Liberg, D; Leanderson, T			Spi-C, a novel Ets protein that is temporally regulated during B lymphocyte development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR PU.1; CONSERVED SEQUENCE ELEMENTS; TISSUE-SPECIFIC EXPRESSION; T-CELLS; INSITU HYBRIDIZATION; KAPPA-PROMOTERS; CHAIN GENE; BINDING; DOMAIN; DNA	A novel Ets protein was isolated by yeast one-hybrid screening of a cDNA library made from lipopolysaccharide-stimulated mouse splenic B cells, using the SP6 kappa promoter kappa Y element as a bait. The novel Ets protein was most closely related to PU.1 and Spi-B within the DNA binding Ets domain and was therefore named Spi-C. However, Spi-C may represent a novel subgroup within the Ets protein family, as it differed significantly from Spi-B and PU.1 within helix 1 of the Ets domain. Spi-C was encoded by a single-copy gene that was mapped to chromosome 10, region C. Spi-C interacted with DNA similarly to PU.1 as judged by methylation interference, band-shift and site selection analysis, and activated transcription of a kappa Y element reporter gene upon co-transfection of HeLa cells. Spi-C RNA was expressed in mature B lymphocytes and at lower levels in macrophages, Furthermore, pre-B cell and plasma cell lines were Spi-C-negative, suggesting that Spi-C might be a regulatory molecule during a specific phase of B lymphoid development.	Univ Lund, Dept Cell & Mol Biol, Immunol Unit, S-22007 Lund, Sweden	Lund University	Leanderson, T (corresponding author), Univ Lund, Dept Cell & Mol Biol, Immunol Unit, POB 7031, S-22007 Lund, Sweden.		Bemark, Mats/B-2578-2019	Bemark, Mats/0000-0001-7416-9819				ATCHISON ML, 1990, EMBO J, V9, P3109, DOI 10.1002/j.1460-2075.1990.tb07508.x; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Bemark M, 1998, IMMUNOGENETICS, V47, P183, DOI 10.1007/s002510050347; Bemark M, 1997, EUR J IMMUNOL, V27, P1308, DOI 10.1002/eji.1830270603; BHAT NK, 1989, J IMMUNOL, V142, P672; BHAT NK, 1987, P NATL ACAD SCI USA, V84, P3161, DOI 10.1073/pnas.84.10.3161; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; FALKNER FG, 1984, NATURE, V310, P71, DOI 10.1038/310071a0; GRANT PA, 1995, EMBO J, V14, P4501, DOI 10.1002/j.1460-2075.1995.tb00129.x; HAGMAN J, 1992, P NATL ACAD SCI USA, V89, P8889, DOI 10.1073/pnas.89.19.8889; HENG HHQ, 1993, CHROMOSOMA, V102, P325, DOI 10.1007/BF00661275; HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; LEIDEN JM, 1992, J VIROL, V66, P5890, DOI 10.1128/JVI.66.10.5890-5897.1992; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Martensson IL, 1997, J EXP MED, V185, P653, DOI 10.1084/jem.185.4.653; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; NELSEN B, 1993, SCIENCE, V261, P82, DOI 10.1126/science.8316859; OMORI SA, 1993, P NATL ACAD SCI USA, V90, P11723, DOI 10.1073/pnas.90.24.11723; PAIGE CJ, 1978, J IMMUNOL, V121, P641; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; PONGUBALA JMR, 1993, SCIENCE, V259, P1622, DOI 10.1126/science.8456286; RAY D, 1992, MOL CELL BIOL, V12, P4297, DOI 10.1128/MCB.12.10.4297; RAYGALLET D, 1995, ONCOGENE, V11, P303; Sambrook J., 2002, MOL CLONING LAB MANU; SCHWARZENBACH H, 1995, J BIOL CHEM, V270, P898, DOI 10.1074/jbc.270.2.898; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHIN MK, 1993, GENE DEV, V7, P2006, DOI 10.1101/gad.7.10.2006; SIGVARDSSON M, 1995, MOL CELL BIOL, V15, P1343; Sigvardsson M, 1996, J IMMUNOL, V156, P3788; SIGVARDSSON M, 1995, EUR J IMMUNOL, V25, P298, DOI 10.1002/eji.1830250150; Singh H, 1996, CURR OPIN IMMUNOL, V8, P160, DOI 10.1016/S0952-7915(96)80053-7; Su GH, 1996, J EXP MED, V184, P203, DOI 10.1084/jem.184.1.203; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; TREISMAN R, 1992, EMBO J, V11, P4631, DOI 10.1002/j.1460-2075.1992.tb05565.x; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; WATSON DK, 1988, P NATL ACAD SCI USA, V85, P7862, DOI 10.1073/pnas.85.21.7862; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373	44	45	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10259	10267		10.1074/jbc.274.15.10259	http://dx.doi.org/10.1074/jbc.274.15.10259			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187812	hybrid			2022-12-27	WOS:000079663500051
J	Craddock, BL; Orchiston, EA; Hinton, HJ; Welham, MJ				Craddock, BL; Orchiston, EA; Hinton, HJ; Welham, MJ			Dissociation of apoptosis from proliferation, protein kinase B activation, and BAD phosphorylation in interleukin-3-mediated phosphoinositide 3-kinase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; GROWTH-FACTOR-I; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; HEMATOPOIETIC-CELLS; COLORIMETRIC ASSAY; 3T3-L1 ADIPOCYTES; MAMMALIAN-CELLS; GENE-EXPRESSION; SURVIVAL FACTOR	Interleukin-3 (IL-3) acts as both a growth and survival factor for many hemopoietic cells. IL-3 treatment of responsive cells leads to the rapid and transient activation of Class I-A phosphoinositide-3-kinases (PI3Ks) and the serine/threonine kinase Akt/protein kinase B (PKB) and phosphorylation of BAD. Each of these molecules has been implicated in anti-apoptotic signaling in a wide range of cells. Using regulated expression of dominant-negative p85 (Delta p85) in stably transfected IL-3-dependent BaF/3 cells, we have specifically investigated the role of class I-A PI3K in IL-3 signaling. The major functional consequence of Delta p85 expression in these cells is a highly reproducible, dramatic reduction in IL-3-induced proliferation. Expression of Delta p85 reduces IL-3-induced PKB phosphorylation and activation and phosphorylation of BAD dramatically, to levels seen in unstimulated cells. Despite these reductions, the levels of apoptosis observed in the same cells are very low and do not account for the reduction in IL-3-dependent proliferation we observe. These results show that Delta p85 inhibits both PKB activity and BAD phosphorylation without significantly affecting levels of apoptosis, suggesting that there are targets other than PKB and BAD that can transmit survival signals in these cells. Our data indicate that the prime target for PI3K action in IL-3 signaling is at the level of regulation of proliferation.	Univ Bath, Dept Pharmacol, Bath BA2 7AY, Avon, England	University of Bath	Welham, MJ (corresponding author), Univ Bath, Dept Pharmacol, Bath BA2 7AY, Avon, England.	M.J.Welham@bath.ac.uk						Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bone H, 1997, J BIOL CHEM, V272, P14470, DOI 10.1074/jbc.272.22.14470; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Casagrande F, 1998, FEBS LETT, V422, P385, DOI 10.1016/S0014-5793(98)00043-X; Chantry D, 1997, J BIOL CHEM, V272, P19236, DOI 10.1074/jbc.272.31.19236; COSMAN D, 1993, CYTOKINE, V5, P95, DOI 10.1016/1043-4666(93)90047-9; Craddock BL, 1997, J BIOL CHEM, V272, P29281, DOI 10.1074/jbc.272.46.29281; Datta K, 1996, J BIOL CHEM, V271, P30835, DOI 10.1074/jbc.271.48.30835; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Groot RP, 1998, CELL SIGNAL, V10, P619, DOI 10.1016/S0898-6568(98)00023-0; delPeso L, 1997, SCIENCE, V278, P687; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; GOLD MR, 1994, J BIOL CHEM, V269, P5403; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1994, TRENDS BIOTECHNOL, V12, P58, DOI 10.1016/0167-7799(94)90101-5; Gotoh N, 1996, EMBO J, V15, P6197, DOI 10.1002/j.1460-2075.1996.tb01008.x; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; IHLE JN, 1992, CHEM IMMUNOL, V51, P65; Jascur T, 1997, J BIOL CHEM, V272, P14483, DOI 10.1074/jbc.272.22.14483; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kulik G, 1998, MOL CELL BIOL, V18, P6711, DOI 10.1128/MCB.18.11.6711; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; LAM K, 1994, J BIOL CHEM, V269, P20648; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; McIlroy J, 1997, MOL CELL BIOL, V17, P248, DOI 10.1128/MCB.17.1.248; Minshall C, 1996, J IMMUNOL, V156, P939; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; Rahimi N, 1996, J BIOL CHEM, V271, P24850, DOI 10.1074/jbc.271.40.24850; ROCHE H, 1994, ANN ONCOL S8, V5, P91; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Scheid MP, 1998, P NATL ACAD SCI USA, V95, P7439, DOI 10.1073/pnas.95.13.7439; SCHEID MP, 1995, BIOCHEM J, V312, P159, DOI 10.1042/bj3120159; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; Shepherd PR, 1996, TRENDS CELL BIOL, V6, P92, DOI 10.1016/0962-8924(96)80998-6; Tanti JF, 1996, J BIOL CHEM, V271, P25227, DOI 10.1074/jbc.271.41.25227; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WELHAM MJ, 1994, J BIOL CHEM, V269, P23764; WELHAM MJ, 1994, J BIOL CHEM, V269, P21165; WELHAM MJ, 1992, J IMMUNOL, V149, P2772; YANO H, 1993, J BIOL CHEM, V268, P25846; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	61	87	87	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10633	10640		10.1074/jbc.274.15.10633	http://dx.doi.org/10.1074/jbc.274.15.10633			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187860	hybrid			2022-12-27	WOS:000079663500099
J	Farrar, SJ; Whiting, PJ; Bonnert, TP; McKernan, RM				Farrar, SJ; Whiting, PJ; Bonnert, TP; McKernan, RM			Stoichiometry of a ligand-gated ion channel determined by fluorescence energy transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT GABA(A) RECEPTOR; A RECEPTOR; ACETYLCHOLINE-RECEPTOR; GAMMA-SUBUNIT; RAT-BRAIN; ACID; EXPRESSION; POPULATIONS; MODULATION; ANTIBODIES	We have developed a method to determine the stoichiometry of subunits within an oligomeric cell surface receptor using fluorescently tagged antibodies to the individual subunits and measuring energy transfer between them. Anti-c-Myc monoclonal antibody (mAb 9-E10) derivatized with a fluorophore (europium cryptate, EuK) was used to individually label c-Myc-tagged alpha(1)-, beta(2)-, or gamma(2)-subunits of the hetero-oligomeric gamma-aminobutyric acid (GABA(A)) receptor in intact cells. The maximal fluorescent signal derived from the alpha(1)(c-Myc)beta(2)gamma(2) and the alpha(1)beta(2)(c-Myc)gamma(2) receptors was twice that obtained with alpha(1)beta(2)gamma(2)(c-Myc), suggesting that there are 2x alpha-, 2x beta-, and 1x gamma-subunits in a receptor monomer, This observation was extended using fluorescence energy transfer. Receptors were half-maximally saturated with EuK-anti-c-Myc mAb, and the remaining alpha(1)(c-Myc) subunits were labeled with excess anti-c-Myc mAb derivatized with the fluorescence energy acceptor, XL665. On exposure to laser light, energy transfer from EuK to XL665 occurred with alpha(1)(c-Myc)beta(2)gamma(2) and alpha(1)beta(2)(c-Myc)gamma(2), but no significant energy transfer was observed with alpha(1)beta(2)gamma(2)(c-Myc) receptors, indicating the absence of a second gamma-subunit in a receptor monomer, We confirm that the GABA, receptor subtype, alpha(1)beta(2)gamma(2), is composed of two copies each of the alpha- and beta-subunits and one copy of the gamma-subunit (i,e, (alpha(1)),(beta(2))(2)(gamma(2))(1)) and conclude that this method would have general applicability to other multisubunit cell surface proteins.	Merck Sharp & Dohme Res Labs, Dept Biochem & Mol Biol, Harlow CM20 2QR, Essex, England	Merck & Company	McKernan, RM (corresponding author), Merck Sharp & Dohme Res Labs, Dept Biochem & Mol Biol, Terlings Pk,Eastwick Rd, Harlow CM20 2QR, Essex, England.			Whiting, Paul/0000-0002-4121-1379				ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; BACKUS KH, 1993, NEUROREPORT, V5, P285, DOI 10.1097/00001756-199312000-00026; Chang YC, 1996, J NEUROSCI, V16, P5415; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; Damjanovich S, 1997, P NATL ACAD SCI USA, V94, P13134, DOI 10.1073/pnas.94.24.13134; DUGGAN MJ, 1991, J BIOL CHEM, V266, P24778; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; HADINGHAM KL, 1992, P NATL ACAD SCI USA, V89, P6378, DOI 10.1073/pnas.89.14.6378; IM WB, 1995, J BIOL CHEM, V270, P26063, DOI 10.1074/jbc.270.44.26063; KHAN ZU, 1994, J NEUROCHEM, V63, P1466; LUDDENS H, 1991, J RECEPTOR RES, V11, P523; MAMALAKI C, 1989, J NEUROCHEM, V52, P124, DOI 10.1111/j.1471-4159.1989.tb10906.x; MATHIS G, 1995, CLIN CHEM, V41, P1391; MCKERNAN RM, 1991, NEURON, V7, P667, DOI 10.1016/0896-6273(91)90379-E; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; MERTENS S, 1993, J BIOL CHEM, V268, P5965; NAYEEM N, 1994, J NEUROCHEM, V62, P815; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; QUIRK K, 1994, MOL PHARMACOL, V45, P1061; RAFTERY MA, 1980, SCIENCE, V208, P1454, DOI 10.1126/science.7384786; THOMAS DD, 1978, P NATL ACAD SCI USA, V75, P5746, DOI 10.1073/pnas.75.12.5746; Tretter V, 1997, J NEUROSCI, V17, P2728; WINGROVE PB, 1994, P NATL ACAD SCI USA, V91, P4569, DOI 10.1073/pnas.91.10.4569; Wingrove PB, 1997, MOL PHARMACOL, V52, P874, DOI 10.1124/mol.52.5.874; ZEZULA J, 1991, FEBS LETT, V284, P15, DOI 10.1016/0014-5793(91)80750-W	26	214	221	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10100	10104		10.1074/jbc.274.15.10100	http://dx.doi.org/10.1074/jbc.274.15.10100			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187791	hybrid			2022-12-27	WOS:000079663500030
J	Green, J; Marshall, FA				Green, J; Marshall, FA			Identification of a surface of FNR overlapping activating region 1 that is required for repression of gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI FNR; TRANSCRIPTION ACTIVATION; CLASS-I; DEPENDENT PROMOTERS; PROTEIN; CONTACT; SITE	A library of Escherichia coli fnr mutants has been screened to identify FNR (regulator of fumarate and nitrate reduction) variants that are defective repressors, but competent activators. All but one of seventeen variants had substitutions close to or within the face of FNR that contains activating region 1 (AR1). Activating region 1 is known to contact the alpha subunit of RNA polymerase to facilitate transcription activation. It is now evident that this face also has a role in FNR-mediated repression. Single amino acid substitutions at Lys(54), Gly(74), Ala(95), Met(147), Leu(193), Arg(197), or Leu(239), and double substitutions at Ser(13) and Ser(145), Cys(16) and Ile(45), Tyr(69) and Ser(133), or Lys(164) and Phe(191), impaired FNR-mediated repression of ndh without greatly affecting activation from model Class I (FNR site at -71.5) and Class II (FNR site at -41.5) FNR-activated promoters. Although repression was impaired in a second group of FNR variants with substitutions at Leu(34), Arg(7) and Leul(193), Phe(92), or Ser(178), transcription activation from the simple FNR-dependent promoters was severely reduced. However, expression from pyfiD (FNR sites at -40.5 and -93.5) and a derivative lacking the site at -93.5, pyfiD-/+, remained relatively high indicating that this second group have a context-dependent activation defect as well as a repression defect. The prediction that the substitutions affecting repression were likely to be in solvent exposed regions of FNR was supported by analysis of peptides produced by partial proteolysis of FNR. Thus, FNR-mediated repression at promoters with multiple FNR sites requires regions of FNR that are different from, but overlap, AR1.	Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Green, J (corresponding author), Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.							BELL A, 1994, MOL MICROBIOL, V11, P383, DOI 10.1111/j.1365-2958.1994.tb00318.x; CHOY H, 1996, ESCHERICHIA COLI SAL; COLE ST, 1980, MOL GEN GENET, V178, P409, DOI 10.1007/BF00270492; Green J, 1998, MOL MICROBIOL, V29, P1113, DOI 10.1046/j.1365-2958.1998.01002.x; Green J, 1997, MICROBIOL-SGM, V143, P3785, DOI 10.1099/00221287-143-12-3785; GREEN J, 1994, MOL MICROBIOL, V12, P433, DOI 10.1111/j.1365-2958.1994.tb01032.x; Green J, 1996, MOL MICROBIOL, V19, P125, DOI 10.1046/j.1365-2958.1996.353884.x; Green J, 1997, MOL MICROBIOL, V24, P593, DOI 10.1046/j.1365-2958.1997.3801737.x; Guest John R., 1996, P317; Meng WM, 1997, MICROBIOL-SGM, V143, P1521, DOI 10.1099/00221287-143-5-1521; Miller J. H, 1972, EXPT MOL GENETICS; Ralph ET, 1998, P NATL ACAD SCI USA, V95, P10449, DOI 10.1073/pnas.95.18.10449; Roy S, 1998, J BIOL CHEM, V273, P14059, DOI 10.1074/jbc.273.23.14059; Savery N, 1996, PHILOS T ROY SOC B, V351, P543, DOI 10.1098/rstb.1996.0053; SHARROCKS AD, 1991, P ROY SOC B-BIOL SCI, V245, P219, DOI 10.1098/rspb.1991.0113; SPIRO S, 1987, J GEN MICROBIOL, V133, P3279; TAKAHASHI K, 1994, FEBS LETT, V340, P59, DOI 10.1016/0014-5793(94)80173-8; Tran QH, 1997, EUR J BIOCHEM, V244, P155, DOI 10.1111/j.1432-1033.1997.00155.x; Williams SM, 1997, NUCLEIC ACIDS RES, V25, P4028, DOI 10.1093/nar/25.20.4028; Williams SM, 1998, FEMS MICROBIOL LETT, V163, P203, DOI 10.1111/j.1574-6968.1998.tb13046.x; WING HJ, 1995, J BACTERIOL, V177, P6704, DOI 10.1128/jb.177.23.6704-6710.1995; ZHOU YH, 1994, J MOL BIOL, V243, P603, DOI 10.1016/0022-2836(94)90035-3	22	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10244	10248		10.1074/jbc.274.15.10244	http://dx.doi.org/10.1074/jbc.274.15.10244			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187810	hybrid			2022-12-27	WOS:000079663500049
J	Kim, CY; Takahashi, K; Nguyen, TB; Roberts, JKM; Webster, C				Kim, CY; Takahashi, K; Nguyen, TB; Roberts, JKM; Webster, C			Identification of a nucleic acid binding domain in eukaryotic initiation factor eIFiso4G from wheat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS INITIATION; FACTOR 4G EIF4G; MESSENGER-RNA; ISOZYME FORM; 7-METHYLGUANOSINE 5'-TRIPHOSPHATE; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL DOMAINS; ELONGATION-FACTORS; FACTOR EIF-4-GAMMA; FACTOR EIF-4E	Higher plants have two complexes that bind the m (7)G-cap structure of mRNA and mediate interactions between mRNA and ribosomal subunits, designated eIF4F and eIFiso4F. Both complexes contain a small subunit that binds the 5'-cap structure of mRNA, and a large subunit, eIF4G or eIFiso4G, that binds other translation factors and RNA. Sequence-specific proteases were used to cleave native cap-binding complexes into structural domains, which were purified by affinity chromatography. We show here that eIFiso4G contains a central protease-resistant domain that binds specifically to nucleic acids. This domain spans Gln(170) to Glu(443) and includes four of the six homology blocks shared by eIFiso4G and eIF4G. A slightly shorter overlapping sequence, from Gly(202) to Lys(445), had no nucleic acid binding activity, indicating that the N-terminal end of the nucleic acid binding site lies within Gln(170) to Arg(201). The binding of the central domain and native eIFiso4F to RNA homopolymers and double- and single-stranded DNAs was studied. Both molecules had highest affinity for poly(G) and recognized single- and double-stranded sequences.	Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Webster, C (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.			Kim, Chang-Yub/0000-0001-9353-5909				ALLEN ML, 1992, J BIOL CHEM, V267, P23232; ALTMANN M, 1995, EMBO J, V14, P3820, DOI 10.1002/j.1460-2075.1995.tb00051.x; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BOKROS CL, 1995, P NATL ACAD SCI USA, V92, P7120, DOI 10.1073/pnas.92.15.7120; BROWNING KS, 1987, J BIOL CHEM, V262, P11228; BROWNING KS, 1992, J BIOL CHEM, V267, P10096; BROWNING KS, 1990, J BIOL CHEM, V265, P17967; Browning KS, 1996, PLANT MOL BIOL, V32, P107, DOI 10.1007/BF00039380; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CHAVAN AJ, 1990, BIOCHEMISTRY-US, V29, P5521, DOI 10.1021/bi00475a016; GALLIE DR, 1994, J BIOL CHEM, V269, P17166; GEISLER N, 1977, BIOCHEMISTRY-US, V16, P938, DOI 10.1021/bi00624a020; Genetic Computer Group, 1994, PROGR MAN WISC PACK; GOYER C, 1993, MOL CELL BIOL, V13, P4860, DOI 10.1128/MCB.13.8.4860; Gradi A, 1998, MOL CELL BIOL, V18, P334, DOI 10.1128/MCB.18.1.334; HERSHEY JWB, 1994, BIOCHIMIE, V76, P845; HUDGAHL JD, 1995, PLANT CELL, V7, P2129; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; LANG V, 1994, J BIOL CHEM, V269, P6117; LAX S, 1985, P NATL ACAD SCI USA, V82, P330, DOI 10.1073/pnas.82.2.330; LAX SR, 1986, METHOD ENZYMOL, V118, P109; LAZARISKARATZAS A, 1992, MOL CELL BIOL, V12, P1234, DOI 10.1128/MCB.12.3.1234; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; LEJBKOWICZ F, 1992, P NATL ACAD SCI USA, V89, P9612, DOI 10.1073/pnas.89.20.9612; LOOMIS W.D., 1969, METHOD ENZYMOL, V13, P555; MADER S, 1995, MOL CELL BIOL, V15, P4990; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Metz AM, 1996, J BIOL CHEM, V271, P31033, DOI 10.1074/jbc.271.49.31033; OHLMANN T, 1995, NUCLEIC ACIDS RES, V23, P334; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; ROSENWALD IB, 1995, J BIOL CHEM, V270, P21176, DOI 10.1074/jbc.270.36.21176; SHA M, 1995, J BIOL CHEM, V270, P29904; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; YAN RQ, 1992, J BIOL CHEM, V267, P23226	38	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10603	10608		10.1074/jbc.274.15.10603	http://dx.doi.org/10.1074/jbc.274.15.10603			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187856	hybrid			2022-12-27	WOS:000079663500095
J	Mirochnitchenko, O; Weisbrot-Lefkowitz, M; Reuhl, K; Chen, LS; Yang, C; Inouye, M				Mirochnitchenko, O; Weisbrot-Lefkowitz, M; Reuhl, K; Chen, LS; Yang, C; Inouye, M			Acetaminophen toxicity - Opposite effects of two forms of glutathione peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; INDUCED HEPATOTOXICITY; LIPID-PEROXIDATION; BENZOQUINONE IMINE; TRANSGENIC MICE; RAT-LIVER; PARACETAMOL; MECHANISM; CATALASE	Acetaminophen is one of the most extensively used analgesics/antipyretics worldwide, and overdose or idiopathic reaction causes major morbidity and mortality in its victims. Research into the mechanisms of toxicity and possible therapeutic intervention is therefore essential. In this study, the response of transgenic mice overexpressing human antioxidant enzymes to acute acetaminophen overdose was investigated. Animals overexpressing superoxide dismutase or plasma glutathione peroxidase demonstrated dramatic resistance to acetaminophen toxicity. Intravenous injection of glutathione peroxidase provided normal mice with nearly complete protection against a lethal dose of acetaminophen. Surprisingly, animals overexpressing intracellular glutathione peroxidase in the liver were significantly more sensitive to acetaminophen toxicity compared with nontransgenic littermates. This sensitivity appears to be due to the inability of these animals to efficiently recover glutathione depleted as a result of acetaminophen metabolism. Finally, the results suggest that glutathione peroxidase overexpression modulates the synthesis of several acetaminophen metabolites. Our results demonstrate the ability of glutathione peroxidase levels to influence the outcome of acetaminophen toxicity.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; Rutgers State Univ, Coll Pharm, Neurotoxicol Labs, Piscataway, NJ 08854 USA; Rutgers State Univ, Coll Pharm, Canc Res Lab, Dept Biol Chem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Inouye, M (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Lane, Piscataway, NJ 08854 USA.	inouye@rwja.umdnj.edu						AMIMOTO T, 1995, FREE RADICAL BIO MED, V19, P169, DOI 10.1016/0891-5849(94)00233-A; ARNAIZ SL, 1995, FREE RADICAL BIO MED, V19, P303, DOI 10.1016/0891-5849(95)00023-Q; BARANOWITZ SA, 1994, INT J VITAM NUTR RES, V65, P1175; BJORNSTEDT M, 1994, J BIOL CHEM, V269, P29382; Gibson JD, 1996, CHEM RES TOXICOL, V9, P580, DOI 10.1021/tx950153d; Goldin RD, 1996, J PATHOL, V179, P432; JOLLOW DJ, 1974, PHARMACOLOGY, V12, P251, DOI 10.1159/000136547; KELLER RJ, 1991, DRUG METAB DISPOS, V19, P184; KYLE ME, 1987, BIOCHEM BIOPH RES CO, V149, P889, DOI 10.1016/0006-291X(87)90491-8; Lin M C, 1996, J Biochem Toxicol, V11, P11, DOI 10.1002/(SICI)1522-7146(1996)11:1<11::AID-JBT2>3.0.CO;2-Y; MASON RP, 1986, FED PROC, V45, P2493; MASUGI F, 1976, INT J VITAM NUTR RES, V46, P187; MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5; Mirochnitchenko O, 1996, J IMMUNOL, V156, P1578; MIROCHNITCHENKO O, 1995, P NATL ACAD SCI USA, V92, P8120, DOI 10.1073/pnas.92.18.8120; MOHANDAS J, 1981, TOXICOL APPL PHARM, V61, P252, DOI 10.1016/0041-008X(81)90415-4; NAKAE D, 1990, AM J PATHOL, V136, P787; NAKAMURA M, 1989, J BIOL CHEM, V264, P12909; Nakatani T, 1997, EXP CELL RES, V236, P137, DOI 10.1006/excr.1997.3715; OZDEMIRLER G, 1994, J APPL TOXICOL, V14, P297, DOI 10.1002/jat.2550140410; Pirmohamed M, 1996, CLIN PHARMACOKINET, V31, P215, DOI 10.2165/00003088-199631030-00005; POTTER DW, 1987, J BIOL CHEM, V262, P966; RAVINDRANATH V, 1994, METHOD ENZYMOL, V233, P610; ROSEN GM, 1984, MOL PHARMACOL, V25, P151; SCHMITT K, 1990, PHOTOCHEM PHOTOBIOL, V51, P719, DOI 10.1111/php.1990.51.6.719; Smith CV, 1996, TOXICOL APPL PHARM, V140, P1, DOI 10.1006/taap.1996.0191; THOMAS SHL, 1993, PHARMACOL THERAPEUT, V60, P91, DOI 10.1016/0163-7258(93)90023-7; TOUSSAINT O, 1993, TOXICOLOGY, V81, P89, DOI 10.1016/0300-483X(93)90001-9; VENDEMIALE G, 1995, HEPATOLOGY, V21, P1450, DOI 10.1002/hep.1840210532; VERMEULEN NPE, 1992, DRUG METAB REV, V24, P367, DOI 10.3109/03602539208996298; Yagi K, 1996, BIOCHEM BIOPH RES CO, V219, P486, DOI 10.1006/bbrc.1996.0260	31	92	100	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10349	10355		10.1074/jbc.274.15.10349	http://dx.doi.org/10.1074/jbc.274.15.10349			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187823	hybrid			2022-12-27	WOS:000079663500062
J	Steinert, PM; Chou, YH; Prahlad, V; Parry, DAD; Marekov, LN; Wu, KC; Jang, SI; Goldman, RD				Steinert, PM; Chou, YH; Prahlad, V; Parry, DAD; Marekov, LN; Wu, KC; Jang, SI; Goldman, RD			A high molecular weight intermediate filament-associated protein in BHK-21 cells is nestin, a type VI intermediate filament protein - Limited co-assembly in vitro to form heteropolymers with type III vimentin and type IV alpha-internexin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL; NF-L; END DOMAINS; ROD DOMAIN; IN-VIVO; INVITRO; EXPRESSION; MOUSE; RAT; GENE	BHK-21 fibroblasts contain type III vimentin/desmin intermediate filament (IF) proteins that typically coisolate and co-cycle in in vitro experiments with certain high molecular weight proteins. Here, we report purification of one of these and demonstrate that it is in fact the type VI IF protein nestin, Nestin is expressed in several fibroblastic but not epithelioid cell lines. We show that nestin forms homodimers and homotetramers but does not form IF by itself in vitro, In mixtures, nestin preferentially co-assembles with purified vimentin or the type IV IF protein alpha-internexin to form heterodimer coiled-coil molecules. These molecules may co-assemble into 10 nm IF provided that the total amount of nestin does not exceed about 25%. However, nestin does not dimerize with types I/II keratin IF chains. The bulk of the nestin protein consists of a long carboxyl-terminal tail composed of various highly charged peptide repeats. By analogy with the larger neurofilament chains, we postulate that these sequences serve as cross-bridgers or spacers between IF and/or other cytoskeletal constituents. In this way, we propose that direct incorporation of modest amounts of nestin into the backbone of cytoplasmic types III and IV Ifs affords a simple yet flexible method for the regulation of their dynamic supramolecular organization and function in cells.	NIAMSD, Skin Biol Lab, NIH, Bethesda, MD 20892 USA; Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Northwestern University; Massey University	Steinert, PM (corresponding author), NIAMSD, Skin Biol Lab, NIH, Bldg 6,Rm 425,9000 Rockville Pike, Bethesda, MD 20892 USA.	pemast@helix.nih.gov		Prahlad, Veena/0000-0002-0413-6074	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036806, R01GM036806] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM36806-4] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], [No title captured]; Athlan ES, 1997, J NEUROSCI RES, V47, P300; Athlan ES, 1997, J BIOL CHEM, V272, P31073, DOI 10.1074/jbc.272.49.31073; Ausubel FM, 1991, CURRENT PROTOCOLS MO; AYNARDI MW, 1984, J CELL BIOL, V98, P1407, DOI 10.1083/jcb.98.4.1407; BECKER B, 1995, BIOCHEM BIOPH RES CO, V213, P796, DOI 10.1006/bbrc.1995.2200; Candi E, 1998, P NATL ACAD SCI USA, V95, P2067, DOI 10.1073/pnas.95.5.2067; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; Carpenter DA, 1996, J CELL SCI, V109, P2493; CHING GY, 1993, J CELL BIOL, V122, P1323, DOI 10.1083/jcb.122.6.1323; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CHUI FC, 1989, NEURON, V2, P1435; COHLBERG JA, 1995, J BIOL CHEM, V270, P9334, DOI 10.1074/jbc.270.16.9334; CONWAY JF, 1990, INT J BIOL MACROMOL, V12, P328, DOI 10.1016/0141-8130(90)90023-4; DAHLSTRAND J, 1992, J CELL SCI, V103, P589; FLIEGNER KH, 1994, J COMP NEUROL, V342, P161, DOI 10.1002/cne.903420202; Frojdman K, 1997, DIFFERENTIATION, V61, P243, DOI 10.1046/j.1432-0436.1997.6140243.x; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; GREEN KJ, 1990, J BIOL CHEM, V265, P2603; HATZFELD M, 1990, J CELL BIOL, V110, P1199, DOI 10.1083/jcb.110.4.1199; HEINS S, 1993, J CELL BIOL, V123, P1517, DOI 10.1083/jcb.123.6.1517; Hemken PM, 1997, J BIOL CHEM, V272, P32489, DOI 10.1074/jbc.272.51.32489; HEMMATIBRIVANLOU A, 1992, NEURON, V9, P417, DOI 10.1016/0896-6273(92)90180-L; HIROKAWA N, 1984, J CELL BIOL, V98, P1523, DOI 10.1083/jcb.98.4.1523; HISANAGA S, 1988, J MOL BIOL, V202, P297, DOI 10.1016/0022-2836(88)90459-7; HOULE J, 1983, DEV BRAIN RES, V9, P189, DOI 10.1016/0165-3806(83)90051-2; IP W, 1985, J MOL BIOL, V183, P365, DOI 10.1016/0022-2836(85)90007-5; KACHINSKY AM, 1995, J HISTOCHEM CYTOCHEM, V43, P843, DOI 10.1177/43.8.7542682; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JH, 1996, J BIOL CHEM, V271, P4561; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Liem RKH, 1993, CURR OPIN CELL BIOL, V5, P12, DOI 10.1016/S0955-0674(05)80003-1; LIESKA N, 1985, J CELL BIOL, V101, P802, DOI 10.1083/jcb.101.3.802; LIN RCS, 1995, NEUROBIOL DIS, V2, P79, DOI 10.1006/nbdi.1995.0008; MACK JW, 1993, J MOL BIOL, V232, P50, DOI 10.1006/jmbi.1993.1369; Meng JJ, 1997, J BIOL CHEM, V272, P21495, DOI 10.1074/jbc.272.34.21495; PACHTER JS, 1985, J CELL BIOL, V101, P1316, DOI 10.1083/jcb.101.4.1316; PARRY DAD, 1975, J MOL BIOL, V98, P519, DOI 10.1016/S0022-2836(75)80084-2; PARRY DAD, 1995, INTERMEDIATE FILAMEN; PARYSEK LM, 1987, J NEUROSCI, V7, P781; PARYSEK LM, 1991, J NEUROSCI RES, V30, P80, DOI 10.1002/jnr.490300110; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360; PRICE MG, 1983, J CELL BIOL, V97, P1860, DOI 10.1083/jcb.97.6.1860; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; STARGER JM, 1978, J CELL BIOL, V78, P93, DOI 10.1083/jcb.78.1.93; STEINERT PM, 1978, J MOL BIOL, V123, P49, DOI 10.1016/0022-2836(78)90376-5; STEINERT PM, 1991, J STRUCT BIOL, V107, P175, DOI 10.1016/1047-8477(91)90020-W; STEINERT PM, 1980, P NATL ACAD SCI-BIOL, V77, P4534, DOI 10.1073/pnas.77.8.4534; STEINERT PM, 1990, J BIOL CHEM, V265, P8766; STEINERT PM, 1990, CELL, V60, P521, DOI 10.1016/0092-8674(90)90651-T; Steinert PM, 1999, J BIOL CHEM, V274, P1657, DOI 10.1074/jbc.274.3.1657; STEINERT PM, 1978, P NATL ACAD SCI USA, V75, P6098, DOI 10.1073/pnas.75.12.6098; STEINERT PM, 1981, P NATL ACAD SCI-BIOL, V78, P3692, DOI 10.1073/pnas.78.6.3692; TANAKA T, 1991, J BIOL CHEM, V266, P12555; TAPSCOTT SJ, 1981, DEV BIOL, V86, P40, DOI 10.1016/0012-1606(81)90313-4; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Terling C, 1995, INT J DEV BIOL, V39, P947; VANDENHEUVEL RMM, 1987, J CELL SCI, V88, P475; WEINBERG WC, 1993, J INVEST DERMATOL, V100, P229, DOI 10.1111/1523-1747.ep12468971; WICHE G, 1991, J CELL BIOL, V114, P83, DOI 10.1083/jcb.114.1.83; WONG J, 1990, J NEUROSCI RES, V27, P332, DOI 10.1002/jnr.490270312; Wroblewski J, 1997, DIFFERENTIATION, V61, P151, DOI 10.1046/j.1432-0436.1997.6130151.x; YANG HY, 1992, CELL MOTIL CYTOSKEL, V22, P185, DOI 10.1002/cm.970220306; YANG HY, 1985, J CELL BIOL, V100, P620, DOI 10.1083/jcb.100.2.620; YUSPA SH, 1974, EXP CELL RES, V86, P95, DOI 10.1016/0014-4827(74)90653-3	70	150	160	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9881	9890		10.1074/jbc.274.14.9881	http://dx.doi.org/10.1074/jbc.274.14.9881			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092680	hybrid			2022-12-27	WOS:000079451800099
J	Shinohara, H; Balboa, MA; Johnson, CA; Balsinde, J; Dennis, EA				Shinohara, H; Balboa, MA; Johnson, CA; Balsinde, J; Dennis, EA			Regulation of delayed prostaglandin production in activated P388D(1) macrophages by Group IV cytosolic and Group V secretory phospholipase A(2)s	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID MOBILIZATION; MAST-CELLS; D-2 GENERATION; E-2 GENERATION; EXPRESSION; INHIBITION; SYNTHASE-2; METABOLISM; ENZYMES; IIA	Group V secretory phospholipase A(2) (sPLA(2)) rather than Group IIA sPLA(2) is involved in short term, immediate arachidonic acid mobilization and prostaglandin E-2 (PGE(2)) production in the macrophage-like cell line P388D(1). When a new clone of these cells, P388D(1)/MAB, selected on the basis of high responsivity to lipopolysaccharide plus platelet-activating factor, was studied, delayed PGE(2) production (6-24 h) in response to lipopolysaccharide alone occurred in parallel with the induction of Group V sPLA(2) and cyclooxygenase-a (COX-2), No changes in the level of cytosolic phospholipase A(2) (cPLA(2)) or COX-1 were observed, and Group IIA sPLA(2) was not detectable. Use of a potent and selective sPLA(2) inhibitor, 3-(3-acetamide 1-benzyl-2-ethylindolyl-5-oxy)-propanesulfonic acid (LY311727), and an antisense oligonucleotide specific for Group V sPLA(2) revealed that delayed PGE, was largely dependent on the induction of Group V sPLA(2). Also, COX-2, not COX-1, was found to mediate delayed PGE(2) production because the response was completely blocked by the specific COX-2 inhibitor NS-398, Delayed PGE(2) production and Group V sPLA(2) expression were also found to be blunted by the inhibitor methylarachidonyl fluorophosphonate, Because inhibition of Ca2+-independent PLA(2) by an antisense technique did not have any effect on the arachidonic acid release, the data using methylarachidonyl fluorophosphonate suggest a key role for the cPLA(2) in the response as well. Collectively, the results suggest a model whereby cPLA(2) activation regulates Group V sPLA(2) expression, which in turn is responsible for delayed PGE(2) production via COX-2.	Univ Calif San Diego, Sch Med, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Revelle Coll, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Dennis, EA (corresponding author), Univ Calif San Diego, Sch Med, Dept Chem & Biochem, La Jolla, CA 92093 USA.		Dennis, Edward A./M-5554-2019; Balboa, María A./V-9493-2018; Balsinde, Jesús/C-7833-2018	Dennis, Edward A./0000-0003-3738-3140; Balboa, María A./0000-0002-2130-5298; Balsinde, Jesús/0000-0002-4157-6714	NICHD NIH HHS [HD 26171] Funding Source: Medline; NIGMS NIH HHS [GM 20501] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026171] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Balboa MA, 1996, J BIOL CHEM, V271, P32381, DOI 10.1074/jbc.271.50.32381; Balsinde J, 1996, EUR J BIOCHEM, V235, P480, DOI 10.1111/j.1432-1033.1996.00480.x; Balsinde J, 1998, P NATL ACAD SCI USA, V95, P7951, DOI 10.1073/pnas.95.14.7951; Balsinde J, 1997, BIOCHEM J, V321, P805, DOI 10.1042/bj3210805; BALSINDE J, 1994, P NATL ACAD SCI USA, V91, P11060, DOI 10.1073/pnas.91.23.11060; BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; Bingham CO, 1996, J BIOL CHEM, V271, P25936, DOI 10.1074/jbc.271.42.25936; Chen YJ, 1998, BBA-LIPID LIPID MET, V1394, P57, DOI 10.1016/S0005-2760(98)00098-8; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; GLASER KB, 1990, J BIOL CHEM, V265, P8658; Herschman HR, 1996, BBA-LIPID LIPID MET, V1299, P125, DOI 10.1016/0005-2760(95)00194-8; Kuwata H, 1998, J BIOL CHEM, V273, P1733, DOI 10.1074/jbc.273.3.1733; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Lio YC, 1996, BBA-LIPID LIPID MET, V1302, P55, DOI 10.1016/0005-2760(96)00002-1; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 1996, J BIOL CHEM, V271, P30041, DOI 10.1074/jbc.271.47.30041; Murakami M, 1997, J BIOL CHEM, V272, P19891, DOI 10.1074/jbc.272.32.19891; MURAKAMI M, 1995, J BIOL CHEM, V270, P3239, DOI 10.1074/jbc.270.7.3239; Murakami M, 1997, CRIT REV IMMUNOL, V17, P225, DOI 10.1615/CritRevImmunol.v17.i3-4.10; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Reddy ST, 1997, J BIOL CHEM, V272, P3231, DOI 10.1074/jbc.272.6.3231; SCHEVITZ RW, 1995, NAT STRUCT BIOL, V2, P458, DOI 10.1038/nsb0695-458; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Surette ME, 1998, BIOCHEM J, V330, P915; Tischfield JA, 1997, J BIOL CHEM, V272, P17247, DOI 10.1074/jbc.272.28.17247	27	142	143	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12263	12268		10.1074/jbc.274.18.12263	http://dx.doi.org/10.1074/jbc.274.18.12263			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212194	hybrid, Green Published			2022-12-27	WOS:000080056800014
J	Dhanabal, M; Ramchandran, R; Waterman, MJF; Lu, H; Knebelmann, B; Segal, M; Sukhatme, VP				Dhanabal, M; Ramchandran, R; Waterman, MJF; Lu, H; Knebelmann, B; Segal, M; Sukhatme, VP			Endostatin induces endothelial cell apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLOW CYTOMETRIC DETECTION; ANNEXIN-V; PHOSPHATIDYLSERINE EXPRESSION; SOLID TUMORS; BCL-2; ANGIOGENESIS; DEATH; VASCULATURE; THERAPY; BAX	Endostatin, a carboxyl-terminal fragment of collagen XVIII, has been shown to regress tumors in mice. In this study, we have analyzed the mechanism of endostatin action on endothelial cells and nonendothelial cells. Endostatin treatment of cow pulmonary artery endothelial cells caused apoptosis, as demonstrated by three methods, annexin V-fluorescein isothiocyanate staining, caspase 3, and terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling assay. Moreover, addition of endostatin led to a marked reduction of the Bcl-2 and Bcl-X-L anti-apoptotic protein, whereas Bax protein levels were unaffected. These effects were not seen in several nonendothelial cells. Collectively, these findings provide important mechanistic insight into endostatin action.	Beth Israel Deaconess Med Ctr, Dept Med, Div Renal, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Sukhatme, VP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Renal, Dana 517,330 Brookline Ave, Boston, MA 02215 USA.	vsukhatm@bidmc.harvard.edu	Sukhatme, Vikas/W-2776-2019					Allen RT, 1998, CELL MOL LIFE SCI, V54, P427, DOI 10.1007/s000180050171; BAILLIE CT, 1995, BRIT J CANCER, V72, P257, DOI 10.1038/bjc.1995.323; BICKNELL R, 1994, ANN ONCOL, V5, pS45, DOI 10.1093/annonc/5.suppl_4.S45; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; BURROWS FJ, 1994, PHARMACOL THERAPEUT, V64, P155, DOI 10.1016/0163-7258(94)90037-X; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Cho JH, 1998, PATHOL RES PRACT, V194, P309, DOI 10.1016/S0344-0338(98)80054-X; Claesson-Welsh L, 1998, P NATL ACAD SCI USA, V95, P5579, DOI 10.1073/pnas.95.10.5579; Dhanabal M, 1999, CANCER RES, V59, P189; FAN TPD, 1995, TRENDS PHARMACOL SCI, V16, P57, DOI 10.1016/S0165-6147(00)88979-8; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Jacobson MD, 1997, CURR BIOL, V7, pR277, DOI 10.1016/S0960-9822(06)00136-9; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Newton K, 1998, CURR OPIN GENET DEV, V8, P68, DOI 10.1016/S0959-437X(98)80064-6; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; THORPE PE, 1995, BREAST CANCER RES TR, V36, P237, DOI 10.1007/BF00666044; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01	26	510	614	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11721	11726		10.1074/jbc.274.17.11721	http://dx.doi.org/10.1074/jbc.274.17.11721			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206987	hybrid			2022-12-27	WOS:000079834800043
J	Obin, M; Mesco, E; Gong, X; Haas, AL; Joseph, J; Taylor, A				Obin, M; Mesco, E; Gong, X; Haas, AL; Joseph, J; Taylor, A			Neurite outgrowth in PC12 cells - Distinguishing the roles of ubiquitylation and ubiquitin-dependent proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END RULE PATHWAY; NERVE GROWTH-FACTOR; PROTEIN-DEGRADATION; CONJUGATING ENZYMES; NEURONAL DIFFERENTIATION; PROTEASOME; GENE; LACTACYSTIN; INHIBITORS; COMPLEX	Nerve growth factor (NGF)-induced neurite outgrowth from rat PC12 cells was coincident with elevated (ra-fold) levels of endogenous ubiquitin (Ub) protein conjugates, elevated rates of formation of I-125-labeled Ub similar to E1 (Ub-activating enzyme) thiol esters and I-125-labeled Ub similar to E2 (Ub carrier protein) thiol esters in vitro, and enhanced capacity to synthesize I-125-labeled Ub-protein conjugates de novo. Activities of at least four E2s were increased in NGF-treated cells, including E2(14K), a component of the N-end rule pathway. Ubiquitylation of I-125-labeled beta-lactoglobulin was up to 4-fold greater in supernatants from NGF-treated cells versus untreated cells and was selectively inhibited by the dipeptide Leu-Ala, an inhibitor of Ub isopeptide ligase (E3), However, Uh-dependent proteolysis of I-125-labeled beta-lactoglobulin was not increased in supernatants from NGF-treated cells, suggesting that neurite outgrowth is promoted by enhanced rates of synthesis (rather than degradation) of Uh-protein conjugates, Consistent with this observation, neurite outgrowth was induced by proteasome inhibitors (lactacystin and clasto-lactacystin beta-lactone) and was associated with elevated levels of ubiquitylated protein and stabilization of the Uh-dependent substrate, p53. Lactacystin-induced neurite outgrowth was blocked by the dipeptide Leu-Ala (2 mM) but not by His-Ala These data 1) demonstrate that the enhanced pool of ubiquitylated protein observed during neuritogenesis in PC12 cells reflects coordinated up-regulation of Ub-conjugating activity, 2) suggest that Ub-dependent proteolysis is a negative regulator of neurite outgrowth in vitro, and 3) support a role for E2(14K)/E3-mediated protein ubiquitylation in PC12 cell neurite outgrowth.	Tufts Univ, JMUSDA, HNRCA, Lab Nutr & Vis Res, Boston, MA 02111 USA; Tufts Univ, JMUSDA, HNRCA, Neurosci Lab, Boston, MA 02111 USA; Savannah State Univ, Dept Biol & Life Sci, Savannah, GA 31404 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Tufts University; United States Department of Agriculture (USDA); Tufts University; United States Department of Agriculture (USDA); University System of Georgia; Savannah State University; Medical College of Wisconsin	Obin, M (corresponding author), Tufts Univ, JMUSDA, HNRCA, Lab Nutr & Vis Res, 711 Washington St, Boston, MA 02111 USA.				NEI NIH HHS [EY11703] Funding Source: Medline; NIGMS NIH HHS [GM34009] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIELLO LP, 1986, BIOCHEMISTRY-US, V25, P3944, DOI 10.1021/bi00361a031; BAKER RT, 1991, P NATL ACAD SCI USA, V88, P1090, DOI 10.1073/pnas.88.4.1090; BONFANTI L, 1992, J COMP NEUROL, V322, P35, DOI 10.1002/cne.903220104; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; FAHRBACH SE, 1994, J COMP NEUROL, V343, P464, DOI 10.1002/cne.903430309; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; FENTEANY G, 1994, P NATL ACAD SCI USA, V91, P3358, DOI 10.1073/pnas.91.8.3358; FIGUEIREDOPEREIRA ME, 1994, J NEUROCHEM, V63, P1578; Flann S, 1997, NEUROSCIENCE, V81, P173, DOI 10.1016/S0306-4522(97)00196-6; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; Haas AL, 1997, FASEB J, V11, P1257; HAAS AL, 1988, J BIOL CHEM, V263, P13268; HAAS AL, 1995, J BIOL CHEM, V270, P9407, DOI 10.1074/jbc.270.16.9407; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HONDERMARCK H, 1992, BIOCHEM BIOPH RES CO, V189, P280, DOI 10.1016/0006-291X(92)91555-5; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; JahngenHodge J, 1997, J BIOL CHEM, V272, P28218, DOI 10.1074/jbc.272.45.28218; Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Maufroid JP, 1996, INT J DEV BIOL, V40, P609; MURALIDHAR MG, 1993, NEURON, V11, P253, DOI 10.1016/0896-6273(93)90182-Q; Obin M, 1998, FASEB J, V12, P561, DOI 10.1096/fasebj.12.7.561; OBIN M, 1995, CURR EYE RES, V14, P751, DOI 10.3109/02713689508995796; Obin MS, 1996, J BIOL CHEM, V271, P14473, DOI 10.1074/jbc.271.24.14473; OH CE, 1994, J NEUROSCI, V14, P3166; OMURA S, 1991, J ANTIBIOT, V44, P113, DOI 10.7164/antibiotics.44.113; PAN ZH, 1993, J NEUROCHEM, V61, P1713, DOI 10.1111/j.1471-4159.1993.tb09808.x; PICKART CM, 1988, J BIOL CHEM, V263, P12028; RECHSTEINER M, 1998, UBIQUITIN BIOL CELL, P147; REISS Y, 1988, J BIOL CHEM, V263, P2693; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SMITHTHOMAS LC, 1994, DEV BRAIN RES, V81, P171, DOI 10.1016/0165-3806(94)90303-4; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; Taban CH, 1996, EXPERIENTIA, V52, P865, DOI 10.1007/BF01938871; TAKADA K, 1994, NEUROCHEM RES, V19, P391, DOI 10.1007/BF00967315; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; TSUBUKI S, 1993, BIOCHEM BIOPH RES CO, V196, P1195, DOI 10.1006/bbrc.1993.2378; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Wang YM, 1997, NEUROCHEM RES, V22, P1453, DOI 10.1023/A:1021998227237; WILKINSON KD, 1995, ANNU REV NUTR, V15, P161, DOI 10.1146/annurev.nu.15.070195.001113; WING SS, 1992, J BIOL CHEM, V267, P6495	45	86	91	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11789	11795		10.1074/jbc.274.17.11789	http://dx.doi.org/10.1074/jbc.274.17.11789			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206996	hybrid			2022-12-27	WOS:000079834800052
J	Witkowski, A; Joshi, AK; Rangan, VS; Falick, AM; Witkowska, HE; Smith, S				Witkowski, A; Joshi, AK; Rangan, VS; Falick, AM; Witkowska, HE; Smith, S			Dibromopropanone cross-linking of the phosphopantetheine and active-site cysteine thiols of the animal fatty acid synthase can occur both inter- and intrasubunit - Reevaluation of the side-by-side, antiparallel subunit model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT MAMMARY-GLAND; MASS-SPECTROMETRY; MULTIFUNCTIONAL ENZYME; MOLECULAR-CLONING; CHICKEN LIVER; IN-VITRO; SYNTHETASE; DOMAINS; CDNA; COMPLEMENTATION	The objective of this study was to test a new model for the homodimeric animal FAS which implies that the condensation reaction can be catalyzed by the aminoterminal beta-ketoacyl synthase domain in cooperation with the penultimate carboxyl-terminal acyl carrier protein domain of either subunit, Treatment of animal fatty acid synthase dimers with dibromopropanone generates three new molecular species with decreased electrophoretic mobilities; none of these species are formed by fatty acid synthase mutant dimers lacking either the active-site cysteine of the beta-ketoacyl synthase domain (C161A) or the phosphopantetheine thiol of the acyl carrier protein domain (S2151A), A double affinity-labeling strategy was used to isolate dimers that carried one or both mutations on one or both subunits; the heterodimers were treated with dibromopropanone and analyzed by a combination of sodium dodecyl sulfate/polyacrylamide gel electrophoresis, Western blotting, gel filtration, and matrix-assisted laser desorption mass spectrometry, Thus the two slowest moving of these species, which accounted for 45 and 15% of the total, were identified as doubly and singly cross-linked dimers, respectively, whereas the fastest moving species, which accounted for 35% of the total, was identified as originating from internally cross-linked subunits, These results show that the two polypeptides of the fatty acid synthase are oriented such that head-to-tail contacts are formed both between and within subunits, and provide the first structural evidence in support of the new model.	Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; PE Biosyst, S San Francisco, CA 94080 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Smith, S (corresponding author), Childrens Hosp Oakland, Res Inst, 747 52nd St, Oakland, CA 94609 USA.			Witkowski, Andrzej/0000-0002-0442-4586	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016073] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK16073] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMY CM, 1989, P NATL ACAD SCI USA, V86, P3114, DOI 10.1073/pnas.86.9.3114; CHANG SI, 1990, ACCOUNTS CHEM RES, V23, P363, DOI 10.1021/ar00179a003; CHANG SI, 1989, P NATL ACAD SCI USA, V86, P8373, DOI 10.1073/pnas.86.21.8373; FERNANDEZPATRON C, 1992, BIOTECHNIQUES, V12, P564; HOLZER KP, 1989, P NATL ACAD SCI USA, V86, P4387, DOI 10.1073/pnas.86.12.4387; Joshi AK, 1998, BIOCHEMISTRY-US, V37, P2515, DOI 10.1021/bi971886v; JOSHI AK, 1993, BIOCHEM J, V296, P143, DOI 10.1042/bj2960143; Joshi AK, 1998, J BIOL CHEM, V273, P4937, DOI 10.1074/jbc.273.9.4937; JOSHI AK, 1993, J BIOL CHEM, V268, P22508; Joshi AK, 1997, BIOCHEMISTRY-US, V36, P2316, DOI 10.1021/bi9626968; KUMAR S, 1970, BIOCHEM BIOPH RES CO, V40, P825, DOI 10.1016/0006-291X(70)90977-0; MOCK KK, 1992, RAPID COMMUN MASS SP, V6, P233, DOI 10.1002/rcm.1290060402; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PETITHORY JR, 1993, BIOCHEM J, V292, P361, DOI 10.1042/bj2920361; Rangan VS, 1998, J BIOL CHEM, V273, P34949, DOI 10.1074/jbc.273.52.34949; SCHWEIZER M, 1989, NUCLEIC ACIDS RES, V17, P567, DOI 10.1093/nar/17.2.567; SINGH N, 1984, J BIOL CHEM, V259, P3605; Smith S, 1975, Methods Enzymol, V35, P65, DOI 10.1016/0076-6879(75)35139-2; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; SMITH S, 1985, EUR J BIOCHEM, V152, P547, DOI 10.1111/j.1432-1033.1985.tb09230.x; SMITH S, 1971, J BIOL CHEM, V246, P6428; STOOPS JK, 1982, J BIOL CHEM, V257, P3230; STOOPS JK, 1981, J BIOL CHEM, V256, P5128; STRUPAT K, 1994, ANAL CHEM, V66, P464, DOI 10.1021/ac00076a008; VESTAL ML, 1995, RAPID COMMUN MASS SP, V9, P1044, DOI 10.1002/rcm.1290091115; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Witkowski A, 1996, BIOCHEMISTRY-US, V35, P10569, DOI 10.1021/bi960910m; WITKOWSKI A, 1991, EUR J BIOCHEM, V198, P571, DOI 10.1111/j.1432-1033.1991.tb16052.x; WITKOWSKI A, 1992, J BIOL CHEM, V267, P18488; Witkowski A, 1997, BIOCHEMISTRY-US, V36, P16338, DOI 10.1021/bi972242q	31	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11557	11563		10.1074/jbc.274.17.11557	http://dx.doi.org/10.1074/jbc.274.17.11557			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206962	hybrid			2022-12-27	WOS:000079834800018
J	Zhu, HJ; Sizeland, AM				Zhu, HJ; Sizeland, AM			A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II RECEPTOR; HETEROOLIGOMERIC COMPLEXES; CYTOPLASMIC DOMAINS; SIGNAL-TRANSDUCTION; EXPRESSION; KINASE; TRANSPHOSPHORYLATION; PHOSPHORYLATION; SUPERFAMILY; PROTEINS	Transforming growth factor-beta (TGF-beta) delivers diverse growth and differentiation signals by binding two distantly related transmembrane serine/threonine kinase receptors: the type I receptor (T beta RI) and the type II receptor (T beta RII), In an attempt to establish the role of the transmembrane domain in receptor signaling, two chimeric TGF-beta receptors, T beta RI-II-I and T beta RII-I-II, containing the opposite transmembrane domain were generated. When transfected into a mutant mink lung epithelial cell line R1B, which lacks functional T beta RI, T beta RI-II-I restored TGF-beta 1-induced transcriptional activation of a TGF-beta reporter p3TP-Lux to similar to 25% of the levels restored by wild-type T beta RI, In the mutant mink lung epithelial cell line DR26, which contains a truncated, nonfunctional T beta RII, wild-type receptor T beta RII restored the TGF-beta responsiveness, while the T beta RII-I-II cDNA was inactive, When both T beta RI and T beta RII were transfected into R1B, DR26, or Mv1Lu cells, a low level of constitutive p3TP-Lux activity was observed. However, cotransfection of both transmembrane chimeric receptors, T beta RI-II-I and T beta RII-I-II, or the wild-type T beta RI with the transmembrane chimeric T beta RII-I-II resulted in high levels of ligand-independent receptor activation. These results suggest that the transmembrane domains of both TGF-beta receptors are essential and play a pivotal role in receptor activation. To investigate the role of the transmembrane domain further, four type II transmembrane mutants were generated: T beta RII Delta-1, T beta RII Delta-2, T beta RII Delta-3, and T beta RII Delta-4, which have one, two, three, or four amino acids deleted at the N terminus of the transmembrane domain, respectively. Interestingly, co expression of T beta RII Delta-1 with the wild-type T beta RI in DR26 cells resulted in high levels of constitutive activation, while only low levels of the activation were observed when T beta RII Delta-2, T beta RII Delta-3, or T beta RII Delta-4 were co-expressed with the wildtype T beta RI, However, T beta RII Delta-1 restored very little the TGF-beta responsiveness in DR26cells, Expression of T beta RII Delta-2, T beta RII Delta-3, and T beta RII Delta-4 resulted in a progressive increase in TGF-P responsiveness, with T beta RII Delta-4 reaching the level of activity of the wild-type T beta RII, Furthermore, like T beta RII-I-II, co-expression of T beta RII Delta-1 with T beta RI-II-I also resulted in high levels of constitutive activation. These results are consistent with an important role for the transmembrane region of the receptors, We further propose a model of receptor activation in which receptor activation occurs via relative orientational rotation.	Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia	Ludwig Institute for Cancer Research; Royal Melbourne Hospital	Zhu, HJ (corresponding author), Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia.			Zhu, Hong-Jian/0000-0002-1478-995X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders RA, 1996, J BIOL CHEM, V271, P21758, DOI 10.1074/jbc.271.36.21758; BASSING CH, 1994, SCIENCE, V263, P87, DOI 10.1126/science.8272871; CARCAMO J, 1995, MOL CELL BIOL, V15, P1573; CHEN RH, 1995, J BIOL CHEM, V270, P12235, DOI 10.1074/jbc.270.20.12235; CHEN RH, 1994, J BIOL CHEM, V269, P22868; Fakhrai H, 1996, P NATL ACAD SCI USA, V93, P2909, DOI 10.1073/pnas.93.7.2909; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; KALKHOVEN E, 1995, CELL GROWTH DIFFER, V6, P1151; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; LAIHO M, 1991, J BIOL CHEM, V266, P9108; Lin Herbert Y., 1993, Trends in Cell Biology, V3, P14, DOI 10.1016/0962-8924(93)90195-7; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; Luo KX, 1996, EMBO J, V15, P4485, DOI 10.1002/j.1460-2075.1996.tb00826.x; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; Mingarro I, 1996, PROTEIN SCI, V5, P1339, DOI 10.1002/pro.5560050712; MIYAZONO K, 1993, GROWTH FACTORS, V8, P11, DOI 10.3109/08977199309029130; OKADOME T, 1994, J BIOL CHEM, V269, P30753; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; RODRIGUEZ C, 1995, J BIOL CHEM, V270, P15919, DOI 10.1074/jbc.270.27.15919; Souchelnytskyi S, 1996, EMBO J, V15, P6231, DOI 10.1002/j.1460-2075.1996.tb01013.x; tenDijke P, 1996, CURR OPIN CELL BIOL, V8, P139; VENTURA F, 1994, EMBO J, V13, P5581, DOI 10.1002/j.1460-2075.1994.tb06895.x; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; YAMASHITA H, 1994, J BIOL CHEM, V269, P20172	31	37	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11773	11781		10.1074/jbc.274.17.11773	http://dx.doi.org/10.1074/jbc.274.17.11773			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206994	hybrid			2022-12-27	WOS:000079834800050
J	Dalle, S; Smith, P; Blache, P; Le-Nguyen, D; Le Brigand, L; Bergeron, F; Ashcroft, FM; Bataille, D				Dalle, S; Smith, P; Blache, P; Le-Nguyen, D; Le Brigand, L; Bergeron, F; Ashcroft, FM; Bataille, D			Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER PLASMA-MEMBRANE; PANCREATIC B-CELLS; BETA-CELLS; CA-2+ PUMP; CHANNELS; CALCIUM; DIHYDROPYRIDINES; ENDOPEPTIDASE; SOMATOSTATIN; ACTIVATION	Using the MIN6 B-cell line, we investigated the hypothesis that miniglucagon, the C-terminal (19-29) fragment processed from glucagon and present in pancreatic A cells, modulates insulin release, and we analyzed its cellular mode of action. We show that, at concentrations ranging from 0.01 to 1000 phr, miniglucagon dose-dependently (ID50 = 1 pM) inhibited by 80-100% the insulin release triggered by glucose, glucagon, glucagonlike peptide-1-(7-36) amide (tGLP-1), or glibenclamide, but not that induced by carbachol, Miniglucagon had no significant effects on cellular cAMP levels. The increase in Ca-45(2+) uptake induced by depolarizing agents (glucose or extracellular K+), by glucagon, or by the Ca2+ channel agonist Bay K-8644 was blocked by miniglucagon at the doses active on insulin release. Electrophysiological experiments indicated that miniglucagon induces membrane hyperpolarization, probably by opening potassium channels, which terminated glucose-induced electrical activity. Pretreatment with pertussis toxin abolished the effects of miniglucagon on insulin release. It is concluded that miniglucagon is a highly potent and efficient inhibitor of insulin release by dosing, via hyperpolarization, voltage-dependent Ca2+ channels linked to a pathway involving a pertussis toxin-sensitive G protein.	CHU Arnaud de Villeneuve, INSERM, U376, F-34295 Montpellier, France; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; University of Oxford	Bataille, D (corresponding author), CHU Arnaud de Villeneuve, INSERM, U376, F-34295 Montpellier, France.		blache, philippe/C-2009-2008	Smith, Paul/0000-0002-8710-6830				ASHCROFT FM, 1994, J CELL BIOCHEM, V56, P1; BATAILLE D, 1992, BIOMED RES-TOKYO, V13, P137; BATAILLE D, 1996, GLUACON, V3, P31; BATAILLE D, 1992, INT GLUCAGON MONITOR, V2, P1; BECHEM M, 1988, TRENDS PHARMACOL SCI, V9, P257, DOI 10.1016/0165-6147(88)90156-3; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BLACHE P, 1989, CR ACAD SCI III-VIE, V308, P467; BLACHE P, 1990, J BIOL CHEM, V265, P21514; BLACHE P, 1993, J BIOL CHEM, V268, P21748; BLACHE P, 1988, BIOMED RES S3, V9, P19; BROWN AM, 1984, NATURE, V311, P570, DOI 10.1038/311570a0; COHEN P, 1987, BIOCHIMIE, V69, P87, DOI 10.1016/0300-9084(87)90239-2; COOK DL, 1982, DIABETES, V31, P985, DOI 10.2337/diabetes.31.11.985; DELAAGE MA, 1978, MOL BIOL PHARM CYCLI, P151; DOCHERTY K, 1982, ANNU REV PHYSIOL, V44, P625, DOI 10.1146/annurev.ph.44.030182.003205; DREWS G, 1990, ENDOCRINOLOGY, V126, P1646, DOI 10.1210/endo-126-3-1646; Gilon P, 1997, J PHYSIOL-LONDON, V499, P65, DOI 10.1113/jphysiol.1997.sp021911; Hughes SJ, 1998, DIABETES, V47, P73, DOI 10.2337/diabetes.47.1.73; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; KERVRAN A, 1976, DIABETES METAB, V2, P67; KOFOD H, 1988, AM J PHYSIOL, V254, pE454, DOI 10.1152/ajpendo.1988.254.4.E454; LAZURE C, 1983, CAN J BIOCHEM CELL B, V61, P501, DOI 10.1139/o83-066; LENGUYEN D, 1988, PEPTIDE CHEM 1987, P391; LOTERSZTAJN S, 1990, J BIOL CHEM, V265, P9876; MALAISSELAGAE F, 1984, BIOCHEM BIOPH RES CO, V123, P1062, DOI 10.1016/S0006-291X(84)80241-7; MALLAT A, 1987, NATURE, V325, P620, DOI 10.1038/325620a0; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; PACE CS, 1977, AM J PHYSIOL, V233, pC164, DOI 10.1152/ajpcell.1977.233.5.C164; PACE CS, 1981, DIABETES, V30, P836, DOI 10.2337/diabetes.30.10.836; PAVOINE C, 1991, AM J PHYSIOL, V260, pC993, DOI 10.1152/ajpcell.1991.260.5.C993; RAJAN AS, 1989, DIABETES, V38, P874, DOI 10.2337/diabetes.38.7.874; Renstrom E, 1996, NEURON, V17, P513, DOI 10.1016/S0896-6273(00)80183-X; RODBELL M, 1983, GLUCAGON, V1, P263; RORSMAN P, 1991, NATURE, V349, P77, DOI 10.1038/349077a0; SMITH PA, 1993, J GEN PHYSIOL, V101, P767, DOI 10.1085/jgp.101.5.767; THOMAS L, 1991, P NATL ACAD SCI USA, V88, P5297, DOI 10.1073/pnas.88.12.5297; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914	37	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10869	10876		10.1074/jbc.274.16.10869	http://dx.doi.org/10.1074/jbc.274.16.10869			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196164	hybrid			2022-12-27	WOS:000079751900032
J	Gengrinovitch, S; Berman, B; David, G; Witte, L; Neufeld, G; Ron, D				Gengrinovitch, S; Berman, B; David, G; Witte, L; Neufeld, G; Ron, D			Glypican-1 is a VEGF(165) binding proteoglycan that acts as an extracellular chaperone for VEGF(165)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST GROWTH-FACTOR; HEPARAN-SULFATE PROTEOGLYCAN; PLATELET FACTOR-IV; VASCULAR ENDOTHELIAL-CELLS; FACTOR VEGF; MOLECULAR-CLONING; SOLUBLE RECEPTOR; NERVOUS-SYSTEM; CORE PROTEIN; MEMBRANE	Glypican-1 is a member of a family of glycosylphosphatidylinositol anchored cell surface heparan sulfate proteoglycans implicated in the control of cellular growth and differentiation. The 165-amino acid form of vascular endothelial growth factor (VEGF(165)) is a mitogen for endothelial cells and a potent angiogenic factor in vivo. Heparin binds to VEGF(165) and enhances its binding to VEGF receptors. However, native HSPGs that bind VEGF(165) and modulate its receptor binding have not been identified. Among the glypicans, glypican-1 is the only member that is expressed in the vascular system. We have therefore examined whether glypican-1 can interact with VEGF(165). Glypican-1 from rat myoblasts binds specifically to VEGF(165) but not to VEGF(121). The binding has an apparent dissociation constant of 3 x 10(-10) M. The binding of glypican-1 to VEGF(165) is mediated by the heparan sulfate chains of glypican-1, because heparinase treatment abolishes this interaction. Only an excess of heparin or heparan sulfates but not other types of glycosaminoglycans inhibited this interaction. VEGF(165) interacts specifically not only with rat myoblast glypican-1 but also with human endothelial cell-derived glypican-1. The binding of I-125-VEGF(165) to heparinase-treated human vascular endothelial cells is reduced following heparinase treatment, and addition of glypican-1 restores the binding. Glypican-1 also potentiates the binding of I-125-VEGF(165) to a soluble extracellular domain of the VEGF receptor KDR/flk-1. Furthermore, we show that glypican-1 acts as an extracellular chaperone that can restore the receptor binding ability of VEGF(165), which has been damaged by oxidation. Taken together, these results suggest that glypican-1 may play an important role in the control of angiogenesis by regulating the activity of VEGF(165), a regulation that may be critical under conditions such as wound repair, in which oxidizing agents that can impair the activity of VEGF are produced, and in situations were the concentrations of active VEGF are limiting.	Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; Flanders Interuniv, Inst Biotechnol, B-3000 Louvain, Belgium; ImClone Syst Inc, New York, NY 10014 USA	Technion Israel Institute of Technology; KU Leuven; Eli Lilly	Ron, D (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	dinar@techninix.tecnion.ac.il	Neufeld, Gera/F-1524-2019					AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; AZIZKHAN RG, 1980, J EXP MED, V152, P931, DOI 10.1084/jem.152.4.931; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; BonnehBarkay D, 1997, J BIOL CHEM, V272, P12415, DOI 10.1074/jbc.272.19.12415; CAREY DJ, 1989, J CELL BIOL, V108, P1891, DOI 10.1083/jcb.108.5.1891; CHIANG MK, 1995, GROWTH FACTORS, V12, P1, DOI 10.3109/08977199509003208; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Cohen T, 1992, GROWTH FACTORS, V7, P131, DOI 10.3109/08977199209046402; DAVID G, 1990, J CELL BIOL, V111, P3165, DOI 10.1083/jcb.111.6.3165; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; DEBOECK H, 1987, BIOCHEM J, V247, P765, DOI 10.1042/bj2470765; Dougher AM, 1997, GROWTH FACTORS, V14, P257, DOI 10.3109/08977199709021524; FILMUS J, 1995, BIOCHEM J, V311, P561, DOI 10.1042/bj3110561; FOLKMAN J, 1992, ADV EXP MED BIOL, V313, P355; GENGRINOVITCH S, 1995, J BIOL CHEM, V270, P15059, DOI 10.1074/jbc.270.25.15059; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; GitayGoren H, 1996, J BIOL CHEM, V271, P5519, DOI 10.1074/jbc.271.10.5519; GOSPODAROWICZ D, 1986, J CELL PHYSIOL, V128, P475, DOI 10.1002/jcp.1041280317; HECK DE, 1992, J BIOL CHEM, V267, P21277; KARTHIKEYAN L, 1992, BIOCHEM BIOPH RES CO, V188, P395, DOI 10.1016/0006-291X(92)92398-H; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; KINSELLA MG, 1988, BIOCHEMISTRY-US, V27, P2136, DOI 10.1021/bi00406a048; KOJIMA T, 1992, J BIOL CHEM, V267, P4870; LAMMI M, 1988, ANAL BIOCHEM, V168, P352, DOI 10.1016/0003-2697(88)90329-6; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LEVINE SP, 1990, BLOOD, V75, P902; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; MERTENS G, 1992, J BIOL CHEM, V267, P20435; MOSCATELLI D, 1992, J BIOL CHEM, V267, P25803; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Neufeld G, 1996, CANCER METAST REV, V15, P153, DOI 10.1007/BF00437467; NEUFELD G, 1985, J BIOL CHEM, V260, P3860; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Poltorak Z, 1997, J BIOL CHEM, V272, P7151, DOI 10.1074/jbc.272.11.7151; RAPRAEGER AC, 1994, EXTRACELLULAR MATRIX, V245, P240; RAVID K, 1991, P NATL ACAD SCI USA, V88, P1521, DOI 10.1073/pnas.88.4.1521; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; RON D, 1993, J BIOL CHEM, V268, P2984; RON D, 1993, J BIOL CHEM, V268, P5388; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Ruef J, 1997, CIRC RES, V81, P24, DOI 10.1161/01.RES.81.1.24; SASISEKHARAN R, 1994, P NATL ACAD SCI USA, V91, P1524, DOI 10.1073/pnas.91.4.1524; SCHRAUFSTATTER IU, 1988, METHOD ENZYMOL, V163, P328; Song HH, 1997, J BIOL CHEM, V272, P7574, DOI 10.1074/jbc.272.12.7574; Steinfeld R, 1996, J CELL BIOL, V133, P405, DOI 10.1083/jcb.133.2.405; STIPP CS, 1994, J CELL BIOL, V124, P149, DOI 10.1083/jcb.124.1.149; TESSLER S, 1994, J BIOL CHEM, V269, P12456; Veugelers M, 1997, GENOMICS, V40, P24, DOI 10.1006/geno.1996.4518; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; WATANABE K, 1995, J CELL BIOL, V130, P1207, DOI 10.1083/jcb.130.5.1207; Weksberg R, 1996, NAT GENET, V12, P225, DOI 10.1038/ng0396-225	54	153	158	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10816	10822		10.1074/jbc.274.16.10816	http://dx.doi.org/10.1074/jbc.274.16.10816			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196157	hybrid			2022-12-27	WOS:000079751900025
J	Gotte, M; Maier, G; Onori, AM; Cellai, L; Wainberg, MA; Heumann, H				Gotte, M; Maier, G; Onori, AM; Cellai, L; Wainberg, MA; Heumann, H			Temporal coordination between initiation of HIV (+)-strand DNA synthesis and primer removal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE RESULT; RNASE-H; POLYPURINE TRACT; RETROTRANSPOSON TY1; RIBONUCLEASE H; BINDING; TRNA(3)(LYS); SEQUENCE; SITE	In this study, we have analyzed the interdependence between the polymerase and RNase H active sites of human immunodeficiency virus-1 reverse transcriptase (RT) using an in vitro system that closely mimics the initiation of (+)-strand DNA synthesis, Time course experiments show that RT pauses after addition of the 12th DNA residue, and at this stage the RNase H activity starts to cleave the RNA primer from newly synthesized DNA. Comparison of cleavage profiles obtained with 3'- and 5'-end-labeled primer strands indicates that RT now translocates in the opposite direction, i.e. in the 5' direction of the RNA strand. DNA synthesis resumes again in the 3' direction, after the RNA-DNA junction was efficiently cleaved. Moreover, we further characterized complexes generated before, during, and after position +12, by treating these with Fe2+ to localize the RNase H active site on the DNA template. Initially, when RT binds the RNA/DNA substrate, oxidative strand breaks were seen at a distance of 18 base pairs upstream from the primer terminus, whereas 17 base pairs were observed at later stages when the enzyme binds more and more DNA/DNA These data show that the initiation of (+)-strand synthesis is accompanied by a conformational change of the polymerase-competent complex.	McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada; CNR, Ist Strutturistica Chim, I-00016 Monterotondo, Rome, Italy; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Lady Davis Institute; McGill University; Consiglio Nazionale delle Ricerche (CNR); Max Planck Society	Gotte, M (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, McGill AIDS Ctr, 3755 Chem Cote-Ste-Catherine, Montreal, PQ H3T 1E2, Canada.							DAS AT, 1995, J VIROL, V69, P3090, DOI 10.1128/JVI.69.5.3090-3097.1995; DESTEFANO JJ, 1995, NUCLEIC ACIDS RES, V23, P3901, DOI 10.1093/nar/23.19.3901; Fedoroff OY, 1997, J MOL BIOL, V269, P225, DOI 10.1006/jmbi.1997.1024; FEDOROFF OY, 1993, J MOL BIOL, V233, P509, DOI 10.1006/jmbi.1993.1528; FUENTES GM, 1995, J BIOL CHEM, V270, P28169, DOI 10.1074/jbc.270.47.28169; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; GOSH M, 1997, BIOCHEMISTRY-US, V36, P5758; Gotte M, 1998, J BIOL CHEM, V273, P10139, DOI 10.1074/jbc.273.17.10139; GOTTE M, 1995, EMBO J, V14, P833, DOI 10.1002/j.1460-2075.1995.tb07061.x; Gotte M, 1996, FEBS LETT, V390, P226, DOI 10.1016/0014-5793(96)00662-X; HEYMAN T, 1995, J MOL BIOL, V253, P291, DOI 10.1006/jmbi.1995.0553; HOSTOMSKY Z, 1994, J VIROL, V68, P1970, DOI 10.1128/JVI.68.3.1970-1971.1994; HUBER HE, 1990, J BIOL CHEM, V265, P10565; Hughes SH, 1996, J VIROL, V70, P2679, DOI 10.1128/JVI.70.5.2679-2683.1996; ISEL C, 1995, J MOL BIOL, V247, P236, DOI 10.1006/jmbi.1994.0136; Isel C, 1996, EMBO J, V15, P917, DOI 10.1002/j.1460-2075.1996.tb00426.x; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Lanchy JM, 1996, EMBO J, V15, P7178, DOI 10.1002/j.1460-2075.1996.tb01109.x; LAUERMANN V, 1995, J VIROL, V69, P7845, DOI 10.1128/JVI.69.12.7845-7850.1995; Lauermann V, 1997, EMBO J, V16, P6603, DOI 10.1093/emboj/16.21.6603; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; LI XG, 1994, J VIROL, V68, P6198, DOI 10.1128/JVI.68.10.6198-6206.1994; Mak J, 1997, J VIROL, V71, P8087, DOI 10.1128/JVI.71.11.8087-8095.1997; MARQUET R, 1995, BIOCHIMIE, V77, P113, DOI 10.1016/0300-9084(96)88114-4; METZGER W, 1993, P NATL ACAD SCI USA, V90, P5909, DOI 10.1073/pnas.90.13.5909; Palaniappan C, 1997, J BIOL CHEM, V272, P11157, DOI 10.1074/jbc.272.17.11157; Palaniappan C, 1998, J BIOL CHEM, V273, P3808, DOI 10.1074/jbc.273.7.3808; Powell MD, 1997, J BIOL CHEM, V272, P13262, DOI 10.1074/jbc.272.20.13262; Powell MD, 1996, J VIROL, V70, P5288, DOI 10.1128/JVI.70.8.5288-5296.1996; Saenger W, 1983, PRINCIPLES NUCL ACID; SCHATZ O, 1990, EMBO J, V9, P1171, DOI 10.1002/j.1460-2075.1990.tb08224.x; Telesnitsky A., 1997, P121; VINK C, 1991, J VIROL, V65, P4636, DOI 10.1128/JVI.65.9.4636-4644.1991; WAKEFIELD JK, 1995, J VIROL, V69, P6021, DOI 10.1128/JVI.69.10.6021-6029.1995; WOHRL BM, 1990, BIOCHEMISTRY-US, V29, P10141, DOI 10.1021/bi00496a001; WOHRL BM, 1995, BIOCHEMISTRY-US, V34, P5343	37	51	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					11159	11169		10.1074/jbc.274.16.11159	http://dx.doi.org/10.1074/jbc.274.16.11159			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196201	hybrid			2022-12-27	WOS:000079751900069
J	McDonald, PH; Cote, NL; Lin, FT; Premont, RT; Pitcher, JA; Lefkowitz, RJ				McDonald, PH; Cote, NL; Lin, FT; Premont, RT; Pitcher, JA; Lefkowitz, RJ			Identification of NSF as a beta-arrestin1-binding protein - Implications for beta(2)-adrenergic receptor regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE FUSION PROTEIN; BETA-ADRENERGIC-RECEPTOR; MEDIATED ENDOCYTOSIS; COUPLED RECEPTORS; AMPA RECEPTORS; ARRESTIN; SEQUESTRATION; KINASES; INTERNALIZATION; DESENSITIZATION	Previous studies have demonstrated that beta-arrestin1 serves to target G protein-coupled receptors for internalization via clathrin-coated pits and that its endocytic function is regulated by dephosphorylation at the plasma membrane. Using the yeast two-hybrid system, we have identified a novel beta-arrestin1-binding protein, NSF N-ethylmaleimide-sensitive fusion protein), an ATPase essential for many intracellular transport reactions. We demonstrate that purified recombinant beta-arrestin1 and NSF interact in vitro and that these proteins can be coimmunoprecipitated from cells. beta-Arrestin1-NSF complex formation exhibits a conformational dependence with beta-arrestin1 preferentially interacting with the ATP bound form of NSF, In contrast to the beta-arrestin1-clathrin interaction, however, the phosphorylation state of beta-arrestin1 does not affect NSF binding, Functionally, overexpression of NSF in HEK 293 cells significantly enhances agonist-mediated beta(2)-adrenergic receptor (beta(2)-AR) internalization. Furthermore, when coexpressed with a beta-arrestin1 mutant (beta arr1S412D) that mimics a constitutively phosphorylated form of beta-arrestin1 and that acts as a dominant negative with regards to beta(2)-AR internalization, NSF rescues the beta arr1S412D-mediated inhibition of beta(2)-AR internalization. The demonstration of beta-arrestin1-NSF complex formation and the functional consequences of NSF overexpression suggest a hitherto unappreciated role for NSF in facilitating clathrin coat-mediated G protein-coupled receptor internalization.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med Cardiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Box 3821, Durham, NC 27710 USA.		Pitcher, Julie/ABH-2078-2020; Lefkowitz, Robert/AAW-2649-2021	Premont, Richard/0000-0002-8053-5026	NHLBI NIH HHS [HL16037] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; BARAK LS, 1994, J BIOL CHEM, V269, P2790; BLOCK MR, 1992, METHOD ENZYMOL, V219, P300; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Ferguson SSG, 1996, BIOCHEM SOC T, V24, P953, DOI 10.1042/bst0240953; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin JW, 1998, NEURON, V21, P267, DOI 10.1016/S0896-6273(00)80534-6; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; PIPPIG S, 1993, J BIOL CHEM, V268, P3201; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Steel GJ, 1996, EMBO J, V15, P745, DOI 10.1002/j.1460-2075.1996.tb00410.x; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	27	118	120	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10677	10680		10.1074/jbc.274.16.10677	http://dx.doi.org/10.1074/jbc.274.16.10677			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196135	hybrid			2022-12-27	WOS:000079751900003
J	Bandyopadhyay, P; Ma, XM; Linehan-Stieers, C; Kren, BT; Steer, CJ				Bandyopadhyay, P; Ma, XM; Linehan-Stieers, C; Kren, BT; Steer, CJ			Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides - Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED GENE-TRANSFER; FACTOR-IX GENE; IN-VIVO; MAMMALIAN-CELLS; ANTISENSE OLIGONUCLEOTIDES; SUSTAINED EXPRESSION; NONVIRAL VECTOR; HEPATOMA-CELLS; CONDENSED DNA; HUH-7 CELLS	Chimeric RNA/DNA oligonucleotides have been shown to promote single nucleotide exchange in genomic DNA. A chimeric molecule was designed to introduce an A to C nucleotide conversion at the Ser(365) position of the rat factor IX gene. The oligonucleotides were encapsulated in positive, neutral, and negatively charged liposomes containing galactocerebroside or complexed with lactosylated polyethyleneimine. The formulations were evaluated for stability and efficiency in targeting hepatocytes via the asialoglycoprotein receptor. Physical characterization and electron microscopy revealed that the oligonucleotides were efficiently encapsulated within the liposomes, with the positive and negative formulations remaining stable for at least 1 month. Transfection efficiencies in isolated rat hepatocytes approached 100% with each of the formulations. However, the negative liposomes and 25-kDa lactosylated polyethyleneimine provided the most intense nuclear fluorescence with the fluorescein-labeled oligonucleotides. The lactosylated polyethyleneimine and the three different liposomal formulations resulted in A to C conversion efficiencies of 19-24%. In addition, lactosylated polyethyleneimine was also highly effective in transfecting plasmid DNA into isolated hepatocytes. The results suggest that both the liposomal and polyethyleneimine formulations are simple to prepare and stable and give reliable, reproducible results. They provide efficient delivery systems to hepatocytes for the introduction or repair of genetic mutations by the chimeric RNA/DNA oligonucleotides.	Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Cell Biol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Steer, CJ (corresponding author), Univ Minnesota, Sch Med, Dept Med, Box 36 UMHC,420 Delaware St SE, Minneapolis, MN 55455 USA.	steer001@maroon.tc.umn.edu						Abdallah B, 1996, HUM GENE THER, V7, P1947, DOI 10.1089/hum.1996.7.16-1947; Alexeev V, 1998, NAT BIOTECHNOL, V16, P1343, DOI 10.1038/4322; Bandyopadhyay P, 1998, BIOTECHNIQUES, V25, P282, DOI 10.2144/98252gt03; BENNETT CF, 1992, MOL PHARMACOL, V41, P1023; Boletta A, 1997, HUM GENE THER, V8, P1243, DOI 10.1089/hum.1997.8.10-1243; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; CAPACCIOLI S, 1993, BIOCHEM BIOPH RES CO, V197, P818, DOI 10.1006/bbrc.1993.2552; CHIN D J, 1990, New Biologist, V2, P1091; CHOWDHURY NR, 1993, J BIOL CHEM, V268, P11265; ColeStrauss A, 1996, SCIENCE, V273, P1386, DOI 10.1126/science.273.5280.1386; ColeStrauss A, 1997, ANTISENSE NUCLEIC A, V7, P211, DOI 10.1089/oli.1.1997.7.211; Connelly S, 1996, BLOOD, V87, P4671, DOI 10.1182/blood.V87.11.4671.bloodjournal87114671; Daemen T, 1997, HEPATOLOGY, V26, P416, DOI 10.1002/hep.510260223; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fabrega AJ, 1996, TRANSPLANTATION, V62, P1866, DOI 10.1097/00007890-199612270-00032; Fasbender A, 1997, GENE THER, V4, P716, DOI 10.1038/sj.gt.3300459; FELGNER JH, 1994, J BIOL CHEM, V269, P2550; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FINDEIS MA, 1994, METHODS ENZYMOL, V247, P341; FISHER TL, 1993, NUCLEIC ACIDS RES, V21, P3857, DOI 10.1093/nar/21.16.3857; FRALEY R, 1981, BIOCHEMISTRY-US, V20, P6978, DOI 10.1021/bi00527a031; GABIZON A, 1992, BIOCHIM BIOPHYS ACTA, V1103, P94, DOI 10.1016/0005-2736(92)90061-P; Gao X, 1996, BIOCHEMISTRY-US, V35, P1027, DOI 10.1021/bi952436a; Gao X, 1995, GENE THER, V2, P710; Ghoumari AM, 1996, GENE THER, V3, P483; GRAY GR, 1974, ARCH BIOCHEM BIOPHYS, V163, P426, DOI 10.1016/0003-9861(74)90495-0; HAMILTONATTWELL VL, 1987, J MICROSC-OXFORD, V145, P347; Hara T, 1997, P NATL ACAD SCI USA, V94, P14547, DOI 10.1073/pnas.94.26.14547; Higgins GM, 1931, ARCH PATHOL, V12, P186; HOLMEN SL, 1995, IN VITRO CELL DEV-AN, V31, P347; Ilan Y, 1997, J CLIN INVEST, V99, P1098, DOI 10.1172/JCI119238; Kaufman SL, 1996, ANAL CHEM, V68, P1895, DOI 10.1021/ac951128f; Kmiec EB, 1995, ADV DRUG DELIVER REV, V17, P333, DOI 10.1016/0169-409X(95)00068-I; Kren BT, 1997, HEPATOLOGY, V25, P1462, DOI 10.1002/hep.510250626; Kren BT, 1998, NAT MED, V4, P285, DOI 10.1038/nm0398-285; Kren BT, 1998, HEPATOLOGY, V28, p498A; LAPPALAINEN K, 1994, PHARMACEUT RES, V11, P1127, DOI 10.1023/A:1018932714745; Lee RJ, 1996, J BIOL CHEM, V271, P8481, DOI 10.1074/jbc.271.14.8481; LEONETTI JP, 1991, P NATL ACAD SCI USA, V88, P2702, DOI 10.1073/pnas.88.7.2702; LOKE SL, 1989, P NATL ACAD SCI USA, V86, P3474, DOI 10.1073/pnas.86.10.3474; MARIASH CN, 1986, J BIOL CHEM, V261, P9583; MARTINEZFONG D, 1994, HEPATOLOGY, V20, P1602, DOI 10.1002/hep.1840200633; MELCHIOR WB, 1973, P NATL ACAD SCI USA, V70, P298, DOI 10.1073/pnas.70.2.298; Mouradian S, 1997, ANAL CHEM, V69, P919, DOI 10.1021/ac960785k; PERALES JC, 1994, P NATL ACAD SCI USA, V91, P4086, DOI 10.1073/pnas.91.9.4086; Perales JC, 1997, J BIOL CHEM, V272, P7398, DOI 10.1074/jbc.272.11.7398; Pollard H, 1998, J BIOL CHEM, V273, P7507, DOI 10.1074/jbc.273.13.7507; REMY JS, 1995, P NATL ACAD SCI USA, V92, P1744, DOI 10.1073/pnas.92.5.1744; SARKAR G, 1990, GENOMICS, V6, P133, DOI 10.1016/0888-7543(90)90458-7; SMITH JG, 1993, BIOCHIM BIOPHYS ACTA, V1154, P327, DOI 10.1016/0304-4157(93)90004-8; SPANJER HH, 1983, BIOCHIM BIOPHYS ACTA, V734, P40, DOI 10.1016/0005-2736(83)90072-X; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Takahashi M, 1996, J BIOL CHEM, V271, P26536, DOI 10.1074/jbc.271.43.26536; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; WU GY, 1988, BIOCHEMISTRY-US, V27, P887, DOI 10.1021/bi00403a008; Yoon K, 1996, P NATL ACAD SCI USA, V93, P2071, DOI 10.1073/pnas.93.5.2071; ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997; ZHOU XH, 1994, BBA-BIOMEMBRANES, V1189, P195, DOI 10.1016/0005-2736(94)90066-3; ZHU N, 1993, SCIENCE, V261, P209, DOI 10.1126/science.7687073	59	110	120	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10163	10172		10.1074/jbc.274.15.10163	http://dx.doi.org/10.1074/jbc.274.15.10163			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187800	hybrid			2022-12-27	WOS:000079663500039
J	Bogdanov, M; Umeda, M; Dowhan, W				Bogdanov, M; Umeda, M; Dowhan, W			Phospholipid-assisted refolding of an integral membrane protein - Minimum structural features for phosphatidylethanolamine to act as a molecular chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMORPHIC PHASE-BEHAVIOR; X-RAY-DIFFRACTION; ESCHERICHIA-COLI; LACTOSE PERMEASE; P-31 NMR; PHOSPHATIDYLSERINE DECARBOXYLASE; INTERMEDIATE; TRANSITIONS; BILAYER; TRANSPORT	Escherichia coli-derived phosphatidylethanolamine (PE) or PE with fully saturated fatty acids was able to correct in vitro a defect in folding in the lipid dependent epitope 4B1 of lactose permease (LacY) resulting from in vivo assembly in the absence of PE. PE plasmalogen, PE with two unsaturated fatty acids, and lyso-PE, which all do not favor bilayer organization, did not support proper refolding, Proper refolding occurred when these latter lipids were mixed with a bilayer-forming lipid (phosphatidylglycerol), which alone could not support refolding, L-Phosphatidylserine (PS; natural diastereomer) did support proper refolding, PE derivatives of increasing degrees of methylation were progressively less effective in supporting refolding, with phosphatidylcholine being completely ineffective. Therefore, the properties of nonmethylated aminophospholipids capable of organization into a bilayer configuration are essential for the recovery of the native state of epitope 4B1 after misassembly in vivo in the absence of PE, Neither D-PS (sn-glycero-l-phosphate backbone) nor P-D-S (D-serine in the head group) is competent in supporting proper refolding unless used in binary mixtures with phosphatidylglycerol. The detailed characterization of phospholipid-assisted refolding reported here further supports a specific rather than nonspecific role for PE in structural maturation of lactose permease in vivo (Bogdanov, RI., and Dowhan, W, (1998) EMBO J, 17, 5255-5264).	Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA; Tokyo Metropolitan Inst Med Sci, Dept Mol Biodynam, Tokyo 113, Japan	University of Texas System; Tokyo Metropolitan Institute of Medical Science	Dowhan, W (corresponding author), Univ Texas, Sch Med, Dept Biochem & Mol Biol, POB 20708, Houston, TX 77225 USA.	wdowhan@bmb.med.uth.tmc.edu	Bogdanov, Mikhail/J-3695-2017		NIGMS NIH HHS [GM24078] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn T, 1998, J BIOL CHEM, V273, P21692, DOI 10.1074/jbc.273.34.21692; BIBI E, 1990, P NATL ACAD SCI USA, V87, P4325, DOI 10.1073/pnas.87.11.4325; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; BOGDANOV M, 1995, J BIOL CHEM, V270, P732, DOI 10.1074/jbc.270.2.732; BROWN MF, 1994, CHEM PHYS LIPIDS, V73, P159, DOI 10.1016/0009-3084(94)90180-5; BROWNING JL, 1980, BIOCHEMISTRY-US, V19, P1262, DOI 10.1021/bi00547a034; CHEN CC, 1984, J BIOL CHEM, V259, P150; CULLIS PR, 1978, BIOCHIM BIOPHYS ACTA, V513, P31, DOI 10.1016/0005-2736(78)90109-8; CULLIS PR, 1991, LIPID POLYMORPHISM M, P35; de Cock H, 1999, J BIOL CHEM, V274, P5114, DOI 10.1074/jbc.274.8.5114; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; deCock H, 1996, EMBO J, V15, P5567, DOI 10.1002/j.1460-2075.1996.tb00941.x; DORSET DL, 1990, BIOCHIM BIOPHYS ACTA, V1028, P299, DOI 10.1016/0005-2736(90)90179-R; DOWHAN W, 1992, METHOD ENZYMOL, V209, P348; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; EPAND RM, 1990, CHEM PHYS LIPIDS, V52, P227, DOI 10.1016/0009-3084(90)90118-B; Epand RM, 1998, BIOCHEMISTRY-US, V37, P12068, DOI 10.1021/bi980527c; FARREN SB, 1980, BIOCHEM BIOPH RES CO, V97, P182, DOI 10.1016/S0006-291X(80)80152-5; FINE JB, 1982, J LIPID RES, V23, P660; GRUNER SM, 1988, BIOCHEMISTRY-US, V27, P2853, DOI 10.1021/bi00408a029; HARLOS K, 1981, BIOCHEMISTRY-US, V20, P2888, DOI 10.1021/bi00513a027; HAWROT E, 1978, J BIOL CHEM, V253, P8213; Kaback HR, 1997, CURR OPIN STRUC BIOL, V7, P537, DOI 10.1016/S0959-440X(97)80119-4; LEWIS RNAH, 1993, BIOPHYS J, V64, P1081, DOI 10.1016/S0006-3495(93)81474-7; LI L, 1995, CHEM PHYS LIPIDS, V76, P135, DOI 10.1016/0009-3084(95)02437-N; LOHNER K, 1991, BIOCHIM BIOPHYS ACTA, V1061, P132, DOI 10.1016/0005-2736(91)90277-F; MANNOCK DA, 1992, BIOPHYS J, V63, P1355, DOI 10.1016/S0006-3495(92)81713-7; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Marsh D., 1993, PROTEIN LIPID INTERA, P41; NEWTON AC, 1994, BIOCHEMISTRY-US, V33, P6651, DOI 10.1021/bi00187a035; PAGE MGP, 1988, J BIOL CHEM, V263, P15897; RIETVELD AG, 1995, EMBO J, V14, P5506, DOI 10.1002/j.1460-2075.1995.tb00237.x; SAHINTOTH M, 1992, P NATL ACAD SCI USA, V89, P10547, DOI 10.1073/pnas.89.21.10547; SEDDON JM, 1983, BIOCHEMISTRY-US, V22, P1280, DOI 10.1021/bi00274a045; SELINSKY BS, 1992, STRUCTURE BIOL MEMBR, P603; SkorkoGlonek J, 1997, J BIOL CHEM, V272, P8974; Starling AP, 1996, BIOCHEM J, V320, P309, DOI 10.1042/bj3200309; Sun JZ, 1996, BIOCHEMISTRY-US, V35, P990, DOI 10.1021/bi952166w; Sun JZ, 1997, BIOCHEMISTRY-US, V36, P274, DOI 10.1021/bi962292f; SURREY T, 1992, P NATL ACAD SCI USA, V89, P7457, DOI 10.1073/pnas.89.16.7457; TAKI T, 1994, ANAL BIOCHEM, V221, P312, DOI 10.1006/abio.1994.1418; TILCOCK CPS, 1982, BIOCHIM BIOPHYS ACTA, V684, P212, DOI 10.1016/0005-2736(82)90008-6; TILCOCK CPS, 1986, BIOCHEMISTRY-US, V25, P816, DOI 10.1021/bi00352a013; UJWAL ML, 1994, MOL MEMBR BIOL, V11, P9, DOI 10.3109/09687689409161024; Varela MF, 1996, BBA-BIOENERGETICS, V1276, P21, DOI 10.1016/0005-2728(96)00030-8; Voss J, 1997, BIOCHEMISTRY-US, V36, P15055, DOI 10.1021/bi971726j; ZARDENETA G, 1993, BIOCHEMISTRY-US, V32, P13941, DOI 10.1021/bi00213a025; ZARDENETA G, 1992, J BIOL CHEM, V267, P5811; ZARDENETA G, 1992, EUR J BIOCHEM, V210, P831, DOI 10.1111/j.1432-1033.1992.tb17486.x	50	111	117	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12339	12345		10.1074/jbc.274.18.12339	http://dx.doi.org/10.1074/jbc.274.18.12339			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212204	hybrid			2022-12-27	WOS:000080056800024
J	Groh, S; Marty, I; Ottolia, M; Prestipino, G; Chapel, A; Villaz, M; Ronjat, M				Groh, S; Marty, I; Ottolia, M; Prestipino, G; Chapel, A; Villaz, M; Ronjat, M			Functional interaction of the cytoplasmic domain of triadin with the skeletal ryanodine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE CHANNEL; CA2+ RELEASE; DIHYDROPYRIDINE RECEPTOR; GLYCOPROTEIN TRIADIN; CA-2+ RELEASE; MUSCLE; CALSEQUESTRIN; VESICLES; PROTEIN	Triadin has been shown to co-localize with the ryanodine receptor in the sarcoplasmic reticulum membrane. We show that immunoprecipitation of solubilized sarcoplasmic reticulum membrane with antibodies directed against triadin or ryanodine receptor, leads to the coimmunoprecipitation of ryanodine receptor and triadin, We then investigated the functional importance of the cytoplasmic domain of triadin (residues 1-47) in the control of Ca2+ release from sarcoplasmic reticulum, We show that antibodies directed against a synthetic peptide encompassing residues 2-17, induce a decrease in the rate of Ca2+ release from sarcoplasmic reticulum vesicles as well as a decrease in the open probability of the ryanodine receptor Ca2+ channel incorporated in lipid bilayers, Using surface plasmon resonance spectroscopy, we defined a discrete domain (residues 18-46) of the cytoplasmic part of triadin interacting with the purified ryanodine receptor. This interaction is optimal at low Ca2+ concentration (up to pCa 5) and inhibited by increasing calcium concentration (IC50 of 300 mu M). The direct molecular interaction of this triadin domain with the ryanodine receptor was confirmed by overlay assay and shown to induce the inhibition of the Ca2+ channel activity of purified RyR in bilayer, We propose that this interaction plays a critical role in the control, by triadin, of the Ca2+ channel behavior of the ryanodine receptor and therefore may represent an important step in the regulation process of excitation-contraction coupling in skeletal muscle.	CEA, DBMS, Lab Canaux Ion & Signalisat, F-38054 Grenoble, France; CNR, Ist Cibernet & Biofis, I-16149 Genoa, Italy; CEA, DBMS, Lab Chim Prot, F-38054 Grenoble, France	CEA; Consiglio Nazionale delle Ricerche (CNR); CEA	Ronjat, M (corresponding author), CEA, DBMS, Lab Canaux Ion & Signalisat, 17 Rue Martyrs, F-38054 Grenoble, France.	mronjat@cea.fr	Marty, Isabelle/ABF-5362-2020; Marty, Isabelle/N-7114-2017	Marty, Isabelle/0000-0003-3625-913X; Ronjat, Michel/0000-0002-9728-6425				BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; BRANDT NR, 1992, FEBS LETT, V299, P57, DOI 10.1016/0014-5793(92)80100-U; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; BURATTI R, 1995, BIOCHEM BIOPH RES CO, V213, P1082, DOI 10.1006/bbrc.1995.2238; CASWELL AH, 1991, BIOCHEMISTRY-US, V30, P7507, DOI 10.1021/bi00244a020; CATTERALL WA, 1991, CELL, V64, P871, DOI 10.1016/0092-8674(91)90309-M; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; GILCHRIST JSC, 1992, J BIOL CHEM, V267, P20850; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; IKEMOTO N, 1989, J BIOENERG BIOMEMBR, V21, P247, DOI 10.1007/BF00812071; IKEMOTO N, 1984, J BIOL CHEM, V259, P3151; IKEMOTO N, 1989, BIOCHEMISTRY-US, V28, P6764, DOI 10.1021/bi00442a033; IMAGAWA T, 1987, J BIOL CHEM, V262, P16636; Jones LR, 1995, J BIOL CHEM, V270, P30787, DOI 10.1074/jbc.270.51.30787; KIM KC, 1990, BIOCHEMISTRY-US, V29, P9281, DOI 10.1021/bi00491a025; KNUDSON CM, 1993, J BIOL CHEM, V268, P12637; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LEUNG AT, 1988, J BIOL CHEM, V263, P994; LIU GH, 1994, J BIOL CHEM, V269, P33028; MARSILI V, 1992, J MUSCLE RES CELL M, V13, P511, DOI 10.1007/BF01737993; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; MARTY I, 1995, BIOCHEM J, V307, P769, DOI 10.1042/bj3070769; MEISSNER G, 1987, J BIOL CHEM, V262, P3065; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; MOUTIN MJ, 1988, J BIOL CHEM, V263, P4228; Ohkura M, 1998, BIOCHEMISTRY-US, V37, P12987, DOI 10.1021/bi972803d; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PESSAH IN, 1986, J BIOL CHEM, V261, P8643; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Treves S, 1997, BIOCHEMISTRY-US, V36, P11496, DOI 10.1021/bi970160w; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389	36	70	71	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	1999	274	18					12278	12283		10.1074/jbc.274.18.12278	http://dx.doi.org/10.1074/jbc.274.18.12278			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192BC	10212196	hybrid			2022-12-27	WOS:000080056800016
J	Bertero, MG; Gonzales, B; Tarricone, C; Ceciliani, F; Galizzi, A				Bertero, MG; Gonzales, B; Tarricone, C; Ceciliani, F; Galizzi, A			Overproduction and characterization of the Bacillus subtilis anti-sigma factor FlgM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SIGMA(F); COLI RNA-POLYMERASE; FLAGELLUM-SPECIFIC SIGMA; SALMONELLA-TYPHIMURIUM; GENE-EXPRESSION; BACTERIOPHAGE-T4 ASIA; NEGATIVE REGULATOR; FACTOR SPOIIAB; PROTEIN; INHIBITION	FlgM is an anti-sigma factor of the flagellar-specific sigma (sigma) subunit of RNA polymerase in Bacillus subtilis, and it is responsible of the coupling of late flagellar gene expression to the completion of the hook-basal body structure. We have overproduced the protein in soluble form and characterized it. FlgM forms dimers as shown by gel exclusion chromatography and native polyacrylamide gel electrophoresis and interacts in vitro with the cognate sigma(D) factor. The FlgM .sigma(D) complex is a stable heterodimer as demonstrated by gel exclusion chromatography, chemical cross-linking, native polyacrylamide gel electrophoresis, and isoelectric focusing. sigma(D) belongs to the group of sigma factors able to bind to the promoter sequence even in the absence of core RNA polymerase. The FlgM .sigma(D) complex gave a shift in a DNA mobility shift assay with a probe containing a sigma(D)-dependent promoter sequence. Limited proteolysis studies indicate the presence of two structural motifs, corresponding to the N- and C-terminal regions, respectively.	Univ Pavia, Dipartimento Genet & Microbiol A Buzzati Traverso, I-27100 Pavia, Italy; Univ Milan, Dipartimento Fisiol Vet & Biochim, I-20133 Milan, Italy	University of Pavia; University of Milan	Galizzi, A (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol A Buzzati Traverso, Via Abbiategrasso 207, I-27100 Pavia, Italy.		Ceciliani, Fabrizio/Q-6551-2017	Ceciliani, Fabrizio/0000-0002-9199-5757; Bertero, Michela/0000-0002-2012-6706				Adelman K, 1997, J BIOL CHEM, V272, P27435, DOI 10.1074/jbc.272.43.27435; ALPER S, 1994, CELL, V77, P195, DOI 10.1016/0092-8674(94)90312-3; Alper S, 1996, J MOL BIOL, V260, P165, DOI 10.1006/jmbi.1996.0390; BENSON AK, 1993, P NATL ACAD SCI USA, V90, P2330, DOI 10.1073/pnas.90.6.2330; BROWN KL, 1995, MOL MICROBIOL, V16, P397, DOI 10.1111/j.1365-2958.1995.tb02405.x; Caramori T, 1996, J BACTERIOL, V178, P3113, DOI 10.1128/jb.178.11.3113-3118.1996; Chadsey MS, 1998, GENE DEV, V12, P3123, DOI 10.1101/gad.12.19.3123; CHEN YF, 1995, J MOL BIOL, V249, P743, DOI 10.1006/jmbi.1995.0333; Colland F, 1998, MOL MICROBIOL, V27, P819, DOI 10.1046/j.1365-2958.1998.00729.x; Daughdrill GW, 1997, NAT STRUCT BIOL, V4, P285, DOI 10.1038/nsb0497-285; Decatur AL, 1996, GENE DEV, V10, P2348, DOI 10.1101/gad.10.18.2348; DIEDERICH B, 1994, GENE DEV, V8, P2653, DOI 10.1101/gad.8.21.2653; DOMBROSKI AJ, 1993, GENE DEV, V7, P2446, DOI 10.1101/gad.7.12a.2446; DUFOUR A, 1994, J BACTERIOL, V176, P1813, DOI 10.1128/jb.176.7.1813-1820.1994; DUNCAN L, 1993, P NATL ACAD SCI USA, V90, P2325, DOI 10.1073/pnas.90.6.2325; Duncan L, 1996, J MOL BIOL, V260, P147, DOI 10.1006/jmbi.1996.0389; Fredrick K, 1996, J BACTERIOL, V178, P7010, DOI 10.1128/jb.178.23.7010-7013.1996; GILLEN KL, 1991, J BACTERIOL, V173, P6453, DOI 10.1128/jb.173.20.6453-6459.1991; Gorham HC, 1996, MOL MICROBIOL, V19, P171, DOI 10.1046/j.1365-2958.1996.360888.x; Huang XJ, 1998, J BACTERIOL, V180, P3765, DOI 10.1128/JB.180.15.3765-3770.1998; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; Iyoda S, 1995, MOL GEN GENET, V249, P417; KUTSUKAKE K, 1994, MOL GEN GENET, V243, P605, DOI 10.1007/BF00279569; KUTSUKAKE K, 1994, EMBO J, V13, P4568, DOI 10.1002/j.1460-2075.1994.tb06778.x; Magnin T, 1996, MOL MICROBIOL, V19, P901, DOI 10.1046/j.1365-2958.1996.434964.x; MIN KT, 1993, CELL, V74, P735, DOI 10.1016/0092-8674(93)90520-Z; MIREL DB, 1994, J BACTERIOL, V176, P4492, DOI 10.1128/JB.176.15.4492-4500.1994; OHNISHI K, 1992, MOL MICROBIOL, V6, P3149, DOI 10.1111/j.1365-2958.1992.tb01771.x; ORSINI G, 1993, J BACTERIOL, V175, P85, DOI 10.1128/JB.175.1.85-93.1993; Schurr MJ, 1996, J BACTERIOL, V178, P4997, DOI 10.1128/jb.178.16.4997-5004.1996; Schweder T, 1996, J BACTERIOL, V178, P470, DOI 10.1128/jb.178.2.470-476.1996; Severinova E, 1998, J MOL BIOL, V279, P9, DOI 10.1006/jmbi.1998.1742; Severinova E, 1996, J MOL BIOL, V263, P637, DOI 10.1006/jmbi.1996.0604; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Xie ZD, 1996, J BACTERIOL, V178, P4990, DOI 10.1128/jb.178.16.4990-4996.1996	35	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12103	12107		10.1074/jbc.274.17.12103	http://dx.doi.org/10.1074/jbc.274.17.12103			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207036	hybrid			2022-12-27	WOS:000079834800092
J	Hayman, ML; Read, LK				Hayman, ML; Read, LK			Trypanosoma brucei RBP16 is a mitochondrial Y-box family protein with guide RNA binding activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD-SHOCK DOMAIN; MESSENGER-RNA; RIBONUCLEOPROTEIN COMPLEXES; KINETOPLASTID MITOCHONDRIA; IN-VITRO; LEISHMANIA-TARENTOLAE; ESCHERICHIA-COLI; LIFE-CYCLE; IDENTIFICATION; MOLECULES	Trypanosoma brucei mitochondria possess a unique mechanism of mRNA maturation called RNA editing, In this process, uridylate residues are inserted and deleted posttranscriptionally into pre-mRNA to create translatable messages. The genetic information for RNA editing resides in small RNA molecules called guide RNAs (gRNAs), Thus, proteins in direct contact with gRNA are likely to catalyze or influence RNA editing. Herein we characterize an abundant gRNA-binding protein from T, brucei mitochondria. This protein, which we term RBP16 (for RNA-binding protein of 16 kDa), binds to different gRNA molecules. The major determinant of this interaction is the oligo(U) tail, present on the 3'-ends of gRNAs. RBP16 forms multiple, stable complexes with gRNA in vitro, and immunoprecipitation experiments provide evidence for an association between RBP16 and gRNA within T, brucei mitochondria. Mature RBP16 contains a cold shock domain at the N terminus and a C-terminal region rich in arginine and glycine, The presence of the cold shock domain places RBP16 as the first organellar member of the highly conserved Y-box protein family. The arginine and glycine rich C terminus in combination with the cold shock domain predicts that RBP16 will be involved in the regulation of gene expression at the posttranscriptional level.	SUNY Buffalo, Sch Med, Dept Microbiol, Buffalo, NY 14214 USA; SUNY Buffalo, Sch Med, Ctr Microbial Pathogenesis, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Read, LK (corresponding author), SUNY Buffalo, Sch Med, Dept Microbiol, 138 Farber Hall, Buffalo, NY 14214 USA.	lread@acsu.buffalo.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM053502] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53502] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER BK, 1991, MOL CELL BIOL, V11, P5878, DOI 10.1128/MCB.11.12.5878; Alfonzo JD, 1997, NUCLEIC ACIDS RES, V25, P3751, DOI 10.1093/nar/25.19.3751; Allen TE, 1998, MOL CELL BIOL, V18, P6014, DOI 10.1128/MCB.18.10.6014; ANSORGE W, 1985, J BIOCHEM BIOPH METH, V11, P13, DOI 10.1016/0165-022X(85)90037-5; Arts GJ, 1996, BBA-GENE STRUCT EXPR, V1307, P39; AUSABEL F, 1995, CURRENT PROTOCOLS MO; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; BRADDOCK M, 1994, NUCLEIC ACIDS RES, V22, P5255, DOI 10.1093/nar/22.24.5255; Bringaud F, 1997, MOL CELL BIOL, V17, P3915, DOI 10.1128/MCB.17.7.3915; BRINGAUD F, 1995, MOL BIOCHEM PARASIT, V71, P65, DOI 10.1016/0166-6851(95)00023-T; BRUN R, 1979, ACTA TROP, V36, P289; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Franco GR, 1997, GENE, V198, P5, DOI 10.1016/S0378-1119(97)00261-8; GOLDSTEIN J, 1990, P NATL ACAD SCI USA, V87, P283, DOI 10.1073/pnas.87.1.283; GORINGER HU, 1994, P NATL ACAD SCI USA, V91, P1776, DOI 10.1073/pnas.91.5.1776; Graumann P, 1997, MOL MICROBIOL, V25, P741, DOI 10.1046/j.1365-2958.1997.5121878.x; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; HANCOCK K, 1992, J BIOL CHEM, V267, P23963; HARRIS ME, 1990, J BIOL CHEM, V265, P11368; Hermann T, 1997, NUCLEIC ACIDS RES, V25, P2311, DOI 10.1093/nar/25.12.2311; JASMER DP, 1985, MOL CELL BIOL, V5, P3041, DOI 10.1128/MCB.5.11.3041; Jiang WN, 1997, J BIOL CHEM, V272, P196; KICK D, 1987, NUCLEIC ACIDS RES, V15, P4099, DOI 10.1093/nar/15.10.4099; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; KOLLER J, 1994, NUCLEIC ACIDS RES, V22, P1988, DOI 10.1093/nar/22.11.1988; Koller J, 1997, J BIOL CHEM, V272, P3749, DOI 10.1074/jbc.272.6.3749; KOSLOWSKY DJ, 1992, MOL CELL BIOL, V12, P2043, DOI 10.1128/MCB.12.5.2043; LANDSMAN D, 1992, NUCLEIC ACIDS RES, V20, P2861, DOI 10.1093/nar/20.11.2861; LEEGWATER P, 1995, EUR J BIOCHEM, V227, P780, DOI 10.1111/j.1432-1033.1995.tb20201.x; Matsumoto K, 1998, TRENDS CELL BIOL, V8, P318, DOI 10.1016/S0962-8924(98)01300-2; Matsumoto K, 1996, J BIOL CHEM, V271, P22706, DOI 10.1074/jbc.271.37.22706; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; PARSONS M, 1991, EXP PARASITOL, V73, P101, DOI 10.1016/0014-4894(91)90012-L; POLLARD VW, 1990, CELL, V63, P783, DOI 10.1016/0092-8674(90)90144-4; READ LK, 1994, MOL CELL BIOL, V14, P2629, DOI 10.1128/MCB.14.4.2629; RILEY GR, 1995, NUCLEIC ACIDS RES, V23, P708, DOI 10.1093/nar/23.4.708; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; Salvetti A, 1998, DEV BIOL, V201, P217, DOI 10.1006/dbio.1998.8996; SCHMID B, 1995, NUCLEIC ACIDS RES, V23, P3093, DOI 10.1093/nar/23.16.3093; SEIWERT SD, 1994, SCIENCE, V266, P114, DOI 10.1126/science.7524149; SKEHEL PA, 1994, GENE, V145, P231, DOI 10.1016/0378-1119(94)90011-6; Sommerville J, 1996, FASEB J, V10, P435, DOI 10.1096/fasebj.10.4.8647342; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; Thieringer HA, 1997, NUCLEIC ACIDS RES, V25, P4764, DOI 10.1093/nar/25.23.4764; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vanhamme L, 1998, J BIOL CHEM, V273, P21825, DOI 10.1074/jbc.273.34.21825	48	85	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12067	12074		10.1074/jbc.274.17.12067	http://dx.doi.org/10.1074/jbc.274.17.12067			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207031	hybrid			2022-12-27	WOS:000079834800087
J	Suetomi, K; Lu, ZJ; Heck, T; Wood, TG; Prusak, DJ; Dunn, KJ; Navarro, J				Suetomi, K; Lu, ZJ; Heck, T; Wood, TG; Prusak, DJ; Dunn, KJ; Navarro, J			Differential mechanisms of recognition and activation of interleukin-8 receptor subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; AMINO TERMINUS; PROTEIN; BINDING; CHEMOKINES; EXPRESSION; NEUTROPHIL; SURFACE; IDENTIFICATION; SPECIFICITY	We have probed an epitope sequence (His(18)-Pro(19)- Lys(20)-Phe(21)) in interleukin-8 (IL-8) by site-directed mutagenesis, This work shows that single and double Ala substitutions of His(18) and Phe(21) in IL-8 reduced up to 77-fold the binding affinity to IL-8 receptor subtypes A (CXCR1) and B (CXCR2) and to the Duffy antigen. These Ala mutants triggered neutrophil degranulation and induced calcium responses mediated by CXCR1 and CXCR2, Single Asp or Ser substitutions, H18D, F21D, F21S, and double substitutions, H18A/F21D, H18A/F21S, and H18D/F21D, reduced up to 431-fold the binding affinity to CXCR1, CXCR2, and the Duffy antigen, Interestingly, double mutants with charged residue substitutions failed to trigger degranulation or to induce wildtype calcium responses mediated by CXCR1, Except for the H18A and F21A mutants, all other IL-8 mutants failed to induce superoxide production in neutrophils, This study demonstrates that IL-8 recognizes and activates CXCR1, CXCR2, and the Duffy antigen by distinct mechanisms.	Univ Texas, Med Branch, Dept Physiol & Biophys, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA; Genet Inst, Cambridge, MA 02140 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Navarro, J (corresponding author), Univ Texas, Med Branch, Dept Physiol & Biophys, Galveston, TX 77555 USA.		Wood, Thomas/GWZ-2481-2022; Wood, Thomas/B-6172-2012	Wood, Thomas/0000-0001-8962-8571; Navarro, Javier/0000-0001-7098-4373	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034031] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34031] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; BALDWIN ET, 1991, P NATL ACAD SCI USA, V88, P502, DOI 10.1073/pnas.88.2.502; Baly D, 1997, METHOD ENZYMOL, V287, P69; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075; CLARKLEWIS I, 1993, P NATL ACAD SCI USA, V90, P3574, DOI 10.1073/pnas.90.8.3574; CLORE GM, 1995, FASEB J, V9, P57, DOI 10.1096/fasebj.9.1.7821760; CLUBB RT, 1994, FEBS LETT, V338, P93, DOI 10.1016/0014-5793(94)80123-1; GAYLE RB, 1993, J BIOL CHEM, V268, P7283; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hammond MEW, 1996, J BIOL CHEM, V271, P8228, DOI 10.1074/jbc.271.14.8228; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; HORUK R, 1994, J BIOL CHEM, V269, P17730; HORUK R, 1994, IMMUNOL TODAY, V15, P169, DOI 10.1016/0167-5699(94)90314-X; HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3; LAROSA GJ, 1992, J BIOL CHEM, V267, P25402; LEE J, 1992, J BIOL CHEM, V267, P16283; LU ZJ, 1995, BIO-TECHNOL, V13, P366, DOI 10.1038/nbt0495-366; MOSER B, 1990, J EXP MED, V171, P1797, DOI 10.1084/jem.171.5.1797; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Prado GN, 1996, J BIOL CHEM, V271, P19186, DOI 10.1074/jbc.271.32.19186; SCHRAUFSTATTER IU, 1995, J BIOL CHEM, V270, P10428, DOI 10.1074/jbc.270.18.10428; SKLAR LA, 1985, J BIOL CHEM, V260, P1461; THOMAS KM, 1991, J BIOL CHEM, V266, P14839; Williams G, 1996, J BIOL CHEM, V271, P9579, DOI 10.1074/jbc.271.16.9579; WILLIAMSON K, 1988, BIOCHEMISTRY-US, V27, P5371, DOI 10.1021/bi00414a062; WOOD TG, 1994, CHALL MOD MED, V3, P217; WYMANN MP, 1987, ANAL BIOCHEM, V165, P371, DOI 10.1016/0003-2697(87)90284-3	29	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11768	11772		10.1074/jbc.274.17.11768	http://dx.doi.org/10.1074/jbc.274.17.11768			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206993	hybrid			2022-12-27	WOS:000079834800049
J	Tan, MJ; Li, SJ; Swaroop, MJ; Guan, KL; Oberley, LW; Sun, Y				Tan, MJ; Li, SJ; Swaroop, MJ; Guan, KL; Oberley, LW; Sun, Y			Transcriptional activation of the human glutathione peroxidase promoter by p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; NUCLEAR ANTIGEN PROMOTER; TUMOR-SUPPRESSOR GENE; CARCINOMA CELL-LINES; NASOPHARYNGEAL CARCINOMA; ANTIOXIDANT ENZYMES; TISSUE INHIBITOR; CYCLE CONTROL; BINDING-SITE; DNA-DAMAGE	Glutathione peroxidase (GPX) is a primary antioxidant enzyme that scavenges hydrogen peroxide or organic hydroperoxides. We have recently found that GPX is induced by etoposide, a topoisomerase II inhibitor and a p53 activator. In a search for a cis-element that confers potential p53 regulation of GPX, we identified a p53 binding site in the promoter of the GPX gene. This site bound to purified p53 as well as p53 in nuclear extract activated by etoposide. A luciferase reporter driven by a 262-base pair GPX promoter fragment was transcriptionally activated by wild type p53 in a p53 binding site-dependent manner. The same reporter was also activated in a p53 binding site-independent manner by several p53 mutants. The p53 binding and transactivation of the GPX promoter were enhanced by etoposide in p53-positive U2-OS cells. Etoposide-induced transactivation was blocked by a dominant negative p53 mutant, indicating that endogenous wild type p53, upon activation by etoposide, transactivated the GPX promoter, Furthermore, expression of endogenous GPX was induced significantly at both mRNA and enzyme activity levels by etoposide in U2-OS cells but not in p53-negative Saos-2 cells. This is the first report demonstrating that GPX is a novel p53 target gene. The finding links the p53 tumor suppressor to an antioxidant enzyme and will facilitate study of the p53 signaling pathway and antioxidant enzyme regulation.	Parke Davis Pharmaceut Res, Dept Mol Biol, Ann Arbor, MI 48105 USA; Univ Iowa, Radiat Res Lab, Iowa City, IA 52242 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Pfizer; University of Iowa; University of Michigan System; University of Michigan	Sun, Y (corresponding author), Parke Davis Pharmaceut Res, Dept Mol Biol, Ann Arbor, MI 48105 USA.		Guan, Kun-Liang/ADK-7088-2022	Swaroop, Manju/0000-0002-0576-1664				ASAHI M, 1995, J BIOL CHEM, V270, P21035, DOI 10.1074/jbc.270.36.21035; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bian JH, 1997, P NATL ACAD SCI USA, V94, P14753, DOI 10.1073/pnas.94.26.14753; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Bian JH, 1996, CARCINOGENESIS, V17, P2559, DOI 10.1093/carcin/17.12.2559; BLUM J, 1985, ARCH BIOCHEM BIOPHYS, V240, P500, DOI 10.1016/0003-9861(85)90056-6; Bouck N, 1996, BBA-REV CANCER, V1287, P63, DOI 10.1016/0304-419X(96)00005-4; CHADA S, 1990, GENOMICS, V6, P268, DOI 10.1016/0888-7543(90)90566-D; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; CHIN KV, 1992, SCIENCE, V255, P459, DOI 10.1126/science.1346476; CHU FF, 1993, J BIOL CHEM, V268, P2571; COWAN DB, 1992, J MOL CELL CARDIOL, V24, P423, DOI 10.1016/0022-2828(92)93196-Q; COWAN DB, 1993, J BIOL CHEM, V268, P26904; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; DEB S, 1992, J VIROL, V66, P6164, DOI 10.1128/JVI.66.10.6164-6170.1992; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Flohe L., 1989, GLUTATHIONE CHEM BIO, P644; FRANK L, 1984, PEDIATR RES, V18, P240, DOI 10.1203/00006450-198403000-00004; Fuchs EJ, 1997, CANCER RES, V57, P2550; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; GOLDSMITH ME, 1995, J BIOL CHEM, V270, P2894; GREENBLATT MS, 1994, CANCER RES, V54, P4855; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; IGRISHI T, 1985, J BIOCH, V9, P117; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1995, CANCER METAST REV, V14, P3, DOI 10.1007/BF00690207; Kayanoki Y, 1996, J BIOCHEM-TOKYO, V119, P817; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Komarova EA, 1998, ONCOGENE, V17, P1089, DOI 10.1038/sj.onc.1202303; LAI GM, 1991, INT J CANCER, V49, P688, DOI 10.1002/ijc.2910490511; LANE DP, 1994, BRIT MED BULL, V50, P582, DOI 10.1093/oxfordjournals.bmb.a072911; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIEBMANN J, 1995, CANCER RES, V55, P4465; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; LOWE SW, 1994, COLD SPRING HARB SYM, V59, P419, DOI 10.1101/SQB.1994.059.01.047; LudesMeyers JH, 1996, MOL CELL BIOL, V16, P6009; Masanek U, 1997, ANTI-CANCER DRUG, V8, P189, DOI 10.1097/00001813-199702000-00010; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MILLS GC, 1957, J BIOL CHEM, V229, P189; MIRAULT ME, 1991, J BIOL CHEM, V266, P20752; MIYASHITA T, 1995, CELL, V80, P293; Morris GF, 1996, P NATL ACAD SCI USA, V93, P895, DOI 10.1073/pnas.93.2.895; MOSCOW JA, 1989, MOL PHARMACOL, V36, P22; MOSCOW JA, 1992, J BIOL CHEM, V267, P5949; MULLENBACH GT, 1988, PROTEIN ENG, V2, P239, DOI 10.1093/protein/2.3.239; OGAWA J, 1993, CANCER-AM CANCER SOC, V71, P2204, DOI 10.1002/1097-0142(19930401)71:7<2204::AID-CNCR2820710707>3.0.CO;2-O; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; PAGILA DE, 1967, J LAB CLIN MED, V70, P158; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; RAYCROFT L, 1991, MOL CELL BIOL, V11, P6067, DOI 10.1128/MCB.11.12.6067; ROTTER V, 1994, SEMIN CANCER BIOL, V5, P229; SELIVANOVA G, 1995, ADV CANCER RES, V66, P143, DOI 10.1016/S0065-230X(08)60253-5; SHIVAKUMAR CV, 1995, MOL CELL BIOL, V15, P6785; SPALLHOLZ JE, 1991, PEROXIDASES CHEM BIO, V1, P259; SUKENAGA Y, 1987, NUCLEIC ACIDS RES, V15, P7178, DOI 10.1093/nar/15.17.7178; SUN Y, 1993, P NATL ACAD SCI USA, V90, P2827, DOI 10.1073/pnas.90.7.2827; SUN Y, 1994, CANCER RES, V54, P1139; Sun Y, 1997, ONCOGENE, V14, P385, DOI 10.1038/sj.onc.1200834; SUN Y, 1993, FASEB J, V7, P944, DOI 10.1096/fasebj.7.10.8344492; SUN Y, 1990, FREE RADICAL BIO MED, V8, P583, DOI 10.1016/0891-5849(90)90156-D; Tan MJ, 1999, FEBS LETT, V445, P265, DOI 10.1016/S0014-5793(99)00135-0; THUKRAL SK, 1995, MOL CELL BIOL, V15, P5196; URSINI F, 1987, CHEM PHYS LIPIDS, V44, P255, DOI 10.1016/0009-3084(87)90053-3; VOJTA PJ, 1995, BBA-REV CANCER, V1242, P29, DOI 10.1016/0304-419X(95)00002-W; VOLM M, 1995, INT J CANCER, V63, P193, DOI 10.1002/ijc.2910630208; Wallingford JB, 1997, CURR BIOL, V7, P747, DOI 10.1016/S0960-9822(06)00333-2; Wang YX, 1999, FEBS LETT, V445, P269, DOI 10.1016/S0014-5793(99)00136-2; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7	73	185	192	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					12061	12066		10.1074/jbc.274.17.12061	http://dx.doi.org/10.1074/jbc.274.17.12061			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10207030	hybrid			2022-12-27	WOS:000079834800086
J	Zhu, GY; Qu, ZQ; Cui, NG; Jiang, C				Zhu, GY; Qu, ZQ; Cui, NG; Jiang, C			Suppression of Kir2.3 activity by protein kinase C phosphorylation of the channel protein at threonine 53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER POTASSIUM CHANNEL; RECTIFYING K+ CHANNEL; XENOPUS OOCYTES; DUAL MODULATION; INHIBITION; NEURONS; ATP; CONDUCTANCE; CELLS	Kir2.3 plays an important part in the maintenance of membrane potential in neurons and myocardium. Identification of intracellular signaling molecules controlling this channel thus may lead to an understanding of the regulation of membrane excitability. To determine whether Kir2.3 is modulated by direct phosphorylation of its channel protein and identify the phosphorylation site of protein kinase C (PKC), we performed experiments using several recombinant and mutant Kir2.3 channels, Whole-cell Kir2.3 currents were inhibited by phorbol la-myristate 13-acetate (PMA) in Xenopus oocytes. When the N-terminal region of Kir2.3 was replaced with that of Kir2.1, another member in the Kir2 family that is insensitive to PMA, the chimerical channel lost its PMA sensitivity. However, substitution of the C terminus was ineffective. Four potential PKC phosphorylation sites in the N terminus were studied by comparing mutations of serine or threonine with their counterpart residues in Kir2.1. Whereas substitutions of serine residues at positions 5, 36, and 39 had no effect on the channel sensitivity to PMA, mutation of threonine 53 completely eliminated the channel response to PMA. Interestingly, creation of this threonine residue at the corresponding position (I79T) in Kir2.1 lent the mutant channel a PMA sensitivity almost identical to the wildtype Kir2.3. These results therefore indicate that Kir2.3 is directly modulated by PKC phosphorylation of its channel protein and threonine 53 is the PKC phosphorylation site in Kir2.3.	Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Jiang, C (corresponding author), Georgia State Univ, Dept Biol, 24 Peachtree Cent Ave, Atlanta, GA 30303 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058410] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58410-01, R01 HL058410] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Cohen NA, 1996, J BIOL CHEM, V271, P32301, DOI 10.1074/jbc.271.50.32301; COULTER KL, 1995, NEURON, V15, P1157, DOI 10.1016/0896-6273(95)90103-5; DiMagno L, 1996, PFLUG ARCH EUR J PHY, V431, P335, DOI 10.1007/BF02207270; FAKLER B, 1994, NEURON, V13, P1413, DOI 10.1016/0896-6273(94)90426-X; Garcia DE, 1998, J NEUROSCI, V18, P2834; Henry P, 1996, J PHYSIOL-LONDON, V495, P681, DOI 10.1113/jphysiol.1996.sp021625; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; Jiang C, 1997, J NEUROPHYSIOL, V77, P93, DOI 10.1152/jn.1997.77.1.93; JIANG C, 1994, J NEUROSCI, V14, P5590; Jones SVP, 1997, NEUROPHARMACOLOGY, V36, P209, DOI 10.1016/S0028-3908(96)00142-6; Macica CM, 1998, AM J PHYSIOL-RENAL, V274, pF175, DOI 10.1152/ajprenal.1998.274.1.F175; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; PERIER F, 1994, P NATL ACAD SCI USA, V91, P6240, DOI 10.1073/pnas.91.13.6240; SATO R, 1995, J MEMBRANE BIOL, V148, P185; SCHWAB A, 1993, J MEMBRANE BIOL, V132, P125; Shin KS, 1997, J BIOL CHEM, V272, P21227, DOI 10.1074/jbc.272.34.21227; Shyng SL, 1996, P NATL ACAD SCI USA, V93, P12014, DOI 10.1073/pnas.93.21.12014; SULLIVAN SK, 1990, P NATL ACAD SCI USA, V87, P4553, DOI 10.1073/pnas.87.12.4553; TABCHARANI JA, 1994, J MEMBRANE BIOL, V142, P255; TAKANO K, 1995, NEURON, V14, P999, DOI 10.1016/0896-6273(95)90338-0; TANG WM, 1994, FEBS LETT, V348, P239, DOI 10.1016/0014-5793(94)00612-1; Visentin S, 1997, J NEUROSCI RES, V47, P233; WANG WH, 1991, P NATL ACAD SCI USA, V88, P9722, DOI 10.1073/pnas.88.21.9722; Welling PA, 1997, AM J PHYSIOL-RENAL, V273, pF825, DOI 10.1152/ajprenal.1997.273.5.F825; WU T, 1995, NEUROSCI LETT, V184, P121, DOI 10.1016/0304-3940(94)11185-L	25	32	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11643	11646		10.1074/jbc.274.17.11643	http://dx.doi.org/10.1074/jbc.274.17.11643			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206975	hybrid			2022-12-27	WOS:000079834800031
J	Zou, H; Li, YC; Liu, HS; Wang, XD				Zou, H; Li, YC; Liu, HS; Wang, XD			An APAF-1 center dot cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; CYTOCHROME-C; ELEGANS CED-4; PROTEASE; PATHWAYS; OLIGOMERIZATION; REQUIREMENT; CASPASE-3; APAF-1; DATP	We report here the reconstitution of the de novo procaspase-9 activation pathway using highly purified cytochrome c, recombinant APAF-1, and recombinant procaspase-9, APAF-1 binds and hydrolyzes ATP or dATP to ADP or dADP, respectively. The hydrolysis of ATP/dATP and the binding of cytochrome c promote APAF-1 oligomerization, forming a large multimeric APAF-1 cytochrome c complex. Such a complex can be isolated using gel filtration chromatography and is by itself sufficient to recruit and activate procaspase-9, The stoichiometric ratio of procaspase-9 to APAF-1 is approximately 1 to 1 in the complex. Once activated, caspase-9 disassociates from the complex and becomes available to cleave and activate downstream caspases such as caspase-3.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Howard Hughes Inst, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wang, XD (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	xwang@biochem.swmed.edu		Wang, Xiaodong/0000-0001-9885-356X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057158] Funding Source: NIH RePORTER; NIGMS NIH HHS [GMRO1-57158] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chinnaiyan AM, 1997, SCIENCE, V275, P1122, DOI 10.1126/science.275.5303.1122; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Seshagiri S, 1997, CURR BIOL, V7, P455, DOI 10.1016/S0960-9822(06)00216-8; SKOOG L, 1974, J BIOL CHEM, V249, P6434; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang XL, 1998, SCIENCE, V281, P1355, DOI 10.1126/science.281.5381.1355; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; YUAN JY, 1992, DEVELOPMENT, V116, P309; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	31	1694	1783	4	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	1999	274	17					11549	11556		10.1074/jbc.274.17.11549	http://dx.doi.org/10.1074/jbc.274.17.11549			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	188EX	10206961	hybrid			2022-12-27	WOS:000079834800017
J	Li, J; Wang, CC				Li, J; Wang, CC			"Half of the sites" binding of D-glyceraldehyde-3-phosphate dehydrogenase folding intermediate with GroEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; CHAPERONE-LIKE ACTIVITY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; THERMOTOGA-MARITIMA; LOW-TEMPERATURE; ATP; REACTIVATION; DISSOCIATION; CONSEQUENCES; DENATURATION	Two D-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) folding intermediate subunits bind with chaperonin 60 (GroEL) to form a stable complex, which can no longer bind with additional GAPDH intermediate subunits, but does bind with one more lysozyme folding intermediate or one chaperonin 10 (GroES) molecule, suggesting that the two GAPDH subunits bind at one end of the GroEL molecule displaying a "half of the sites" binding profile. For lysozyme, GroEL binds with either one or two folding intermediates to form a stable 1:1 or 1:2 complex with one substrate on each end of the GroEL double ring for the latter, The 1:1 complex of GroEL.GroES binds with one lysozyme or one dimeric GAPDH folding intermediate to form a stable ternary complex. Both complexes of GroEL lysozyme, and GroEL GAPDH, bind with one GroES molecule only at the other end of the GroEL molecule forming a trans ternary complex. According to the stoichiometry of GroEL binding with the GAPDH folding intermediate and the formation of ternary complexes containing GroEL GAPDH,, it is suggested that the folding intermediate of GAPDH binds, very likely in the dimeric form, with GroEL at one end only.	Acad Sinica, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Wang, CC (corresponding author), Acad Sinica, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.							AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; BARTHOLMES P, 1978, EUR J BIOCHEM, V87, P563, DOI 10.1111/j.1432-1033.1978.tb12407.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; CAI H, 1994, J BIOL CHEM, V269, P24550; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Churchich JE, 1997, J BIOL CHEM, V272, P19645, DOI 10.1074/jbc.272.32.19645; Clark AC, 1997, J MOL BIOL, V268, P512, DOI 10.1006/jmbi.1997.0969; CORRALES FJ, 1995, P NATL ACAD SCI USA, V92, P5326, DOI 10.1073/pnas.92.12.5326; Coyle JE, 1997, FOLD DES, V2, pR93, DOI 10.1016/S1359-0278(97)00046-1; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; GOLDBERG ME, 1991, BIOCHEMISTRY-US, V30, P2790, DOI 10.1021/bi00225a008; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; HE RQ, 1993, BIOCHIM BIOPHYS ACTA, V1163, P315, DOI 10.1016/0167-4838(93)90168-Q; ITZHAKI LS, 1995, BIOCHEMISTRY-US, V34, P14581, DOI 10.1021/bi00044a037; KREBS H, 1979, EUR J BIOCHEM, V100, P359, DOI 10.1111/j.1432-1033.1979.tb04178.x; LANDRY SJ, 1991, BIOCHEMISTRY-US, V30, P7359, DOI 10.1021/bi00244a001; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Li XL, 1998, BIOCHEM J, V331, P505, DOI 10.1042/bj3310505; LIN ZL, 1995, J BIOL CHEM, V270, P1011, DOI 10.1074/jbc.270.3.1011; MARANGOS PJ, 1974, BIOCHEMISTRY-US, V13, P904, DOI 10.1021/bi00702a012; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; PUIG A, 1994, J BIOL CHEM, V269, P7764; QUAN H, 1995, J BIOL CHEM, V270, P17078, DOI 10.1074/jbc.270.29.17078; REHABER V, 1992, J BIOL CHEM, V267, P10999; REHABER V, 1993, FEBS LETT, V317, P163, DOI 10.1016/0014-5793(93)81514-Z; RUDOLPH R, 1977, EUR J BIOCHEM, V81, P563, DOI 10.1111/j.1432-1033.1977.tb11983.x; SCHEEK RM, 1982, METHOD ENZYMOL, V89, P305; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; SCHULTES V, 1991, FEBS LETT, V290, P235, DOI 10.1016/0014-5793(91)81268-D; Song SY, 1998, ACTA CRYSTALLOGR D, V54, P558, DOI 10.1107/S090744499701620X; Sparrer H, 1997, J BIOL CHEM, V272, P14080, DOI 10.1074/jbc.272.22.14080; Thiyagarajan P, 1996, STRUCTURE, V4, P79, DOI 10.1016/S0969-2126(96)00011-1; TILLY K, 1981, P NATL ACAD SCI-BIOL, V78, P1629, DOI 10.1073/pnas.78.3.1629; Torella C, 1998, J BIOL CHEM, V273, P3915, DOI 10.1074/jbc.273.7.3915; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zheng WD, 1997, ARCH BIOCHEM BIOPHYS, V337, P326, DOI 10.1006/abbi.1996.9783; ZHENG XX, 1993, J BIOL CHEM, V268, P7489	38	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 16	1999	274	16					10790	10794		10.1074/jbc.274.16.10790	http://dx.doi.org/10.1074/jbc.274.16.10790			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186VV	10196153	hybrid			2022-12-27	WOS:000079751900021
J	Guan, L; Ehrmann, M; Yoneyama, H; Nakae, T				Guan, L; Ehrmann, M; Yoneyama, H; Nakae, T			Membrane topology of the xenobiotic-exporting subunit, MexB, of the MexA,B-OprM extrusion pump in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKALINE-PHOSPHATASE FUSIONS; MULTIDRUG EFFLUX SYSTEM; GRAM-NEGATIVE BACTERIA; PHOA-GENE FUSIONS; ESCHERICHIA-COLI; INNER MEMBRANE; RESISTANCE GENE; DRUG EXTRUSION; ACTIVE EFFLUX; PROTEIN	The MexA,B-OprM efflux pump assembly of Pseudomonas aeruginosa consists of two inner membrane proteins and one outer membrane protein. The cytoplasmic membrane protein, MexB, appears to function as the xenobiotic-exporting subunit, whereas the MexA and OprM proteins are supposed to function as the membrane fusion protein and the outer membrane channel protein, respectively. Computer-aided hydropathy analyses of MexB predicted the presence of up to 17 potential transmembrane segments. To verify the prediction, we analyzed the membrane topology of MexB using the alkaline phosphatase gene fusion method. We obtained the following unique characteristics. MexB bears 12 membrane spanning segments leaving both the amino and carboxyl termini in the cytoplasmic side of the inner membrane. Both the first and fourth periplasmic loops had very long hydrophilic domains containing 311 and 314 amino acid residues, respectively. This fact suggests that these loops may interact with other pump subunits, such as the membrane fusion protein MexA and the outer membrane protein OprM, Alignment of the amino- and the carboxyl-terminal halves of MexB showed a 30% homology and transmembrane segments 1, 2, 3, 4, 5, and 6 could be overlaid with the segments 7, 8, 9, 10, 11, and 12, respectively. This result suggested that the MexB has a a-fold repeat that strengthen the experimentally determined topology model. This paper reports the structure of the pump subunit, MexB, of the MexA,B-OprM efflux pump assembly. This is the first time to verify the topology of the resistant-nodulation-division efflux pump protein.	Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 2591193, Japan; Univ Konstanz, Dept Biol, D-78457 Constance, Germany	Tokai University; University of Konstanz	Nakae, T (corresponding author), Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 2591193, Japan.	nakae@is.icc.u-tokai.ac.jp	Ehrmann, Michael/A-7307-2012; Guan, Lan/B-5288-2010	Ehrmann, Michael/0000-0002-1927-260X; 				ALLARD JD, 1992, J BIOL CHEM, V267, P17809; BOYD D, 1993, J BACTERIOL, V175, P553, DOI 10.1128/JB.175.2.553-556.1993; BROWN MRW, 1975, RESISTANCE PSEUDOMON, P71; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; DINH T, 1994, J BACTERIOL, V176, P3825, DOI 10.1128/JB.176.13.3825-3831.1994; DONG QH, 1994, MOL MICROBIOL, V14, P185, DOI 10.1111/j.1365-2958.1994.tb01278.x; EHRMANN M, 1990, P NATL ACAD SCI USA, V87, P7574, DOI 10.1073/pnas.87.19.7574; Ehrmann M, 1997, P NATL ACAD SCI USA, V94, P13111, DOI 10.1073/pnas.94.24.13111; Enomoto H, 1998, BBA-BIOMEMBRANES, V1370, P77, DOI 10.1016/S0005-2736(97)00245-9; FUJII R, 1994, JPN J CANCER RES, V85, P426, DOI 10.1111/j.1349-7006.1994.tb02376.x; FUKUDA H, 1990, ANTIMICROB AGENTS CH, V34, P1757, DOI 10.1128/AAC.34.9.1757; GOLDSTEIN LJ, 1989, J NATL CANCER I, V81, P116, DOI 10.1093/jnci/81.2.116; Gotoh N, 1998, FEMS MICROBIOL LETT, V165, P21, DOI 10.1016/S0378-1097(98)00250-X; GOTT P, 1988, MOL MICROBIOL, V2, P655, DOI 10.1111/j.1365-2958.1988.tb00074.x; GUTIERREZ C, 1989, NUCLEIC ACIDS RES, V17, P3999, DOI 10.1093/nar/17.10.3999; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HIRAI K, 1987, ANTIMICROB AGENTS CH, V31, P582, DOI 10.1128/AAC.31.4.582; Kohler T, 1997, MOL MICROBIOL, V23, P345, DOI 10.1046/j.1365-2958.1997.2281594.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEI Y, 1991, BIOCHEM BIOPH RES CO, V178, P1043, DOI 10.1016/0006-291X(91)90997-L; Ma Dzwokai, 1994, Trends in Microbiology, V2, P489, DOI 10.1016/0966-842X(94)90654-8; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; MANOIL C, 1990, J BACTERIOL, V172, P515, DOI 10.1128/jb.172.2.515-518.1990; MICHAELIS S, 1983, J BACTERIOL, V154, P366, DOI 10.1128/JB.154.1.366-374.1983; MORSHED SRM, 1995, BIOCHEM BIOPH RES CO, V210, P356, DOI 10.1006/bbrc.1995.1669; Nakae Taiji, 1997, J Infect Chemother, V3, P173, DOI 10.1007/BF02490031; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Ocaktan A, 1997, J BIOL CHEM, V272, P21964, DOI 10.1074/jbc.272.35.21964; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Ramos JL, 1998, J BACTERIOL, V180, P3323, DOI 10.1128/JB.180.13.3323-3329.1998; RELLA M, 1982, ANTIMICROB AGENTS CH, V22, P242, DOI 10.1128/AAC.22.2.242; SAIER MH, 1994, MOL MICROBIOL, V11, P841, DOI 10.1111/j.1365-2958.1994.tb00362.x; Srikumar R, 1997, J BACTERIOL, V179, P7875, DOI 10.1128/jb.179.24.7875-7881.1997; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Yoneyama H, 1997, BIOCHEM BIOPH RES CO, V233, P611, DOI 10.1006/bbrc.1997.6506; Yoneyama H, 1998, BIOCHEM BIOPH RES CO, V244, P898, DOI 10.1006/bbrc.1998.8351	38	49	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10517	10522		10.1074/jbc.274.15.10517	http://dx.doi.org/10.1074/jbc.274.15.10517			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187844	hybrid			2022-12-27	WOS:000079663500083
J	Roux, S; Terouanne, B; Couette, B; Rafestin-Oblin, ME; Nicolas, JC				Roux, S; Terouanne, B; Couette, B; Rafestin-Oblin, ME; Nicolas, JC			Conformational change in the human glucocorticoid receptor induced by ligand binding is altered by mutation of isoleucine 747 by a threonine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; RETINOIC ACID RECEPTOR; HEAT-SHOCK PROTEIN; ESTROGEN-RECEPTOR; NUCLEAR RECEPTORS; ANDROGEN RECEPTOR; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; TRANSACTIVATION DOMAIN; PROGESTERONE-RECEPTOR	Limited proteolysis experiments were performed to study conformation changes induced by ligand binding on in vitro produced wild-type and 1747T mutant glucocorticoid receptors, Dexamethasone-induced conformational changes were characterized by two resistant proteolysis fragments of 30 and 27 kDa. Although dexamethasone binding affinity was only slightly altered by the 1747T substitution (Roux, S., Terouanne, B., Balaguer, P., Loffreda-Jausons, N., Pons, M., Chambon, P., Gronemeyer, H., and Nicolas, J,-C, (1996) Mot. Endocrinol, 10, 1214-1226), higher dexamethasone concentrations were required to obtain the same proteolysis pattern. This difference was less marked when proteolysis experiments were conducted at 0 degrees C, indicating that a step of the conformational change after ligand binding was affected by the mutation. In contrast, RU486 binding to the wild-type receptor induced a different conformational change that was not affected by the mutation. Analysis of proteolysis fragments obtained in the presence of dexamethasone or RU486 indicated that the RU486-induced conformational change affected the C-terminal part of the ligand binding domain differently. These data suggest that the ligand-induced conformational change occurs via a multistep process. In the first step, characterized by compaction of the ligand binding domain, the mutation has no effect, The second step, which stabilizes the activated conformation and does not occur at 4 degrees C, seems to be a key element in the activation process that can be altered by the mutation. This step could involve modification of the helix H12 position, explaining why the conformation induced by RU486 is not affected by the mutation.	INSERM, U439, F-34090 Montpellier, France; Fac Med Xavier Bichat, INSERM, U478, F-75870 Paris 18, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Nicolas, JC (corresponding author), INSERM, U439, 70 Rue Navacelles, F-34090 Montpellier, France.		Roux, Stephane/X-1326-2019; Couette, Brigitte/N-5579-2018	Roux, Stephane/0000-0003-4885-6732; 				ALLAN GF, 1992, J BIOL CHEM, V267, P19513; ALLAN GF, 1992, P NATL ACAD SCI USA, V89, P11750, DOI 10.1073/pnas.89.24.11750; BARETTINO D, 1994, EMBO J, V13, P3039, DOI 10.1002/j.1460-2075.1994.tb06603.x; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BEEKMAN JM, 1993, MOL ENDOCRINOL, V7, P1266, DOI 10.1210/me.7.10.1266; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Carlson KE, 1997, BIOCHEMISTRY-US, V36, P14897, DOI 10.1021/bi971746l; CHEN DG, 1994, MOL ENDOCRINOL, V8, P422, DOI 10.1210/me.8.4.422; Couette B, 1996, BIOCHEM J, V315, P421, DOI 10.1042/bj3150421; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; Danielson M, 1991, NUCLEAR HORMONE RECE, P39; DEBELLIS A, 1994, J CLIN ENDOCR METAB, V78, P513, DOI 10.1210/jc.78.3.513; DENIS M, 1988, J BIOL CHEM, V263, P18520; DENIS M, 1988, NATURE, V333, P686, DOI 10.1038/333686a0; DENIS M, 1989, J BIOL CHEM, V264, P6005; DURAND B, 1994, EMBO J, V13, P5370, DOI 10.1002/j.1460-2075.1994.tb06872.x; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; HALACHMI S, 1994, SCIENCE, V264, P1455, DOI 10.1126/science.8197458; Henttu PMA, 1997, MOL CELL BIOL, V17, P1832, DOI 10.1128/MCB.17.4.1832; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; HURLEY DM, 1991, J CLIN INVEST, V87, P680, DOI 10.1172/JCI115046; KALLIO PJ, 1994, ENDOCRINOLOGY, V134, P998, DOI 10.1210/en.134.2.998; KANG KI, 1994, P NATL ACAD SCI USA, V91, P340, DOI 10.1073/pnas.91.1.340; KEIDEL S, 1994, MOL CELL BIOL, V14, P287, DOI 10.1128/MCB.14.1.287; KEIGHTLEY MC, 1994, MOL ENDOCRINOL, V8, P431, DOI 10.1210/me.8.4.431; KUIL CW, 1995, J BIOL CHEM, V270, P27569, DOI 10.1074/jbc.270.46.27569; KUIL CW, 1994, MOL CELL ENDOCRINOL, V102, pR1, DOI 10.1016/0303-7207(94)90112-0; LEE SY, 1995, MOL ENDOCRINOL, V9, P826, DOI 10.1210/me.9.7.826; LEID M, 1994, J BIOL CHEM, V269, P14175; LENG XH, 1995, MOL CELL BIOL, V15, P255, DOI 10.1128/MCB.15.1.255; LENG XH, 1993, J STEROID BIOCHEM, V46, P643, DOI 10.1016/0960-0760(93)90306-H; MALCHOFF DM, 1993, J CLIN INVEST, V91, P1918, DOI 10.1172/JCI116410; MCDONNELL DP, 1995, MOL ENDOCRINOL, V9, P659, DOI 10.1210/me.9.6.659; Modarress KJ, 1997, J BIOL CHEM, V272, P23986, DOI 10.1074/jbc.272.38.23986; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; ONATE SA, 1995, SCIENCE, V270, P1354; Parker MG, 1993, CURR OPIN CELL BIOL, V5, P499, DOI 10.1016/0955-0674(93)90016-J; PELEG S, 1995, J BIOL CHEM, V270, P10551, DOI 10.1074/jbc.270.18.10551; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Roux S, 1996, MOL ENDOCRINOL, V10, P1214, DOI 10.1210/me.10.10.1214; RUSCONI S, 1987, EMBO J, V6, P1309, DOI 10.1002/j.1460-2075.1987.tb02369.x; SAATCIOGLU F, 1993, MOL CELL BIOL, V13, P3675, DOI 10.1128/MCB.13.6.3675; SANCHEZ ER, 1987, J BIOL CHEM, V262, P6986; SCHERRER LC, 1993, BIOCHEMISTRY-US, V32, P5381, DOI 10.1021/bi00071a013; SEIELSTAD DA, 1995, BIOCHEMISTRY-US, V34, P12605, DOI 10.1021/bi00039a016; SIMONS SS, 1989, J BIOL CHEM, V264, P14493; SIMONS SS, 1994, VITAM HORM, P49; SMITH DF, 1990, MOL ENDOCRINOL, V4, P1704, DOI 10.1210/mend-4-11-1704; SMITH DF, 1993, MOL ENDOCRINOL, V7, P4, DOI 10.1210/me.7.1.4; TATE BF, 1994, MOL CELL BIOL, V14, P2323, DOI 10.1128/MCB.14.4.2323; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; TRAPP T, 1995, BIOCHEM BIOPH RES CO, V215, P286, DOI 10.1006/bbrc.1995.2464; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; WARRIAR N, 1994, J BIOL CHEM, V269, P29010; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; WEISS K, 1996, MOL ENDOCRINOL, V10, P1338; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; ZHENG Z, 1994, ENDOCRINOLOGY, V135, P248; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	63	14	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10059	10065		10.1074/jbc.274.15.10059	http://dx.doi.org/10.1074/jbc.274.15.10059			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187785	hybrid			2022-12-27	WOS:000079663500024
J	Sakurai, H; Miyoshi, H; Toriumi, W; Sugita, T				Sakurai, H; Miyoshi, H; Toriumi, W; Sugita, T			Functional interactions of transforming growth factor beta-activated kinase 1 with I kappa B kinases to stimulate NF-kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC PHOSPHORYLATION; TUMOR-NECROSIS-FACTOR; SIGNAL-TRANSDUCTION; IKK-ALPHA; TERMINAL KINASE; PROTEIN; COMPLEX; DEGRADATION; UBIQUITINATION; FAMILY	Several mitogen-activated protein kinase kinase kinases play critical roles in nuclear factor-kappa B (NF-kappa B) activation. We recently reported that the overexpression of transforming growth factor-beta-activated kinase 1 (TAK1), a member of the mitogen-activated protein kinase kinase kinase family, together with its activator TAK1-binding protein 1 (TAB1) stimulates NF-kappa B activation. Here we investigated the molecular mechanism of TAK1-induced NF-kappa B activation. Dominant negative mutants of I kappa B kinase (IKK) alpha and IKK beta inhibited TAK1-induced NF-kappa B activation, TAK1 activated IKK alpha and IKK beta in the presence of TAB1, IKK alpha and IKK beta were coimmunoprecipitated with TAK1 in the absence of TAB1. TAB1-induced TAK1 activation promoted the dissociation of active forms of IKK alpha and IKK beta from active TAK1, whereas the IKK mutants remained to interact with active TAK1, Furthermore, tumor necrosis factor-alpha activated endogenous TAK1, and the kinase-negative TAK1 acted as a dominant negative inhibitor against tumor necrosis factor-alpha induced NF-kappa B activation. These results demonstrated a novel signaling pathway to NF-kappa B activation through TAK1 in which TAK1 may act as a regulatory kinase of IKKs.	Tanabe Seiyaku Co Ltd, Discovery Res Lab, Yodogawa Ku, Osaka 5328505, Japan	Mitsubishi Tanabe Pharma Corporation	Sugita, T (corresponding author), Tanabe Seiyaku Co Ltd, Discovery Res Lab, Yodogawa Ku, 16-89 Kashima 3 Chome, Osaka 5328505, Japan.		Sakurai, Hiroaki/AAE-4294-2019	Sakurai, Hiroaki/0000-0003-0657-9570				Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chu ZL, 1998, J BIOL CHEM, V273, P15891, DOI 10.1074/jbc.273.26.15891; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; EllingerZiegelbauer H, 1997, J BIOL CHEM, V272, P2668, DOI 10.1074/jbc.272.5.2668; Ghoda L, 1997, J BIOL CHEM, V272, P21281, DOI 10.1074/jbc.272.34.21281; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hirano M, 1996, J BIOL CHEM, V271, P13234, DOI 10.1074/jbc.271.22.13234; HU MC, 1996, GENE DEV, V10, P2551; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Li Z, 1997, MOL CELL BIOL, V17, P6184, DOI 10.1128/MCB.17.10.6184; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Meyer CF, 1996, J BIOL CHEM, V271, P8971, DOI 10.1074/jbc.271.15.8971; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rodriguez MS, 1996, ONCOGENE, V12, P2425; Roff M, 1996, J BIOL CHEM, V271, P7844, DOI 10.1074/jbc.271.13.7844; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; SAKURAI H, 1992, J NEUROCHEM, V59, P2067; Sakurai H, 1998, BIOCHEM BIOPH RES CO, V243, P545, DOI 10.1006/bbrc.1998.8124; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Simeonidis S, 1997, P NATL ACAD SCI USA, V94, P14372, DOI 10.1073/pnas.94.26.14372; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; Weil R, 1997, J BIOL CHEM, V272, P9942; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xu SC, 1996, P NATL ACAD SCI USA, V93, P5291, DOI 10.1073/pnas.93.11.5291; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x	51	197	205	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10641	10648		10.1074/jbc.274.15.10641	http://dx.doi.org/10.1074/jbc.274.15.10641			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187861	hybrid			2022-12-27	WOS:000079663500100
J	Walters, RW; Grunst, T; Bergelson, JM; Finberg, RW; Welsh, MJ; Zabner, J				Walters, RW; Grunst, T; Bergelson, JM; Finberg, RW; Welsh, MJ; Zabner, J			Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED GENE-TRANSFER; CYSTIC-FIBROSIS; TRACHEAL EPITHELIUM; NASAL EPITHELIUM; HELA-CELLS; COOPERATIVE BINDING; IN-VITRO; VIRUS; ENTRY; VECTOR	Recent identification of two receptors for the adenovirus fiber protein, coxsackie B and adenovirus type 2 and 5 receptor (CAR), and the major histocompatibility complex (MHC) Class I alpha-2 domain allows the molecular basis of adenoviral infection to be investigated. Earlier work has shown that human airway epithelia are resistant to infection by adenovirus, Therefore, we examined the expression and localization of CAR and MHC Class I in an in vitro model of well differentiated, ciliated human airway epithelia. We found that airway epithelia express CAR and MHC Class I. However, neither receptor was present in the apical membrane; instead, both were polarized to the basolateral membrane. These findings explain the relative resistance to adenovirus infection from the apical surface. In contrast, when the virus was applied to the basolateral surface, gene transfer was much more efficient because of an interaction of adenovirus fiber with its receptors, In addition, when the integrity of the tight junctions was transiently disrupted, apically applied adenovirus gained access to the basolateral surface and enhanced gene transfer. These data suggest that the receptors required for efficient infection are not available on the apical surface, and interventions that allow access to the basolateral space where fiber receptors are located increase gene transfer efficiency.	Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Childrens Hosp Philadelphia, Div Immunol & Infect Dis, Philadelphia, PA 19104 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Dana-Farber Cancer Institute	Zabner, J (corresponding author), Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Internal Med, 500 EMRB, Iowa City, IA 52242 USA.	Joseph-Zabner@uiowa.edu	Finberg, Robert W/E-3323-2010	Welsh, Michael/0000-0002-1646-6206; Zabner, Joseph/0000-0002-9606-1339				Arcasoy SM, 1997, AM J RESP CELL MOL, V17, P422, DOI 10.1165/ajrcmb.17.4.2714; Azizi F, 1997, EXP LUNG RES, V23, P257, DOI 10.3109/01902149709087371; BAI M, 1993, J VIROL, V67, P5198, DOI 10.1128/JVI.67.9.5198-5205.1993; BASAK S, 1989, J VIROL, V63, P3164, DOI 10.1128/JVI.63.7.3164-3167.1989; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; BHAT M, 1993, PHARMACEUT RES, V10, P991, DOI 10.1023/A:1018906504944; BLAU DM, 1995, VIROLOGY, V210, P91, DOI 10.1006/viro.1995.1320; CLAYSON ET, 1988, MOL CELL BIOL, V8, P3391, DOI 10.1128/MCB.8.8.3391; DEFER C, 1990, J VIROL, V64, P3661, DOI 10.1128/JVI.64.8.3661-3673.1990; Douglas JT, 1996, NAT BIOTECHNOL, V14, P1574, DOI 10.1038/nbt1196-1574; Flotte TR, 1998, GENE THER, V5, P166, DOI 10.1038/sj.gt.3300579; Gall J, 1996, J VIROL, V70, P2116, DOI 10.1128/JVI.70.4.2116-2123.1996; Ginsberg HS, 1984, ADENOVIRUSES; Goldman M, 1996, GENE THER, V3, P811; GOLDMAN MJ, 1995, J VIROL, V69, P5951, DOI 10.1128/JVI.69.10.5951-5958.1995; Greber UF, 1997, EMBO J, V16, P5998, DOI 10.1093/emboj/16.19.5998; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Greber Urs F., 1994, Trends in Microbiology, V2, P52, DOI 10.1016/0966-842X(94)90126-0; GRUBB BR, 1994, NATURE, V371, P802, DOI 10.1038/371802a0; HAY JG, 1995, HUM GENE THER, V6, P1487, DOI 10.1089/hum.1995.6.11-1487; Hong SS, 1997, EMBO J, V16, P2294, DOI 10.1093/emboj/16.9.2294; KNOWLES MR, 1995, NEW ENGL J MED, V333, P823, DOI 10.1056/NEJM199509283331302; KONDO M, 1991, AM J PHYSIOL, V261, pL106, DOI 10.1152/ajplung.1991.261.2.L106; Krasnykh VN, 1996, J VIROL, V70, P6839, DOI 10.1128/JVI.70.10.6839-6846.1996; Leopold PL, 1998, HUM GENE THER, V9, P367, DOI 10.1089/hum.1998.9.3-367; Lin XQ, 1997, AM J VET RES, V58, P1120; MARTINEZPALOMO A, 1980, J CELL BIOL, V87, P736, DOI 10.1083/jcb.87.3.736; MATHIAS P, 1994, J VIROL, V68, P6811, DOI 10.1128/JVI.68.10.6811-6814.1994; Mayr GA, 1997, J VIROL, V71, P412, DOI 10.1128/JVI.71.1.412-418.1997; MCCRAY PB, 1997, CELL VISION, V4, P42; PERSSON R, 1985, J VIROL, V54, P92, DOI 10.1128/JVI.54.1.92-97.1985; PERSSON R, 1983, J VIROL, V46, P956, DOI 10.1128/JVI.46.3.956-963.1983; Pickles RJ, 1998, J VIROL, V72, P6014, DOI 10.1128/JVI.72.7.6014-6023.1998; Pickles RJ, 1996, HUM GENE THER, V7, P921, DOI 10.1089/hum.1996.7.8-921; PRINCE GA, 1993, J VIROL, V67, P101, DOI 10.1128/JVI.67.1.101-111.1993; RICH DP, 1993, HUM GENE THER, V4, P461, DOI 10.1089/hum.1993.4.4-461; Roelvink PW, 1996, J VIROL, V70, P7614, DOI 10.1128/JVI.70.11.7614-7621.1996; ROSSEN JWA, 1995, VIROLOGY, V210, P54, DOI 10.1006/viro.1995.1316; ROSSEN JWA, 1994, J VIROL, V68, P7966, DOI 10.1128/JVI.68.12.7966-7973.1994; Schultze B, 1996, J GEN VIROL, V77, P2507, DOI 10.1099/0022-1317-77-10-2507; Schultze B, 1995, Adv Exp Med Biol, V380, P375; SETH P, 1984, J BIOL CHEM, V259, P4350; SETH P, 1994, J VIROL, V68, P933, DOI 10.1128/JVI.68.2.933-940.1994; Stevenson SC, 1997, J VIROL, V71, P4782, DOI 10.1128/JVI.71.6.4782-4790.1997; SVENSSON L, 1991, J VIROL, V65, P4190, DOI 10.1128/JVI.65.8.4190-4197.1991; SVENSSON U, 1985, J VIROL, V55, P442, DOI 10.1128/JVI.55.2.442-449.1985; Topp KS, 1997, EXP EYE RES, V64, P343, DOI 10.1006/exer.1996.0209; WELSH MJ, 1995, HUM GENE THER, V6, P205, DOI 10.1089/hum.1995.6.2-205; WICKHAM TJ, 1994, J CELL BIOL, V127, P257, DOI 10.1083/jcb.127.1.257; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; YAMAYA M, 1992, AM J PHYSIOL, V262, pL713, DOI 10.1152/ajplung.1992.262.6.L713; Zabner J, 1996, GENE THER, V3, P458; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1; Zabner J, 1996, J CLIN INVEST, V97, P1504, DOI 10.1172/JCI118573; Zabner J, 1997, J CLIN INVEST, V100, P1144, DOI 10.1172/JCI119625; Zabner J, 1996, J VIROL, V70, P6994, DOI 10.1128/JVI.70.10.6994-7003.1996; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	57	286	308	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	1999	274	15					10219	10226		10.1074/jbc.274.15.10219	http://dx.doi.org/10.1074/jbc.274.15.10219			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	185HT	10187807	hybrid			2022-12-27	WOS:000079663500046
J	Khoo, KH; Jarboe, E; Barker, A; Torrelles, J; Kuo, CW; Chatterjee, D				Khoo, KH; Jarboe, E; Barker, A; Torrelles, J; Kuo, CW; Chatterjee, D			Altered expression profile of the surface glycopeptidolipids in drug-resistant clinical isolates of Mycobacterium avium complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROUGH VARIANTS; CELL-WALL; ARABINAN BIOSYNTHESIS; INTRACELLULARE; ETHAMBUTOL; ANTIGENS; AIDS; LIPOARABINOMANNAN; GLYCOLIPIDS; LIPIDS	Members of the Mycobacterium avium complex are the most frequently encountered opportunistic bacterial pathogens among patients in the advanced stage of AIDS. Two clinical isolates of the same strain, numbers 397 and 417, were obtained from an AIDS patient with disseminated M. avium complex infection before and after treatment with a regimen of clarithromycin and ethambutol, To identify the biochemical consequence of drug treatment, the expression and chemical composition of their major cell wall constituents, the arabinogalactan, lipoarabinomannan, and the surface glycopeptidolipids (GPL), were critically examined. Through thin layer chromatography, mass spectrometry, and chemical analysis, it was found that the GPL expression profiles differ significantly in that several apolar GPLs were overexpressed in the clinically resistant 417 isolate at the expense of the serotype 1 polar GPL, which was the single predominant band in the ethambutol-susceptible 397 isolate. Thus, instead of additional rhamnosylation on the 6-deoxytalose (6-dTal) appendage to give the serotype 1-specific disaccharide hapten, the accumulation of this nonextended apolar GPL probably provided more precursor substrate available for further nonsaccharide substitutions including a higher degree of O-methylation to give 3-O-Me-6-dTal and the unusual 4-O-sulfation on 6-dTal. Further data showed that this alteration effectively neutralized ethambutol, which is known to inhibit arabinan synthesis. Thus, in contrast with derived Emb-resistant mutants of Mycobacterium smegmatis or Mycobacterium tuberculosis, which are devoid of a surface GPL layer, the lipoarabinomannan from resistant 417 isolate grown in the presence of this drug was not apparently truncated.	Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA; Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan	Colorado State University; Academia Sinica - Taiwan	Chatterjee, D (corresponding author), Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA.	delphi@lamar.colostate.edu	Torrelles, Jordi/E-4204-2011; Khoo, Kay-Hooi/E-1989-2019	Khoo, Kay-Hooi/0000-0003-2906-406X	FOGARTY INTERNATIONAL CENTER [R03TW000943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041925, R21AI037139, R01AI037139] Funding Source: NIH RePORTER; FIC NIH HHS [TW 00943] Funding Source: Medline; NIAID NIH HHS [AI-37139, AI 41925] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aspinall GO, 1995, ADV CARBOHYD CHEM BI, V51, P169, DOI 10.1016/S0065-2318(08)60194-8; BARROW WW, 1993, INFECT IMMUN, V61, P5286, DOI 10.1128/IAI.61.12.5286-5293.1993; BARROW WW, 1982, J BACTERIOL, V150, P381, DOI 10.1128/JB.150.1.381-384.1982; BARROW WW, 1995, INFECT IMMUN, V63, P126, DOI 10.1128/IAI.63.1.126-133.1995; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; BELISLE JT, 1994, RES MICROBIOL, V145, P237, DOI 10.1016/0923-2508(94)90024-8; BELISLE JT, 1991, J BACTERIOL, V173, P6991, DOI 10.1128/jb.173.21.6991-6997.1991; BRENNAN PJ, 1979, J BIOL CHEM, V254, P4205; Brennan PJ, 1988, MICROBIAL LIPIDS, V1, P203; BROWNBACK PE, 1988, INFECT IMMUN, V56, P1044, DOI 10.1128/IAI.56.5.1044-1050.1988; CHAISSON RE, 1994, ANN INTERN MED, V121, P905, DOI 10.7326/0003-4819-121-12-199412150-00001; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; Chatterjee D, 1997, CURR OPIN CHEM BIOL, V1, P579, DOI 10.1016/S1367-5931(97)80055-5; CHIU J, 1990, ANN INTERN MED, V113, P358, DOI 10.7326/0003-4819-113-5-358; Chopra I, 1998, TUBERCLE LUNG DIS, V78, P89, DOI 10.1016/S0962-8479(98)80001-4; Eckstein TM, 1998, J BACTERIOL, V180, P5567, DOI 10.1128/JB.180.21.5567-5573.1998; Frehel C, 1989, Acta Leprol, V7 Suppl 1, P160; FREHEL C, 1986, ANN INST PASTEUR MIC, V137B, P239, DOI 10.1016/S0769-2609(86)80115-6; Jarboe E, 1998, DIAGN MICR INFEC DIS, V30, P197, DOI 10.1016/S0732-8893(97)00241-1; KAJIOKA R, 1978, SCAND J RESPIR DIS, V59, P91; Khoo KH, 1996, J BIOL CHEM, V271, P28682, DOI 10.1074/jbc.271.45.28682; Khoo KH, 1996, J BIOL CHEM, V271, P12333, DOI 10.1074/jbc.271.21.12333; KORVICK JA, 1996, MYCOBACTERIUM AVIUM, P241; MARIN LML, 1992, BIOCHEMISTRY-US, V31, P11106, DOI 10.1021/bi00160a021; MCNEIL M, 1989, METHOD ENZYMOL, V179, P215; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; MOEHRING JM, 1965, AM REV RESPIR DIS, V92, P704; RASTOGI N, 1989, ZBL BAKT-INT J MED M, V270, P345; RASTOGI N, 1981, ANTIMICROB AGENTS CH, V20, P666, DOI 10.1128/AAC.20.5.666; SCHAEFER WB, 1970, AM REV RESPIR DIS, V102, P499; SLUTSKY AM, 1994, J CLIN MICROBIOL, V32, P1773, DOI 10.1128/JCM.32.7.1773-1778.1994	31	42	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	1999	274	14					9778	9785		10.1074/jbc.274.14.9778	http://dx.doi.org/10.1074/jbc.274.14.9778			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	181PX	10092667	hybrid			2022-12-27	WOS:000079451800086
